data_1cx1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cx1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.6 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 42.2 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.458 -0.571 . . . . 3.0 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 7' ' ' VAL . 19.5 tp10 -35.85 119.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 4.75 109.344 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.19 -31.96 18.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 5.44 109.801 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.47 129.92 24.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 2.86 108.968 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -67.33 59.36 0.69 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.424 2.083 . . . . 4.15 113.343 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.469 ' CE1' ' HA3' ' A' ' 20' ' ' GLY . 36.2 t60 -165.38 126.65 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.007 . . . . 2.52 109.752 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.543 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -170.37 70.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 2.33 109.318 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.458 ' HA ' ' NE2' ' A' ' 145' ' ' GLN . 30.5 t -161.33 82.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 2.28 109.8 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.2 m-30 -90.12 24.84 2.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 2.6 109.243 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.23 17.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 1.66 109.815 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.677 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 19.6 mm-40 -109.67 -49.5 3.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.184 -0.947 . . . . 2.13 109.588 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.8 p -136.39 152.03 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 2.74 109.377 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.736 ' H ' ' CD2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -85.07 26.97 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 3.06 109.191 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.469 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 44.41 -151.64 0.64 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.572 -1.411 . . . . 1.72 109.572 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 67.4 Cg_endo -81.0 9.45 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.748 2.299 . . . . 1.97 112.555 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.789 ' NE1' ' CD2' ' A' ' 55' ' ' TYR . 10.6 m95 -70.94 172.15 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.006 . . . . 2.88 109.275 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.92 177.64 4.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 2.07 109.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.631 ' O ' ' CD1' ' A' ' 24' ' ' LEU . 4.2 pp -178.46 123.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 2.79 109.349 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.593 ' C ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.2 169.12 2.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 2.48 110.305 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 -26.54 22.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.098 -1.201 . . . . 1.7 110.098 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.799 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.9 -142.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.276 . . . . 1.51 109.394 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.799 ' N ' ' OG1' ' A' ' 27' ' ' THR . 67.0 p -91.14 132.56 35.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.251 -0.906 . . . . 2.11 109.236 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -36.83 101.75 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 2.85 109.234 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.527 ' CB ' ' SD ' ' A' ' 37' ' ' MET . 50.3 Cg_exo -48.16 159.06 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.303 2.002 . . . . 1.4 111.551 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.11 114.35 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.937 -1.102 . . . . 1.53 110.659 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.677 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -74.05 79.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.049 -0.722 . . . . 2.56 109.049 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.26 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.519 -0.738 . . . . 1.81 109.872 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 33' ' ' ALA . 69.0 m-20 -35.65 -70.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 2.21 109.441 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.88 33.12 1.28 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.626 -1.39 . . . . 1.23 109.626 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -153.35 150.6 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 3.37 109.664 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.527 ' SD ' ' CB ' ' A' ' 30' ' ' PRO . 33.7 ttp -109.05 132.23 54.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 1.4 109.769 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 58.4 m -124.02 156.25 36.82 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.675 -0.81 . . . . 1.06 110.211 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.9 m -131.47 129.58 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.684 -0.858 . . . . 1.95 108.684 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.638 ' N ' ' OG ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -73.65 109.39 7.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 4.79 109.622 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.2 mm? -118.19 35.01 0.21 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.155 -0.965 . . . . 3.97 110.897 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 98.6 Cg_endo -81.87 -24.02 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.521 2.148 . . . . 4.21 111.738 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 42' ' ' PRO . . . -26.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.076 -0.81 . . . . 2.09 111.076 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.36 54.61 0.01 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.42 -1.872 . . . . 2.62 108.42 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 136' ' ' ALA . 20.7 mt-30 -99.7 111.92 24.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 2.96 109.97 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -81.74 55.26 4.88 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.46 -1.456 . . . . 2.38 109.46 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.642 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -166.87 96.34 0.69 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 4.04 109.427 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 50' ' ' ASP . 56.1 Cg_exo -47.77 -40.46 31.6 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 2.75 112.494 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.458 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 19.3 p90 -62.95 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 4.57 109.413 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -133.16 -57.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 2.38 109.659 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.1 146.36 47.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 1.47 109.728 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 133' ' ' LEU . . . 163.35 175.72 34.61 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.615 -1.278 . . . . 0.96 110.359 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.652 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 2.1 mm? -100.36 167.91 10.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.617 -0.931 . . . . 1.51 108.736 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -154.47 155.4 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 1.51 109.875 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.789 ' CD2' ' NE1' ' A' ' 22' ' ' TRP . 30.1 t80 -177.75 148.91 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 2.45 109.436 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.64 168.14 9.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 2.95 109.568 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' CG1' ' A' ' 58' ' ' VAL . . . 101.47 81.72 1.6 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 2.52 109.604 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.754 ' CG2' ' H ' ' A' ' 128' ' ' GLN . 5.9 m -163.21 59.76 0.87 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 4.19 109.39 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 56.9 Cg_exo -47.0 149.85 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.881 2.388 . . . . 2.79 112.274 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 1.6 t -144.62 121.74 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 3.62 109.522 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -96.81 94.89 1.67 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.493 -1.443 . . . . 3.37 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.534 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 13.6 tt0 -38.46 117.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 6.05 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 128.2 -35.82 2.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.664 -1.374 . . . . 3.09 109.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' OG ' ' A' ' 115' ' ' SER . 28.2 mt-10 -99.91 172.33 7.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.234 -1.156 . . . . 4.03 109.5 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -113.78 137.5 51.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 3.28 109.482 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' A' ' 60' ' ' VAL . 37.1 m-85 -105.72 -178.78 3.75 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.21 -0.932 . . . . 2.59 109.463 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -150.91 140.38 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 3.18 109.917 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.73 120.41 38.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 4.0 109.01 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.68 89.89 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 2.8 109.44 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.4 137.01 33.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 2.64 110.675 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.555 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.06 105.63 17.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 2.25 109.058 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.553 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -175.28 169.82 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.828 -1.17 . . . . 1.45 110.677 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.43 159.82 41.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.042 -0.725 . . . . 1.28 109.042 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -102.91 137.56 40.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 1.07 109.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.52 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.44 112.54 6.57 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.258 -0.901 . . . . 1.68 109.639 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.3 Cg_exo -63.87 -141.72 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.633 0 C-N-CA 124.218 -1.159 . . . . 1.32 112.439 -0.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' OD1' ' OG1' ' A' ' 103' ' ' THR . 0.6 OUTLIER -104.94 151.03 24.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 1.75 110.023 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' O ' ' A' ' 137' ' ' GLY . 1.7 mtm 166.25 163.5 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.817 -0.809 . . . . 2.72 108.817 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -83.95 153.9 13.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.744 2.296 . . . . 1.83 112.591 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.73 ' CG1' ' HH ' ' A' ' 139' ' ' TYR . 17.5 m -128.5 -166.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 2.57 109.253 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 132' ' ' HIS . 57.0 ttt180 -136.65 141.61 43.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.067 -1.02 . . . . 6.46 109.836 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.97 149.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 4.19 109.259 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' CD1' ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -142.79 149.22 38.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 2.9 109.876 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.575 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.3 t -151.4 146.09 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 2.31 109.696 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.86 -142.0 7.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 1.75 109.476 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 22.8 pt-20 -90.07 -158.78 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -1.193 . . . . 2.54 109.471 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 1.77 109.518 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.48 -0.563 . . . . 6.42 109.48 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -115.86 169.92 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 2.66 109.921 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.9 -23.34 11.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.647 -0.871 . . . . 3.93 108.647 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.799 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.97 34.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 4.15 109.123 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.59 104.74 17.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 4.6 109.64 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.26 176.48 8.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 3.96 109.515 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.47 14.11 0.61 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.643 -1.383 . . . . 3.67 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -112.33 60.84 0.63 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -1.182 . . . . 3.79 109.546 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.52 101.93 30.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 2.22 109.083 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.462 ' HD2' ' HH ' ' A' ' 111' ' ' TYR . 59.3 Cg_endo -78.32 131.97 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.539 2.159 . . . . 3.49 112.593 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.08 134.48 23.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 3.46 109.264 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.638 ' C ' ' H ' ' A' ' 105' ' ' GLU . 9.0 t -138.32 -161.63 1.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 2.83 109.523 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.433 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -62.6 37.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.445 -1.462 . . . . 2.83 109.445 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.638 ' H ' ' C ' ' A' ' 103' ' ' THR . 13.8 tp10 -112.25 93.1 20.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 3.02 109.359 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.53 118.18 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.715 2.277 . . . . 1.42 112.177 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 173.96 -175.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 1.81 109.48 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.4 118.82 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 2.19 110.283 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.727 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -93.26 137.13 32.87 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.356 -1.35 . . . . 5.23 107.356 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.44 118.58 37.14 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.441 -0.787 . . . . 3.28 109.666 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.462 ' HH ' ' HD2' ' A' ' 101' ' ' PRO . 4.2 m-30 -107.94 109.92 21.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.036 -1.098 . . . . 3.78 108.036 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.27 45.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 3.99 110.066 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.799 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -133.57 166.88 21.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 3.1 109.176 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.13 126.47 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.228 -0.92 . . . . 2.65 109.866 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.9 m -69.25 122.78 19.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 4.28 109.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.534 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -117.67 -9.98 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 7.59 109.54 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 118' ' ' THR . 13.1 tp -141.49 124.2 16.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 5.5 109.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.45 ' N ' HD12 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -63.92 144.74 56.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 4.48 109.498 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 32.9 m-85 -142.88 92.22 7.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 5.99 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.35 165.81 20.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.76 2.307 . . . . 4.64 112.215 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.99 -17.93 10.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.766 2.31 . . . . 4.46 112.007 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.99 132.29 54.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 4.14 109.509 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 133.44 50.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.523 -1.431 . . . . 4.24 109.523 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 123' ' ' GLY . 1.3 t70 37.92 22.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -1.132 . . . . 3.59 109.48 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -151.77 72.07 8.05 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 2.78 109.397 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.22 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.791 2.327 . . . . 1.57 112.233 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.452 ' HA3' ' H ' ' A' ' 57' ' ' GLY . . . -72.92 157.07 52.24 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.631 -1.388 . . . . 1.25 109.631 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.754 ' H ' ' CG2' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -150.77 140.44 21.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -1.131 . . . . 2.18 109.587 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.591 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 4.5 p -161.53 112.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 1.87 108.828 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.74 112.22 17.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 1.45 110.12 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -71.8 113.79 9.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.646 -0.872 . . . . 2.4 108.646 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' ARG . 1.6 m170 -99.66 100.69 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.199 -0.938 . . . . 2.98 109.828 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.416 ' CD1' ' HA2' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -109.72 -21.34 12.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 2.61 109.075 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.626 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -47.19 139.81 8.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.166 -1.573 . . . . 2.32 109.166 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 138' ' ' ALA . 1.0 OUTLIER 179.54 129.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.108 . . . . 5.66 109.234 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.01 -22.76 0.65 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.618 -1.253 . . . . 2.71 107.618 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.642 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -105.24 7.11 43.3 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.466 -1.854 . . . . 3.14 108.466 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -51.82 -145.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.803 -0.822 . . . . 2.84 110.285 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.73 ' HH ' ' CG1' ' A' ' 80' ' ' VAL . 0.0 OUTLIER 171.89 -112.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 2.44 110.024 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.14 136.04 45.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 1.86 109.061 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.553 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 52.9 t80 -122.7 116.71 24.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 2.48 109.816 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.495 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 12.4 m -106.75 114.29 28.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -0.907 . . . . 0.74 109.561 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -119.97 141.2 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 1.69 109.471 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.677 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 2.0 p -127.72 -17.21 4.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.163 -0.68 . . . . 1.63 109.163 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.677 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -152.28 159.28 43.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.379 -0.825 . . . . 3.82 109.378 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.9 p -165.94 126.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 2.92 109.429 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.51 ' OG ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -167.21 146.39 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 3.25 109.428 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.26 146.39 37.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 5.12 109.511 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.756 ' HG1' ' H ' ' A' ' 150' ' ' THR . 2.1 t -133.57 -157.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -0.876 . . . . 3.35 109.483 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.756 ' H ' ' HG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 2.29 109.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.467 -0.568 . . . . 3.0 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -141.15 64.39 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 4.75 109.507 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER -79.95 16.46 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.925 . . . . 5.44 109.403 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.697 ' O ' ' N ' ' A' ' 12' ' ' HIS . 1.2 tt -118.08 82.33 17.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.143 -1.058 . . . . 2.86 108.143 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.551 ' C ' ' OH ' ' A' ' 55' ' ' TYR . 36.7 Cg_exo -53.02 36.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.099 2.533 . . . . 4.15 113.285 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.697 ' N ' ' O ' ' A' ' 10' ' ' LEU . 38.8 t60 -170.34 138.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.995 -1.066 . . . . 2.52 109.579 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.517 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.35 70.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 2.33 109.592 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -169.84 77.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.974 . . . . 2.28 109.903 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.15 22.13 3.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 2.6 109.031 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.09 -25.0 20.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 1.66 109.883 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 16.7 mm-40 -109.7 -58.92 1.99 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.048 -1.032 . . . . 2.13 109.663 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 m -142.84 143.46 32.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.868 . . . . 2.74 109.503 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.764 ' H ' ' CD2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -46.69 -34.23 4.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 3.06 109.137 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 79.99 -164.01 47.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.586 -1.406 . . . . 1.72 109.586 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 22' ' ' TRP . 34.8 Cg_exo -53.83 -21.52 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.841 2.36 . . . . 1.97 112.326 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CD1' ' CD1' ' A' ' 55' ' ' TYR . 4.3 m95 -53.05 -167.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.88 109.356 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 161.9 39.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 2.07 109.391 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD11 ' CG ' ' A' ' 30' ' ' PRO . 2.2 pp -160.08 137.88 9.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 2.79 109.688 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 2.48 109.331 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 110.14 -28.58 10.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.84 -1.304 . . . . 1.7 109.84 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.784 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.9 -142.7 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.296 . . . . 1.51 109.454 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.784 ' N ' ' OG1' ' A' ' 27' ' ' THR . 3.6 p -91.62 -165.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 2.11 109.313 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.17 111.86 49.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 2.85 109.003 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' CG ' HD11 ' A' ' 24' ' ' LEU . 78.5 Cg_exo -44.21 154.76 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.216 1.944 . . . . 1.4 111.981 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 37' ' ' MET . 23.7 t -139.43 100.35 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.971 . . . . 1.53 110.21 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.71 82.58 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.65 0.738 . . . . 2.56 109.179 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.78 -114.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.76 . . . . 1.81 110.023 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' HB2' HH11 ' A' ' 36' ' ' ARG . 2.1 m-20 -58.35 66.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 2.21 109.759 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 59.27 6.19 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 1.23 109.562 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.653 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.45 141.84 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.216 . . . . 3.37 109.424 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -113.8 123.55 50.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.369 -0.832 . . . . 1.4 109.031 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.547 ' SG ' ' C ' ' A' ' 141' ' ' PHE . 4.5 t -128.15 153.2 47.13 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.272 -0.971 . . . . 1.06 110.559 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.15 120.02 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.548 -0.908 . . . . 1.95 108.548 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.8 OUTLIER -77.39 117.44 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 4.79 109.469 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 137' ' ' GLY . 4.5 mm? -114.6 94.45 36.76 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.257 -0.902 . . . . 3.97 109.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.36 -43.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.223 2.615 . . . . 4.21 111.984 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.77 141.47 3.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.397 -1.481 . . . . 2.09 109.397 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.19 -0.43 1.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.999 -1.24 . . . . 2.62 109.999 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.577 ' OE1' ' O ' ' A' ' 50' ' ' ASP . 5.6 mm-40 -99.17 -160.92 0.83 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.127 -1.22 . . . . 2.96 109.428 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.43 -57.74 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 2.38 109.842 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.68 ' OD1' ' CD1' ' A' ' 49' ' ' TRP . 3.5 p30 -99.76 150.94 37.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.224 -1.162 . . . . 4.04 109.58 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' ASP . 84.8 Cg_exo -40.18 -55.41 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.875 2.383 . . . . 2.75 112.343 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.68 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 2.1 p90 -70.63 47.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 4.57 109.463 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 47' ' ' ASN . 67.8 m-20 -116.11 -8.51 11.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 2.38 109.709 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.8 116.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.952 . . . . 1.47 109.564 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.501 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 174.3 166.99 33.18 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.68 -1.248 . . . . 0.96 110.186 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.97 -169.48 1.62 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -1.093 . . . . 1.51 109.421 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -159.64 162.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 1.51 109.805 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.791 ' CD1' ' CD1' ' A' ' 22' ' ' TRP . 20.1 t80 -176.82 140.4 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.821 . . . . 2.45 109.403 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -113.31 -164.19 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.38 -0.825 . . . . 2.95 109.472 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 9' ' ' LEU . . . 86.06 47.07 5.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.504 -1.438 . . . . 2.52 109.504 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.46 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 22.2 t -151.12 75.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 4.19 109.521 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' VAL . 75.7 Cg_exo -44.04 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.906 2.404 . . . . 2.79 112.191 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 119' ' ' PHE . 2.7 t -142.37 120.86 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 3.62 109.595 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -137.93 107.67 0.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.323 -1.511 . . . . 3.37 109.323 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.7 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.3 tm-20 -42.46 172.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 6.05 109.182 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.671 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 80.67 -45.15 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.479 . . . . 3.09 109.404 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -99.56 135.56 40.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 4.03 109.084 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.4 m -99.84 148.78 24.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.168 -0.957 . . . . 3.28 109.763 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -107.92 177.98 4.65 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 2.59 109.583 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -151.39 160.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.489 -0.757 . . . . 3.18 109.468 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 109' ' ' ARG . 10.1 tp -143.69 114.3 7.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 4.0 109.666 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 4.8 p -109.23 83.66 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.966 . . . . 2.8 108.828 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.613 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 24.9 p90 -93.89 132.99 37.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 2.64 111.302 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.563 ' HG1' ' H ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -83.71 98.68 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 2.25 108.445 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -144.97 152.03 39.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.05 . . . . 1.45 110.093 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.7 p -132.95 121.99 23.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.486 -0.759 . . . . 1.28 109.055 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -83.48 132.96 34.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 1.07 109.511 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.468 ' OG1' ' CB ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.62 117.08 16.31 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.323 -0.86 . . . . 1.68 109.242 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.24 -142.46 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 124.256 -1.143 . . . . 1.32 112.227 -0.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -96.58 148.42 22.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 1.75 109.336 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.408 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER 168.27 153.03 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.685 . . . . 2.72 109.29 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.88 117.92 5.1 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.705 2.27 . . . . 1.83 112.001 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.93 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 2.57 109.442 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 132' ' ' HIS . 18.0 ttm180 -114.68 90.29 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 6.46 109.528 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.49 154.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.225 -0.922 . . . . 4.19 108.993 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.44 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -154.25 162.97 40.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.01 . . . . 2.9 110.082 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.577 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -153.62 160.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 2.31 109.358 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.44 -145.07 10.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.667 -1.373 . . . . 1.75 109.667 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.68 ' OE1' ' CZ ' ' A' ' 119' ' ' PHE . 2.9 pt-20 -90.19 163.1 14.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 2.54 109.446 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 1.77 109.49 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.303 0.573 . . . . 6.42 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -125.94 176.91 6.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 2.66 110.03 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.12 -20.98 5.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.841 -0.8 . . . . 3.93 108.841 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.804 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.84 34.04 0.92 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 4.15 109.149 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.5 92.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 4.6 109.888 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.535 ' NE2' ' CD1' ' A' ' 111' ' ' TYR . 4.5 mt-30 -99.77 137.78 37.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 3.96 109.514 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.48 -13.54 2.3 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.652 -1.379 . . . . 3.67 109.652 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.38 80.61 1.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.166 -1.197 . . . . 3.79 109.587 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.17 84.52 14.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 2.22 109.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.95 127.31 18.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.989 2.46 . . . . 3.49 112.614 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -144.94 127.03 15.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.866 . . . . 3.46 109.325 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 1.7 t -91.98 -169.99 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 2.83 109.511 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.17 13.31 67.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 2.83 109.534 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -103.06 152.77 38.6 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 3.02 109.424 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.31 118.3 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.848 2.365 . . . . 1.42 112.2 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.447 ' HB1' ' NH2' ' A' ' 109' ' ' ARG . . . -162.87 146.44 11.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 1.81 109.477 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.499 ' C ' ' HE ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -90.15 132.86 35.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 2.19 109.712 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 68' ' ' LEU . 3.6 mmp_? -101.96 134.11 45.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.91 -1.144 . . . . 5.23 107.91 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -109.69 106.05 15.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.033 -0.667 . . . . 3.28 110.389 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.535 ' CD1' ' NE2' ' A' ' 97' ' ' GLN . 42.1 m-85 -109.74 124.88 52.01 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.312 -0.996 . . . . 3.78 108.312 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.07 163.79 23.0 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 3.99 109.922 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.804 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 4.2 p90 -166.76 -168.2 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 3.1 109.471 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.98 154.01 25.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 2.65 109.458 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -90.24 59.12 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 4.28 109.799 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.516 ' C ' ' O ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -33.62 -40.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 7.59 109.908 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' OG ' ' A' ' 115' ' ' SER . 2.8 mt -109.93 -169.55 1.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 5.5 109.767 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.684 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.7 OUTLIER -129.76 158.85 38.26 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.257 -0.902 . . . . 4.48 109.585 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 49.4 m-85 -166.42 96.53 0.73 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 5.99 109.28 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.81 165.56 24.4 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.591 2.194 . . . . 4.64 112.334 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.51 -13.09 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.951 2.434 . . . . 4.46 112.095 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -109.46 8.49 25.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 4.14 109.535 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . -96.87 174.02 29.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.495 -1.442 . . . . 4.24 109.495 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.15 34.61 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 3.59 109.482 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 123' ' ' GLY . . . 179.87 87.8 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 2.78 109.424 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.38 -160.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.784 2.323 . . . . 1.57 112.328 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.565 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -64.62 154.6 48.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.556 -1.418 . . . . 1.25 109.556 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.44 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -149.7 140.74 22.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -1.153 . . . . 2.18 109.633 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 23.7 t -144.78 144.15 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 1.87 108.454 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.61 114.33 2.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.98 -1.075 . . . . 1.45 110.015 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.5 m-30 -94.66 88.2 5.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.425 -0.797 . . . . 2.4 109.263 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 27.9 m170 -99.42 137.64 37.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.955 . . . . 2.98 109.747 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 134' ' ' GLY . 0.2 OUTLIER -129.36 52.54 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.61 109.536 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . . . -40.01 123.73 2.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.902 -1.279 . . . . 2.32 109.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' A' ' 138' ' ' ALA . 2.2 mptp? -167.5 44.81 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.711 -0.876 . . . . 5.66 108.831 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . 40.97 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.412 -1.329 . . . . 2.71 107.412 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . 69.87 28.38 71.99 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.779 -1.728 . . . . 3.14 108.779 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.695 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -91.7 56.55 3.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -1.203 . . . . 2.84 110.377 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CE1' ' HB2' ' A' ' 135' ' ' LYS . 10.6 p90 -177.11 -153.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.838 -1.164 . . . . 2.44 110.459 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.468 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 1.0 OUTLIER -159.3 157.35 30.34 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.696 -0.853 . . . . 1.86 108.696 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.547 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 13.0 t80 -135.28 103.17 5.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.041 -1.037 . . . . 2.48 110.07 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.7 m -106.44 110.6 22.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.74 110.169 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.494 HG12 ' N ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -138.97 146.22 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 1.69 109.505 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 143' ' ' ILE . 3.6 p -136.31 -4.55 2.11 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.355 -0.538 . . . . 1.63 109.688 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.563 ' H ' ' HG1' ' A' ' 71' ' ' THR . 2.3 mt-30 -140.83 151.27 44.22 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.272 -0.971 . . . . 3.82 110.073 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.44 HG21 ' CH2' ' A' ' 22' ' ' TRP . 13.0 p -163.08 122.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -0.845 . . . . 2.92 109.507 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.96 139.69 23.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 3.25 109.637 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.591 ' CD1' ' C ' ' A' ' 148' ' ' LEU . 0.6 OUTLIER -113.17 149.47 33.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 5.12 109.403 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.654 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER -167.7 -163.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 3.35 109.531 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.654 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 2.29 109.346 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.667 ' N ' ' HG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.492 -0.559 . . . . 3.0 109.492 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.535 ' CD ' ' O ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -96.81 126.29 41.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 4.75 109.486 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.418 HD13 ' CG ' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -84.06 -13.82 52.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.153 -0.967 . . . . 5.44 109.596 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.563 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -119.89 83.37 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 2.86 108.692 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.28 34.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.025 2.484 . . . . 4.15 111.87 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.563 ' H ' HD13 ' A' ' 10' ' ' LEU . 44.3 t60 -134.78 99.03 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.425 -0.797 . . . . 2.52 109.475 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.545 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -137.58 54.97 1.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 2.33 109.333 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.647 ' O ' ' N ' ' A' ' 16' ' ' ALA . 22.7 t -159.61 83.3 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 2.28 109.675 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -63.43 50.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 2.6 108.868 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -55.52 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 1.66 110.13 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -109.88 39.37 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 2.13 109.851 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.6 153.3 2.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.145 -0.972 . . . . 2.74 109.699 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.698 ' CD1' ' H ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 3.06 109.563 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' N ' HD21 ' A' ' 19' ' ' LEU . . . 76.61 174.16 38.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.781 -1.328 . . . . 1.72 109.781 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.23 -16.37 4.72 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.694 2.263 . . . . 1.97 112.039 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 14.3 m95 -68.15 160.98 27.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 2.88 109.08 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -109.68 148.24 31.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.009 . . . . 2.07 109.642 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -135.35 129.58 33.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 2.79 109.51 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.619 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.27 159.63 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 2.48 109.573 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.9 -32.34 7.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.042 -1.223 . . . . 1.7 110.042 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.754 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.7 -141.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.105 -1.232 . . . . 1.51 109.662 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.754 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.1 p -91.09 132.39 36.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 2.11 109.316 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 tt0 -36.88 102.56 0.24 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 2.85 109.072 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' SER . 50.0 Cg_exo -46.54 152.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.296 1.997 . . . . 1.4 111.689 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 81.6 t -137.74 115.25 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 1.53 110.241 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.61 90.88 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.573 -0.704 . . . . 2.56 109.75 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.53 -112.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 1.81 109.664 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' HB2' HH11 ' A' ' 36' ' ' ARG . 0.2 OUTLIER -59.43 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 2.21 109.626 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 60.0 5.03 3.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 1.23 109.552 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.627 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -123.04 148.39 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -1.145 . . . . 3.37 109.531 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.625 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.5 OUTLIER -114.39 132.39 56.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 1.4 109.713 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.17 153.01 40.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 1.06 109.676 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' HB ' ' HG1' ' A' ' 27' ' ' THR . 1.3 m -126.07 137.88 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.905 -0.776 . . . . 1.95 108.905 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.701 ' H ' ' HG ' ' A' ' 28' ' ' SER . 17.6 m-20 -73.0 110.14 7.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 4.79 109.475 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 139' ' ' TYR . 4.2 mm? -117.81 75.02 9.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 3.97 109.556 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.01 -157.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.767 2.311 . . . . 4.21 112.195 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.47 130.12 9.68 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 2.09 109.548 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.99 35.81 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.532 -1.427 . . . . 2.62 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.593 HE22 ' CB ' ' A' ' 50' ' ' ASP . 3.3 mm-40 -99.93 106.1 17.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -1.122 . . . . 2.96 109.491 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.2 14.42 1.25 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.659 -1.376 . . . . 2.38 109.659 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.751 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -179.91 151.04 0.57 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.195 -1.179 . . . . 4.04 109.519 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 50' ' ' ASP . 44.5 Cg_endo -71.8 -54.16 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.853 2.369 . . . . 2.75 112.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.447 ' CE3' ' HG2' ' A' ' 48' ' ' PRO . 11.1 p90 -62.88 45.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 4.57 109.384 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -135.48 39.75 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 2.38 109.353 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.594 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 156.92 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 1.47 109.528 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.83 170.08 20.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.644 -1.382 . . . . 0.96 109.644 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.7 pp -108.58 142.82 38.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -1.113 . . . . 1.51 109.422 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.0 174.79 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 1.51 109.896 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.684 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 48.8 t80 179.11 144.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 2.45 109.527 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.684 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -99.72 -164.84 1.16 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 2.95 109.463 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.91 66.95 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.602 -1.399 . . . . 2.52 109.602 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.738 ' CG1' ' H ' ' A' ' 128' ' ' GLN . 8.9 p -151.85 73.68 7.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.253 -1.145 . . . . 4.19 109.466 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.418 ' CG ' HD13 ' A' ' 9' ' ' LEU . 58.2 Cg_endo -76.14 157.91 37.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.873 2.382 . . . . 2.79 112.364 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.465 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 3.4 t -148.83 102.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 3.62 109.386 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -73.72 119.87 6.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.595 -1.402 . . . . 3.37 109.595 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.539 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 15.7 tt0 -58.63 125.37 23.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.136 . . . . 6.05 109.53 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 132.85 -47.56 1.0 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.679 -1.368 . . . . 3.09 109.679 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.575 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.8 mt-10 -99.8 166.89 10.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -1.15 . . . . 4.03 109.594 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.46 134.32 49.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 3.28 109.434 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.465 ' CE1' ' HA ' ' A' ' 60' ' ' VAL . 38.1 m-85 -97.22 -179.09 4.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 2.59 109.499 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -154.71 139.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 3.18 109.576 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.3 tp -120.88 118.17 29.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 4.0 109.416 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.04 83.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.577 -0.898 . . . . 2.8 108.577 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 28.0 p90 -93.73 143.14 26.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.855 . . . . 2.64 111.358 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.784 ' HG1' ' N ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -89.33 130.59 35.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.488 -0.93 . . . . 2.25 108.488 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.787 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -170.29 135.19 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.891 -1.13 . . . . 1.45 110.254 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.9 p -119.82 122.91 42.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.821 . . . . 1.28 108.946 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.566 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -85.57 125.74 33.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 1.07 109.565 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -138.76 113.63 8.5 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.271 -0.893 . . . . 1.68 109.75 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.3 Cg_exo -64.54 -141.81 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.624 0 C-N-CA 124.349 -1.104 . . . . 1.32 112.276 -0.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -99.17 151.03 21.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 1.75 109.825 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.511 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.35 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.861 -0.792 . . . . 2.72 108.861 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.12 168.94 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.829 2.353 . . . . 1.83 112.86 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.531 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 2.9 m -137.21 170.85 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 2.57 109.128 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.622 HH11 ' CB ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -116.4 105.52 12.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 6.46 109.771 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.87 159.43 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.261 -0.9 . . . . 4.19 109.219 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.69 149.65 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 2.9 109.834 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.576 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -149.13 155.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 2.31 109.701 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.96 -133.27 5.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.563 -1.415 . . . . 1.75 109.563 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.4 pm0 -90.08 -179.07 5.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 2.54 109.384 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 1.77 109.546 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.557 ' O ' ' CE1' ' A' ' 119' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.299 0.571 . . . . 6.42 110.011 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.44 161.03 13.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.287 -0.883 . . . . 2.66 110.081 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -119.91 -14.14 8.97 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.733 -0.84 . . . . 3.93 108.733 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.755 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.56 36.03 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.381 -0.825 . . . . 4.15 108.916 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -80.67 70.99 7.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 4.6 109.624 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.86 111.01 23.35 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 3.96 108.851 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.13 13.27 55.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 3.67 109.711 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.92 67.52 0.78 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.174 -1.192 . . . . 3.79 109.824 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.32 99.76 29.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.074 -1.016 . . . . 2.22 109.288 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.83 135.99 11.69 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.606 2.204 . . . . 3.49 112.673 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.465 HD21 ' NE ' ' A' ' 109' ' ' ARG . 94.2 mt -142.15 131.11 23.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 3.46 109.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.8 t -92.41 -165.56 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 2.83 109.491 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.19 33.9 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.499 -1.44 . . . . 2.83 109.499 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -121.53 138.48 28.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.248 -1.148 . . . . 3.02 109.433 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.27 120.5 6.01 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.593 2.195 . . . . 1.42 112.069 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.678 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -171.03 160.43 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 1.81 109.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 149.07 22.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 2.19 109.687 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.787 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -114.3 136.43 52.98 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.745 -1.206 . . . . 5.23 107.745 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -114.34 107.94 16.24 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.848 -0.741 . . . . 3.28 110.706 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 8.0 m-85 -109.77 115.98 30.84 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.374 -0.972 . . . . 3.78 108.374 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.71 142.63 32.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.831 . . . . 3.99 109.712 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.92 163.94 26.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 3.1 109.413 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.5 109.34 21.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 2.65 109.798 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.7 m -56.23 105.66 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.287 -0.883 . . . . 4.28 109.193 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.697 ' H ' ' ND2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -108.8 -10.31 15.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 7.59 109.616 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.48 ' O ' ' CD2' ' A' ' 119' ' ' PHE . 0.9 OUTLIER -136.59 126.5 25.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 5.5 109.531 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.64 117.72 5.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 4.48 109.372 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.557 ' CE1' ' O ' ' A' ' 92' ' ' ARG . 57.9 m-85 -120.78 66.74 13.9 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 5.99 109.588 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.78 166.58 27.15 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.783 2.322 . . . . 4.64 112.154 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -79.87 -13.2 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.853 2.369 . . . . 4.46 112.003 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -109.57 -12.71 14.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.331 -0.855 . . . . 4.14 109.642 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.06 -70.95 0.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 4.24 109.423 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.75 -7.21 4.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 3.59 109.387 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -179.96 150.02 0.53 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 2.78 109.377 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.23 -7.11 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.943 2.429 . . . . 1.57 112.217 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.12 172.37 12.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 1.25 109.56 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.738 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 6.5 tp-100 -153.81 140.29 18.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 2.18 109.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 t -153.68 87.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.374 -0.973 . . . . 1.87 108.374 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.4 123.44 41.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 1.45 110.532 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.58 81.52 1.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.61 -0.885 . . . . 2.4 108.61 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 81' ' ' ARG . 32.4 m170 -99.65 136.27 39.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 2.98 109.956 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.506 ' CD2' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -131.05 -5.47 3.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.343 -0.848 . . . . 2.61 109.353 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -43.26 124.41 4.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.473 -1.451 . . . . 2.32 109.473 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.666 ' O ' ' N ' ' A' ' 137' ' ' GLY . 15.6 mttp -163.93 128.21 2.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 5.66 109.74 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.62 -14.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.294 -1.002 . . . . 2.71 108.294 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -118.16 3.15 16.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.227 -1.549 . . . . 3.14 109.227 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -51.42 -161.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -1.07 . . . . 2.84 109.647 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -168.35 -113.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.051 -1.031 . . . . 2.44 110.24 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -125.85 139.82 53.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 1.86 109.127 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.3 t80 -121.36 107.61 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 2.48 109.79 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.17 91.29 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.74 109.863 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.87 141.88 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 1.69 109.072 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.2 p -138.48 -0.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.56 -0.712 . . . . 1.63 109.443 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.784 ' N ' ' HG1' ' A' ' 71' ' ' THR . 2.5 mt-30 -149.57 160.94 43.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.975 . . . . 3.82 110.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.607 ' CG1' ' O ' ' A' ' 146' ' ' VAL . 9.9 p -166.64 103.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.83 . . . . 2.92 109.44 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.3 144.18 36.16 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 3.25 109.624 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.425 ' C ' ' CD1' ' A' ' 148' ' ' LEU . 1.3 tp -134.21 113.49 12.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 5.12 109.337 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.667 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 9.0 t -155.76 -166.35 2.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 3.35 109.54 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 2.29 109.417 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.399 -0.593 . . . . 3.0 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.531 ' OE2' ' OG ' ' A' ' 147' ' ' SER . 7.7 tp10 -65.26 109.86 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 4.75 109.578 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -32.68 39.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 5.44 109.328 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.751 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -113.02 96.06 36.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 2.86 109.073 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.02 38.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.844 2.363 . . . . 4.15 112.852 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.623 ' N ' ' O ' ' A' ' 10' ' ' LEU . 27.7 t60 -129.81 131.42 46.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 2.52 109.316 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.781 ' HG1' ' H ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -170.16 56.17 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 2.33 109.334 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.651 ' C ' ' H ' ' A' ' 16' ' ' ALA . 8.3 t -158.57 68.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 2.28 109.711 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -65.48 34.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 2.6 108.949 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.651 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -81.56 -33.38 31.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.66 109.85 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.587 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 14.9 mm-40 -109.84 -70.2 0.82 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.137 -0.977 . . . . 2.13 109.556 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 20' ' ' GLY . 49.8 m -107.49 144.08 34.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 2.74 109.462 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -61.9 12.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 3.06 109.703 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 66.23 177.12 7.5 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.83 -1.308 . . . . 1.72 109.83 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.04 10.97 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.687 2.258 . . . . 1.97 112.204 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.751 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.2 m0 -74.41 -174.15 1.94 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 2.88 109.501 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.6 m -117.3 145.78 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 2.07 109.287 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.633 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 6.4 tt -151.67 143.86 23.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 2.79 110.407 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.711 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.34 175.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.587 -0.696 . . . . 2.48 109.479 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.12 -23.35 18.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.967 -1.253 . . . . 1.7 109.967 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.72 -142.98 0.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.252 . . . . 1.51 109.339 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.3 p -91.72 -164.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 2.11 109.223 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 3.4 tm-20 -90.12 111.33 46.2 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 2.85 108.774 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.421 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 72.9 Cg_exo -43.32 147.48 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.24 1.96 . . . . 1.4 112.009 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.98 95.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.53 109.866 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.97 88.25 4.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 2.56 109.451 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -74.02 -140.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 1.81 109.952 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' A' ' 33' ' ' ALA . 24.4 t70 -35.33 -87.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 2.21 109.523 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.28 36.87 2.17 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.621 -1.391 . . . . 1.23 109.621 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.641 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.34 157.48 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -1.2 . . . . 3.37 109.579 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.615 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -129.51 135.27 48.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.324 -0.86 . . . . 1.4 109.333 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 143.23 50.66 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.479 -0.888 . . . . 1.06 110.281 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -113.62 144.15 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.796 -0.816 . . . . 1.95 108.796 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -76.84 106.26 8.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 4.79 109.624 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 42' ' ' PRO . 4.4 mm? -116.41 81.53 11.07 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 3.97 109.344 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 41' ' ' LEU . 50.7 Cg_exo -49.54 -144.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.944 2.429 . . . . 4.21 112.275 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.04 70.33 0.29 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 2.09 109.557 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.05 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.554 -1.419 . . . . 2.62 109.554 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 46' ' ' GLY . 2.8 mt-30 -99.99 91.51 4.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 2.96 109.428 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -39.66 -43.64 2.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.558 -1.417 . . . . 2.38 109.558 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.632 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -99.89 128.57 30.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.247 -1.149 . . . . 4.04 109.382 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.28 -26.17 7.75 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.499 2.133 . . . . 2.75 112.626 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.656 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -92.02 34.18 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.976 . . . . 4.57 109.868 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.656 ' OD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.9 OUTLIER -100.19 1.76 42.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 2.38 109.676 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.5 -173.52 1.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 1.47 109.713 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.29 -171.77 14.29 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.486 -1.446 . . . . 0.96 109.486 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.471 HD13 ' CD2' ' A' ' 131' ' ' PHE . 1.3 pp -115.89 140.71 48.97 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.244 -1.15 . . . . 1.51 109.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -128.22 163.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 1.51 109.614 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.694 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 20.2 t80 -159.82 155.42 25.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 2.45 109.444 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.694 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -113.09 -164.29 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.201 -0.937 . . . . 2.95 109.471 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 73.95 69.57 1.37 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 2.52 109.365 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 57' ' ' GLY . 49.0 t -162.05 96.85 1.21 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 4.19 109.447 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.15 121.92 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.652 2.235 . . . . 2.79 112.09 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.641 ' C ' ' HH ' ' A' ' 66' ' ' TYR . 73.0 t -103.33 155.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 3.62 109.594 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.76 ' N ' ' HH ' ' A' ' 66' ' ' TYR . . . -162.67 129.29 2.02 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.614 -1.394 . . . . 3.37 109.614 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.709 ' CA ' ' HG ' ' A' ' 115' ' ' SER . 1.7 pp20? -61.28 -161.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -1.104 . . . . 6.05 109.383 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 62' ' ' GLU . . . 62.22 -49.19 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 3.09 109.67 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.3 mm-40 -99.76 160.3 14.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 4.03 109.261 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.8 m -112.94 146.4 39.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 3.28 109.683 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.76 ' HH ' ' N ' ' A' ' 61' ' ' GLY . 81.1 m-85 -106.14 174.33 5.93 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.238 -0.914 . . . . 2.59 109.803 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.411 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.5 t -152.19 128.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.524 -0.735 . . . . 3.18 109.247 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 109' ' ' ARG . 6.7 tp -114.8 116.8 29.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.092 -1.005 . . . . 4.0 109.851 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.78 81.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 2.8 108.83 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 12.5 p90 -93.67 138.63 31.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.64 111.139 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.785 ' HG1' ' H ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -86.88 133.09 33.65 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.642 -0.873 . . . . 2.25 108.642 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 141' ' ' PHE . . . -173.83 128.29 0.4 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.98 -1.075 . . . . 1.45 110.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -111.24 122.41 47.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 1.28 108.873 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -80.91 129.74 34.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 1.07 109.652 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.526 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -142.73 111.67 5.78 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.332 -0.855 . . . . 1.68 109.594 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.56 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.0 Cg_exo -63.81 -141.82 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.248 -1.146 . . . . 1.32 112.372 -0.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -106.62 155.74 19.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.75 109.701 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.51 167.22 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 2.72 108.942 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -84.7 149.29 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.779 2.319 . . . . 1.83 112.59 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.629 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 1.2 m -125.61 179.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.895 . . . . 2.57 109.315 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.723 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -127.96 97.95 4.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 6.46 109.816 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -99.6 143.17 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.37 -0.831 . . . . 4.19 108.845 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.459 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 2.1 pp -145.63 156.71 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 2.9 109.988 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.581 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -155.07 146.99 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 2.31 109.345 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 170.16 -148.74 11.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.711 -1.356 . . . . 1.75 109.711 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.12 -161.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -1.119 . . . . 2.54 109.456 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.496 -1.442 . . . . 1.77 109.496 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.531 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.433 -0.58 . . . . 6.42 109.433 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.581 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -116.39 164.85 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 2.66 109.969 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.438 ' N ' ' HG1' ' A' ' 93' ' ' THR . . . -109.93 -21.19 12.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.757 -0.831 . . . . 3.93 108.757 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.458 ' CD1' HG21 ' A' ' 84' ' ' VAL . 2.1 t80 -90.66 38.13 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.497 -0.927 . . . . 4.15 108.497 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.68 114.55 19.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 4.6 109.932 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.499 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -141.06 132.98 27.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 3.96 108.725 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -121.65 9.32 9.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.776 -1.33 . . . . 3.67 109.776 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.35 65.31 0.76 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -1.169 . . . . 3.79 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.89 94.9 21.66 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 2.22 109.152 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.9 133.93 10.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.745 2.297 . . . . 3.49 112.793 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD21 ' NE ' ' A' ' 109' ' ' ARG . 35.6 mt -136.92 137.17 39.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 3.46 109.144 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 74' ' ' ALA . 9.0 t -96.87 -155.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.935 . . . . 2.83 109.509 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -104.46 56.86 0.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 2.83 109.542 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -150.85 150.47 27.97 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.299 -1.118 . . . . 3.02 109.433 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 118.33 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.717 2.278 . . . . 1.42 112.137 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.606 ' CB ' HH22 ' A' ' 109' ' ' ARG . . . -166.39 147.3 6.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 1.81 109.543 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.648 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -90.41 144.45 25.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 2.19 109.797 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.648 ' NH1' ' O ' ' A' ' 108' ' ' THR . 0.3 OUTLIER -105.14 134.18 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.939 -1.134 . . . . 5.23 107.939 178.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -109.54 105.27 14.53 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.92 -0.712 . . . . 3.28 110.163 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.499 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 39.0 m-85 -109.6 102.29 11.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.448 -0.945 . . . . 3.78 108.448 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.47 166.41 11.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.301 -0.874 . . . . 3.99 109.901 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.509 ' O ' ' CB ' ' A' ' 65' ' ' SER . 2.3 p90 -177.67 -162.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 3.1 109.237 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.05 143.05 50.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.339 -0.85 . . . . 2.65 109.38 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.709 ' HG ' ' CA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -86.89 161.56 18.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 4.28 109.678 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -127.86 -15.28 4.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 7.59 109.602 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.568 ' CD2' ' CZ ' ' A' ' 119' ' ' PHE . 1.6 tp -123.43 155.63 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 5.5 109.543 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 109.33 21.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 4.48 109.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.568 ' CZ ' ' CD2' ' A' ' 117' ' ' LEU . 23.8 m-85 -114.77 92.46 29.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.892 . . . . 5.99 109.58 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.23 165.9 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.774 2.316 . . . . 4.64 112.122 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.11 -22.74 7.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.796 2.331 . . . . 4.46 111.989 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.03 115.27 29.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.842 . . . . 4.14 109.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 147.07 -136.53 6.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 4.24 109.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' GLY . 10.8 m-20 -43.79 -85.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -1.136 . . . . 3.59 109.458 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -129.86 149.7 73.8 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 2.78 109.458 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.24 -158.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.722 2.281 . . . . 1.57 112.244 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -65.37 163.27 39.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.482 -1.447 . . . . 1.25 109.482 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.16 153.05 38.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -1.107 . . . . 2.18 109.682 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 128' ' ' GLN . 45.7 t -155.84 131.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.187 -1.042 . . . . 1.87 108.187 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.65 100.09 3.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.888 -1.132 . . . . 1.45 110.531 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.471 ' CD2' HD13 ' A' ' 53' ' ' LEU . 2.9 m-30 -85.04 99.23 10.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.522 -0.918 . . . . 2.4 108.522 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 49' ' ' TRP . 41.6 m170 -99.77 136.1 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 2.98 109.816 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.691 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -132.73 -36.47 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 2.61 109.397 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -40.8 116.59 0.85 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 2.32 109.426 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.676 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.6 mtpp -163.83 149.62 11.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 5.66 109.631 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -42.91 -15.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 2.71 108.475 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -114.43 -4.14 22.06 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.259 -1.536 . . . . 3.14 109.259 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.665 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -42.96 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -1.082 . . . . 2.84 109.485 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -168.68 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 2.44 109.876 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -124.17 134.07 53.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 1.86 108.911 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.1 t80 -114.79 105.89 13.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.06 -1.025 . . . . 2.48 109.736 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.95 87.77 3.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.74 109.888 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 140.68 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 1.69 109.058 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.436 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 42.6 p -137.56 -1.0 2.11 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.667 -0.646 . . . . 1.63 109.453 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.785 ' H ' ' HG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -151.26 167.27 28.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 3.82 109.881 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.781 ' H ' ' HG1' ' A' ' 13' ' ' THR . 2.9 p -175.73 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 2.92 109.416 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.531 ' OG ' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -131.53 131.3 43.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 3.25 109.778 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 149' ' ' THR . 5.2 tp -110.4 118.86 37.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 5.12 109.324 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.459 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -123.19 175.19 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 3.35 109.502 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.681 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.29 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 150' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.359 -0.608 . . . . 3.0 109.359 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -134.06 96.33 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 4.75 109.531 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.03 -40.78 91.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 5.44 109.403 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.766 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -114.92 94.21 37.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.853 . . . . 2.86 109.004 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 45.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.791 2.327 . . . . 4.15 112.557 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 10' ' ' LEU . 34.1 t60 -137.94 130.78 29.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.023 . . . . 2.52 109.575 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 t -170.08 70.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 2.33 109.376 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.639 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.5 m -164.66 63.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 2.28 109.629 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.588 ' CD2' ' CD1' ' A' ' 143' ' ' ILE . 4.3 m-30 -67.73 27.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 2.6 109.118 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.639 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.09 -40.05 12.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.66 109.867 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 13.4 mm-40 -109.71 -73.09 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 2.13 109.671 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -88.04 145.55 25.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 2.74 109.445 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.501 ' CD2' ' SD ' ' A' ' 37' ' ' MET . 7.1 mt -62.17 -59.22 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 3.06 109.437 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.28 169.92 14.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 1.72 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.417 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 43.2 Cg_endo -72.2 5.04 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.852 2.368 . . . . 1.97 112.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.766 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.8 m95 -76.17 -175.47 3.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.88 109.463 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 2.07 109.237 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' A' ' 24' ' ' LEU . 3.3 pp -142.84 131.96 23.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 2.79 109.433 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.12 170.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 2.48 109.782 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.88 -31.09 8.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.029 -1.229 . . . . 1.7 110.029 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.82 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.97 -142.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.271 . . . . 1.51 109.417 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.82 ' N ' ' OG1' ' A' ' 27' ' ' THR . 90.1 p -90.81 138.53 31.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.975 . . . . 2.11 109.45 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 28' ' ' SER . 4.9 mt-10 -41.38 104.19 0.33 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 2.85 109.179 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.471 ' CB ' ' SD ' ' A' ' 37' ' ' MET . 51.3 Cg_exo -46.78 156.73 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.366 2.044 . . . . 1.4 111.854 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -143.42 122.04 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 1.53 110.09 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.715 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.62 85.26 3.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 2.56 109.501 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 1.81 109.761 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.24 -67.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 2.21 109.522 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.49 48.48 0.75 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.629 -1.389 . . . . 1.23 109.629 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.574 ' CB ' ' NH1' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -170.69 148.48 2.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.126 -1.22 . . . . 3.37 109.657 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.501 ' SD ' ' CD2' ' A' ' 19' ' ' LEU . 36.4 ttp -109.77 128.63 55.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 1.4 109.107 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -123.46 159.97 27.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.06 110.2 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.422 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.2 m -128.88 134.51 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.901 -0.777 . . . . 1.95 108.901 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.57 106.51 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.825 . . . . 4.79 109.705 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 139' ' ' TYR . 4.2 mm? -118.15 61.04 4.01 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.276 -0.89 . . . . 3.97 109.334 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.37 -91.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.726 2.284 . . . . 4.21 112.283 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -150.89 158.88 27.89 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.516 -1.434 . . . . 2.09 109.516 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.92 42.59 1.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 2.62 109.459 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.656 HE21 ' C ' ' A' ' 134' ' ' GLY . 3.8 mm100 -99.87 148.26 24.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 2.96 109.297 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.94 -69.59 0.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.959 -1.256 . . . . 2.38 109.959 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.686 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.8 p30 -99.79 145.26 29.85 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.129 -1.218 . . . . 4.04 109.616 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.75 -20.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.892 2.395 . . . . 2.75 112.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.686 ' CE3' ' OD1' ' A' ' 47' ' ' ASN . 1.3 p-90 -119.49 36.94 4.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 4.57 110.355 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 8.5 m-20 -79.81 -0.35 34.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.091 -1.005 . . . . 2.38 109.097 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.43 126.61 1.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 1.47 109.315 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.0 -173.91 43.51 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.84 -1.304 . . . . 0.96 109.84 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 5.3 mt -106.9 -178.02 3.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.148 . . . . 1.51 109.545 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -165.54 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 1.51 109.707 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.697 ' CE2' ' CD1' ' A' ' 10' ' ' LEU . 37.6 t80 -179.77 137.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 2.45 109.396 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.459 HD22 ' HG2' ' A' ' 128' ' ' GLN . 1.1 m-80 -119.05 86.11 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.248 -0.907 . . . . 2.95 109.518 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.23 66.56 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 2.52 109.591 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -166.01 85.51 0.96 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.248 -1.148 . . . . 4.19 109.528 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.57 175.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.781 2.32 . . . . 2.79 112.212 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -136.91 131.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 3.62 109.507 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -117.11 80.53 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 3.37 109.475 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 61' ' ' GLY . 28.6 tt0 -35.23 118.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -1.087 . . . . 6.05 109.589 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 129.15 -39.48 1.84 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.646 -1.382 . . . . 3.09 109.646 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.554 ' O ' ' OG ' ' A' ' 115' ' ' SER . 1.9 mt-10 -99.94 173.06 6.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 4.03 109.62 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.5 m -119.34 143.63 47.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 3.28 109.326 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.482 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 27.5 m-85 -108.81 -178.39 3.57 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 2.59 109.659 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 1.8 t -151.7 158.36 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 3.18 109.497 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' CD1' ' CD2' ' A' ' 148' ' ' LEU . 11.7 tp -143.05 112.01 6.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 4.0 109.68 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.31 86.81 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 2.8 108.787 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.9 p90 -93.98 141.51 28.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 2.64 111.16 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.692 ' CB ' ' HG ' ' A' ' 144' ' ' SER . 2.7 p -84.82 88.55 7.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 2.25 108.3 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB3' ' CE1' ' A' ' 141' ' ' PHE . . . -129.68 156.96 43.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.117 . . . . 1.45 110.756 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.8 p -147.36 120.11 8.64 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.596 -0.89 . . . . 1.28 108.596 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.595 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -88.13 133.36 34.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 1.07 109.839 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.456 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.8 116.9 16.05 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.431 -0.793 . . . . 1.68 109.078 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.595 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -66.07 -142.53 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.676 0 C-N-CA 124.29 -1.129 . . . . 1.32 112.551 -0.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.652 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -106.86 154.79 20.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 1.75 109.724 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.8 mtm 167.08 169.67 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.778 . . . . 2.72 109.092 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.15 131.65 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.872 2.381 . . . . 1.83 112.55 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.612 ' CG1' ' HH ' ' A' ' 139' ' ' TYR . 1.2 m -107.26 174.03 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 2.57 109.279 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -126.48 98.29 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 6.46 109.804 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.68 155.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.27 -0.894 . . . . 4.19 109.165 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD21 ' CE1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -147.69 157.98 43.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 2.9 109.798 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.578 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.4 OUTLIER -151.98 164.4 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 2.31 109.38 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 146.73 -159.24 27.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.612 -1.395 . . . . 1.75 109.612 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.684 ' OE1' ' CE1' ' A' ' 119' ' ' PHE . 7.3 pt-20 -90.2 -155.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.129 . . . . 2.54 109.45 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.567 -1.413 . . . . 1.77 109.567 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.619 ' CZ ' ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.53 -0.545 . . . . 6.42 109.53 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -111.34 172.16 7.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 2.66 109.988 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.76 -18.99 5.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.892 -0.781 . . . . 3.93 108.892 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.94 34.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 4.15 109.308 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 82.18 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 4.6 109.428 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 98' ' ' GLY . 2.1 tt0 -103.41 156.86 17.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 3.96 109.093 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -146.24 7.86 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.696 -1.362 . . . . 3.67 109.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -120.69 75.62 1.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.167 -1.196 . . . . 3.79 109.78 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . . . -120.34 86.51 38.74 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 2.22 109.242 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -66.52 127.54 17.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.149 2.566 . . . . 3.49 112.82 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.57 147.61 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 3.46 108.999 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.578 ' O ' ' O ' ' A' ' 74' ' ' ALA . 5.0 t -97.61 -170.58 2.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 2.83 109.828 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 105' ' ' GLU . . . -103.72 36.34 4.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.691 -1.364 . . . . 2.83 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 104' ' ' GLY . 71.3 mt-10 -156.09 148.21 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 3.02 109.262 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -40.8 118.26 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.696 2.264 . . . . 1.42 112.143 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.541 ' CB ' ' NH1' ' A' ' 109' ' ' ARG . . . -160.9 138.34 9.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 1.81 109.648 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.418 ' CG2' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.54 151.51 21.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 2.19 109.907 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.541 ' NH1' ' CB ' ' A' ' 107' ' ' ALA . 3.7 mpt_? -124.36 142.14 51.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 5.23 108.029 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.63 104.67 12.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 3.28 110.757 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 8.8 m-30 -109.88 120.11 41.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.499 -0.926 . . . . 3.78 108.499 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -124.95 169.65 11.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 3.99 109.67 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.5 p90 -155.23 -177.76 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 3.1 109.499 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.535 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -111.4 106.14 14.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.364 -0.835 . . . . 2.65 109.558 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.554 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.8 m -36.01 129.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 4.28 109.347 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.469 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 10.9 m120 -125.17 -7.21 7.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 7.59 109.507 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.469 ' HB3' ' CE2' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -148.94 129.98 14.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 5.5 109.424 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.26 113.25 18.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 4.48 109.551 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CE1' ' OE1' ' A' ' 86' ' ' GLU . 44.6 m-85 -110.02 146.94 35.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 5.99 109.353 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.47 166.3 30.22 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.691 2.261 . . . . 4.64 112.163 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 126' ' ' PRO . 73.4 Cg_endo -81.02 -39.72 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.777 2.318 . . . . 4.46 112.071 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -122.44 -150.93 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.874 . . . . 4.14 109.478 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.08 -142.54 15.66 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.572 -1.411 . . . . 4.24 109.572 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -114.33 10.94 17.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -1.094 . . . . 3.59 109.447 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.466 ' N ' ' CD ' ' A' ' 126' ' ' PRO . . . -165.75 54.22 0.33 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 2.78 109.545 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 55.1 Cg_endo -74.09 -158.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.846 2.364 . . . . 1.57 112.223 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 126' ' ' PRO . . . -39.97 155.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.627 -1.389 . . . . 1.25 109.627 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -155.2 137.85 15.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -1.159 . . . . 2.18 109.553 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 8.3 p -153.48 149.34 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.674 -0.861 . . . . 1.87 108.674 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -159.13 115.57 2.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.033 . . . . 1.45 110.207 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 6.8 m-30 -85.63 105.29 16.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 2.4 108.435 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 49' ' ' TRP . 56.9 m170 -99.43 121.24 40.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 2.98 109.757 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -152.17 66.7 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 2.61 109.496 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.656 ' C ' HE21 ' A' ' 45' ' ' GLN . . . -157.11 103.91 0.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 2.32 109.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -153.48 -175.34 5.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 5.66 109.638 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -44.87 -12.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.34 -0.985 . . . . 2.71 108.34 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -113.33 1.94 25.17 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.345 -1.502 . . . . 3.14 109.345 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -37.44 165.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.392 -1.064 . . . . 2.84 109.656 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -161.21 -108.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 2.44 109.555 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -138.66 139.61 38.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 1.86 109.111 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.659 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 30.7 t80 -124.34 120.4 32.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.062 -1.024 . . . . 2.48 109.921 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.87 101.74 8.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.74 109.893 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.588 ' CD1' ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -100.82 135.66 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.69 109.013 179.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.692 ' HG ' ' CB ' ' A' ' 71' ' ' THR . 3.5 p -109.16 -21.28 12.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.902 -0.777 . . . . 1.63 108.902 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.68 ' N ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -170.43 -174.94 1.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.256 -0.978 . . . . 3.82 110.533 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 146' ' ' VAL . 9.8 p -161.42 108.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.872 -0.788 . . . . 2.92 108.872 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.11 143.27 33.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 3.25 110.197 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.521 ' CD1' ' C ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -123.9 110.27 14.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.46 -0.775 . . . . 5.12 109.039 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.4 ' N ' HD11 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -131.58 167.79 18.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 3.35 109.808 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.445 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 2.29 109.328 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' O ' ' CB ' ' A' ' 149' ' ' THR . 1.4 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.422 -0.584 . . . . 3.0 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.46 109.02 11.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 4.75 109.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.79 -50.1 13.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 5.44 109.318 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.694 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -96.55 108.6 43.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 2.86 109.352 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.7 29.13 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.089 1.86 . . . . 4.15 111.624 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.672 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 19.4 t60 -124.36 72.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 2.52 109.586 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 5.7 t -112.06 41.67 1.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 2.33 109.318 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.659 ' C ' ' H ' ' A' ' 16' ' ' ALA . 32.7 m -127.0 64.94 1.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 2.28 109.779 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.573 ' CE1' ' NE2' ' A' ' 12' ' ' HIS . 3.5 m-85 -67.2 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 2.6 109.029 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.12 -20.49 23.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.66 110.113 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 34.2 mt-10 -109.9 -83.91 0.56 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.02 -1.05 . . . . 2.13 109.948 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 m -104.94 151.77 23.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 2.74 109.628 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -47.99 62.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 3.06 109.423 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 102.54 -173.03 22.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.725 -1.35 . . . . 1.72 109.725 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 36.0 Cg_endo -69.21 -18.38 39.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 1.97 112.194 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.694 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 11.2 m0 -56.79 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 2.88 109.139 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 m -151.43 136.78 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 2.07 109.599 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.656 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 9.3 tt -133.28 152.74 51.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 2.79 109.574 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.87 177.43 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 2.48 109.444 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 93.03 -30.33 7.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.831 -1.307 . . . . 1.7 109.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.829 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.96 -141.96 0.38 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -1.185 . . . . 1.51 109.276 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.829 ' N ' ' OG1' ' A' ' 27' ' ' THR . 23.7 p -90.68 140.27 29.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.171 -0.956 . . . . 2.11 108.989 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.535 ' C ' ' O ' ' A' ' 28' ' ' SER . 2.6 mp0 -36.95 128.67 0.75 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 2.85 109.102 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HB2' ' CG ' ' A' ' 37' ' ' MET . 43.3 Cg_endo -71.73 158.75 52.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.262 1.975 . . . . 1.4 111.681 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -145.83 116.28 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.025 -1.047 . . . . 1.53 110.589 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -71.17 72.64 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 2.56 109.14 178.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -73.43 -135.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 1.81 109.78 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -41.66 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.792 . . . . 2.21 109.34 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 34.52 45.47 0.5 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.7 -1.36 . . . . 1.23 109.7 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -164.01 146.61 9.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.097 -1.237 . . . . 3.37 109.812 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.426 ' CG ' ' HB2' ' A' ' 30' ' ' PRO . 11.8 tmm? -108.97 124.77 51.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 1.4 109.121 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 2.0 t -124.79 155.02 40.04 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 1.06 110.378 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HB ' ' HG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -127.48 164.55 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.459 -0.941 . . . . 1.95 108.459 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' CG ' ' OG ' ' A' ' 28' ' ' SER . 21.0 m-20 -99.09 112.69 24.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 4.79 109.627 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.667 ' CD2' ' N ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.27 84.65 9.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 3.97 109.202 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.42 -92.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.848 2.366 . . . . 4.21 112.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' GLY . . . -162.33 -139.99 2.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.439 . . . . 2.09 109.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 43' ' ' GLY . . . 35.79 43.09 0.57 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.549 -1.42 . . . . 2.62 109.549 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 46' ' ' GLY . 15.6 mm-40 -99.9 129.74 46.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -1.17 . . . . 2.96 109.489 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -35.75 -44.28 0.67 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 2.38 109.619 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.669 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -179.95 157.49 0.79 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 4.04 109.5 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.4 -34.97 3.39 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.794 2.329 . . . . 2.75 112.379 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.684 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 35.5 p90 -101.74 60.86 0.88 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 4.57 109.501 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 26.8 m-20 -136.58 0.92 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 2.38 109.483 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.41 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -162.58 -170.87 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.47 109.459 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 -155.96 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.96 109.517 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 53' ' ' LEU . 1.5 pt? -127.04 157.62 39.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.18 -1.188 . . . . 1.51 109.66 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.26 -176.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 1.51 110.102 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.549 ' CZ ' ' CD1' ' A' ' 10' ' ' LEU . 30.4 t80 177.93 147.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.34 0.591 . . . . 2.45 109.576 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.82 129.57 56.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.321 -0.862 . . . . 2.95 109.48 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.29 84.03 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.386 -1.486 . . . . 2.52 109.386 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.681 ' CG1' ' H ' ' A' ' 128' ' ' GLN . 1.3 p -169.88 70.45 0.63 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.111 . . . . 4.19 109.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.688 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.61 159.58 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.824 2.349 . . . . 2.79 111.963 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.45 ' C ' ' HG ' ' A' ' 115' ' ' SER . 2.0 t -151.39 85.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.165 -0.959 . . . . 3.62 109.723 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.56 ' C ' ' OG ' ' A' ' 115' ' ' SER . . . -88.69 112.22 3.9 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.087 -1.605 . . . . 3.37 109.087 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' N ' ' OG ' ' A' ' 115' ' ' SER . 34.5 mt-10 -31.01 135.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.553 -0.969 . . . . 6.05 110.037 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.449 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 95.37 -16.54 61.06 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.972 -1.251 . . . . 3.09 109.972 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' H ' ' HB3' ' A' ' 115' ' ' SER . 17.4 mt-10 -99.89 146.93 26.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 4.03 109.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 150' ' ' THR . 4.0 m -111.87 133.63 53.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 3.28 109.159 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.688 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 30.8 m-85 -109.7 178.07 4.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.147 -0.97 . . . . 2.59 109.921 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.422 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.4 t -151.8 165.55 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.504 -0.747 . . . . 3.18 109.476 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.465 HD21 ' CD1' ' A' ' 70' ' ' PHE . 1.9 tp -147.34 111.13 5.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.868 . . . . 4.0 109.476 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.9 p -109.83 93.15 4.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 2.8 109.163 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.696 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.92 143.77 26.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.205 -0.935 . . . . 2.64 110.679 -179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.674 ' HG1' ' N ' ' A' ' 145' ' ' GLN . 1.5 p -101.58 108.52 20.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.43 -0.952 . . . . 2.25 108.43 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -154.43 143.4 21.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.789 -1.194 . . . . 1.45 110.597 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -113.98 127.22 55.87 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.631 -0.878 . . . . 1.28 108.631 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.581 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -97.42 129.3 44.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 1.07 110.009 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.459 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.6 115.89 14.82 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.394 -0.816 . . . . 1.68 109.156 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -65.85 -142.54 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.435 -1.069 . . . . 1.32 112.489 -0.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -106.2 150.32 25.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 1.75 109.532 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.5 155.11 0.15 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 2.72 109.476 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.94 122.84 8.46 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.825 2.35 . . . . 1.83 112.143 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.58 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 1.5 m -93.85 175.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 2.57 109.378 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.729 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.05 145.77 36.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 6.46 109.688 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.608 ' O ' ' NH2' ' A' ' 81' ' ' ARG . 1.4 p -147.29 152.4 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 4.19 109.326 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 pp -155.43 149.27 25.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 2.9 109.81 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.572 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -144.7 152.58 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 2.31 109.453 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 168.24 -150.24 15.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.758 -1.337 . . . . 1.75 109.758 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.539 ' C ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -90.15 -165.1 1.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -1.064 . . . . 2.54 109.598 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 1.77 109.526 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.431 -0.581 . . . . 6.42 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.572 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -100.25 164.8 11.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 2.66 109.862 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.18 -17.77 10.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.396 -0.815 . . . . 3.93 108.829 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.64 35.38 0.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.362 -0.836 . . . . 4.15 109.193 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -77.85 88.43 4.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 4.6 109.605 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.66 ' O ' ' NH2' ' A' ' 81' ' ' ARG . 4.0 pt20 -121.98 148.81 44.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 3.96 109.353 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.687 ' CA ' ' HE ' ' A' ' 81' ' ' ARG . . . -136.76 30.11 2.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.83 -1.308 . . . . 3.67 109.83 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.544 ' O ' ' OH ' ' A' ' 111' ' ' TYR . 1.7 m -115.12 66.72 0.69 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -1.19 . . . . 3.79 109.636 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.89 93.45 17.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 2.22 109.563 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.6 118.42 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.713 2.276 . . . . 3.49 112.218 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.3 mt -120.56 155.92 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 3.46 109.494 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 1.3 t -110.39 -167.29 1.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 2.83 109.616 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -78.98 -25.75 59.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.761 -1.335 . . . . 2.83 109.761 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.83 164.01 17.32 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 3.02 109.408 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -43.28 118.73 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.688 2.259 . . . . 1.42 112.088 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.26 117.97 16.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 1.81 109.746 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.667 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.69 148.98 21.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 2.19 110.21 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.667 ' NH1' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -127.84 139.69 52.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.21 -1.033 . . . . 5.23 108.21 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.99 104.87 9.82 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.957 -0.697 . . . . 3.28 109.991 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.544 ' OH ' ' O ' ' A' ' 99' ' ' SER . 41.2 m-85 -109.69 129.61 55.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.221 -0.924 . . . . 3.78 108.867 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.42 157.01 43.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.833 . . . . 3.99 109.775 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.4 p90 -146.28 -178.51 6.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 3.1 109.552 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.57 137.03 47.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.463 -0.773 . . . . 2.65 109.642 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.56 ' OG ' ' C ' ' A' ' 61' ' ' GLY . 22.8 t -64.11 118.39 8.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 4.28 109.602 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -18.82 13.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 7.59 109.233 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -132.5 -162.6 1.25 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.292 -0.88 . . . . 5.5 109.568 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.708 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -118.92 133.82 55.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.266 -0.896 . . . . 4.48 109.506 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -153.66 70.57 6.62 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 5.99 109.534 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.75 169.46 1.8 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.815 2.343 . . . . 4.64 112.009 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.16 -31.41 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.754 2.302 . . . . 4.46 112.06 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 123' ' ' GLY . 24.1 t0 -119.25 -11.94 9.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 4.14 109.572 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -56.94 -150.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 4.24 109.564 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 123' ' ' GLY . 0.5 OUTLIER -36.33 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -1.152 . . . . 3.59 109.415 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -115.61 150.11 44.18 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 2.78 109.445 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.9 -158.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.761 2.307 . . . . 1.57 112.252 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . -82.34 166.62 46.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.552 -1.419 . . . . 1.25 109.552 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.681 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -147.25 142.62 27.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 2.18 109.867 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.596 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 5.2 p -163.24 110.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.278 -1.008 . . . . 1.87 108.278 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -118.83 132.27 56.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 1.45 110.871 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.435 ' HB2' ' CD2' ' A' ' 53' ' ' LEU . 4.0 m-30 -101.02 111.83 24.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 2.4 108.199 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.526 ' CE1' ' CB ' ' A' ' 49' ' ' TRP . 58.5 m170 -99.37 131.12 45.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 2.98 109.565 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 141' ' ' PHE . 3.0 mt -133.23 -43.45 0.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 2.61 109.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -38.79 127.43 1.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.841 -1.304 . . . . 2.32 109.841 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.67 ' O ' ' N ' ' A' ' 137' ' ' GLY . 31.4 mtmt -164.69 134.79 3.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 5.66 109.584 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -40.29 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.389 -0.967 . . . . 2.71 108.389 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.13 14.8 7.85 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.047 -1.621 . . . . 3.14 109.047 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.614 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.5 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -1.038 . . . . 2.84 110.062 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.58 ' OH ' ' CG1' ' A' ' 80' ' ' VAL . 8.3 p90 -160.03 -130.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.004 -1.06 . . . . 2.44 109.429 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 22.5 mt-10 -116.93 135.81 53.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 1.86 109.33 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 14.8 t80 -118.51 108.45 15.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 2.48 110.038 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.48 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 78.7 m -111.94 100.83 9.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.297 -0.877 . . . . 0.74 110.003 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.466 HG23 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -112.99 143.75 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 1.69 109.086 179.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' PHE . 6.0 p -131.8 -5.84 3.6 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.64 . . . . 1.63 109.275 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' HG1' ' A' ' 71' ' ' THR . 1.3 mt-30 -153.85 160.02 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.299 -0.961 . . . . 3.82 110.233 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.613 ' N ' ' OG1' ' A' ' 13' ' ' THR . 10.8 p -178.15 124.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.007 -0.738 . . . . 2.92 109.007 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.95 135.41 29.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 3.25 109.911 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 149' ' ' THR . 0.3 OUTLIER -108.38 144.51 35.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 5.12 109.362 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 2.8 t -164.97 -173.26 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 3.35 109.559 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 65' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 2.29 109.437 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLU . 58.0 t . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.307 0.575 . . . . 3.0 109.523 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -36.07 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 4.75 109.423 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . 12.1 mt -103.82 11.43 35.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.284 -0.885 . . . . 5.44 109.679 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.705 ' O ' ' N ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -114.38 113.7 45.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 2.86 108.444 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.51 19.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.647 2.232 . . . . 4.15 113.66 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.705 ' N ' ' O ' ' A' ' 10' ' ' LEU . 83.5 t60 -170.69 136.89 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.674 -1.266 . . . . 2.52 110.404 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.591 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.3 OUTLIER -170.83 68.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 2.33 109.341 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.564 ' HG ' ' C ' ' A' ' 13' ' ' THR . 50.5 m -170.31 87.66 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 2.28 110.083 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -90.24 41.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 2.6 109.056 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.22 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 1.66 109.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -109.75 39.47 2.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.195 -0.941 . . . . 2.13 109.696 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.21 148.89 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 2.74 109.53 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.06 -10.85 60.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 3.06 109.427 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 75.03 -146.81 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.357 -1.497 . . . . 1.72 109.357 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 22' ' ' TRP . 64.6 Cg_endo -81.53 -23.1 5.16 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.893 2.396 . . . . 1.97 112.076 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.574 ' O ' ' O ' ' A' ' 21' ' ' PRO . 11.3 m0 -45.94 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 2.88 108.896 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -113.53 164.81 13.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 2.07 108.985 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.544 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 3.0 mt -156.54 132.63 9.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 2.79 109.78 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.733 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 171.63 -167.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 2.48 109.394 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.0 -30.39 0.93 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.754 -1.339 . . . . 1.7 109.754 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.733 ' HG1' ' H ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -109.87 -141.12 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -1.186 . . . . 1.51 109.445 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.733 ' H ' ' HG1' ' A' ' 27' ' ' THR . 11.4 p -90.92 -162.75 0.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.084 -0.709 . . . . 2.11 109.084 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.4 111.63 48.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 2.85 109.134 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' CG ' HD11 ' A' ' 24' ' ' LEU . 53.0 Cg_exo -50.04 140.87 31.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.167 1.911 . . . . 1.4 111.786 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.19 112.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.033 . . . . 1.53 109.898 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' HA ' ' CB ' ' A' ' 37' ' ' MET . 0.9 OUTLIER -90.03 127.24 36.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 2.56 109.349 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -120.8 -110.07 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.955 . . . . 1.81 109.62 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 3.4 p-10 -60.28 63.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.96 . . . . 2.21 109.595 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 69.33 -17.51 0.6 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.676 -1.369 . . . . 1.23 109.676 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -106.04 170.74 7.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -1.194 . . . . 3.37 109.736 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.414 ' CB ' ' HA ' ' A' ' 32' ' ' PHE . 9.6 ptt? -148.28 166.23 28.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 1.4 109.09 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -146.65 150.79 36.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 1.06 110.535 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.97 148.6 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.245 -1.02 . . . . 1.95 108.245 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 1.1 m-20 -83.85 105.85 15.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 4.79 109.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 139' ' ' TYR . 1.8 mm? -112.97 78.25 2.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 3.97 108.898 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.26 -159.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.771 2.314 . . . . 4.21 112.388 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.87 63.01 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 2.09 109.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.26 36.01 0.96 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.451 -1.46 . . . . 2.62 109.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 6.1 mm-40 -99.97 112.7 24.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -1.126 . . . . 2.96 109.544 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.644 ' C ' HD21 ' A' ' 47' ' ' ASN . . . -54.75 -10.94 2.51 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.571 -1.412 . . . . 2.38 109.571 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.644 HD21 ' C ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -165.85 156.61 11.76 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -1.178 . . . . 4.04 109.444 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HG3' ' NH1' ' A' ' 81' ' ' ARG . 44.5 Cg_endo -72.6 -27.27 15.58 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.711 2.274 . . . . 2.75 112.216 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 1.6 p90 -83.72 35.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 4.57 109.444 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.663 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 19.8 m-20 -136.82 46.33 2.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 2.38 109.465 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 172.5 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 1.47 109.451 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.86 -163.33 25.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.534 -1.426 . . . . 0.96 109.534 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.537 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -119.75 -172.7 2.39 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.223 -1.163 . . . . 1.51 109.388 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 93.2 t -162.08 167.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 1.51 108.943 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.56 ' CD2' ' NE1' ' A' ' 22' ' ' TRP . 20.0 t80 -176.19 172.94 2.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 2.45 109.516 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.26 -164.61 1.03 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.218 -0.926 . . . . 2.95 109.626 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 10' ' ' LEU . . . 79.96 64.84 1.82 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.517 -1.433 . . . . 2.52 109.517 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.23 79.78 6.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.176 -1.191 . . . . 4.19 109.405 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.77 120.33 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.737 2.292 . . . . 2.79 112.08 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.41 119.15 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 3.62 109.619 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.677 ' N ' ' OH ' ' A' ' 66' ' ' TYR . . . -128.58 95.93 0.4 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.332 -1.507 . . . . 3.37 109.332 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.674 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -35.2 144.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 6.05 109.372 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.34 -36.39 4.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 3.09 109.522 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.74 178.58 4.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -1.167 . . . . 4.03 109.224 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -132.51 119.91 21.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.126 -0.984 . . . . 3.28 109.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.677 ' OH ' ' N ' ' A' ' 61' ' ' GLY . 56.1 m-85 -94.06 162.93 13.68 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.302 -0.874 . . . . 2.59 109.431 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.7 t -146.9 108.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.693 . . . . 3.18 109.557 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 69' ' ' SER . 7.8 tt -96.29 144.83 26.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.071 -1.018 . . . . 4.0 109.22 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.46 ' N ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.85 104.85 5.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.888 . . . . 2.8 108.98 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 109' ' ' ARG . 2.9 p90 -94.17 143.48 26.34 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.082 -1.047 . . . . 2.64 110.899 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.733 ' HG1' ' H ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.62 96.74 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.557 -0.905 . . . . 2.25 108.557 179.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -164.21 178.6 7.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.874 -1.141 . . . . 1.45 110.838 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 153.68 36.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.064 -0.717 . . . . 1.28 109.064 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -95.85 138.83 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 1.07 109.558 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.508 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -137.47 114.28 9.58 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 121.156 -0.965 . . . . 1.68 109.712 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 31.5 Cg_endo -64.64 -144.38 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.075 -1.219 . . . . 1.32 111.875 -0.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.85 150.78 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.59 -1.319 . . . . 1.75 109.589 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.557 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER 159.65 156.98 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 2.72 109.334 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.575 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 62.5 Cg_endo -76.99 147.96 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.918 2.412 . . . . 1.83 112.422 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 81' ' ' ARG . 0.8 OUTLIER -111.19 -172.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 2.57 109.343 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 132' ' ' HIS . 0.3 OUTLIER -122.43 142.75 50.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 6.46 109.556 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.3 p -146.92 149.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.243 -0.91 . . . . 4.19 109.396 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.27 151.55 31.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 2.9 109.735 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.583 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -150.76 169.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 2.31 109.345 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.81 -155.96 26.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.631 -1.388 . . . . 1.75 109.631 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -90.39 -174.13 4.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.127 . . . . 2.54 109.495 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.496 -1.442 . . . . 1.77 109.496 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.633 ' CD ' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.285 0.564 . . . . 6.42 109.588 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.718 ' HG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -122.51 174.43 7.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 2.66 109.99 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.718 ' N ' ' HG1' ' A' ' 93' ' ' THR . . . -126.69 -18.04 4.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.73 . . . . 3.93 109.115 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.644 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.74 41.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 4.15 109.356 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.96 81.22 8.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 4.6 109.602 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.1 tt0 -127.07 114.93 18.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.206 -0.934 . . . . 3.96 109.046 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.34 21.97 29.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.805 -1.318 . . . . 3.67 109.805 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -110.11 90.86 3.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -1.17 . . . . 3.79 109.531 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.411 ' HA ' ' HH ' ' A' ' 111' ' ' TYR . . . -128.07 86.86 57.01 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 2.22 109.57 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.81 118.94 5.91 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.964 2.443 . . . . 3.49 112.395 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.89 168.02 11.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 3.46 109.346 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -122.82 -177.68 3.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 2.83 109.563 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -91.6 59.21 2.95 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.513 -1.435 . . . . 2.83 109.513 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -171.78 131.72 0.75 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 3.02 109.191 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -41.04 122.65 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.488 2.125 . . . . 1.42 112.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.84 146.06 9.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 1.81 109.565 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.417 ' CG2' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.75 150.31 21.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 2.19 110.26 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -126.47 152.33 46.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.379 -1.341 . . . . 5.23 107.379 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' O ' ' CD1' ' A' ' 111' ' ' TYR . 13.8 mp0 -125.02 158.29 34.08 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.375 -0.93 . . . . 3.28 110.701 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.653 ' CD1' ' O ' ' A' ' 110' ' ' GLU . 42.9 m-85 -160.57 103.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.474 -0.936 . . . . 3.78 108.474 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -114.02 169.6 8.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 3.99 109.836 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.644 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 3.7 p90 -177.5 -173.5 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 3.1 109.857 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.69 150.91 39.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.52 -0.737 . . . . 2.65 109.418 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -90.2 169.77 10.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 4.28 109.842 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -125.07 -20.28 4.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 7.59 109.285 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 118' ' ' THR . 9.3 tt -128.46 170.86 12.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 5.5 109.305 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.592 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -89.76 107.75 19.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 4.48 109.542 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.661 ' CE2' ' OE2' ' A' ' 86' ' ' GLU . 42.5 m-85 -117.14 75.95 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 5.99 109.499 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.56 163.27 32.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.682 2.255 . . . . 4.64 112.269 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.03 -12.97 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.846 2.364 . . . . 4.46 111.965 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.46 129.44 55.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 4.14 109.487 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.64 -65.18 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.425 -1.47 . . . . 4.24 109.425 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -172.91 47.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -1.135 . . . . 3.59 109.463 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.608 ' C ' ' H ' ' A' ' 127' ' ' GLY . . . 179.92 58.83 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 2.78 109.585 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.22 -2.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.11 2.54 . . . . 1.57 112.078 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 122.29 150.21 8.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.286 -1.526 . . . . 1.25 109.286 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.99 129.73 16.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.236 . . . . 2.18 109.846 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 1.4 p -153.15 94.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.289 -1.004 . . . . 1.87 108.289 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.9 136.42 42.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.282 -0.886 . . . . 1.45 110.563 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -105.92 96.04 6.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.825 -0.805 . . . . 2.4 108.825 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 54.8 m170 -99.95 129.08 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 2.98 109.785 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.512 ' CD2' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -132.05 -28.4 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 2.61 109.45 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -46.28 144.95 3.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 2.32 109.693 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.682 ' O ' ' N ' ' A' ' 137' ' ' GLY . 14.6 mtpp -164.08 141.04 6.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.139 . . . . 5.66 109.668 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.33 -20.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 2.71 108.602 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -131.36 18.1 4.99 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 3.14 108.943 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.605 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.45 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 2.84 110.218 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.575 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -153.78 -110.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 2.44 109.394 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.63 152.74 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.896 -1.128 . . . . 1.86 109.023 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.546 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 50.3 t80 -134.29 123.8 24.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.006 -1.059 . . . . 2.48 110.181 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 1.8 m -112.67 118.78 35.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.74 109.43 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.458 HD12 HG21 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -128.61 145.03 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.006 0.908 . . . . 1.69 109.859 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.674 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 93.0 p -135.37 -19.75 1.66 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.27 -0.641 . . . . 1.63 109.27 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.733 ' H ' ' HG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -148.9 163.18 38.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.917 . . . . 3.82 109.484 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.467 HG11 ' CZ2' ' A' ' 22' ' ' TRP . 10.5 p -177.2 123.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.92 109.556 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.52 151.61 9.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 3.25 109.524 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.663 ' H ' ' CD2' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -115.96 173.19 6.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 5.12 109.584 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER -157.01 -166.89 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 3.35 109.467 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.653 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.2 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 2.29 109.484 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.369 -0.604 . . . . 3.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -86.04 84.53 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 4.75 109.503 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mt -67.01 -22.0 65.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 5.44 109.297 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' HIS . 3.1 tm? -126.26 78.16 71.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 2.86 108.679 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.32 40.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.03 2.487 . . . . 4.15 112.77 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' LEU . 9.3 t60 -136.2 94.29 3.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 2.52 109.516 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.549 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -140.19 52.66 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 2.33 109.328 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -146.48 71.92 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 2.28 109.676 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.463 ' CE2' HD21 ' A' ' 19' ' ' LEU . 4.7 m-30 -63.0 41.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 2.6 109.048 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.654 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -90.1 -39.13 13.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 1.66 109.959 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 8.4 mt-10 -109.74 -83.71 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 2.13 109.856 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -103.34 144.11 31.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 2.74 109.589 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.463 HD21 ' CE2' ' A' ' 15' ' ' PHE . 4.5 mt -58.15 -55.85 29.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 3.06 109.469 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 102.53 -163.66 16.52 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.4 . . . . 1.72 109.601 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.04 -36.91 67.06 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.74 2.294 . . . . 1.97 112.117 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.536 ' CH2' ' CG1' ' A' ' 146' ' ' VAL . 21.2 m95 -55.09 159.91 2.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 2.88 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.06 177.29 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 2.07 109.342 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.555 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.3 pt? -176.06 151.53 1.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 2.79 109.631 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 170.32 178.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 2.48 109.713 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.22 -4.55 85.89 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.297 . . . . 1.7 109.859 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.792 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.74 -143.17 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.27 . . . . 1.51 109.504 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.792 ' N ' ' OG1' ' A' ' 27' ' ' THR . 86.1 p -91.5 -151.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.314 -0.866 . . . . 2.11 109.003 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -90.68 110.41 41.22 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 2.85 109.102 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 56.4 Cg_endo -76.43 143.12 24.38 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.144 1.896 . . . . 1.4 111.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -144.65 122.03 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 1.53 110.631 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.27 84.6 5.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.682 . . . . 2.56 109.182 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.75 -140.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.81 109.976 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.54 -68.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 2.21 109.401 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . -143.46 43.85 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.438 -1.465 . . . . 1.23 109.438 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.53 145.49 11.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 3.37 109.63 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 37' ' ' MET . 18.4 tmm? -111.23 132.75 54.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 1.4 109.042 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.3 m -123.48 152.11 42.05 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.06 110.24 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 30' ' ' PRO . 3.4 m -135.25 115.62 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.392 -0.966 . . . . 1.95 108.392 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.577 ' N ' ' HG ' ' A' ' 28' ' ' SER . 3.4 m-20 -72.41 123.64 23.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 4.79 109.929 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.461 ' CD2' ' OG1' ' A' ' 27' ' ' THR . 3.7 mm? -132.52 61.07 54.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.912 . . . . 3.97 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 43' ' ' GLY . 53.8 Cg_endo -96.05 -43.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.456 2.771 . . . . 4.21 112.164 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 42' ' ' PRO . . . -16.76 -108.13 0.0 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 111.771 -0.532 . . . . 2.09 111.771 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.07 61.63 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.197 -1.561 . . . . 2.62 109.197 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 136' ' ' ALA . 2.7 mm100 -99.37 97.15 8.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -1.208 . . . . 2.96 109.7 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.51 58.92 3.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.658 -1.377 . . . . 2.38 109.658 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.608 ' C ' ' H ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -152.51 90.19 3.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 4.04 109.464 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.62 2.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.907 2.405 . . . . 2.75 112.503 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.685 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -127.67 34.54 4.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 4.57 109.599 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.685 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 1.4 m-20 -109.98 -2.25 17.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 2.38 109.57 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.9 172.14 2.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -0.964 . . . . 1.47 109.689 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.3 178.0 19.63 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.718 -1.353 . . . . 0.96 109.718 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.5 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 8.2 mt -88.14 -176.57 5.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -1.092 . . . . 1.51 109.234 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.23 162.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 1.51 110.015 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.589 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 26.3 t80 175.83 146.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.586 -0.696 . . . . 2.45 109.297 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.589 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -112.93 -164.69 0.93 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.281 -0.887 . . . . 2.95 109.494 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.24 56.65 7.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.647 -1.381 . . . . 2.52 109.647 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.613 ' CG1' ' O ' ' A' ' 58' ' ' VAL . 8.5 p -126.06 92.02 46.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 4.19 109.377 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.39 131.4 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.718 2.279 . . . . 2.79 112.277 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.466 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 21.1 t -141.98 113.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 3.62 109.462 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -93.37 111.38 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.534 -1.426 . . . . 3.37 109.534 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.506 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 1.8 tm-20 -42.47 145.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 6.05 109.486 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.677 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 106.14 -35.02 5.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 3.09 109.633 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.622 ' O ' ' N ' ' A' ' 115' ' ' SER . 13.3 mt-10 -99.97 173.14 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 4.03 109.558 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.578 ' O ' ' OG1' ' A' ' 150' ' ' THR . 51.7 m -121.02 143.79 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 3.28 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 22.0 m-85 -109.31 -178.5 3.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 2.59 109.703 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.439 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 1.9 t -152.21 159.18 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.487 -0.758 . . . . 3.18 109.554 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 109' ' ' ARG . 1.8 tp -143.29 114.06 7.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 4.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.8 p -109.24 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 2.8 108.878 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.3 p90 -94.08 150.19 20.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 2.64 111.013 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.47 135.19 37.42 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.537 -0.912 . . . . 2.25 108.537 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . . . -171.68 135.16 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.011 -1.055 . . . . 1.45 110.089 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -130.58 120.97 24.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 1.28 108.979 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -96.18 138.88 33.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 1.07 109.611 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.457 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.6 116.15 16.07 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.903 . . . . 1.68 109.465 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.01 -144.44 0.17 OUTLIER 'Cis proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.217 -1.16 . . . . 1.32 112.225 0.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' OG1' ' A' ' 103' ' ' THR . 4.0 m-20 -109.21 163.17 13.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.75 110.154 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.465 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.0 mtm 165.17 168.08 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.701 -0.851 . . . . 2.72 108.701 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.36 137.91 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.741 2.294 . . . . 1.83 112.466 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 81' ' ' ARG . 0.8 OUTLIER -112.56 -178.4 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.57 109.198 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 132' ' ' HIS . 7.7 ttt180 -121.75 155.72 34.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 6.46 109.772 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HB ' HE21 ' A' ' 97' ' ' GLN . 35.1 t -154.58 150.85 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 4.19 109.11 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -146.78 147.03 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.091 -1.006 . . . . 2.9 109.769 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.584 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -153.66 156.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 2.31 109.576 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.07 -161.52 24.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 1.75 109.593 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.73 -177.06 5.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 2.54 109.536 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.56 -1.416 . . . . 1.77 109.56 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.56 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.501 -0.555 . . . . 6.42 109.501 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -102.47 169.81 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 2.66 110.119 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.29 -16.84 6.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.886 -0.783 . . . . 3.93 108.886 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.64 36.45 0.9 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 4.15 109.281 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.15 71.45 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.95 . . . . 4.6 109.548 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.437 HE21 ' HB ' ' A' ' 82' ' ' VAL . 12.6 pt20 -100.07 167.27 10.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 3.96 109.467 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -146.47 8.38 1.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.695 -1.362 . . . . 3.67 109.695 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -116.23 94.22 4.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -1.159 . . . . 3.79 109.628 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.469 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . . . -134.1 85.36 39.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 2.22 109.485 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.99 133.28 57.2 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.957 2.438 . . . . 3.49 112.47 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -148.74 123.94 10.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 3.46 109.257 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.683 ' HG1' ' H ' ' A' ' 104' ' ' GLY . 0.1 OUTLIER -116.07 175.67 5.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 2.83 109.607 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.683 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -67.52 32.93 0.21 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.395 -1.482 . . . . 2.83 109.395 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.613 ' H ' ' C ' ' A' ' 103' ' ' THR . 15.1 tt0 -110.41 95.44 22.46 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.357 -1.084 . . . . 3.02 109.362 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -47.29 118.34 2.81 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.572 2.182 . . . . 1.42 112.254 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.58 ' CB ' HH12 ' A' ' 109' ' ' ARG . . . -175.73 166.79 3.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 1.81 109.31 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -90.44 145.44 24.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 2.19 110.311 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.58 HH12 ' CB ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -108.62 138.76 44.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.711 -1.218 . . . . 5.23 107.711 178.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.01 102.28 11.29 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.434 -0.791 . . . . 3.28 110.526 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 12.3 m-30 -109.53 115.0 29.11 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.484 -0.932 . . . . 3.78 108.484 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -125.66 165.41 18.63 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.3 -0.875 . . . . 3.99 109.573 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.5 p90 -154.19 -178.06 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.875 . . . . 3.1 109.511 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.539 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -105.99 101.09 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 2.65 109.513 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 34.9 p -36.22 104.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 4.28 109.353 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 114' ' ' THR . 2.4 m120 -93.44 -32.89 14.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 7.59 109.405 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.449 HD21 ' N ' ' A' ' 117' ' ' LEU . 4.6 mm? -122.39 -175.22 3.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 5.5 109.28 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.53 114.95 27.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 4.48 109.629 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 117' ' ' LEU . 5.5 m-85 -112.85 79.24 3.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.955 . . . . 5.99 109.35 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.82 152.24 28.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.705 2.27 . . . . 4.64 112.245 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 125' ' ' ALA . 71.8 Cg_endo -80.33 -32.68 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.597 2.198 . . . . 4.46 111.814 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 123' ' ' GLY . 24.3 m-20 -109.84 -30.34 7.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 4.14 109.55 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -36.46 -34.04 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 4.24 109.531 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.6 OUTLIER -173.72 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 3.59 109.508 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -137.18 153.24 74.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 2.78 109.566 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -68.8 -10.97 30.64 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.947 2.432 . . . . 1.57 112.337 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.9 178.21 17.29 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 1.25 109.348 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -154.35 120.99 5.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -1.227 . . . . 2.18 109.775 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.4 t -144.42 120.7 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.711 -0.848 . . . . 1.87 108.711 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.38 131.55 24.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.013 . . . . 1.45 110.444 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -94.46 115.62 27.82 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.666 -0.864 . . . . 2.4 108.666 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.581 ' O ' ' O ' ' A' ' 81' ' ' ARG . 23.8 m170 -100.02 122.81 43.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 2.98 110.064 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.545 ' CD2' ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -147.13 10.22 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.862 . . . . 2.61 109.27 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.557 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -75.52 126.71 8.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.304 -1.518 . . . . 2.32 109.304 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 138' ' ' ALA . 6.7 mtpm? -165.81 131.27 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 5.66 109.618 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.685 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -49.34 -29.89 6.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.409 -1.33 . . . . 2.71 107.409 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -96.19 7.42 66.77 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.14 -1.984 . . . . 3.14 108.14 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.52 -130.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.862 0.839 . . . . 2.84 110.743 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.686 ' CD2' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER 162.38 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 2.44 109.515 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.63 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -84.42 125.55 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 1.86 109.09 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 13.6 t80 -106.39 112.78 25.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.803 . . . . 2.48 109.285 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.7 m -113.78 96.27 5.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.1 -1.0 . . . . 0.74 110.086 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.417 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -107.96 142.91 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.69 109.221 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.602 ' H ' ' HG1' ' A' ' 71' ' ' THR . 3.5 p -134.33 -3.82 2.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.647 -0.658 . . . . 1.63 109.278 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 9.4 mt-30 -147.54 162.08 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 3.82 110.124 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.549 ' N ' ' OG1' ' A' ' 13' ' ' THR . 93.2 t -160.11 79.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.955 -0.757 . . . . 2.92 108.955 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.423 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -80.3 147.82 30.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 3.25 110.051 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 tp -151.6 112.24 4.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.426 -0.796 . . . . 5.12 109.183 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -166.66 -155.86 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 3.35 109.532 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 65' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 2.29 109.348 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.637 ' C ' ' HG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.496 -0.557 . . . . 3.0 109.496 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 4.75 109.44 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 -30.99 52.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 5.44 109.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.741 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -114.95 96.11 43.81 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 2.86 109.325 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.79 45.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.748 2.299 . . . . 4.15 112.673 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.56 ' N ' ' O ' ' A' ' 10' ' ' LEU . 54.8 t60 -133.25 107.46 8.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.98 . . . . 2.52 109.438 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER -147.28 59.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 2.33 109.465 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 16' ' ' ALA . 47.3 t -160.9 69.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 2.28 109.658 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.3 m-30 -62.57 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 2.6 109.209 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -83.44 -34.69 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 1.66 109.737 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.687 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 21.8 mm-40 -109.72 -84.71 0.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 2.13 109.344 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 20' ' ' GLY . 3.8 p -103.04 142.87 33.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 2.74 109.233 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.82 6.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.098 -1.001 . . . . 3.06 109.496 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 73.64 -148.65 40.51 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.201 -1.16 . . . . 1.72 110.201 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 22' ' ' TRP . 98.6 Cg_endo -88.94 -10.64 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.268 2.646 . . . . 1.97 111.996 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.741 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.4 m95 -54.94 -170.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 2.88 109.757 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -128.26 166.18 19.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 2.07 109.255 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.698 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -170.74 156.34 5.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 2.79 109.755 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER 158.13 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 2.48 109.803 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 89.6 -28.83 6.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.965 -1.112 . . . . 1.7 110.411 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.758 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.71 -141.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.349 . . . . 1.51 109.627 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' ' OG1' ' A' ' 27' ' ' THR . 16.3 p -91.02 133.14 35.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.459 -0.776 . . . . 2.11 109.43 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -36.99 101.34 0.22 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 2.85 109.214 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 51.5 Cg_exo -46.63 150.5 2.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.35 2.033 . . . . 1.4 111.709 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.7 t -136.57 117.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.998 . . . . 1.53 110.207 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -81.45 89.16 6.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.725 . . . . 2.56 109.763 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -63.6 -140.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 1.81 109.492 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -40.09 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 2.21 109.541 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.97 35.64 1.96 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.568 -1.413 . . . . 1.23 109.568 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.17 152.1 31.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -1.128 . . . . 3.37 109.508 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.28 134.52 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 1.4 109.303 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.71 154.23 46.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.335 -0.946 . . . . 1.06 110.471 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.5 m -123.65 134.12 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.629 -0.878 . . . . 1.95 108.629 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.671 ' N ' ' OG ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -74.99 105.85 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 4.79 109.795 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.443 HD23 ' HG1' ' A' ' 27' ' ' THR . 4.5 mm? -117.94 74.82 10.17 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 3.97 109.314 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.47 -56.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.784 2.323 . . . . 4.21 112.195 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 45' ' ' GLN . . . 161.44 -150.66 20.49 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.543 -1.423 . . . . 2.09 109.543 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.03 -0.36 6.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 2.62 109.501 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.635 ' O ' ' N ' ' A' ' 47' ' ' ASN . 2.8 mt-30 -99.38 73.63 1.88 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.256 -1.143 . . . . 2.96 109.539 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.85 49.88 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.392 -1.483 . . . . 2.38 109.392 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.674 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -160.84 87.33 1.74 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -1.114 . . . . 4.04 109.429 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.59 -9.88 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.912 2.408 . . . . 2.75 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.459 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -112.34 31.42 6.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 4.57 109.548 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 30.6 m-20 -123.02 36.78 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 2.38 109.364 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 175.46 119.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.47 109.389 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.37 -152.71 23.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.884 -1.286 . . . . 0.96 109.884 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -144.24 170.46 15.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 1.51 109.355 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.463 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -152.97 172.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.05 -1.031 . . . . 1.51 110.084 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.603 ' CZ ' ' CD1' ' A' ' 10' ' ' LEU . 58.3 t80 -178.43 148.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 2.45 109.556 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.454 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -110.93 -164.92 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 2.95 109.575 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.08 67.39 1.63 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.399 . . . . 2.52 109.604 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.454 ' N ' ' HA3' ' A' ' 127' ' ' GLY . 3.9 t -147.96 91.93 4.77 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -1.185 . . . . 4.19 109.505 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.683 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 60.9 Cg_endo -80.44 154.19 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.763 2.309 . . . . 2.79 112.128 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 59' ' ' PRO . 2.0 t -151.7 148.39 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 3.62 109.736 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -142.94 116.07 0.98 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.228 -1.549 . . . . 3.37 109.228 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.674 ' N ' ' OE2' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -34.35 146.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -1.151 . . . . 6.05 109.762 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.679 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 91.75 -16.6 58.91 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.88 -1.288 . . . . 3.09 109.88 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.671 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.6 mt-10 -112.47 160.92 17.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -1.219 . . . . 4.03 109.836 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -128.29 140.91 51.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 3.28 109.116 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 20.9 m-85 -107.07 177.13 4.95 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.077 -1.014 . . . . 2.59 109.885 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.58 165.25 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.468 -0.77 . . . . 3.18 109.593 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.3 tp -149.9 118.82 6.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 4.0 109.515 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.96 80.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 2.8 109.151 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 50.2 p90 -94.44 146.14 24.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.718 . . . . 2.64 110.831 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.17 138.48 32.81 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.642 -0.873 . . . . 2.25 108.642 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -176.24 122.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.012 -1.055 . . . . 1.45 110.142 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.429 ' HG ' ' HB2' ' A' ' 142' ' ' CYS . 1.5 p -112.44 122.5 47.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -91.24 132.65 35.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.258 -0.901 . . . . 1.07 109.85 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.478 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -135.63 113.97 11.11 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.384 -0.823 . . . . 1.68 109.28 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.578 ' O ' ' C ' ' A' ' 74' ' ' ALA . 18.7 Cg_exo -65.21 -142.25 0.15 OUTLIER 'Cis proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.321 -1.116 . . . . 1.32 112.636 -0.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.662 ' O ' ' SD ' ' A' ' 78' ' ' MET . 1.1 m-20 -108.59 154.97 21.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 1.75 109.726 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 170.34 154.44 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 2.72 109.433 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.19 129.08 12.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.778 2.319 . . . . 1.83 112.306 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.497 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 0.8 OUTLIER -106.12 -178.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 2.57 109.244 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -129.16 147.08 50.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 6.46 109.715 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -150.0 155.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 4.19 109.216 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.412 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -141.65 151.28 42.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.132 -0.98 . . . . 2.9 109.856 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.574 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -150.33 162.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 2.31 109.472 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 139.56 -147.75 19.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.708 -1.357 . . . . 1.75 109.708 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.685 ' OE2' ' CZ ' ' A' ' 119' ' ' PHE . 0.2 OUTLIER -90.41 162.45 15.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -1.114 . . . . 2.54 109.469 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.493 -1.443 . . . . 1.77 109.493 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.718 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 6.42 109.637 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -101.9 174.18 6.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 2.66 109.877 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -127.43 -17.16 4.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.49 -0.756 . . . . 3.93 109.168 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.4 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.72 36.42 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 4.15 109.43 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -83.96 70.99 10.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 4.6 109.479 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.774 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -102.03 178.86 4.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 3.96 109.563 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.633 ' CA ' ' OE1' ' A' ' 97' ' ' GLN . . . -157.75 17.09 0.33 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.617 -1.393 . . . . 3.67 109.617 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.774 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.7 m -111.05 63.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 3.79 109.686 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.12 97.18 29.02 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 2.22 109.253 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.58 118.2 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.67 2.247 . . . . 3.49 112.667 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 102' ' ' LEU . 4.1 mm? -115.87 143.05 45.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 3.46 109.169 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.625 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -127.36 166.56 17.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 2.83 109.522 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.93 24.49 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 2.83 109.505 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.625 ' H ' ' C ' ' A' ' 103' ' ' THR . 13.3 tt0 -109.9 96.59 25.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 3.02 109.363 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.14 118.43 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.551 2.167 . . . . 1.42 112.195 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.62 ' O ' ' NE ' ' A' ' 109' ' ' ARG . . . -169.99 164.2 9.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.846 . . . . 1.81 109.439 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.29 140.24 29.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 2.19 109.859 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.724 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -105.45 134.8 47.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.842 -1.17 . . . . 5.23 107.842 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -109.11 99.79 9.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 3.28 110.893 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.3 m-30 -109.93 130.3 55.55 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.319 -0.993 . . . . 3.78 108.319 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -134.4 163.21 30.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 3.99 109.849 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.621 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -142.97 173.47 11.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 3.1 109.516 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 121.33 42.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 2.65 109.776 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 93.5 p -48.97 143.81 5.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 4.28 109.431 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.56 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 6.7 p-10 -134.31 -46.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 7.59 109.516 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 119' ' ' PHE . 5.0 tt -109.97 175.25 5.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 5.5 109.461 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -92.95 124.32 36.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 4.48 109.864 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.685 ' CZ ' ' OE2' ' A' ' 86' ' ' GLU . 45.0 m-85 -134.75 93.63 17.75 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 5.99 109.258 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.6 165.53 22.66 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.678 2.252 . . . . 4.64 112.267 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.83 -14.5 12.47 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.858 2.372 . . . . 4.46 112.079 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 2.5 p-10 -109.65 115.52 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 4.14 109.527 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . 167.64 173.17 35.5 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 4.24 109.475 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.97 26.64 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 3.59 109.499 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 123' ' ' GLY . . . 179.94 74.11 0.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 2.78 109.543 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' A' ' 127' ' ' GLY . 56.0 Cg_endo -75.31 -158.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.77 2.314 . . . . 1.57 112.249 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -39.16 163.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.587 -1.405 . . . . 1.25 109.587 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -162.28 122.22 2.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -1.181 . . . . 2.18 109.721 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.409 ' CG2' HG13 ' A' ' 84' ' ' VAL . 8.4 p -146.53 130.52 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.424 -0.954 . . . . 1.87 108.424 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' CB ' HG12 ' A' ' 54' ' ' VAL . . . -148.26 123.26 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.961 -1.087 . . . . 1.45 110.731 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.9 m-30 -86.92 118.93 26.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.807 -1.183 . . . . 2.4 107.807 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.412 ' ND1' HD21 ' A' ' 83' ' ' LEU . 6.1 m170 -99.94 131.87 45.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 2.98 110.151 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 134' ' ' GLY . 3.8 mp -134.4 -105.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 2.61 109.124 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 32.49 98.16 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.048 -1.221 . . . . 2.32 110.048 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.7 mtpt -146.68 123.67 11.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 5.66 109.857 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.16 -20.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.147 -0.97 . . . . 2.71 108.46 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -120.66 13.35 10.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.025 -1.63 . . . . 3.14 109.025 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.616 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -52.17 -152.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.967 . . . . 2.84 110.26 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 11.9 p90 -164.63 -131.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -0.99 . . . . 2.44 109.374 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.417 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 26.5 mt-10 -120.3 128.29 53.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 1.86 109.38 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 143' ' ' ILE . 5.5 t80 -107.91 111.36 23.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 2.48 109.661 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.429 ' HB2' ' HG ' ' A' ' 73' ' ' SER . 1.7 m -107.5 88.43 2.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.74 110.141 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.458 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -99.32 135.87 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 1.69 108.844 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 15' ' ' PHE . 60.0 p -128.05 -0.9 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 1.63 109.313 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 23.7 mt-30 -152.2 174.61 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 3.82 109.977 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.627 ' O ' ' CG1' ' A' ' 146' ' ' VAL . 8.0 p -177.24 92.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 2.92 109.102 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.39 144.68 31.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 3.25 110.056 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 149' ' ' THR . 8.9 tp -130.08 120.09 24.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 5.12 109.019 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.637 ' HG1' ' C ' ' A' ' 7' ' ' VAL . 2.6 t -158.06 -170.18 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 3.35 109.661 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.486 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 2.29 109.45 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.645 ' H ' ' HG1' ' A' ' 149' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.368 -0.604 . . . . 3.0 109.368 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -175.33 86.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 4.75 109.636 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -83.97 -18.57 36.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 5.44 109.425 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.669 ' O ' ' N ' ' A' ' 12' ' ' HIS . 3.0 tm? -130.06 86.31 54.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 2.86 108.782 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.37 41.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.35 2.7 . . . . 4.15 113.509 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.669 ' N ' ' O ' ' A' ' 10' ' ' LEU . 16.8 t60 -152.26 111.69 3.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.878 -1.139 . . . . 2.52 109.463 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.541 ' OG1' ' C ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -159.89 65.65 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 2.33 109.506 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 16' ' ' ALA . 23.4 m -153.03 66.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 2.28 109.592 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -63.22 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 2.6 109.11 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -89.95 -78.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 1.66 109.915 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.16 38.61 2.25 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.247 -0.908 . . . . 2.13 109.867 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.97 150.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 2.74 109.59 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.04 -69.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 3.06 109.577 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 113.53 -172.03 14.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.408 -1.477 . . . . 1.72 109.408 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.468 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.5 Cg_endo -70.31 -10.0 27.15 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.703 2.269 . . . . 1.97 112.189 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.555 ' CH2' ' CG2' ' A' ' 146' ' ' VAL . 7.8 m95 -61.91 -169.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 2.88 109.246 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -150.37 162.27 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 2.07 109.496 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 pp -160.82 149.96 16.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 2.79 109.489 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -177.52 133.92 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 2.48 109.437 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.405 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 148.51 -40.08 0.94 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.827 -1.309 . . . . 1.7 109.827 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.817 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -110.01 -141.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 1.51 109.39 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.817 ' N ' ' OG1' ' A' ' 27' ' ' THR . 47.8 p -90.86 155.86 18.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 2.11 109.434 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -49.91 110.89 1.79 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.85 109.03 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HB3' ' SD ' ' A' ' 37' ' ' MET . 49.9 Cg_exo -47.29 171.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.192 1.928 . . . . 1.4 111.775 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.51 109.68 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.026 -1.046 . . . . 1.53 110.054 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.725 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.2 85.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 2.56 109.289 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.19 -140.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 1.81 109.74 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.609 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 7.3 p-10 -53.23 -57.0 12.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 2.21 109.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.38 44.47 0.69 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.405 -1.478 . . . . 1.23 109.405 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.46 143.96 7.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -1.118 . . . . 3.37 109.728 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.53 ' SD ' ' C ' ' A' ' 37' ' ' MET . 4.9 tmm? -110.87 124.86 52.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 1.4 109.058 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.6 m -122.12 157.98 30.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -0.902 . . . . 1.06 110.226 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 146.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 1.95 108.687 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.474 ' C ' ' CD ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -75.67 121.39 22.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 4.79 109.207 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.652 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.3 mm? -117.76 36.7 0.23 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.084 -1.01 . . . . 3.97 110.998 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 84.8 Cg_endo -80.59 -95.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.491 2.127 . . . . 4.21 111.427 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . 46.33 -107.8 0.21 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.699 -0.961 . . . . 2.09 110.699 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.4 57.31 0.01 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.44 -1.864 . . . . 2.62 108.44 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 136' ' ' ALA . 32.8 mt-30 -99.58 104.75 16.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -1.056 . . . . 2.96 110.027 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -77.55 40.42 1.79 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.408 -1.477 . . . . 2.38 109.408 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.648 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 0.3 OUTLIER -159.43 93.04 1.8 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 4.04 109.528 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.66 ' O ' ' N ' ' A' ' 50' ' ' ASP . 52.0 Cg_exo -49.6 -38.8 45.93 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.804 2.336 . . . . 2.75 112.407 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.458 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 11.8 p90 -62.68 50.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 4.57 109.527 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.3 m-20 -149.48 13.29 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 2.38 109.698 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.405 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . 175.18 152.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 1.47 109.515 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.1 176.05 24.38 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.923 -1.271 . . . . 0.96 109.923 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 53' ' ' LEU . 5.4 mt -85.18 -177.15 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -1.134 . . . . 1.51 109.205 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -162.16 159.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.151 -0.968 . . . . 1.51 110.989 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.634 ' OH ' ' CD2' ' A' ' 10' ' ' LEU . 41.2 t80 178.63 124.19 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.41 -0.589 . . . . 2.45 109.41 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -101.35 -171.23 1.95 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.24 -0.913 . . . . 2.95 109.498 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.528 ' O ' ' CG1' ' A' ' 58' ' ' VAL . . . 80.88 72.24 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.65 -1.38 . . . . 2.52 109.65 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 57' ' ' GLY . 11.0 m -161.92 68.12 2.18 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 4.19 109.413 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.36 148.59 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.854 2.369 . . . . 2.79 112.227 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.61 101.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 3.62 109.53 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -92.45 116.02 4.97 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.481 -1.448 . . . . 3.37 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.626 ' C ' ' HG ' ' A' ' 115' ' ' SER . 1.6 tm-20 -47.74 149.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.143 -1.21 . . . . 6.05 109.544 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 93.39 -24.37 25.71 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.748 -1.341 . . . . 3.09 109.748 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.721 ' H ' ' HG ' ' A' ' 115' ' ' SER . 1.4 mm-40 -101.52 164.62 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -1.172 . . . . 4.03 109.659 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.413 ' HG ' ' HA ' ' A' ' 114' ' ' THR . 47.7 m -131.34 135.27 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 3.28 109.433 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 63.0 m-85 -105.36 178.19 4.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.229 -0.92 . . . . 2.59 109.852 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 3.0 t -152.03 151.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 3.18 109.31 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tp -137.58 118.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 4.0 109.785 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -109.64 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.518 -0.919 . . . . 2.8 108.518 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.0 p90 -94.12 145.99 24.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 2.64 111.453 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -91.78 134.29 34.87 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.321 -0.992 . . . . 2.25 108.321 178.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.769 ' N ' ' NH2' ' A' ' 109' ' ' ARG . . . -164.0 113.31 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.816 -1.178 . . . . 1.45 110.395 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 p -103.48 122.6 45.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.641 -0.874 . . . . 1.28 108.641 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.566 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -93.31 135.39 34.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 1.07 109.752 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.516 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.21 112.07 6.63 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.225 -0.922 . . . . 1.68 109.717 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.7 Cg_exo -64.09 -141.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.748 0 C-N-CA 124.253 -1.145 . . . . 1.32 112.393 -0.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.48 150.71 24.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 1.75 109.757 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.715 ' CE ' ' HZ1' ' A' ' 135' ' ' LYS . 0.5 OUTLIER 173.01 154.54 0.25 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.72 109.34 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.25 140.68 22.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.767 2.311 . . . . 1.83 112.149 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.561 ' O ' ' O ' ' A' ' 98' ' ' GLY . 7.3 m -111.84 -179.55 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 2.57 109.461 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.721 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.24 151.21 44.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 6.46 109.565 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -154.37 154.51 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 4.19 109.536 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.705 ' CD1' HE22 ' A' ' 128' ' ' GLN . 0.8 OUTLIER -151.19 141.93 22.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.957 . . . . 2.9 109.751 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.598 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -153.34 146.36 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 2.31 109.663 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.12 -132.09 4.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.588 -1.405 . . . . 1.75 109.588 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' CD ' ' CE1' ' A' ' 119' ' ' PHE . 15.2 pt-20 -90.33 134.31 34.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 2.54 109.417 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.614 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.646 -1.382 . . . . 1.77 109.646 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.521 -0.548 . . . . 6.42 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -176.83 -164.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 2.66 109.692 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.7 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.7 -25.63 10.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.614 -0.884 . . . . 3.93 108.614 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -91.17 35.99 0.92 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 4.15 108.992 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.18 43.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.079 -1.013 . . . . 4.6 109.492 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.42 114.47 28.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.264 -0.897 . . . . 3.96 109.149 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -103.57 13.94 53.98 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 3.67 109.543 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -92.6 64.02 4.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -1.124 . . . . 3.79 109.526 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.72 101.8 30.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 2.22 109.166 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.54 121.79 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.519 2.146 . . . . 3.49 112.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.45 ' CD2' ' CZ ' ' A' ' 109' ' ' ARG . 63.0 mt -127.33 130.33 49.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 3.46 109.327 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.656 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -119.73 -179.78 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 2.83 109.601 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -66.76 24.05 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.445 -1.462 . . . . 2.83 109.445 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.656 ' H ' ' C ' ' A' ' 103' ' ' THR . 6.7 tm-20 -112.17 92.98 20.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.304 -1.115 . . . . 3.02 109.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.83 118.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.66 2.24 . . . . 1.42 112.255 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.648 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . . . -166.06 162.41 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 1.81 109.406 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 146.71 23.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 2.19 109.914 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.769 ' NH2' ' N ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -109.75 134.81 51.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.66 -1.237 . . . . 5.23 107.66 177.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.54 ' OE1' ' C ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -114.35 102.26 9.94 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.93 -0.708 . . . . 3.28 110.599 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 14.8 m-85 -109.83 122.0 46.52 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.498 -0.927 . . . . 3.78 108.498 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.68 133.75 55.64 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.251 -0.906 . . . . 3.99 109.721 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.727 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -118.3 164.11 15.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 3.1 109.285 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.522 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -104.79 104.9 14.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 2.65 109.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.721 ' HG ' ' H ' ' A' ' 64' ' ' GLU . 53.7 p -35.93 107.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 4.28 109.25 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 15.7 t30 -86.04 -55.06 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 7.59 109.706 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.712 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -111.31 -158.64 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 5.5 109.804 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.712 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -117.24 150.56 38.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.363 -0.836 . . . . 4.48 109.393 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 72.8 m-85 -162.45 73.91 2.17 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.86 . . . . 5.99 109.548 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.35 167.87 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.858 2.372 . . . . 4.64 112.011 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.53 -15.66 10.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.813 2.342 . . . . 4.46 112.091 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.637 ' OD2' ' N ' ' A' ' 123' ' ' GLY . 5.5 p-10 -111.29 -113.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.888 . . . . 4.14 109.443 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.637 ' N ' ' OD2' ' A' ' 122' ' ' ASP . . . 36.12 -112.5 0.13 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.654 -1.379 . . . . 4.24 109.654 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.8 -102.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -1.16 . . . . 3.59 109.527 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.614 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -101.84 152.73 38.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 2.78 109.493 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 -158.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.838 2.359 . . . . 1.57 112.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -77.17 164.2 52.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.586 -1.406 . . . . 1.25 109.586 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.705 HE22 ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -142.36 126.24 17.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 2.18 109.439 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.09 90.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.57 -0.9 . . . . 1.87 108.57 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.62 122.14 46.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 1.45 110.45 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -84.21 117.13 23.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.422 -0.955 . . . . 2.4 108.422 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.567 ' O ' ' O ' ' A' ' 81' ' ' ARG . 13.4 m170 -99.5 119.38 37.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 2.98 110.044 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -136.59 -0.9 2.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 2.61 109.421 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.78 135.0 32.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.256 -1.538 . . . . 2.32 109.256 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.715 ' HZ1' ' CE ' ' A' ' 78' ' ' MET . 9.3 mtmt -166.81 129.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 5.66 109.552 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.02 -26.67 1.88 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.467 -1.308 . . . . 2.71 107.467 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -104.28 11.98 51.53 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.293 -1.923 . . . . 3.14 108.293 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.51 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.645 0.736 . . . . 2.84 110.641 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 179.93 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.609 -1.307 . . . . 2.44 110.715 -179.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.428 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 49.7 mt-10 -123.67 143.57 50.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 1.86 109.25 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.556 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 15.2 t80 -126.22 120.63 30.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 2.48 109.727 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -119.06 97.29 5.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.74 109.853 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.454 HG21 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -106.45 141.61 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 1.69 109.261 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.592 ' H ' ' HG1' ' A' ' 71' ' ' THR . 58.4 p -139.02 -2.62 1.66 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.617 -0.677 . . . . 1.63 109.556 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 71' ' ' THR . 14.0 mt-30 -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 3.82 110.242 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.555 ' CG2' ' CH2' ' A' ' 22' ' ' TRP . 2.8 p -160.94 73.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.004 -0.739 . . . . 2.92 109.004 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.443 ' N ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -76.48 147.1 38.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 3.25 110.18 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.6 tp -138.56 101.59 4.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.492 -0.755 . . . . 5.12 109.106 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.645 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -149.07 -176.61 5.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 3.35 109.726 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.518 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.9 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 2.29 109.281 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.425 -0.583 . . . . 3.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.39 104.38 16.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 4.75 109.531 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.34 -15.83 55.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 5.44 109.523 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.516 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -121.75 94.97 48.17 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 2.86 108.819 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.99 26.83 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.388 2.059 . . . . 4.15 111.548 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.516 ' H ' HD13 ' A' ' 10' ' ' LEU . 30.6 t60 -123.39 84.71 2.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 2.52 109.594 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.624 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -129.1 50.26 2.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 2.33 109.331 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.661 ' C ' ' H ' ' A' ' 16' ' ' ALA . 25.0 p -128.26 64.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 2.28 109.786 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -64.73 35.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.957 . . . . 2.6 108.967 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.661 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.35 -48.73 6.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 1.66 110.282 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.3 mm-40 -109.9 -83.51 0.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 2.13 109.87 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 m -76.95 144.5 38.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 2.74 109.662 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.407 ' CD2' HD12 ' A' ' 24' ' ' LEU . 1.6 tp -60.13 -57.86 11.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.322 -0.861 . . . . 3.06 109.487 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.3 -177.83 17.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.559 -1.416 . . . . 1.72 109.559 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.78 -5.94 16.41 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.857 2.371 . . . . 1.97 112.16 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.516 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 8.8 m95 -65.35 -164.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 2.88 109.222 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB3' ' HH ' ' A' ' 25' ' ' TYR . 1.6 m -144.58 131.88 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 2.07 109.845 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.7 148.94 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 2.79 109.452 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.694 ' HH ' ' CG1' ' A' ' 54' ' ' VAL . 0.0 OUTLIER 163.9 -168.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 2.48 109.749 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.84 -22.89 1.77 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.103 -1.199 . . . . 1.7 110.103 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.8 ' HG1' ' H ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.77 -142.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.249 . . . . 1.51 109.224 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.8 ' H ' ' HG1' ' A' ' 27' ' ' THR . 91.1 p -90.95 129.9 36.92 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.171 -0.955 . . . . 2.11 109.17 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.562 ' C ' ' O ' ' A' ' 28' ' ' SER . 18.5 mt-10 -33.93 98.53 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 2.85 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 28' ' ' SER . 54.9 Cg_exo -46.92 146.14 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.372 2.048 . . . . 1.4 111.821 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.94 116.58 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.053 . . . . 1.53 110.014 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.73 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.81 89.69 3.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.46 -0.775 . . . . 2.56 109.472 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.16 -140.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.5 -0.75 . . . . 1.81 110.295 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -69.56 15.55 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 2.21 110.358 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 33' ' ' ALA . . . 148.71 -6.75 0.89 Allowed Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.396 -1.383 . . . . 1.23 110.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.628 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.73 146.08 47.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.359 . . . . 3.37 109.803 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.572 ' SD ' ' C ' ' A' ' 37' ' ' MET . 1.6 tmm? -109.84 129.76 55.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 1.4 108.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.03 145.8 51.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 1.06 110.57 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG13 ' HG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -115.58 174.95 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.567 -0.901 . . . . 1.95 108.567 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.707 ' H ' ' HG ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -134.39 135.22 42.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.028 -1.045 . . . . 4.79 109.696 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.48 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 3.7 mm? -135.62 60.91 39.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.985 . . . . 3.97 110.489 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 41' ' ' LEU . 61.2 Cg_endo -98.38 -15.16 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.091 2.528 . . . . 4.21 112.203 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.38 -142.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.932 -0.867 . . . . 2.09 110.932 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.424 ' HA2' ' CB ' ' A' ' 136' ' ' ALA . . . -133.98 78.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.678 -1.369 . . . . 2.62 109.678 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -99.7 127.02 45.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -1.217 . . . . 2.96 109.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.77 64.81 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.579 -1.408 . . . . 2.38 109.579 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.659 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -173.56 135.19 0.66 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.152 . . . . 4.04 109.411 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.676 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 60.1 Cg_endo -75.94 -13.31 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.549 2.166 . . . . 2.75 112.375 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.691 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -111.77 38.65 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 4.57 110.002 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.691 ' OD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -119.35 38.08 3.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 2.38 109.542 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 160.39 133.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.47 109.639 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.36 -162.22 28.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.866 -1.294 . . . . 0.96 109.866 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -136.06 168.84 18.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -1.174 . . . . 1.51 109.293 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.694 ' CG1' ' HH ' ' A' ' 25' ' ' TYR . 1.5 p -155.48 164.8 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.083 -1.011 . . . . 1.51 110.137 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 63.7 t80 -178.63 141.67 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.576 -0.703 . . . . 2.45 109.656 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.691 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 8.2 m120 -88.1 -152.86 0.22 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.331 -0.856 . . . . 2.95 109.366 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.82 79.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 2.52 109.546 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.486 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 5.6 t -117.76 68.57 6.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.15 . . . . 4.19 109.562 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.05 160.7 48.69 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.716 2.277 . . . . 2.79 112.132 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.469 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 20.3 t -151.94 132.31 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 3.62 109.612 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.581 ' C ' ' HG ' ' A' ' 115' ' ' SER . . . -108.35 104.22 1.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.495 -1.442 . . . . 3.37 109.495 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.8 tm-20 -35.4 121.0 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -1.119 . . . . 6.05 109.562 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 115' ' ' SER . . . 130.66 -45.09 1.16 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.889 -1.285 . . . . 3.09 109.889 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.5 mm-40 -100.03 171.76 7.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -1.156 . . . . 4.03 109.804 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.2 m -116.21 144.71 43.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 3.28 109.297 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.554 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 20.2 m-85 -108.28 179.43 4.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.198 -0.939 . . . . 2.59 109.773 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG12 ' CG ' ' A' ' 110' ' ' GLU . 1.4 t -150.34 141.74 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -0.766 . . . . 3.18 109.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 HD21 ' CE1' ' A' ' 70' ' ' PHE . 3.8 tp -124.59 119.9 30.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 4.0 108.883 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -115.65 90.13 3.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.031 . . . . 2.8 109.897 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.64 147.58 22.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 2.64 110.878 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.405 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -97.1 113.64 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 2.25 109.176 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -178.58 176.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.914 -1.116 . . . . 1.45 110.667 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -156.07 154.04 30.35 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.087 -0.708 . . . . 1.28 109.087 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -94.04 134.18 36.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 1.07 109.612 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.451 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.71 116.04 14.73 Favored Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.279 -0.888 . . . . 1.68 109.559 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.5 Cg_exo -65.89 -141.9 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.427 -1.072 . . . . 1.32 112.562 -0.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -91.26 151.96 20.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 1.75 109.786 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.1 mtp 161.09 157.3 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 2.72 109.347 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 64.2 Cg_endo -77.56 147.32 25.06 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.779 2.32 . . . . 1.83 112.235 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 m -113.91 170.68 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 2.57 109.425 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -109.93 151.21 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 6.46 109.352 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 97' ' ' GLN . 19.5 t -152.59 149.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 4.19 109.581 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.732 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.3 pp -150.92 145.84 25.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 2.9 109.463 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.467 HG23 ' CD2' ' A' ' 95' ' ' PHE . 1.4 t -146.49 152.06 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 2.31 109.729 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 163.64 -148.45 14.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 1.75 109.455 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.667 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 12.1 pm0 -90.14 179.1 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -1.102 . . . . 2.54 109.339 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.409 . . . . 1.77 109.576 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.716 HH11 ' CG ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.471 -0.566 . . . . 6.42 109.471 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -104.37 161.41 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 2.66 109.958 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -112.26 -18.68 12.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.704 -0.85 . . . . 3.93 108.704 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.677 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.79 35.78 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 4.15 109.286 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.89 57.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 4.6 109.394 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.683 ' OE1' ' N ' ' A' ' 98' ' ' GLY . 0.1 OUTLIER -100.0 129.5 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 3.96 108.87 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 97' ' ' GLN . . . -119.21 -9.9 8.43 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.763 -1.208 . . . . 3.67 110.142 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.673 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 1.8 m -80.42 77.1 7.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.253 . . . . 3.79 109.551 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.88 85.33 22.56 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 2.22 109.593 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.73 127.28 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.976 2.451 . . . . 3.49 112.509 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.466 HD22 ' NH2' ' A' ' 109' ' ' ARG . 6.3 mt -142.28 127.56 18.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 3.46 109.379 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.751 ' HG1' ' H ' ' A' ' 104' ' ' GLY . 9.3 t -111.67 -165.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 2.83 109.733 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.751 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -84.18 31.99 3.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.438 . . . . 2.83 109.504 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.68 96.44 23.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 3.02 109.345 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -46.88 118.2 2.58 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.53 2.153 . . . . 1.42 112.248 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -169.13 169.8 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 1.81 109.491 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.25 143.85 26.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 2.19 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.719 ' N ' ' CD ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.17 131.64 51.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.79 -1.189 . . . . 5.23 107.79 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.421 ' CG ' HG12 ' A' ' 67' ' ' VAL . 14.6 tt0 -117.4 96.18 5.29 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.632 -0.827 . . . . 3.28 110.548 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 6.7 m-30 -109.46 117.24 33.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.178 -1.045 . . . . 3.78 108.178 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -115.98 174.18 6.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -0.893 . . . . 3.99 109.822 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 2.0 p90 -154.71 179.28 9.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.333 -0.854 . . . . 3.1 109.618 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.52 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -107.64 106.9 17.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.438 -0.789 . . . . 2.65 109.614 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.581 ' HG ' ' C ' ' A' ' 61' ' ' GLY . 8.2 t -36.06 116.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 4.28 109.322 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.503 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -96.95 -50.46 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 7.59 109.527 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 118' ' ' THR . 2.5 mt -112.92 -166.0 1.04 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 5.5 109.662 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.468 ' H ' HD21 ' A' ' 117' ' ' LEU . 0.7 OUTLIER -108.01 124.75 50.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 4.48 109.419 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.644 ' CE1' ' CD ' ' A' ' 86' ' ' GLU . 34.1 m-85 -137.02 66.04 53.37 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 5.99 109.472 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.64 166.9 25.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.858 2.372 . . . . 4.64 112.097 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.99 -19.66 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.763 2.309 . . . . 4.46 112.002 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.61 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -110.28 111.76 23.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 4.14 109.455 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.02 -138.06 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.575 -1.41 . . . . 4.24 109.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.12 . . . . 3.59 109.484 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.86 149.75 66.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 2.78 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.12 -158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.789 2.326 . . . . 1.57 112.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -64.93 172.29 20.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.648 -1.381 . . . . 1.25 109.648 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.6 114.36 5.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -1.129 . . . . 2.18 109.739 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 129' ' ' VAL . 0.8 OUTLIER -133.34 134.11 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.952 -1.129 . . . . 1.87 107.952 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.12 119.91 5.7 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.836 -1.146 . . . . 1.45 110.718 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.7 m-30 -83.9 120.57 26.24 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.048 -1.093 . . . . 2.4 108.048 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.732 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 1.6 m170 -99.67 116.09 30.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 2.98 109.896 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -138.45 37.44 2.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 2.61 109.162 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -92.72 110.39 3.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.437 -1.465 . . . . 2.32 109.437 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 137' ' ' GLY . 56.8 mttt -159.78 134.87 8.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -1.14 . . . . 5.66 109.856 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -37.25 -23.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.701 -0.852 . . . . 2.71 108.701 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.731 ' C ' ' H ' ' A' ' 139' ' ' TYR . . . -135.11 24.38 3.42 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.51 -1.436 . . . . 3.14 109.51 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.719 ' O ' ' CG ' ' A' ' 139' ' ' TYR . . . -52.93 7.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.299 . . . . 2.84 110.486 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.731 ' H ' ' C ' ' A' ' 137' ' ' GLY . 6.3 p90 48.32 -165.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.379 0.609 . . . . 2.44 110.751 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 4.8 mt-10 -96.99 159.59 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.86 110.459 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -129.81 102.64 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.907 -0.775 . . . . 2.48 108.907 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 7.5 m -87.06 119.25 27.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.74 110.267 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.439 HG21 ' SD ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -133.23 144.73 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.822 0.82 . . . . 1.69 109.35 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.463 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 92.9 p -136.85 -11.64 1.75 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.284 -0.567 . . . . 1.63 109.556 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -155.88 168.47 27.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.98 . . . . 3.82 109.997 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.624 ' N ' ' OG1' ' A' ' 13' ' ' THR . 7.8 p -150.37 131.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.432 -0.792 . . . . 2.92 109.26 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -115.57 150.3 36.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.089 -1.007 . . . . 3.25 109.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 149' ' ' THR . 1.7 tp -157.86 114.01 2.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 5.12 109.365 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.45 ' N ' HD12 ' A' ' 148' ' ' LEU . 9.7 t -164.36 -155.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 3.35 109.478 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.93 . . . . 2.29 109.361 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.473 -0.566 . . . . 3.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.555 ' OE2' ' N ' ' A' ' 148' ' ' LEU . 25.1 tp10 -87.52 97.02 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 4.75 109.504 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.88 -35.42 72.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 5.44 109.444 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -110.47 93.96 17.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 2.86 108.65 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.81 26.46 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.299 1.999 . . . . 4.15 111.525 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.533 ' H ' HD13 ' A' ' 10' ' ' LEU . 46.4 t60 -119.88 95.56 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 2.52 109.602 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.465 ' HG1' ' HB3' ' A' ' 145' ' ' GLN . 2.6 t -130.4 51.07 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 2.33 109.304 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.642 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.7 m -114.4 52.91 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 2.28 109.769 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.02 20.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 2.6 108.984 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.11 -65.62 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 1.66 110.009 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 18' ' ' SER . 1.4 mt-10 -109.96 38.88 2.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 2.13 109.911 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 2.5 p 170.16 144.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.161 -0.962 . . . . 2.74 109.708 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.02 -69.19 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 3.06 109.433 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.18 177.58 19.53 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.546 -1.422 . . . . 1.72 109.546 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -53.5 -21.47 18.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.762 2.308 . . . . 1.97 112.048 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.481 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 18.0 m95 -58.33 167.81 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 2.88 109.502 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.9 m -132.45 176.58 8.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 2.07 109.046 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pp -175.63 153.15 1.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 2.79 110.059 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.688 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -178.44 136.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.538 -0.726 . . . . 2.48 109.111 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 135.27 -27.68 3.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.944 -1.263 . . . . 1.7 109.944 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.769 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.66 -141.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.027 -1.278 . . . . 1.51 109.554 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.769 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.8 p -91.52 -167.17 1.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.959 -0.756 . . . . 2.11 108.959 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.57 110.61 42.43 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 2.85 108.916 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -45.37 138.24 10.31 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.228 1.952 . . . . 1.4 111.829 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 12.5 p -118.69 93.52 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 1.53 109.932 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.07 81.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.506 -0.746 . . . . 2.56 109.446 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -98.74 -109.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 1.81 109.617 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 35' ' ' GLY . 3.0 t0 -51.62 79.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 2.21 109.577 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 35.62 47.14 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.586 -1.405 . . . . 1.23 109.586 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -176.51 151.56 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 3.37 109.498 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 37' ' ' MET . 4.8 ptt? -109.46 130.94 55.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 1.4 109.803 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.447 ' H ' HG13 ' A' ' 31' ' ' VAL . 56.5 m -109.97 128.74 55.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.793 . . . . 1.06 109.563 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.1 133.04 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 1.95 109.22 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.3 m-20 -80.53 128.76 33.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 4.79 109.248 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.642 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 3.5 mm? -110.28 95.54 22.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 3.97 109.587 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.675 ' O ' ' NZ ' ' A' ' 135' ' ' LYS . 52.5 Cg_endo -78.95 144.08 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.604 2.203 . . . . 4.21 112.147 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -81.09 161.49 43.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.826 -1.31 . . . . 2.09 109.826 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.16 -7.25 1.16 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.059 -1.216 . . . . 2.62 110.059 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.457 ' OE1' ' CB ' ' A' ' 50' ' ' ASP . 41.5 mt-30 -120.69 174.3 6.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.023 -1.281 . . . . 2.96 109.785 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.97 -8.25 3.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.488 -1.445 . . . . 2.38 109.488 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.68 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -99.96 133.29 21.74 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -1.175 . . . . 4.04 109.353 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.17 1.03 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.478 2.119 . . . . 2.75 112.652 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.67 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.1 p-90 -118.53 38.39 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 4.57 110.09 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 0.8 OUTLIER -112.41 12.72 20.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.998 . . . . 2.38 109.691 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . 179.72 134.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 1.47 109.383 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.63 171.13 34.92 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.609 -1.281 . . . . 0.96 110.222 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.545 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 7.3 mt -75.65 -178.19 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -1.153 . . . . 1.51 109.31 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 99.2 t -161.08 167.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 1.51 109.65 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 32.0 t80 176.22 145.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.512 -0.743 . . . . 2.45 109.414 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.577 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -107.66 171.7 7.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.936 . . . . 2.95 109.589 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.545 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 93.62 70.87 1.13 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 2.52 109.53 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 57' ' ' GLY . 43.0 t -162.41 86.79 1.45 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 4.19 109.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -79.07 162.88 25.86 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.676 2.251 . . . . 2.79 112.153 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.464 ' HA ' ' HH ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.26 114.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 3.62 109.654 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -108.6 135.31 12.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.295 -1.522 . . . . 3.37 109.295 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' HB3' ' N ' ' A' ' 118' ' ' THR . 6.5 pt-20 -72.7 139.32 47.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -1.156 . . . . 6.05 109.656 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 125.24 -50.0 0.89 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.631 -1.387 . . . . 3.09 109.631 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.97 157.76 16.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.126 -1.22 . . . . 4.03 109.654 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 150' ' ' THR . 71.0 m -100.01 134.36 43.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 3.28 109.294 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 74.8 m-85 -92.95 174.48 7.21 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 2.59 109.689 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 66' ' ' TYR . 54.4 t -162.6 118.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 3.18 109.482 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 tt -109.6 158.71 17.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 4.0 109.158 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.535 ' OG ' ' OG ' ' A' ' 147' ' ' SER . 0.2 OUTLIER -154.41 106.46 2.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 2.8 109.427 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 2.1 p90 -94.39 147.51 23.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.106 -0.996 . . . . 2.64 110.378 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -100.19 94.54 6.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.851 -0.796 . . . . 2.25 108.851 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 107' ' ' ALA . . . -163.79 -177.08 4.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.039 -1.038 . . . . 1.45 109.709 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 105' ' ' GLU . 13.2 p -164.46 136.92 4.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -0.827 . . . . 1.28 109.333 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -87.81 145.11 26.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 1.07 109.119 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 104' ' ' GLY . 0.7 OUTLIER -131.8 116.76 16.01 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 1.68 109.343 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.3 Cg_exo -66.07 -142.59 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.384 -1.09 . . . . 1.32 112.495 -0.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -95.35 151.53 19.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 1.75 109.576 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.574 ' SD ' ' CG ' ' A' ' 139' ' ' TYR . 7.4 ptm 178.21 151.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 2.72 109.511 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.674 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 56.8 Cg_endo -74.41 122.01 7.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.764 2.309 . . . . 1.83 112.233 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 m -102.39 172.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 2.57 109.476 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 79' ' ' PRO . 8.8 mpt_? -114.14 166.27 11.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 6.46 109.461 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 81' ' ' ARG . 88.5 t -160.32 156.45 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 4.19 109.311 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.545 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -159.56 148.08 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 2.9 109.441 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -150.76 148.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -0.972 . . . . 2.31 109.929 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.83 2.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.218 -1.553 . . . . 1.75 109.218 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.5 pt-20 -90.35 178.7 6.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -1.172 . . . . 2.54 109.384 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.54 -1.424 . . . . 1.77 109.54 179.88 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.724 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.489 -0.56 . . . . 6.42 109.489 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.508 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -127.95 161.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 2.66 109.824 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.95 -19.88 12.94 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.871 -0.789 . . . . 3.93 108.871 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' CD2' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.0 39.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 4.15 109.212 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -86.73 94.26 9.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 4.6 109.83 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.682 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 6.5 pt20 -116.62 -156.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.168 -0.958 . . . . 3.96 109.164 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . 177.14 -26.05 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.981 -1.247 . . . . 3.67 109.981 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -91.87 94.81 9.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -1.226 . . . . 3.79 109.811 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.471 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -133.16 79.23 62.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 2.22 109.361 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.76 132.28 41.02 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.051 2.501 . . . . 3.49 112.657 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 mt -124.35 151.06 44.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 3.46 109.208 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 74' ' ' ALA . 13.6 t -95.26 -162.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 2.83 109.831 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 75' ' ' THR . . . -96.02 -32.92 6.54 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 2.83 109.777 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 73' ' ' SER . 1.6 mp0 -99.96 164.09 17.13 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.138 -1.213 . . . . 3.02 109.485 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.14 128.66 7.71 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.841 2.361 . . . . 1.42 112.019 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 72' ' ' ALA . . . -160.73 140.91 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 1.81 109.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.7 OUTLIER -90.99 144.29 25.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.802 . . . . 2.19 110.204 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.723 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -128.43 149.99 50.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.023 -1.473 . . . . 5.23 107.023 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -139.56 159.71 41.54 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.655 -1.218 . . . . 3.28 111.186 -178.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.682 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 7.1 m-85 -134.86 121.11 20.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.3 -1.0 . . . . 3.78 108.3 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.407 ' CB ' HG23 ' A' ' 67' ' ' VAL . . . -114.49 139.56 49.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 3.99 109.655 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -147.77 164.03 34.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 3.1 109.629 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.48 ' H ' ' HG1' ' A' ' 114' ' ' THR . 0.7 OUTLIER -97.39 112.38 24.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.422 -0.799 . . . . 2.65 109.497 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.614 ' O ' ' N ' ' A' ' 63' ' ' GLY . 6.6 t -60.83 109.18 0.99 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.957 . . . . 4.28 109.452 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -123.52 22.99 9.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 7.59 109.435 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.91 104.96 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 5.5 109.366 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.457 ' N ' ' HB3' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -51.51 107.51 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 4.48 109.45 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -124.9 92.08 48.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 5.99 109.635 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.546 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 31.9 Cg_exo -56.46 -170.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.519 2.146 . . . . 4.64 111.367 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.546 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 23.3 Cg_exo -60.74 -76.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.282 1.988 . . . . 4.46 111.283 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 30.6 t0 -173.06 -163.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.123 -0.986 . . . . 4.14 109.887 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.532 ' H ' ' CG ' ' A' ' 122' ' ' ASP . . . -109.48 -35.63 2.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.195 -1.962 . . . . 4.24 108.195 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -128.93 -41.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 3.59 108.286 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -113.35 92.93 24.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.362 -0.977 . . . . 2.78 108.362 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 125' ' ' ALA . 45.3 Cg_exo -48.63 -139.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.727 2.284 . . . . 1.57 113.15 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -33.07 155.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.856 -1.298 . . . . 1.25 109.856 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -158.92 151.56 21.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.333 -1.098 . . . . 2.18 109.46 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.1 t -153.53 155.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.448 -0.945 . . . . 1.87 108.448 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -163.35 111.32 1.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.908 -1.12 . . . . 1.45 110.468 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -83.37 101.41 11.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.089 -1.078 . . . . 2.4 108.089 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.563 ' O ' ' O ' ' A' ' 81' ' ' ARG . 5.0 m170 -98.83 128.57 45.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 2.98 110.476 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.49 ' CD2' ' OH ' ' A' ' 139' ' ' TYR . 0.2 OUTLIER -112.73 -45.62 3.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.907 -0.775 . . . . 2.61 108.907 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.81 153.85 29.78 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.103 -1.199 . . . . 2.32 110.103 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.675 ' NZ ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -99.66 -143.66 0.33 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.044 . . . . 5.66 109.304 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.477 ' H ' ' HA2' ' A' ' 43' ' ' GLY . . . 67.44 -61.07 0.37 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.017 -1.105 . . . . 2.71 108.017 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -88.97 35.22 3.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.016 -2.034 . . . . 3.14 108.016 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 41' ' ' LEU . . . -28.75 151.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.868 -0.784 . . . . 2.84 110.631 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.586 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 5.1 p90 -173.99 -132.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.767 -0.827 . . . . 2.44 108.767 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 14.5 mt-10 -146.73 127.33 14.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 1.86 109.741 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 72' ' ' ALA . 66.1 t80 -117.46 106.66 13.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 2.48 109.131 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.467 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 72.4 m -109.81 120.58 42.93 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.084 -1.01 . . . . 0.74 110.546 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.36 146.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.76 . . . . 1.69 109.052 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.482 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 93.3 p -126.75 -10.04 6.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.962 -0.755 . . . . 1.63 108.962 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.57 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -161.9 167.24 25.03 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.607 -0.837 . . . . 3.82 109.813 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' A' ' 146' ' ' VAL . 9.3 p -149.38 123.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 2.92 109.382 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.535 ' OG ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -105.57 165.69 10.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.177 -0.952 . . . . 3.25 109.592 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.555 ' N ' ' OE2' ' A' ' 8' ' ' GLU . 10.0 tp -173.87 120.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 5.12 109.428 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.669 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.5 OUTLIER 179.0 -156.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 3.35 109.475 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.669 ' N ' ' OG1' ' A' ' 149' ' ' THR . 8.8 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 2.29 109.531 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.74 ' N ' ' OG1' ' A' ' 149' ' ' THR . 2.1 p . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.687 0.756 . . . . 3.0 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.643 ' N ' ' OG1' ' A' ' 149' ' ' THR . 3.6 mt-10 159.25 84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.31 -0.626 . . . . 4.75 109.31 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mp -91.52 17.03 9.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.223 -0.923 . . . . 5.44 109.16 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 12' ' ' HIS . 3.1 tm? -175.27 96.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 2.86 109.155 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.66 43.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.05 2.5 . . . . 4.15 113.396 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.577 ' N ' ' O ' ' A' ' 10' ' ' LEU . 9.8 t60 -162.84 103.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 2.52 109.492 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.543 ' OG1' ' C ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -150.42 45.17 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 2.33 109.367 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 16' ' ' ALA . 2.0 t -140.24 93.71 2.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 2.28 109.562 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 144' ' ' SER . 8.6 m-85 -75.91 39.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 2.6 109.196 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.03 -33.08 16.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.66 109.756 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.685 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 22.2 mt-10 -109.85 -76.66 0.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 2.13 109.63 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -111.87 143.93 42.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 2.74 109.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.8 pt? -49.36 -33.76 14.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 3.06 109.591 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' H ' HD23 ' A' ' 19' ' ' LEU . . . 91.08 -159.71 26.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 1.72 109.5 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.09 -9.18 17.87 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.72 2.28 . . . . 1.97 112.233 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.472 ' CZ2' HG12 ' A' ' 146' ' ' VAL . 13.8 m95 -68.44 150.25 48.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 2.88 109.006 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -109.89 170.29 8.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 2.07 110.058 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.649 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.4 pp -176.57 165.05 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 2.79 109.6 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.758 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.35 -165.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 2.48 109.503 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.43 -21.14 2.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.197 -1.161 . . . . 1.7 110.197 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.765 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.71 -143.64 0.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.28 . . . . 1.51 109.459 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.765 ' N ' ' OG1' ' A' ' 27' ' ' THR . 49.4 p -92.13 -159.07 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.293 -0.879 . . . . 2.11 108.85 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -90.36 127.34 53.36 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 2.85 108.593 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -69.01 135.79 33.23 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.02 1.813 . . . . 1.4 111.495 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.73 110.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 1.53 110.362 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.82 73.76 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 2.56 109.238 178.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.14 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 1.81 109.901 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 12.4 t70 -45.72 83.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 2.21 109.521 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 42.37 35.16 1.81 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.535 -1.426 . . . . 1.23 109.535 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.457 ' NE ' ' HB3' ' A' ' 34' ' ' ASP . 9.6 ptp180 -148.46 142.58 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 3.37 109.666 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.618 ' SD ' ' C ' ' A' ' 37' ' ' MET . 14.7 tmm? -112.68 127.73 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 1.4 109.578 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.661 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -122.57 138.52 54.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.838 . . . . 1.06 109.858 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.18 150.85 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.415 -0.957 . . . . 1.95 108.415 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.542 ' OD2' ' OG ' ' A' ' 28' ' ' SER . 21.9 m-20 -81.06 119.69 23.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.1 -1.0 . . . . 4.79 109.348 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.669 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 3.0 mm? -116.37 32.79 0.16 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.092 -1.005 . . . . 3.97 110.736 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 86.1 Cg_endo -81.07 -97.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.194 1.929 . . . . 4.21 111.697 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.435 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . 54.21 -96.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.424 -1.07 . . . . 2.09 110.424 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.71 48.84 0.04 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.425 -1.87 . . . . 2.62 108.425 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.674 ' O ' ' N ' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -99.73 116.26 31.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.463 -1.022 . . . . 2.96 109.857 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -76.18 52.75 3.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.524 -1.43 . . . . 2.38 109.524 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.67 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -161.19 134.73 4.84 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.227 -1.16 . . . . 4.04 109.462 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 63.1 Cg_endo -76.83 0.35 9.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.605 2.203 . . . . 2.75 112.724 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.468 ' HA ' ' CE1' ' A' ' 132' ' ' HIS . 5.2 p90 -110.15 67.88 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 4.57 109.649 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 1.2 m-20 -140.18 -31.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 2.38 109.763 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.87 163.88 38.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 1.47 109.605 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.9 171.49 14.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.875 -1.29 . . . . 0.96 109.875 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.472 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.8 pp -107.41 145.82 32.47 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -1.14 . . . . 1.51 109.162 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -131.19 169.83 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.951 . . . . 1.51 110.068 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 40.5 t80 -171.09 143.3 1.93 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.495 -0.753 . . . . 2.45 109.42 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -113.16 -167.28 1.17 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.302 -0.874 . . . . 2.95 109.397 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.7 55.62 2.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.64 -1.384 . . . . 2.52 109.64 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.411 ' CG2' HD23 ' A' ' 148' ' ' LEU . 1.1 p -149.08 100.5 3.41 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 4.19 109.421 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.93 126.96 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.49 2.126 . . . . 2.79 112.018 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -103.19 74.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.92 . . . . 3.62 109.813 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -84.71 90.64 1.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.953 -1.659 . . . . 3.37 108.953 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -34.56 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -1.127 . . . . 6.05 109.884 -179.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.73 -67.18 0.56 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.638 -1.385 . . . . 3.09 109.638 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -100.0 170.68 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -1.152 . . . . 4.03 109.632 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 m -99.98 139.41 35.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 3.28 109.323 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.05 177.64 4.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -0.98 . . . . 2.59 109.846 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -150.63 137.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 3.18 109.634 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tp -119.94 115.1 23.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 4.0 109.106 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -112.98 100.29 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 2.8 109.33 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -94.1 135.04 35.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 2.64 110.599 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.679 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 10.9 p -93.49 94.22 8.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.441 -0.948 . . . . 2.25 108.441 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -165.36 164.2 19.77 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.617 -1.233 . . . . 1.45 110.624 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -139.81 146.61 39.63 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.843 -0.799 . . . . 1.28 108.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -84.6 133.8 34.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 1.07 109.358 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.506 ' O ' ' CD ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.71 115.74 15.83 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.37 -0.831 . . . . 1.68 109.062 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -67.1 -142.2 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.605 0 C-N-CA 124.311 -1.12 . . . . 1.32 112.298 0.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.64 149.36 22.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 1.75 109.613 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.5 mtt 159.73 163.47 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 2.72 109.372 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.33 150.78 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.877 2.384 . . . . 1.83 112.224 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.23 169.0 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 2.57 109.393 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 132' ' ' HIS . 13.5 ttt180 -114.2 137.68 51.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 6.46 109.52 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.81 149.45 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.341 -0.85 . . . . 4.19 109.38 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -147.5 147.09 29.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 2.9 109.752 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.567 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.2 t -151.8 149.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 2.31 109.614 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 160.62 -147.03 13.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.584 -1.407 . . . . 1.75 109.584 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.667 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.1 pm0 -90.04 176.85 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -1.162 . . . . 2.54 109.547 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.603 -1.399 . . . . 1.77 109.603 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.456 ' NH2' HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.46 -0.57 . . . . 6.42 109.46 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.567 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -105.42 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 2.66 109.951 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.444 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.88 -24.8 10.64 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.771 -0.826 . . . . 3.93 108.771 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -91.03 33.84 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 4.15 109.186 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.84 59.25 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 4.6 109.582 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.6 tt0 -103.07 156.4 17.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 3.96 109.134 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -145.87 8.54 1.53 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.696 -1.362 . . . . 3.67 109.696 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.33 59.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -1.165 . . . . 3.79 109.589 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.54 107.37 50.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 2.22 109.204 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -78.04 134.36 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.528 2.152 . . . . 3.49 112.544 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 mt -131.2 156.63 45.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 3.46 109.411 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -103.44 -155.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 2.83 109.512 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.634 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -113.45 30.76 7.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 2.83 109.523 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -154.41 149.89 21.12 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -1.179 . . . . 3.02 109.379 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.26 126.2 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.872 2.381 . . . . 1.42 112.106 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.504 ' CB ' ' NH1' ' A' ' 109' ' ' ARG . . . -163.34 132.84 4.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 1.81 109.655 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.35 141.39 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 2.19 110.395 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.504 ' NH1' ' CB ' ' A' ' 107' ' ' ALA . 3.9 mpt_? -120.16 143.61 48.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.317 -1.364 . . . . 5.23 107.317 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -128.88 112.74 14.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.977 . . . . 3.28 110.838 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 4.5 m-30 -113.44 115.28 27.8 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.201 -1.037 . . . . 3.78 108.201 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.96 171.87 7.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.277 -0.889 . . . . 3.99 110.024 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -173.14 175.45 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 3.1 109.673 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.501 ' H ' ' HG1' ' A' ' 114' ' ' THR . 0.7 OUTLIER -87.7 113.19 23.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 2.65 109.751 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.8 t -52.82 110.03 0.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 4.28 109.39 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 114' ' ' THR . 30.4 m120 -129.14 28.61 5.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.838 . . . . 7.59 109.505 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 60' ' ' VAL . 4.6 tp -133.4 118.47 18.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 5.5 109.398 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -77.59 127.38 32.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.881 . . . . 4.48 109.558 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 8.4 m-85 -163.52 94.63 1.08 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 5.99 109.363 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.67 165.78 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.604 2.203 . . . . 4.64 112.259 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.0 -14.93 12.03 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.815 2.343 . . . . 4.46 112.044 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.84 121.67 45.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 4.14 109.478 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.67 -175.42 19.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 4.24 109.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.93 53.5 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 3.59 109.454 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -178.03 65.69 0.19 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.78 109.464 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.12 -158.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.874 2.383 . . . . 1.57 112.301 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.95 157.29 39.15 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.538 -1.425 . . . . 1.25 109.538 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.667 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -146.94 126.58 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 2.18 109.878 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.42 85.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.66 -0.867 . . . . 1.87 108.66 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.403 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -103.31 127.1 50.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 1.45 110.56 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' A' ' 53' ' ' LEU . 2.9 m-30 -105.12 96.75 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.295 -1.002 . . . . 2.4 108.295 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.468 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 9.3 m170 -99.39 138.37 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 2.98 110.238 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -141.83 6.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 2.61 109.21 179.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -62.11 147.51 48.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.572 -1.411 . . . . 2.32 109.572 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.624 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 0.4 OUTLIER 179.48 132.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -1.09 . . . . 5.66 109.339 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -47.14 -24.3 0.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.765 -1.198 . . . . 2.71 107.765 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.611 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -106.29 8.55 41.41 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.577 -1.809 . . . . 3.14 108.577 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -49.12 -163.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.919 . . . . 2.84 110.023 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD2' ' C ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -173.73 -112.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 2.44 109.94 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.506 ' CD ' ' O ' ' A' ' 75' ' ' THR . 2.2 mp0 -129.61 153.79 47.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.754 -1.216 . . . . 1.86 109.678 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.661 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 26.7 t80 -136.29 126.49 26.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.226 -0.921 . . . . 2.48 109.721 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.85 98.61 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.74 110.185 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.466 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -109.81 143.82 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.405 -0.809 . . . . 1.69 108.883 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 15' ' ' PHE . 95.4 p -128.89 -18.1 3.85 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.075 -0.65 . . . . 1.63 109.409 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.679 ' N ' ' OG1' ' A' ' 71' ' ' THR . 4.2 mt-30 -152.74 166.79 31.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.173 -1.011 . . . . 3.82 110.61 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.543 ' C ' ' OG1' ' A' ' 13' ' ' THR . 7.3 p -169.92 91.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.917 -0.772 . . . . 2.92 108.917 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.73 140.67 29.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 3.25 110.482 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.411 HD23 ' CG2' ' A' ' 58' ' ' VAL . 6.9 tp -124.23 94.82 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.608 -0.886 . . . . 5.12 108.608 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.74 ' OG1' ' N ' ' A' ' 7' ' ' VAL . 8.2 t 177.87 -144.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 3.35 109.156 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.469 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.109 -0.994 . . . . 2.29 109.658 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.397 -0.594 . . . . 3.0 109.397 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.12 100.4 13.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 4.75 109.551 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.56 -8.63 56.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 5.44 109.496 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 12' ' ' HIS . 1.3 tm? -140.96 85.93 11.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 2.86 108.797 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.58 40.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.996 2.464 . . . . 4.15 112.22 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.558 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 19.6 t60 -143.11 123.1 13.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 2.52 109.641 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.567 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -170.1 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -0.858 . . . . 2.33 109.199 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.645 ' C ' ' H ' ' A' ' 16' ' ' ALA . 46.2 m -109.94 63.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 2.28 109.719 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -66.5 21.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 2.6 109.188 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.07 -63.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 1.66 109.939 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' SER . 3.4 mm-40 -111.73 39.87 2.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 2.13 109.912 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 1.9 m 160.39 147.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 2.74 109.79 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 -72.04 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 3.06 109.608 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 118.98 -167.48 13.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.515 -1.434 . . . . 1.72 109.515 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 17.1 Cg_exo -62.02 -20.14 68.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.567 2.178 . . . . 1.97 111.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 13.8 m95 -65.46 -166.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 2.88 109.414 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -150.29 174.65 12.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 2.07 109.619 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.662 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 54.7 tp -170.85 148.1 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 2.79 109.451 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.745 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 165.04 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 2.48 109.691 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 79.31 -22.09 3.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.849 -1.3 . . . . 1.7 109.849 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.94 -142.01 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -1.213 . . . . 1.51 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.1 p -90.67 136.91 32.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 2.11 109.163 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 28' ' ' SER . 51.9 mm-40 -32.5 97.03 0.1 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 2.85 109.732 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 28' ' ' SER . 32.1 Cg_exo -53.13 163.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 1.4 111.342 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 30' ' ' PRO . 97.0 t -154.17 134.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.155 . . . . 1.53 110.742 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -90.07 85.91 6.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.583 0.706 . . . . 2.56 109.407 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.52 -139.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.81 109.996 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.55 76.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.406 -0.809 . . . . 2.21 110.059 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 55.49 23.38 34.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.942 -1.263 . . . . 1.23 109.942 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 33' ' ' ALA . 2.2 ptp180 -136.25 143.15 44.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -1.211 . . . . 3.37 109.435 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.77 ' SD ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -114.61 148.4 38.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 1.4 109.411 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.77 ' N ' ' SD ' ' A' ' 37' ' ' MET . 3.8 t -157.03 163.37 39.13 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.574 -0.85 . . . . 1.06 110.17 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.14 150.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.265 -1.013 . . . . 1.95 108.265 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -97.9 99.25 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 4.79 110.183 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 8.5 mp -113.15 91.09 17.77 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 3.97 109.12 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.45 -87.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.906 2.404 . . . . 4.21 112.318 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.2 96.19 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.441 . . . . 2.09 109.499 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.47 31.96 0.05 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.515 -1.434 . . . . 2.62 109.515 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.453 ' NE2' ' HA3' ' A' ' 134' ' ' GLY . 2.9 mt-30 -99.99 174.19 6.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -1.173 . . . . 2.96 109.41 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.66 -41.88 8.06 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 2.38 109.502 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' OD2' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -167.01 157.54 10.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 4.04 109.426 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.51 -39.87 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.842 2.361 . . . . 2.75 112.211 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.608 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 4.9 p90 -91.9 55.33 2.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.917 . . . . 4.57 109.47 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.649 ' OD2' ' N ' ' A' ' 47' ' ' ASN . 70.4 m-20 -128.33 1.94 5.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 2.38 109.458 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.419 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -175.31 172.95 2.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 1.47 109.509 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.42 -164.38 23.47 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.586 -1.405 . . . . 0.96 109.586 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 131' ' ' PHE . 1.1 pp -109.73 161.77 15.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -1.093 . . . . 1.51 109.2 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 2.1 t -152.21 161.12 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 1.51 109.769 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 33.1 t80 -175.31 147.79 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 2.45 109.476 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.681 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.3 m-80 -107.16 160.94 15.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.263 -0.898 . . . . 2.95 109.396 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.75 74.15 0.67 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 2.52 109.577 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -155.45 66.2 4.64 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.247 -1.149 . . . . 4.19 109.439 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.63 137.01 41.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.759 2.306 . . . . 2.79 112.155 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 10.6 t -135.66 139.99 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 3.62 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -107.73 117.17 5.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.51 -1.436 . . . . 3.37 109.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -45.69 128.03 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 6.05 109.526 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 113.25 -25.77 11.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.686 -1.366 . . . . 3.09 109.686 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . 4.9 mt-10 -100.05 173.58 6.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -1.163 . . . . 4.03 109.646 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 3.28 109.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 60' ' ' VAL . 41.7 m-85 -104.36 -179.63 4.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.268 -0.895 . . . . 2.59 109.592 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -160.93 143.84 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 3.18 109.668 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.52 118.46 24.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 4.0 109.512 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.51 94.59 5.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 2.8 109.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 4.4 p90 -93.64 147.01 23.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.096 -1.002 . . . . 2.64 110.954 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.3 p -95.02 112.56 24.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.188 -1.041 . . . . 2.25 108.188 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.433 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -165.51 153.71 11.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.696 -1.253 . . . . 1.45 110.797 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.52 148.67 49.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.713 -0.847 . . . . 1.28 108.713 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' N ' ' O ' ' A' ' 103' ' ' THR . . . -113.13 124.79 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 1.07 109.984 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.606 ' CA ' ' H ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -130.72 132.79 24.17 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.309 -0.869 . . . . 1.68 108.704 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.611 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.5 Cg_exo -73.15 27.7 0.43 Allowed 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 124.665 -0.973 . . . . 1.32 112.779 -0.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.716 ' O ' ' SD ' ' A' ' 78' ' ' MET . 2.4 m-20 89.29 152.52 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.514 -0.551 . . . . 1.75 109.514 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.716 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 161.54 174.57 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.965 -1.124 . . . . 2.72 107.965 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.548 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 10.5 Cg_endo -81.98 145.74 14.18 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.454 2.102 . . . . 1.83 112.218 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.566 ' O ' ' O ' ' A' ' 98' ' ' GLY . 7.5 m -113.58 159.15 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 2.57 109.719 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.726 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.12 123.5 49.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 6.46 109.236 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.18 149.09 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 4.19 109.521 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 1.3 pp -145.67 144.41 30.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.9 109.664 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -151.82 151.48 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 2.31 109.781 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.52 -137.6 5.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.451 -1.46 . . . . 1.75 109.451 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -88.52 -165.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 2.54 109.446 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.56 -1.416 . . . . 1.77 109.56 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.619 HH11 ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.481 -0.563 . . . . 6.42 109.481 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -128.28 167.95 16.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 2.66 109.892 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.548 ' N ' ' HG1' ' A' ' 93' ' ' THR . . . -109.92 -23.15 11.51 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.651 -0.87 . . . . 3.93 108.651 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.99 36.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.358 -0.839 . . . . 4.15 108.945 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -84.5 44.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 4.6 109.595 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.581 ' CG ' ' O ' ' A' ' 97' ' ' GLN . 10.1 pt20 -102.4 121.18 41.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 3.96 109.341 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -111.24 6.3 28.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.587 -1.405 . . . . 3.67 109.587 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.37 77.26 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -1.139 . . . . 3.79 109.514 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . . . -116.98 81.8 12.75 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.117 -0.99 . . . . 2.22 109.448 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 45.2 Cg_exo -52.09 143.05 42.76 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.845 2.363 . . . . 3.49 112.29 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.447 HD23 ' NH1' ' A' ' 109' ' ' ARG . 14.0 mt -143.58 154.19 43.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 3.46 109.505 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.44 -162.4 0.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.83 109.608 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.676 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -102.1 -9.68 41.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.64 -1.384 . . . . 2.83 109.64 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.549 ' OE2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -99.89 134.46 20.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.181 -1.188 . . . . 3.02 108.957 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.549 ' O ' ' OE2' ' A' ' 105' ' ' GLU . 85.7 Cg_exo -37.27 117.55 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 1.42 112.139 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.43 137.08 16.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 1.81 109.674 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.428 ' CG2' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.07 152.5 20.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 2.19 109.831 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.718 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -129.36 138.92 51.81 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.051 -1.092 . . . . 5.23 108.051 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.628 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -120.57 118.45 30.24 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.759 -0.776 . . . . 3.28 110.671 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.483 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 7.3 m-85 -115.16 118.83 34.44 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.549 -0.908 . . . . 3.78 108.549 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.85 146.64 32.0 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 3.99 109.948 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.739 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -129.71 163.35 26.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 3.1 109.32 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.53 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -97.96 104.44 16.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 2.65 109.63 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.4 m -37.16 104.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 4.28 109.305 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.15 14.72 27.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 7.59 109.556 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 118' ' ' THR . 8.3 tt -169.21 171.86 7.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 5.5 109.444 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.559 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -95.26 114.84 26.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.175 -0.953 . . . . 4.48 109.697 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 117' ' ' LEU . 55.5 m-85 -110.58 94.53 19.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 5.99 109.402 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.26 158.18 23.05 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.611 2.207 . . . . 4.64 112.196 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.34 -27.53 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.723 2.282 . . . . 4.46 111.948 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 19.3 p-10 -109.96 -163.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 4.14 109.478 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . 66.23 169.3 3.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.573 -1.411 . . . . 4.24 109.573 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.22 45.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 3.59 109.423 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 123' ' ' GLY . . . -163.18 55.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 2.78 109.54 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 47.5 Cg_endo -72.91 -158.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.827 2.352 . . . . 1.57 112.189 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -86.91 157.06 29.26 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.542 -1.423 . . . . 1.25 109.542 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -141.91 114.48 8.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -1.178 . . . . 2.18 109.582 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.491 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 2.5 t -131.66 128.5 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 1.87 108.853 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.0 114.56 3.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 1.45 110.101 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.481 ' CD2' HD23 ' A' ' 53' ' ' LEU . 4.9 m-30 -92.21 119.38 31.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.645 -0.872 . . . . 2.4 108.645 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 42.0 m170 -105.4 127.1 52.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 2.98 109.623 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -128.87 -34.67 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 2.61 109.468 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.54 127.16 0.57 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.651 -1.38 . . . . 2.32 109.651 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.678 ' O ' ' N ' ' A' ' 137' ' ' GLY . 16.4 mttt -166.99 130.71 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 5.66 109.73 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.36 -19.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.095 -1.076 . . . . 2.71 108.095 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.1 17.11 7.14 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.815 -1.714 . . . . 3.14 108.815 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.622 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -51.43 -151.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.943 . . . . 2.84 110.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.549 ' OH ' ' CG1' ' A' ' 80' ' ' VAL . 2.7 p90 -171.91 -161.82 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 2.44 109.511 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.57 142.85 26.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 1.86 109.718 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.559 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 31.1 t80 -128.07 107.61 9.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.481 -0.762 . . . . 2.48 109.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 69.8 m -110.36 102.84 11.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.11 -0.994 . . . . 0.74 110.989 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.469 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -120.88 144.43 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.486 -0.931 . . . . 1.69 108.486 178.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 143' ' ' ILE . 29.6 p -121.91 -8.7 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.95 -0.7 . . . . 1.63 109.815 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.582 ' O ' ' OG1' ' A' ' 71' ' ' THR . 11.9 pt20 -168.9 176.77 5.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.649 -1.22 . . . . 3.82 111.023 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.564 ' O ' ' OG1' ' A' ' 13' ' ' THR . 7.3 p -170.42 159.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.073 -0.714 . . . . 2.92 109.073 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.74 158.54 44.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 3.25 109.78 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 149' ' ' THR . 1.1 pp -143.72 155.22 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 5.12 109.428 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.78 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 3.35 109.546 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.664 ' N ' ' OG1' ' A' ' 149' ' ' THR . 4.7 t . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 2.29 109.493 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.393 -0.595 . . . . 3.0 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -125.67 86.13 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 4.75 109.479 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.46 -33.84 74.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 5.44 109.395 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER -108.17 95.43 15.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.632 -0.877 . . . . 2.86 108.632 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.39 49.1 1.35 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.081 1.854 . . . . 4.15 111.983 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.572 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 82.0 t60 -152.77 129.46 10.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.391 -0.818 . . . . 2.52 109.639 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -167.45 57.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 2.33 109.492 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.8 t -151.22 67.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 2.28 109.552 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -62.64 39.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 2.6 109.091 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -86.79 -36.84 18.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 1.66 109.858 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.691 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 15.3 mm-40 -111.7 -57.73 2.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 2.13 109.581 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 p -128.2 143.54 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 2.74 109.468 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 19' ' ' LEU . 1.8 pt? -55.36 -15.98 3.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 3.06 109.465 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 83.43 -154.37 31.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.571 -1.411 . . . . 1.72 109.571 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.47 -11.51 15.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 1.97 112.089 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.481 ' HE1' HD13 ' A' ' 10' ' ' LEU . 10.9 m95 -65.14 -163.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 2.88 109.307 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -156.58 164.0 38.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 2.07 109.313 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.623 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -168.38 160.07 11.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 2.79 109.803 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.73 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 167.04 177.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 2.48 109.558 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 92.26 -23.44 27.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.941 -1.264 . . . . 1.7 109.941 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.785 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.86 -142.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.24 . . . . 1.51 109.271 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.785 ' N ' ' OG1' ' A' ' 27' ' ' THR . 33.4 p -91.09 130.19 37.01 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.185 -0.947 . . . . 2.11 109.096 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.554 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -35.81 100.44 0.2 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 2.85 109.176 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' N ' ' O ' ' A' ' 28' ' ' SER . 64.2 Cg_exo -46.11 154.07 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.381 2.054 . . . . 1.4 111.643 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -138.53 115.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.996 -1.065 . . . . 1.53 110.395 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.45 84.28 3.18 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.534 0.683 . . . . 2.56 109.218 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -78.39 -119.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.425 -0.797 . . . . 1.81 110.229 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.772 ' H ' HH12 ' A' ' 36' ' ' ARG . 22.5 t0 -58.36 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.21 110.15 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 64.04 8.28 28.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.748 -1.341 . . . . 1.23 109.748 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.772 HH12 ' H ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -126.91 144.45 50.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -1.233 . . . . 3.37 109.604 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.574 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -109.87 130.44 55.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 1.4 109.015 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -127.77 153.51 46.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.44 -0.904 . . . . 1.06 110.593 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.5 m -122.69 163.43 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.351 -0.981 . . . . 1.95 108.351 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.613 ' N ' ' OG ' ' A' ' 28' ' ' SER . 34.3 m-20 -107.78 102.54 11.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 4.79 110.189 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.547 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.2 mm? -126.33 48.23 2.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 3.97 109.265 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 76.9 Cg_exo -39.02 -71.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.904 2.402 . . . . 4.21 112.34 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.7 77.85 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 2.09 109.545 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.87 28.69 0.23 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.477 -1.449 . . . . 2.62 109.477 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.405 ' NE2' ' HB3' ' A' ' 50' ' ' ASP . 8.7 mm-40 -99.95 144.04 29.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 2.96 109.501 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.29 -66.18 1.89 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.55 -1.42 . . . . 2.38 109.55 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.772 ' ND2' ' NE1' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -99.89 156.72 35.01 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.172 -1.193 . . . . 4.04 109.518 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 50' ' ' ASP . 46.3 Cg_endo -72.63 -33.52 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.827 2.351 . . . . 2.75 112.314 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.772 ' NE1' ' ND2' ' A' ' 47' ' ' ASN . 28.7 p90 -73.65 21.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 4.57 109.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 23.2 m-20 -102.49 26.57 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 2.38 109.51 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 168.99 129.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 1.47 109.488 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.29 163.96 13.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.8 -1.32 . . . . 0.96 109.8 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -92.03 -169.31 2.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -1.098 . . . . 1.51 109.341 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 1.5 p -174.32 165.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.288 -0.883 . . . . 1.51 110.182 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.692 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 16.5 t80 173.16 140.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.511 -0.743 . . . . 2.45 109.405 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.692 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -102.5 -177.24 3.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.185 -0.947 . . . . 2.95 109.618 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.37 61.81 1.37 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.626 -1.389 . . . . 2.52 109.626 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.556 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 4.8 m -152.56 60.34 3.35 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 4.19 109.415 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 54.4 Cg_exo -47.22 146.9 6.14 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.875 2.383 . . . . 2.79 112.192 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.03 92.36 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 3.62 109.502 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -84.66 111.35 3.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 3.37 109.513 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.56 123.53 13.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -1.104 . . . . 6.05 109.466 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.79 -44.41 1.18 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 3.09 109.669 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.57 ' O ' ' OG ' ' A' ' 115' ' ' SER . 7.2 mt-10 -100.01 -179.98 4.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -1.152 . . . . 4.03 109.634 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' OG1' ' A' ' 150' ' ' THR . 69.7 m -128.19 138.32 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.386 -0.821 . . . . 3.28 109.362 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 44.5 m-85 -101.95 179.48 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 2.59 109.624 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -152.15 141.72 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 3.18 109.234 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.439 ' CD1' ' CD2' ' A' ' 148' ' ' LEU . 6.3 tp -127.91 113.11 15.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 4.0 109.954 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.543 ' O ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.54 92.59 4.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.421 -0.955 . . . . 2.8 108.421 179.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 30.9 p90 -93.87 147.92 22.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 2.64 111.074 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -98.59 105.24 17.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.265 -1.013 . . . . 2.25 108.265 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . . . -152.02 159.18 43.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.725 -1.235 . . . . 1.45 110.823 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.26 124.65 20.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.807 -0.812 . . . . 1.28 108.807 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -86.16 129.46 34.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 1.07 109.787 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.464 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.53 116.09 14.96 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 1.68 109.302 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.73 -142.52 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 124.374 -1.094 . . . . 1.32 112.463 -0.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -95.5 151.49 19.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.917 . . . . 1.75 109.66 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 160.37 162.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 2.72 109.401 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.568 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 57.8 Cg_endo -76.2 138.74 20.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.922 2.415 . . . . 1.83 112.526 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.566 ' O ' ' O ' ' A' ' 98' ' ' GLY . 0.7 OUTLIER -104.91 169.76 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 2.57 109.287 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -109.91 149.03 30.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.399 -0.813 . . . . 6.46 109.444 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.3 t -152.64 148.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 4.19 109.343 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.623 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.4 pp -152.55 146.07 24.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 2.9 109.739 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.508 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -153.69 149.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 2.31 109.63 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.94 -141.29 7.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.48 -1.448 . . . . 1.75 109.48 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -89.94 -158.62 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -1.127 . . . . 2.54 109.459 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.447 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.478 -1.449 . . . . 1.77 109.478 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.253 0.549 . . . . 6.42 109.536 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.35 163.86 16.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 2.66 109.89 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.04 -20.33 12.75 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.801 -0.815 . . . . 3.93 108.801 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.81 36.16 0.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.844 . . . . 4.15 109.16 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.83 56.34 3.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 4.6 109.558 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -107.42 124.63 50.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 3.96 109.192 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -117.52 3.5 17.86 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.545 -1.422 . . . . 3.67 109.545 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -89.28 72.61 8.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -1.157 . . . . 3.79 109.466 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.16 93.76 39.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 2.22 109.446 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 12.5 Cg_exo -65.98 116.9 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.855 2.37 . . . . 3.49 112.512 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -117.42 152.88 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 3.46 109.339 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 8.5 t -105.21 -161.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.92 . . . . 2.83 109.651 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.414 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -93.59 -22.31 26.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.75 -1.34 . . . . 2.83 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -99.96 149.88 36.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.213 . . . . 3.02 109.437 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.46 118.87 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.771 2.314 . . . . 1.42 112.062 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -144.17 126.01 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 1.81 109.718 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.429 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.1 151.54 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 2.19 110.075 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.704 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -135.38 138.2 43.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.471 -0.937 . . . . 5.23 108.471 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.67 111.65 19.44 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.979 -0.688 . . . . 3.28 110.516 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -109.86 117.74 34.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.562 -0.903 . . . . 3.78 108.562 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.28 140.65 39.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.219 -0.926 . . . . 3.99 109.665 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.721 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -126.3 162.87 24.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 3.1 109.45 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -98.94 103.48 15.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.65 109.531 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.4 m -37.15 110.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 4.28 109.356 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 9.8 p-10 -115.98 -10.38 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 7.59 109.467 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 119' ' ' PHE . 2.1 mm? -130.1 128.47 41.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 5.5 109.459 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.13 113.81 12.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 4.48 109.465 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 117' ' ' LEU . 18.3 m-85 -125.31 75.55 68.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 5.99 109.483 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -52.91 167.2 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.746 2.297 . . . . 4.64 112.069 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.67 -24.44 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.771 2.314 . . . . 4.46 112.076 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -110.39 160.77 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 4.14 109.5 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.9 -137.16 13.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.541 -1.424 . . . . 4.24 109.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 123' ' ' GLY . 20.5 m-20 -36.7 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 3.59 109.497 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.5 150.55 34.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 2.78 109.419 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.68 -158.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.801 2.334 . . . . 1.57 112.2 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.474 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -61.86 168.03 14.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.531 -1.427 . . . . 1.25 109.531 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.97 133.22 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -1.108 . . . . 2.18 109.595 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.414 ' CG2' HG13 ' A' ' 58' ' ' VAL . 59.8 t -139.56 151.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.644 -0.872 . . . . 1.87 108.644 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.41 ' N ' HG12 ' A' ' 129' ' ' VAL . . . -167.02 112.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 1.45 110.207 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -85.56 112.9 21.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.319 -0.863 . . . . 2.4 108.703 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.623 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 2.4 m170 -99.77 120.51 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.98 109.978 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.612 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -140.06 5.09 2.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 2.61 109.271 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -80.26 122.18 5.67 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.526 -1.43 . . . . 2.32 109.526 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.69 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.4 mtpp -163.96 135.78 4.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 5.66 109.668 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.91 -13.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.404 -0.961 . . . . 2.71 108.404 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -121.57 5.35 10.8 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.099 -1.601 . . . . 3.14 109.099 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -52.34 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -1.035 . . . . 2.84 109.937 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.568 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -170.78 -161.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.934 -1.103 . . . . 2.44 109.411 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -80.18 143.34 33.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 1.86 109.486 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.471 ' CG ' HD22 ' A' ' 133' ' ' LEU . 28.6 t80 -126.56 110.27 13.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 2.48 109.239 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.0 104.83 14.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.74 110.558 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.464 HG21 ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -120.27 142.77 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 1.69 108.74 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 24.8 p -137.73 -3.42 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.636 -0.665 . . . . 1.63 109.567 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.539 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -154.92 160.24 41.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.143 -0.973 . . . . 3.82 110.061 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.599 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.2 t -143.38 152.61 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.434 -0.791 . . . . 2.92 109.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.437 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 26.5 t -125.62 128.23 47.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 3.25 109.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.528 ' CD1' ' C ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -129.82 111.6 12.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 5.12 109.208 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.4 OUTLIER -160.98 -171.66 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 3.35 109.626 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 65' ' ' SER . 7.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 2.29 109.433 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.573 ' O ' ' OG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.412 -0.588 . . . . 3.0 109.412 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -85.53 82.16 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 4.75 109.477 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -44.39 -19.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 5.44 109.444 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER -121.66 84.17 42.76 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.86 108.628 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.1 20.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.973 2.448 . . . . 4.15 112.131 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.619 ' H ' ' C ' ' A' ' 10' ' ' LEU . 69.9 t60 -118.64 99.29 6.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 2.52 109.672 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.622 ' O ' ' CG2' ' A' ' 13' ' ' THR . 5.5 t -139.12 56.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 2.33 109.339 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.65 ' C ' ' H ' ' A' ' 16' ' ' ALA . 44.4 m -142.49 61.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 2.28 109.785 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.7 m-30 -66.05 33.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 2.6 109.0 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.06 -35.26 15.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.66 110.014 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -109.97 -84.53 0.55 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.121 -0.987 . . . . 2.13 109.599 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 p -94.35 144.02 25.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.74 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' CD2' ' SD ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -55.77 -53.57 55.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 3.06 109.459 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.457 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 111.98 -164.14 12.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 1.72 109.682 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 56.7 Cg_endo -76.31 -4.51 15.15 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.833 2.355 . . . . 1.97 112.367 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.487 ' HE1' HD11 ' A' ' 10' ' ' LEU . 8.3 m95 -66.67 -177.63 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 2.88 109.418 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -133.6 167.32 20.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 2.07 109.277 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' O ' ' CD1' ' A' ' 24' ' ' LEU . 1.5 pp 179.43 142.76 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.133 -0.979 . . . . 2.79 109.809 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.82 173.78 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.464 -0.773 . . . . 2.48 109.453 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 102.29 -31.87 8.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.199 -1.16 . . . . 1.7 110.199 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.79 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.86 -141.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.957 -1.319 . . . . 1.51 109.645 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.79 ' N ' ' OG1' ' A' ' 27' ' ' THR . 13.7 p -91.35 132.71 36.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.538 -0.726 . . . . 2.11 109.329 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 pt-20 -37.44 106.96 0.37 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.139 -0.976 . . . . 2.85 109.055 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HB2' ' SD ' ' A' ' 37' ' ' MET . 53.6 Cg_exo -45.54 150.01 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.226 1.951 . . . . 1.4 111.691 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 t -136.83 123.07 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 1.53 110.103 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.84 115.4 17.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 2.56 109.362 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' A' ' 35' ' ' GLY . . . -81.76 -140.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 1.81 109.733 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.53 13.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 2.21 110.057 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 33' ' ' ALA . . . 144.11 -4.77 1.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.945 -1.262 . . . . 1.23 109.945 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -121.57 152.22 39.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.005 -1.291 . . . . 3.37 109.571 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.61 ' SD ' ' CD2' ' A' ' 19' ' ' LEU . 59.2 ttp -116.65 134.37 54.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 1.4 109.338 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -129.93 154.11 47.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.228 -0.92 . . . . 1.06 110.161 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HB ' ' HG1' ' A' ' 27' ' ' THR . 2.9 m -123.74 140.85 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.682 -0.858 . . . . 1.95 108.682 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 28' ' ' SER . 53.1 m-20 -79.8 108.87 13.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 4.79 109.704 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.579 ' O ' ' O ' ' A' ' 139' ' ' TYR . 8.2 mp -116.29 76.29 6.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 3.97 109.508 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 61.2 Cg_endo -77.54 -74.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.796 2.331 . . . . 4.21 112.201 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . -173.52 -157.37 15.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.588 -1.405 . . . . 2.09 109.588 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 77.19 -4.0 56.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.658 -1.377 . . . . 2.62 109.658 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 47' ' ' ASN . 7.8 mm-40 -100.01 66.79 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -1.119 . . . . 2.96 109.435 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.77 49.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.59 -1.404 . . . . 2.38 109.59 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.634 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -169.68 89.28 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.107 . . . . 4.04 109.422 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.7 -0.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.876 2.384 . . . . 2.75 112.356 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.674 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -122.88 34.08 5.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 4.57 109.572 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.0 m-20 -108.7 -19.62 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 2.38 109.654 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.411 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -139.77 177.42 7.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 1.47 109.71 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.65 171.82 13.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.615 -1.394 . . . . 0.96 109.615 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.497 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 3.2 mt -89.74 -177.29 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 1.51 109.323 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.31 174.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 1.51 109.92 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' HB2' ' CD2' ' A' ' 22' ' ' TRP . 18.1 t80 176.98 129.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.43 -0.794 . . . . 2.45 109.46 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.38 115.14 28.78 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.252 -0.905 . . . . 2.95 109.525 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 70.96 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.48 -1.448 . . . . 2.52 109.48 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -170.06 95.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.343 -1.092 . . . . 4.19 109.416 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.35 127.06 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.594 2.196 . . . . 2.79 112.186 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.1 t -100.03 135.19 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 3.62 109.578 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -115.23 101.79 1.07 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 3.37 109.338 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.603 ' C ' ' HG ' ' A' ' 115' ' ' SER . 14.9 tt0 -35.53 144.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.166 . . . . 6.05 109.612 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.675 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 96.35 -25.94 23.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.692 -1.363 . . . . 3.09 109.692 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.672 ' H ' ' HG ' ' A' ' 115' ' ' SER . 18.0 mt-10 -104.84 164.84 11.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -1.175 . . . . 4.03 109.767 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 58.2 m -120.7 141.41 50.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 3.28 109.228 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 28.0 m-85 -108.55 -179.21 3.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 2.59 109.73 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.0 t -152.76 144.83 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.489 -0.757 . . . . 3.18 109.341 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.44 116.46 16.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 4.0 109.797 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.441 ' OG ' ' CB ' ' A' ' 147' ' ' SER . 2.0 p -109.74 95.88 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 2.8 108.874 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.655 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -93.08 139.41 30.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 2.64 110.85 -179.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -94.51 104.75 16.71 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.857 -0.794 . . . . 2.25 108.857 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . . . -175.97 169.18 2.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.792 -1.192 . . . . 1.45 110.635 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.16 172.18 13.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.763 -0.829 . . . . 1.28 108.763 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 103' ' ' THR . . . -120.59 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 1.07 109.949 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.47 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.59 115.6 14.73 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.311 -0.868 . . . . 1.68 109.468 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.0 Cg_exo -65.79 -142.18 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 124.392 -1.087 . . . . 1.32 112.341 -0.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -102.23 149.36 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 1.75 109.602 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.15 153.58 0.13 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 2.72 109.438 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.72 163.78 28.68 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.829 2.353 . . . . 1.83 112.491 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 35.8 m -136.5 -178.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.346 -0.846 . . . . 2.57 109.305 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.703 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -126.56 117.78 23.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 6.46 109.658 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.7 151.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 4.19 109.259 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.456 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 2.9 pp -143.03 156.39 44.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 2.9 109.909 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -154.03 159.8 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 2.31 109.428 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 144.99 -142.92 11.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.578 -1.409 . . . . 1.75 109.578 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HB3' ' CD1' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -90.17 -165.88 1.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 2.54 109.44 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.465 ' H ' ' HB1' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.556 -1.418 . . . . 1.77 109.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.718 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.414 -0.588 . . . . 6.42 109.414 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.77 173.53 11.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 2.66 109.966 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -123.65 -19.62 5.74 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.823 -0.806 . . . . 3.93 108.823 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.583 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.68 34.72 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 4.15 109.203 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 4.6 109.538 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.496 ' CG ' ' N ' ' A' ' 98' ' ' GLY . 4.9 pt20 -107.79 -156.25 0.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 3.96 109.425 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -173.16 -35.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.688 -1.365 . . . . 3.67 109.688 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -80.07 90.21 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -1.146 . . . . 3.79 109.518 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.13 78.71 51.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 2.22 109.461 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.83 127.14 24.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.018 2.479 . . . . 3.49 112.547 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.9 mt -140.41 145.74 37.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.46 109.297 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -127.45 175.11 8.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 2.83 109.701 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -77.79 17.68 5.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 2.83 109.527 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 103' ' ' THR . 21.8 mt-10 -102.48 103.8 33.94 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.279 -1.13 . . . . 3.02 109.165 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -44.75 117.5 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.3 2.0 . . . . 1.42 112.188 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.468 ' HB3' HH12 ' A' ' 109' ' ' ARG . . . -165.16 156.82 14.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.925 . . . . 1.81 109.603 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.639 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.24 136.02 33.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.368 -0.833 . . . . 2.19 110.221 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.639 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -110.23 142.02 42.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.665 -1.235 . . . . 5.23 107.665 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.75 105.69 13.59 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.763 -0.775 . . . . 3.28 110.457 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -109.09 109.18 20.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.172 -1.048 . . . . 3.78 108.172 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -116.85 169.14 9.62 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 3.99 109.807 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.3 p90 -154.73 -178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.835 . . . . 3.1 109.514 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -109.92 106.15 15.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.36 -0.837 . . . . 2.65 109.689 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.675 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 59.8 p -35.97 119.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 4.28 109.316 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.527 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 3.7 m120 -96.26 -49.24 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 7.59 109.576 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.716 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.81 -156.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 5.5 109.646 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.716 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -119.52 144.83 46.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.349 -0.844 . . . . 4.48 109.491 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.56 ' CD1' ' O ' ' A' ' 118' ' ' THR . 74.6 m-85 -157.86 62.29 2.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 5.99 109.497 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.503 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 45.7 Cg_exo -52.28 -173.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.852 2.368 . . . . 4.64 112.071 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 5.0 Cg_exo -71.23 -31.45 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.047 2.498 . . . . 4.46 111.857 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -111.0 -161.56 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 4.14 109.478 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 88.21 -149.02 21.08 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.514 -1.435 . . . . 4.24 109.514 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.654 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -44.73 -50.03 10.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 3.59 109.434 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' H ' ' A' ' 87' ' ' GLY . . . -165.68 155.09 10.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.78 109.457 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.91 -158.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 1.57 112.205 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.99 168.61 9.88 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.546 -1.422 . . . . 1.25 109.546 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.566 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -148.86 118.77 7.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -1.175 . . . . 2.18 109.656 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.9 t -136.02 137.74 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 1.87 108.636 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.27 112.15 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.999 -1.063 . . . . 1.45 110.506 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.4 m-30 -89.0 110.43 21.12 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.519 -0.919 . . . . 2.4 108.519 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.464 ' CD2' ' HA ' ' A' ' 49' ' ' TRP . 31.2 m80 -99.69 138.37 36.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 2.98 110.031 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.65 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -155.93 17.11 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 2.61 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -77.18 139.09 22.85 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.616 -1.393 . . . . 2.32 109.616 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 137' ' ' GLY . 18.7 mtpt -166.25 127.49 1.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.134 . . . . 5.66 109.81 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.17 -15.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.0 -1.111 . . . . 2.71 108.0 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.52 17.13 6.96 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.747 -1.741 . . . . 3.14 108.747 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.86 -158.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.918 . . . . 2.84 110.714 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.643 ' OH ' ' CG1' ' A' ' 80' ' ' VAL . 2.2 p90 -152.73 -119.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 2.44 109.391 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.464 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 2.3 mt-10 -135.9 143.88 45.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 1.86 109.228 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 38.1 t80 -124.5 127.39 47.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 2.48 109.454 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.94 115.56 25.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.74 110.506 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.466 HG22 ' CE2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -125.41 143.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.759 0.79 . . . . 1.69 109.017 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.635 ' HG ' HE21 ' A' ' 145' ' ' GLN . 52.3 p -120.66 -19.86 7.28 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.466 -0.939 . . . . 1.63 108.466 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.635 HE21 ' HG ' ' A' ' 144' ' ' SER . 4.9 pt20 -171.36 172.27 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.843 -0.743 . . . . 3.82 109.646 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.548 ' O ' ' OG1' ' A' ' 13' ' ' THR . 8.8 p -147.16 141.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 2.92 109.51 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.441 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -114.91 158.94 21.29 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.912 . . . . 3.25 109.527 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 149' ' ' THR . 1.6 tp -168.22 114.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 5.12 109.381 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 7' ' ' VAL . 7.0 t -156.68 -164.03 1.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 3.35 109.484 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.419 ' N ' ' OG1' ' A' ' 149' ' ' THR . 7.7 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 2.29 109.464 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.755 ' H ' ' HG1' ' A' ' 149' ' ' THR . 48.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.311 -0.626 . . . . 3.0 109.311 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.631 ' C ' ' H ' ' A' ' 10' ' ' LEU . 6.3 pm0 -51.02 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 4.75 109.669 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' VAL . 8.6 mp -54.22 -1.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 5.44 109.276 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.722 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -140.5 95.85 7.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 2.86 108.943 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.07 38.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 4.15 112.703 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.678 ' N ' ' O ' ' A' ' 10' ' ' LEU . 33.7 t60 -133.44 115.65 15.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 2.52 109.337 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.579 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -154.41 63.38 0.68 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.347 -0.846 . . . . 2.33 109.283 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.66 ' C ' ' H ' ' A' ' 16' ' ' ALA . 16.2 m -159.47 66.8 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 2.28 109.512 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.662 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.8 m-30 -67.11 27.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 2.6 109.195 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.17 -29.53 18.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.847 . . . . 1.66 109.956 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 4.3 mt-10 -109.73 -83.64 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 2.13 109.78 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.4 m -96.46 143.77 27.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 2.74 109.593 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.437 HD22 ' SD ' ' A' ' 37' ' ' MET . 3.9 mt -54.11 -51.38 64.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 3.06 109.418 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.37 -171.59 16.76 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.591 -1.404 . . . . 1.72 109.591 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 22' ' ' TRP . 47.5 Cg_endo -72.99 -18.54 24.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.759 2.306 . . . . 1.97 112.147 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.722 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.5 m95 -53.06 -174.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 2.88 109.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -135.81 173.79 11.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 2.07 109.525 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 pp -177.81 142.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 2.79 109.446 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.594 ' C ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.91 170.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 2.48 109.793 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.06 -29.73 10.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.97 -1.252 . . . . 1.7 109.97 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.773 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.73 -141.94 0.38 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.083 -1.245 . . . . 1.51 109.3 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.773 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.7 p -91.15 -170.58 2.7 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 2.11 109.172 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.22 111.34 46.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.85 109.041 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 76.7 Cg_exo -44.66 134.9 9.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.201 1.934 . . . . 1.4 111.921 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 37' ' ' MET . 9.2 t -116.95 105.07 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 1.53 109.918 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -69.24 77.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.568 -0.708 . . . . 2.56 109.416 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -60.67 -140.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.81 109.766 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -35.48 -76.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 2.21 109.503 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.21 49.71 0.71 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.586 -1.406 . . . . 1.23 109.586 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -173.15 150.38 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 3.37 109.398 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.437 ' SD ' HD22 ' A' ' 19' ' ' LEU . 4.5 ptt? -108.87 134.03 52.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 1.4 109.562 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.68 135.51 54.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.627 -0.829 . . . . 1.06 110.427 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.1 m -106.07 140.66 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.672 -0.862 . . . . 1.95 108.672 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.35 106.53 9.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 4.79 109.922 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 139' ' ' TYR . 6.6 mp -114.26 80.67 5.92 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 3.97 109.157 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.23 -95.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 4.21 112.263 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.17 137.29 4.85 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.651 -1.379 . . . . 2.09 109.651 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 155.71 -17.85 0.49 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 2.62 109.51 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.555 HE22 ' N ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -99.51 61.99 1.2 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.235 -1.156 . . . . 2.96 109.632 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -36.48 -33.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.249 -1.54 . . . . 2.38 109.249 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -107.69 101.83 41.97 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.364 -1.08 . . . . 4.04 109.037 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.449 ' O ' ' CG ' ' A' ' 132' ' ' HIS . 36.2 Cg_exo -56.36 44.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.457 2.105 . . . . 2.75 112.315 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.693 ' CH2' ' OD2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -117.12 49.75 1.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.99 . . . . 4.57 111.28 -179.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.693 ' OD2' ' CH2' ' A' ' 49' ' ' TRP . 23.9 m-20 -165.07 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 2.38 109.465 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.555 ' N ' HE22 ' A' ' 45' ' ' GLN . . . -81.06 120.04 24.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 1.47 109.546 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.59 179.2 37.03 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.683 -1.246 . . . . 0.96 110.041 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.713 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.5 mm? -100.07 168.01 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -1.04 . . . . 1.51 109.009 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -155.89 166.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 1.51 109.825 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 10' ' ' LEU . 13.1 t80 173.92 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 2.45 109.571 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.568 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-80 -98.93 150.03 22.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 2.95 109.548 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.69 52.54 0.14 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 2.52 109.589 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.461 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 14.7 t -142.79 70.59 19.64 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 4.19 109.457 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -47.66 143.57 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.834 2.356 . . . . 2.79 112.208 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.53 122.04 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 3.62 109.461 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.17 91.72 0.69 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 3.37 109.492 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 3.5 tm-20 -41.81 120.42 1.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 6.05 109.46 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.31 -48.82 0.93 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.807 -1.317 . . . . 3.09 109.807 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.6 mp0 -100.03 179.71 4.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 4.03 109.623 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -120.28 140.99 50.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 3.28 109.396 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.481 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 38.6 m-85 -109.53 -178.13 3.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.202 -0.936 . . . . 2.59 109.474 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.9 t -152.79 130.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 3.18 109.511 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 69' ' ' SER . 8.0 tt -110.7 147.51 34.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 4.0 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.496 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 1.6 p -130.2 91.05 3.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 2.8 109.455 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 109' ' ' ARG . 29.5 p90 -94.63 139.56 31.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 2.64 110.966 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.1 p -97.0 134.68 40.05 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.641 -0.874 . . . . 2.25 108.641 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.789 ' N ' HH22 ' A' ' 109' ' ' ARG . . . 169.37 -170.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.951 -1.093 . . . . 1.45 110.481 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -169.11 147.68 3.88 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.816 -0.809 . . . . 1.28 108.816 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -104.72 134.04 48.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.116 -0.99 . . . . 1.07 109.85 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.45 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.04 116.4 15.63 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.4 -0.812 . . . . 1.68 109.292 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.21 -142.29 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.665 0 C-N-CA 124.297 -1.126 . . . . 1.32 112.344 -0.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -104.96 148.8 26.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.75 109.253 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.724 ' SD ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 ptp 174.43 154.45 0.3 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 2.72 109.535 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.14 117.93 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.57 2.18 . . . . 1.83 111.871 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -97.45 179.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.878 . . . . 2.57 109.536 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -120.14 150.92 39.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 6.46 109.65 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -142.47 147.89 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 4.19 109.118 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.46 ' HB3' HH12 ' A' ' 81' ' ' ARG . 1.3 pp -143.81 148.26 35.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 2.9 110.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.593 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -154.41 164.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.775 . . . . 2.31 109.413 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.68 -138.9 6.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.687 -1.365 . . . . 1.75 109.687 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.1 pm0 -90.17 177.31 6.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -1.145 . . . . 2.54 109.489 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.523 -1.431 . . . . 1.77 109.523 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.54 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.427 -0.583 . . . . 6.42 109.427 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER 179.96 -179.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 2.66 109.954 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.575 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.04 -22.1 4.91 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.873 -0.788 . . . . 3.93 108.873 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.67 43.06 1.13 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.286 -0.884 . . . . 4.15 109.227 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -86.59 61.0 6.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.111 -0.993 . . . . 4.6 109.464 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.5 tt0 -99.93 161.57 13.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 3.96 109.04 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -135.43 -30.22 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.781 -1.327 . . . . 3.67 109.781 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.01 95.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.259 -1.142 . . . . 3.79 109.819 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.635 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -137.41 77.48 40.82 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 2.22 109.32 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.03 120.06 6.2 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.027 2.485 . . . . 3.49 112.701 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -137.9 132.88 33.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 3.46 109.357 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 5.1 t -128.84 -151.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 2.83 109.521 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.31 58.34 2.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.632 -1.387 . . . . 2.83 109.632 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.23 84.25 59.8 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -1.104 . . . . 3.02 109.481 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 107' ' ' ALA . 51.0 Cg_exo -48.65 124.91 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.814 2.343 . . . . 1.42 112.188 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.637 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . . . 161.03 174.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 1.81 109.444 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.08 131.9 35.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 2.19 109.929 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.789 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -100.74 140.97 34.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.092 -1.448 . . . . 5.23 107.092 177.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -108.73 123.39 48.93 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.515 -0.874 . . . . 3.28 110.94 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.635 ' OH ' ' CB ' ' A' ' 100' ' ' ALA . 7.5 m-85 -109.96 119.56 39.7 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.302 -0.999 . . . . 3.78 108.302 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.96 124.68 45.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.941 . . . . 3.99 109.941 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.704 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -133.5 165.42 24.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 3.1 109.436 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.16 125.68 51.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 2.65 109.748 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 4.2 m -52.7 124.38 13.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.28 -0.887 . . . . 4.28 109.213 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -111.04 -46.67 3.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.151 -0.968 . . . . 7.59 109.698 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -120.96 139.72 52.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 5.5 109.638 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.682 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -70.19 159.56 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 4.48 109.291 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.682 ' CG ' ' O ' ' A' ' 118' ' ' THR . 32.1 m-85 -168.05 93.44 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 5.99 109.492 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.09 165.8 21.31 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.722 2.281 . . . . 4.64 112.177 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.81 -15.05 12.22 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.716 2.278 . . . . 4.46 112.042 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.83 132.65 53.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 4.14 109.442 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.41 -137.47 9.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.546 -1.422 . . . . 4.24 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.638 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -121.48 39.14 3.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 3.59 109.454 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -179.92 71.23 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 2.78 109.495 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.72 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.752 2.301 . . . . 1.57 112.306 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -65.59 154.28 50.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.599 -1.401 . . . . 1.25 109.599 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 9.2 tp-100 -151.52 130.46 12.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.104 -1.233 . . . . 2.18 109.578 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 21.2 t -138.47 139.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 1.87 108.623 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.08 1.94 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.855 -1.153 . . . . 1.45 110.929 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.3 m-30 -90.72 112.09 23.71 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.207 -1.035 . . . . 2.4 108.207 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.449 ' CG ' ' O ' ' A' ' 48' ' ' PRO . 34.8 m170 -99.88 131.3 45.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 2.98 110.259 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.58 -23.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 2.61 109.896 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.06 133.65 0.37 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.763 -1.335 . . . . 2.32 109.763 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 137' ' ' GLY . 29.7 mtmt -169.03 127.03 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -1.135 . . . . 5.66 109.763 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.91 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.911 -1.144 . . . . 2.71 107.911 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.04 18.61 7.44 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.037 -1.625 . . . . 3.14 109.037 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.44 -154.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.625 -0.926 . . . . 2.84 110.756 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.724 ' CD1' ' SD ' ' A' ' 78' ' ' MET . 7.4 p90 -158.91 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.995 -1.066 . . . . 2.44 109.277 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.455 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 74.6 mm-40 -126.65 130.55 50.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 1.86 108.867 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -107.71 114.64 28.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 2.48 109.974 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.482 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 36.6 m -110.93 114.35 27.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.275 -0.891 . . . . 0.74 109.65 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.46 HD12 ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -123.26 145.03 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 1.69 109.517 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.662 ' O ' ' N ' ' A' ' 15' ' ' PHE . 0.7 OUTLIER -131.0 -12.74 3.64 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.299 -0.63 . . . . 1.63 109.299 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.578 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -158.93 158.95 34.34 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.372 -0.931 . . . . 3.82 110.181 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -162.39 129.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 2.92 108.91 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.96 144.06 8.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.062 . . . . 3.25 109.675 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 149' ' ' THR . 1.5 pp -122.11 164.99 16.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 5.12 109.523 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.755 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -177.68 -174.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 3.35 109.655 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.597 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.6 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 2.29 109.438 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.676 ' O ' ' N ' ' A' ' 9' ' ' LEU . 2.6 p . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.469 -0.567 . . . . 3.0 109.469 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 7' ' ' VAL . 8.4 tt0 -37.21 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 4.75 109.626 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 mt -61.92 -34.59 76.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 5.44 109.275 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.603 ' CD2' ' OH ' ' A' ' 55' ' ' TYR . 2.8 tm? -107.53 100.4 34.04 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 2.86 108.576 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.39 30.42 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.7 2.267 . . . . 4.15 112.997 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.599 ' H ' ' CD1' ' A' ' 10' ' ' LEU . 28.2 t60 -115.42 82.05 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.848 -1.158 . . . . 2.52 109.369 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.617 ' HG1' ' H ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -121.27 45.85 2.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 2.33 109.338 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.1 t -125.45 72.19 1.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 2.28 109.461 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -83.21 23.95 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.198 -0.939 . . . . 2.6 109.362 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.02 -35.12 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 1.66 109.696 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 26.4 mm-40 -109.86 -83.16 0.56 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.138 -0.976 . . . . 2.13 109.729 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 m -88.22 144.44 26.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 2.74 109.535 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.434 HD23 ' SD ' ' A' ' 37' ' ' MET . 7.4 mt -60.56 -58.45 8.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 3.06 109.515 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.471 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.1 -169.98 13.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 1.72 109.573 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 22' ' ' TRP . 55.9 Cg_endo -75.4 -19.21 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.793 2.329 . . . . 1.97 112.205 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.57 ' O ' ' O ' ' A' ' 21' ' ' PRO . 11.3 m95 -50.95 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 2.88 109.345 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -143.25 169.85 16.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 2.07 109.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.76 138.64 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 2.79 109.574 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.96 159.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 2.48 109.439 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 107.45 -26.91 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.865 -1.294 . . . . 1.7 109.865 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.78 -142.35 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 1.51 109.201 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 12.4 p -91.61 -162.14 0.89 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.459 -0.775 . . . . 2.11 108.999 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.01 131.4 39.27 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 2.85 108.811 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.66 132.29 23.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.246 1.964 . . . . 1.4 111.839 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 37' ' ' MET . 40.8 t -118.83 111.19 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.53 109.888 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.707 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.49 85.54 5.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.657 -0.652 . . . . 2.56 109.49 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.25 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 1.81 109.689 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.26 -68.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 2.21 109.369 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.55 35.19 1.82 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.465 . . . . 1.23 109.436 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.77 147.89 28.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -1.12 . . . . 3.37 109.64 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.434 ' SD ' HD23 ' A' ' 19' ' ' LEU . 2.5 ptt? -121.18 132.78 55.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 1.4 109.231 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 m -128.89 145.02 51.33 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.452 -0.899 . . . . 1.06 110.376 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' HB ' ' HG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.16 145.43 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.705 -0.85 . . . . 1.95 108.705 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.671 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -75.12 123.39 25.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 4.79 109.802 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 42' ' ' PRO . 4.4 mm? -122.69 75.02 45.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 3.97 109.258 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 41' ' ' LEU . 51.6 Cg_exo -48.14 -167.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.871 2.381 . . . . 4.21 112.359 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 136' ' ' ALA . . . -124.45 62.01 0.58 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.507 -1.437 . . . . 2.09 109.507 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . -154.48 15.28 0.55 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 2.62 109.627 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -99.93 91.35 4.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -1.164 . . . . 2.96 109.477 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.29 -7.95 61.26 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.496 -1.442 . . . . 2.38 109.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.57 ' OD1' ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -99.9 121.68 53.38 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.274 -1.133 . . . . 4.04 109.371 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.17 5.86 4.28 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.433 2.089 . . . . 2.75 112.308 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.469 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -122.98 33.15 5.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 4.57 109.604 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 34.5 m-20 -126.02 43.17 3.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 2.38 109.433 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 159.59 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 1.47 109.553 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 164.88 157.97 10.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.009 -1.236 . . . . 0.96 110.009 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 7.5 mt -77.17 -176.3 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -1.135 . . . . 1.51 109.157 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.88 159.18 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.51 109.593 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.603 ' OH ' ' CD2' ' A' ' 10' ' ' LEU . 46.2 t80 178.92 143.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.384 -0.823 . . . . 2.45 109.648 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.4 m-80 -111.17 -164.75 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 2.95 109.524 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 82.82 74.33 1.2 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 2.52 109.572 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 57' ' ' GLY . 52.2 t -161.12 77.57 2.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.107 . . . . 4.19 109.52 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.45 155.99 1.95 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.815 2.343 . . . . 2.79 112.135 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.99 114.66 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 3.62 109.614 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -138.99 101.89 0.33 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.256 -1.537 . . . . 3.37 109.256 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.625 ' OE1' ' N ' ' A' ' 63' ' ' GLY . 7.0 tp10 -38.19 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -1.087 . . . . 6.05 109.452 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.625 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 103.35 -56.41 0.6 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.576 -1.409 . . . . 3.09 109.576 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.66 141.89 31.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.116 . . . . 4.03 109.334 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -99.89 120.54 39.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 3.28 109.553 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' C ' ' CG2' ' A' ' 67' ' ' VAL . 81.7 m-85 -85.55 174.71 9.26 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 2.59 109.505 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.442 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -155.43 132.82 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 3.18 109.323 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tt -114.07 130.56 56.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.966 . . . . 4.0 109.498 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.2 p -118.16 94.86 4.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 2.8 108.736 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 11.2 p90 -93.28 135.48 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.05 -1.031 . . . . 2.64 111.091 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.457 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 19.1 p -90.31 109.25 20.35 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.547 -0.908 . . . . 2.25 108.547 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 141' ' ' PHE . . . -158.89 165.92 33.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.624 -1.23 . . . . 1.45 110.817 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.8 p -129.42 163.1 26.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.914 -0.773 . . . . 1.28 108.914 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.582 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -124.39 119.3 28.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 1.07 109.593 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.46 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.79 116.74 16.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.057 -1.027 . . . . 1.68 110.113 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.582 ' O ' ' O ' ' A' ' 74' ' ' ALA . 20.1 Cg_exo -65.87 -142.15 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.687 0 C-N-CA 124.232 -1.153 . . . . 1.32 112.05 -0.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' C ' ' CG ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -97.86 149.39 22.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 1.75 109.208 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.697 ' SD ' ' CE2' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 165.21 159.82 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 2.72 109.795 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.34 119.24 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.711 2.274 . . . . 1.83 112.032 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.19 169.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 2.57 109.44 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.729 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.1 OUTLIER -109.83 139.42 44.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.917 . . . . 6.46 109.313 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -141.05 148.26 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 4.19 109.533 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -147.21 144.0 28.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 2.9 109.487 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.498 ' CG2' ' CD2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -152.84 145.03 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 2.31 110.342 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 128' ' ' GLN . . . 142.21 -109.62 0.58 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.881 -1.288 . . . . 1.75 109.881 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' CD ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -89.98 164.87 14.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -1.181 . . . . 2.54 109.663 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.593 -1.403 . . . . 1.77 109.593 179.862 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 6.42 109.766 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.688 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 1.8 t -128.85 -150.93 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 2.66 110.275 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.688 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -119.01 -22.32 7.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.239 -0.652 . . . . 3.93 109.239 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.498 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.11 41.66 1.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.787 -1.196 . . . . 4.15 109.235 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -90.01 44.28 1.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.983 -1.073 . . . . 4.6 109.537 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 111' ' ' TYR . 7.3 pt20 -106.67 137.18 45.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 3.96 109.431 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 82' ' ' VAL . . . -128.49 20.28 5.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.664 -1.374 . . . . 3.67 109.664 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -104.84 76.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 3.79 109.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.76 102.03 53.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 2.22 109.333 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.79 118.81 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.702 2.268 . . . . 3.49 112.608 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.6 159.82 33.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 3.46 109.522 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 2.4 t -103.5 -148.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 2.83 109.86 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.597 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -110.2 29.65 9.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 2.83 109.805 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -139.59 147.96 54.15 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.201 -1.176 . . . . 3.02 109.205 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -40.48 117.35 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.592 2.194 . . . . 1.42 111.882 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.38 127.69 11.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.151 -0.968 . . . . 1.81 109.811 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.62 141.14 29.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.44 -0.787 . . . . 2.19 109.853 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.711 HH12 ' HH ' ' A' ' 111' ' ' TYR . 9.1 mmm-85 -113.26 136.44 52.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.377 -0.972 . . . . 5.23 108.377 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -117.18 107.36 14.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.175 -0.61 . . . . 3.28 109.883 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.711 ' HH ' HH12 ' A' ' 109' ' ' ARG . 42.3 m-85 -109.95 114.76 28.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 3.78 109.083 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.436 ' C ' ' CD2' ' A' ' 113' ' ' PHE . . . -103.38 170.48 7.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -0.873 . . . . 3.99 109.611 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.436 ' CD2' ' C ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 179.05 161.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 3.1 109.767 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.37 155.01 20.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 2.65 109.307 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -90.13 44.15 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 4.28 109.954 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 115' ' ' SER . 6.9 m120 -39.92 -17.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 7.59 109.576 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.2 mm? -109.87 143.82 39.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 5.5 109.436 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.85 107.75 18.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 4.48 109.681 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 117' ' ' LEU . 43.0 m-85 -133.69 98.26 15.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 5.99 109.181 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.28 165.58 23.34 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.52 2.147 . . . . 4.64 112.239 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.03 -14.59 12.16 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.836 2.357 . . . . 4.46 112.069 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -109.66 123.24 49.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 4.14 109.602 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.554 ' O ' ' OD1' ' A' ' 124' ' ' ASP . . . 150.02 -84.34 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.478 -1.449 . . . . 4.24 109.478 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 123' ' ' GLY . 4.5 m-20 -162.21 -37.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 3.59 109.452 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -112.59 93.45 23.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 2.78 109.417 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.98 -159.17 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.744 2.296 . . . . 1.57 112.273 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.57 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -72.84 -178.99 35.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 1.25 109.603 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.458 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -170.25 141.18 2.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -1.094 . . . . 2.18 109.707 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.437 ' N ' ' HG2' ' A' ' 128' ' ' GLN . 67.3 t -138.71 151.48 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.973 -1.121 . . . . 1.87 107.973 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -165.66 111.72 0.9 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.815 -1.154 . . . . 1.45 110.48 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.514 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.8 m-30 -94.12 84.38 4.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.456 -0.942 . . . . 2.4 108.456 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.446 ' ND1' ' HA ' ' A' ' 49' ' ' TRP . 19.6 m170 -98.73 132.53 44.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 2.98 110.173 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.65 2.32 2.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 2.61 109.268 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -48.95 136.4 19.8 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.517 -1.433 . . . . 2.32 109.517 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.668 ' O ' ' N ' ' A' ' 137' ' ' GLY . 19.5 mtpt -165.72 130.14 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -1.157 . . . . 5.66 109.869 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 43' ' ' GLY . . . -42.58 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.87 -1.159 . . . . 2.71 107.87 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.47 17.1 7.44 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.734 -1.747 . . . . 3.14 108.734 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.637 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -51.13 -149.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.903 . . . . 2.84 110.432 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.697 ' CE2' ' SD ' ' A' ' 78' ' ' MET . 0.0 OUTLIER -171.7 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.008 . . . . 2.44 110.597 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.674 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 13.9 mt-10 -137.26 140.79 41.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 1.86 109.351 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CE2' HG22 ' A' ' 143' ' ' ILE . 42.0 t80 -117.53 128.3 54.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.865 . . . . 2.48 109.374 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.41 110.66 17.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.126 -0.984 . . . . 0.74 109.977 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.467 HG22 ' CE2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -119.66 144.68 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 1.69 109.279 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 88.6 p -130.06 -15.23 3.81 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.205 -0.665 . . . . 1.63 109.205 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.466 ' CG ' ' C ' ' A' ' 144' ' ' SER . 3.0 mt-30 -155.51 177.52 11.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 3.82 110.015 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.617 ' H ' ' HG1' ' A' ' 13' ' ' THR . 3.9 p -177.04 124.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.815 . . . . 2.92 109.461 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 176.74 11.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 3.25 109.775 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 149' ' ' THR . 1.3 pp -155.37 -161.35 1.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 5.12 109.394 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.66 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 3.35 109.5 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.44 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 2.29 109.371 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.271 0.558 . . . . 3.0 109.511 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -85.74 83.08 7.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 4.75 109.468 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.93 -33.03 73.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 5.44 109.426 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -109.07 96.02 19.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 2.86 108.653 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.5 27.07 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.32 2.014 . . . . 4.15 111.693 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.502 ' H ' HD13 ' A' ' 10' ' ' LEU . 48.2 t60 -128.31 74.21 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 2.52 109.478 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 10.1 t -112.96 41.58 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 2.33 109.43 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.653 ' C ' ' H ' ' A' ' 16' ' ' ALA . 6.5 t -115.85 59.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 2.28 109.668 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -65.49 16.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 2.6 109.263 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.05 -22.39 21.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 1.66 109.848 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -109.81 -84.29 0.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.13 109.633 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m -109.0 153.78 23.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 2.74 109.443 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD21 ' SD ' ' A' ' 37' ' ' MET . 2.2 mt -56.76 -54.26 48.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 3.06 109.547 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 103.22 -149.24 17.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.72 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.72 -27.49 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.748 2.299 . . . . 1.97 112.252 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.508 ' CH2' ' CG1' ' A' ' 146' ' ' VAL . 15.4 m95 -52.01 167.59 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 2.88 109.256 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -131.87 179.25 6.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -0.959 . . . . 2.07 109.676 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' CD2' HD21 ' A' ' 19' ' ' LEU . 2.9 pp 179.35 152.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 2.79 109.504 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -179.06 152.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 2.48 109.529 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.71 -24.63 13.01 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.909 -1.139 . . . . 1.7 110.435 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.78 -144.27 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.381 . . . . 1.51 109.583 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 7.9 p -92.8 135.22 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 2.11 109.291 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -41.27 104.25 0.34 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.976 -1.078 . . . . 2.85 108.588 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 28' ' ' SER . 51.7 Cg_exo -46.95 166.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.183 1.922 . . . . 1.4 111.83 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 t -151.08 121.16 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.07 -1.019 . . . . 1.53 110.182 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -76.2 92.96 3.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.85 . . . . 2.56 109.341 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.68 -140.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 1.81 109.531 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' OD1' ' C ' ' A' ' 34' ' ' ASP . 39.6 t0 -58.6 -43.41 89.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.965 . . . . 2.21 109.368 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.74 48.35 0.38 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.271 -1.531 . . . . 1.23 109.271 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -171.29 146.29 2.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -1.11 . . . . 3.37 109.496 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.432 ' SD ' HD21 ' A' ' 19' ' ' LEU . 40.4 ttp -109.58 133.76 52.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.246 -0.908 . . . . 1.4 109.068 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.696 ' SG ' ' OE2' ' A' ' 140' ' ' GLU . 0.5 OUTLIER -127.76 173.61 9.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.229 -0.919 . . . . 1.06 110.434 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.416 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 3.1 m -149.26 144.97 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.875 -0.787 . . . . 1.95 108.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' N ' ' OG ' ' A' ' 28' ' ' SER . 35.4 m-20 -82.48 106.48 14.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.88 . . . . 4.79 109.289 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD21 ' HG1' ' A' ' 27' ' ' THR . 3.8 mm? -113.5 80.1 4.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 3.97 109.654 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.37 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.756 2.304 . . . . 4.21 112.238 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -120.24 115.58 3.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.539 -1.425 . . . . 2.09 109.539 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.623 ' H ' ' H ' ' A' ' 136' ' ' ALA . . . -174.88 -40.83 0.05 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.843 -1.303 . . . . 2.62 109.843 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.722 ' NE2' ' HZ2' ' A' ' 135' ' ' LYS . 12.0 mt-30 -100.0 125.35 46.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -1.153 . . . . 2.96 109.586 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.89 65.88 0.27 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 2.38 109.344 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.659 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -146.03 96.6 4.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.36 -1.082 . . . . 4.04 109.396 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 53.1 Cg_exo -48.44 4.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.852 2.368 . . . . 2.75 113.079 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.62 ' H ' ' C ' ' A' ' 47' ' ' ASN . 1.4 p-90 -127.59 34.32 4.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.885 -1.134 . . . . 4.57 109.667 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.659 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 30.7 m-20 -132.97 39.05 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 2.38 109.215 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 158.78 94.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 1.47 109.259 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.9 174.13 45.21 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.864 -1.295 . . . . 0.96 109.864 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 6.6 mt -95.05 -178.1 4.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 1.51 109.526 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.49 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -162.94 162.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 1.51 109.293 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 15.2 t80 172.26 140.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 2.45 109.72 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.689 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.4 m120 -94.38 -168.1 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 2.95 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.534 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 82.3 74.62 1.17 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 2.52 109.463 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 57' ' ' GLY . 48.6 t -161.31 69.74 2.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.275 -1.132 . . . . 4.19 109.547 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.85 120.51 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.789 2.326 . . . . 2.79 112.136 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 t -112.5 141.25 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 3.62 109.532 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -116.5 98.9 0.83 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.464 -1.454 . . . . 3.37 109.464 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 61.8 tt0 -35.64 130.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 6.05 109.546 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 111.08 -32.36 6.57 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 3.09 109.626 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.3 mt-10 -100.01 177.9 4.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -1.157 . . . . 4.03 109.525 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -128.53 143.79 51.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 3.28 109.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 27.2 m-85 -112.75 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.156 -0.965 . . . . 2.59 109.677 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.406 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.4 t -152.8 137.24 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.551 -0.718 . . . . 3.18 109.281 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.83 121.51 38.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 4.0 109.782 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.1 p -109.52 85.47 2.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 2.8 108.745 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.7 p90 -93.63 143.56 26.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 2.64 111.167 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.751 ' HG1' ' CB ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -93.39 122.91 36.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.609 -0.885 . . . . 2.25 108.609 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.793 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -163.44 147.11 10.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 1.45 110.385 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.37 135.9 52.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.877 -0.786 . . . . 1.28 108.877 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -107.6 116.73 32.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 1.07 109.819 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' ' CG ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -131.24 119.09 17.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 1.68 109.831 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.9 Cg_exo -66.17 -142.19 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.305 -1.123 . . . . 1.32 112.372 -0.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 159.24 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 1.75 109.809 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.513 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.9 mtt 162.83 154.98 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 2.72 109.215 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.71 148.65 32.9 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.812 2.341 . . . . 1.83 112.628 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.453 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 0.6 OUTLIER -122.91 172.1 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 2.57 109.056 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 132' ' ' HIS . 14.9 ttt180 -134.81 95.54 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 6.46 109.921 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 132' ' ' HIS . 1.4 m -99.88 148.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 4.19 108.939 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.6 pp -139.73 152.98 47.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 2.9 109.99 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.3 t -149.15 157.7 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 2.31 109.389 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.88 -143.78 8.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.622 -1.391 . . . . 1.75 109.622 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.662 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 0.3 OUTLIER -90.24 -176.33 4.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 2.54 109.409 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.613 -1.395 . . . . 1.77 109.613 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.706 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.437 -0.579 . . . . 6.42 109.437 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.18 169.43 10.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 2.66 109.954 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.02 -15.9 6.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 3.93 108.881 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.482 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.51 36.88 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 4.15 109.155 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -76.38 98.1 4.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.98 . . . . 4.6 109.504 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -106.15 137.12 44.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 3.96 109.128 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.562 ' N ' ' NE2' ' A' ' 97' ' ' GLN . . . -136.73 -0.25 2.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.766 -1.334 . . . . 3.67 109.766 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.686 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.6 m -122.8 63.37 0.98 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.131 -1.217 . . . . 3.79 109.773 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.68 ' N ' ' OE1' ' A' ' 97' ' ' GLN . . . -112.89 96.39 37.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 2.22 109.494 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.41 125.76 5.84 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.791 2.327 . . . . 3.49 112.573 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.456 HD22 ' NE ' ' A' ' 109' ' ' ARG . 70.7 mt -133.4 149.24 51.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 3.46 109.271 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 105' ' ' GLU . 1.8 t -136.69 -174.92 3.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 2.83 109.58 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -63.13 38.62 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.566 -1.414 . . . . 2.83 109.566 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.619 ' H ' ' C ' ' A' ' 103' ' ' THR . 17.3 tp10 -117.33 78.85 11.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 3.02 109.387 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.53 118.94 2.83 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.801 2.334 . . . . 1.42 112.17 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.671 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -174.32 169.72 3.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 1.81 109.58 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.82 141.15 29.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 2.19 109.881 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.793 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.55 137.06 49.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.705 -1.22 . . . . 5.23 107.705 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 110' ' ' GLU . 6.2 mp0 -111.22 107.43 16.74 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.847 -0.741 . . . . 3.28 110.977 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.476 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.6 m-30 -109.89 110.69 21.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.186 -1.042 . . . . 3.78 108.186 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.13 153.25 22.36 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.232 -0.917 . . . . 3.99 109.777 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -141.08 173.82 11.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 3.1 109.289 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -101.35 111.44 23.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 2.65 109.655 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 64' ' ' GLU . 6.9 t -41.03 125.99 2.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 4.28 109.353 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 6.4 p-10 -121.21 -30.64 4.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 7.59 109.522 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.97 123.82 41.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 5.5 109.472 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.56 116.28 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 4.48 109.393 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 23.8 m-85 -122.45 79.61 46.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 5.99 109.48 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.83 168.98 2.05 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.808 2.338 . . . . 4.64 111.96 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.66 -16.89 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.696 2.264 . . . . 4.46 112.117 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.59 176.59 4.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 4.14 109.409 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.78 -156.17 18.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 4.24 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 5.0 p-10 -35.87 -72.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -1.134 . . . . 3.59 109.565 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -137.63 150.34 67.84 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 2.78 109.463 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.86 -158.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.824 2.35 . . . . 1.57 112.246 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -58.36 157.31 19.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.428 . . . . 1.25 109.529 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.3 149.42 34.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -1.165 . . . . 2.18 109.484 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.421 HG23 ' CG1' ' A' ' 84' ' ' VAL . 58.0 t -150.58 150.83 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.627 -0.879 . . . . 1.87 108.627 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.35 99.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.004 -1.06 . . . . 1.45 110.369 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -70.18 114.34 8.23 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 2.4 108.144 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 48' ' ' PRO . 1.2 m170 -99.28 133.2 43.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 2.98 110.388 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 134' ' ' GLY . 4.6 mp -127.81 -40.79 1.7 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.78 . . . . 2.61 109.064 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 55.71 147.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 2.32 109.693 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.722 ' HZ2' ' NE2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -99.8 -150.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.169 . . . . 5.66 109.547 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.623 ' H ' ' H ' ' A' ' 44' ' ' GLY . . . 78.46 6.11 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 2.71 109.055 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.29 10.03 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.136 -1.586 . . . . 3.14 109.136 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.02 -149.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -1.084 . . . . 2.84 109.573 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -166.74 -114.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.392 -0.818 . . . . 2.44 109.828 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.696 ' OE2' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.02 141.58 51.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 1.86 108.773 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.646 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 18.2 t80 -125.84 114.86 19.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -0.841 . . . . 2.48 110.045 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 140' ' ' GLU . 1.5 m -117.71 103.16 9.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.74 110.014 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.448 HG23 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -115.33 143.42 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 1.69 109.013 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.445 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 49.6 p -137.84 -1.17 2.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.601 -0.687 . . . . 1.63 109.358 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.751 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 7.3 mt-30 -153.06 153.84 33.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 3.82 109.98 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.644 ' N ' ' OG1' ' A' ' 13' ' ' THR . 88.1 t -160.18 121.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 2.92 109.369 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 p -152.01 171.73 17.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.011 . . . . 3.25 109.702 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 1.9 pt? -157.94 -162.44 1.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 5.12 109.508 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.668 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER 165.34 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 3.35 109.443 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.668 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.5 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 2.29 109.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.685 ' H ' ' HG1' ' A' ' 149' ' ' THR . 1.4 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.474 -0.565 . . . . 3.0 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.651 ' OE1' ' N ' ' A' ' 9' ' ' LEU . 3.8 tp10 -49.93 106.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 4.75 109.485 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.651 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 3.9 mt -85.7 28.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.91 . . . . 5.44 109.445 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.624 ' O ' ' N ' ' A' ' 12' ' ' HIS . 3.0 tm? -157.19 89.09 2.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 2.86 108.889 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -53.72 43.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.186 2.591 . . . . 4.15 113.321 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 10' ' ' LEU . 11.7 t60 -158.39 102.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.892 -1.13 . . . . 2.52 109.53 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.735 ' HG1' ' H ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -147.04 43.91 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 2.33 109.469 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 16' ' ' ALA . 68.8 m -155.77 81.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 2.28 109.947 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.416 ' CZ ' HG12 ' A' ' 146' ' ' VAL . 6.6 m-85 -69.41 36.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 2.6 108.988 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -78.46 -30.43 47.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.236 -0.915 . . . . 1.66 109.599 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 1.9 mt-10 -110.38 -73.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 2.13 109.501 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.8 m -109.24 145.25 36.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 2.74 109.504 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -51.39 -48.22 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 3.06 109.522 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 97.74 -172.87 27.65 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.502 -1.439 . . . . 1.72 109.502 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.0 Cg_endo -69.86 -20.68 34.07 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.739 2.293 . . . . 1.97 112.189 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.575 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 8.6 m95 -53.55 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.993 . . . . 2.88 109.286 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -141.51 167.53 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 2.07 109.782 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.688 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -174.58 167.59 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 2.79 109.4 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.737 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.74 -176.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 2.48 109.649 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 94.34 -28.85 9.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 1.7 109.842 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.814 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.85 -142.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 1.51 109.306 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.814 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.6 p -91.02 -163.8 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 2.11 109.254 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.25 111.58 47.83 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 2.85 109.022 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HB3' ' CG ' ' A' ' 37' ' ' MET . 56.3 Cg_exo -45.71 159.76 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.268 1.979 . . . . 1.4 112.022 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -143.52 109.24 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 1.53 109.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -69.82 72.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 2.56 109.456 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -65.31 -138.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.81 109.644 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -49.67 81.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.82 . . . . 2.21 109.526 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 47.5 30.68 6.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.639 -1.384 . . . . 1.23 109.639 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.45 142.81 30.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -1.144 . . . . 3.37 109.564 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.417 ' CG ' ' HB3' ' A' ' 30' ' ' PRO . 5.3 ttp -109.87 125.24 52.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 1.4 109.163 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.431 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 56.8 m -124.6 154.79 40.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.917 . . . . 1.06 110.084 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.96 139.4 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.525 -0.734 . . . . 1.95 109.025 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.12 122.21 33.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 4.79 109.649 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 9.0 mp -113.29 92.98 24.29 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 3.97 109.344 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 51.1 Cg_exo -50.03 -57.02 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.031 2.487 . . . . 4.21 112.625 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 117.99 146.53 8.17 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.783 -1.327 . . . . 2.09 109.783 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 33.34 0.73 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.863 -1.295 . . . . 2.62 109.863 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.525 ' NE2' ' CB ' ' A' ' 50' ' ' ASP . 9.1 mt-30 -118.26 150.48 39.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.113 -1.228 . . . . 2.96 109.648 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.13 56.83 0.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.383 -1.487 . . . . 2.38 109.383 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.623 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -174.48 98.49 0.29 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.199 -1.177 . . . . 4.04 109.393 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' CZ3' ' A' ' 49' ' ' TRP . 77.6 Cg_exo -46.27 -21.62 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.613 2.209 . . . . 2.75 112.431 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 39.2 p90 -106.9 65.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 4.57 109.494 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' NE2' ' A' ' 45' ' ' GLN . 1.2 m-20 -134.99 6.57 3.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 2.38 109.695 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -177.06 154.75 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 1.47 109.721 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.11 -169.33 26.29 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.879 -1.288 . . . . 0.96 109.879 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.681 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -97.34 152.18 19.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -1.074 . . . . 1.51 109.134 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.53 162.87 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 1.51 110.083 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.69 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 18.7 t80 175.58 149.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 2.45 109.4 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.69 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 1.4 m-80 -101.37 176.8 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 2.95 109.527 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.6 76.99 1.34 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 2.52 109.563 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.8 70.3 4.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 4.19 109.498 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.674 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.48 131.67 28.28 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.801 2.334 . . . . 2.79 112.191 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.07 114.24 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 3.62 109.521 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.628 ' C ' ' HG ' ' A' ' 115' ' ' SER . . . -117.18 103.55 1.11 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.521 -1.432 . . . . 3.37 109.521 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HB2' ' N ' ' A' ' 117' ' ' LEU . 3.4 tm-20 -47.34 139.05 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.138 . . . . 6.05 109.529 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.11 -37.18 3.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.688 -1.365 . . . . 3.09 109.688 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' SER . 2.7 mt-10 -99.99 168.88 9.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -1.18 . . . . 4.03 109.574 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.6 m -115.0 139.93 49.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 3.28 109.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.674 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 22.9 m-85 -104.61 -178.32 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.115 -0.99 . . . . 2.59 109.549 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.456 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -153.76 121.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 3.18 109.639 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.52 115.96 30.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 4.0 109.23 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -109.88 86.46 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.067 -1.02 . . . . 2.8 109.198 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 6.9 p90 -94.9 139.29 31.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.442 -0.786 . . . . 2.64 111.295 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.493 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -98.35 119.6 37.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.499 -0.926 . . . . 2.25 108.499 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . . . -171.57 134.68 0.85 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.077 -1.015 . . . . 1.45 110.024 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.453 ' HB2' ' N ' ' A' ' 105' ' ' GLU . 53.2 p -124.26 122.38 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 1.28 109.21 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.596 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -91.67 135.95 33.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 1.07 109.386 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.449 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.16 117.06 16.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.351 -0.843 . . . . 1.68 109.49 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -66.52 -142.42 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.66 0 C-N-CA 124.305 -1.123 . . . . 1.32 112.199 -0.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.453 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.7 OUTLIER -104.85 152.18 22.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 1.75 109.38 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.453 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 1.4 mtm -176.42 156.93 1.52 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 2.72 109.157 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.82 118.9 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.752 2.301 . . . . 1.83 112.402 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 98' ' ' GLY . 4.7 m -99.19 176.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 2.57 109.275 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.657 ' N ' ' O ' ' A' ' 132' ' ' HIS . 18.7 ttm180 -122.67 146.47 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 6.46 109.728 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.29 155.27 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.301 -0.874 . . . . 4.19 109.45 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.11 156.95 43.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 2.9 109.608 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.577 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.0 OUTLIER -146.79 138.3 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 2.31 109.681 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.56 -155.71 22.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.472 -1.451 . . . . 1.75 109.472 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.691 ' OE2' ' CG ' ' A' ' 119' ' ' PHE . 21.6 pm0 -88.82 -155.02 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 2.54 109.482 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.423 ' CA ' HE22 ' A' ' 128' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.77 109.669 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.58 ' O ' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.51 -0.552 . . . . 6.42 109.51 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.669 ' HG1' ' H ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -99.94 176.37 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 2.66 109.786 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.669 ' H ' ' HG1' ' A' ' 93' ' ' THR . . . -113.93 -22.77 9.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.897 -0.779 . . . . 3.93 108.897 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.84 34.26 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 4.15 109.35 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' OE1' ' C ' ' A' ' 96' ' ' GLU . 1.3 tm-20 -79.03 82.21 5.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 4.6 109.486 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.52 ' CG ' ' N ' ' A' ' 98' ' ' GLY . 3.9 pt20 -108.99 -160.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 3.96 109.522 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 97' ' ' GLN . . . -173.49 -41.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.534 -1.426 . . . . 3.67 109.534 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.48 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 3.79 109.585 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 98' ' ' GLY . . . -122.02 96.3 46.8 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 2.22 109.417 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.42 130.7 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.815 2.344 . . . . 3.49 112.754 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -132.65 140.32 48.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 3.46 109.297 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.66 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -93.93 -160.98 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 2.83 109.514 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.66 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -107.66 33.08 6.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 2.83 109.637 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.453 ' N ' ' HB2' ' A' ' 73' ' ' SER . 0.4 OUTLIER -119.12 142.07 31.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -1.166 . . . . 3.02 109.351 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 107' ' ' ALA . 55.3 Cg_endo -73.52 136.55 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.584 2.189 . . . . 1.42 112.217 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 106' ' ' PRO . . . 165.48 160.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 1.81 109.662 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.56 131.03 35.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 2.19 110.062 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 69' ' ' SER . 3.2 mmt180 -93.51 146.42 23.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.648 -1.612 . . . . 5.23 106.648 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.02 105.83 16.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.936 -1.103 . . . . 3.28 110.192 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.48 76.2 0.99 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.683 -0.858 . . . . 3.78 108.683 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.97 164.89 11.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 3.99 109.712 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 4.2 p90 -164.96 -174.21 3.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 3.1 109.607 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.28 112.22 24.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -0.811 . . . . 2.65 109.57 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.628 ' HG ' ' C ' ' A' ' 61' ' ' GLY . 6.8 t -47.27 125.11 7.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 4.28 109.395 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.453 ' O ' ' CD2' ' A' ' 117' ' ' LEU . 7.8 t-20 -124.2 1.03 8.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 7.59 109.422 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -145.98 120.41 9.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 5.5 109.444 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.648 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -67.93 140.16 56.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 4.48 109.58 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.691 ' CG ' ' OE2' ' A' ' 86' ' ' GLU . 18.4 m-85 -170.01 76.67 0.64 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 5.99 109.524 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.12 169.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.86 2.373 . . . . 4.64 111.944 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 125' ' ' ALA . 66.2 Cg_endo -80.46 -16.14 10.81 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.801 2.334 . . . . 4.46 112.082 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 123' ' ' GLY . 17.4 p-10 -109.95 -46.43 3.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 4.14 109.516 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -39.42 -45.02 2.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.489 -1.444 . . . . 4.24 109.489 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.19 -73.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 3.59 109.473 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -139.82 162.19 52.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 2.78 109.4 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.68 -5.37 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.028 2.485 . . . . 1.57 112.202 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 120.82 161.19 11.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.51 -1.436 . . . . 1.25 109.51 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 2.3 tt0 -149.15 105.82 3.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -1.148 . . . . 2.18 109.718 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 1.7 p -139.09 118.39 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.648 -0.871 . . . . 1.87 108.648 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.23 139.34 31.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 1.45 110.583 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -94.73 109.31 21.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.711 -0.848 . . . . 2.4 108.711 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.657 ' O ' ' N ' ' A' ' 81' ' ' ARG . 6.3 m170 -99.74 119.8 38.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 2.98 109.733 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -112.3 -3.56 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 2.61 109.126 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 46.13 -179.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.377 -1.489 . . . . 2.32 109.377 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.429 ' NZ ' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mtmt -125.41 24.28 7.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.282 . . . . 5.66 109.592 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.2 -21.69 63.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.714 -1.217 . . . . 2.71 107.714 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.698 ' O ' ' CD2' ' A' ' 139' ' ' TYR . . . -130.1 54.91 0.78 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.655 -2.178 . . . . 3.14 107.655 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -29.62 154.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.807 0.813 . . . . 2.84 110.825 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 174.5 -163.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 2.44 109.132 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.43 120.28 39.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 1.86 109.728 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 72' ' ' ALA . 6.4 t80 -102.15 106.87 17.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.867 . . . . 2.48 108.796 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.37 101.18 10.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.74 110.566 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 140.71 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 1.69 108.878 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.677 ' OG ' ' NE2' ' A' ' 145' ' ' GLN . 53.0 p -133.43 -7.51 2.91 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.553 -0.717 . . . . 1.63 109.516 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.677 ' NE2' ' OG ' ' A' ' 144' ' ' SER . 1.8 mm-40 -146.62 161.46 40.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 3.82 109.663 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.735 ' H ' ' HG1' ' A' ' 13' ' ' THR . 8.4 p -176.23 109.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.92 109.758 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 p -153.54 162.77 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 3.25 109.47 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.43 171.97 13.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 5.12 109.42 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.685 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -165.85 -168.19 1.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 3.35 109.482 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.581 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.3 t . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.203 -0.935 . . . . 2.29 109.486 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.576 ' O ' ' C ' ' A' ' 8' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.272 -0.64 . . . . 3.0 109.272 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.576 ' C ' ' O ' ' A' ' 7' ' ' VAL . 5.6 tt0 24.23 65.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.025 0.44 . . . . 4.75 110.659 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' HG ' ' CG1' ' A' ' 7' ' ' VAL . 12.3 mt -56.02 -49.12 74.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 5.44 108.859 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 55' ' ' TYR . 1.2 tp -101.34 116.05 64.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.003 . . . . 2.86 108.293 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.58 27.84 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.215 1.943 . . . . 4.15 111.946 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.484 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 35.9 t60 -137.02 139.15 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 2.52 109.502 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.576 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.07 54.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 2.33 109.338 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -164.41 73.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 2.28 109.572 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -62.97 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 2.6 108.897 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -74.05 -46.96 40.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 1.66 109.925 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.674 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.9 mt-10 -109.78 -84.02 0.56 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 2.13 109.542 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.8 m -94.41 142.98 26.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 2.74 109.465 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.62 -12.56 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 3.06 109.558 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.463 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 82.1 -147.05 25.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.36 -1.496 . . . . 1.72 109.36 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.31 -11.78 13.1 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.671 2.247 . . . . 1.97 112.143 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.6 m95 -66.51 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 2.88 109.284 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -156.44 126.84 6.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 2.07 109.559 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.634 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -121.08 133.17 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.958 . . . . 2.79 109.554 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.681 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.97 153.35 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 2.48 109.597 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 109.69 -22.92 23.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.951 -1.259 . . . . 1.7 109.951 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.823 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.91 -142.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.998 -1.295 . . . . 1.51 109.373 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.823 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.3 p -90.96 141.54 28.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 2.11 109.41 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -37.38 101.59 0.22 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.966 . . . . 2.85 109.236 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' SER . 59.9 Cg_exo -46.27 160.94 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.404 2.069 . . . . 1.4 111.879 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.615 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 7.7 p -138.35 97.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 1.53 110.318 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.32 84.41 3.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.454 -0.779 . . . . 2.56 109.096 178.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.15 -140.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 1.81 109.925 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 2.21 109.563 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . -141.73 47.25 0.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.727 -1.349 . . . . 1.23 109.727 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.716 ' NH2' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -168.43 148.88 4.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 3.37 109.752 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.509 ' SD ' ' CD1' ' A' ' 24' ' ' LEU . 58.2 ttp -123.43 129.24 50.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.419 -0.8 . . . . 1.4 109.224 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.716 ' SG ' ' NH2' ' A' ' 36' ' ' ARG . 59.3 m -122.65 146.55 47.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.607 -0.837 . . . . 1.06 110.072 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG2' HD13 ' A' ' 41' ' ' LEU . 3.0 m -122.69 160.25 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.62 -0.881 . . . . 1.95 108.62 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.637 ' H ' ' HG ' ' A' ' 28' ' ' SER . 2.9 m-20 -105.9 99.69 9.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 4.79 110.119 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 7.2 mp -113.73 79.76 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 3.97 109.137 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.18 -158.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.872 2.381 . . . . 4.21 112.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 136' ' ' ALA . . . -96.09 123.85 7.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.444 -1.462 . . . . 2.09 109.444 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.0 -14.83 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 2.62 109.535 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 27.4 mt-30 -99.79 70.11 1.62 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -1.184 . . . . 2.96 109.435 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.83 49.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.548 -1.421 . . . . 2.38 109.548 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -164.65 87.14 1.08 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.223 -1.163 . . . . 4.04 109.494 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 51.3 Cg_exo -48.73 -6.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.826 2.351 . . . . 2.75 112.173 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.497 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.3 p90 -100.25 37.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 4.57 109.485 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 46.3 m-20 -146.1 32.79 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 2.38 109.434 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 172.97 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 1.47 109.403 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.6 173.7 41.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.783 -1.327 . . . . 0.96 109.783 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 53' ' ' LEU . 5.2 mp -99.67 175.94 5.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 1.51 109.245 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 0.6 OUTLIER -152.95 167.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 1.51 110.51 -179.61 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.687 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 5.4 t80 -177.65 132.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 2.45 109.162 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.687 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -107.59 159.79 16.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.946 . . . . 2.95 109.66 -179.709 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.01 77.52 1.03 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.447 . . . . 2.52 109.484 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 58' ' ' VAL . 55.2 t -149.85 60.91 4.71 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.142 . . . . 4.19 109.556 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 50.5 Cg_exo -48.57 142.59 17.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.775 2.316 . . . . 2.79 112.102 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 3.0 t -134.45 153.97 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 3.62 109.629 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -136.04 112.34 0.96 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.461 -1.455 . . . . 3.37 109.461 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.2 tm-20 -39.06 135.11 0.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.144 . . . . 6.05 109.668 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.22 -14.36 63.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.885 -1.286 . . . . 3.09 109.885 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' OG ' ' A' ' 115' ' ' SER . 2.2 mm-40 -100.79 157.45 16.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 4.03 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 150' ' ' THR . 70.8 m -118.96 121.37 39.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 3.28 109.176 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 60' ' ' VAL . 51.7 m-85 -98.19 178.54 5.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.203 -0.935 . . . . 2.59 109.743 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -163.61 133.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 3.18 109.41 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -118.18 122.03 42.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 4.0 109.736 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.4 p -112.2 100.25 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.88 -0.785 . . . . 2.8 108.88 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 2.2 p90 -93.96 146.31 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 2.64 110.95 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -99.63 107.01 19.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.124 -1.065 . . . . 2.25 108.124 178.534 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -157.52 156.26 31.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.697 -1.252 . . . . 1.45 110.862 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' GLU . 97.0 p -132.27 121.48 23.66 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.856 -0.794 . . . . 1.28 108.856 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -81.53 129.91 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 1.07 109.817 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.601 ' HG1' ' CB ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -130.81 116.92 17.17 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.382 -0.824 . . . . 1.68 109.287 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.591 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.35 -144.77 0.18 OUTLIER 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.104 -1.207 . . . . 1.32 111.998 0.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' ' CG ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.03 154.62 19.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.698 -1.251 . . . . 1.75 109.39 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.657 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 157.17 154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.385 -0.822 . . . . 2.72 109.264 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.565 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 68.0 Cg_endo -77.55 141.96 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.821 2.347 . . . . 1.83 112.356 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 98' ' ' GLY . 35.1 m -108.4 170.3 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 2.57 109.362 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 132' ' ' HIS . 0.1 OUTLIER -109.85 156.18 20.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 6.46 109.437 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 97' ' ' GLN . 2.7 p -156.94 159.31 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 4.19 109.51 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.55 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -154.66 143.67 21.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 2.9 109.702 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.595 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.4 OUTLIER -153.79 161.18 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 2.31 109.467 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 133.77 -164.56 24.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 1.75 109.548 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.687 ' OE2' ' CZ ' ' A' ' 119' ' ' PHE . 12.7 pm0 -84.08 35.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 2.54 109.428 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' O ' ' OE1' ' A' ' 128' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.636 -1.386 . . . . 1.77 109.636 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.66 HH11 ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.294 0.568 . . . . 6.42 109.789 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.761 ' HG1' ' H ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -144.05 -172.34 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 2.66 109.984 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.761 ' H ' ' HG1' ' A' ' 93' ' ' THR . . . -125.28 -23.39 4.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.89 -0.781 . . . . 3.93 108.89 179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.47 ' CD2' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.47 42.52 1.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 4.15 109.254 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.528 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.87 49.4 1.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.988 -1.07 . . . . 4.6 109.482 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -112.52 153.87 26.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 3.96 109.234 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -140.21 4.33 2.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 3.67 109.576 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -77.28 62.31 2.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.79 109.451 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.47 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -104.7 106.71 55.9 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 2.22 109.324 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.63 123.44 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.576 2.184 . . . . 3.49 112.676 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.32 173.24 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 3.46 109.358 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -138.11 -174.11 3.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 2.83 109.788 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -86.78 42.39 3.15 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.626 -1.389 . . . . 2.83 109.626 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.9 mt-10 -162.24 160.95 21.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 3.02 109.114 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.5 115.58 2.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.641 2.227 . . . . 1.42 111.715 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.39 124.65 9.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 1.81 109.754 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.418 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.49 150.28 21.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.809 . . . . 2.19 109.994 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -131.4 143.08 50.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.706 -1.22 . . . . 5.23 107.706 178.246 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.671 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 5.3 mt-10 -127.32 128.26 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.374 -0.93 . . . . 3.28 110.814 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' CB ' ' A' ' 100' ' ' ALA . 6.9 m-85 -124.56 119.08 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.655 -0.869 . . . . 3.78 108.655 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.34 146.85 29.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 3.99 110.007 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.728 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -130.92 164.68 24.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 3.1 109.267 179.681 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.475 ' H ' ' HG1' ' A' ' 114' ' ' THR . 0.8 OUTLIER -100.4 122.4 43.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 2.65 109.819 -179.703 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 6.1 m -59.77 129.83 43.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 4.28 109.393 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -114.99 -19.81 10.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 7.59 109.551 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -142.44 -153.1 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 5.5 109.276 179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.56 148.4 47.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.246 -0.909 . . . . 4.48 109.687 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.687 ' CZ ' ' OE2' ' A' ' 86' ' ' GLU . 44.4 m-85 -147.47 91.46 5.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 5.99 109.302 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.84 165.74 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.815 2.343 . . . . 4.64 112.227 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 -15.5 12.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.697 2.265 . . . . 4.46 112.02 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.83 132.42 54.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -0.873 . . . . 4.14 109.549 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.28 -148.05 19.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 4.24 109.525 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.5 30.0 7.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 3.59 109.441 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.85 70.0 0.21 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 2.78 109.437 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.55 -158.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.842 2.361 . . . . 1.57 112.185 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.38 149.91 50.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.528 -1.429 . . . . 1.25 109.528 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.566 ' OE1' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -148.09 128.02 13.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 2.18 109.536 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 32.8 t -138.75 137.45 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.465 -0.939 . . . . 1.87 108.465 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -155.24 109.74 2.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.186 -1.006 . . . . 1.45 110.262 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -80.6 103.53 10.52 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.847 -0.797 . . . . 2.4 108.847 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CD2' ' O ' ' A' ' 48' ' ' PRO . 7.0 m170 -99.58 128.77 45.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.935 . . . . 2.98 109.713 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.667 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.69 -32.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 2.61 109.449 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.554 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -39.6 131.96 2.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.566 -1.414 . . . . 2.32 109.566 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 137' ' ' GLY . 47.2 mttt -165.6 140.4 4.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 5.66 109.594 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.82 -20.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 2.71 108.565 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.51 12.93 7.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.112 -1.595 . . . . 3.14 109.112 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -50.42 -164.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -1.039 . . . . 2.84 109.898 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.565 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 1.1 p90 -166.61 -161.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 2.44 109.385 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.601 ' CB ' ' HG1' ' A' ' 75' ' ' THR . 3.0 mt-10 -81.67 151.31 27.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 1.86 109.733 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 12.8 t80 -137.19 113.36 9.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.893 . . . . 2.48 109.319 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.7 m -106.14 96.53 6.54 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.128 -0.983 . . . . 0.74 110.154 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -107.05 139.05 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 1.69 108.954 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.673 ' OG ' ' NE2' ' A' ' 145' ' ' GLN . 78.3 p -132.81 -14.03 2.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.563 -0.711 . . . . 1.63 109.715 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.673 ' NE2' ' OG ' ' A' ' 144' ' ' SER . 0.8 OUTLIER -147.9 164.59 33.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 3.82 110.146 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 146' ' ' VAL . 8.7 p -178.51 126.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.935 -0.765 . . . . 2.92 108.935 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.48 147.73 40.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.068 -1.02 . . . . 3.25 110.076 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 32.2 tp -116.72 135.6 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 5.12 109.231 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -150.68 -177.25 5.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.025 . . . . 3.35 109.725 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.564 ' N ' ' OG1' ' A' ' 149' ' ' THR . 2.7 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 2.29 109.576 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.676 ' H ' ' HG1' ' A' ' 149' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.364 0.602 . . . . 2.19 109.39 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.7 79.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.858 . . . . 2.74 109.715 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.81 -14.27 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.898 . . . . 2.31 109.19 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.634 ' CD1' ' O ' ' A' ' 12' ' ' HIS . 1.1 tm? -126.38 85.88 59.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 2.52 108.874 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.91 37.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.154 2.57 . . . . 2.27 112.391 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.634 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 57.2 t60 -145.53 101.1 3.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 1.45 109.315 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.7 t -142.37 52.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.267 -0.895 . . . . 1.53 109.453 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.628 ' C ' ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -139.38 68.11 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 2.22 109.609 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -67.1 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 2.24 109.127 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.628 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.25 -36.07 14.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 1.53 110.196 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 3.0 mm-40 -109.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 2.97 110.137 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -99.38 151.29 21.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.89 109.87 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.405 ' CD2' HD22 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -59.37 -60.02 4.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.845 . . . . 2.49 109.304 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.37 -164.32 12.32 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.84 109.523 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.55 -2.71 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.834 2.356 . . . . 0.93 112.276 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.535 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 11.8 m95 -75.13 -177.09 3.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.89 . . . . 0.64 109.321 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -140.07 175.84 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 1.22 109.295 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' TYR . 1.8 pp -179.29 164.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 2.43 109.938 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.675 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 162.71 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 2.99 109.718 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.61 -21.97 9.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.038 -1.225 . . . . 0.64 110.038 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.879 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.69 -142.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.287 . . . . 1.15 109.49 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.2 p -91.78 -175.87 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 1.05 108.984 179.389 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -81.02 111.65 25.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 2.59 108.815 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 28' ' ' SER . 54.1 Cg_exo -49.26 155.02 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.317 2.011 . . . . 1.16 111.855 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 37' ' ' MET . 44.9 t -142.41 106.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 1.75 109.986 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.68 82.92 3.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 2.24 109.128 179.127 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.569 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 1.36 109.938 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' ALA . 2.6 m-20 -41.47 -65.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 2.49 109.448 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.88 26.34 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.299 -1.52 . . . . 1.29 109.299 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -141.03 145.02 35.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -1.122 . . . . 4.18 109.641 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.443 ' SD ' ' HB3' ' A' ' 30' ' ' PRO . 45.4 ttp -112.85 127.35 56.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 1.54 109.128 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.606 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -121.3 156.82 31.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 1.22 110.346 -179.358 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -125.61 142.23 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.685 -0.857 . . . . 1.21 108.685 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' N ' ' OG ' ' A' ' 28' ' ' SER . 5.7 m-20 -77.26 111.98 13.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 1.52 109.817 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 139' ' ' TYR . 4.6 mm? -122.87 68.56 34.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 2.01 109.408 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.99 -92.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.835 2.357 . . . . 1.93 112.308 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.07 36.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.53 -1.428 . . . . 2.47 109.53 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.86 -9.02 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 1.79 109.482 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -99.87 119.03 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 2.45 109.522 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.52 46.94 1.18 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.513 -1.435 . . . . 2.54 109.513 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.561 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -171.25 102.95 0.39 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.174 -1.192 . . . . 2.4 109.67 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -47.32 -26.11 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.322 . . . . 1.97 112.363 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.646 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 27.0 p90 -93.98 44.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 4.27 109.665 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.48 ' CG ' ' CG ' ' A' ' 47' ' ' ASN . 1.9 m-20 -131.35 11.88 4.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 1.97 109.343 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.3 140.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 1.39 109.269 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 146.57 -174.36 26.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.678 -1.369 . . . . 0.65 109.678 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.499 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -104.21 -173.57 2.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -1.197 . . . . 2.13 109.921 -179.953 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.54 172.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.704 . . . . 2.1 109.376 -179.767 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 17.8 t80 170.48 142.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 2.28 109.664 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.635 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -103.27 -164.72 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.252 -0.905 . . . . 0.95 109.469 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.72 68.89 1.44 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.411 -1.476 . . . . 0.95 109.411 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.407 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 43.4 t -153.93 73.82 6.38 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.33 -1.1 . . . . 2.24 109.544 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.25 120.85 7.66 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.553 2.169 . . . . 1.14 112.043 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.39 130.19 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.226 -0.921 . . . . 1.69 109.663 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -113.08 102.52 1.29 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.94 109.362 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.567 ' O ' ' OE1' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -42.8 124.76 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 2.73 109.598 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.02 -39.18 2.14 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.77 -1.332 . . . . 1.08 109.77 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.58 ' O ' ' OG ' ' A' ' 115' ' ' SER . 10.3 mt-10 -100.22 170.12 8.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -1.147 . . . . 2.59 109.697 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -116.85 145.14 43.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 1.13 109.269 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 33.3 m-85 -110.84 179.49 4.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.123 -0.986 . . . . 2.34 109.671 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.3 t -152.78 149.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 1.57 109.316 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' ARG . 3.4 tp -134.06 116.96 16.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 1.48 109.858 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 83.2 p -109.4 85.85 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.464 -0.939 . . . . 1.78 108.464 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 49.9 p90 -92.61 137.08 32.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 1.57 111.275 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.3 p -84.24 114.41 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.193 -1.04 . . . . 1.27 108.193 178.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 148.04 15.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.781 -1.199 . . . . 1.34 110.671 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 131.12 39.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.689 -0.856 . . . . 0.95 108.689 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -93.36 127.57 39.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 1.18 109.728 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.497 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -134.19 114.39 12.64 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.307 -0.871 . . . . 1.28 109.261 179.882 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.635 ' O ' ' C ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.74 -141.98 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.895 -1.294 . . . . 0.89 112.407 -0.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.663 ' O ' ' CG ' ' A' ' 78' ' ' MET . 1.4 m-20 -98.94 160.15 14.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 1.4 109.634 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.663 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 156.91 155.83 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.85 . . . . 2.2 109.268 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.62 145.3 41.5 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.884 2.389 . . . . 0.79 112.376 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 0.7 OUTLIER -117.45 172.7 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 1.33 109.222 179.939 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 132' ' ' HIS . 20.0 ttt180 -119.69 134.36 55.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.93 . . . . 3.61 109.6 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.527 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -137.99 150.13 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 2.13 109.248 179.795 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.468 HD21 ' CE1' ' A' ' 132' ' ' HIS . 0.8 OUTLIER -145.99 152.33 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 1.46 109.832 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.622 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -154.95 154.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.923 . . . . 1.16 109.632 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 148.33 -149.04 21.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.653 -1.379 . . . . 0.7 109.653 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.674 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.9 pm0 -90.08 178.38 6.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 2.74 109.715 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.544 -1.422 . . . . 1.63 109.544 179.994 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.849 HH11 ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.317 0.58 . . . . 3.93 109.452 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -125.78 -171.37 2.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 1.48 109.814 -179.815 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.665 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -118.45 -24.06 6.96 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.904 -0.776 . . . . 1.41 108.904 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CG ' ' CG2' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -90.49 41.36 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -0.958 . . . . 2.51 108.719 179.915 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.46 64.75 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.971 . . . . 2.78 109.886 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' VAL . 4.0 pt20 -109.08 153.9 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 2.28 109.177 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.6 11.61 4.3 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.8 -1.32 . . . . 1.01 109.8 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -105.36 77.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -1.181 . . . . 1.18 109.388 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.81 79.53 24.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.943 . . . . 1.17 109.677 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -52.75 126.45 21.18 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.882 2.388 . . . . 1.09 112.384 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.525 HD21 ' HE ' ' A' ' 109' ' ' ARG . 20.6 mt -133.02 137.78 46.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 1.83 109.326 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.1 OUTLIER -109.06 -179.33 3.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 1.68 109.477 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.473 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -84.63 40.56 2.97 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.525 -1.43 . . . . 1.35 109.525 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.38 120.59 12.66 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -1.111 . . . . 3.49 109.402 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.35 118.42 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.391 2.06 . . . . 1.33 111.806 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -160.85 141.96 11.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.92 109.904 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.456 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.0 138.57 31.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.774 . . . . 1.41 109.706 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 69' ' ' SER . 18.4 mmt180 -109.03 136.62 48.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 4.81 108.685 178.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 10.4 mt-10 -113.95 103.36 11.08 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.181 -0.607 . . . . 2.38 109.698 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 16.1 m-85 -109.13 120.09 41.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 2.36 108.424 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.45 156.53 25.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.306 -0.872 . . . . 1.44 109.923 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.0 p90 -144.78 178.98 7.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.456 -0.778 . . . . 2.66 109.161 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.458 ' H ' ' HG1' ' A' ' 114' ' ' THR . 0.7 OUTLIER -105.4 115.8 30.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.448 -0.782 . . . . 1.58 109.633 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 10.7 m -48.82 123.2 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.907 . . . . 2.01 109.418 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 114' ' ' THR . 16.0 m120 -113.97 -38.25 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 3.03 109.571 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -112.93 143.21 44.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 3.06 109.618 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.67 103.99 11.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 1.48 109.54 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.668 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 43.5 m-85 -112.26 95.97 33.07 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 2.72 109.247 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.56 166.15 24.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.682 2.254 . . . . 1.49 112.274 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.54 -19.61 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.9 2.4 . . . . 1.58 111.934 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.1 136.64 54.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 3.5 109.457 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.84 -111.87 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 2.42 109.548 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.37 -17.56 14.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -1.128 . . . . 3.67 109.418 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -167.38 122.31 0.84 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 2.66 109.384 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.63 -159.74 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.542 2.162 . . . . 1.72 112.195 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.407 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -57.87 168.59 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 1.2 109.493 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.21 135.08 12.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 2.81 109.433 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 t -141.12 148.79 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 2.01 108.769 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 129' ' ' VAL . . . -166.27 105.77 0.66 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.101 -0.999 . . . . 1.19 110.029 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.475 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 7.7 m-30 -83.56 109.99 17.86 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.33 -0.989 . . . . 2.26 108.33 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.468 ' CE1' HD21 ' A' ' 83' ' ' LEU . 44.4 m170 -99.38 120.23 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.945 . . . . 1.4 110.084 -179.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.633 ' CD2' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -129.97 -7.56 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 1.4 109.141 179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -57.69 126.03 41.02 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.401 -1.48 . . . . 1.52 109.401 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 137' ' ' GLY . 11.0 mtpt -161.55 128.23 3.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -1.187 . . . . 5.09 109.987 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.08 -18.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.94 -1.133 . . . . 1.95 107.94 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.703 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -118.27 10.14 13.29 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.837 -1.705 . . . . 2.05 108.837 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.703 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.76 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.61 -0.936 . . . . 2.18 109.858 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.645 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -168.74 -114.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.012 . . . . 2.62 110.038 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.4 mt-10 -130.8 138.48 49.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 2.3 109.235 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 12.2 t80 -117.35 116.62 27.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 2.38 109.595 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.01 98.38 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.52 110.043 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.476 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -114.06 141.67 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 1.44 109.256 179.548 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 86.5 p -130.74 -10.68 3.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.682 -0.636 . . . . 1.13 109.346 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.644 ' N ' ' OG1' ' A' ' 71' ' ' THR . 3.8 mt-30 -148.37 177.41 9.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 2.42 110.359 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' A' ' 146' ' ' VAL . 1.1 p -179.17 117.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 1.69 108.821 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.57 ' OG ' ' OG ' ' A' ' 69' ' ' SER . 60.1 p -124.6 151.17 45.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.013 -1.054 . . . . 1.89 110.123 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.582 ' CD1' ' C ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -135.67 122.39 21.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.458 -0.776 . . . . 1.91 108.968 179.728 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.676 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 1.2 t -148.21 -159.97 1.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.053 -1.03 . . . . 1.59 109.666 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.624 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.2 t . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 1.98 109.33 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 5.8 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 4.81 109.514 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.508 ' O ' ' C ' ' A' ' 4' ' ' ASP . 3.5 mm? -75.55 174.1 10.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 5.68 109.501 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.525 ' O ' ' OG ' ' A' ' 5' ' ' SER . 49.2 t0 -35.99 115.64 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 5.38 109.45 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 6' ' ' GLU . 24.8 p 59.09 101.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 4.83 109.504 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -40.71 168.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 3.43 109.432 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.6 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 42.2 t -106.87 54.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 3.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 7' ' ' VAL . 19.5 tp10 -35.85 119.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 4.75 109.344 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.19 -31.96 18.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 5.44 109.801 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.47 129.92 24.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 2.86 108.968 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -67.33 59.36 0.69 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.424 2.083 . . . . 4.15 113.343 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.469 ' CE1' ' HA3' ' A' ' 20' ' ' GLY . 36.2 t60 -165.38 126.65 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.007 . . . . 2.52 109.752 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.543 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -170.37 70.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 2.33 109.318 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.458 ' HA ' ' NE2' ' A' ' 145' ' ' GLN . 30.5 t -161.33 82.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 2.28 109.8 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.2 m-30 -90.12 24.84 2.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 2.6 109.243 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.23 17.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 1.66 109.815 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.677 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 19.6 mm-40 -109.67 -49.5 3.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.184 -0.947 . . . . 2.13 109.588 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.8 p -136.39 152.03 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 2.74 109.377 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.736 ' H ' ' CD2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -85.07 26.97 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 3.06 109.191 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.469 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 44.41 -151.64 0.64 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.572 -1.411 . . . . 1.72 109.572 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 67.4 Cg_endo -81.0 9.45 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.748 2.299 . . . . 1.97 112.555 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.789 ' NE1' ' CD2' ' A' ' 55' ' ' TYR . 10.6 m95 -70.94 172.15 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.006 . . . . 2.88 109.275 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.92 177.64 4.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 2.07 109.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.631 ' O ' ' CD1' ' A' ' 24' ' ' LEU . 4.2 pp -178.46 123.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 2.79 109.349 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.593 ' C ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.2 169.12 2.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 2.48 110.305 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 -26.54 22.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.098 -1.201 . . . . 1.7 110.098 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.799 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.9 -142.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.276 . . . . 1.51 109.394 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.799 ' N ' ' OG1' ' A' ' 27' ' ' THR . 67.0 p -91.14 132.56 35.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.251 -0.906 . . . . 2.11 109.236 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -36.83 101.75 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 2.85 109.234 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' CB ' ' SD ' ' A' ' 37' ' ' MET . 50.3 Cg_exo -48.16 159.06 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.303 2.002 . . . . 1.4 111.551 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.11 114.35 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.937 -1.102 . . . . 1.53 110.659 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.677 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -74.05 79.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.049 -0.722 . . . . 2.56 109.049 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.26 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.519 -0.738 . . . . 1.81 109.872 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 33' ' ' ALA . 69.0 m-20 -35.65 -70.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 2.21 109.441 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.88 33.12 1.28 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.626 -1.39 . . . . 1.23 109.626 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -153.35 150.6 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 3.37 109.664 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.527 ' SD ' ' CB ' ' A' ' 30' ' ' PRO . 33.7 ttp -109.05 132.23 54.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 1.4 109.769 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 58.4 m -124.02 156.25 36.82 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.675 -0.81 . . . . 1.06 110.211 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.9 m -131.47 129.58 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.684 -0.858 . . . . 1.95 108.684 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.638 ' N ' ' OG ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -73.65 109.39 7.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 4.79 109.622 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.2 mm? -118.19 35.01 0.21 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.155 -0.965 . . . . 3.97 110.897 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 98.6 Cg_endo -81.87 -24.02 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.521 2.148 . . . . 4.21 111.738 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 42' ' ' PRO . . . -26.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.076 -0.81 . . . . 2.09 111.076 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.36 54.61 0.01 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.42 -1.872 . . . . 2.62 108.42 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 136' ' ' ALA . 20.7 mt-30 -99.7 111.92 24.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 2.96 109.97 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -81.74 55.26 4.88 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.46 -1.456 . . . . 2.38 109.46 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.642 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -166.87 96.34 0.69 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 4.04 109.427 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 50' ' ' ASP . 56.1 Cg_exo -47.77 -40.46 31.6 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 2.75 112.494 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.458 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 19.3 p90 -62.95 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 4.57 109.413 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -133.16 -57.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 2.38 109.659 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.1 146.36 47.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 1.47 109.728 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 133' ' ' LEU . . . 163.35 175.72 34.61 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.615 -1.278 . . . . 0.96 110.359 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.652 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 2.1 mm? -100.36 167.91 10.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.617 -0.931 . . . . 1.51 108.736 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -154.47 155.4 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 1.51 109.875 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.789 ' CD2' ' NE1' ' A' ' 22' ' ' TRP . 30.1 t80 -177.75 148.91 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 2.45 109.436 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.64 168.14 9.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 2.95 109.568 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' CG1' ' A' ' 58' ' ' VAL . . . 101.47 81.72 1.6 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 2.52 109.604 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.754 ' CG2' ' H ' ' A' ' 128' ' ' GLN . 5.9 m -163.21 59.76 0.87 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 4.19 109.39 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 56.9 Cg_exo -47.0 149.85 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.881 2.388 . . . . 2.79 112.274 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 1.6 t -144.62 121.74 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 3.62 109.522 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -96.81 94.89 1.67 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.493 -1.443 . . . . 3.37 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.534 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 13.6 tt0 -38.46 117.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 6.05 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 128.2 -35.82 2.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.664 -1.374 . . . . 3.09 109.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' OG ' ' A' ' 115' ' ' SER . 28.2 mt-10 -99.91 172.33 7.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.234 -1.156 . . . . 4.03 109.5 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -113.78 137.5 51.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 3.28 109.482 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' A' ' 60' ' ' VAL . 37.1 m-85 -105.72 -178.78 3.75 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.21 -0.932 . . . . 2.59 109.463 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -150.91 140.38 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 3.18 109.917 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.73 120.41 38.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 4.0 109.01 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.68 89.89 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 2.8 109.44 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.4 137.01 33.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 2.64 110.675 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.555 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.06 105.63 17.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 2.25 109.058 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.553 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -175.28 169.82 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.828 -1.17 . . . . 1.45 110.677 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.43 159.82 41.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.042 -0.725 . . . . 1.28 109.042 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -102.91 137.56 40.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 1.07 109.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.52 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.44 112.54 6.57 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.258 -0.901 . . . . 1.68 109.639 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.3 Cg_exo -63.87 -141.72 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.633 0 C-N-CA 124.218 -1.159 . . . . 1.32 112.439 -0.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' OD1' ' OG1' ' A' ' 103' ' ' THR . 0.6 OUTLIER -104.94 151.03 24.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 1.75 110.023 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' O ' ' A' ' 137' ' ' GLY . 1.7 mtm 166.25 163.5 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.817 -0.809 . . . . 2.72 108.817 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -83.95 153.9 13.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.744 2.296 . . . . 1.83 112.591 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.73 ' CG1' ' HH ' ' A' ' 139' ' ' TYR . 17.5 m -128.5 -166.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 2.57 109.253 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 132' ' ' HIS . 57.0 ttt180 -136.65 141.61 43.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.067 -1.02 . . . . 6.46 109.836 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.97 149.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 4.19 109.259 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' CD1' ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -142.79 149.22 38.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 2.9 109.876 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.575 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.3 t -151.4 146.09 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 2.31 109.696 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.86 -142.0 7.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 1.75 109.476 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 22.8 pt-20 -90.07 -158.78 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -1.193 . . . . 2.54 109.471 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.62 50.47 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 1.77 109.518 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.7 140.45 3.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.499 -1.44 . . . . 2.54 109.499 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . 94.59 -132.37 11.12 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 4.77 109.587 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -40.13 -32.44 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -1.14 . . . . 5.79 109.443 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.639 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 8.1 m-85 60.7 -37.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.769 . . . . 6.33 109.808 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -55.19 130.17 41.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 6.42 109.48 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -115.86 169.92 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 2.66 109.921 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.9 -23.34 11.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.647 -0.871 . . . . 3.93 108.647 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.799 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.97 34.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 4.15 109.123 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.59 104.74 17.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 4.6 109.64 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -141.26 176.48 8.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 3.96 109.515 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.47 14.11 0.61 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.643 -1.383 . . . . 3.67 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -112.33 60.84 0.63 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -1.182 . . . . 3.79 109.546 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.52 101.93 30.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 2.22 109.083 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.462 ' HD2' ' HH ' ' A' ' 111' ' ' TYR . 59.3 Cg_endo -78.32 131.97 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.539 2.159 . . . . 3.49 112.593 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.08 134.48 23.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 3.46 109.264 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.638 ' C ' ' H ' ' A' ' 105' ' ' GLU . 9.0 t -138.32 -161.63 1.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 2.83 109.523 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.433 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -62.6 37.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.445 -1.462 . . . . 2.83 109.445 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.638 ' H ' ' C ' ' A' ' 103' ' ' THR . 13.8 tp10 -112.25 93.1 20.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 3.02 109.359 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.53 118.18 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.715 2.277 . . . . 1.42 112.177 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 173.96 -175.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 1.81 109.48 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.4 118.82 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 2.19 110.283 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.727 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -93.26 137.13 32.87 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.356 -1.35 . . . . 5.23 107.356 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.44 118.58 37.14 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.441 -0.787 . . . . 3.28 109.666 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.462 ' HH ' ' HD2' ' A' ' 101' ' ' PRO . 4.2 m-30 -107.94 109.92 21.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.036 -1.098 . . . . 3.78 108.036 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.27 45.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 3.99 110.066 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.799 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -133.57 166.88 21.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 3.1 109.176 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.13 126.47 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.228 -0.92 . . . . 2.65 109.866 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.9 m -69.25 122.78 19.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 4.28 109.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.534 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -117.67 -9.98 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 7.59 109.54 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 118' ' ' THR . 13.1 tp -141.49 124.2 16.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 5.5 109.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.45 ' N ' HD12 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -63.92 144.74 56.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 4.48 109.498 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 32.9 m-85 -142.88 92.22 7.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 5.99 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.35 165.81 20.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.76 2.307 . . . . 4.64 112.215 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.99 -17.93 10.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.766 2.31 . . . . 4.46 112.007 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.99 132.29 54.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 4.14 109.509 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 133.44 50.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.523 -1.431 . . . . 4.24 109.523 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 123' ' ' GLY . 1.3 t70 37.92 22.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -1.132 . . . . 3.59 109.48 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -151.77 72.07 8.05 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 2.78 109.397 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.22 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.791 2.327 . . . . 1.57 112.233 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.452 ' HA3' ' H ' ' A' ' 57' ' ' GLY . . . -72.92 157.07 52.24 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.631 -1.388 . . . . 1.25 109.631 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.754 ' H ' ' CG2' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -150.77 140.44 21.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -1.131 . . . . 2.18 109.587 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.591 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 4.5 p -161.53 112.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 1.87 108.828 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.74 112.22 17.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 1.45 110.12 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -71.8 113.79 9.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.646 -0.872 . . . . 2.4 108.646 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' ARG . 1.6 m170 -99.66 100.69 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.199 -0.938 . . . . 2.98 109.828 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.416 ' CD1' ' HA2' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -109.72 -21.34 12.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 2.61 109.075 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.626 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -47.19 139.81 8.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.166 -1.573 . . . . 2.32 109.166 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 138' ' ' ALA . 1.0 OUTLIER 179.54 129.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.108 . . . . 5.66 109.234 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.01 -22.76 0.65 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.618 -1.253 . . . . 2.71 107.618 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.642 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -105.24 7.11 43.3 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.466 -1.854 . . . . 3.14 108.466 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -51.82 -145.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.803 -0.822 . . . . 2.84 110.285 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.73 ' HH ' ' CG1' ' A' ' 80' ' ' VAL . 0.0 OUTLIER 171.89 -112.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 2.44 110.024 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.14 136.04 45.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 1.86 109.061 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.553 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 52.9 t80 -122.7 116.71 24.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 2.48 109.816 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.495 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 12.4 m -106.75 114.29 28.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -0.907 . . . . 0.74 109.561 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -119.97 141.2 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 1.69 109.471 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.677 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 2.0 p -127.72 -17.21 4.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.163 -0.68 . . . . 1.63 109.163 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.677 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -152.28 159.28 43.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.379 -0.825 . . . . 3.82 109.378 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.9 p -165.94 126.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 2.92 109.429 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.51 ' OG ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -167.21 146.39 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 3.25 109.428 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.26 146.39 37.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 5.12 109.511 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.756 ' HG1' ' H ' ' A' ' 150' ' ' THR . 2.1 t -133.57 -157.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -0.876 . . . . 3.35 109.483 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.756 ' H ' ' HG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -139.64 -41.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 2.29 109.358 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.519 ' N ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER 71.38 104.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.422 -0.799 . . . . 2.54 109.427 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -135.68 149.24 49.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 3.09 109.437 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.41 ' HG1' ' HG ' ' A' ' 3' ' ' LEU . 29.7 m . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.95 -1.024 . . . . 3.68 109.48 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.531 -0.544 . . . . 5.8 109.531 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -91.72 -112.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 4.81 109.452 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.674 ' CD2' ' H ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER -168.1 -156.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 5.68 109.471 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.674 ' H ' ' CD2' ' A' ' 3' ' ' LEU . 26.5 t70 -118.07 25.47 10.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 5.38 109.492 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.568 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -103.89 35.8 2.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 4.83 109.477 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 5' ' ' SER . 30.2 mt-10 35.89 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 3.43 109.41 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 151' ' ' SER . 2.1 t -45.73 162.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.89 . . . . 3.0 109.467 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -141.15 64.39 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 4.75 109.507 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER -79.95 16.46 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.925 . . . . 5.44 109.403 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' O ' ' N ' ' A' ' 12' ' ' HIS . 1.2 tt -118.08 82.33 17.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.143 -1.058 . . . . 2.86 108.143 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' C ' ' OH ' ' A' ' 55' ' ' TYR . 36.7 Cg_exo -53.02 36.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.099 2.533 . . . . 4.15 113.285 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.697 ' N ' ' O ' ' A' ' 10' ' ' LEU . 38.8 t60 -170.34 138.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.995 -1.066 . . . . 2.52 109.579 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.517 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.35 70.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 2.33 109.592 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -169.84 77.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.974 . . . . 2.28 109.903 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.15 22.13 3.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 2.6 109.031 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.09 -25.0 20.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 1.66 109.883 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 16.7 mm-40 -109.7 -58.92 1.99 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.048 -1.032 . . . . 2.13 109.663 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 m -142.84 143.46 32.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.868 . . . . 2.74 109.503 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.764 ' H ' ' CD2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -46.69 -34.23 4.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 3.06 109.137 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 79.99 -164.01 47.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.586 -1.406 . . . . 1.72 109.586 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 22' ' ' TRP . 34.8 Cg_exo -53.83 -21.52 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.841 2.36 . . . . 1.97 112.326 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CD1' ' CD1' ' A' ' 55' ' ' TYR . 4.3 m95 -53.05 -167.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.88 109.356 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 161.9 39.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 2.07 109.391 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD11 ' CG ' ' A' ' 30' ' ' PRO . 2.2 pp -160.08 137.88 9.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 2.79 109.688 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 2.48 109.331 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 110.14 -28.58 10.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.84 -1.304 . . . . 1.7 109.84 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.784 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.9 -142.7 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.296 . . . . 1.51 109.454 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.784 ' N ' ' OG1' ' A' ' 27' ' ' THR . 3.6 p -91.62 -165.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 2.11 109.313 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.17 111.86 49.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 2.85 109.003 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' CG ' HD11 ' A' ' 24' ' ' LEU . 78.5 Cg_exo -44.21 154.76 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.216 1.944 . . . . 1.4 111.981 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 37' ' ' MET . 23.7 t -139.43 100.35 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.971 . . . . 1.53 110.21 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.71 82.58 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.65 0.738 . . . . 2.56 109.179 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.78 -114.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.76 . . . . 1.81 110.023 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' HB2' HH11 ' A' ' 36' ' ' ARG . 2.1 m-20 -58.35 66.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 2.21 109.759 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 59.27 6.19 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 1.23 109.562 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.653 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.45 141.84 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.216 . . . . 3.37 109.424 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -113.8 123.55 50.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.369 -0.832 . . . . 1.4 109.031 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.547 ' SG ' ' C ' ' A' ' 141' ' ' PHE . 4.5 t -128.15 153.2 47.13 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.272 -0.971 . . . . 1.06 110.559 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.15 120.02 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.548 -0.908 . . . . 1.95 108.548 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.8 OUTLIER -77.39 117.44 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 4.79 109.469 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 137' ' ' GLY . 4.5 mm? -114.6 94.45 36.76 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.257 -0.902 . . . . 3.97 109.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.36 -43.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.223 2.615 . . . . 4.21 111.984 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.77 141.47 3.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.397 -1.481 . . . . 2.09 109.397 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.19 -0.43 1.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.999 -1.24 . . . . 2.62 109.999 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.577 ' OE1' ' O ' ' A' ' 50' ' ' ASP . 5.6 mm-40 -99.17 -160.92 0.83 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.127 -1.22 . . . . 2.96 109.428 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.43 -57.74 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 2.38 109.842 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.68 ' OD1' ' CD1' ' A' ' 49' ' ' TRP . 3.5 p30 -99.76 150.94 37.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.224 -1.162 . . . . 4.04 109.58 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' ASP . 84.8 Cg_exo -40.18 -55.41 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.875 2.383 . . . . 2.75 112.343 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.68 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 2.1 p90 -70.63 47.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 4.57 109.463 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 47' ' ' ASN . 67.8 m-20 -116.11 -8.51 11.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 2.38 109.709 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.8 116.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.952 . . . . 1.47 109.564 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.501 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 174.3 166.99 33.18 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.68 -1.248 . . . . 0.96 110.186 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.97 -169.48 1.62 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -1.093 . . . . 1.51 109.421 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -159.64 162.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 1.51 109.805 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.791 ' CD1' ' CD1' ' A' ' 22' ' ' TRP . 20.1 t80 -176.82 140.4 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.821 . . . . 2.45 109.403 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -113.31 -164.19 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.38 -0.825 . . . . 2.95 109.472 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 9' ' ' LEU . . . 86.06 47.07 5.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.504 -1.438 . . . . 2.52 109.504 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.46 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 22.2 t -151.12 75.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 4.19 109.521 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' VAL . 75.7 Cg_exo -44.04 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.906 2.404 . . . . 2.79 112.191 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 119' ' ' PHE . 2.7 t -142.37 120.86 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 3.62 109.595 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -137.93 107.67 0.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.323 -1.511 . . . . 3.37 109.323 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.7 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.3 tm-20 -42.46 172.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 6.05 109.182 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.671 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 80.67 -45.15 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.479 . . . . 3.09 109.404 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -99.56 135.56 40.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 4.03 109.084 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.4 m -99.84 148.78 24.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.168 -0.957 . . . . 3.28 109.763 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -107.92 177.98 4.65 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 2.59 109.583 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -151.39 160.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.489 -0.757 . . . . 3.18 109.468 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 109' ' ' ARG . 10.1 tp -143.69 114.3 7.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 4.0 109.666 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 4.8 p -109.23 83.66 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.966 . . . . 2.8 108.828 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.613 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 24.9 p90 -93.89 132.99 37.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 2.64 111.302 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.563 ' HG1' ' H ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -83.71 98.68 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 2.25 108.445 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -144.97 152.03 39.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.05 . . . . 1.45 110.093 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.7 p -132.95 121.99 23.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.486 -0.759 . . . . 1.28 109.055 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -83.48 132.96 34.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 1.07 109.511 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.468 ' OG1' ' CB ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.62 117.08 16.31 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.323 -0.86 . . . . 1.68 109.242 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.24 -142.46 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 124.256 -1.143 . . . . 1.32 112.227 -0.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -96.58 148.42 22.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 1.75 109.336 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.408 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER 168.27 153.03 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.685 . . . . 2.72 109.29 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.88 117.92 5.1 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.705 2.27 . . . . 1.83 112.001 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.93 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 2.57 109.442 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 132' ' ' HIS . 18.0 ttm180 -114.68 90.29 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 6.46 109.528 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.49 154.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.225 -0.922 . . . . 4.19 108.993 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.44 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -154.25 162.97 40.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.01 . . . . 2.9 110.082 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.577 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -153.62 160.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 2.31 109.358 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.44 -145.07 10.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.667 -1.373 . . . . 1.75 109.667 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.68 ' OE1' ' CZ ' ' A' ' 119' ' ' PHE . 2.9 pt-20 -90.19 163.1 14.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 2.54 109.446 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.82 22.98 12.17 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 1.77 109.49 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -155.57 -156.74 7.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.54 -1.424 . . . . 2.54 109.54 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.28 -55.78 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 4.77 109.551 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.687 ' O ' ' CG ' ' A' ' 91' ' ' TYR . . . -176.52 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 5.79 109.451 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.687 ' CG ' ' O ' ' A' ' 90' ' ' ALA . 7.5 m-85 -178.36 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 6.33 109.576 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 91' ' ' TYR . 8.3 mmt180 -34.72 117.0 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 6.42 109.564 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -125.94 176.91 6.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 2.66 110.03 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.12 -20.98 5.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.841 -0.8 . . . . 3.93 108.841 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.804 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.84 34.04 0.92 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 4.15 109.149 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.5 92.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 4.6 109.888 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.535 ' NE2' ' CD1' ' A' ' 111' ' ' TYR . 4.5 mt-30 -99.77 137.78 37.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 3.96 109.514 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.48 -13.54 2.3 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.652 -1.379 . . . . 3.67 109.652 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.38 80.61 1.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.166 -1.197 . . . . 3.79 109.587 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.17 84.52 14.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 2.22 109.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.95 127.31 18.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.989 2.46 . . . . 3.49 112.614 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -144.94 127.03 15.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.866 . . . . 3.46 109.325 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 1.7 t -91.98 -169.99 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 2.83 109.511 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.17 13.31 67.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 2.83 109.534 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -103.06 152.77 38.6 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 3.02 109.424 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.31 118.3 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.848 2.365 . . . . 1.42 112.2 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.447 ' HB1' ' NH2' ' A' ' 109' ' ' ARG . . . -162.87 146.44 11.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 1.81 109.477 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.499 ' C ' ' HE ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -90.15 132.86 35.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 2.19 109.712 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 68' ' ' LEU . 3.6 mmp_? -101.96 134.11 45.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.91 -1.144 . . . . 5.23 107.91 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -109.69 106.05 15.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.033 -0.667 . . . . 3.28 110.389 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.535 ' CD1' ' NE2' ' A' ' 97' ' ' GLN . 42.1 m-85 -109.74 124.88 52.01 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.312 -0.996 . . . . 3.78 108.312 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.07 163.79 23.0 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 3.99 109.922 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.804 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 4.2 p90 -166.76 -168.2 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 3.1 109.471 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.98 154.01 25.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 2.65 109.458 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -90.24 59.12 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 4.28 109.799 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.516 ' C ' ' O ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -33.62 -40.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 7.59 109.908 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' OG ' ' A' ' 115' ' ' SER . 2.8 mt -109.93 -169.55 1.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 5.5 109.767 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.684 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.7 OUTLIER -129.76 158.85 38.26 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.257 -0.902 . . . . 4.48 109.585 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 49.4 m-85 -166.42 96.53 0.73 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 5.99 109.28 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.81 165.56 24.4 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.591 2.194 . . . . 4.64 112.334 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.51 -13.09 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.951 2.434 . . . . 4.46 112.095 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -109.46 8.49 25.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 4.14 109.535 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . -96.87 174.02 29.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.495 -1.442 . . . . 4.24 109.495 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.15 34.61 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 3.59 109.482 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 123' ' ' GLY . . . 179.87 87.8 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 2.78 109.424 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.38 -160.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.784 2.323 . . . . 1.57 112.328 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.565 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -64.62 154.6 48.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.556 -1.418 . . . . 1.25 109.556 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.44 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -149.7 140.74 22.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -1.153 . . . . 2.18 109.633 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 23.7 t -144.78 144.15 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 1.87 108.454 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.61 114.33 2.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.98 -1.075 . . . . 1.45 110.015 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.5 m-30 -94.66 88.2 5.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.425 -0.797 . . . . 2.4 109.263 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 27.9 m170 -99.42 137.64 37.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.955 . . . . 2.98 109.747 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 134' ' ' GLY . 0.2 OUTLIER -129.36 52.54 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.61 109.536 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . . . -40.01 123.73 2.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.902 -1.279 . . . . 2.32 109.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' A' ' 138' ' ' ALA . 2.2 mptp? -167.5 44.81 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.711 -0.876 . . . . 5.66 108.831 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . 40.97 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.412 -1.329 . . . . 2.71 107.412 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . 69.87 28.38 71.99 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.779 -1.728 . . . . 3.14 108.779 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.695 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -91.7 56.55 3.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -1.203 . . . . 2.84 110.377 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CE1' ' HB2' ' A' ' 135' ' ' LYS . 10.6 p90 -177.11 -153.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.838 -1.164 . . . . 2.44 110.459 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.468 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 1.0 OUTLIER -159.3 157.35 30.34 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.696 -0.853 . . . . 1.86 108.696 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.547 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 13.0 t80 -135.28 103.17 5.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.041 -1.037 . . . . 2.48 110.07 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.7 m -106.44 110.6 22.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.74 110.169 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.494 HG12 ' N ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -138.97 146.22 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 1.69 109.505 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.494 ' N ' HG12 ' A' ' 143' ' ' ILE . 3.6 p -136.31 -4.55 2.11 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.355 -0.538 . . . . 1.63 109.688 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.563 ' H ' ' HG1' ' A' ' 71' ' ' THR . 2.3 mt-30 -140.83 151.27 44.22 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.272 -0.971 . . . . 3.82 110.073 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.44 HG21 ' CH2' ' A' ' 22' ' ' TRP . 13.0 p -163.08 122.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -0.845 . . . . 2.92 109.507 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.96 139.69 23.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 3.25 109.637 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.591 ' CD1' ' C ' ' A' ' 148' ' ' LEU . 0.6 OUTLIER -113.17 149.47 33.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 5.12 109.403 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.654 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER -167.7 -163.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 3.35 109.531 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.654 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -172.92 -41.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 2.29 109.346 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 150' ' ' THR . 40.0 p 45.02 -166.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.471 -0.768 . . . . 2.54 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.69 20.1 10.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 3.09 109.447 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.028 -0.987 . . . . 3.68 109.438 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.504 -0.554 . . . . 5.8 109.504 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 1' ' ' ALA . 56.7 p 53.46 79.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 4.81 109.437 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 4' ' ' ASP . 2.3 mp -141.03 175.18 9.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 5.68 109.491 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -56.76 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 5.38 109.497 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER 48.77 100.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 4.83 109.482 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.32 124.0 25.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 3.43 109.45 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.667 ' N ' ' HG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER -84.4 92.98 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 3.0 109.492 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.535 ' CD ' ' O ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -96.81 126.29 41.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 4.75 109.486 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD13 ' CG ' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -84.06 -13.82 52.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.153 -0.967 . . . . 5.44 109.596 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.563 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -119.89 83.37 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 2.86 108.692 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.28 34.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.025 2.484 . . . . 4.15 111.87 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.563 ' H ' HD13 ' A' ' 10' ' ' LEU . 44.3 t60 -134.78 99.03 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.425 -0.797 . . . . 2.52 109.475 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.545 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -137.58 54.97 1.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 2.33 109.333 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.647 ' O ' ' N ' ' A' ' 16' ' ' ALA . 22.7 t -159.61 83.3 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 2.28 109.675 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -63.43 50.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 2.6 108.868 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -55.52 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 1.66 110.13 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -109.88 39.37 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 2.13 109.851 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.6 153.3 2.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.145 -0.972 . . . . 2.74 109.699 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.698 ' CD1' ' H ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 3.06 109.563 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' N ' HD21 ' A' ' 19' ' ' LEU . . . 76.61 174.16 38.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.781 -1.328 . . . . 1.72 109.781 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.23 -16.37 4.72 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.694 2.263 . . . . 1.97 112.039 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 14.3 m95 -68.15 160.98 27.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 2.88 109.08 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -109.68 148.24 31.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.009 . . . . 2.07 109.642 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -135.35 129.58 33.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 2.79 109.51 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.619 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.27 159.63 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 2.48 109.573 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.9 -32.34 7.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.042 -1.223 . . . . 1.7 110.042 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.754 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.7 -141.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.105 -1.232 . . . . 1.51 109.662 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.754 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.1 p -91.09 132.39 36.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 2.11 109.316 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 tt0 -36.88 102.56 0.24 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 2.85 109.072 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' SER . 50.0 Cg_exo -46.54 152.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.296 1.997 . . . . 1.4 111.689 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 81.6 t -137.74 115.25 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 1.53 110.241 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.61 90.88 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.573 -0.704 . . . . 2.56 109.75 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.53 -112.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 1.81 109.664 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' HB2' HH11 ' A' ' 36' ' ' ARG . 0.2 OUTLIER -59.43 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 2.21 109.626 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 60.0 5.03 3.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 1.23 109.552 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.627 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -123.04 148.39 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -1.145 . . . . 3.37 109.531 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.625 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.5 OUTLIER -114.39 132.39 56.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 1.4 109.713 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.17 153.01 40.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 1.06 109.676 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' HB ' ' HG1' ' A' ' 27' ' ' THR . 1.3 m -126.07 137.88 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.905 -0.776 . . . . 1.95 108.905 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.701 ' H ' ' HG ' ' A' ' 28' ' ' SER . 17.6 m-20 -73.0 110.14 7.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 4.79 109.475 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 139' ' ' TYR . 4.2 mm? -117.81 75.02 9.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 3.97 109.556 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.01 -157.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.767 2.311 . . . . 4.21 112.195 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.47 130.12 9.68 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 2.09 109.548 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.99 35.81 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.532 -1.427 . . . . 2.62 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.593 HE22 ' CB ' ' A' ' 50' ' ' ASP . 3.3 mm-40 -99.93 106.1 17.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -1.122 . . . . 2.96 109.491 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.2 14.42 1.25 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.659 -1.376 . . . . 2.38 109.659 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.751 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -179.91 151.04 0.57 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.195 -1.179 . . . . 4.04 109.519 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 50' ' ' ASP . 44.5 Cg_endo -71.8 -54.16 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.853 2.369 . . . . 2.75 112.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.447 ' CE3' ' HG2' ' A' ' 48' ' ' PRO . 11.1 p90 -62.88 45.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 4.57 109.384 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.656 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -135.48 39.75 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 2.38 109.353 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.594 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 156.92 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 1.47 109.528 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.83 170.08 20.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.644 -1.382 . . . . 0.96 109.644 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.7 pp -108.58 142.82 38.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -1.113 . . . . 1.51 109.422 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.0 174.79 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 1.51 109.896 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.684 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 48.8 t80 179.11 144.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 2.45 109.527 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.684 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -99.72 -164.84 1.16 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 2.95 109.463 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.91 66.95 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.602 -1.399 . . . . 2.52 109.602 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.738 ' CG1' ' H ' ' A' ' 128' ' ' GLN . 8.9 p -151.85 73.68 7.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.253 -1.145 . . . . 4.19 109.466 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.418 ' CG ' HD13 ' A' ' 9' ' ' LEU . 58.2 Cg_endo -76.14 157.91 37.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.873 2.382 . . . . 2.79 112.364 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.465 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 3.4 t -148.83 102.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 3.62 109.386 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -73.72 119.87 6.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.595 -1.402 . . . . 3.37 109.595 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.539 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 15.7 tt0 -58.63 125.37 23.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.136 . . . . 6.05 109.53 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 132.85 -47.56 1.0 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.679 -1.368 . . . . 3.09 109.679 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.575 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.8 mt-10 -99.8 166.89 10.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -1.15 . . . . 4.03 109.594 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.46 134.32 49.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 3.28 109.434 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.465 ' CE1' ' HA ' ' A' ' 60' ' ' VAL . 38.1 m-85 -97.22 -179.09 4.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 2.59 109.499 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -154.71 139.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 3.18 109.576 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.3 tp -120.88 118.17 29.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 4.0 109.416 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.04 83.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.577 -0.898 . . . . 2.8 108.577 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 28.0 p90 -93.73 143.14 26.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.855 . . . . 2.64 111.358 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.784 ' HG1' ' N ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -89.33 130.59 35.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.488 -0.93 . . . . 2.25 108.488 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.787 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -170.29 135.19 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.891 -1.13 . . . . 1.45 110.254 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.9 p -119.82 122.91 42.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.821 . . . . 1.28 108.946 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.566 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -85.57 125.74 33.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 1.07 109.565 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -138.76 113.63 8.5 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.271 -0.893 . . . . 1.68 109.75 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.3 Cg_exo -64.54 -141.81 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.624 0 C-N-CA 124.349 -1.104 . . . . 1.32 112.276 -0.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -99.17 151.03 21.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 1.75 109.825 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.511 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.35 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.861 -0.792 . . . . 2.72 108.861 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.12 168.94 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.829 2.353 . . . . 1.83 112.86 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.531 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 2.9 m -137.21 170.85 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 2.57 109.128 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.622 HH11 ' CB ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -116.4 105.52 12.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 6.46 109.771 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.87 159.43 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.261 -0.9 . . . . 4.19 109.219 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.69 149.65 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 2.9 109.834 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.576 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -149.13 155.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 2.31 109.701 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.96 -133.27 5.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.563 -1.415 . . . . 1.75 109.563 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.4 pm0 -90.08 -179.07 5.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 2.54 109.384 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -169.07 32.82 0.18 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 1.77 109.546 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -143.77 -100.35 0.33 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 2.54 109.604 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' GLY . . . -44.17 -100.84 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.554 -1.418 . . . . 4.77 109.554 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.96 25.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 5.79 109.446 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 124' ' ' ASP . 3.6 m-85 -66.15 80.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 6.33 109.583 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -29.85 151.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.69 . . . . 6.42 110.011 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.44 161.03 13.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.287 -0.883 . . . . 2.66 110.081 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -119.91 -14.14 8.97 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.733 -0.84 . . . . 3.93 108.733 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.755 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.56 36.03 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.381 -0.825 . . . . 4.15 108.916 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -80.67 70.99 7.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 4.6 109.624 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.86 111.01 23.35 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 3.96 108.851 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.13 13.27 55.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 3.67 109.711 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.92 67.52 0.78 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.174 -1.192 . . . . 3.79 109.824 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.32 99.76 29.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.074 -1.016 . . . . 2.22 109.288 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.83 135.99 11.69 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.606 2.204 . . . . 3.49 112.673 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.465 HD21 ' NE ' ' A' ' 109' ' ' ARG . 94.2 mt -142.15 131.11 23.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 3.46 109.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.8 t -92.41 -165.56 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 2.83 109.491 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.19 33.9 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.499 -1.44 . . . . 2.83 109.499 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -121.53 138.48 28.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.248 -1.148 . . . . 3.02 109.433 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.27 120.5 6.01 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.593 2.195 . . . . 1.42 112.069 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.678 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -171.03 160.43 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 1.81 109.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 149.07 22.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 2.19 109.687 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.787 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -114.3 136.43 52.98 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.745 -1.206 . . . . 5.23 107.745 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -114.34 107.94 16.24 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.848 -0.741 . . . . 3.28 110.706 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 8.0 m-85 -109.77 115.98 30.84 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.374 -0.972 . . . . 3.78 108.374 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.71 142.63 32.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.831 . . . . 3.99 109.712 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.92 163.94 26.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 3.1 109.413 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.5 109.34 21.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 2.65 109.798 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.7 m -56.23 105.66 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.287 -0.883 . . . . 4.28 109.193 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.697 ' H ' ' ND2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -108.8 -10.31 15.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 7.59 109.616 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.48 ' O ' ' CD2' ' A' ' 119' ' ' PHE . 0.9 OUTLIER -136.59 126.5 25.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 5.5 109.531 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.64 117.72 5.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 4.48 109.372 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.557 ' CE1' ' O ' ' A' ' 92' ' ' ARG . 57.9 m-85 -120.78 66.74 13.9 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 5.99 109.588 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.78 166.58 27.15 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.783 2.322 . . . . 4.64 112.154 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -79.87 -13.2 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.853 2.369 . . . . 4.46 112.003 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -109.57 -12.71 14.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.331 -0.855 . . . . 4.14 109.642 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.06 -70.95 0.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 4.24 109.423 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.637 ' CG ' ' CE1' ' A' ' 91' ' ' TYR . 1.4 m-20 -129.75 -7.21 4.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 3.59 109.387 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -179.96 150.02 0.53 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 2.78 109.377 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.23 -7.11 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.943 2.429 . . . . 1.57 112.217 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.12 172.37 12.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 1.25 109.56 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.738 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 6.5 tp-100 -153.81 140.29 18.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 2.18 109.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 t -153.68 87.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.374 -0.973 . . . . 1.87 108.374 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.4 123.44 41.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 1.45 110.532 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.58 81.52 1.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.61 -0.885 . . . . 2.4 108.61 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 81' ' ' ARG . 32.4 m170 -99.65 136.27 39.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 2.98 109.956 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.506 ' CD2' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -131.05 -5.47 3.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.343 -0.848 . . . . 2.61 109.353 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -43.26 124.41 4.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.473 -1.451 . . . . 2.32 109.473 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.666 ' O ' ' N ' ' A' ' 137' ' ' GLY . 15.6 mttp -163.93 128.21 2.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 5.66 109.74 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.62 -14.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.294 -1.002 . . . . 2.71 108.294 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -118.16 3.15 16.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.227 -1.549 . . . . 3.14 109.227 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -51.42 -161.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -1.07 . . . . 2.84 109.647 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.656 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -168.35 -113.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.051 -1.031 . . . . 2.44 110.24 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -125.85 139.82 53.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 1.86 109.127 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.3 t80 -121.36 107.61 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 2.48 109.79 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.17 91.29 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.74 109.863 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.87 141.88 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 1.69 109.072 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.2 p -138.48 -0.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.56 -0.712 . . . . 1.63 109.443 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.784 ' N ' ' HG1' ' A' ' 71' ' ' THR . 2.5 mt-30 -149.57 160.94 43.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.975 . . . . 3.82 110.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.607 ' CG1' ' O ' ' A' ' 146' ' ' VAL . 9.9 p -166.64 103.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.83 . . . . 2.92 109.44 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.3 144.18 36.16 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 3.25 109.624 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.425 ' C ' ' CD1' ' A' ' 148' ' ' LEU . 1.3 tp -134.21 113.49 12.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 5.12 109.337 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.667 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 9.0 t -155.76 -166.35 2.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 3.35 109.54 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -133.68 -41.05 0.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 2.29 109.417 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.52 ' N ' ' CG2' ' A' ' 150' ' ' THR . 47.9 m -60.99 148.64 39.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.474 -0.766 . . . . 2.54 109.455 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.18 -165.28 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 3.09 109.483 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.96 -1.019 . . . . 3.68 109.392 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' H3 ' ' H ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.433 -0.58 . . . . 5.8 109.433 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.43 ' H ' ' H3 ' ' A' ' 1' ' ' ALA . 18.6 t -100.46 -117.85 0.16 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 4.81 109.497 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -147.2 -162.59 1.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 5.68 109.419 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.561 ' O ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -53.61 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 5.38 109.402 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.566 ' HG ' ' H ' ' A' ' 6' ' ' GLU . 29.6 t -72.87 174.66 7.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 4.83 109.502 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.566 ' H ' ' HG ' ' A' ' 5' ' ' SER . 0.6 OUTLIER 35.04 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 3.43 109.57 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 HG22 ' CA ' ' A' ' 151' ' ' SER . 20.2 t -98.68 84.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 3.0 109.399 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' OE2' ' OG ' ' A' ' 147' ' ' SER . 7.7 tp10 -65.26 109.86 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 4.75 109.578 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -32.68 39.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 5.44 109.328 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.751 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -113.02 96.06 36.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 2.86 109.073 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.02 38.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.844 2.363 . . . . 4.15 112.852 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.623 ' N ' ' O ' ' A' ' 10' ' ' LEU . 27.7 t60 -129.81 131.42 46.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 2.52 109.316 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.781 ' HG1' ' H ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -170.16 56.17 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 2.33 109.334 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.651 ' C ' ' H ' ' A' ' 16' ' ' ALA . 8.3 t -158.57 68.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 2.28 109.711 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -65.48 34.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 2.6 108.949 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.651 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -81.56 -33.38 31.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.66 109.85 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.587 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 14.9 mm-40 -109.84 -70.2 0.82 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.137 -0.977 . . . . 2.13 109.556 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 20' ' ' GLY . 49.8 m -107.49 144.08 34.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 2.74 109.462 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -61.9 12.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 3.06 109.703 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 66.23 177.12 7.5 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.83 -1.308 . . . . 1.72 109.83 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.04 10.97 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.687 2.258 . . . . 1.97 112.204 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.751 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.2 m0 -74.41 -174.15 1.94 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 2.88 109.501 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' VAL . 1.6 m -117.3 145.78 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 2.07 109.287 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.633 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 6.4 tt -151.67 143.86 23.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 2.79 110.407 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.711 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.34 175.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.587 -0.696 . . . . 2.48 109.479 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.12 -23.35 18.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.967 -1.253 . . . . 1.7 109.967 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.72 -142.98 0.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.252 . . . . 1.51 109.339 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.3 p -91.72 -164.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 2.11 109.223 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 29' ' ' GLU . 3.4 tm-20 -90.12 111.33 46.2 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 2.85 108.774 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.421 ' O ' ' OE1' ' A' ' 29' ' ' GLU . 72.9 Cg_exo -43.32 147.48 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.24 1.96 . . . . 1.4 112.009 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.98 95.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.53 109.866 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.97 88.25 4.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 2.56 109.451 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -74.02 -140.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 1.81 109.952 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' A' ' 33' ' ' ALA . 24.4 t70 -35.33 -87.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 2.21 109.523 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -131.28 36.87 2.17 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.621 -1.391 . . . . 1.23 109.621 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.641 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.34 157.48 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -1.2 . . . . 3.37 109.579 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.615 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -129.51 135.27 48.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.324 -0.86 . . . . 1.4 109.333 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 143.23 50.66 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.479 -0.888 . . . . 1.06 110.281 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -113.62 144.15 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.796 -0.816 . . . . 1.95 108.796 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -76.84 106.26 8.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 4.79 109.624 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 42' ' ' PRO . 4.4 mm? -116.41 81.53 11.07 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 3.97 109.344 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 41' ' ' LEU . 50.7 Cg_exo -49.54 -144.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.944 2.429 . . . . 4.21 112.275 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.04 70.33 0.29 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 2.09 109.557 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.05 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.554 -1.419 . . . . 2.62 109.554 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 46' ' ' GLY . 2.8 mt-30 -99.99 91.51 4.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 2.96 109.428 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -39.66 -43.64 2.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.558 -1.417 . . . . 2.38 109.558 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.632 ' H ' ' ND2' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -99.89 128.57 30.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.247 -1.149 . . . . 4.04 109.382 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.28 -26.17 7.75 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.499 2.133 . . . . 2.75 112.626 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.656 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -92.02 34.18 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.976 . . . . 4.57 109.868 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.656 ' OD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.9 OUTLIER -100.19 1.76 42.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 2.38 109.676 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.5 -173.52 1.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 1.47 109.713 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.29 -171.77 14.29 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.486 -1.446 . . . . 0.96 109.486 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD13 ' CD2' ' A' ' 131' ' ' PHE . 1.3 pp -115.89 140.71 48.97 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.244 -1.15 . . . . 1.51 109.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -128.22 163.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 1.51 109.614 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.694 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 20.2 t80 -159.82 155.42 25.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 2.45 109.444 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.694 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -113.09 -164.29 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.201 -0.937 . . . . 2.95 109.471 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 73.95 69.57 1.37 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 2.52 109.365 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 57' ' ' GLY . 49.0 t -162.05 96.85 1.21 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 4.19 109.447 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.15 121.92 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.652 2.235 . . . . 2.79 112.09 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.641 ' C ' ' HH ' ' A' ' 66' ' ' TYR . 73.0 t -103.33 155.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 3.62 109.594 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.76 ' N ' ' HH ' ' A' ' 66' ' ' TYR . . . -162.67 129.29 2.02 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.614 -1.394 . . . . 3.37 109.614 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.709 ' CA ' ' HG ' ' A' ' 115' ' ' SER . 1.7 pp20? -61.28 -161.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -1.104 . . . . 6.05 109.383 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 62' ' ' GLU . . . 62.22 -49.19 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 3.09 109.67 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.3 mm-40 -99.76 160.3 14.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 4.03 109.261 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.8 m -112.94 146.4 39.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 3.28 109.683 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.76 ' HH ' ' N ' ' A' ' 61' ' ' GLY . 81.1 m-85 -106.14 174.33 5.93 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.238 -0.914 . . . . 2.59 109.803 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.411 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.5 t -152.19 128.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.524 -0.735 . . . . 3.18 109.247 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 109' ' ' ARG . 6.7 tp -114.8 116.8 29.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.092 -1.005 . . . . 4.0 109.851 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.78 81.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 2.8 108.83 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 12.5 p90 -93.67 138.63 31.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.64 111.139 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.785 ' HG1' ' H ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -86.88 133.09 33.65 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.642 -0.873 . . . . 2.25 108.642 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 141' ' ' PHE . . . -173.83 128.29 0.4 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.98 -1.075 . . . . 1.45 110.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -111.24 122.41 47.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 1.28 108.873 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -80.91 129.74 34.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 1.07 109.652 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.526 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -142.73 111.67 5.78 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.332 -0.855 . . . . 1.68 109.594 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.0 Cg_exo -63.81 -141.82 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.248 -1.146 . . . . 1.32 112.372 -0.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -106.62 155.74 19.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.75 109.701 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.51 167.22 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 2.72 108.942 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -84.7 149.29 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.779 2.319 . . . . 1.83 112.59 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.629 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 1.2 m -125.61 179.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.895 . . . . 2.57 109.315 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.723 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -127.96 97.95 4.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 6.46 109.816 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -99.6 143.17 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.37 -0.831 . . . . 4.19 108.845 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.459 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 2.1 pp -145.63 156.71 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 2.9 109.988 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.581 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -155.07 146.99 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 2.31 109.345 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 170.16 -148.74 11.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.711 -1.356 . . . . 1.75 109.711 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.12 -161.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -1.119 . . . . 2.54 109.456 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -150.66 92.87 0.14 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.496 -1.442 . . . . 1.77 109.496 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -155.5 -133.74 1.75 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.664 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . -78.32 146.91 30.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.535 -1.426 . . . . 4.77 109.535 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' O ' ' CD2' ' A' ' 91' ' ' TYR . . . 62.4 -38.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -1.161 . . . . 5.79 109.496 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 89' ' ' GLY . 1.7 m-85 75.2 16.16 2.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 6.33 109.49 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.531 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -37.15 112.19 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 6.42 109.433 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.581 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -116.39 164.85 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 2.66 109.969 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.438 ' N ' ' HG1' ' A' ' 93' ' ' THR . . . -109.93 -21.19 12.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.757 -0.831 . . . . 3.93 108.757 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.458 ' CD1' HG21 ' A' ' 84' ' ' VAL . 2.1 t80 -90.66 38.13 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.497 -0.927 . . . . 4.15 108.497 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.68 114.55 19.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 4.6 109.932 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.499 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -141.06 132.98 27.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 3.96 108.725 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -121.65 9.32 9.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.776 -1.33 . . . . 3.67 109.776 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.35 65.31 0.76 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -1.169 . . . . 3.79 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.89 94.9 21.66 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 2.22 109.152 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.9 133.93 10.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.745 2.297 . . . . 3.49 112.793 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD21 ' NE ' ' A' ' 109' ' ' ARG . 35.6 mt -136.92 137.17 39.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 3.46 109.144 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 74' ' ' ALA . 9.0 t -96.87 -155.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.935 . . . . 2.83 109.509 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -104.46 56.86 0.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 2.83 109.542 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -150.85 150.47 27.97 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.299 -1.118 . . . . 3.02 109.433 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 118.33 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.717 2.278 . . . . 1.42 112.137 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.606 ' CB ' HH22 ' A' ' 109' ' ' ARG . . . -166.39 147.3 6.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 1.81 109.543 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.648 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -90.41 144.45 25.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 2.19 109.797 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.648 ' NH1' ' O ' ' A' ' 108' ' ' THR . 0.3 OUTLIER -105.14 134.18 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.939 -1.134 . . . . 5.23 107.939 178.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -109.54 105.27 14.53 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.92 -0.712 . . . . 3.28 110.163 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.499 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 39.0 m-85 -109.6 102.29 11.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.448 -0.945 . . . . 3.78 108.448 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.47 166.41 11.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.301 -0.874 . . . . 3.99 109.901 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.509 ' O ' ' CB ' ' A' ' 65' ' ' SER . 2.3 p90 -177.67 -162.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 3.1 109.237 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.05 143.05 50.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.339 -0.85 . . . . 2.65 109.38 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.709 ' HG ' ' CA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -86.89 161.56 18.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 4.28 109.678 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -127.86 -15.28 4.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 7.59 109.602 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.568 ' CD2' ' CZ ' ' A' ' 119' ' ' PHE . 1.6 tp -123.43 155.63 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 5.5 109.543 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 109.33 21.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 4.48 109.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.568 ' CZ ' ' CD2' ' A' ' 117' ' ' LEU . 23.8 m-85 -114.77 92.46 29.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.892 . . . . 5.99 109.58 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.23 165.9 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.774 2.316 . . . . 4.64 112.122 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.11 -22.74 7.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.796 2.331 . . . . 4.46 111.989 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.03 115.27 29.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.842 . . . . 4.14 109.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 147.07 -136.53 6.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 4.24 109.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' GLY . 10.8 m-20 -43.79 -85.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -1.136 . . . . 3.59 109.458 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -129.86 149.7 73.8 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 2.78 109.458 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.24 -158.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.722 2.281 . . . . 1.57 112.244 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -65.37 163.27 39.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.482 -1.447 . . . . 1.25 109.482 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.16 153.05 38.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -1.107 . . . . 2.18 109.682 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 128' ' ' GLN . 45.7 t -155.84 131.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.187 -1.042 . . . . 1.87 108.187 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.65 100.09 3.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.888 -1.132 . . . . 1.45 110.531 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.471 ' CD2' HD13 ' A' ' 53' ' ' LEU . 2.9 m-30 -85.04 99.23 10.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.522 -0.918 . . . . 2.4 108.522 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 49' ' ' TRP . 41.6 m170 -99.77 136.1 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 2.98 109.816 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.691 ' N ' ' CD1' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -132.73 -36.47 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 2.61 109.397 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -40.8 116.59 0.85 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 2.32 109.426 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.676 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.6 mtpp -163.83 149.62 11.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 5.66 109.631 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -42.91 -15.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 2.71 108.475 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -114.43 -4.14 22.06 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.259 -1.536 . . . . 3.14 109.259 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.665 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -42.96 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -1.082 . . . . 2.84 109.485 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -168.68 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 2.44 109.876 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -124.17 134.07 53.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 1.86 108.911 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.1 t80 -114.79 105.89 13.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.06 -1.025 . . . . 2.48 109.736 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.95 87.77 3.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.74 109.888 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 140.68 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 1.69 109.058 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.436 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 42.6 p -137.56 -1.0 2.11 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.667 -0.646 . . . . 1.63 109.453 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.785 ' H ' ' HG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -151.26 167.27 28.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 3.82 109.881 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.781 ' H ' ' HG1' ' A' ' 13' ' ' THR . 2.9 p -175.73 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 2.92 109.416 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.531 ' OG ' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -131.53 131.3 43.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 3.25 109.778 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 149' ' ' THR . 5.2 tp -110.4 118.86 37.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 5.12 109.324 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.459 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -123.19 175.19 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 3.35 109.502 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.681 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -165.66 -41.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.29 109.343 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 150' ' ' THR . 0.3 OUTLIER 50.25 170.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 2.54 109.447 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.51 -177.69 4.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 3.09 109.546 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.004 -0.998 . . . . 3.68 109.428 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.6 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.321 0.581 . . . . 5.8 109.545 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.9 m 156.12 78.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 4.81 109.479 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.9 OUTLIER -167.4 -156.12 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 5.68 109.44 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 3' ' ' LEU . 11.0 p30 -56.27 -147.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 5.38 109.411 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.539 ' C ' ' O ' ' A' ' 4' ' ' ASP . 2.9 p 36.12 -155.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 4.83 109.532 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' CA ' ' HG1' ' A' ' 149' ' ' THR . 0.4 OUTLIER -131.0 109.09 10.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 3.43 109.445 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.466 HG21 ' H1 ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -51.53 165.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 3.0 109.359 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -134.06 96.33 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 4.75 109.531 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 mt -66.03 -40.78 91.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 5.44 109.403 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.766 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -114.92 94.21 37.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.853 . . . . 2.86 109.004 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 45.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.791 2.327 . . . . 4.15 112.557 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 10' ' ' LEU . 34.1 t60 -137.94 130.78 29.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.023 . . . . 2.52 109.575 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 t -170.08 70.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 2.33 109.376 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.639 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.5 m -164.66 63.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 2.28 109.629 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.588 ' CD2' ' CD1' ' A' ' 143' ' ' ILE . 4.3 m-30 -67.73 27.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 2.6 109.118 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.639 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.09 -40.05 12.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.66 109.867 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 13.4 mm-40 -109.71 -73.09 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 2.13 109.671 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -88.04 145.55 25.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 2.74 109.445 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.501 ' CD2' ' SD ' ' A' ' 37' ' ' MET . 7.1 mt -62.17 -59.22 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 3.06 109.437 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.28 169.92 14.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 1.72 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.417 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 43.2 Cg_endo -72.2 5.04 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.852 2.368 . . . . 1.97 112.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.766 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.8 m95 -76.17 -175.47 3.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.88 109.463 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 2.07 109.237 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' A' ' 24' ' ' LEU . 3.3 pp -142.84 131.96 23.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 2.79 109.433 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.12 170.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 2.48 109.782 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.88 -31.09 8.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.029 -1.229 . . . . 1.7 110.029 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.82 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.97 -142.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.271 . . . . 1.51 109.417 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.82 ' N ' ' OG1' ' A' ' 27' ' ' THR . 90.1 p -90.81 138.53 31.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.975 . . . . 2.11 109.45 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 28' ' ' SER . 4.9 mt-10 -41.38 104.19 0.33 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 2.85 109.179 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.471 ' CB ' ' SD ' ' A' ' 37' ' ' MET . 51.3 Cg_exo -46.78 156.73 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.366 2.044 . . . . 1.4 111.854 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -143.42 122.04 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 1.53 110.09 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.715 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.62 85.26 3.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 2.56 109.501 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 1.81 109.761 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.24 -67.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 2.21 109.522 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.49 48.48 0.75 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.629 -1.389 . . . . 1.23 109.629 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.574 ' CB ' ' NH1' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -170.69 148.48 2.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.126 -1.22 . . . . 3.37 109.657 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.501 ' SD ' ' CD2' ' A' ' 19' ' ' LEU . 36.4 ttp -109.77 128.63 55.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 1.4 109.107 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -123.46 159.97 27.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.06 110.2 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.422 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.2 m -128.88 134.51 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.901 -0.777 . . . . 1.95 108.901 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.57 106.51 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.825 . . . . 4.79 109.705 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 139' ' ' TYR . 4.2 mm? -118.15 61.04 4.01 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.276 -0.89 . . . . 3.97 109.334 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.37 -91.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.726 2.284 . . . . 4.21 112.283 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -150.89 158.88 27.89 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.516 -1.434 . . . . 2.09 109.516 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.92 42.59 1.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 2.62 109.459 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.656 HE21 ' C ' ' A' ' 134' ' ' GLY . 3.8 mm100 -99.87 148.26 24.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 2.96 109.297 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.94 -69.59 0.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.959 -1.256 . . . . 2.38 109.959 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.686 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.8 p30 -99.79 145.26 29.85 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.129 -1.218 . . . . 4.04 109.616 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.75 -20.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.892 2.395 . . . . 2.75 112.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.686 ' CE3' ' OD1' ' A' ' 47' ' ' ASN . 1.3 p-90 -119.49 36.94 4.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 4.57 110.355 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 8.5 m-20 -79.81 -0.35 34.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.091 -1.005 . . . . 2.38 109.097 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.43 126.61 1.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 1.47 109.315 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.0 -173.91 43.51 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.84 -1.304 . . . . 0.96 109.84 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 5.3 mt -106.9 -178.02 3.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.148 . . . . 1.51 109.545 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -165.54 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 1.51 109.707 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.697 ' CE2' ' CD1' ' A' ' 10' ' ' LEU . 37.6 t80 -179.77 137.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 2.45 109.396 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.459 HD22 ' HG2' ' A' ' 128' ' ' GLN . 1.1 m-80 -119.05 86.11 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.248 -0.907 . . . . 2.95 109.518 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.23 66.56 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 2.52 109.591 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -166.01 85.51 0.96 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.248 -1.148 . . . . 4.19 109.528 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.57 175.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.781 2.32 . . . . 2.79 112.212 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -136.91 131.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 3.62 109.507 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -117.11 80.53 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 3.37 109.475 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 61' ' ' GLY . 28.6 tt0 -35.23 118.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -1.087 . . . . 6.05 109.589 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 129.15 -39.48 1.84 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.646 -1.382 . . . . 3.09 109.646 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.554 ' O ' ' OG ' ' A' ' 115' ' ' SER . 1.9 mt-10 -99.94 173.06 6.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 4.03 109.62 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.5 m -119.34 143.63 47.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 3.28 109.326 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 27.5 m-85 -108.81 -178.39 3.57 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 2.59 109.659 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 1.8 t -151.7 158.36 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 3.18 109.497 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' CD1' ' CD2' ' A' ' 148' ' ' LEU . 11.7 tp -143.05 112.01 6.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 4.0 109.68 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.31 86.81 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 2.8 108.787 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.9 p90 -93.98 141.51 28.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 2.64 111.16 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.692 ' CB ' ' HG ' ' A' ' 144' ' ' SER . 2.7 p -84.82 88.55 7.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 2.25 108.3 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB3' ' CE1' ' A' ' 141' ' ' PHE . . . -129.68 156.96 43.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.117 . . . . 1.45 110.756 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.8 p -147.36 120.11 8.64 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.596 -0.89 . . . . 1.28 108.596 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.595 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -88.13 133.36 34.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 1.07 109.839 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.456 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.8 116.9 16.05 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.431 -0.793 . . . . 1.68 109.078 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.595 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -66.07 -142.53 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.676 0 C-N-CA 124.29 -1.129 . . . . 1.32 112.551 -0.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.652 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -106.86 154.79 20.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 1.75 109.724 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.8 mtm 167.08 169.67 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.778 . . . . 2.72 109.092 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.15 131.65 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.872 2.381 . . . . 1.83 112.55 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.612 ' CG1' ' HH ' ' A' ' 139' ' ' TYR . 1.2 m -107.26 174.03 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 2.57 109.279 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -126.48 98.29 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 6.46 109.804 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.68 155.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.27 -0.894 . . . . 4.19 109.165 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD21 ' CE1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -147.69 157.98 43.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 2.9 109.798 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.578 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.4 OUTLIER -151.98 164.4 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 2.31 109.38 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 146.73 -159.24 27.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.612 -1.395 . . . . 1.75 109.612 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.684 ' OE1' ' CE1' ' A' ' 119' ' ' PHE . 7.3 pt-20 -90.2 -155.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.129 . . . . 2.54 109.45 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.67 72.9 0.08 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.567 -1.413 . . . . 1.77 109.567 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -143.12 -88.48 0.1 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 2.54 109.655 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.643 ' C ' ' H ' ' A' ' 91' ' ' TYR . . . -57.09 -136.16 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.591 -1.404 . . . . 4.77 109.591 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.508 ' O ' ' C ' ' A' ' 91' ' ' TYR . . . -63.66 36.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -1.13 . . . . 5.79 109.489 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.643 ' H ' ' C ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 36.03 52.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 6.33 109.4 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.619 ' CZ ' ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -82.01 113.63 20.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 6.42 109.53 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -111.34 172.16 7.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 2.66 109.988 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.76 -18.99 5.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.892 -0.781 . . . . 3.93 108.892 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.94 34.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 4.15 109.308 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 82.18 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 4.6 109.428 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 98' ' ' GLY . 2.1 tt0 -103.41 156.86 17.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 3.96 109.093 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -146.24 7.86 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.696 -1.362 . . . . 3.67 109.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -120.69 75.62 1.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.167 -1.196 . . . . 3.79 109.78 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . . . -120.34 86.51 38.74 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 2.22 109.242 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -66.52 127.54 17.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.149 2.566 . . . . 3.49 112.82 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.57 147.61 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 3.46 108.999 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.578 ' O ' ' O ' ' A' ' 74' ' ' ALA . 5.0 t -97.61 -170.58 2.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 2.83 109.828 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 105' ' ' GLU . . . -103.72 36.34 4.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.691 -1.364 . . . . 2.83 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 104' ' ' GLY . 71.3 mt-10 -156.09 148.21 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 3.02 109.262 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -40.8 118.26 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.696 2.264 . . . . 1.42 112.143 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.541 ' CB ' ' NH1' ' A' ' 109' ' ' ARG . . . -160.9 138.34 9.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 1.81 109.648 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.418 ' CG2' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.54 151.51 21.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 2.19 109.907 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.541 ' NH1' ' CB ' ' A' ' 107' ' ' ALA . 3.7 mpt_? -124.36 142.14 51.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 5.23 108.029 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.63 104.67 12.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 3.28 110.757 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 8.8 m-30 -109.88 120.11 41.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.499 -0.926 . . . . 3.78 108.499 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -124.95 169.65 11.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 3.99 109.67 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.5 p90 -155.23 -177.76 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 3.1 109.499 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.535 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -111.4 106.14 14.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.364 -0.835 . . . . 2.65 109.558 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.554 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.8 m -36.01 129.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 4.28 109.347 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.469 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 10.9 m120 -125.17 -7.21 7.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 7.59 109.507 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.469 ' HB3' ' CE2' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -148.94 129.98 14.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 5.5 109.424 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.26 113.25 18.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 4.48 109.551 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CE1' ' OE1' ' A' ' 86' ' ' GLU . 44.6 m-85 -110.02 146.94 35.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 5.99 109.353 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.47 166.3 30.22 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.691 2.261 . . . . 4.64 112.163 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 126' ' ' PRO . 73.4 Cg_endo -81.02 -39.72 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.777 2.318 . . . . 4.46 112.071 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -122.44 -150.93 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.874 . . . . 4.14 109.478 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.08 -142.54 15.66 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.572 -1.411 . . . . 4.24 109.572 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -114.33 10.94 17.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -1.094 . . . . 3.59 109.447 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.466 ' N ' ' CD ' ' A' ' 126' ' ' PRO . . . -165.75 54.22 0.33 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 2.78 109.545 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 55.1 Cg_endo -74.09 -158.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.846 2.364 . . . . 1.57 112.223 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 126' ' ' PRO . . . -39.97 155.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.627 -1.389 . . . . 1.25 109.627 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -155.2 137.85 15.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -1.159 . . . . 2.18 109.553 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 8.3 p -153.48 149.34 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.674 -0.861 . . . . 1.87 108.674 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -159.13 115.57 2.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.033 . . . . 1.45 110.207 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 6.8 m-30 -85.63 105.29 16.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 2.4 108.435 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 49' ' ' TRP . 56.9 m170 -99.43 121.24 40.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 2.98 109.757 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -152.17 66.7 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 2.61 109.496 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.656 ' C ' HE21 ' A' ' 45' ' ' GLN . . . -157.11 103.91 0.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 2.32 109.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -153.48 -175.34 5.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 5.66 109.638 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -44.87 -12.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.34 -0.985 . . . . 2.71 108.34 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -113.33 1.94 25.17 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.345 -1.502 . . . . 3.14 109.345 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -37.44 165.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.392 -1.064 . . . . 2.84 109.656 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -161.21 -108.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 2.44 109.555 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -138.66 139.61 38.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 1.86 109.111 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.659 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 30.7 t80 -124.34 120.4 32.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.062 -1.024 . . . . 2.48 109.921 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.87 101.74 8.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.74 109.893 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.588 ' CD1' ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -100.82 135.66 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.69 109.013 179.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.692 ' HG ' ' CB ' ' A' ' 71' ' ' THR . 3.5 p -109.16 -21.28 12.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.902 -0.777 . . . . 1.63 108.902 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.68 ' N ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -170.43 -174.94 1.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.256 -0.978 . . . . 3.82 110.533 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 146' ' ' VAL . 9.8 p -161.42 108.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.872 -0.788 . . . . 2.92 108.872 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.11 143.27 33.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 3.25 110.197 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.521 ' CD1' ' C ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -123.9 110.27 14.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.46 -0.775 . . . . 5.12 109.039 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.501 ' HG1' ' CA ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -131.58 167.79 18.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 3.35 109.808 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.7 OUTLIER -145.14 -41.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 2.29 109.328 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.515 ' N ' ' CG2' ' A' ' 150' ' ' THR . 6.9 t 64.22 103.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.435 -0.791 . . . . 2.54 109.431 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.55 99.48 6.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 3.09 109.454 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.01 -0.995 . . . . 3.68 109.427 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.479 -0.563 . . . . 5.8 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t 54.86 40.9 32.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 4.81 109.442 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 4' ' ' ASP . 2.5 mt -86.62 -173.53 4.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 5.68 109.509 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.57 ' O ' ' O ' ' A' ' 5' ' ' SER . 2.1 t70 -57.69 -140.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 5.38 109.474 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 4' ' ' ASP . 18.1 t -51.44 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 4.83 109.456 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -52.87 135.25 36.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 3.43 109.446 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' O ' ' CB ' ' A' ' 149' ' ' THR . 1.4 t -75.45 76.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 3.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.46 109.02 11.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 4.75 109.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.79 -50.1 13.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 5.44 109.318 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.694 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -96.55 108.6 43.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 2.86 109.352 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.7 29.13 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.089 1.86 . . . . 4.15 111.624 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.672 ' CG ' ' O ' ' A' ' 12' ' ' HIS . 19.4 t60 -124.36 72.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 2.52 109.586 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 5.7 t -112.06 41.67 1.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 2.33 109.318 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.659 ' C ' ' H ' ' A' ' 16' ' ' ALA . 32.7 m -127.0 64.94 1.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 2.28 109.779 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.573 ' CE1' ' NE2' ' A' ' 12' ' ' HIS . 3.5 m-85 -67.2 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 2.6 109.029 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.659 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.12 -20.49 23.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.66 110.113 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 34.2 mt-10 -109.9 -83.91 0.56 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.02 -1.05 . . . . 2.13 109.948 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 m -104.94 151.77 23.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 2.74 109.628 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -47.99 62.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 3.06 109.423 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 102.54 -173.03 22.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.725 -1.35 . . . . 1.72 109.725 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 36.0 Cg_endo -69.21 -18.38 39.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 1.97 112.194 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.694 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 11.2 m0 -56.79 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 2.88 109.139 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 m -151.43 136.78 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 2.07 109.599 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.656 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 9.3 tt -133.28 152.74 51.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 2.79 109.574 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.87 177.43 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 2.48 109.444 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 93.03 -30.33 7.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.831 -1.307 . . . . 1.7 109.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.829 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.96 -141.96 0.38 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -1.185 . . . . 1.51 109.276 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.829 ' N ' ' OG1' ' A' ' 27' ' ' THR . 23.7 p -90.68 140.27 29.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.171 -0.956 . . . . 2.11 108.989 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' C ' ' O ' ' A' ' 28' ' ' SER . 2.6 mp0 -36.95 128.67 0.75 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 2.85 109.102 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HB2' ' CG ' ' A' ' 37' ' ' MET . 43.3 Cg_endo -71.73 158.75 52.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.262 1.975 . . . . 1.4 111.681 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -145.83 116.28 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.025 -1.047 . . . . 1.53 110.589 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -71.17 72.64 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 2.56 109.14 178.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -73.43 -135.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 1.81 109.78 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -41.66 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.792 . . . . 2.21 109.34 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 34.52 45.47 0.5 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.7 -1.36 . . . . 1.23 109.7 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -164.01 146.61 9.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.097 -1.237 . . . . 3.37 109.812 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.426 ' CG ' ' HB2' ' A' ' 30' ' ' PRO . 11.8 tmm? -108.97 124.77 51.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 1.4 109.121 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 2.0 t -124.79 155.02 40.04 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 1.06 110.378 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HB ' ' HG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -127.48 164.55 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.459 -0.941 . . . . 1.95 108.459 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' CG ' ' OG ' ' A' ' 28' ' ' SER . 21.0 m-20 -99.09 112.69 24.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 4.79 109.627 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.667 ' CD2' ' N ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.27 84.65 9.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 3.97 109.202 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.42 -92.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.848 2.366 . . . . 4.21 112.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' GLY . . . -162.33 -139.99 2.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.439 . . . . 2.09 109.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 43' ' ' GLY . . . 35.79 43.09 0.57 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.549 -1.42 . . . . 2.62 109.549 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 46' ' ' GLY . 15.6 mm-40 -99.9 129.74 46.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -1.17 . . . . 2.96 109.489 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -35.75 -44.28 0.67 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 2.38 109.619 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.669 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -179.95 157.49 0.79 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 4.04 109.5 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.4 -34.97 3.39 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.794 2.329 . . . . 2.75 112.379 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.684 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 35.5 p90 -101.74 60.86 0.88 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 4.57 109.501 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 26.8 m-20 -136.58 0.92 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 2.38 109.483 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.41 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -162.58 -170.87 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.47 109.459 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 -155.96 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.96 109.517 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 53' ' ' LEU . 1.5 pt? -127.04 157.62 39.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.18 -1.188 . . . . 1.51 109.66 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.26 -176.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 1.51 110.102 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.549 ' CZ ' ' CD1' ' A' ' 10' ' ' LEU . 30.4 t80 177.93 147.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.34 0.591 . . . . 2.45 109.576 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.82 129.57 56.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.321 -0.862 . . . . 2.95 109.48 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.29 84.03 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.386 -1.486 . . . . 2.52 109.386 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.681 ' CG1' ' H ' ' A' ' 128' ' ' GLN . 1.3 p -169.88 70.45 0.63 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.111 . . . . 4.19 109.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.688 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.61 159.58 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.824 2.349 . . . . 2.79 111.963 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.45 ' C ' ' HG ' ' A' ' 115' ' ' SER . 2.0 t -151.39 85.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.165 -0.959 . . . . 3.62 109.723 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.56 ' C ' ' OG ' ' A' ' 115' ' ' SER . . . -88.69 112.22 3.9 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.087 -1.605 . . . . 3.37 109.087 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' N ' ' OG ' ' A' ' 115' ' ' SER . 34.5 mt-10 -31.01 135.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.553 -0.969 . . . . 6.05 110.037 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 95.37 -16.54 61.06 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.972 -1.251 . . . . 3.09 109.972 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' H ' ' HB3' ' A' ' 115' ' ' SER . 17.4 mt-10 -99.89 146.93 26.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 4.03 109.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 150' ' ' THR . 4.0 m -111.87 133.63 53.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 3.28 109.159 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.688 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 30.8 m-85 -109.7 178.07 4.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.147 -0.97 . . . . 2.59 109.921 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.422 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.4 t -151.8 165.55 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.504 -0.747 . . . . 3.18 109.476 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.465 HD21 ' CD1' ' A' ' 70' ' ' PHE . 1.9 tp -147.34 111.13 5.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.868 . . . . 4.0 109.476 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.9 p -109.83 93.15 4.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 2.8 109.163 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.696 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.92 143.77 26.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.205 -0.935 . . . . 2.64 110.679 -179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.674 ' HG1' ' N ' ' A' ' 145' ' ' GLN . 1.5 p -101.58 108.52 20.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.43 -0.952 . . . . 2.25 108.43 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -154.43 143.4 21.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.789 -1.194 . . . . 1.45 110.597 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -113.98 127.22 55.87 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.631 -0.878 . . . . 1.28 108.631 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.581 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -97.42 129.3 44.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 1.07 110.009 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.459 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.6 115.89 14.82 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.394 -0.816 . . . . 1.68 109.156 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -65.85 -142.54 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.435 -1.069 . . . . 1.32 112.489 -0.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -106.2 150.32 25.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 1.75 109.532 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.5 155.11 0.15 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 2.72 109.476 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.94 122.84 8.46 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.825 2.35 . . . . 1.83 112.143 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.58 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 1.5 m -93.85 175.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 2.57 109.378 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.729 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.05 145.77 36.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 6.46 109.688 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.608 ' O ' ' NH2' ' A' ' 81' ' ' ARG . 1.4 p -147.29 152.4 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 4.19 109.326 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 pp -155.43 149.27 25.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 2.9 109.81 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.572 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -144.7 152.58 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 2.31 109.453 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 168.24 -150.24 15.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.758 -1.337 . . . . 1.75 109.758 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.539 ' C ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -90.15 -165.1 1.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -1.064 . . . . 2.54 109.598 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.54 -0.59 6.71 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 1.77 109.526 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . 177.13 -171.98 44.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.533 -1.427 . . . . 2.54 109.533 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.623 ' O ' ' CB ' ' A' ' 90' ' ' ALA . . . 48.22 17.17 0.61 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 4.77 109.595 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.623 ' CB ' ' O ' ' A' ' 89' ' ' GLY . . . 155.81 55.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -1.146 . . . . 5.79 109.374 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -45.65 -43.18 12.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 6.33 109.526 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 91' ' ' TYR . 11.4 ptm180 -36.01 111.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 6.42 109.431 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.572 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -100.25 164.8 11.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 2.66 109.862 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.18 -17.77 10.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.396 -0.815 . . . . 3.93 108.829 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.64 35.38 0.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.362 -0.836 . . . . 4.15 109.193 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -77.85 88.43 4.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 4.6 109.605 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.66 ' O ' ' NH2' ' A' ' 81' ' ' ARG . 4.0 pt20 -121.98 148.81 44.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 3.96 109.353 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.687 ' CA ' ' HE ' ' A' ' 81' ' ' ARG . . . -136.76 30.11 2.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.83 -1.308 . . . . 3.67 109.83 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.544 ' O ' ' OH ' ' A' ' 111' ' ' TYR . 1.7 m -115.12 66.72 0.69 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -1.19 . . . . 3.79 109.636 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.89 93.45 17.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 2.22 109.563 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.6 118.42 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.713 2.276 . . . . 3.49 112.218 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 25.3 mt -120.56 155.92 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 3.46 109.494 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 1.3 t -110.39 -167.29 1.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 2.83 109.616 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -78.98 -25.75 59.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.761 -1.335 . . . . 2.83 109.761 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.83 164.01 17.32 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 3.02 109.408 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -43.28 118.73 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.688 2.259 . . . . 1.42 112.088 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.26 117.97 16.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 1.81 109.746 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.667 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.69 148.98 21.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 2.19 110.21 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.667 ' NH1' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -127.84 139.69 52.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.21 -1.033 . . . . 5.23 108.21 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.99 104.87 9.82 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.957 -0.697 . . . . 3.28 109.991 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.544 ' OH ' ' O ' ' A' ' 99' ' ' SER . 41.2 m-85 -109.69 129.61 55.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.221 -0.924 . . . . 3.78 108.867 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.42 157.01 43.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.833 . . . . 3.99 109.775 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.4 p90 -146.28 -178.51 6.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 3.1 109.552 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.57 137.03 47.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.463 -0.773 . . . . 2.65 109.642 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.56 ' OG ' ' C ' ' A' ' 61' ' ' GLY . 22.8 t -64.11 118.39 8.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 4.28 109.602 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -18.82 13.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 7.59 109.233 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -132.5 -162.6 1.25 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.292 -0.88 . . . . 5.5 109.568 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.708 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -118.92 133.82 55.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.266 -0.896 . . . . 4.48 109.506 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -153.66 70.57 6.62 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 5.99 109.534 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.75 169.46 1.8 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.815 2.343 . . . . 4.64 112.009 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.16 -31.41 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.754 2.302 . . . . 4.46 112.06 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 123' ' ' GLY . 24.1 t0 -119.25 -11.94 9.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 4.14 109.572 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -56.94 -150.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 4.24 109.564 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 123' ' ' GLY . 0.5 OUTLIER -36.33 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -1.152 . . . . 3.59 109.415 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -115.61 150.11 44.18 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 2.78 109.445 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.9 -158.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.761 2.307 . . . . 1.57 112.252 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . -82.34 166.62 46.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.552 -1.419 . . . . 1.25 109.552 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.681 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -147.25 142.62 27.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 2.18 109.867 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.596 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 5.2 p -163.24 110.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.278 -1.008 . . . . 1.87 108.278 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -118.83 132.27 56.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 1.45 110.871 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.435 ' HB2' ' CD2' ' A' ' 53' ' ' LEU . 4.0 m-30 -101.02 111.83 24.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 2.4 108.199 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.526 ' CE1' ' CB ' ' A' ' 49' ' ' TRP . 58.5 m170 -99.37 131.12 45.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 2.98 109.565 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 141' ' ' PHE . 3.0 mt -133.23 -43.45 0.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 2.61 109.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -38.79 127.43 1.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.841 -1.304 . . . . 2.32 109.841 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.67 ' O ' ' N ' ' A' ' 137' ' ' GLY . 31.4 mtmt -164.69 134.79 3.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 5.66 109.584 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -40.29 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.389 -0.967 . . . . 2.71 108.389 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.13 14.8 7.85 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.047 -1.621 . . . . 3.14 109.047 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.614 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.5 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -1.038 . . . . 2.84 110.062 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.58 ' OH ' ' CG1' ' A' ' 80' ' ' VAL . 8.3 p90 -160.03 -130.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.004 -1.06 . . . . 2.44 109.429 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 22.5 mt-10 -116.93 135.81 53.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 1.86 109.33 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 14.8 t80 -118.51 108.45 15.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 2.48 110.038 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.48 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 78.7 m -111.94 100.83 9.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.297 -0.877 . . . . 0.74 110.003 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.466 HG23 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -112.99 143.75 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 1.69 109.086 179.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' PHE . 6.0 p -131.8 -5.84 3.6 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.64 . . . . 1.63 109.275 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' HG1' ' A' ' 71' ' ' THR . 1.3 mt-30 -153.85 160.02 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.299 -0.961 . . . . 3.82 110.233 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.613 ' N ' ' OG1' ' A' ' 13' ' ' THR . 10.8 p -178.15 124.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.007 -0.738 . . . . 2.92 109.007 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.95 135.41 29.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 3.25 109.911 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 149' ' ' THR . 0.3 OUTLIER -108.38 144.51 35.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 5.12 109.362 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 2.8 t -164.97 -173.26 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 3.35 109.559 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.642 ' O ' ' CB ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -139.13 -103.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 2.29 109.437 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.642 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.5 OUTLIER 84.88 92.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.86 . . . . 2.54 109.449 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.87 -155.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 3.09 109.44 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.0 -1.0 . . . . 3.68 109.452 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.425 -0.583 . . . . 5.8 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 1.1 p -95.79 -57.89 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 4.81 109.432 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.493 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.0 OUTLIER 52.79 20.6 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 5.68 109.325 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 1.8 m-20 -63.64 83.72 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.712 -0.617 . . . . 5.38 109.498 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ASP . 33.9 t 58.38 150.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 4.83 109.48 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -53.83 178.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 3.43 109.502 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLU . 58.0 t -150.88 75.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 3.0 109.523 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -36.07 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 4.75 109.423 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . 12.1 mt -103.82 11.43 35.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.284 -0.885 . . . . 5.44 109.679 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.705 ' O ' ' N ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -114.38 113.7 45.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 2.86 108.444 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.51 19.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.647 2.232 . . . . 4.15 113.66 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.705 ' N ' ' O ' ' A' ' 10' ' ' LEU . 83.5 t60 -170.69 136.89 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.674 -1.266 . . . . 2.52 110.404 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.591 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.3 OUTLIER -170.83 68.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 2.33 109.341 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.564 ' HG ' ' C ' ' A' ' 13' ' ' THR . 50.5 m -170.31 87.66 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 2.28 110.083 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -90.24 41.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 2.6 109.056 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.22 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 1.66 109.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -109.75 39.47 2.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.195 -0.941 . . . . 2.13 109.696 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.21 148.89 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 2.74 109.53 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 pp -74.06 -10.85 60.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 3.06 109.427 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 75.03 -146.81 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.357 -1.497 . . . . 1.72 109.357 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 22' ' ' TRP . 64.6 Cg_endo -81.53 -23.1 5.16 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.893 2.396 . . . . 1.97 112.076 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.574 ' O ' ' O ' ' A' ' 21' ' ' PRO . 11.3 m0 -45.94 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 2.88 108.896 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -113.53 164.81 13.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 2.07 108.985 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.544 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 3.0 mt -156.54 132.63 9.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 2.79 109.78 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.733 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 171.63 -167.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 2.48 109.394 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.0 -30.39 0.93 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.754 -1.339 . . . . 1.7 109.754 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.733 ' HG1' ' H ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -109.87 -141.12 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -1.186 . . . . 1.51 109.445 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.733 ' H ' ' HG1' ' A' ' 27' ' ' THR . 11.4 p -90.92 -162.75 0.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.084 -0.709 . . . . 2.11 109.084 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.4 111.63 48.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 2.85 109.134 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' CG ' HD11 ' A' ' 24' ' ' LEU . 53.0 Cg_exo -50.04 140.87 31.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.167 1.911 . . . . 1.4 111.786 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.19 112.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.033 . . . . 1.53 109.898 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' HA ' ' CB ' ' A' ' 37' ' ' MET . 0.9 OUTLIER -90.03 127.24 36.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 2.56 109.349 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -120.8 -110.07 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.955 . . . . 1.81 109.62 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.67 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 3.4 p-10 -60.28 63.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.96 . . . . 2.21 109.595 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 69.33 -17.51 0.6 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.676 -1.369 . . . . 1.23 109.676 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -106.04 170.74 7.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -1.194 . . . . 3.37 109.736 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.414 ' CB ' ' HA ' ' A' ' 32' ' ' PHE . 9.6 ptt? -148.28 166.23 28.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 1.4 109.09 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -146.65 150.79 36.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 1.06 110.535 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.97 148.6 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.245 -1.02 . . . . 1.95 108.245 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 1.1 m-20 -83.85 105.85 15.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 4.79 109.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 139' ' ' TYR . 1.8 mm? -112.97 78.25 2.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 3.97 108.898 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.26 -159.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.771 2.314 . . . . 4.21 112.388 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.87 63.01 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 2.09 109.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.26 36.01 0.96 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.451 -1.46 . . . . 2.62 109.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 6.1 mm-40 -99.97 112.7 24.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -1.126 . . . . 2.96 109.544 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.644 ' C ' HD21 ' A' ' 47' ' ' ASN . . . -54.75 -10.94 2.51 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.571 -1.412 . . . . 2.38 109.571 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.644 HD21 ' C ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -165.85 156.61 11.76 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -1.178 . . . . 4.04 109.444 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HG3' ' NH1' ' A' ' 81' ' ' ARG . 44.5 Cg_endo -72.6 -27.27 15.58 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.711 2.274 . . . . 2.75 112.216 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 1.6 p90 -83.72 35.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 4.57 109.444 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.663 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 19.8 m-20 -136.82 46.33 2.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 2.38 109.465 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 172.5 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 1.47 109.451 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.86 -163.33 25.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.534 -1.426 . . . . 0.96 109.534 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.537 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -119.75 -172.7 2.39 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.223 -1.163 . . . . 1.51 109.388 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 93.2 t -162.08 167.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 1.51 108.943 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.56 ' CD2' ' NE1' ' A' ' 22' ' ' TRP . 20.0 t80 -176.19 172.94 2.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 2.45 109.516 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.26 -164.61 1.03 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.218 -0.926 . . . . 2.95 109.626 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 10' ' ' LEU . . . 79.96 64.84 1.82 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.517 -1.433 . . . . 2.52 109.517 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.23 79.78 6.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.176 -1.191 . . . . 4.19 109.405 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.77 120.33 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.737 2.292 . . . . 2.79 112.08 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.41 119.15 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 3.62 109.619 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.677 ' N ' ' OH ' ' A' ' 66' ' ' TYR . . . -128.58 95.93 0.4 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.332 -1.507 . . . . 3.37 109.332 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.674 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -35.2 144.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 6.05 109.372 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.34 -36.39 4.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 3.09 109.522 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.74 178.58 4.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -1.167 . . . . 4.03 109.224 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -132.51 119.91 21.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.126 -0.984 . . . . 3.28 109.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' OH ' ' N ' ' A' ' 61' ' ' GLY . 56.1 m-85 -94.06 162.93 13.68 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.302 -0.874 . . . . 2.59 109.431 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.7 t -146.9 108.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.693 . . . . 3.18 109.557 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 69' ' ' SER . 7.8 tt -96.29 144.83 26.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.071 -1.018 . . . . 4.0 109.22 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.46 ' N ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.85 104.85 5.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.888 . . . . 2.8 108.98 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 109' ' ' ARG . 2.9 p90 -94.17 143.48 26.34 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.082 -1.047 . . . . 2.64 110.899 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.733 ' HG1' ' H ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.62 96.74 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.557 -0.905 . . . . 2.25 108.557 179.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -164.21 178.6 7.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.874 -1.141 . . . . 1.45 110.838 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 153.68 36.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.064 -0.717 . . . . 1.28 109.064 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -95.85 138.83 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 1.07 109.558 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.508 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -137.47 114.28 9.58 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 121.156 -0.965 . . . . 1.68 109.712 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 31.5 Cg_endo -64.64 -144.38 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.075 -1.219 . . . . 1.32 111.875 -0.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.85 150.78 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.59 -1.319 . . . . 1.75 109.589 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.557 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER 159.65 156.98 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 2.72 109.334 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.575 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 62.5 Cg_endo -76.99 147.96 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.918 2.412 . . . . 1.83 112.422 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 81' ' ' ARG . 0.8 OUTLIER -111.19 -172.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 2.57 109.343 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 132' ' ' HIS . 0.3 OUTLIER -122.43 142.75 50.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 6.46 109.556 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.3 p -146.92 149.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.243 -0.91 . . . . 4.19 109.396 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.27 151.55 31.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 2.9 109.735 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.583 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -150.76 169.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 2.31 109.345 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.81 -155.96 26.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.631 -1.388 . . . . 1.75 109.631 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.662 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -90.39 -174.13 4.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.127 . . . . 2.54 109.495 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.81 36.08 1.07 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.496 -1.442 . . . . 1.77 109.496 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.452 ' N ' ' HB2' ' A' ' 91' ' ' TYR . . . -92.41 47.22 2.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.563 -1.415 . . . . 2.54 109.563 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 64.94 -121.11 20.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.417 -1.473 . . . . 4.77 109.417 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -44.73 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -1.164 . . . . 5.79 109.193 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 89' ' ' GLY . 5.0 m-85 -60.04 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.378 -0.826 . . . . 6.33 109.528 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.633 ' CD ' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -51.42 173.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 6.42 109.588 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.718 ' HG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -122.51 174.43 7.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 2.66 109.99 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.718 ' N ' ' HG1' ' A' ' 93' ' ' THR . . . -126.69 -18.04 4.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.73 . . . . 3.93 109.115 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.644 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.74 41.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 4.15 109.356 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.96 81.22 8.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 4.6 109.602 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.1 tt0 -127.07 114.93 18.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.206 -0.934 . . . . 3.96 109.046 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.34 21.97 29.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.805 -1.318 . . . . 3.67 109.805 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -110.11 90.86 3.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -1.17 . . . . 3.79 109.531 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.411 ' HA ' ' HH ' ' A' ' 111' ' ' TYR . . . -128.07 86.86 57.01 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 2.22 109.57 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.81 118.94 5.91 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.964 2.443 . . . . 3.49 112.395 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.89 168.02 11.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 3.46 109.346 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -122.82 -177.68 3.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 2.83 109.563 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -91.6 59.21 2.95 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.513 -1.435 . . . . 2.83 109.513 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -171.78 131.72 0.75 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 3.02 109.191 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -41.04 122.65 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.488 2.125 . . . . 1.42 112.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.84 146.06 9.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 1.81 109.565 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.417 ' CG2' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.75 150.31 21.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 2.19 110.26 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -126.47 152.33 46.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.379 -1.341 . . . . 5.23 107.379 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' O ' ' CD1' ' A' ' 111' ' ' TYR . 13.8 mp0 -125.02 158.29 34.08 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.375 -0.93 . . . . 3.28 110.701 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.653 ' CD1' ' O ' ' A' ' 110' ' ' GLU . 42.9 m-85 -160.57 103.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.474 -0.936 . . . . 3.78 108.474 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -114.02 169.6 8.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 3.99 109.836 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.644 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 3.7 p90 -177.5 -173.5 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 3.1 109.857 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.69 150.91 39.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.52 -0.737 . . . . 2.65 109.418 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -90.2 169.77 10.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 4.28 109.842 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -125.07 -20.28 4.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 7.59 109.285 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 118' ' ' THR . 9.3 tt -128.46 170.86 12.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 5.5 109.305 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.592 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -89.76 107.75 19.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 4.48 109.542 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.661 ' CE2' ' OE2' ' A' ' 86' ' ' GLU . 42.5 m-85 -117.14 75.95 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 5.99 109.499 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.56 163.27 32.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.682 2.255 . . . . 4.64 112.269 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.03 -12.97 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.846 2.364 . . . . 4.46 111.965 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.46 129.44 55.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 4.14 109.487 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.64 -65.18 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.425 -1.47 . . . . 4.24 109.425 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -172.91 47.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -1.135 . . . . 3.59 109.463 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.608 ' C ' ' H ' ' A' ' 127' ' ' GLY . . . 179.92 58.83 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 2.78 109.585 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.22 -2.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.11 2.54 . . . . 1.57 112.078 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 122.29 150.21 8.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.286 -1.526 . . . . 1.25 109.286 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.99 129.73 16.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.236 . . . . 2.18 109.846 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 1.4 p -153.15 94.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.289 -1.004 . . . . 1.87 108.289 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.9 136.42 42.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.282 -0.886 . . . . 1.45 110.563 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -105.92 96.04 6.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.825 -0.805 . . . . 2.4 108.825 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 54.8 m170 -99.95 129.08 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 2.98 109.785 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.512 ' CD2' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -132.05 -28.4 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 2.61 109.45 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -46.28 144.95 3.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 2.32 109.693 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.682 ' O ' ' N ' ' A' ' 137' ' ' GLY . 14.6 mtpp -164.08 141.04 6.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.139 . . . . 5.66 109.668 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.33 -20.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 2.71 108.602 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -131.36 18.1 4.99 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 3.14 108.943 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.605 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.45 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 2.84 110.218 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.575 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -153.78 -110.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 2.44 109.394 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.63 152.74 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.896 -1.128 . . . . 1.86 109.023 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.546 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 50.3 t80 -134.29 123.8 24.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.006 -1.059 . . . . 2.48 110.181 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 1.8 m -112.67 118.78 35.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.74 109.43 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.458 HD12 HG21 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -128.61 145.03 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.006 0.908 . . . . 1.69 109.859 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.674 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 93.0 p -135.37 -19.75 1.66 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.27 -0.641 . . . . 1.63 109.27 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.733 ' H ' ' HG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -148.9 163.18 38.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.917 . . . . 3.82 109.484 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.467 HG11 ' CZ2' ' A' ' 22' ' ' TRP . 10.5 p -177.2 123.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.92 109.556 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.52 151.61 9.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 3.25 109.524 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.663 ' H ' ' CD2' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -115.96 173.19 6.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 5.12 109.584 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER -157.01 -166.89 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 3.35 109.467 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.653 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.2 t -165.02 -153.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 2.29 109.484 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.453 ' HB2' ' H ' ' A' ' 3' ' ' LEU . 2.6 p -151.26 99.48 2.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 2.54 109.472 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.88 -172.71 4.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 3.09 109.47 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.981 -1.009 . . . . 3.68 109.463 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.478 -0.564 . . . . 5.8 109.478 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 t 56.5 -73.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 4.81 109.425 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER 53.59 -156.83 0.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 5.68 109.467 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.683 ' N ' ' HG1' ' A' ' 153' ' ' THR . 7.8 t0 55.8 -170.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 5.38 109.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.528 ' C ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -36.21 147.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 4.83 109.454 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' HA ' ' HG ' ' A' ' 151' ' ' SER . 9.3 mt-10 -71.25 132.6 45.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 3.43 109.533 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.754 ' H ' ' HG ' ' A' ' 151' ' ' SER . 2.3 t -63.73 82.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 3.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' GLU . 1.8 tp10 -86.04 84.53 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 4.75 109.503 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mt -67.01 -22.0 65.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 5.44 109.297 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' HIS . 3.1 tm? -126.26 78.16 71.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 2.86 108.679 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.32 40.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.03 2.487 . . . . 4.15 112.77 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' LEU . 9.3 t60 -136.2 94.29 3.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 2.52 109.516 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.549 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -140.19 52.66 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 2.33 109.328 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -146.48 71.92 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 2.28 109.676 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.463 ' CE2' HD21 ' A' ' 19' ' ' LEU . 4.7 m-30 -63.0 41.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 2.6 109.048 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.654 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -90.1 -39.13 13.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 1.66 109.959 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 8.4 mt-10 -109.74 -83.71 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 2.13 109.856 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -103.34 144.11 31.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 2.74 109.589 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.463 HD21 ' CE2' ' A' ' 15' ' ' PHE . 4.5 mt -58.15 -55.85 29.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 3.06 109.469 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 102.53 -163.66 16.52 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.4 . . . . 1.72 109.601 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.04 -36.91 67.06 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.74 2.294 . . . . 1.97 112.117 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.536 ' CH2' ' CG1' ' A' ' 146' ' ' VAL . 21.2 m95 -55.09 159.91 2.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 2.88 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.06 177.29 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 2.07 109.342 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.555 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.3 pt? -176.06 151.53 1.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 2.79 109.631 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 170.32 178.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 2.48 109.713 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.22 -4.55 85.89 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.297 . . . . 1.7 109.859 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.792 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.74 -143.17 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.27 . . . . 1.51 109.504 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.792 ' N ' ' OG1' ' A' ' 27' ' ' THR . 86.1 p -91.5 -151.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.314 -0.866 . . . . 2.11 109.003 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -90.68 110.41 41.22 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 2.85 109.102 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 56.4 Cg_endo -76.43 143.12 24.38 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.144 1.896 . . . . 1.4 111.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -144.65 122.03 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 1.53 110.631 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.27 84.6 5.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.682 . . . . 2.56 109.182 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.75 -140.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.81 109.976 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.54 -68.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 2.21 109.401 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . -143.46 43.85 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.438 -1.465 . . . . 1.23 109.438 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.53 145.49 11.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 3.37 109.63 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 37' ' ' MET . 18.4 tmm? -111.23 132.75 54.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 1.4 109.042 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.3 m -123.48 152.11 42.05 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.06 110.24 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 30' ' ' PRO . 3.4 m -135.25 115.62 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.392 -0.966 . . . . 1.95 108.392 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.577 ' N ' ' HG ' ' A' ' 28' ' ' SER . 3.4 m-20 -72.41 123.64 23.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 4.79 109.929 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.461 ' CD2' ' OG1' ' A' ' 27' ' ' THR . 3.7 mm? -132.52 61.07 54.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.912 . . . . 3.97 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 43' ' ' GLY . 53.8 Cg_endo -96.05 -43.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.456 2.771 . . . . 4.21 112.164 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 42' ' ' PRO . . . -16.76 -108.13 0.0 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 111.771 -0.532 . . . . 2.09 111.771 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.07 61.63 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.197 -1.561 . . . . 2.62 109.197 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 136' ' ' ALA . 2.7 mm100 -99.37 97.15 8.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -1.208 . . . . 2.96 109.7 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.51 58.92 3.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.658 -1.377 . . . . 2.38 109.658 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.608 ' C ' ' H ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -152.51 90.19 3.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 4.04 109.464 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.62 2.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.907 2.405 . . . . 2.75 112.503 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.685 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -127.67 34.54 4.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 4.57 109.599 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.685 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 1.4 m-20 -109.98 -2.25 17.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 2.38 109.57 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.9 172.14 2.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -0.964 . . . . 1.47 109.689 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.3 178.0 19.63 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.718 -1.353 . . . . 0.96 109.718 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.5 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 8.2 mt -88.14 -176.57 5.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -1.092 . . . . 1.51 109.234 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.23 162.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 1.51 110.015 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.589 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 26.3 t80 175.83 146.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.586 -0.696 . . . . 2.45 109.297 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.589 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -112.93 -164.69 0.93 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.281 -0.887 . . . . 2.95 109.494 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.24 56.65 7.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.647 -1.381 . . . . 2.52 109.647 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.613 ' CG1' ' O ' ' A' ' 58' ' ' VAL . 8.5 p -126.06 92.02 46.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 4.19 109.377 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.39 131.4 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.718 2.279 . . . . 2.79 112.277 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.466 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 21.1 t -141.98 113.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 3.62 109.462 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -93.37 111.38 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.534 -1.426 . . . . 3.37 109.534 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.506 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 1.8 tm-20 -42.47 145.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 6.05 109.486 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.677 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 106.14 -35.02 5.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 3.09 109.633 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.622 ' O ' ' N ' ' A' ' 115' ' ' SER . 13.3 mt-10 -99.97 173.14 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 4.03 109.558 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.578 ' O ' ' OG1' ' A' ' 150' ' ' THR . 51.7 m -121.02 143.79 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 3.28 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 22.0 m-85 -109.31 -178.5 3.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 2.59 109.703 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.439 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 1.9 t -152.21 159.18 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.487 -0.758 . . . . 3.18 109.554 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 109' ' ' ARG . 1.8 tp -143.29 114.06 7.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 4.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.8 p -109.24 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 2.8 108.878 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.3 p90 -94.08 150.19 20.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 2.64 111.013 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.47 135.19 37.42 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.537 -0.912 . . . . 2.25 108.537 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . . . -171.68 135.16 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.011 -1.055 . . . . 1.45 110.089 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -130.58 120.97 24.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 1.28 108.979 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -96.18 138.88 33.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 1.07 109.611 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.457 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.6 116.15 16.07 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.903 . . . . 1.68 109.465 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.01 -144.44 0.17 OUTLIER 'Cis proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.217 -1.16 . . . . 1.32 112.225 0.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' OG1' ' A' ' 103' ' ' THR . 4.0 m-20 -109.21 163.17 13.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.75 110.154 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.465 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.0 mtm 165.17 168.08 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.701 -0.851 . . . . 2.72 108.701 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.36 137.91 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.741 2.294 . . . . 1.83 112.466 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 81' ' ' ARG . 0.8 OUTLIER -112.56 -178.4 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.57 109.198 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.581 ' O ' ' O ' ' A' ' 132' ' ' HIS . 7.7 ttt180 -121.75 155.72 34.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 6.46 109.772 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HB ' HE21 ' A' ' 97' ' ' GLN . 35.1 t -154.58 150.85 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 4.19 109.11 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -146.78 147.03 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.091 -1.006 . . . . 2.9 109.769 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.584 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -153.66 156.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 2.31 109.576 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.07 -161.52 24.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 1.75 109.593 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.669 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.73 -177.06 5.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 2.54 109.536 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.22 0.19 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.56 -1.416 . . . . 1.77 109.56 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.42 -115.9 1.15 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.409 . . . . 2.54 109.579 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.638 ' O ' ' CD2' ' A' ' 91' ' ' TYR . . . -125.47 139.04 11.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 4.77 109.516 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.62 -41.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -1.164 . . . . 5.79 109.359 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.638 ' CD2' ' O ' ' A' ' 89' ' ' GLY . 1.5 m-85 -73.75 80.23 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 6.33 109.431 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.56 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.45 -178.61 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 6.42 109.501 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -102.47 169.81 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 2.66 110.119 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.29 -16.84 6.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.886 -0.783 . . . . 3.93 108.886 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.64 36.45 0.9 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 4.15 109.281 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.15 71.45 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.95 . . . . 4.6 109.548 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.437 HE21 ' HB ' ' A' ' 82' ' ' VAL . 12.6 pt20 -100.07 167.27 10.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 3.96 109.467 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -146.47 8.38 1.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.695 -1.362 . . . . 3.67 109.695 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -116.23 94.22 4.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -1.159 . . . . 3.79 109.628 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.469 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . . . -134.1 85.36 39.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 2.22 109.485 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.99 133.28 57.2 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.957 2.438 . . . . 3.49 112.47 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.4 mt -148.74 123.94 10.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 3.46 109.257 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.683 ' HG1' ' H ' ' A' ' 104' ' ' GLY . 0.1 OUTLIER -116.07 175.67 5.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 2.83 109.607 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.683 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -67.52 32.93 0.21 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.395 -1.482 . . . . 2.83 109.395 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.613 ' H ' ' C ' ' A' ' 103' ' ' THR . 15.1 tt0 -110.41 95.44 22.46 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.357 -1.084 . . . . 3.02 109.362 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -47.29 118.34 2.81 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.572 2.182 . . . . 1.42 112.254 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.58 ' CB ' HH12 ' A' ' 109' ' ' ARG . . . -175.73 166.79 3.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 1.81 109.31 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -90.44 145.44 24.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 2.19 110.311 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.58 HH12 ' CB ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -108.62 138.76 44.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.711 -1.218 . . . . 5.23 107.711 178.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.01 102.28 11.29 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.434 -0.791 . . . . 3.28 110.526 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 12.3 m-30 -109.53 115.0 29.11 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.484 -0.932 . . . . 3.78 108.484 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -125.66 165.41 18.63 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.3 -0.875 . . . . 3.99 109.573 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.5 p90 -154.19 -178.06 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.875 . . . . 3.1 109.511 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.539 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -105.99 101.09 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 2.65 109.513 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 34.9 p -36.22 104.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 4.28 109.353 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 114' ' ' THR . 2.4 m120 -93.44 -32.89 14.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 7.59 109.405 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.449 HD21 ' N ' ' A' ' 117' ' ' LEU . 4.6 mm? -122.39 -175.22 3.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 5.5 109.28 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.53 114.95 27.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 4.48 109.629 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 117' ' ' LEU . 5.5 m-85 -112.85 79.24 3.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.955 . . . . 5.99 109.35 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.82 152.24 28.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.705 2.27 . . . . 4.64 112.245 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 125' ' ' ALA . 71.8 Cg_endo -80.33 -32.68 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.597 2.198 . . . . 4.46 111.814 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 123' ' ' GLY . 24.3 m-20 -109.84 -30.34 7.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 4.14 109.55 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -36.46 -34.04 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 4.24 109.531 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.6 OUTLIER -173.72 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 3.59 109.508 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -137.18 153.24 74.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 2.78 109.566 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -68.8 -10.97 30.64 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.947 2.432 . . . . 1.57 112.337 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.9 178.21 17.29 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 1.25 109.348 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -154.35 120.99 5.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -1.227 . . . . 2.18 109.775 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.4 t -144.42 120.7 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.711 -0.848 . . . . 1.87 108.711 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.38 131.55 24.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.013 . . . . 1.45 110.444 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -94.46 115.62 27.82 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.666 -0.864 . . . . 2.4 108.666 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.581 ' O ' ' O ' ' A' ' 81' ' ' ARG . 23.8 m170 -100.02 122.81 43.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 2.98 110.064 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.545 ' CD2' ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -147.13 10.22 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.862 . . . . 2.61 109.27 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.557 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -75.52 126.71 8.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.304 -1.518 . . . . 2.32 109.304 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 138' ' ' ALA . 6.7 mtpm? -165.81 131.27 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 5.66 109.618 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.685 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -49.34 -29.89 6.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.409 -1.33 . . . . 2.71 107.409 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -96.19 7.42 66.77 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.14 -1.984 . . . . 3.14 108.14 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.52 -130.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.862 0.839 . . . . 2.84 110.743 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.686 ' CD2' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER 162.38 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 2.44 109.515 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.63 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -84.42 125.55 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 1.86 109.09 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 13.6 t80 -106.39 112.78 25.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.803 . . . . 2.48 109.285 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.7 m -113.78 96.27 5.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.1 -1.0 . . . . 0.74 110.086 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.417 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -107.96 142.91 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.69 109.221 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.602 ' H ' ' HG1' ' A' ' 71' ' ' THR . 3.5 p -134.33 -3.82 2.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.647 -0.658 . . . . 1.63 109.278 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 9.4 mt-30 -147.54 162.08 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 3.82 110.124 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.549 ' N ' ' OG1' ' A' ' 13' ' ' THR . 93.2 t -160.11 79.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.955 -0.757 . . . . 2.92 108.955 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.423 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -80.3 147.82 30.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 3.25 110.051 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 tp -151.6 112.24 4.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.426 -0.796 . . . . 5.12 109.183 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -166.66 -155.86 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 3.35 109.532 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 65' ' ' SER . 0.8 OUTLIER -144.71 -41.19 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 2.29 109.348 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.754 ' HG ' ' H ' ' A' ' 7' ' ' VAL . 1.5 p -52.24 164.92 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 2.54 109.462 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.99 96.62 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 3.09 109.545 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.683 ' HG1' ' N ' ' A' ' 4' ' ' ASP . 31.8 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.042 -0.98 . . . . 3.68 109.428 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.528 -0.545 . . . . 5.8 109.528 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.645 ' HG ' ' N ' ' A' ' 3' ' ' LEU . 25.2 t -58.19 -123.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 4.81 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.645 ' N ' ' HG ' ' A' ' 2' ' ' SER . 1.8 mm? -71.52 20.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 5.68 109.415 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 2' ' ' SER . 0.3 OUTLIER 63.46 173.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.415 -0.587 . . . . 5.38 109.415 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 4' ' ' ASP . 13.6 p 36.07 -155.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 4.83 109.512 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.83 134.21 45.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 3.43 109.433 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.637 ' C ' ' HG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER -80.33 66.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 3.0 109.496 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 4.75 109.44 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 -30.99 52.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 5.44 109.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.741 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -114.95 96.11 43.81 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 2.86 109.325 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.79 45.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.748 2.299 . . . . 4.15 112.673 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.56 ' N ' ' O ' ' A' ' 10' ' ' LEU . 54.8 t60 -133.25 107.46 8.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.98 . . . . 2.52 109.438 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER -147.28 59.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 2.33 109.465 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 16' ' ' ALA . 47.3 t -160.9 69.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 2.28 109.658 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.3 m-30 -62.57 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 2.6 109.209 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -83.44 -34.69 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 1.66 109.737 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.687 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 21.8 mm-40 -109.72 -84.71 0.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 2.13 109.344 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 20' ' ' GLY . 3.8 p -103.04 142.87 33.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 2.74 109.233 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.82 6.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.098 -1.001 . . . . 3.06 109.496 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 73.64 -148.65 40.51 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.201 -1.16 . . . . 1.72 110.201 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 22' ' ' TRP . 98.6 Cg_endo -88.94 -10.64 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.268 2.646 . . . . 1.97 111.996 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.741 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.4 m95 -54.94 -170.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 2.88 109.757 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -128.26 166.18 19.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 2.07 109.255 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.698 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -170.74 156.34 5.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 2.79 109.755 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER 158.13 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 2.48 109.803 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 89.6 -28.83 6.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.965 -1.112 . . . . 1.7 110.411 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.758 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.71 -141.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.349 . . . . 1.51 109.627 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' ' OG1' ' A' ' 27' ' ' THR . 16.3 p -91.02 133.14 35.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.459 -0.776 . . . . 2.11 109.43 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -36.99 101.34 0.22 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 2.85 109.214 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 51.5 Cg_exo -46.63 150.5 2.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.35 2.033 . . . . 1.4 111.709 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.7 t -136.57 117.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.998 . . . . 1.53 110.207 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -81.45 89.16 6.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.725 . . . . 2.56 109.763 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -63.6 -140.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 1.81 109.492 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -40.09 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 2.21 109.541 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.97 35.64 1.96 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.568 -1.413 . . . . 1.23 109.568 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.17 152.1 31.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -1.128 . . . . 3.37 109.508 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.28 134.52 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 1.4 109.303 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.71 154.23 46.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.335 -0.946 . . . . 1.06 110.471 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.5 m -123.65 134.12 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.629 -0.878 . . . . 1.95 108.629 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.671 ' N ' ' OG ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -74.99 105.85 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 4.79 109.795 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.443 HD23 ' HG1' ' A' ' 27' ' ' THR . 4.5 mm? -117.94 74.82 10.17 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 3.97 109.314 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.47 -56.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.784 2.323 . . . . 4.21 112.195 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 45' ' ' GLN . . . 161.44 -150.66 20.49 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.543 -1.423 . . . . 2.09 109.543 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.03 -0.36 6.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 2.62 109.501 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.635 ' O ' ' N ' ' A' ' 47' ' ' ASN . 2.8 mt-30 -99.38 73.63 1.88 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.256 -1.143 . . . . 2.96 109.539 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.85 49.88 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.392 -1.483 . . . . 2.38 109.392 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.674 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -160.84 87.33 1.74 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -1.114 . . . . 4.04 109.429 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.59 -9.88 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.912 2.408 . . . . 2.75 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.459 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -112.34 31.42 6.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 4.57 109.548 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 30.6 m-20 -123.02 36.78 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 2.38 109.364 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 175.46 119.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.47 109.389 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.37 -152.71 23.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.884 -1.286 . . . . 0.96 109.884 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -144.24 170.46 15.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 1.51 109.355 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.463 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -152.97 172.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.05 -1.031 . . . . 1.51 110.084 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.603 ' CZ ' ' CD1' ' A' ' 10' ' ' LEU . 58.3 t80 -178.43 148.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 2.45 109.556 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.454 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -110.93 -164.92 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 2.95 109.575 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.08 67.39 1.63 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.399 . . . . 2.52 109.604 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.454 ' N ' ' HA3' ' A' ' 127' ' ' GLY . 3.9 t -147.96 91.93 4.77 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -1.185 . . . . 4.19 109.505 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.683 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 60.9 Cg_endo -80.44 154.19 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.763 2.309 . . . . 2.79 112.128 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 59' ' ' PRO . 2.0 t -151.7 148.39 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 3.62 109.736 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -142.94 116.07 0.98 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.228 -1.549 . . . . 3.37 109.228 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.674 ' N ' ' OE2' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -34.35 146.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -1.151 . . . . 6.05 109.762 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.679 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 91.75 -16.6 58.91 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.88 -1.288 . . . . 3.09 109.88 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.671 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.6 mt-10 -112.47 160.92 17.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -1.219 . . . . 4.03 109.836 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -128.29 140.91 51.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 3.28 109.116 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 20.9 m-85 -107.07 177.13 4.95 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.077 -1.014 . . . . 2.59 109.885 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.58 165.25 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.468 -0.77 . . . . 3.18 109.593 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.3 tp -149.9 118.82 6.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 4.0 109.515 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.96 80.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 2.8 109.151 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 50.2 p90 -94.44 146.14 24.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.718 . . . . 2.64 110.831 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.17 138.48 32.81 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.642 -0.873 . . . . 2.25 108.642 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -176.24 122.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.012 -1.055 . . . . 1.45 110.142 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.429 ' HG ' ' HB2' ' A' ' 142' ' ' CYS . 1.5 p -112.44 122.5 47.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -91.24 132.65 35.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.258 -0.901 . . . . 1.07 109.85 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.478 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -135.63 113.97 11.11 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.384 -0.823 . . . . 1.68 109.28 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.578 ' O ' ' C ' ' A' ' 74' ' ' ALA . 18.7 Cg_exo -65.21 -142.25 0.15 OUTLIER 'Cis proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.321 -1.116 . . . . 1.32 112.636 -0.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.662 ' O ' ' SD ' ' A' ' 78' ' ' MET . 1.1 m-20 -108.59 154.97 21.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 1.75 109.726 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 170.34 154.44 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 2.72 109.433 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.19 129.08 12.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.778 2.319 . . . . 1.83 112.306 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.497 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 0.8 OUTLIER -106.12 -178.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 2.57 109.244 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -129.16 147.08 50.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 6.46 109.715 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -150.0 155.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 4.19 109.216 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.412 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -141.65 151.28 42.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.132 -0.98 . . . . 2.9 109.856 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.574 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -150.33 162.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 2.31 109.472 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 139.56 -147.75 19.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.708 -1.357 . . . . 1.75 109.708 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.685 ' OE2' ' CZ ' ' A' ' 119' ' ' PHE . 0.2 OUTLIER -90.41 162.45 15.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -1.114 . . . . 2.54 109.469 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.02 62.42 0.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.493 -1.443 . . . . 1.77 109.493 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.44 -157.72 7.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 2.54 109.58 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . -101.16 -97.59 2.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.528 -1.429 . . . . 4.77 109.528 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -36.09 -50.13 0.69 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -1.189 . . . . 5.79 109.415 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -59.45 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 6.33 109.463 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.718 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.92 170.9 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 6.42 109.637 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -101.9 174.18 6.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 2.66 109.877 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -127.43 -17.16 4.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.49 -0.756 . . . . 3.93 109.168 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.4 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.72 36.42 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 4.15 109.43 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -83.96 70.99 10.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 4.6 109.479 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.774 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -102.03 178.86 4.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 3.96 109.563 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.633 ' CA ' ' OE1' ' A' ' 97' ' ' GLN . . . -157.75 17.09 0.33 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.617 -1.393 . . . . 3.67 109.617 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.774 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.7 m -111.05 63.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 3.79 109.686 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.12 97.18 29.02 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 2.22 109.253 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.58 118.2 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.67 2.247 . . . . 3.49 112.667 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 102' ' ' LEU . 4.1 mm? -115.87 143.05 45.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 3.46 109.169 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.625 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -127.36 166.56 17.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 2.83 109.522 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.93 24.49 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 2.83 109.505 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.625 ' H ' ' C ' ' A' ' 103' ' ' THR . 13.3 tt0 -109.9 96.59 25.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 3.02 109.363 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.14 118.43 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.551 2.167 . . . . 1.42 112.195 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.62 ' O ' ' NE ' ' A' ' 109' ' ' ARG . . . -169.99 164.2 9.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.846 . . . . 1.81 109.439 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.29 140.24 29.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 2.19 109.859 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.724 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -105.45 134.8 47.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.842 -1.17 . . . . 5.23 107.842 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -109.11 99.79 9.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 3.28 110.893 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.3 m-30 -109.93 130.3 55.55 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.319 -0.993 . . . . 3.78 108.319 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -134.4 163.21 30.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 3.99 109.849 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.621 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -142.97 173.47 11.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 3.1 109.516 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 121.33 42.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 2.65 109.776 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 93.5 p -48.97 143.81 5.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 4.28 109.431 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.56 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 6.7 p-10 -134.31 -46.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 7.59 109.516 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 119' ' ' PHE . 5.0 tt -109.97 175.25 5.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 5.5 109.461 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.46 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -92.95 124.32 36.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 4.48 109.864 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.685 ' CZ ' ' OE2' ' A' ' 86' ' ' GLU . 45.0 m-85 -134.75 93.63 17.75 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 5.99 109.258 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.6 165.53 22.66 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.678 2.252 . . . . 4.64 112.267 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.83 -14.5 12.47 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.858 2.372 . . . . 4.46 112.079 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 2.5 p-10 -109.65 115.52 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 4.14 109.527 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . 167.64 173.17 35.5 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 4.24 109.475 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.97 26.64 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 3.59 109.499 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 123' ' ' GLY . . . 179.94 74.11 0.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 2.78 109.543 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' A' ' 127' ' ' GLY . 56.0 Cg_endo -75.31 -158.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.77 2.314 . . . . 1.57 112.249 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -39.16 163.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.587 -1.405 . . . . 1.25 109.587 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -162.28 122.22 2.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -1.181 . . . . 2.18 109.721 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.409 ' CG2' HG13 ' A' ' 84' ' ' VAL . 8.4 p -146.53 130.52 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.424 -0.954 . . . . 1.87 108.424 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' CB ' HG12 ' A' ' 54' ' ' VAL . . . -148.26 123.26 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.961 -1.087 . . . . 1.45 110.731 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.9 m-30 -86.92 118.93 26.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.807 -1.183 . . . . 2.4 107.807 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.412 ' ND1' HD21 ' A' ' 83' ' ' LEU . 6.1 m170 -99.94 131.87 45.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 2.98 110.151 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 134' ' ' GLY . 3.8 mp -134.4 -105.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 2.61 109.124 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 32.49 98.16 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.048 -1.221 . . . . 2.32 110.048 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.7 mtpt -146.68 123.67 11.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 5.66 109.857 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.16 -20.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.147 -0.97 . . . . 2.71 108.46 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -120.66 13.35 10.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.025 -1.63 . . . . 3.14 109.025 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.616 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -52.17 -152.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.967 . . . . 2.84 110.26 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 11.9 p90 -164.63 -131.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -0.99 . . . . 2.44 109.374 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.417 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 26.5 mt-10 -120.3 128.29 53.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 1.86 109.38 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 143' ' ' ILE . 5.5 t80 -107.91 111.36 23.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 2.48 109.661 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.429 ' HB2' ' HG ' ' A' ' 73' ' ' SER . 1.7 m -107.5 88.43 2.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.74 110.141 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.458 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -99.32 135.87 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 1.69 108.844 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 15' ' ' PHE . 60.0 p -128.05 -0.9 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 1.63 109.313 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 23.7 mt-30 -152.2 174.61 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 3.82 109.977 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.627 ' O ' ' CG1' ' A' ' 146' ' ' VAL . 8.0 p -177.24 92.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 2.92 109.102 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.39 144.68 31.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 3.25 110.056 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 149' ' ' THR . 8.9 tp -130.08 120.09 24.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 5.12 109.019 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.637 ' HG1' ' C ' ' A' ' 7' ' ' VAL . 2.6 t -158.06 -170.18 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 3.35 109.661 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.645 ' O ' ' CB ' ' A' ' 151' ' ' SER . 0.7 OUTLIER -139.97 -103.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 2.29 109.45 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.645 ' CB ' ' O ' ' A' ' 150' ' ' THR . 4.0 p 85.23 62.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 2.54 109.445 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 48.02 -148.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 3.09 109.47 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.969 -1.015 . . . . 3.68 109.434 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.498 -0.556 . . . . 5.8 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.795 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -87.16 -79.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 4.81 109.456 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.795 ' H ' ' HG ' ' A' ' 2' ' ' SER . 1.9 mt -143.5 157.16 44.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 5.68 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' O ' ' C ' ' A' ' 5' ' ' SER . 25.5 m-20 -93.06 -164.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 5.38 109.444 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 36.14 35.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.857 . . . . 4.83 109.462 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 5' ' ' SER . 2.6 mp0 50.62 168.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.39 -0.819 . . . . 3.43 109.476 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.645 ' H ' ' HG1' ' A' ' 149' ' ' THR . 0.7 OUTLIER -102.63 -156.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 3.0 109.368 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -175.33 86.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 4.75 109.636 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -83.97 -18.57 36.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 5.44 109.425 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.669 ' O ' ' N ' ' A' ' 12' ' ' HIS . 3.0 tm? -130.06 86.31 54.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 2.86 108.782 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.37 41.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.35 2.7 . . . . 4.15 113.509 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.669 ' N ' ' O ' ' A' ' 10' ' ' LEU . 16.8 t60 -152.26 111.69 3.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.878 -1.139 . . . . 2.52 109.463 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.541 ' OG1' ' C ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -159.89 65.65 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 2.33 109.506 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 16' ' ' ALA . 23.4 m -153.03 66.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 2.28 109.592 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -63.22 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 2.6 109.11 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.636 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -89.95 -78.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 1.66 109.915 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.16 38.61 2.25 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.247 -0.908 . . . . 2.13 109.867 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.97 150.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 2.74 109.59 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.04 -69.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 3.06 109.577 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 113.53 -172.03 14.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.408 -1.477 . . . . 1.72 109.408 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.468 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.5 Cg_endo -70.31 -10.0 27.15 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.703 2.269 . . . . 1.97 112.189 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.555 ' CH2' ' CG2' ' A' ' 146' ' ' VAL . 7.8 m95 -61.91 -169.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 2.88 109.246 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -150.37 162.27 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 2.07 109.496 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 pp -160.82 149.96 16.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 2.79 109.489 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -177.52 133.92 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 2.48 109.437 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.405 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 148.51 -40.08 0.94 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.827 -1.309 . . . . 1.7 109.827 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.817 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -110.01 -141.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 1.51 109.39 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.817 ' N ' ' OG1' ' A' ' 27' ' ' THR . 47.8 p -90.86 155.86 18.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 2.11 109.434 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -49.91 110.89 1.79 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.85 109.03 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HB3' ' SD ' ' A' ' 37' ' ' MET . 49.9 Cg_exo -47.29 171.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.192 1.928 . . . . 1.4 111.775 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.51 109.68 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.026 -1.046 . . . . 1.53 110.054 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.725 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.2 85.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 2.56 109.289 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.19 -140.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 1.81 109.74 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.609 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 7.3 p-10 -53.23 -57.0 12.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 2.21 109.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.38 44.47 0.69 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.405 -1.478 . . . . 1.23 109.405 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.46 143.96 7.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -1.118 . . . . 3.37 109.728 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.53 ' SD ' ' C ' ' A' ' 37' ' ' MET . 4.9 tmm? -110.87 124.86 52.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 1.4 109.058 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.6 m -122.12 157.98 30.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -0.902 . . . . 1.06 110.226 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 146.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 1.95 108.687 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.474 ' C ' ' CD ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -75.67 121.39 22.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 4.79 109.207 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.652 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.3 mm? -117.76 36.7 0.23 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.084 -1.01 . . . . 3.97 110.998 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 84.8 Cg_endo -80.59 -95.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.491 2.127 . . . . 4.21 111.427 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . 46.33 -107.8 0.21 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.699 -0.961 . . . . 2.09 110.699 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.4 57.31 0.01 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.44 -1.864 . . . . 2.62 108.44 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 136' ' ' ALA . 32.8 mt-30 -99.58 104.75 16.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -1.056 . . . . 2.96 110.027 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -77.55 40.42 1.79 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.408 -1.477 . . . . 2.38 109.408 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.648 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 0.3 OUTLIER -159.43 93.04 1.8 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 4.04 109.528 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.66 ' O ' ' N ' ' A' ' 50' ' ' ASP . 52.0 Cg_exo -49.6 -38.8 45.93 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.804 2.336 . . . . 2.75 112.407 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.458 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 11.8 p90 -62.68 50.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 4.57 109.527 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.3 m-20 -149.48 13.29 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 2.38 109.698 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.405 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . 175.18 152.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 1.47 109.515 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.1 176.05 24.38 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.923 -1.271 . . . . 0.96 109.923 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 53' ' ' LEU . 5.4 mt -85.18 -177.15 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -1.134 . . . . 1.51 109.205 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -162.16 159.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.151 -0.968 . . . . 1.51 110.989 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.634 ' OH ' ' CD2' ' A' ' 10' ' ' LEU . 41.2 t80 178.63 124.19 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.41 -0.589 . . . . 2.45 109.41 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -101.35 -171.23 1.95 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.24 -0.913 . . . . 2.95 109.498 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.528 ' O ' ' CG1' ' A' ' 58' ' ' VAL . . . 80.88 72.24 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.65 -1.38 . . . . 2.52 109.65 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 57' ' ' GLY . 11.0 m -161.92 68.12 2.18 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 4.19 109.413 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.36 148.59 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.854 2.369 . . . . 2.79 112.227 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.61 101.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 3.62 109.53 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -92.45 116.02 4.97 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.481 -1.448 . . . . 3.37 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.626 ' C ' ' HG ' ' A' ' 115' ' ' SER . 1.6 tm-20 -47.74 149.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.143 -1.21 . . . . 6.05 109.544 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 93.39 -24.37 25.71 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.748 -1.341 . . . . 3.09 109.748 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.721 ' H ' ' HG ' ' A' ' 115' ' ' SER . 1.4 mm-40 -101.52 164.62 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -1.172 . . . . 4.03 109.659 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.413 ' HG ' ' HA ' ' A' ' 114' ' ' THR . 47.7 m -131.34 135.27 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 3.28 109.433 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 63.0 m-85 -105.36 178.19 4.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.229 -0.92 . . . . 2.59 109.852 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 3.0 t -152.03 151.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 3.18 109.31 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tp -137.58 118.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 4.0 109.785 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -109.64 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.518 -0.919 . . . . 2.8 108.518 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.0 p90 -94.12 145.99 24.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 2.64 111.453 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -91.78 134.29 34.87 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.321 -0.992 . . . . 2.25 108.321 178.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.769 ' N ' ' NH2' ' A' ' 109' ' ' ARG . . . -164.0 113.31 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.816 -1.178 . . . . 1.45 110.395 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 p -103.48 122.6 45.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.641 -0.874 . . . . 1.28 108.641 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.566 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -93.31 135.39 34.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 1.07 109.752 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.516 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.21 112.07 6.63 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.225 -0.922 . . . . 1.68 109.717 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.7 Cg_exo -64.09 -141.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.748 0 C-N-CA 124.253 -1.145 . . . . 1.32 112.393 -0.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.48 150.71 24.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 1.75 109.757 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.715 ' CE ' ' HZ1' ' A' ' 135' ' ' LYS . 0.5 OUTLIER 173.01 154.54 0.25 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.72 109.34 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.25 140.68 22.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.767 2.311 . . . . 1.83 112.149 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.561 ' O ' ' O ' ' A' ' 98' ' ' GLY . 7.3 m -111.84 -179.55 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 2.57 109.461 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.721 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.24 151.21 44.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 6.46 109.565 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 p -154.37 154.51 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 4.19 109.536 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.705 ' CD1' HE22 ' A' ' 128' ' ' GLN . 0.8 OUTLIER -151.19 141.93 22.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.957 . . . . 2.9 109.751 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.598 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -153.34 146.36 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 2.31 109.663 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.12 -132.09 4.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.588 -1.405 . . . . 1.75 109.588 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' CD ' ' CE1' ' A' ' 119' ' ' PHE . 15.2 pt-20 -90.33 134.31 34.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 2.54 109.417 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.614 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -114.35 93.98 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.646 -1.382 . . . . 1.77 109.646 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . 166.63 119.43 0.48 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 90' ' ' ALA . . . 42.03 99.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.615 -1.394 . . . . 4.77 109.615 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 89' ' ' GLY . . . 82.51 80.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 5.79 109.461 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.528 ' O ' ' C ' ' A' ' 92' ' ' ARG . 32.9 m-85 -59.81 -2.15 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 6.33 109.489 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.528 ' C ' ' O ' ' A' ' 91' ' ' TYR . 2.8 ptp180 -35.75 150.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 6.42 109.521 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -176.83 -164.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 2.66 109.692 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.7 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.7 -25.63 10.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.614 -0.884 . . . . 3.93 108.614 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -91.17 35.99 0.92 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 4.15 108.992 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.18 43.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.079 -1.013 . . . . 4.6 109.492 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.42 114.47 28.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.264 -0.897 . . . . 3.96 109.149 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -103.57 13.94 53.98 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 3.67 109.543 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -92.6 64.02 4.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -1.124 . . . . 3.79 109.526 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.72 101.8 30.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 2.22 109.166 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.54 121.79 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.519 2.146 . . . . 3.49 112.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.45 ' CD2' ' CZ ' ' A' ' 109' ' ' ARG . 63.0 mt -127.33 130.33 49.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 3.46 109.327 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.656 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -119.73 -179.78 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 2.83 109.601 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -66.76 24.05 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.445 -1.462 . . . . 2.83 109.445 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.656 ' H ' ' C ' ' A' ' 103' ' ' THR . 6.7 tm-20 -112.17 92.98 20.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.304 -1.115 . . . . 3.02 109.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.83 118.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.66 2.24 . . . . 1.42 112.255 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.648 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . . . -166.06 162.41 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 1.81 109.406 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 146.71 23.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 2.19 109.914 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.769 ' NH2' ' N ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -109.75 134.81 51.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.66 -1.237 . . . . 5.23 107.66 177.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.54 ' OE1' ' C ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -114.35 102.26 9.94 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.93 -0.708 . . . . 3.28 110.599 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 14.8 m-85 -109.83 122.0 46.52 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.498 -0.927 . . . . 3.78 108.498 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.68 133.75 55.64 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.251 -0.906 . . . . 3.99 109.721 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.727 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -118.3 164.11 15.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 3.1 109.285 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.522 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -104.79 104.9 14.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 2.65 109.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.721 ' HG ' ' H ' ' A' ' 64' ' ' GLU . 53.7 p -35.93 107.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 4.28 109.25 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 15.7 t30 -86.04 -55.06 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 7.59 109.706 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.712 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -111.31 -158.64 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 5.5 109.804 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.712 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -117.24 150.56 38.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.363 -0.836 . . . . 4.48 109.393 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 72.8 m-85 -162.45 73.91 2.17 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.86 . . . . 5.99 109.548 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.35 167.87 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.858 2.372 . . . . 4.64 112.011 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.53 -15.66 10.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.813 2.342 . . . . 4.46 112.091 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.637 ' OD2' ' N ' ' A' ' 123' ' ' GLY . 5.5 p-10 -111.29 -113.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.888 . . . . 4.14 109.443 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.637 ' N ' ' OD2' ' A' ' 122' ' ' ASP . . . 36.12 -112.5 0.13 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.654 -1.379 . . . . 4.24 109.654 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.8 -102.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -1.16 . . . . 3.59 109.527 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.614 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -101.84 152.73 38.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 2.78 109.493 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 -158.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.838 2.359 . . . . 1.57 112.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -77.17 164.2 52.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.586 -1.406 . . . . 1.25 109.586 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.705 HE22 ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -142.36 126.24 17.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 2.18 109.439 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.09 90.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.57 -0.9 . . . . 1.87 108.57 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.62 122.14 46.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 1.45 110.45 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -84.21 117.13 23.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.422 -0.955 . . . . 2.4 108.422 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.567 ' O ' ' O ' ' A' ' 81' ' ' ARG . 13.4 m170 -99.5 119.38 37.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 2.98 110.044 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -136.59 -0.9 2.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 2.61 109.421 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.78 135.0 32.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.256 -1.538 . . . . 2.32 109.256 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.715 ' HZ1' ' CE ' ' A' ' 78' ' ' MET . 9.3 mtmt -166.81 129.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 5.66 109.552 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.02 -26.67 1.88 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.467 -1.308 . . . . 2.71 107.467 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -104.28 11.98 51.53 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.293 -1.923 . . . . 3.14 108.293 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.51 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.645 0.736 . . . . 2.84 110.641 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 179.93 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.609 -1.307 . . . . 2.44 110.715 -179.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.428 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 49.7 mt-10 -123.67 143.57 50.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 1.86 109.25 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.556 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 15.2 t80 -126.22 120.63 30.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 2.48 109.727 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -119.06 97.29 5.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.74 109.853 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.454 HG21 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -106.45 141.61 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 1.69 109.261 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.592 ' H ' ' HG1' ' A' ' 71' ' ' THR . 58.4 p -139.02 -2.62 1.66 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.617 -0.677 . . . . 1.63 109.556 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 71' ' ' THR . 14.0 mt-30 -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 3.82 110.242 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.555 ' CG2' ' CH2' ' A' ' 22' ' ' TRP . 2.8 p -160.94 73.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.004 -0.739 . . . . 2.92 109.004 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.443 ' N ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -76.48 147.1 38.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 3.25 110.18 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.6 tp -138.56 101.59 4.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.492 -0.755 . . . . 5.12 109.106 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.645 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -149.07 -176.61 5.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 3.35 109.726 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.69 ' HG1' ' N ' ' A' ' 151' ' ' SER . 1.9 t -139.06 -111.5 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 2.29 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.69 ' N ' ' HG1' ' A' ' 150' ' ' THR . 0.1 OUTLIER 64.33 -168.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 2.54 109.541 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.667 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -169.94 89.63 0.17 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.915 . . . . 3.09 109.483 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.031 -0.985 . . . . 3.68 109.479 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.453 -0.573 . . . . 5.8 109.453 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 41.73 -88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 4.81 109.475 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.648 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -85.0 155.56 21.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 5.68 109.488 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 3' ' ' LEU . 26.2 m-20 -36.17 112.95 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 5.38 109.478 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER 57.31 -156.46 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 4.83 109.452 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' N ' ' OG ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -131.53 129.74 41.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 3.43 109.468 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 t -57.91 95.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 3.0 109.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.39 104.38 16.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 4.75 109.531 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.34 -15.83 55.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 5.44 109.523 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -121.75 94.97 48.17 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 2.86 108.819 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.99 26.83 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.388 2.059 . . . . 4.15 111.548 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.516 ' H ' HD13 ' A' ' 10' ' ' LEU . 30.6 t60 -123.39 84.71 2.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 2.52 109.594 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.624 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -129.1 50.26 2.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 2.33 109.331 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.661 ' C ' ' H ' ' A' ' 16' ' ' ALA . 25.0 p -128.26 64.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 2.28 109.786 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -64.73 35.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.957 . . . . 2.6 108.967 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.661 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.35 -48.73 6.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 1.66 110.282 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.3 mm-40 -109.9 -83.51 0.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 2.13 109.87 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 m -76.95 144.5 38.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 2.74 109.662 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.407 ' CD2' HD12 ' A' ' 24' ' ' LEU . 1.6 tp -60.13 -57.86 11.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.322 -0.861 . . . . 3.06 109.487 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.3 -177.83 17.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.559 -1.416 . . . . 1.72 109.559 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.78 -5.94 16.41 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.857 2.371 . . . . 1.97 112.16 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.516 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 8.8 m95 -65.35 -164.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 2.88 109.222 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB3' ' HH ' ' A' ' 25' ' ' TYR . 1.6 m -144.58 131.88 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 2.07 109.845 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.7 148.94 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 2.79 109.452 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.694 ' HH ' ' CG1' ' A' ' 54' ' ' VAL . 0.0 OUTLIER 163.9 -168.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 2.48 109.749 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.84 -22.89 1.77 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.103 -1.199 . . . . 1.7 110.103 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.8 ' HG1' ' H ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.77 -142.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.249 . . . . 1.51 109.224 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.8 ' H ' ' HG1' ' A' ' 27' ' ' THR . 91.1 p -90.95 129.9 36.92 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.171 -0.955 . . . . 2.11 109.17 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.562 ' C ' ' O ' ' A' ' 28' ' ' SER . 18.5 mt-10 -33.93 98.53 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 2.85 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 28' ' ' SER . 54.9 Cg_exo -46.92 146.14 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.372 2.048 . . . . 1.4 111.821 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.94 116.58 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.053 . . . . 1.53 110.014 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.73 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.81 89.69 3.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.46 -0.775 . . . . 2.56 109.472 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.16 -140.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.5 -0.75 . . . . 1.81 110.295 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -69.56 15.55 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 2.21 110.358 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 33' ' ' ALA . . . 148.71 -6.75 0.89 Allowed Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.396 -1.383 . . . . 1.23 110.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.628 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.73 146.08 47.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.359 . . . . 3.37 109.803 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.572 ' SD ' ' C ' ' A' ' 37' ' ' MET . 1.6 tmm? -109.84 129.76 55.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 1.4 108.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.03 145.8 51.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 1.06 110.57 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG13 ' HG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -115.58 174.95 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.567 -0.901 . . . . 1.95 108.567 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.707 ' H ' ' HG ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -134.39 135.22 42.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.028 -1.045 . . . . 4.79 109.696 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.48 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 3.7 mm? -135.62 60.91 39.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.985 . . . . 3.97 110.489 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 41' ' ' LEU . 61.2 Cg_endo -98.38 -15.16 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.091 2.528 . . . . 4.21 112.203 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.38 -142.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.932 -0.867 . . . . 2.09 110.932 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.424 ' HA2' ' CB ' ' A' ' 136' ' ' ALA . . . -133.98 78.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.678 -1.369 . . . . 2.62 109.678 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -99.7 127.02 45.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -1.217 . . . . 2.96 109.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.77 64.81 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.579 -1.408 . . . . 2.38 109.579 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.659 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -173.56 135.19 0.66 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.152 . . . . 4.04 109.411 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.676 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 60.1 Cg_endo -75.94 -13.31 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.549 2.166 . . . . 2.75 112.375 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.691 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -111.77 38.65 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 4.57 110.002 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.691 ' OD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -119.35 38.08 3.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 2.38 109.542 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 160.39 133.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.47 109.639 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.36 -162.22 28.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.866 -1.294 . . . . 0.96 109.866 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -136.06 168.84 18.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -1.174 . . . . 1.51 109.293 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.694 ' CG1' ' HH ' ' A' ' 25' ' ' TYR . 1.5 p -155.48 164.8 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.083 -1.011 . . . . 1.51 110.137 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 63.7 t80 -178.63 141.67 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.576 -0.703 . . . . 2.45 109.656 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.691 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 8.2 m120 -88.1 -152.86 0.22 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.331 -0.856 . . . . 2.95 109.366 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.82 79.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 2.52 109.546 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.486 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 5.6 t -117.76 68.57 6.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.15 . . . . 4.19 109.562 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.05 160.7 48.69 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.716 2.277 . . . . 2.79 112.132 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.469 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 20.3 t -151.94 132.31 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 3.62 109.612 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.581 ' C ' ' HG ' ' A' ' 115' ' ' SER . . . -108.35 104.22 1.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.495 -1.442 . . . . 3.37 109.495 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.8 tm-20 -35.4 121.0 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -1.119 . . . . 6.05 109.562 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 115' ' ' SER . . . 130.66 -45.09 1.16 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.889 -1.285 . . . . 3.09 109.889 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.51 ' OE1' ' OG1' ' A' ' 153' ' ' THR . 1.5 mm-40 -100.03 171.76 7.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -1.156 . . . . 4.03 109.804 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.2 m -116.21 144.71 43.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 3.28 109.297 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.554 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 20.2 m-85 -108.28 179.43 4.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.198 -0.939 . . . . 2.59 109.773 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG12 ' CG ' ' A' ' 110' ' ' GLU . 1.4 t -150.34 141.74 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -0.766 . . . . 3.18 109.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 HD21 ' CE1' ' A' ' 70' ' ' PHE . 3.8 tp -124.59 119.9 30.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 4.0 108.883 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -115.65 90.13 3.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.031 . . . . 2.8 109.897 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.72 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.64 147.58 22.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 2.64 110.878 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.405 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -97.1 113.64 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 2.25 109.176 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -178.58 176.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.914 -1.116 . . . . 1.45 110.667 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -156.07 154.04 30.35 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.087 -0.708 . . . . 1.28 109.087 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -94.04 134.18 36.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 1.07 109.612 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.451 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.71 116.04 14.73 Favored Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.279 -0.888 . . . . 1.68 109.559 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.5 Cg_exo -65.89 -141.9 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.427 -1.072 . . . . 1.32 112.562 -0.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -91.26 151.96 20.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 1.75 109.786 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.1 mtp 161.09 157.3 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 2.72 109.347 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 64.2 Cg_endo -77.56 147.32 25.06 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.779 2.32 . . . . 1.83 112.235 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 m -113.91 170.68 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 2.57 109.425 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -109.93 151.21 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 6.46 109.352 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 97' ' ' GLN . 19.5 t -152.59 149.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 4.19 109.581 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.732 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.3 pp -150.92 145.84 25.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 2.9 109.463 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.467 HG23 ' CD2' ' A' ' 95' ' ' PHE . 1.4 t -146.49 152.06 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 2.31 109.729 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 163.64 -148.45 14.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 1.75 109.455 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.667 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 12.1 pm0 -90.14 179.1 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -1.102 . . . . 2.54 109.339 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.66 49.0 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.409 . . . . 1.77 109.576 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.35 35.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.428 . . . . 2.54 109.531 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.71 -69.49 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.512 -1.435 . . . . 4.77 109.512 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -132.55 -4.15 3.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -1.164 . . . . 5.79 109.501 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CG ' ' C ' ' A' ' 90' ' ' ALA . 5.8 m-85 68.43 -7.49 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 6.33 109.443 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.716 ' CG ' HH11 ' A' ' 92' ' ' ARG . 1.0 OUTLIER -86.29 113.07 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 6.42 109.471 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -104.37 161.41 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 2.66 109.958 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -112.26 -18.68 12.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.704 -0.85 . . . . 3.93 108.704 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.677 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.79 35.78 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 4.15 109.286 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.89 57.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 4.6 109.394 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.683 ' OE1' ' N ' ' A' ' 98' ' ' GLY . 0.1 OUTLIER -100.0 129.5 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 3.96 108.87 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 97' ' ' GLN . . . -119.21 -9.9 8.43 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.763 -1.208 . . . . 3.67 110.142 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.673 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 1.8 m -80.42 77.1 7.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.253 . . . . 3.79 109.551 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.88 85.33 22.56 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 2.22 109.593 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.73 127.28 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.976 2.451 . . . . 3.49 112.509 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.466 HD22 ' NH2' ' A' ' 109' ' ' ARG . 6.3 mt -142.28 127.56 18.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 3.46 109.379 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.751 ' HG1' ' H ' ' A' ' 104' ' ' GLY . 9.3 t -111.67 -165.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 2.83 109.733 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.751 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -84.18 31.99 3.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.438 . . . . 2.83 109.504 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.68 96.44 23.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 3.02 109.345 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -46.88 118.2 2.58 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.53 2.153 . . . . 1.42 112.248 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -169.13 169.8 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 1.81 109.491 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.25 143.85 26.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 2.19 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.719 ' CD ' ' N ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.17 131.64 51.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.79 -1.189 . . . . 5.23 107.79 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.421 ' CG ' HG12 ' A' ' 67' ' ' VAL . 14.6 tt0 -117.4 96.18 5.29 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.632 -0.827 . . . . 3.28 110.548 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 6.7 m-30 -109.46 117.24 33.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.178 -1.045 . . . . 3.78 108.178 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -115.98 174.18 6.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -0.893 . . . . 3.99 109.822 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 2.0 p90 -154.71 179.28 9.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.333 -0.854 . . . . 3.1 109.618 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.52 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -107.64 106.9 17.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.438 -0.789 . . . . 2.65 109.614 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.581 ' HG ' ' C ' ' A' ' 61' ' ' GLY . 8.2 t -36.06 116.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 4.28 109.322 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.503 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -96.95 -50.46 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 7.59 109.527 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 118' ' ' THR . 2.5 mt -112.92 -166.0 1.04 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 5.5 109.662 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.468 ' H ' HD21 ' A' ' 117' ' ' LEU . 0.7 OUTLIER -108.01 124.75 50.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 4.48 109.419 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.644 ' CE1' ' CD ' ' A' ' 86' ' ' GLU . 34.1 m-85 -137.02 66.04 53.37 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 5.99 109.472 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.64 166.9 25.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.858 2.372 . . . . 4.64 112.097 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.99 -19.66 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.763 2.309 . . . . 4.46 112.002 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -110.28 111.76 23.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 4.14 109.455 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.02 -138.06 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.575 -1.41 . . . . 4.24 109.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.12 . . . . 3.59 109.484 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.86 149.75 66.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 2.78 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.12 -158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.789 2.326 . . . . 1.57 112.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -64.93 172.29 20.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.648 -1.381 . . . . 1.25 109.648 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.6 114.36 5.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -1.129 . . . . 2.18 109.739 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 129' ' ' VAL . 0.8 OUTLIER -133.34 134.11 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.952 -1.129 . . . . 1.87 107.952 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.12 119.91 5.7 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.836 -1.146 . . . . 1.45 110.718 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.7 m-30 -83.9 120.57 26.24 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.048 -1.093 . . . . 2.4 108.048 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.732 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 1.6 m170 -99.67 116.09 30.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 2.98 109.896 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -138.45 37.44 2.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 2.61 109.162 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -92.72 110.39 3.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.437 -1.465 . . . . 2.32 109.437 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 137' ' ' GLY . 56.8 mttt -159.78 134.87 8.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -1.14 . . . . 5.66 109.856 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -37.25 -23.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.701 -0.852 . . . . 2.71 108.701 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.731 ' C ' ' H ' ' A' ' 139' ' ' TYR . . . -135.11 24.38 3.42 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.51 -1.436 . . . . 3.14 109.51 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.719 ' O ' ' CG ' ' A' ' 139' ' ' TYR . . . -52.93 7.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.299 . . . . 2.84 110.486 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.731 ' H ' ' C ' ' A' ' 137' ' ' GLY . 6.3 p90 48.32 -165.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.379 0.609 . . . . 2.44 110.751 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 4.8 mt-10 -96.99 159.59 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.86 110.459 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -129.81 102.64 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.907 -0.775 . . . . 2.48 108.907 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 7.5 m -87.06 119.25 27.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.74 110.267 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.439 HG21 ' SD ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -133.23 144.73 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.822 0.82 . . . . 1.69 109.35 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.463 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 92.9 p -136.85 -11.64 1.75 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.284 -0.567 . . . . 1.63 109.556 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -155.88 168.47 27.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.98 . . . . 3.82 109.997 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.624 ' N ' ' OG1' ' A' ' 13' ' ' THR . 7.8 p -150.37 131.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.432 -0.792 . . . . 2.92 109.26 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -115.57 150.3 36.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.089 -1.007 . . . . 3.25 109.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 149' ' ' THR . 1.7 tp -157.86 114.01 2.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 5.12 109.365 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.45 ' N ' HD12 ' A' ' 148' ' ' LEU . 9.7 t -164.36 -155.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 3.35 109.478 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.517 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -135.49 -41.05 0.71 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.93 . . . . 2.29 109.361 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.561 ' O ' ' O ' ' A' ' 152' ' ' ALA . 0.9 OUTLIER 58.21 55.65 4.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.75 . . . . 2.54 109.478 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 151' ' ' SER . . . 38.87 -164.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 3.09 109.485 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.51 ' OG1' ' OE1' ' A' ' 64' ' ' GLU . 62.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.002 -0.999 . . . . 3.68 109.48 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.312 0.577 . . . . 5.8 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.635 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 11.1 t -105.08 -139.99 0.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 4.81 109.488 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.635 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.9 mp -99.11 173.29 6.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 5.68 109.492 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 3' ' ' LEU . 10.5 t70 -35.91 130.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 5.38 109.496 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER 44.74 -169.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 4.83 109.412 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -155.87 143.01 19.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 3.43 109.537 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.65 87.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 3.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.555 ' OE2' ' N ' ' A' ' 148' ' ' LEU . 25.1 tp10 -87.52 97.02 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 4.75 109.504 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.88 -35.42 72.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 5.44 109.444 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -110.47 93.96 17.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 2.86 108.65 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.81 26.46 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.299 1.999 . . . . 4.15 111.525 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.533 ' H ' HD13 ' A' ' 10' ' ' LEU . 46.4 t60 -119.88 95.56 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 2.52 109.602 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.465 ' HG1' ' HB3' ' A' ' 145' ' ' GLN . 2.6 t -130.4 51.07 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 2.33 109.304 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.642 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.7 m -114.4 52.91 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 2.28 109.769 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.02 20.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 2.6 108.984 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.11 -65.62 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 1.66 110.009 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 18' ' ' SER . 1.4 mt-10 -109.96 38.88 2.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 2.13 109.911 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 2.5 p 170.16 144.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.161 -0.962 . . . . 2.74 109.708 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.02 -69.19 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 3.06 109.433 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.18 177.58 19.53 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.546 -1.422 . . . . 1.72 109.546 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -53.5 -21.47 18.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.762 2.308 . . . . 1.97 112.048 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.481 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 18.0 m95 -58.33 167.81 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 2.88 109.502 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.9 m -132.45 176.58 8.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 2.07 109.046 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pp -175.63 153.15 1.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 2.79 110.059 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.688 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -178.44 136.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.538 -0.726 . . . . 2.48 109.111 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 135.27 -27.68 3.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.944 -1.263 . . . . 1.7 109.944 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.769 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.66 -141.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.027 -1.278 . . . . 1.51 109.554 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.769 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.8 p -91.52 -167.17 1.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.959 -0.756 . . . . 2.11 108.959 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.57 110.61 42.43 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 2.85 108.916 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -45.37 138.24 10.31 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.228 1.952 . . . . 1.4 111.829 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 12.5 p -118.69 93.52 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 1.53 109.932 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.07 81.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.506 -0.746 . . . . 2.56 109.446 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -98.74 -109.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 1.81 109.617 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 35' ' ' GLY . 3.0 t0 -51.62 79.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 2.21 109.577 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 35.62 47.14 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.586 -1.405 . . . . 1.23 109.586 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -176.51 151.56 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 3.37 109.498 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 37' ' ' MET . 4.8 ptt? -109.46 130.94 55.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 1.4 109.803 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.447 ' H ' HG13 ' A' ' 31' ' ' VAL . 56.5 m -109.97 128.74 55.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.793 . . . . 1.06 109.563 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.1 133.04 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 1.95 109.22 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.3 m-20 -80.53 128.76 33.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 4.79 109.248 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.642 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 3.5 mm? -110.28 95.54 22.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 3.97 109.587 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.675 ' O ' ' NZ ' ' A' ' 135' ' ' LYS . 52.5 Cg_endo -78.95 144.08 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.604 2.203 . . . . 4.21 112.147 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -81.09 161.49 43.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.826 -1.31 . . . . 2.09 109.826 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.16 -7.25 1.16 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.059 -1.216 . . . . 2.62 110.059 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.457 ' OE1' ' CB ' ' A' ' 50' ' ' ASP . 41.5 mt-30 -120.69 174.3 6.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.023 -1.281 . . . . 2.96 109.785 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.97 -8.25 3.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.488 -1.445 . . . . 2.38 109.488 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.68 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -99.96 133.29 21.74 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -1.175 . . . . 4.04 109.353 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.17 1.03 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.478 2.119 . . . . 2.75 112.652 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.67 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.1 p-90 -118.53 38.39 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 4.57 110.09 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 0.8 OUTLIER -112.41 12.72 20.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.998 . . . . 2.38 109.691 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . 179.72 134.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 1.47 109.383 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.63 171.13 34.92 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.609 -1.281 . . . . 0.96 110.222 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.545 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 7.3 mt -75.65 -178.19 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -1.153 . . . . 1.51 109.31 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 53' ' ' LEU . 99.2 t -161.08 167.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 1.51 109.65 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 32.0 t80 176.22 145.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.512 -0.743 . . . . 2.45 109.414 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.577 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -107.66 171.7 7.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.936 . . . . 2.95 109.589 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.545 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 93.62 70.87 1.13 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 2.52 109.53 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 57' ' ' GLY . 43.0 t -162.41 86.79 1.45 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 4.19 109.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -79.07 162.88 25.86 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.676 2.251 . . . . 2.79 112.153 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.464 ' HA ' ' HH ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.26 114.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 3.62 109.654 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -108.6 135.31 12.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.295 -1.522 . . . . 3.37 109.295 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' HB3' ' N ' ' A' ' 118' ' ' THR . 6.5 pt-20 -72.7 139.32 47.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -1.156 . . . . 6.05 109.656 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 125.24 -50.0 0.89 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.631 -1.387 . . . . 3.09 109.631 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.97 157.76 16.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.126 -1.22 . . . . 4.03 109.654 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 150' ' ' THR . 71.0 m -100.01 134.36 43.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 3.28 109.294 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 74.8 m-85 -92.95 174.48 7.21 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 2.59 109.689 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 66' ' ' TYR . 54.4 t -162.6 118.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 3.18 109.482 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 tt -109.6 158.71 17.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 4.0 109.158 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.535 ' OG ' ' OG ' ' A' ' 147' ' ' SER . 0.2 OUTLIER -154.41 106.46 2.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 2.8 109.427 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 2.1 p90 -94.39 147.51 23.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.106 -0.996 . . . . 2.64 110.378 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -100.19 94.54 6.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.851 -0.796 . . . . 2.25 108.851 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 107' ' ' ALA . . . -163.79 -177.08 4.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.039 -1.038 . . . . 1.45 109.709 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 105' ' ' GLU . 13.2 p -164.46 136.92 4.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -0.827 . . . . 1.28 109.333 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -87.81 145.11 26.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 1.07 109.119 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 104' ' ' GLY . 0.7 OUTLIER -131.8 116.76 16.01 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 1.68 109.343 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.3 Cg_exo -66.07 -142.59 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.384 -1.09 . . . . 1.32 112.495 -0.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -95.35 151.53 19.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 1.75 109.576 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.574 ' SD ' ' CG ' ' A' ' 139' ' ' TYR . 7.4 ptm 178.21 151.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 2.72 109.511 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.674 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 56.8 Cg_endo -74.41 122.01 7.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.764 2.309 . . . . 1.83 112.233 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 m -102.39 172.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 2.57 109.476 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 79' ' ' PRO . 8.8 mpt_? -114.14 166.27 11.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 6.46 109.461 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 81' ' ' ARG . 88.5 t -160.32 156.45 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 4.19 109.311 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.545 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -159.56 148.08 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 2.9 109.441 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -150.76 148.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -0.972 . . . . 2.31 109.929 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.83 2.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.218 -1.553 . . . . 1.75 109.218 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.5 pt-20 -90.35 178.7 6.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -1.172 . . . . 2.54 109.384 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.52 38.68 1.82 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.54 -1.424 . . . . 1.77 109.54 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 122' ' ' ASP . . . 162.41 126.17 0.81 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.533 -1.427 . . . . 2.54 109.533 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . 122.61 -149.64 16.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.503 -1.439 . . . . 4.77 109.503 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -54.25 -3.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 5.79 109.494 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 3.8 m-85 53.47 1.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.898 . . . . 6.33 109.566 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.724 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -57.57 118.92 5.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 6.42 109.489 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.508 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -127.95 161.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 2.66 109.824 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.95 -19.88 12.94 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.871 -0.789 . . . . 3.93 108.871 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' CD2' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.0 39.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 4.15 109.212 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -86.73 94.26 9.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 4.6 109.83 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.682 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 6.5 pt20 -116.62 -156.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.168 -0.958 . . . . 3.96 109.164 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . 177.14 -26.05 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.981 -1.247 . . . . 3.67 109.981 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -91.87 94.81 9.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -1.226 . . . . 3.79 109.811 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.471 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -133.16 79.23 62.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 2.22 109.361 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.76 132.28 41.02 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.051 2.501 . . . . 3.49 112.657 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 mt -124.35 151.06 44.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 3.46 109.208 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 74' ' ' ALA . 13.6 t -95.26 -162.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 2.83 109.831 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 75' ' ' THR . . . -96.02 -32.92 6.54 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 2.83 109.777 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 73' ' ' SER . 1.6 mp0 -99.96 164.09 17.13 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.138 -1.213 . . . . 3.02 109.485 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.14 128.66 7.71 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.841 2.361 . . . . 1.42 112.019 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 72' ' ' ALA . . . -160.73 140.91 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 1.81 109.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.7 OUTLIER -90.99 144.29 25.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.802 . . . . 2.19 110.204 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.723 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -128.43 149.99 50.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.023 -1.473 . . . . 5.23 107.023 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -139.56 159.71 41.54 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.655 -1.218 . . . . 3.28 111.186 -178.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.682 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 7.1 m-85 -134.86 121.11 20.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.3 -1.0 . . . . 3.78 108.3 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.407 ' CB ' HG23 ' A' ' 67' ' ' VAL . . . -114.49 139.56 49.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 3.99 109.655 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -147.77 164.03 34.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 3.1 109.629 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.48 ' H ' ' HG1' ' A' ' 114' ' ' THR . 0.7 OUTLIER -97.39 112.38 24.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.422 -0.799 . . . . 2.65 109.497 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.614 ' O ' ' N ' ' A' ' 63' ' ' GLY . 6.6 t -60.83 109.18 0.99 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.957 . . . . 4.28 109.452 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -123.52 22.99 9.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 7.59 109.435 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.91 104.96 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 5.5 109.366 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.457 ' N ' ' HB3' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -51.51 107.51 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 4.48 109.45 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -124.9 92.08 48.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 5.99 109.635 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.546 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 31.9 Cg_exo -56.46 -170.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.519 2.146 . . . . 4.64 111.367 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.546 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 23.3 Cg_exo -60.74 -76.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.282 1.988 . . . . 4.46 111.283 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 88' ' ' GLY . 30.6 t0 -173.06 -163.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.123 -0.986 . . . . 4.14 109.887 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.532 ' H ' ' CG ' ' A' ' 122' ' ' ASP . . . -109.48 -35.63 2.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.195 -1.962 . . . . 4.24 108.195 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -128.93 -41.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 3.59 108.286 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -113.35 92.93 24.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.362 -0.977 . . . . 2.78 108.362 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 125' ' ' ALA . 45.3 Cg_exo -48.63 -139.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.727 2.284 . . . . 1.57 113.15 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -33.07 155.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.856 -1.298 . . . . 1.25 109.856 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -158.92 151.56 21.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.333 -1.098 . . . . 2.18 109.46 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.1 t -153.53 155.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.448 -0.945 . . . . 1.87 108.448 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -163.35 111.32 1.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.908 -1.12 . . . . 1.45 110.468 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -83.37 101.41 11.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.089 -1.078 . . . . 2.4 108.089 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.563 ' O ' ' O ' ' A' ' 81' ' ' ARG . 5.0 m170 -98.83 128.57 45.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 2.98 110.476 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.49 ' CD2' ' OH ' ' A' ' 139' ' ' TYR . 0.2 OUTLIER -112.73 -45.62 3.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.907 -0.775 . . . . 2.61 108.907 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.81 153.85 29.78 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.103 -1.199 . . . . 2.32 110.103 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' NZ ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -99.66 -143.66 0.33 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.044 . . . . 5.66 109.304 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.477 ' H ' ' HA2' ' A' ' 43' ' ' GLY . . . 67.44 -61.07 0.37 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.017 -1.105 . . . . 2.71 108.017 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -88.97 35.22 3.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.016 -2.034 . . . . 3.14 108.016 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 41' ' ' LEU . . . -28.75 151.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.868 -0.784 . . . . 2.84 110.631 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.586 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 5.1 p90 -173.99 -132.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.767 -0.827 . . . . 2.44 108.767 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 14.5 mt-10 -146.73 127.33 14.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 1.86 109.741 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 72' ' ' ALA . 66.1 t80 -117.46 106.66 13.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 2.48 109.131 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.467 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 72.4 m -109.81 120.58 42.93 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.084 -1.01 . . . . 0.74 110.546 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.36 146.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.76 . . . . 1.69 109.052 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.482 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 93.3 p -126.75 -10.04 6.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.962 -0.755 . . . . 1.63 108.962 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.57 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -161.9 167.24 25.03 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.607 -0.837 . . . . 3.82 109.813 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' A' ' 146' ' ' VAL . 9.3 p -149.38 123.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 2.92 109.382 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.535 ' OG ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -105.57 165.69 10.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.177 -0.952 . . . . 3.25 109.592 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.555 ' N ' ' OE2' ' A' ' 8' ' ' GLU . 10.0 tp -173.87 120.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 5.12 109.428 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.669 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.5 OUTLIER 179.0 -156.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 3.35 109.475 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.731 ' HG1' ' H ' ' A' ' 151' ' ' SER . 8.8 t -131.32 -123.7 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 2.29 109.531 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.731 ' H ' ' HG1' ' A' ' 150' ' ' THR . 5.0 p -166.1 66.97 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 2.54 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.34 -160.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 3.09 109.445 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.979 -1.01 . . . . 3.68 109.475 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.307 0.575 . . . . 5.8 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.689 ' HG ' ' N ' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -111.39 -140.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 4.81 109.452 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 2' ' ' SER . 2.8 mp 37.16 -161.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 5.68 109.441 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.414 ' HB3' ' CG ' ' A' ' 64' ' ' GLU . 5.4 m-20 60.3 47.11 9.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 5.38 109.433 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.715 ' HG ' ' N ' ' A' ' 6' ' ' GLU . 2.5 p -178.82 -151.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 4.83 109.452 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 8' ' ' GLU . 3.8 mt-10 -115.4 17.77 16.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 3.43 109.985 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.74 ' N ' ' OG1' ' A' ' 149' ' ' THR . 2.1 p 28.82 29.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.687 0.756 . . . . 3.0 109.497 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.777 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.6 mt-10 159.25 84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.31 -0.626 . . . . 4.75 109.31 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mp -91.52 17.03 9.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.223 -0.923 . . . . 5.44 109.16 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 12' ' ' HIS . 3.1 tm? -175.27 96.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 2.86 109.155 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.66 43.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.05 2.5 . . . . 4.15 113.396 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.577 ' N ' ' O ' ' A' ' 10' ' ' LEU . 9.8 t60 -162.84 103.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 2.52 109.492 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.543 ' OG1' ' C ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -150.42 45.17 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 2.33 109.367 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 16' ' ' ALA . 2.0 t -140.24 93.71 2.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 2.28 109.562 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 144' ' ' SER . 8.6 m-85 -75.91 39.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 2.6 109.196 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.03 -33.08 16.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.66 109.756 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.685 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 22.2 mt-10 -109.85 -76.66 0.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 2.13 109.63 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -111.87 143.93 42.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 2.74 109.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.8 pt? -49.36 -33.76 14.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 3.06 109.591 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' H ' HD23 ' A' ' 19' ' ' LEU . . . 91.08 -159.71 26.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 1.72 109.5 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.09 -9.18 17.87 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.72 2.28 . . . . 1.97 112.233 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.472 ' CZ2' HG12 ' A' ' 146' ' ' VAL . 13.8 m95 -68.44 150.25 48.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 2.88 109.006 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -109.89 170.29 8.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 2.07 110.058 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.649 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.4 pp -176.57 165.05 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 2.79 109.6 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.758 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.35 -165.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 2.48 109.503 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.43 -21.14 2.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.197 -1.161 . . . . 1.7 110.197 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.765 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.71 -143.64 0.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.28 . . . . 1.51 109.459 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.765 ' N ' ' OG1' ' A' ' 27' ' ' THR . 49.4 p -92.13 -159.07 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.293 -0.879 . . . . 2.11 108.85 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -90.36 127.34 53.36 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 2.85 108.593 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -69.01 135.79 33.23 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.02 1.813 . . . . 1.4 111.495 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.73 110.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 1.53 110.362 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.82 73.76 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 2.56 109.238 178.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.14 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 1.81 109.901 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 12.4 t70 -45.72 83.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 2.21 109.521 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 42.37 35.16 1.81 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.535 -1.426 . . . . 1.23 109.535 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.457 ' NE ' ' HB3' ' A' ' 34' ' ' ASP . 9.6 ptp180 -148.46 142.58 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 3.37 109.666 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.618 ' SD ' ' C ' ' A' ' 37' ' ' MET . 14.7 tmm? -112.68 127.73 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 1.4 109.578 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.661 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -122.57 138.52 54.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.838 . . . . 1.06 109.858 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.18 150.85 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.415 -0.957 . . . . 1.95 108.415 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.542 ' OD2' ' OG ' ' A' ' 28' ' ' SER . 21.9 m-20 -81.06 119.69 23.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.1 -1.0 . . . . 4.79 109.348 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.669 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 3.0 mm? -116.37 32.79 0.16 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.092 -1.005 . . . . 3.97 110.736 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 86.1 Cg_endo -81.07 -97.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.194 1.929 . . . . 4.21 111.697 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.435 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . 54.21 -96.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.424 -1.07 . . . . 2.09 110.424 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.71 48.84 0.04 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.425 -1.87 . . . . 2.62 108.425 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.674 ' O ' ' N ' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -99.73 116.26 31.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.463 -1.022 . . . . 2.96 109.857 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -76.18 52.75 3.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.524 -1.43 . . . . 2.38 109.524 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.67 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -161.19 134.73 4.84 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.227 -1.16 . . . . 4.04 109.462 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 63.1 Cg_endo -76.83 0.35 9.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.605 2.203 . . . . 2.75 112.724 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.468 ' HA ' ' CE1' ' A' ' 132' ' ' HIS . 5.2 p90 -110.15 67.88 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 4.57 109.649 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 1.2 m-20 -140.18 -31.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 2.38 109.763 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.87 163.88 38.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 1.47 109.605 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.9 171.49 14.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.875 -1.29 . . . . 0.96 109.875 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.472 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.8 pp -107.41 145.82 32.47 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -1.14 . . . . 1.51 109.162 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -131.19 169.83 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.951 . . . . 1.51 110.068 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 40.5 t80 -171.09 143.3 1.93 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.495 -0.753 . . . . 2.45 109.42 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -113.16 -167.28 1.17 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.302 -0.874 . . . . 2.95 109.397 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.7 55.62 2.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.64 -1.384 . . . . 2.52 109.64 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.411 ' CG2' HD23 ' A' ' 148' ' ' LEU . 1.1 p -149.08 100.5 3.41 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 4.19 109.421 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.93 126.96 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.49 2.126 . . . . 2.79 112.018 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -103.19 74.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.92 . . . . 3.62 109.813 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -84.71 90.64 1.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.953 -1.659 . . . . 3.37 108.953 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -34.56 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -1.127 . . . . 6.05 109.884 -179.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.73 -67.18 0.56 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.638 -1.385 . . . . 3.09 109.638 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' A' ' 4' ' ' ASP . 7.3 mp0 -100.0 170.68 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -1.152 . . . . 4.03 109.632 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 m -99.98 139.41 35.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 3.28 109.323 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.05 177.64 4.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -0.98 . . . . 2.59 109.846 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -150.63 137.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 3.18 109.634 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tp -119.94 115.1 23.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 4.0 109.106 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -112.98 100.29 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 2.8 109.33 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -94.1 135.04 35.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 2.64 110.599 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.679 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 10.9 p -93.49 94.22 8.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.441 -0.948 . . . . 2.25 108.441 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -165.36 164.2 19.77 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.617 -1.233 . . . . 1.45 110.624 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -139.81 146.61 39.63 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.843 -0.799 . . . . 1.28 108.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -84.6 133.8 34.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 1.07 109.358 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.506 ' O ' ' CD ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.71 115.74 15.83 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.37 -0.831 . . . . 1.68 109.062 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -67.1 -142.2 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.605 0 C-N-CA 124.311 -1.12 . . . . 1.32 112.298 0.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.64 149.36 22.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 1.75 109.613 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.5 mtt 159.73 163.47 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 2.72 109.372 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.33 150.78 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.877 2.384 . . . . 1.83 112.224 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.23 169.0 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 2.57 109.393 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 132' ' ' HIS . 13.5 ttt180 -114.2 137.68 51.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 6.46 109.52 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.81 149.45 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.341 -0.85 . . . . 4.19 109.38 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -147.5 147.09 29.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 2.9 109.752 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.567 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.2 t -151.8 149.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 2.31 109.614 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 160.62 -147.03 13.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.584 -1.407 . . . . 1.75 109.584 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.667 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.1 pm0 -90.04 176.85 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -1.162 . . . . 2.54 109.547 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.72 22.87 4.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.603 -1.399 . . . . 1.77 109.603 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -166.32 148.13 13.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 2.54 109.558 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' GLY . . . 56.35 145.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.547 -1.421 . . . . 4.77 109.547 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.634 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . 36.26 76.26 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -1.122 . . . . 5.79 109.445 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -64.82 15.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 6.33 109.521 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.634 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -86.03 116.99 24.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 6.42 109.46 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.567 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -105.42 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 2.66 109.951 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.444 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.88 -24.8 10.64 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.771 -0.826 . . . . 3.93 108.771 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -91.03 33.84 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 4.15 109.186 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.84 59.25 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 4.6 109.582 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.6 tt0 -103.07 156.4 17.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 3.96 109.134 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -145.87 8.54 1.53 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.696 -1.362 . . . . 3.67 109.696 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.33 59.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -1.165 . . . . 3.79 109.589 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.54 107.37 50.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 2.22 109.204 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -78.04 134.36 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.528 2.152 . . . . 3.49 112.544 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 mt -131.2 156.63 45.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 3.46 109.411 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -103.44 -155.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 2.83 109.512 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.634 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -113.45 30.76 7.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 2.83 109.523 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -154.41 149.89 21.12 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -1.179 . . . . 3.02 109.379 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.26 126.2 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.872 2.381 . . . . 1.42 112.106 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.504 ' CB ' ' NH1' ' A' ' 109' ' ' ARG . . . -163.34 132.84 4.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 1.81 109.655 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.35 141.39 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 2.19 110.395 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.504 ' NH1' ' CB ' ' A' ' 107' ' ' ALA . 3.9 mpt_? -120.16 143.61 48.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.317 -1.364 . . . . 5.23 107.317 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -128.88 112.74 14.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.977 . . . . 3.28 110.838 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 4.5 m-30 -113.44 115.28 27.8 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.201 -1.037 . . . . 3.78 108.201 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.96 171.87 7.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.277 -0.889 . . . . 3.99 110.024 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -173.14 175.45 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 3.1 109.673 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.501 ' H ' ' HG1' ' A' ' 114' ' ' THR . 0.7 OUTLIER -87.7 113.19 23.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 2.65 109.751 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.8 t -52.82 110.03 0.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 4.28 109.39 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 114' ' ' THR . 30.4 m120 -129.14 28.61 5.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.838 . . . . 7.59 109.505 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 60' ' ' VAL . 4.6 tp -133.4 118.47 18.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 5.5 109.398 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -77.59 127.38 32.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.881 . . . . 4.48 109.558 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 8.4 m-85 -163.52 94.63 1.08 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 5.99 109.363 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.67 165.78 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.604 2.203 . . . . 4.64 112.259 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.0 -14.93 12.03 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.815 2.343 . . . . 4.46 112.044 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.84 121.67 45.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 4.14 109.478 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.67 -175.42 19.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 4.24 109.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.533 ' O ' ' C ' ' A' ' 88' ' ' GLY . 6.7 m-20 -79.93 53.5 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 3.59 109.454 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -178.03 65.69 0.19 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.78 109.464 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.12 -158.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.874 2.383 . . . . 1.57 112.301 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.95 157.29 39.15 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.538 -1.425 . . . . 1.25 109.538 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.667 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -146.94 126.58 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 2.18 109.878 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.42 85.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.66 -0.867 . . . . 1.87 108.66 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' HB3' ' CD1' ' A' ' 83' ' ' LEU . . . -103.31 127.1 50.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 1.45 110.56 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' A' ' 53' ' ' LEU . 2.9 m-30 -105.12 96.75 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.295 -1.002 . . . . 2.4 108.295 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.468 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 9.3 m170 -99.39 138.37 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 2.98 110.238 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -141.83 6.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 2.61 109.21 179.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -62.11 147.51 48.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.572 -1.411 . . . . 2.32 109.572 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.624 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 0.4 OUTLIER 179.48 132.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -1.09 . . . . 5.66 109.339 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -47.14 -24.3 0.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.765 -1.198 . . . . 2.71 107.765 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.611 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -106.29 8.55 41.41 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.577 -1.809 . . . . 3.14 108.577 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -49.12 -163.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.919 . . . . 2.84 110.023 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD2' ' C ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -173.73 -112.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 2.44 109.94 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.506 ' CD ' ' O ' ' A' ' 75' ' ' THR . 2.2 mp0 -129.61 153.79 47.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.754 -1.216 . . . . 1.86 109.678 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.661 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 26.7 t80 -136.29 126.49 26.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.226 -0.921 . . . . 2.48 109.721 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.85 98.61 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.74 110.185 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.466 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -109.81 143.82 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.405 -0.809 . . . . 1.69 108.883 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 15' ' ' PHE . 95.4 p -128.89 -18.1 3.85 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.075 -0.65 . . . . 1.63 109.409 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.679 ' N ' ' OG1' ' A' ' 71' ' ' THR . 4.2 mt-30 -152.74 166.79 31.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.173 -1.011 . . . . 3.82 110.61 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.543 ' C ' ' OG1' ' A' ' 13' ' ' THR . 7.3 p -169.92 91.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.917 -0.772 . . . . 2.92 108.917 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.73 140.67 29.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 3.25 110.482 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.411 HD23 ' CG2' ' A' ' 58' ' ' VAL . 6.9 tp -124.23 94.82 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.608 -0.886 . . . . 5.12 108.608 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.74 ' OG1' ' N ' ' A' ' 7' ' ' VAL . 8.2 t 177.87 -144.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 3.35 109.156 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.632 ' CG2' ' OG ' ' A' ' 5' ' ' SER . 9.1 t -125.97 -160.8 1.0 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.109 -0.994 . . . . 2.29 109.658 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.63 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.4 OUTLIER 84.37 110.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.366 -0.833 . . . . 2.54 109.388 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.689 ' N ' ' HG ' ' A' ' 2' ' ' SER . . . -156.21 94.18 1.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 3.09 109.541 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.977 -1.011 . . . . 3.68 109.472 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.425 -0.583 . . . . 5.8 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.692 ' HG ' ' N ' ' A' ' 3' ' ' LEU . 44.8 p -80.76 -139.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 4.81 109.505 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.692 ' N ' ' HG ' ' A' ' 2' ' ' SER . 0.6 OUTLIER -44.72 165.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 5.68 109.439 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 3' ' ' LEU . 7.3 m-20 -36.42 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 5.38 109.527 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER 58.36 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 4.83 109.491 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -36.48 125.17 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 3.43 109.496 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.17 88.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 3.0 109.397 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.12 100.4 13.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 4.75 109.551 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.56 -8.63 56.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 5.44 109.496 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 12' ' ' HIS . 1.3 tm? -140.96 85.93 11.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 2.86 108.797 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.58 40.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.996 2.464 . . . . 4.15 112.22 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.558 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 19.6 t60 -143.11 123.1 13.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 2.52 109.641 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.567 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -170.1 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -0.858 . . . . 2.33 109.199 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.645 ' C ' ' H ' ' A' ' 16' ' ' ALA . 46.2 m -109.94 63.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 2.28 109.719 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -66.5 21.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 2.6 109.188 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.07 -63.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 1.66 109.939 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' SER . 3.4 mm-40 -111.73 39.87 2.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 2.13 109.912 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 1.9 m 160.39 147.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 2.74 109.79 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 -72.04 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 3.06 109.608 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 118.98 -167.48 13.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.515 -1.434 . . . . 1.72 109.515 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 17.1 Cg_exo -62.02 -20.14 68.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.567 2.178 . . . . 1.97 111.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 13.8 m95 -65.46 -166.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 2.88 109.414 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -150.29 174.65 12.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 2.07 109.619 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.662 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 54.7 tp -170.85 148.1 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 2.79 109.451 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.745 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 165.04 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 2.48 109.691 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 79.31 -22.09 3.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.849 -1.3 . . . . 1.7 109.849 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.94 -142.01 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -1.213 . . . . 1.51 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.1 p -90.67 136.91 32.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 2.11 109.163 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 28' ' ' SER . 51.9 mm-40 -32.5 97.03 0.1 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 2.85 109.732 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 28' ' ' SER . 32.1 Cg_exo -53.13 163.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 1.4 111.342 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 30' ' ' PRO . 97.0 t -154.17 134.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.155 . . . . 1.53 110.742 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -90.07 85.91 6.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.583 0.706 . . . . 2.56 109.407 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.52 -139.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.81 109.996 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.55 76.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.406 -0.809 . . . . 2.21 110.059 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 55.49 23.38 34.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.942 -1.263 . . . . 1.23 109.942 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 33' ' ' ALA . 2.2 ptp180 -136.25 143.15 44.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -1.211 . . . . 3.37 109.435 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.77 ' SD ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -114.61 148.4 38.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 1.4 109.411 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.77 ' N ' ' SD ' ' A' ' 37' ' ' MET . 3.8 t -157.03 163.37 39.13 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.574 -0.85 . . . . 1.06 110.17 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 m -136.14 150.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.265 -1.013 . . . . 1.95 108.265 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -97.9 99.25 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 4.79 110.183 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 8.5 mp -113.15 91.09 17.77 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 3.97 109.12 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.45 -87.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.906 2.404 . . . . 4.21 112.318 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.2 96.19 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.441 . . . . 2.09 109.499 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.47 31.96 0.05 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.515 -1.434 . . . . 2.62 109.515 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.453 ' NE2' ' HA3' ' A' ' 134' ' ' GLY . 2.9 mt-30 -99.99 174.19 6.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -1.173 . . . . 2.96 109.41 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.66 -41.88 8.06 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 2.38 109.502 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' OD2' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -167.01 157.54 10.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 4.04 109.426 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.51 -39.87 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.842 2.361 . . . . 2.75 112.211 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.608 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 4.9 p90 -91.9 55.33 2.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.917 . . . . 4.57 109.47 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.649 ' OD2' ' N ' ' A' ' 47' ' ' ASN . 70.4 m-20 -128.33 1.94 5.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 2.38 109.458 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.419 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -175.31 172.95 2.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 1.47 109.509 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.42 -164.38 23.47 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.586 -1.405 . . . . 0.96 109.586 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 131' ' ' PHE . 1.1 pp -109.73 161.77 15.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -1.093 . . . . 1.51 109.2 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 2.1 t -152.21 161.12 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 1.51 109.769 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 33.1 t80 -175.31 147.79 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 2.45 109.476 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.681 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.3 m-80 -107.16 160.94 15.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.263 -0.898 . . . . 2.95 109.396 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.75 74.15 0.67 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 2.52 109.577 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -155.45 66.2 4.64 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.247 -1.149 . . . . 4.19 109.439 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.63 137.01 41.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.759 2.306 . . . . 2.79 112.155 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 10.6 t -135.66 139.99 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 3.62 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -107.73 117.17 5.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.51 -1.436 . . . . 3.37 109.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -45.69 128.03 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 6.05 109.526 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 113.25 -25.77 11.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.686 -1.366 . . . . 3.09 109.686 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . 4.9 mt-10 -100.05 173.58 6.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -1.163 . . . . 4.03 109.646 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 3.28 109.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 60' ' ' VAL . 41.7 m-85 -104.36 -179.63 4.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.268 -0.895 . . . . 2.59 109.592 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -160.93 143.84 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 3.18 109.668 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.52 118.46 24.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 4.0 109.512 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.51 94.59 5.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 2.8 109.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 4.4 p90 -93.64 147.01 23.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.096 -1.002 . . . . 2.64 110.954 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.3 p -95.02 112.56 24.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.188 -1.041 . . . . 2.25 108.188 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -165.51 153.71 11.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.696 -1.253 . . . . 1.45 110.797 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.52 148.67 49.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.713 -0.847 . . . . 1.28 108.713 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' N ' ' O ' ' A' ' 103' ' ' THR . . . -113.13 124.79 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 1.07 109.984 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.606 ' CA ' ' H ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -130.72 132.79 24.17 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.309 -0.869 . . . . 1.68 108.704 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.611 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.5 Cg_exo -73.15 27.7 0.43 Allowed 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 124.665 -0.973 . . . . 1.32 112.779 -0.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.716 ' O ' ' SD ' ' A' ' 78' ' ' MET . 2.4 m-20 89.29 152.52 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.514 -0.551 . . . . 1.75 109.514 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.716 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 161.54 174.57 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.965 -1.124 . . . . 2.72 107.965 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.548 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 10.5 Cg_endo -81.98 145.74 14.18 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.454 2.102 . . . . 1.83 112.218 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.566 ' O ' ' O ' ' A' ' 98' ' ' GLY . 7.5 m -113.58 159.15 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 2.57 109.719 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.726 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.12 123.5 49.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 6.46 109.236 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.18 149.09 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 4.19 109.521 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 1.3 pp -145.67 144.41 30.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.9 109.664 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -151.82 151.48 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 2.31 109.781 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.52 -137.6 5.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.451 -1.46 . . . . 1.75 109.451 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 89' ' ' GLY . 3.3 pt-20 -88.52 -165.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 2.54 109.446 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.9 50.34 0.49 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.56 -1.416 . . . . 1.77 109.56 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -162.03 -150.86 6.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 2.54 109.587 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . -44.88 166.63 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 4.77 109.51 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.629 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . 43.31 74.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -1.157 . . . . 5.79 109.468 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -65.5 15.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 6.33 109.461 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.629 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -60.93 122.73 15.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.243 -0.91 . . . . 6.42 109.481 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -128.28 167.95 16.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 2.66 109.892 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.548 ' N ' ' HG1' ' A' ' 93' ' ' THR . . . -109.92 -23.15 11.51 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.651 -0.87 . . . . 3.93 108.651 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.99 36.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.358 -0.839 . . . . 4.15 108.945 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -84.5 44.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 4.6 109.595 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.581 ' CG ' ' O ' ' A' ' 97' ' ' GLN . 10.1 pt20 -102.4 121.18 41.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 3.96 109.341 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -111.24 6.3 28.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.587 -1.405 . . . . 3.67 109.587 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.37 77.26 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -1.139 . . . . 3.79 109.514 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . . . -116.98 81.8 12.75 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.117 -0.99 . . . . 2.22 109.448 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 45.2 Cg_exo -52.09 143.05 42.76 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.845 2.363 . . . . 3.49 112.29 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.447 HD23 ' NH1' ' A' ' 109' ' ' ARG . 14.0 mt -143.58 154.19 43.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 3.46 109.505 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.44 -162.4 0.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.83 109.608 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.676 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -102.1 -9.68 41.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.64 -1.384 . . . . 2.83 109.64 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.549 ' OE2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -99.89 134.46 20.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.181 -1.188 . . . . 3.02 108.957 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.549 ' O ' ' OE2' ' A' ' 105' ' ' GLU . 85.7 Cg_exo -37.27 117.55 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 1.42 112.139 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.43 137.08 16.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 1.81 109.674 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.428 ' CG2' HG21 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.07 152.5 20.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 2.19 109.831 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.718 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -129.36 138.92 51.81 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.051 -1.092 . . . . 5.23 108.051 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.628 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -120.57 118.45 30.24 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.759 -0.776 . . . . 3.28 110.671 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.483 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 7.3 m-85 -115.16 118.83 34.44 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.549 -0.908 . . . . 3.78 108.549 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.85 146.64 32.0 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 3.99 109.948 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.739 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -129.71 163.35 26.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 3.1 109.32 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.53 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -97.96 104.44 16.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 2.65 109.63 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.4 m -37.16 104.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 4.28 109.305 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.15 14.72 27.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 7.59 109.556 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 118' ' ' THR . 8.3 tt -169.21 171.86 7.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 5.5 109.444 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.559 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -95.26 114.84 26.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.175 -0.953 . . . . 4.48 109.697 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 117' ' ' LEU . 55.5 m-85 -110.58 94.53 19.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 5.99 109.402 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.26 158.18 23.05 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.611 2.207 . . . . 4.64 112.196 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.34 -27.53 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.723 2.282 . . . . 4.46 111.948 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 19.3 p-10 -109.96 -163.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 4.14 109.478 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . 66.23 169.3 3.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.573 -1.411 . . . . 4.24 109.573 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.22 45.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 3.59 109.423 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 123' ' ' GLY . . . -163.18 55.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 2.78 109.54 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 47.5 Cg_endo -72.91 -158.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.827 2.352 . . . . 1.57 112.189 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -86.91 157.06 29.26 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.542 -1.423 . . . . 1.25 109.542 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -141.91 114.48 8.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -1.178 . . . . 2.18 109.582 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.491 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 2.5 t -131.66 128.5 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 1.87 108.853 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.0 114.56 3.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 1.45 110.101 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.481 ' CD2' HD23 ' A' ' 53' ' ' LEU . 4.9 m-30 -92.21 119.38 31.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.645 -0.872 . . . . 2.4 108.645 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 42.0 m170 -105.4 127.1 52.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 2.98 109.623 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -128.87 -34.67 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 2.61 109.468 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.54 127.16 0.57 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.651 -1.38 . . . . 2.32 109.651 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.678 ' O ' ' N ' ' A' ' 137' ' ' GLY . 16.4 mttt -166.99 130.71 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 5.66 109.73 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.36 -19.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.095 -1.076 . . . . 2.71 108.095 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.1 17.11 7.14 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.815 -1.714 . . . . 3.14 108.815 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.622 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -51.43 -151.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.943 . . . . 2.84 110.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.549 ' OH ' ' CG1' ' A' ' 80' ' ' VAL . 2.7 p90 -171.91 -161.82 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 2.44 109.511 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.57 142.85 26.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 1.86 109.718 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.559 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 31.1 t80 -128.07 107.61 9.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.481 -0.762 . . . . 2.48 109.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 69.8 m -110.36 102.84 11.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.11 -0.994 . . . . 0.74 110.989 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.469 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -120.88 144.43 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.486 -0.931 . . . . 1.69 108.486 178.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 143' ' ' ILE . 29.6 p -121.91 -8.7 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.95 -0.7 . . . . 1.63 109.815 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.582 ' O ' ' OG1' ' A' ' 71' ' ' THR . 11.9 pt20 -168.9 176.77 5.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.649 -1.22 . . . . 3.82 111.023 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.564 ' O ' ' OG1' ' A' ' 13' ' ' THR . 7.3 p -170.42 159.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.073 -0.714 . . . . 2.92 109.073 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.74 158.54 44.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 3.25 109.78 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 149' ' ' THR . 1.1 pp -143.72 155.22 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 5.12 109.428 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.78 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 3.35 109.546 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.664 ' N ' ' OG1' ' A' ' 149' ' ' THR . 4.7 t -126.73 -121.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 2.29 109.493 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.602 ' H ' ' HG1' ' A' ' 150' ' ' THR . 0.2 OUTLIER 177.34 161.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 2.54 109.434 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.14 95.3 9.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 3.09 109.421 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.022 -0.99 . . . . 3.68 109.516 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.558 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.452 -0.573 . . . . 5.8 109.452 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -57.68 -139.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 4.81 109.461 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 5' ' ' SER . 1.0 OUTLIER 38.47 -160.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 5.68 109.426 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' LEU . 8.1 m-20 42.63 19.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 5.38 109.455 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -177.23 -155.96 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 4.83 109.47 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 7' ' ' VAL . 5.9 pm0 -171.69 89.53 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.838 . . . . 3.43 109.447 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 6' ' ' GLU . 2.3 t -43.2 142.25 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 3.0 109.393 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -125.67 86.13 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 4.75 109.479 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.46 -33.84 74.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 5.44 109.395 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER -108.17 95.43 15.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.632 -0.877 . . . . 2.86 108.632 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.39 49.1 1.35 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.081 1.854 . . . . 4.15 111.983 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.572 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 82.0 t60 -152.77 129.46 10.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.391 -0.818 . . . . 2.52 109.639 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -167.45 57.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 2.33 109.492 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.8 t -151.22 67.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 2.28 109.552 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -62.64 39.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 2.6 109.091 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -86.79 -36.84 18.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 1.66 109.858 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.691 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 15.3 mm-40 -111.7 -57.73 2.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 2.13 109.581 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 p -128.2 143.54 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 2.74 109.468 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 19' ' ' LEU . 1.8 pt? -55.36 -15.98 3.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 3.06 109.465 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 83.43 -154.37 31.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.571 -1.411 . . . . 1.72 109.571 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.47 -11.51 15.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 1.97 112.089 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.481 ' HE1' HD13 ' A' ' 10' ' ' LEU . 10.9 m95 -65.14 -163.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 2.88 109.307 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -156.58 164.0 38.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 2.07 109.313 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.623 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -168.38 160.07 11.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 2.79 109.803 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.73 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 167.04 177.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 2.48 109.558 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 92.26 -23.44 27.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.941 -1.264 . . . . 1.7 109.941 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.785 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.86 -142.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.24 . . . . 1.51 109.271 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.785 ' N ' ' OG1' ' A' ' 27' ' ' THR . 33.4 p -91.09 130.19 37.01 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.185 -0.947 . . . . 2.11 109.096 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.554 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -35.81 100.44 0.2 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 2.85 109.176 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' N ' ' O ' ' A' ' 28' ' ' SER . 64.2 Cg_exo -46.11 154.07 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.381 2.054 . . . . 1.4 111.643 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 t -138.53 115.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.996 -1.065 . . . . 1.53 110.395 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.45 84.28 3.18 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.534 0.683 . . . . 2.56 109.218 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -78.39 -119.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.425 -0.797 . . . . 1.81 110.229 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.772 ' H ' HH12 ' A' ' 36' ' ' ARG . 22.5 t0 -58.36 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.21 110.15 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 64.04 8.28 28.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.748 -1.341 . . . . 1.23 109.748 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.772 HH12 ' H ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -126.91 144.45 50.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -1.233 . . . . 3.37 109.604 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.574 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -109.87 130.44 55.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 1.4 109.015 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -127.77 153.51 46.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.44 -0.904 . . . . 1.06 110.593 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.5 m -122.69 163.43 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.351 -0.981 . . . . 1.95 108.351 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.613 ' N ' ' OG ' ' A' ' 28' ' ' SER . 34.3 m-20 -107.78 102.54 11.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 4.79 110.189 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.547 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.2 mm? -126.33 48.23 2.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 3.97 109.265 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 76.9 Cg_exo -39.02 -71.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.904 2.402 . . . . 4.21 112.34 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.7 77.85 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 2.09 109.545 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.87 28.69 0.23 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.477 -1.449 . . . . 2.62 109.477 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.405 ' NE2' ' HB3' ' A' ' 50' ' ' ASP . 8.7 mm-40 -99.95 144.04 29.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 2.96 109.501 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.29 -66.18 1.89 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.55 -1.42 . . . . 2.38 109.55 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.772 ' ND2' ' NE1' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -99.89 156.72 35.01 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.172 -1.193 . . . . 4.04 109.518 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 50' ' ' ASP . 46.3 Cg_endo -72.63 -33.52 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.827 2.351 . . . . 2.75 112.314 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.772 ' NE1' ' ND2' ' A' ' 47' ' ' ASN . 28.7 p90 -73.65 21.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 4.57 109.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 23.2 m-20 -102.49 26.57 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 2.38 109.51 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 168.99 129.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 1.47 109.488 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.29 163.96 13.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.8 -1.32 . . . . 0.96 109.8 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -92.03 -169.31 2.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -1.098 . . . . 1.51 109.341 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 1.5 p -174.32 165.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.288 -0.883 . . . . 1.51 110.182 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.692 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 16.5 t80 173.16 140.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.511 -0.743 . . . . 2.45 109.405 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.692 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -102.5 -177.24 3.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.185 -0.947 . . . . 2.95 109.618 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.37 61.81 1.37 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.626 -1.389 . . . . 2.52 109.626 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.556 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 4.8 m -152.56 60.34 3.35 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 4.19 109.415 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 54.4 Cg_exo -47.22 146.9 6.14 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.875 2.383 . . . . 2.79 112.192 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.03 92.36 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 3.62 109.502 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -84.66 111.35 3.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 3.37 109.513 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.56 123.53 13.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -1.104 . . . . 6.05 109.466 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.79 -44.41 1.18 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 3.09 109.669 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.57 ' O ' ' OG ' ' A' ' 115' ' ' SER . 7.2 mt-10 -100.01 -179.98 4.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -1.152 . . . . 4.03 109.634 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' OG1' ' A' ' 150' ' ' THR . 69.7 m -128.19 138.32 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.386 -0.821 . . . . 3.28 109.362 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 44.5 m-85 -101.95 179.48 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 2.59 109.624 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -152.15 141.72 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 3.18 109.234 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.439 ' CD1' ' CD2' ' A' ' 148' ' ' LEU . 6.3 tp -127.91 113.11 15.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 4.0 109.954 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.543 ' O ' ' OG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.54 92.59 4.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.421 -0.955 . . . . 2.8 108.421 179.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 30.9 p90 -93.87 147.92 22.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 2.64 111.074 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -98.59 105.24 17.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.265 -1.013 . . . . 2.25 108.265 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . . . -152.02 159.18 43.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.725 -1.235 . . . . 1.45 110.823 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.26 124.65 20.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.807 -0.812 . . . . 1.28 108.807 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -86.16 129.46 34.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 1.07 109.787 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.464 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.53 116.09 14.96 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 1.68 109.302 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.73 -142.52 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 124.374 -1.094 . . . . 1.32 112.463 -0.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -95.5 151.49 19.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.917 . . . . 1.75 109.66 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 160.37 162.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 2.72 109.401 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.568 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 57.8 Cg_endo -76.2 138.74 20.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.922 2.415 . . . . 1.83 112.526 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.566 ' O ' ' O ' ' A' ' 98' ' ' GLY . 0.7 OUTLIER -104.91 169.76 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 2.57 109.287 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -109.91 149.03 30.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.399 -0.813 . . . . 6.46 109.444 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.3 t -152.64 148.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 4.19 109.343 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.623 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.4 pp -152.55 146.07 24.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 2.9 109.739 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.508 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -153.69 149.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 2.31 109.63 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.94 -141.29 7.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.48 -1.448 . . . . 1.75 109.48 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -89.94 -158.62 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -1.127 . . . . 2.54 109.459 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.447 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -166.24 68.98 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.478 -1.449 . . . . 1.77 109.478 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . 171.58 109.15 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.507 -1.437 . . . . 2.54 109.507 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 54.05 164.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 4.77 109.539 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 63.14 -45.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -1.155 . . . . 5.79 109.52 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.605 ' N ' ' O ' ' A' ' 89' ' ' GLY . 56.5 m-85 44.55 10.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 6.33 109.475 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -76.79 114.09 15.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 6.42 109.536 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.35 163.86 16.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 2.66 109.89 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.04 -20.33 12.75 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.801 -0.815 . . . . 3.93 108.801 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.81 36.16 0.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.844 . . . . 4.15 109.16 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.83 56.34 3.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 4.6 109.558 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -107.42 124.63 50.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 3.96 109.192 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -117.52 3.5 17.86 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.545 -1.422 . . . . 3.67 109.545 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -89.28 72.61 8.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -1.157 . . . . 3.79 109.466 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.16 93.76 39.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 2.22 109.446 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 12.5 Cg_exo -65.98 116.9 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.855 2.37 . . . . 3.49 112.512 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -117.42 152.88 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 3.46 109.339 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 8.5 t -105.21 -161.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.92 . . . . 2.83 109.651 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.414 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -93.59 -22.31 26.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.75 -1.34 . . . . 2.83 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -99.96 149.88 36.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.213 . . . . 3.02 109.437 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.46 118.87 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.771 2.314 . . . . 1.42 112.062 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -144.17 126.01 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 1.81 109.718 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.429 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.1 151.54 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 2.19 110.075 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.704 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -135.38 138.2 43.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.471 -0.937 . . . . 5.23 108.471 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.67 111.65 19.44 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.979 -0.688 . . . . 3.28 110.516 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -109.86 117.74 34.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.562 -0.903 . . . . 3.78 108.562 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.28 140.65 39.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.219 -0.926 . . . . 3.99 109.665 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.721 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -126.3 162.87 24.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 3.1 109.45 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -98.94 103.48 15.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.65 109.531 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.4 m -37.15 110.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 4.28 109.356 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 9.8 p-10 -115.98 -10.38 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 7.59 109.467 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 119' ' ' PHE . 2.1 mm? -130.1 128.47 41.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 5.5 109.459 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.13 113.81 12.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 4.48 109.465 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 117' ' ' LEU . 18.3 m-85 -125.31 75.55 68.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 5.99 109.483 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -52.91 167.2 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.746 2.297 . . . . 4.64 112.069 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.67 -24.44 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.771 2.314 . . . . 4.46 112.076 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -110.39 160.77 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 4.14 109.5 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.9 -137.16 13.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.541 -1.424 . . . . 4.24 109.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 123' ' ' GLY . 20.5 m-20 -36.7 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 3.59 109.497 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.5 150.55 34.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 2.78 109.419 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.68 -158.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.801 2.334 . . . . 1.57 112.2 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.474 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -61.86 168.03 14.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.531 -1.427 . . . . 1.25 109.531 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.97 133.22 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -1.108 . . . . 2.18 109.595 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.414 ' CG2' HG13 ' A' ' 58' ' ' VAL . 59.8 t -139.56 151.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.644 -0.872 . . . . 1.87 108.644 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.41 ' N ' HG12 ' A' ' 129' ' ' VAL . . . -167.02 112.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 1.45 110.207 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -85.56 112.9 21.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.319 -0.863 . . . . 2.4 108.703 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.623 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 2.4 m170 -99.77 120.51 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.98 109.978 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.612 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -140.06 5.09 2.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 2.61 109.271 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -80.26 122.18 5.67 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.526 -1.43 . . . . 2.32 109.526 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.69 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.4 mtpp -163.96 135.78 4.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 5.66 109.668 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.91 -13.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.404 -0.961 . . . . 2.71 108.404 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -121.57 5.35 10.8 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.099 -1.601 . . . . 3.14 109.099 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -52.34 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -1.035 . . . . 2.84 109.937 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.568 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -170.78 -161.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.934 -1.103 . . . . 2.44 109.411 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -80.18 143.34 33.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 1.86 109.486 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.471 ' CG ' HD22 ' A' ' 133' ' ' LEU . 28.6 t80 -126.56 110.27 13.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 2.48 109.239 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.0 104.83 14.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.74 110.558 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.464 HG21 ' CD2' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -120.27 142.77 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 1.69 108.74 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 24.8 p -137.73 -3.42 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.636 -0.665 . . . . 1.63 109.567 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.539 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -154.92 160.24 41.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.143 -0.973 . . . . 3.82 110.061 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.599 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.2 t -143.38 152.61 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.434 -0.791 . . . . 2.92 109.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.437 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 26.5 t -125.62 128.23 47.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 3.25 109.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.528 ' CD1' ' C ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -129.82 111.6 12.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 5.12 109.208 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.4 OUTLIER -160.98 -171.66 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 3.35 109.626 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 65' ' ' SER . 7.7 t -156.85 -122.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 2.29 109.433 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.553 ' H ' ' CG2' ' A' ' 150' ' ' THR . 2.7 m -160.48 58.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 2.54 109.437 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.454 ' N ' ' HB3' ' A' ' 2' ' ' SER . . . -150.61 -166.98 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 3.09 109.516 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.976 -1.011 . . . . 3.68 109.495 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.327 0.584 . . . . 5.8 109.53 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 t -141.27 71.3 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 4.81 109.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.567 ' O ' ' O ' ' A' ' 151' ' ' SER . 1.1 mm? -128.54 -173.34 2.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 5.68 109.422 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 5' ' ' SER . 3.9 p30 -89.33 -140.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 5.38 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 52.63 -171.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 4.83 109.427 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -147.89 103.61 3.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 3.43 109.506 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.573 ' O ' ' OG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER -76.99 97.2 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 3.0 109.412 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -85.53 82.16 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 4.75 109.477 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -44.39 -19.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 5.44 109.444 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER -121.66 84.17 42.76 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.86 108.628 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.1 20.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.973 2.448 . . . . 4.15 112.131 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.619 ' H ' ' C ' ' A' ' 10' ' ' LEU . 69.9 t60 -118.64 99.29 6.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 2.52 109.672 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.622 ' O ' ' CG2' ' A' ' 13' ' ' THR . 5.5 t -139.12 56.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 2.33 109.339 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.65 ' C ' ' H ' ' A' ' 16' ' ' ALA . 44.4 m -142.49 61.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 2.28 109.785 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.7 m-30 -66.05 33.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 2.6 109.0 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.06 -35.26 15.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.66 110.014 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -109.97 -84.53 0.55 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.121 -0.987 . . . . 2.13 109.599 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 p -94.35 144.02 25.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.74 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' CD2' ' SD ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -55.77 -53.57 55.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 3.06 109.459 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 111.98 -164.14 12.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 1.72 109.682 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 56.7 Cg_endo -76.31 -4.51 15.15 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.833 2.355 . . . . 1.97 112.367 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.487 ' HE1' HD11 ' A' ' 10' ' ' LEU . 8.3 m95 -66.67 -177.63 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 2.88 109.418 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -133.6 167.32 20.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 2.07 109.277 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' O ' ' CD1' ' A' ' 24' ' ' LEU . 1.5 pp 179.43 142.76 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.133 -0.979 . . . . 2.79 109.809 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.82 173.78 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.464 -0.773 . . . . 2.48 109.453 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 102.29 -31.87 8.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.199 -1.16 . . . . 1.7 110.199 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.79 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.86 -141.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.957 -1.319 . . . . 1.51 109.645 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.79 ' N ' ' OG1' ' A' ' 27' ' ' THR . 13.7 p -91.35 132.71 36.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.538 -0.726 . . . . 2.11 109.329 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 pt-20 -37.44 106.96 0.37 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.139 -0.976 . . . . 2.85 109.055 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HB2' ' SD ' ' A' ' 37' ' ' MET . 53.6 Cg_exo -45.54 150.01 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.226 1.951 . . . . 1.4 111.691 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 t -136.83 123.07 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 1.53 110.103 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.84 115.4 17.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 2.56 109.362 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' A' ' 35' ' ' GLY . . . -81.76 -140.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 1.81 109.733 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.53 13.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 2.21 110.057 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 33' ' ' ALA . . . 144.11 -4.77 1.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.945 -1.262 . . . . 1.23 109.945 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -121.57 152.22 39.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.005 -1.291 . . . . 3.37 109.571 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.61 ' SD ' ' CD2' ' A' ' 19' ' ' LEU . 59.2 ttp -116.65 134.37 54.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 1.4 109.338 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -129.93 154.11 47.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.228 -0.92 . . . . 1.06 110.161 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HB ' ' HG1' ' A' ' 27' ' ' THR . 2.9 m -123.74 140.85 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.682 -0.858 . . . . 1.95 108.682 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 28' ' ' SER . 53.1 m-20 -79.8 108.87 13.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 4.79 109.704 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.579 ' O ' ' O ' ' A' ' 139' ' ' TYR . 8.2 mp -116.29 76.29 6.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 3.97 109.508 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 61.2 Cg_endo -77.54 -74.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.796 2.331 . . . . 4.21 112.201 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . -173.52 -157.37 15.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.588 -1.405 . . . . 2.09 109.588 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 77.19 -4.0 56.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.658 -1.377 . . . . 2.62 109.658 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 47' ' ' ASN . 7.8 mm-40 -100.01 66.79 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -1.119 . . . . 2.96 109.435 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.77 49.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.59 -1.404 . . . . 2.38 109.59 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.634 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -169.68 89.28 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.107 . . . . 4.04 109.422 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.7 -0.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.876 2.384 . . . . 2.75 112.356 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.674 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -122.88 34.08 5.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 4.57 109.572 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.0 m-20 -108.7 -19.62 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 2.38 109.654 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.411 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -139.77 177.42 7.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 1.47 109.71 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.65 171.82 13.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.615 -1.394 . . . . 0.96 109.615 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.497 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 3.2 mt -89.74 -177.29 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 1.51 109.323 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.31 174.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 1.51 109.92 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' HB2' ' CD2' ' A' ' 22' ' ' TRP . 18.1 t80 176.98 129.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.43 -0.794 . . . . 2.45 109.46 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.38 115.14 28.78 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.252 -0.905 . . . . 2.95 109.525 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 70.96 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.48 -1.448 . . . . 2.52 109.48 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -170.06 95.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.343 -1.092 . . . . 4.19 109.416 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.35 127.06 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.594 2.196 . . . . 2.79 112.186 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.1 t -100.03 135.19 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 3.62 109.578 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -115.23 101.79 1.07 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 3.37 109.338 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.603 ' C ' ' HG ' ' A' ' 115' ' ' SER . 14.9 tt0 -35.53 144.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.166 . . . . 6.05 109.612 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.675 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 96.35 -25.94 23.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.692 -1.363 . . . . 3.09 109.692 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.672 ' H ' ' HG ' ' A' ' 115' ' ' SER . 18.0 mt-10 -104.84 164.84 11.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -1.175 . . . . 4.03 109.767 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 58.2 m -120.7 141.41 50.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 3.28 109.228 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 28.0 m-85 -108.55 -179.21 3.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 2.59 109.73 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.0 t -152.76 144.83 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.489 -0.757 . . . . 3.18 109.341 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.44 116.46 16.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 4.0 109.797 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.441 ' OG ' ' CB ' ' A' ' 147' ' ' SER . 2.0 p -109.74 95.88 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 2.8 108.874 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.655 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -93.08 139.41 30.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 2.64 110.85 -179.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -94.51 104.75 16.71 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.857 -0.794 . . . . 2.25 108.857 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . . . -175.97 169.18 2.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.792 -1.192 . . . . 1.45 110.635 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.16 172.18 13.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.763 -0.829 . . . . 1.28 108.763 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 103' ' ' THR . . . -120.59 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 1.07 109.949 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.47 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.59 115.6 14.73 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.311 -0.868 . . . . 1.68 109.468 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.0 Cg_exo -65.79 -142.18 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 124.392 -1.087 . . . . 1.32 112.341 -0.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -102.23 149.36 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 1.75 109.602 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.15 153.58 0.13 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 2.72 109.438 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.72 163.78 28.68 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.829 2.353 . . . . 1.83 112.491 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 35.8 m -136.5 -178.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.346 -0.846 . . . . 2.57 109.305 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.703 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -126.56 117.78 23.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 6.46 109.658 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.7 151.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 4.19 109.259 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.456 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 2.9 pp -143.03 156.39 44.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 2.9 109.909 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -154.03 159.8 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 2.31 109.428 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 144.99 -142.92 11.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.578 -1.409 . . . . 1.75 109.578 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.67 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -90.17 -165.88 1.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 2.54 109.44 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.465 ' H ' ' HB1' ' A' ' 125' ' ' ALA . . . -149.46 84.29 0.17 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.556 -1.418 . . . . 1.77 109.556 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.67 ' N ' ' OE2' ' A' ' 86' ' ' GLU . . . -130.67 -154.47 7.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.481 -1.448 . . . . 2.54 109.481 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.685 ' O ' ' CD2' ' A' ' 91' ' ' TYR . . . -70.83 -66.68 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 4.77 109.496 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' TYR . . . -66.3 2.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -1.17 . . . . 5.79 109.477 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.685 ' CD2' ' O ' ' A' ' 89' ' ' GLY . 39.6 m-85 38.58 47.86 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 6.33 109.456 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.718 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -63.8 117.23 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 6.42 109.414 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -139.77 173.53 11.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 2.66 109.966 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -123.65 -19.62 5.74 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.823 -0.806 . . . . 3.93 108.823 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.583 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.68 34.72 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 4.15 109.203 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 4.6 109.538 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.496 ' CG ' ' N ' ' A' ' 98' ' ' GLY . 4.9 pt20 -107.79 -156.25 0.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 3.96 109.425 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -173.16 -35.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.688 -1.365 . . . . 3.67 109.688 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -80.07 90.21 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -1.146 . . . . 3.79 109.518 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.13 78.71 51.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 2.22 109.461 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.83 127.14 24.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.018 2.479 . . . . 3.49 112.547 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.9 mt -140.41 145.74 37.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.46 109.297 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -127.45 175.11 8.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 2.83 109.701 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -77.79 17.68 5.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 2.83 109.527 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 103' ' ' THR . 21.8 mt-10 -102.48 103.8 33.94 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.279 -1.13 . . . . 3.02 109.165 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -44.75 117.5 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.3 2.0 . . . . 1.42 112.188 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.468 ' HB3' HH12 ' A' ' 109' ' ' ARG . . . -165.16 156.82 14.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.925 . . . . 1.81 109.603 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.639 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.24 136.02 33.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.368 -0.833 . . . . 2.19 110.221 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.639 ' CZ ' ' O ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -110.23 142.02 42.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.665 -1.235 . . . . 5.23 107.665 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.75 105.69 13.59 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.763 -0.775 . . . . 3.28 110.457 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -109.09 109.18 20.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.172 -1.048 . . . . 3.78 108.172 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 66' ' ' TYR . . . -116.85 169.14 9.62 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 3.99 109.807 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.3 p90 -154.73 -178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.835 . . . . 3.1 109.514 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -109.92 106.15 15.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.36 -0.837 . . . . 2.65 109.689 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.675 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 59.8 p -35.97 119.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 4.28 109.316 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.527 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 3.7 m120 -96.26 -49.24 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 7.59 109.576 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.716 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.81 -156.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 5.5 109.646 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.716 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -119.52 144.83 46.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.349 -0.844 . . . . 4.48 109.491 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.56 ' CD1' ' O ' ' A' ' 118' ' ' THR . 74.6 m-85 -157.86 62.29 2.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 5.99 109.497 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.503 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 45.7 Cg_exo -52.28 -173.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.852 2.368 . . . . 4.64 112.071 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 5.0 Cg_exo -71.23 -31.45 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.047 2.498 . . . . 4.46 111.857 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -111.0 -161.56 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 4.14 109.478 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 88.21 -149.02 21.08 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.514 -1.435 . . . . 4.24 109.514 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.654 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -44.73 -50.03 10.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 3.59 109.434 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' H ' ' A' ' 87' ' ' GLY . . . -165.68 155.09 10.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.78 109.457 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.91 -158.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 1.57 112.205 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.99 168.61 9.88 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.546 -1.422 . . . . 1.25 109.546 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.566 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -148.86 118.77 7.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -1.175 . . . . 2.18 109.656 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.9 t -136.02 137.74 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 1.87 108.636 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.27 112.15 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.999 -1.063 . . . . 1.45 110.506 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.4 m-30 -89.0 110.43 21.12 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.519 -0.919 . . . . 2.4 108.519 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.464 ' CD2' ' HA ' ' A' ' 49' ' ' TRP . 31.2 m80 -99.69 138.37 36.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 2.98 110.031 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.65 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -155.93 17.11 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 2.61 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -77.18 139.09 22.85 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.616 -1.393 . . . . 2.32 109.616 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 137' ' ' GLY . 18.7 mtpt -166.25 127.49 1.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.134 . . . . 5.66 109.81 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.17 -15.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.0 -1.111 . . . . 2.71 108.0 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.52 17.13 6.96 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.747 -1.741 . . . . 3.14 108.747 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.86 -158.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.918 . . . . 2.84 110.714 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.643 ' OH ' ' CG1' ' A' ' 80' ' ' VAL . 2.2 p90 -152.73 -119.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 2.44 109.391 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.464 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 2.3 mt-10 -135.9 143.88 45.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 1.86 109.228 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 38.1 t80 -124.5 127.39 47.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 2.48 109.454 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.94 115.56 25.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.74 110.506 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.466 HG22 ' CE2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -125.41 143.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.759 0.79 . . . . 1.69 109.017 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.635 ' HG ' HE21 ' A' ' 145' ' ' GLN . 52.3 p -120.66 -19.86 7.28 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.466 -0.939 . . . . 1.63 108.466 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.635 HE21 ' HG ' ' A' ' 144' ' ' SER . 4.9 pt20 -171.36 172.27 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.843 -0.743 . . . . 3.82 109.646 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.548 ' O ' ' OG1' ' A' ' 13' ' ' THR . 8.8 p -147.16 141.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 2.92 109.51 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.441 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -114.91 158.94 21.29 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.912 . . . . 3.25 109.527 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 149' ' ' THR . 1.6 tp -168.22 114.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 5.12 109.381 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 7' ' ' VAL . 7.0 t -156.68 -164.03 1.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 3.35 109.484 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.758 ' HG1' ' H ' ' A' ' 151' ' ' SER . 7.7 t -150.88 -143.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 2.29 109.464 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.758 ' H ' ' HG1' ' A' ' 150' ' ' THR . 1.1 m 38.49 39.72 0.33 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 2.54 109.488 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.32 126.06 22.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 3.09 109.499 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.07 -0.967 . . . . 3.68 109.499 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.485 -0.561 . . . . 5.8 109.485 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -106.72 80.01 1.41 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 4.81 109.436 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.622 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER -147.81 -175.51 4.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 5.68 109.642 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 1.7 t70 84.58 168.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 5.38 109.587 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.565 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.8 OUTLIER 48.08 175.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 4.83 109.484 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.91 121.13 16.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 3.43 109.564 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.755 ' H ' ' HG1' ' A' ' 149' ' ' THR . 48.6 t -108.79 64.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 3.0 109.311 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.631 ' C ' ' H ' ' A' ' 10' ' ' LEU . 6.3 pm0 -51.02 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 4.75 109.669 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' VAL . 8.6 mp -54.22 -1.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 5.44 109.276 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.722 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -140.5 95.85 7.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 2.86 108.943 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.07 38.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 4.15 112.703 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.678 ' N ' ' O ' ' A' ' 10' ' ' LEU . 33.7 t60 -133.44 115.65 15.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 2.52 109.337 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.579 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -154.41 63.38 0.68 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.347 -0.846 . . . . 2.33 109.283 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.66 ' C ' ' H ' ' A' ' 16' ' ' ALA . 16.2 m -159.47 66.8 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 2.28 109.512 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.662 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.8 m-30 -67.11 27.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 2.6 109.195 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.17 -29.53 18.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.847 . . . . 1.66 109.956 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 4.3 mt-10 -109.73 -83.64 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 2.13 109.78 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.4 m -96.46 143.77 27.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 2.74 109.593 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD22 ' SD ' ' A' ' 37' ' ' MET . 3.9 mt -54.11 -51.38 64.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 3.06 109.418 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.37 -171.59 16.76 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.591 -1.404 . . . . 1.72 109.591 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 22' ' ' TRP . 47.5 Cg_endo -72.99 -18.54 24.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.759 2.306 . . . . 1.97 112.147 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.722 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.5 m95 -53.06 -174.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 2.88 109.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -135.81 173.79 11.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 2.07 109.525 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 pp -177.81 142.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 2.79 109.446 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.594 ' C ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.91 170.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 2.48 109.793 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.06 -29.73 10.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.97 -1.252 . . . . 1.7 109.97 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.773 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.73 -141.94 0.38 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.083 -1.245 . . . . 1.51 109.3 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.773 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.7 p -91.15 -170.58 2.7 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 2.11 109.172 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.22 111.34 46.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.85 109.041 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 76.7 Cg_exo -44.66 134.9 9.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.201 1.934 . . . . 1.4 111.921 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 37' ' ' MET . 9.2 t -116.95 105.07 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 1.53 109.918 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -69.24 77.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.568 -0.708 . . . . 2.56 109.416 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -60.67 -140.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.81 109.766 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -35.48 -76.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 2.21 109.503 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.21 49.71 0.71 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.586 -1.406 . . . . 1.23 109.586 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -173.15 150.38 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 3.37 109.398 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.437 ' SD ' HD22 ' A' ' 19' ' ' LEU . 4.5 ptt? -108.87 134.03 52.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 1.4 109.562 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.68 135.51 54.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.627 -0.829 . . . . 1.06 110.427 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.1 m -106.07 140.66 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.672 -0.862 . . . . 1.95 108.672 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.35 106.53 9.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 4.79 109.922 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 139' ' ' TYR . 6.6 mp -114.26 80.67 5.92 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 3.97 109.157 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.23 -95.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 4.21 112.263 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.17 137.29 4.85 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.651 -1.379 . . . . 2.09 109.651 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 155.71 -17.85 0.49 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 2.62 109.51 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.555 HE22 ' N ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -99.51 61.99 1.2 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.235 -1.156 . . . . 2.96 109.632 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -36.48 -33.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.249 -1.54 . . . . 2.38 109.249 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -107.69 101.83 41.97 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.364 -1.08 . . . . 4.04 109.037 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' O ' ' CG ' ' A' ' 132' ' ' HIS . 36.2 Cg_exo -56.36 44.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.457 2.105 . . . . 2.75 112.315 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.693 ' CH2' ' OD2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -117.12 49.75 1.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.99 . . . . 4.57 111.28 -179.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.693 ' OD2' ' CH2' ' A' ' 49' ' ' TRP . 23.9 m-20 -165.07 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 2.38 109.465 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.555 ' N ' HE22 ' A' ' 45' ' ' GLN . . . -81.06 120.04 24.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 1.47 109.546 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.59 179.2 37.03 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.683 -1.246 . . . . 0.96 110.041 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.713 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.5 mm? -100.07 168.01 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -1.04 . . . . 1.51 109.009 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -155.89 166.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 1.51 109.825 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 10' ' ' LEU . 13.1 t80 173.92 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 2.45 109.571 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.568 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-80 -98.93 150.03 22.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 2.95 109.548 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.69 52.54 0.14 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 2.52 109.589 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.461 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 14.7 t -142.79 70.59 19.64 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 4.19 109.457 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -47.66 143.57 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.834 2.356 . . . . 2.79 112.208 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.53 122.04 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 3.62 109.461 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.17 91.72 0.69 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 3.37 109.492 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 3.5 tm-20 -41.81 120.42 1.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 6.05 109.46 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.31 -48.82 0.93 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.807 -1.317 . . . . 3.09 109.807 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.6 mp0 -100.03 179.71 4.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 4.03 109.623 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -120.28 140.99 50.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 3.28 109.396 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.481 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 38.6 m-85 -109.53 -178.13 3.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.202 -0.936 . . . . 2.59 109.474 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.9 t -152.79 130.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 3.18 109.511 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 69' ' ' SER . 8.0 tt -110.7 147.51 34.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 4.0 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.496 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 1.6 p -130.2 91.05 3.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 2.8 109.455 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 109' ' ' ARG . 29.5 p90 -94.63 139.56 31.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 2.64 110.966 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.1 p -97.0 134.68 40.05 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.641 -0.874 . . . . 2.25 108.641 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.789 ' N ' HH22 ' A' ' 109' ' ' ARG . . . 169.37 -170.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.951 -1.093 . . . . 1.45 110.481 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -169.11 147.68 3.88 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.816 -0.809 . . . . 1.28 108.816 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -104.72 134.04 48.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.116 -0.99 . . . . 1.07 109.85 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.45 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.04 116.4 15.63 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.4 -0.812 . . . . 1.68 109.292 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.21 -142.29 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.665 0 C-N-CA 124.297 -1.126 . . . . 1.32 112.344 -0.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -104.96 148.8 26.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.75 109.253 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.724 ' SD ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 ptp 174.43 154.45 0.3 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 2.72 109.535 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.14 117.93 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.57 2.18 . . . . 1.83 111.871 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -97.45 179.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.878 . . . . 2.57 109.536 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.0 OUTLIER -120.14 150.92 39.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 6.46 109.65 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -142.47 147.89 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 4.19 109.118 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' HB3' HH12 ' A' ' 81' ' ' ARG . 1.3 pp -143.81 148.26 35.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 2.9 110.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.593 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -154.41 164.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.775 . . . . 2.31 109.413 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.68 -138.9 6.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.687 -1.365 . . . . 1.75 109.687 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.1 pm0 -90.17 177.31 6.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -1.145 . . . . 2.54 109.489 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.89 57.44 0.72 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.523 -1.431 . . . . 1.77 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.33 -176.9 39.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.538 -1.425 . . . . 2.54 109.538 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' A' ' 91' ' ' TYR . . . 68.84 -149.7 49.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.576 -1.41 . . . . 4.77 109.576 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.625 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -59.93 6.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -1.141 . . . . 5.79 109.508 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.642 ' H ' ' C ' ' A' ' 89' ' ' GLY . 80.6 m-85 57.66 -2.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 6.33 109.483 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -52.77 -174.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 6.42 109.427 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER 179.96 -179.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 2.66 109.954 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.575 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.04 -22.1 4.91 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.873 -0.788 . . . . 3.93 108.873 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.67 43.06 1.13 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.286 -0.884 . . . . 4.15 109.227 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -86.59 61.0 6.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.111 -0.993 . . . . 4.6 109.464 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.5 tt0 -99.93 161.57 13.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 3.96 109.04 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -135.43 -30.22 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.781 -1.327 . . . . 3.67 109.781 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.01 95.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.259 -1.142 . . . . 3.79 109.819 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.635 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -137.41 77.48 40.82 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 2.22 109.32 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.03 120.06 6.2 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.027 2.485 . . . . 3.49 112.701 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.9 mt -137.9 132.88 33.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 3.46 109.357 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 5.1 t -128.84 -151.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 2.83 109.521 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.31 58.34 2.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.632 -1.387 . . . . 2.83 109.632 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.23 84.25 59.8 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -1.104 . . . . 3.02 109.481 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 107' ' ' ALA . 51.0 Cg_exo -48.65 124.91 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.814 2.343 . . . . 1.42 112.188 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.637 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . . . 161.03 174.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 1.81 109.444 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.08 131.9 35.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 2.19 109.929 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.789 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -100.74 140.97 34.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.092 -1.448 . . . . 5.23 107.092 177.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -108.73 123.39 48.93 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.515 -0.874 . . . . 3.28 110.94 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.635 ' OH ' ' CB ' ' A' ' 100' ' ' ALA . 7.5 m-85 -109.96 119.56 39.7 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.302 -0.999 . . . . 3.78 108.302 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.96 124.68 45.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.941 . . . . 3.99 109.941 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.704 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -133.5 165.42 24.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 3.1 109.436 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.16 125.68 51.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 2.65 109.748 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 4.2 m -52.7 124.38 13.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.28 -0.887 . . . . 4.28 109.213 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -111.04 -46.67 3.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.151 -0.968 . . . . 7.59 109.698 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -120.96 139.72 52.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 5.5 109.638 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.682 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -70.19 159.56 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 4.48 109.291 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.682 ' CG ' ' O ' ' A' ' 118' ' ' THR . 32.1 m-85 -168.05 93.44 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 5.99 109.492 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.09 165.8 21.31 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.722 2.281 . . . . 4.64 112.177 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.81 -15.05 12.22 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.716 2.278 . . . . 4.46 112.042 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.83 132.65 53.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 4.14 109.442 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.41 -137.47 9.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.546 -1.422 . . . . 4.24 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.638 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -121.48 39.14 3.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 3.59 109.454 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -179.92 71.23 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 2.78 109.495 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.72 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.752 2.301 . . . . 1.57 112.306 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -65.59 154.28 50.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.599 -1.401 . . . . 1.25 109.599 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 9.2 tp-100 -151.52 130.46 12.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.104 -1.233 . . . . 2.18 109.578 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 21.2 t -138.47 139.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 1.87 108.623 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.08 1.94 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.855 -1.153 . . . . 1.45 110.929 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.3 m-30 -90.72 112.09 23.71 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.207 -1.035 . . . . 2.4 108.207 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.449 ' CG ' ' O ' ' A' ' 48' ' ' PRO . 34.8 m170 -99.88 131.3 45.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 2.98 110.259 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.58 -23.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 2.61 109.896 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.06 133.65 0.37 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.763 -1.335 . . . . 2.32 109.763 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 137' ' ' GLY . 29.7 mtmt -169.03 127.03 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -1.135 . . . . 5.66 109.763 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.91 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.911 -1.144 . . . . 2.71 107.911 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.04 18.61 7.44 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.037 -1.625 . . . . 3.14 109.037 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.44 -154.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.625 -0.926 . . . . 2.84 110.756 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.724 ' CD1' ' SD ' ' A' ' 78' ' ' MET . 7.4 p90 -158.91 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.995 -1.066 . . . . 2.44 109.277 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.455 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 74.6 mm-40 -126.65 130.55 50.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 1.86 108.867 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -107.71 114.64 28.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 2.48 109.974 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.482 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 36.6 m -110.93 114.35 27.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.275 -0.891 . . . . 0.74 109.65 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.46 HD12 ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -123.26 145.03 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 1.69 109.517 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.662 ' O ' ' N ' ' A' ' 15' ' ' PHE . 0.7 OUTLIER -131.0 -12.74 3.64 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.299 -0.63 . . . . 1.63 109.299 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.578 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -158.93 158.95 34.34 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.372 -0.931 . . . . 3.82 110.181 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -162.39 129.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 2.92 108.91 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.96 144.06 8.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.062 . . . . 3.25 109.675 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 149' ' ' THR . 1.5 pp -122.11 164.99 16.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 5.12 109.523 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.755 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -177.68 -174.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 3.35 109.655 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.597 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.6 t -178.54 -159.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 2.29 109.438 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.561 ' O ' ' O ' ' A' ' 150' ' ' THR . 25.8 t 33.4 -155.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 2.54 109.863 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.489 ' CB ' ' OG ' ' A' ' 5' ' ' SER . . . 174.52 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 3.09 109.467 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.036 -0.983 . . . . 3.68 109.463 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.294 0.569 . . . . 5.8 109.504 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 3' ' ' LEU . 91.4 p 36.74 -140.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 4.81 109.508 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER 54.18 156.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 5.68 109.572 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 3' ' ' LEU . 3.3 m-20 38.79 -164.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 5.38 109.535 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.534 ' C ' ' O ' ' A' ' 4' ' ' ASP . 18.5 m 35.83 84.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 4.83 109.551 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' A' ' 8' ' ' GLU . 48.5 mp0 -52.79 117.09 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 3.43 109.421 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.676 ' O ' ' N ' ' A' ' 9' ' ' LEU . 2.6 p -68.59 35.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 3.0 109.469 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.59 ' H ' ' C ' ' A' ' 6' ' ' GLU . 8.4 tt0 -37.21 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 4.75 109.626 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 mt -61.92 -34.59 76.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 5.44 109.275 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.603 ' CD2' ' OH ' ' A' ' 55' ' ' TYR . 2.8 tm? -107.53 100.4 34.04 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 2.86 108.576 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.39 30.42 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.7 2.267 . . . . 4.15 112.997 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.599 ' H ' ' CD1' ' A' ' 10' ' ' LEU . 28.2 t60 -115.42 82.05 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.848 -1.158 . . . . 2.52 109.369 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.617 ' HG1' ' H ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -121.27 45.85 2.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 2.33 109.338 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.1 t -125.45 72.19 1.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 2.28 109.461 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -83.21 23.95 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.198 -0.939 . . . . 2.6 109.362 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.02 -35.12 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 1.66 109.696 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 26.4 mm-40 -109.86 -83.16 0.56 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.138 -0.976 . . . . 2.13 109.729 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 m -88.22 144.44 26.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 2.74 109.535 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.434 HD23 ' SD ' ' A' ' 37' ' ' MET . 7.4 mt -60.56 -58.45 8.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 3.06 109.515 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.1 -169.98 13.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 1.72 109.573 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 22' ' ' TRP . 55.9 Cg_endo -75.4 -19.21 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.793 2.329 . . . . 1.97 112.205 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.57 ' O ' ' O ' ' A' ' 21' ' ' PRO . 11.3 m95 -50.95 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 2.88 109.345 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -143.25 169.85 16.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 2.07 109.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.76 138.64 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 2.79 109.574 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.96 159.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 2.48 109.439 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 107.45 -26.91 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.865 -1.294 . . . . 1.7 109.865 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.78 -142.35 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 1.51 109.201 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 12.4 p -91.61 -162.14 0.89 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.459 -0.775 . . . . 2.11 108.999 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.01 131.4 39.27 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 2.85 108.811 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.66 132.29 23.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.246 1.964 . . . . 1.4 111.839 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 37' ' ' MET . 40.8 t -118.83 111.19 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.53 109.888 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.707 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.49 85.54 5.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.657 -0.652 . . . . 2.56 109.49 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.25 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 1.81 109.689 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.26 -68.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 2.21 109.369 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.55 35.19 1.82 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.465 . . . . 1.23 109.436 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.77 147.89 28.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -1.12 . . . . 3.37 109.64 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.434 ' SD ' HD23 ' A' ' 19' ' ' LEU . 2.5 ptt? -121.18 132.78 55.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 1.4 109.231 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 m -128.89 145.02 51.33 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.452 -0.899 . . . . 1.06 110.376 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' HB ' ' HG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.16 145.43 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.705 -0.85 . . . . 1.95 108.705 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.671 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -75.12 123.39 25.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 4.79 109.802 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 42' ' ' PRO . 4.4 mm? -122.69 75.02 45.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 3.97 109.258 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 41' ' ' LEU . 51.6 Cg_exo -48.14 -167.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.871 2.381 . . . . 4.21 112.359 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 136' ' ' ALA . . . -124.45 62.01 0.58 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.507 -1.437 . . . . 2.09 109.507 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . -154.48 15.28 0.55 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 2.62 109.627 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -99.93 91.35 4.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -1.164 . . . . 2.96 109.477 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.29 -7.95 61.26 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.496 -1.442 . . . . 2.38 109.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.57 ' OD1' ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -99.9 121.68 53.38 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.274 -1.133 . . . . 4.04 109.371 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.17 5.86 4.28 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.433 2.089 . . . . 2.75 112.308 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.469 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -122.98 33.15 5.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 4.57 109.604 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 34.5 m-20 -126.02 43.17 3.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 2.38 109.433 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 159.59 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 1.47 109.553 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 164.88 157.97 10.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.009 -1.236 . . . . 0.96 110.009 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 7.5 mt -77.17 -176.3 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -1.135 . . . . 1.51 109.157 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.88 159.18 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 1.51 109.593 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.603 ' OH ' ' CD2' ' A' ' 10' ' ' LEU . 46.2 t80 178.92 143.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.384 -0.823 . . . . 2.45 109.648 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.4 m-80 -111.17 -164.75 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 2.95 109.524 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 82.82 74.33 1.2 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 2.52 109.572 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 57' ' ' GLY . 52.2 t -161.12 77.57 2.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.107 . . . . 4.19 109.52 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.45 155.99 1.95 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.815 2.343 . . . . 2.79 112.135 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.99 114.66 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 3.62 109.614 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -138.99 101.89 0.33 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.256 -1.537 . . . . 3.37 109.256 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.625 ' OE1' ' N ' ' A' ' 63' ' ' GLY . 7.0 tp10 -38.19 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -1.087 . . . . 6.05 109.452 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.625 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 103.35 -56.41 0.6 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.576 -1.409 . . . . 3.09 109.576 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 152' ' ' ALA . 3.9 mm-40 -99.66 141.89 31.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.116 . . . . 4.03 109.334 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -99.89 120.54 39.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 3.28 109.553 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' C ' ' CG2' ' A' ' 67' ' ' VAL . 81.7 m-85 -85.55 174.71 9.26 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 2.59 109.505 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.442 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -155.43 132.82 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 3.18 109.323 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tt -114.07 130.56 56.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.966 . . . . 4.0 109.498 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.2 p -118.16 94.86 4.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 2.8 108.736 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 70' ' ' PHE . 11.2 p90 -93.28 135.48 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.05 -1.031 . . . . 2.64 111.091 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.457 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 19.1 p -90.31 109.25 20.35 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.547 -0.908 . . . . 2.25 108.547 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 141' ' ' PHE . . . -158.89 165.92 33.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.624 -1.23 . . . . 1.45 110.817 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.8 p -129.42 163.1 26.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.914 -0.773 . . . . 1.28 108.914 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.582 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -124.39 119.3 28.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 1.07 109.593 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.46 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.79 116.74 16.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.057 -1.027 . . . . 1.68 110.113 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.582 ' O ' ' O ' ' A' ' 74' ' ' ALA . 20.1 Cg_exo -65.87 -142.15 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.687 0 C-N-CA 124.232 -1.153 . . . . 1.32 112.05 -0.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' C ' ' CG ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -97.86 149.39 22.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 1.75 109.208 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.697 ' SD ' ' CE2' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 165.21 159.82 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 2.72 109.795 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.34 119.24 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.711 2.274 . . . . 1.83 112.032 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.19 169.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 2.57 109.44 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.729 ' CG ' HH11 ' A' ' 81' ' ' ARG . 0.1 OUTLIER -109.83 139.42 44.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.917 . . . . 6.46 109.313 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -141.05 148.26 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 4.19 109.533 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.4 OUTLIER -147.21 144.0 28.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 2.9 109.487 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' CG2' ' CD2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -152.84 145.03 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 2.31 110.342 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 128' ' ' GLN . . . 142.21 -109.62 0.58 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.881 -1.288 . . . . 1.75 109.881 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' CD ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -89.98 164.87 14.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -1.181 . . . . 2.54 109.663 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.81 -34.03 0.36 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.593 -1.403 . . . . 1.77 109.593 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -80.93 165.58 47.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 35.7 -130.34 0.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.573 -1.411 . . . . 4.77 109.573 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -142.13 39.82 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -1.16 . . . . 5.79 109.439 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.564 ' O ' ' C ' ' A' ' 92' ' ' ARG . 2.8 m-30 -57.67 80.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 6.33 109.555 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 90' ' ' ALA . 6.5 ptp180 -29.76 149.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.549 -0.719 . . . . 6.42 109.766 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.688 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 1.8 t -128.85 -150.93 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 2.66 110.275 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.688 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -119.01 -22.32 7.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.239 -0.652 . . . . 3.93 109.239 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.498 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.11 41.66 1.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.787 -1.196 . . . . 4.15 109.235 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -90.01 44.28 1.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.983 -1.073 . . . . 4.6 109.537 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 111' ' ' TYR . 7.3 pt20 -106.67 137.18 45.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 3.96 109.431 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 82' ' ' VAL . . . -128.49 20.28 5.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.664 -1.374 . . . . 3.67 109.664 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -104.84 76.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 3.79 109.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.76 102.03 53.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 2.22 109.333 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.79 118.81 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.702 2.268 . . . . 3.49 112.608 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.6 159.82 33.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 3.46 109.522 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 2.4 t -103.5 -148.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 2.83 109.86 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.597 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -110.2 29.65 9.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 2.83 109.805 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -139.59 147.96 54.15 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.201 -1.176 . . . . 3.02 109.205 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -40.48 117.35 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.592 2.194 . . . . 1.42 111.882 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.38 127.69 11.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.151 -0.968 . . . . 1.81 109.811 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.62 141.14 29.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.44 -0.787 . . . . 2.19 109.853 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.711 HH12 ' HH ' ' A' ' 111' ' ' TYR . 9.1 mmm-85 -113.26 136.44 52.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.377 -0.972 . . . . 5.23 108.377 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -117.18 107.36 14.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.175 -0.61 . . . . 3.28 109.883 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.711 ' HH ' HH12 ' A' ' 109' ' ' ARG . 42.3 m-85 -109.95 114.76 28.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 3.78 109.083 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.436 ' C ' ' CD2' ' A' ' 113' ' ' PHE . . . -103.38 170.48 7.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -0.873 . . . . 3.99 109.611 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.436 ' CD2' ' C ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 179.05 161.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 3.1 109.767 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.37 155.01 20.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 2.65 109.307 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -90.13 44.15 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 4.28 109.954 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 115' ' ' SER . 6.9 m120 -39.92 -17.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 7.59 109.576 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.2 mm? -109.87 143.82 39.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 5.5 109.436 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.85 107.75 18.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 4.48 109.681 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 117' ' ' LEU . 43.0 m-85 -133.69 98.26 15.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 5.99 109.181 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.28 165.58 23.34 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.52 2.147 . . . . 4.64 112.239 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.03 -14.59 12.16 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.836 2.357 . . . . 4.46 112.069 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -109.66 123.24 49.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 4.14 109.602 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.554 ' O ' ' OD1' ' A' ' 124' ' ' ASP . . . 150.02 -84.34 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.478 -1.449 . . . . 4.24 109.478 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 123' ' ' GLY . 4.5 m-20 -162.21 -37.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 3.59 109.452 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -112.59 93.45 23.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 2.78 109.417 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.98 -159.17 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.744 2.296 . . . . 1.57 112.273 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.57 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -72.84 -178.99 35.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 1.25 109.603 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.458 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -170.25 141.18 2.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -1.094 . . . . 2.18 109.707 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.437 ' N ' ' HG2' ' A' ' 128' ' ' GLN . 67.3 t -138.71 151.48 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.973 -1.121 . . . . 1.87 107.973 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -165.66 111.72 0.9 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.815 -1.154 . . . . 1.45 110.48 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.514 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.8 m-30 -94.12 84.38 4.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.456 -0.942 . . . . 2.4 108.456 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.446 ' ND1' ' HA ' ' A' ' 49' ' ' TRP . 19.6 m170 -98.73 132.53 44.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 2.98 110.173 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.65 2.32 2.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 2.61 109.268 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -48.95 136.4 19.8 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.517 -1.433 . . . . 2.32 109.517 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.668 ' O ' ' N ' ' A' ' 137' ' ' GLY . 19.5 mtpt -165.72 130.14 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -1.157 . . . . 5.66 109.869 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 43' ' ' GLY . . . -42.58 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.87 -1.159 . . . . 2.71 107.87 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.47 17.1 7.44 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.734 -1.747 . . . . 3.14 108.734 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.637 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -51.13 -149.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.903 . . . . 2.84 110.432 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.697 ' CE2' ' SD ' ' A' ' 78' ' ' MET . 0.0 OUTLIER -171.7 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.008 . . . . 2.44 110.597 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.674 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 13.9 mt-10 -137.26 140.79 41.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 1.86 109.351 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CE2' HG22 ' A' ' 143' ' ' ILE . 42.0 t80 -117.53 128.3 54.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.865 . . . . 2.48 109.374 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.41 110.66 17.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.126 -0.984 . . . . 0.74 109.977 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.467 HG22 ' CE2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -119.66 144.68 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 1.69 109.279 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 88.6 p -130.06 -15.23 3.81 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.205 -0.665 . . . . 1.63 109.205 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.466 ' CG ' ' C ' ' A' ' 144' ' ' SER . 3.0 mt-30 -155.51 177.52 11.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 3.82 110.015 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.617 ' H ' ' HG1' ' A' ' 13' ' ' THR . 3.9 p -177.04 124.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.815 . . . . 2.92 109.461 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 176.74 11.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 3.25 109.775 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 149' ' ' THR . 1.3 pp -155.37 -161.35 1.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 5.12 109.394 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.66 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 3.35 109.5 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -123.53 -41.26 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 2.29 109.371 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.504 ' N ' ' CG2' ' A' ' 150' ' ' THR . 3.0 m 45.19 65.65 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.389 -0.819 . . . . 2.54 109.499 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.556 ' O ' ' OE1' ' A' ' 64' ' ' GLU . . . 61.3 -157.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 3.09 109.486 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.069 -0.967 . . . . 3.68 109.456 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.482 -0.562 . . . . 5.8 109.482 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.643 ' H ' ' CB ' ' A' ' 152' ' ' ALA . 1.3 m 43.0 80.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 4.81 109.431 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 tp -113.91 137.92 51.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 5.68 109.422 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.45 22.67 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 5.38 109.405 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.97 -159.51 0.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 4.83 109.521 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 8' ' ' GLU . 53.2 mt-10 -118.18 74.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 3.43 109.503 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLU . 4.2 t -36.81 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 3.0 109.511 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' GLU . 4.9 tt0 -85.74 83.08 7.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 4.75 109.468 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.93 -33.03 73.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 5.44 109.426 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -109.07 96.02 19.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 2.86 108.653 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.5 27.07 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.32 2.014 . . . . 4.15 111.693 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.502 ' H ' HD13 ' A' ' 10' ' ' LEU . 48.2 t60 -128.31 74.21 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 2.52 109.478 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 10.1 t -112.96 41.58 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 2.33 109.43 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.653 ' C ' ' H ' ' A' ' 16' ' ' ALA . 6.5 t -115.85 59.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 2.28 109.668 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -65.49 16.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 2.6 109.263 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.05 -22.39 21.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 1.66 109.848 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -109.81 -84.29 0.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.13 109.633 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m -109.0 153.78 23.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 2.74 109.443 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD21 ' SD ' ' A' ' 37' ' ' MET . 2.2 mt -56.76 -54.26 48.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 3.06 109.547 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.46 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 103.22 -149.24 17.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.72 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.72 -27.49 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.748 2.299 . . . . 1.97 112.252 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.508 ' CH2' ' CG1' ' A' ' 146' ' ' VAL . 15.4 m95 -52.01 167.59 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 2.88 109.256 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -131.87 179.25 6.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -0.959 . . . . 2.07 109.676 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' CD2' HD21 ' A' ' 19' ' ' LEU . 2.9 pp 179.35 152.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 2.79 109.504 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -179.06 152.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 2.48 109.529 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.71 -24.63 13.01 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.909 -1.139 . . . . 1.7 110.435 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.78 -144.27 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.381 . . . . 1.51 109.583 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 7.9 p -92.8 135.22 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 2.11 109.291 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -41.27 104.25 0.34 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.976 -1.078 . . . . 2.85 108.588 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 28' ' ' SER . 51.7 Cg_exo -46.95 166.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.183 1.922 . . . . 1.4 111.83 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 t -151.08 121.16 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.07 -1.019 . . . . 1.53 110.182 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -76.2 92.96 3.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.85 . . . . 2.56 109.341 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.68 -140.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 1.81 109.531 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' OD1' ' C ' ' A' ' 34' ' ' ASP . 39.6 t0 -58.6 -43.41 89.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.965 . . . . 2.21 109.368 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.74 48.35 0.38 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.271 -1.531 . . . . 1.23 109.271 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -171.29 146.29 2.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -1.11 . . . . 3.37 109.496 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.432 ' SD ' HD21 ' A' ' 19' ' ' LEU . 40.4 ttp -109.58 133.76 52.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.246 -0.908 . . . . 1.4 109.068 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.696 ' SG ' ' OE2' ' A' ' 140' ' ' GLU . 0.5 OUTLIER -127.76 173.61 9.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.229 -0.919 . . . . 1.06 110.434 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.416 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 3.1 m -149.26 144.97 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.875 -0.787 . . . . 1.95 108.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' N ' ' OG ' ' A' ' 28' ' ' SER . 35.4 m-20 -82.48 106.48 14.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.88 . . . . 4.79 109.289 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD21 ' HG1' ' A' ' 27' ' ' THR . 3.8 mm? -113.5 80.1 4.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 3.97 109.654 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.37 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.756 2.304 . . . . 4.21 112.238 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -120.24 115.58 3.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.539 -1.425 . . . . 2.09 109.539 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.623 ' H ' ' H ' ' A' ' 136' ' ' ALA . . . -174.88 -40.83 0.05 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.843 -1.303 . . . . 2.62 109.843 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.722 ' NE2' ' HZ2' ' A' ' 135' ' ' LYS . 12.0 mt-30 -100.0 125.35 46.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -1.153 . . . . 2.96 109.586 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.89 65.88 0.27 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 2.38 109.344 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.659 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -146.03 96.6 4.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.36 -1.082 . . . . 4.04 109.396 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 53.1 Cg_exo -48.44 4.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.852 2.368 . . . . 2.75 113.079 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.62 ' H ' ' C ' ' A' ' 47' ' ' ASN . 1.4 p-90 -127.59 34.32 4.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.885 -1.134 . . . . 4.57 109.667 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.659 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 30.7 m-20 -132.97 39.05 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 2.38 109.215 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 158.78 94.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 1.47 109.259 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.9 174.13 45.21 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.864 -1.295 . . . . 0.96 109.864 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 6.6 mt -95.05 -178.1 4.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 1.51 109.526 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.49 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -162.94 162.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 1.51 109.293 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 15.2 t80 172.26 140.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 2.45 109.72 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.689 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.4 m120 -94.38 -168.1 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 2.95 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.534 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 82.3 74.62 1.17 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 2.52 109.463 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 57' ' ' GLY . 48.6 t -161.31 69.74 2.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.275 -1.132 . . . . 4.19 109.547 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.85 120.51 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.789 2.326 . . . . 2.79 112.136 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 t -112.5 141.25 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 3.62 109.532 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -116.5 98.9 0.83 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.464 -1.454 . . . . 3.37 109.464 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 61.8 tt0 -35.64 130.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 6.05 109.546 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 111.08 -32.36 6.57 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 3.09 109.626 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.3 mt-10 -100.01 177.9 4.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -1.157 . . . . 4.03 109.525 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -128.53 143.79 51.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 3.28 109.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 27.2 m-85 -112.75 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.156 -0.965 . . . . 2.59 109.677 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.406 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.4 t -152.8 137.24 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.551 -0.718 . . . . 3.18 109.281 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.83 121.51 38.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 4.0 109.782 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.1 p -109.52 85.47 2.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 2.8 108.745 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.7 p90 -93.63 143.56 26.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 2.64 111.167 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.751 ' HG1' ' CB ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -93.39 122.91 36.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.609 -0.885 . . . . 2.25 108.609 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.793 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -163.44 147.11 10.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 1.45 110.385 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.37 135.9 52.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.877 -0.786 . . . . 1.28 108.877 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -107.6 116.73 32.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 1.07 109.819 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' ' CG ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -131.24 119.09 17.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 1.68 109.831 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.9 Cg_exo -66.17 -142.19 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.305 -1.123 . . . . 1.32 112.372 -0.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 159.24 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 1.75 109.809 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.513 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.9 mtt 162.83 154.98 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 2.72 109.215 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.71 148.65 32.9 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.812 2.341 . . . . 1.83 112.628 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.453 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 0.6 OUTLIER -122.91 172.1 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 2.57 109.056 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 132' ' ' HIS . 14.9 ttt180 -134.81 95.54 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 6.46 109.921 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 132' ' ' HIS . 1.4 m -99.88 148.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 4.19 108.939 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.6 pp -139.73 152.98 47.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 2.9 109.99 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.3 t -149.15 157.7 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 2.31 109.389 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.88 -143.78 8.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.622 -1.391 . . . . 1.75 109.622 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.662 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 0.3 OUTLIER -90.24 -176.33 4.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 2.54 109.409 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -126.33 66.99 0.54 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.613 -1.395 . . . . 1.77 109.613 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.53 ' O ' ' CD ' ' A' ' 86' ' ' GLU . . . 110.34 167.65 19.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.568 -1.413 . . . . 2.54 109.568 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -32.53 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.502 -1.439 . . . . 4.77 109.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -172.19 73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -1.17 . . . . 5.79 109.47 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -36.94 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 6.33 109.438 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.706 HH11 ' CG ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -42.98 119.55 1.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 6.42 109.437 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.18 169.43 10.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 2.66 109.954 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.02 -15.9 6.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 3.93 108.881 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.482 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.51 36.88 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 4.15 109.155 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -76.38 98.1 4.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.98 . . . . 4.6 109.504 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -106.15 137.12 44.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 3.96 109.128 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.562 ' N ' ' NE2' ' A' ' 97' ' ' GLN . . . -136.73 -0.25 2.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.766 -1.334 . . . . 3.67 109.766 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.686 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.6 m -122.8 63.37 0.98 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.131 -1.217 . . . . 3.79 109.773 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.68 ' N ' ' OE1' ' A' ' 97' ' ' GLN . . . -112.89 96.39 37.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 2.22 109.494 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.41 125.76 5.84 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.791 2.327 . . . . 3.49 112.573 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.456 HD22 ' NE ' ' A' ' 109' ' ' ARG . 70.7 mt -133.4 149.24 51.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 3.46 109.271 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 105' ' ' GLU . 1.8 t -136.69 -174.92 3.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 2.83 109.58 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -63.13 38.62 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.566 -1.414 . . . . 2.83 109.566 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.619 ' H ' ' C ' ' A' ' 103' ' ' THR . 17.3 tp10 -117.33 78.85 11.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 3.02 109.387 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.53 118.94 2.83 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.801 2.334 . . . . 1.42 112.17 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.671 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -174.32 169.72 3.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 1.81 109.58 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.82 141.15 29.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 2.19 109.881 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.793 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.55 137.06 49.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.705 -1.22 . . . . 5.23 107.705 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 110' ' ' GLU . 6.2 mp0 -111.22 107.43 16.74 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.847 -0.741 . . . . 3.28 110.977 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.476 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.6 m-30 -109.89 110.69 21.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.186 -1.042 . . . . 3.78 108.186 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.13 153.25 22.36 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.232 -0.917 . . . . 3.99 109.777 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -141.08 173.82 11.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 3.1 109.289 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -101.35 111.44 23.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 2.65 109.655 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 64' ' ' GLU . 6.9 t -41.03 125.99 2.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 4.28 109.353 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 6.4 p-10 -121.21 -30.64 4.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 7.59 109.522 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -123.97 123.82 41.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 5.5 109.472 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.56 116.28 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 4.48 109.393 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 23.8 m-85 -122.45 79.61 46.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 5.99 109.48 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.83 168.98 2.05 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.808 2.338 . . . . 4.64 111.96 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.66 -16.89 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.696 2.264 . . . . 4.46 112.117 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.59 176.59 4.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 4.14 109.409 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.78 -156.17 18.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 4.24 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 5.0 p-10 -35.87 -72.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -1.134 . . . . 3.59 109.565 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -137.63 150.34 67.84 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 2.78 109.463 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.86 -158.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.824 2.35 . . . . 1.57 112.246 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -58.36 157.31 19.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.428 . . . . 1.25 109.529 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.3 149.42 34.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -1.165 . . . . 2.18 109.484 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.421 HG23 ' CG1' ' A' ' 84' ' ' VAL . 58.0 t -150.58 150.83 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.627 -0.879 . . . . 1.87 108.627 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.35 99.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.004 -1.06 . . . . 1.45 110.369 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -70.18 114.34 8.23 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 2.4 108.144 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 48' ' ' PRO . 1.2 m170 -99.28 133.2 43.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 2.98 110.388 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 134' ' ' GLY . 4.6 mp -127.81 -40.79 1.7 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.78 . . . . 2.61 109.064 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 55.71 147.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 2.32 109.693 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.722 ' HZ2' ' NE2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -99.8 -150.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.169 . . . . 5.66 109.547 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.623 ' H ' ' H ' ' A' ' 44' ' ' GLY . . . 78.46 6.11 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 2.71 109.055 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.29 10.03 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.136 -1.586 . . . . 3.14 109.136 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.02 -149.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -1.084 . . . . 2.84 109.573 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -166.74 -114.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.392 -0.818 . . . . 2.44 109.828 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.696 ' OE2' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.02 141.58 51.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 1.86 108.773 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.646 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 18.2 t80 -125.84 114.86 19.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -0.841 . . . . 2.48 110.045 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 140' ' ' GLU . 1.5 m -117.71 103.16 9.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.74 110.014 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.448 HG23 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -115.33 143.42 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 1.69 109.013 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.445 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 49.6 p -137.84 -1.17 2.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.601 -0.687 . . . . 1.63 109.358 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.751 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 7.3 mt-30 -153.06 153.84 33.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 3.82 109.98 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.644 ' N ' ' OG1' ' A' ' 13' ' ' THR . 88.1 t -160.18 121.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 2.92 109.369 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 p -152.01 171.73 17.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.011 . . . . 3.25 109.702 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 1.9 pt? -157.94 -162.44 1.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 5.12 109.508 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.668 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER 165.34 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 3.35 109.443 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.668 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.5 t -163.93 -115.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 2.29 109.458 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 153' ' ' THR . 0.5 OUTLIER 158.9 35.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 2.54 109.393 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.643 ' CB ' ' H ' ' A' ' 2' ' ' SER . . . 37.06 23.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 3.09 109.444 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 151' ' ' SER . 10.4 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.043 -0.979 . . . . 3.68 109.461 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.499 -0.556 . . . . 5.8 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 152' ' ' ALA . 95.0 p -72.72 -107.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 4.81 109.445 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 4' ' ' ASP . 4.4 tp 53.1 -155.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 5.68 109.415 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.616 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -44.43 176.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 5.38 109.538 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER 84.13 164.17 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 4.83 109.478 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -106.87 133.14 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 3.43 109.502 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.685 ' H ' ' HG1' ' A' ' 149' ' ' THR . 1.4 t -107.21 51.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.867 . . . . 3.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.651 ' OE1' ' N ' ' A' ' 9' ' ' LEU . 3.8 tp10 -49.93 106.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 4.75 109.485 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.651 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 3.9 mt -85.7 28.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.91 . . . . 5.44 109.445 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.624 ' O ' ' N ' ' A' ' 12' ' ' HIS . 3.0 tm? -157.19 89.09 2.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 2.86 108.889 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -53.72 43.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.186 2.591 . . . . 4.15 113.321 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 10' ' ' LEU . 11.7 t60 -158.39 102.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.892 -1.13 . . . . 2.52 109.53 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.735 ' HG1' ' H ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -147.04 43.91 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 2.33 109.469 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 16' ' ' ALA . 68.8 m -155.77 81.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 2.28 109.947 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.416 ' CZ ' HG12 ' A' ' 146' ' ' VAL . 6.6 m-85 -69.41 36.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 2.6 108.988 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -78.46 -30.43 47.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.236 -0.915 . . . . 1.66 109.599 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 1.9 mt-10 -110.38 -73.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 2.13 109.501 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.8 m -109.24 145.25 36.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 2.74 109.504 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mt -51.39 -48.22 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 3.06 109.522 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 97.74 -172.87 27.65 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.502 -1.439 . . . . 1.72 109.502 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.0 Cg_endo -69.86 -20.68 34.07 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.739 2.293 . . . . 1.97 112.189 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.575 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 8.6 m95 -53.55 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.993 . . . . 2.88 109.286 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -141.51 167.53 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 2.07 109.782 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.688 ' CD1' ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -174.58 167.59 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 2.79 109.4 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.737 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.74 -176.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 2.48 109.649 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 94.34 -28.85 9.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 1.7 109.842 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.814 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.85 -142.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 1.51 109.306 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.814 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.6 p -91.02 -163.8 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 2.11 109.254 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.25 111.58 47.83 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 2.85 109.022 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HB3' ' CG ' ' A' ' 37' ' ' MET . 56.3 Cg_exo -45.71 159.76 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.268 1.979 . . . . 1.4 112.022 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -143.52 109.24 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 1.53 109.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -69.82 72.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 2.56 109.456 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -65.31 -138.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.81 109.644 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -49.67 81.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.82 . . . . 2.21 109.526 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 47.5 30.68 6.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.639 -1.384 . . . . 1.23 109.639 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.45 142.81 30.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -1.144 . . . . 3.37 109.564 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.417 ' CG ' ' HB3' ' A' ' 30' ' ' PRO . 5.3 ttp -109.87 125.24 52.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 1.4 109.163 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.431 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 56.8 m -124.6 154.79 40.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.917 . . . . 1.06 110.084 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.96 139.4 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.525 -0.734 . . . . 1.95 109.025 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.12 122.21 33.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 4.79 109.649 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 9.0 mp -113.29 92.98 24.29 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 3.97 109.344 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 51.1 Cg_exo -50.03 -57.02 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.031 2.487 . . . . 4.21 112.625 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 117.99 146.53 8.17 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.783 -1.327 . . . . 2.09 109.783 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 33.34 0.73 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.863 -1.295 . . . . 2.62 109.863 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.525 ' NE2' ' CB ' ' A' ' 50' ' ' ASP . 9.1 mt-30 -118.26 150.48 39.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.113 -1.228 . . . . 2.96 109.648 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.13 56.83 0.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.383 -1.487 . . . . 2.38 109.383 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.623 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -174.48 98.49 0.29 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.199 -1.177 . . . . 4.04 109.393 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' CZ3' ' A' ' 49' ' ' TRP . 77.6 Cg_exo -46.27 -21.62 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.613 2.209 . . . . 2.75 112.431 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 39.2 p90 -106.9 65.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 4.57 109.494 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' NE2' ' A' ' 45' ' ' GLN . 1.2 m-20 -134.99 6.57 3.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 2.38 109.695 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -177.06 154.75 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 1.47 109.721 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.11 -169.33 26.29 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.879 -1.288 . . . . 0.96 109.879 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.681 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -97.34 152.18 19.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -1.074 . . . . 1.51 109.134 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.53 162.87 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 1.51 110.083 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.69 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 18.7 t80 175.58 149.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 2.45 109.4 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.69 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 1.4 m-80 -101.37 176.8 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 2.95 109.527 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.6 76.99 1.34 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 2.52 109.563 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.8 70.3 4.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 4.19 109.498 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.674 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.48 131.67 28.28 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.801 2.334 . . . . 2.79 112.191 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.07 114.24 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 3.62 109.521 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.628 ' C ' ' HG ' ' A' ' 115' ' ' SER . . . -117.18 103.55 1.11 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.521 -1.432 . . . . 3.37 109.521 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HB2' ' N ' ' A' ' 117' ' ' LEU . 3.4 tm-20 -47.34 139.05 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.138 . . . . 6.05 109.529 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.11 -37.18 3.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.688 -1.365 . . . . 3.09 109.688 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' SER . 2.7 mt-10 -99.99 168.88 9.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -1.18 . . . . 4.03 109.574 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.6 m -115.0 139.93 49.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 3.28 109.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.674 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 22.9 m-85 -104.61 -178.32 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.115 -0.99 . . . . 2.59 109.549 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.456 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -153.76 121.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 3.18 109.639 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.52 115.96 30.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 4.0 109.23 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -109.88 86.46 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.067 -1.02 . . . . 2.8 109.198 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 6.9 p90 -94.9 139.29 31.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.442 -0.786 . . . . 2.64 111.295 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.493 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -98.35 119.6 37.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.499 -0.926 . . . . 2.25 108.499 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . . . -171.57 134.68 0.85 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.077 -1.015 . . . . 1.45 110.024 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.453 ' HB2' ' N ' ' A' ' 105' ' ' GLU . 53.2 p -124.26 122.38 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 1.28 109.21 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.596 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -91.67 135.95 33.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 1.07 109.386 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.449 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.16 117.06 16.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.351 -0.843 . . . . 1.68 109.49 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -66.52 -142.42 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.66 0 C-N-CA 124.305 -1.123 . . . . 1.32 112.199 -0.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.453 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.7 OUTLIER -104.85 152.18 22.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 1.75 109.38 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.453 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 1.4 mtm -176.42 156.93 1.52 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 2.72 109.157 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.82 118.9 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.752 2.301 . . . . 1.83 112.402 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 98' ' ' GLY . 4.7 m -99.19 176.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 2.57 109.275 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.657 ' N ' ' O ' ' A' ' 132' ' ' HIS . 18.7 ttm180 -122.67 146.47 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 6.46 109.728 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.29 155.27 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.301 -0.874 . . . . 4.19 109.45 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.11 156.95 43.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 2.9 109.608 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.577 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.0 OUTLIER -146.79 138.3 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 2.31 109.681 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.56 -155.71 22.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.472 -1.451 . . . . 1.75 109.472 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.691 ' OE2' ' CG ' ' A' ' 119' ' ' PHE . 21.6 pm0 -88.82 -155.02 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 2.54 109.482 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.423 ' CA ' HE22 ' A' ' 128' ' ' GLN . . . 167.56 14.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.77 109.669 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.35 -110.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 2.54 109.49 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' TYR . . . -81.9 -135.3 1.99 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.46 -1.456 . . . . 4.77 109.46 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.48 0.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 5.79 109.393 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER -69.77 80.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 6.33 109.46 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.58 ' O ' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -71.52 167.62 19.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.943 . . . . 6.42 109.51 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.669 ' HG1' ' H ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -99.94 176.37 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 2.66 109.786 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.669 ' H ' ' HG1' ' A' ' 93' ' ' THR . . . -113.93 -22.77 9.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.897 -0.779 . . . . 3.93 108.897 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.84 34.26 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 4.15 109.35 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' OE1' ' C ' ' A' ' 96' ' ' GLU . 1.3 tm-20 -79.03 82.21 5.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 4.6 109.486 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.52 ' CG ' ' N ' ' A' ' 98' ' ' GLY . 3.9 pt20 -108.99 -160.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 3.96 109.522 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 97' ' ' GLN . . . -173.49 -41.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.534 -1.426 . . . . 3.67 109.534 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.48 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 3.79 109.585 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 98' ' ' GLY . . . -122.02 96.3 46.8 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 2.22 109.417 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.42 130.7 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.815 2.344 . . . . 3.49 112.754 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -132.65 140.32 48.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 3.46 109.297 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.66 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -93.93 -160.98 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 2.83 109.514 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.66 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -107.66 33.08 6.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 2.83 109.637 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.453 ' N ' ' HB2' ' A' ' 73' ' ' SER . 0.4 OUTLIER -119.12 142.07 31.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -1.166 . . . . 3.02 109.351 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 107' ' ' ALA . 55.3 Cg_endo -73.52 136.55 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.584 2.189 . . . . 1.42 112.217 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 106' ' ' PRO . . . 165.48 160.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 1.81 109.662 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.56 131.03 35.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 2.19 110.062 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 69' ' ' SER . 3.2 mmt180 -93.51 146.42 23.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.648 -1.612 . . . . 5.23 106.648 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.02 105.83 16.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.936 -1.103 . . . . 3.28 110.192 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.48 76.2 0.99 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.683 -0.858 . . . . 3.78 108.683 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.97 164.89 11.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 3.99 109.712 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 4.2 p90 -164.96 -174.21 3.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 3.1 109.607 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.28 112.22 24.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -0.811 . . . . 2.65 109.57 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.628 ' HG ' ' C ' ' A' ' 61' ' ' GLY . 6.8 t -47.27 125.11 7.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 4.28 109.395 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.453 ' O ' ' CD2' ' A' ' 117' ' ' LEU . 7.8 t-20 -124.2 1.03 8.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 7.59 109.422 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -145.98 120.41 9.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 5.5 109.444 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.648 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -67.93 140.16 56.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 4.48 109.58 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.691 ' CG ' ' OE2' ' A' ' 86' ' ' GLU . 18.4 m-85 -170.01 76.67 0.64 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 5.99 109.524 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.12 169.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.86 2.373 . . . . 4.64 111.944 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 125' ' ' ALA . 66.2 Cg_endo -80.46 -16.14 10.81 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.801 2.334 . . . . 4.46 112.082 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 123' ' ' GLY . 17.4 p-10 -109.95 -46.43 3.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 4.14 109.516 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -39.42 -45.02 2.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.489 -1.444 . . . . 4.24 109.489 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.19 -73.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 3.59 109.473 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -139.82 162.19 52.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 2.78 109.4 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.68 -5.37 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.028 2.485 . . . . 1.57 112.202 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 120.82 161.19 11.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.51 -1.436 . . . . 1.25 109.51 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 2.3 tt0 -149.15 105.82 3.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -1.148 . . . . 2.18 109.718 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 1.7 p -139.09 118.39 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.648 -0.871 . . . . 1.87 108.648 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.23 139.34 31.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 1.45 110.583 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -94.73 109.31 21.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.711 -0.848 . . . . 2.4 108.711 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.657 ' O ' ' N ' ' A' ' 81' ' ' ARG . 6.3 m170 -99.74 119.8 38.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 2.98 109.733 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -112.3 -3.56 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 2.61 109.126 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 46.13 -179.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.377 -1.489 . . . . 2.32 109.377 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.429 ' NZ ' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mtmt -125.41 24.28 7.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.282 . . . . 5.66 109.592 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.2 -21.69 63.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.714 -1.217 . . . . 2.71 107.714 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.698 ' O ' ' CD2' ' A' ' 139' ' ' TYR . . . -130.1 54.91 0.78 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.655 -2.178 . . . . 3.14 107.655 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -29.62 154.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.807 0.813 . . . . 2.84 110.825 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.7 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 174.5 -163.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 2.44 109.132 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.43 120.28 39.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 1.86 109.728 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 72' ' ' ALA . 6.4 t80 -102.15 106.87 17.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.867 . . . . 2.48 108.796 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.37 101.18 10.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.74 110.566 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 140.71 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 1.69 108.878 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.677 ' OG ' ' NE2' ' A' ' 145' ' ' GLN . 53.0 p -133.43 -7.51 2.91 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.553 -0.717 . . . . 1.63 109.516 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.677 ' NE2' ' OG ' ' A' ' 144' ' ' SER . 1.8 mm-40 -146.62 161.46 40.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 3.82 109.663 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.735 ' H ' ' HG1' ' A' ' 13' ' ' THR . 8.4 p -176.23 109.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.92 109.758 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 p -153.54 162.77 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 3.25 109.47 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.43 171.97 13.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 5.12 109.42 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.685 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -165.85 -168.19 1.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 3.35 109.482 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.581 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.3 t -146.36 -135.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.203 -0.935 . . . . 2.29 109.486 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.45 ' N ' ' CG2' ' A' ' 150' ' ' THR . 0.0 OUTLIER 170.95 125.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 2.54 109.426 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.646 ' N ' ' OG ' ' A' ' 2' ' ' SER . . . 60.74 166.35 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 3.09 109.417 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.979 -1.01 . . . . 3.68 109.491 -179.992 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.477 -0.564 . . . . 5.8 109.477 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.546 ' O ' ' C ' ' A' ' 3' ' ' LEU . 0.7 OUTLIER -113.71 -33.75 5.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 4.81 109.432 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -35.09 111.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 5.68 109.618 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.571 ' OD1' ' OG ' ' A' ' 5' ' ' SER . 7.1 p30 -148.46 19.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 5.38 109.277 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.571 ' OG ' ' OD1' ' A' ' 4' ' ' ASP . 2.1 p 167.92 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 4.83 109.276 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.654 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -34.71 120.87 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 3.43 109.698 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.576 ' O ' ' C ' ' A' ' 8' ' ' GLU . 1.0 OUTLIER -71.25 23.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 3.0 109.272 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.623 ' H ' ' C ' ' A' ' 6' ' ' GLU . 5.6 tt0 24.23 65.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.025 0.44 . . . . 4.75 110.659 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' HG ' ' CG1' ' A' ' 7' ' ' VAL . 12.3 mt -56.02 -49.12 74.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 5.44 108.859 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 55' ' ' TYR . 1.2 tp -101.34 116.05 64.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.003 . . . . 2.86 108.293 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.58 27.84 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.215 1.943 . . . . 4.15 111.946 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.484 ' O ' ' CD2' ' A' ' 10' ' ' LEU . 35.9 t60 -137.02 139.15 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 2.52 109.502 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.576 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.07 54.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 2.33 109.338 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -164.41 73.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 2.28 109.572 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -62.97 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 2.6 108.897 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -74.05 -46.96 40.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 1.66 109.925 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.674 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.9 mt-10 -109.78 -84.02 0.56 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 2.13 109.542 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.8 m -94.41 142.98 26.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 2.74 109.465 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.62 -12.56 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 3.06 109.558 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.463 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 82.1 -147.05 25.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.36 -1.496 . . . . 1.72 109.36 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.31 -11.78 13.1 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.671 2.247 . . . . 1.97 112.143 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.6 m95 -66.51 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 2.88 109.284 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -156.44 126.84 6.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 2.07 109.559 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.634 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -121.08 133.17 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.958 . . . . 2.79 109.554 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.681 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.97 153.35 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 2.48 109.597 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 109.69 -22.92 23.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.951 -1.259 . . . . 1.7 109.951 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.823 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.91 -142.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.998 -1.295 . . . . 1.51 109.373 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.823 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.3 p -90.96 141.54 28.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 2.11 109.41 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -37.38 101.59 0.22 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.966 . . . . 2.85 109.236 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' SER . 59.9 Cg_exo -46.27 160.94 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.404 2.069 . . . . 1.4 111.879 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.615 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 7.7 p -138.35 97.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 1.53 110.318 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.32 84.41 3.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.454 -0.779 . . . . 2.56 109.096 178.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.15 -140.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 1.81 109.925 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 2.21 109.563 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . -141.73 47.25 0.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.727 -1.349 . . . . 1.23 109.727 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.716 ' NH2' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -168.43 148.88 4.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 3.37 109.752 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.509 ' SD ' ' CD1' ' A' ' 24' ' ' LEU . 58.2 ttp -123.43 129.24 50.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.419 -0.8 . . . . 1.4 109.224 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.716 ' SG ' ' NH2' ' A' ' 36' ' ' ARG . 59.3 m -122.65 146.55 47.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.607 -0.837 . . . . 1.06 110.072 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG2' HD13 ' A' ' 41' ' ' LEU . 3.0 m -122.69 160.25 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.62 -0.881 . . . . 1.95 108.62 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.637 ' H ' ' HG ' ' A' ' 28' ' ' SER . 2.9 m-20 -105.9 99.69 9.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 4.79 110.119 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 7.2 mp -113.73 79.76 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 3.97 109.137 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.18 -158.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.872 2.381 . . . . 4.21 112.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 136' ' ' ALA . . . -96.09 123.85 7.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.444 -1.462 . . . . 2.09 109.444 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.0 -14.83 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 2.62 109.535 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 27.4 mt-30 -99.79 70.11 1.62 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -1.184 . . . . 2.96 109.435 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.83 49.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.548 -1.421 . . . . 2.38 109.548 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -164.65 87.14 1.08 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.223 -1.163 . . . . 4.04 109.494 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 51.3 Cg_exo -48.73 -6.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.826 2.351 . . . . 2.75 112.173 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.497 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.3 p90 -100.25 37.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 4.57 109.485 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 46.3 m-20 -146.1 32.79 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 2.38 109.434 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 172.97 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 1.47 109.403 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.6 173.7 41.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.783 -1.327 . . . . 0.96 109.783 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 53' ' ' LEU . 5.2 mp -99.67 175.94 5.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 1.51 109.245 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 0.6 OUTLIER -152.95 167.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 1.51 110.51 -179.61 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.687 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 5.4 t80 -177.65 132.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 2.45 109.162 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.687 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -107.59 159.79 16.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.946 . . . . 2.95 109.66 -179.709 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.01 77.52 1.03 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.447 . . . . 2.52 109.484 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 58' ' ' VAL . 55.2 t -149.85 60.91 4.71 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.142 . . . . 4.19 109.556 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 50.5 Cg_exo -48.57 142.59 17.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.775 2.316 . . . . 2.79 112.102 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 3.0 t -134.45 153.97 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 3.62 109.629 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -136.04 112.34 0.96 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.461 -1.455 . . . . 3.37 109.461 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.2 tm-20 -39.06 135.11 0.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.144 . . . . 6.05 109.668 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.22 -14.36 63.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.885 -1.286 . . . . 3.09 109.885 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' OG ' ' A' ' 115' ' ' SER . 2.2 mm-40 -100.79 157.45 16.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 4.03 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 150' ' ' THR . 70.8 m -118.96 121.37 39.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 3.28 109.176 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 60' ' ' VAL . 51.7 m-85 -98.19 178.54 5.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.203 -0.935 . . . . 2.59 109.743 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -163.61 133.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 3.18 109.41 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -118.18 122.03 42.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 4.0 109.736 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.4 p -112.2 100.25 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.88 -0.785 . . . . 2.8 108.88 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 2.2 p90 -93.96 146.31 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 2.64 110.95 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -99.63 107.01 19.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.124 -1.065 . . . . 2.25 108.124 178.534 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -157.52 156.26 31.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.697 -1.252 . . . . 1.45 110.862 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' GLU . 97.0 p -132.27 121.48 23.66 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.856 -0.794 . . . . 1.28 108.856 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -81.53 129.91 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 1.07 109.817 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.601 ' HG1' ' CB ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -130.81 116.92 17.17 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.382 -0.824 . . . . 1.68 109.287 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.591 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.35 -144.77 0.18 OUTLIER 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.104 -1.207 . . . . 1.32 111.998 0.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' ' CG ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.03 154.62 19.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.698 -1.251 . . . . 1.75 109.39 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.657 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 157.17 154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.385 -0.822 . . . . 2.72 109.264 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.565 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 68.0 Cg_endo -77.55 141.96 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.821 2.347 . . . . 1.83 112.356 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 98' ' ' GLY . 35.1 m -108.4 170.3 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 2.57 109.362 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 132' ' ' HIS . 0.1 OUTLIER -109.85 156.18 20.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 6.46 109.437 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 97' ' ' GLN . 2.7 p -156.94 159.31 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 4.19 109.51 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.55 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -154.66 143.67 21.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 2.9 109.702 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.595 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.4 OUTLIER -153.79 161.18 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 2.31 109.467 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 133.77 -164.56 24.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 1.75 109.548 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.687 ' OE2' ' CZ ' ' A' ' 119' ' ' PHE . 12.7 pm0 -84.08 35.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 2.54 109.428 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' O ' ' OE1' ' A' ' 128' ' ' GLN . . . -41.41 86.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.636 -1.386 . . . . 1.77 109.636 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 86' ' ' GLU . . . -139.76 59.53 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.627 -1.389 . . . . 2.54 109.627 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.663 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 56.0 123.48 0.01 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.482 -1.447 . . . . 4.77 109.482 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 62.89 -49.7 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 5.79 109.392 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.663 ' N ' ' O ' ' A' ' 89' ' ' GLY . 40.3 m-85 -53.86 79.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 6.33 109.39 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.66 HH11 ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -48.09 -175.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 6.42 109.789 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.761 ' HG1' ' H ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -144.05 -172.34 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 2.66 109.984 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.761 ' H ' ' HG1' ' A' ' 93' ' ' THR . . . -125.28 -23.39 4.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.89 -0.781 . . . . 3.93 108.89 179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.47 ' CD2' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.47 42.52 1.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 4.15 109.254 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.87 49.4 1.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.988 -1.07 . . . . 4.6 109.482 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -112.52 153.87 26.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 3.96 109.234 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -140.21 4.33 2.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 3.67 109.576 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -77.28 62.31 2.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.79 109.451 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.47 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -104.7 106.71 55.9 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 2.22 109.324 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.63 123.44 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.576 2.184 . . . . 3.49 112.676 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.32 173.24 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 3.46 109.358 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -138.11 -174.11 3.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 2.83 109.788 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -86.78 42.39 3.15 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.626 -1.389 . . . . 2.83 109.626 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.9 mt-10 -162.24 160.95 21.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 3.02 109.114 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.5 115.58 2.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.641 2.227 . . . . 1.42 111.715 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.39 124.65 9.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 1.81 109.754 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.418 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.49 150.28 21.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.809 . . . . 2.19 109.994 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -131.4 143.08 50.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.706 -1.22 . . . . 5.23 107.706 178.246 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.671 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 5.3 mt-10 -127.32 128.26 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.374 -0.93 . . . . 3.28 110.814 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' CB ' ' A' ' 100' ' ' ALA . 6.9 m-85 -124.56 119.08 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.655 -0.869 . . . . 3.78 108.655 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.34 146.85 29.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 3.99 110.007 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.728 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -130.92 164.68 24.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 3.1 109.267 179.681 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.475 ' H ' ' HG1' ' A' ' 114' ' ' THR . 0.8 OUTLIER -100.4 122.4 43.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 2.65 109.819 -179.703 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 6.1 m -59.77 129.83 43.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 4.28 109.393 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -114.99 -19.81 10.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 7.59 109.551 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -142.44 -153.1 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 5.5 109.276 179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.56 148.4 47.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.246 -0.909 . . . . 4.48 109.687 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.687 ' CZ ' ' OE2' ' A' ' 86' ' ' GLU . 44.4 m-85 -147.47 91.46 5.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 5.99 109.302 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.84 165.74 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.815 2.343 . . . . 4.64 112.227 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 -15.5 12.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.697 2.265 . . . . 4.46 112.02 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.83 132.42 54.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -0.873 . . . . 4.14 109.549 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.28 -148.05 19.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 4.24 109.525 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.5 30.0 7.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 3.59 109.441 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.401 ' CB ' ' CG ' ' A' ' 91' ' ' TYR . . . -177.85 70.0 0.21 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 2.78 109.437 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.55 -158.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.842 2.361 . . . . 1.57 112.185 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.38 149.91 50.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.528 -1.429 . . . . 1.25 109.528 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.566 ' OE1' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -148.09 128.02 13.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 2.18 109.536 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 32.8 t -138.75 137.45 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.465 -0.939 . . . . 1.87 108.465 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -155.24 109.74 2.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.186 -1.006 . . . . 1.45 110.262 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -80.6 103.53 10.52 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.847 -0.797 . . . . 2.4 108.847 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CD2' ' O ' ' A' ' 48' ' ' PRO . 7.0 m170 -99.58 128.77 45.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.935 . . . . 2.98 109.713 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.667 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.69 -32.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 2.61 109.449 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.554 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -39.6 131.96 2.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.566 -1.414 . . . . 2.32 109.566 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 137' ' ' GLY . 47.2 mttt -165.6 140.4 4.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 5.66 109.594 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.82 -20.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 2.71 108.565 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.51 12.93 7.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.112 -1.595 . . . . 3.14 109.112 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -50.42 -164.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -1.039 . . . . 2.84 109.898 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.565 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 1.1 p90 -166.61 -161.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 2.44 109.385 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.601 ' CB ' ' HG1' ' A' ' 75' ' ' THR . 3.0 mt-10 -81.67 151.31 27.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 1.86 109.733 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 12.8 t80 -137.19 113.36 9.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.893 . . . . 2.48 109.319 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.7 m -106.14 96.53 6.54 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.128 -0.983 . . . . 0.74 110.154 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -107.05 139.05 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 1.69 108.954 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.673 ' OG ' ' NE2' ' A' ' 145' ' ' GLN . 78.3 p -132.81 -14.03 2.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.563 -0.711 . . . . 1.63 109.715 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.673 ' NE2' ' OG ' ' A' ' 144' ' ' SER . 0.8 OUTLIER -147.9 164.59 33.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 3.82 110.146 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 146' ' ' VAL . 8.7 p -178.51 126.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.935 -0.765 . . . . 2.92 108.935 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.48 147.73 40.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.068 -1.02 . . . . 3.25 110.076 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 32.2 tp -116.72 135.6 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 5.12 109.231 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -150.68 -177.25 5.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.025 . . . . 3.35 109.725 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.564 ' N ' ' OG1' ' A' ' 149' ' ' THR . 2.7 t -133.6 -152.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 2.29 109.576 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -118.01 127.72 54.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.835 . . . . 2.54 109.49 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.557 ' O ' ' O ' ' A' ' 151' ' ' SER . . . -38.21 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 3.09 109.526 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.002 -0.999 . . . . 3.68 109.467 -179.95 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.458 -0.571 . . . . 8.12 109.458 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.592 ' HG ' ' H ' ' A' ' 152' ' ' ALA . 1.7 p 52.24 -74.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 5.6 108.956 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.761 ' N ' ' O ' ' A' ' 1' ' ' ALA . 3.9 tp 69.5 -153.43 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.288 -0.882 . . . . 5.9 110.048 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 5' ' ' SER . 8.5 m-20 -43.19 156.71 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 4.43 109.06 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 71.12 111.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 3.49 109.53 -179.847 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 8' ' ' GLU . 6.8 mp0 -71.21 135.88 47.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.967 . . . . 3.68 109.184 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.676 ' H ' ' HG1' ' A' ' 149' ' ' THR . 1.8 t -66.48 77.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.024 . . . . 2.19 109.39 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 6' ' ' GLU . 1.4 tp10 -67.7 79.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.858 . . . . 2.74 109.715 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.81 -14.27 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.898 . . . . 2.31 109.19 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.634 ' CD1' ' O ' ' A' ' 12' ' ' HIS . 1.1 tm? -126.38 85.88 59.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 2.52 108.874 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.91 37.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.154 2.57 . . . . 2.27 112.391 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.634 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 57.2 t60 -145.53 101.1 3.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 1.45 109.315 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.7 t -142.37 52.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.267 -0.895 . . . . 1.53 109.453 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.628 ' C ' ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -139.38 68.11 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 2.22 109.609 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -67.1 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 2.24 109.127 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.25 -36.07 14.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 1.53 110.196 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 3.0 mm-40 -109.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 2.97 110.137 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -99.38 151.29 21.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.89 109.87 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.405 ' CD2' HD22 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -59.37 -60.02 4.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.845 . . . . 2.49 109.304 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.37 -164.32 12.32 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.84 109.523 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.55 -2.71 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.834 2.356 . . . . 0.93 112.276 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.535 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 11.8 m95 -75.13 -177.09 3.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.89 . . . . 0.64 109.321 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -140.07 175.84 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 1.22 109.295 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' TYR . 1.8 pp -179.29 164.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 2.43 109.938 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.675 ' CD1' ' N ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 162.71 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 2.99 109.718 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.61 -21.97 9.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.038 -1.225 . . . . 0.64 110.038 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.879 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.69 -142.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.287 . . . . 1.15 109.49 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.2 p -91.78 -175.87 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 1.05 108.984 179.389 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -81.02 111.65 25.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 2.59 108.815 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 28' ' ' SER . 54.1 Cg_exo -49.26 155.02 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.317 2.011 . . . . 1.16 111.855 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 37' ' ' MET . 44.9 t -142.41 106.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 1.75 109.986 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.68 82.92 3.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 2.24 109.128 179.127 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.569 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 1.36 109.938 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' ALA . 2.6 m-20 -41.47 -65.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 2.49 109.448 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.88 26.34 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.299 -1.52 . . . . 1.29 109.299 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -141.03 145.02 35.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -1.122 . . . . 4.18 109.641 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.443 ' SD ' ' HB3' ' A' ' 30' ' ' PRO . 45.4 ttp -112.85 127.35 56.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 1.54 109.128 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.606 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -121.3 156.82 31.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 1.22 110.346 -179.358 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -125.61 142.23 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.685 -0.857 . . . . 1.21 108.685 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' N ' ' OG ' ' A' ' 28' ' ' SER . 5.7 m-20 -77.26 111.98 13.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 1.52 109.817 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 139' ' ' TYR . 4.6 mm? -122.87 68.56 34.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 2.01 109.408 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.99 -92.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.835 2.357 . . . . 1.93 112.308 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.07 36.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.53 -1.428 . . . . 2.47 109.53 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.86 -9.02 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 1.79 109.482 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -99.87 119.03 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 2.45 109.522 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.52 46.94 1.18 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.513 -1.435 . . . . 2.54 109.513 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.561 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -171.25 102.95 0.39 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.174 -1.192 . . . . 2.4 109.67 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -47.32 -26.11 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.322 . . . . 1.97 112.363 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.646 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 27.0 p90 -93.98 44.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 4.27 109.665 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.48 ' CG ' ' CG ' ' A' ' 47' ' ' ASN . 1.9 m-20 -131.35 11.88 4.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 1.97 109.343 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.3 140.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 1.39 109.269 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 146.57 -174.36 26.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.678 -1.369 . . . . 0.65 109.678 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.499 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -104.21 -173.57 2.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -1.197 . . . . 2.13 109.921 -179.953 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.54 172.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.704 . . . . 2.1 109.376 -179.767 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 17.8 t80 170.48 142.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 2.28 109.664 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.635 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -103.27 -164.72 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.252 -0.905 . . . . 0.95 109.469 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.72 68.89 1.44 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.411 -1.476 . . . . 0.95 109.411 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.407 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 43.4 t -153.93 73.82 6.38 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.33 -1.1 . . . . 2.24 109.544 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.25 120.85 7.66 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.553 2.169 . . . . 1.14 112.043 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.39 130.19 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.226 -0.921 . . . . 1.69 109.663 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -113.08 102.52 1.29 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.94 109.362 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.567 ' O ' ' OE1' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -42.8 124.76 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 2.73 109.598 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.02 -39.18 2.14 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.77 -1.332 . . . . 1.08 109.77 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.58 ' O ' ' OG ' ' A' ' 115' ' ' SER . 10.3 mt-10 -100.22 170.12 8.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -1.147 . . . . 2.59 109.697 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -116.85 145.14 43.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 1.13 109.269 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 33.3 m-85 -110.84 179.49 4.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.123 -0.986 . . . . 2.34 109.671 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.3 t -152.78 149.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 1.57 109.316 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' ARG . 3.4 tp -134.06 116.96 16.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 1.48 109.858 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 83.2 p -109.4 85.85 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.464 -0.939 . . . . 1.78 108.464 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 49.9 p90 -92.61 137.08 32.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 1.57 111.275 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.3 p -84.24 114.41 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.193 -1.04 . . . . 1.27 108.193 178.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 148.04 15.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.781 -1.199 . . . . 1.34 110.671 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 131.12 39.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.689 -0.856 . . . . 0.95 108.689 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -93.36 127.57 39.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 1.18 109.728 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.497 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -134.19 114.39 12.64 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.307 -0.871 . . . . 1.28 109.261 179.882 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.635 ' O ' ' C ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.74 -141.98 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.895 -1.294 . . . . 0.89 112.407 -0.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.663 ' O ' ' CG ' ' A' ' 78' ' ' MET . 1.4 m-20 -98.94 160.15 14.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 1.4 109.634 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.663 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 156.91 155.83 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.85 . . . . 2.2 109.268 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.62 145.3 41.5 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.884 2.389 . . . . 0.79 112.376 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 0.7 OUTLIER -117.45 172.7 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 1.33 109.222 179.939 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' A' ' 132' ' ' HIS . 20.0 ttt180 -119.69 134.36 55.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.93 . . . . 3.61 109.6 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.527 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -137.99 150.13 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 2.13 109.248 179.795 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.468 HD21 ' CE1' ' A' ' 132' ' ' HIS . 0.8 OUTLIER -145.99 152.33 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 1.46 109.832 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.622 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -154.95 154.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.923 . . . . 1.16 109.632 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 148.33 -149.04 21.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.653 -1.379 . . . . 0.7 109.653 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.674 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.9 pm0 -90.08 178.38 6.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 2.74 109.715 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.08 62.63 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.544 -1.422 . . . . 1.63 109.544 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.36 115.02 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.467 -1.453 . . . . 2.2 109.467 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 87.65 117.83 1.27 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 2.74 109.397 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 62.16 -39.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -1.179 . . . . 3.21 109.102 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.668 ' N ' ' O ' ' A' ' 89' ' ' GLY . 78.5 m-85 60.6 -42.64 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.436 -0.79 . . . . 5.92 109.825 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.849 HH11 ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -33.6 132.19 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.974 . . . . 3.93 109.452 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -125.78 -171.37 2.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 1.48 109.814 -179.815 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.665 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -118.45 -24.06 6.96 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.904 -0.776 . . . . 1.41 108.904 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CG ' ' CG2' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -90.49 41.36 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -0.958 . . . . 2.51 108.719 179.915 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.46 64.75 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.971 . . . . 2.78 109.886 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' VAL . 4.0 pt20 -109.08 153.9 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 2.28 109.177 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.6 11.61 4.3 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.8 -1.32 . . . . 1.01 109.8 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -105.36 77.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -1.181 . . . . 1.18 109.388 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.81 79.53 24.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.943 . . . . 1.17 109.677 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -52.75 126.45 21.18 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.882 2.388 . . . . 1.09 112.384 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.525 HD21 ' HE ' ' A' ' 109' ' ' ARG . 20.6 mt -133.02 137.78 46.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 1.83 109.326 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.1 OUTLIER -109.06 -179.33 3.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 1.68 109.477 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.473 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -84.63 40.56 2.97 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.525 -1.43 . . . . 1.35 109.525 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.38 120.59 12.66 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -1.111 . . . . 3.49 109.402 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.35 118.42 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.391 2.06 . . . . 1.33 111.806 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -160.85 141.96 11.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.92 109.904 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.456 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.0 138.57 31.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.774 . . . . 1.41 109.706 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 69' ' ' SER . 18.4 mmt180 -109.03 136.62 48.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 4.81 108.685 178.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 10.4 mt-10 -113.95 103.36 11.08 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.181 -0.607 . . . . 2.38 109.698 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 16.1 m-85 -109.13 120.09 41.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 2.36 108.424 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.45 156.53 25.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.306 -0.872 . . . . 1.44 109.923 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.0 p90 -144.78 178.98 7.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.456 -0.778 . . . . 2.66 109.161 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.458 ' H ' ' HG1' ' A' ' 114' ' ' THR . 0.7 OUTLIER -105.4 115.8 30.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.448 -0.782 . . . . 1.58 109.633 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 10.7 m -48.82 123.2 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.907 . . . . 2.01 109.418 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 114' ' ' THR . 16.0 m120 -113.97 -38.25 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 3.03 109.571 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -112.93 143.21 44.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 3.06 109.618 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.67 103.99 11.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 1.48 109.54 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.668 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 43.5 m-85 -112.26 95.97 33.07 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 2.72 109.247 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.56 166.15 24.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.682 2.254 . . . . 1.49 112.274 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.54 -19.61 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.9 2.4 . . . . 1.58 111.934 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.1 136.64 54.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 3.5 109.457 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.84 -111.87 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 2.42 109.548 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.37 -17.56 14.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -1.128 . . . . 3.67 109.418 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -167.38 122.31 0.84 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 2.66 109.384 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.63 -159.74 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.542 2.162 . . . . 1.72 112.195 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.407 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -57.87 168.59 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 1.2 109.493 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.21 135.08 12.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 2.81 109.433 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 t -141.12 148.79 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 2.01 108.769 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 129' ' ' VAL . . . -166.27 105.77 0.66 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.101 -0.999 . . . . 1.19 110.029 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.475 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 7.7 m-30 -83.56 109.99 17.86 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.33 -0.989 . . . . 2.26 108.33 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.468 ' CE1' HD21 ' A' ' 83' ' ' LEU . 44.4 m170 -99.38 120.23 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.945 . . . . 1.4 110.084 -179.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.633 ' CD2' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -129.97 -7.56 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 1.4 109.141 179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -57.69 126.03 41.02 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.401 -1.48 . . . . 1.52 109.401 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 137' ' ' GLY . 11.0 mtpt -161.55 128.23 3.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -1.187 . . . . 5.09 109.987 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.08 -18.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.94 -1.133 . . . . 1.95 107.94 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.703 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -118.27 10.14 13.29 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.837 -1.705 . . . . 2.05 108.837 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.703 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.76 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.61 -0.936 . . . . 2.18 109.858 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.645 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 0.0 OUTLIER -168.74 -114.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.012 . . . . 2.62 110.038 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.4 mt-10 -130.8 138.48 49.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 2.3 109.235 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 12.2 t80 -117.35 116.62 27.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 2.38 109.595 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.01 98.38 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.52 110.043 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.476 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -114.06 141.67 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 1.44 109.256 179.548 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 86.5 p -130.74 -10.68 3.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.682 -0.636 . . . . 1.13 109.346 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.644 ' N ' ' OG1' ' A' ' 71' ' ' THR . 3.8 mt-30 -148.37 177.41 9.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 2.42 110.359 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' A' ' 146' ' ' VAL . 1.1 p -179.17 117.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 1.69 108.821 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.57 ' OG ' ' OG ' ' A' ' 69' ' ' SER . 60.1 p -124.6 151.17 45.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.013 -1.054 . . . . 1.89 110.123 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.582 ' CD1' ' C ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -135.67 122.39 21.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.458 -0.776 . . . . 1.91 108.968 179.728 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.676 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 1.2 t -148.21 -159.97 1.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.053 -1.03 . . . . 1.59 109.666 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.624 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.2 t -141.59 -41.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 1.98 109.33 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.543 ' N ' ' CG2' ' A' ' 150' ' ' THR . 1.1 t 41.58 64.31 1.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.785 . . . . 3.62 109.311 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.592 ' H ' ' HG ' ' A' ' 2' ' ' SER . . . -71.1 140.22 50.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 4.91 109.504 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.081 -0.961 . . . . 8.09 109.382 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 7' ' ' VAL . 42.2 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.458 -0.571 . . . . 2.8300000000000001 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 7' ' ' VAL . 19.5 tp10 -35.85 119.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 4.75 109.344 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' A' ' 148' ' ' LEU . 12.3 mt -88.19 -31.96 18.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 4.9500000000000002 109.801 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 57' ' ' GLY . 1.0 OUTLIER -113.47 129.92 24.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 2.8599999999999999 108.968 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -67.33 59.36 0.69 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.424 2.083 . . . . 3.8300000000000001 113.343 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.496 ' C ' HG22 ' A' ' 13' ' ' THR . 36.2 t60 -165.38 126.65 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.007 . . . . 2.52 109.752 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -170.37 70.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 1.97 109.318 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.5 t -161.33 82.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 1.96 109.8 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.2 m-30 -90.12 24.84 2.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 1.76 109.243 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.23 17.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 1.1799999999999999 109.815 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.677 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 19.6 mm-40 -109.67 -49.5 3.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.184 -0.947 . . . . 2.1299999999999999 109.588 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.8 p -136.39 152.03 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 2.2599999999999998 109.377 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.983 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -85.07 26.97 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 2.6000000000000001 109.191 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 44.41 -151.64 0.64 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.572 -1.411 . . . . 1.6200000000000001 109.572 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 67.4 Cg_endo -81.0 9.45 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.748 2.299 . . . . 1.7 112.555 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.789 ' NE1' ' CD2' ' A' ' 55' ' ' TYR . 10.6 m95 -70.94 172.15 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.006 . . . . 2.4199999999999999 109.275 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.92 177.64 4.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.6399999999999999 109.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.968 ' O ' HD12 ' A' ' 24' ' ' LEU . 4.2 pp -178.46 123.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 2.0499999999999998 109.349 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.2 169.12 2.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 1.72 110.305 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 -26.54 22.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.098 -1.201 . . . . 1.7 110.098 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.799 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.9 -142.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.276 . . . . 0.96999999999999997 109.394 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.799 ' N ' ' OG1' ' A' ' 27' ' ' THR . 67.0 p -91.14 132.56 35.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.251 -0.906 . . . . 1.8 109.236 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -36.83 101.75 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 2.3999999999999999 109.234 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.708 ' HG2' HD13 ' A' ' 24' ' ' LEU . 50.3 Cg_exo -48.16 159.06 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.303 2.002 . . . . 1.1299999999999999 111.551 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' MET . 3.5 t -148.11 114.35 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.937 -1.102 . . . . 1.05 110.659 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.677 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -74.05 79.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.049 -0.722 . . . . 1.8200000000000001 109.049 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.26 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.519 -0.738 . . . . 1.1699999999999999 109.872 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 33' ' ' ALA . 69.0 m-20 -35.65 -70.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 2.21 109.441 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.88 33.12 1.28 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.626 -1.39 . . . . 1.1899999999999999 109.626 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -153.35 150.6 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 2.9100000000000001 109.664 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.527 ' SD ' ' CB ' ' A' ' 30' ' ' PRO . 33.7 ttp -109.05 132.23 54.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.93000000000000005 109.769 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 58.4 m -124.02 156.25 36.82 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.675 -0.81 . . . . 1.0600000000000001 110.211 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.9 m -131.47 129.58 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.684 -0.858 . . . . 1.3700000000000001 108.684 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' H ' ' HG ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -73.65 109.39 7.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 4.79 109.622 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.2 mm? -118.19 35.01 0.21 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.155 -0.965 . . . . 3.54 110.897 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 98.6 Cg_endo -81.87 -24.02 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.521 2.148 . . . . 3.7400000000000002 111.738 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 42' ' ' PRO . . . -26.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.076 -0.81 . . . . 2.0299999999999998 111.076 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.36 54.61 0.01 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.42 -1.872 . . . . 2.4100000000000001 108.42 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 136' ' ' ALA . 20.7 mt-30 -99.7 111.92 24.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 2.96 109.97 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.531 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -81.74 55.26 4.88 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.46 -1.456 . . . . 2.0800000000000001 109.46 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -166.87 96.34 0.69 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 3.6099999999999999 109.427 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 50' ' ' ASP . 56.1 Cg_exo -47.77 -40.46 31.6 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 2.3599999999999999 112.494 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 19.3 p90 -62.95 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 3.8700000000000001 109.413 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -133.16 -57.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 2.3799999999999999 109.659 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.702 ' HB1' HG22 ' A' ' 27' ' ' THR . . . -122.1 146.36 47.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 1.1100000000000001 109.728 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.612 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 163.35 175.72 34.61 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.615 -1.278 . . . . 0.93999999999999995 110.359 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 53' ' ' LEU . 2.1 mm? -100.36 167.91 10.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.617 -0.931 . . . . 0.95999999999999996 108.736 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -154.47 155.4 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.92000000000000004 109.875 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.789 ' CD2' ' NE1' ' A' ' 22' ' ' TRP . 30.1 t80 -177.75 148.91 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 1.71 109.436 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.502 ' ND2' ' HG2' ' A' ' 126' ' ' PRO . 8.4 m-20 -101.64 168.14 9.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 2.7799999999999998 109.568 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.732 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 101.47 81.72 1.6 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 2.48 109.604 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.755 ' CG2' ' H ' ' A' ' 128' ' ' GLN . 5.9 m -163.21 59.76 0.87 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 3.79 109.39 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 56.9 Cg_exo -47.0 149.85 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.881 2.388 . . . . 2.3999999999999999 112.274 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.475 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 1.6 t -144.62 121.74 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 3.0800000000000001 109.522 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -96.81 94.89 1.67 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.493 -1.443 . . . . 3.0499999999999998 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.534 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 13.6 tt0 -38.46 117.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 6.0499999999999998 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 128.2 -35.82 2.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.664 -1.374 . . . . 2.54 109.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.91 172.33 7.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.234 -1.156 . . . . 4.0300000000000002 109.5 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -113.78 137.5 51.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 2.9100000000000001 109.482 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.486 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 37.1 m-85 -105.72 -178.78 3.75 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.21 -0.932 . . . . 2.3799999999999999 109.463 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -150.91 140.38 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 2.6099999999999999 109.917 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.587 HD12 ' HB3' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -116.73 120.41 38.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 3.6099999999999999 109.01 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.68 89.89 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 2.27 109.44 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.682 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.4 137.01 33.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 2.0099999999999998 110.675 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.555 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.06 105.63 17.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 1.8 109.058 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.553 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -175.28 169.82 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.828 -1.17 . . . . 0.95999999999999996 110.677 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.43 159.82 41.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.042 -0.725 . . . . 0.93000000000000005 109.042 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.834 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -102.91 137.56 40.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.67000000000000004 109.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.52 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.44 112.54 6.57 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.258 -0.901 . . . . 0.96999999999999997 109.639 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.3 Cg_exo -63.87 -141.72 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.633 0 C-N-CA 124.218 -1.159 . . . . 1.02 112.439 -0.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -104.94 151.03 24.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 1.75 110.023 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' O ' ' A' ' 137' ' ' GLY . 1.7 mtm 166.25 163.5 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.817 -0.809 . . . . 2.1600000000000001 108.817 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -83.95 153.9 13.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.744 2.296 . . . . 1.3799999999999999 112.591 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.633 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 17.5 m -128.5 -166.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 2.0099999999999998 109.253 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 132' ' ' HIS . 57.0 ttt180 -136.65 141.61 43.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.067 -1.02 . . . . 6.0099999999999998 109.836 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' OE1' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.97 149.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 3.7599999999999998 109.259 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.594 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -142.79 149.22 38.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 2.29 109.876 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 129' ' ' VAL . 1.3 t -151.4 146.09 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 1.8899999999999999 109.696 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.86 -142.0 7.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 1.49 109.476 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 22.8 pt-20 -90.07 -158.78 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -1.193 . . . . 2.54 109.471 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 1.3799999999999999 109.518 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.538 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.48 -0.563 . . . . 5.7400000000000002 109.48 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -115.86 169.92 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 2.27 109.921 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.9 -23.34 11.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.647 -0.871 . . . . 3.2799999999999998 108.647 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.799 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.97 34.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 3.6499999999999999 109.123 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB2' HG23 ' A' ' 93' ' ' THR . 0.6 OUTLIER -89.59 104.74 17.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 4.5999999999999996 109.64 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.498 ' OE1' HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -141.26 176.48 8.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 3.46 109.515 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.47 14.11 0.61 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.643 -1.383 . . . . 3.6699999999999999 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -112.33 60.84 0.63 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -1.182 . . . . 3.79 109.546 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.52 101.93 30.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 1.96 109.083 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.32 131.97 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.539 2.159 . . . . 2.9700000000000002 112.593 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.08 134.48 23.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 3.0600000000000001 109.264 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.664 ' O ' ' N ' ' A' ' 105' ' ' GLU . 9.0 t -138.32 -161.63 1.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 2.3399999999999999 109.523 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.514 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -62.6 37.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.445 -1.462 . . . . 2.1699999999999999 109.445 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 103' ' ' THR . 13.8 tp10 -112.25 93.1 20.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 3.02 109.359 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 58.4 Cg_endo -79.53 118.18 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.715 2.277 . . . . 1.4199999999999999 112.177 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 173.96 -175.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 1.3700000000000001 109.48 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.4 118.82 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 1.72 110.283 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -93.26 137.13 32.87 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.356 -1.35 . . . . 4.7000000000000002 107.356 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.44 118.58 37.14 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.441 -0.787 . . . . 3.2799999999999998 109.666 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -107.94 109.92 21.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.036 -1.098 . . . . 2.96 108.036 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.27 45.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 3.4100000000000001 110.066 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.799 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -133.57 166.88 21.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 2.77 109.176 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.13 126.47 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.228 -0.92 . . . . 2.23 109.866 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 63' ' ' GLY . 3.9 m -69.25 122.78 19.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 4.1100000000000003 109.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.534 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 5.5 t-20 -117.67 -9.98 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 6.8600000000000003 109.54 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.641 HD23 ' CZ ' ' A' ' 119' ' ' PHE . 13.1 tp -141.49 124.2 16.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 5.1200000000000001 109.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.459 ' N ' HD12 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -63.92 144.74 56.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 4.0599999999999996 109.498 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.641 ' CZ ' HD23 ' A' ' 117' ' ' LEU . 32.9 m-85 -142.88 92.22 7.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 5.4400000000000004 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.35 165.81 20.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.76 2.307 . . . . 4.04 112.215 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.99 -17.93 10.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.766 2.31 . . . . 3.8999999999999999 112.007 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.99 132.29 54.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 4.1399999999999997 109.509 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 133.44 50.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.523 -1.431 . . . . 3.5699999999999998 109.523 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 123' ' ' GLY . 1.3 t70 37.92 22.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -1.132 . . . . 3.5899999999999999 109.48 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -151.77 72.07 8.05 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 2.0800000000000001 109.397 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.502 ' HG2' ' ND2' ' A' ' 56' ' ' ASN . 55.2 Cg_endo -74.22 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.791 2.327 . . . . 1.3899999999999999 112.233 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.513 ' HA3' ' H ' ' A' ' 57' ' ' GLY . . . -72.92 157.07 52.24 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.631 -1.388 . . . . 1.1899999999999999 109.631 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.755 ' H ' ' CG2' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -150.77 140.44 21.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -1.131 . . . . 2.0099999999999998 109.587 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 129' ' ' VAL . 4.5 p -161.53 112.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 1.28 108.828 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.414 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -122.74 112.22 17.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.97999999999999998 110.12 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -71.8 113.79 9.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.646 -0.872 . . . . 1.73 108.646 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' ARG . 1.6 m170 -99.66 100.69 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.199 -0.938 . . . . 2.3199999999999998 109.828 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.682 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -109.72 -21.34 12.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 2.1099999999999999 109.075 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.626 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -47.19 139.81 8.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.166 -1.573 . . . . 1.77 109.166 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.626 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER 179.54 129.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.108 . . . . 5.0599999999999996 109.234 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.01 -22.76 0.65 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.618 -1.253 . . . . 2.6400000000000001 107.618 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.642 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -105.24 7.11 43.3 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.466 -1.854 . . . . 2.5099999999999998 108.466 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.618 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -51.82 -145.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.803 -0.822 . . . . 2.3199999999999998 110.285 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.834 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 171.89 -112.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 1.6100000000000001 110.024 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.14 136.04 45.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 1.6499999999999999 109.061 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.553 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 52.9 t80 -122.7 116.71 24.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 1.6799999999999999 109.816 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.51 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 12.4 m -106.75 114.29 28.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -0.907 . . . . 0.73999999999999999 109.561 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.748 HD12 ' N ' ' A' ' 144' ' ' SER . 0.1 OUTLIER -119.97 141.2 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 1.22 109.471 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.748 ' N ' HD12 ' A' ' 143' ' ' ILE . 2.0 p -127.72 -17.21 4.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.163 -0.68 . . . . 1.3300000000000001 109.163 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.651 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.8 OUTLIER -152.28 159.28 43.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.379 -0.825 . . . . 3.2999999999999998 109.378 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 146' ' ' VAL . 11.9 p -165.94 126.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 2.2599999999999998 109.429 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.509 ' OG ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -167.21 146.39 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 2.7599999999999998 109.428 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.587 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.8 pp -111.26 146.39 37.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 4.5700000000000003 109.511 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 150' ' ' THR . 2.1 t -133.57 -157.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -0.876 . . . . 3.0699999999999998 109.483 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.55 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 2.0 109.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.467 -0.568 . . . . 2.8300000000000001 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -141.15 64.39 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 4.75 109.507 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.825 ' HB2' HD11 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -79.95 16.46 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.925 . . . . 4.9500000000000002 109.403 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.697 ' O ' ' N ' ' A' ' 12' ' ' HIS . 1.2 tt -118.08 82.33 17.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.143 -1.058 . . . . 2.8599999999999999 108.143 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.551 ' C ' ' OH ' ' A' ' 55' ' ' TYR . 36.7 Cg_exo -53.02 36.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.099 2.533 . . . . 3.8300000000000001 113.285 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.697 ' N ' ' O ' ' A' ' 10' ' ' LEU . 38.8 t60 -170.34 138.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.995 -1.066 . . . . 2.52 109.579 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.517 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.35 70.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 1.97 109.592 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -169.84 77.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.974 . . . . 1.96 109.903 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.15 22.13 3.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 1.76 109.031 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.09 -25.0 20.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 1.1799999999999999 109.883 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 16.7 mm-40 -109.7 -58.92 1.99 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.048 -1.032 . . . . 2.1299999999999999 109.663 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 m -142.84 143.46 32.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.868 . . . . 2.2599999999999998 109.503 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.93 ' N ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -46.69 -34.23 4.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 2.6000000000000001 109.137 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 79.99 -164.01 47.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.586 -1.406 . . . . 1.6200000000000001 109.586 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 22' ' ' TRP . 34.8 Cg_exo -53.83 -21.52 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.841 2.36 . . . . 1.7 112.326 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CD1' ' CD1' ' A' ' 55' ' ' TYR . 4.3 m95 -53.05 -167.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.4199999999999999 109.356 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 161.9 39.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 1.6399999999999999 109.391 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.643 HD22 ' HG2' ' A' ' 30' ' ' PRO . 2.2 pp -160.08 137.88 9.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 2.0499999999999998 109.688 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 1.72 109.331 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.572 ' O ' ' NE2' ' A' ' 45' ' ' GLN . . . 110.14 -28.58 10.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.84 -1.304 . . . . 1.7 109.84 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.784 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.9 -142.7 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.296 . . . . 0.96999999999999997 109.454 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.784 ' N ' ' OG1' ' A' ' 27' ' ' THR . 3.6 p -91.62 -165.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 1.8 109.313 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.17 111.86 49.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 2.3999999999999999 109.003 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.643 ' HG2' HD22 ' A' ' 24' ' ' LEU . 78.5 Cg_exo -44.21 154.76 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.216 1.944 . . . . 1.1299999999999999 111.981 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' MET . 23.7 t -139.43 100.35 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.971 . . . . 1.05 110.21 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.71 82.58 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.65 0.738 . . . . 1.8200000000000001 109.179 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.78 -114.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.76 . . . . 1.1699999999999999 110.023 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 2.1 m-20 -58.35 66.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 2.21 109.759 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 59.27 6.19 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 1.1899999999999999 109.562 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.663 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.45 141.84 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.216 . . . . 2.9100000000000001 109.424 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -113.8 123.55 50.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 109.031 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.547 ' SG ' ' C ' ' A' ' 141' ' ' PHE . 4.5 t -128.15 153.2 47.13 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.272 -0.971 . . . . 1.0600000000000001 110.559 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.15 120.02 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.548 -0.908 . . . . 1.3700000000000001 108.548 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.568 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -77.39 117.44 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 4.79 109.469 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.671 HD21 ' OG1' ' A' ' 27' ' ' THR . 4.5 mm? -114.6 94.45 36.76 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.257 -0.902 . . . . 3.54 109.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.36 -43.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.223 2.615 . . . . 3.7400000000000002 111.984 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.77 141.47 3.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.397 -1.481 . . . . 2.0299999999999998 109.397 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.19 -0.43 1.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.999 -1.24 . . . . 2.4100000000000001 109.999 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.918 HE21 ' HB2' ' A' ' 51' ' ' ALA . 7.9 mm100 -99.17 -160.92 0.83 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.127 -1.22 . . . . 2.96 109.428 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.43 -57.74 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 2.0800000000000001 109.842 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.68 ' OD1' ' CD1' ' A' ' 49' ' ' TRP . 3.5 p30 -99.76 150.94 37.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.224 -1.162 . . . . 3.6099999999999999 109.58 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' ASP . 84.8 Cg_exo -40.18 -55.41 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.875 2.383 . . . . 2.3599999999999999 112.343 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.68 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 2.1 p90 -70.63 47.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 3.8700000000000001 109.463 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.727 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 67.8 m-20 -116.11 -8.51 11.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 2.3799999999999999 109.709 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.918 ' HB2' HE21 ' A' ' 45' ' ' GLN . . . -172.8 116.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.952 . . . . 1.1100000000000001 109.564 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.501 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 174.3 166.99 33.18 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.68 -1.248 . . . . 0.93999999999999995 110.186 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.97 -169.48 1.62 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -1.093 . . . . 0.95999999999999996 109.421 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -159.64 162.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.92000000000000004 109.805 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.791 ' CD1' ' CD1' ' A' ' 22' ' ' TRP . 20.1 t80 -176.82 140.4 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.821 . . . . 1.71 109.403 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 127' ' ' GLY . 2.7 m-20 -113.31 -164.19 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.38 -0.825 . . . . 2.7799999999999998 109.472 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 9' ' ' LEU . . . 86.06 47.07 5.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.504 -1.438 . . . . 2.48 109.504 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.538 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 22.2 t -151.12 75.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 3.79 109.521 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' VAL . 75.7 Cg_exo -44.04 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.906 2.404 . . . . 2.3999999999999999 112.191 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 119' ' ' PHE . 2.7 t -142.37 120.86 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 3.0800000000000001 109.595 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -137.93 107.67 0.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.323 -1.511 . . . . 3.0499999999999998 109.323 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.7 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.3 tm-20 -42.46 172.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 6.0499999999999998 109.182 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.671 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 80.67 -45.15 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.479 . . . . 2.54 109.404 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -99.56 135.56 40.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 4.0300000000000002 109.084 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.4 m -99.84 148.78 24.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.168 -0.957 . . . . 2.9100000000000001 109.763 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -107.92 177.98 4.65 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 2.3799999999999999 109.583 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -151.39 160.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.489 -0.757 . . . . 2.6099999999999999 109.468 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 109' ' ' ARG . 10.1 tp -143.69 114.3 7.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 3.6099999999999999 109.666 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 4.8 p -109.23 83.66 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.966 . . . . 2.27 108.828 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.613 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 24.9 p90 -93.89 132.99 37.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 2.0099999999999998 111.302 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.673 HG23 ' CG2' ' A' ' 108' ' ' THR . 0.8 OUTLIER -83.71 98.68 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 1.8 108.445 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -144.97 152.03 39.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.05 . . . . 0.95999999999999996 110.093 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.7 p -132.95 121.99 23.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.486 -0.759 . . . . 0.93000000000000005 109.055 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -83.48 132.96 34.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.67000000000000004 109.511 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.468 ' OG1' ' CB ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.62 117.08 16.31 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.323 -0.86 . . . . 0.96999999999999997 109.242 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.24 -142.46 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 124.256 -1.143 . . . . 1.02 112.227 -0.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -96.58 148.42 22.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 1.75 109.336 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.417 ' CE ' ' HB3' ' A' ' 139' ' ' TYR . 0.1 OUTLIER 168.27 153.03 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.685 . . . . 2.1600000000000001 109.29 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.88 117.92 5.1 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.705 2.27 . . . . 1.3799999999999999 112.001 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.483 ' CG1' HD23 ' A' ' 133' ' ' LEU . 27.2 m -79.93 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 2.0099999999999998 109.442 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 132' ' ' HIS . 18.0 ttm180 -114.68 90.29 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 6.0099999999999998 109.528 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.49 154.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.225 -0.922 . . . . 3.7599999999999998 108.993 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.44 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -154.25 162.97 40.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.01 . . . . 2.29 110.082 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.577 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -153.62 160.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 1.8899999999999999 109.358 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.44 -145.07 10.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.667 -1.373 . . . . 1.49 109.667 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.722 ' HB2' ' HB1' ' A' ' 125' ' ' ALA . 2.9 pt-20 -90.19 163.1 14.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 2.54 109.446 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 1.3799999999999999 109.49 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.303 0.573 . . . . 5.7400000000000002 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -125.94 176.91 6.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 2.27 110.03 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.12 -20.98 5.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.841 -0.8 . . . . 3.2799999999999998 108.841 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.804 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.84 34.04 0.92 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 3.6499999999999999 109.149 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.5 92.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 4.5999999999999996 109.888 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 111' ' ' TYR . 4.5 mt-30 -99.77 137.78 37.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 3.46 109.514 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.48 -13.54 2.3 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.652 -1.379 . . . . 3.6699999999999999 109.652 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.38 80.61 1.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.166 -1.197 . . . . 3.79 109.587 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.17 84.52 14.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 1.96 109.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.95 127.31 18.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.989 2.46 . . . . 2.9700000000000002 112.614 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.545 HD21 ' CG ' ' A' ' 109' ' ' ARG . 11.4 mt -144.94 127.03 15.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.866 . . . . 3.0600000000000001 109.325 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 1.7 t -91.98 -169.99 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 2.3399999999999999 109.511 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.17 13.31 67.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 2.1699999999999999 109.534 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.494 ' H ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -103.06 152.77 38.6 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 3.02 109.424 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.31 118.3 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.848 2.365 . . . . 1.4199999999999999 112.2 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.87 146.44 11.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 1.3700000000000001 109.477 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.673 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.15 132.86 35.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 1.72 109.712 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.545 ' CG ' HD21 ' A' ' 102' ' ' LEU . 3.6 mmp_? -101.96 134.11 45.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.91 -1.144 . . . . 4.7000000000000002 107.91 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -109.69 106.05 15.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.033 -0.667 . . . . 3.2799999999999998 110.389 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CB ' HE22 ' A' ' 97' ' ' GLN . 42.1 m-85 -109.74 124.88 52.01 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.312 -0.996 . . . . 2.96 108.312 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.07 163.79 23.0 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 3.4100000000000001 109.922 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.804 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 4.2 p90 -166.76 -168.2 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 2.77 109.471 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.98 154.01 25.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 2.23 109.458 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -90.24 59.12 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 4.1100000000000003 109.799 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.516 ' C ' ' O ' ' A' ' 115' ' ' SER . 6.6 t-20 -33.62 -40.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 6.8600000000000003 109.908 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' OG ' ' A' ' 115' ' ' SER . 2.8 mt -109.93 -169.55 1.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 5.1200000000000001 109.767 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.684 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.7 OUTLIER -129.76 158.85 38.26 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.257 -0.902 . . . . 4.0599999999999996 109.585 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 49.4 m-85 -166.42 96.53 0.73 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 5.4400000000000004 109.28 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.81 165.56 24.4 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.591 2.194 . . . . 4.04 112.334 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.51 -13.09 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.951 2.434 . . . . 3.8999999999999999 112.095 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -109.46 8.49 25.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 4.1399999999999997 109.535 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . -96.87 174.02 29.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.495 -1.442 . . . . 3.5699999999999998 109.495 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 27.3 t0 -71.15 34.61 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 3.5899999999999999 109.482 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 86' ' ' GLU . . . 179.87 87.8 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 109.424 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.38 -160.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.784 2.323 . . . . 1.3899999999999999 112.328 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.716 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -64.62 154.6 48.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.556 -1.418 . . . . 1.1899999999999999 109.556 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.7 140.74 22.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -1.153 . . . . 2.0099999999999998 109.633 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.7 t -144.78 144.15 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 1.28 108.454 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.489 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -157.61 114.33 2.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.98 -1.075 . . . . 0.97999999999999998 110.015 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.5 m-30 -94.66 88.2 5.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.425 -0.797 . . . . 1.73 109.263 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 27.9 m170 -99.42 137.64 37.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.955 . . . . 2.3199999999999998 109.747 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.36 52.54 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.1099999999999999 109.536 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . . . -40.01 123.73 2.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.902 -1.279 . . . . 1.77 109.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' A' ' 138' ' ' ALA . 2.2 mptp? -167.5 44.81 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.711 -0.876 . . . . 5.0599999999999996 108.831 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . 40.97 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.412 -1.329 . . . . 2.6400000000000001 107.412 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . 69.87 28.38 71.99 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.779 -1.728 . . . . 2.5099999999999998 108.779 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.695 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -91.7 56.55 3.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -1.203 . . . . 2.3199999999999998 110.377 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 135' ' ' LYS . 10.6 p90 -177.11 -153.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.838 -1.164 . . . . 1.6100000000000001 110.459 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.468 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 1.0 OUTLIER -159.3 157.35 30.34 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.696 -0.853 . . . . 1.6499999999999999 108.696 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.547 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 13.0 t80 -135.28 103.17 5.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.041 -1.037 . . . . 1.6799999999999999 110.07 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.7 m -106.44 110.6 22.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 110.169 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.488 HG12 ' N ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -138.97 146.22 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 1.22 109.505 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.488 ' N ' HG12 ' A' ' 143' ' ' ILE . 3.6 p -136.31 -4.55 2.11 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.355 -0.538 . . . . 1.3300000000000001 109.688 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.505 ' CD ' HG21 ' A' ' 71' ' ' THR . 2.3 mt-30 -140.83 151.27 44.22 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.272 -0.971 . . . . 3.2999999999999998 110.073 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.578 HG21 ' CH2' ' A' ' 22' ' ' TRP . 13.0 p -163.08 122.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -0.845 . . . . 2.2599999999999998 109.507 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.96 139.69 23.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 2.7599999999999998 109.637 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.825 HD11 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -113.17 149.47 33.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 4.5700000000000003 109.403 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.805 ' N ' HD12 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -167.7 -163.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 3.0699999999999998 109.531 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.654 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 2.0 109.346 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.459 ' O ' ' OG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.492 -0.559 . . . . 2.8300000000000001 109.492 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.535 ' CD ' ' O ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -96.81 126.29 41.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 4.75 109.486 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.43 HD13 ' CG ' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -84.06 -13.82 52.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.153 -0.967 . . . . 4.9500000000000002 109.596 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.65 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -119.89 83.37 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 2.8599999999999999 108.692 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.28 34.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.025 2.484 . . . . 3.8300000000000001 111.87 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.65 ' H ' HD13 ' A' ' 10' ' ' LEU . 44.3 t60 -134.78 99.03 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.425 -0.797 . . . . 2.52 109.475 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.543 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -137.58 54.97 1.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.97 109.333 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.647 ' O ' ' N ' ' A' ' 16' ' ' ALA . 22.7 t -159.61 83.3 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 1.96 109.675 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -63.43 50.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 1.76 108.868 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -55.52 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 1.1799999999999999 110.13 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -109.88 39.37 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 2.1299999999999999 109.851 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.6 153.3 2.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.145 -0.972 . . . . 2.2599999999999998 109.699 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.947 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 2.6000000000000001 109.563 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' H ' HD22 ' A' ' 19' ' ' LEU . . . 76.61 174.16 38.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.781 -1.328 . . . . 1.6200000000000001 109.781 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.23 -16.37 4.72 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.694 2.263 . . . . 1.7 112.039 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.833 ' CH2' HG21 ' A' ' 146' ' ' VAL . 14.3 m95 -68.15 160.98 27.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 2.4199999999999999 109.08 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -109.68 148.24 31.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.009 . . . . 1.6399999999999999 109.642 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -135.35 129.58 33.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 2.0499999999999998 109.51 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.619 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.27 159.63 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 1.72 109.573 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.9 -32.34 7.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.042 -1.223 . . . . 1.7 110.042 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.754 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.7 -141.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.105 -1.232 . . . . 0.96999999999999997 109.662 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.754 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.1 p -91.09 132.39 36.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 1.8 109.316 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 tt0 -36.88 102.56 0.24 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 2.3999999999999999 109.072 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' SER . 50.0 Cg_exo -46.54 152.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.296 1.997 . . . . 1.1299999999999999 111.689 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' MET . 81.6 t -137.74 115.25 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 1.05 110.241 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.61 90.88 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.573 -0.704 . . . . 1.8200000000000001 109.75 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.53 -112.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 1.1699999999999999 109.664 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -59.43 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 2.21 109.626 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 60.0 5.03 3.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 1.1899999999999999 109.552 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.634 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -123.04 148.39 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -1.145 . . . . 2.9100000000000001 109.531 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.625 ' C ' ' SD ' ' A' ' 37' ' ' MET . 0.5 OUTLIER -114.39 132.39 56.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 0.93000000000000005 109.713 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.17 153.01 40.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 1.0600000000000001 109.676 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.3 m -126.07 137.88 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.905 -0.776 . . . . 1.3700000000000001 108.905 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.633 ' N ' ' OG ' ' A' ' 28' ' ' SER . 17.6 m-20 -73.0 110.14 7.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 4.79 109.475 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.618 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.2 mm? -117.81 75.02 9.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 3.54 109.556 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.01 -157.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.767 2.311 . . . . 3.7400000000000002 112.195 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.47 130.12 9.68 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 2.0299999999999998 109.548 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.99 35.81 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.532 -1.427 . . . . 2.4100000000000001 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.619 HE22 ' CB ' ' A' ' 50' ' ' ASP . 3.3 mm-40 -99.93 106.1 17.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -1.122 . . . . 2.96 109.491 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.2 14.42 1.25 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.659 -1.376 . . . . 2.0800000000000001 109.659 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.596 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -179.91 151.04 0.57 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.195 -1.179 . . . . 3.6099999999999999 109.519 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 50' ' ' ASP . 44.5 Cg_endo -71.8 -54.16 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.853 2.369 . . . . 2.3599999999999999 112.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.459 ' CE3' ' HG2' ' A' ' 48' ' ' PRO . 11.1 p90 -62.88 45.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 3.8700000000000001 109.384 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.789 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -135.48 39.75 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 2.3799999999999999 109.353 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 156.92 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 1.1100000000000001 109.528 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.83 170.08 20.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.644 -1.382 . . . . 0.93999999999999995 109.644 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 143' ' ' ILE . 1.7 pp -108.58 142.82 38.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -1.113 . . . . 0.95999999999999996 109.422 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 55' ' ' TYR . 4.5 t -120.0 174.79 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.92000000000000004 109.896 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.684 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 48.8 t80 179.11 144.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.71 109.527 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.684 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -99.72 -164.84 1.16 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 2.7799999999999998 109.463 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.91 66.95 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.602 -1.399 . . . . 2.48 109.602 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.766 ' CG1' ' H ' ' A' ' 128' ' ' GLN . 8.9 p -151.85 73.68 7.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.253 -1.145 . . . . 3.79 109.466 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.43 ' CG ' HD13 ' A' ' 9' ' ' LEU . 58.2 Cg_endo -76.14 157.91 37.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.873 2.382 . . . . 2.3999999999999999 112.364 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.723 HG13 ' CD1' ' A' ' 66' ' ' TYR . 3.4 t -148.83 102.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 3.0800000000000001 109.386 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -73.72 119.87 6.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.595 -1.402 . . . . 3.0499999999999998 109.595 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.539 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 15.7 tt0 -58.63 125.37 23.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.136 . . . . 6.0499999999999998 109.53 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 132.85 -47.56 1.0 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.679 -1.368 . . . . 2.54 109.679 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.8 mt-10 -99.8 166.89 10.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -1.15 . . . . 4.0300000000000002 109.594 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.46 134.32 49.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 2.9100000000000001 109.434 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.723 ' CD1' HG13 ' A' ' 60' ' ' VAL . 38.1 m-85 -97.22 -179.09 4.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 2.3799999999999999 109.499 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -154.71 139.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 2.6099999999999999 109.576 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 68' ' ' LEU . 9.3 tp -120.88 118.17 29.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 3.6099999999999999 109.416 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.04 83.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.577 -0.898 . . . . 2.27 108.577 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 28.0 p90 -93.73 143.14 26.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.855 . . . . 2.0099999999999998 111.358 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -89.33 130.59 35.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.488 -0.93 . . . . 1.8 108.488 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.798 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -170.29 135.19 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.891 -1.13 . . . . 0.95999999999999996 110.254 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.9 p -119.82 122.91 42.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.821 . . . . 0.93000000000000005 108.946 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.879 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -85.57 125.74 33.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.67000000000000004 109.565 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -138.76 113.63 8.5 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.271 -0.893 . . . . 0.96999999999999997 109.75 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.3 Cg_exo -64.54 -141.81 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.624 0 C-N-CA 124.349 -1.104 . . . . 1.02 112.276 -0.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -99.17 151.03 21.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 1.75 109.825 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.511 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.35 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.861 -0.792 . . . . 2.1600000000000001 108.861 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.12 168.94 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.829 2.353 . . . . 1.3799999999999999 112.86 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 100' ' ' ALA . 2.9 m -137.21 170.85 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 2.0099999999999998 109.128 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.715 ' HD3' ' HZ1' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -116.4 105.52 12.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 6.0099999999999998 109.771 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.87 159.43 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.261 -0.9 . . . . 3.7599999999999998 109.219 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -157.69 149.65 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 2.29 109.834 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.51 ' CG1' HG21 ' A' ' 58' ' ' VAL . 1.1 t -149.13 155.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 1.8899999999999999 109.701 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.96 -133.27 5.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.563 -1.415 . . . . 1.49 109.563 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.4 pm0 -90.08 -179.07 5.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 2.54 109.384 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 1.3799999999999999 109.546 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.557 ' O ' ' CE1' ' A' ' 119' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.299 0.571 . . . . 5.7400000000000002 110.011 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.44 161.03 13.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.287 -0.883 . . . . 2.27 110.081 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -119.91 -14.14 8.97 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.733 -0.84 . . . . 3.2799999999999998 108.733 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.755 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.56 36.03 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.381 -0.825 . . . . 3.6499999999999999 108.916 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -80.67 70.99 7.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 4.5999999999999996 109.624 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.86 111.01 23.35 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 3.46 108.851 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.13 13.27 55.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 3.6699999999999999 109.711 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.92 67.52 0.78 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.174 -1.192 . . . . 3.79 109.824 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -107.32 99.76 29.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.074 -1.016 . . . . 1.96 109.288 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.83 135.99 11.69 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.606 2.204 . . . . 2.9700000000000002 112.673 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 74' ' ' ALA . 94.2 mt -142.15 131.11 23.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 3.0600000000000001 109.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 105' ' ' GLU . 9.8 t -92.41 -165.56 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 109.491 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.19 33.9 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.499 -1.44 . . . . 2.1699999999999999 109.499 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.505 ' H ' HG23 ' A' ' 103' ' ' THR . 8.7 pt-20 -121.53 138.48 28.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.248 -1.148 . . . . 3.02 109.433 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.27 120.5 6.01 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.593 2.195 . . . . 1.4199999999999999 112.069 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.678 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -171.03 160.43 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 1.3700000000000001 109.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.593 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.93 149.07 22.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 1.72 109.687 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.798 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -114.3 136.43 52.98 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.745 -1.206 . . . . 4.7000000000000002 107.745 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -114.34 107.94 16.24 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.848 -0.741 . . . . 3.2799999999999998 110.706 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 8.0 m-85 -109.77 115.98 30.84 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.374 -0.972 . . . . 2.96 108.374 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -101.71 142.63 32.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.831 . . . . 3.4100000000000001 109.712 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.92 163.94 26.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 2.77 109.413 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.5 109.34 21.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 2.23 109.798 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.7 m -56.23 105.66 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.287 -0.883 . . . . 4.1100000000000003 109.193 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.85 ' O ' HD22 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -108.8 -10.31 15.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 6.8600000000000003 109.616 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -136.59 126.5 25.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 5.1200000000000001 109.531 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.64 117.72 5.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 4.0599999999999996 109.372 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.557 ' CE1' ' O ' ' A' ' 92' ' ' ARG . 57.9 m-85 -120.78 66.74 13.9 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 5.4400000000000004 109.588 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.78 166.58 27.15 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.783 2.322 . . . . 4.04 112.154 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 65.6 Cg_endo -79.87 -13.2 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.853 2.369 . . . . 3.8999999999999999 112.003 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -109.57 -12.71 14.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.331 -0.855 . . . . 4.1399999999999997 109.642 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.06 -70.95 0.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 3.5699999999999998 109.423 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 1.4 m-20 -129.75 -7.21 4.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 3.5899999999999999 109.387 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -179.96 150.02 0.53 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 2.0800000000000001 109.377 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HA ' ' CA ' ' A' ' 121' ' ' PRO . 10.4 Cg_endo -57.23 -7.11 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.943 2.429 . . . . 1.3899999999999999 112.217 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.12 172.37 12.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 1.1899999999999999 109.56 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.766 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 37.6 tp60 -153.81 140.29 18.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 2.0099999999999998 109.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 84' ' ' VAL . 3.6 t -153.68 87.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.374 -0.973 . . . . 1.28 108.374 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.533 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -97.4 123.44 41.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.97999999999999998 110.532 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.58 81.52 1.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.61 -0.885 . . . . 1.73 108.61 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 81' ' ' ARG . 61.3 m-70 -99.65 136.27 39.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 2.3199999999999998 109.956 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.578 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -131.05 -5.47 3.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.343 -0.848 . . . . 2.1099999999999999 109.353 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -43.26 124.41 4.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.473 -1.451 . . . . 1.77 109.473 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.715 ' HZ1' ' HD3' ' A' ' 81' ' ' ARG . 15.6 mttp -163.93 128.21 2.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 5.0599999999999996 109.74 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.62 -14.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.294 -1.002 . . . . 2.6400000000000001 108.294 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -118.16 3.15 16.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.227 -1.549 . . . . 2.5099999999999998 109.227 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -51.42 -161.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -1.07 . . . . 2.3199999999999998 109.647 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.879 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -168.35 -113.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.051 -1.031 . . . . 1.6100000000000001 110.24 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -125.85 139.82 53.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 1.6499999999999999 109.127 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.3 t80 -121.36 107.61 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 1.6799999999999999 109.79 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.17 91.29 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.73999999999999999 109.863 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.642 HD13 HD21 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -107.87 141.88 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 1.22 109.072 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.2 p -138.48 -0.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.56 -0.712 . . . . 1.3300000000000001 109.443 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.642 ' N ' ' OG1' ' A' ' 71' ' ' THR . 10.5 mt-30 -149.57 160.94 43.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.975 . . . . 3.2999999999999998 110.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.833 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.9 p -166.64 103.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.83 . . . . 2.2599999999999998 109.44 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.3 144.18 36.16 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 2.7599999999999998 109.624 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 149' ' ' THR . 1.3 tp -134.21 113.49 12.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 4.5700000000000003 109.337 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.679 ' N ' HD12 ' A' ' 148' ' ' LEU . 9.0 t -155.76 -166.35 2.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 3.0699999999999998 109.54 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 2.0 109.417 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.589 ' N ' ' HG1' ' A' ' 149' ' ' THR . 20.2 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.399 -0.593 . . . . 2.8300000000000001 109.399 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' OE2' ' OG ' ' A' ' 147' ' ' SER . 7.7 tp10 -65.26 109.86 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 4.75 109.578 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -32.68 39.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 4.9500000000000002 109.328 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.939 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -113.02 96.06 36.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 2.8599999999999999 109.073 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.02 38.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.844 2.363 . . . . 3.8300000000000001 112.852 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.679 ' N ' ' O ' ' A' ' 10' ' ' LEU . 27.7 t60 -129.81 131.42 46.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 2.52 109.316 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 56.17 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 1.97 109.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 16' ' ' ALA . 8.3 t -158.57 68.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 1.96 109.711 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -65.48 34.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 1.76 108.949 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -81.56 -33.38 31.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.1799999999999999 109.85 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.587 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 14.9 mm-40 -109.84 -70.2 0.82 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.137 -0.977 . . . . 2.1299999999999999 109.556 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 20' ' ' GLY . 49.8 m -107.49 144.08 34.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 2.2599999999999998 109.462 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -61.9 12.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 2.6000000000000001 109.703 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.626 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 66.23 177.12 7.5 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.83 -1.308 . . . . 1.6200000000000001 109.83 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.04 10.97 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.687 2.258 . . . . 1.7 112.204 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.795 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.2 m0 -74.41 -174.15 1.94 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 2.4199999999999999 109.501 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.405 ' CB ' HG13 ' A' ' 54' ' ' VAL . 1.6 m -117.3 145.78 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 1.6399999999999999 109.287 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.633 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 6.4 tt -151.67 143.86 23.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 2.0499999999999998 110.407 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.711 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.34 175.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.587 -0.696 . . . . 1.72 109.479 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.12 -23.35 18.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.967 -1.253 . . . . 1.7 109.967 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.72 -142.98 0.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.252 . . . . 0.96999999999999997 109.339 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.3 p -91.72 -164.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 1.8 109.223 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 29' ' ' GLU . 3.4 tm-20 -90.12 111.33 46.2 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 2.3999999999999999 108.774 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.471 ' CG ' HD22 ' A' ' 24' ' ' LEU . 72.9 Cg_exo -43.32 147.48 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.24 1.96 . . . . 1.1299999999999999 112.009 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 37' ' ' MET . 3.8 t -129.98 95.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.05 109.866 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.97 88.25 4.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.8200000000000001 109.451 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -74.02 -140.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 1.1699999999999999 109.952 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' A' ' 33' ' ' ALA . 24.4 t70 -35.33 -87.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 2.21 109.523 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -131.28 36.87 2.17 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.621 -1.391 . . . . 1.1899999999999999 109.621 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.34 157.48 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -1.2 . . . . 2.9100000000000001 109.579 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.615 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -129.51 135.27 48.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.324 -0.86 . . . . 0.93000000000000005 109.333 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 143.23 50.66 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.479 -0.888 . . . . 1.0600000000000001 110.281 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -113.62 144.15 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.796 -0.816 . . . . 1.3700000000000001 108.796 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.658 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -76.84 106.26 8.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 4.79 109.624 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.4 mm? -116.41 81.53 11.07 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 3.54 109.344 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.865 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 50.7 Cg_exo -49.54 -144.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.944 2.429 . . . . 3.7400000000000002 112.275 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.04 70.33 0.29 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 2.0299999999999998 109.557 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.05 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.554 -1.419 . . . . 2.4100000000000001 109.554 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 46' ' ' GLY . 3.9 mt-30 -99.99 91.51 4.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 2.96 109.428 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -39.66 -43.64 2.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.558 -1.417 . . . . 2.0800000000000001 109.558 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.503 ' CG ' ' CG ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -99.89 128.57 30.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.247 -1.149 . . . . 3.6099999999999999 109.382 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.28 -26.17 7.75 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.499 2.133 . . . . 2.3599999999999999 112.626 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.656 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -92.02 34.18 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.976 . . . . 3.8700000000000001 109.868 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.656 ' OD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.9 OUTLIER -100.19 1.76 42.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 2.3799999999999999 109.676 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.5 -173.52 1.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 1.1100000000000001 109.713 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.29 -171.77 14.29 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.486 -1.446 . . . . 0.93999999999999995 109.486 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.3 pp -115.89 140.71 48.97 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.244 -1.15 . . . . 0.95999999999999996 109.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -128.22 163.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.92000000000000004 109.614 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.939 ' CE2' HD12 ' A' ' 10' ' ' LEU . 20.2 t80 -159.82 155.42 25.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 1.71 109.444 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.694 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 4.2 m-20 -113.09 -164.29 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.201 -0.937 . . . . 2.7799999999999998 109.471 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.691 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 73.95 69.57 1.37 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 2.48 109.365 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 HD21 ' A' ' 148' ' ' LEU . 49.0 t -162.05 96.85 1.21 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 3.79 109.447 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.15 121.92 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.652 2.235 . . . . 2.3999999999999999 112.09 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 73.0 t -103.33 155.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 3.0800000000000001 109.594 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 60' ' ' VAL . . . -162.67 129.29 2.02 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.614 -1.394 . . . . 3.0499999999999998 109.614 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.691 ' N ' ' OG ' ' A' ' 115' ' ' SER . 1.7 pp20? -61.28 -161.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -1.104 . . . . 6.0499999999999998 109.383 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 62' ' ' GLU . . . 62.22 -49.19 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 2.54 109.67 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.3 mm-40 -99.76 160.3 14.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 4.0300000000000002 109.261 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.8 m -112.94 146.4 39.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 2.9100000000000001 109.683 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.681 ' CD2' ' OG1' ' A' ' 150' ' ' THR . 81.1 m-85 -106.14 174.33 5.93 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.238 -0.914 . . . . 2.3799999999999999 109.803 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.5 t -152.19 128.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.524 -0.735 . . . . 2.6099999999999999 109.247 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 109' ' ' ARG . 6.7 tp -114.8 116.8 29.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.092 -1.005 . . . . 3.6099999999999999 109.851 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.78 81.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 2.27 108.83 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 12.5 p90 -93.67 138.63 31.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.0099999999999998 111.139 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.668 HG23 ' CG2' ' A' ' 108' ' ' THR . 0.7 OUTLIER -86.88 133.09 33.65 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.642 -0.873 . . . . 1.8 108.642 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -173.83 128.29 0.4 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.98 -1.075 . . . . 0.95999999999999996 110.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -111.24 122.41 47.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.93000000000000005 108.873 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.79 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -80.91 129.74 34.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.67000000000000004 109.652 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.526 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -142.73 111.67 5.78 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.332 -0.855 . . . . 0.96999999999999997 109.594 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.56 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.0 Cg_exo -63.81 -141.82 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.248 -1.146 . . . . 1.02 112.372 -0.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -106.62 155.74 19.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.75 109.701 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.51 167.22 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 2.1600000000000001 108.942 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -84.7 149.29 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.779 2.319 . . . . 1.3799999999999999 112.59 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.636 HG22 ' HB3' ' A' ' 100' ' ' ALA . 1.2 m -125.61 179.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.895 . . . . 2.0099999999999998 109.315 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -127.96 97.95 4.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 6.0099999999999998 109.816 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -99.6 143.17 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.37 -0.831 . . . . 3.7599999999999998 108.845 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.602 HD21 ' CE1' ' A' ' 132' ' ' HIS . 2.1 pp -145.63 156.71 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 2.29 109.988 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -155.07 146.99 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 1.8899999999999999 109.345 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 170.16 -148.74 11.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.711 -1.356 . . . . 1.49 109.711 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.706 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.12 -161.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -1.119 . . . . 2.54 109.456 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.496 -1.442 . . . . 1.3799999999999999 109.496 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.539 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.433 -0.58 . . . . 5.7400000000000002 109.433 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -116.39 164.85 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 2.27 109.969 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.497 ' HB1' ' HE2' ' A' ' 113' ' ' PHE . . . -109.93 -21.19 12.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.757 -0.831 . . . . 3.2799999999999998 108.757 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' HG23 ' A' ' 84' ' ' VAL . 2.1 t80 -90.66 38.13 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.497 -0.927 . . . . 3.6499999999999999 108.497 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.68 114.55 19.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 4.5999999999999996 109.932 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.499 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -141.06 132.98 27.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 3.46 108.725 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -121.65 9.32 9.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.776 -1.33 . . . . 3.6699999999999999 109.776 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.35 65.31 0.76 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -1.169 . . . . 3.79 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.636 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.89 94.9 21.66 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 1.96 109.152 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.9 133.93 10.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.745 2.297 . . . . 2.9700000000000002 112.793 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 109' ' ' ARG . 35.6 mt -136.92 137.17 39.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 3.0600000000000001 109.144 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 9.0 t -96.87 -155.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.935 . . . . 2.3399999999999999 109.509 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -104.46 56.86 0.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 2.1699999999999999 109.542 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -150.85 150.47 27.97 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.299 -1.118 . . . . 3.02 109.433 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 118.33 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.717 2.278 . . . . 1.4199999999999999 112.137 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.831 ' HB3' HH22 ' A' ' 109' ' ' ARG . . . -166.39 147.3 6.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 1.3700000000000001 109.543 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.668 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.41 144.45 25.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.72 109.797 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.831 HH22 ' HB3' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -105.14 134.18 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.939 -1.134 . . . . 4.7000000000000002 107.939 178.167 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -109.54 105.27 14.53 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.92 -0.712 . . . . 3.2799999999999998 110.163 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.499 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 39.0 m-85 -109.6 102.29 11.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.448 -0.945 . . . . 2.96 108.448 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -110.47 166.41 11.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.301 -0.874 . . . . 3.4100000000000001 109.901 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.509 ' O ' ' CB ' ' A' ' 65' ' ' SER . 2.3 p90 -177.67 -162.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 2.77 109.237 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -123.05 143.05 50.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.339 -0.85 . . . . 2.23 109.38 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.691 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -86.89 161.56 18.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 4.1100000000000003 109.678 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -127.86 -15.28 4.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 6.8600000000000003 109.602 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.574 HD23 ' CE2' ' A' ' 119' ' ' PHE . 1.6 tp -123.43 155.63 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 5.1200000000000001 109.543 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 109.33 21.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 4.0599999999999996 109.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.574 ' CE2' HD23 ' A' ' 117' ' ' LEU . 23.8 m-85 -114.77 92.46 29.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.892 . . . . 5.4400000000000004 109.58 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.23 165.9 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.774 2.316 . . . . 4.04 112.122 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.11 -22.74 7.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.796 2.331 . . . . 3.8999999999999999 111.989 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.03 115.27 29.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.842 . . . . 4.1399999999999997 109.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 147.07 -136.53 6.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 3.5699999999999998 109.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' GLY . 10.8 m-20 -43.79 -85.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -1.136 . . . . 3.5899999999999999 109.458 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -129.86 149.7 73.8 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 2.0800000000000001 109.458 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HG2' HD21 ' A' ' 56' ' ' ASN . 46.9 Cg_endo -72.24 -158.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.722 2.281 . . . . 1.3899999999999999 112.244 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.524 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -65.37 163.27 39.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.482 -1.447 . . . . 1.1899999999999999 109.482 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.16 153.05 38.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -1.107 . . . . 2.0099999999999998 109.682 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.443 HG23 ' C ' ' A' ' 128' ' ' GLN . 45.7 t -155.84 131.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.187 -1.042 . . . . 1.28 108.187 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -139.65 100.09 3.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.888 -1.132 . . . . 0.97999999999999998 110.531 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD2' HD11 ' A' ' 53' ' ' LEU . 2.9 m-30 -85.04 99.23 10.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.522 -0.918 . . . . 1.73 108.522 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.602 ' CE1' HD21 ' A' ' 83' ' ' LEU . 41.6 m170 -99.77 136.1 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 2.3199999999999998 109.816 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -132.73 -36.47 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 2.1099999999999999 109.397 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -40.8 116.59 0.85 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 1.77 109.426 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.945 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 6.6 mtpp -163.83 149.62 11.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 5.0599999999999996 109.631 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -42.91 -15.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 2.6400000000000001 108.475 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -114.43 -4.14 22.06 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.259 -1.536 . . . . 2.5099999999999998 109.259 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.945 ' HB2' ' H ' ' A' ' 135' ' ' LYS . . . -42.96 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -1.082 . . . . 2.3199999999999998 109.485 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.79 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -168.68 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 1.6100000000000001 109.876 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -124.17 134.07 53.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 1.6499999999999999 108.911 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.1 t80 -114.79 105.89 13.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.06 -1.025 . . . . 1.6799999999999999 109.736 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.95 87.77 3.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.73999999999999999 109.888 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 140.68 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 1.22 109.058 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.436 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 42.6 p -137.56 -1.0 2.11 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.667 -0.646 . . . . 1.3300000000000001 109.453 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.566 ' N ' ' OG1' ' A' ' 71' ' ' THR . 5.1 mt-30 -151.26 167.27 28.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 3.2999999999999998 109.881 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 146' ' ' VAL . 2.9 p -175.73 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 2.2599999999999998 109.416 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.524 ' OG ' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -131.53 131.3 43.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 2.7599999999999998 109.778 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.694 HD21 HG13 ' A' ' 58' ' ' VAL . 5.2 tp -110.4 118.86 37.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 4.5700000000000003 109.324 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -123.19 175.19 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 3.0699999999999998 109.502 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.681 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.0 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 150' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.359 -0.608 . . . . 2.8300000000000001 109.359 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -134.06 96.33 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 4.75 109.531 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 9' ' ' LEU . 12.4 mt -66.03 -40.78 91.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 4.9500000000000002 109.403 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.838 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -114.92 94.21 37.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.853 . . . . 2.8599999999999999 109.004 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 45.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.791 2.327 . . . . 3.8300000000000001 112.557 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 10' ' ' LEU . 34.1 t60 -137.94 130.78 29.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.023 . . . . 2.52 109.575 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 t -170.08 70.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 1.97 109.376 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.5 m -164.66 63.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.96 109.629 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.824 ' CD2' HD11 ' A' ' 143' ' ' ILE . 4.3 m-30 -67.73 27.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.76 109.118 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.706 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.09 -40.05 12.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.1799999999999999 109.867 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 13.4 mm-40 -109.71 -73.09 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 2.1299999999999999 109.671 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -88.04 145.55 25.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 2.2599999999999998 109.445 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' SD ' ' A' ' 37' ' ' MET . 7.1 mt -62.17 -59.22 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 2.6000000000000001 109.437 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.28 169.92 14.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 1.6200000000000001 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.445 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 43.2 Cg_endo -72.2 5.04 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.852 2.368 . . . . 1.7 112.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.978 ' CH2' HG21 ' A' ' 146' ' ' VAL . 10.8 m95 -76.17 -175.47 3.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.4199999999999999 109.463 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 1.6399999999999999 109.237 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.054 ' O ' HD12 ' A' ' 24' ' ' LEU . 3.3 pp -142.84 131.96 23.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 2.0499999999999998 109.433 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.12 170.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 1.72 109.782 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.88 -31.09 8.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.029 -1.229 . . . . 1.7 110.029 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.82 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.97 -142.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.271 . . . . 0.96999999999999997 109.417 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.82 ' N ' ' OG1' ' A' ' 27' ' ' THR . 90.1 p -90.81 138.53 31.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.975 . . . . 1.8 109.45 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 28' ' ' SER . 4.9 mt-10 -41.38 104.19 0.33 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 2.3999999999999999 109.179 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HG2' HD22 ' A' ' 24' ' ' LEU . 51.3 Cg_exo -46.78 156.73 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.366 2.044 . . . . 1.1299999999999999 111.854 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -143.42 122.04 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 1.05 110.09 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.715 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.62 85.26 3.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 1.8200000000000001 109.501 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 1.1699999999999999 109.761 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.24 -67.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 2.21 109.522 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.706 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.49 48.48 0.75 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.629 -1.389 . . . . 1.1899999999999999 109.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.58 ' HB2' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -170.69 148.48 2.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.126 -1.22 . . . . 2.9100000000000001 109.657 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 19' ' ' LEU . 36.4 ttp -109.77 128.63 55.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.93000000000000005 109.107 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -123.46 159.97 27.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.2 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m -128.88 134.51 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.901 -0.777 . . . . 1.3700000000000001 108.901 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.612 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -73.57 106.51 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.825 . . . . 4.79 109.705 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.2 mm? -118.15 61.04 4.01 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.276 -0.89 . . . . 3.54 109.334 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.37 -91.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.726 2.284 . . . . 3.7400000000000002 112.283 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -150.89 158.88 27.89 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.516 -1.434 . . . . 2.0299999999999998 109.516 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.92 42.59 1.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 2.4100000000000001 109.459 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.693 HE21 ' C ' ' A' ' 134' ' ' GLY . 3.8 mm100 -99.87 148.26 24.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 2.96 109.297 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.94 -69.59 0.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.959 -1.256 . . . . 2.0800000000000001 109.959 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.686 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.8 p30 -99.79 145.26 29.85 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.129 -1.218 . . . . 3.6099999999999999 109.616 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.75 -20.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.892 2.395 . . . . 2.3599999999999999 112.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.686 ' CE3' ' OD1' ' A' ' 47' ' ' ASN . 1.3 p-90 -119.49 36.94 4.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 3.8700000000000001 110.355 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 8.5 m-20 -79.81 -0.35 34.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.091 -1.005 . . . . 2.3799999999999999 109.097 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 27' ' ' THR . . . -166.43 126.61 1.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 1.1100000000000001 109.315 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.489 ' C ' HD23 ' A' ' 53' ' ' LEU . . . 169.0 -173.91 43.51 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.84 -1.304 . . . . 0.93999999999999995 109.84 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.591 ' C ' HG22 ' A' ' 54' ' ' VAL . 5.3 mt -106.9 -178.02 3.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.148 . . . . 0.95999999999999996 109.545 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -165.54 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.92000000000000004 109.707 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.977 ' O ' HG12 ' A' ' 129' ' ' VAL . 37.6 t80 -179.77 137.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 1.71 109.396 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.539 HD22 ' HG3' ' A' ' 128' ' ' GLN . 2.4 m120 -119.05 86.11 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.248 -0.907 . . . . 2.7799999999999998 109.518 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.23 66.56 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 2.48 109.591 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 58' ' ' VAL . 2.5 p -166.01 85.51 0.96 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.248 -1.148 . . . . 3.79 109.528 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.57 175.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.781 2.32 . . . . 2.3999999999999999 112.212 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.427 HG21 ' HD2' ' A' ' 119' ' ' PHE . 58.1 t -136.91 131.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 3.0800000000000001 109.507 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -117.11 80.53 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 3.0499999999999998 109.475 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 61' ' ' GLY . 28.6 tt0 -35.23 118.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -1.087 . . . . 6.0499999999999998 109.589 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 129.15 -39.48 1.84 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.646 -1.382 . . . . 2.54 109.646 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.9 mt-10 -99.94 173.06 6.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 4.0300000000000002 109.62 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.5 m -119.34 143.63 47.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 2.9100000000000001 109.326 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.642 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 27.5 m-85 -108.81 -178.39 3.57 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 2.3799999999999999 109.659 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.8 t -151.7 158.36 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 2.6099999999999999 109.497 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.586 HD12 HD22 ' A' ' 148' ' ' LEU . 11.7 tp -143.05 112.01 6.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 3.6099999999999999 109.68 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.31 86.81 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 2.27 108.787 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.9 p90 -93.98 141.51 28.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 2.0099999999999998 111.16 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 2.7 p -84.82 88.55 7.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 1.8 108.3 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -129.68 156.96 43.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.117 . . . . 0.95999999999999996 110.756 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.8 p -147.36 120.11 8.64 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.596 -0.89 . . . . 0.93000000000000005 108.596 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.595 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -88.13 133.36 34.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.67000000000000004 109.839 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.456 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.8 116.9 16.05 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.431 -0.793 . . . . 0.96999999999999997 109.078 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.595 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -66.07 -142.53 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.676 0 C-N-CA 124.29 -1.129 . . . . 1.02 112.551 -0.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.652 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -106.86 154.79 20.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 1.75 109.724 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.8 mtm 167.08 169.67 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.778 . . . . 2.1600000000000001 109.092 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.15 131.65 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.872 2.381 . . . . 1.3799999999999999 112.55 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.956 HG12 ' OH ' ' A' ' 139' ' ' TYR . 1.2 m -107.26 174.03 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 2.0099999999999998 109.279 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -126.48 98.29 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 6.0099999999999998 109.804 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -102.68 155.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.27 -0.894 . . . . 3.7599999999999998 109.165 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.863 HD21 ' CE1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -147.69 157.98 43.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 2.29 109.798 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.4 OUTLIER -151.98 164.4 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 1.8899999999999999 109.38 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 146.73 -159.24 27.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.612 -1.395 . . . . 1.49 109.612 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.684 ' OE1' ' CE1' ' A' ' 119' ' ' PHE . 7.3 pt-20 -90.2 -155.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.129 . . . . 2.54 109.45 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.567 -1.413 . . . . 1.3799999999999999 109.567 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.619 ' CZ ' ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.53 -0.545 . . . . 5.7400000000000002 109.53 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -111.34 172.16 7.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 2.27 109.988 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.76 -18.99 5.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.892 -0.781 . . . . 3.2799999999999998 108.892 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.94 34.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 3.6499999999999999 109.308 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 82.18 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 4.5999999999999996 109.428 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -103.41 156.86 17.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 3.46 109.093 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -146.24 7.86 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.696 -1.362 . . . . 3.6699999999999999 109.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -120.69 75.62 1.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.167 -1.196 . . . . 3.79 109.78 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.704 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -120.34 86.51 38.74 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 1.96 109.242 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.641 ' O ' HD22 ' A' ' 102' ' ' LEU . 13.1 Cg_exo -66.52 127.54 17.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.149 2.566 . . . . 2.9700000000000002 112.82 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 101' ' ' PRO . 3.5 mm? -118.57 147.61 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 3.0600000000000001 108.999 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.578 ' O ' ' O ' ' A' ' 74' ' ' ALA . 5.0 t -97.61 -170.58 2.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 2.3399999999999999 109.828 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 105' ' ' GLU . . . -103.72 36.34 4.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.691 -1.364 . . . . 2.1699999999999999 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' H ' HG23 ' A' ' 103' ' ' THR . 71.3 mt-10 -156.09 148.21 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 3.02 109.262 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -40.8 118.26 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.696 2.264 . . . . 1.4199999999999999 112.143 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.663 ' HB1' ' NH1' ' A' ' 109' ' ' ARG . . . -160.9 138.34 9.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 1.3700000000000001 109.648 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.531 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.54 151.51 21.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 1.72 109.907 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.663 ' NH1' ' HB1' ' A' ' 107' ' ' ALA . 3.7 mpt_? -124.36 142.14 51.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 4.7000000000000002 108.029 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.63 104.67 12.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 3.2799999999999998 110.757 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.561 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 8.8 m-30 -109.88 120.11 41.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.499 -0.926 . . . . 2.96 108.499 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.655 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -124.95 169.65 11.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 3.4100000000000001 109.67 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.5 p90 -155.23 -177.76 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 2.77 109.499 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.535 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -111.4 106.14 14.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.364 -0.835 . . . . 2.23 109.558 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.535 ' C ' ' O ' ' A' ' 114' ' ' THR . 3.8 m -36.01 129.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 4.1100000000000003 109.347 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.469 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 10.9 m120 -125.17 -7.21 7.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 6.8600000000000003 109.507 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -148.94 129.98 14.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 5.1200000000000001 109.424 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.471 ' N ' HD13 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -80.26 113.25 18.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 4.0599999999999996 109.551 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CE1' ' OE1' ' A' ' 86' ' ' GLU . 44.6 m-85 -110.02 146.94 35.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 5.4400000000000004 109.353 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.47 166.3 30.22 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.691 2.261 . . . . 4.04 112.163 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 126' ' ' PRO . 73.4 Cg_endo -81.02 -39.72 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.777 2.318 . . . . 3.8999999999999999 112.071 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -122.44 -150.93 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.874 . . . . 4.1399999999999997 109.478 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.08 -142.54 15.66 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.572 -1.411 . . . . 3.5699999999999998 109.572 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -114.33 10.94 17.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -1.094 . . . . 3.5899999999999999 109.447 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.51 ' HB1' ' C ' ' A' ' 87' ' ' GLY . . . -165.75 54.22 0.33 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 2.0800000000000001 109.545 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 55.1 Cg_endo -74.09 -158.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.846 2.364 . . . . 1.3899999999999999 112.223 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 126' ' ' PRO . . . -39.97 155.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.627 -1.389 . . . . 1.1899999999999999 109.627 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -155.2 137.85 15.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -1.159 . . . . 2.0099999999999998 109.553 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.977 HG12 ' O ' ' A' ' 55' ' ' TYR . 8.3 p -153.48 149.34 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.674 -0.861 . . . . 1.28 108.674 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -159.13 115.57 2.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.033 . . . . 0.97999999999999998 110.207 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.563 ' HA ' HG12 ' A' ' 82' ' ' VAL . 6.8 m-30 -85.63 105.29 16.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 1.73 108.435 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.863 ' CE1' HD21 ' A' ' 83' ' ' LEU . 56.9 m170 -99.43 121.24 40.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 2.3199999999999998 109.757 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.86 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -152.17 66.7 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 2.1099999999999999 109.496 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.693 ' C ' HE21 ' A' ' 45' ' ' GLN . . . -157.11 103.91 0.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 1.77 109.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -153.48 -175.34 5.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 5.0599999999999996 109.638 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -44.87 -12.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.34 -0.985 . . . . 2.6400000000000001 108.34 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -113.33 1.94 25.17 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.345 -1.502 . . . . 2.5099999999999998 109.345 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -37.44 165.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.392 -1.064 . . . . 2.3199999999999998 109.656 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.956 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -161.21 -108.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 1.6100000000000001 109.555 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -138.66 139.61 38.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 1.6499999999999999 109.111 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.659 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 30.7 t80 -124.34 120.4 32.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.062 -1.024 . . . . 1.6799999999999999 109.921 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.87 101.74 8.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.73999999999999999 109.893 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.824 HD11 ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -100.82 135.66 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.22 109.013 179.215 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.57 ' OG ' ' OG1' ' A' ' 71' ' ' THR . 3.5 p -109.16 -21.28 12.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.902 -0.777 . . . . 1.3300000000000001 108.902 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.68 ' N ' ' OG1' ' A' ' 71' ' ' THR . 2.5 pt20 -170.43 -174.94 1.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.256 -0.978 . . . . 3.2999999999999998 110.533 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.978 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.8 p -161.42 108.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.872 -0.788 . . . . 2.2599999999999998 108.872 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.11 143.27 33.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 2.7599999999999998 110.197 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.586 HD22 HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -123.9 110.27 14.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.46 -0.775 . . . . 4.5700000000000003 109.039 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.551 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -131.58 167.79 18.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 3.0699999999999998 109.808 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.495 ' H ' HG12 ' A' ' 7' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 2.0 109.328 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.788 ' N ' ' HG1' ' A' ' 149' ' ' THR . 1.4 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.422 -0.584 . . . . 2.8300000000000001 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.46 109.02 11.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 4.75 109.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.455 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -77.79 -50.1 13.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 4.9500000000000002 109.318 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.732 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -96.55 108.6 43.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 2.8599999999999999 109.352 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.7 29.13 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.089 1.86 . . . . 3.8300000000000001 111.624 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.672 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 19.4 t60 -124.36 72.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 2.52 109.586 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 5.7 t -112.06 41.67 1.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 1.97 109.318 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.623 ' C ' ' H ' ' A' ' 16' ' ' ALA . 32.7 m -127.0 64.94 1.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 1.96 109.779 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.573 ' CE1' ' NE2' ' A' ' 12' ' ' HIS . 3.5 m-85 -67.2 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.76 109.029 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.623 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.12 -20.49 23.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.1799999999999999 110.113 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 34.2 mt-10 -109.9 -83.91 0.56 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.02 -1.05 . . . . 2.1299999999999999 109.948 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 m -104.94 151.77 23.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 2.2599999999999998 109.628 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -47.99 62.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 2.6000000000000001 109.423 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 102.54 -173.03 22.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.725 -1.35 . . . . 1.6200000000000001 109.725 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 36.0 Cg_endo -69.21 -18.38 39.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 1.7 112.194 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.732 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 11.2 m0 -56.79 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 2.4199999999999999 109.139 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 1.6 m -151.43 136.78 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.6399999999999999 109.599 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 25' ' ' TYR . 9.3 tt -133.28 152.74 51.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 2.0499999999999998 109.574 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.87 177.43 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 1.72 109.444 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 93.03 -30.33 7.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.831 -1.307 . . . . 1.7 109.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.829 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.96 -141.96 0.38 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -1.185 . . . . 0.96999999999999997 109.276 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.829 ' N ' ' OG1' ' A' ' 27' ' ' THR . 23.7 p -90.68 140.27 29.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.171 -0.956 . . . . 1.8 108.989 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 2.6 mp0 -36.95 128.67 0.75 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 2.3999999999999999 109.102 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HG3' HD22 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -71.73 158.75 52.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.262 1.975 . . . . 1.1299999999999999 111.681 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -145.83 116.28 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.025 -1.047 . . . . 1.05 110.589 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -71.17 72.64 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 1.8200000000000001 109.14 178.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -73.43 -135.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 1.1699999999999999 109.78 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -41.66 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.792 . . . . 2.21 109.34 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 34.52 45.47 0.5 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.7 -1.36 . . . . 1.1899999999999999 109.7 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -164.01 146.61 9.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.097 -1.237 . . . . 2.9100000000000001 109.812 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.45 ' CG ' ' HB2' ' A' ' 30' ' ' PRO . 11.8 tmm? -108.97 124.77 51.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.93000000000000005 109.121 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 2.0 t -124.79 155.02 40.04 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 1.0600000000000001 110.378 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.751 HG23 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -127.48 164.55 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.459 -0.941 . . . . 1.3700000000000001 108.459 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' CG ' ' OG ' ' A' ' 28' ' ' SER . 21.0 m-20 -99.09 112.69 24.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 4.79 109.627 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.973 ' N ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.27 84.65 9.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 3.54 109.202 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.42 -92.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.848 2.366 . . . . 3.7400000000000002 112.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' GLY . . . -162.33 -139.99 2.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.439 . . . . 2.0299999999999998 109.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 43' ' ' GLY . . . 35.79 43.09 0.57 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.549 -1.42 . . . . 2.4100000000000001 109.549 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 46' ' ' GLY . 15.6 mm-40 -99.9 129.74 46.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -1.17 . . . . 2.96 109.489 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -35.75 -44.28 0.67 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 2.0800000000000001 109.619 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.669 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -179.95 157.49 0.79 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 3.6099999999999999 109.5 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.4 -34.97 3.39 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.794 2.329 . . . . 2.3599999999999999 112.379 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.684 ' CD1' ' O ' ' A' ' 49' ' ' TRP . 35.5 p90 -101.74 60.86 0.88 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 3.8700000000000001 109.501 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 26.8 m-20 -136.58 0.92 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 2.3799999999999999 109.483 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.41 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -162.58 -170.87 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.1100000000000001 109.459 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 -155.96 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.93999999999999995 109.517 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 53' ' ' LEU . 1.5 pt? -127.04 157.62 39.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.18 -1.188 . . . . 0.95999999999999996 109.66 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 55' ' ' TYR . 1.3 p -138.26 -176.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.92000000000000004 110.102 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.67 ' H ' HG22 ' A' ' 54' ' ' VAL . 30.4 t80 177.93 147.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.34 0.591 . . . . 1.71 109.576 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.485 ' ND2' ' HG2' ' A' ' 126' ' ' PRO . 8.9 m-20 -111.82 129.57 56.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.321 -0.862 . . . . 2.7799999999999998 109.48 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' H ' ' HA3' ' A' ' 127' ' ' GLY . . . 147.29 84.03 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.386 -1.486 . . . . 2.48 109.386 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 58' ' ' VAL . 1.3 p -169.88 70.45 0.63 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.111 . . . . 3.79 109.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.688 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.61 159.58 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.824 2.349 . . . . 2.3999999999999999 111.963 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 2.0 t -151.39 85.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.165 -0.959 . . . . 3.0800000000000001 109.723 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.56 ' C ' ' OG ' ' A' ' 115' ' ' SER . . . -88.69 112.22 3.9 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.087 -1.605 . . . . 3.0499999999999998 109.087 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' N ' ' OG ' ' A' ' 115' ' ' SER . 34.5 mt-10 -31.01 135.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.553 -0.969 . . . . 6.0499999999999998 110.037 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 95.37 -16.54 61.06 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.972 -1.251 . . . . 2.54 109.972 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 115' ' ' SER . 17.4 mt-10 -99.89 146.93 26.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 4.0300000000000002 109.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 150' ' ' THR . 4.0 m -111.87 133.63 53.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 2.9100000000000001 109.159 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.688 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 30.8 m-85 -109.7 178.07 4.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.147 -0.97 . . . . 2.3799999999999999 109.921 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.4 t -151.8 165.55 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.504 -0.747 . . . . 2.6099999999999999 109.476 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 148' ' ' LEU . 1.9 tp -147.34 111.13 5.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.868 . . . . 3.6099999999999999 109.476 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.9 p -109.83 93.15 4.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 2.27 109.163 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.92 143.77 26.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.205 -0.935 . . . . 2.0099999999999998 110.679 -179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.5 p -101.58 108.52 20.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.43 -0.952 . . . . 1.8 108.43 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.515 ' O ' HD22 ' A' ' 102' ' ' LEU . . . -154.43 143.4 21.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.789 -1.194 . . . . 0.95999999999999996 110.597 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -113.98 127.22 55.87 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.631 -0.878 . . . . 0.93000000000000005 108.631 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -97.42 129.3 44.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.67000000000000004 110.009 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.459 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.6 115.89 14.82 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.394 -0.816 . . . . 0.96999999999999997 109.156 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -65.85 -142.54 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.435 -1.069 . . . . 1.02 112.489 -0.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -106.2 150.32 25.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 1.75 109.532 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.5 155.11 0.15 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 2.1600000000000001 109.476 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 45.5 Cg_endo -72.94 122.84 8.46 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.825 2.35 . . . . 1.3799999999999999 112.143 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 102' ' ' LEU . 1.5 m -93.85 175.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 2.0099999999999998 109.378 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.74 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.05 145.77 36.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 6.0099999999999998 109.688 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.787 HG13 ' HG2' ' A' ' 97' ' ' GLN . 1.4 p -147.29 152.4 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 3.7599999999999998 109.326 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 130' ' ' ALA . 2.6 pp -155.43 149.27 25.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 2.29 109.81 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 128' ' ' GLN . 1.1 t -144.7 152.58 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 1.8899999999999999 109.453 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 168.24 -150.24 15.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.758 -1.337 . . . . 1.49 109.758 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.539 ' C ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -90.15 -165.1 1.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -1.064 . . . . 2.54 109.598 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 1.3799999999999999 109.526 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.431 -0.581 . . . . 5.7400000000000002 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -100.25 164.8 11.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 2.27 109.862 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.18 -17.77 10.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.396 -0.815 . . . . 3.2799999999999998 108.829 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.414 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.64 35.38 0.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.362 -0.836 . . . . 3.6499999999999999 109.193 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -77.85 88.43 4.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 4.5999999999999996 109.605 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.787 ' HG2' HG13 ' A' ' 82' ' ' VAL . 4.0 pt20 -121.98 148.81 44.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 3.46 109.353 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.716 ' CA ' ' HE ' ' A' ' 81' ' ' ARG . . . -136.76 30.11 2.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.83 -1.308 . . . . 3.6699999999999999 109.83 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.544 ' O ' ' OH ' ' A' ' 111' ' ' TYR . 1.7 m -115.12 66.72 0.69 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -1.19 . . . . 3.79 109.636 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.89 93.45 17.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 1.96 109.563 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.6 118.42 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.713 2.276 . . . . 2.9700000000000002 112.218 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.714 HD12 HG11 ' A' ' 80' ' ' VAL . 25.3 mt -120.56 155.92 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 3.0600000000000001 109.494 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 1.3 t -110.39 -167.29 1.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 2.3399999999999999 109.616 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -78.98 -25.75 59.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.761 -1.335 . . . . 2.1699999999999999 109.761 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.83 164.01 17.32 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 3.02 109.408 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -43.28 118.73 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.688 2.259 . . . . 1.4199999999999999 112.088 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.514 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . . . -135.26 117.97 16.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 1.3700000000000001 109.746 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.667 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.69 148.98 21.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 1.72 110.21 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.667 ' NH1' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -127.84 139.69 52.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.21 -1.033 . . . . 4.7000000000000002 108.21 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.99 104.87 9.82 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.957 -0.697 . . . . 3.2799999999999998 109.991 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.544 ' OH ' ' O ' ' A' ' 99' ' ' SER . 41.2 m-85 -109.69 129.61 55.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.221 -0.924 . . . . 2.96 108.867 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -129.42 157.01 43.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.833 . . . . 3.4100000000000001 109.775 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.539 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 3.4 p90 -146.28 -178.51 6.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 2.77 109.552 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.57 137.03 47.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.463 -0.773 . . . . 2.23 109.642 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.56 ' OG ' ' C ' ' A' ' 61' ' ' GLY . 22.8 t -64.11 118.39 8.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 4.1100000000000003 109.602 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -18.82 13.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 6.8600000000000003 109.233 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -132.5 -162.6 1.25 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.292 -0.88 . . . . 5.1200000000000001 109.568 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.708 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -118.92 133.82 55.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.266 -0.896 . . . . 4.0599999999999996 109.506 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -153.66 70.57 6.62 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 5.4400000000000004 109.534 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.443 ' HB2' ' H ' ' A' ' 123' ' ' GLY . 39.4 Cg_exo -56.75 169.46 1.8 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.815 2.343 . . . . 4.04 112.009 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.16 -31.41 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.754 2.302 . . . . 3.8999999999999999 112.06 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 123' ' ' GLY . 24.1 t0 -119.25 -11.94 9.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 4.1399999999999997 109.572 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -56.94 -150.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 3.5699999999999998 109.564 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 123' ' ' GLY . 0.5 OUTLIER -36.33 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -1.152 . . . . 3.5899999999999999 109.415 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -115.61 150.11 44.18 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 2.0800000000000001 109.445 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HG2' ' ND2' ' A' ' 56' ' ' ASN . 43.9 Cg_endo -71.9 -158.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.761 2.307 . . . . 1.3899999999999999 112.252 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . -82.34 166.62 46.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.552 -1.419 . . . . 1.1899999999999999 109.552 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.68 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 1.3 tt0 -147.25 142.62 27.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 2.0099999999999998 109.867 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 129' ' ' VAL . 5.2 p -163.24 110.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.278 -1.008 . . . . 1.28 108.278 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -118.83 132.27 56.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.97999999999999998 110.871 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.464 ' HB2' ' CD2' ' A' ' 53' ' ' LEU . 4.0 m-30 -101.02 111.83 24.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 1.73 108.199 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -99.37 131.12 45.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 2.3199999999999998 109.565 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 141' ' ' PHE . 3.0 mt -133.23 -43.45 0.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 109.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -38.79 127.43 1.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.841 -1.304 . . . . 1.77 109.841 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.716 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 31.4 mtmt -164.69 134.79 3.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 5.0599999999999996 109.584 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -40.29 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.389 -0.967 . . . . 2.6400000000000001 108.389 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.13 14.8 7.85 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.047 -1.621 . . . . 2.5099999999999998 109.047 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.716 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -49.5 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -1.038 . . . . 2.3199999999999998 110.062 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.673 ' OH ' HG12 ' A' ' 80' ' ' VAL . 8.3 p90 -160.03 -130.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.004 -1.06 . . . . 1.6100000000000001 109.429 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 22.5 mt-10 -116.93 135.81 53.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 1.6499999999999999 109.33 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 14.8 t80 -118.51 108.45 15.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 1.6799999999999999 110.038 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.504 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 78.7 m -111.94 100.83 9.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.297 -0.877 . . . . 0.73999999999999999 110.003 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.99 143.75 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 1.22 109.086 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' PHE . 6.0 p -131.8 -5.84 3.6 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.64 . . . . 1.3300000000000001 109.275 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.571 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.3 mt-30 -153.85 160.02 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.299 -0.961 . . . . 3.2999999999999998 110.233 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.613 ' N ' ' OG1' ' A' ' 13' ' ' THR . 10.8 p -178.15 124.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.007 -0.738 . . . . 2.2599999999999998 109.007 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.95 135.41 29.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 2.7599999999999998 109.911 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.584 HD11 HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -108.38 144.51 35.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 4.5700000000000003 109.362 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.788 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 2.8 t -164.97 -173.26 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 3.0699999999999998 109.559 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.569 HG23 HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 2.0 109.437 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLU . 58.0 t . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.307 0.575 . . . . 2.8300000000000001 109.523 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -36.07 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 4.75 109.423 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . 12.1 mt -103.82 11.43 35.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.284 -0.885 . . . . 4.9500000000000002 109.679 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.705 ' O ' ' N ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -114.38 113.7 45.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 2.8599999999999999 108.444 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.51 19.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.647 2.232 . . . . 3.8300000000000001 113.66 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.705 ' N ' ' O ' ' A' ' 10' ' ' LEU . 54.6 t-80 -170.69 136.89 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.674 -1.266 . . . . 2.52 110.404 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.591 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.3 OUTLIER -170.83 68.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 1.97 109.341 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 13' ' ' THR . 50.5 m -170.31 87.66 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 1.96 110.083 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -90.24 41.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 1.76 109.056 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.22 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 1.1799999999999999 109.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -109.75 39.47 2.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.195 -0.941 . . . . 2.1299999999999999 109.696 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.21 148.89 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 2.2599999999999998 109.53 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 19' ' ' LEU . 1.6 pp -74.06 -10.85 60.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 2.6000000000000001 109.427 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.03 -146.81 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.357 -1.497 . . . . 1.6200000000000001 109.357 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 22' ' ' TRP . 64.6 Cg_endo -81.53 -23.1 5.16 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.893 2.396 . . . . 1.7 112.076 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.679 ' CH2' HG11 ' A' ' 146' ' ' VAL . 11.3 m0 -45.94 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 2.4199999999999999 108.896 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -113.53 164.81 13.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 1.6399999999999999 108.985 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' A' ' 30' ' ' PRO . 3.0 mt -156.54 132.63 9.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 2.0499999999999998 109.78 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.733 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 171.63 -167.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 1.72 109.394 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.0 -30.39 0.93 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.754 -1.339 . . . . 1.7 109.754 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.746 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -109.87 -141.12 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -1.186 . . . . 0.96999999999999997 109.445 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.746 ' N ' ' OG1' ' A' ' 27' ' ' THR . 11.4 p -90.92 -162.75 0.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.084 -0.709 . . . . 1.8 109.084 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.4 111.63 48.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 2.3999999999999999 109.134 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.818 ' HG2' HD13 ' A' ' 24' ' ' LEU . 53.0 Cg_exo -50.04 140.87 31.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.167 1.911 . . . . 1.1299999999999999 111.786 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.19 112.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.033 . . . . 1.05 109.898 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.422 ' HA ' ' CB ' ' A' ' 37' ' ' MET . 0.9 OUTLIER -90.03 127.24 36.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 1.8200000000000001 109.349 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -120.8 -110.07 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.955 . . . . 1.1699999999999999 109.62 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 3.4 p-10 -60.28 63.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.96 . . . . 2.21 109.595 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 69.33 -17.51 0.6 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.676 -1.369 . . . . 1.1899999999999999 109.676 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -106.04 170.74 7.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -1.194 . . . . 2.9100000000000001 109.736 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.492 ' CE ' HD11 ' A' ' 24' ' ' LEU . 9.6 ptt? -148.28 166.23 28.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.93000000000000005 109.09 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -146.65 150.79 36.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 1.0600000000000001 110.535 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.907 HG23 HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.97 148.6 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.245 -1.02 . . . . 1.3700000000000001 108.245 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 1.1 m-20 -83.85 105.85 15.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 4.79 109.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.907 HD21 HG23 ' A' ' 39' ' ' VAL . 1.8 mm? -112.97 78.25 2.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 3.54 108.898 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 62.0 Cg_endo -77.26 -159.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.771 2.314 . . . . 3.7400000000000002 112.388 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.87 63.01 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 2.0299999999999998 109.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.26 36.01 0.96 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.451 -1.46 . . . . 2.4100000000000001 109.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 6.1 mm-40 -99.97 112.7 24.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -1.126 . . . . 2.96 109.544 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.75 -10.94 2.51 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.571 -1.412 . . . . 2.0800000000000001 109.571 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.736 HD22 ' CG ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -165.85 156.61 11.76 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -1.178 . . . . 3.6099999999999999 109.444 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HG3' ' NH1' ' A' ' 81' ' ' ARG . 44.5 Cg_endo -72.6 -27.27 15.58 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.711 2.274 . . . . 2.3599999999999999 112.216 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.615 ' CD1' ' ND2' ' A' ' 47' ' ' ASN . 1.6 p90 -83.72 35.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 3.8700000000000001 109.444 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.736 ' CG ' HD22 ' A' ' 47' ' ' ASN . 19.8 m-20 -136.82 46.33 2.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 2.3799999999999999 109.465 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 172.5 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 1.1100000000000001 109.451 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.86 -163.33 25.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.534 -1.426 . . . . 0.93999999999999995 109.534 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.75 -172.7 2.39 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.223 -1.163 . . . . 0.95999999999999996 109.388 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 55' ' ' TYR . 93.2 t -162.08 167.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.92000000000000004 108.943 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.642 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.0 t80 -176.19 172.94 2.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 1.71 109.516 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -118.26 -164.61 1.03 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.218 -0.926 . . . . 2.7799999999999998 109.626 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.594 ' O ' HD12 ' A' ' 10' ' ' LEU . . . 79.96 64.84 1.82 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.517 -1.433 . . . . 2.48 109.517 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -152.23 79.78 6.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.176 -1.191 . . . . 3.79 109.405 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.77 120.33 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.737 2.292 . . . . 2.3999999999999999 112.08 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.547 HG12 ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -105.41 119.15 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 3.0800000000000001 109.619 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.677 ' N ' ' OH ' ' A' ' 66' ' ' TYR . . . -128.58 95.93 0.4 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.332 -1.507 . . . . 3.0499999999999998 109.332 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.674 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -35.2 144.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 6.0499999999999998 109.372 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.34 -36.39 4.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 2.54 109.522 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 114' ' ' THR . 28.2 mt-10 -99.74 178.58 4.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -1.167 . . . . 4.0300000000000002 109.224 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -132.51 119.91 21.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.126 -0.984 . . . . 2.9100000000000001 109.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.677 ' OH ' ' N ' ' A' ' 61' ' ' GLY . 56.1 m-85 -94.06 162.93 13.68 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.302 -0.874 . . . . 2.3799999999999999 109.431 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.7 t -146.9 108.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.693 . . . . 2.6099999999999999 109.557 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 69' ' ' SER . 7.8 tt -96.29 144.83 26.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.071 -1.018 . . . . 3.6099999999999999 109.22 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.877 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.85 104.85 5.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.888 . . . . 2.27 108.98 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 109' ' ' ARG . 2.9 p90 -94.17 143.48 26.34 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.082 -1.047 . . . . 2.0099999999999998 110.899 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.62 96.74 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.557 -0.905 . . . . 1.8 108.557 179.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -164.21 178.6 7.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.874 -1.141 . . . . 0.95999999999999996 110.838 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 153.68 36.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.064 -0.717 . . . . 0.93000000000000005 109.064 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -95.85 138.83 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.67000000000000004 109.558 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.508 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -137.47 114.28 9.58 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 121.156 -0.965 . . . . 0.96999999999999997 109.712 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 31.5 Cg_endo -64.64 -144.38 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.075 -1.219 . . . . 1.02 111.875 -0.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.85 150.78 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.59 -1.319 . . . . 1.75 109.589 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.557 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER 159.65 156.98 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 2.1600000000000001 109.334 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.574 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 62.5 Cg_endo -76.99 147.96 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.918 2.412 . . . . 1.3799999999999999 112.422 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.733 HG11 HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -111.19 -172.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 2.0099999999999998 109.343 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.661 ' N ' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -122.43 142.75 50.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 6.0099999999999998 109.556 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.3 p -146.92 149.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.243 -0.91 . . . . 3.7599999999999998 109.396 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -151.27 151.55 31.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 2.29 109.735 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.524 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -150.76 169.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 1.8899999999999999 109.345 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.81 -155.96 26.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.631 -1.388 . . . . 1.49 109.631 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.72 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -90.39 -174.13 4.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.127 . . . . 2.54 109.495 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.496 -1.442 . . . . 1.3799999999999999 109.496 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.65 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.285 0.564 . . . . 5.7400000000000002 109.588 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -122.51 174.43 7.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 2.27 109.99 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -126.69 -18.04 4.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.73 . . . . 3.2799999999999998 109.115 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.644 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.74 41.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 3.6499999999999999 109.356 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.96 81.22 8.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 4.5999999999999996 109.602 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.1 tt0 -127.07 114.93 18.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.206 -0.934 . . . . 3.46 109.046 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.34 21.97 29.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.805 -1.318 . . . . 3.6699999999999999 109.805 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 97' ' ' GLN . 1.7 m -110.11 90.86 3.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -1.17 . . . . 3.79 109.531 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.678 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -128.07 86.86 57.01 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 1.96 109.57 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.81 118.94 5.91 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.964 2.443 . . . . 2.9700000000000002 112.395 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.733 HD12 HG11 ' A' ' 80' ' ' VAL . 12.2 mt -120.89 168.02 11.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 3.0600000000000001 109.346 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -122.82 -177.68 3.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 2.3399999999999999 109.563 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -91.6 59.21 2.95 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.513 -1.435 . . . . 2.1699999999999999 109.513 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -171.78 131.72 0.75 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 3.02 109.191 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -41.04 122.65 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.488 2.125 . . . . 1.4199999999999999 112.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.84 146.06 9.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 1.3700000000000001 109.565 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.434 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.75 150.31 21.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 1.72 110.26 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -126.47 152.33 46.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.379 -1.341 . . . . 4.7000000000000002 107.379 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' O ' ' CD1' ' A' ' 111' ' ' TYR . 13.8 mp0 -125.02 158.29 34.08 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.375 -0.93 . . . . 3.2799999999999998 110.701 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.653 ' CD1' ' O ' ' A' ' 110' ' ' GLU . 42.9 m-85 -160.57 103.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.474 -0.936 . . . . 2.96 108.474 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.682 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -114.02 169.6 8.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 3.4100000000000001 109.836 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.644 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 3.7 p90 -177.5 -173.5 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 2.77 109.857 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -119.69 150.91 39.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.52 -0.737 . . . . 2.23 109.418 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.547 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -90.2 169.77 10.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 4.1100000000000003 109.842 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -125.07 -20.28 4.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 6.8600000000000003 109.285 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 118' ' ' THR . 9.3 tt -128.46 170.86 12.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 5.1200000000000001 109.305 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.884 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -89.76 107.75 19.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 4.0599999999999996 109.542 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.715 ' CE1' HD22 ' A' ' 117' ' ' LEU . 42.5 m-85 -117.14 75.95 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 5.4400000000000004 109.499 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.56 163.27 32.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.682 2.255 . . . . 4.04 112.269 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.03 -12.97 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.846 2.364 . . . . 3.8999999999999999 111.965 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.46 129.44 55.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 4.1399999999999997 109.487 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.64 -65.18 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.425 -1.47 . . . . 3.5699999999999998 109.425 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -172.91 47.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -1.135 . . . . 3.5899999999999999 109.463 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 127' ' ' GLY . . . 179.92 58.83 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 2.0800000000000001 109.585 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.22 -2.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.11 2.54 . . . . 1.3899999999999999 112.078 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 122.29 150.21 8.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.286 -1.526 . . . . 1.1899999999999999 109.286 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -146.99 129.73 16.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.236 . . . . 2.0099999999999998 109.846 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 1.4 p -153.15 94.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.289 -1.004 . . . . 1.28 108.289 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.571 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -102.9 136.42 42.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.282 -0.886 . . . . 0.97999999999999998 110.563 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.515 ' HB2' HD12 ' A' ' 53' ' ' LEU . 2.9 m-30 -105.92 96.04 6.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.825 -0.805 . . . . 1.73 108.825 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 54.8 m170 -99.95 129.08 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 2.3199999999999998 109.785 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.616 HD22 ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -132.05 -28.4 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 2.1099999999999999 109.45 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -46.28 144.95 3.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 1.77 109.693 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.881 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 14.6 mtpp -164.08 141.04 6.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.139 . . . . 5.0599999999999996 109.668 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.33 -20.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 2.6400000000000001 108.602 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -131.36 18.1 4.99 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 2.5099999999999998 108.943 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.881 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -49.45 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 2.3199999999999998 110.218 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.6 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -153.78 -110.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 1.6100000000000001 109.394 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.63 152.74 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.896 -1.128 . . . . 1.6499999999999999 109.023 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.616 ' CG ' HD22 ' A' ' 133' ' ' LEU . 50.3 t80 -134.29 123.8 24.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.006 -1.059 . . . . 1.6799999999999999 110.181 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 1.8 m -112.67 118.78 35.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.73999999999999999 109.43 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.03 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.006 0.908 . . . . 1.22 109.859 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.674 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 93.0 p -135.37 -19.75 1.66 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.27 -0.641 . . . . 1.3300000000000001 109.27 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -148.9 163.18 38.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.917 . . . . 3.2999999999999998 109.484 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.679 HG11 ' CH2' ' A' ' 22' ' ' TRP . 10.5 p -177.2 123.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2599999999999998 109.556 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.52 151.61 9.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 2.7599999999999998 109.524 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 148' ' ' LEU . 1.0 OUTLIER -115.96 173.19 6.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 4.5700000000000003 109.584 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER -157.01 -166.89 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 3.0699999999999998 109.467 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.653 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.2 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 2.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.369 -0.604 . . . . 2.8300000000000001 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -86.04 84.53 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 4.75 109.503 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 59' ' ' PRO . 1.5 mt -67.01 -22.0 65.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 4.9500000000000002 109.297 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.841 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.1 tm? -126.26 78.16 71.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 2.8599999999999999 108.679 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.32 40.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.03 2.487 . . . . 3.8300000000000001 112.77 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.811 ' H ' HD13 ' A' ' 10' ' ' LEU . 9.3 t60 -136.2 94.29 3.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 2.52 109.516 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -140.19 52.66 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 1.97 109.328 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -146.48 71.92 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 1.96 109.676 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 19' ' ' LEU . 4.7 m-30 -63.0 41.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 1.76 109.048 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.654 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -90.1 -39.13 13.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 1.1799999999999999 109.959 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 8.4 mt-10 -109.74 -83.71 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 2.1299999999999999 109.856 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -103.34 144.11 31.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 2.2599999999999998 109.589 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 15' ' ' PHE . 4.5 mt -58.15 -55.85 29.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 2.6000000000000001 109.469 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 102.53 -163.66 16.52 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.4 . . . . 1.6200000000000001 109.601 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.04 -36.91 67.06 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.74 2.294 . . . . 1.7 112.117 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.837 ' CH2' HG11 ' A' ' 146' ' ' VAL . 21.2 m95 -55.09 159.91 2.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 2.4199999999999999 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.06 177.29 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 1.6399999999999999 109.342 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.3 pt? -176.06 151.53 1.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 2.0499999999999998 109.631 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.685 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 170.32 178.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 1.72 109.713 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.585 ' C ' ' HB2' ' A' ' 51' ' ' ALA . . . 86.22 -4.55 85.89 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.297 . . . . 1.7 109.859 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.903 ' OG1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.74 -143.17 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.27 . . . . 0.96999999999999997 109.504 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.792 ' N ' ' OG1' ' A' ' 27' ' ' THR . 86.1 p -91.5 -151.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.314 -0.866 . . . . 1.8 109.003 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -90.68 110.41 41.22 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 2.3999999999999999 109.102 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 56.4 Cg_endo -76.43 143.12 24.38 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.144 1.896 . . . . 1.1299999999999999 111.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -144.65 122.03 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 1.05 110.631 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.27 84.6 5.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.682 . . . . 1.8200000000000001 109.182 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.75 -140.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.1699999999999999 109.976 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.54 -68.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 2.21 109.401 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.638 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.46 43.85 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.438 -1.465 . . . . 1.1899999999999999 109.438 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.53 145.49 11.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 2.9100000000000001 109.63 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 37' ' ' MET . 18.4 tmm? -111.23 132.75 54.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.93000000000000005 109.042 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.3 m -123.48 152.11 42.05 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0600000000000001 110.24 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG13 ' SD ' ' A' ' 37' ' ' MET . 3.4 m -135.25 115.62 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.392 -0.966 . . . . 1.3700000000000001 108.392 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.794 ' O ' HD22 ' A' ' 41' ' ' LEU . 3.4 m-20 -72.41 123.64 23.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 4.79 109.929 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.903 HD21 ' OG1' ' A' ' 27' ' ' THR . 3.7 mm? -132.52 61.07 54.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.912 . . . . 3.54 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 43' ' ' GLY . 53.8 Cg_endo -96.05 -43.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.456 2.771 . . . . 3.7400000000000002 112.164 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 42' ' ' PRO . . . -16.76 -108.13 0.0 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 111.771 -0.532 . . . . 2.0299999999999998 111.771 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.07 61.63 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.197 -1.561 . . . . 2.4100000000000001 109.197 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 136' ' ' ALA . 2.7 mm100 -99.37 97.15 8.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -1.208 . . . . 2.96 109.7 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.51 58.92 3.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.658 -1.377 . . . . 2.0800000000000001 109.658 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.586 ' C ' ' H ' ' A' ' 49' ' ' TRP . 0.8 OUTLIER -152.51 90.19 3.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.6099999999999999 109.464 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.62 2.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.907 2.405 . . . . 2.3599999999999999 112.503 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.685 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -127.67 34.54 4.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 3.8700000000000001 109.599 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.685 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 1.4 m-20 -109.98 -2.25 17.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 2.3799999999999999 109.57 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB2' ' C ' ' A' ' 26' ' ' GLY . . . -176.9 172.14 2.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -0.964 . . . . 1.1100000000000001 109.689 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.638 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 144.3 178.0 19.63 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.718 -1.353 . . . . 0.93999999999999995 109.718 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.567 ' C ' HG22 ' A' ' 54' ' ' VAL . 8.2 mt -88.14 -176.57 5.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -1.092 . . . . 0.95999999999999996 109.234 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.567 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.23 162.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.92000000000000004 110.015 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.589 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 26.3 t80 175.83 146.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.586 -0.696 . . . . 1.71 109.297 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.589 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -112.93 -164.69 0.93 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 109.494 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.24 56.65 7.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.647 -1.381 . . . . 2.48 109.647 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.5 p -126.06 92.02 46.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 3.79 109.377 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.548 ' HG2' HD13 ' A' ' 9' ' ' LEU . 61.1 Cg_endo -80.39 131.4 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.718 2.279 . . . . 2.3999999999999999 112.277 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 21.1 t -141.98 113.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 3.0800000000000001 109.462 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -93.37 111.38 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.534 -1.426 . . . . 3.0499999999999998 109.534 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.506 ' CD ' ' C ' ' A' ' 62' ' ' GLU . 1.8 tm-20 -42.47 145.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 6.0499999999999998 109.486 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.677 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 106.14 -35.02 5.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 2.54 109.633 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.622 ' O ' ' N ' ' A' ' 115' ' ' SER . 13.3 mt-10 -99.97 173.14 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 4.0300000000000002 109.558 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.578 ' O ' ' OG1' ' A' ' 150' ' ' THR . 51.7 m -121.02 143.79 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 2.9100000000000001 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.591 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 22.0 m-85 -109.31 -178.5 3.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 2.3799999999999999 109.703 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.9 t -152.21 159.18 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.487 -0.758 . . . . 2.6099999999999999 109.554 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 131' ' ' PHE . 1.8 tp -143.29 114.06 7.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 3.6099999999999999 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.8 p -109.24 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 2.27 108.878 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.3 p90 -94.08 150.19 20.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 2.0099999999999998 111.013 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.47 135.19 37.42 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.537 -0.912 . . . . 1.8 108.537 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.575 ' O ' HD22 ' A' ' 102' ' ' LEU . . . -171.68 135.16 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.011 -1.055 . . . . 0.95999999999999996 110.089 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -130.58 120.97 24.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.93000000000000005 108.979 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -96.18 138.88 33.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.67000000000000004 109.611 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.457 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.6 116.15 16.07 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.903 . . . . 0.96999999999999997 109.465 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.01 -144.44 0.17 OUTLIER 'Cis proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.217 -1.16 . . . . 1.02 112.225 0.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' OG1' ' A' ' 103' ' ' THR . 4.0 m-20 -109.21 163.17 13.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.75 110.154 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.465 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.0 mtm 165.17 168.08 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.701 -0.851 . . . . 2.1600000000000001 108.701 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.36 137.91 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.741 2.294 . . . . 1.3799999999999999 112.466 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.77 HG12 ' OH ' ' A' ' 139' ' ' TYR . 0.8 OUTLIER -112.56 -178.4 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.0099999999999998 109.198 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.666 ' N ' HG23 ' A' ' 80' ' ' VAL . 7.7 ttt180 -121.75 155.72 34.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 6.0099999999999998 109.772 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG23 ' C ' ' A' ' 81' ' ' ARG . 35.1 t -154.58 150.85 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 3.7599999999999998 109.11 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -146.78 147.03 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.091 -1.006 . . . . 2.29 109.769 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -153.66 156.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.576 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.07 -161.52 24.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 1.49 109.593 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.73 -177.06 5.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 2.54 109.536 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.56 -1.416 . . . . 1.3799999999999999 109.56 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.56 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.501 -0.555 . . . . 5.7400000000000002 109.501 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -102.47 169.81 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 2.27 110.119 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.29 -16.84 6.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.886 -0.783 . . . . 3.2799999999999998 108.886 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.64 36.45 0.9 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 3.6499999999999999 109.281 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.428 ' CG ' HG23 ' A' ' 93' ' ' THR . 29.4 mt-10 -83.15 71.45 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.95 . . . . 4.5999999999999996 109.548 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -100.07 167.27 10.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 3.46 109.467 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -146.47 8.38 1.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.695 -1.362 . . . . 3.6699999999999999 109.695 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -116.23 94.22 4.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -1.159 . . . . 3.79 109.628 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.756 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -134.1 85.36 39.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 1.96 109.485 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.99 133.28 57.2 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.957 2.438 . . . . 2.9700000000000002 112.47 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 72' ' ' ALA . 11.4 mt -148.74 123.94 10.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 3.0600000000000001 109.257 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -116.07 175.67 5.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 2.3399999999999999 109.607 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.422 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -67.52 32.93 0.21 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.395 -1.482 . . . . 2.1699999999999999 109.395 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 103' ' ' THR . 15.1 tt0 -110.41 95.44 22.46 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.357 -1.084 . . . . 3.02 109.362 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -47.29 118.34 2.81 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.572 2.182 . . . . 1.4199999999999999 112.254 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.594 ' CB ' HH12 ' A' ' 109' ' ' ARG . . . -175.73 166.79 3.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 1.3700000000000001 109.31 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -90.44 145.44 24.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 1.72 110.311 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.594 HH12 ' CB ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -108.62 138.76 44.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.711 -1.218 . . . . 4.7000000000000002 107.711 178.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.01 102.28 11.29 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.434 -0.791 . . . . 3.2799999999999998 110.526 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 12.3 m-30 -109.53 115.0 29.11 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.484 -0.932 . . . . 2.96 108.484 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.659 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -125.66 165.41 18.63 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.3 -0.875 . . . . 3.4100000000000001 109.573 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.5 p90 -154.19 -178.06 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.875 . . . . 2.77 109.511 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.539 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -105.99 101.09 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 2.23 109.513 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 34.9 p -36.22 104.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 4.1100000000000003 109.353 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.792 ' C ' HD22 ' A' ' 117' ' ' LEU . 41.1 m-20 -93.44 -32.89 14.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 6.8600000000000003 109.405 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.792 HD22 ' C ' ' A' ' 116' ' ' ASN . 4.6 mm? -122.39 -175.22 3.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 5.1200000000000001 109.28 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.53 114.95 27.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 4.0599999999999996 109.629 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 117' ' ' LEU . 5.5 m-85 -112.85 79.24 3.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.955 . . . . 5.4400000000000004 109.35 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.82 152.24 28.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.705 2.27 . . . . 4.04 112.245 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 125' ' ' ALA . 71.8 Cg_endo -80.33 -32.68 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.597 2.198 . . . . 3.8999999999999999 111.814 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 123' ' ' GLY . 24.3 m-20 -109.84 -30.34 7.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 4.1399999999999997 109.55 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -36.46 -34.04 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 3.5699999999999998 109.531 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.6 OUTLIER -173.72 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 3.5899999999999999 109.508 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -137.18 153.24 74.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 2.0800000000000001 109.566 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -68.8 -10.97 30.64 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.947 2.432 . . . . 1.3899999999999999 112.337 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.9 178.21 17.29 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 1.1899999999999999 109.348 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.584 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 1.2 tt0 -154.35 120.99 5.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -1.227 . . . . 2.0099999999999998 109.775 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 84' ' ' VAL . 16.4 t -144.42 120.7 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.711 -0.848 . . . . 1.28 108.711 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -141.38 131.55 24.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.013 . . . . 0.97999999999999998 110.444 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.472 ' HZ ' HD21 ' A' ' 68' ' ' LEU . 4.7 m-30 -94.46 115.62 27.82 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.666 -0.864 . . . . 1.73 108.666 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.581 ' O ' ' O ' ' A' ' 81' ' ' ARG . 23.8 m170 -100.02 122.81 43.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 2.3199999999999998 110.064 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.701 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -147.13 10.22 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.862 . . . . 2.1099999999999999 109.27 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.557 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -75.52 126.71 8.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.304 -1.518 . . . . 1.77 109.304 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 138' ' ' ALA . 6.7 mtpm? -165.81 131.27 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 5.0599999999999996 109.618 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.685 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -49.34 -29.89 6.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.409 -1.33 . . . . 2.6400000000000001 107.409 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -96.19 7.42 66.77 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.14 -1.984 . . . . 2.5099999999999998 108.14 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.52 -130.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.862 0.839 . . . . 2.3199999999999998 110.743 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.77 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.3 OUTLIER 162.38 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 1.6100000000000001 109.515 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.63 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -84.42 125.55 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 1.6499999999999999 109.09 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 13.6 t80 -106.39 112.78 25.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.803 . . . . 1.6799999999999999 109.285 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.7 m -113.78 96.27 5.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.1 -1.0 . . . . 0.73999999999999999 110.086 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.452 HD11 ' CG2' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -107.96 142.91 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.22 109.221 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 p -134.33 -3.82 2.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.647 -0.658 . . . . 1.3300000000000001 109.278 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 38.3 mt-30 -147.54 162.08 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 3.2999999999999998 110.124 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.837 HG11 ' CH2' ' A' ' 22' ' ' TRP . 93.2 t -160.11 79.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.955 -0.757 . . . . 2.2599999999999998 108.955 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.423 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -80.3 147.82 30.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 2.7599999999999998 110.051 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 149' ' ' THR . 1.2 tp -151.6 112.24 4.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.426 -0.796 . . . . 4.5700000000000003 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.653 ' N ' HD12 ' A' ' 148' ' ' LEU . 7.8 t -166.66 -155.86 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 3.0699999999999998 109.532 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 65' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 2.0 109.348 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.769 ' N ' ' HG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.496 -0.557 . . . . 2.8300000000000001 109.496 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 4.75 109.44 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 -30.99 52.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 4.9500000000000002 109.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.027 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -114.95 96.11 43.81 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 2.8599999999999999 109.325 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.79 45.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.748 2.299 . . . . 3.8300000000000001 112.673 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.622 ' N ' ' O ' ' A' ' 10' ' ' LEU . 54.8 t60 -133.25 107.46 8.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.98 . . . . 2.52 109.438 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.28 59.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 1.97 109.465 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 16' ' ' ALA . 47.3 t -160.9 69.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 1.96 109.658 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.3 m-30 -62.57 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 1.76 109.209 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -83.44 -34.69 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.737 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.687 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 21.8 mm-40 -109.72 -84.71 0.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 2.1299999999999999 109.344 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 20' ' ' GLY . 3.8 p -103.04 142.87 33.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 2.2599999999999998 109.233 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.82 6.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.098 -1.001 . . . . 2.6000000000000001 109.496 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 73.64 -148.65 40.51 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.201 -1.16 . . . . 1.6200000000000001 110.201 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 22' ' ' TRP . 98.6 Cg_endo -88.94 -10.64 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.268 2.646 . . . . 1.7 111.996 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.781 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.4 m95 -54.94 -170.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 2.4199999999999999 109.757 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -128.26 166.18 19.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 1.6399999999999999 109.255 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.832 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -170.74 156.34 5.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 2.0499999999999998 109.755 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER 158.13 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 1.72 109.803 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 89.6 -28.83 6.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.965 -1.112 . . . . 1.7 110.411 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.758 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.71 -141.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.349 . . . . 0.96999999999999997 109.627 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' ' OG1' ' A' ' 27' ' ' THR . 16.3 p -91.02 133.14 35.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.459 -0.776 . . . . 1.8 109.43 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -36.99 101.34 0.22 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 2.3999999999999999 109.214 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 51.5 Cg_exo -46.63 150.5 2.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.35 2.033 . . . . 1.1299999999999999 111.709 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.7 t -136.57 117.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.998 . . . . 1.05 110.207 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -81.45 89.16 6.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.725 . . . . 1.8200000000000001 109.763 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -63.6 -140.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 1.1699999999999999 109.492 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -40.09 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 2.21 109.541 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.558 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -138.97 35.64 1.96 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.568 -1.413 . . . . 1.1899999999999999 109.568 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.17 152.1 31.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -1.128 . . . . 2.9100000000000001 109.508 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.28 134.52 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.93000000000000005 109.303 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.71 154.23 46.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.335 -0.946 . . . . 1.0600000000000001 110.471 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.5 m -123.65 134.12 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.629 -0.878 . . . . 1.3700000000000001 108.629 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.671 ' N ' ' OG ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -74.99 105.85 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 4.79 109.795 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.6 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.5 mm? -117.94 74.82 10.17 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 3.54 109.314 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.47 -56.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.784 2.323 . . . . 3.7400000000000002 112.195 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 136' ' ' ALA . . . 161.44 -150.66 20.49 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.543 -1.423 . . . . 2.0299999999999998 109.543 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.03 -0.36 6.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 2.4100000000000001 109.501 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.671 ' O ' ' N ' ' A' ' 47' ' ' ASN . 2.8 mt-30 -99.38 73.63 1.88 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.256 -1.143 . . . . 2.96 109.539 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.85 49.88 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.392 -1.483 . . . . 2.0800000000000001 109.392 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.674 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -160.84 87.33 1.74 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -1.114 . . . . 3.6099999999999999 109.429 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.59 -9.88 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.912 2.408 . . . . 2.3599999999999999 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -112.34 31.42 6.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 3.8700000000000001 109.548 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 30.6 m-20 -123.02 36.78 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 2.3799999999999999 109.364 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 27' ' ' THR . . . 175.46 119.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.1100000000000001 109.389 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 159.37 -152.71 23.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.884 -1.286 . . . . 0.93999999999999995 109.884 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -144.24 170.46 15.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.95999999999999996 109.355 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.695 HG13 ' HB2' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -152.97 172.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.05 -1.031 . . . . 0.92000000000000004 110.084 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 1.027 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 58.3 t80 -178.43 148.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 1.71 109.556 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.454 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -110.93 -164.92 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 2.7799999999999998 109.575 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.08 67.39 1.63 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.399 . . . . 2.48 109.604 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG13 HD21 ' A' ' 148' ' ' LEU . 3.9 t -147.96 91.93 4.77 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -1.185 . . . . 3.79 109.505 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.683 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 60.9 Cg_endo -80.44 154.19 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.763 2.309 . . . . 2.3999999999999999 112.128 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.592 HG13 ' CE1' ' A' ' 66' ' ' TYR . 2.0 t -151.7 148.39 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 3.0800000000000001 109.736 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -142.94 116.07 0.98 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.228 -1.549 . . . . 3.0499999999999998 109.228 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.684 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -34.35 146.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -1.151 . . . . 6.0499999999999998 109.762 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.679 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 91.75 -16.6 58.91 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.88 -1.288 . . . . 2.54 109.88 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.671 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.6 mt-10 -112.47 160.92 17.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -1.219 . . . . 4.0300000000000002 109.836 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -128.29 140.91 51.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 2.9100000000000001 109.116 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 20.9 m-85 -107.07 177.13 4.95 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.077 -1.014 . . . . 2.3799999999999999 109.885 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -147.58 165.25 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.468 -0.77 . . . . 2.6099999999999999 109.593 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 148' ' ' LEU . 8.3 tp -149.9 118.82 6.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 3.6099999999999999 109.515 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.96 80.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 2.27 109.151 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 50.2 p90 -94.44 146.14 24.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.718 . . . . 2.0099999999999998 110.831 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.17 138.48 32.81 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.642 -0.873 . . . . 1.8 108.642 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.839 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -176.24 122.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.012 -1.055 . . . . 0.95999999999999996 110.142 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -112.44 122.5 47.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.749 -0.834 . . . . 0.93000000000000005 108.749 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -91.24 132.65 35.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.258 -0.901 . . . . 0.67000000000000004 109.85 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.478 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -135.63 113.97 11.11 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.384 -0.823 . . . . 0.96999999999999997 109.28 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.578 ' O ' ' C ' ' A' ' 74' ' ' ALA . 18.7 Cg_exo -65.21 -142.25 0.15 OUTLIER 'Cis proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.321 -1.116 . . . . 1.02 112.636 -0.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.662 ' O ' ' SD ' ' A' ' 78' ' ' MET . 1.1 m-20 -108.59 154.97 21.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 1.75 109.726 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 170.34 154.44 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 2.1600000000000001 109.433 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.19 129.08 12.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.778 2.319 . . . . 1.3799999999999999 112.306 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -106.12 -178.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 2.0099999999999998 109.244 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.65 ' N ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -129.16 147.08 50.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 6.0099999999999998 109.715 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -150.0 155.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 3.7599999999999998 109.216 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.505 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -141.65 151.28 42.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.132 -0.98 . . . . 2.29 109.856 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG13 HG23 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -150.33 162.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 1.8899999999999999 109.472 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 139.56 -147.75 19.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.708 -1.357 . . . . 1.49 109.708 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.715 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.41 162.45 15.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -1.114 . . . . 2.54 109.469 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.563 ' C ' ' HB1' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.493 -1.443 . . . . 1.3799999999999999 109.493 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.732 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 5.7400000000000002 109.637 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -101.9 174.18 6.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 2.27 109.877 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HD21 ' A' ' 116' ' ' ASN . . . -127.43 -17.16 4.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.49 -0.756 . . . . 3.2799999999999998 109.168 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.408 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.72 36.42 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 3.6499999999999999 109.43 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -83.96 70.99 10.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 4.5999999999999996 109.479 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.846 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -102.03 178.86 4.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 3.46 109.563 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.633 ' CA ' ' OE1' ' A' ' 97' ' ' GLN . . . -157.75 17.09 0.33 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.617 -1.393 . . . . 3.6699999999999999 109.617 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.846 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.7 m -111.05 63.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 3.79 109.686 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.12 97.18 29.02 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 1.96 109.253 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.699 ' C ' HD22 ' A' ' 102' ' ' LEU . 60.5 Cg_endo -79.58 118.2 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.67 2.247 . . . . 2.9700000000000002 112.667 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 72' ' ' ALA . 4.1 mm? -115.87 143.05 45.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 3.0600000000000001 109.169 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.613 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -127.36 166.56 17.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 2.3399999999999999 109.522 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.93 24.49 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 2.1699999999999999 109.505 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.613 ' H ' ' C ' ' A' ' 103' ' ' THR . 13.3 tt0 -109.9 96.59 25.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 3.02 109.363 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.14 118.43 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.551 2.167 . . . . 1.4199999999999999 112.195 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.801 ' HB3' ' NH2' ' A' ' 109' ' ' ARG . . . -169.99 164.2 9.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.846 . . . . 1.3700000000000001 109.439 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.579 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.29 140.24 29.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 1.72 109.859 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.801 ' NH2' ' HB3' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -105.45 134.8 47.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.842 -1.17 . . . . 4.7000000000000002 107.842 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -109.11 99.79 9.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 3.2799999999999998 110.893 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.3 m-30 -109.93 130.3 55.55 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.319 -0.993 . . . . 2.96 108.319 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.67 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -134.4 163.21 30.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 3.4100000000000001 109.849 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.621 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -142.97 173.47 11.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 2.77 109.516 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 121.33 42.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 2.23 109.776 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 93.5 p -48.97 143.81 5.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 4.1100000000000003 109.431 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 6.7 p-10 -134.31 -46.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 6.8600000000000003 109.516 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.774 HD22 ' CE1' ' A' ' 119' ' ' PHE . 5.0 tt -109.97 175.25 5.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 5.1200000000000001 109.461 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.727 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -92.95 124.32 36.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 4.0599999999999996 109.864 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.774 ' CE1' HD22 ' A' ' 117' ' ' LEU . 45.0 m-85 -134.75 93.63 17.75 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 5.4400000000000004 109.258 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.6 165.53 22.66 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.678 2.252 . . . . 4.04 112.267 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.83 -14.5 12.47 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.858 2.372 . . . . 3.8999999999999999 112.079 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 2.5 p-10 -109.65 115.52 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 4.1399999999999997 109.527 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . 167.64 173.17 35.5 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 3.5699999999999998 109.475 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -75.97 26.64 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 3.5899999999999999 109.499 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.563 ' HB1' ' C ' ' A' ' 87' ' ' GLY . . . 179.94 74.11 0.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 2.0800000000000001 109.543 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' A' ' 127' ' ' GLY . 56.0 Cg_endo -75.31 -158.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.77 2.314 . . . . 1.3899999999999999 112.249 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -39.16 163.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.587 -1.405 . . . . 1.1899999999999999 109.587 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.592 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 1.1 tt0 -162.28 122.22 2.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -1.181 . . . . 2.0099999999999998 109.721 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 55' ' ' TYR . 8.4 p -146.53 130.52 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.424 -0.954 . . . . 1.28 108.424 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.695 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -148.26 123.26 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.961 -1.087 . . . . 0.97999999999999998 110.731 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.9 m-30 -86.92 118.93 26.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.807 -1.183 . . . . 1.73 107.807 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.505 ' ND1' HD21 ' A' ' 83' ' ' LEU . 6.1 m170 -99.94 131.87 45.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 2.3199999999999998 110.151 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 134' ' ' GLY . 3.8 mp -134.4 -105.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 2.1099999999999999 109.124 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 32.49 98.16 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.048 -1.221 . . . . 1.77 110.048 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.7 mtpt -146.68 123.67 11.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 5.0599999999999996 109.857 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.16 -20.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.147 -0.97 . . . . 2.6400000000000001 108.46 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -120.66 13.35 10.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.025 -1.63 . . . . 2.5099999999999998 109.025 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.616 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -52.17 -152.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.967 . . . . 2.3199999999999998 110.26 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.555 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 11.9 p90 -164.63 -131.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -0.99 . . . . 1.6100000000000001 109.374 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.417 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 26.5 mt-10 -120.3 128.29 53.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 1.6499999999999999 109.38 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.595 ' CD2' HG22 ' A' ' 143' ' ' ILE . 5.5 t80 -107.91 111.36 23.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 1.6799999999999999 109.661 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -107.5 88.43 2.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.73999999999999999 110.141 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.595 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -99.32 135.87 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 1.22 108.844 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 15' ' ' PHE . 60.0 p -128.05 -0.9 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 1.3300000000000001 109.313 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 23.7 mt-30 -152.2 174.61 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 3.2999999999999998 109.977 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 146' ' ' VAL . 8.0 p -177.24 92.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 2.2599999999999998 109.102 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.39 144.68 31.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 2.7599999999999998 110.056 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.641 HD21 HG13 ' A' ' 58' ' ' VAL . 8.9 tp -130.08 120.09 24.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 4.5700000000000003 109.019 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.769 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 2.6 t -158.06 -170.18 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 3.0699999999999998 109.661 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.551 HG23 HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 2.0 109.45 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.872 ' N ' ' HG1' ' A' ' 149' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.368 -0.604 . . . . 2.8300000000000001 109.368 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.484 ' H ' HG12 ' A' ' 7' ' ' VAL . 3.1 tt0 -175.33 86.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 4.75 109.636 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -83.97 -18.57 36.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 4.9500000000000002 109.425 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 10' ' ' LEU . 3.0 tm? -130.06 86.31 54.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 2.8599999999999999 108.782 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.37 41.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.35 2.7 . . . . 3.8300000000000001 113.509 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.709 ' H ' HD13 ' A' ' 10' ' ' LEU . 16.8 t60 -152.26 111.69 3.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.878 -1.139 . . . . 2.52 109.463 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.541 ' OG1' ' C ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -159.89 65.65 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 1.97 109.506 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 16' ' ' ALA . 23.4 m -153.03 66.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 1.96 109.592 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.544 ' CD2' HD11 ' A' ' 143' ' ' ILE . 4.6 m-30 -63.22 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 1.76 109.11 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -89.95 -78.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 1.1799999999999999 109.915 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.16 38.61 2.25 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.247 -0.908 . . . . 2.1299999999999999 109.867 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.97 150.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 2.2599999999999998 109.59 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -87.04 -69.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 2.6000000000000001 109.577 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 113.53 -172.03 14.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.408 -1.477 . . . . 1.6200000000000001 109.408 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.5 Cg_endo -70.31 -10.0 27.15 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.703 2.269 . . . . 1.7 112.189 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.916 ' CH2' HG21 ' A' ' 146' ' ' VAL . 7.8 m95 -61.91 -169.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 2.4199999999999999 109.246 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.8 m -150.37 162.27 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 1.6399999999999999 109.496 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 19' ' ' LEU . 2.7 pp -160.82 149.96 16.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 2.0499999999999998 109.489 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -177.52 133.92 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.72 109.437 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 148.51 -40.08 0.94 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.827 -1.309 . . . . 1.7 109.827 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.817 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -110.01 -141.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.96999999999999997 109.39 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.817 ' N ' ' OG1' ' A' ' 27' ' ' THR . 47.8 p -90.86 155.86 18.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 1.8 109.434 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -49.91 110.89 1.79 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.3999999999999999 109.03 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' CG ' HD13 ' A' ' 24' ' ' LEU . 49.9 Cg_exo -47.29 171.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.192 1.928 . . . . 1.1299999999999999 111.775 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.51 109.68 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.026 -1.046 . . . . 1.05 110.054 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.725 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.2 85.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 1.8200000000000001 109.289 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.19 -140.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 1.1699999999999999 109.74 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.609 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 7.3 p-10 -53.23 -57.0 12.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 2.21 109.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.38 44.47 0.69 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.405 -1.478 . . . . 1.1899999999999999 109.405 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.46 143.96 7.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -1.118 . . . . 2.9100000000000001 109.728 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.53 ' SD ' ' C ' ' A' ' 37' ' ' MET . 4.9 tmm? -110.87 124.86 52.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.93000000000000005 109.058 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.6 m -122.12 157.98 30.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -0.902 . . . . 1.0600000000000001 110.226 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -137.0 146.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 1.3700000000000001 108.687 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.606 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -75.67 121.39 22.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 4.79 109.207 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.652 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.3 mm? -117.76 36.7 0.23 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.084 -1.01 . . . . 3.54 110.998 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 84.8 Cg_endo -80.59 -95.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.491 2.127 . . . . 3.7400000000000002 111.427 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . 46.33 -107.8 0.21 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.699 -0.961 . . . . 2.0299999999999998 110.699 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.4 57.31 0.01 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.44 -1.864 . . . . 2.4100000000000001 108.44 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 136' ' ' ALA . 32.8 mt-30 -99.58 104.75 16.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -1.056 . . . . 2.96 110.027 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' N ' ' HB2' ' A' ' 136' ' ' ALA . . . -77.55 40.42 1.79 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.408 -1.477 . . . . 2.0800000000000001 109.408 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.648 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.3 OUTLIER -159.43 93.04 1.8 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 3.6099999999999999 109.528 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.66 ' O ' ' N ' ' A' ' 50' ' ' ASP . 52.0 Cg_exo -49.6 -38.8 45.93 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.804 2.336 . . . . 2.3599999999999999 112.407 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.475 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 11.8 p90 -62.68 50.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 3.8700000000000001 109.527 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.3 m-20 -149.48 13.29 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 2.3799999999999999 109.698 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 175.18 152.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 1.1100000000000001 109.515 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.1 176.05 24.38 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.923 -1.271 . . . . 0.93999999999999995 109.923 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 53' ' ' LEU . 5.4 mt -85.18 -177.15 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -1.134 . . . . 0.95999999999999996 109.205 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -162.16 159.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.151 -0.968 . . . . 0.92000000000000004 110.989 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.634 ' OH ' ' CD2' ' A' ' 10' ' ' LEU . 41.2 t80 178.63 124.19 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.41 -0.589 . . . . 1.71 109.41 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 7.6 m-20 -101.35 -171.23 1.95 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.24 -0.913 . . . . 2.7799999999999998 109.498 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.694 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 80.88 72.24 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.65 -1.38 . . . . 2.48 109.65 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 57' ' ' GLY . 11.0 m -161.92 68.12 2.18 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 3.79 109.413 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.36 148.59 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.854 2.369 . . . . 2.3999999999999999 112.227 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.61 101.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 3.0800000000000001 109.53 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -92.45 116.02 4.97 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.481 -1.448 . . . . 3.0499999999999998 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' C ' ' OG ' ' A' ' 115' ' ' SER . 1.6 tm-20 -47.74 149.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.143 -1.21 . . . . 6.0499999999999998 109.544 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 93.39 -24.37 25.71 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.748 -1.341 . . . . 2.54 109.748 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.661 ' N ' ' OG ' ' A' ' 115' ' ' SER . 1.4 mm-40 -101.52 164.62 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -1.172 . . . . 4.0300000000000002 109.659 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.482 ' OG ' HG22 ' A' ' 114' ' ' THR . 47.7 m -131.34 135.27 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 2.9100000000000001 109.433 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 63.0 m-85 -105.36 178.19 4.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.229 -0.92 . . . . 2.3799999999999999 109.852 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 3.0 t -152.03 151.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 2.6099999999999999 109.31 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 148' ' ' LEU . 6.5 tp -137.58 118.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 3.6099999999999999 109.785 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -109.64 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.518 -0.919 . . . . 2.27 108.518 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.0 p90 -94.12 145.99 24.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 2.0099999999999998 111.453 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -91.78 134.29 34.87 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.321 -0.992 . . . . 1.8 108.321 178.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.769 ' N ' ' NH2' ' A' ' 109' ' ' ARG . . . -164.0 113.31 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.816 -1.178 . . . . 0.95999999999999996 110.395 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HG ' ' HB2' ' A' ' 142' ' ' CYS . 23.9 p -103.48 122.6 45.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.641 -0.874 . . . . 0.93000000000000005 108.641 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.836 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -93.31 135.39 34.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.67000000000000004 109.752 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.516 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.21 112.07 6.63 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.225 -0.922 . . . . 0.96999999999999997 109.717 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.7 Cg_exo -64.09 -141.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.748 0 C-N-CA 124.253 -1.145 . . . . 1.02 112.393 -0.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.48 150.71 24.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 1.75 109.757 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.644 ' CE ' ' HZ1' ' A' ' 135' ' ' LYS . 0.5 OUTLIER 173.01 154.54 0.25 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.1600000000000001 109.34 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.25 140.68 22.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.767 2.311 . . . . 1.3799999999999999 112.149 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 100' ' ' ALA . 7.3 m -111.84 -179.55 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 2.0099999999999998 109.461 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.733 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.24 151.21 44.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 6.0099999999999998 109.565 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 97' ' ' GLN . 2.1 p -154.37 154.51 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 3.7599999999999998 109.536 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.74 ' CD1' HE22 ' A' ' 128' ' ' GLN . 0.8 OUTLIER -151.19 141.93 22.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.957 . . . . 2.29 109.751 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 129' ' ' VAL . 0.9 OUTLIER -153.34 146.36 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 1.8899999999999999 109.663 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.12 -132.09 4.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.588 -1.405 . . . . 1.49 109.588 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' CD ' ' CE1' ' A' ' 119' ' ' PHE . 15.2 pt-20 -90.33 134.31 34.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 2.54 109.417 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.614 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.646 -1.382 . . . . 1.3799999999999999 109.646 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.521 -0.548 . . . . 5.7400000000000002 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -176.83 -164.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 2.27 109.692 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.7 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.7 -25.63 10.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.614 -0.884 . . . . 3.2799999999999998 108.614 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -91.17 35.99 0.92 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 3.6499999999999999 108.992 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.18 43.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.079 -1.013 . . . . 4.5999999999999996 109.492 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.504 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -104.42 114.47 28.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.264 -0.897 . . . . 3.46 109.149 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -103.57 13.94 53.98 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 3.6699999999999999 109.543 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -92.6 64.02 4.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -1.124 . . . . 3.79 109.526 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . . . -104.72 101.8 30.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 1.96 109.166 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.54 121.79 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.519 2.146 . . . . 2.9700000000000002 112.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.541 HD22 ' CZ ' ' A' ' 109' ' ' ARG . 63.0 mt -127.33 130.33 49.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 3.0600000000000001 109.327 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -119.73 -179.78 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 2.3399999999999999 109.601 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -66.76 24.05 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.445 -1.462 . . . . 2.1699999999999999 109.445 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.627 ' OE2' ' HB2' ' A' ' 107' ' ' ALA . 6.7 tm-20 -112.17 92.98 20.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.304 -1.115 . . . . 3.02 109.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.83 118.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.66 2.24 . . . . 1.4199999999999999 112.255 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.648 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . . . -166.06 162.41 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 1.3700000000000001 109.406 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.59 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -91.19 146.71 23.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 1.72 109.914 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.769 ' NH2' ' N ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -109.75 134.81 51.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.66 -1.237 . . . . 4.7000000000000002 107.66 177.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.54 ' OE1' ' C ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -114.35 102.26 9.94 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.93 -0.708 . . . . 3.2799999999999998 110.599 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 14.8 m-85 -109.83 122.0 46.52 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.498 -0.927 . . . . 2.96 108.498 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.68 133.75 55.64 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.251 -0.906 . . . . 3.4100000000000001 109.721 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.727 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -118.3 164.11 15.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 2.77 109.285 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.522 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -104.79 104.9 14.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 2.23 109.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 53.7 p -35.93 107.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 4.1100000000000003 109.25 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 15.7 t30 -86.04 -55.06 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 6.8600000000000003 109.706 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.705 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -111.31 -158.64 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 5.1200000000000001 109.804 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.705 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -117.24 150.56 38.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.363 -0.836 . . . . 4.0599999999999996 109.393 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 72.8 m-85 -162.45 73.91 2.17 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.86 . . . . 5.4400000000000004 109.548 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.35 167.87 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.858 2.372 . . . . 4.04 112.011 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.53 -15.66 10.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.813 2.342 . . . . 3.8999999999999999 112.091 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.637 ' OD2' ' N ' ' A' ' 123' ' ' GLY . 5.5 p-10 -111.29 -113.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.888 . . . . 4.1399999999999997 109.443 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.637 ' N ' ' OD2' ' A' ' 122' ' ' ASP . . . 36.12 -112.5 0.13 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.654 -1.379 . . . . 3.5699999999999998 109.654 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.8 -102.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -1.16 . . . . 3.5899999999999999 109.527 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.614 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -101.84 152.73 38.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 2.0800000000000001 109.493 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 -158.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.838 2.359 . . . . 1.3899999999999999 112.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -77.17 164.2 52.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.586 -1.406 . . . . 1.1899999999999999 109.586 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.74 HE22 ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -142.36 126.24 17.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 2.0099999999999998 109.439 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.649 HG22 ' CG1' ' A' ' 84' ' ' VAL . 19.3 t -139.09 90.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.57 -0.9 . . . . 1.28 108.57 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -112.62 122.14 46.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.97999999999999998 110.45 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -84.21 117.13 23.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.422 -0.955 . . . . 1.73 108.422 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.567 ' O ' ' O ' ' A' ' 81' ' ' ARG . 13.4 m170 -99.5 119.38 37.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 2.3199999999999998 110.044 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.802 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -136.59 -0.9 2.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 2.1099999999999999 109.421 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.78 135.0 32.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.256 -1.538 . . . . 1.77 109.256 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.644 ' HZ1' ' CE ' ' A' ' 78' ' ' MET . 9.3 mtmt -166.81 129.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 5.0599999999999996 109.552 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.02 -26.67 1.88 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.467 -1.308 . . . . 2.6400000000000001 107.467 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -104.28 11.98 51.53 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.293 -1.923 . . . . 2.5099999999999998 108.293 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.51 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.645 0.736 . . . . 2.3199999999999998 110.641 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.836 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 179.93 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.609 -1.307 . . . . 1.6100000000000001 110.715 -179.078 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.428 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 49.7 mt-10 -123.67 143.57 50.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 1.6499999999999999 109.25 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.556 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 15.2 t80 -126.22 120.63 30.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 1.6799999999999999 109.727 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.487 ' HB2' ' HG ' ' A' ' 73' ' ' SER . 1.7 m -119.06 97.29 5.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 109.853 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.544 HD11 ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -106.45 141.61 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 1.22 109.261 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.4 p -139.02 -2.62 1.66 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.617 -0.677 . . . . 1.3300000000000001 109.556 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 71' ' ' THR . 14.0 mt-30 -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 3.2999999999999998 110.242 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.916 HG21 ' CH2' ' A' ' 22' ' ' TRP . 2.8 p -160.94 73.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.004 -0.739 . . . . 2.2599999999999998 109.004 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.443 ' N ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -76.48 147.1 38.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 2.7599999999999998 110.18 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 58' ' ' VAL . 8.6 tp -138.56 101.59 4.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.492 -0.755 . . . . 4.5700000000000003 109.106 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.872 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -149.07 -176.61 5.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 3.0699999999999998 109.726 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.518 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.9 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 2.0 109.281 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.698 ' N ' ' HG1' ' A' ' 149' ' ' THR . 22.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.425 -0.583 . . . . 2.8300000000000001 109.425 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.39 104.38 16.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 4.75 109.531 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.34 -15.83 55.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 4.9500000000000002 109.523 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -121.75 94.97 48.17 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 2.8599999999999999 108.819 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.99 26.83 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.388 2.059 . . . . 3.8300000000000001 111.548 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.562 ' H ' HD13 ' A' ' 10' ' ' LEU . 30.6 t60 -123.39 84.71 2.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 2.52 109.594 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -129.1 50.26 2.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 1.97 109.331 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 16' ' ' ALA . 25.0 p -128.26 64.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 1.96 109.786 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CE2' HD21 ' A' ' 24' ' ' LEU . 4.5 m-30 -64.73 35.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.957 . . . . 1.76 108.967 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.625 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.35 -48.73 6.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 1.1799999999999999 110.282 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.3 mm-40 -109.9 -83.51 0.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 2.1299999999999999 109.87 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 m -76.95 144.5 38.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 2.2599999999999998 109.662 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.704 ' CD2' HD13 ' A' ' 24' ' ' LEU . 1.6 tp -60.13 -57.86 11.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.322 -0.861 . . . . 2.6000000000000001 109.487 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.3 -177.83 17.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.559 -1.416 . . . . 1.6200000000000001 109.559 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.78 -5.94 16.41 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.857 2.371 . . . . 1.7 112.16 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.947 ' CH2' HG21 ' A' ' 146' ' ' VAL . 8.8 m95 -65.35 -164.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 2.4199999999999999 109.222 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.6 m -144.58 131.88 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 1.6399999999999999 109.845 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.899 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.7 148.94 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 2.0499999999999998 109.452 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 163.9 -168.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 1.72 109.749 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.84 -22.89 1.77 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.103 -1.199 . . . . 1.7 110.103 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.77 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.77 -142.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.249 . . . . 0.96999999999999997 109.224 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.77 ' N ' ' OG1' ' A' ' 27' ' ' THR . 91.1 p -90.95 129.9 36.92 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.171 -0.955 . . . . 1.8 109.17 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.562 ' C ' ' O ' ' A' ' 28' ' ' SER . 18.5 mt-10 -33.93 98.53 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 2.3999999999999999 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 28' ' ' SER . 54.9 Cg_exo -46.92 146.14 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.372 2.048 . . . . 1.1299999999999999 111.821 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.94 116.58 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.053 . . . . 1.05 110.014 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.73 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.81 89.69 3.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.46 -0.775 . . . . 1.8200000000000001 109.472 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.16 -140.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.5 -0.75 . . . . 1.1699999999999999 110.295 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -69.56 15.55 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 2.21 110.358 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.612 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 148.71 -6.75 0.89 Allowed Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.396 -1.383 . . . . 1.1899999999999999 110.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.631 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.73 146.08 47.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.359 . . . . 2.9100000000000001 109.803 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.572 ' SD ' ' C ' ' A' ' 37' ' ' MET . 1.6 tmm? -109.84 129.76 55.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 0.93000000000000005 108.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.03 145.8 51.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 1.0600000000000001 110.57 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -115.58 174.95 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.983 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -134.39 135.22 42.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.028 -1.045 . . . . 4.79 109.696 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.983 HD22 ' C ' ' A' ' 40' ' ' ASP . 3.7 mm? -135.62 60.91 39.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.985 . . . . 3.54 110.489 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 41' ' ' LEU . 61.2 Cg_endo -98.38 -15.16 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.091 2.528 . . . . 3.7400000000000002 112.203 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.38 -142.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.932 -0.867 . . . . 2.0299999999999998 110.932 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 136' ' ' ALA . . . -133.98 78.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.678 -1.369 . . . . 2.4100000000000001 109.678 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -99.7 127.02 45.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -1.217 . . . . 2.96 109.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.77 64.81 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.579 -1.408 . . . . 2.0800000000000001 109.579 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.683 ' ND2' ' CG ' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -173.56 135.19 0.66 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.152 . . . . 3.6099999999999999 109.411 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.676 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 60.1 Cg_endo -75.94 -13.31 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.549 2.166 . . . . 2.3599999999999999 112.375 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.691 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -111.77 38.65 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 3.8700000000000001 110.002 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.743 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -119.35 38.08 3.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 2.3799999999999999 109.542 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.743 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 160.39 133.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.1100000000000001 109.639 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.36 -162.22 28.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.866 -1.294 . . . . 0.93999999999999995 109.866 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -136.06 168.84 18.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -1.174 . . . . 0.95999999999999996 109.293 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 23' ' ' SER . 1.5 p -155.48 164.8 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.083 -1.011 . . . . 0.92000000000000004 110.137 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 63.7 t80 -178.63 141.67 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.576 -0.703 . . . . 1.71 109.656 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.691 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 78.6 m-20 -88.1 -152.86 0.22 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.331 -0.856 . . . . 2.7799999999999998 109.366 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.82 79.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 2.48 109.546 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.802 HG22 ' CD2' ' A' ' 148' ' ' LEU . 5.6 t -117.76 68.57 6.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.15 . . . . 3.79 109.562 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.405 ' C ' HG23 ' A' ' 60' ' ' VAL . 38.0 Cg_endo -70.05 160.7 48.69 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.716 2.277 . . . . 2.3999999999999999 112.132 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.85 HG12 ' OG ' ' A' ' 115' ' ' SER . 20.3 t -151.94 132.31 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 3.0800000000000001 109.612 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.35 104.22 1.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.495 -1.442 . . . . 3.0499999999999998 109.495 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.8 tm-20 -35.4 121.0 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -1.119 . . . . 6.0499999999999998 109.562 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 130.66 -45.09 1.16 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.889 -1.285 . . . . 2.54 109.889 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.5 mm-40 -100.03 171.76 7.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -1.156 . . . . 4.0300000000000002 109.804 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.2 m -116.21 144.71 43.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 2.9100000000000001 109.297 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.728 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 20.2 m-85 -108.28 179.43 4.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.198 -0.939 . . . . 2.3799999999999999 109.773 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.4 t -150.34 141.74 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -0.766 . . . . 2.6099999999999999 109.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 70' ' ' PHE . 3.8 tp -124.59 119.9 30.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 3.6099999999999999 108.883 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -115.65 90.13 3.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.031 . . . . 2.27 109.897 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.72 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.64 147.58 22.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 2.0099999999999998 110.878 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -97.1 113.64 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 1.8 109.176 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -178.58 176.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.914 -1.116 . . . . 0.95999999999999996 110.667 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -156.07 154.04 30.35 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.087 -0.708 . . . . 0.93000000000000005 109.087 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -94.04 134.18 36.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.67000000000000004 109.612 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.451 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.71 116.04 14.73 Favored Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.279 -0.888 . . . . 0.96999999999999997 109.559 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.5 Cg_exo -65.89 -141.9 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.427 -1.072 . . . . 1.02 112.562 -0.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -91.26 151.96 20.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 1.75 109.786 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.1 mtp 161.09 157.3 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 2.1600000000000001 109.347 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 64.2 Cg_endo -77.56 147.32 25.06 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.779 2.32 . . . . 1.3799999999999999 112.235 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 100' ' ' ALA . 4.4 m -113.91 170.68 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 2.0099999999999998 109.425 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.419 ' C ' HG23 ' A' ' 82' ' ' VAL . 2.3 mtp180 -109.93 151.21 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 6.0099999999999998 109.352 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 97' ' ' GLN . 19.5 t -152.59 149.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 3.7599999999999998 109.581 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.732 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.3 pp -150.92 145.84 25.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 2.29 109.463 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.4 t -146.49 152.06 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 1.8899999999999999 109.729 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 163.64 -148.45 14.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 1.49 109.455 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.667 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 12.1 pm0 -90.14 179.1 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -1.102 . . . . 2.54 109.339 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.409 . . . . 1.3799999999999999 109.576 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.724 ' CG ' HH11 ' A' ' 92' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.471 -0.566 . . . . 5.7400000000000002 109.471 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -104.37 161.41 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 2.27 109.958 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -112.26 -18.68 12.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.704 -0.85 . . . . 3.2799999999999998 108.704 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.677 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.79 35.78 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 3.6499999999999999 109.286 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.89 57.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 4.5999999999999996 109.394 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.689 HE22 ' CA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -100.0 129.5 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 3.46 108.87 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 97' ' ' GLN . . . -119.21 -9.9 8.43 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.763 -1.208 . . . . 3.6699999999999999 110.142 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.689 ' CA ' HE22 ' A' ' 97' ' ' GLN . 1.8 m -80.42 77.1 7.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.253 . . . . 3.79 109.551 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -117.88 85.33 22.56 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.96 109.593 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.73 127.28 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.976 2.451 . . . . 2.9700000000000002 112.509 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.567 HD21 ' NE ' ' A' ' 109' ' ' ARG . 6.3 mt -142.28 127.56 18.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 3.0600000000000001 109.379 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 105' ' ' GLU . 9.3 t -111.67 -165.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 2.3399999999999999 109.733 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.18 31.99 3.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.438 . . . . 2.1699999999999999 109.504 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' H ' HG23 ' A' ' 103' ' ' THR . 2.8 mt-10 -109.68 96.44 23.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 3.02 109.345 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -46.88 118.2 2.58 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.53 2.153 . . . . 1.4199999999999999 112.248 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -169.13 169.8 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 1.3700000000000001 109.491 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.25 143.85 26.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 1.72 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.719 ' CD ' ' N ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.17 131.64 51.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.79 -1.189 . . . . 4.7000000000000002 107.79 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' CG ' HG12 ' A' ' 67' ' ' VAL . 14.6 tt0 -117.4 96.18 5.29 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.632 -0.827 . . . . 3.2799999999999998 110.548 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 6.7 m-30 -109.46 117.24 33.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.178 -1.045 . . . . 2.96 108.178 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.728 ' HB1' ' O ' ' A' ' 66' ' ' TYR . . . -115.98 174.18 6.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -0.893 . . . . 3.4100000000000001 109.822 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 2.0 p90 -154.71 179.28 9.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.333 -0.854 . . . . 2.77 109.618 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.52 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -107.64 106.9 17.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.438 -0.789 . . . . 2.23 109.614 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.85 ' OG ' HG12 ' A' ' 60' ' ' VAL . 8.2 t -36.06 116.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 4.1100000000000003 109.322 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -96.95 -50.46 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 6.8600000000000003 109.527 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 117' ' ' LEU . 2.5 mt -112.92 -166.0 1.04 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 5.1200000000000001 109.662 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.01 124.75 50.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 4.0599999999999996 109.419 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.644 ' CE1' ' CD ' ' A' ' 86' ' ' GLU . 34.1 m-85 -137.02 66.04 53.37 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 5.4400000000000004 109.472 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.64 166.9 25.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.858 2.372 . . . . 4.04 112.097 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.99 -19.66 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.763 2.309 . . . . 3.8999999999999999 112.002 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -110.28 111.76 23.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 4.1399999999999997 109.455 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.02 -138.06 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.575 -1.41 . . . . 3.5699999999999998 109.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.12 . . . . 3.5899999999999999 109.484 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.86 149.75 66.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 2.0800000000000001 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.12 -158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.789 2.326 . . . . 1.3899999999999999 112.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.56 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -64.93 172.29 20.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.648 -1.381 . . . . 1.1899999999999999 109.648 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.6 114.36 5.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -1.129 . . . . 2.0099999999999998 109.739 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -133.34 134.11 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.952 -1.129 . . . . 1.28 107.952 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.12 119.91 5.7 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.836 -1.146 . . . . 0.97999999999999998 110.718 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.7 m-30 -83.9 120.57 26.24 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.048 -1.093 . . . . 1.73 108.048 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.732 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 1.6 m170 -99.67 116.09 30.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 2.3199999999999998 109.896 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -138.45 37.44 2.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 2.1099999999999999 109.162 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -92.72 110.39 3.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.437 -1.465 . . . . 1.77 109.437 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 137' ' ' GLY . 56.8 mttt -159.78 134.87 8.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -1.14 . . . . 5.0599999999999996 109.856 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -37.25 -23.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.701 -0.852 . . . . 2.6400000000000001 108.701 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.725 ' C ' ' H ' ' A' ' 139' ' ' TYR . . . -135.11 24.38 3.42 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.51 -1.436 . . . . 2.5099999999999998 109.51 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.785 ' HB3' ' CB ' ' A' ' 41' ' ' LEU . . . -52.93 7.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.299 . . . . 2.3199999999999998 110.486 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.725 ' H ' ' C ' ' A' ' 137' ' ' GLY . 6.3 p90 48.32 -165.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.379 0.609 . . . . 1.6100000000000001 110.751 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 4.8 mt-10 -96.99 159.59 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.6499999999999999 110.459 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -129.81 102.64 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.907 -0.775 . . . . 1.6799999999999999 108.907 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 7.5 m -87.06 119.25 27.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.73999999999999999 110.267 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.447 HG23 ' SD ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -133.23 144.73 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.822 0.82 . . . . 1.22 109.35 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.463 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 92.9 p -136.85 -11.64 1.75 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.284 -0.567 . . . . 1.3300000000000001 109.556 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' SER . 1.6 mt-30 -155.88 168.47 27.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.98 . . . . 3.2999999999999998 109.997 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.947 HG21 ' CH2' ' A' ' 22' ' ' TRP . 7.8 p -150.37 131.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.432 -0.792 . . . . 2.2599999999999998 109.26 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -115.57 150.3 36.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.089 -1.007 . . . . 2.7599999999999998 109.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.802 ' CD2' HG22 ' A' ' 58' ' ' VAL . 1.7 tp -157.86 114.01 2.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 4.5700000000000003 109.365 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.698 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 9.7 t -164.36 -155.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 3.0699999999999998 109.478 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.428 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.93 . . . . 2.0 109.361 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.473 -0.566 . . . . 2.8300000000000001 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.555 ' OE2' ' N ' ' A' ' 148' ' ' LEU . 25.1 tp10 -87.52 97.02 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 4.75 109.504 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.553 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.88 -35.42 72.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 4.9500000000000002 109.444 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.564 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -110.47 93.96 17.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 2.8599999999999999 108.65 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.81 26.46 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.299 1.999 . . . . 3.8300000000000001 111.525 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.564 ' H ' HD13 ' A' ' 10' ' ' LEU . 46.4 t60 -119.88 95.56 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 2.52 109.602 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 2.6 t -130.4 51.07 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 1.97 109.304 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.7 m -114.4 52.91 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 1.96 109.769 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.02 20.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 1.76 108.984 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.608 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.11 -65.62 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 1.1799999999999999 110.009 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 18' ' ' SER . 1.4 mt-10 -109.96 38.88 2.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 2.1299999999999999 109.911 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 2.5 p 170.16 144.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.161 -0.962 . . . . 2.2599999999999998 109.708 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.603 HD11 ' CD2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.02 -69.19 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 2.6000000000000001 109.433 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.18 177.58 19.53 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.546 -1.422 . . . . 1.6200000000000001 109.546 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -53.5 -21.47 18.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.762 2.308 . . . . 1.7 112.048 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.676 ' CH2' HG21 ' A' ' 146' ' ' VAL . 18.0 m95 -58.33 167.81 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 2.4199999999999999 109.502 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.9 m -132.45 176.58 8.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 1.6399999999999999 109.046 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.603 ' CD2' HD11 ' A' ' 19' ' ' LEU . 1.4 pp -175.63 153.15 1.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 2.0499999999999998 110.059 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.688 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -178.44 136.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.538 -0.726 . . . . 1.72 109.111 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 135.27 -27.68 3.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.944 -1.263 . . . . 1.7 109.944 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.769 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.66 -141.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.027 -1.278 . . . . 0.96999999999999997 109.554 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.769 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.8 p -91.52 -167.17 1.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.959 -0.756 . . . . 1.8 108.959 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.57 110.61 42.43 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 2.3999999999999999 108.916 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -45.37 138.24 10.31 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.228 1.952 . . . . 1.1299999999999999 111.829 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 31' ' ' VAL . 12.5 p -118.69 93.52 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 1.05 109.932 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.07 81.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.506 -0.746 . . . . 1.8200000000000001 109.446 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -98.74 -109.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 1.1699999999999999 109.617 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 35' ' ' GLY . 3.0 t0 -51.62 79.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 2.21 109.577 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 35.62 47.14 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.586 -1.405 . . . . 1.1899999999999999 109.586 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -176.51 151.56 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 2.9100000000000001 109.498 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 37' ' ' MET . 4.8 ptt? -109.46 130.94 55.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.93000000000000005 109.803 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.5 m -109.97 128.74 55.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.793 . . . . 1.0600000000000001 109.563 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.1 133.04 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 1.3700000000000001 109.22 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.3 m-20 -80.53 128.76 33.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 4.79 109.248 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.824 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 3.5 mm? -110.28 95.54 22.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 3.54 109.587 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.675 ' O ' ' NZ ' ' A' ' 135' ' ' LYS . 52.5 Cg_endo -78.95 144.08 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.604 2.203 . . . . 3.7400000000000002 112.147 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' HB2' ' A' ' 138' ' ' ALA . . . -81.09 161.49 43.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.826 -1.31 . . . . 2.0299999999999998 109.826 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.16 -7.25 1.16 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.059 -1.216 . . . . 2.4100000000000001 110.059 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.457 ' OE1' ' CB ' ' A' ' 50' ' ' ASP . 41.5 mt-30 -120.69 174.3 6.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.023 -1.281 . . . . 2.96 109.785 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.97 -8.25 3.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.488 -1.445 . . . . 2.0800000000000001 109.488 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.531 ' CG ' ' OD1' ' A' ' 50' ' ' ASP . 1.2 p30 -99.96 133.29 21.74 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -1.175 . . . . 3.6099999999999999 109.353 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.17 1.03 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.478 2.119 . . . . 2.3599999999999999 112.652 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.67 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.1 p-90 -118.53 38.39 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 3.8700000000000001 110.09 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 0.8 OUTLIER -112.41 12.72 20.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.998 . . . . 2.3799999999999999 109.691 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . 179.72 134.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 1.1100000000000001 109.383 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 169.63 171.13 34.92 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.609 -1.281 . . . . 0.93999999999999995 110.222 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 54' ' ' VAL . 7.3 mt -75.65 -178.19 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -1.153 . . . . 0.95999999999999996 109.31 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.637 HG12 ' N ' ' A' ' 55' ' ' TYR . 99.2 t -161.08 167.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.92000000000000004 109.65 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.637 ' N ' HG12 ' A' ' 54' ' ' VAL . 32.0 t80 176.22 145.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.512 -0.743 . . . . 1.71 109.414 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.577 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 4.4 m-20 -107.66 171.7 7.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.936 . . . . 2.7799999999999998 109.589 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 93.62 70.87 1.13 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 2.48 109.53 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 57' ' ' GLY . 43.0 t -162.41 86.79 1.45 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 3.79 109.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.553 ' HD2' HD13 ' A' ' 9' ' ' LEU . 59.1 Cg_endo -79.07 162.88 25.86 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.676 2.251 . . . . 2.3999999999999999 112.153 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.26 114.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 3.0800000000000001 109.654 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -108.6 135.31 12.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.295 -1.522 . . . . 3.0499999999999998 109.295 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CD ' HG23 ' A' ' 118' ' ' THR . 6.5 pt-20 -72.7 139.32 47.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -1.156 . . . . 6.0499999999999998 109.656 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 125.24 -50.0 0.89 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.631 -1.387 . . . . 2.54 109.631 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.97 157.76 16.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.126 -1.22 . . . . 4.0300000000000002 109.654 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -100.01 134.36 43.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 2.9100000000000001 109.294 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.696 ' O ' HG23 ' A' ' 67' ' ' VAL . 74.8 m-85 -92.95 174.48 7.21 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 2.3799999999999999 109.689 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 66' ' ' TYR . 54.4 t -162.6 118.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 2.6099999999999999 109.482 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 69' ' ' SER . 9.7 tt -109.6 158.71 17.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 3.6099999999999999 109.158 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.697 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -154.41 106.46 2.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 2.27 109.427 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 2.1 p90 -94.39 147.51 23.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.106 -0.996 . . . . 2.0099999999999998 110.378 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -100.19 94.54 6.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.851 -0.796 . . . . 1.8 108.851 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HB2' ' HB ' ' A' ' 143' ' ' ILE . . . -163.79 -177.08 4.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.039 -1.038 . . . . 0.95999999999999996 109.709 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.417 ' HA ' HD22 ' A' ' 102' ' ' LEU . 13.2 p -164.46 136.92 4.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -0.827 . . . . 0.93000000000000005 109.333 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -87.81 145.11 26.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.67000000000000004 109.119 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 104' ' ' GLY . 0.7 OUTLIER -131.8 116.76 16.01 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.96999999999999997 109.343 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.3 Cg_exo -66.07 -142.59 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.384 -1.09 . . . . 1.02 112.495 -0.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -95.35 151.53 19.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 1.75 109.576 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.574 ' SD ' ' CG ' ' A' ' 139' ' ' TYR . 7.4 ptm 178.21 151.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 2.1600000000000001 109.511 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.674 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 56.8 Cg_endo -74.41 122.01 7.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.764 2.309 . . . . 1.3799999999999999 112.233 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.94 HG11 HD12 ' A' ' 102' ' ' LEU . 2.9 m -102.39 172.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 2.0099999999999998 109.476 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 79' ' ' PRO . 8.8 mpt_? -114.14 166.27 11.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 6.0099999999999998 109.461 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 81' ' ' ARG . 88.5 t -160.32 156.45 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 3.7599999999999998 109.311 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.715 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -159.56 148.08 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 2.29 109.441 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -150.76 148.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -0.972 . . . . 1.8899999999999999 109.929 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.83 2.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.218 -1.553 . . . . 1.49 109.218 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.5 pt-20 -90.35 178.7 6.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -1.172 . . . . 2.54 109.384 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.54 -1.424 . . . . 1.3799999999999999 109.54 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.738 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.489 -0.56 . . . . 5.7400000000000002 109.489 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.508 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -127.95 161.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 2.27 109.824 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.95 -19.88 12.94 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.871 -0.789 . . . . 3.2799999999999998 108.871 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.0 39.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 3.6499999999999999 109.212 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -86.73 94.26 9.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 4.5999999999999996 109.83 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.832 ' NE2' ' CD2' ' A' ' 111' ' ' TYR . 6.9 pt20 -116.62 -156.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.168 -0.958 . . . . 3.46 109.164 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . 177.14 -26.05 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.981 -1.247 . . . . 3.6699999999999999 109.981 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -91.87 94.81 9.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -1.226 . . . . 3.79 109.811 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.575 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -133.16 79.23 62.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 1.96 109.361 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.76 132.28 41.02 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.051 2.501 . . . . 2.9700000000000002 112.657 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.94 HD12 HG11 ' A' ' 80' ' ' VAL . 12.3 mt -124.35 151.06 44.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 3.0600000000000001 109.208 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 74' ' ' ALA . 13.6 t -95.26 -162.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 2.3399999999999999 109.831 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 75' ' ' THR . . . -96.02 -32.92 6.54 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 2.1699999999999999 109.777 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 103' ' ' THR . 1.6 mp0 -99.96 164.09 17.13 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.138 -1.213 . . . . 3.02 109.485 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.14 128.66 7.71 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.841 2.361 . . . . 1.4199999999999999 112.019 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 72' ' ' ALA . . . -160.73 140.91 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 1.3700000000000001 109.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -90.99 144.29 25.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.802 . . . . 1.72 110.204 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 109' ' ' ARG . 0.0 OUTLIER -128.43 149.99 50.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.023 -1.473 . . . . 4.7000000000000002 107.023 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.503 ' N ' ' CD ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -139.56 159.71 41.54 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.655 -1.218 . . . . 3.2799999999999998 111.186 -178.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.832 ' CD2' ' NE2' ' A' ' 97' ' ' GLN . 7.1 m-85 -134.86 121.11 20.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.3 -1.0 . . . . 2.96 108.3 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' A' ' 67' ' ' VAL . . . -114.49 139.56 49.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 3.4100000000000001 109.655 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -147.77 164.03 34.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 2.77 109.629 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.39 112.38 24.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.422 -0.799 . . . . 2.23 109.497 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.672 ' O ' ' N ' ' A' ' 63' ' ' GLY . 6.6 t -60.83 109.18 0.99 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.957 . . . . 4.1100000000000003 109.452 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.52 22.99 9.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 6.8600000000000003 109.435 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' A' ' 119' ' ' PHE . 0.4 OUTLIER -148.91 104.96 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 5.1200000000000001 109.366 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.542 HG23 ' CD ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -51.51 107.51 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 4.0599999999999996 109.45 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CE2' HD12 ' A' ' 117' ' ' LEU . 7.3 m-85 -124.9 92.08 48.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 5.4400000000000004 109.635 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.546 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 31.9 Cg_exo -56.46 -170.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.519 2.146 . . . . 4.04 111.367 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.546 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 23.3 Cg_exo -60.74 -76.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.282 1.988 . . . . 3.8999999999999999 111.283 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 30.6 t0 -173.06 -163.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.123 -0.986 . . . . 4.1399999999999997 109.887 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.495 ' H ' ' CG ' ' A' ' 122' ' ' ASP . . . -109.48 -35.63 2.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.195 -1.962 . . . . 3.5699999999999998 108.195 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -128.93 -41.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 3.5899999999999999 108.286 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -113.35 92.93 24.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.362 -0.977 . . . . 2.0800000000000001 108.362 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 125' ' ' ALA . 45.3 Cg_exo -48.63 -139.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.727 2.284 . . . . 1.3899999999999999 113.15 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -33.07 155.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.856 -1.298 . . . . 1.1899999999999999 109.856 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -158.92 151.56 21.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.333 -1.098 . . . . 2.0099999999999998 109.46 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 84' ' ' VAL . 17.1 t -153.53 155.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.448 -0.945 . . . . 1.28 108.448 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -163.35 111.32 1.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.908 -1.12 . . . . 0.97999999999999998 110.468 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.404 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 5.0 m-30 -83.37 101.41 11.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.089 -1.078 . . . . 1.73 108.089 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.715 ' ND1' HD21 ' A' ' 83' ' ' LEU . 5.0 m170 -98.83 128.57 45.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 2.3199999999999998 110.476 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.2 OUTLIER -112.73 -45.62 3.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.907 -0.775 . . . . 2.1099999999999999 108.907 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.81 153.85 29.78 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.103 -1.199 . . . . 1.77 110.103 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.675 ' NZ ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -99.66 -143.66 0.33 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.044 . . . . 5.0599999999999996 109.304 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 135' ' ' LYS . . . 67.44 -61.07 0.37 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.017 -1.105 . . . . 2.6400000000000001 108.017 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -88.97 35.22 3.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.016 -2.034 . . . . 2.5099999999999998 108.016 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.824 ' HB1' ' O ' ' A' ' 41' ' ' LEU . . . -28.75 151.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.868 -0.784 . . . . 2.3199999999999998 110.631 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.586 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 5.1 p90 -173.99 -132.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.767 -0.827 . . . . 1.6100000000000001 108.767 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 14.5 mt-10 -146.73 127.33 14.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 1.6499999999999999 109.741 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -117.46 106.66 13.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 1.6799999999999999 109.131 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.494 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 72.4 m -109.81 120.58 42.93 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.084 -1.01 . . . . 0.73999999999999999 110.546 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -120.36 146.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.76 . . . . 1.22 109.052 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.482 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 93.3 p -126.75 -10.04 6.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.962 -0.755 . . . . 1.3300000000000001 108.962 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.57 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -161.9 167.24 25.03 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.607 -0.837 . . . . 3.2999999999999998 109.813 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.676 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.3 p -149.38 123.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 2.2599999999999998 109.382 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.57 165.69 10.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.177 -0.952 . . . . 2.7599999999999998 109.592 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 58' ' ' VAL . 10.0 tp -173.87 120.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 4.5700000000000003 109.428 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.669 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.5 OUTLIER 179.0 -156.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 3.0699999999999998 109.475 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.669 ' N ' ' OG1' ' A' ' 149' ' ' THR . 8.8 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 2.0 109.531 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.85 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.687 0.756 . . . . 2.8300000000000001 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.643 ' N ' ' OG1' ' A' ' 149' ' ' THR . 3.6 mt-10 159.25 84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.31 -0.626 . . . . 4.75 109.31 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.436 HD23 ' HD2' ' A' ' 59' ' ' PRO . 2.2 mp -91.52 17.03 9.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.223 -0.923 . . . . 4.9500000000000002 109.16 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 12' ' ' HIS . 3.1 tm? -175.27 96.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 2.8599999999999999 109.155 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.66 43.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.05 2.5 . . . . 3.8300000000000001 113.396 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.698 ' N ' HD13 ' A' ' 10' ' ' LEU . 9.8 t60 -162.84 103.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 2.52 109.492 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.549 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -150.42 45.17 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 1.97 109.367 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 16' ' ' ALA . 2.0 t -140.24 93.71 2.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.96 109.562 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 144' ' ' SER . 8.6 m-85 -75.91 39.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 1.76 109.196 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.618 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.03 -33.08 16.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.1799999999999999 109.756 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.685 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 22.2 mt-10 -109.85 -76.66 0.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 2.1299999999999999 109.63 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -111.87 143.93 42.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 2.2599999999999998 109.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -49.36 -33.76 14.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 2.6000000000000001 109.591 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 91.08 -159.71 26.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 1.6200000000000001 109.5 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.09 -9.18 17.87 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.72 2.28 . . . . 1.7 112.233 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 13.8 m95 -68.44 150.25 48.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 2.4199999999999999 109.006 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -109.89 170.29 8.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 1.6399999999999999 110.058 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.649 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.4 pp -176.57 165.05 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 2.0499999999999998 109.6 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.758 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.35 -165.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 1.72 109.503 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.43 -21.14 2.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.197 -1.161 . . . . 1.7 110.197 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.765 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.71 -143.64 0.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.28 . . . . 0.96999999999999997 109.459 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.765 ' N ' ' OG1' ' A' ' 27' ' ' THR . 49.4 p -92.13 -159.07 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.293 -0.879 . . . . 1.8 108.85 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -90.36 127.34 53.36 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 2.3999999999999999 108.593 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HG3' HD11 ' A' ' 24' ' ' LEU . 33.0 Cg_endo -69.01 135.79 33.23 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.02 1.813 . . . . 1.1299999999999999 111.495 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.73 110.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 1.05 110.362 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.82 73.76 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 1.8200000000000001 109.238 178.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.14 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 1.1699999999999999 109.901 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.454 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 12.4 t70 -45.72 83.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 2.21 109.521 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 42.37 35.16 1.81 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.535 -1.426 . . . . 1.1899999999999999 109.535 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 33' ' ' ALA . 9.6 ptp180 -148.46 142.58 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 2.9100000000000001 109.666 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.618 ' C ' ' SD ' ' A' ' 37' ' ' MET . 14.7 tmm? -112.68 127.73 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.93000000000000005 109.578 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.661 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -122.57 138.52 54.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.838 . . . . 1.0600000000000001 109.858 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.18 150.85 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.415 -0.957 . . . . 1.3700000000000001 108.415 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.756 ' C ' HD22 ' A' ' 41' ' ' LEU . 21.9 m-20 -81.06 119.69 23.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.1 -1.0 . . . . 4.79 109.348 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.786 ' N ' HD22 ' A' ' 41' ' ' LEU . 3.0 mm? -116.37 32.79 0.16 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.092 -1.005 . . . . 3.54 110.736 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 86.1 Cg_endo -81.07 -97.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.194 1.929 . . . . 3.7400000000000002 111.697 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.21 -96.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.424 -1.07 . . . . 2.0299999999999998 110.424 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.71 48.84 0.04 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.425 -1.87 . . . . 2.4100000000000001 108.425 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.674 ' O ' ' N ' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -99.73 116.26 31.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.463 -1.022 . . . . 2.96 109.857 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -76.18 52.75 3.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.524 -1.43 . . . . 2.0800000000000001 109.524 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' OD1' ' OD1' ' A' ' 50' ' ' ASP . 2.2 p30 -161.19 134.73 4.84 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.227 -1.16 . . . . 3.6099999999999999 109.462 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 63.1 Cg_endo -76.83 0.35 9.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.605 2.203 . . . . 2.3599999999999999 112.724 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.485 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 5.2 p90 -110.15 67.88 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 3.8700000000000001 109.649 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.523 ' OD1' ' OD1' ' A' ' 47' ' ' ASN . 1.2 m-20 -140.18 -31.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 2.3799999999999999 109.763 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.658 ' HB1' HG22 ' A' ' 27' ' ' THR . . . -152.87 163.88 38.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 109.605 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 144.9 171.49 14.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.875 -1.29 . . . . 0.93999999999999995 109.875 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.459 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.8 pp -107.41 145.82 32.47 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -1.14 . . . . 0.95999999999999996 109.162 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 55' ' ' TYR . 17.7 t -131.19 169.83 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.951 . . . . 0.92000000000000004 110.068 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 40.5 t80 -171.09 143.3 1.93 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.495 -0.753 . . . . 1.71 109.42 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 7.4 m-20 -113.16 -167.28 1.17 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.302 -0.874 . . . . 2.7799999999999998 109.397 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.7 55.62 2.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.64 -1.384 . . . . 2.48 109.64 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.578 ' CG2' HD21 ' A' ' 148' ' ' LEU . 1.1 p -149.08 100.5 3.41 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 3.79 109.421 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HD2' HD23 ' A' ' 9' ' ' LEU . 58.3 Cg_endo -78.93 126.96 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.49 2.126 . . . . 2.3999999999999999 112.018 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -103.19 74.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.92 . . . . 3.0800000000000001 109.813 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -84.71 90.64 1.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.953 -1.659 . . . . 3.0499999999999998 108.953 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -34.56 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -1.127 . . . . 6.0499999999999998 109.884 -179.471 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.73 -67.18 0.56 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.638 -1.385 . . . . 2.54 109.638 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -100.0 170.68 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -1.152 . . . . 4.0300000000000002 109.632 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 m -99.98 139.41 35.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 2.9100000000000001 109.323 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.05 177.64 4.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -0.98 . . . . 2.3799999999999999 109.846 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.658 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.6 t -150.63 137.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 2.6099999999999999 109.634 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tp -119.94 115.1 23.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 3.6099999999999999 109.106 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -112.98 100.29 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 2.27 109.33 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -94.1 135.04 35.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 2.0099999999999998 110.599 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.679 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 10.9 p -93.49 94.22 8.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.441 -0.948 . . . . 1.8 108.441 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 143' ' ' ILE . . . -165.36 164.2 19.77 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.617 -1.233 . . . . 0.95999999999999996 110.624 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -139.81 146.61 39.63 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.843 -0.799 . . . . 0.93000000000000005 108.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -84.6 133.8 34.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.67000000000000004 109.358 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.506 ' O ' ' CD ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.71 115.74 15.83 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.37 -0.831 . . . . 0.96999999999999997 109.062 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -67.1 -142.2 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.605 0 C-N-CA 124.311 -1.12 . . . . 1.02 112.298 0.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.64 149.36 22.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 1.75 109.613 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.5 mtt 159.73 163.47 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.372 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.33 150.78 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.877 2.384 . . . . 1.3799999999999999 112.224 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -116.23 169.0 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 2.0099999999999998 109.393 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 132' ' ' HIS . 13.5 ttt180 -114.2 137.68 51.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 6.0099999999999998 109.52 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.81 149.45 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.341 -0.85 . . . . 3.7599999999999998 109.38 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -147.5 147.09 29.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 2.29 109.752 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.2 t -151.8 149.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 1.8899999999999999 109.614 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 160.62 -147.03 13.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.584 -1.407 . . . . 1.49 109.584 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.667 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.1 pm0 -90.04 176.85 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -1.162 . . . . 2.54 109.547 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.603 -1.399 . . . . 1.3799999999999999 109.603 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HE ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.46 -0.57 . . . . 5.7400000000000002 109.46 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -105.42 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 2.27 109.951 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.659 ' HB2' HD22 ' A' ' 117' ' ' LEU . . . -109.88 -24.8 10.64 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.771 -0.826 . . . . 3.2799999999999998 108.771 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -91.03 33.84 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 3.6499999999999999 109.186 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.84 59.25 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 4.5999999999999996 109.582 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.6 tt0 -103.07 156.4 17.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 3.46 109.134 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -145.87 8.54 1.53 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.696 -1.362 . . . . 3.6699999999999999 109.696 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.33 59.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -1.165 . . . . 3.79 109.589 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.545 ' HB3' HG23 ' A' ' 80' ' ' VAL . . . -101.54 107.37 50.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 1.96 109.204 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -78.04 134.36 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.528 2.152 . . . . 2.9700000000000002 112.544 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 102' ' ' LEU . 12.3 mt -131.2 156.63 45.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 3.0600000000000001 109.411 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -103.44 -155.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 2.3399999999999999 109.512 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.634 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -113.45 30.76 7.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 2.1699999999999999 109.523 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -154.41 149.89 21.12 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -1.179 . . . . 3.02 109.379 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.26 126.2 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.872 2.381 . . . . 1.4199999999999999 112.106 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.888 ' HB1' ' NH1' ' A' ' 109' ' ' ARG . . . -163.34 132.84 4.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 1.3700000000000001 109.655 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.35 141.39 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 1.72 110.395 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.888 ' NH1' ' HB1' ' A' ' 107' ' ' ALA . 3.9 mpt_? -120.16 143.61 48.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.317 -1.364 . . . . 4.7000000000000002 107.317 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -128.88 112.74 14.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.977 . . . . 3.2799999999999998 110.838 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 4.5 m-30 -113.44 115.28 27.8 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.201 -1.037 . . . . 2.96 108.201 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.658 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -117.96 171.87 7.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.277 -0.889 . . . . 3.4100000000000001 110.024 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -173.14 175.45 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 2.77 109.673 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -87.7 113.19 23.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 2.23 109.751 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.8 t -52.82 110.03 0.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 4.1100000000000003 109.39 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 114' ' ' THR . 30.4 m120 -129.14 28.61 5.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.838 . . . . 6.8600000000000003 109.505 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' A' ' 94' ' ' ALA . 4.6 tp -133.4 118.47 18.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 5.1200000000000001 109.398 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -77.59 127.38 32.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.881 . . . . 4.0599999999999996 109.558 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 8.4 m-85 -163.52 94.63 1.08 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 5.4400000000000004 109.363 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.67 165.78 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.604 2.203 . . . . 4.04 112.259 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.0 -14.93 12.03 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.815 2.343 . . . . 3.8999999999999999 112.044 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.84 121.67 45.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 4.1399999999999997 109.478 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.67 -175.42 19.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 3.5699999999999998 109.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.93 53.5 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 3.5899999999999999 109.454 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 119' ' ' PHE . . . -178.03 65.69 0.19 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.0800000000000001 109.464 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.12 -158.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.874 2.383 . . . . 1.3899999999999999 112.301 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.444 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -80.95 157.29 39.15 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.538 -1.425 . . . . 1.1899999999999999 109.538 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.667 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -146.94 126.58 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 2.0099999999999998 109.878 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.42 85.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.66 -0.867 . . . . 1.28 108.66 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.659 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -103.31 127.1 50.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.97999999999999998 110.56 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.435 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . 2.9 m-30 -105.12 96.75 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.295 -1.002 . . . . 1.73 108.295 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 9.3 m170 -99.39 138.37 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 2.3199999999999998 110.238 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.853 ' N ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -141.83 6.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 2.1099999999999999 109.21 179.681 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -62.11 147.51 48.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.572 -1.411 . . . . 1.77 109.572 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.624 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 0.4 OUTLIER 179.48 132.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -1.09 . . . . 5.0599999999999996 109.339 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -47.14 -24.3 0.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.765 -1.198 . . . . 2.6400000000000001 107.765 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.611 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -106.29 8.55 41.41 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.577 -1.809 . . . . 2.5099999999999998 108.577 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.12 -163.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.919 . . . . 2.3199999999999998 110.023 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD2' ' C ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -173.73 -112.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 1.6100000000000001 109.94 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.506 ' CD ' ' O ' ' A' ' 75' ' ' THR . 2.2 mp0 -129.61 153.79 47.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.754 -1.216 . . . . 1.6499999999999999 109.678 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.661 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 26.7 t80 -136.29 126.49 26.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.226 -0.921 . . . . 1.6799999999999999 109.721 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.85 98.61 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.73999999999999999 110.185 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.587 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -109.81 143.82 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.405 -0.809 . . . . 1.22 108.883 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 15' ' ' PHE . 95.4 p -128.89 -18.1 3.85 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.075 -0.65 . . . . 1.3300000000000001 109.409 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.679 ' N ' ' OG1' ' A' ' 71' ' ' THR . 15.1 mt-30 -152.74 166.79 31.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.173 -1.011 . . . . 3.2999999999999998 110.61 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 146' ' ' VAL . 7.3 p -169.92 91.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.917 -0.772 . . . . 2.2599999999999998 108.917 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.73 140.67 29.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 2.7599999999999998 110.482 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.578 HD21 ' CG2' ' A' ' 58' ' ' VAL . 6.9 tp -124.23 94.82 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.608 -0.886 . . . . 4.5700000000000003 108.608 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.74 ' OG1' ' N ' ' A' ' 7' ' ' VAL . 8.2 t 177.87 -144.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 3.0699999999999998 109.156 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.471 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 9.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.109 -0.994 . . . . 2.0 109.658 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.397 -0.594 . . . . 2.8300000000000001 109.397 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.12 100.4 13.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 4.75 109.551 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.56 -8.63 56.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 4.9500000000000002 109.496 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.683 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.3 tm? -140.96 85.93 11.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 2.8599999999999999 108.797 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.58 40.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.996 2.464 . . . . 3.8300000000000001 112.22 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.683 ' H ' HD13 ' A' ' 10' ' ' LEU . 19.6 t60 -143.11 123.1 13.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 2.52 109.641 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.567 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -170.1 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -0.858 . . . . 1.97 109.199 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.627 ' C ' ' H ' ' A' ' 16' ' ' ALA . 46.2 m -109.94 63.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 1.96 109.719 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -66.5 21.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 1.76 109.188 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.07 -63.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 1.1799999999999999 109.939 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' SER . 3.4 mm-40 -111.73 39.87 2.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 2.1299999999999999 109.912 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 1.9 m 160.39 147.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 2.2599999999999998 109.79 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 -72.04 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 2.6000000000000001 109.608 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 118.98 -167.48 13.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.515 -1.434 . . . . 1.6200000000000001 109.515 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 17.1 Cg_exo -62.02 -20.14 68.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.567 2.178 . . . . 1.7 111.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 13.8 m95 -65.46 -166.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 2.4199999999999999 109.414 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -150.29 174.65 12.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 1.6399999999999999 109.619 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.662 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 54.7 tp -170.85 148.1 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 2.0499999999999998 109.451 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.745 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 165.04 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 1.72 109.691 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 79.31 -22.09 3.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.849 -1.3 . . . . 1.7 109.849 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.94 -142.01 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -1.213 . . . . 0.96999999999999997 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.1 p -90.67 136.91 32.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 1.8 109.163 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 28' ' ' SER . 51.9 mm-40 -32.5 97.03 0.1 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 2.3999999999999999 109.732 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 28' ' ' SER . 32.1 Cg_exo -53.13 163.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 1.1299999999999999 111.342 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 30' ' ' PRO . 97.0 t -154.17 134.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.155 . . . . 1.05 110.742 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -90.07 85.91 6.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.583 0.706 . . . . 1.8200000000000001 109.407 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.52 -139.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.1699999999999999 109.996 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.55 76.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.406 -0.809 . . . . 2.21 110.059 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 55.49 23.38 34.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.942 -1.263 . . . . 1.1899999999999999 109.942 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 33' ' ' ALA . 2.2 ptp180 -136.25 143.15 44.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -1.211 . . . . 2.9100000000000001 109.435 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.77 ' SD ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -114.61 148.4 38.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.93000000000000005 109.411 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.77 ' N ' ' SD ' ' A' ' 37' ' ' MET . 3.8 t -157.03 163.37 39.13 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.574 -0.85 . . . . 1.0600000000000001 110.17 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG23 HD13 ' A' ' 41' ' ' LEU . 21.5 m -136.14 150.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.265 -1.013 . . . . 1.3700000000000001 108.265 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.733 ' C ' HD12 ' A' ' 41' ' ' LEU . 18.9 m-20 -97.9 99.25 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 4.79 110.183 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.733 HD12 ' C ' ' A' ' 40' ' ' ASP . 8.5 mp -113.15 91.09 17.77 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 3.54 109.12 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.45 -87.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.906 2.404 . . . . 3.7400000000000002 112.318 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.2 96.19 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.441 . . . . 2.0299999999999998 109.499 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.47 31.96 0.05 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.515 -1.434 . . . . 2.4100000000000001 109.515 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.479 ' NE2' ' HA3' ' A' ' 134' ' ' GLY . 2.9 mt-30 -99.99 174.19 6.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -1.173 . . . . 2.96 109.41 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.66 -41.88 8.06 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 2.0800000000000001 109.502 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.757 ' ND2' ' CD1' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -167.01 157.54 10.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 3.6099999999999999 109.426 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.51 -39.87 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.842 2.361 . . . . 2.3599999999999999 112.211 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.757 ' CD1' ' ND2' ' A' ' 47' ' ' ASN . 4.9 p90 -91.9 55.33 2.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.917 . . . . 3.8700000000000001 109.47 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.713 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 70.4 m-20 -128.33 1.94 5.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 2.3799999999999999 109.458 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.416 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -175.31 172.95 2.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 1.1100000000000001 109.509 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 24' ' ' LEU . . . 131.42 -164.38 23.47 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.586 -1.405 . . . . 0.93999999999999995 109.586 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD21 ' CD2' ' A' ' 131' ' ' PHE . 1.1 pp -109.73 161.77 15.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -1.093 . . . . 0.95999999999999996 109.2 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 129' ' ' VAL . 2.1 t -152.21 161.12 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.92000000000000004 109.769 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 33.1 t80 -175.31 147.79 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 1.71 109.476 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.681 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.3 m-80 -107.16 160.94 15.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.263 -0.898 . . . . 2.7799999999999998 109.396 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 112.75 74.15 0.67 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 2.48 109.577 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.498 HG22 ' HA3' ' A' ' 127' ' ' GLY . 19.7 m -155.45 66.2 4.64 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.247 -1.149 . . . . 3.79 109.439 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.63 137.01 41.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.759 2.306 . . . . 2.3999999999999999 112.155 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 66' ' ' TYR . 10.6 t -135.66 139.99 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 3.0800000000000001 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -107.73 117.17 5.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.51 -1.436 . . . . 3.0499999999999998 109.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -45.69 128.03 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 6.0499999999999998 109.526 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.461 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 113.25 -25.77 11.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.686 -1.366 . . . . 2.54 109.686 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' O ' ' OG ' ' A' ' 115' ' ' SER . 4.9 mt-10 -100.05 173.58 6.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -1.163 . . . . 4.0300000000000002 109.646 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 2.9100000000000001 109.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.711 ' CD1' HG22 ' A' ' 60' ' ' VAL . 41.7 m-85 -104.36 -179.63 4.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.268 -0.895 . . . . 2.3799999999999999 109.592 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 112' ' ' ALA . 1.4 p -160.93 143.84 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 2.6099999999999999 109.668 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -126.52 118.46 24.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 3.6099999999999999 109.512 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.51 94.59 5.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 2.27 109.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 4.4 p90 -93.64 147.01 23.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.096 -1.002 . . . . 2.0099999999999998 110.954 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.3 p -95.02 112.56 24.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.188 -1.041 . . . . 1.8 108.188 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 143' ' ' ILE . . . -165.51 153.71 11.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.696 -1.253 . . . . 0.95999999999999996 110.797 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.52 148.67 49.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.713 -0.847 . . . . 0.93000000000000005 108.713 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' N ' ' O ' ' A' ' 103' ' ' THR . . . -113.13 124.79 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.984 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.584 ' CA ' ' H ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -130.72 132.79 24.17 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.309 -0.869 . . . . 0.96999999999999997 108.704 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.611 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.5 Cg_exo -73.15 27.7 0.43 Allowed 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 124.665 -0.973 . . . . 1.02 112.779 -0.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.716 ' O ' ' SD ' ' A' ' 78' ' ' MET . 2.4 m-20 89.29 152.52 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.514 -0.551 . . . . 1.75 109.514 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.716 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 161.54 174.57 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.965 -1.124 . . . . 2.1600000000000001 107.965 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.507 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 10.5 Cg_endo -81.98 145.74 14.18 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.454 2.102 . . . . 1.3799999999999999 112.218 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.886 HG12 ' OH ' ' A' ' 139' ' ' TYR . 7.5 m -113.58 159.15 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 2.0099999999999998 109.719 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.12 123.5 49.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 6.0099999999999998 109.236 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.415 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER -136.18 149.09 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 3.7599999999999998 109.521 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 1.3 pp -145.67 144.41 30.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.29 109.664 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -151.82 151.48 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 1.8899999999999999 109.781 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.52 -137.6 5.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.451 -1.46 . . . . 1.49 109.451 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -88.52 -165.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 2.54 109.446 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.56 -1.416 . . . . 1.3799999999999999 109.56 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.639 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.481 -0.563 . . . . 5.7400000000000002 109.481 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -128.28 167.95 16.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 2.27 109.892 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.92 -23.15 11.51 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.651 -0.87 . . . . 3.2799999999999998 108.651 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.99 36.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.358 -0.839 . . . . 3.6499999999999999 108.945 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -84.5 44.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 4.5999999999999996 109.595 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.581 ' O ' ' CG ' ' A' ' 97' ' ' GLN . 10.1 pt20 -102.4 121.18 41.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 3.46 109.341 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -111.24 6.3 28.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.587 -1.405 . . . . 3.6699999999999999 109.587 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.37 77.26 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -1.139 . . . . 3.79 109.514 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.759 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -116.98 81.8 12.75 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.117 -0.99 . . . . 1.96 109.448 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 45.2 Cg_exo -52.09 143.05 42.76 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.845 2.363 . . . . 2.9700000000000002 112.29 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.466 HD12 HG11 ' A' ' 80' ' ' VAL . 14.0 mt -143.58 154.19 43.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 3.0600000000000001 109.505 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.44 -162.4 0.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.3399999999999999 109.608 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.676 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -102.1 -9.68 41.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.64 -1.384 . . . . 2.1699999999999999 109.64 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.549 ' OE2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -99.89 134.46 20.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.181 -1.188 . . . . 3.02 108.957 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.549 ' O ' ' OE2' ' A' ' 105' ' ' GLU . 85.7 Cg_exo -37.27 117.55 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 1.4199999999999999 112.139 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.43 137.08 16.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 1.3700000000000001 109.674 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.07 152.5 20.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 1.72 109.831 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.729 ' CG ' HH11 ' A' ' 109' ' ' ARG . 0.0 OUTLIER -129.36 138.92 51.81 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.051 -1.092 . . . . 4.7000000000000002 108.051 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -120.57 118.45 30.24 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.759 -0.776 . . . . 3.2799999999999998 110.671 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.759 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 7.3 m-85 -115.16 118.83 34.44 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.549 -0.908 . . . . 2.96 108.549 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.422 ' HB2' HG23 ' A' ' 67' ' ' VAL . . . -107.85 146.64 32.0 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 3.4100000000000001 109.948 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.739 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -129.71 163.35 26.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 2.77 109.32 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.53 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -97.96 104.44 16.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 2.23 109.63 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.4 m -37.16 104.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 4.1100000000000003 109.305 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.15 14.72 27.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 6.8600000000000003 109.556 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 118' ' ' THR . 8.3 tt -169.21 171.86 7.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 5.1200000000000001 109.444 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.842 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -95.26 114.84 26.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.175 -0.953 . . . . 4.0599999999999996 109.697 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 117' ' ' LEU . 55.5 m-85 -110.58 94.53 19.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 5.4400000000000004 109.402 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.26 158.18 23.05 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.611 2.207 . . . . 4.04 112.196 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.34 -27.53 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.723 2.282 . . . . 3.8999999999999999 111.948 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 19.3 p-10 -109.96 -163.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 4.1399999999999997 109.478 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 66.23 169.3 3.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.573 -1.411 . . . . 3.5699999999999998 109.573 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.22 45.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 3.5899999999999999 109.423 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -163.18 55.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 2.0800000000000001 109.54 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 47.5 Cg_endo -72.91 -158.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.827 2.352 . . . . 1.3899999999999999 112.189 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.498 ' HA3' HG22 ' A' ' 58' ' ' VAL . . . -86.91 157.06 29.26 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.542 -1.423 . . . . 1.1899999999999999 109.542 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -141.91 114.48 8.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -1.178 . . . . 2.0099999999999998 109.582 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.5 t -131.66 128.5 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 1.28 108.853 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -157.0 114.56 3.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.97999999999999998 110.101 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.477 ' CD2' HD21 ' A' ' 53' ' ' LEU . 4.9 m-30 -92.21 119.38 31.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.645 -0.872 . . . . 1.73 108.645 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 42.0 m170 -105.4 127.1 52.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 2.3199999999999998 109.623 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -128.87 -34.67 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 2.1099999999999999 109.468 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.54 127.16 0.57 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.651 -1.38 . . . . 1.77 109.651 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.684 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 16.4 mttt -166.99 130.71 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 5.0599999999999996 109.73 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.36 -19.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.095 -1.076 . . . . 2.6400000000000001 108.095 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.1 17.11 7.14 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.815 -1.714 . . . . 2.5099999999999998 108.815 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.684 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -51.43 -151.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.943 . . . . 2.3199999999999998 110.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.886 ' OH ' HG12 ' A' ' 80' ' ' VAL . 2.7 p90 -171.91 -161.82 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 1.6100000000000001 109.511 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.57 142.85 26.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 1.6499999999999999 109.718 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.559 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 31.1 t80 -128.07 107.61 9.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.481 -0.762 . . . . 1.6799999999999999 109.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 69.8 m -110.36 102.84 11.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.11 -0.994 . . . . 0.73999999999999999 110.989 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -120.88 144.43 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.486 -0.931 . . . . 1.22 108.486 178.334 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 143' ' ' ILE . 29.6 p -121.91 -8.7 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.95 -0.7 . . . . 1.3300000000000001 109.815 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.582 ' O ' ' OG1' ' A' ' 71' ' ' THR . 11.9 pt20 -168.9 176.77 5.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.649 -1.22 . . . . 3.2999999999999998 111.023 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.562 ' O ' ' OG1' ' A' ' 13' ' ' THR . 7.3 p -170.42 159.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.073 -0.714 . . . . 2.2599999999999998 109.073 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.467 ' N ' HG22 ' A' ' 146' ' ' VAL . 0.3 OUTLIER -148.74 158.54 44.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 2.7599999999999998 109.78 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 149' ' ' THR . 1.1 pp -143.72 155.22 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 4.5700000000000003 109.428 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.78 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 3.0699999999999998 109.546 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.664 ' N ' ' OG1' ' A' ' 149' ' ' THR . 4.7 t . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 2.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.393 -0.595 . . . . 2.8300000000000001 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -125.67 86.13 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 4.75 109.479 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.46 -33.84 74.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 4.9500000000000002 109.395 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER -108.17 95.43 15.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.632 -0.877 . . . . 2.8599999999999999 108.632 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.39 49.1 1.35 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.081 1.854 . . . . 3.8300000000000001 111.983 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.619 ' H ' HD13 ' A' ' 10' ' ' LEU . 82.0 t60 -152.77 129.46 10.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.391 -0.818 . . . . 2.52 109.639 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.637 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -167.45 57.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 1.97 109.492 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.8 t -151.22 67.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 1.96 109.552 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -62.64 39.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 1.76 109.091 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -86.79 -36.84 18.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 1.1799999999999999 109.858 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.691 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 15.3 mm-40 -111.7 -57.73 2.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 2.1299999999999999 109.581 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 p -128.2 143.54 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 2.2599999999999998 109.468 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.857 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -55.36 -15.98 3.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 2.6000000000000001 109.465 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 83.43 -154.37 31.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.571 -1.411 . . . . 1.6200000000000001 109.571 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.47 -11.51 15.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 1.7 112.089 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 10.9 m95 -65.14 -163.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 2.4199999999999999 109.307 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.671 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.7 m -156.58 164.0 38.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 1.6399999999999999 109.313 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -168.38 160.07 11.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 2.0499999999999998 109.803 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.73 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 167.04 177.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 1.72 109.558 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 92.26 -23.44 27.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.941 -1.264 . . . . 1.7 109.941 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.785 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.86 -142.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.24 . . . . 0.96999999999999997 109.271 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.785 ' N ' ' OG1' ' A' ' 27' ' ' THR . 33.4 p -91.09 130.19 37.01 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.185 -0.947 . . . . 1.8 109.096 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.554 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -35.81 100.44 0.2 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 2.3999999999999999 109.176 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HG2' HD13 ' A' ' 24' ' ' LEU . 64.2 Cg_exo -46.11 154.07 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.381 2.054 . . . . 1.1299999999999999 111.643 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' MET . 4.2 t -138.53 115.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.996 -1.065 . . . . 1.05 110.395 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.45 84.28 3.18 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.534 0.683 . . . . 1.8200000000000001 109.218 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -78.39 -119.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.425 -0.797 . . . . 1.1699999999999999 110.229 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.804 ' H ' HH12 ' A' ' 36' ' ' ARG . 22.5 t0 -58.36 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.21 110.15 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 64.04 8.28 28.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.748 -1.341 . . . . 1.1899999999999999 109.748 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.804 HH12 ' H ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -126.91 144.45 50.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -1.233 . . . . 2.9100000000000001 109.604 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.778 ' HE2' HG13 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -109.87 130.44 55.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.93000000000000005 109.015 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -127.77 153.51 46.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.44 -0.904 . . . . 1.0600000000000001 110.593 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.778 HG13 ' HE2' ' A' ' 37' ' ' MET . 1.5 m -122.69 163.43 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.351 -0.981 . . . . 1.3700000000000001 108.351 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.864 ' C ' HD22 ' A' ' 41' ' ' LEU . 34.3 m-20 -107.78 102.54 11.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 4.79 110.189 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.864 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.2 mm? -126.33 48.23 2.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 3.54 109.265 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 76.9 Cg_exo -39.02 -71.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.904 2.402 . . . . 3.7400000000000002 112.34 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.7 77.85 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 2.0299999999999998 109.545 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.87 28.69 0.23 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.477 -1.449 . . . . 2.4100000000000001 109.477 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.425 ' NE2' ' HB3' ' A' ' 50' ' ' ASP . 8.7 mm-40 -99.95 144.04 29.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 2.96 109.501 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.29 -66.18 1.89 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.55 -1.42 . . . . 2.0800000000000001 109.55 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.772 ' ND2' ' NE1' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -99.89 156.72 35.01 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.172 -1.193 . . . . 3.6099999999999999 109.518 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 50' ' ' ASP . 46.3 Cg_endo -72.63 -33.52 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.827 2.351 . . . . 2.3599999999999999 112.314 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.772 ' NE1' ' ND2' ' A' ' 47' ' ' ASN . 28.7 p90 -73.65 21.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 3.8700000000000001 109.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 23.2 m-20 -102.49 26.57 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 2.3799999999999999 109.51 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 168.99 129.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 1.1100000000000001 109.488 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 159.29 163.96 13.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.8 -1.32 . . . . 0.93999999999999995 109.8 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -92.03 -169.31 2.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -1.098 . . . . 0.95999999999999996 109.341 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 23' ' ' SER . 1.5 p -174.32 165.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.288 -0.883 . . . . 0.92000000000000004 110.182 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.692 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 16.5 t80 173.16 140.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.511 -0.743 . . . . 1.71 109.405 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.692 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -102.5 -177.24 3.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.185 -0.947 . . . . 2.7799999999999998 109.618 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.37 61.81 1.37 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.626 -1.389 . . . . 2.48 109.626 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 58' ' ' VAL . 4.8 m -152.56 60.34 3.35 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 3.79 109.415 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 54.4 Cg_exo -47.22 146.9 6.14 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.875 2.383 . . . . 2.3999999999999999 112.192 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.03 92.36 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 3.0800000000000001 109.502 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -84.66 111.35 3.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 3.0499999999999998 109.513 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.56 123.53 13.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -1.104 . . . . 6.0499999999999998 109.466 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.79 -44.41 1.18 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 2.54 109.669 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' O ' ' OG ' ' A' ' 115' ' ' SER . 7.2 mt-10 -100.01 -179.98 4.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -1.152 . . . . 4.0300000000000002 109.634 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' OG1' ' A' ' 150' ' ' THR . 69.7 m -128.19 138.32 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.386 -0.821 . . . . 2.9100000000000001 109.362 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 44.5 m-85 -101.95 179.48 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 2.3799999999999999 109.624 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -152.15 141.72 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 2.6099999999999999 109.234 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.718 ' CD1' HD22 ' A' ' 148' ' ' LEU . 6.3 tp -127.91 113.11 15.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 3.6099999999999999 109.954 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.54 92.59 4.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.421 -0.955 . . . . 2.27 108.421 179.231 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 30.9 p90 -93.87 147.92 22.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 2.0099999999999998 111.074 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -98.59 105.24 17.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.265 -1.013 . . . . 1.8 108.265 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.482 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -152.02 159.18 43.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.725 -1.235 . . . . 0.95999999999999996 110.823 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.26 124.65 20.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.807 -0.812 . . . . 0.93000000000000005 108.807 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -86.16 129.46 34.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.67000000000000004 109.787 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.464 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.53 116.09 14.96 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.96999999999999997 109.302 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.73 -142.52 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 124.374 -1.094 . . . . 1.02 112.463 -0.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -95.5 151.49 19.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.917 . . . . 1.75 109.66 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 160.37 162.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 2.1600000000000001 109.401 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.568 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 57.8 Cg_endo -76.2 138.74 20.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.922 2.415 . . . . 1.3799999999999999 112.526 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -104.91 169.76 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 2.0099999999999998 109.287 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.741 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -109.91 149.03 30.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.399 -0.813 . . . . 6.0099999999999998 109.444 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 81' ' ' ARG . 19.3 t -152.64 148.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 3.7599999999999998 109.343 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.623 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.4 pp -152.55 146.07 24.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 2.29 109.739 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 129' ' ' VAL . 0.9 OUTLIER -153.69 149.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 1.8899999999999999 109.63 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.94 -141.29 7.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.48 -1.448 . . . . 1.49 109.48 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.734 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -89.94 -158.62 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -1.127 . . . . 2.54 109.459 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.507 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.478 -1.449 . . . . 1.3799999999999999 109.478 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.253 0.549 . . . . 5.7400000000000002 109.536 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.35 163.86 16.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 2.27 109.89 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.04 -20.33 12.75 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.801 -0.815 . . . . 3.2799999999999998 108.801 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.81 36.16 0.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.844 . . . . 3.6499999999999999 109.16 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.83 56.34 3.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 4.5999999999999996 109.558 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -107.42 124.63 50.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 3.46 109.192 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -117.52 3.5 17.86 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.545 -1.422 . . . . 3.6699999999999999 109.545 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -89.28 72.61 8.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -1.157 . . . . 3.79 109.466 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.812 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -116.16 93.76 39.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 1.96 109.446 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 12.5 Cg_exo -65.98 116.9 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.855 2.37 . . . . 2.9700000000000002 112.512 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 101' ' ' PRO . 3.3 mm? -117.42 152.88 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 3.0600000000000001 109.339 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 8.5 t -105.21 -161.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.92 . . . . 2.3399999999999999 109.651 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -93.59 -22.31 26.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.75 -1.34 . . . . 2.1699999999999999 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -99.96 149.88 36.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.213 . . . . 3.02 109.437 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.46 118.87 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.771 2.314 . . . . 1.4199999999999999 112.062 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -144.17 126.01 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 1.3700000000000001 109.718 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.1 151.54 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 1.72 110.075 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.714 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -135.38 138.2 43.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.471 -0.937 . . . . 4.7000000000000002 108.471 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -117.67 111.65 19.44 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.979 -0.688 . . . . 3.2799999999999998 110.516 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -109.86 117.74 34.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.562 -0.903 . . . . 2.96 108.562 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.28 140.65 39.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.219 -0.926 . . . . 3.4100000000000001 109.665 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.721 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -126.3 162.87 24.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 2.77 109.45 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -98.94 103.48 15.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.23 109.531 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 61' ' ' GLY . 3.4 m -37.15 110.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 4.1100000000000003 109.356 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.819 ' O ' HD22 ' A' ' 117' ' ' LEU . 9.8 p-10 -115.98 -10.38 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 6.8600000000000003 109.467 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.819 HD22 ' O ' ' A' ' 116' ' ' ASN . 2.1 mm? -130.1 128.47 41.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 5.1200000000000001 109.459 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.13 113.81 12.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 4.0599999999999996 109.465 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 117' ' ' LEU . 18.3 m-85 -125.31 75.55 68.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 5.4400000000000004 109.483 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -52.91 167.2 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.746 2.297 . . . . 4.04 112.069 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.67 -24.44 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.771 2.314 . . . . 3.8999999999999999 112.076 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -110.39 160.77 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 4.1399999999999997 109.5 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.9 -137.16 13.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.541 -1.424 . . . . 3.5699999999999998 109.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 123' ' ' GLY . 20.5 m-20 -36.7 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 3.5899999999999999 109.497 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.5 150.55 34.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 2.0800000000000001 109.419 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.68 -158.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.801 2.334 . . . . 1.3899999999999999 112.2 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.517 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -61.86 168.03 14.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.531 -1.427 . . . . 1.1899999999999999 109.531 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.507 ' NE2' ' HA3' ' A' ' 87' ' ' GLY . 3.7 tp60 -155.97 133.22 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -1.108 . . . . 2.0099999999999998 109.595 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.517 HG22 HG13 ' A' ' 84' ' ' VAL . 59.8 t -139.56 151.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.644 -0.872 . . . . 1.28 108.644 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -167.02 112.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 0.97999999999999998 110.207 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -85.56 112.9 21.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.319 -0.863 . . . . 1.73 108.703 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.623 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 2.4 m170 -99.77 120.51 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.3199999999999998 109.978 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -140.06 5.09 2.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 2.1099999999999999 109.271 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -80.26 122.18 5.67 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.526 -1.43 . . . . 1.77 109.526 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.69 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.4 mtpp -163.96 135.78 4.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 5.0599999999999996 109.668 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.91 -13.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.404 -0.961 . . . . 2.6400000000000001 108.404 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -121.57 5.35 10.8 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.099 -1.601 . . . . 2.5099999999999998 109.099 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -52.34 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -1.035 . . . . 2.3199999999999998 109.937 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.568 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -170.78 -161.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.934 -1.103 . . . . 1.6100000000000001 109.411 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -80.18 143.34 33.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 1.6499999999999999 109.486 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.482 ' CE1' ' HB1' ' A' ' 72' ' ' ALA . 28.6 t80 -126.56 110.27 13.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 1.6799999999999999 109.239 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.0 104.83 14.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 110.558 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.51 HG23 ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -120.27 142.77 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 1.22 108.74 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 24.8 p -137.73 -3.42 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.636 -0.665 . . . . 1.3300000000000001 109.567 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.539 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.4 mt-30 -154.92 160.24 41.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.143 -0.973 . . . . 3.2999999999999998 110.061 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.637 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.2 t -143.38 152.61 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.434 -0.791 . . . . 2.2599999999999998 109.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 69' ' ' SER . 26.5 t -125.62 128.23 47.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 2.7599999999999998 109.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.718 HD22 ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -129.82 111.6 12.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 4.5700000000000003 109.208 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.584 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -160.98 -171.66 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 3.0699999999999998 109.626 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 65' ' ' SER . 7.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 2.0 109.433 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.82 ' N ' ' HG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.412 -0.588 . . . . 2.8300000000000001 109.412 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -85.53 82.16 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 4.75 109.477 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.615 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -44.39 -19.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 4.9500000000000002 109.444 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER -121.66 84.17 42.76 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.8599999999999999 108.628 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.1 20.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.973 2.448 . . . . 3.8300000000000001 112.131 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.58 ' H ' ' C ' ' A' ' 10' ' ' LEU . 69.9 t60 -118.64 99.29 6.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 2.52 109.672 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.892 ' O ' HG23 ' A' ' 13' ' ' THR . 5.5 t -139.12 56.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 1.97 109.339 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.619 ' C ' ' H ' ' A' ' 16' ' ' ALA . 44.4 m -142.49 61.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 1.96 109.785 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.7 m-30 -66.05 33.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 1.76 109.0 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.626 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.06 -35.26 15.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.1799999999999999 110.014 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -109.97 -84.53 0.55 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.121 -0.987 . . . . 2.1299999999999999 109.599 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 p -94.35 144.02 25.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.2599999999999998 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -55.77 -53.57 55.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 2.6000000000000001 109.459 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.472 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 111.98 -164.14 12.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 1.6200000000000001 109.682 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 56.7 Cg_endo -76.31 -4.51 15.15 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.833 2.355 . . . . 1.7 112.367 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.863 ' CH2' HG11 ' A' ' 146' ' ' VAL . 8.3 m95 -66.67 -177.63 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 2.4199999999999999 109.418 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -133.6 167.32 20.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 1.6399999999999999 109.277 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.008 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.5 pp 179.43 142.76 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.133 -0.979 . . . . 2.0499999999999998 109.809 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.82 173.78 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.464 -0.773 . . . . 1.72 109.453 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 102.29 -31.87 8.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.199 -1.16 . . . . 1.7 110.199 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.79 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.86 -141.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.957 -1.319 . . . . 0.96999999999999997 109.645 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.79 ' N ' ' OG1' ' A' ' 27' ' ' THR . 13.7 p -91.35 132.71 36.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.538 -0.726 . . . . 1.8 109.329 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 pt-20 -37.44 106.96 0.37 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.139 -0.976 . . . . 2.3999999999999999 109.055 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HG2' HD22 ' A' ' 24' ' ' LEU . 53.6 Cg_exo -45.54 150.01 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.226 1.951 . . . . 1.1299999999999999 111.691 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 t -136.83 123.07 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 1.05 110.103 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.84 115.4 17.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 1.8200000000000001 109.362 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 35' ' ' GLY . . . -81.76 -140.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 1.1699999999999999 109.733 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.53 13.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 2.21 110.057 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.626 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 144.11 -4.77 1.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.945 -1.262 . . . . 1.1899999999999999 109.945 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -121.57 152.22 39.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.005 -1.291 . . . . 2.9100000000000001 109.571 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.656 ' SD ' HD23 ' A' ' 19' ' ' LEU . 59.2 ttp -116.65 134.37 54.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.93000000000000005 109.338 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -129.93 154.11 47.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 110.161 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.9 m -123.74 140.85 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.682 -0.858 . . . . 1.3700000000000001 108.682 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.72 ' C ' HD12 ' A' ' 41' ' ' LEU . 53.1 m-20 -79.8 108.87 13.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 4.79 109.704 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 133' ' ' LEU . 8.2 mp -116.29 76.29 6.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 3.54 109.508 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 61.2 Cg_endo -77.54 -74.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.796 2.331 . . . . 3.7400000000000002 112.201 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . -173.52 -157.37 15.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.588 -1.405 . . . . 2.0299999999999998 109.588 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 77.19 -4.0 56.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.658 -1.377 . . . . 2.4100000000000001 109.658 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.671 ' O ' ' N ' ' A' ' 47' ' ' ASN . 7.8 mm-40 -100.01 66.79 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -1.119 . . . . 2.96 109.435 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.77 49.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.59 -1.404 . . . . 2.0800000000000001 109.59 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.674 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -169.68 89.28 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.107 . . . . 3.6099999999999999 109.422 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.7 -0.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.876 2.384 . . . . 2.3599999999999999 112.356 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.674 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -122.88 34.08 5.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 3.8700000000000001 109.572 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 2.0 m-20 -108.7 -19.62 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 2.3799999999999999 109.654 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -139.77 177.42 7.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 1.1100000000000001 109.71 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 128.65 171.82 13.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.615 -1.394 . . . . 0.93999999999999995 109.615 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.571 ' C ' HG22 ' A' ' 54' ' ' VAL . 3.2 mt -89.74 -177.29 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 0.95999999999999996 109.323 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.31 174.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.92000000000000004 109.92 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 22' ' ' TRP . 18.1 t80 176.98 129.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.43 -0.794 . . . . 1.71 109.46 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -111.38 115.14 28.78 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.252 -0.905 . . . . 2.7799999999999998 109.525 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 70.96 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.48 -1.448 . . . . 2.48 109.48 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -170.06 95.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.343 -1.092 . . . . 3.79 109.416 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.453 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 58.7 Cg_endo -79.35 127.06 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.594 2.196 . . . . 2.3999999999999999 112.186 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.1 t -100.03 135.19 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 3.0800000000000001 109.578 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -115.23 101.79 1.07 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 3.0499999999999998 109.338 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 61' ' ' GLY . 14.9 tt0 -35.53 144.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.166 . . . . 6.0499999999999998 109.612 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.675 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 96.35 -25.94 23.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.692 -1.363 . . . . 2.54 109.692 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 115' ' ' SER . 18.0 mt-10 -104.84 164.84 11.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -1.175 . . . . 4.0300000000000002 109.767 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 58.2 m -120.7 141.41 50.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 2.9100000000000001 109.228 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.61 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 28.0 m-85 -108.55 -179.21 3.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 2.3799999999999999 109.73 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.675 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.0 t -152.76 144.83 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.489 -0.757 . . . . 2.6099999999999999 109.341 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.44 116.46 16.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 3.6099999999999999 109.797 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.74 95.88 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 2.27 108.874 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -93.08 139.41 30.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 2.0099999999999998 110.85 -179.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -94.51 104.75 16.71 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.857 -0.794 . . . . 1.8 108.857 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -175.97 169.18 2.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.792 -1.192 . . . . 0.95999999999999996 110.635 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.16 172.18 13.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.763 -0.829 . . . . 0.93000000000000005 108.763 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -120.59 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.67000000000000004 109.949 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.47 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.59 115.6 14.73 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.311 -0.868 . . . . 0.96999999999999997 109.468 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.0 Cg_exo -65.79 -142.18 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 124.392 -1.087 . . . . 1.02 112.341 -0.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -102.23 149.36 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 1.75 109.602 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.15 153.58 0.13 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 2.1600000000000001 109.438 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.72 163.78 28.68 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.829 2.353 . . . . 1.3799999999999999 112.491 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 35.8 m -136.5 -178.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.346 -0.846 . . . . 2.0099999999999998 109.305 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.717 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -126.56 117.78 23.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 6.0099999999999998 109.658 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.602 HG13 ' CD ' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -119.7 151.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 3.7599999999999998 109.259 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 130' ' ' ALA . 2.9 pp -143.03 156.39 44.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 2.29 109.909 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.456 ' CG2' ' C ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -154.03 159.8 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 1.8899999999999999 109.428 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 144.99 -142.92 11.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.578 -1.409 . . . . 1.49 109.578 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -90.17 -165.88 1.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 2.54 109.44 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.644 ' H ' ' HB3' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.556 -1.418 . . . . 1.3799999999999999 109.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.414 -0.588 . . . . 5.7400000000000002 109.414 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.463 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -139.77 173.53 11.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 2.27 109.966 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HB1' ' OD1' ' A' ' 116' ' ' ASN . . . -123.65 -19.62 5.74 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.823 -0.806 . . . . 3.2799999999999998 108.823 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.583 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.68 34.72 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 3.6499999999999999 109.203 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 4.5999999999999996 109.538 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' CD ' HG13 ' A' ' 82' ' ' VAL . 4.9 pt20 -107.79 -156.25 0.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 3.46 109.425 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -173.16 -35.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.688 -1.365 . . . . 3.6699999999999999 109.688 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -80.07 90.21 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -1.146 . . . . 3.79 109.518 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' HG23 ' A' ' 80' ' ' VAL . . . -123.13 78.71 51.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 1.96 109.461 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.83 127.14 24.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.018 2.479 . . . . 2.9700000000000002 112.547 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 102' ' ' LEU . 55.9 mt -140.41 145.74 37.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.0600000000000001 109.297 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -127.45 175.11 8.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 2.3399999999999999 109.701 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -77.79 17.68 5.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 2.1699999999999999 109.527 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -102.48 103.8 33.94 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.279 -1.13 . . . . 3.02 109.165 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -44.75 117.5 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.3 2.0 . . . . 1.4199999999999999 112.188 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.762 ' HB1' HH12 ' A' ' 109' ' ' ARG . . . -165.16 156.82 14.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.925 . . . . 1.3700000000000001 109.603 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.639 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.24 136.02 33.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.368 -0.833 . . . . 1.72 110.221 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.762 HH12 ' HB1' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -110.23 142.02 42.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.665 -1.235 . . . . 4.7000000000000002 107.665 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.75 105.69 13.59 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.763 -0.775 . . . . 3.2799999999999998 110.457 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -109.09 109.18 20.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.172 -1.048 . . . . 2.96 108.172 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -116.85 169.14 9.62 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 3.4100000000000001 109.807 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.3 p90 -154.73 -178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.835 . . . . 2.77 109.514 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -109.92 106.15 15.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.36 -0.837 . . . . 2.23 109.689 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.675 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 59.8 p -35.97 119.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 4.1100000000000003 109.316 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.527 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 3.7 m120 -96.26 -49.24 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 6.8600000000000003 109.576 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.72 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.81 -156.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 5.1200000000000001 109.646 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.72 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -119.52 144.83 46.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.349 -0.844 . . . . 4.0599999999999996 109.491 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.56 ' CD1' ' O ' ' A' ' 118' ' ' THR . 74.6 m-85 -157.86 62.29 2.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 5.4400000000000004 109.497 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.503 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 45.7 Cg_exo -52.28 -173.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.852 2.368 . . . . 4.04 112.071 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 5.0 Cg_exo -71.23 -31.45 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.047 2.498 . . . . 3.8999999999999999 111.857 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -111.0 -161.56 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 4.1399999999999997 109.478 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 88.21 -149.02 21.08 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.514 -1.435 . . . . 3.5699999999999998 109.514 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.654 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -44.73 -50.03 10.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 3.5899999999999999 109.434 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.644 ' HB3' ' H ' ' A' ' 87' ' ' GLY . . . -165.68 155.09 10.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.0800000000000001 109.457 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.91 -158.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 1.3899999999999999 112.205 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.99 168.61 9.88 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.546 -1.422 . . . . 1.1899999999999999 109.546 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.566 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 6.6 tp60 -148.86 118.77 7.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -1.175 . . . . 2.0099999999999998 109.656 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 54' ' ' VAL . 38.9 t -136.02 137.74 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 1.28 108.636 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -160.27 112.15 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.999 -1.063 . . . . 0.97999999999999998 110.506 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.4 m-30 -89.0 110.43 21.12 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.519 -0.919 . . . . 1.73 108.519 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -99.69 138.37 36.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 2.3199999999999998 110.031 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -155.93 17.11 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 2.1099999999999999 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -77.18 139.09 22.85 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.616 -1.393 . . . . 1.77 109.616 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 137' ' ' GLY . 18.7 mtpt -166.25 127.49 1.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.134 . . . . 5.0599999999999996 109.81 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.17 -15.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.0 -1.111 . . . . 2.6400000000000001 108.0 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.52 17.13 6.96 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.747 -1.741 . . . . 2.5099999999999998 108.747 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.86 -158.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.918 . . . . 2.3199999999999998 110.714 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.647 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 2.2 p90 -152.73 -119.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 1.6100000000000001 109.391 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.464 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 2.3 mt-10 -135.9 143.88 45.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 1.6499999999999999 109.228 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 38.1 t80 -124.5 127.39 47.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 1.6799999999999999 109.454 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.94 115.56 25.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.73999999999999999 110.506 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.41 143.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.759 0.79 . . . . 1.22 109.017 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' PHE . 52.3 p -120.66 -19.86 7.28 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.466 -0.939 . . . . 1.3300000000000001 108.466 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.563 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.9 pt20 -171.36 172.27 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.843 -0.743 . . . . 3.2999999999999998 109.646 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.863 HG11 ' CH2' ' A' ' 22' ' ' TRP . 8.8 p -147.16 141.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 2.2599999999999998 109.51 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.441 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -114.91 158.94 21.29 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.912 . . . . 2.7599999999999998 109.527 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 149' ' ' THR . 1.6 tp -168.22 114.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 4.5700000000000003 109.381 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.82 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 7.0 t -156.68 -164.03 1.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 3.0699999999999998 109.484 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.419 ' N ' ' OG1' ' A' ' 149' ' ' THR . 7.7 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 2.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.126 ' N ' ' HG1' ' A' ' 149' ' ' THR . 48.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.311 -0.626 . . . . 2.8300000000000001 109.311 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.598 ' C ' ' H ' ' A' ' 10' ' ' LEU . 6.3 pm0 -51.02 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 4.75 109.669 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 7' ' ' VAL . 8.6 mp -54.22 -1.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 4.9500000000000002 109.276 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.05 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -140.5 95.85 7.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 2.8599999999999999 108.943 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.07 38.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 3.8300000000000001 112.703 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.678 ' N ' ' O ' ' A' ' 10' ' ' LEU . 33.7 t60 -133.44 115.65 15.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 2.52 109.337 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.579 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -154.41 63.38 0.68 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.347 -0.846 . . . . 1.97 109.283 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 16' ' ' ALA . 16.2 m -159.47 66.8 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 1.96 109.512 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.8 m-30 -67.11 27.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 1.76 109.195 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.613 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.17 -29.53 18.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.847 . . . . 1.1799999999999999 109.956 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 4.3 mt-10 -109.73 -83.64 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 2.1299999999999999 109.78 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.4 m -96.46 143.77 27.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 2.2599999999999998 109.593 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' A' ' 37' ' ' MET . 3.9 mt -54.11 -51.38 64.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 2.6000000000000001 109.418 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.37 -171.59 16.76 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.591 -1.404 . . . . 1.6200000000000001 109.591 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 22' ' ' TRP . 47.5 Cg_endo -72.99 -18.54 24.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.759 2.306 . . . . 1.7 112.147 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.766 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.5 m95 -53.06 -174.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 2.4199999999999999 109.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -135.81 173.79 11.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 1.6399999999999999 109.525 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.573 HD13 ' CG ' ' A' ' 30' ' ' PRO . 2.7 pp -177.81 142.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 2.0499999999999998 109.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.91 170.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 1.72 109.793 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.06 -29.73 10.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.97 -1.252 . . . . 1.7 109.97 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.773 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.73 -141.94 0.38 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.083 -1.245 . . . . 0.96999999999999997 109.3 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.773 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.7 p -91.15 -170.58 2.7 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 1.8 109.172 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.22 111.34 46.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 109.041 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.573 ' CG ' HD13 ' A' ' 24' ' ' LEU . 76.7 Cg_exo -44.66 134.9 9.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.201 1.934 . . . . 1.1299999999999999 111.921 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 37' ' ' MET . 9.2 t -116.95 105.07 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 1.05 109.918 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -69.24 77.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.568 -0.708 . . . . 1.8200000000000001 109.416 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -60.67 -140.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.1699999999999999 109.766 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -35.48 -76.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 2.21 109.503 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.21 49.71 0.71 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.586 -1.406 . . . . 1.1899999999999999 109.586 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -173.15 150.38 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 2.9100000000000001 109.398 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' HD21 ' A' ' 19' ' ' LEU . 4.5 ptt? -108.87 134.03 52.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 109.562 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.68 135.51 54.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.627 -0.829 . . . . 1.0600000000000001 110.427 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.1 m -106.07 140.66 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.672 -0.862 . . . . 1.3700000000000001 108.672 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.645 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.2 m-20 -77.35 106.53 9.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 4.79 109.922 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 133' ' ' LEU . 6.6 mp -114.26 80.67 5.92 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 3.54 109.157 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.23 -95.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 3.7400000000000002 112.263 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.17 137.29 4.85 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.651 -1.379 . . . . 2.0299999999999998 109.651 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 155.71 -17.85 0.49 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 2.4100000000000001 109.51 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -99.51 61.99 1.2 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.235 -1.156 . . . . 2.96 109.632 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -36.48 -33.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.249 -1.54 . . . . 2.0800000000000001 109.249 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -107.69 101.83 41.97 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.364 -1.08 . . . . 3.6099999999999999 109.037 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.449 ' O ' ' CG ' ' A' ' 132' ' ' HIS . 36.2 Cg_exo -56.36 44.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.457 2.105 . . . . 2.3599999999999999 112.315 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.693 ' CH2' ' OD2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -117.12 49.75 1.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.99 . . . . 3.8700000000000001 111.28 -179.178 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.693 ' OD2' ' CH2' ' A' ' 49' ' ' TRP . 23.9 m-20 -165.07 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 2.3799999999999999 109.465 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.06 120.04 24.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 1.1100000000000001 109.546 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.604 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 162.59 179.2 37.03 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.683 -1.246 . . . . 0.93999999999999995 110.041 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.979 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.5 mm? -100.07 168.01 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -1.04 . . . . 0.95999999999999996 109.009 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -155.89 166.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.92000000000000004 109.825 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 1.05 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 13.1 t80 173.92 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 1.71 109.571 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.568 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-80 -98.93 150.03 22.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 109.548 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.434 ' H ' ' HA3' ' A' ' 127' ' ' GLY . . . 127.69 52.54 0.14 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 2.48 109.589 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.721 HG13 HD22 ' A' ' 148' ' ' LEU . 14.7 t -142.79 70.59 19.64 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 3.79 109.457 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -47.66 143.57 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.834 2.356 . . . . 2.3999999999999999 112.208 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.53 122.04 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 3.0800000000000001 109.461 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.17 91.72 0.69 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 3.0499999999999998 109.492 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 3.5 tm-20 -41.81 120.42 1.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 6.0499999999999998 109.46 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.31 -48.82 0.93 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.807 -1.317 . . . . 2.54 109.807 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.507 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.6 mp0 -100.03 179.71 4.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 4.0300000000000002 109.623 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.57 ' OG ' HG22 ' A' ' 114' ' ' THR . 58.5 m -120.28 140.99 50.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 2.9100000000000001 109.396 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 38.6 m-85 -109.53 -178.13 3.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.202 -0.936 . . . . 2.3799999999999999 109.474 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 66' ' ' TYR . 22.9 t -152.79 130.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 2.6099999999999999 109.511 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 69' ' ' SER . 8.0 tt -110.7 147.51 34.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 3.6099999999999999 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.968 ' N ' HD23 ' A' ' 68' ' ' LEU . 1.6 p -130.2 91.05 3.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 2.27 109.455 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 109' ' ' ARG . 29.5 p90 -94.63 139.56 31.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 2.0099999999999998 110.966 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.801 HG23 HG23 ' A' ' 108' ' ' THR . 1.1 p -97.0 134.68 40.05 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.641 -0.874 . . . . 1.8 108.641 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.803 ' N ' HH22 ' A' ' 109' ' ' ARG . . . 169.37 -170.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.951 -1.093 . . . . 0.95999999999999996 110.481 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -169.11 147.68 3.88 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.816 -0.809 . . . . 0.93000000000000005 108.816 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -104.72 134.04 48.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.116 -0.99 . . . . 0.67000000000000004 109.85 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.45 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.04 116.4 15.63 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.4 -0.812 . . . . 0.96999999999999997 109.292 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.21 -142.29 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.665 0 C-N-CA 124.297 -1.126 . . . . 1.02 112.344 -0.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -104.96 148.8 26.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.75 109.253 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.724 ' SD ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 ptp 174.43 154.45 0.3 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 2.1600000000000001 109.535 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.14 117.93 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.57 2.18 . . . . 1.3799999999999999 111.871 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -97.45 179.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.878 . . . . 2.0099999999999998 109.536 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -120.14 150.92 39.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 6.0099999999999998 109.65 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -142.47 147.89 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 3.7599999999999998 109.118 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -143.81 148.26 35.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 2.29 110.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -154.41 164.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.775 . . . . 1.8899999999999999 109.413 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.68 -138.9 6.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.687 -1.365 . . . . 1.49 109.687 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.1 pm0 -90.17 177.31 6.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -1.145 . . . . 2.54 109.489 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.523 -1.431 . . . . 1.3799999999999999 109.523 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.554 ' C ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.427 -0.583 . . . . 5.7400000000000002 109.427 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER 179.96 -179.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 2.27 109.954 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.575 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.04 -22.1 4.91 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.873 -0.788 . . . . 3.2799999999999998 108.873 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.67 43.06 1.13 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.286 -0.884 . . . . 3.6499999999999999 109.227 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -86.59 61.0 6.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.111 -0.993 . . . . 4.5999999999999996 109.464 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.5 tt0 -99.93 161.57 13.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 3.46 109.04 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -135.43 -30.22 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.781 -1.327 . . . . 3.6699999999999999 109.781 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.01 95.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.259 -1.142 . . . . 3.79 109.819 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.769 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -137.41 77.48 40.82 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 1.96 109.32 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.03 120.06 6.2 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.027 2.485 . . . . 2.9700000000000002 112.701 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.427 HD12 ' CG2' ' A' ' 80' ' ' VAL . 11.9 mt -137.9 132.88 33.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 3.0600000000000001 109.357 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 5.1 t -128.84 -151.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 2.3399999999999999 109.521 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.31 58.34 2.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.632 -1.387 . . . . 2.1699999999999999 109.632 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.23 84.25 59.8 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -1.104 . . . . 3.02 109.481 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.726 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 51.0 Cg_exo -48.65 124.91 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.814 2.343 . . . . 1.4199999999999999 112.188 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 161.03 174.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 1.3700000000000001 109.444 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.801 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.08 131.9 35.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 1.72 109.929 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.803 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -100.74 140.97 34.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.092 -1.448 . . . . 4.7000000000000002 107.092 177.794 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 7.8 mt-10 -108.73 123.39 48.93 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.515 -0.874 . . . . 3.2799999999999998 110.94 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.769 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 7.5 m-85 -109.96 119.56 39.7 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.302 -0.999 . . . . 2.96 108.302 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.96 124.68 45.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.941 . . . . 3.4100000000000001 109.941 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.704 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -133.5 165.42 24.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 2.77 109.436 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.57 HG22 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -108.16 125.68 51.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 2.23 109.748 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 4.2 m -52.7 124.38 13.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.28 -0.887 . . . . 4.1100000000000003 109.213 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.68 ' O ' HD22 ' A' ' 117' ' ' LEU . 3.4 m120 -111.04 -46.67 3.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.151 -0.968 . . . . 6.8600000000000003 109.698 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 116' ' ' ASN . 3.3 mm? -120.96 139.72 52.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 5.1200000000000001 109.638 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.682 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -70.19 159.56 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 4.0599999999999996 109.291 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.682 ' CG ' ' O ' ' A' ' 118' ' ' THR . 32.1 m-85 -168.05 93.44 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 5.4400000000000004 109.492 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.09 165.8 21.31 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.722 2.281 . . . . 4.04 112.177 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.81 -15.05 12.22 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.716 2.278 . . . . 3.8999999999999999 112.042 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.83 132.65 53.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 4.1399999999999997 109.442 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.41 -137.47 9.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.546 -1.422 . . . . 3.5699999999999998 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -121.48 39.14 3.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 3.5899999999999999 109.454 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 86' ' ' GLU . . . -179.92 71.23 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 109.495 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.72 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.752 2.301 . . . . 1.3899999999999999 112.306 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -65.59 154.28 50.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.599 -1.401 . . . . 1.1899999999999999 109.599 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 57.1 tp60 -151.52 130.46 12.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.104 -1.233 . . . . 2.0099999999999998 109.578 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.625 ' CG2' HG21 ' A' ' 58' ' ' VAL . 21.2 t -138.47 139.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 1.28 108.623 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.08 1.94 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.855 -1.153 . . . . 0.97999999999999998 110.929 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.3 m-30 -90.72 112.09 23.71 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.207 -1.035 . . . . 1.73 108.207 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.449 ' CG ' ' O ' ' A' ' 48' ' ' PRO . 34.8 m170 -99.88 131.3 45.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 2.3199999999999998 110.259 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.58 -23.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 2.1099999999999999 109.896 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.06 133.65 0.37 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.763 -1.335 . . . . 1.77 109.763 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 137' ' ' GLY . 29.7 mtmt -169.03 127.03 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -1.135 . . . . 5.0599999999999996 109.763 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.91 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.911 -1.144 . . . . 2.6400000000000001 107.911 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.04 18.61 7.44 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.037 -1.625 . . . . 2.5099999999999998 109.037 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.44 -154.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.625 -0.926 . . . . 2.3199999999999998 110.756 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.724 ' CD1' ' SD ' ' A' ' 78' ' ' MET . 7.4 p90 -158.91 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.995 -1.066 . . . . 1.6100000000000001 109.277 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.455 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 74.6 mm-40 -126.65 130.55 50.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 1.6499999999999999 108.867 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -107.71 114.64 28.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 1.6799999999999999 109.974 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.501 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 36.6 m -110.93 114.35 27.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.275 -0.891 . . . . 0.73999999999999999 109.65 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -123.26 145.03 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 1.22 109.517 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' PHE . 0.7 OUTLIER -131.0 -12.74 3.64 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.299 -0.63 . . . . 1.3300000000000001 109.299 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.578 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -158.93 158.95 34.34 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.372 -0.931 . . . . 3.2999999999999998 110.181 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.527 HG22 ' C ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -162.39 129.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 2.2599999999999998 108.91 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.96 144.06 8.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.062 . . . . 2.7599999999999998 109.675 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.721 HD22 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -122.11 164.99 16.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 4.5700000000000003 109.523 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . 1.126 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -177.68 -174.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 3.0699999999999998 109.655 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.597 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.6 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 2.0 109.438 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.469 -0.567 . . . . 2.8300000000000001 109.469 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 7' ' ' VAL . 8.4 tt0 -37.21 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 4.75 109.626 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 mt -61.92 -34.59 76.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 4.9500000000000002 109.275 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.011 HD13 ' H ' ' A' ' 12' ' ' HIS . 2.8 tm? -107.53 100.4 34.04 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 2.8599999999999999 108.576 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.39 30.42 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.7 2.267 . . . . 3.8300000000000001 112.997 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 1.011 ' H ' HD13 ' A' ' 10' ' ' LEU . 28.2 t60 -115.42 82.05 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.848 -1.158 . . . . 2.52 109.369 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.492 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -121.27 45.85 2.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 1.97 109.338 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.1 t -125.45 72.19 1.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 1.96 109.461 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -83.21 23.95 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.198 -0.939 . . . . 1.76 109.362 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.784 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.02 -35.12 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 1.1799999999999999 109.696 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 26.4 mm-40 -109.86 -83.16 0.56 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.138 -0.976 . . . . 2.1299999999999999 109.729 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 m -88.22 144.44 26.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 2.2599999999999998 109.535 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.56 -58.45 8.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 2.6000000000000001 109.515 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.1 -169.98 13.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 1.6200000000000001 109.573 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 22' ' ' TRP . 55.9 Cg_endo -75.4 -19.21 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.793 2.329 . . . . 1.7 112.205 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.57 ' O ' ' O ' ' A' ' 21' ' ' PRO . 11.3 m95 -50.95 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 2.4199999999999999 109.345 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -143.25 169.85 16.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 1.6399999999999999 109.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.76 138.64 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 2.0499999999999998 109.574 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.96 159.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 1.72 109.439 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 107.45 -26.91 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.865 -1.294 . . . . 1.7 109.865 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.78 -142.35 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.96999999999999997 109.201 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 12.4 p -91.61 -162.14 0.89 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.459 -0.775 . . . . 1.8 108.999 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.01 131.4 39.27 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 2.3999999999999999 108.811 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.66 132.29 23.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.246 1.964 . . . . 1.1299999999999999 111.839 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 37' ' ' MET . 40.8 t -118.83 111.19 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.05 109.888 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.707 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.49 85.54 5.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.657 -0.652 . . . . 1.8200000000000001 109.49 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.25 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 1.1699999999999999 109.689 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.26 -68.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 2.21 109.369 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.784 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -141.55 35.19 1.82 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.465 . . . . 1.1899999999999999 109.436 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.77 147.89 28.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -1.12 . . . . 2.9100000000000001 109.64 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.5 ptt? -121.18 132.78 55.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 0.93000000000000005 109.231 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 m -128.89 145.02 51.33 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.452 -0.899 . . . . 1.0600000000000001 110.376 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.16 145.43 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.705 -0.85 . . . . 1.3700000000000001 108.705 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.695 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -75.12 123.39 25.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 4.79 109.802 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.695 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.4 mm? -122.69 75.02 45.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 3.54 109.258 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.663 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 51.6 Cg_exo -48.14 -167.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.871 2.381 . . . . 3.7400000000000002 112.359 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 136' ' ' ALA . . . -124.45 62.01 0.58 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.507 -1.437 . . . . 2.0299999999999998 109.507 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . -154.48 15.28 0.55 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 2.4100000000000001 109.627 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -99.93 91.35 4.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -1.164 . . . . 2.96 109.477 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.29 -7.95 61.26 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.496 -1.442 . . . . 2.0800000000000001 109.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.72 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -99.9 121.68 53.38 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.274 -1.133 . . . . 3.6099999999999999 109.371 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.17 5.86 4.28 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.433 2.089 . . . . 2.3599999999999999 112.308 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.493 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -122.98 33.15 5.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 3.8700000000000001 109.604 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.762 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 34.5 m-20 -126.02 43.17 3.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 2.3799999999999999 109.433 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 159.59 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 1.1100000000000001 109.553 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 164.88 157.97 10.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.009 -1.236 . . . . 0.93999999999999995 110.009 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.64 ' CD1' HD13 ' A' ' 143' ' ' ILE . 7.5 mt -77.17 -176.3 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -1.135 . . . . 0.95999999999999996 109.157 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.88 159.18 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.92000000000000004 109.593 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' HD23 ' A' ' 10' ' ' LEU . 46.2 t80 178.92 143.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.384 -0.823 . . . . 1.71 109.648 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.4 m-80 -111.17 -164.75 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 2.7799999999999998 109.524 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 82.82 74.33 1.2 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 2.48 109.572 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 57' ' ' GLY . 52.2 t -161.12 77.57 2.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.107 . . . . 3.79 109.52 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.45 155.99 1.95 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.815 2.343 . . . . 2.3999999999999999 112.135 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -135.99 114.66 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 3.0800000000000001 109.614 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -138.99 101.89 0.33 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.256 -1.537 . . . . 3.0499999999999998 109.256 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 63' ' ' GLY . 7.0 tp10 -38.19 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -1.087 . . . . 6.0499999999999998 109.452 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 103.35 -56.41 0.6 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.576 -1.409 . . . . 2.54 109.576 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.66 141.89 31.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.116 . . . . 4.0300000000000002 109.334 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -99.89 120.54 39.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 2.9100000000000001 109.553 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' C ' ' CG2' ' A' ' 67' ' ' VAL . 81.7 m-85 -85.55 174.71 9.26 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 2.3799999999999999 109.505 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.831 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -155.43 132.82 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 2.6099999999999999 109.323 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tt -114.07 130.56 56.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.966 . . . . 3.6099999999999999 109.498 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.2 p -118.16 94.86 4.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 2.27 108.736 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 11.2 p90 -93.28 135.48 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.05 -1.031 . . . . 2.0099999999999998 111.091 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.588 HG22 ' CG2' ' A' ' 108' ' ' THR . 19.1 p -90.31 109.25 20.35 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.547 -0.908 . . . . 1.8 108.547 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -158.89 165.92 33.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.624 -1.23 . . . . 0.95999999999999996 110.817 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.8 p -129.42 163.1 26.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.914 -0.773 . . . . 0.93000000000000005 108.914 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' HB1' ' HE2' ' A' ' 139' ' ' TYR . . . -124.39 119.3 28.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.593 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.46 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.79 116.74 16.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.057 -1.027 . . . . 0.96999999999999997 110.113 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.582 ' O ' ' O ' ' A' ' 74' ' ' ALA . 20.1 Cg_exo -65.87 -142.15 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.687 0 C-N-CA 124.232 -1.153 . . . . 1.02 112.05 -0.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' C ' ' CG ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -97.86 149.39 22.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 1.75 109.208 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.697 ' SD ' ' CE2' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 165.21 159.82 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 2.1600000000000001 109.795 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.34 119.24 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.711 2.274 . . . . 1.3799999999999999 112.032 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.19 169.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 2.0099999999999998 109.44 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.739 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -109.83 139.42 44.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.917 . . . . 6.0099999999999998 109.313 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -141.05 148.26 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 3.7599999999999998 109.533 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -147.21 144.0 28.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 2.29 109.487 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 129' ' ' VAL . 1.0 OUTLIER -152.84 145.03 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 1.8899999999999999 110.342 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 128' ' ' GLN . . . 142.21 -109.62 0.58 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.881 -1.288 . . . . 1.49 109.881 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' CD ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -89.98 164.87 14.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -1.181 . . . . 2.54 109.663 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.593 -1.403 . . . . 1.3799999999999999 109.593 179.862 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 5.7400000000000002 109.766 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.688 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 1.8 t -128.85 -150.93 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 2.27 110.275 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.688 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -119.01 -22.32 7.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.239 -0.652 . . . . 3.2799999999999998 109.239 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.509 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.11 41.66 1.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.787 -1.196 . . . . 3.6499999999999999 109.235 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -90.01 44.28 1.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.983 -1.073 . . . . 4.5999999999999996 109.537 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 111' ' ' TYR . 7.3 pt20 -106.67 137.18 45.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 3.46 109.431 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 82' ' ' VAL . . . -128.49 20.28 5.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.664 -1.374 . . . . 3.6699999999999999 109.664 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -104.84 76.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 3.79 109.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.76 102.03 53.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 1.96 109.333 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.79 118.81 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.702 2.268 . . . . 2.9700000000000002 112.608 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.6 159.82 33.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 3.0600000000000001 109.522 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 2.4 t -103.5 -148.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 2.3399999999999999 109.86 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.597 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -110.2 29.65 9.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 2.1699999999999999 109.805 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.492 ' H ' HG23 ' A' ' 103' ' ' THR . 5.2 pt-20 -139.59 147.96 54.15 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.201 -1.176 . . . . 3.02 109.205 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -40.48 117.35 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.592 2.194 . . . . 1.4199999999999999 111.882 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.38 127.69 11.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.151 -0.968 . . . . 1.3700000000000001 109.811 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.588 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.62 141.14 29.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.44 -0.787 . . . . 1.72 109.853 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 111' ' ' TYR . 9.1 mmm-85 -113.26 136.44 52.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.377 -0.972 . . . . 4.7000000000000002 108.377 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -117.18 107.36 14.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.175 -0.61 . . . . 3.2799999999999998 109.883 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 109' ' ' ARG . 42.3 m-85 -109.95 114.76 28.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 2.96 109.083 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -103.38 170.48 7.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -0.873 . . . . 3.4100000000000001 109.611 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.436 ' CD2' ' C ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 179.05 161.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 2.77 109.767 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.37 155.01 20.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 2.23 109.307 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -90.13 44.15 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 4.1100000000000003 109.954 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 115' ' ' SER . 6.9 m120 -39.92 -17.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 6.8600000000000003 109.576 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.799 HD12 ' CZ ' ' A' ' 119' ' ' PHE . 1.2 mm? -109.87 143.82 39.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 5.1200000000000001 109.436 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.85 107.75 18.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 4.0599999999999996 109.681 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.799 ' CZ ' HD12 ' A' ' 117' ' ' LEU . 43.0 m-85 -133.69 98.26 15.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 5.4400000000000004 109.181 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.28 165.58 23.34 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.52 2.147 . . . . 4.04 112.239 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.03 -14.59 12.16 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.836 2.357 . . . . 3.8999999999999999 112.069 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -109.66 123.24 49.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 4.1399999999999997 109.602 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.554 ' O ' ' OD1' ' A' ' 124' ' ' ASP . . . 150.02 -84.34 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.478 -1.449 . . . . 3.5699999999999998 109.478 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 123' ' ' GLY . 4.5 m-20 -162.21 -37.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 3.5899999999999999 109.452 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -112.59 93.45 23.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 2.0800000000000001 109.417 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.98 -159.17 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.744 2.296 . . . . 1.3899999999999999 112.273 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.57 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -72.84 -178.99 35.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 1.1899999999999999 109.603 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.467 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -170.25 141.18 2.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -1.094 . . . . 2.0099999999999998 109.707 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.797 HG22 HG13 ' A' ' 84' ' ' VAL . 67.3 t -138.71 151.48 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.973 -1.121 . . . . 1.28 107.973 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -165.66 111.72 0.9 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.815 -1.154 . . . . 0.97999999999999998 110.48 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.514 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.8 m-30 -94.12 84.38 4.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.456 -0.942 . . . . 1.73 108.456 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.493 ' NE2' ' HB1' ' A' ' 130' ' ' ALA . 19.6 m170 -98.73 132.53 44.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 2.3199999999999998 110.173 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.828 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.65 2.32 2.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 2.1099999999999999 109.268 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -48.95 136.4 19.8 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.517 -1.433 . . . . 1.77 109.517 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.668 ' O ' ' N ' ' A' ' 137' ' ' GLY . 19.5 mtpt -165.72 130.14 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -1.157 . . . . 5.0599999999999996 109.869 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 43' ' ' GLY . . . -42.58 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.87 -1.159 . . . . 2.6400000000000001 107.87 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.47 17.1 7.44 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.734 -1.747 . . . . 2.5099999999999998 108.734 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 42' ' ' PRO . . . -51.13 -149.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.903 . . . . 2.3199999999999998 110.432 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.697 ' CE2' ' SD ' ' A' ' 78' ' ' MET . 0.0 OUTLIER -171.7 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.008 . . . . 1.6100000000000001 110.597 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.674 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 13.9 mt-10 -137.26 140.79 41.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 1.6499999999999999 109.351 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.627 ' HB2' HD22 ' A' ' 133' ' ' LEU . 42.0 t80 -117.53 128.3 54.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.865 . . . . 1.6799999999999999 109.374 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.41 110.66 17.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.126 -0.984 . . . . 0.73999999999999999 109.977 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.64 HD13 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -119.66 144.68 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 1.22 109.279 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 88.6 p -130.06 -15.23 3.81 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.205 -0.665 . . . . 1.3300000000000001 109.205 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.466 ' CG ' ' C ' ' A' ' 144' ' ' SER . 3.0 mt-30 -155.51 177.52 11.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 3.2999999999999998 110.015 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 146' ' ' VAL . 3.9 p -177.04 124.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.815 . . . . 2.2599999999999998 109.461 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 176.74 11.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 2.7599999999999998 109.775 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.744 ' C ' HG22 ' A' ' 149' ' ' THR . 1.3 pp -155.37 -161.35 1.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 4.5700000000000003 109.394 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.66 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 3.0699999999999998 109.5 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.475 ' H ' HG12 ' A' ' 7' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 2.0 109.371 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.271 0.558 . . . . 2.8300000000000001 109.511 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -85.74 83.08 7.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 4.75 109.468 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.547 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -61.93 -33.03 73.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 4.9500000000000002 109.426 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.612 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -109.07 96.02 19.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 2.8599999999999999 108.653 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.5 27.07 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.32 2.014 . . . . 3.8300000000000001 111.693 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.612 ' H ' HD13 ' A' ' 10' ' ' LEU . 48.2 t60 -128.31 74.21 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 2.52 109.478 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 10.1 t -112.96 41.58 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 1.97 109.43 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 16' ' ' ALA . 6.5 t -115.85 59.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 1.96 109.668 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -65.49 16.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 1.76 109.263 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.05 -22.39 21.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 1.1799999999999999 109.848 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -109.81 -84.29 0.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.1299999999999999 109.633 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m -109.0 153.78 23.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 2.2599999999999998 109.443 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 37' ' ' MET . 2.2 mt -56.76 -54.26 48.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 2.6000000000000001 109.547 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 103.22 -149.24 17.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.6200000000000001 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.72 -27.49 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.748 2.299 . . . . 1.7 112.252 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.903 ' CH2' HG11 ' A' ' 146' ' ' VAL . 15.4 m95 -52.01 167.59 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 2.4199999999999999 109.256 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -131.87 179.25 6.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -0.959 . . . . 1.6399999999999999 109.676 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.443 HD13 ' CG ' ' A' ' 30' ' ' PRO . 2.9 pp 179.35 152.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 2.0499999999999998 109.504 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -179.06 152.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 1.72 109.529 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.71 -24.63 13.01 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.909 -1.139 . . . . 1.7 110.435 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.78 -144.27 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.381 . . . . 0.96999999999999997 109.583 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 7.9 p -92.8 135.22 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 1.8 109.291 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -41.27 104.25 0.34 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.976 -1.078 . . . . 2.3999999999999999 108.588 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' CG ' HD13 ' A' ' 24' ' ' LEU . 51.7 Cg_exo -46.95 166.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.183 1.922 . . . . 1.1299999999999999 111.83 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 t -151.08 121.16 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.07 -1.019 . . . . 1.05 110.182 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -76.2 92.96 3.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.85 . . . . 1.8200000000000001 109.341 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.68 -140.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 1.1699999999999999 109.531 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' C ' ' OD1' ' A' ' 34' ' ' ASP . 39.6 t0 -58.6 -43.41 89.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.965 . . . . 2.21 109.368 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.566 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -160.74 48.35 0.38 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.271 -1.531 . . . . 1.1899999999999999 109.271 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -171.29 146.29 2.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -1.11 . . . . 2.9100000000000001 109.496 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.492 ' SD ' HD21 ' A' ' 19' ' ' LEU . 40.4 ttp -109.58 133.76 52.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.246 -0.908 . . . . 0.93000000000000005 109.068 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.696 ' SG ' ' OE2' ' A' ' 140' ' ' GLU . 0.5 OUTLIER -127.76 173.61 9.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.229 -0.919 . . . . 1.0600000000000001 110.434 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 3.1 m -149.26 144.97 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.875 -0.787 . . . . 1.3700000000000001 108.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.608 ' C ' HD22 ' A' ' 41' ' ' LEU . 35.4 m-20 -82.48 106.48 14.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.88 . . . . 4.79 109.289 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.608 HD22 ' C ' ' A' ' 40' ' ' ASP . 3.8 mm? -113.5 80.1 4.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 3.54 109.654 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.37 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.756 2.304 . . . . 3.7400000000000002 112.238 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -120.24 115.58 3.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.539 -1.425 . . . . 2.0299999999999998 109.539 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.675 ' H ' ' H ' ' A' ' 136' ' ' ALA . . . -174.88 -40.83 0.05 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.843 -1.303 . . . . 2.4100000000000001 109.843 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.818 ' HB2' ' HZ2' ' A' ' 135' ' ' LYS . 37.0 mt-30 -100.0 125.35 46.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -1.153 . . . . 2.96 109.586 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.89 65.88 0.27 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 2.0800000000000001 109.344 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.659 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -146.03 96.6 4.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.36 -1.082 . . . . 3.6099999999999999 109.396 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 53.1 Cg_exo -48.44 4.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.852 2.368 . . . . 2.3599999999999999 113.079 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.598 ' N ' ' O ' ' A' ' 47' ' ' ASN . 1.4 p-90 -127.59 34.32 4.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.885 -1.134 . . . . 3.8700000000000001 109.667 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 30.7 m-20 -132.97 39.05 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 2.3799999999999999 109.215 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 158.78 94.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 1.1100000000000001 109.259 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . -171.9 174.13 45.21 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.864 -1.295 . . . . 0.93999999999999995 109.864 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.537 ' C ' HG22 ' A' ' 54' ' ' VAL . 6.6 mt -95.05 -178.1 4.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 0.95999999999999996 109.526 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.537 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -162.94 162.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.92000000000000004 109.293 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 15.2 t80 172.26 140.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 1.71 109.72 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.689 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 16.1 m-20 -94.38 -168.1 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 2.7799999999999998 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.678 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 82.3 74.62 1.17 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 2.48 109.463 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.741 ' O ' HG12 ' A' ' 58' ' ' VAL . 48.6 t -161.31 69.74 2.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.275 -1.132 . . . . 3.79 109.547 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HD2' HD13 ' A' ' 9' ' ' LEU . 42.0 Cg_endo -71.85 120.51 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.789 2.326 . . . . 2.3999999999999999 112.136 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.727 HG12 ' OG ' ' A' ' 115' ' ' SER . 4.7 t -112.5 141.25 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 3.0800000000000001 109.532 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -116.5 98.9 0.83 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.464 -1.454 . . . . 3.0499999999999998 109.464 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 61.8 tt0 -35.64 130.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 6.0499999999999998 109.546 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 111.08 -32.36 6.57 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 2.54 109.626 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.3 mt-10 -100.01 177.9 4.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -1.157 . . . . 4.0300000000000002 109.525 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -128.53 143.79 51.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 2.9100000000000001 109.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 27.2 m-85 -112.75 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.156 -0.965 . . . . 2.3799999999999999 109.677 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.406 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.4 t -152.8 137.24 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.551 -0.718 . . . . 2.6099999999999999 109.281 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 148' ' ' LEU . 0.7 OUTLIER -120.83 121.51 38.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 3.6099999999999999 109.782 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.1 p -109.52 85.47 2.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 2.27 108.745 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.7 p90 -93.63 143.56 26.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 2.0099999999999998 111.167 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -93.39 122.91 36.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.609 -0.885 . . . . 1.8 108.609 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.801 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -163.44 147.11 10.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 0.95999999999999996 110.385 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.37 135.9 52.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.877 -0.786 . . . . 0.93000000000000005 108.877 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.859 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -107.6 116.73 32.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.67000000000000004 109.819 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' ' CG ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -131.24 119.09 17.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.96999999999999997 109.831 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.9 Cg_exo -66.17 -142.19 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.305 -1.123 . . . . 1.02 112.372 -0.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 159.24 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 1.75 109.809 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.513 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.9 mtt 162.83 154.98 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 2.1600000000000001 109.215 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.71 148.65 32.9 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.812 2.341 . . . . 1.3799999999999999 112.628 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -122.91 172.1 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 2.0099999999999998 109.056 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 132' ' ' HIS . 14.9 ttt180 -134.81 95.54 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 6.0099999999999998 109.921 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' HA ' ' H ' ' A' ' 132' ' ' HIS . 1.4 m -99.88 148.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 3.7599999999999998 108.939 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 83' ' ' LEU . 1.6 pp -139.73 152.98 47.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 2.29 109.99 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.588 HG13 ' HA ' ' A' ' 129' ' ' VAL . 1.3 t -149.15 157.7 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 1.8899999999999999 109.389 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.88 -143.78 8.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.622 -1.391 . . . . 1.49 109.622 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.662 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 0.3 OUTLIER -90.24 -176.33 4.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 2.54 109.409 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.613 -1.395 . . . . 1.3799999999999999 109.613 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.721 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.437 -0.579 . . . . 5.7400000000000002 109.437 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.18 169.43 10.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 2.27 109.954 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 116' ' ' ASN . . . -124.02 -15.9 6.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 3.2799999999999998 108.881 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.482 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.51 36.88 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 3.6499999999999999 109.155 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -76.38 98.1 4.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.98 . . . . 4.5999999999999996 109.504 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.724 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -106.15 137.12 44.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 3.46 109.128 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.562 ' N ' ' NE2' ' A' ' 97' ' ' GLN . . . -136.73 -0.25 2.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.766 -1.334 . . . . 3.6699999999999999 109.766 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.724 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.6 m -122.8 63.37 0.98 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.131 -1.217 . . . . 3.79 109.773 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.812 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -112.89 96.39 37.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 1.96 109.494 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.41 125.76 5.84 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.791 2.327 . . . . 2.9700000000000002 112.573 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 70.7 mt -133.4 149.24 51.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 3.0600000000000001 109.271 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 105' ' ' GLU . 1.8 t -136.69 -174.92 3.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 2.3399999999999999 109.58 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -63.13 38.62 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.566 -1.414 . . . . 2.1699999999999999 109.566 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 103' ' ' THR . 17.3 tp10 -117.33 78.85 11.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 3.02 109.387 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.53 118.94 2.83 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.801 2.334 . . . . 1.4199999999999999 112.17 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.671 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -174.32 169.72 3.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 1.3700000000000001 109.58 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.543 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.82 141.15 29.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 1.72 109.881 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.801 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.55 137.06 49.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.705 -1.22 . . . . 4.7000000000000002 107.705 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 110' ' ' GLU . 6.2 mp0 -111.22 107.43 16.74 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.847 -0.741 . . . . 3.2799999999999998 110.977 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.6 m-30 -109.89 110.69 21.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.186 -1.042 . . . . 2.96 108.186 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.13 153.25 22.36 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.232 -0.917 . . . . 3.4100000000000001 109.777 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.667 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -141.08 173.82 11.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 2.77 109.289 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -101.35 111.44 23.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 2.23 109.655 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.727 ' OG ' HG12 ' A' ' 60' ' ' VAL . 6.9 t -41.03 125.99 2.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 4.1100000000000003 109.353 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.737 ' O ' HD22 ' A' ' 117' ' ' LEU . 6.4 p-10 -121.21 -30.64 4.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 6.8600000000000003 109.522 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 116' ' ' ASN . 3.4 mm? -123.97 123.82 41.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 5.1200000000000001 109.472 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -65.56 116.28 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 4.0599999999999996 109.393 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 23.8 m-85 -122.45 79.61 46.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 5.4400000000000004 109.48 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.83 168.98 2.05 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.808 2.338 . . . . 4.04 111.96 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.66 -16.89 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.696 2.264 . . . . 3.8999999999999999 112.117 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.59 176.59 4.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 4.1399999999999997 109.409 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.78 -156.17 18.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 3.5699999999999998 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 5.0 p-10 -35.87 -72.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -1.134 . . . . 3.5899999999999999 109.565 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -137.63 150.34 67.84 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 2.0800000000000001 109.463 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.535 ' HG2' HD21 ' A' ' 56' ' ' ASN . 43.4 Cg_endo -71.86 -158.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.824 2.35 . . . . 1.3899999999999999 112.246 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -58.36 157.31 19.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.428 . . . . 1.1899999999999999 109.529 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.3 149.42 34.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -1.165 . . . . 2.0099999999999998 109.484 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.588 ' HA ' HG13 ' A' ' 84' ' ' VAL . 58.0 t -150.58 150.83 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.627 -0.879 . . . . 1.28 108.627 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.35 99.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.004 -1.06 . . . . 0.97999999999999998 110.369 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 4.8 m-30 -70.18 114.34 8.23 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 1.73 108.144 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 48' ' ' PRO . 1.2 m170 -99.28 133.2 43.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 2.3199999999999998 110.388 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 134' ' ' GLY . 4.6 mp -127.81 -40.79 1.7 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.78 . . . . 2.1099999999999999 109.064 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 55.71 147.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 1.77 109.693 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.818 ' HZ2' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -99.8 -150.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.169 . . . . 5.0599999999999996 109.547 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 135' ' ' LYS . . . 78.46 6.11 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 2.6400000000000001 109.055 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.29 10.03 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.136 -1.586 . . . . 2.5099999999999998 109.136 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.02 -149.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -1.084 . . . . 2.3199999999999998 109.573 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.859 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -166.74 -114.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.392 -0.818 . . . . 1.6100000000000001 109.828 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.696 ' OE2' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.02 141.58 51.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 1.6499999999999999 108.773 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.666 ' CE1' ' HB1' ' A' ' 72' ' ' ALA . 18.2 t80 -125.84 114.86 19.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -0.841 . . . . 1.6799999999999999 110.045 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 140' ' ' GLU . 1.5 m -117.71 103.16 9.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.73999999999999999 110.014 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 143.42 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 1.22 109.013 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.445 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 49.6 p -137.84 -1.17 2.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.601 -0.687 . . . . 1.3300000000000001 109.358 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.571 ' O ' ' OG1' ' A' ' 71' ' ' THR . 7.3 mt-30 -153.06 153.84 33.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 3.2999999999999998 109.98 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.903 HG11 ' CH2' ' A' ' 22' ' ' TRP . 88.1 t -160.18 121.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 2.2599999999999998 109.369 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 p -152.01 171.73 17.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.011 . . . . 2.7599999999999998 109.702 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.817 ' N ' HD23 ' A' ' 148' ' ' LEU . 1.9 pt? -157.94 -162.44 1.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 4.5700000000000003 109.508 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.34 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 3.0699999999999998 109.443 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.668 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.5 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 2.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' N ' ' HG1' ' A' ' 149' ' ' THR . 1.4 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.474 -0.565 . . . . 2.8300000000000001 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.651 ' OE1' ' N ' ' A' ' 9' ' ' LEU . 3.8 tp10 -49.93 106.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 4.75 109.485 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.651 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 3.9 mt -85.7 28.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.91 . . . . 4.9500000000000002 109.445 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.749 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.0 tm? -157.19 89.09 2.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 2.8599999999999999 108.889 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -53.72 43.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.186 2.591 . . . . 3.8300000000000001 113.321 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.675 ' N ' ' O ' ' A' ' 10' ' ' LEU . 11.7 t60 -158.39 102.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.892 -1.13 . . . . 2.52 109.53 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.443 ' CB ' ' O ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -147.04 43.91 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 1.97 109.469 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 16' ' ' ALA . 68.8 m -155.77 81.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.96 109.947 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.41 36.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 1.76 108.988 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -78.46 -30.43 47.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.599 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 1.9 mt-10 -110.38 -73.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 2.1299999999999999 109.501 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.8 m -109.24 145.25 36.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 2.2599999999999998 109.504 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 37' ' ' MET . 4.4 mt -51.39 -48.22 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 2.6000000000000001 109.522 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 97.74 -172.87 27.65 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.502 -1.439 . . . . 1.6200000000000001 109.502 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.0 Cg_endo -69.86 -20.68 34.07 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.739 2.293 . . . . 1.7 112.189 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.575 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 8.6 m95 -53.55 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.993 . . . . 2.4199999999999999 109.286 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -141.51 167.53 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 1.6399999999999999 109.782 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.908 HD22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -174.58 167.59 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 2.0499999999999998 109.4 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.737 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.74 -176.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 1.72 109.649 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 94.34 -28.85 9.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 1.7 109.842 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.814 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.85 -142.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 0.96999999999999997 109.306 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.814 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.6 p -91.02 -163.8 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 1.8 109.254 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.25 111.58 47.83 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 2.3999999999999999 109.022 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HB3' ' CG ' ' A' ' 37' ' ' MET . 56.3 Cg_exo -45.71 159.76 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.268 1.979 . . . . 1.1299999999999999 112.022 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -143.52 109.24 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 1.05 109.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -69.82 72.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 1.8200000000000001 109.456 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -65.31 -138.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.1699999999999999 109.644 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.67 81.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.82 . . . . 2.21 109.526 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 47.5 30.68 6.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.639 -1.384 . . . . 1.1899999999999999 109.639 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.45 142.81 30.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -1.144 . . . . 2.9100000000000001 109.564 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 19' ' ' LEU . 5.3 ttp -109.87 125.24 52.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.93000000000000005 109.163 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 56.8 m -124.6 154.79 40.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.917 . . . . 1.0600000000000001 110.084 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.96 139.4 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.525 -0.734 . . . . 1.3700000000000001 109.025 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.719 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -91.12 122.21 33.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 4.79 109.649 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.761 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 9.0 mp -113.29 92.98 24.29 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 3.54 109.344 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 51.1 Cg_exo -50.03 -57.02 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.031 2.487 . . . . 3.7400000000000002 112.625 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 138' ' ' ALA . . . 117.99 146.53 8.17 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.783 -1.327 . . . . 2.0299999999999998 109.783 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 33.34 0.73 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.863 -1.295 . . . . 2.4100000000000001 109.863 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.501 ' NE2' ' HE2' ' A' ' 135' ' ' LYS . 30.9 mt-30 -118.26 150.48 39.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.113 -1.228 . . . . 2.96 109.648 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.13 56.83 0.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.383 -1.487 . . . . 2.0800000000000001 109.383 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.661 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -174.48 98.49 0.29 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.199 -1.177 . . . . 3.6099999999999999 109.393 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD2' ' CZ3' ' A' ' 49' ' ' TRP . 77.6 Cg_exo -46.27 -21.62 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.613 2.209 . . . . 2.3599999999999999 112.431 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 39.2 p90 -106.9 65.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 3.8700000000000001 109.494 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.661 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 1.2 m-20 -134.99 6.57 3.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 2.3799999999999999 109.695 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -177.06 154.75 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 1.1100000000000001 109.721 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.43 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 144.11 -169.33 26.29 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.879 -1.288 . . . . 0.93999999999999995 109.879 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.975 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -97.34 152.18 19.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -1.074 . . . . 0.95999999999999996 109.134 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.901 HG13 ' HB2' ' A' ' 130' ' ' ALA . 2.0 t -144.53 162.87 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.92000000000000004 110.083 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.69 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 18.7 t80 175.58 149.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 1.71 109.4 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.69 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 1.4 m-80 -101.37 176.8 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 2.7799999999999998 109.527 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 95.6 76.99 1.34 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 2.48 109.563 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 57' ' ' GLY . 0.7 OUTLIER -156.8 70.3 4.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 3.79 109.498 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.674 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.48 131.67 28.28 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.801 2.334 . . . . 2.3999999999999999 112.191 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.07 114.24 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 3.0800000000000001 109.521 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.18 103.55 1.11 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.521 -1.432 . . . . 3.0499999999999998 109.521 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HB2' ' N ' ' A' ' 117' ' ' LEU . 3.4 tm-20 -47.34 139.05 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.138 . . . . 6.0499999999999998 109.529 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.11 -37.18 3.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.688 -1.365 . . . . 2.54 109.688 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' SER . 2.7 mt-10 -99.99 168.88 9.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -1.18 . . . . 4.0300000000000002 109.574 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.6 m -115.0 139.93 49.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 2.9100000000000001 109.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.674 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 22.9 m-85 -104.61 -178.32 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.115 -0.99 . . . . 2.3799999999999999 109.549 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -153.76 121.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 2.6099999999999999 109.639 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 148' ' ' LEU . 1.4 tp -111.52 115.96 30.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 3.6099999999999999 109.23 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -109.88 86.46 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.067 -1.02 . . . . 2.27 109.198 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 6.9 p90 -94.9 139.29 31.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.442 -0.786 . . . . 2.0099999999999998 111.295 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 108' ' ' THR . 0.7 OUTLIER -98.35 119.6 37.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.499 -0.926 . . . . 1.8 108.499 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 141' ' ' PHE . . . -171.57 134.68 0.85 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.077 -1.015 . . . . 0.95999999999999996 110.024 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB2' ' N ' ' A' ' 105' ' ' GLU . 53.2 p -124.26 122.38 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 109.21 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.596 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -91.67 135.95 33.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.67000000000000004 109.386 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.449 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.16 117.06 16.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.351 -0.843 . . . . 0.96999999999999997 109.49 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -66.52 -142.42 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.66 0 C-N-CA 124.305 -1.123 . . . . 1.02 112.199 -0.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.453 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.7 OUTLIER -104.85 152.18 22.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 1.75 109.38 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.453 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 1.4 mtm -176.42 156.93 1.52 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 2.1600000000000001 109.157 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.82 118.9 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.752 2.301 . . . . 1.3799999999999999 112.402 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 98' ' ' GLY . 4.7 m -99.19 176.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 2.0099999999999998 109.275 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 132' ' ' HIS . 18.7 ttm180 -122.67 146.47 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 6.0099999999999998 109.728 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.29 155.27 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.301 -0.874 . . . . 3.7599999999999998 109.45 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.11 156.95 43.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 2.29 109.608 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.556 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.0 OUTLIER -146.79 138.3 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 1.8899999999999999 109.681 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.56 -155.71 22.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.472 -1.451 . . . . 1.49 109.472 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.691 ' OE2' ' CG ' ' A' ' 119' ' ' PHE . 21.6 pm0 -88.82 -155.02 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 2.54 109.482 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.559 ' HA3' HE22 ' A' ' 128' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.3799999999999999 109.669 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.58 ' O ' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.51 -0.552 . . . . 5.7400000000000002 109.51 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.94 176.37 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 2.27 109.786 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.505 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -113.93 -22.77 9.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.897 -0.779 . . . . 3.2799999999999998 108.897 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.84 34.26 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 3.6499999999999999 109.35 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 1.3 tm-20 -79.03 82.21 5.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 4.5999999999999996 109.486 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.52 ' CG ' ' N ' ' A' ' 98' ' ' GLY . 3.9 pt20 -108.99 -160.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 3.46 109.522 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 97' ' ' GLN . . . -173.49 -41.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.534 -1.426 . . . . 3.6699999999999999 109.534 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.48 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 3.79 109.585 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 98' ' ' GLY . . . -122.02 96.3 46.8 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 1.96 109.417 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.42 130.7 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.815 2.344 . . . . 2.9700000000000002 112.754 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -132.65 140.32 48.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 3.0600000000000001 109.297 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.66 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -93.93 -160.98 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 2.3399999999999999 109.514 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.66 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -107.66 33.08 6.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 2.1699999999999999 109.637 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.474 ' N ' ' HB2' ' A' ' 73' ' ' SER . 0.4 OUTLIER -119.12 142.07 31.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -1.166 . . . . 3.02 109.351 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.682 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 55.3 Cg_endo -73.52 136.55 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.584 2.189 . . . . 1.4199999999999999 112.217 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 165.48 160.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 1.3700000000000001 109.662 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -83.56 131.03 35.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 1.72 110.062 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 69' ' ' SER . 3.2 mmt180 -93.51 146.42 23.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.648 -1.612 . . . . 4.7000000000000002 106.648 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.02 105.83 16.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.936 -1.103 . . . . 3.2799999999999998 110.192 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.48 76.2 0.99 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.683 -0.858 . . . . 2.96 108.683 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.851 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -99.97 164.89 11.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 3.4100000000000001 109.712 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 4.2 p90 -164.96 -174.21 3.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 2.77 109.607 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.41 HG22 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -109.28 112.22 24.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -0.811 . . . . 2.23 109.57 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 64' ' ' GLU . 6.8 t -47.27 125.11 7.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 4.1100000000000003 109.395 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.792 ' O ' HD22 ' A' ' 117' ' ' LEU . 7.8 t-20 -124.2 1.03 8.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 6.8600000000000003 109.422 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -145.98 120.41 9.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 5.1200000000000001 109.444 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.648 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -67.93 140.16 56.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 4.0599999999999996 109.58 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.691 ' CG ' ' OE2' ' A' ' 86' ' ' GLU . 18.4 m-85 -170.01 76.67 0.64 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 5.4400000000000004 109.524 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.12 169.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.86 2.373 . . . . 4.04 111.944 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 125' ' ' ALA . 66.2 Cg_endo -80.46 -16.14 10.81 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.801 2.334 . . . . 3.8999999999999999 112.082 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 123' ' ' GLY . 17.4 p-10 -109.95 -46.43 3.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 4.1399999999999997 109.516 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -39.42 -45.02 2.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.489 -1.444 . . . . 3.5699999999999998 109.489 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.19 -73.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 3.5899999999999999 109.473 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -139.82 162.19 52.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 2.0800000000000001 109.4 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 125' ' ' ALA . 6.6 Cg_endo -52.68 -5.37 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.028 2.485 . . . . 1.3899999999999999 112.202 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 120.82 161.19 11.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.51 -1.436 . . . . 1.1899999999999999 109.51 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 2.0 tt0 -149.15 105.82 3.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -1.148 . . . . 2.0099999999999998 109.718 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 84' ' ' VAL . 1.7 p -139.09 118.39 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.648 -0.871 . . . . 1.28 108.648 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.901 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -142.23 139.34 31.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 0.97999999999999998 110.583 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -94.73 109.31 21.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.711 -0.848 . . . . 1.73 108.711 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.644 ' O ' ' N ' ' A' ' 81' ' ' ARG . 6.3 m170 -99.74 119.8 38.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 2.3199999999999998 109.733 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.883 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -112.3 -3.56 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 2.1099999999999999 109.126 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 46.13 -179.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.377 -1.489 . . . . 1.77 109.377 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.501 ' HE2' ' NE2' ' A' ' 45' ' ' GLN . 3.3 mtmt -125.41 24.28 7.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.282 . . . . 5.0599999999999996 109.592 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.2 -21.69 63.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.714 -1.217 . . . . 2.6400000000000001 107.714 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.698 ' O ' ' CD2' ' A' ' 139' ' ' TYR . . . -130.1 54.91 0.78 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.655 -2.178 . . . . 2.5099999999999998 107.655 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.761 ' HB1' ' O ' ' A' ' 41' ' ' LEU . . . -29.62 154.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.807 0.813 . . . . 2.3199999999999998 110.825 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 174.5 -163.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 1.6100000000000001 109.132 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.43 120.28 39.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 1.6499999999999999 109.728 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 72' ' ' ALA . 6.4 t80 -102.15 106.87 17.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.867 . . . . 1.6799999999999999 108.796 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.37 101.18 10.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.73999999999999999 110.566 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 140.71 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 1.22 108.878 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.717 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 53.0 p -133.43 -7.51 2.91 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 109.516 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.717 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -146.62 161.46 40.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 3.2999999999999998 109.663 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 146' ' ' VAL . 8.4 p -176.23 109.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.2599999999999998 109.758 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 p -153.54 162.77 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 2.7599999999999998 109.47 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.701 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.5 pp -143.43 171.97 13.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 4.5700000000000003 109.42 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -165.85 -168.19 1.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 3.0699999999999998 109.482 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.581 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.3 t . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.203 -0.935 . . . . 2.0 109.486 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.272 -0.64 . . . . 2.8300000000000001 109.272 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.576 ' C ' ' O ' ' A' ' 7' ' ' VAL . 5.6 tt0 24.23 65.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.025 0.44 . . . . 4.75 110.659 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' ' 148' ' ' LEU . 12.3 mt -56.02 -49.12 74.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 4.9500000000000002 108.859 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 55' ' ' TYR . 1.2 tp -101.34 116.05 64.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.003 . . . . 2.8599999999999999 108.293 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.58 27.84 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.215 1.943 . . . . 3.8300000000000001 111.946 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.551 ' O ' HD23 ' A' ' 10' ' ' LEU . 9.1 t-80 -137.02 139.15 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 2.52 109.502 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.576 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.07 54.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 1.97 109.338 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -164.41 73.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.96 109.572 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -62.97 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.76 108.897 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -74.05 -46.96 40.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 1.1799999999999999 109.925 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.674 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.9 mt-10 -109.78 -84.02 0.56 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 2.1299999999999999 109.542 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.8 m -94.41 142.98 26.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 2.2599999999999998 109.465 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.692 ' HB2' HD21 ' A' ' 24' ' ' LEU . 2.1 pp -57.62 -12.56 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 2.6000000000000001 109.558 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.571 ' O ' HD12 ' A' ' 19' ' ' LEU . . . 82.1 -147.05 25.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.36 -1.496 . . . . 1.6200000000000001 109.36 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.31 -11.78 13.1 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.671 2.247 . . . . 1.7 112.143 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.591 ' CH2' HG11 ' A' ' 146' ' ' VAL . 10.6 m95 -66.51 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 2.4199999999999999 109.284 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.726 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 m -156.44 126.84 6.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 1.6399999999999999 109.559 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.841 ' N ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -121.08 133.17 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.958 . . . . 2.0499999999999998 109.554 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.681 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.97 153.35 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 1.72 109.597 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 109.69 -22.92 23.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.951 -1.259 . . . . 1.7 109.951 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.823 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.91 -142.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.998 -1.295 . . . . 0.96999999999999997 109.373 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.823 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.3 p -90.96 141.54 28.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 1.8 109.41 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -37.38 101.59 0.22 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.966 . . . . 2.3999999999999999 109.236 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HG2' HD12 ' A' ' 24' ' ' LEU . 59.9 Cg_exo -46.27 160.94 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.404 2.069 . . . . 1.1299999999999999 111.879 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.828 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.7 p -138.35 97.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 1.05 110.318 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.32 84.41 3.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.454 -0.779 . . . . 1.8200000000000001 109.096 178.921 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.15 -140.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 1.1699999999999999 109.925 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 2.21 109.563 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . -141.73 47.25 0.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.727 -1.349 . . . . 1.1899999999999999 109.727 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.716 ' NH2' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -168.43 148.88 4.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 2.9100000000000001 109.752 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.736 ' CE ' HD13 ' A' ' 24' ' ' LEU . 58.2 ttp -123.43 129.24 50.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.419 -0.8 . . . . 0.93000000000000005 109.224 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.716 ' SG ' ' NH2' ' A' ' 36' ' ' ARG . 59.3 m -122.65 146.55 47.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.607 -0.837 . . . . 1.0600000000000001 110.072 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HD13 ' A' ' 41' ' ' LEU . 3.0 m -122.69 160.25 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.62 -0.881 . . . . 1.3700000000000001 108.62 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.772 ' C ' HD12 ' A' ' 41' ' ' LEU . 2.9 m-20 -105.9 99.69 9.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 4.79 110.119 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.772 HD12 ' C ' ' A' ' 40' ' ' ASP . 7.2 mp -113.73 79.76 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 3.54 109.137 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.18 -158.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.872 2.381 . . . . 3.7400000000000002 112.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 136' ' ' ALA . . . -96.09 123.85 7.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.444 -1.462 . . . . 2.0299999999999998 109.444 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.0 -14.83 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 2.4100000000000001 109.535 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 27.4 mt-30 -99.79 70.11 1.62 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -1.184 . . . . 2.96 109.435 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.83 49.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.548 -1.421 . . . . 2.0800000000000001 109.548 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -164.65 87.14 1.08 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.223 -1.163 . . . . 3.6099999999999999 109.494 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 51.3 Cg_exo -48.73 -6.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.826 2.351 . . . . 2.3599999999999999 112.173 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.479 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.3 p90 -100.25 37.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 3.8700000000000001 109.485 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 46.3 m-20 -146.1 32.79 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 2.3799999999999999 109.434 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 172.97 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 1.1100000000000001 109.403 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.6 173.7 41.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.783 -1.327 . . . . 0.93999999999999995 109.783 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 5.2 mp -99.67 175.94 5.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 0.95999999999999996 109.245 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 0.6 OUTLIER -152.95 167.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.92000000000000004 110.51 -179.61 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.687 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 5.4 t80 -177.65 132.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 1.71 109.162 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.687 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 3.6 m-20 -107.59 159.79 16.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.946 . . . . 2.7799999999999998 109.66 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.01 77.52 1.03 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.447 . . . . 2.48 109.484 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 58' ' ' VAL . 55.2 t -149.85 60.91 4.71 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.142 . . . . 3.79 109.556 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 50.5 Cg_exo -48.57 142.59 17.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.775 2.316 . . . . 2.3999999999999999 112.102 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 3.0 t -134.45 153.97 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 3.0800000000000001 109.629 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -136.04 112.34 0.96 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.461 -1.455 . . . . 3.0499999999999998 109.461 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.2 tm-20 -39.06 135.11 0.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.144 . . . . 6.0499999999999998 109.668 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 97.22 -14.36 63.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.885 -1.286 . . . . 2.54 109.885 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' HB2' ' A' ' 115' ' ' SER . 2.2 mm-40 -100.79 157.45 16.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 4.0300000000000002 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -118.96 121.37 39.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 2.9100000000000001 109.176 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 51.7 m-85 -98.19 178.54 5.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.203 -0.935 . . . . 2.3799999999999999 109.743 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -163.61 133.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 2.6099999999999999 109.41 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -118.18 122.03 42.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 3.6099999999999999 109.736 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.4 p -112.2 100.25 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.88 -0.785 . . . . 2.27 108.88 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 2.2 p90 -93.96 146.31 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 2.0099999999999998 110.95 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -99.63 107.01 19.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.124 -1.065 . . . . 1.8 108.124 178.534 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -157.52 156.26 31.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.697 -1.252 . . . . 0.95999999999999996 110.862 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' GLU . 97.0 p -132.27 121.48 23.66 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.856 -0.794 . . . . 0.93000000000000005 108.856 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -81.53 129.91 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.817 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.463 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -130.81 116.92 17.17 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.382 -0.824 . . . . 0.96999999999999997 109.287 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.591 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.35 -144.77 0.18 OUTLIER 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.104 -1.207 . . . . 1.02 111.998 0.042 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' ' CG ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.03 154.62 19.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.698 -1.251 . . . . 1.75 109.39 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.657 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 157.17 154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.385 -0.822 . . . . 2.1600000000000001 109.264 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.552 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 68.0 Cg_endo -77.55 141.96 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.821 2.347 . . . . 1.3799999999999999 112.356 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 98' ' ' GLY . 35.1 m -108.4 170.3 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 2.0099999999999998 109.362 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 132' ' ' HIS . 0.1 OUTLIER -109.85 156.18 20.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 6.0099999999999998 109.437 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 83' ' ' LEU . 2.7 p -156.94 159.31 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 3.7599999999999998 109.51 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.693 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -154.66 143.67 21.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 2.29 109.702 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.692 ' CG1' HG22 ' A' ' 129' ' ' VAL . 0.4 OUTLIER -153.79 161.18 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 1.8899999999999999 109.467 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 133.77 -164.56 24.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 1.49 109.548 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.687 ' OE2' ' CZ ' ' A' ' 119' ' ' PHE . 12.7 pm0 -84.08 35.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 2.54 109.428 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' O ' ' OE1' ' A' ' 128' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.636 -1.386 . . . . 1.3799999999999999 109.636 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.68 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.294 0.568 . . . . 5.7400000000000002 109.789 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.622 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -144.05 -172.34 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 2.27 109.984 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -125.28 -23.39 4.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.89 -0.781 . . . . 3.2799999999999998 108.89 179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.47 42.52 1.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 3.6499999999999999 109.254 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.528 ' CD ' ' O ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.87 49.4 1.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.988 -1.07 . . . . 4.5999999999999996 109.482 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -112.52 153.87 26.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 3.46 109.234 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -140.21 4.33 2.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 3.6699999999999999 109.576 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -77.28 62.31 2.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.79 109.451 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.47 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -104.7 106.71 55.9 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 1.96 109.324 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.726 ' O ' HD22 ' A' ' 102' ' ' LEU . 60.6 Cg_endo -78.63 123.44 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.576 2.184 . . . . 2.9700000000000002 112.676 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 101' ' ' PRO . 4.3 mm? -124.32 173.24 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 3.0600000000000001 109.358 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -138.11 -174.11 3.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 2.3399999999999999 109.788 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -86.78 42.39 3.15 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.626 -1.389 . . . . 2.1699999999999999 109.626 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.9 mt-10 -162.24 160.95 21.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 3.02 109.114 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.5 115.58 2.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.641 2.227 . . . . 1.4199999999999999 111.715 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.39 124.65 9.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 1.3700000000000001 109.754 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.49 150.28 21.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.809 . . . . 1.72 109.994 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -131.4 143.08 50.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.706 -1.22 . . . . 4.7000000000000002 107.706 178.246 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.671 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 5.3 mt-10 -127.32 128.26 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.374 -0.93 . . . . 3.2799999999999998 110.814 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' CB ' ' A' ' 100' ' ' ALA . 6.9 m-85 -124.56 119.08 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.655 -0.869 . . . . 2.96 108.655 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.625 ' HB2' HG23 ' A' ' 67' ' ' VAL . . . -106.34 146.85 29.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 3.4100000000000001 110.007 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.728 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -130.92 164.68 24.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 2.77 109.267 179.681 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.4 122.4 43.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 2.23 109.819 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.495 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 6.1 m -59.77 129.83 43.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 4.1100000000000003 109.393 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -114.99 -19.81 10.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 6.8600000000000003 109.551 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.892 ' H ' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -142.44 -153.1 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 5.1200000000000001 109.276 179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.56 148.4 47.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.246 -0.909 . . . . 4.0599999999999996 109.687 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.818 ' CE2' HD13 ' A' ' 117' ' ' LEU . 44.4 m-85 -147.47 91.46 5.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 5.4400000000000004 109.302 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.84 165.74 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.815 2.343 . . . . 4.04 112.227 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 -15.5 12.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.697 2.265 . . . . 3.8999999999999999 112.02 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.83 132.42 54.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -0.873 . . . . 4.1399999999999997 109.549 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.28 -148.05 19.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 3.5699999999999998 109.525 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.5 30.0 7.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 3.5899999999999999 109.441 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.85 70.0 0.21 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 2.0800000000000001 109.437 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.55 -158.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.842 2.361 . . . . 1.3899999999999999 112.185 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.38 149.91 50.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.528 -1.429 . . . . 1.1899999999999999 109.528 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.566 ' OE1' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -148.09 128.02 13.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 2.0099999999999998 109.536 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.692 HG22 ' CG1' ' A' ' 84' ' ' VAL . 32.8 t -138.75 137.45 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.465 -0.939 . . . . 1.28 108.465 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -155.24 109.74 2.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.186 -1.006 . . . . 0.97999999999999998 110.262 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -80.6 103.53 10.52 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.847 -0.797 . . . . 1.73 108.847 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.693 ' ND1' HD21 ' A' ' 83' ' ' LEU . 7.0 m170 -99.58 128.77 45.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.935 . . . . 2.3199999999999998 109.713 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.69 -32.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 2.1099999999999999 109.449 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.554 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -39.6 131.96 2.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.566 -1.414 . . . . 1.77 109.566 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.858 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 47.2 mttt -165.6 140.4 4.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 5.0599999999999996 109.594 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.82 -20.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 2.6400000000000001 108.565 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.51 12.93 7.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.112 -1.595 . . . . 2.5099999999999998 109.112 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.858 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -50.42 -164.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -1.039 . . . . 2.3199999999999998 109.898 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.556 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 1.1 p90 -166.61 -161.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 1.6100000000000001 109.385 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -81.67 151.31 27.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 1.6499999999999999 109.733 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 12.8 t80 -137.19 113.36 9.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.893 . . . . 1.6799999999999999 109.319 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.7 m -106.14 96.53 6.54 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.128 -0.983 . . . . 0.73999999999999999 110.154 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.509 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.05 139.05 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 1.22 108.954 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.725 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 78.3 p -132.81 -14.03 2.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.563 -0.711 . . . . 1.3300000000000001 109.715 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.725 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -147.9 164.59 33.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 3.2999999999999998 110.146 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.591 HG11 ' CH2' ' A' ' 22' ' ' TRP . 8.7 p -178.51 126.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.935 -0.765 . . . . 2.2599999999999998 108.935 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.48 147.73 40.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.068 -1.02 . . . . 2.7599999999999998 110.076 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 9' ' ' LEU . 32.2 tp -116.72 135.6 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 4.5700000000000003 109.231 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -150.68 -177.25 5.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.025 . . . . 3.0699999999999998 109.725 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.564 ' N ' ' OG1' ' A' ' 149' ' ' THR . 2.7 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 2.0 109.576 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.816 ' N ' ' HG1' ' A' ' 149' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.364 0.602 . . . . 1.73 109.39 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.7 79.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.858 . . . . 2.7400000000000002 109.715 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.81 -14.27 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.898 . . . . 1.72 109.19 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -126.38 85.88 59.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 1.96 108.874 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.91 37.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.154 2.57 . . . . 1.8700000000000001 112.391 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.712 ' H ' HD13 ' A' ' 10' ' ' LEU . 57.2 t60 -145.53 101.1 3.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 1.26 109.315 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 13' ' ' THR . 7.7 t -142.37 52.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.267 -0.895 . . . . 1.0900000000000001 109.453 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -139.38 68.11 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 1.8799999999999999 109.609 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -67.1 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 1.3200000000000001 109.127 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.25 -36.07 14.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 1.0800000000000001 110.196 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 3.0 mm-40 -109.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 2.9700000000000002 110.137 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -99.38 151.29 21.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.6499999999999999 109.87 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.817 ' CD2' HD21 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -59.37 -60.02 4.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.845 . . . . 1.95 109.304 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.503 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.37 -164.32 12.32 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.67000000000000004 109.523 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.55 -2.71 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.834 2.356 . . . . 0.70999999999999996 112.276 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.557 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 11.8 m95 -75.13 -177.09 3.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.89 . . . . 0.56999999999999995 109.321 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -140.07 175.84 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.83999999999999997 109.295 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.817 HD21 ' CD2' ' A' ' 19' ' ' LEU . 1.8 pp -179.29 164.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 1.9099999999999999 109.938 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.675 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 162.71 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 2.6499999999999999 109.718 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.61 -21.97 9.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.038 -1.225 . . . . 0.57999999999999996 110.038 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.879 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.69 -142.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.287 . . . . 0.56999999999999995 109.49 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.2 p -91.78 -175.87 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.92000000000000004 108.984 179.389 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -81.02 111.65 25.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 2.5899999999999999 108.815 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 28' ' ' SER . 54.1 Cg_exo -49.26 155.02 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.317 2.011 . . . . 0.88 111.855 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' MET . 44.9 t -142.41 106.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 1.1599999999999999 109.986 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.68 82.92 3.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 1.3700000000000001 109.128 179.127 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.569 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.72999999999999998 109.938 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' ALA . 2.6 m-20 -41.47 -65.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 2.4900000000000002 109.448 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -147.88 26.34 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.299 -1.52 . . . . 0.81999999999999995 109.299 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -141.03 145.02 35.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -1.122 . . . . 3.4700000000000002 109.641 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 30' ' ' PRO . 45.4 ttp -112.85 127.35 56.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 1.4399999999999999 109.128 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.606 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -121.3 156.82 31.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 1.22 110.346 -179.358 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 HD23 ' A' ' 41' ' ' LEU . 2.2 m -125.61 142.23 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.685 -0.857 . . . . 0.53000000000000003 108.685 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.784 ' C ' HD22 ' A' ' 41' ' ' LEU . 5.7 m-20 -77.26 111.98 13.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 1.52 109.817 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.6 mm? -122.87 68.56 34.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 1.4299999999999999 109.408 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.99 -92.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.835 2.357 . . . . 1.9299999999999999 112.308 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.07 36.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.53 -1.428 . . . . 2.02 109.53 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.86 -9.02 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 1.7 109.482 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.684 HE22 ' HB2' ' A' ' 51' ' ' ALA . 16.3 mt-30 -99.87 119.03 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 2.0800000000000001 109.522 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.52 46.94 1.18 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.513 -1.435 . . . . 2.0299999999999998 109.513 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.583 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -171.25 102.95 0.39 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.174 -1.192 . . . . 2.29 109.67 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -47.32 -26.11 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.322 . . . . 1.5800000000000001 112.363 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.646 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 27.0 p90 -93.98 44.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 3.3399999999999999 109.665 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.583 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 1.9 m-20 -131.35 11.88 4.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 1.97 109.343 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.684 ' HB2' HE22 ' A' ' 45' ' ' GLN . . . -174.3 140.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 0.91000000000000003 109.269 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 146.57 -174.36 26.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.678 -1.369 . . . . 0.59999999999999998 109.678 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' C ' HG22 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -104.21 -173.57 2.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -1.197 . . . . 1.6499999999999999 109.921 -179.953 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.54 172.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.704 . . . . 1.48 109.376 -179.767 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 17.8 t80 170.48 142.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 1.4399999999999999 109.664 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.635 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 8.6 m-20 -103.27 -164.72 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.252 -0.905 . . . . 0.94999999999999996 109.469 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 58' ' ' VAL . . . 79.72 68.89 1.44 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.411 -1.476 . . . . 0.83999999999999997 109.411 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 57' ' ' GLY . 43.4 t -153.93 73.82 6.38 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.33 -1.1 . . . . 1.6299999999999999 109.544 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.25 120.85 7.66 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.553 2.169 . . . . 0.83999999999999997 112.043 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.39 130.19 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.226 -0.921 . . . . 1.1599999999999999 109.663 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -113.08 102.52 1.29 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.81999999999999995 109.362 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.567 ' O ' ' OE1' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -42.8 124.76 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 2.73 109.598 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.02 -39.18 2.14 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.77 -1.332 . . . . 0.98999999999999999 109.77 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.534 ' O ' ' OG ' ' A' ' 115' ' ' SER . 10.3 mt-10 -100.22 170.12 8.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -1.147 . . . . 2.5899999999999999 109.697 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -116.85 145.14 43.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.81999999999999995 109.269 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 33.3 m-85 -110.84 179.49 4.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.123 -0.986 . . . . 1.47 109.671 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.3 t -152.78 149.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.98999999999999999 109.316 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' ARG . 3.4 tp -134.06 116.96 16.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.85999999999999999 109.858 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 83.2 p -109.4 85.85 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.464 -0.939 . . . . 1.1499999999999999 108.464 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 49.9 p90 -92.61 137.08 32.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 1.05 111.275 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.3 p -84.24 114.41 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.193 -1.04 . . . . 0.72999999999999998 108.193 178.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 148.04 15.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.781 -1.199 . . . . 0.69999999999999996 110.671 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 131.12 39.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.689 -0.856 . . . . 0.78000000000000003 108.689 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.774 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -93.36 127.57 39.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 109.728 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.497 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -134.19 114.39 12.64 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.307 -0.871 . . . . 0.60999999999999999 109.261 179.882 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.635 ' O ' ' C ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.74 -141.98 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.895 -1.294 . . . . 0.80000000000000004 112.407 -0.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.663 ' O ' ' CG ' ' A' ' 78' ' ' MET . 1.4 m-20 -98.94 160.15 14.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 1.3999999999999999 109.634 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.663 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 156.91 155.83 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.85 . . . . 1.9299999999999999 109.268 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.62 145.3 41.5 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.884 2.389 . . . . 0.79000000000000004 112.376 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.112 HG11 HD12 ' A' ' 102' ' ' LEU . 0.7 OUTLIER -117.45 172.7 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.76000000000000001 109.222 179.939 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.483 ' N ' HG23 ' A' ' 80' ' ' VAL . 20.0 ttt180 -119.69 134.36 55.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.93 . . . . 3.0499999999999998 109.6 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.527 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -137.99 150.13 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 1.55 109.248 179.795 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -145.99 152.33 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.85999999999999999 109.832 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.756 HG13 HG22 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -154.95 154.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.923 . . . . 0.56999999999999995 109.632 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 148.33 -149.04 21.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.653 -1.379 . . . . 0.57999999999999996 109.653 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.76 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.9 pm0 -90.08 178.38 6.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 2.7400000000000002 109.715 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.544 -1.422 . . . . 1.6299999999999999 109.544 179.994 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.871 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.317 0.58 . . . . 3.4199999999999999 109.452 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -125.78 -171.37 2.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.96999999999999997 109.814 -179.815 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.665 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -118.45 -24.06 6.96 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.904 -0.776 . . . . 0.94999999999999996 108.904 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -90.49 41.36 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -0.958 . . . . 1.6299999999999999 108.719 179.915 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.46 64.75 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.971 . . . . 2.7799999999999998 109.886 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' VAL . 4.0 pt20 -109.08 153.9 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 2.2799999999999998 109.177 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.6 11.61 4.3 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.8 -1.32 . . . . 0.94999999999999996 109.8 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -105.36 77.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -1.181 . . . . 0.88 109.388 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.797 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -119.81 79.53 24.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.943 . . . . 0.58999999999999997 109.677 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -52.75 126.45 21.18 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.882 2.388 . . . . 0.73999999999999999 112.384 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.112 HD12 HG11 ' A' ' 80' ' ' VAL . 20.6 mt -133.02 137.78 46.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 1.1699999999999999 109.326 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.1 OUTLIER -109.06 -179.33 3.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 1.0800000000000001 109.477 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.473 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -84.63 40.56 2.97 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.525 -1.43 . . . . 1.3500000000000001 109.525 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.38 120.59 12.66 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -1.111 . . . . 3.4900000000000002 109.402 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.35 118.42 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.391 2.06 . . . . 0.97999999999999998 111.806 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -160.85 141.96 11.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.48 109.904 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.0 138.57 31.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.774 . . . . 0.96999999999999997 109.706 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 69' ' ' SER . 18.4 mmt180 -109.03 136.62 48.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 4.1799999999999997 108.685 178.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 10.4 mt-10 -113.95 103.36 11.08 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.181 -0.607 . . . . 2.3799999999999999 109.698 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 16.1 m-85 -109.13 120.09 41.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 1.51 108.424 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.45 156.53 25.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.306 -0.872 . . . . 0.87 109.923 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.0 p90 -144.78 178.98 7.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.456 -0.778 . . . . 1.8300000000000001 109.161 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -105.4 115.8 30.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.448 -0.782 . . . . 1.0900000000000001 109.633 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 10.7 m -48.82 123.2 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.907 . . . . 1.6200000000000001 109.418 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 114' ' ' THR . 16.0 m120 -113.97 -38.25 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 2.3900000000000001 109.571 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -112.93 143.21 44.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 2.54 109.618 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.67 103.99 11.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 1.0800000000000001 109.54 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.668 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 43.5 m-85 -112.26 95.97 33.07 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 1.9299999999999999 109.247 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.56 166.15 24.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.682 2.254 . . . . 1.21 112.274 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.54 -19.61 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.9 2.4 . . . . 1.5800000000000001 111.934 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.1 136.64 54.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 3.5 109.457 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.84 -111.87 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 2.0899999999999999 109.548 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.37 -17.56 14.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -1.128 . . . . 3.6699999999999999 109.418 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -167.38 122.31 0.84 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 2.1000000000000001 109.384 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HG2' ' ND2' ' A' ' 56' ' ' ASN . 59.0 Cg_endo -76.63 -159.74 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.542 2.162 . . . . 1.72 112.195 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -57.87 168.59 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.78000000000000003 109.493 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.21 135.08 12.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 2.1899999999999999 109.433 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.756 HG22 HG13 ' A' ' 84' ' ' VAL . 41.3 t -141.12 148.79 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.4299999999999999 108.769 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.27 105.77 0.66 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.101 -0.999 . . . . 0.46999999999999997 110.029 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 7.7 m-30 -83.56 109.99 17.86 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.33 -0.989 . . . . 1.3799999999999999 108.33 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.418 ' CE1' HD21 ' A' ' 83' ' ' LEU . 44.4 m170 -99.38 120.23 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.945 . . . . 1.1399999999999999 110.084 -179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.839 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -129.97 -7.56 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 1.1499999999999999 109.141 179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -57.69 126.03 41.02 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.401 -1.48 . . . . 1.27 109.401 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.708 ' O ' ' N ' ' A' ' 138' ' ' ALA . 11.0 mtpt -161.55 128.23 3.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -1.187 . . . . 4.7400000000000002 109.987 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.08 -18.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.94 -1.133 . . . . 1.5900000000000001 107.94 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.703 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -118.27 10.14 13.29 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.837 -1.705 . . . . 1.6100000000000001 108.837 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.708 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.76 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.61 -0.936 . . . . 1.6899999999999999 109.858 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.828 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -168.74 -114.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.012 . . . . 2.0 110.038 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.4 mt-10 -130.8 138.48 49.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 2.2999999999999998 109.235 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 12.2 t80 -117.35 116.62 27.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 1.47 109.595 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.01 98.38 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.44 110.043 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -114.06 141.67 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.81999999999999995 109.256 179.548 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 86.5 p -130.74 -10.68 3.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.682 -0.636 . . . . 0.64000000000000001 109.346 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.644 ' N ' ' OG1' ' A' ' 71' ' ' THR . 18.2 mt-30 -148.37 177.41 9.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 1.9399999999999999 110.359 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.606 ' O ' ' CG1' ' A' ' 146' ' ' VAL . 1.1 p -179.17 117.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 1.1499999999999999 108.821 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.57 ' OG ' ' OG ' ' A' ' 69' ' ' SER . 60.1 p -124.6 151.17 45.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.013 -1.054 . . . . 1.6100000000000001 110.123 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.957 HD12 ' N ' ' A' ' 149' ' ' THR . 0.2 OUTLIER -135.67 122.39 21.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.458 -0.776 . . . . 1.3 108.968 179.728 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.957 ' N ' HD12 ' A' ' 148' ' ' LEU . 1.2 t -148.21 -159.97 1.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.053 -1.03 . . . . 1.21 109.666 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.624 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.2 t . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 1.77 109.33 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 5.4699999999999998 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 4.5300000000000002 109.514 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.508 ' O ' ' C ' ' A' ' 4' ' ' ASP . 3.5 mm? -75.55 174.1 10.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 5.1399999999999997 109.501 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.522 ' O ' ' OG ' ' A' ' 5' ' ' SER . 49.2 t0 -35.99 115.64 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 5.3799999999999999 109.45 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 6' ' ' GLU . 24.8 p 59.09 101.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 4.8300000000000001 109.504 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -40.71 168.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 3.4300000000000002 109.432 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 7' ' ' VAL . 42.2 t -106.87 54.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 2.8300000000000001 109.458 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 7' ' ' VAL . 19.5 tp10 -35.85 119.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 4.75 109.344 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' A' ' 148' ' ' LEU . 12.3 mt -88.19 -31.96 18.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 4.9500000000000002 109.801 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 57' ' ' GLY . 1.0 OUTLIER -113.47 129.92 24.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 2.8599999999999999 108.968 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -67.33 59.36 0.69 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.424 2.083 . . . . 3.8300000000000001 113.343 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.496 ' C ' HG22 ' A' ' 13' ' ' THR . 36.2 t60 -165.38 126.65 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.007 . . . . 2.52 109.752 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -170.37 70.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 1.97 109.318 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.5 t -161.33 82.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 1.96 109.8 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.2 m-30 -90.12 24.84 2.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 1.76 109.243 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.23 17.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 1.1799999999999999 109.815 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.677 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 19.6 mm-40 -109.67 -49.5 3.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.184 -0.947 . . . . 2.1299999999999999 109.588 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.8 p -136.39 152.03 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 2.2599999999999998 109.377 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.983 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -85.07 26.97 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 2.6000000000000001 109.191 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 44.41 -151.64 0.64 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.572 -1.411 . . . . 1.6200000000000001 109.572 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 67.4 Cg_endo -81.0 9.45 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.748 2.299 . . . . 1.7 112.555 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.789 ' NE1' ' CD2' ' A' ' 55' ' ' TYR . 10.6 m95 -70.94 172.15 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.006 . . . . 2.4199999999999999 109.275 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.92 177.64 4.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.6399999999999999 109.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.968 ' O ' HD12 ' A' ' 24' ' ' LEU . 4.2 pp -178.46 123.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 2.0499999999999998 109.349 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.2 169.12 2.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 1.72 110.305 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 -26.54 22.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.098 -1.201 . . . . 1.7 110.098 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.799 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.9 -142.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.276 . . . . 0.96999999999999997 109.394 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.799 ' N ' ' OG1' ' A' ' 27' ' ' THR . 67.0 p -91.14 132.56 35.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.251 -0.906 . . . . 1.8 109.236 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -36.83 101.75 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 2.3999999999999999 109.234 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.708 ' HG2' HD13 ' A' ' 24' ' ' LEU . 50.3 Cg_exo -48.16 159.06 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.303 2.002 . . . . 1.1299999999999999 111.551 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' MET . 3.5 t -148.11 114.35 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.937 -1.102 . . . . 1.05 110.659 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.677 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -74.05 79.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.049 -0.722 . . . . 1.8200000000000001 109.049 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.26 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.519 -0.738 . . . . 1.1699999999999999 109.872 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 33' ' ' ALA . 69.0 m-20 -35.65 -70.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 2.21 109.441 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.88 33.12 1.28 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.626 -1.39 . . . . 1.1899999999999999 109.626 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -153.35 150.6 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 2.9100000000000001 109.664 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.527 ' SD ' ' CB ' ' A' ' 30' ' ' PRO . 33.7 ttp -109.05 132.23 54.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.93000000000000005 109.769 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 58.4 m -124.02 156.25 36.82 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.675 -0.81 . . . . 1.0600000000000001 110.211 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.9 m -131.47 129.58 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.684 -0.858 . . . . 1.3700000000000001 108.684 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' H ' ' HG ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -73.65 109.39 7.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 4.79 109.622 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.2 mm? -118.19 35.01 0.21 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.155 -0.965 . . . . 3.54 110.897 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 98.6 Cg_endo -81.87 -24.02 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.521 2.148 . . . . 3.7400000000000002 111.738 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 42' ' ' PRO . . . -26.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.076 -0.81 . . . . 2.0299999999999998 111.076 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.36 54.61 0.01 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.42 -1.872 . . . . 2.4100000000000001 108.42 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 136' ' ' ALA . 20.7 mt-30 -99.7 111.92 24.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 2.96 109.97 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.531 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -81.74 55.26 4.88 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.46 -1.456 . . . . 2.0800000000000001 109.46 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -166.87 96.34 0.69 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 3.6099999999999999 109.427 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 50' ' ' ASP . 56.1 Cg_exo -47.77 -40.46 31.6 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 2.3599999999999999 112.494 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 19.3 p90 -62.95 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 3.8700000000000001 109.413 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -133.16 -57.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 2.3799999999999999 109.659 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.702 ' HB1' HG22 ' A' ' 27' ' ' THR . . . -122.1 146.36 47.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 1.1100000000000001 109.728 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.612 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 163.35 175.72 34.61 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.615 -1.278 . . . . 0.93999999999999995 110.359 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 53' ' ' LEU . 2.1 mm? -100.36 167.91 10.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.617 -0.931 . . . . 0.95999999999999996 108.736 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -154.47 155.4 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.92000000000000004 109.875 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.789 ' CD2' ' NE1' ' A' ' 22' ' ' TRP . 30.1 t80 -177.75 148.91 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 1.71 109.436 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.502 ' ND2' ' HG2' ' A' ' 126' ' ' PRO . 8.4 m-20 -101.64 168.14 9.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 2.7799999999999998 109.568 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.732 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 101.47 81.72 1.6 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 2.48 109.604 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.755 ' CG2' ' H ' ' A' ' 128' ' ' GLN . 5.9 m -163.21 59.76 0.87 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 3.79 109.39 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 56.9 Cg_exo -47.0 149.85 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.881 2.388 . . . . 2.3999999999999999 112.274 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 1.6 t -144.62 121.74 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 3.0800000000000001 109.522 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -96.81 94.89 1.67 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.493 -1.443 . . . . 3.0499999999999998 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.534 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 13.6 tt0 -38.46 117.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 6.0499999999999998 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 128.2 -35.82 2.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.664 -1.374 . . . . 2.54 109.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.91 172.33 7.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.234 -1.156 . . . . 4.0300000000000002 109.5 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -113.78 137.5 51.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 2.9100000000000001 109.482 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.486 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 37.1 m-85 -105.72 -178.78 3.75 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.21 -0.932 . . . . 2.3799999999999999 109.463 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -150.91 140.38 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 2.6099999999999999 109.917 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.587 HD12 ' HB3' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -116.73 120.41 38.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 3.6099999999999999 109.01 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.68 89.89 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 2.27 109.44 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.682 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.4 137.01 33.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 2.0099999999999998 110.675 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.555 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.06 105.63 17.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 1.8 109.058 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.553 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -175.28 169.82 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.828 -1.17 . . . . 0.95999999999999996 110.677 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.43 159.82 41.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.042 -0.725 . . . . 0.93000000000000005 109.042 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.834 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -102.91 137.56 40.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.67000000000000004 109.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.52 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.44 112.54 6.57 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.258 -0.901 . . . . 0.96999999999999997 109.639 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.3 Cg_exo -63.87 -141.72 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.633 0 C-N-CA 124.218 -1.159 . . . . 1.02 112.439 -0.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -104.94 151.03 24.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 1.75 110.023 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' O ' ' A' ' 137' ' ' GLY . 1.7 mtm 166.25 163.5 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.817 -0.809 . . . . 2.1600000000000001 108.817 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -83.95 153.9 13.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.744 2.296 . . . . 1.3799999999999999 112.591 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.633 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 17.5 m -128.5 -166.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 2.0099999999999998 109.253 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 132' ' ' HIS . 57.0 ttt180 -136.65 141.61 43.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.067 -1.02 . . . . 6.0099999999999998 109.836 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' OE1' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.97 149.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 3.7599999999999998 109.259 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.594 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -142.79 149.22 38.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 2.29 109.876 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 129' ' ' VAL . 1.3 t -151.4 146.09 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 1.8899999999999999 109.696 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.86 -142.0 7.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 1.49 109.476 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 22.8 pt-20 -90.07 -158.78 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -1.193 . . . . 2.54 109.471 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.62 50.47 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 1.3799999999999999 109.518 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.7 140.45 3.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.499 -1.44 . . . . 2.54 109.499 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . 94.59 -132.37 11.12 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 4.1399999999999997 109.587 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -40.13 -32.44 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -1.14 . . . . 5.1299999999999999 109.443 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.639 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 8.1 m-85 60.7 -37.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.769 . . . . 5.79 109.808 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -55.19 130.17 41.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 5.7400000000000002 109.48 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -115.86 169.92 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 2.27 109.921 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.9 -23.34 11.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.647 -0.871 . . . . 3.2799999999999998 108.647 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.799 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.97 34.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 3.6499999999999999 109.123 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB2' HG23 ' A' ' 93' ' ' THR . 0.6 OUTLIER -89.59 104.74 17.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 4.5999999999999996 109.64 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.498 ' OE1' HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -141.26 176.48 8.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 3.46 109.515 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.47 14.11 0.61 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.643 -1.383 . . . . 3.6699999999999999 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -112.33 60.84 0.63 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -1.182 . . . . 3.79 109.546 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.52 101.93 30.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 1.96 109.083 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.32 131.97 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.539 2.159 . . . . 2.9700000000000002 112.593 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.08 134.48 23.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 3.0600000000000001 109.264 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.664 ' O ' ' N ' ' A' ' 105' ' ' GLU . 9.0 t -138.32 -161.63 1.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 2.3399999999999999 109.523 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.514 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -62.6 37.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.445 -1.462 . . . . 2.1699999999999999 109.445 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 103' ' ' THR . 13.8 tp10 -112.25 93.1 20.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 3.02 109.359 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 58.4 Cg_endo -79.53 118.18 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.715 2.277 . . . . 1.4199999999999999 112.177 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 173.96 -175.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 1.3700000000000001 109.48 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.4 118.82 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 1.72 110.283 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -93.26 137.13 32.87 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.356 -1.35 . . . . 4.7000000000000002 107.356 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.44 118.58 37.14 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.441 -0.787 . . . . 3.2799999999999998 109.666 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -107.94 109.92 21.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.036 -1.098 . . . . 2.96 108.036 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.27 45.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 3.4100000000000001 110.066 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.799 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -133.57 166.88 21.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 2.77 109.176 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.13 126.47 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.228 -0.92 . . . . 2.23 109.866 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 63' ' ' GLY . 3.9 m -69.25 122.78 19.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 4.1100000000000003 109.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.534 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 5.5 t-20 -117.67 -9.98 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 6.8600000000000003 109.54 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.641 HD23 ' CZ ' ' A' ' 119' ' ' PHE . 13.1 tp -141.49 124.2 16.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 5.1200000000000001 109.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.459 ' N ' HD12 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -63.92 144.74 56.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 4.0599999999999996 109.498 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.641 ' CZ ' HD23 ' A' ' 117' ' ' LEU . 32.9 m-85 -142.88 92.22 7.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 5.4400000000000004 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.35 165.81 20.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.76 2.307 . . . . 4.04 112.215 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.99 -17.93 10.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.766 2.31 . . . . 3.8999999999999999 112.007 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.99 132.29 54.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 4.1399999999999997 109.509 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 133.44 50.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.523 -1.431 . . . . 3.5699999999999998 109.523 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 123' ' ' GLY . 1.3 t70 37.92 22.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -1.132 . . . . 3.5899999999999999 109.48 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -151.77 72.07 8.05 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 2.0800000000000001 109.397 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.502 ' HG2' ' ND2' ' A' ' 56' ' ' ASN . 55.2 Cg_endo -74.22 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.791 2.327 . . . . 1.3899999999999999 112.233 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.513 ' HA3' ' H ' ' A' ' 57' ' ' GLY . . . -72.92 157.07 52.24 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.631 -1.388 . . . . 1.1899999999999999 109.631 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.755 ' H ' ' CG2' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -150.77 140.44 21.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -1.131 . . . . 2.0099999999999998 109.587 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 129' ' ' VAL . 4.5 p -161.53 112.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 1.28 108.828 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.414 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -122.74 112.22 17.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.97999999999999998 110.12 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -71.8 113.79 9.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.646 -0.872 . . . . 1.73 108.646 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' ARG . 1.6 m170 -99.66 100.69 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.199 -0.938 . . . . 2.3199999999999998 109.828 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.682 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -109.72 -21.34 12.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 2.1099999999999999 109.075 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.626 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -47.19 139.81 8.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.166 -1.573 . . . . 1.77 109.166 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.626 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER 179.54 129.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.108 . . . . 5.0599999999999996 109.234 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.01 -22.76 0.65 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.618 -1.253 . . . . 2.6400000000000001 107.618 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.642 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -105.24 7.11 43.3 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.466 -1.854 . . . . 2.5099999999999998 108.466 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.618 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -51.82 -145.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.803 -0.822 . . . . 2.3199999999999998 110.285 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.834 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 171.89 -112.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 1.6100000000000001 110.024 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.14 136.04 45.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 1.6499999999999999 109.061 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.553 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 52.9 t80 -122.7 116.71 24.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 1.6799999999999999 109.816 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.51 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 12.4 m -106.75 114.29 28.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -0.907 . . . . 0.73999999999999999 109.561 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.748 HD12 ' N ' ' A' ' 144' ' ' SER . 0.1 OUTLIER -119.97 141.2 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 1.22 109.471 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.748 ' N ' HD12 ' A' ' 143' ' ' ILE . 2.0 p -127.72 -17.21 4.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.163 -0.68 . . . . 1.3300000000000001 109.163 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.651 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.8 OUTLIER -152.28 159.28 43.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.379 -0.825 . . . . 3.2999999999999998 109.378 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 146' ' ' VAL . 11.9 p -165.94 126.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 2.2599999999999998 109.429 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.509 ' OG ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -167.21 146.39 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 2.7599999999999998 109.428 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.587 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.8 pp -111.26 146.39 37.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 4.5700000000000003 109.511 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 150' ' ' THR . 2.1 t -133.57 -157.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -0.876 . . . . 3.0699999999999998 109.483 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.55 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -139.64 -41.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 2.0 109.358 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.519 ' N ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER 71.38 104.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.422 -0.799 . . . . 2.1499999999999999 109.427 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -135.68 149.24 49.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 2.8199999999999998 109.437 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.95 -1.024 . . . . 3.54 109.48 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.531 -0.544 . . . . 5.4699999999999998 109.531 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -91.72 -112.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 4.5300000000000002 109.452 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.667 ' CD2' ' H ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER -168.1 -156.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 5.1399999999999997 109.471 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.667 ' H ' ' CD2' ' A' ' 3' ' ' LEU . 26.5 t70 -118.07 25.47 10.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 5.3799999999999999 109.492 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.568 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -103.89 35.8 2.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 4.8300000000000001 109.477 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 5' ' ' SER . 30.2 mt-10 35.89 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 3.4300000000000002 109.41 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 7' ' ' VAL . 2.1 t -45.73 162.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.89 . . . . 2.8300000000000001 109.467 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -141.15 64.39 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 4.75 109.507 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.825 ' HB2' HD11 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -79.95 16.46 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.925 . . . . 4.9500000000000002 109.403 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' O ' ' N ' ' A' ' 12' ' ' HIS . 1.2 tt -118.08 82.33 17.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.143 -1.058 . . . . 2.8599999999999999 108.143 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' C ' ' OH ' ' A' ' 55' ' ' TYR . 36.7 Cg_exo -53.02 36.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.099 2.533 . . . . 3.8300000000000001 113.285 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.697 ' N ' ' O ' ' A' ' 10' ' ' LEU . 38.8 t60 -170.34 138.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.995 -1.066 . . . . 2.52 109.579 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.517 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.35 70.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 1.97 109.592 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -169.84 77.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.974 . . . . 1.96 109.903 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.15 22.13 3.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 1.76 109.031 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.09 -25.0 20.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 1.1799999999999999 109.883 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 16.7 mm-40 -109.7 -58.92 1.99 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.048 -1.032 . . . . 2.1299999999999999 109.663 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 m -142.84 143.46 32.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.868 . . . . 2.2599999999999998 109.503 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -46.69 -34.23 4.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 2.6000000000000001 109.137 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 79.99 -164.01 47.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.586 -1.406 . . . . 1.6200000000000001 109.586 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 22' ' ' TRP . 34.8 Cg_exo -53.83 -21.52 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.841 2.36 . . . . 1.7 112.326 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CD1' ' CD1' ' A' ' 55' ' ' TYR . 4.3 m95 -53.05 -167.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.4199999999999999 109.356 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 161.9 39.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 1.6399999999999999 109.391 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.643 HD22 ' HG2' ' A' ' 30' ' ' PRO . 2.2 pp -160.08 137.88 9.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 2.0499999999999998 109.688 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 1.72 109.331 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.572 ' O ' ' NE2' ' A' ' 45' ' ' GLN . . . 110.14 -28.58 10.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.84 -1.304 . . . . 1.7 109.84 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.784 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.9 -142.7 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.296 . . . . 0.96999999999999997 109.454 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.784 ' N ' ' OG1' ' A' ' 27' ' ' THR . 3.6 p -91.62 -165.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 1.8 109.313 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.17 111.86 49.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 2.3999999999999999 109.003 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.643 ' HG2' HD22 ' A' ' 24' ' ' LEU . 78.5 Cg_exo -44.21 154.76 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.216 1.944 . . . . 1.1299999999999999 111.981 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' MET . 23.7 t -139.43 100.35 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.971 . . . . 1.05 110.21 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.71 82.58 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.65 0.738 . . . . 1.8200000000000001 109.179 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.78 -114.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.76 . . . . 1.1699999999999999 110.023 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 2.1 m-20 -58.35 66.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 2.21 109.759 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 59.27 6.19 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 1.1899999999999999 109.562 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.45 141.84 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.216 . . . . 2.9100000000000001 109.424 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -113.8 123.55 50.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 109.031 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.547 ' SG ' ' C ' ' A' ' 141' ' ' PHE . 4.5 t -128.15 153.2 47.13 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.272 -0.971 . . . . 1.0600000000000001 110.559 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.15 120.02 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.548 -0.908 . . . . 1.3700000000000001 108.548 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.568 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -77.39 117.44 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 4.79 109.469 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.671 HD21 ' OG1' ' A' ' 27' ' ' THR . 4.5 mm? -114.6 94.45 36.76 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.257 -0.902 . . . . 3.54 109.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.36 -43.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.223 2.615 . . . . 3.7400000000000002 111.984 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.77 141.47 3.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.397 -1.481 . . . . 2.0299999999999998 109.397 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.19 -0.43 1.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.999 -1.24 . . . . 2.4100000000000001 109.999 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.918 HE21 ' HB2' ' A' ' 51' ' ' ALA . 7.9 mm100 -99.17 -160.92 0.83 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.127 -1.22 . . . . 2.96 109.428 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.43 -57.74 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 2.0800000000000001 109.842 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.68 ' OD1' ' CD1' ' A' ' 49' ' ' TRP . 3.5 p30 -99.76 150.94 37.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.224 -1.162 . . . . 3.6099999999999999 109.58 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' ASP . 84.8 Cg_exo -40.18 -55.41 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.875 2.383 . . . . 2.3599999999999999 112.343 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.68 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 2.1 p90 -70.63 47.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 3.8700000000000001 109.463 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.727 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 67.8 m-20 -116.11 -8.51 11.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 2.3799999999999999 109.709 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.918 ' HB2' HE21 ' A' ' 45' ' ' GLN . . . -172.8 116.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.952 . . . . 1.1100000000000001 109.564 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.501 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 174.3 166.99 33.18 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.68 -1.248 . . . . 0.93999999999999995 110.186 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.97 -169.48 1.62 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -1.093 . . . . 0.95999999999999996 109.421 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -159.64 162.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.92000000000000004 109.805 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.791 ' CD1' ' CD1' ' A' ' 22' ' ' TRP . 20.1 t80 -176.82 140.4 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.821 . . . . 1.71 109.403 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 127' ' ' GLY . 2.7 m-20 -113.31 -164.19 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.38 -0.825 . . . . 2.7799999999999998 109.472 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 9' ' ' LEU . . . 86.06 47.07 5.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.504 -1.438 . . . . 2.48 109.504 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.538 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 22.2 t -151.12 75.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 3.79 109.521 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' VAL . 75.7 Cg_exo -44.04 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.906 2.404 . . . . 2.3999999999999999 112.191 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 119' ' ' PHE . 2.7 t -142.37 120.86 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 3.0800000000000001 109.595 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -137.93 107.67 0.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.323 -1.511 . . . . 3.0499999999999998 109.323 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.7 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.3 tm-20 -42.46 172.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 6.0499999999999998 109.182 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.671 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 80.67 -45.15 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.479 . . . . 2.54 109.404 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -99.56 135.56 40.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 4.0300000000000002 109.084 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.4 m -99.84 148.78 24.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.168 -0.957 . . . . 2.9100000000000001 109.763 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -107.92 177.98 4.65 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 2.3799999999999999 109.583 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -151.39 160.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.489 -0.757 . . . . 2.6099999999999999 109.468 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 109' ' ' ARG . 10.1 tp -143.69 114.3 7.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 3.6099999999999999 109.666 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 4.8 p -109.23 83.66 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.966 . . . . 2.27 108.828 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.613 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 24.9 p90 -93.89 132.99 37.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 2.0099999999999998 111.302 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.673 HG23 ' CG2' ' A' ' 108' ' ' THR . 0.8 OUTLIER -83.71 98.68 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 1.8 108.445 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -144.97 152.03 39.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.05 . . . . 0.95999999999999996 110.093 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.7 p -132.95 121.99 23.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.486 -0.759 . . . . 0.93000000000000005 109.055 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -83.48 132.96 34.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.67000000000000004 109.511 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.468 ' OG1' ' CB ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.62 117.08 16.31 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.323 -0.86 . . . . 0.96999999999999997 109.242 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.24 -142.46 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 124.256 -1.143 . . . . 1.02 112.227 -0.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -96.58 148.42 22.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 1.75 109.336 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.417 ' CE ' ' HB3' ' A' ' 139' ' ' TYR . 0.1 OUTLIER 168.27 153.03 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.685 . . . . 2.1600000000000001 109.29 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.88 117.92 5.1 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.705 2.27 . . . . 1.3799999999999999 112.001 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.483 ' CG1' HD23 ' A' ' 133' ' ' LEU . 27.2 m -79.93 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 2.0099999999999998 109.442 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 132' ' ' HIS . 18.0 ttm180 -114.68 90.29 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 6.0099999999999998 109.528 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.49 154.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.225 -0.922 . . . . 3.7599999999999998 108.993 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.44 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -154.25 162.97 40.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.01 . . . . 2.29 110.082 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.577 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -153.62 160.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 1.8899999999999999 109.358 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.44 -145.07 10.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.667 -1.373 . . . . 1.49 109.667 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.722 ' HB2' ' HB1' ' A' ' 125' ' ' ALA . 2.9 pt-20 -90.19 163.1 14.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 2.54 109.446 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.82 22.98 12.17 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 1.3799999999999999 109.49 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -155.57 -156.74 7.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.54 -1.424 . . . . 2.54 109.54 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.28 -55.78 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 4.1399999999999997 109.551 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.687 ' O ' ' CG ' ' A' ' 91' ' ' TYR . . . -176.52 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 5.1299999999999999 109.451 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.687 ' CG ' ' O ' ' A' ' 90' ' ' ALA . 7.5 m-85 -178.36 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 5.79 109.576 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 91' ' ' TYR . 8.3 mmt180 -34.72 117.0 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 5.7400000000000002 109.564 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -125.94 176.91 6.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 2.27 110.03 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.12 -20.98 5.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.841 -0.8 . . . . 3.2799999999999998 108.841 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.804 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.84 34.04 0.92 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 3.6499999999999999 109.149 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.5 92.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 4.5999999999999996 109.888 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 111' ' ' TYR . 4.5 mt-30 -99.77 137.78 37.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 3.46 109.514 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.48 -13.54 2.3 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.652 -1.379 . . . . 3.6699999999999999 109.652 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.38 80.61 1.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.166 -1.197 . . . . 3.79 109.587 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.17 84.52 14.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 1.96 109.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.95 127.31 18.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.989 2.46 . . . . 2.9700000000000002 112.614 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.545 HD21 ' CG ' ' A' ' 109' ' ' ARG . 11.4 mt -144.94 127.03 15.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.866 . . . . 3.0600000000000001 109.325 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 1.7 t -91.98 -169.99 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 2.3399999999999999 109.511 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.17 13.31 67.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 2.1699999999999999 109.534 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.494 ' H ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -103.06 152.77 38.6 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 3.02 109.424 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.31 118.3 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.848 2.365 . . . . 1.4199999999999999 112.2 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.87 146.44 11.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 1.3700000000000001 109.477 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.673 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.15 132.86 35.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 1.72 109.712 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.545 ' CG ' HD21 ' A' ' 102' ' ' LEU . 3.6 mmp_? -101.96 134.11 45.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.91 -1.144 . . . . 4.7000000000000002 107.91 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -109.69 106.05 15.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.033 -0.667 . . . . 3.2799999999999998 110.389 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CB ' HE22 ' A' ' 97' ' ' GLN . 42.1 m-85 -109.74 124.88 52.01 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.312 -0.996 . . . . 2.96 108.312 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.07 163.79 23.0 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 3.4100000000000001 109.922 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.804 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 4.2 p90 -166.76 -168.2 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 2.77 109.471 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.98 154.01 25.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 2.23 109.458 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -90.24 59.12 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 4.1100000000000003 109.799 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.516 ' C ' ' O ' ' A' ' 115' ' ' SER . 6.6 t-20 -33.62 -40.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 6.8600000000000003 109.908 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' OG ' ' A' ' 115' ' ' SER . 2.8 mt -109.93 -169.55 1.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 5.1200000000000001 109.767 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.684 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.7 OUTLIER -129.76 158.85 38.26 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.257 -0.902 . . . . 4.0599999999999996 109.585 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 49.4 m-85 -166.42 96.53 0.73 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 5.4400000000000004 109.28 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.81 165.56 24.4 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.591 2.194 . . . . 4.04 112.334 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.51 -13.09 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.951 2.434 . . . . 3.8999999999999999 112.095 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -109.46 8.49 25.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 4.1399999999999997 109.535 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . -96.87 174.02 29.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.495 -1.442 . . . . 3.5699999999999998 109.495 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 27.3 t0 -71.15 34.61 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 3.5899999999999999 109.482 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 86' ' ' GLU . . . 179.87 87.8 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 109.424 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.38 -160.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.784 2.323 . . . . 1.3899999999999999 112.328 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.716 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -64.62 154.6 48.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.556 -1.418 . . . . 1.1899999999999999 109.556 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.7 140.74 22.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -1.153 . . . . 2.0099999999999998 109.633 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.7 t -144.78 144.15 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 1.28 108.454 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.489 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -157.61 114.33 2.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.98 -1.075 . . . . 0.97999999999999998 110.015 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.5 m-30 -94.66 88.2 5.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.425 -0.797 . . . . 1.73 109.263 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 27.9 m170 -99.42 137.64 37.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.955 . . . . 2.3199999999999998 109.747 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.36 52.54 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.1099999999999999 109.536 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . . . -40.01 123.73 2.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.902 -1.279 . . . . 1.77 109.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' A' ' 138' ' ' ALA . 2.2 mptp? -167.5 44.81 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.711 -0.876 . . . . 5.0599999999999996 108.831 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . 40.97 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.412 -1.329 . . . . 2.6400000000000001 107.412 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . 69.87 28.38 71.99 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.779 -1.728 . . . . 2.5099999999999998 108.779 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.695 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -91.7 56.55 3.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -1.203 . . . . 2.3199999999999998 110.377 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 135' ' ' LYS . 10.6 p90 -177.11 -153.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.838 -1.164 . . . . 1.6100000000000001 110.459 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.468 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 1.0 OUTLIER -159.3 157.35 30.34 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.696 -0.853 . . . . 1.6499999999999999 108.696 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.547 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 13.0 t80 -135.28 103.17 5.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.041 -1.037 . . . . 1.6799999999999999 110.07 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.7 m -106.44 110.6 22.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 110.169 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.488 HG12 ' N ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -138.97 146.22 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 1.22 109.505 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.488 ' N ' HG12 ' A' ' 143' ' ' ILE . 3.6 p -136.31 -4.55 2.11 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.355 -0.538 . . . . 1.3300000000000001 109.688 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.505 ' CD ' HG21 ' A' ' 71' ' ' THR . 2.3 mt-30 -140.83 151.27 44.22 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.272 -0.971 . . . . 3.2999999999999998 110.073 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.578 HG21 ' CH2' ' A' ' 22' ' ' TRP . 13.0 p -163.08 122.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -0.845 . . . . 2.2599999999999998 109.507 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.96 139.69 23.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 2.7599999999999998 109.637 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.825 HD11 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -113.17 149.47 33.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 4.5700000000000003 109.403 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.805 ' N ' HD12 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -167.7 -163.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 3.0699999999999998 109.531 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.654 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -172.92 -41.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 2.0 109.346 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 150' ' ' THR . 40.0 p 45.02 -166.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.471 -0.768 . . . . 2.1499999999999999 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.69 20.1 10.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 2.8199999999999998 109.447 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.43 ' OXT' HG22 ' A' ' 153' ' ' THR . 4.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.028 -0.987 . . . . 3.54 109.438 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.504 -0.554 . . . . 5.4699999999999998 109.504 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.925 ' O ' HD12 ' A' ' 3' ' ' LEU . 56.7 p 53.46 79.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 4.5300000000000002 109.437 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.925 HD12 ' O ' ' A' ' 2' ' ' SER . 2.3 mp -141.03 175.18 9.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 5.1399999999999997 109.491 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -56.76 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 5.3799999999999999 109.497 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER 48.77 100.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 4.8300000000000001 109.482 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.32 124.0 25.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 3.4300000000000002 109.45 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.459 ' O ' ' OG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER -84.4 92.98 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 2.8300000000000001 109.492 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.535 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -96.81 126.29 41.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 4.75 109.486 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.43 HD13 ' CG ' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -84.06 -13.82 52.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.153 -0.967 . . . . 4.9500000000000002 109.596 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.65 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -119.89 83.37 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 2.8599999999999999 108.692 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.28 34.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.025 2.484 . . . . 3.8300000000000001 111.87 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.65 ' H ' HD13 ' A' ' 10' ' ' LEU . 44.3 t60 -134.78 99.03 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.425 -0.797 . . . . 2.52 109.475 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.543 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -137.58 54.97 1.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.97 109.333 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.647 ' O ' ' N ' ' A' ' 16' ' ' ALA . 22.7 t -159.61 83.3 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 1.96 109.675 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -63.43 50.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 1.76 108.868 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -55.52 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 1.1799999999999999 110.13 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -109.88 39.37 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 2.1299999999999999 109.851 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.6 153.3 2.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.145 -0.972 . . . . 2.2599999999999998 109.699 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.947 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 2.6000000000000001 109.563 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' H ' HD22 ' A' ' 19' ' ' LEU . . . 76.61 174.16 38.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.781 -1.328 . . . . 1.6200000000000001 109.781 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.23 -16.37 4.72 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.694 2.263 . . . . 1.7 112.039 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.833 ' CH2' HG21 ' A' ' 146' ' ' VAL . 14.3 m95 -68.15 160.98 27.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 2.4199999999999999 109.08 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -109.68 148.24 31.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.009 . . . . 1.6399999999999999 109.642 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -135.35 129.58 33.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 2.0499999999999998 109.51 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.619 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.27 159.63 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 1.72 109.573 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.9 -32.34 7.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.042 -1.223 . . . . 1.7 110.042 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.754 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.7 -141.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.105 -1.232 . . . . 0.96999999999999997 109.662 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.754 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.1 p -91.09 132.39 36.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 1.8 109.316 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 tt0 -36.88 102.56 0.24 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 2.3999999999999999 109.072 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' SER . 50.0 Cg_exo -46.54 152.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.296 1.997 . . . . 1.1299999999999999 111.689 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' MET . 81.6 t -137.74 115.25 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 1.05 110.241 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.61 90.88 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.573 -0.704 . . . . 1.8200000000000001 109.75 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.53 -112.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 1.1699999999999999 109.664 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -59.43 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 2.21 109.626 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 60.0 5.03 3.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 1.1899999999999999 109.552 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.634 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -123.04 148.39 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -1.145 . . . . 2.9100000000000001 109.531 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.625 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.5 OUTLIER -114.39 132.39 56.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 0.93000000000000005 109.713 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.17 153.01 40.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 1.0600000000000001 109.676 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.3 m -126.07 137.88 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.905 -0.776 . . . . 1.3700000000000001 108.905 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.633 ' N ' ' OG ' ' A' ' 28' ' ' SER . 17.6 m-20 -73.0 110.14 7.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 4.79 109.475 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.618 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.2 mm? -117.81 75.02 9.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 3.54 109.556 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.01 -157.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.767 2.311 . . . . 3.7400000000000002 112.195 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.47 130.12 9.68 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 2.0299999999999998 109.548 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.99 35.81 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.532 -1.427 . . . . 2.4100000000000001 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.619 HE22 ' CB ' ' A' ' 50' ' ' ASP . 3.3 mm-40 -99.93 106.1 17.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -1.122 . . . . 2.96 109.491 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.2 14.42 1.25 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.659 -1.376 . . . . 2.0800000000000001 109.659 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.596 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -179.91 151.04 0.57 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.195 -1.179 . . . . 3.6099999999999999 109.519 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 50' ' ' ASP . 44.5 Cg_endo -71.8 -54.16 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.853 2.369 . . . . 2.3599999999999999 112.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.459 ' CE3' ' HG2' ' A' ' 48' ' ' PRO . 11.1 p90 -62.88 45.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 3.8700000000000001 109.384 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.789 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -135.48 39.75 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 2.3799999999999999 109.353 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 156.92 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 1.1100000000000001 109.528 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.83 170.08 20.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.644 -1.382 . . . . 0.93999999999999995 109.644 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 143' ' ' ILE . 1.7 pp -108.58 142.82 38.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -1.113 . . . . 0.95999999999999996 109.422 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 55' ' ' TYR . 4.5 t -120.0 174.79 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.92000000000000004 109.896 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.684 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 48.8 t80 179.11 144.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.71 109.527 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.684 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -99.72 -164.84 1.16 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 2.7799999999999998 109.463 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.91 66.95 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.602 -1.399 . . . . 2.48 109.602 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.766 ' CG1' ' H ' ' A' ' 128' ' ' GLN . 8.9 p -151.85 73.68 7.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.253 -1.145 . . . . 3.79 109.466 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.43 ' CG ' HD13 ' A' ' 9' ' ' LEU . 58.2 Cg_endo -76.14 157.91 37.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.873 2.382 . . . . 2.3999999999999999 112.364 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.723 HG13 ' CD1' ' A' ' 66' ' ' TYR . 3.4 t -148.83 102.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 3.0800000000000001 109.386 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -73.72 119.87 6.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.595 -1.402 . . . . 3.0499999999999998 109.595 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.539 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 15.7 tt0 -58.63 125.37 23.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.136 . . . . 6.0499999999999998 109.53 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 132.85 -47.56 1.0 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.679 -1.368 . . . . 2.54 109.679 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.8 mt-10 -99.8 166.89 10.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -1.15 . . . . 4.0300000000000002 109.594 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.46 134.32 49.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 2.9100000000000001 109.434 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.723 ' CD1' HG13 ' A' ' 60' ' ' VAL . 38.1 m-85 -97.22 -179.09 4.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 2.3799999999999999 109.499 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -154.71 139.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 2.6099999999999999 109.576 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HA ' HD12 ' A' ' 68' ' ' LEU . 9.3 tp -120.88 118.17 29.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 3.6099999999999999 109.416 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.04 83.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.577 -0.898 . . . . 2.27 108.577 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 28.0 p90 -93.73 143.14 26.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.855 . . . . 2.0099999999999998 111.358 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -89.33 130.59 35.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.488 -0.93 . . . . 1.8 108.488 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.798 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -170.29 135.19 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.891 -1.13 . . . . 0.95999999999999996 110.254 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.9 p -119.82 122.91 42.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.821 . . . . 0.93000000000000005 108.946 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.879 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -85.57 125.74 33.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.67000000000000004 109.565 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -138.76 113.63 8.5 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.271 -0.893 . . . . 0.96999999999999997 109.75 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.3 Cg_exo -64.54 -141.81 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.624 0 C-N-CA 124.349 -1.104 . . . . 1.02 112.276 -0.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -99.17 151.03 21.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 1.75 109.825 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.511 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.35 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.861 -0.792 . . . . 2.1600000000000001 108.861 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.12 168.94 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.829 2.353 . . . . 1.3799999999999999 112.86 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 100' ' ' ALA . 2.9 m -137.21 170.85 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 2.0099999999999998 109.128 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.715 ' HD3' ' HZ1' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -116.4 105.52 12.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 6.0099999999999998 109.771 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.87 159.43 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.261 -0.9 . . . . 3.7599999999999998 109.219 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -157.69 149.65 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 2.29 109.834 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.51 ' CG1' HG21 ' A' ' 58' ' ' VAL . 1.1 t -149.13 155.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 1.8899999999999999 109.701 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.96 -133.27 5.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.563 -1.415 . . . . 1.49 109.563 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.4 pm0 -90.08 -179.07 5.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 2.54 109.384 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -169.07 32.82 0.18 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 1.3799999999999999 109.546 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -143.77 -100.35 0.33 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 2.54 109.604 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' GLY . . . -44.17 -100.84 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.554 -1.418 . . . . 4.1399999999999997 109.554 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.96 25.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 5.1299999999999999 109.446 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 124' ' ' ASP . 3.6 m-85 -66.15 80.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 5.79 109.583 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -29.85 151.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.69 . . . . 5.7400000000000002 110.011 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.44 161.03 13.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.287 -0.883 . . . . 2.27 110.081 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -119.91 -14.14 8.97 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.733 -0.84 . . . . 3.2799999999999998 108.733 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.755 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.56 36.03 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.381 -0.825 . . . . 3.6499999999999999 108.916 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -80.67 70.99 7.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 4.5999999999999996 109.624 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.86 111.01 23.35 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 3.46 108.851 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.13 13.27 55.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 3.6699999999999999 109.711 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.92 67.52 0.78 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.174 -1.192 . . . . 3.79 109.824 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -107.32 99.76 29.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.074 -1.016 . . . . 1.96 109.288 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.83 135.99 11.69 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.606 2.204 . . . . 2.9700000000000002 112.673 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 74' ' ' ALA . 94.2 mt -142.15 131.11 23.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 3.0600000000000001 109.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 105' ' ' GLU . 9.8 t -92.41 -165.56 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 109.491 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.19 33.9 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.499 -1.44 . . . . 2.1699999999999999 109.499 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.505 ' H ' HG23 ' A' ' 103' ' ' THR . 8.7 pt-20 -121.53 138.48 28.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.248 -1.148 . . . . 3.02 109.433 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.27 120.5 6.01 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.593 2.195 . . . . 1.4199999999999999 112.069 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.678 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -171.03 160.43 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 1.3700000000000001 109.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.593 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.93 149.07 22.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 1.72 109.687 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.798 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -114.3 136.43 52.98 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.745 -1.206 . . . . 4.7000000000000002 107.745 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -114.34 107.94 16.24 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.848 -0.741 . . . . 3.2799999999999998 110.706 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 8.0 m-85 -109.77 115.98 30.84 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.374 -0.972 . . . . 2.96 108.374 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -101.71 142.63 32.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.831 . . . . 3.4100000000000001 109.712 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.92 163.94 26.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 2.77 109.413 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.5 109.34 21.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 2.23 109.798 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.7 m -56.23 105.66 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.287 -0.883 . . . . 4.1100000000000003 109.193 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.85 ' O ' HD22 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -108.8 -10.31 15.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 6.8600000000000003 109.616 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -136.59 126.5 25.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 5.1200000000000001 109.531 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.64 117.72 5.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 4.0599999999999996 109.372 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.557 ' CE1' ' O ' ' A' ' 92' ' ' ARG . 57.9 m-85 -120.78 66.74 13.9 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 5.4400000000000004 109.588 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.78 166.58 27.15 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.783 2.322 . . . . 4.04 112.154 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 65.6 Cg_endo -79.87 -13.2 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.853 2.369 . . . . 3.8999999999999999 112.003 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -109.57 -12.71 14.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.331 -0.855 . . . . 4.1399999999999997 109.642 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.06 -70.95 0.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 3.5699999999999998 109.423 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.637 ' CG ' ' CE1' ' A' ' 91' ' ' TYR . 1.4 m-20 -129.75 -7.21 4.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 3.5899999999999999 109.387 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -179.96 150.02 0.53 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 2.0800000000000001 109.377 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HA ' ' CA ' ' A' ' 121' ' ' PRO . 10.4 Cg_endo -57.23 -7.11 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.943 2.429 . . . . 1.3899999999999999 112.217 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.12 172.37 12.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 1.1899999999999999 109.56 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.766 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 37.6 tp60 -153.81 140.29 18.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 2.0099999999999998 109.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 84' ' ' VAL . 3.6 t -153.68 87.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.374 -0.973 . . . . 1.28 108.374 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.533 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -97.4 123.44 41.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.97999999999999998 110.532 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.58 81.52 1.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.61 -0.885 . . . . 1.73 108.61 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 81' ' ' ARG . 61.3 m-70 -99.65 136.27 39.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 2.3199999999999998 109.956 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -131.05 -5.47 3.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.343 -0.848 . . . . 2.1099999999999999 109.353 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -43.26 124.41 4.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.473 -1.451 . . . . 1.77 109.473 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.715 ' HZ1' ' HD3' ' A' ' 81' ' ' ARG . 15.6 mttp -163.93 128.21 2.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 5.0599999999999996 109.74 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.62 -14.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.294 -1.002 . . . . 2.6400000000000001 108.294 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -118.16 3.15 16.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.227 -1.549 . . . . 2.5099999999999998 109.227 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -51.42 -161.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -1.07 . . . . 2.3199999999999998 109.647 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.879 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -168.35 -113.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.051 -1.031 . . . . 1.6100000000000001 110.24 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -125.85 139.82 53.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 1.6499999999999999 109.127 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.3 t80 -121.36 107.61 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 1.6799999999999999 109.79 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.17 91.29 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.73999999999999999 109.863 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.642 HD13 HD21 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -107.87 141.88 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 1.22 109.072 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.2 p -138.48 -0.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.56 -0.712 . . . . 1.3300000000000001 109.443 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.642 ' N ' ' OG1' ' A' ' 71' ' ' THR . 10.5 mt-30 -149.57 160.94 43.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.975 . . . . 3.2999999999999998 110.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.833 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.9 p -166.64 103.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.83 . . . . 2.2599999999999998 109.44 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.3 144.18 36.16 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 2.7599999999999998 109.624 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 149' ' ' THR . 1.3 tp -134.21 113.49 12.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 4.5700000000000003 109.337 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.679 ' N ' HD12 ' A' ' 148' ' ' LEU . 9.0 t -155.76 -166.35 2.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 3.0699999999999998 109.54 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -133.68 -41.05 0.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 2.0 109.417 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.52 ' N ' ' CG2' ' A' ' 150' ' ' THR . 47.9 m -60.99 148.64 39.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.474 -0.766 . . . . 2.1499999999999999 109.455 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.18 -165.28 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 2.8199999999999998 109.483 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.96 -1.019 . . . . 3.54 109.392 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.433 -0.58 . . . . 5.4699999999999998 109.433 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 t -100.46 -117.85 0.16 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 4.5300000000000002 109.497 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -147.2 -162.59 1.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 5.1399999999999997 109.419 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.561 ' O ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -53.61 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 5.3799999999999999 109.402 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 6' ' ' GLU . 29.6 t -72.87 174.66 7.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 4.8300000000000001 109.502 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 5' ' ' SER . 0.6 OUTLIER 35.04 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 3.4300000000000002 109.57 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 151' ' ' SER . 20.2 t -98.68 84.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 2.8300000000000001 109.399 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' OE2' ' OG ' ' A' ' 147' ' ' SER . 7.7 tp10 -65.26 109.86 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 4.75 109.578 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -32.68 39.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 4.9500000000000002 109.328 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.939 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -113.02 96.06 36.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 2.8599999999999999 109.073 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.02 38.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.844 2.363 . . . . 3.8300000000000001 112.852 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.679 ' N ' ' O ' ' A' ' 10' ' ' LEU . 27.7 t60 -129.81 131.42 46.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 2.52 109.316 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 56.17 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 1.97 109.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 16' ' ' ALA . 8.3 t -158.57 68.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 1.96 109.711 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -65.48 34.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 1.76 108.949 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -81.56 -33.38 31.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.1799999999999999 109.85 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.587 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 14.9 mm-40 -109.84 -70.2 0.82 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.137 -0.977 . . . . 2.1299999999999999 109.556 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 20' ' ' GLY . 49.8 m -107.49 144.08 34.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 2.2599999999999998 109.462 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -61.9 12.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 2.6000000000000001 109.703 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.626 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 66.23 177.12 7.5 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.83 -1.308 . . . . 1.6200000000000001 109.83 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.04 10.97 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.687 2.258 . . . . 1.7 112.204 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.795 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.2 m0 -74.41 -174.15 1.94 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 2.4199999999999999 109.501 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.405 ' CB ' HG13 ' A' ' 54' ' ' VAL . 1.6 m -117.3 145.78 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 1.6399999999999999 109.287 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.633 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 6.4 tt -151.67 143.86 23.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 2.0499999999999998 110.407 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.711 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.34 175.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.587 -0.696 . . . . 1.72 109.479 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.12 -23.35 18.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.967 -1.253 . . . . 1.7 109.967 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.72 -142.98 0.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.252 . . . . 0.96999999999999997 109.339 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.3 p -91.72 -164.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 1.8 109.223 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 29' ' ' GLU . 3.4 tm-20 -90.12 111.33 46.2 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 2.3999999999999999 108.774 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.471 ' CG ' HD22 ' A' ' 24' ' ' LEU . 72.9 Cg_exo -43.32 147.48 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.24 1.96 . . . . 1.1299999999999999 112.009 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 37' ' ' MET . 3.8 t -129.98 95.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.05 109.866 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.97 88.25 4.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.8200000000000001 109.451 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -74.02 -140.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 1.1699999999999999 109.952 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' A' ' 33' ' ' ALA . 24.4 t70 -35.33 -87.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 2.21 109.523 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -131.28 36.87 2.17 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.621 -1.391 . . . . 1.1899999999999999 109.621 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.34 157.48 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -1.2 . . . . 2.9100000000000001 109.579 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.615 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -129.51 135.27 48.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.324 -0.86 . . . . 0.93000000000000005 109.333 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 143.23 50.66 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.479 -0.888 . . . . 1.0600000000000001 110.281 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -113.62 144.15 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.796 -0.816 . . . . 1.3700000000000001 108.796 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.658 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -76.84 106.26 8.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 4.79 109.624 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.4 mm? -116.41 81.53 11.07 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 3.54 109.344 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.865 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 50.7 Cg_exo -49.54 -144.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.944 2.429 . . . . 3.7400000000000002 112.275 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.04 70.33 0.29 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 2.0299999999999998 109.557 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.05 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.554 -1.419 . . . . 2.4100000000000001 109.554 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 46' ' ' GLY . 3.9 mt-30 -99.99 91.51 4.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 2.96 109.428 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -39.66 -43.64 2.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.558 -1.417 . . . . 2.0800000000000001 109.558 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.503 ' CG ' ' CG ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -99.89 128.57 30.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.247 -1.149 . . . . 3.6099999999999999 109.382 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.28 -26.17 7.75 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.499 2.133 . . . . 2.3599999999999999 112.626 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.656 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -92.02 34.18 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.976 . . . . 3.8700000000000001 109.868 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.656 ' OD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.9 OUTLIER -100.19 1.76 42.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 2.3799999999999999 109.676 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.5 -173.52 1.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 1.1100000000000001 109.713 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.29 -171.77 14.29 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.486 -1.446 . . . . 0.93999999999999995 109.486 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.3 pp -115.89 140.71 48.97 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.244 -1.15 . . . . 0.95999999999999996 109.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -128.22 163.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.92000000000000004 109.614 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.939 ' CE2' HD12 ' A' ' 10' ' ' LEU . 20.2 t80 -159.82 155.42 25.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 1.71 109.444 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.694 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 4.2 m-20 -113.09 -164.29 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.201 -0.937 . . . . 2.7799999999999998 109.471 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.691 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 73.95 69.57 1.37 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 2.48 109.365 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 HD21 ' A' ' 148' ' ' LEU . 49.0 t -162.05 96.85 1.21 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 3.79 109.447 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.15 121.92 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.652 2.235 . . . . 2.3999999999999999 112.09 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 73.0 t -103.33 155.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 3.0800000000000001 109.594 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 60' ' ' VAL . . . -162.67 129.29 2.02 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.614 -1.394 . . . . 3.0499999999999998 109.614 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.691 ' N ' ' OG ' ' A' ' 115' ' ' SER . 1.7 pp20? -61.28 -161.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -1.104 . . . . 6.0499999999999998 109.383 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 62' ' ' GLU . . . 62.22 -49.19 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 2.54 109.67 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.3 mm-40 -99.76 160.3 14.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 4.0300000000000002 109.261 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.8 m -112.94 146.4 39.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 2.9100000000000001 109.683 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.681 ' CD2' ' OG1' ' A' ' 150' ' ' THR . 81.1 m-85 -106.14 174.33 5.93 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.238 -0.914 . . . . 2.3799999999999999 109.803 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.5 t -152.19 128.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.524 -0.735 . . . . 2.6099999999999999 109.247 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 109' ' ' ARG . 6.7 tp -114.8 116.8 29.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.092 -1.005 . . . . 3.6099999999999999 109.851 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.78 81.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 2.27 108.83 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 12.5 p90 -93.67 138.63 31.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.0099999999999998 111.139 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.668 HG23 ' CG2' ' A' ' 108' ' ' THR . 0.7 OUTLIER -86.88 133.09 33.65 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.642 -0.873 . . . . 1.8 108.642 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -173.83 128.29 0.4 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.98 -1.075 . . . . 0.95999999999999996 110.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -111.24 122.41 47.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.93000000000000005 108.873 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.79 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -80.91 129.74 34.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.67000000000000004 109.652 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.526 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -142.73 111.67 5.78 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.332 -0.855 . . . . 0.96999999999999997 109.594 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.0 Cg_exo -63.81 -141.82 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.248 -1.146 . . . . 1.02 112.372 -0.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -106.62 155.74 19.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.75 109.701 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.51 167.22 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 2.1600000000000001 108.942 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -84.7 149.29 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.779 2.319 . . . . 1.3799999999999999 112.59 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.636 HG22 ' HB3' ' A' ' 100' ' ' ALA . 1.2 m -125.61 179.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.895 . . . . 2.0099999999999998 109.315 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -127.96 97.95 4.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 6.0099999999999998 109.816 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -99.6 143.17 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.37 -0.831 . . . . 3.7599999999999998 108.845 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.602 HD21 ' CE1' ' A' ' 132' ' ' HIS . 2.1 pp -145.63 156.71 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 2.29 109.988 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -155.07 146.99 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 1.8899999999999999 109.345 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 170.16 -148.74 11.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.711 -1.356 . . . . 1.49 109.711 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.706 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.12 -161.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -1.119 . . . . 2.54 109.456 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -150.66 92.87 0.14 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.496 -1.442 . . . . 1.3799999999999999 109.496 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -155.5 -133.74 1.75 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.664 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . -78.32 146.91 30.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.535 -1.426 . . . . 4.1399999999999997 109.535 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' O ' ' CD2' ' A' ' 91' ' ' TYR . . . 62.4 -38.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -1.161 . . . . 5.1299999999999999 109.496 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 89' ' ' GLY . 1.7 m-85 75.2 16.16 2.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 5.79 109.49 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -37.15 112.19 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 5.7400000000000002 109.433 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -116.39 164.85 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 2.27 109.969 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.497 ' HB1' ' HE2' ' A' ' 113' ' ' PHE . . . -109.93 -21.19 12.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.757 -0.831 . . . . 3.2799999999999998 108.757 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' HG23 ' A' ' 84' ' ' VAL . 2.1 t80 -90.66 38.13 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.497 -0.927 . . . . 3.6499999999999999 108.497 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.68 114.55 19.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 4.5999999999999996 109.932 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.499 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -141.06 132.98 27.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 3.46 108.725 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -121.65 9.32 9.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.776 -1.33 . . . . 3.6699999999999999 109.776 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.35 65.31 0.76 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -1.169 . . . . 3.79 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.636 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.89 94.9 21.66 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 1.96 109.152 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.9 133.93 10.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.745 2.297 . . . . 2.9700000000000002 112.793 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 109' ' ' ARG . 35.6 mt -136.92 137.17 39.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 3.0600000000000001 109.144 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 9.0 t -96.87 -155.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.935 . . . . 2.3399999999999999 109.509 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -104.46 56.86 0.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 2.1699999999999999 109.542 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -150.85 150.47 27.97 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.299 -1.118 . . . . 3.02 109.433 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 118.33 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.717 2.278 . . . . 1.4199999999999999 112.137 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.831 ' HB3' HH22 ' A' ' 109' ' ' ARG . . . -166.39 147.3 6.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 1.3700000000000001 109.543 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.668 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.41 144.45 25.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.72 109.797 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.831 HH22 ' HB3' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -105.14 134.18 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.939 -1.134 . . . . 4.7000000000000002 107.939 178.167 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -109.54 105.27 14.53 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.92 -0.712 . . . . 3.2799999999999998 110.163 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.499 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 39.0 m-85 -109.6 102.29 11.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.448 -0.945 . . . . 2.96 108.448 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -110.47 166.41 11.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.301 -0.874 . . . . 3.4100000000000001 109.901 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.509 ' O ' ' CB ' ' A' ' 65' ' ' SER . 2.3 p90 -177.67 -162.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 2.77 109.237 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -123.05 143.05 50.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.339 -0.85 . . . . 2.23 109.38 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.691 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -86.89 161.56 18.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 4.1100000000000003 109.678 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -127.86 -15.28 4.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 6.8600000000000003 109.602 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.574 HD23 ' CE2' ' A' ' 119' ' ' PHE . 1.6 tp -123.43 155.63 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 5.1200000000000001 109.543 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 109.33 21.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 4.0599999999999996 109.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.574 ' CE2' HD23 ' A' ' 117' ' ' LEU . 23.8 m-85 -114.77 92.46 29.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.892 . . . . 5.4400000000000004 109.58 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.23 165.9 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.774 2.316 . . . . 4.04 112.122 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.11 -22.74 7.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.796 2.331 . . . . 3.8999999999999999 111.989 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.03 115.27 29.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.842 . . . . 4.1399999999999997 109.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 147.07 -136.53 6.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 3.5699999999999998 109.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' GLY . 10.8 m-20 -43.79 -85.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -1.136 . . . . 3.5899999999999999 109.458 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -129.86 149.7 73.8 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 2.0800000000000001 109.458 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HG2' HD21 ' A' ' 56' ' ' ASN . 46.9 Cg_endo -72.24 -158.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.722 2.281 . . . . 1.3899999999999999 112.244 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.524 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -65.37 163.27 39.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.482 -1.447 . . . . 1.1899999999999999 109.482 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.16 153.05 38.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -1.107 . . . . 2.0099999999999998 109.682 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.443 HG23 ' C ' ' A' ' 128' ' ' GLN . 45.7 t -155.84 131.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.187 -1.042 . . . . 1.28 108.187 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -139.65 100.09 3.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.888 -1.132 . . . . 0.97999999999999998 110.531 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD2' HD11 ' A' ' 53' ' ' LEU . 2.9 m-30 -85.04 99.23 10.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.522 -0.918 . . . . 1.73 108.522 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' CE1' HD21 ' A' ' 83' ' ' LEU . 41.6 m170 -99.77 136.1 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 2.3199999999999998 109.816 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -132.73 -36.47 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 2.1099999999999999 109.397 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -40.8 116.59 0.85 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 1.77 109.426 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.945 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 6.6 mtpp -163.83 149.62 11.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 5.0599999999999996 109.631 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -42.91 -15.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 2.6400000000000001 108.475 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -114.43 -4.14 22.06 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.259 -1.536 . . . . 2.5099999999999998 109.259 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.945 ' HB2' ' H ' ' A' ' 135' ' ' LYS . . . -42.96 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -1.082 . . . . 2.3199999999999998 109.485 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.79 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -168.68 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 1.6100000000000001 109.876 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -124.17 134.07 53.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 1.6499999999999999 108.911 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.1 t80 -114.79 105.89 13.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.06 -1.025 . . . . 1.6799999999999999 109.736 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.95 87.77 3.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.73999999999999999 109.888 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 140.68 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 1.22 109.058 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.436 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 42.6 p -137.56 -1.0 2.11 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.667 -0.646 . . . . 1.3300000000000001 109.453 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.566 ' N ' ' OG1' ' A' ' 71' ' ' THR . 5.1 mt-30 -151.26 167.27 28.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 3.2999999999999998 109.881 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 146' ' ' VAL . 2.9 p -175.73 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 2.2599999999999998 109.416 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.524 ' OG ' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -131.53 131.3 43.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 2.7599999999999998 109.778 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.694 HD21 HG13 ' A' ' 58' ' ' VAL . 5.2 tp -110.4 118.86 37.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 4.5700000000000003 109.324 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -123.19 175.19 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 3.0699999999999998 109.502 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.681 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -165.66 -41.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.0 109.343 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 150' ' ' THR . 0.3 OUTLIER 50.25 170.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 2.1499999999999999 109.447 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.51 -177.69 4.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 2.8199999999999998 109.546 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 153' ' ' THR . 5.7 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.004 -0.998 . . . . 3.54 109.428 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.6 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.321 0.581 . . . . 5.4699999999999998 109.545 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.9 m 156.12 78.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 4.5300000000000002 109.479 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.9 OUTLIER -167.4 -156.12 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 5.1399999999999997 109.44 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 3' ' ' LEU . 11.0 p30 -56.27 -147.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 5.3799999999999999 109.411 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.539 ' C ' ' O ' ' A' ' 4' ' ' ASP . 2.9 p 36.12 -155.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 4.8300000000000001 109.532 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.0 109.09 10.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 3.4300000000000002 109.445 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 150' ' ' THR . 1.0 OUTLIER -51.53 165.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 2.8300000000000001 109.359 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -134.06 96.33 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 4.75 109.531 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 9' ' ' LEU . 12.4 mt -66.03 -40.78 91.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 4.9500000000000002 109.403 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.838 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -114.92 94.21 37.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.853 . . . . 2.8599999999999999 109.004 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 45.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.791 2.327 . . . . 3.8300000000000001 112.557 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 10' ' ' LEU . 34.1 t60 -137.94 130.78 29.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.023 . . . . 2.52 109.575 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 t -170.08 70.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 1.97 109.376 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.5 m -164.66 63.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.96 109.629 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.824 ' CD2' HD11 ' A' ' 143' ' ' ILE . 4.3 m-30 -67.73 27.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.76 109.118 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.706 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.09 -40.05 12.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.1799999999999999 109.867 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 13.4 mm-40 -109.71 -73.09 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 2.1299999999999999 109.671 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -88.04 145.55 25.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 2.2599999999999998 109.445 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' SD ' ' A' ' 37' ' ' MET . 7.1 mt -62.17 -59.22 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 2.6000000000000001 109.437 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.28 169.92 14.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 1.6200000000000001 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.445 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 43.2 Cg_endo -72.2 5.04 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.852 2.368 . . . . 1.7 112.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.978 ' CH2' HG21 ' A' ' 146' ' ' VAL . 10.8 m95 -76.17 -175.47 3.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.4199999999999999 109.463 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 1.6399999999999999 109.237 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.054 ' O ' HD12 ' A' ' 24' ' ' LEU . 3.3 pp -142.84 131.96 23.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 2.0499999999999998 109.433 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.12 170.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 1.72 109.782 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.88 -31.09 8.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.029 -1.229 . . . . 1.7 110.029 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.82 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.97 -142.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.271 . . . . 0.96999999999999997 109.417 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.82 ' N ' ' OG1' ' A' ' 27' ' ' THR . 90.1 p -90.81 138.53 31.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.975 . . . . 1.8 109.45 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 28' ' ' SER . 4.9 mt-10 -41.38 104.19 0.33 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 2.3999999999999999 109.179 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HG2' HD22 ' A' ' 24' ' ' LEU . 51.3 Cg_exo -46.78 156.73 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.366 2.044 . . . . 1.1299999999999999 111.854 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -143.42 122.04 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 1.05 110.09 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.715 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.62 85.26 3.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 1.8200000000000001 109.501 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 1.1699999999999999 109.761 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.24 -67.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 2.21 109.522 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.706 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.49 48.48 0.75 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.629 -1.389 . . . . 1.1899999999999999 109.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.58 ' HB2' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -170.69 148.48 2.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.126 -1.22 . . . . 2.9100000000000001 109.657 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 19' ' ' LEU . 36.4 ttp -109.77 128.63 55.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.93000000000000005 109.107 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -123.46 159.97 27.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.2 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m -128.88 134.51 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.901 -0.777 . . . . 1.3700000000000001 108.901 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.612 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -73.57 106.51 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.825 . . . . 4.79 109.705 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.2 mm? -118.15 61.04 4.01 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.276 -0.89 . . . . 3.54 109.334 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.37 -91.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.726 2.284 . . . . 3.7400000000000002 112.283 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -150.89 158.88 27.89 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.516 -1.434 . . . . 2.0299999999999998 109.516 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.92 42.59 1.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 2.4100000000000001 109.459 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.693 HE21 ' C ' ' A' ' 134' ' ' GLY . 3.8 mm100 -99.87 148.26 24.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 2.96 109.297 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.94 -69.59 0.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.959 -1.256 . . . . 2.0800000000000001 109.959 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.686 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.8 p30 -99.79 145.26 29.85 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.129 -1.218 . . . . 3.6099999999999999 109.616 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.75 -20.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.892 2.395 . . . . 2.3599999999999999 112.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.686 ' CE3' ' OD1' ' A' ' 47' ' ' ASN . 1.3 p-90 -119.49 36.94 4.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 3.8700000000000001 110.355 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 8.5 m-20 -79.81 -0.35 34.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.091 -1.005 . . . . 2.3799999999999999 109.097 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 27' ' ' THR . . . -166.43 126.61 1.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 1.1100000000000001 109.315 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' C ' HD23 ' A' ' 53' ' ' LEU . . . 169.0 -173.91 43.51 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.84 -1.304 . . . . 0.93999999999999995 109.84 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' C ' HG22 ' A' ' 54' ' ' VAL . 5.3 mt -106.9 -178.02 3.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.148 . . . . 0.95999999999999996 109.545 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -165.54 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.92000000000000004 109.707 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.977 ' O ' HG12 ' A' ' 129' ' ' VAL . 37.6 t80 -179.77 137.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 1.71 109.396 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.539 HD22 ' HG3' ' A' ' 128' ' ' GLN . 2.4 m120 -119.05 86.11 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.248 -0.907 . . . . 2.7799999999999998 109.518 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.23 66.56 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 2.48 109.591 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 58' ' ' VAL . 2.5 p -166.01 85.51 0.96 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.248 -1.148 . . . . 3.79 109.528 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.57 175.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.781 2.32 . . . . 2.3999999999999999 112.212 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.427 HG21 ' HD2' ' A' ' 119' ' ' PHE . 58.1 t -136.91 131.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 3.0800000000000001 109.507 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -117.11 80.53 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 3.0499999999999998 109.475 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 61' ' ' GLY . 28.6 tt0 -35.23 118.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -1.087 . . . . 6.0499999999999998 109.589 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 129.15 -39.48 1.84 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.646 -1.382 . . . . 2.54 109.646 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.9 mt-10 -99.94 173.06 6.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 4.0300000000000002 109.62 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.5 m -119.34 143.63 47.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 2.9100000000000001 109.326 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.642 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 27.5 m-85 -108.81 -178.39 3.57 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 2.3799999999999999 109.659 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.8 t -151.7 158.36 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 2.6099999999999999 109.497 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.586 HD12 HD22 ' A' ' 148' ' ' LEU . 11.7 tp -143.05 112.01 6.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 3.6099999999999999 109.68 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.31 86.81 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 2.27 108.787 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.9 p90 -93.98 141.51 28.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 2.0099999999999998 111.16 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 2.7 p -84.82 88.55 7.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 1.8 108.3 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -129.68 156.96 43.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.117 . . . . 0.95999999999999996 110.756 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.8 p -147.36 120.11 8.64 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.596 -0.89 . . . . 0.93000000000000005 108.596 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.595 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -88.13 133.36 34.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.67000000000000004 109.839 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.456 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.8 116.9 16.05 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.431 -0.793 . . . . 0.96999999999999997 109.078 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.595 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -66.07 -142.53 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.676 0 C-N-CA 124.29 -1.129 . . . . 1.02 112.551 -0.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.652 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -106.86 154.79 20.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 1.75 109.724 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.8 mtm 167.08 169.67 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.778 . . . . 2.1600000000000001 109.092 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.15 131.65 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.872 2.381 . . . . 1.3799999999999999 112.55 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.956 HG12 ' OH ' ' A' ' 139' ' ' TYR . 1.2 m -107.26 174.03 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 2.0099999999999998 109.279 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -126.48 98.29 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 6.0099999999999998 109.804 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -102.68 155.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.27 -0.894 . . . . 3.7599999999999998 109.165 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.863 HD21 ' CE1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -147.69 157.98 43.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 2.29 109.798 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.4 OUTLIER -151.98 164.4 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 1.8899999999999999 109.38 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 146.73 -159.24 27.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.612 -1.395 . . . . 1.49 109.612 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.684 ' OE1' ' CE1' ' A' ' 119' ' ' PHE . 7.3 pt-20 -90.2 -155.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.129 . . . . 2.54 109.45 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . -175.67 72.9 0.08 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.567 -1.413 . . . . 1.3799999999999999 109.567 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -143.12 -88.48 0.1 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 2.54 109.655 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . -57.09 -136.16 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.591 -1.404 . . . . 4.1399999999999997 109.591 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.508 ' O ' ' C ' ' A' ' 91' ' ' TYR . . . -63.66 36.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -1.13 . . . . 5.1299999999999999 109.489 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 36.03 52.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 5.79 109.4 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.619 ' CZ ' ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -82.01 113.63 20.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 5.7400000000000002 109.53 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -111.34 172.16 7.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 2.27 109.988 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.76 -18.99 5.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.892 -0.781 . . . . 3.2799999999999998 108.892 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.94 34.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 3.6499999999999999 109.308 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 82.18 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 4.5999999999999996 109.428 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -103.41 156.86 17.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 3.46 109.093 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -146.24 7.86 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.696 -1.362 . . . . 3.6699999999999999 109.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -120.69 75.62 1.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.167 -1.196 . . . . 3.79 109.78 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.704 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -120.34 86.51 38.74 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 1.96 109.242 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.641 ' O ' HD22 ' A' ' 102' ' ' LEU . 13.1 Cg_exo -66.52 127.54 17.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.149 2.566 . . . . 2.9700000000000002 112.82 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 101' ' ' PRO . 3.5 mm? -118.57 147.61 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 3.0600000000000001 108.999 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.578 ' O ' ' O ' ' A' ' 74' ' ' ALA . 5.0 t -97.61 -170.58 2.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 2.3399999999999999 109.828 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 105' ' ' GLU . . . -103.72 36.34 4.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.691 -1.364 . . . . 2.1699999999999999 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' H ' HG23 ' A' ' 103' ' ' THR . 71.3 mt-10 -156.09 148.21 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 3.02 109.262 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -40.8 118.26 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.696 2.264 . . . . 1.4199999999999999 112.143 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.663 ' HB1' ' NH1' ' A' ' 109' ' ' ARG . . . -160.9 138.34 9.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 1.3700000000000001 109.648 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.531 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.54 151.51 21.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 1.72 109.907 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.663 ' NH1' ' HB1' ' A' ' 107' ' ' ALA . 3.7 mpt_? -124.36 142.14 51.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 4.7000000000000002 108.029 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.63 104.67 12.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 3.2799999999999998 110.757 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.561 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 8.8 m-30 -109.88 120.11 41.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.499 -0.926 . . . . 2.96 108.499 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.655 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -124.95 169.65 11.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 3.4100000000000001 109.67 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.5 p90 -155.23 -177.76 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 2.77 109.499 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.535 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -111.4 106.14 14.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.364 -0.835 . . . . 2.23 109.558 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.535 ' C ' ' O ' ' A' ' 114' ' ' THR . 3.8 m -36.01 129.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 4.1100000000000003 109.347 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.469 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 10.9 m120 -125.17 -7.21 7.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 6.8600000000000003 109.507 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -148.94 129.98 14.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 5.1200000000000001 109.424 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.471 ' N ' HD13 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -80.26 113.25 18.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 4.0599999999999996 109.551 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CE1' ' OE1' ' A' ' 86' ' ' GLU . 44.6 m-85 -110.02 146.94 35.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 5.4400000000000004 109.353 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.47 166.3 30.22 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.691 2.261 . . . . 4.04 112.163 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 126' ' ' PRO . 73.4 Cg_endo -81.02 -39.72 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.777 2.318 . . . . 3.8999999999999999 112.071 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -122.44 -150.93 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.874 . . . . 4.1399999999999997 109.478 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.08 -142.54 15.66 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.572 -1.411 . . . . 3.5699999999999998 109.572 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -114.33 10.94 17.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -1.094 . . . . 3.5899999999999999 109.447 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.51 ' HB1' ' C ' ' A' ' 87' ' ' GLY . . . -165.75 54.22 0.33 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 2.0800000000000001 109.545 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 55.1 Cg_endo -74.09 -158.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.846 2.364 . . . . 1.3899999999999999 112.223 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 126' ' ' PRO . . . -39.97 155.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.627 -1.389 . . . . 1.1899999999999999 109.627 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -155.2 137.85 15.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -1.159 . . . . 2.0099999999999998 109.553 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.977 HG12 ' O ' ' A' ' 55' ' ' TYR . 8.3 p -153.48 149.34 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.674 -0.861 . . . . 1.28 108.674 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -159.13 115.57 2.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.033 . . . . 0.97999999999999998 110.207 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.563 ' HA ' HG12 ' A' ' 82' ' ' VAL . 6.8 m-30 -85.63 105.29 16.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 1.73 108.435 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.863 ' CE1' HD21 ' A' ' 83' ' ' LEU . 56.9 m170 -99.43 121.24 40.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 2.3199999999999998 109.757 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.86 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -152.17 66.7 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 2.1099999999999999 109.496 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.693 ' C ' HE21 ' A' ' 45' ' ' GLN . . . -157.11 103.91 0.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 1.77 109.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -153.48 -175.34 5.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 5.0599999999999996 109.638 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -44.87 -12.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.34 -0.985 . . . . 2.6400000000000001 108.34 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -113.33 1.94 25.17 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.345 -1.502 . . . . 2.5099999999999998 109.345 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -37.44 165.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.392 -1.064 . . . . 2.3199999999999998 109.656 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.956 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -161.21 -108.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 1.6100000000000001 109.555 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -138.66 139.61 38.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 1.6499999999999999 109.111 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.659 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 30.7 t80 -124.34 120.4 32.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.062 -1.024 . . . . 1.6799999999999999 109.921 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.87 101.74 8.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.73999999999999999 109.893 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.824 HD11 ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -100.82 135.66 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.22 109.013 179.215 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.57 ' OG ' ' OG1' ' A' ' 71' ' ' THR . 3.5 p -109.16 -21.28 12.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.902 -0.777 . . . . 1.3300000000000001 108.902 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.68 ' N ' ' OG1' ' A' ' 71' ' ' THR . 2.5 pt20 -170.43 -174.94 1.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.256 -0.978 . . . . 3.2999999999999998 110.533 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.978 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.8 p -161.42 108.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.872 -0.788 . . . . 2.2599999999999998 108.872 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.11 143.27 33.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 2.7599999999999998 110.197 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.586 HD22 HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -123.9 110.27 14.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.46 -0.775 . . . . 4.5700000000000003 109.039 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.551 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -131.58 167.79 18.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 3.0699999999999998 109.808 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.7 OUTLIER -145.14 -41.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 2.0 109.328 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.515 ' N ' ' CG2' ' A' ' 150' ' ' THR . 6.9 t 64.22 103.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.435 -0.791 . . . . 2.1499999999999999 109.431 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.509 ' HB3' ' OG ' ' A' ' 2' ' ' SER . . . -118.55 99.48 6.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 2.8199999999999998 109.454 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.01 -0.995 . . . . 3.54 109.427 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.479 -0.563 . . . . 5.4699999999999998 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t 54.86 40.9 32.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 4.5300000000000002 109.442 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 4' ' ' ASP . 2.5 mt -86.62 -173.53 4.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 5.1399999999999997 109.509 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.57 ' O ' ' O ' ' A' ' 5' ' ' SER . 2.1 t70 -57.69 -140.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 5.3799999999999999 109.474 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 4' ' ' ASP . 18.1 t -51.44 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 4.8300000000000001 109.456 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -52.87 135.25 36.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 3.4300000000000002 109.446 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 150' ' ' THR . 1.4 t -75.45 76.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 2.8300000000000001 109.422 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.46 109.02 11.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 4.75 109.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.455 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -77.79 -50.1 13.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 4.9500000000000002 109.318 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.732 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -96.55 108.6 43.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 2.8599999999999999 109.352 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.7 29.13 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.089 1.86 . . . . 3.8300000000000001 111.624 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.672 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 19.4 t60 -124.36 72.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 2.52 109.586 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 5.7 t -112.06 41.67 1.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 1.97 109.318 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.623 ' C ' ' H ' ' A' ' 16' ' ' ALA . 32.7 m -127.0 64.94 1.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 1.96 109.779 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.573 ' CE1' ' NE2' ' A' ' 12' ' ' HIS . 3.5 m-85 -67.2 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.76 109.029 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.623 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.12 -20.49 23.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.1799999999999999 110.113 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 34.2 mt-10 -109.9 -83.91 0.56 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.02 -1.05 . . . . 2.1299999999999999 109.948 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 m -104.94 151.77 23.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 2.2599999999999998 109.628 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -47.99 62.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 2.6000000000000001 109.423 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 102.54 -173.03 22.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.725 -1.35 . . . . 1.6200000000000001 109.725 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 36.0 Cg_endo -69.21 -18.38 39.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 1.7 112.194 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.732 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 11.2 m0 -56.79 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 2.4199999999999999 109.139 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 1.6 m -151.43 136.78 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.6399999999999999 109.599 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 25' ' ' TYR . 9.3 tt -133.28 152.74 51.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 2.0499999999999998 109.574 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.87 177.43 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 1.72 109.444 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 93.03 -30.33 7.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.831 -1.307 . . . . 1.7 109.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.829 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.96 -141.96 0.38 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -1.185 . . . . 0.96999999999999997 109.276 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.829 ' N ' ' OG1' ' A' ' 27' ' ' THR . 23.7 p -90.68 140.27 29.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.171 -0.956 . . . . 1.8 108.989 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 2.6 mp0 -36.95 128.67 0.75 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 2.3999999999999999 109.102 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HG3' HD22 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -71.73 158.75 52.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.262 1.975 . . . . 1.1299999999999999 111.681 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -145.83 116.28 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.025 -1.047 . . . . 1.05 110.589 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -71.17 72.64 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 1.8200000000000001 109.14 178.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -73.43 -135.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 1.1699999999999999 109.78 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -41.66 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.792 . . . . 2.21 109.34 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 34.52 45.47 0.5 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.7 -1.36 . . . . 1.1899999999999999 109.7 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -164.01 146.61 9.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.097 -1.237 . . . . 2.9100000000000001 109.812 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.45 ' CG ' ' HB2' ' A' ' 30' ' ' PRO . 11.8 tmm? -108.97 124.77 51.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.93000000000000005 109.121 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 2.0 t -124.79 155.02 40.04 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 1.0600000000000001 110.378 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.751 HG23 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -127.48 164.55 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.459 -0.941 . . . . 1.3700000000000001 108.459 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' CG ' ' OG ' ' A' ' 28' ' ' SER . 21.0 m-20 -99.09 112.69 24.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 4.79 109.627 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.973 ' N ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.27 84.65 9.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 3.54 109.202 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.42 -92.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.848 2.366 . . . . 3.7400000000000002 112.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' GLY . . . -162.33 -139.99 2.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.439 . . . . 2.0299999999999998 109.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 43' ' ' GLY . . . 35.79 43.09 0.57 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.549 -1.42 . . . . 2.4100000000000001 109.549 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 46' ' ' GLY . 15.6 mm-40 -99.9 129.74 46.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -1.17 . . . . 2.96 109.489 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -35.75 -44.28 0.67 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 2.0800000000000001 109.619 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.669 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -179.95 157.49 0.79 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 3.6099999999999999 109.5 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.4 -34.97 3.39 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.794 2.329 . . . . 2.3599999999999999 112.379 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.684 ' CD1' ' O ' ' A' ' 49' ' ' TRP . 35.5 p90 -101.74 60.86 0.88 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 3.8700000000000001 109.501 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 26.8 m-20 -136.58 0.92 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 2.3799999999999999 109.483 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.41 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -162.58 -170.87 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.1100000000000001 109.459 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 -155.96 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.93999999999999995 109.517 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 53' ' ' LEU . 1.5 pt? -127.04 157.62 39.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.18 -1.188 . . . . 0.95999999999999996 109.66 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 55' ' ' TYR . 1.3 p -138.26 -176.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.92000000000000004 110.102 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.67 ' H ' HG22 ' A' ' 54' ' ' VAL . 30.4 t80 177.93 147.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.34 0.591 . . . . 1.71 109.576 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.485 ' ND2' ' HG2' ' A' ' 126' ' ' PRO . 8.9 m-20 -111.82 129.57 56.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.321 -0.862 . . . . 2.7799999999999998 109.48 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' H ' ' HA3' ' A' ' 127' ' ' GLY . . . 147.29 84.03 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.386 -1.486 . . . . 2.48 109.386 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 58' ' ' VAL . 1.3 p -169.88 70.45 0.63 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.111 . . . . 3.79 109.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.688 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.61 159.58 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.824 2.349 . . . . 2.3999999999999999 111.963 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 2.0 t -151.39 85.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.165 -0.959 . . . . 3.0800000000000001 109.723 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.56 ' C ' ' OG ' ' A' ' 115' ' ' SER . . . -88.69 112.22 3.9 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.087 -1.605 . . . . 3.0499999999999998 109.087 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' N ' ' OG ' ' A' ' 115' ' ' SER . 34.5 mt-10 -31.01 135.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.553 -0.969 . . . . 6.0499999999999998 110.037 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 95.37 -16.54 61.06 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.972 -1.251 . . . . 2.54 109.972 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 115' ' ' SER . 17.4 mt-10 -99.89 146.93 26.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 4.0300000000000002 109.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 150' ' ' THR . 4.0 m -111.87 133.63 53.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 2.9100000000000001 109.159 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.688 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 30.8 m-85 -109.7 178.07 4.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.147 -0.97 . . . . 2.3799999999999999 109.921 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.4 t -151.8 165.55 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.504 -0.747 . . . . 2.6099999999999999 109.476 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 148' ' ' LEU . 1.9 tp -147.34 111.13 5.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.868 . . . . 3.6099999999999999 109.476 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.9 p -109.83 93.15 4.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 2.27 109.163 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.92 143.77 26.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.205 -0.935 . . . . 2.0099999999999998 110.679 -179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.5 p -101.58 108.52 20.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.43 -0.952 . . . . 1.8 108.43 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.515 ' O ' HD22 ' A' ' 102' ' ' LEU . . . -154.43 143.4 21.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.789 -1.194 . . . . 0.95999999999999996 110.597 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -113.98 127.22 55.87 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.631 -0.878 . . . . 0.93000000000000005 108.631 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -97.42 129.3 44.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.67000000000000004 110.009 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.459 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.6 115.89 14.82 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.394 -0.816 . . . . 0.96999999999999997 109.156 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -65.85 -142.54 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.435 -1.069 . . . . 1.02 112.489 -0.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -106.2 150.32 25.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 1.75 109.532 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.5 155.11 0.15 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 2.1600000000000001 109.476 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 45.5 Cg_endo -72.94 122.84 8.46 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.825 2.35 . . . . 1.3799999999999999 112.143 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 102' ' ' LEU . 1.5 m -93.85 175.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 2.0099999999999998 109.378 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.74 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.05 145.77 36.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 6.0099999999999998 109.688 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.787 HG13 ' HG2' ' A' ' 97' ' ' GLN . 1.4 p -147.29 152.4 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 3.7599999999999998 109.326 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 130' ' ' ALA . 2.6 pp -155.43 149.27 25.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 2.29 109.81 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 128' ' ' GLN . 1.1 t -144.7 152.58 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 1.8899999999999999 109.453 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 168.24 -150.24 15.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.758 -1.337 . . . . 1.49 109.758 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.539 ' C ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -90.15 -165.1 1.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -1.064 . . . . 2.54 109.598 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.54 -0.59 6.71 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 1.3799999999999999 109.526 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . 177.13 -171.98 44.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.533 -1.427 . . . . 2.54 109.533 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.788 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 48.22 17.17 0.61 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 4.1399999999999997 109.595 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 155.81 55.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -1.146 . . . . 5.1299999999999999 109.374 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -45.65 -43.18 12.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 5.79 109.526 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 91' ' ' TYR . 11.4 ptm180 -36.01 111.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 5.7400000000000002 109.431 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -100.25 164.8 11.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 2.27 109.862 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.18 -17.77 10.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.396 -0.815 . . . . 3.2799999999999998 108.829 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.414 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.64 35.38 0.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.362 -0.836 . . . . 3.6499999999999999 109.193 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -77.85 88.43 4.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 4.5999999999999996 109.605 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.787 ' HG2' HG13 ' A' ' 82' ' ' VAL . 4.0 pt20 -121.98 148.81 44.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 3.46 109.353 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.716 ' CA ' ' HE ' ' A' ' 81' ' ' ARG . . . -136.76 30.11 2.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.83 -1.308 . . . . 3.6699999999999999 109.83 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.544 ' O ' ' OH ' ' A' ' 111' ' ' TYR . 1.7 m -115.12 66.72 0.69 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -1.19 . . . . 3.79 109.636 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.89 93.45 17.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 1.96 109.563 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.6 118.42 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.713 2.276 . . . . 2.9700000000000002 112.218 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.714 HD12 HG11 ' A' ' 80' ' ' VAL . 25.3 mt -120.56 155.92 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 3.0600000000000001 109.494 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 1.3 t -110.39 -167.29 1.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 2.3399999999999999 109.616 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -78.98 -25.75 59.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.761 -1.335 . . . . 2.1699999999999999 109.761 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.83 164.01 17.32 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 3.02 109.408 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -43.28 118.73 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.688 2.259 . . . . 1.4199999999999999 112.088 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.514 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . . . -135.26 117.97 16.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 1.3700000000000001 109.746 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.667 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.69 148.98 21.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 1.72 110.21 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.667 ' NH1' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -127.84 139.69 52.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.21 -1.033 . . . . 4.7000000000000002 108.21 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.99 104.87 9.82 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.957 -0.697 . . . . 3.2799999999999998 109.991 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.544 ' OH ' ' O ' ' A' ' 99' ' ' SER . 41.2 m-85 -109.69 129.61 55.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.221 -0.924 . . . . 2.96 108.867 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -129.42 157.01 43.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.833 . . . . 3.4100000000000001 109.775 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.539 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 3.4 p90 -146.28 -178.51 6.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 2.77 109.552 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.57 137.03 47.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.463 -0.773 . . . . 2.23 109.642 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.56 ' OG ' ' C ' ' A' ' 61' ' ' GLY . 22.8 t -64.11 118.39 8.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 4.1100000000000003 109.602 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -18.82 13.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 6.8600000000000003 109.233 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -132.5 -162.6 1.25 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.292 -0.88 . . . . 5.1200000000000001 109.568 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.708 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -118.92 133.82 55.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.266 -0.896 . . . . 4.0599999999999996 109.506 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -153.66 70.57 6.62 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 5.4400000000000004 109.534 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.443 ' HB2' ' H ' ' A' ' 123' ' ' GLY . 39.4 Cg_exo -56.75 169.46 1.8 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.815 2.343 . . . . 4.04 112.009 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.16 -31.41 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.754 2.302 . . . . 3.8999999999999999 112.06 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 123' ' ' GLY . 24.1 t0 -119.25 -11.94 9.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 4.1399999999999997 109.572 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -56.94 -150.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 3.5699999999999998 109.564 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 123' ' ' GLY . 0.5 OUTLIER -36.33 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -1.152 . . . . 3.5899999999999999 109.415 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -115.61 150.11 44.18 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 2.0800000000000001 109.445 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HG2' ' ND2' ' A' ' 56' ' ' ASN . 43.9 Cg_endo -71.9 -158.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.761 2.307 . . . . 1.3899999999999999 112.252 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . -82.34 166.62 46.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.552 -1.419 . . . . 1.1899999999999999 109.552 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.68 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 1.3 tt0 -147.25 142.62 27.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 2.0099999999999998 109.867 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 129' ' ' VAL . 5.2 p -163.24 110.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.278 -1.008 . . . . 1.28 108.278 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -118.83 132.27 56.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.97999999999999998 110.871 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.464 ' HB2' ' CD2' ' A' ' 53' ' ' LEU . 4.0 m-30 -101.02 111.83 24.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 1.73 108.199 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -99.37 131.12 45.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 2.3199999999999998 109.565 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 141' ' ' PHE . 3.0 mt -133.23 -43.45 0.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 109.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -38.79 127.43 1.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.841 -1.304 . . . . 1.77 109.841 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.716 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 31.4 mtmt -164.69 134.79 3.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 5.0599999999999996 109.584 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -40.29 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.389 -0.967 . . . . 2.6400000000000001 108.389 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.13 14.8 7.85 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.047 -1.621 . . . . 2.5099999999999998 109.047 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.716 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -49.5 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -1.038 . . . . 2.3199999999999998 110.062 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.673 ' OH ' HG12 ' A' ' 80' ' ' VAL . 8.3 p90 -160.03 -130.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.004 -1.06 . . . . 1.6100000000000001 109.429 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 22.5 mt-10 -116.93 135.81 53.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 1.6499999999999999 109.33 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 14.8 t80 -118.51 108.45 15.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 1.6799999999999999 110.038 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.504 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 78.7 m -111.94 100.83 9.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.297 -0.877 . . . . 0.73999999999999999 110.003 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.99 143.75 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 1.22 109.086 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' PHE . 6.0 p -131.8 -5.84 3.6 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.64 . . . . 1.3300000000000001 109.275 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.571 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.3 mt-30 -153.85 160.02 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.299 -0.961 . . . . 3.2999999999999998 110.233 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.613 ' N ' ' OG1' ' A' ' 13' ' ' THR . 10.8 p -178.15 124.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.007 -0.738 . . . . 2.2599999999999998 109.007 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.95 135.41 29.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 2.7599999999999998 109.911 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.584 HD11 HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -108.38 144.51 35.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 4.5700000000000003 109.362 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 2.8 t -164.97 -173.26 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 3.0699999999999998 109.559 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.713 HG23 ' H ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -139.13 -103.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 2.0 109.437 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.713 ' H ' HG23 ' A' ' 150' ' ' THR . 0.5 OUTLIER 84.88 92.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.86 . . . . 2.1499999999999999 109.449 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.87 -155.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 2.8199999999999998 109.44 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.568 ' OXT' HG22 ' A' ' 153' ' ' THR . 16.6 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.0 -1.0 . . . . 3.54 109.452 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.425 -0.583 . . . . 5.4699999999999998 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 1.1 p -95.79 -57.89 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 4.5300000000000002 109.432 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.515 ' H ' ' HB2' ' A' ' 151' ' ' SER . 1.0 OUTLIER 52.79 20.6 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 5.1399999999999997 109.325 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 1.8 m-20 -63.64 83.72 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.712 -0.617 . . . . 5.3799999999999999 109.498 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ASP . 33.9 t 58.38 150.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 4.8300000000000001 109.48 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -53.83 178.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 3.4300000000000002 109.502 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLU . 58.0 t -150.88 75.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 2.8300000000000001 109.523 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -36.07 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 4.75 109.423 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . 12.1 mt -103.82 11.43 35.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.284 -0.885 . . . . 4.9500000000000002 109.679 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.705 ' O ' ' N ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -114.38 113.7 45.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 2.8599999999999999 108.444 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.51 19.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.647 2.232 . . . . 3.8300000000000001 113.66 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.705 ' N ' ' O ' ' A' ' 10' ' ' LEU . 54.6 t-80 -170.69 136.89 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.674 -1.266 . . . . 2.52 110.404 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.591 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.3 OUTLIER -170.83 68.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 1.97 109.341 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 13' ' ' THR . 50.5 m -170.31 87.66 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 1.96 110.083 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -90.24 41.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 1.76 109.056 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.22 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 1.1799999999999999 109.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -109.75 39.47 2.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.195 -0.941 . . . . 2.1299999999999999 109.696 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.21 148.89 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 2.2599999999999998 109.53 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 19' ' ' LEU . 1.6 pp -74.06 -10.85 60.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 2.6000000000000001 109.427 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.03 -146.81 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.357 -1.497 . . . . 1.6200000000000001 109.357 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 22' ' ' TRP . 64.6 Cg_endo -81.53 -23.1 5.16 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.893 2.396 . . . . 1.7 112.076 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.679 ' CH2' HG11 ' A' ' 146' ' ' VAL . 11.3 m0 -45.94 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 2.4199999999999999 108.896 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -113.53 164.81 13.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 1.6399999999999999 108.985 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' A' ' 30' ' ' PRO . 3.0 mt -156.54 132.63 9.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 2.0499999999999998 109.78 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.733 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 171.63 -167.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 1.72 109.394 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.0 -30.39 0.93 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.754 -1.339 . . . . 1.7 109.754 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.746 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -109.87 -141.12 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -1.186 . . . . 0.96999999999999997 109.445 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.746 ' N ' ' OG1' ' A' ' 27' ' ' THR . 11.4 p -90.92 -162.75 0.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.084 -0.709 . . . . 1.8 109.084 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.4 111.63 48.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 2.3999999999999999 109.134 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.818 ' HG2' HD13 ' A' ' 24' ' ' LEU . 53.0 Cg_exo -50.04 140.87 31.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.167 1.911 . . . . 1.1299999999999999 111.786 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.19 112.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.033 . . . . 1.05 109.898 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.422 ' HA ' ' CB ' ' A' ' 37' ' ' MET . 0.9 OUTLIER -90.03 127.24 36.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 1.8200000000000001 109.349 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -120.8 -110.07 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.955 . . . . 1.1699999999999999 109.62 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 3.4 p-10 -60.28 63.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.96 . . . . 2.21 109.595 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 69.33 -17.51 0.6 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.676 -1.369 . . . . 1.1899999999999999 109.676 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -106.04 170.74 7.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -1.194 . . . . 2.9100000000000001 109.736 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.492 ' CE ' HD11 ' A' ' 24' ' ' LEU . 9.6 ptt? -148.28 166.23 28.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.93000000000000005 109.09 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -146.65 150.79 36.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 1.0600000000000001 110.535 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.907 HG23 HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.97 148.6 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.245 -1.02 . . . . 1.3700000000000001 108.245 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 1.1 m-20 -83.85 105.85 15.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 4.79 109.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.907 HD21 HG23 ' A' ' 39' ' ' VAL . 1.8 mm? -112.97 78.25 2.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 3.54 108.898 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 62.0 Cg_endo -77.26 -159.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.771 2.314 . . . . 3.7400000000000002 112.388 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.87 63.01 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 2.0299999999999998 109.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.26 36.01 0.96 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.451 -1.46 . . . . 2.4100000000000001 109.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 6.1 mm-40 -99.97 112.7 24.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -1.126 . . . . 2.96 109.544 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.75 -10.94 2.51 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.571 -1.412 . . . . 2.0800000000000001 109.571 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.736 HD22 ' CG ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -165.85 156.61 11.76 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -1.178 . . . . 3.6099999999999999 109.444 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HG3' ' NH1' ' A' ' 81' ' ' ARG . 44.5 Cg_endo -72.6 -27.27 15.58 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.711 2.274 . . . . 2.3599999999999999 112.216 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.615 ' CD1' ' ND2' ' A' ' 47' ' ' ASN . 1.6 p90 -83.72 35.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 3.8700000000000001 109.444 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.736 ' CG ' HD22 ' A' ' 47' ' ' ASN . 19.8 m-20 -136.82 46.33 2.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 2.3799999999999999 109.465 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 172.5 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 1.1100000000000001 109.451 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.86 -163.33 25.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.534 -1.426 . . . . 0.93999999999999995 109.534 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.75 -172.7 2.39 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.223 -1.163 . . . . 0.95999999999999996 109.388 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 55' ' ' TYR . 93.2 t -162.08 167.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.92000000000000004 108.943 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.642 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.0 t80 -176.19 172.94 2.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 1.71 109.516 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -118.26 -164.61 1.03 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.218 -0.926 . . . . 2.7799999999999998 109.626 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.594 ' O ' HD12 ' A' ' 10' ' ' LEU . . . 79.96 64.84 1.82 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.517 -1.433 . . . . 2.48 109.517 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -152.23 79.78 6.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.176 -1.191 . . . . 3.79 109.405 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.77 120.33 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.737 2.292 . . . . 2.3999999999999999 112.08 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG12 ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -105.41 119.15 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 3.0800000000000001 109.619 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.677 ' N ' ' OH ' ' A' ' 66' ' ' TYR . . . -128.58 95.93 0.4 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.332 -1.507 . . . . 3.0499999999999998 109.332 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.674 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -35.2 144.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 6.0499999999999998 109.372 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.34 -36.39 4.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 2.54 109.522 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 114' ' ' THR . 28.2 mt-10 -99.74 178.58 4.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -1.167 . . . . 4.0300000000000002 109.224 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -132.51 119.91 21.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.126 -0.984 . . . . 2.9100000000000001 109.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' OH ' ' N ' ' A' ' 61' ' ' GLY . 56.1 m-85 -94.06 162.93 13.68 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.302 -0.874 . . . . 2.3799999999999999 109.431 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.7 t -146.9 108.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.693 . . . . 2.6099999999999999 109.557 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 69' ' ' SER . 7.8 tt -96.29 144.83 26.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.071 -1.018 . . . . 3.6099999999999999 109.22 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.877 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.85 104.85 5.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.888 . . . . 2.27 108.98 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 109' ' ' ARG . 2.9 p90 -94.17 143.48 26.34 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.082 -1.047 . . . . 2.0099999999999998 110.899 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.62 96.74 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.557 -0.905 . . . . 1.8 108.557 179.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -164.21 178.6 7.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.874 -1.141 . . . . 0.95999999999999996 110.838 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 153.68 36.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.064 -0.717 . . . . 0.93000000000000005 109.064 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -95.85 138.83 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.67000000000000004 109.558 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.508 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -137.47 114.28 9.58 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 121.156 -0.965 . . . . 0.96999999999999997 109.712 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 31.5 Cg_endo -64.64 -144.38 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.075 -1.219 . . . . 1.02 111.875 -0.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.85 150.78 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.59 -1.319 . . . . 1.75 109.589 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.557 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER 159.65 156.98 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 2.1600000000000001 109.334 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.574 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 62.5 Cg_endo -76.99 147.96 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.918 2.412 . . . . 1.3799999999999999 112.422 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.733 HG11 HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -111.19 -172.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 2.0099999999999998 109.343 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.661 ' N ' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -122.43 142.75 50.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 6.0099999999999998 109.556 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.3 p -146.92 149.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.243 -0.91 . . . . 3.7599999999999998 109.396 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -151.27 151.55 31.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 2.29 109.735 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.524 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -150.76 169.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 1.8899999999999999 109.345 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.81 -155.96 26.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.631 -1.388 . . . . 1.49 109.631 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.72 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -90.39 -174.13 4.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.127 . . . . 2.54 109.495 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.81 36.08 1.07 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.496 -1.442 . . . . 1.3799999999999999 109.496 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.468 ' N ' ' HB2' ' A' ' 91' ' ' TYR . . . -92.41 47.22 2.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.563 -1.415 . . . . 2.54 109.563 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 64.94 -121.11 20.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.417 -1.473 . . . . 4.1399999999999997 109.417 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -44.73 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -1.164 . . . . 5.1299999999999999 109.193 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 89' ' ' GLY . 5.0 m-85 -60.04 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.378 -0.826 . . . . 5.79 109.528 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.689 ' H ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -51.42 173.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 5.7400000000000002 109.588 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -122.51 174.43 7.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 2.27 109.99 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -126.69 -18.04 4.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.73 . . . . 3.2799999999999998 109.115 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.644 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.74 41.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 3.6499999999999999 109.356 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.96 81.22 8.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 4.5999999999999996 109.602 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.1 tt0 -127.07 114.93 18.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.206 -0.934 . . . . 3.46 109.046 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.34 21.97 29.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.805 -1.318 . . . . 3.6699999999999999 109.805 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 97' ' ' GLN . 1.7 m -110.11 90.86 3.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -1.17 . . . . 3.79 109.531 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.678 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -128.07 86.86 57.01 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 1.96 109.57 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.81 118.94 5.91 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.964 2.443 . . . . 2.9700000000000002 112.395 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.733 HD12 HG11 ' A' ' 80' ' ' VAL . 12.2 mt -120.89 168.02 11.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 3.0600000000000001 109.346 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -122.82 -177.68 3.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 2.3399999999999999 109.563 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -91.6 59.21 2.95 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.513 -1.435 . . . . 2.1699999999999999 109.513 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -171.78 131.72 0.75 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 3.02 109.191 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -41.04 122.65 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.488 2.125 . . . . 1.4199999999999999 112.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.84 146.06 9.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 1.3700000000000001 109.565 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.434 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.75 150.31 21.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 1.72 110.26 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -126.47 152.33 46.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.379 -1.341 . . . . 4.7000000000000002 107.379 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' O ' ' CD1' ' A' ' 111' ' ' TYR . 13.8 mp0 -125.02 158.29 34.08 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.375 -0.93 . . . . 3.2799999999999998 110.701 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.653 ' CD1' ' O ' ' A' ' 110' ' ' GLU . 42.9 m-85 -160.57 103.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.474 -0.936 . . . . 2.96 108.474 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.682 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -114.02 169.6 8.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 3.4100000000000001 109.836 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.644 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 3.7 p90 -177.5 -173.5 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 2.77 109.857 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -119.69 150.91 39.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.52 -0.737 . . . . 2.23 109.418 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.547 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -90.2 169.77 10.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 4.1100000000000003 109.842 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -125.07 -20.28 4.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 6.8600000000000003 109.285 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 118' ' ' THR . 9.3 tt -128.46 170.86 12.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 5.1200000000000001 109.305 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.884 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -89.76 107.75 19.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 4.0599999999999996 109.542 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.715 ' CE1' HD22 ' A' ' 117' ' ' LEU . 42.5 m-85 -117.14 75.95 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 5.4400000000000004 109.499 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.56 163.27 32.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.682 2.255 . . . . 4.04 112.269 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.03 -12.97 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.846 2.364 . . . . 3.8999999999999999 111.965 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.46 129.44 55.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 4.1399999999999997 109.487 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.64 -65.18 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.425 -1.47 . . . . 3.5699999999999998 109.425 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -172.91 47.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -1.135 . . . . 3.5899999999999999 109.463 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 127' ' ' GLY . . . 179.92 58.83 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 2.0800000000000001 109.585 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.22 -2.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.11 2.54 . . . . 1.3899999999999999 112.078 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 122.29 150.21 8.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.286 -1.526 . . . . 1.1899999999999999 109.286 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -146.99 129.73 16.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.236 . . . . 2.0099999999999998 109.846 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 1.4 p -153.15 94.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.289 -1.004 . . . . 1.28 108.289 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.571 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -102.9 136.42 42.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.282 -0.886 . . . . 0.97999999999999998 110.563 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.515 ' HB2' HD12 ' A' ' 53' ' ' LEU . 2.9 m-30 -105.92 96.04 6.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.825 -0.805 . . . . 1.73 108.825 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 54.8 m170 -99.95 129.08 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 2.3199999999999998 109.785 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.616 HD22 ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -132.05 -28.4 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 2.1099999999999999 109.45 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -46.28 144.95 3.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 1.77 109.693 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.881 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 14.6 mtpp -164.08 141.04 6.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.139 . . . . 5.0599999999999996 109.668 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.33 -20.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 2.6400000000000001 108.602 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -131.36 18.1 4.99 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 2.5099999999999998 108.943 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.881 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -49.45 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 2.3199999999999998 110.218 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.6 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -153.78 -110.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 1.6100000000000001 109.394 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.63 152.74 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.896 -1.128 . . . . 1.6499999999999999 109.023 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.616 ' CG ' HD22 ' A' ' 133' ' ' LEU . 50.3 t80 -134.29 123.8 24.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.006 -1.059 . . . . 1.6799999999999999 110.181 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 1.8 m -112.67 118.78 35.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.73999999999999999 109.43 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.03 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.006 0.908 . . . . 1.22 109.859 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.674 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 93.0 p -135.37 -19.75 1.66 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.27 -0.641 . . . . 1.3300000000000001 109.27 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -148.9 163.18 38.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.917 . . . . 3.2999999999999998 109.484 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.679 HG11 ' CH2' ' A' ' 22' ' ' TRP . 10.5 p -177.2 123.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2599999999999998 109.556 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.52 151.61 9.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 2.7599999999999998 109.524 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 148' ' ' LEU . 1.0 OUTLIER -115.96 173.19 6.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 4.5700000000000003 109.584 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER -157.01 -166.89 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 3.0699999999999998 109.467 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.653 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.2 t -165.02 -153.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 2.0 109.484 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.515 ' HB2' ' H ' ' A' ' 3' ' ' LEU . 2.6 p -151.26 99.48 2.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 2.1499999999999999 109.472 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.88 -172.71 4.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 2.8199999999999998 109.47 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.981 -1.009 . . . . 3.54 109.463 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.478 -0.564 . . . . 5.4699999999999998 109.478 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 t 56.5 -73.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 4.5300000000000002 109.425 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER 53.59 -156.83 0.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 5.1399999999999997 109.467 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' O ' ' C ' ' A' ' 5' ' ' SER . 7.8 t0 55.8 -170.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 5.3799999999999999 109.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.528 ' C ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -36.21 147.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 4.8300000000000001 109.454 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 8' ' ' GLU . 9.3 mt-10 -71.25 132.6 45.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 3.4300000000000002 109.533 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.959 HG23 ' OG ' ' A' ' 151' ' ' SER . 2.3 t -63.73 82.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 2.8300000000000001 109.369 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' GLU . 1.8 tp10 -86.04 84.53 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 4.75 109.503 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 59' ' ' PRO . 1.5 mt -67.01 -22.0 65.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 4.9500000000000002 109.297 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 10' ' ' LEU . 3.1 tm? -126.26 78.16 71.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 2.8599999999999999 108.679 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.32 40.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.03 2.487 . . . . 3.8300000000000001 112.77 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.811 ' H ' HD13 ' A' ' 10' ' ' LEU . 9.3 t60 -136.2 94.29 3.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 2.52 109.516 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -140.19 52.66 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 1.97 109.328 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -146.48 71.92 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 1.96 109.676 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 19' ' ' LEU . 4.7 m-30 -63.0 41.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 1.76 109.048 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.654 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -90.1 -39.13 13.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 1.1799999999999999 109.959 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 8.4 mt-10 -109.74 -83.71 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 2.1299999999999999 109.856 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -103.34 144.11 31.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 2.2599999999999998 109.589 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 15' ' ' PHE . 4.5 mt -58.15 -55.85 29.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 2.6000000000000001 109.469 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 102.53 -163.66 16.52 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.4 . . . . 1.6200000000000001 109.601 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.04 -36.91 67.06 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.74 2.294 . . . . 1.7 112.117 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.837 ' CH2' HG11 ' A' ' 146' ' ' VAL . 21.2 m95 -55.09 159.91 2.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 2.4199999999999999 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.06 177.29 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 1.6399999999999999 109.342 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 24' ' ' LEU . 1.3 pt? -176.06 151.53 1.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 2.0499999999999998 109.631 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.685 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 170.32 178.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 1.72 109.713 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.585 ' C ' ' HB2' ' A' ' 51' ' ' ALA . . . 86.22 -4.55 85.89 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.297 . . . . 1.7 109.859 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.903 ' OG1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.74 -143.17 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.27 . . . . 0.96999999999999997 109.504 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.792 ' N ' ' OG1' ' A' ' 27' ' ' THR . 86.1 p -91.5 -151.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.314 -0.866 . . . . 1.8 109.003 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -90.68 110.41 41.22 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 2.3999999999999999 109.102 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 56.4 Cg_endo -76.43 143.12 24.38 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.144 1.896 . . . . 1.1299999999999999 111.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -144.65 122.03 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 1.05 110.631 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.27 84.6 5.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.682 . . . . 1.8200000000000001 109.182 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.75 -140.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.1699999999999999 109.976 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.54 -68.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 2.21 109.401 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.638 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.46 43.85 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.438 -1.465 . . . . 1.1899999999999999 109.438 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.53 145.49 11.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 2.9100000000000001 109.63 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 37' ' ' MET . 18.4 tmm? -111.23 132.75 54.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.93000000000000005 109.042 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.3 m -123.48 152.11 42.05 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0600000000000001 110.24 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG13 ' SD ' ' A' ' 37' ' ' MET . 3.4 m -135.25 115.62 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.392 -0.966 . . . . 1.3700000000000001 108.392 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.794 ' O ' HD22 ' A' ' 41' ' ' LEU . 3.4 m-20 -72.41 123.64 23.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 4.79 109.929 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.903 HD21 ' OG1' ' A' ' 27' ' ' THR . 3.7 mm? -132.52 61.07 54.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.912 . . . . 3.54 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 43' ' ' GLY . 53.8 Cg_endo -96.05 -43.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.456 2.771 . . . . 3.7400000000000002 112.164 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 42' ' ' PRO . . . -16.76 -108.13 0.0 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 111.771 -0.532 . . . . 2.0299999999999998 111.771 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.07 61.63 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.197 -1.561 . . . . 2.4100000000000001 109.197 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 136' ' ' ALA . 2.7 mm100 -99.37 97.15 8.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -1.208 . . . . 2.96 109.7 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.51 58.92 3.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.658 -1.377 . . . . 2.0800000000000001 109.658 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.586 ' C ' ' H ' ' A' ' 49' ' ' TRP . 0.8 OUTLIER -152.51 90.19 3.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.6099999999999999 109.464 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.62 2.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.907 2.405 . . . . 2.3599999999999999 112.503 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.685 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -127.67 34.54 4.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 3.8700000000000001 109.599 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.685 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 1.4 m-20 -109.98 -2.25 17.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 2.3799999999999999 109.57 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB2' ' C ' ' A' ' 26' ' ' GLY . . . -176.9 172.14 2.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -0.964 . . . . 1.1100000000000001 109.689 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.638 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 144.3 178.0 19.63 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.718 -1.353 . . . . 0.93999999999999995 109.718 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.567 ' C ' HG22 ' A' ' 54' ' ' VAL . 8.2 mt -88.14 -176.57 5.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -1.092 . . . . 0.95999999999999996 109.234 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.23 162.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.92000000000000004 110.015 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.589 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 26.3 t80 175.83 146.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.586 -0.696 . . . . 1.71 109.297 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.589 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -112.93 -164.69 0.93 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 109.494 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.24 56.65 7.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.647 -1.381 . . . . 2.48 109.647 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.847 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.5 p -126.06 92.02 46.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 3.79 109.377 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.548 ' HG2' HD13 ' A' ' 9' ' ' LEU . 61.1 Cg_endo -80.39 131.4 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.718 2.279 . . . . 2.3999999999999999 112.277 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 21.1 t -141.98 113.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 3.0800000000000001 109.462 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -93.37 111.38 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.534 -1.426 . . . . 3.0499999999999998 109.534 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.506 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 1.8 tm-20 -42.47 145.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 6.0499999999999998 109.486 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.677 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 106.14 -35.02 5.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 2.54 109.633 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.622 ' O ' ' N ' ' A' ' 115' ' ' SER . 13.3 mt-10 -99.97 173.14 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 4.0300000000000002 109.558 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.578 ' O ' ' OG1' ' A' ' 150' ' ' THR . 51.7 m -121.02 143.79 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 2.9100000000000001 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.591 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 22.0 m-85 -109.31 -178.5 3.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 2.3799999999999999 109.703 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.9 t -152.21 159.18 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.487 -0.758 . . . . 2.6099999999999999 109.554 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 131' ' ' PHE . 1.8 tp -143.29 114.06 7.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 3.6099999999999999 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.8 p -109.24 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 2.27 108.878 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.3 p90 -94.08 150.19 20.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 2.0099999999999998 111.013 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.47 135.19 37.42 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.537 -0.912 . . . . 1.8 108.537 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.575 ' O ' HD22 ' A' ' 102' ' ' LEU . . . -171.68 135.16 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.011 -1.055 . . . . 0.95999999999999996 110.089 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -130.58 120.97 24.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.93000000000000005 108.979 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -96.18 138.88 33.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.67000000000000004 109.611 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.457 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.6 116.15 16.07 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.903 . . . . 0.96999999999999997 109.465 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.01 -144.44 0.17 OUTLIER 'Cis proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.217 -1.16 . . . . 1.02 112.225 0.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' OG1' ' A' ' 103' ' ' THR . 4.0 m-20 -109.21 163.17 13.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.75 110.154 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.465 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.0 mtm 165.17 168.08 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.701 -0.851 . . . . 2.1600000000000001 108.701 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.36 137.91 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.741 2.294 . . . . 1.3799999999999999 112.466 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.77 HG12 ' OH ' ' A' ' 139' ' ' TYR . 0.8 OUTLIER -112.56 -178.4 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.0099999999999998 109.198 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.666 ' N ' HG23 ' A' ' 80' ' ' VAL . 7.7 ttt180 -121.75 155.72 34.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 6.0099999999999998 109.772 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG23 ' C ' ' A' ' 81' ' ' ARG . 35.1 t -154.58 150.85 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 3.7599999999999998 109.11 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -146.78 147.03 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.091 -1.006 . . . . 2.29 109.769 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -153.66 156.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.576 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.07 -161.52 24.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 1.49 109.593 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.73 -177.06 5.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 2.54 109.536 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.22 0.19 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.56 -1.416 . . . . 1.3799999999999999 109.56 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.42 -115.9 1.15 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.409 . . . . 2.54 109.579 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . -125.47 139.04 11.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 4.1399999999999997 109.516 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 89' ' ' GLY . . . 62.62 -41.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -1.164 . . . . 5.1299999999999999 109.359 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.678 ' N ' ' O ' ' A' ' 89' ' ' GLY . 1.5 m-85 -73.75 80.23 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 5.79 109.431 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.56 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.45 -178.61 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 5.7400000000000002 109.501 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -102.47 169.81 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 2.27 110.119 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.29 -16.84 6.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.886 -0.783 . . . . 3.2799999999999998 108.886 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.64 36.45 0.9 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 3.6499999999999999 109.281 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.428 ' CG ' HG23 ' A' ' 93' ' ' THR . 29.4 mt-10 -83.15 71.45 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.95 . . . . 4.5999999999999996 109.548 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -100.07 167.27 10.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 3.46 109.467 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -146.47 8.38 1.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.695 -1.362 . . . . 3.6699999999999999 109.695 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -116.23 94.22 4.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -1.159 . . . . 3.79 109.628 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.756 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -134.1 85.36 39.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 1.96 109.485 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.99 133.28 57.2 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.957 2.438 . . . . 2.9700000000000002 112.47 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 72' ' ' ALA . 11.4 mt -148.74 123.94 10.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 3.0600000000000001 109.257 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -116.07 175.67 5.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 2.3399999999999999 109.607 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.422 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -67.52 32.93 0.21 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.395 -1.482 . . . . 2.1699999999999999 109.395 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 103' ' ' THR . 15.1 tt0 -110.41 95.44 22.46 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.357 -1.084 . . . . 3.02 109.362 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -47.29 118.34 2.81 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.572 2.182 . . . . 1.4199999999999999 112.254 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.594 ' CB ' HH12 ' A' ' 109' ' ' ARG . . . -175.73 166.79 3.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 1.3700000000000001 109.31 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -90.44 145.44 24.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 1.72 110.311 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.594 HH12 ' CB ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -108.62 138.76 44.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.711 -1.218 . . . . 4.7000000000000002 107.711 178.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.01 102.28 11.29 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.434 -0.791 . . . . 3.2799999999999998 110.526 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 12.3 m-30 -109.53 115.0 29.11 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.484 -0.932 . . . . 2.96 108.484 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.659 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -125.66 165.41 18.63 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.3 -0.875 . . . . 3.4100000000000001 109.573 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.5 p90 -154.19 -178.06 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.875 . . . . 2.77 109.511 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.539 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -105.99 101.09 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 2.23 109.513 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 34.9 p -36.22 104.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 4.1100000000000003 109.353 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.792 ' C ' HD22 ' A' ' 117' ' ' LEU . 41.1 m-20 -93.44 -32.89 14.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 6.8600000000000003 109.405 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.792 HD22 ' C ' ' A' ' 116' ' ' ASN . 4.6 mm? -122.39 -175.22 3.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 5.1200000000000001 109.28 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.53 114.95 27.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 4.0599999999999996 109.629 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 117' ' ' LEU . 5.5 m-85 -112.85 79.24 3.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.955 . . . . 5.4400000000000004 109.35 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.82 152.24 28.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.705 2.27 . . . . 4.04 112.245 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 125' ' ' ALA . 71.8 Cg_endo -80.33 -32.68 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.597 2.198 . . . . 3.8999999999999999 111.814 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 123' ' ' GLY . 24.3 m-20 -109.84 -30.34 7.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 4.1399999999999997 109.55 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -36.46 -34.04 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 3.5699999999999998 109.531 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.6 OUTLIER -173.72 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 3.5899999999999999 109.508 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -137.18 153.24 74.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 2.0800000000000001 109.566 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -68.8 -10.97 30.64 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.947 2.432 . . . . 1.3899999999999999 112.337 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.9 178.21 17.29 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 1.1899999999999999 109.348 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.584 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 1.2 tt0 -154.35 120.99 5.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -1.227 . . . . 2.0099999999999998 109.775 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 84' ' ' VAL . 16.4 t -144.42 120.7 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.711 -0.848 . . . . 1.28 108.711 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -141.38 131.55 24.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.013 . . . . 0.97999999999999998 110.444 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.472 ' HZ ' HD21 ' A' ' 68' ' ' LEU . 4.7 m-30 -94.46 115.62 27.82 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.666 -0.864 . . . . 1.73 108.666 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.581 ' O ' ' O ' ' A' ' 81' ' ' ARG . 23.8 m170 -100.02 122.81 43.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 2.3199999999999998 110.064 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -147.13 10.22 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.862 . . . . 2.1099999999999999 109.27 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.557 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -75.52 126.71 8.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.304 -1.518 . . . . 1.77 109.304 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 138' ' ' ALA . 6.7 mtpm? -165.81 131.27 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 5.0599999999999996 109.618 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.685 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -49.34 -29.89 6.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.409 -1.33 . . . . 2.6400000000000001 107.409 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -96.19 7.42 66.77 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.14 -1.984 . . . . 2.5099999999999998 108.14 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.52 -130.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.862 0.839 . . . . 2.3199999999999998 110.743 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.77 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.3 OUTLIER 162.38 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 1.6100000000000001 109.515 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.63 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -84.42 125.55 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 1.6499999999999999 109.09 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 13.6 t80 -106.39 112.78 25.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.803 . . . . 1.6799999999999999 109.285 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.7 m -113.78 96.27 5.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.1 -1.0 . . . . 0.73999999999999999 110.086 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.452 HD11 ' CG2' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -107.96 142.91 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.22 109.221 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 p -134.33 -3.82 2.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.647 -0.658 . . . . 1.3300000000000001 109.278 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 38.3 mt-30 -147.54 162.08 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 3.2999999999999998 110.124 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.837 HG11 ' CH2' ' A' ' 22' ' ' TRP . 93.2 t -160.11 79.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.955 -0.757 . . . . 2.2599999999999998 108.955 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.423 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -80.3 147.82 30.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 2.7599999999999998 110.051 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 149' ' ' THR . 1.2 tp -151.6 112.24 4.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.426 -0.796 . . . . 4.5700000000000003 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.653 ' N ' HD12 ' A' ' 148' ' ' LEU . 7.8 t -166.66 -155.86 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 3.0699999999999998 109.532 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 65' ' ' SER . 0.8 OUTLIER -144.71 -41.19 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 2.0 109.348 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.959 ' OG ' HG23 ' A' ' 7' ' ' VAL . 1.5 p -52.24 164.92 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 2.1499999999999999 109.462 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.99 96.62 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 2.8199999999999998 109.545 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 4' ' ' ASP . 31.8 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.042 -0.98 . . . . 3.54 109.428 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.528 -0.545 . . . . 5.4699999999999998 109.528 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 4' ' ' ASP . 25.2 t -58.19 -123.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 4.5300000000000002 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.492 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.8 mm? -71.52 20.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 5.1399999999999997 109.415 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.562 ' H ' ' C ' ' A' ' 2' ' ' SER . 0.3 OUTLIER 63.46 173.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.415 -0.587 . . . . 5.3799999999999999 109.415 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 4' ' ' ASP . 13.6 p 36.07 -155.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 4.8300000000000001 109.512 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.83 134.21 45.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 3.4300000000000002 109.433 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 150' ' ' THR . 0.2 OUTLIER -80.33 66.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 2.8300000000000001 109.496 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 4.75 109.44 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 -30.99 52.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 4.9500000000000002 109.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.027 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -114.95 96.11 43.81 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 2.8599999999999999 109.325 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.79 45.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.748 2.299 . . . . 3.8300000000000001 112.673 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.622 ' N ' ' O ' ' A' ' 10' ' ' LEU . 54.8 t60 -133.25 107.46 8.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.98 . . . . 2.52 109.438 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.28 59.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 1.97 109.465 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 16' ' ' ALA . 47.3 t -160.9 69.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 1.96 109.658 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.3 m-30 -62.57 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 1.76 109.209 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -83.44 -34.69 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.737 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.687 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 21.8 mm-40 -109.72 -84.71 0.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 2.1299999999999999 109.344 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 20' ' ' GLY . 3.8 p -103.04 142.87 33.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 2.2599999999999998 109.233 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.82 6.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.098 -1.001 . . . . 2.6000000000000001 109.496 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 73.64 -148.65 40.51 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.201 -1.16 . . . . 1.6200000000000001 110.201 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 22' ' ' TRP . 98.6 Cg_endo -88.94 -10.64 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.268 2.646 . . . . 1.7 111.996 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.781 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.4 m95 -54.94 -170.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 2.4199999999999999 109.757 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -128.26 166.18 19.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 1.6399999999999999 109.255 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.832 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -170.74 156.34 5.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 2.0499999999999998 109.755 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER 158.13 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 1.72 109.803 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 89.6 -28.83 6.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.965 -1.112 . . . . 1.7 110.411 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.758 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.71 -141.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.349 . . . . 0.96999999999999997 109.627 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' ' OG1' ' A' ' 27' ' ' THR . 16.3 p -91.02 133.14 35.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.459 -0.776 . . . . 1.8 109.43 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -36.99 101.34 0.22 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 2.3999999999999999 109.214 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 51.5 Cg_exo -46.63 150.5 2.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.35 2.033 . . . . 1.1299999999999999 111.709 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.7 t -136.57 117.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.998 . . . . 1.05 110.207 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -81.45 89.16 6.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.725 . . . . 1.8200000000000001 109.763 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -63.6 -140.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 1.1699999999999999 109.492 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -40.09 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 2.21 109.541 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.558 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -138.97 35.64 1.96 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.568 -1.413 . . . . 1.1899999999999999 109.568 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.17 152.1 31.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -1.128 . . . . 2.9100000000000001 109.508 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.28 134.52 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.93000000000000005 109.303 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.71 154.23 46.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.335 -0.946 . . . . 1.0600000000000001 110.471 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.5 m -123.65 134.12 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.629 -0.878 . . . . 1.3700000000000001 108.629 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.671 ' N ' ' OG ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -74.99 105.85 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 4.79 109.795 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.6 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.5 mm? -117.94 74.82 10.17 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 3.54 109.314 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.47 -56.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.784 2.323 . . . . 3.7400000000000002 112.195 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 136' ' ' ALA . . . 161.44 -150.66 20.49 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.543 -1.423 . . . . 2.0299999999999998 109.543 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.03 -0.36 6.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 2.4100000000000001 109.501 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.671 ' O ' ' N ' ' A' ' 47' ' ' ASN . 2.8 mt-30 -99.38 73.63 1.88 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.256 -1.143 . . . . 2.96 109.539 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.85 49.88 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.392 -1.483 . . . . 2.0800000000000001 109.392 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.674 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -160.84 87.33 1.74 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -1.114 . . . . 3.6099999999999999 109.429 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.59 -9.88 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.912 2.408 . . . . 2.3599999999999999 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -112.34 31.42 6.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 3.8700000000000001 109.548 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 30.6 m-20 -123.02 36.78 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 2.3799999999999999 109.364 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 27' ' ' THR . . . 175.46 119.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.1100000000000001 109.389 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 159.37 -152.71 23.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.884 -1.286 . . . . 0.93999999999999995 109.884 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -144.24 170.46 15.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.95999999999999996 109.355 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.695 HG13 ' HB2' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -152.97 172.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.05 -1.031 . . . . 0.92000000000000004 110.084 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 1.027 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 58.3 t80 -178.43 148.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 1.71 109.556 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.454 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -110.93 -164.92 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 2.7799999999999998 109.575 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.08 67.39 1.63 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.399 . . . . 2.48 109.604 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG13 HD21 ' A' ' 148' ' ' LEU . 3.9 t -147.96 91.93 4.77 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -1.185 . . . . 3.79 109.505 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.683 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 60.9 Cg_endo -80.44 154.19 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.763 2.309 . . . . 2.3999999999999999 112.128 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.592 HG13 ' CE1' ' A' ' 66' ' ' TYR . 2.0 t -151.7 148.39 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 3.0800000000000001 109.736 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -142.94 116.07 0.98 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.228 -1.549 . . . . 3.0499999999999998 109.228 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.684 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -34.35 146.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -1.151 . . . . 6.0499999999999998 109.762 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.679 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 91.75 -16.6 58.91 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.88 -1.288 . . . . 2.54 109.88 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.671 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.6 mt-10 -112.47 160.92 17.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -1.219 . . . . 4.0300000000000002 109.836 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -128.29 140.91 51.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 2.9100000000000001 109.116 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 20.9 m-85 -107.07 177.13 4.95 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.077 -1.014 . . . . 2.3799999999999999 109.885 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -147.58 165.25 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.468 -0.77 . . . . 2.6099999999999999 109.593 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 148' ' ' LEU . 8.3 tp -149.9 118.82 6.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 3.6099999999999999 109.515 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.96 80.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 2.27 109.151 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 50.2 p90 -94.44 146.14 24.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.718 . . . . 2.0099999999999998 110.831 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.17 138.48 32.81 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.642 -0.873 . . . . 1.8 108.642 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.839 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -176.24 122.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.012 -1.055 . . . . 0.95999999999999996 110.142 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -112.44 122.5 47.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.749 -0.834 . . . . 0.93000000000000005 108.749 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -91.24 132.65 35.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.258 -0.901 . . . . 0.67000000000000004 109.85 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.478 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -135.63 113.97 11.11 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.384 -0.823 . . . . 0.96999999999999997 109.28 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.578 ' O ' ' C ' ' A' ' 74' ' ' ALA . 18.7 Cg_exo -65.21 -142.25 0.15 OUTLIER 'Cis proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.321 -1.116 . . . . 1.02 112.636 -0.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.662 ' O ' ' SD ' ' A' ' 78' ' ' MET . 1.1 m-20 -108.59 154.97 21.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 1.75 109.726 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 170.34 154.44 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 2.1600000000000001 109.433 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.19 129.08 12.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.778 2.319 . . . . 1.3799999999999999 112.306 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -106.12 -178.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 2.0099999999999998 109.244 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.65 ' N ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -129.16 147.08 50.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 6.0099999999999998 109.715 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -150.0 155.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 3.7599999999999998 109.216 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.505 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -141.65 151.28 42.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.132 -0.98 . . . . 2.29 109.856 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG13 HG23 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -150.33 162.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 1.8899999999999999 109.472 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 139.56 -147.75 19.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.708 -1.357 . . . . 1.49 109.708 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.715 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.41 162.45 15.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -1.114 . . . . 2.54 109.469 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.563 ' C ' ' HB1' ' A' ' 125' ' ' ALA . . . -112.02 62.42 0.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.493 -1.443 . . . . 1.3799999999999999 109.493 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.44 -157.72 7.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 2.54 109.58 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . -101.16 -97.59 2.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.528 -1.429 . . . . 4.1399999999999997 109.528 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -36.09 -50.13 0.69 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -1.189 . . . . 5.1299999999999999 109.415 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -59.45 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 5.79 109.463 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.732 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.92 170.9 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 5.7400000000000002 109.637 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -101.9 174.18 6.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 2.27 109.877 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HD21 ' A' ' 116' ' ' ASN . . . -127.43 -17.16 4.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.49 -0.756 . . . . 3.2799999999999998 109.168 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.408 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.72 36.42 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 3.6499999999999999 109.43 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -83.96 70.99 10.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 4.5999999999999996 109.479 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.846 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -102.03 178.86 4.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 3.46 109.563 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.633 ' CA ' ' OE1' ' A' ' 97' ' ' GLN . . . -157.75 17.09 0.33 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.617 -1.393 . . . . 3.6699999999999999 109.617 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.846 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.7 m -111.05 63.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 3.79 109.686 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.12 97.18 29.02 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 1.96 109.253 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.699 ' C ' HD22 ' A' ' 102' ' ' LEU . 60.5 Cg_endo -79.58 118.2 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.67 2.247 . . . . 2.9700000000000002 112.667 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 72' ' ' ALA . 4.1 mm? -115.87 143.05 45.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 3.0600000000000001 109.169 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.613 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -127.36 166.56 17.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 2.3399999999999999 109.522 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.93 24.49 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 2.1699999999999999 109.505 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.613 ' H ' ' C ' ' A' ' 103' ' ' THR . 13.3 tt0 -109.9 96.59 25.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 3.02 109.363 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.14 118.43 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.551 2.167 . . . . 1.4199999999999999 112.195 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.801 ' HB3' ' NH2' ' A' ' 109' ' ' ARG . . . -169.99 164.2 9.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.846 . . . . 1.3700000000000001 109.439 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.579 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.29 140.24 29.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 1.72 109.859 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.801 ' NH2' ' HB3' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -105.45 134.8 47.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.842 -1.17 . . . . 4.7000000000000002 107.842 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -109.11 99.79 9.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 3.2799999999999998 110.893 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.3 m-30 -109.93 130.3 55.55 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.319 -0.993 . . . . 2.96 108.319 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.67 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -134.4 163.21 30.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 3.4100000000000001 109.849 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.621 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -142.97 173.47 11.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 2.77 109.516 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 121.33 42.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 2.23 109.776 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 93.5 p -48.97 143.81 5.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 4.1100000000000003 109.431 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 6.7 p-10 -134.31 -46.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 6.8600000000000003 109.516 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.774 HD22 ' CE1' ' A' ' 119' ' ' PHE . 5.0 tt -109.97 175.25 5.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 5.1200000000000001 109.461 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.727 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -92.95 124.32 36.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 4.0599999999999996 109.864 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.774 ' CE1' HD22 ' A' ' 117' ' ' LEU . 45.0 m-85 -134.75 93.63 17.75 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 5.4400000000000004 109.258 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.6 165.53 22.66 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.678 2.252 . . . . 4.04 112.267 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.83 -14.5 12.47 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.858 2.372 . . . . 3.8999999999999999 112.079 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 2.5 p-10 -109.65 115.52 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 4.1399999999999997 109.527 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . 167.64 173.17 35.5 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 3.5699999999999998 109.475 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -75.97 26.64 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 3.5899999999999999 109.499 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.563 ' HB1' ' C ' ' A' ' 87' ' ' GLY . . . 179.94 74.11 0.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 2.0800000000000001 109.543 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' A' ' 127' ' ' GLY . 56.0 Cg_endo -75.31 -158.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.77 2.314 . . . . 1.3899999999999999 112.249 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -39.16 163.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.587 -1.405 . . . . 1.1899999999999999 109.587 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.592 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 1.1 tt0 -162.28 122.22 2.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -1.181 . . . . 2.0099999999999998 109.721 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 55' ' ' TYR . 8.4 p -146.53 130.52 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.424 -0.954 . . . . 1.28 108.424 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.695 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -148.26 123.26 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.961 -1.087 . . . . 0.97999999999999998 110.731 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.9 m-30 -86.92 118.93 26.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.807 -1.183 . . . . 1.73 107.807 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.505 ' ND1' HD21 ' A' ' 83' ' ' LEU . 6.1 m170 -99.94 131.87 45.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 2.3199999999999998 110.151 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 134' ' ' GLY . 3.8 mp -134.4 -105.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 2.1099999999999999 109.124 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 32.49 98.16 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.048 -1.221 . . . . 1.77 110.048 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.7 mtpt -146.68 123.67 11.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 5.0599999999999996 109.857 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.16 -20.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.147 -0.97 . . . . 2.6400000000000001 108.46 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -120.66 13.35 10.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.025 -1.63 . . . . 2.5099999999999998 109.025 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.616 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -52.17 -152.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.967 . . . . 2.3199999999999998 110.26 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.555 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 11.9 p90 -164.63 -131.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -0.99 . . . . 1.6100000000000001 109.374 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.417 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 26.5 mt-10 -120.3 128.29 53.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 1.6499999999999999 109.38 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.595 ' CD2' HG22 ' A' ' 143' ' ' ILE . 5.5 t80 -107.91 111.36 23.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 1.6799999999999999 109.661 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -107.5 88.43 2.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.73999999999999999 110.141 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.595 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -99.32 135.87 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 1.22 108.844 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 15' ' ' PHE . 60.0 p -128.05 -0.9 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 1.3300000000000001 109.313 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 23.7 mt-30 -152.2 174.61 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 3.2999999999999998 109.977 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 146' ' ' VAL . 8.0 p -177.24 92.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 2.2599999999999998 109.102 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.39 144.68 31.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 2.7599999999999998 110.056 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.641 HD21 HG13 ' A' ' 58' ' ' VAL . 8.9 tp -130.08 120.09 24.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 4.5700000000000003 109.019 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.486 ' OG1' ' N ' ' A' ' 150' ' ' THR . 2.6 t -158.06 -170.18 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 3.0699999999999998 109.661 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.708 HG23 ' H ' ' A' ' 151' ' ' SER . 0.7 OUTLIER -139.97 -103.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 2.0 109.45 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.708 ' H ' HG23 ' A' ' 150' ' ' THR . 4.0 p 85.23 62.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 2.1499999999999999 109.445 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.517 ' HB3' ' OG ' ' A' ' 2' ' ' SER . . . 48.02 -148.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 2.8199999999999998 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.969 -1.015 . . . . 3.54 109.434 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.498 -0.556 . . . . 5.4699999999999998 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.656 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -87.16 -79.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 4.5300000000000002 109.456 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.656 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.9 mt -143.5 157.16 44.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 5.1399999999999997 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' O ' ' C ' ' A' ' 5' ' ' SER . 25.5 m-20 -93.06 -164.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 5.3799999999999999 109.444 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 36.14 35.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.857 . . . . 4.8300000000000001 109.462 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 5' ' ' SER . 2.6 mp0 50.62 168.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.39 -0.819 . . . . 3.4300000000000002 109.476 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -102.63 -156.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 2.8300000000000001 109.368 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.484 ' H ' HG12 ' A' ' 7' ' ' VAL . 3.1 tt0 -175.33 86.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 4.75 109.636 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -83.97 -18.57 36.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 4.9500000000000002 109.425 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 10' ' ' LEU . 3.0 tm? -130.06 86.31 54.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 2.8599999999999999 108.782 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.37 41.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.35 2.7 . . . . 3.8300000000000001 113.509 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.709 ' H ' HD13 ' A' ' 10' ' ' LEU . 16.8 t60 -152.26 111.69 3.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.878 -1.139 . . . . 2.52 109.463 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.541 ' OG1' ' C ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -159.89 65.65 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 1.97 109.506 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 16' ' ' ALA . 23.4 m -153.03 66.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 1.96 109.592 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.544 ' CD2' HD11 ' A' ' 143' ' ' ILE . 4.6 m-30 -63.22 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 1.76 109.11 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -89.95 -78.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 1.1799999999999999 109.915 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.16 38.61 2.25 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.247 -0.908 . . . . 2.1299999999999999 109.867 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.97 150.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 2.2599999999999998 109.59 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -87.04 -69.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 2.6000000000000001 109.577 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 113.53 -172.03 14.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.408 -1.477 . . . . 1.6200000000000001 109.408 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.5 Cg_endo -70.31 -10.0 27.15 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.703 2.269 . . . . 1.7 112.189 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.916 ' CH2' HG21 ' A' ' 146' ' ' VAL . 7.8 m95 -61.91 -169.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 2.4199999999999999 109.246 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.8 m -150.37 162.27 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 1.6399999999999999 109.496 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 19' ' ' LEU . 2.7 pp -160.82 149.96 16.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 2.0499999999999998 109.489 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -177.52 133.92 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.72 109.437 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 148.51 -40.08 0.94 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.827 -1.309 . . . . 1.7 109.827 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.817 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -110.01 -141.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.96999999999999997 109.39 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.817 ' N ' ' OG1' ' A' ' 27' ' ' THR . 47.8 p -90.86 155.86 18.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 1.8 109.434 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -49.91 110.89 1.79 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.3999999999999999 109.03 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' CG ' HD13 ' A' ' 24' ' ' LEU . 49.9 Cg_exo -47.29 171.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.192 1.928 . . . . 1.1299999999999999 111.775 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.51 109.68 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.026 -1.046 . . . . 1.05 110.054 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.725 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.2 85.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 1.8200000000000001 109.289 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.19 -140.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 1.1699999999999999 109.74 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.609 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 7.3 p-10 -53.23 -57.0 12.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 2.21 109.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.38 44.47 0.69 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.405 -1.478 . . . . 1.1899999999999999 109.405 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.46 143.96 7.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -1.118 . . . . 2.9100000000000001 109.728 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.53 ' SD ' ' C ' ' A' ' 37' ' ' MET . 4.9 tmm? -110.87 124.86 52.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.93000000000000005 109.058 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.6 m -122.12 157.98 30.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -0.902 . . . . 1.0600000000000001 110.226 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -137.0 146.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 1.3700000000000001 108.687 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.606 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -75.67 121.39 22.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 4.79 109.207 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.652 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.3 mm? -117.76 36.7 0.23 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.084 -1.01 . . . . 3.54 110.998 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 84.8 Cg_endo -80.59 -95.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.491 2.127 . . . . 3.7400000000000002 111.427 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . 46.33 -107.8 0.21 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.699 -0.961 . . . . 2.0299999999999998 110.699 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.4 57.31 0.01 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.44 -1.864 . . . . 2.4100000000000001 108.44 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 136' ' ' ALA . 32.8 mt-30 -99.58 104.75 16.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -1.056 . . . . 2.96 110.027 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' N ' ' HB2' ' A' ' 136' ' ' ALA . . . -77.55 40.42 1.79 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.408 -1.477 . . . . 2.0800000000000001 109.408 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.648 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.3 OUTLIER -159.43 93.04 1.8 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 3.6099999999999999 109.528 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.66 ' O ' ' N ' ' A' ' 50' ' ' ASP . 52.0 Cg_exo -49.6 -38.8 45.93 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.804 2.336 . . . . 2.3599999999999999 112.407 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.475 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 11.8 p90 -62.68 50.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 3.8700000000000001 109.527 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.3 m-20 -149.48 13.29 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 2.3799999999999999 109.698 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 175.18 152.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 1.1100000000000001 109.515 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.1 176.05 24.38 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.923 -1.271 . . . . 0.93999999999999995 109.923 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 53' ' ' LEU . 5.4 mt -85.18 -177.15 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -1.134 . . . . 0.95999999999999996 109.205 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -162.16 159.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.151 -0.968 . . . . 0.92000000000000004 110.989 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.634 ' OH ' ' CD2' ' A' ' 10' ' ' LEU . 41.2 t80 178.63 124.19 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.41 -0.589 . . . . 1.71 109.41 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 7.6 m-20 -101.35 -171.23 1.95 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.24 -0.913 . . . . 2.7799999999999998 109.498 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.694 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 80.88 72.24 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.65 -1.38 . . . . 2.48 109.65 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 57' ' ' GLY . 11.0 m -161.92 68.12 2.18 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 3.79 109.413 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.36 148.59 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.854 2.369 . . . . 2.3999999999999999 112.227 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.61 101.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 3.0800000000000001 109.53 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -92.45 116.02 4.97 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.481 -1.448 . . . . 3.0499999999999998 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' C ' ' OG ' ' A' ' 115' ' ' SER . 1.6 tm-20 -47.74 149.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.143 -1.21 . . . . 6.0499999999999998 109.544 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 93.39 -24.37 25.71 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.748 -1.341 . . . . 2.54 109.748 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.661 ' N ' ' OG ' ' A' ' 115' ' ' SER . 1.4 mm-40 -101.52 164.62 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -1.172 . . . . 4.0300000000000002 109.659 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.482 ' OG ' HG22 ' A' ' 114' ' ' THR . 47.7 m -131.34 135.27 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 2.9100000000000001 109.433 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 63.0 m-85 -105.36 178.19 4.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.229 -0.92 . . . . 2.3799999999999999 109.852 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 3.0 t -152.03 151.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 2.6099999999999999 109.31 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 148' ' ' LEU . 6.5 tp -137.58 118.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 3.6099999999999999 109.785 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -109.64 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.518 -0.919 . . . . 2.27 108.518 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.0 p90 -94.12 145.99 24.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 2.0099999999999998 111.453 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -91.78 134.29 34.87 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.321 -0.992 . . . . 1.8 108.321 178.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.769 ' N ' ' NH2' ' A' ' 109' ' ' ARG . . . -164.0 113.31 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.816 -1.178 . . . . 0.95999999999999996 110.395 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HG ' ' HB2' ' A' ' 142' ' ' CYS . 23.9 p -103.48 122.6 45.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.641 -0.874 . . . . 0.93000000000000005 108.641 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.836 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -93.31 135.39 34.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.67000000000000004 109.752 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.516 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.21 112.07 6.63 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.225 -0.922 . . . . 0.96999999999999997 109.717 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.7 Cg_exo -64.09 -141.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.748 0 C-N-CA 124.253 -1.145 . . . . 1.02 112.393 -0.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.48 150.71 24.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 1.75 109.757 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.644 ' CE ' ' HZ1' ' A' ' 135' ' ' LYS . 0.5 OUTLIER 173.01 154.54 0.25 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.1600000000000001 109.34 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.25 140.68 22.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.767 2.311 . . . . 1.3799999999999999 112.149 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 100' ' ' ALA . 7.3 m -111.84 -179.55 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 2.0099999999999998 109.461 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.733 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.24 151.21 44.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 6.0099999999999998 109.565 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 97' ' ' GLN . 2.1 p -154.37 154.51 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 3.7599999999999998 109.536 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.74 ' CD1' HE22 ' A' ' 128' ' ' GLN . 0.8 OUTLIER -151.19 141.93 22.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.957 . . . . 2.29 109.751 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 129' ' ' VAL . 0.9 OUTLIER -153.34 146.36 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 1.8899999999999999 109.663 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.12 -132.09 4.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.588 -1.405 . . . . 1.49 109.588 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' CD ' ' CE1' ' A' ' 119' ' ' PHE . 15.2 pt-20 -90.33 134.31 34.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 2.54 109.417 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.614 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -114.35 93.98 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.646 -1.382 . . . . 1.3799999999999999 109.646 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . 166.63 119.43 0.48 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 90' ' ' ALA . . . 42.03 99.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.615 -1.394 . . . . 4.1399999999999997 109.615 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 89' ' ' GLY . . . 82.51 80.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 5.1299999999999999 109.461 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.528 ' O ' ' C ' ' A' ' 92' ' ' ARG . 32.9 m-85 -59.81 -2.15 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 5.79 109.489 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.624 ' HG2' ' HB1' ' A' ' 90' ' ' ALA . 2.8 ptp180 -35.75 150.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 5.7400000000000002 109.521 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -176.83 -164.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 2.27 109.692 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.7 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.7 -25.63 10.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.614 -0.884 . . . . 3.2799999999999998 108.614 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -91.17 35.99 0.92 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 3.6499999999999999 108.992 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.18 43.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.079 -1.013 . . . . 4.5999999999999996 109.492 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.504 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -104.42 114.47 28.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.264 -0.897 . . . . 3.46 109.149 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -103.57 13.94 53.98 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 3.6699999999999999 109.543 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -92.6 64.02 4.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -1.124 . . . . 3.79 109.526 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . . . -104.72 101.8 30.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 1.96 109.166 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.54 121.79 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.519 2.146 . . . . 2.9700000000000002 112.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.541 HD22 ' CZ ' ' A' ' 109' ' ' ARG . 63.0 mt -127.33 130.33 49.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 3.0600000000000001 109.327 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -119.73 -179.78 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 2.3399999999999999 109.601 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -66.76 24.05 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.445 -1.462 . . . . 2.1699999999999999 109.445 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.627 ' OE2' ' HB2' ' A' ' 107' ' ' ALA . 6.7 tm-20 -112.17 92.98 20.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.304 -1.115 . . . . 3.02 109.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.83 118.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.66 2.24 . . . . 1.4199999999999999 112.255 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.648 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . . . -166.06 162.41 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 1.3700000000000001 109.406 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.59 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -91.19 146.71 23.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 1.72 109.914 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.769 ' NH2' ' N ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -109.75 134.81 51.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.66 -1.237 . . . . 4.7000000000000002 107.66 177.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.54 ' OE1' ' C ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -114.35 102.26 9.94 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.93 -0.708 . . . . 3.2799999999999998 110.599 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 14.8 m-85 -109.83 122.0 46.52 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.498 -0.927 . . . . 2.96 108.498 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.68 133.75 55.64 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.251 -0.906 . . . . 3.4100000000000001 109.721 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.727 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -118.3 164.11 15.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 2.77 109.285 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.522 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -104.79 104.9 14.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 2.23 109.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 53.7 p -35.93 107.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 4.1100000000000003 109.25 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 15.7 t30 -86.04 -55.06 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 6.8600000000000003 109.706 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.705 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -111.31 -158.64 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 5.1200000000000001 109.804 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.705 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -117.24 150.56 38.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.363 -0.836 . . . . 4.0599999999999996 109.393 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 72.8 m-85 -162.45 73.91 2.17 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.86 . . . . 5.4400000000000004 109.548 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.35 167.87 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.858 2.372 . . . . 4.04 112.011 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.53 -15.66 10.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.813 2.342 . . . . 3.8999999999999999 112.091 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.637 ' OD2' ' N ' ' A' ' 123' ' ' GLY . 5.5 p-10 -111.29 -113.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.888 . . . . 4.1399999999999997 109.443 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.637 ' N ' ' OD2' ' A' ' 122' ' ' ASP . . . 36.12 -112.5 0.13 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.654 -1.379 . . . . 3.5699999999999998 109.654 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.8 -102.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -1.16 . . . . 3.5899999999999999 109.527 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.614 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -101.84 152.73 38.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 2.0800000000000001 109.493 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 -158.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.838 2.359 . . . . 1.3899999999999999 112.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -77.17 164.2 52.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.586 -1.406 . . . . 1.1899999999999999 109.586 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.74 HE22 ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -142.36 126.24 17.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 2.0099999999999998 109.439 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.649 HG22 ' CG1' ' A' ' 84' ' ' VAL . 19.3 t -139.09 90.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.57 -0.9 . . . . 1.28 108.57 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -112.62 122.14 46.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.97999999999999998 110.45 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -84.21 117.13 23.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.422 -0.955 . . . . 1.73 108.422 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.567 ' O ' ' O ' ' A' ' 81' ' ' ARG . 13.4 m170 -99.5 119.38 37.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 2.3199999999999998 110.044 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.802 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -136.59 -0.9 2.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 2.1099999999999999 109.421 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.78 135.0 32.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.256 -1.538 . . . . 1.77 109.256 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.644 ' HZ1' ' CE ' ' A' ' 78' ' ' MET . 9.3 mtmt -166.81 129.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 5.0599999999999996 109.552 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.02 -26.67 1.88 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.467 -1.308 . . . . 2.6400000000000001 107.467 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -104.28 11.98 51.53 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.293 -1.923 . . . . 2.5099999999999998 108.293 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.51 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.645 0.736 . . . . 2.3199999999999998 110.641 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.836 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 179.93 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.609 -1.307 . . . . 1.6100000000000001 110.715 -179.078 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.428 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 49.7 mt-10 -123.67 143.57 50.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 1.6499999999999999 109.25 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.556 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 15.2 t80 -126.22 120.63 30.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 1.6799999999999999 109.727 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.487 ' HB2' ' HG ' ' A' ' 73' ' ' SER . 1.7 m -119.06 97.29 5.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 109.853 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.544 HD11 ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -106.45 141.61 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 1.22 109.261 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.4 p -139.02 -2.62 1.66 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.617 -0.677 . . . . 1.3300000000000001 109.556 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 71' ' ' THR . 14.0 mt-30 -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 3.2999999999999998 110.242 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.916 HG21 ' CH2' ' A' ' 22' ' ' TRP . 2.8 p -160.94 73.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.004 -0.739 . . . . 2.2599999999999998 109.004 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.443 ' N ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -76.48 147.1 38.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 2.7599999999999998 110.18 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 58' ' ' VAL . 8.6 tp -138.56 101.59 4.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.492 -0.755 . . . . 4.5700000000000003 109.106 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.2 OUTLIER -149.07 -176.61 5.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 3.0699999999999998 109.726 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 151' ' ' SER . 1.9 t -139.06 -111.5 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 2.0 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.681 ' H ' HG23 ' A' ' 150' ' ' THR . 0.1 OUTLIER 64.33 -168.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 2.1499999999999999 109.541 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.667 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -169.94 89.63 0.17 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.915 . . . . 2.8199999999999998 109.483 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 153' ' ' THR . 72.1 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.031 -0.985 . . . . 3.54 109.479 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.453 -0.573 . . . . 5.4699999999999998 109.453 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 41.73 -88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 4.5300000000000002 109.475 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.773 HD13 ' H ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -85.0 155.56 21.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 5.1399999999999997 109.488 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.773 ' H ' HD13 ' A' ' 3' ' ' LEU . 26.2 m-20 -36.17 112.95 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 5.3799999999999999 109.478 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER 57.31 -156.46 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 4.8300000000000001 109.452 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' HB2' HG21 ' A' ' 149' ' ' THR . 0.3 OUTLIER -131.53 129.74 41.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 3.4300000000000002 109.468 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 t -57.91 95.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 2.8300000000000001 109.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.39 104.38 16.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 4.75 109.531 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.34 -15.83 55.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 4.9500000000000002 109.523 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -121.75 94.97 48.17 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 2.8599999999999999 108.819 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.99 26.83 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.388 2.059 . . . . 3.8300000000000001 111.548 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.562 ' H ' HD13 ' A' ' 10' ' ' LEU . 30.6 t60 -123.39 84.71 2.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 2.52 109.594 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -129.1 50.26 2.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 1.97 109.331 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 16' ' ' ALA . 25.0 p -128.26 64.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 1.96 109.786 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CE2' HD21 ' A' ' 24' ' ' LEU . 4.5 m-30 -64.73 35.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.957 . . . . 1.76 108.967 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.625 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.35 -48.73 6.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 1.1799999999999999 110.282 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.3 mm-40 -109.9 -83.51 0.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 2.1299999999999999 109.87 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 m -76.95 144.5 38.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 2.2599999999999998 109.662 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.704 ' CD2' HD13 ' A' ' 24' ' ' LEU . 1.6 tp -60.13 -57.86 11.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.322 -0.861 . . . . 2.6000000000000001 109.487 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.3 -177.83 17.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.559 -1.416 . . . . 1.6200000000000001 109.559 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.78 -5.94 16.41 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.857 2.371 . . . . 1.7 112.16 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.947 ' CH2' HG21 ' A' ' 146' ' ' VAL . 8.8 m95 -65.35 -164.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 2.4199999999999999 109.222 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.6 m -144.58 131.88 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 1.6399999999999999 109.845 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.899 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.7 148.94 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 2.0499999999999998 109.452 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 163.9 -168.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 1.72 109.749 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.84 -22.89 1.77 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.103 -1.199 . . . . 1.7 110.103 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.77 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.77 -142.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.249 . . . . 0.96999999999999997 109.224 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.77 ' N ' ' OG1' ' A' ' 27' ' ' THR . 91.1 p -90.95 129.9 36.92 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.171 -0.955 . . . . 1.8 109.17 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.562 ' C ' ' O ' ' A' ' 28' ' ' SER . 18.5 mt-10 -33.93 98.53 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 2.3999999999999999 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 28' ' ' SER . 54.9 Cg_exo -46.92 146.14 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.372 2.048 . . . . 1.1299999999999999 111.821 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.94 116.58 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.053 . . . . 1.05 110.014 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.73 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.81 89.69 3.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.46 -0.775 . . . . 1.8200000000000001 109.472 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.16 -140.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.5 -0.75 . . . . 1.1699999999999999 110.295 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -69.56 15.55 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 2.21 110.358 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.612 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 148.71 -6.75 0.89 Allowed Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.396 -1.383 . . . . 1.1899999999999999 110.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.631 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.73 146.08 47.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.359 . . . . 2.9100000000000001 109.803 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.572 ' SD ' ' C ' ' A' ' 37' ' ' MET . 1.6 tmm? -109.84 129.76 55.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 0.93000000000000005 108.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.03 145.8 51.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 1.0600000000000001 110.57 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -115.58 174.95 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.983 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -134.39 135.22 42.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.028 -1.045 . . . . 4.79 109.696 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.983 HD22 ' C ' ' A' ' 40' ' ' ASP . 3.7 mm? -135.62 60.91 39.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.985 . . . . 3.54 110.489 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 41' ' ' LEU . 61.2 Cg_endo -98.38 -15.16 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.091 2.528 . . . . 3.7400000000000002 112.203 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.38 -142.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.932 -0.867 . . . . 2.0299999999999998 110.932 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 136' ' ' ALA . . . -133.98 78.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.678 -1.369 . . . . 2.4100000000000001 109.678 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -99.7 127.02 45.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -1.217 . . . . 2.96 109.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.77 64.81 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.579 -1.408 . . . . 2.0800000000000001 109.579 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.683 ' ND2' ' CG ' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -173.56 135.19 0.66 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.152 . . . . 3.6099999999999999 109.411 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.676 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 60.1 Cg_endo -75.94 -13.31 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.549 2.166 . . . . 2.3599999999999999 112.375 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.691 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -111.77 38.65 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 3.8700000000000001 110.002 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.743 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -119.35 38.08 3.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 2.3799999999999999 109.542 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.743 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 160.39 133.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.1100000000000001 109.639 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.36 -162.22 28.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.866 -1.294 . . . . 0.93999999999999995 109.866 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -136.06 168.84 18.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -1.174 . . . . 0.95999999999999996 109.293 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 23' ' ' SER . 1.5 p -155.48 164.8 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.083 -1.011 . . . . 0.92000000000000004 110.137 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 63.7 t80 -178.63 141.67 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.576 -0.703 . . . . 1.71 109.656 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.691 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 78.6 m-20 -88.1 -152.86 0.22 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.331 -0.856 . . . . 2.7799999999999998 109.366 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.82 79.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 2.48 109.546 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.802 HG22 ' CD2' ' A' ' 148' ' ' LEU . 5.6 t -117.76 68.57 6.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.15 . . . . 3.79 109.562 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.405 ' C ' HG23 ' A' ' 60' ' ' VAL . 38.0 Cg_endo -70.05 160.7 48.69 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.716 2.277 . . . . 2.3999999999999999 112.132 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.85 HG12 ' OG ' ' A' ' 115' ' ' SER . 20.3 t -151.94 132.31 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 3.0800000000000001 109.612 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.35 104.22 1.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.495 -1.442 . . . . 3.0499999999999998 109.495 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.8 tm-20 -35.4 121.0 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -1.119 . . . . 6.0499999999999998 109.562 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 130.66 -45.09 1.16 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.889 -1.285 . . . . 2.54 109.889 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.509 ' OE1' ' OG1' ' A' ' 153' ' ' THR . 1.5 mm-40 -100.03 171.76 7.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -1.156 . . . . 4.0300000000000002 109.804 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.2 m -116.21 144.71 43.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 2.9100000000000001 109.297 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.728 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 20.2 m-85 -108.28 179.43 4.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.198 -0.939 . . . . 2.3799999999999999 109.773 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.4 t -150.34 141.74 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -0.766 . . . . 2.6099999999999999 109.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 70' ' ' PHE . 3.8 tp -124.59 119.9 30.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 3.6099999999999999 108.883 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -115.65 90.13 3.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.031 . . . . 2.27 109.897 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.72 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.64 147.58 22.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 2.0099999999999998 110.878 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -97.1 113.64 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 1.8 109.176 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -178.58 176.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.914 -1.116 . . . . 0.95999999999999996 110.667 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -156.07 154.04 30.35 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.087 -0.708 . . . . 0.93000000000000005 109.087 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -94.04 134.18 36.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.67000000000000004 109.612 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.451 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.71 116.04 14.73 Favored Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.279 -0.888 . . . . 0.96999999999999997 109.559 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.5 Cg_exo -65.89 -141.9 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.427 -1.072 . . . . 1.02 112.562 -0.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -91.26 151.96 20.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 1.75 109.786 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.1 mtp 161.09 157.3 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 2.1600000000000001 109.347 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 64.2 Cg_endo -77.56 147.32 25.06 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.779 2.32 . . . . 1.3799999999999999 112.235 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 100' ' ' ALA . 4.4 m -113.91 170.68 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 2.0099999999999998 109.425 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' C ' HG23 ' A' ' 82' ' ' VAL . 2.3 mtp180 -109.93 151.21 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 6.0099999999999998 109.352 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 97' ' ' GLN . 19.5 t -152.59 149.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 3.7599999999999998 109.581 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.732 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.3 pp -150.92 145.84 25.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 2.29 109.463 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.4 t -146.49 152.06 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 1.8899999999999999 109.729 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 163.64 -148.45 14.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 1.49 109.455 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.667 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 12.1 pm0 -90.14 179.1 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -1.102 . . . . 2.54 109.339 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.66 49.0 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.409 . . . . 1.3799999999999999 109.576 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 125' ' ' ALA . . . 153.35 35.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.428 . . . . 2.54 109.531 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.71 -69.49 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.512 -1.435 . . . . 4.1399999999999997 109.512 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -132.55 -4.15 3.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -1.164 . . . . 5.1299999999999999 109.501 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CG ' ' C ' ' A' ' 90' ' ' ALA . 5.8 m-85 68.43 -7.49 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 5.79 109.443 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.724 ' CG ' HH11 ' A' ' 92' ' ' ARG . 1.0 OUTLIER -86.29 113.07 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 5.7400000000000002 109.471 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -104.37 161.41 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 2.27 109.958 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -112.26 -18.68 12.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.704 -0.85 . . . . 3.2799999999999998 108.704 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.677 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.79 35.78 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 3.6499999999999999 109.286 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.89 57.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 4.5999999999999996 109.394 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.689 HE22 ' CA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -100.0 129.5 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 3.46 108.87 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 97' ' ' GLN . . . -119.21 -9.9 8.43 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.763 -1.208 . . . . 3.6699999999999999 110.142 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.689 ' CA ' HE22 ' A' ' 97' ' ' GLN . 1.8 m -80.42 77.1 7.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.253 . . . . 3.79 109.551 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -117.88 85.33 22.56 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.96 109.593 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.73 127.28 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.976 2.451 . . . . 2.9700000000000002 112.509 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.567 HD21 ' NE ' ' A' ' 109' ' ' ARG . 6.3 mt -142.28 127.56 18.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 3.0600000000000001 109.379 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 105' ' ' GLU . 9.3 t -111.67 -165.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 2.3399999999999999 109.733 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.18 31.99 3.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.438 . . . . 2.1699999999999999 109.504 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' H ' HG23 ' A' ' 103' ' ' THR . 2.8 mt-10 -109.68 96.44 23.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 3.02 109.345 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -46.88 118.2 2.58 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.53 2.153 . . . . 1.4199999999999999 112.248 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -169.13 169.8 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 1.3700000000000001 109.491 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.25 143.85 26.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 1.72 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.719 ' CD ' ' N ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.17 131.64 51.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.79 -1.189 . . . . 4.7000000000000002 107.79 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' CG ' HG12 ' A' ' 67' ' ' VAL . 14.6 tt0 -117.4 96.18 5.29 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.632 -0.827 . . . . 3.2799999999999998 110.548 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 6.7 m-30 -109.46 117.24 33.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.178 -1.045 . . . . 2.96 108.178 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.728 ' HB1' ' O ' ' A' ' 66' ' ' TYR . . . -115.98 174.18 6.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -0.893 . . . . 3.4100000000000001 109.822 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 2.0 p90 -154.71 179.28 9.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.333 -0.854 . . . . 2.77 109.618 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.52 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -107.64 106.9 17.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.438 -0.789 . . . . 2.23 109.614 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.85 ' OG ' HG12 ' A' ' 60' ' ' VAL . 8.2 t -36.06 116.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 4.1100000000000003 109.322 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -96.95 -50.46 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 6.8600000000000003 109.527 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 117' ' ' LEU . 2.5 mt -112.92 -166.0 1.04 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 5.1200000000000001 109.662 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.01 124.75 50.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 4.0599999999999996 109.419 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.644 ' CE1' ' CD ' ' A' ' 86' ' ' GLU . 34.1 m-85 -137.02 66.04 53.37 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 5.4400000000000004 109.472 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.64 166.9 25.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.858 2.372 . . . . 4.04 112.097 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.99 -19.66 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.763 2.309 . . . . 3.8999999999999999 112.002 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -110.28 111.76 23.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 4.1399999999999997 109.455 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.02 -138.06 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.575 -1.41 . . . . 3.5699999999999998 109.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.12 . . . . 3.5899999999999999 109.484 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' A' ' 88' ' ' GLY . . . -125.86 149.75 66.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 2.0800000000000001 109.429 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.12 -158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.789 2.326 . . . . 1.3899999999999999 112.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.56 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -64.93 172.29 20.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.648 -1.381 . . . . 1.1899999999999999 109.648 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.6 114.36 5.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -1.129 . . . . 2.0099999999999998 109.739 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -133.34 134.11 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.952 -1.129 . . . . 1.28 107.952 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.12 119.91 5.7 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.836 -1.146 . . . . 0.97999999999999998 110.718 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.7 m-30 -83.9 120.57 26.24 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.048 -1.093 . . . . 1.73 108.048 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.732 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 1.6 m170 -99.67 116.09 30.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 2.3199999999999998 109.896 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -138.45 37.44 2.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 2.1099999999999999 109.162 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -92.72 110.39 3.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.437 -1.465 . . . . 1.77 109.437 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 137' ' ' GLY . 56.8 mttt -159.78 134.87 8.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -1.14 . . . . 5.0599999999999996 109.856 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -37.25 -23.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.701 -0.852 . . . . 2.6400000000000001 108.701 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.725 ' C ' ' H ' ' A' ' 139' ' ' TYR . . . -135.11 24.38 3.42 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.51 -1.436 . . . . 2.5099999999999998 109.51 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.785 ' HB3' ' CB ' ' A' ' 41' ' ' LEU . . . -52.93 7.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.299 . . . . 2.3199999999999998 110.486 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.725 ' H ' ' C ' ' A' ' 137' ' ' GLY . 6.3 p90 48.32 -165.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.379 0.609 . . . . 1.6100000000000001 110.751 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 4.8 mt-10 -96.99 159.59 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.6499999999999999 110.459 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -129.81 102.64 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.907 -0.775 . . . . 1.6799999999999999 108.907 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 7.5 m -87.06 119.25 27.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.73999999999999999 110.267 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.447 HG23 ' SD ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -133.23 144.73 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.822 0.82 . . . . 1.22 109.35 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.463 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 92.9 p -136.85 -11.64 1.75 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.284 -0.567 . . . . 1.3300000000000001 109.556 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' SER . 1.6 mt-30 -155.88 168.47 27.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.98 . . . . 3.2999999999999998 109.997 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.947 HG21 ' CH2' ' A' ' 22' ' ' TRP . 7.8 p -150.37 131.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.432 -0.792 . . . . 2.2599999999999998 109.26 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -115.57 150.3 36.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.089 -1.007 . . . . 2.7599999999999998 109.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.802 ' CD2' HG22 ' A' ' 58' ' ' VAL . 1.7 tp -157.86 114.01 2.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 4.5700000000000003 109.365 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.672 ' N ' HD12 ' A' ' 148' ' ' LEU . 9.7 t -164.36 -155.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 3.0699999999999998 109.478 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.517 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -135.49 -41.05 0.71 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.93 . . . . 2.0 109.361 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.561 ' O ' ' O ' ' A' ' 152' ' ' ALA . 0.9 OUTLIER 58.21 55.65 4.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.75 . . . . 2.1499999999999999 109.478 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 151' ' ' SER . . . 38.87 -164.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 2.8199999999999998 109.485 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.509 ' OG1' ' OE1' ' A' ' 64' ' ' GLU . 62.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.002 -0.999 . . . . 3.54 109.48 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.312 0.577 . . . . 5.4699999999999998 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.668 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 11.1 t -105.08 -139.99 0.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 4.5300000000000002 109.488 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.668 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.9 mp -99.11 173.29 6.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 5.1399999999999997 109.492 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 3' ' ' LEU . 10.5 t70 -35.91 130.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 5.3799999999999999 109.496 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER 44.74 -169.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 4.8300000000000001 109.412 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -155.87 143.01 19.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 3.4300000000000002 109.537 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.65 87.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 2.8300000000000001 109.473 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.555 ' OE2' ' N ' ' A' ' 148' ' ' LEU . 25.1 tp10 -87.52 97.02 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 4.75 109.504 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.553 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.88 -35.42 72.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 4.9500000000000002 109.444 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.564 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -110.47 93.96 17.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 2.8599999999999999 108.65 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.81 26.46 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.299 1.999 . . . . 3.8300000000000001 111.525 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.564 ' H ' HD13 ' A' ' 10' ' ' LEU . 46.4 t60 -119.88 95.56 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 2.52 109.602 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 2.6 t -130.4 51.07 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 1.97 109.304 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.7 m -114.4 52.91 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 1.96 109.769 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.02 20.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 1.76 108.984 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.608 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.11 -65.62 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 1.1799999999999999 110.009 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 18' ' ' SER . 1.4 mt-10 -109.96 38.88 2.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 2.1299999999999999 109.911 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 2.5 p 170.16 144.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.161 -0.962 . . . . 2.2599999999999998 109.708 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.603 HD11 ' CD2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.02 -69.19 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 2.6000000000000001 109.433 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.18 177.58 19.53 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.546 -1.422 . . . . 1.6200000000000001 109.546 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -53.5 -21.47 18.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.762 2.308 . . . . 1.7 112.048 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.676 ' CH2' HG21 ' A' ' 146' ' ' VAL . 18.0 m95 -58.33 167.81 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 2.4199999999999999 109.502 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.9 m -132.45 176.58 8.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 1.6399999999999999 109.046 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.603 ' CD2' HD11 ' A' ' 19' ' ' LEU . 1.4 pp -175.63 153.15 1.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 2.0499999999999998 110.059 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.688 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -178.44 136.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.538 -0.726 . . . . 1.72 109.111 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 135.27 -27.68 3.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.944 -1.263 . . . . 1.7 109.944 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.769 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.66 -141.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.027 -1.278 . . . . 0.96999999999999997 109.554 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.769 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.8 p -91.52 -167.17 1.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.959 -0.756 . . . . 1.8 108.959 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.57 110.61 42.43 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 2.3999999999999999 108.916 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -45.37 138.24 10.31 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.228 1.952 . . . . 1.1299999999999999 111.829 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.777 ' O ' HG13 ' A' ' 31' ' ' VAL . 12.5 p -118.69 93.52 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 1.05 109.932 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.07 81.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.506 -0.746 . . . . 1.8200000000000001 109.446 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -98.74 -109.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 1.1699999999999999 109.617 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 35' ' ' GLY . 3.0 t0 -51.62 79.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 2.21 109.577 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 35.62 47.14 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.586 -1.405 . . . . 1.1899999999999999 109.586 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -176.51 151.56 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 2.9100000000000001 109.498 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 37' ' ' MET . 4.8 ptt? -109.46 130.94 55.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.93000000000000005 109.803 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.5 m -109.97 128.74 55.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.793 . . . . 1.0600000000000001 109.563 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.1 133.04 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 1.3700000000000001 109.22 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.3 m-20 -80.53 128.76 33.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 4.79 109.248 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.824 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 3.5 mm? -110.28 95.54 22.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 3.54 109.587 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.675 ' O ' ' NZ ' ' A' ' 135' ' ' LYS . 52.5 Cg_endo -78.95 144.08 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.604 2.203 . . . . 3.7400000000000002 112.147 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' HB2' ' A' ' 138' ' ' ALA . . . -81.09 161.49 43.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.826 -1.31 . . . . 2.0299999999999998 109.826 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.16 -7.25 1.16 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.059 -1.216 . . . . 2.4100000000000001 110.059 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.457 ' OE1' ' CB ' ' A' ' 50' ' ' ASP . 41.5 mt-30 -120.69 174.3 6.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.023 -1.281 . . . . 2.96 109.785 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.97 -8.25 3.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.488 -1.445 . . . . 2.0800000000000001 109.488 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.531 ' CG ' ' OD1' ' A' ' 50' ' ' ASP . 1.2 p30 -99.96 133.29 21.74 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -1.175 . . . . 3.6099999999999999 109.353 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.17 1.03 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.478 2.119 . . . . 2.3599999999999999 112.652 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.67 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.1 p-90 -118.53 38.39 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 3.8700000000000001 110.09 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 0.8 OUTLIER -112.41 12.72 20.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.998 . . . . 2.3799999999999999 109.691 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . 179.72 134.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 1.1100000000000001 109.383 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 169.63 171.13 34.92 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.609 -1.281 . . . . 0.93999999999999995 110.222 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 54' ' ' VAL . 7.3 mt -75.65 -178.19 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -1.153 . . . . 0.95999999999999996 109.31 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.637 HG12 ' N ' ' A' ' 55' ' ' TYR . 99.2 t -161.08 167.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.92000000000000004 109.65 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.637 ' N ' HG12 ' A' ' 54' ' ' VAL . 32.0 t80 176.22 145.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.512 -0.743 . . . . 1.71 109.414 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.577 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 4.4 m-20 -107.66 171.7 7.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.936 . . . . 2.7799999999999998 109.589 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 93.62 70.87 1.13 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 2.48 109.53 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 57' ' ' GLY . 43.0 t -162.41 86.79 1.45 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 3.79 109.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.553 ' HD2' HD13 ' A' ' 9' ' ' LEU . 59.1 Cg_endo -79.07 162.88 25.86 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.676 2.251 . . . . 2.3999999999999999 112.153 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.26 114.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 3.0800000000000001 109.654 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -108.6 135.31 12.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.295 -1.522 . . . . 3.0499999999999998 109.295 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CD ' HG23 ' A' ' 118' ' ' THR . 6.5 pt-20 -72.7 139.32 47.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -1.156 . . . . 6.0499999999999998 109.656 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 125.24 -50.0 0.89 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.631 -1.387 . . . . 2.54 109.631 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.97 157.76 16.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.126 -1.22 . . . . 4.0300000000000002 109.654 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -100.01 134.36 43.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 2.9100000000000001 109.294 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.696 ' O ' HG23 ' A' ' 67' ' ' VAL . 74.8 m-85 -92.95 174.48 7.21 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 2.3799999999999999 109.689 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 66' ' ' TYR . 54.4 t -162.6 118.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 2.6099999999999999 109.482 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 69' ' ' SER . 9.7 tt -109.6 158.71 17.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 3.6099999999999999 109.158 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.697 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -154.41 106.46 2.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 2.27 109.427 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 2.1 p90 -94.39 147.51 23.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.106 -0.996 . . . . 2.0099999999999998 110.378 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -100.19 94.54 6.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.851 -0.796 . . . . 1.8 108.851 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HB2' ' HB ' ' A' ' 143' ' ' ILE . . . -163.79 -177.08 4.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.039 -1.038 . . . . 0.95999999999999996 109.709 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.417 ' HA ' HD22 ' A' ' 102' ' ' LEU . 13.2 p -164.46 136.92 4.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -0.827 . . . . 0.93000000000000005 109.333 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -87.81 145.11 26.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.67000000000000004 109.119 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 104' ' ' GLY . 0.7 OUTLIER -131.8 116.76 16.01 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.96999999999999997 109.343 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.3 Cg_exo -66.07 -142.59 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.384 -1.09 . . . . 1.02 112.495 -0.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -95.35 151.53 19.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 1.75 109.576 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.574 ' SD ' ' CG ' ' A' ' 139' ' ' TYR . 7.4 ptm 178.21 151.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 2.1600000000000001 109.511 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.674 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 56.8 Cg_endo -74.41 122.01 7.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.764 2.309 . . . . 1.3799999999999999 112.233 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.94 HG11 HD12 ' A' ' 102' ' ' LEU . 2.9 m -102.39 172.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 2.0099999999999998 109.476 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 79' ' ' PRO . 8.8 mpt_? -114.14 166.27 11.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 6.0099999999999998 109.461 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 81' ' ' ARG . 88.5 t -160.32 156.45 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 3.7599999999999998 109.311 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.715 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -159.56 148.08 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 2.29 109.441 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -150.76 148.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -0.972 . . . . 1.8899999999999999 109.929 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.83 2.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.218 -1.553 . . . . 1.49 109.218 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.5 pt-20 -90.35 178.7 6.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -1.172 . . . . 2.54 109.384 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 125' ' ' ALA . . . -133.52 38.68 1.82 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.54 -1.424 . . . . 1.3799999999999999 109.54 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 122' ' ' ASP . . . 162.41 126.17 0.81 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.533 -1.427 . . . . 2.54 109.533 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . 122.61 -149.64 16.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.503 -1.439 . . . . 4.1399999999999997 109.503 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.596 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -54.25 -3.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 5.1299999999999999 109.494 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 3.8 m-85 53.47 1.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.898 . . . . 5.79 109.566 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.738 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.2 OUTLIER -57.57 118.92 5.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 5.7400000000000002 109.489 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.508 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -127.95 161.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 2.27 109.824 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.95 -19.88 12.94 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.871 -0.789 . . . . 3.2799999999999998 108.871 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.0 39.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 3.6499999999999999 109.212 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -86.73 94.26 9.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 4.5999999999999996 109.83 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.832 ' NE2' ' CD2' ' A' ' 111' ' ' TYR . 6.9 pt20 -116.62 -156.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.168 -0.958 . . . . 3.46 109.164 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . 177.14 -26.05 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.981 -1.247 . . . . 3.6699999999999999 109.981 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -91.87 94.81 9.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -1.226 . . . . 3.79 109.811 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.575 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -133.16 79.23 62.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 1.96 109.361 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.76 132.28 41.02 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.051 2.501 . . . . 2.9700000000000002 112.657 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.94 HD12 HG11 ' A' ' 80' ' ' VAL . 12.3 mt -124.35 151.06 44.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 3.0600000000000001 109.208 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 74' ' ' ALA . 13.6 t -95.26 -162.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 2.3399999999999999 109.831 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 75' ' ' THR . . . -96.02 -32.92 6.54 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 2.1699999999999999 109.777 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 103' ' ' THR . 1.6 mp0 -99.96 164.09 17.13 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.138 -1.213 . . . . 3.02 109.485 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.14 128.66 7.71 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.841 2.361 . . . . 1.4199999999999999 112.019 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 72' ' ' ALA . . . -160.73 140.91 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 1.3700000000000001 109.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -90.99 144.29 25.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.802 . . . . 1.72 110.204 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.73 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -128.43 149.99 50.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.023 -1.473 . . . . 4.7000000000000002 107.023 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -139.56 159.71 41.54 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.655 -1.218 . . . . 3.2799999999999998 111.186 -178.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.832 ' CD2' ' NE2' ' A' ' 97' ' ' GLN . 7.1 m-85 -134.86 121.11 20.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.3 -1.0 . . . . 2.96 108.3 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' A' ' 67' ' ' VAL . . . -114.49 139.56 49.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 3.4100000000000001 109.655 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -147.77 164.03 34.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 2.77 109.629 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.39 112.38 24.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.422 -0.799 . . . . 2.23 109.497 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.672 ' O ' ' N ' ' A' ' 63' ' ' GLY . 6.6 t -60.83 109.18 0.99 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.957 . . . . 4.1100000000000003 109.452 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.52 22.99 9.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 6.8600000000000003 109.435 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' A' ' 119' ' ' PHE . 0.4 OUTLIER -148.91 104.96 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 5.1200000000000001 109.366 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.542 HG23 ' CD ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -51.51 107.51 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 4.0599999999999996 109.45 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CE2' HD12 ' A' ' 117' ' ' LEU . 7.3 m-85 -124.9 92.08 48.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 5.4400000000000004 109.635 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.546 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 31.9 Cg_exo -56.46 -170.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.519 2.146 . . . . 4.04 111.367 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.546 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 23.3 Cg_exo -60.74 -76.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.282 1.988 . . . . 3.8999999999999999 111.283 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 88' ' ' GLY . 30.6 t0 -173.06 -163.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.123 -0.986 . . . . 4.1399999999999997 109.887 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.495 ' H ' ' CG ' ' A' ' 122' ' ' ASP . . . -109.48 -35.63 2.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.195 -1.962 . . . . 3.5699999999999998 108.195 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -128.93 -41.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 3.5899999999999999 108.286 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -113.35 92.93 24.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.362 -0.977 . . . . 2.0800000000000001 108.362 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 125' ' ' ALA . 45.3 Cg_exo -48.63 -139.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.727 2.284 . . . . 1.3899999999999999 113.15 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -33.07 155.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.856 -1.298 . . . . 1.1899999999999999 109.856 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -158.92 151.56 21.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.333 -1.098 . . . . 2.0099999999999998 109.46 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 84' ' ' VAL . 17.1 t -153.53 155.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.448 -0.945 . . . . 1.28 108.448 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -163.35 111.32 1.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.908 -1.12 . . . . 0.97999999999999998 110.468 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.404 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 5.0 m-30 -83.37 101.41 11.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.089 -1.078 . . . . 1.73 108.089 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.715 ' ND1' HD21 ' A' ' 83' ' ' LEU . 5.0 m170 -98.83 128.57 45.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 2.3199999999999998 110.476 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -112.73 -45.62 3.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.907 -0.775 . . . . 2.1099999999999999 108.907 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.81 153.85 29.78 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.103 -1.199 . . . . 1.77 110.103 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' NZ ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -99.66 -143.66 0.33 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.044 . . . . 5.0599999999999996 109.304 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 135' ' ' LYS . . . 67.44 -61.07 0.37 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.017 -1.105 . . . . 2.6400000000000001 108.017 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -88.97 35.22 3.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.016 -2.034 . . . . 2.5099999999999998 108.016 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.824 ' HB1' ' O ' ' A' ' 41' ' ' LEU . . . -28.75 151.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.868 -0.784 . . . . 2.3199999999999998 110.631 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.586 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 5.1 p90 -173.99 -132.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.767 -0.827 . . . . 1.6100000000000001 108.767 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 14.5 mt-10 -146.73 127.33 14.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 1.6499999999999999 109.741 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -117.46 106.66 13.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 1.6799999999999999 109.131 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.494 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 72.4 m -109.81 120.58 42.93 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.084 -1.01 . . . . 0.73999999999999999 110.546 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -120.36 146.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.76 . . . . 1.22 109.052 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.482 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 93.3 p -126.75 -10.04 6.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.962 -0.755 . . . . 1.3300000000000001 108.962 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.57 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -161.9 167.24 25.03 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.607 -0.837 . . . . 3.2999999999999998 109.813 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.676 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.3 p -149.38 123.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 2.2599999999999998 109.382 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.57 165.69 10.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.177 -0.952 . . . . 2.7599999999999998 109.592 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 58' ' ' VAL . 10.0 tp -173.87 120.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 4.5700000000000003 109.428 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.669 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.5 OUTLIER 179.0 -156.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 3.0699999999999998 109.475 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.728 HG23 ' N ' ' A' ' 151' ' ' SER . 8.8 t -131.32 -123.7 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 2.0 109.531 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.728 ' N ' HG23 ' A' ' 150' ' ' THR . 5.0 p -166.1 66.97 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 2.1499999999999999 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.34 -160.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 2.8199999999999998 109.445 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.979 -1.01 . . . . 3.54 109.475 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.307 0.575 . . . . 5.4699999999999998 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.594 ' OG ' ' N ' ' A' ' 151' ' ' SER . 0.3 OUTLIER -111.39 -140.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 4.5300000000000002 109.452 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 2' ' ' SER . 2.8 mp 37.16 -161.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 5.1399999999999997 109.441 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 60.3 47.11 9.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 5.3799999999999999 109.433 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.706 ' OG ' HG22 ' A' ' 150' ' ' THR . 2.5 p -178.82 -151.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 4.8300000000000001 109.452 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 8' ' ' GLU . 3.8 mt-10 -115.4 17.77 16.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 3.4300000000000002 109.985 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.85 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.1 p 28.82 29.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.687 0.756 . . . . 2.8300000000000001 109.497 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.777 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.6 mt-10 159.25 84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.31 -0.626 . . . . 4.75 109.31 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.436 HD23 ' HD2' ' A' ' 59' ' ' PRO . 2.2 mp -91.52 17.03 9.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.223 -0.923 . . . . 4.9500000000000002 109.16 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 12' ' ' HIS . 3.1 tm? -175.27 96.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 2.8599999999999999 109.155 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.66 43.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.05 2.5 . . . . 3.8300000000000001 113.396 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.698 ' N ' HD13 ' A' ' 10' ' ' LEU . 9.8 t60 -162.84 103.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 2.52 109.492 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.549 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -150.42 45.17 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 1.97 109.367 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 16' ' ' ALA . 2.0 t -140.24 93.71 2.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.96 109.562 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 144' ' ' SER . 8.6 m-85 -75.91 39.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 1.76 109.196 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.618 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.03 -33.08 16.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.1799999999999999 109.756 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.685 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 22.2 mt-10 -109.85 -76.66 0.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 2.1299999999999999 109.63 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -111.87 143.93 42.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 2.2599999999999998 109.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -49.36 -33.76 14.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 2.6000000000000001 109.591 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 91.08 -159.71 26.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 1.6200000000000001 109.5 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.09 -9.18 17.87 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.72 2.28 . . . . 1.7 112.233 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 13.8 m95 -68.44 150.25 48.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 2.4199999999999999 109.006 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -109.89 170.29 8.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 1.6399999999999999 110.058 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.649 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.4 pp -176.57 165.05 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 2.0499999999999998 109.6 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.758 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.35 -165.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 1.72 109.503 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.43 -21.14 2.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.197 -1.161 . . . . 1.7 110.197 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.765 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.71 -143.64 0.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.28 . . . . 0.96999999999999997 109.459 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.765 ' N ' ' OG1' ' A' ' 27' ' ' THR . 49.4 p -92.13 -159.07 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.293 -0.879 . . . . 1.8 108.85 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -90.36 127.34 53.36 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 2.3999999999999999 108.593 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HG3' HD11 ' A' ' 24' ' ' LEU . 33.0 Cg_endo -69.01 135.79 33.23 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.02 1.813 . . . . 1.1299999999999999 111.495 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.73 110.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 1.05 110.362 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.82 73.76 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 1.8200000000000001 109.238 178.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.14 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 1.1699999999999999 109.901 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.454 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 12.4 t70 -45.72 83.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 2.21 109.521 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 42.37 35.16 1.81 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.535 -1.426 . . . . 1.1899999999999999 109.535 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 33' ' ' ALA . 9.6 ptp180 -148.46 142.58 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 2.9100000000000001 109.666 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.618 ' C ' ' SD ' ' A' ' 37' ' ' MET . 14.7 tmm? -112.68 127.73 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.93000000000000005 109.578 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.661 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -122.57 138.52 54.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.838 . . . . 1.0600000000000001 109.858 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.18 150.85 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.415 -0.957 . . . . 1.3700000000000001 108.415 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.756 ' C ' HD22 ' A' ' 41' ' ' LEU . 21.9 m-20 -81.06 119.69 23.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.1 -1.0 . . . . 4.79 109.348 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.786 ' N ' HD22 ' A' ' 41' ' ' LEU . 3.0 mm? -116.37 32.79 0.16 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.092 -1.005 . . . . 3.54 110.736 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 86.1 Cg_endo -81.07 -97.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.194 1.929 . . . . 3.7400000000000002 111.697 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.21 -96.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.424 -1.07 . . . . 2.0299999999999998 110.424 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.71 48.84 0.04 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.425 -1.87 . . . . 2.4100000000000001 108.425 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.674 ' O ' ' N ' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -99.73 116.26 31.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.463 -1.022 . . . . 2.96 109.857 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -76.18 52.75 3.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.524 -1.43 . . . . 2.0800000000000001 109.524 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' OD1' ' OD1' ' A' ' 50' ' ' ASP . 2.2 p30 -161.19 134.73 4.84 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.227 -1.16 . . . . 3.6099999999999999 109.462 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 63.1 Cg_endo -76.83 0.35 9.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.605 2.203 . . . . 2.3599999999999999 112.724 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.485 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 5.2 p90 -110.15 67.88 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 3.8700000000000001 109.649 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.523 ' OD1' ' OD1' ' A' ' 47' ' ' ASN . 1.2 m-20 -140.18 -31.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 2.3799999999999999 109.763 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.658 ' HB1' HG22 ' A' ' 27' ' ' THR . . . -152.87 163.88 38.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 109.605 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 144.9 171.49 14.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.875 -1.29 . . . . 0.93999999999999995 109.875 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.459 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.8 pp -107.41 145.82 32.47 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -1.14 . . . . 0.95999999999999996 109.162 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 55' ' ' TYR . 17.7 t -131.19 169.83 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.951 . . . . 0.92000000000000004 110.068 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 40.5 t80 -171.09 143.3 1.93 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.495 -0.753 . . . . 1.71 109.42 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 7.4 m-20 -113.16 -167.28 1.17 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.302 -0.874 . . . . 2.7799999999999998 109.397 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.7 55.62 2.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.64 -1.384 . . . . 2.48 109.64 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.578 ' CG2' HD21 ' A' ' 148' ' ' LEU . 1.1 p -149.08 100.5 3.41 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 3.79 109.421 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HD2' HD23 ' A' ' 9' ' ' LEU . 58.3 Cg_endo -78.93 126.96 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.49 2.126 . . . . 2.3999999999999999 112.018 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -103.19 74.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.92 . . . . 3.0800000000000001 109.813 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -84.71 90.64 1.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.953 -1.659 . . . . 3.0499999999999998 108.953 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -34.56 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -1.127 . . . . 6.0499999999999998 109.884 -179.471 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.73 -67.18 0.56 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.638 -1.385 . . . . 2.54 109.638 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -100.0 170.68 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -1.152 . . . . 4.0300000000000002 109.632 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 m -99.98 139.41 35.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 2.9100000000000001 109.323 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.05 177.64 4.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -0.98 . . . . 2.3799999999999999 109.846 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.658 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.6 t -150.63 137.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 2.6099999999999999 109.634 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tp -119.94 115.1 23.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 3.6099999999999999 109.106 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -112.98 100.29 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 2.27 109.33 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -94.1 135.04 35.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 2.0099999999999998 110.599 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.679 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 10.9 p -93.49 94.22 8.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.441 -0.948 . . . . 1.8 108.441 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 143' ' ' ILE . . . -165.36 164.2 19.77 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.617 -1.233 . . . . 0.95999999999999996 110.624 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -139.81 146.61 39.63 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.843 -0.799 . . . . 0.93000000000000005 108.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -84.6 133.8 34.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.67000000000000004 109.358 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.506 ' O ' ' CD ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.71 115.74 15.83 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.37 -0.831 . . . . 0.96999999999999997 109.062 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -67.1 -142.2 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.605 0 C-N-CA 124.311 -1.12 . . . . 1.02 112.298 0.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.64 149.36 22.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 1.75 109.613 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.5 mtt 159.73 163.47 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.372 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.33 150.78 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.877 2.384 . . . . 1.3799999999999999 112.224 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -116.23 169.0 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 2.0099999999999998 109.393 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 132' ' ' HIS . 13.5 ttt180 -114.2 137.68 51.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 6.0099999999999998 109.52 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.81 149.45 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.341 -0.85 . . . . 3.7599999999999998 109.38 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -147.5 147.09 29.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 2.29 109.752 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.2 t -151.8 149.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 1.8899999999999999 109.614 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 160.62 -147.03 13.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.584 -1.407 . . . . 1.49 109.584 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.667 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.1 pm0 -90.04 176.85 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -1.162 . . . . 2.54 109.547 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.72 22.87 4.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.603 -1.399 . . . . 1.3799999999999999 109.603 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -166.32 148.13 13.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 2.54 109.558 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' GLY . . . 56.35 145.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.547 -1.421 . . . . 4.1399999999999997 109.547 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . 36.26 76.26 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -1.122 . . . . 5.1299999999999999 109.445 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -64.82 15.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 5.79 109.521 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -86.03 116.99 24.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 5.7400000000000002 109.46 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -105.42 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 2.27 109.951 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.659 ' HB2' HD22 ' A' ' 117' ' ' LEU . . . -109.88 -24.8 10.64 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.771 -0.826 . . . . 3.2799999999999998 108.771 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -91.03 33.84 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 3.6499999999999999 109.186 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.84 59.25 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 4.5999999999999996 109.582 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.6 tt0 -103.07 156.4 17.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 3.46 109.134 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -145.87 8.54 1.53 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.696 -1.362 . . . . 3.6699999999999999 109.696 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.33 59.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -1.165 . . . . 3.79 109.589 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.545 ' HB3' HG23 ' A' ' 80' ' ' VAL . . . -101.54 107.37 50.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 1.96 109.204 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -78.04 134.36 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.528 2.152 . . . . 2.9700000000000002 112.544 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 102' ' ' LEU . 12.3 mt -131.2 156.63 45.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 3.0600000000000001 109.411 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -103.44 -155.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 2.3399999999999999 109.512 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.634 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -113.45 30.76 7.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 2.1699999999999999 109.523 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -154.41 149.89 21.12 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -1.179 . . . . 3.02 109.379 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.26 126.2 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.872 2.381 . . . . 1.4199999999999999 112.106 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.888 ' HB1' ' NH1' ' A' ' 109' ' ' ARG . . . -163.34 132.84 4.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 1.3700000000000001 109.655 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.35 141.39 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 1.72 110.395 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.888 ' NH1' ' HB1' ' A' ' 107' ' ' ALA . 3.9 mpt_? -120.16 143.61 48.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.317 -1.364 . . . . 4.7000000000000002 107.317 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -128.88 112.74 14.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.977 . . . . 3.2799999999999998 110.838 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 4.5 m-30 -113.44 115.28 27.8 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.201 -1.037 . . . . 2.96 108.201 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.658 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -117.96 171.87 7.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.277 -0.889 . . . . 3.4100000000000001 110.024 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -173.14 175.45 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 2.77 109.673 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -87.7 113.19 23.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 2.23 109.751 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.8 t -52.82 110.03 0.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 4.1100000000000003 109.39 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 114' ' ' THR . 30.4 m120 -129.14 28.61 5.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.838 . . . . 6.8600000000000003 109.505 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' A' ' 94' ' ' ALA . 4.6 tp -133.4 118.47 18.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 5.1200000000000001 109.398 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -77.59 127.38 32.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.881 . . . . 4.0599999999999996 109.558 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 8.4 m-85 -163.52 94.63 1.08 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 5.4400000000000004 109.363 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.67 165.78 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.604 2.203 . . . . 4.04 112.259 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.0 -14.93 12.03 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.815 2.343 . . . . 3.8999999999999999 112.044 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.84 121.67 45.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 4.1399999999999997 109.478 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.67 -175.42 19.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 3.5699999999999998 109.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.533 ' O ' ' C ' ' A' ' 88' ' ' GLY . 6.7 m-20 -79.93 53.5 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 3.5899999999999999 109.454 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 119' ' ' PHE . . . -178.03 65.69 0.19 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.0800000000000001 109.464 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.12 -158.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.874 2.383 . . . . 1.3899999999999999 112.301 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.444 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -80.95 157.29 39.15 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.538 -1.425 . . . . 1.1899999999999999 109.538 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.667 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -146.94 126.58 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 2.0099999999999998 109.878 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.42 85.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.66 -0.867 . . . . 1.28 108.66 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.659 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -103.31 127.1 50.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.97999999999999998 110.56 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.435 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . 2.9 m-30 -105.12 96.75 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.295 -1.002 . . . . 1.73 108.295 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 9.3 m170 -99.39 138.37 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 2.3199999999999998 110.238 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.853 ' N ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -141.83 6.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 2.1099999999999999 109.21 179.681 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -62.11 147.51 48.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.572 -1.411 . . . . 1.77 109.572 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.624 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 0.4 OUTLIER 179.48 132.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -1.09 . . . . 5.0599999999999996 109.339 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -47.14 -24.3 0.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.765 -1.198 . . . . 2.6400000000000001 107.765 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.611 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -106.29 8.55 41.41 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.577 -1.809 . . . . 2.5099999999999998 108.577 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.12 -163.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.919 . . . . 2.3199999999999998 110.023 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD2' ' C ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -173.73 -112.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 1.6100000000000001 109.94 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.506 ' CD ' ' O ' ' A' ' 75' ' ' THR . 2.2 mp0 -129.61 153.79 47.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.754 -1.216 . . . . 1.6499999999999999 109.678 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.661 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 26.7 t80 -136.29 126.49 26.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.226 -0.921 . . . . 1.6799999999999999 109.721 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.85 98.61 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.73999999999999999 110.185 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.587 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -109.81 143.82 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.405 -0.809 . . . . 1.22 108.883 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 15' ' ' PHE . 95.4 p -128.89 -18.1 3.85 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.075 -0.65 . . . . 1.3300000000000001 109.409 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.679 ' N ' ' OG1' ' A' ' 71' ' ' THR . 15.1 mt-30 -152.74 166.79 31.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.173 -1.011 . . . . 3.2999999999999998 110.61 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 146' ' ' VAL . 7.3 p -169.92 91.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.917 -0.772 . . . . 2.2599999999999998 108.917 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.73 140.67 29.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 2.7599999999999998 110.482 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.578 HD21 ' CG2' ' A' ' 58' ' ' VAL . 6.9 tp -124.23 94.82 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.608 -0.886 . . . . 4.5700000000000003 108.608 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.74 ' OG1' ' N ' ' A' ' 7' ' ' VAL . 8.2 t 177.87 -144.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 3.0699999999999998 109.156 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.706 HG22 ' OG ' ' A' ' 5' ' ' SER . 9.1 t -125.97 -160.8 1.0 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.109 -0.994 . . . . 2.0 109.658 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.63 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.4 OUTLIER 84.37 110.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.366 -0.833 . . . . 2.1499999999999999 109.388 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.21 94.18 1.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 2.8199999999999998 109.541 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.977 -1.011 . . . . 3.54 109.472 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.425 -0.583 . . . . 5.4699999999999998 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 3' ' ' LEU . 44.8 p -80.76 -139.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 4.5300000000000002 109.505 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' SER . 0.6 OUTLIER -44.72 165.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 5.1399999999999997 109.439 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 3' ' ' LEU . 7.3 m-20 -36.42 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 5.3799999999999999 109.527 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER 58.36 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 4.8300000000000001 109.491 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -36.48 125.17 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 3.4300000000000002 109.496 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.17 88.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 2.8300000000000001 109.397 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.12 100.4 13.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 4.75 109.551 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.56 -8.63 56.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 4.9500000000000002 109.496 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.683 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.3 tm? -140.96 85.93 11.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 2.8599999999999999 108.797 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.58 40.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.996 2.464 . . . . 3.8300000000000001 112.22 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.683 ' H ' HD13 ' A' ' 10' ' ' LEU . 19.6 t60 -143.11 123.1 13.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 2.52 109.641 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.567 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -170.1 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -0.858 . . . . 1.97 109.199 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.627 ' C ' ' H ' ' A' ' 16' ' ' ALA . 46.2 m -109.94 63.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 1.96 109.719 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -66.5 21.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 1.76 109.188 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.07 -63.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 1.1799999999999999 109.939 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' SER . 3.4 mm-40 -111.73 39.87 2.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 2.1299999999999999 109.912 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 1.9 m 160.39 147.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 2.2599999999999998 109.79 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 -72.04 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 2.6000000000000001 109.608 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 118.98 -167.48 13.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.515 -1.434 . . . . 1.6200000000000001 109.515 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 17.1 Cg_exo -62.02 -20.14 68.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.567 2.178 . . . . 1.7 111.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 13.8 m95 -65.46 -166.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 2.4199999999999999 109.414 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -150.29 174.65 12.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 1.6399999999999999 109.619 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.662 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 54.7 tp -170.85 148.1 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 2.0499999999999998 109.451 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.745 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 165.04 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 1.72 109.691 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 79.31 -22.09 3.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.849 -1.3 . . . . 1.7 109.849 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.94 -142.01 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -1.213 . . . . 0.96999999999999997 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.1 p -90.67 136.91 32.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 1.8 109.163 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 28' ' ' SER . 51.9 mm-40 -32.5 97.03 0.1 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 2.3999999999999999 109.732 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 28' ' ' SER . 32.1 Cg_exo -53.13 163.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 1.1299999999999999 111.342 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 30' ' ' PRO . 97.0 t -154.17 134.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.155 . . . . 1.05 110.742 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -90.07 85.91 6.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.583 0.706 . . . . 1.8200000000000001 109.407 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.52 -139.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.1699999999999999 109.996 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.55 76.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.406 -0.809 . . . . 2.21 110.059 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 55.49 23.38 34.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.942 -1.263 . . . . 1.1899999999999999 109.942 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 33' ' ' ALA . 2.2 ptp180 -136.25 143.15 44.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -1.211 . . . . 2.9100000000000001 109.435 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.77 ' SD ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -114.61 148.4 38.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.93000000000000005 109.411 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.77 ' N ' ' SD ' ' A' ' 37' ' ' MET . 3.8 t -157.03 163.37 39.13 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.574 -0.85 . . . . 1.0600000000000001 110.17 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG23 HD13 ' A' ' 41' ' ' LEU . 21.5 m -136.14 150.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.265 -1.013 . . . . 1.3700000000000001 108.265 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.733 ' C ' HD12 ' A' ' 41' ' ' LEU . 18.9 m-20 -97.9 99.25 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 4.79 110.183 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.733 HD12 ' C ' ' A' ' 40' ' ' ASP . 8.5 mp -113.15 91.09 17.77 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 3.54 109.12 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.45 -87.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.906 2.404 . . . . 3.7400000000000002 112.318 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.2 96.19 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.441 . . . . 2.0299999999999998 109.499 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.47 31.96 0.05 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.515 -1.434 . . . . 2.4100000000000001 109.515 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.479 ' NE2' ' HA3' ' A' ' 134' ' ' GLY . 2.9 mt-30 -99.99 174.19 6.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -1.173 . . . . 2.96 109.41 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.66 -41.88 8.06 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 2.0800000000000001 109.502 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.757 ' ND2' ' CD1' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -167.01 157.54 10.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 3.6099999999999999 109.426 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.51 -39.87 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.842 2.361 . . . . 2.3599999999999999 112.211 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.757 ' CD1' ' ND2' ' A' ' 47' ' ' ASN . 4.9 p90 -91.9 55.33 2.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.917 . . . . 3.8700000000000001 109.47 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.713 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 70.4 m-20 -128.33 1.94 5.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 2.3799999999999999 109.458 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.416 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -175.31 172.95 2.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 1.1100000000000001 109.509 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 24' ' ' LEU . . . 131.42 -164.38 23.47 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.586 -1.405 . . . . 0.93999999999999995 109.586 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD21 ' CD2' ' A' ' 131' ' ' PHE . 1.1 pp -109.73 161.77 15.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -1.093 . . . . 0.95999999999999996 109.2 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 129' ' ' VAL . 2.1 t -152.21 161.12 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.92000000000000004 109.769 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 33.1 t80 -175.31 147.79 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 1.71 109.476 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.681 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.3 m-80 -107.16 160.94 15.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.263 -0.898 . . . . 2.7799999999999998 109.396 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 112.75 74.15 0.67 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 2.48 109.577 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.498 HG22 ' HA3' ' A' ' 127' ' ' GLY . 19.7 m -155.45 66.2 4.64 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.247 -1.149 . . . . 3.79 109.439 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.63 137.01 41.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.759 2.306 . . . . 2.3999999999999999 112.155 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 66' ' ' TYR . 10.6 t -135.66 139.99 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 3.0800000000000001 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -107.73 117.17 5.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.51 -1.436 . . . . 3.0499999999999998 109.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -45.69 128.03 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 6.0499999999999998 109.526 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.461 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 113.25 -25.77 11.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.686 -1.366 . . . . 2.54 109.686 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' O ' ' OG ' ' A' ' 115' ' ' SER . 4.9 mt-10 -100.05 173.58 6.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -1.163 . . . . 4.0300000000000002 109.646 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 2.9100000000000001 109.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.711 ' CD1' HG22 ' A' ' 60' ' ' VAL . 41.7 m-85 -104.36 -179.63 4.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.268 -0.895 . . . . 2.3799999999999999 109.592 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 112' ' ' ALA . 1.4 p -160.93 143.84 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 2.6099999999999999 109.668 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -126.52 118.46 24.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 3.6099999999999999 109.512 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.51 94.59 5.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 2.27 109.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 4.4 p90 -93.64 147.01 23.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.096 -1.002 . . . . 2.0099999999999998 110.954 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.3 p -95.02 112.56 24.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.188 -1.041 . . . . 1.8 108.188 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 143' ' ' ILE . . . -165.51 153.71 11.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.696 -1.253 . . . . 0.95999999999999996 110.797 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.52 148.67 49.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.713 -0.847 . . . . 0.93000000000000005 108.713 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' N ' ' O ' ' A' ' 103' ' ' THR . . . -113.13 124.79 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.984 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.584 ' CA ' ' H ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -130.72 132.79 24.17 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.309 -0.869 . . . . 0.96999999999999997 108.704 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.611 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.5 Cg_exo -73.15 27.7 0.43 Allowed 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 124.665 -0.973 . . . . 1.02 112.779 -0.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.716 ' O ' ' SD ' ' A' ' 78' ' ' MET . 2.4 m-20 89.29 152.52 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.514 -0.551 . . . . 1.75 109.514 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.716 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 161.54 174.57 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.965 -1.124 . . . . 2.1600000000000001 107.965 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.507 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 10.5 Cg_endo -81.98 145.74 14.18 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.454 2.102 . . . . 1.3799999999999999 112.218 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.886 HG12 ' OH ' ' A' ' 139' ' ' TYR . 7.5 m -113.58 159.15 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 2.0099999999999998 109.719 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.12 123.5 49.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 6.0099999999999998 109.236 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.415 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER -136.18 149.09 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 3.7599999999999998 109.521 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 1.3 pp -145.67 144.41 30.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.29 109.664 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -151.82 151.48 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 1.8899999999999999 109.781 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.52 -137.6 5.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.451 -1.46 . . . . 1.49 109.451 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 89' ' ' GLY . 3.3 pt-20 -88.52 -165.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 2.54 109.446 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.9 50.34 0.49 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.56 -1.416 . . . . 1.3799999999999999 109.56 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -162.03 -150.86 6.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 2.54 109.587 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . -44.88 166.63 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 4.1399999999999997 109.51 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . 43.31 74.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -1.157 . . . . 5.1299999999999999 109.468 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -65.5 15.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 5.79 109.461 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.639 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -60.93 122.73 15.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.243 -0.91 . . . . 5.7400000000000002 109.481 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -128.28 167.95 16.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 2.27 109.892 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.92 -23.15 11.51 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.651 -0.87 . . . . 3.2799999999999998 108.651 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.99 36.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.358 -0.839 . . . . 3.6499999999999999 108.945 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -84.5 44.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 4.5999999999999996 109.595 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.581 ' O ' ' CG ' ' A' ' 97' ' ' GLN . 10.1 pt20 -102.4 121.18 41.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 3.46 109.341 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -111.24 6.3 28.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.587 -1.405 . . . . 3.6699999999999999 109.587 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.37 77.26 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -1.139 . . . . 3.79 109.514 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.759 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -116.98 81.8 12.75 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.117 -0.99 . . . . 1.96 109.448 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 45.2 Cg_exo -52.09 143.05 42.76 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.845 2.363 . . . . 2.9700000000000002 112.29 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.466 HD12 HG11 ' A' ' 80' ' ' VAL . 14.0 mt -143.58 154.19 43.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 3.0600000000000001 109.505 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.44 -162.4 0.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.3399999999999999 109.608 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.676 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -102.1 -9.68 41.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.64 -1.384 . . . . 2.1699999999999999 109.64 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.549 ' OE2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -99.89 134.46 20.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.181 -1.188 . . . . 3.02 108.957 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.549 ' O ' ' OE2' ' A' ' 105' ' ' GLU . 85.7 Cg_exo -37.27 117.55 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 1.4199999999999999 112.139 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.43 137.08 16.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 1.3700000000000001 109.674 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.07 152.5 20.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 1.72 109.831 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.729 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -129.36 138.92 51.81 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.051 -1.092 . . . . 4.7000000000000002 108.051 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.628 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -120.57 118.45 30.24 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.759 -0.776 . . . . 3.2799999999999998 110.671 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.759 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 7.3 m-85 -115.16 118.83 34.44 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.549 -0.908 . . . . 2.96 108.549 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.422 ' HB2' HG23 ' A' ' 67' ' ' VAL . . . -107.85 146.64 32.0 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 3.4100000000000001 109.948 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.739 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -129.71 163.35 26.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 2.77 109.32 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.53 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -97.96 104.44 16.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 2.23 109.63 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.4 m -37.16 104.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 4.1100000000000003 109.305 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.15 14.72 27.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 6.8600000000000003 109.556 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 118' ' ' THR . 8.3 tt -169.21 171.86 7.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 5.1200000000000001 109.444 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.842 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -95.26 114.84 26.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.175 -0.953 . . . . 4.0599999999999996 109.697 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 117' ' ' LEU . 55.5 m-85 -110.58 94.53 19.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 5.4400000000000004 109.402 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.26 158.18 23.05 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.611 2.207 . . . . 4.04 112.196 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.34 -27.53 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.723 2.282 . . . . 3.8999999999999999 111.948 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 19.3 p-10 -109.96 -163.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 4.1399999999999997 109.478 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 66.23 169.3 3.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.573 -1.411 . . . . 3.5699999999999998 109.573 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.22 45.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 3.5899999999999999 109.423 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -163.18 55.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 2.0800000000000001 109.54 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 47.5 Cg_endo -72.91 -158.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.827 2.352 . . . . 1.3899999999999999 112.189 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.498 ' HA3' HG22 ' A' ' 58' ' ' VAL . . . -86.91 157.06 29.26 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.542 -1.423 . . . . 1.1899999999999999 109.542 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -141.91 114.48 8.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -1.178 . . . . 2.0099999999999998 109.582 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.5 t -131.66 128.5 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 1.28 108.853 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -157.0 114.56 3.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.97999999999999998 110.101 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.477 ' CD2' HD21 ' A' ' 53' ' ' LEU . 4.9 m-30 -92.21 119.38 31.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.645 -0.872 . . . . 1.73 108.645 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 42.0 m170 -105.4 127.1 52.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 2.3199999999999998 109.623 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -128.87 -34.67 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 2.1099999999999999 109.468 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.54 127.16 0.57 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.651 -1.38 . . . . 1.77 109.651 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.684 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 16.4 mttt -166.99 130.71 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 5.0599999999999996 109.73 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.36 -19.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.095 -1.076 . . . . 2.6400000000000001 108.095 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.1 17.11 7.14 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.815 -1.714 . . . . 2.5099999999999998 108.815 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.684 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -51.43 -151.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.943 . . . . 2.3199999999999998 110.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.886 ' OH ' HG12 ' A' ' 80' ' ' VAL . 2.7 p90 -171.91 -161.82 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 1.6100000000000001 109.511 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.57 142.85 26.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 1.6499999999999999 109.718 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.559 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 31.1 t80 -128.07 107.61 9.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.481 -0.762 . . . . 1.6799999999999999 109.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 69.8 m -110.36 102.84 11.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.11 -0.994 . . . . 0.73999999999999999 110.989 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -120.88 144.43 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.486 -0.931 . . . . 1.22 108.486 178.334 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 143' ' ' ILE . 29.6 p -121.91 -8.7 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.95 -0.7 . . . . 1.3300000000000001 109.815 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.582 ' O ' ' OG1' ' A' ' 71' ' ' THR . 11.9 pt20 -168.9 176.77 5.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.649 -1.22 . . . . 3.2999999999999998 111.023 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.562 ' O ' ' OG1' ' A' ' 13' ' ' THR . 7.3 p -170.42 159.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.073 -0.714 . . . . 2.2599999999999998 109.073 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.467 ' N ' HG22 ' A' ' 146' ' ' VAL . 0.3 OUTLIER -148.74 158.54 44.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 2.7599999999999998 109.78 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 149' ' ' THR . 1.1 pp -143.72 155.22 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 4.5700000000000003 109.428 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.78 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 3.0699999999999998 109.546 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.664 ' N ' ' OG1' ' A' ' 149' ' ' THR . 4.7 t -126.73 -121.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 2.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 150' ' ' THR . 0.2 OUTLIER 177.34 161.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 2.1499999999999999 109.434 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.14 95.3 9.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 2.8199999999999998 109.421 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.022 -0.99 . . . . 3.54 109.516 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.558 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.452 -0.573 . . . . 5.4699999999999998 109.452 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -57.68 -139.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 4.5300000000000002 109.461 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 5' ' ' SER . 1.0 OUTLIER 38.47 -160.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 5.1399999999999997 109.426 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' LEU . 8.1 m-20 42.63 19.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 5.3799999999999999 109.455 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -177.23 -155.96 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 4.8300000000000001 109.47 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 7' ' ' VAL . 5.9 pm0 -171.69 89.53 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.838 . . . . 3.4300000000000002 109.447 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 7' ' ' VAL . 2.3 t -43.2 142.25 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 2.8300000000000001 109.393 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -125.67 86.13 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 4.75 109.479 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.46 -33.84 74.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 4.9500000000000002 109.395 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER -108.17 95.43 15.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.632 -0.877 . . . . 2.8599999999999999 108.632 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.39 49.1 1.35 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.081 1.854 . . . . 3.8300000000000001 111.983 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.619 ' H ' HD13 ' A' ' 10' ' ' LEU . 82.0 t60 -152.77 129.46 10.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.391 -0.818 . . . . 2.52 109.639 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.637 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -167.45 57.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 1.97 109.492 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.8 t -151.22 67.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 1.96 109.552 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -62.64 39.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 1.76 109.091 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -86.79 -36.84 18.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 1.1799999999999999 109.858 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.691 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 15.3 mm-40 -111.7 -57.73 2.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 2.1299999999999999 109.581 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 p -128.2 143.54 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 2.2599999999999998 109.468 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.857 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -55.36 -15.98 3.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 2.6000000000000001 109.465 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 83.43 -154.37 31.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.571 -1.411 . . . . 1.6200000000000001 109.571 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.47 -11.51 15.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 1.7 112.089 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 10.9 m95 -65.14 -163.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 2.4199999999999999 109.307 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.671 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.7 m -156.58 164.0 38.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 1.6399999999999999 109.313 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -168.38 160.07 11.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 2.0499999999999998 109.803 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.73 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 167.04 177.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 1.72 109.558 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 92.26 -23.44 27.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.941 -1.264 . . . . 1.7 109.941 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.785 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.86 -142.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.24 . . . . 0.96999999999999997 109.271 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.785 ' N ' ' OG1' ' A' ' 27' ' ' THR . 33.4 p -91.09 130.19 37.01 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.185 -0.947 . . . . 1.8 109.096 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.554 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -35.81 100.44 0.2 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 2.3999999999999999 109.176 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HG2' HD13 ' A' ' 24' ' ' LEU . 64.2 Cg_exo -46.11 154.07 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.381 2.054 . . . . 1.1299999999999999 111.643 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' MET . 4.2 t -138.53 115.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.996 -1.065 . . . . 1.05 110.395 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.45 84.28 3.18 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.534 0.683 . . . . 1.8200000000000001 109.218 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -78.39 -119.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.425 -0.797 . . . . 1.1699999999999999 110.229 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.804 ' H ' HH12 ' A' ' 36' ' ' ARG . 22.5 t0 -58.36 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.21 110.15 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 64.04 8.28 28.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.748 -1.341 . . . . 1.1899999999999999 109.748 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.804 HH12 ' H ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -126.91 144.45 50.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -1.233 . . . . 2.9100000000000001 109.604 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.778 ' HE2' HG13 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -109.87 130.44 55.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.93000000000000005 109.015 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -127.77 153.51 46.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.44 -0.904 . . . . 1.0600000000000001 110.593 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.778 HG13 ' HE2' ' A' ' 37' ' ' MET . 1.5 m -122.69 163.43 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.351 -0.981 . . . . 1.3700000000000001 108.351 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.864 ' C ' HD22 ' A' ' 41' ' ' LEU . 34.3 m-20 -107.78 102.54 11.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 4.79 110.189 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.864 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.2 mm? -126.33 48.23 2.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 3.54 109.265 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 76.9 Cg_exo -39.02 -71.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.904 2.402 . . . . 3.7400000000000002 112.34 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.7 77.85 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 2.0299999999999998 109.545 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.87 28.69 0.23 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.477 -1.449 . . . . 2.4100000000000001 109.477 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.425 ' NE2' ' HB3' ' A' ' 50' ' ' ASP . 8.7 mm-40 -99.95 144.04 29.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 2.96 109.501 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.29 -66.18 1.89 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.55 -1.42 . . . . 2.0800000000000001 109.55 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.772 ' ND2' ' NE1' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -99.89 156.72 35.01 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.172 -1.193 . . . . 3.6099999999999999 109.518 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 50' ' ' ASP . 46.3 Cg_endo -72.63 -33.52 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.827 2.351 . . . . 2.3599999999999999 112.314 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.772 ' NE1' ' ND2' ' A' ' 47' ' ' ASN . 28.7 p90 -73.65 21.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 3.8700000000000001 109.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 23.2 m-20 -102.49 26.57 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 2.3799999999999999 109.51 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 168.99 129.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 1.1100000000000001 109.488 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 159.29 163.96 13.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.8 -1.32 . . . . 0.93999999999999995 109.8 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -92.03 -169.31 2.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -1.098 . . . . 0.95999999999999996 109.341 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 23' ' ' SER . 1.5 p -174.32 165.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.288 -0.883 . . . . 0.92000000000000004 110.182 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.692 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 16.5 t80 173.16 140.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.511 -0.743 . . . . 1.71 109.405 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.692 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -102.5 -177.24 3.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.185 -0.947 . . . . 2.7799999999999998 109.618 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.37 61.81 1.37 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.626 -1.389 . . . . 2.48 109.626 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 58' ' ' VAL . 4.8 m -152.56 60.34 3.35 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 3.79 109.415 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 54.4 Cg_exo -47.22 146.9 6.14 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.875 2.383 . . . . 2.3999999999999999 112.192 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.03 92.36 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 3.0800000000000001 109.502 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -84.66 111.35 3.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 3.0499999999999998 109.513 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.56 123.53 13.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -1.104 . . . . 6.0499999999999998 109.466 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.79 -44.41 1.18 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 2.54 109.669 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' O ' ' OG ' ' A' ' 115' ' ' SER . 7.2 mt-10 -100.01 -179.98 4.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -1.152 . . . . 4.0300000000000002 109.634 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' OG1' ' A' ' 150' ' ' THR . 69.7 m -128.19 138.32 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.386 -0.821 . . . . 2.9100000000000001 109.362 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 44.5 m-85 -101.95 179.48 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 2.3799999999999999 109.624 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -152.15 141.72 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 2.6099999999999999 109.234 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.718 ' CD1' HD22 ' A' ' 148' ' ' LEU . 6.3 tp -127.91 113.11 15.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 3.6099999999999999 109.954 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.54 92.59 4.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.421 -0.955 . . . . 2.27 108.421 179.231 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 30.9 p90 -93.87 147.92 22.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 2.0099999999999998 111.074 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -98.59 105.24 17.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.265 -1.013 . . . . 1.8 108.265 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.482 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -152.02 159.18 43.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.725 -1.235 . . . . 0.95999999999999996 110.823 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.26 124.65 20.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.807 -0.812 . . . . 0.93000000000000005 108.807 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -86.16 129.46 34.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.67000000000000004 109.787 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.464 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.53 116.09 14.96 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.96999999999999997 109.302 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.73 -142.52 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 124.374 -1.094 . . . . 1.02 112.463 -0.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -95.5 151.49 19.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.917 . . . . 1.75 109.66 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 160.37 162.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 2.1600000000000001 109.401 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.568 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 57.8 Cg_endo -76.2 138.74 20.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.922 2.415 . . . . 1.3799999999999999 112.526 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -104.91 169.76 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 2.0099999999999998 109.287 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.741 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -109.91 149.03 30.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.399 -0.813 . . . . 6.0099999999999998 109.444 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 81' ' ' ARG . 19.3 t -152.64 148.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 3.7599999999999998 109.343 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.623 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.4 pp -152.55 146.07 24.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 2.29 109.739 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 129' ' ' VAL . 0.9 OUTLIER -153.69 149.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 1.8899999999999999 109.63 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.94 -141.29 7.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.48 -1.448 . . . . 1.49 109.48 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.734 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -89.94 -158.62 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -1.127 . . . . 2.54 109.459 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.507 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . -166.24 68.98 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.478 -1.449 . . . . 1.3799999999999999 109.478 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . 171.58 109.15 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.507 -1.437 . . . . 2.54 109.507 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 54.05 164.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 4.1399999999999997 109.539 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 63.14 -45.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -1.155 . . . . 5.1299999999999999 109.52 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.668 ' N ' ' O ' ' A' ' 89' ' ' GLY . 56.5 m-85 44.55 10.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 5.79 109.475 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -76.79 114.09 15.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 5.7400000000000002 109.536 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.35 163.86 16.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 2.27 109.89 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.04 -20.33 12.75 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.801 -0.815 . . . . 3.2799999999999998 108.801 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.81 36.16 0.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.844 . . . . 3.6499999999999999 109.16 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.83 56.34 3.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 4.5999999999999996 109.558 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -107.42 124.63 50.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 3.46 109.192 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -117.52 3.5 17.86 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.545 -1.422 . . . . 3.6699999999999999 109.545 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -89.28 72.61 8.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -1.157 . . . . 3.79 109.466 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.812 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -116.16 93.76 39.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 1.96 109.446 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 12.5 Cg_exo -65.98 116.9 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.855 2.37 . . . . 2.9700000000000002 112.512 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 101' ' ' PRO . 3.3 mm? -117.42 152.88 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 3.0600000000000001 109.339 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 8.5 t -105.21 -161.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.92 . . . . 2.3399999999999999 109.651 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -93.59 -22.31 26.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.75 -1.34 . . . . 2.1699999999999999 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -99.96 149.88 36.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.213 . . . . 3.02 109.437 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.46 118.87 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.771 2.314 . . . . 1.4199999999999999 112.062 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -144.17 126.01 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 1.3700000000000001 109.718 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.1 151.54 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 1.72 110.075 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.714 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -135.38 138.2 43.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.471 -0.937 . . . . 4.7000000000000002 108.471 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -117.67 111.65 19.44 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.979 -0.688 . . . . 3.2799999999999998 110.516 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -109.86 117.74 34.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.562 -0.903 . . . . 2.96 108.562 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.28 140.65 39.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.219 -0.926 . . . . 3.4100000000000001 109.665 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.721 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -126.3 162.87 24.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 2.77 109.45 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -98.94 103.48 15.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.23 109.531 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 61' ' ' GLY . 3.4 m -37.15 110.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 4.1100000000000003 109.356 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.819 ' O ' HD22 ' A' ' 117' ' ' LEU . 9.8 p-10 -115.98 -10.38 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 6.8600000000000003 109.467 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.819 HD22 ' O ' ' A' ' 116' ' ' ASN . 2.1 mm? -130.1 128.47 41.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 5.1200000000000001 109.459 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.13 113.81 12.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 4.0599999999999996 109.465 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 117' ' ' LEU . 18.3 m-85 -125.31 75.55 68.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 5.4400000000000004 109.483 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -52.91 167.2 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.746 2.297 . . . . 4.04 112.069 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.67 -24.44 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.771 2.314 . . . . 3.8999999999999999 112.076 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -110.39 160.77 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 4.1399999999999997 109.5 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.9 -137.16 13.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.541 -1.424 . . . . 3.5699999999999998 109.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 123' ' ' GLY . 20.5 m-20 -36.7 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 3.5899999999999999 109.497 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.5 150.55 34.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 2.0800000000000001 109.419 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.68 -158.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.801 2.334 . . . . 1.3899999999999999 112.2 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.517 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -61.86 168.03 14.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.531 -1.427 . . . . 1.1899999999999999 109.531 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.507 ' NE2' ' HA3' ' A' ' 87' ' ' GLY . 3.7 tp60 -155.97 133.22 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -1.108 . . . . 2.0099999999999998 109.595 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.517 HG22 HG13 ' A' ' 84' ' ' VAL . 59.8 t -139.56 151.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.644 -0.872 . . . . 1.28 108.644 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -167.02 112.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 0.97999999999999998 110.207 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -85.56 112.9 21.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.319 -0.863 . . . . 1.73 108.703 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.623 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 2.4 m170 -99.77 120.51 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.3199999999999998 109.978 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -140.06 5.09 2.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 2.1099999999999999 109.271 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -80.26 122.18 5.67 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.526 -1.43 . . . . 1.77 109.526 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.69 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.4 mtpp -163.96 135.78 4.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 5.0599999999999996 109.668 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.91 -13.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.404 -0.961 . . . . 2.6400000000000001 108.404 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -121.57 5.35 10.8 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.099 -1.601 . . . . 2.5099999999999998 109.099 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -52.34 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -1.035 . . . . 2.3199999999999998 109.937 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.568 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -170.78 -161.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.934 -1.103 . . . . 1.6100000000000001 109.411 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -80.18 143.34 33.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 1.6499999999999999 109.486 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.482 ' CE1' ' HB1' ' A' ' 72' ' ' ALA . 28.6 t80 -126.56 110.27 13.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 1.6799999999999999 109.239 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.0 104.83 14.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 110.558 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.51 HG23 ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -120.27 142.77 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 1.22 108.74 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 24.8 p -137.73 -3.42 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.636 -0.665 . . . . 1.3300000000000001 109.567 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.539 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.4 mt-30 -154.92 160.24 41.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.143 -0.973 . . . . 3.2999999999999998 110.061 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.637 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.2 t -143.38 152.61 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.434 -0.791 . . . . 2.2599999999999998 109.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 69' ' ' SER . 26.5 t -125.62 128.23 47.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 2.7599999999999998 109.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.718 HD22 ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -129.82 111.6 12.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 4.5700000000000003 109.208 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.584 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -160.98 -171.66 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 3.0699999999999998 109.626 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.727 HG23 ' N ' ' A' ' 151' ' ' SER . 7.7 t -156.85 -122.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 2.0 109.433 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.727 ' N ' HG23 ' A' ' 150' ' ' THR . 2.7 m -160.48 58.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 2.1499999999999999 109.437 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.467 ' N ' ' HB3' ' A' ' 2' ' ' SER . . . -150.61 -166.98 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 2.8199999999999998 109.516 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.976 -1.011 . . . . 3.54 109.495 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.327 0.584 . . . . 5.4699999999999998 109.53 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.698 ' O ' HD22 ' A' ' 3' ' ' LEU . 11.4 t -141.27 71.3 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 4.5300000000000002 109.498 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 2' ' ' SER . 1.1 mm? -128.54 -173.34 2.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 5.1399999999999997 109.422 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 5' ' ' SER . 3.9 p30 -89.33 -140.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 5.3799999999999999 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 52.63 -171.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 4.8300000000000001 109.427 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -147.89 103.61 3.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 3.4300000000000002 109.506 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.573 ' O ' ' OG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER -76.99 97.2 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 2.8300000000000001 109.412 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -85.53 82.16 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 4.75 109.477 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.615 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -44.39 -19.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 4.9500000000000002 109.444 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER -121.66 84.17 42.76 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.8599999999999999 108.628 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.1 20.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.973 2.448 . . . . 3.8300000000000001 112.131 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.58 ' H ' ' C ' ' A' ' 10' ' ' LEU . 69.9 t60 -118.64 99.29 6.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 2.52 109.672 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.892 ' O ' HG23 ' A' ' 13' ' ' THR . 5.5 t -139.12 56.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 1.97 109.339 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.619 ' C ' ' H ' ' A' ' 16' ' ' ALA . 44.4 m -142.49 61.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 1.96 109.785 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.7 m-30 -66.05 33.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 1.76 109.0 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.626 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.06 -35.26 15.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.1799999999999999 110.014 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -109.97 -84.53 0.55 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.121 -0.987 . . . . 2.1299999999999999 109.599 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 p -94.35 144.02 25.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.2599999999999998 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -55.77 -53.57 55.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 2.6000000000000001 109.459 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.472 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 111.98 -164.14 12.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 1.6200000000000001 109.682 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 56.7 Cg_endo -76.31 -4.51 15.15 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.833 2.355 . . . . 1.7 112.367 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.863 ' CH2' HG11 ' A' ' 146' ' ' VAL . 8.3 m95 -66.67 -177.63 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 2.4199999999999999 109.418 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -133.6 167.32 20.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 1.6399999999999999 109.277 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.008 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.5 pp 179.43 142.76 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.133 -0.979 . . . . 2.0499999999999998 109.809 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.82 173.78 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.464 -0.773 . . . . 1.72 109.453 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 102.29 -31.87 8.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.199 -1.16 . . . . 1.7 110.199 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.79 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.86 -141.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.957 -1.319 . . . . 0.96999999999999997 109.645 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.79 ' N ' ' OG1' ' A' ' 27' ' ' THR . 13.7 p -91.35 132.71 36.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.538 -0.726 . . . . 1.8 109.329 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 pt-20 -37.44 106.96 0.37 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.139 -0.976 . . . . 2.3999999999999999 109.055 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HG2' HD22 ' A' ' 24' ' ' LEU . 53.6 Cg_exo -45.54 150.01 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.226 1.951 . . . . 1.1299999999999999 111.691 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 t -136.83 123.07 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 1.05 110.103 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.84 115.4 17.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 1.8200000000000001 109.362 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 35' ' ' GLY . . . -81.76 -140.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 1.1699999999999999 109.733 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.53 13.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 2.21 110.057 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.626 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 144.11 -4.77 1.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.945 -1.262 . . . . 1.1899999999999999 109.945 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -121.57 152.22 39.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.005 -1.291 . . . . 2.9100000000000001 109.571 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.656 ' SD ' HD23 ' A' ' 19' ' ' LEU . 59.2 ttp -116.65 134.37 54.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.93000000000000005 109.338 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -129.93 154.11 47.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 110.161 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.9 m -123.74 140.85 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.682 -0.858 . . . . 1.3700000000000001 108.682 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.72 ' C ' HD12 ' A' ' 41' ' ' LEU . 53.1 m-20 -79.8 108.87 13.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 4.79 109.704 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 133' ' ' LEU . 8.2 mp -116.29 76.29 6.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 3.54 109.508 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 61.2 Cg_endo -77.54 -74.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.796 2.331 . . . . 3.7400000000000002 112.201 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . -173.52 -157.37 15.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.588 -1.405 . . . . 2.0299999999999998 109.588 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 77.19 -4.0 56.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.658 -1.377 . . . . 2.4100000000000001 109.658 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.671 ' O ' ' N ' ' A' ' 47' ' ' ASN . 7.8 mm-40 -100.01 66.79 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -1.119 . . . . 2.96 109.435 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.77 49.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.59 -1.404 . . . . 2.0800000000000001 109.59 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.674 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -169.68 89.28 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.107 . . . . 3.6099999999999999 109.422 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.7 -0.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.876 2.384 . . . . 2.3599999999999999 112.356 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.674 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -122.88 34.08 5.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 3.8700000000000001 109.572 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 2.0 m-20 -108.7 -19.62 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 2.3799999999999999 109.654 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -139.77 177.42 7.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 1.1100000000000001 109.71 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 128.65 171.82 13.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.615 -1.394 . . . . 0.93999999999999995 109.615 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.571 ' C ' HG22 ' A' ' 54' ' ' VAL . 3.2 mt -89.74 -177.29 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 0.95999999999999996 109.323 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.31 174.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.92000000000000004 109.92 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 22' ' ' TRP . 18.1 t80 176.98 129.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.43 -0.794 . . . . 1.71 109.46 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -111.38 115.14 28.78 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.252 -0.905 . . . . 2.7799999999999998 109.525 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 70.96 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.48 -1.448 . . . . 2.48 109.48 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -170.06 95.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.343 -1.092 . . . . 3.79 109.416 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 58.7 Cg_endo -79.35 127.06 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.594 2.196 . . . . 2.3999999999999999 112.186 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.1 t -100.03 135.19 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 3.0800000000000001 109.578 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -115.23 101.79 1.07 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 3.0499999999999998 109.338 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 61' ' ' GLY . 14.9 tt0 -35.53 144.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.166 . . . . 6.0499999999999998 109.612 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.675 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 96.35 -25.94 23.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.692 -1.363 . . . . 2.54 109.692 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 115' ' ' SER . 18.0 mt-10 -104.84 164.84 11.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -1.175 . . . . 4.0300000000000002 109.767 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 58.2 m -120.7 141.41 50.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 2.9100000000000001 109.228 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.61 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 28.0 m-85 -108.55 -179.21 3.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 2.3799999999999999 109.73 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.675 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.0 t -152.76 144.83 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.489 -0.757 . . . . 2.6099999999999999 109.341 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.44 116.46 16.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 3.6099999999999999 109.797 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.74 95.88 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 2.27 108.874 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -93.08 139.41 30.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 2.0099999999999998 110.85 -179.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -94.51 104.75 16.71 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.857 -0.794 . . . . 1.8 108.857 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -175.97 169.18 2.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.792 -1.192 . . . . 0.95999999999999996 110.635 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.16 172.18 13.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.763 -0.829 . . . . 0.93000000000000005 108.763 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -120.59 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.67000000000000004 109.949 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.47 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.59 115.6 14.73 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.311 -0.868 . . . . 0.96999999999999997 109.468 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.0 Cg_exo -65.79 -142.18 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 124.392 -1.087 . . . . 1.02 112.341 -0.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -102.23 149.36 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 1.75 109.602 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.15 153.58 0.13 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 2.1600000000000001 109.438 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.72 163.78 28.68 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.829 2.353 . . . . 1.3799999999999999 112.491 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 35.8 m -136.5 -178.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.346 -0.846 . . . . 2.0099999999999998 109.305 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.717 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -126.56 117.78 23.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 6.0099999999999998 109.658 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.602 HG13 ' CD ' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -119.7 151.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 3.7599999999999998 109.259 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 130' ' ' ALA . 2.9 pp -143.03 156.39 44.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 2.29 109.909 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.456 ' CG2' ' C ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -154.03 159.8 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 1.8899999999999999 109.428 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 144.99 -142.92 11.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.578 -1.409 . . . . 1.49 109.578 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.67 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -90.17 -165.88 1.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 2.54 109.44 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.644 ' H ' ' HB3' ' A' ' 125' ' ' ALA . . . -149.46 84.29 0.17 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.556 -1.418 . . . . 1.3799999999999999 109.556 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.67 ' N ' ' OE2' ' A' ' 86' ' ' GLU . . . -130.67 -154.47 7.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.481 -1.448 . . . . 2.54 109.481 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.685 ' O ' ' CD2' ' A' ' 91' ' ' TYR . . . -70.83 -66.68 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 4.1399999999999997 109.496 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' TYR . . . -66.3 2.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -1.17 . . . . 5.1299999999999999 109.477 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.685 ' CD2' ' O ' ' A' ' 89' ' ' GLY . 39.6 m-85 38.58 47.86 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 5.79 109.456 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -63.8 117.23 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 5.7400000000000002 109.414 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -139.77 173.53 11.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 2.27 109.966 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HB1' ' OD1' ' A' ' 116' ' ' ASN . . . -123.65 -19.62 5.74 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.823 -0.806 . . . . 3.2799999999999998 108.823 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.583 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.68 34.72 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 3.6499999999999999 109.203 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 4.5999999999999996 109.538 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' CD ' HG13 ' A' ' 82' ' ' VAL . 4.9 pt20 -107.79 -156.25 0.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 3.46 109.425 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -173.16 -35.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.688 -1.365 . . . . 3.6699999999999999 109.688 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -80.07 90.21 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -1.146 . . . . 3.79 109.518 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' HG23 ' A' ' 80' ' ' VAL . . . -123.13 78.71 51.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 1.96 109.461 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.83 127.14 24.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.018 2.479 . . . . 2.9700000000000002 112.547 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 102' ' ' LEU . 55.9 mt -140.41 145.74 37.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.0600000000000001 109.297 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -127.45 175.11 8.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 2.3399999999999999 109.701 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -77.79 17.68 5.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 2.1699999999999999 109.527 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -102.48 103.8 33.94 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.279 -1.13 . . . . 3.02 109.165 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -44.75 117.5 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.3 2.0 . . . . 1.4199999999999999 112.188 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.762 ' HB1' HH12 ' A' ' 109' ' ' ARG . . . -165.16 156.82 14.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.925 . . . . 1.3700000000000001 109.603 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.639 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.24 136.02 33.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.368 -0.833 . . . . 1.72 110.221 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.762 HH12 ' HB1' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -110.23 142.02 42.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.665 -1.235 . . . . 4.7000000000000002 107.665 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.75 105.69 13.59 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.763 -0.775 . . . . 3.2799999999999998 110.457 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -109.09 109.18 20.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.172 -1.048 . . . . 2.96 108.172 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -116.85 169.14 9.62 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 3.4100000000000001 109.807 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.3 p90 -154.73 -178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.835 . . . . 2.77 109.514 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -109.92 106.15 15.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.36 -0.837 . . . . 2.23 109.689 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.675 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 59.8 p -35.97 119.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 4.1100000000000003 109.316 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.527 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 3.7 m120 -96.26 -49.24 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 6.8600000000000003 109.576 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.72 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.81 -156.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 5.1200000000000001 109.646 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.72 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -119.52 144.83 46.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.349 -0.844 . . . . 4.0599999999999996 109.491 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.56 ' CD1' ' O ' ' A' ' 118' ' ' THR . 74.6 m-85 -157.86 62.29 2.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 5.4400000000000004 109.497 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.503 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 45.7 Cg_exo -52.28 -173.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.852 2.368 . . . . 4.04 112.071 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 5.0 Cg_exo -71.23 -31.45 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.047 2.498 . . . . 3.8999999999999999 111.857 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -111.0 -161.56 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 4.1399999999999997 109.478 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 88.21 -149.02 21.08 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.514 -1.435 . . . . 3.5699999999999998 109.514 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.654 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -44.73 -50.03 10.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 3.5899999999999999 109.434 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.644 ' HB3' ' H ' ' A' ' 87' ' ' GLY . . . -165.68 155.09 10.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.0800000000000001 109.457 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.91 -158.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 1.3899999999999999 112.205 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.99 168.61 9.88 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.546 -1.422 . . . . 1.1899999999999999 109.546 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.566 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 6.6 tp60 -148.86 118.77 7.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -1.175 . . . . 2.0099999999999998 109.656 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 54' ' ' VAL . 38.9 t -136.02 137.74 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 1.28 108.636 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -160.27 112.15 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.999 -1.063 . . . . 0.97999999999999998 110.506 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.4 m-30 -89.0 110.43 21.12 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.519 -0.919 . . . . 1.73 108.519 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -99.69 138.37 36.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 2.3199999999999998 110.031 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -155.93 17.11 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 2.1099999999999999 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -77.18 139.09 22.85 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.616 -1.393 . . . . 1.77 109.616 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 137' ' ' GLY . 18.7 mtpt -166.25 127.49 1.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.134 . . . . 5.0599999999999996 109.81 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.17 -15.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.0 -1.111 . . . . 2.6400000000000001 108.0 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.52 17.13 6.96 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.747 -1.741 . . . . 2.5099999999999998 108.747 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.86 -158.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.918 . . . . 2.3199999999999998 110.714 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.647 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 2.2 p90 -152.73 -119.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 1.6100000000000001 109.391 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.464 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 2.3 mt-10 -135.9 143.88 45.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 1.6499999999999999 109.228 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 38.1 t80 -124.5 127.39 47.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 1.6799999999999999 109.454 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.94 115.56 25.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.73999999999999999 110.506 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.41 143.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.759 0.79 . . . . 1.22 109.017 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' PHE . 52.3 p -120.66 -19.86 7.28 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.466 -0.939 . . . . 1.3300000000000001 108.466 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.563 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.9 pt20 -171.36 172.27 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.843 -0.743 . . . . 3.2999999999999998 109.646 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.863 HG11 ' CH2' ' A' ' 22' ' ' TRP . 8.8 p -147.16 141.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 2.2599999999999998 109.51 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.441 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -114.91 158.94 21.29 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.912 . . . . 2.7599999999999998 109.527 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 149' ' ' THR . 1.6 tp -168.22 114.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 4.5700000000000003 109.381 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.678 ' N ' HD12 ' A' ' 148' ' ' LEU . 7.0 t -156.68 -164.03 1.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 3.0699999999999998 109.484 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.774 HG23 ' N ' ' A' ' 151' ' ' SER . 7.7 t -150.88 -143.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 2.0 109.464 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.774 ' N ' HG23 ' A' ' 150' ' ' THR . 1.1 m 38.49 39.72 0.33 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 2.1499999999999999 109.488 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.32 126.06 22.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 2.8199999999999998 109.499 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.07 -0.967 . . . . 3.54 109.499 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.485 -0.561 . . . . 5.4699999999999998 109.485 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -106.72 80.01 1.41 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 4.5300000000000002 109.436 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.622 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER -147.81 -175.51 4.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 5.1399999999999997 109.642 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 1.7 t70 84.58 168.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 5.3799999999999999 109.587 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.841 ' OG ' ' HB1' ' A' ' 152' ' ' ALA . 0.8 OUTLIER 48.08 175.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 4.8300000000000001 109.484 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.91 121.13 16.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 3.4300000000000002 109.564 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.78 ' O ' HD12 ' A' ' 9' ' ' LEU . 48.6 t -108.79 64.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 2.8300000000000001 109.311 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.598 ' C ' ' H ' ' A' ' 10' ' ' LEU . 6.3 pm0 -51.02 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 4.75 109.669 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 7' ' ' VAL . 8.6 mp -54.22 -1.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 4.9500000000000002 109.276 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.05 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -140.5 95.85 7.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 2.8599999999999999 108.943 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.07 38.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 3.8300000000000001 112.703 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.678 ' N ' ' O ' ' A' ' 10' ' ' LEU . 33.7 t60 -133.44 115.65 15.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 2.52 109.337 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.579 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -154.41 63.38 0.68 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.347 -0.846 . . . . 1.97 109.283 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 16' ' ' ALA . 16.2 m -159.47 66.8 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 1.96 109.512 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.8 m-30 -67.11 27.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 1.76 109.195 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.17 -29.53 18.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.847 . . . . 1.1799999999999999 109.956 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 4.3 mt-10 -109.73 -83.64 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 2.1299999999999999 109.78 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.4 m -96.46 143.77 27.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 2.2599999999999998 109.593 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' A' ' 37' ' ' MET . 3.9 mt -54.11 -51.38 64.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 2.6000000000000001 109.418 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.37 -171.59 16.76 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.591 -1.404 . . . . 1.6200000000000001 109.591 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 22' ' ' TRP . 47.5 Cg_endo -72.99 -18.54 24.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.759 2.306 . . . . 1.7 112.147 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.766 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.5 m95 -53.06 -174.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 2.4199999999999999 109.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -135.81 173.79 11.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 1.6399999999999999 109.525 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.573 HD13 ' CG ' ' A' ' 30' ' ' PRO . 2.7 pp -177.81 142.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 2.0499999999999998 109.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.91 170.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 1.72 109.793 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.06 -29.73 10.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.97 -1.252 . . . . 1.7 109.97 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.773 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.73 -141.94 0.38 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.083 -1.245 . . . . 0.96999999999999997 109.3 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.773 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.7 p -91.15 -170.58 2.7 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 1.8 109.172 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.22 111.34 46.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 109.041 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.573 ' CG ' HD13 ' A' ' 24' ' ' LEU . 76.7 Cg_exo -44.66 134.9 9.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.201 1.934 . . . . 1.1299999999999999 111.921 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 37' ' ' MET . 9.2 t -116.95 105.07 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 1.05 109.918 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -69.24 77.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.568 -0.708 . . . . 1.8200000000000001 109.416 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -60.67 -140.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.1699999999999999 109.766 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -35.48 -76.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 2.21 109.503 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.21 49.71 0.71 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.586 -1.406 . . . . 1.1899999999999999 109.586 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -173.15 150.38 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 2.9100000000000001 109.398 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' HD21 ' A' ' 19' ' ' LEU . 4.5 ptt? -108.87 134.03 52.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 109.562 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.68 135.51 54.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.627 -0.829 . . . . 1.0600000000000001 110.427 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.1 m -106.07 140.66 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.672 -0.862 . . . . 1.3700000000000001 108.672 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.2 m-20 -77.35 106.53 9.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 4.79 109.922 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 133' ' ' LEU . 6.6 mp -114.26 80.67 5.92 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 3.54 109.157 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.23 -95.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 3.7400000000000002 112.263 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.17 137.29 4.85 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.651 -1.379 . . . . 2.0299999999999998 109.651 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 155.71 -17.85 0.49 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 2.4100000000000001 109.51 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -99.51 61.99 1.2 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.235 -1.156 . . . . 2.96 109.632 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -36.48 -33.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.249 -1.54 . . . . 2.0800000000000001 109.249 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -107.69 101.83 41.97 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.364 -1.08 . . . . 3.6099999999999999 109.037 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' O ' ' CG ' ' A' ' 132' ' ' HIS . 36.2 Cg_exo -56.36 44.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.457 2.105 . . . . 2.3599999999999999 112.315 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.693 ' CH2' ' OD2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -117.12 49.75 1.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.99 . . . . 3.8700000000000001 111.28 -179.178 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.693 ' OD2' ' CH2' ' A' ' 49' ' ' TRP . 23.9 m-20 -165.07 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 2.3799999999999999 109.465 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.06 120.04 24.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 1.1100000000000001 109.546 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.604 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 162.59 179.2 37.03 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.683 -1.246 . . . . 0.93999999999999995 110.041 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.979 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.5 mm? -100.07 168.01 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -1.04 . . . . 0.95999999999999996 109.009 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -155.89 166.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.92000000000000004 109.825 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 1.05 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 13.1 t80 173.92 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 1.71 109.571 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.568 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-80 -98.93 150.03 22.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 109.548 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' H ' ' HA3' ' A' ' 127' ' ' GLY . . . 127.69 52.54 0.14 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 2.48 109.589 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.721 HG13 HD22 ' A' ' 148' ' ' LEU . 14.7 t -142.79 70.59 19.64 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 3.79 109.457 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -47.66 143.57 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.834 2.356 . . . . 2.3999999999999999 112.208 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.53 122.04 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 3.0800000000000001 109.461 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.17 91.72 0.69 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 3.0499999999999998 109.492 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 3.5 tm-20 -41.81 120.42 1.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 6.0499999999999998 109.46 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.31 -48.82 0.93 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.807 -1.317 . . . . 2.54 109.807 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.6 mp0 -100.03 179.71 4.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 4.0300000000000002 109.623 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.57 ' OG ' HG22 ' A' ' 114' ' ' THR . 58.5 m -120.28 140.99 50.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 2.9100000000000001 109.396 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 38.6 m-85 -109.53 -178.13 3.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.202 -0.936 . . . . 2.3799999999999999 109.474 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 66' ' ' TYR . 22.9 t -152.79 130.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 2.6099999999999999 109.511 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 69' ' ' SER . 8.0 tt -110.7 147.51 34.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 3.6099999999999999 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.968 ' N ' HD23 ' A' ' 68' ' ' LEU . 1.6 p -130.2 91.05 3.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 2.27 109.455 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 109' ' ' ARG . 29.5 p90 -94.63 139.56 31.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 2.0099999999999998 110.966 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.801 HG23 HG23 ' A' ' 108' ' ' THR . 1.1 p -97.0 134.68 40.05 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.641 -0.874 . . . . 1.8 108.641 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.803 ' N ' HH22 ' A' ' 109' ' ' ARG . . . 169.37 -170.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.951 -1.093 . . . . 0.95999999999999996 110.481 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -169.11 147.68 3.88 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.816 -0.809 . . . . 0.93000000000000005 108.816 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -104.72 134.04 48.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.116 -0.99 . . . . 0.67000000000000004 109.85 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.45 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.04 116.4 15.63 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.4 -0.812 . . . . 0.96999999999999997 109.292 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.21 -142.29 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.665 0 C-N-CA 124.297 -1.126 . . . . 1.02 112.344 -0.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -104.96 148.8 26.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.75 109.253 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.724 ' SD ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 ptp 174.43 154.45 0.3 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 2.1600000000000001 109.535 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.14 117.93 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.57 2.18 . . . . 1.3799999999999999 111.871 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -97.45 179.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.878 . . . . 2.0099999999999998 109.536 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -120.14 150.92 39.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 6.0099999999999998 109.65 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -142.47 147.89 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 3.7599999999999998 109.118 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -143.81 148.26 35.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 2.29 110.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -154.41 164.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.775 . . . . 1.8899999999999999 109.413 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.68 -138.9 6.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.687 -1.365 . . . . 1.49 109.687 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.1 pm0 -90.17 177.31 6.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -1.145 . . . . 2.54 109.489 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.89 57.44 0.72 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.523 -1.431 . . . . 1.3799999999999999 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.33 -176.9 39.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.538 -1.425 . . . . 2.54 109.538 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.605 ' C ' ' H ' ' A' ' 91' ' ' TYR . . . 68.84 -149.7 49.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.576 -1.41 . . . . 4.1399999999999997 109.576 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -59.93 6.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -1.141 . . . . 5.1299999999999999 109.508 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.605 ' H ' ' C ' ' A' ' 89' ' ' GLY . 80.6 m-85 57.66 -2.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 5.79 109.483 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.587 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -52.77 -174.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 5.7400000000000002 109.427 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER 179.96 -179.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 2.27 109.954 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.575 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.04 -22.1 4.91 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.873 -0.788 . . . . 3.2799999999999998 108.873 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.67 43.06 1.13 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.286 -0.884 . . . . 3.6499999999999999 109.227 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -86.59 61.0 6.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.111 -0.993 . . . . 4.5999999999999996 109.464 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.5 tt0 -99.93 161.57 13.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 3.46 109.04 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -135.43 -30.22 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.781 -1.327 . . . . 3.6699999999999999 109.781 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.01 95.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.259 -1.142 . . . . 3.79 109.819 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.769 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -137.41 77.48 40.82 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 1.96 109.32 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.03 120.06 6.2 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.027 2.485 . . . . 2.9700000000000002 112.701 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.427 HD12 ' CG2' ' A' ' 80' ' ' VAL . 11.9 mt -137.9 132.88 33.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 3.0600000000000001 109.357 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 5.1 t -128.84 -151.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 2.3399999999999999 109.521 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.31 58.34 2.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.632 -1.387 . . . . 2.1699999999999999 109.632 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.23 84.25 59.8 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -1.104 . . . . 3.02 109.481 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.726 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 51.0 Cg_exo -48.65 124.91 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.814 2.343 . . . . 1.4199999999999999 112.188 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 161.03 174.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 1.3700000000000001 109.444 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.801 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.08 131.9 35.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 1.72 109.929 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.803 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -100.74 140.97 34.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.092 -1.448 . . . . 4.7000000000000002 107.092 177.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 7.8 mt-10 -108.73 123.39 48.93 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.515 -0.874 . . . . 3.2799999999999998 110.94 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.769 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 7.5 m-85 -109.96 119.56 39.7 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.302 -0.999 . . . . 2.96 108.302 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.96 124.68 45.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.941 . . . . 3.4100000000000001 109.941 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.704 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -133.5 165.42 24.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 2.77 109.436 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.57 HG22 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -108.16 125.68 51.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 2.23 109.748 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 4.2 m -52.7 124.38 13.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.28 -0.887 . . . . 4.1100000000000003 109.213 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.68 ' O ' HD22 ' A' ' 117' ' ' LEU . 3.4 m120 -111.04 -46.67 3.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.151 -0.968 . . . . 6.8600000000000003 109.698 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 116' ' ' ASN . 3.3 mm? -120.96 139.72 52.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 5.1200000000000001 109.638 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.682 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -70.19 159.56 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 4.0599999999999996 109.291 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.682 ' CG ' ' O ' ' A' ' 118' ' ' THR . 32.1 m-85 -168.05 93.44 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 5.4400000000000004 109.492 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.09 165.8 21.31 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.722 2.281 . . . . 4.04 112.177 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.81 -15.05 12.22 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.716 2.278 . . . . 3.8999999999999999 112.042 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.83 132.65 53.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 4.1399999999999997 109.442 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.41 -137.47 9.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.546 -1.422 . . . . 3.5699999999999998 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -121.48 39.14 3.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 3.5899999999999999 109.454 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 86' ' ' GLU . . . -179.92 71.23 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 109.495 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.72 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.752 2.301 . . . . 1.3899999999999999 112.306 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -65.59 154.28 50.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.599 -1.401 . . . . 1.1899999999999999 109.599 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 57.1 tp60 -151.52 130.46 12.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.104 -1.233 . . . . 2.0099999999999998 109.578 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.625 ' CG2' HG21 ' A' ' 58' ' ' VAL . 21.2 t -138.47 139.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 1.28 108.623 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.08 1.94 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.855 -1.153 . . . . 0.97999999999999998 110.929 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.3 m-30 -90.72 112.09 23.71 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.207 -1.035 . . . . 1.73 108.207 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.449 ' CG ' ' O ' ' A' ' 48' ' ' PRO . 34.8 m170 -99.88 131.3 45.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 2.3199999999999998 110.259 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.58 -23.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 2.1099999999999999 109.896 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.06 133.65 0.37 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.763 -1.335 . . . . 1.77 109.763 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 137' ' ' GLY . 29.7 mtmt -169.03 127.03 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -1.135 . . . . 5.0599999999999996 109.763 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.91 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.911 -1.144 . . . . 2.6400000000000001 107.911 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.04 18.61 7.44 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.037 -1.625 . . . . 2.5099999999999998 109.037 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.44 -154.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.625 -0.926 . . . . 2.3199999999999998 110.756 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.724 ' CD1' ' SD ' ' A' ' 78' ' ' MET . 7.4 p90 -158.91 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.995 -1.066 . . . . 1.6100000000000001 109.277 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.455 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 74.6 mm-40 -126.65 130.55 50.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 1.6499999999999999 108.867 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -107.71 114.64 28.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 1.6799999999999999 109.974 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.501 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 36.6 m -110.93 114.35 27.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.275 -0.891 . . . . 0.73999999999999999 109.65 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -123.26 145.03 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 1.22 109.517 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' PHE . 0.7 OUTLIER -131.0 -12.74 3.64 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.299 -0.63 . . . . 1.3300000000000001 109.299 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.578 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -158.93 158.95 34.34 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.372 -0.931 . . . . 3.2999999999999998 110.181 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.527 HG22 ' C ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -162.39 129.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 2.2599999999999998 108.91 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.96 144.06 8.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.062 . . . . 2.7599999999999998 109.675 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.721 HD22 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -122.11 164.99 16.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 4.5700000000000003 109.523 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.76 ' CB ' ' H ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -177.68 -174.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 3.0699999999999998 109.655 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.777 HG23 ' N ' ' A' ' 151' ' ' SER . 1.6 t -178.54 -159.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 2.0 109.438 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.777 ' N ' HG23 ' A' ' 150' ' ' THR . 25.8 t 33.4 -155.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 2.1499999999999999 109.863 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.841 ' HB1' ' OG ' ' A' ' 5' ' ' SER . . . 174.52 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 2.8199999999999998 109.467 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.036 -0.983 . . . . 3.54 109.463 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.294 0.569 . . . . 5.4699999999999998 109.504 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 3' ' ' LEU . 91.4 p 36.74 -140.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 4.5300000000000002 109.508 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER 54.18 156.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 5.1399999999999997 109.572 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 3' ' ' LEU . 3.3 m-20 38.79 -164.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 5.3799999999999999 109.535 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.534 ' C ' ' O ' ' A' ' 4' ' ' ASP . 18.5 m 35.83 84.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 4.8300000000000001 109.551 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 8' ' ' GLU . 48.5 mp0 -52.79 117.09 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 3.4300000000000002 109.421 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.6 p -68.59 35.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 2.8300000000000001 109.469 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 6' ' ' GLU . 8.4 tt0 -37.21 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 4.75 109.626 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 mt -61.92 -34.59 76.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 4.9500000000000002 109.275 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.011 HD13 ' H ' ' A' ' 12' ' ' HIS . 2.8 tm? -107.53 100.4 34.04 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 2.8599999999999999 108.576 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.39 30.42 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.7 2.267 . . . . 3.8300000000000001 112.997 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 1.011 ' H ' HD13 ' A' ' 10' ' ' LEU . 28.2 t60 -115.42 82.05 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.848 -1.158 . . . . 2.52 109.369 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.492 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -121.27 45.85 2.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 1.97 109.338 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.1 t -125.45 72.19 1.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 1.96 109.461 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -83.21 23.95 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.198 -0.939 . . . . 1.76 109.362 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.784 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.02 -35.12 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 1.1799999999999999 109.696 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 26.4 mm-40 -109.86 -83.16 0.56 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.138 -0.976 . . . . 2.1299999999999999 109.729 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 m -88.22 144.44 26.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 2.2599999999999998 109.535 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.56 -58.45 8.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 2.6000000000000001 109.515 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.1 -169.98 13.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 1.6200000000000001 109.573 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 22' ' ' TRP . 55.9 Cg_endo -75.4 -19.21 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.793 2.329 . . . . 1.7 112.205 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.57 ' O ' ' O ' ' A' ' 21' ' ' PRO . 11.3 m95 -50.95 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 2.4199999999999999 109.345 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -143.25 169.85 16.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 1.6399999999999999 109.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.76 138.64 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 2.0499999999999998 109.574 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.96 159.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 1.72 109.439 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 107.45 -26.91 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.865 -1.294 . . . . 1.7 109.865 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.78 -142.35 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.96999999999999997 109.201 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 12.4 p -91.61 -162.14 0.89 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.459 -0.775 . . . . 1.8 108.999 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.01 131.4 39.27 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 2.3999999999999999 108.811 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.66 132.29 23.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.246 1.964 . . . . 1.1299999999999999 111.839 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 37' ' ' MET . 40.8 t -118.83 111.19 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.05 109.888 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.707 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.49 85.54 5.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.657 -0.652 . . . . 1.8200000000000001 109.49 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.25 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 1.1699999999999999 109.689 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.26 -68.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 2.21 109.369 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.784 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -141.55 35.19 1.82 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.465 . . . . 1.1899999999999999 109.436 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.77 147.89 28.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -1.12 . . . . 2.9100000000000001 109.64 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.5 ptt? -121.18 132.78 55.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 0.93000000000000005 109.231 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 m -128.89 145.02 51.33 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.452 -0.899 . . . . 1.0600000000000001 110.376 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.16 145.43 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.705 -0.85 . . . . 1.3700000000000001 108.705 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.695 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -75.12 123.39 25.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 4.79 109.802 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.695 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.4 mm? -122.69 75.02 45.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 3.54 109.258 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.663 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 51.6 Cg_exo -48.14 -167.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.871 2.381 . . . . 3.7400000000000002 112.359 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 136' ' ' ALA . . . -124.45 62.01 0.58 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.507 -1.437 . . . . 2.0299999999999998 109.507 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . -154.48 15.28 0.55 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 2.4100000000000001 109.627 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -99.93 91.35 4.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -1.164 . . . . 2.96 109.477 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.29 -7.95 61.26 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.496 -1.442 . . . . 2.0800000000000001 109.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.72 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -99.9 121.68 53.38 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.274 -1.133 . . . . 3.6099999999999999 109.371 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.17 5.86 4.28 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.433 2.089 . . . . 2.3599999999999999 112.308 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.493 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -122.98 33.15 5.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 3.8700000000000001 109.604 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.762 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 34.5 m-20 -126.02 43.17 3.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 2.3799999999999999 109.433 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 159.59 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 1.1100000000000001 109.553 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 164.88 157.97 10.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.009 -1.236 . . . . 0.93999999999999995 110.009 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.64 ' CD1' HD13 ' A' ' 143' ' ' ILE . 7.5 mt -77.17 -176.3 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -1.135 . . . . 0.95999999999999996 109.157 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.88 159.18 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.92000000000000004 109.593 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' HD23 ' A' ' 10' ' ' LEU . 46.2 t80 178.92 143.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.384 -0.823 . . . . 1.71 109.648 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.4 m-80 -111.17 -164.75 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 2.7799999999999998 109.524 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 82.82 74.33 1.2 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 2.48 109.572 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 57' ' ' GLY . 52.2 t -161.12 77.57 2.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.107 . . . . 3.79 109.52 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.45 155.99 1.95 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.815 2.343 . . . . 2.3999999999999999 112.135 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -135.99 114.66 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 3.0800000000000001 109.614 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -138.99 101.89 0.33 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.256 -1.537 . . . . 3.0499999999999998 109.256 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 63' ' ' GLY . 7.0 tp10 -38.19 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -1.087 . . . . 6.0499999999999998 109.452 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 103.35 -56.41 0.6 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.576 -1.409 . . . . 2.54 109.576 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 152' ' ' ALA . 3.9 mm-40 -99.66 141.89 31.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.116 . . . . 4.0300000000000002 109.334 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -99.89 120.54 39.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 2.9100000000000001 109.553 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' C ' ' CG2' ' A' ' 67' ' ' VAL . 81.7 m-85 -85.55 174.71 9.26 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 2.3799999999999999 109.505 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.831 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -155.43 132.82 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 2.6099999999999999 109.323 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tt -114.07 130.56 56.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.966 . . . . 3.6099999999999999 109.498 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.2 p -118.16 94.86 4.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 2.27 108.736 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 11.2 p90 -93.28 135.48 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.05 -1.031 . . . . 2.0099999999999998 111.091 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.588 HG22 ' CG2' ' A' ' 108' ' ' THR . 19.1 p -90.31 109.25 20.35 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.547 -0.908 . . . . 1.8 108.547 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -158.89 165.92 33.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.624 -1.23 . . . . 0.95999999999999996 110.817 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.8 p -129.42 163.1 26.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.914 -0.773 . . . . 0.93000000000000005 108.914 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' HB1' ' HE2' ' A' ' 139' ' ' TYR . . . -124.39 119.3 28.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.593 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.46 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.79 116.74 16.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.057 -1.027 . . . . 0.96999999999999997 110.113 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.582 ' O ' ' O ' ' A' ' 74' ' ' ALA . 20.1 Cg_exo -65.87 -142.15 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.687 0 C-N-CA 124.232 -1.153 . . . . 1.02 112.05 -0.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' C ' ' CG ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -97.86 149.39 22.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 1.75 109.208 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.697 ' SD ' ' CE2' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 165.21 159.82 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 2.1600000000000001 109.795 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.34 119.24 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.711 2.274 . . . . 1.3799999999999999 112.032 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.19 169.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 2.0099999999999998 109.44 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.739 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -109.83 139.42 44.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.917 . . . . 6.0099999999999998 109.313 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -141.05 148.26 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 3.7599999999999998 109.533 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -147.21 144.0 28.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 2.29 109.487 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 129' ' ' VAL . 1.0 OUTLIER -152.84 145.03 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 1.8899999999999999 110.342 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 128' ' ' GLN . . . 142.21 -109.62 0.58 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.881 -1.288 . . . . 1.49 109.881 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' CD ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -89.98 164.87 14.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -1.181 . . . . 2.54 109.663 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.81 -34.03 0.36 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.593 -1.403 . . . . 1.3799999999999999 109.593 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -80.93 165.58 47.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 35.7 -130.34 0.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.573 -1.411 . . . . 4.1399999999999997 109.573 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -142.13 39.82 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -1.16 . . . . 5.1299999999999999 109.439 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.564 ' O ' ' C ' ' A' ' 92' ' ' ARG . 2.8 m-30 -57.67 80.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 5.79 109.555 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 90' ' ' ALA . 6.5 ptp180 -29.76 149.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.549 -0.719 . . . . 5.7400000000000002 109.766 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.688 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 1.8 t -128.85 -150.93 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 2.27 110.275 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.688 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -119.01 -22.32 7.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.239 -0.652 . . . . 3.2799999999999998 109.239 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.509 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.11 41.66 1.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.787 -1.196 . . . . 3.6499999999999999 109.235 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -90.01 44.28 1.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.983 -1.073 . . . . 4.5999999999999996 109.537 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 111' ' ' TYR . 7.3 pt20 -106.67 137.18 45.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 3.46 109.431 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 82' ' ' VAL . . . -128.49 20.28 5.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.664 -1.374 . . . . 3.6699999999999999 109.664 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -104.84 76.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 3.79 109.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.76 102.03 53.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 1.96 109.333 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.79 118.81 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.702 2.268 . . . . 2.9700000000000002 112.608 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.6 159.82 33.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 3.0600000000000001 109.522 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 2.4 t -103.5 -148.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 2.3399999999999999 109.86 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.597 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -110.2 29.65 9.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 2.1699999999999999 109.805 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.492 ' H ' HG23 ' A' ' 103' ' ' THR . 5.2 pt-20 -139.59 147.96 54.15 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.201 -1.176 . . . . 3.02 109.205 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -40.48 117.35 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.592 2.194 . . . . 1.4199999999999999 111.882 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.38 127.69 11.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.151 -0.968 . . . . 1.3700000000000001 109.811 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.588 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.62 141.14 29.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.44 -0.787 . . . . 1.72 109.853 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 111' ' ' TYR . 9.1 mmm-85 -113.26 136.44 52.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.377 -0.972 . . . . 4.7000000000000002 108.377 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -117.18 107.36 14.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.175 -0.61 . . . . 3.2799999999999998 109.883 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 109' ' ' ARG . 42.3 m-85 -109.95 114.76 28.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 2.96 109.083 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -103.38 170.48 7.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -0.873 . . . . 3.4100000000000001 109.611 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.436 ' CD2' ' C ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 179.05 161.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 2.77 109.767 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.37 155.01 20.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 2.23 109.307 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -90.13 44.15 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 4.1100000000000003 109.954 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 115' ' ' SER . 6.9 m120 -39.92 -17.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 6.8600000000000003 109.576 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.799 HD12 ' CZ ' ' A' ' 119' ' ' PHE . 1.2 mm? -109.87 143.82 39.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 5.1200000000000001 109.436 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.85 107.75 18.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 4.0599999999999996 109.681 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.799 ' CZ ' HD12 ' A' ' 117' ' ' LEU . 43.0 m-85 -133.69 98.26 15.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 5.4400000000000004 109.181 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.28 165.58 23.34 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.52 2.147 . . . . 4.04 112.239 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.03 -14.59 12.16 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.836 2.357 . . . . 3.8999999999999999 112.069 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -109.66 123.24 49.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 4.1399999999999997 109.602 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.554 ' O ' ' OD1' ' A' ' 124' ' ' ASP . . . 150.02 -84.34 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.478 -1.449 . . . . 3.5699999999999998 109.478 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 123' ' ' GLY . 4.5 m-20 -162.21 -37.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 3.5899999999999999 109.452 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -112.59 93.45 23.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 2.0800000000000001 109.417 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.98 -159.17 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.744 2.296 . . . . 1.3899999999999999 112.273 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.57 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -72.84 -178.99 35.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 1.1899999999999999 109.603 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.467 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -170.25 141.18 2.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -1.094 . . . . 2.0099999999999998 109.707 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.797 HG22 HG13 ' A' ' 84' ' ' VAL . 67.3 t -138.71 151.48 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.973 -1.121 . . . . 1.28 107.973 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -165.66 111.72 0.9 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.815 -1.154 . . . . 0.97999999999999998 110.48 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.514 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.8 m-30 -94.12 84.38 4.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.456 -0.942 . . . . 1.73 108.456 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.493 ' NE2' ' HB1' ' A' ' 130' ' ' ALA . 19.6 m170 -98.73 132.53 44.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 2.3199999999999998 110.173 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.828 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.65 2.32 2.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 2.1099999999999999 109.268 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -48.95 136.4 19.8 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.517 -1.433 . . . . 1.77 109.517 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.668 ' O ' ' N ' ' A' ' 137' ' ' GLY . 19.5 mtpt -165.72 130.14 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -1.157 . . . . 5.0599999999999996 109.869 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 43' ' ' GLY . . . -42.58 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.87 -1.159 . . . . 2.6400000000000001 107.87 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.47 17.1 7.44 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.734 -1.747 . . . . 2.5099999999999998 108.734 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 42' ' ' PRO . . . -51.13 -149.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.903 . . . . 2.3199999999999998 110.432 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.697 ' CE2' ' SD ' ' A' ' 78' ' ' MET . 0.0 OUTLIER -171.7 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.008 . . . . 1.6100000000000001 110.597 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.674 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 13.9 mt-10 -137.26 140.79 41.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 1.6499999999999999 109.351 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.627 ' HB2' HD22 ' A' ' 133' ' ' LEU . 42.0 t80 -117.53 128.3 54.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.865 . . . . 1.6799999999999999 109.374 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.41 110.66 17.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.126 -0.984 . . . . 0.73999999999999999 109.977 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.64 HD13 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -119.66 144.68 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 1.22 109.279 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 88.6 p -130.06 -15.23 3.81 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.205 -0.665 . . . . 1.3300000000000001 109.205 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.466 ' CG ' ' C ' ' A' ' 144' ' ' SER . 3.0 mt-30 -155.51 177.52 11.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 3.2999999999999998 110.015 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 146' ' ' VAL . 3.9 p -177.04 124.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.815 . . . . 2.2599999999999998 109.461 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 176.74 11.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 2.7599999999999998 109.775 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.744 ' C ' HG22 ' A' ' 149' ' ' THR . 1.3 pp -155.37 -161.35 1.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 4.5700000000000003 109.394 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.66 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 3.0699999999999998 109.5 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -123.53 -41.26 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 2.0 109.371 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.504 ' N ' ' CG2' ' A' ' 150' ' ' THR . 3.0 m 45.19 65.65 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.389 -0.819 . . . . 2.1499999999999999 109.499 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.556 ' O ' ' OE1' ' A' ' 64' ' ' GLU . . . 61.3 -157.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 2.8199999999999998 109.486 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.069 -0.967 . . . . 3.54 109.456 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.482 -0.562 . . . . 5.4699999999999998 109.482 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.722 ' H ' ' CB ' ' A' ' 152' ' ' ALA . 1.3 m 43.0 80.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 4.5300000000000002 109.431 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.544 HD23 ' OG ' ' A' ' 5' ' ' SER . 1.5 tp -113.91 137.92 51.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 5.1399999999999997 109.422 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.45 22.67 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 5.3799999999999999 109.405 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.544 ' OG ' HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -99.97 -159.51 0.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 4.8300000000000001 109.521 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 8' ' ' GLU . 53.2 mt-10 -118.18 74.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 3.4300000000000002 109.503 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLU . 4.2 t -36.81 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 2.8300000000000001 109.511 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' GLU . 4.9 tt0 -85.74 83.08 7.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 4.75 109.468 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.547 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -61.93 -33.03 73.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 4.9500000000000002 109.426 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.612 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -109.07 96.02 19.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 2.8599999999999999 108.653 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.5 27.07 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.32 2.014 . . . . 3.8300000000000001 111.693 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.612 ' H ' HD13 ' A' ' 10' ' ' LEU . 48.2 t60 -128.31 74.21 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 2.52 109.478 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 10.1 t -112.96 41.58 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 1.97 109.43 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 16' ' ' ALA . 6.5 t -115.85 59.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 1.96 109.668 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -65.49 16.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 1.76 109.263 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.05 -22.39 21.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 1.1799999999999999 109.848 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -109.81 -84.29 0.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.1299999999999999 109.633 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m -109.0 153.78 23.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 2.2599999999999998 109.443 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 37' ' ' MET . 2.2 mt -56.76 -54.26 48.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 2.6000000000000001 109.547 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 103.22 -149.24 17.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.6200000000000001 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.72 -27.49 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.748 2.299 . . . . 1.7 112.252 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.903 ' CH2' HG11 ' A' ' 146' ' ' VAL . 15.4 m95 -52.01 167.59 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 2.4199999999999999 109.256 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -131.87 179.25 6.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -0.959 . . . . 1.6399999999999999 109.676 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.443 HD13 ' CG ' ' A' ' 30' ' ' PRO . 2.9 pp 179.35 152.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 2.0499999999999998 109.504 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -179.06 152.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 1.72 109.529 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.71 -24.63 13.01 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.909 -1.139 . . . . 1.7 110.435 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.78 -144.27 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.381 . . . . 0.96999999999999997 109.583 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 7.9 p -92.8 135.22 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 1.8 109.291 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -41.27 104.25 0.34 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.976 -1.078 . . . . 2.3999999999999999 108.588 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' CG ' HD13 ' A' ' 24' ' ' LEU . 51.7 Cg_exo -46.95 166.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.183 1.922 . . . . 1.1299999999999999 111.83 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 t -151.08 121.16 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.07 -1.019 . . . . 1.05 110.182 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -76.2 92.96 3.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.85 . . . . 1.8200000000000001 109.341 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.68 -140.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 1.1699999999999999 109.531 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' OD1' ' C ' ' A' ' 34' ' ' ASP . 39.6 t0 -58.6 -43.41 89.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.965 . . . . 2.21 109.368 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.566 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -160.74 48.35 0.38 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.271 -1.531 . . . . 1.1899999999999999 109.271 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -171.29 146.29 2.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -1.11 . . . . 2.9100000000000001 109.496 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.492 ' SD ' HD21 ' A' ' 19' ' ' LEU . 40.4 ttp -109.58 133.76 52.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.246 -0.908 . . . . 0.93000000000000005 109.068 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.696 ' SG ' ' OE2' ' A' ' 140' ' ' GLU . 0.5 OUTLIER -127.76 173.61 9.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.229 -0.919 . . . . 1.0600000000000001 110.434 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 3.1 m -149.26 144.97 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.875 -0.787 . . . . 1.3700000000000001 108.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.608 ' C ' HD22 ' A' ' 41' ' ' LEU . 35.4 m-20 -82.48 106.48 14.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.88 . . . . 4.79 109.289 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.608 HD22 ' C ' ' A' ' 40' ' ' ASP . 3.8 mm? -113.5 80.1 4.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 3.54 109.654 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.37 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.756 2.304 . . . . 3.7400000000000002 112.238 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -120.24 115.58 3.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.539 -1.425 . . . . 2.0299999999999998 109.539 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.675 ' H ' ' H ' ' A' ' 136' ' ' ALA . . . -174.88 -40.83 0.05 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.843 -1.303 . . . . 2.4100000000000001 109.843 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.818 ' HB2' ' HZ2' ' A' ' 135' ' ' LYS . 37.0 mt-30 -100.0 125.35 46.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -1.153 . . . . 2.96 109.586 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.89 65.88 0.27 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 2.0800000000000001 109.344 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.659 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -146.03 96.6 4.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.36 -1.082 . . . . 3.6099999999999999 109.396 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 53.1 Cg_exo -48.44 4.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.852 2.368 . . . . 2.3599999999999999 113.079 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.598 ' N ' ' O ' ' A' ' 47' ' ' ASN . 1.4 p-90 -127.59 34.32 4.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.885 -1.134 . . . . 3.8700000000000001 109.667 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 30.7 m-20 -132.97 39.05 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 2.3799999999999999 109.215 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 158.78 94.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 1.1100000000000001 109.259 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . -171.9 174.13 45.21 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.864 -1.295 . . . . 0.93999999999999995 109.864 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.537 ' C ' HG22 ' A' ' 54' ' ' VAL . 6.6 mt -95.05 -178.1 4.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 0.95999999999999996 109.526 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.537 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -162.94 162.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.92000000000000004 109.293 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 15.2 t80 172.26 140.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 1.71 109.72 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.689 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 16.1 m-20 -94.38 -168.1 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 2.7799999999999998 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.678 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 82.3 74.62 1.17 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 2.48 109.463 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 58' ' ' VAL . 48.6 t -161.31 69.74 2.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.275 -1.132 . . . . 3.79 109.547 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HD2' HD13 ' A' ' 9' ' ' LEU . 42.0 Cg_endo -71.85 120.51 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.789 2.326 . . . . 2.3999999999999999 112.136 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.727 HG12 ' OG ' ' A' ' 115' ' ' SER . 4.7 t -112.5 141.25 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 3.0800000000000001 109.532 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -116.5 98.9 0.83 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.464 -1.454 . . . . 3.0499999999999998 109.464 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 61.8 tt0 -35.64 130.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 6.0499999999999998 109.546 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 111.08 -32.36 6.57 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 2.54 109.626 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.3 mt-10 -100.01 177.9 4.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -1.157 . . . . 4.0300000000000002 109.525 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -128.53 143.79 51.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 2.9100000000000001 109.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 27.2 m-85 -112.75 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.156 -0.965 . . . . 2.3799999999999999 109.677 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.406 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.4 t -152.8 137.24 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.551 -0.718 . . . . 2.6099999999999999 109.281 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 148' ' ' LEU . 0.7 OUTLIER -120.83 121.51 38.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 3.6099999999999999 109.782 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.1 p -109.52 85.47 2.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 2.27 108.745 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.7 p90 -93.63 143.56 26.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 2.0099999999999998 111.167 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -93.39 122.91 36.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.609 -0.885 . . . . 1.8 108.609 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.801 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -163.44 147.11 10.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 0.95999999999999996 110.385 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.37 135.9 52.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.877 -0.786 . . . . 0.93000000000000005 108.877 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.859 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -107.6 116.73 32.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.67000000000000004 109.819 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' ' CG ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -131.24 119.09 17.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.96999999999999997 109.831 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.9 Cg_exo -66.17 -142.19 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.305 -1.123 . . . . 1.02 112.372 -0.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 159.24 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 1.75 109.809 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.513 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.9 mtt 162.83 154.98 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 2.1600000000000001 109.215 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.71 148.65 32.9 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.812 2.341 . . . . 1.3799999999999999 112.628 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -122.91 172.1 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 2.0099999999999998 109.056 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 132' ' ' HIS . 14.9 ttt180 -134.81 95.54 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 6.0099999999999998 109.921 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' HA ' ' H ' ' A' ' 132' ' ' HIS . 1.4 m -99.88 148.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 3.7599999999999998 108.939 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.6 pp -139.73 152.98 47.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 2.29 109.99 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.588 HG13 ' HA ' ' A' ' 129' ' ' VAL . 1.3 t -149.15 157.7 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 1.8899999999999999 109.389 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.88 -143.78 8.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.622 -1.391 . . . . 1.49 109.622 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.662 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 0.3 OUTLIER -90.24 -176.33 4.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 2.54 109.409 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -126.33 66.99 0.54 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.613 -1.395 . . . . 1.3799999999999999 109.613 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.53 ' O ' ' CD ' ' A' ' 86' ' ' GLU . . . 110.34 167.65 19.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.568 -1.413 . . . . 2.54 109.568 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -32.53 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.502 -1.439 . . . . 4.1399999999999997 109.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -172.19 73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -1.17 . . . . 5.1299999999999999 109.47 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -36.94 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 5.79 109.438 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.721 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.1 OUTLIER -42.98 119.55 1.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 5.7400000000000002 109.437 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.18 169.43 10.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 2.27 109.954 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 116' ' ' ASN . . . -124.02 -15.9 6.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 3.2799999999999998 108.881 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.482 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.51 36.88 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 3.6499999999999999 109.155 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -76.38 98.1 4.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.98 . . . . 4.5999999999999996 109.504 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.724 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -106.15 137.12 44.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 3.46 109.128 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.562 ' N ' ' NE2' ' A' ' 97' ' ' GLN . . . -136.73 -0.25 2.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.766 -1.334 . . . . 3.6699999999999999 109.766 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.724 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.6 m -122.8 63.37 0.98 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.131 -1.217 . . . . 3.79 109.773 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.812 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -112.89 96.39 37.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 1.96 109.494 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.41 125.76 5.84 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.791 2.327 . . . . 2.9700000000000002 112.573 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 70.7 mt -133.4 149.24 51.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 3.0600000000000001 109.271 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 105' ' ' GLU . 1.8 t -136.69 -174.92 3.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 2.3399999999999999 109.58 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -63.13 38.62 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.566 -1.414 . . . . 2.1699999999999999 109.566 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 103' ' ' THR . 17.3 tp10 -117.33 78.85 11.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 3.02 109.387 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.53 118.94 2.83 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.801 2.334 . . . . 1.4199999999999999 112.17 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.671 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -174.32 169.72 3.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 1.3700000000000001 109.58 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.543 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.82 141.15 29.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 1.72 109.881 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.801 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.55 137.06 49.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.705 -1.22 . . . . 4.7000000000000002 107.705 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 110' ' ' GLU . 6.2 mp0 -111.22 107.43 16.74 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.847 -0.741 . . . . 3.2799999999999998 110.977 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.6 m-30 -109.89 110.69 21.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.186 -1.042 . . . . 2.96 108.186 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.13 153.25 22.36 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.232 -0.917 . . . . 3.4100000000000001 109.777 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.667 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -141.08 173.82 11.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 2.77 109.289 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -101.35 111.44 23.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 2.23 109.655 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.727 ' OG ' HG12 ' A' ' 60' ' ' VAL . 6.9 t -41.03 125.99 2.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 4.1100000000000003 109.353 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.737 ' O ' HD22 ' A' ' 117' ' ' LEU . 6.4 p-10 -121.21 -30.64 4.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 6.8600000000000003 109.522 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 116' ' ' ASN . 3.4 mm? -123.97 123.82 41.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 5.1200000000000001 109.472 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -65.56 116.28 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 4.0599999999999996 109.393 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 23.8 m-85 -122.45 79.61 46.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 5.4400000000000004 109.48 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.83 168.98 2.05 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.808 2.338 . . . . 4.04 111.96 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.66 -16.89 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.696 2.264 . . . . 3.8999999999999999 112.117 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.59 176.59 4.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 4.1399999999999997 109.409 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.78 -156.17 18.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 3.5699999999999998 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 5.0 p-10 -35.87 -72.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -1.134 . . . . 3.5899999999999999 109.565 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -137.63 150.34 67.84 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 2.0800000000000001 109.463 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.535 ' HG2' HD21 ' A' ' 56' ' ' ASN . 43.4 Cg_endo -71.86 -158.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.824 2.35 . . . . 1.3899999999999999 112.246 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -58.36 157.31 19.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.428 . . . . 1.1899999999999999 109.529 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.3 149.42 34.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -1.165 . . . . 2.0099999999999998 109.484 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.588 ' HA ' HG13 ' A' ' 84' ' ' VAL . 58.0 t -150.58 150.83 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.627 -0.879 . . . . 1.28 108.627 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.35 99.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.004 -1.06 . . . . 0.97999999999999998 110.369 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 4.8 m-30 -70.18 114.34 8.23 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 1.73 108.144 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 48' ' ' PRO . 1.2 m170 -99.28 133.2 43.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 2.3199999999999998 110.388 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 134' ' ' GLY . 4.6 mp -127.81 -40.79 1.7 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.78 . . . . 2.1099999999999999 109.064 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 55.71 147.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 1.77 109.693 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.818 ' HZ2' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -99.8 -150.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.169 . . . . 5.0599999999999996 109.547 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 135' ' ' LYS . . . 78.46 6.11 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 2.6400000000000001 109.055 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.29 10.03 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.136 -1.586 . . . . 2.5099999999999998 109.136 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.02 -149.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -1.084 . . . . 2.3199999999999998 109.573 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.859 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -166.74 -114.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.392 -0.818 . . . . 1.6100000000000001 109.828 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.696 ' OE2' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.02 141.58 51.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 1.6499999999999999 108.773 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.666 ' CE1' ' HB1' ' A' ' 72' ' ' ALA . 18.2 t80 -125.84 114.86 19.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -0.841 . . . . 1.6799999999999999 110.045 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 140' ' ' GLU . 1.5 m -117.71 103.16 9.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.73999999999999999 110.014 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 143.42 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 1.22 109.013 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.445 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 49.6 p -137.84 -1.17 2.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.601 -0.687 . . . . 1.3300000000000001 109.358 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.571 ' O ' ' OG1' ' A' ' 71' ' ' THR . 7.3 mt-30 -153.06 153.84 33.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 3.2999999999999998 109.98 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.903 HG11 ' CH2' ' A' ' 22' ' ' TRP . 88.1 t -160.18 121.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 2.2599999999999998 109.369 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 p -152.01 171.73 17.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.011 . . . . 2.7599999999999998 109.702 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.817 HD23 ' N ' ' A' ' 148' ' ' LEU . 1.9 pt? -157.94 -162.44 1.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 4.5700000000000003 109.508 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.34 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 3.0699999999999998 109.443 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.668 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.5 t -163.93 -115.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 2.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 153' ' ' THR . 0.5 OUTLIER 158.9 35.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 2.1499999999999999 109.393 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.722 ' CB ' ' H ' ' A' ' 2' ' ' SER . . . 37.06 23.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 2.8199999999999998 109.444 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 151' ' ' SER . 10.4 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.043 -0.979 . . . . 3.54 109.461 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.499 -0.556 . . . . 5.4699999999999998 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 152' ' ' ALA . 95.0 p -72.72 -107.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 4.5300000000000002 109.445 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 4' ' ' ASP . 4.4 tp 53.1 -155.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 5.1399999999999997 109.415 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.616 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -44.43 176.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 5.3799999999999999 109.538 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER 84.13 164.17 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 4.8300000000000001 109.478 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -106.87 133.14 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 3.4300000000000002 109.502 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.21 51.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.867 . . . . 2.8300000000000001 109.474 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.651 ' OE1' ' N ' ' A' ' 9' ' ' LEU . 3.8 tp10 -49.93 106.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 4.75 109.485 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.651 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 3.9 mt -85.7 28.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.91 . . . . 4.9500000000000002 109.445 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.749 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.0 tm? -157.19 89.09 2.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 2.8599999999999999 108.889 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -53.72 43.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.186 2.591 . . . . 3.8300000000000001 113.321 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.675 ' N ' ' O ' ' A' ' 10' ' ' LEU . 11.7 t60 -158.39 102.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.892 -1.13 . . . . 2.52 109.53 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.443 ' CB ' ' O ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -147.04 43.91 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 1.97 109.469 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 16' ' ' ALA . 68.8 m -155.77 81.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.96 109.947 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.41 36.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 1.76 108.988 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -78.46 -30.43 47.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.599 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 1.9 mt-10 -110.38 -73.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 2.1299999999999999 109.501 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.8 m -109.24 145.25 36.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 2.2599999999999998 109.504 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 37' ' ' MET . 4.4 mt -51.39 -48.22 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 2.6000000000000001 109.522 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 97.74 -172.87 27.65 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.502 -1.439 . . . . 1.6200000000000001 109.502 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.0 Cg_endo -69.86 -20.68 34.07 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.739 2.293 . . . . 1.7 112.189 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.575 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 8.6 m95 -53.55 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.993 . . . . 2.4199999999999999 109.286 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -141.51 167.53 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 1.6399999999999999 109.782 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.908 HD22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -174.58 167.59 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 2.0499999999999998 109.4 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.737 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.74 -176.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 1.72 109.649 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 94.34 -28.85 9.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 1.7 109.842 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.814 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.85 -142.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 0.96999999999999997 109.306 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.814 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.6 p -91.02 -163.8 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 1.8 109.254 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.25 111.58 47.83 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 2.3999999999999999 109.022 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HB3' ' CG ' ' A' ' 37' ' ' MET . 56.3 Cg_exo -45.71 159.76 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.268 1.979 . . . . 1.1299999999999999 112.022 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -143.52 109.24 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 1.05 109.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -69.82 72.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 1.8200000000000001 109.456 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -65.31 -138.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.1699999999999999 109.644 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.67 81.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.82 . . . . 2.21 109.526 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 47.5 30.68 6.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.639 -1.384 . . . . 1.1899999999999999 109.639 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.45 142.81 30.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -1.144 . . . . 2.9100000000000001 109.564 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 19' ' ' LEU . 5.3 ttp -109.87 125.24 52.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.93000000000000005 109.163 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 56.8 m -124.6 154.79 40.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.917 . . . . 1.0600000000000001 110.084 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.96 139.4 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.525 -0.734 . . . . 1.3700000000000001 109.025 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.719 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -91.12 122.21 33.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 4.79 109.649 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.761 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 9.0 mp -113.29 92.98 24.29 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 3.54 109.344 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 51.1 Cg_exo -50.03 -57.02 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.031 2.487 . . . . 3.7400000000000002 112.625 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 138' ' ' ALA . . . 117.99 146.53 8.17 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.783 -1.327 . . . . 2.0299999999999998 109.783 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 33.34 0.73 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.863 -1.295 . . . . 2.4100000000000001 109.863 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.501 ' NE2' ' HE2' ' A' ' 135' ' ' LYS . 30.9 mt-30 -118.26 150.48 39.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.113 -1.228 . . . . 2.96 109.648 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.13 56.83 0.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.383 -1.487 . . . . 2.0800000000000001 109.383 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.661 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -174.48 98.49 0.29 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.199 -1.177 . . . . 3.6099999999999999 109.393 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD2' ' CZ3' ' A' ' 49' ' ' TRP . 77.6 Cg_exo -46.27 -21.62 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.613 2.209 . . . . 2.3599999999999999 112.431 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 39.2 p90 -106.9 65.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 3.8700000000000001 109.494 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.661 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 1.2 m-20 -134.99 6.57 3.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 2.3799999999999999 109.695 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -177.06 154.75 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 1.1100000000000001 109.721 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.43 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 144.11 -169.33 26.29 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.879 -1.288 . . . . 0.93999999999999995 109.879 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.975 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -97.34 152.18 19.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -1.074 . . . . 0.95999999999999996 109.134 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.901 HG13 ' HB2' ' A' ' 130' ' ' ALA . 2.0 t -144.53 162.87 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.92000000000000004 110.083 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.69 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 18.7 t80 175.58 149.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 1.71 109.4 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.69 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 1.4 m-80 -101.37 176.8 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 2.7799999999999998 109.527 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 95.6 76.99 1.34 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 2.48 109.563 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 57' ' ' GLY . 0.7 OUTLIER -156.8 70.3 4.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 3.79 109.498 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.674 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.48 131.67 28.28 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.801 2.334 . . . . 2.3999999999999999 112.191 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.07 114.24 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 3.0800000000000001 109.521 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.18 103.55 1.11 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.521 -1.432 . . . . 3.0499999999999998 109.521 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HB2' ' N ' ' A' ' 117' ' ' LEU . 3.4 tm-20 -47.34 139.05 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.138 . . . . 6.0499999999999998 109.529 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.11 -37.18 3.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.688 -1.365 . . . . 2.54 109.688 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' SER . 2.7 mt-10 -99.99 168.88 9.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -1.18 . . . . 4.0300000000000002 109.574 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.6 m -115.0 139.93 49.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 2.9100000000000001 109.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.674 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 22.9 m-85 -104.61 -178.32 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.115 -0.99 . . . . 2.3799999999999999 109.549 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -153.76 121.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 2.6099999999999999 109.639 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 148' ' ' LEU . 1.4 tp -111.52 115.96 30.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 3.6099999999999999 109.23 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -109.88 86.46 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.067 -1.02 . . . . 2.27 109.198 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 6.9 p90 -94.9 139.29 31.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.442 -0.786 . . . . 2.0099999999999998 111.295 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 108' ' ' THR . 0.7 OUTLIER -98.35 119.6 37.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.499 -0.926 . . . . 1.8 108.499 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 141' ' ' PHE . . . -171.57 134.68 0.85 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.077 -1.015 . . . . 0.95999999999999996 110.024 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB2' ' N ' ' A' ' 105' ' ' GLU . 53.2 p -124.26 122.38 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 109.21 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.596 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -91.67 135.95 33.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.67000000000000004 109.386 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.449 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.16 117.06 16.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.351 -0.843 . . . . 0.96999999999999997 109.49 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -66.52 -142.42 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.66 0 C-N-CA 124.305 -1.123 . . . . 1.02 112.199 -0.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.453 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.7 OUTLIER -104.85 152.18 22.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 1.75 109.38 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.453 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 1.4 mtm -176.42 156.93 1.52 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 2.1600000000000001 109.157 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.82 118.9 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.752 2.301 . . . . 1.3799999999999999 112.402 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 98' ' ' GLY . 4.7 m -99.19 176.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 2.0099999999999998 109.275 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 132' ' ' HIS . 18.7 ttm180 -122.67 146.47 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 6.0099999999999998 109.728 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.29 155.27 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.301 -0.874 . . . . 3.7599999999999998 109.45 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.11 156.95 43.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 2.29 109.608 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.556 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.0 OUTLIER -146.79 138.3 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 1.8899999999999999 109.681 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.56 -155.71 22.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.472 -1.451 . . . . 1.49 109.472 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.691 ' OE2' ' CG ' ' A' ' 119' ' ' PHE . 21.6 pm0 -88.82 -155.02 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 2.54 109.482 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.559 ' HA3' HE22 ' A' ' 128' ' ' GLN . . . 167.56 14.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.3799999999999999 109.669 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.35 -110.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 2.54 109.49 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 91' ' ' TYR . . . -81.9 -135.3 1.99 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.46 -1.456 . . . . 4.1399999999999997 109.46 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.48 0.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 5.1299999999999999 109.393 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER -69.77 80.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 5.79 109.46 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.58 ' O ' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -71.52 167.62 19.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.943 . . . . 5.7400000000000002 109.51 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.94 176.37 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 2.27 109.786 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.505 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -113.93 -22.77 9.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.897 -0.779 . . . . 3.2799999999999998 108.897 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.84 34.26 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 3.6499999999999999 109.35 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 1.3 tm-20 -79.03 82.21 5.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 4.5999999999999996 109.486 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.52 ' CG ' ' N ' ' A' ' 98' ' ' GLY . 3.9 pt20 -108.99 -160.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 3.46 109.522 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 97' ' ' GLN . . . -173.49 -41.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.534 -1.426 . . . . 3.6699999999999999 109.534 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.48 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 3.79 109.585 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 98' ' ' GLY . . . -122.02 96.3 46.8 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 1.96 109.417 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.42 130.7 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.815 2.344 . . . . 2.9700000000000002 112.754 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -132.65 140.32 48.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 3.0600000000000001 109.297 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.66 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -93.93 -160.98 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 2.3399999999999999 109.514 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.66 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -107.66 33.08 6.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 2.1699999999999999 109.637 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.474 ' N ' ' HB2' ' A' ' 73' ' ' SER . 0.4 OUTLIER -119.12 142.07 31.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -1.166 . . . . 3.02 109.351 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.682 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 55.3 Cg_endo -73.52 136.55 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.584 2.189 . . . . 1.4199999999999999 112.217 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 165.48 160.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 1.3700000000000001 109.662 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -83.56 131.03 35.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 1.72 110.062 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 69' ' ' SER . 3.2 mmt180 -93.51 146.42 23.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.648 -1.612 . . . . 4.7000000000000002 106.648 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.02 105.83 16.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.936 -1.103 . . . . 3.2799999999999998 110.192 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.48 76.2 0.99 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.683 -0.858 . . . . 2.96 108.683 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.851 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -99.97 164.89 11.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 3.4100000000000001 109.712 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 4.2 p90 -164.96 -174.21 3.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 2.77 109.607 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.41 HG22 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -109.28 112.22 24.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -0.811 . . . . 2.23 109.57 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 64' ' ' GLU . 6.8 t -47.27 125.11 7.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 4.1100000000000003 109.395 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.792 ' O ' HD22 ' A' ' 117' ' ' LEU . 7.8 t-20 -124.2 1.03 8.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 6.8600000000000003 109.422 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -145.98 120.41 9.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 5.1200000000000001 109.444 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.648 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -67.93 140.16 56.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 4.0599999999999996 109.58 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.691 ' CG ' ' OE2' ' A' ' 86' ' ' GLU . 18.4 m-85 -170.01 76.67 0.64 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 5.4400000000000004 109.524 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.12 169.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.86 2.373 . . . . 4.04 111.944 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 125' ' ' ALA . 66.2 Cg_endo -80.46 -16.14 10.81 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.801 2.334 . . . . 3.8999999999999999 112.082 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 123' ' ' GLY . 17.4 p-10 -109.95 -46.43 3.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 4.1399999999999997 109.516 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -39.42 -45.02 2.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.489 -1.444 . . . . 3.5699999999999998 109.489 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.19 -73.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 3.5899999999999999 109.473 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -139.82 162.19 52.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 2.0800000000000001 109.4 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 125' ' ' ALA . 6.6 Cg_endo -52.68 -5.37 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.028 2.485 . . . . 1.3899999999999999 112.202 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 120.82 161.19 11.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.51 -1.436 . . . . 1.1899999999999999 109.51 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 2.0 tt0 -149.15 105.82 3.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -1.148 . . . . 2.0099999999999998 109.718 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 84' ' ' VAL . 1.7 p -139.09 118.39 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.648 -0.871 . . . . 1.28 108.648 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.901 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -142.23 139.34 31.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 0.97999999999999998 110.583 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -94.73 109.31 21.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.711 -0.848 . . . . 1.73 108.711 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.644 ' O ' ' N ' ' A' ' 81' ' ' ARG . 6.3 m170 -99.74 119.8 38.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 2.3199999999999998 109.733 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.883 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -112.3 -3.56 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 2.1099999999999999 109.126 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 46.13 -179.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.377 -1.489 . . . . 1.77 109.377 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.501 ' HE2' ' NE2' ' A' ' 45' ' ' GLN . 3.3 mtmt -125.41 24.28 7.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.282 . . . . 5.0599999999999996 109.592 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.2 -21.69 63.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.714 -1.217 . . . . 2.6400000000000001 107.714 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.698 ' O ' ' CD2' ' A' ' 139' ' ' TYR . . . -130.1 54.91 0.78 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.655 -2.178 . . . . 2.5099999999999998 107.655 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.761 ' HB1' ' O ' ' A' ' 41' ' ' LEU . . . -29.62 154.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.807 0.813 . . . . 2.3199999999999998 110.825 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 174.5 -163.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 1.6100000000000001 109.132 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.43 120.28 39.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 1.6499999999999999 109.728 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 72' ' ' ALA . 6.4 t80 -102.15 106.87 17.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.867 . . . . 1.6799999999999999 108.796 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.37 101.18 10.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.73999999999999999 110.566 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 140.71 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 1.22 108.878 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.717 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 53.0 p -133.43 -7.51 2.91 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 109.516 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.717 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -146.62 161.46 40.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 3.2999999999999998 109.663 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 146' ' ' VAL . 8.4 p -176.23 109.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.2599999999999998 109.758 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 p -153.54 162.77 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 2.7599999999999998 109.47 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.701 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.5 pp -143.43 171.97 13.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 4.5700000000000003 109.42 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -165.85 -168.19 1.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 3.0699999999999998 109.482 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.667 HG23 ' N ' ' A' ' 151' ' ' SER . 9.3 t -146.36 -135.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.203 -0.935 . . . . 2.0 109.486 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.667 ' N ' HG23 ' A' ' 150' ' ' THR . 0.0 OUTLIER 170.95 125.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 2.1499999999999999 109.426 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.646 ' N ' ' OG ' ' A' ' 2' ' ' SER . . . 60.74 166.35 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 2.8199999999999998 109.417 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.979 -1.01 . . . . 3.54 109.491 -179.992 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.477 -0.564 . . . . 5.4699999999999998 109.477 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.546 ' O ' ' C ' ' A' ' 3' ' ' LEU . 0.7 OUTLIER -113.71 -33.75 5.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 4.5300000000000002 109.432 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -35.09 111.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 5.1399999999999997 109.618 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.558 ' OD1' ' OG ' ' A' ' 5' ' ' SER . 7.1 p30 -148.46 19.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 5.3799999999999999 109.277 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.558 ' OG ' ' OD1' ' A' ' 4' ' ' ASP . 2.1 p 167.92 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 4.8300000000000001 109.276 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.654 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -34.71 120.87 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 3.4300000000000002 109.698 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -71.25 23.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 2.8300000000000001 109.272 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 6' ' ' GLU . 5.6 tt0 24.23 65.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.025 0.44 . . . . 4.75 110.659 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' ' 148' ' ' LEU . 12.3 mt -56.02 -49.12 74.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 4.9500000000000002 108.859 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 55' ' ' TYR . 1.2 tp -101.34 116.05 64.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.003 . . . . 2.8599999999999999 108.293 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.58 27.84 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.215 1.943 . . . . 3.8300000000000001 111.946 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.551 ' O ' HD23 ' A' ' 10' ' ' LEU . 9.1 t-80 -137.02 139.15 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 2.52 109.502 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.576 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.07 54.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 1.97 109.338 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -164.41 73.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.96 109.572 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -62.97 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.76 108.897 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -74.05 -46.96 40.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 1.1799999999999999 109.925 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.674 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.9 mt-10 -109.78 -84.02 0.56 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 2.1299999999999999 109.542 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.8 m -94.41 142.98 26.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 2.2599999999999998 109.465 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.692 ' HB2' HD21 ' A' ' 24' ' ' LEU . 2.1 pp -57.62 -12.56 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 2.6000000000000001 109.558 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.571 ' O ' HD12 ' A' ' 19' ' ' LEU . . . 82.1 -147.05 25.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.36 -1.496 . . . . 1.6200000000000001 109.36 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.31 -11.78 13.1 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.671 2.247 . . . . 1.7 112.143 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' CH2' HG11 ' A' ' 146' ' ' VAL . 10.6 m95 -66.51 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 2.4199999999999999 109.284 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.726 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 m -156.44 126.84 6.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 1.6399999999999999 109.559 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.841 ' N ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -121.08 133.17 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.958 . . . . 2.0499999999999998 109.554 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.681 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.97 153.35 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 1.72 109.597 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 109.69 -22.92 23.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.951 -1.259 . . . . 1.7 109.951 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.823 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.91 -142.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.998 -1.295 . . . . 0.96999999999999997 109.373 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.823 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.3 p -90.96 141.54 28.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 1.8 109.41 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -37.38 101.59 0.22 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.966 . . . . 2.3999999999999999 109.236 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HG2' HD12 ' A' ' 24' ' ' LEU . 59.9 Cg_exo -46.27 160.94 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.404 2.069 . . . . 1.1299999999999999 111.879 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.828 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.7 p -138.35 97.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 1.05 110.318 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.32 84.41 3.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.454 -0.779 . . . . 1.8200000000000001 109.096 178.921 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.15 -140.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 1.1699999999999999 109.925 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 2.21 109.563 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . -141.73 47.25 0.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.727 -1.349 . . . . 1.1899999999999999 109.727 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.716 ' NH2' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -168.43 148.88 4.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 2.9100000000000001 109.752 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.736 ' CE ' HD13 ' A' ' 24' ' ' LEU . 58.2 ttp -123.43 129.24 50.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.419 -0.8 . . . . 0.93000000000000005 109.224 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.716 ' SG ' ' NH2' ' A' ' 36' ' ' ARG . 59.3 m -122.65 146.55 47.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.607 -0.837 . . . . 1.0600000000000001 110.072 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HD13 ' A' ' 41' ' ' LEU . 3.0 m -122.69 160.25 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.62 -0.881 . . . . 1.3700000000000001 108.62 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.772 ' C ' HD12 ' A' ' 41' ' ' LEU . 2.9 m-20 -105.9 99.69 9.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 4.79 110.119 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.772 HD12 ' C ' ' A' ' 40' ' ' ASP . 7.2 mp -113.73 79.76 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 3.54 109.137 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.18 -158.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.872 2.381 . . . . 3.7400000000000002 112.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 136' ' ' ALA . . . -96.09 123.85 7.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.444 -1.462 . . . . 2.0299999999999998 109.444 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.0 -14.83 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 2.4100000000000001 109.535 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 27.4 mt-30 -99.79 70.11 1.62 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -1.184 . . . . 2.96 109.435 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.83 49.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.548 -1.421 . . . . 2.0800000000000001 109.548 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -164.65 87.14 1.08 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.223 -1.163 . . . . 3.6099999999999999 109.494 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 51.3 Cg_exo -48.73 -6.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.826 2.351 . . . . 2.3599999999999999 112.173 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.479 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.3 p90 -100.25 37.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 3.8700000000000001 109.485 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 46.3 m-20 -146.1 32.79 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 2.3799999999999999 109.434 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 172.97 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 1.1100000000000001 109.403 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.6 173.7 41.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.783 -1.327 . . . . 0.93999999999999995 109.783 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 5.2 mp -99.67 175.94 5.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 0.95999999999999996 109.245 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 0.6 OUTLIER -152.95 167.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.92000000000000004 110.51 -179.61 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.687 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 5.4 t80 -177.65 132.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 1.71 109.162 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.687 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 3.6 m-20 -107.59 159.79 16.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.946 . . . . 2.7799999999999998 109.66 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.01 77.52 1.03 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.447 . . . . 2.48 109.484 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 58' ' ' VAL . 55.2 t -149.85 60.91 4.71 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.142 . . . . 3.79 109.556 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 50.5 Cg_exo -48.57 142.59 17.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.775 2.316 . . . . 2.3999999999999999 112.102 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 3.0 t -134.45 153.97 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 3.0800000000000001 109.629 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -136.04 112.34 0.96 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.461 -1.455 . . . . 3.0499999999999998 109.461 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.2 tm-20 -39.06 135.11 0.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.144 . . . . 6.0499999999999998 109.668 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 97.22 -14.36 63.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.885 -1.286 . . . . 2.54 109.885 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' HB2' ' A' ' 115' ' ' SER . 2.2 mm-40 -100.79 157.45 16.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 4.0300000000000002 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -118.96 121.37 39.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 2.9100000000000001 109.176 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 51.7 m-85 -98.19 178.54 5.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.203 -0.935 . . . . 2.3799999999999999 109.743 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -163.61 133.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 2.6099999999999999 109.41 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -118.18 122.03 42.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 3.6099999999999999 109.736 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.4 p -112.2 100.25 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.88 -0.785 . . . . 2.27 108.88 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 2.2 p90 -93.96 146.31 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 2.0099999999999998 110.95 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -99.63 107.01 19.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.124 -1.065 . . . . 1.8 108.124 178.534 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -157.52 156.26 31.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.697 -1.252 . . . . 0.95999999999999996 110.862 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' GLU . 97.0 p -132.27 121.48 23.66 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.856 -0.794 . . . . 0.93000000000000005 108.856 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -81.53 129.91 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.817 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.463 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -130.81 116.92 17.17 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.382 -0.824 . . . . 0.96999999999999997 109.287 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.591 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.35 -144.77 0.18 OUTLIER 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.104 -1.207 . . . . 1.02 111.998 0.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' ' CG ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.03 154.62 19.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.698 -1.251 . . . . 1.75 109.39 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.657 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 157.17 154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.385 -0.822 . . . . 2.1600000000000001 109.264 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.552 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 68.0 Cg_endo -77.55 141.96 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.821 2.347 . . . . 1.3799999999999999 112.356 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 98' ' ' GLY . 35.1 m -108.4 170.3 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 2.0099999999999998 109.362 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 132' ' ' HIS . 0.1 OUTLIER -109.85 156.18 20.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 6.0099999999999998 109.437 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 83' ' ' LEU . 2.7 p -156.94 159.31 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 3.7599999999999998 109.51 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.693 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -154.66 143.67 21.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 2.29 109.702 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.692 ' CG1' HG22 ' A' ' 129' ' ' VAL . 0.4 OUTLIER -153.79 161.18 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 1.8899999999999999 109.467 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 133.77 -164.56 24.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 1.49 109.548 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.687 ' OE2' ' CZ ' ' A' ' 119' ' ' PHE . 12.7 pm0 -84.08 35.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 2.54 109.428 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' O ' ' OE1' ' A' ' 128' ' ' GLN . . . -41.41 86.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.636 -1.386 . . . . 1.3799999999999999 109.636 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 86' ' ' GLU . . . -139.76 59.53 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.627 -1.389 . . . . 2.54 109.627 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.664 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 56.0 123.48 0.01 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.482 -1.447 . . . . 4.1399999999999997 109.482 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 62.89 -49.7 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 5.1299999999999999 109.392 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 89' ' ' GLY . 40.3 m-85 -53.86 79.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 5.79 109.39 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.68 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -48.09 -175.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 5.7400000000000002 109.789 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.622 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -144.05 -172.34 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 2.27 109.984 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -125.28 -23.39 4.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.89 -0.781 . . . . 3.2799999999999998 108.89 179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.47 42.52 1.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 3.6499999999999999 109.254 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' CD ' ' O ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.87 49.4 1.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.988 -1.07 . . . . 4.5999999999999996 109.482 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -112.52 153.87 26.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 3.46 109.234 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -140.21 4.33 2.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 3.6699999999999999 109.576 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -77.28 62.31 2.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.79 109.451 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.47 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -104.7 106.71 55.9 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 1.96 109.324 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.726 ' O ' HD22 ' A' ' 102' ' ' LEU . 60.6 Cg_endo -78.63 123.44 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.576 2.184 . . . . 2.9700000000000002 112.676 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 101' ' ' PRO . 4.3 mm? -124.32 173.24 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 3.0600000000000001 109.358 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -138.11 -174.11 3.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 2.3399999999999999 109.788 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -86.78 42.39 3.15 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.626 -1.389 . . . . 2.1699999999999999 109.626 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.9 mt-10 -162.24 160.95 21.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 3.02 109.114 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.5 115.58 2.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.641 2.227 . . . . 1.4199999999999999 111.715 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.39 124.65 9.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 1.3700000000000001 109.754 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.49 150.28 21.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.809 . . . . 1.72 109.994 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -131.4 143.08 50.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.706 -1.22 . . . . 4.7000000000000002 107.706 178.246 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.671 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 5.3 mt-10 -127.32 128.26 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.374 -0.93 . . . . 3.2799999999999998 110.814 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' CB ' ' A' ' 100' ' ' ALA . 6.9 m-85 -124.56 119.08 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.655 -0.869 . . . . 2.96 108.655 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.625 ' HB2' HG23 ' A' ' 67' ' ' VAL . . . -106.34 146.85 29.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 3.4100000000000001 110.007 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.728 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -130.92 164.68 24.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 2.77 109.267 179.681 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.4 122.4 43.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 2.23 109.819 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.495 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 6.1 m -59.77 129.83 43.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 4.1100000000000003 109.393 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -114.99 -19.81 10.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 6.8600000000000003 109.551 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.892 ' H ' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -142.44 -153.1 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 5.1200000000000001 109.276 179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.56 148.4 47.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.246 -0.909 . . . . 4.0599999999999996 109.687 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.818 ' CE2' HD13 ' A' ' 117' ' ' LEU . 44.4 m-85 -147.47 91.46 5.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 5.4400000000000004 109.302 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.84 165.74 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.815 2.343 . . . . 4.04 112.227 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 -15.5 12.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.697 2.265 . . . . 3.8999999999999999 112.02 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.83 132.42 54.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -0.873 . . . . 4.1399999999999997 109.549 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.28 -148.05 19.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 3.5699999999999998 109.525 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.5 30.0 7.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 3.5899999999999999 109.441 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 91' ' ' TYR . . . -177.85 70.0 0.21 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 2.0800000000000001 109.437 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.55 -158.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.842 2.361 . . . . 1.3899999999999999 112.185 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.38 149.91 50.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.528 -1.429 . . . . 1.1899999999999999 109.528 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.566 ' OE1' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -148.09 128.02 13.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 2.0099999999999998 109.536 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.692 HG22 ' CG1' ' A' ' 84' ' ' VAL . 32.8 t -138.75 137.45 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.465 -0.939 . . . . 1.28 108.465 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -155.24 109.74 2.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.186 -1.006 . . . . 0.97999999999999998 110.262 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -80.6 103.53 10.52 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.847 -0.797 . . . . 1.73 108.847 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.693 ' ND1' HD21 ' A' ' 83' ' ' LEU . 7.0 m170 -99.58 128.77 45.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.935 . . . . 2.3199999999999998 109.713 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.69 -32.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 2.1099999999999999 109.449 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.554 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -39.6 131.96 2.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.566 -1.414 . . . . 1.77 109.566 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.858 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 47.2 mttt -165.6 140.4 4.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 5.0599999999999996 109.594 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.82 -20.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 2.6400000000000001 108.565 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.51 12.93 7.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.112 -1.595 . . . . 2.5099999999999998 109.112 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.858 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -50.42 -164.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -1.039 . . . . 2.3199999999999998 109.898 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.556 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 1.1 p90 -166.61 -161.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 1.6100000000000001 109.385 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -81.67 151.31 27.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 1.6499999999999999 109.733 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 12.8 t80 -137.19 113.36 9.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.893 . . . . 1.6799999999999999 109.319 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.7 m -106.14 96.53 6.54 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.128 -0.983 . . . . 0.73999999999999999 110.154 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.509 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.05 139.05 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 1.22 108.954 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.725 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 78.3 p -132.81 -14.03 2.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.563 -0.711 . . . . 1.3300000000000001 109.715 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.725 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -147.9 164.59 33.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 3.2999999999999998 110.146 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.591 HG11 ' CH2' ' A' ' 22' ' ' TRP . 8.7 p -178.51 126.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.935 -0.765 . . . . 2.2599999999999998 108.935 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.48 147.73 40.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.068 -1.02 . . . . 2.7599999999999998 110.076 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 9' ' ' LEU . 32.2 tp -116.72 135.6 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 4.5700000000000003 109.231 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -150.68 -177.25 5.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.025 . . . . 3.0699999999999998 109.725 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.817 HG23 ' N ' ' A' ' 151' ' ' SER . 2.7 t -133.6 -152.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 2.0 109.576 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.817 ' N ' HG23 ' A' ' 150' ' ' THR . 0.9 OUTLIER -118.01 127.72 54.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.835 . . . . 2.1499999999999999 109.49 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.557 ' O ' ' O ' ' A' ' 151' ' ' SER . . . -38.21 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 2.8199999999999998 109.526 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.002 -0.999 . . . . 3.54 109.467 -179.95 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.458 -0.571 . . . . 7.8399999999999999 109.458 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.564 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 1.7 p 52.24 -74.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 5.3899999999999997 108.956 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.761 ' N ' ' O ' ' A' ' 1' ' ' ALA . 3.9 tp 69.5 -153.43 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.288 -0.882 . . . . 5.5300000000000002 110.048 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 5' ' ' SER . 8.5 m-20 -43.19 156.71 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 4.4299999999999997 109.06 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 71.12 111.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 3.0699999999999998 109.53 -179.847 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB3' HG21 ' A' ' 149' ' ' THR . 6.8 mp0 -71.21 135.88 47.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.967 . . . . 3.6800000000000002 109.184 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 150' ' ' THR . 1.8 t -66.48 77.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.024 . . . . 1.73 109.39 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 6' ' ' GLU . 1.4 tp10 -67.7 79.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.858 . . . . 2.7400000000000002 109.715 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.81 -14.27 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.898 . . . . 1.72 109.19 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -126.38 85.88 59.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 1.96 108.874 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.91 37.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.154 2.57 . . . . 1.8700000000000001 112.391 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.712 ' H ' HD13 ' A' ' 10' ' ' LEU . 57.2 t60 -145.53 101.1 3.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 1.26 109.315 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 13' ' ' THR . 7.7 t -142.37 52.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.267 -0.895 . . . . 1.0900000000000001 109.453 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -139.38 68.11 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 1.8799999999999999 109.609 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -67.1 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 1.3200000000000001 109.127 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.25 -36.07 14.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 1.0800000000000001 110.196 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 3.0 mm-40 -109.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 2.9700000000000002 110.137 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -99.38 151.29 21.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.6499999999999999 109.87 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.817 ' CD2' HD21 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -59.37 -60.02 4.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.845 . . . . 1.95 109.304 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.503 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.37 -164.32 12.32 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.67000000000000004 109.523 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.55 -2.71 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.834 2.356 . . . . 0.70999999999999996 112.276 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.557 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 11.8 m95 -75.13 -177.09 3.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.89 . . . . 0.56999999999999995 109.321 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -140.07 175.84 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.83999999999999997 109.295 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.817 HD21 ' CD2' ' A' ' 19' ' ' LEU . 1.8 pp -179.29 164.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 1.9099999999999999 109.938 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.675 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 162.71 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 2.6499999999999999 109.718 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.61 -21.97 9.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.038 -1.225 . . . . 0.57999999999999996 110.038 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.879 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.69 -142.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.287 . . . . 0.56999999999999995 109.49 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.2 p -91.78 -175.87 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.92000000000000004 108.984 179.389 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -81.02 111.65 25.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 2.5899999999999999 108.815 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 28' ' ' SER . 54.1 Cg_exo -49.26 155.02 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.317 2.011 . . . . 0.88 111.855 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' MET . 44.9 t -142.41 106.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 1.1599999999999999 109.986 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.68 82.92 3.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 1.3700000000000001 109.128 179.127 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.569 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.72999999999999998 109.938 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' ALA . 2.6 m-20 -41.47 -65.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 2.4900000000000002 109.448 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -147.88 26.34 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.299 -1.52 . . . . 0.81999999999999995 109.299 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -141.03 145.02 35.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -1.122 . . . . 3.4700000000000002 109.641 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 30' ' ' PRO . 45.4 ttp -112.85 127.35 56.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 1.4399999999999999 109.128 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.606 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -121.3 156.82 31.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 1.22 110.346 -179.358 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 HD23 ' A' ' 41' ' ' LEU . 2.2 m -125.61 142.23 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.685 -0.857 . . . . 0.53000000000000003 108.685 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.784 ' C ' HD22 ' A' ' 41' ' ' LEU . 5.7 m-20 -77.26 111.98 13.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 1.52 109.817 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.6 mm? -122.87 68.56 34.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 1.4299999999999999 109.408 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.99 -92.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.835 2.357 . . . . 1.9299999999999999 112.308 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.07 36.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.53 -1.428 . . . . 2.02 109.53 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.86 -9.02 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 1.7 109.482 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.684 HE22 ' HB2' ' A' ' 51' ' ' ALA . 16.3 mt-30 -99.87 119.03 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 2.0800000000000001 109.522 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.52 46.94 1.18 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.513 -1.435 . . . . 2.0299999999999998 109.513 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.583 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -171.25 102.95 0.39 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.174 -1.192 . . . . 2.29 109.67 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -47.32 -26.11 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.322 . . . . 1.5800000000000001 112.363 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.646 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 27.0 p90 -93.98 44.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 3.3399999999999999 109.665 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.583 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 1.9 m-20 -131.35 11.88 4.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 1.97 109.343 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.684 ' HB2' HE22 ' A' ' 45' ' ' GLN . . . -174.3 140.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 0.91000000000000003 109.269 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 146.57 -174.36 26.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.678 -1.369 . . . . 0.59999999999999998 109.678 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' C ' HG22 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -104.21 -173.57 2.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -1.197 . . . . 1.6499999999999999 109.921 -179.953 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.54 172.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.704 . . . . 1.48 109.376 -179.767 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 17.8 t80 170.48 142.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 1.4399999999999999 109.664 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.635 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 8.6 m-20 -103.27 -164.72 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.252 -0.905 . . . . 0.94999999999999996 109.469 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 58' ' ' VAL . . . 79.72 68.89 1.44 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.411 -1.476 . . . . 0.83999999999999997 109.411 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 57' ' ' GLY . 43.4 t -153.93 73.82 6.38 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.33 -1.1 . . . . 1.6299999999999999 109.544 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.25 120.85 7.66 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.553 2.169 . . . . 0.83999999999999997 112.043 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.39 130.19 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.226 -0.921 . . . . 1.1599999999999999 109.663 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -113.08 102.52 1.29 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.81999999999999995 109.362 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.567 ' O ' ' OE1' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -42.8 124.76 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 2.73 109.598 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.02 -39.18 2.14 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.77 -1.332 . . . . 0.98999999999999999 109.77 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.534 ' O ' ' OG ' ' A' ' 115' ' ' SER . 10.3 mt-10 -100.22 170.12 8.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -1.147 . . . . 2.5899999999999999 109.697 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -116.85 145.14 43.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.81999999999999995 109.269 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 33.3 m-85 -110.84 179.49 4.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.123 -0.986 . . . . 1.47 109.671 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.3 t -152.78 149.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.98999999999999999 109.316 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' ARG . 3.4 tp -134.06 116.96 16.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.85999999999999999 109.858 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 83.2 p -109.4 85.85 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.464 -0.939 . . . . 1.1499999999999999 108.464 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 49.9 p90 -92.61 137.08 32.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 1.05 111.275 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.3 p -84.24 114.41 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.193 -1.04 . . . . 0.72999999999999998 108.193 178.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 148.04 15.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.781 -1.199 . . . . 0.69999999999999996 110.671 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 131.12 39.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.689 -0.856 . . . . 0.78000000000000003 108.689 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.774 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -93.36 127.57 39.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 109.728 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.497 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -134.19 114.39 12.64 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.307 -0.871 . . . . 0.60999999999999999 109.261 179.882 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.635 ' O ' ' C ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.74 -141.98 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.895 -1.294 . . . . 0.80000000000000004 112.407 -0.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.663 ' O ' ' CG ' ' A' ' 78' ' ' MET . 1.4 m-20 -98.94 160.15 14.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 1.3999999999999999 109.634 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.663 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 156.91 155.83 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.85 . . . . 1.9299999999999999 109.268 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.62 145.3 41.5 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.884 2.389 . . . . 0.79000000000000004 112.376 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.112 HG11 HD12 ' A' ' 102' ' ' LEU . 0.7 OUTLIER -117.45 172.7 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.76000000000000001 109.222 179.939 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.483 ' N ' HG23 ' A' ' 80' ' ' VAL . 20.0 ttt180 -119.69 134.36 55.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.93 . . . . 3.0499999999999998 109.6 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.527 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -137.99 150.13 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 1.55 109.248 179.795 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -145.99 152.33 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.85999999999999999 109.832 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.756 HG13 HG22 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -154.95 154.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.923 . . . . 0.56999999999999995 109.632 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 148.33 -149.04 21.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.653 -1.379 . . . . 0.57999999999999996 109.653 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.76 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.9 pm0 -90.08 178.38 6.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 2.7400000000000002 109.715 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.08 62.63 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.544 -1.422 . . . . 1.6299999999999999 109.544 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' A' ' 125' ' ' ALA . . . 164.36 115.02 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.467 -1.453 . . . . 2.2000000000000002 109.467 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 87.65 117.83 1.27 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 2.4700000000000002 109.397 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 62.16 -39.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -1.179 . . . . 2.73 109.102 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.699 ' N ' ' O ' ' A' ' 89' ' ' GLY . 78.5 m-85 60.6 -42.64 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.436 -0.79 . . . . 5.7400000000000002 109.825 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.871 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -33.6 132.19 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.974 . . . . 3.4199999999999999 109.452 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -125.78 -171.37 2.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.96999999999999997 109.814 -179.815 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.665 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -118.45 -24.06 6.96 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.904 -0.776 . . . . 0.94999999999999996 108.904 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -90.49 41.36 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -0.958 . . . . 1.6299999999999999 108.719 179.915 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.46 64.75 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.971 . . . . 2.7799999999999998 109.886 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' VAL . 4.0 pt20 -109.08 153.9 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 2.2799999999999998 109.177 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.6 11.61 4.3 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.8 -1.32 . . . . 0.94999999999999996 109.8 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -105.36 77.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -1.181 . . . . 0.88 109.388 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.797 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -119.81 79.53 24.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.943 . . . . 0.58999999999999997 109.677 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -52.75 126.45 21.18 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.882 2.388 . . . . 0.73999999999999999 112.384 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.112 HD12 HG11 ' A' ' 80' ' ' VAL . 20.6 mt -133.02 137.78 46.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 1.1699999999999999 109.326 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.1 OUTLIER -109.06 -179.33 3.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 1.0800000000000001 109.477 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.473 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -84.63 40.56 2.97 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.525 -1.43 . . . . 1.3500000000000001 109.525 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.38 120.59 12.66 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -1.111 . . . . 3.4900000000000002 109.402 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.35 118.42 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.391 2.06 . . . . 0.97999999999999998 111.806 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -160.85 141.96 11.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.48 109.904 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.0 138.57 31.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.774 . . . . 0.96999999999999997 109.706 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 69' ' ' SER . 18.4 mmt180 -109.03 136.62 48.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 4.1799999999999997 108.685 178.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 10.4 mt-10 -113.95 103.36 11.08 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.181 -0.607 . . . . 2.3799999999999999 109.698 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 16.1 m-85 -109.13 120.09 41.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 1.51 108.424 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.45 156.53 25.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.306 -0.872 . . . . 0.87 109.923 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.0 p90 -144.78 178.98 7.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.456 -0.778 . . . . 1.8300000000000001 109.161 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -105.4 115.8 30.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.448 -0.782 . . . . 1.0900000000000001 109.633 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 10.7 m -48.82 123.2 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.907 . . . . 1.6200000000000001 109.418 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 114' ' ' THR . 16.0 m120 -113.97 -38.25 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 2.3900000000000001 109.571 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -112.93 143.21 44.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 2.54 109.618 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.67 103.99 11.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 1.0800000000000001 109.54 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.668 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 43.5 m-85 -112.26 95.97 33.07 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 1.9299999999999999 109.247 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.56 166.15 24.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.682 2.254 . . . . 1.21 112.274 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.54 -19.61 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.9 2.4 . . . . 1.5800000000000001 111.934 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.1 136.64 54.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 3.5 109.457 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.84 -111.87 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 2.0899999999999999 109.548 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.37 -17.56 14.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -1.128 . . . . 3.6699999999999999 109.418 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' A' ' 88' ' ' GLY . . . -167.38 122.31 0.84 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 2.1000000000000001 109.384 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HG2' ' ND2' ' A' ' 56' ' ' ASN . 59.0 Cg_endo -76.63 -159.74 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.542 2.162 . . . . 1.72 112.195 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -57.87 168.59 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.78000000000000003 109.493 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.21 135.08 12.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 2.1899999999999999 109.433 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.756 HG22 HG13 ' A' ' 84' ' ' VAL . 41.3 t -141.12 148.79 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.4299999999999999 108.769 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.27 105.77 0.66 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.101 -0.999 . . . . 0.46999999999999997 110.029 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 7.7 m-30 -83.56 109.99 17.86 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.33 -0.989 . . . . 1.3799999999999999 108.33 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.418 ' CE1' HD21 ' A' ' 83' ' ' LEU . 44.4 m170 -99.38 120.23 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.945 . . . . 1.1399999999999999 110.084 -179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.839 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -129.97 -7.56 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 1.1499999999999999 109.141 179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -57.69 126.03 41.02 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.401 -1.48 . . . . 1.27 109.401 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.708 ' O ' ' N ' ' A' ' 138' ' ' ALA . 11.0 mtpt -161.55 128.23 3.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -1.187 . . . . 4.7400000000000002 109.987 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.08 -18.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.94 -1.133 . . . . 1.5900000000000001 107.94 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.703 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -118.27 10.14 13.29 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.837 -1.705 . . . . 1.6100000000000001 108.837 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.708 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.76 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.61 -0.936 . . . . 1.6899999999999999 109.858 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.828 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -168.74 -114.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.012 . . . . 2.0 110.038 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.4 mt-10 -130.8 138.48 49.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 2.2999999999999998 109.235 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 12.2 t80 -117.35 116.62 27.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 1.47 109.595 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.01 98.38 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.44 110.043 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -114.06 141.67 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.81999999999999995 109.256 179.548 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 86.5 p -130.74 -10.68 3.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.682 -0.636 . . . . 0.64000000000000001 109.346 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.644 ' N ' ' OG1' ' A' ' 71' ' ' THR . 18.2 mt-30 -148.37 177.41 9.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 1.9399999999999999 110.359 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.606 ' O ' ' CG1' ' A' ' 146' ' ' VAL . 1.1 p -179.17 117.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 1.1499999999999999 108.821 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.57 ' OG ' ' OG ' ' A' ' 69' ' ' SER . 60.1 p -124.6 151.17 45.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.013 -1.054 . . . . 1.6100000000000001 110.123 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.957 HD12 ' N ' ' A' ' 149' ' ' THR . 0.2 OUTLIER -135.67 122.39 21.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.458 -0.776 . . . . 1.3 108.968 179.728 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.957 ' N ' HD12 ' A' ' 148' ' ' LEU . 1.2 t -148.21 -159.97 1.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.053 -1.03 . . . . 1.21 109.666 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.624 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.2 t -141.59 -41.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 1.77 109.33 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.543 ' N ' ' CG2' ' A' ' 150' ' ' THR . 1.1 t 41.58 64.31 1.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.785 . . . . 3.2599999999999998 109.311 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.552 ' N ' ' OG ' ' A' ' 2' ' ' SER . . . -71.1 140.22 50.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 4.71 109.504 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.081 -0.961 . . . . 7.5700000000000003 109.382 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 7' ' ' VAL . 42.2 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.458 -0.571 . . . . 2.8300000000000001 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 7' ' ' VAL . 19.5 tp10 -35.85 119.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 4.75 109.344 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' A' ' 148' ' ' LEU . 12.3 mt -88.19 -31.96 18.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 4.9500000000000002 109.801 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 57' ' ' GLY . 1.0 OUTLIER -113.47 129.92 24.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 2.8599999999999999 108.968 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -67.33 59.36 0.69 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.424 2.083 . . . . 3.8300000000000001 113.343 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.496 ' C ' HG22 ' A' ' 13' ' ' THR . 36.2 t60 -165.38 126.65 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.007 . . . . 2.52 109.752 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -170.37 70.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 1.97 109.318 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.47 ' HA ' ' NE2' ' A' ' 145' ' ' GLN . 30.5 t -161.33 82.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 1.96 109.8 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.2 m-30 -90.12 24.84 2.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 1.76 109.243 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.23 17.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 1.1799999999999999 109.815 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.677 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 19.6 mm-40 -109.67 -49.5 3.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.184 -0.947 . . . . 2.1299999999999999 109.588 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.8 p -136.39 152.03 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 2.2599999999999998 109.377 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.983 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -85.07 26.97 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 2.6000000000000001 109.191 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 44.41 -151.64 0.64 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.572 -1.411 . . . . 1.6200000000000001 109.572 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 67.4 Cg_endo -81.0 9.45 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.748 2.299 . . . . 1.7 112.555 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.789 ' NE1' ' CD2' ' A' ' 55' ' ' TYR . 10.6 m95 -70.94 172.15 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.006 . . . . 2.4199999999999999 109.275 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.92 177.64 4.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.6399999999999999 109.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.968 ' O ' HD12 ' A' ' 24' ' ' LEU . 4.2 pp -178.46 123.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 2.0499999999999998 109.349 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.2 169.12 2.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 1.72 110.305 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 -26.54 22.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.098 -1.201 . . . . 1.7 110.098 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.799 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.9 -142.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.276 . . . . 0.96999999999999997 109.394 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.799 ' N ' ' OG1' ' A' ' 27' ' ' THR . 67.0 p -91.14 132.56 35.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.251 -0.906 . . . . 1.8 109.236 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -36.83 101.75 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 2.3999999999999999 109.234 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.708 ' HG2' HD13 ' A' ' 24' ' ' LEU . 50.3 Cg_exo -48.16 159.06 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.303 2.002 . . . . 1.1299999999999999 111.551 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' MET . 3.5 t -148.11 114.35 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.937 -1.102 . . . . 1.05 110.659 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.677 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -74.05 79.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.049 -0.722 . . . . 1.8200000000000001 109.049 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.26 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.519 -0.738 . . . . 1.1699999999999999 109.872 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 33' ' ' ALA . 69.0 m-20 -35.65 -70.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 2.21 109.441 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.88 33.12 1.28 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.626 -1.39 . . . . 1.1899999999999999 109.626 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -153.35 150.6 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 2.9100000000000001 109.664 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.527 ' SD ' ' CB ' ' A' ' 30' ' ' PRO . 33.7 ttp -109.05 132.23 54.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.93000000000000005 109.769 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 58.4 m -124.02 156.25 36.82 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.675 -0.81 . . . . 1.0600000000000001 110.211 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.9 m -131.47 129.58 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.684 -0.858 . . . . 1.3700000000000001 108.684 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' H ' ' HG ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -73.65 109.39 7.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 4.79 109.622 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.2 mm? -118.19 35.01 0.21 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.155 -0.965 . . . . 3.54 110.897 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 98.6 Cg_endo -81.87 -24.02 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.521 2.148 . . . . 3.7400000000000002 111.738 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 42' ' ' PRO . . . -26.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.076 -0.81 . . . . 2.0299999999999998 111.076 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.36 54.61 0.01 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.42 -1.872 . . . . 2.4100000000000001 108.42 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 136' ' ' ALA . 20.7 mt-30 -99.7 111.92 24.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 2.96 109.97 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.531 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -81.74 55.26 4.88 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.46 -1.456 . . . . 2.0800000000000001 109.46 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -166.87 96.34 0.69 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 3.6099999999999999 109.427 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 50' ' ' ASP . 56.1 Cg_exo -47.77 -40.46 31.6 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 2.3599999999999999 112.494 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 19.3 p90 -62.95 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 3.8700000000000001 109.413 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -133.16 -57.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 2.3799999999999999 109.659 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.702 ' HB1' HG22 ' A' ' 27' ' ' THR . . . -122.1 146.36 47.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 1.1100000000000001 109.728 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.612 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 163.35 175.72 34.61 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.615 -1.278 . . . . 0.93999999999999995 110.359 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 53' ' ' LEU . 2.1 mm? -100.36 167.91 10.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.617 -0.931 . . . . 0.95999999999999996 108.736 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -154.47 155.4 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.92000000000000004 109.875 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.789 ' CD2' ' NE1' ' A' ' 22' ' ' TRP . 30.1 t80 -177.75 148.91 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 1.71 109.436 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.64 168.14 9.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 2.7799999999999998 109.568 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.732 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 101.47 81.72 1.6 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 2.48 109.604 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.755 ' CG2' ' H ' ' A' ' 128' ' ' GLN . 5.9 m -163.21 59.76 0.87 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 3.79 109.39 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 56.9 Cg_exo -47.0 149.85 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.881 2.388 . . . . 2.3999999999999999 112.274 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.475 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 1.6 t -144.62 121.74 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 3.0800000000000001 109.522 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -96.81 94.89 1.67 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.493 -1.443 . . . . 3.0499999999999998 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.534 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 13.6 tt0 -38.46 117.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 6.0499999999999998 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 128.2 -35.82 2.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.664 -1.374 . . . . 2.54 109.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.91 172.33 7.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.234 -1.156 . . . . 4.0300000000000002 109.5 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -113.78 137.5 51.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 2.9100000000000001 109.482 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.486 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 37.1 m-85 -105.72 -178.78 3.75 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.21 -0.932 . . . . 2.3799999999999999 109.463 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.407 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -150.91 140.38 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 2.6099999999999999 109.917 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.587 HD12 ' HB3' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -116.73 120.41 38.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 3.6099999999999999 109.01 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.68 89.89 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 2.27 109.44 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.682 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.4 137.01 33.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 2.0099999999999998 110.675 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.555 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.06 105.63 17.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 1.8 109.058 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.553 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -175.28 169.82 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.828 -1.17 . . . . 0.95999999999999996 110.677 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.43 159.82 41.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.042 -0.725 . . . . 0.93000000000000005 109.042 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.834 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -102.91 137.56 40.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.67000000000000004 109.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.52 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.44 112.54 6.57 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.258 -0.901 . . . . 0.96999999999999997 109.639 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.3 Cg_exo -63.87 -141.72 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.633 0 C-N-CA 124.218 -1.159 . . . . 1.02 112.439 -0.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -104.94 151.03 24.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 1.75 110.023 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' O ' ' A' ' 137' ' ' GLY . 1.7 mtm 166.25 163.5 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.817 -0.809 . . . . 2.1600000000000001 108.817 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -83.95 153.9 13.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.744 2.296 . . . . 1.3799999999999999 112.591 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.633 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 17.5 m -128.5 -166.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 2.0099999999999998 109.253 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 132' ' ' HIS . 57.0 ttt180 -136.65 141.61 43.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.067 -1.02 . . . . 6.0099999999999998 109.836 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' OE1' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.97 149.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 3.7599999999999998 109.259 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.594 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -142.79 149.22 38.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 2.29 109.876 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 129' ' ' VAL . 1.3 t -151.4 146.09 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 1.8899999999999999 109.696 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.86 -142.0 7.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 1.49 109.476 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 22.8 pt-20 -90.07 -158.78 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -1.193 . . . . 2.54 109.471 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 1.3799999999999999 109.518 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.538 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.48 -0.563 . . . . 5.7400000000000002 109.48 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -115.86 169.92 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 2.27 109.921 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.9 -23.34 11.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.647 -0.871 . . . . 3.2799999999999998 108.647 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.799 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.97 34.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 3.6499999999999999 109.123 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB2' HG23 ' A' ' 93' ' ' THR . 0.6 OUTLIER -89.59 104.74 17.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 4.5999999999999996 109.64 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.498 ' OE1' HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -141.26 176.48 8.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 3.46 109.515 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.47 14.11 0.61 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.643 -1.383 . . . . 3.6699999999999999 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -112.33 60.84 0.63 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -1.182 . . . . 3.79 109.546 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.52 101.93 30.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 1.96 109.083 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.32 131.97 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.539 2.159 . . . . 2.9700000000000002 112.593 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.08 134.48 23.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 3.0600000000000001 109.264 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.664 ' O ' ' N ' ' A' ' 105' ' ' GLU . 9.0 t -138.32 -161.63 1.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 2.3399999999999999 109.523 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.514 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -62.6 37.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.445 -1.462 . . . . 2.1699999999999999 109.445 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 103' ' ' THR . 13.8 tp10 -112.25 93.1 20.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 3.02 109.359 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 58.4 Cg_endo -79.53 118.18 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.715 2.277 . . . . 1.4199999999999999 112.177 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 173.96 -175.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 1.3700000000000001 109.48 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.4 118.82 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 1.72 110.283 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -93.26 137.13 32.87 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.356 -1.35 . . . . 4.7000000000000002 107.356 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.44 118.58 37.14 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.441 -0.787 . . . . 3.2799999999999998 109.666 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -107.94 109.92 21.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.036 -1.098 . . . . 2.96 108.036 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.27 45.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 3.4100000000000001 110.066 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.799 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -133.57 166.88 21.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 2.77 109.176 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.13 126.47 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.228 -0.92 . . . . 2.23 109.866 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 63' ' ' GLY . 3.9 m -69.25 122.78 19.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 4.1100000000000003 109.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.534 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -117.67 -9.98 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 6.8600000000000003 109.54 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.641 HD23 ' CZ ' ' A' ' 119' ' ' PHE . 13.1 tp -141.49 124.2 16.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 5.1200000000000001 109.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.459 ' N ' HD12 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -63.92 144.74 56.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 4.0599999999999996 109.498 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.641 ' CZ ' HD23 ' A' ' 117' ' ' LEU . 32.9 m-85 -142.88 92.22 7.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 5.4400000000000004 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.35 165.81 20.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.76 2.307 . . . . 4.04 112.215 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.99 -17.93 10.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.766 2.31 . . . . 3.8999999999999999 112.007 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.99 132.29 54.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 4.1399999999999997 109.509 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 133.44 50.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.523 -1.431 . . . . 3.5699999999999998 109.523 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 123' ' ' GLY . 1.3 t70 37.92 22.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -1.132 . . . . 3.5899999999999999 109.48 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -151.77 72.07 8.05 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 2.0800000000000001 109.397 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.22 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.791 2.327 . . . . 1.3899999999999999 112.233 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.513 ' HA3' ' H ' ' A' ' 57' ' ' GLY . . . -72.92 157.07 52.24 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.631 -1.388 . . . . 1.1899999999999999 109.631 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.755 ' H ' ' CG2' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -150.77 140.44 21.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -1.131 . . . . 2.0099999999999998 109.587 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 129' ' ' VAL . 4.5 p -161.53 112.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 1.28 108.828 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.414 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -122.74 112.22 17.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.97999999999999998 110.12 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -71.8 113.79 9.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.646 -0.872 . . . . 1.73 108.646 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' ARG . 1.6 m170 -99.66 100.69 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.199 -0.938 . . . . 2.3199999999999998 109.828 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.682 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -109.72 -21.34 12.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 2.1099999999999999 109.075 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.626 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -47.19 139.81 8.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.166 -1.573 . . . . 1.77 109.166 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.626 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER 179.54 129.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.108 . . . . 5.0599999999999996 109.234 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.01 -22.76 0.65 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.618 -1.253 . . . . 2.6400000000000001 107.618 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.642 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -105.24 7.11 43.3 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.466 -1.854 . . . . 2.5099999999999998 108.466 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.618 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -51.82 -145.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.803 -0.822 . . . . 2.3199999999999998 110.285 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.834 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 171.89 -112.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 1.6100000000000001 110.024 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.14 136.04 45.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 1.6499999999999999 109.061 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.553 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 52.9 t80 -122.7 116.71 24.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 1.6799999999999999 109.816 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.51 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 12.4 m -106.75 114.29 28.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -0.907 . . . . 0.73999999999999999 109.561 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.748 HD12 ' N ' ' A' ' 144' ' ' SER . 0.1 OUTLIER -119.97 141.2 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 1.22 109.471 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.748 ' N ' HD12 ' A' ' 143' ' ' ILE . 2.0 p -127.72 -17.21 4.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.163 -0.68 . . . . 1.3300000000000001 109.163 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.677 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -152.28 159.28 43.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.379 -0.825 . . . . 3.2999999999999998 109.378 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 146' ' ' VAL . 11.9 p -165.94 126.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 2.2599999999999998 109.429 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.509 ' OG ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -167.21 146.39 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 2.7599999999999998 109.428 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.587 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.8 pp -111.26 146.39 37.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 4.5700000000000003 109.511 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 150' ' ' THR . 2.1 t -133.57 -157.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -0.876 . . . . 3.0699999999999998 109.483 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.55 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 2.0 109.358 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.467 -0.568 . . . . 2.8300000000000001 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -141.15 64.39 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 4.75 109.507 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.825 ' HB2' HD11 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -79.95 16.46 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.925 . . . . 4.9500000000000002 109.403 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.697 ' O ' ' N ' ' A' ' 12' ' ' HIS . 1.2 tt -118.08 82.33 17.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.143 -1.058 . . . . 2.8599999999999999 108.143 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.551 ' C ' ' OH ' ' A' ' 55' ' ' TYR . 36.7 Cg_exo -53.02 36.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.099 2.533 . . . . 3.8300000000000001 113.285 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.697 ' N ' ' O ' ' A' ' 10' ' ' LEU . 38.8 t60 -170.34 138.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.995 -1.066 . . . . 2.52 109.579 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.517 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.35 70.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 1.97 109.592 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -169.84 77.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.974 . . . . 1.96 109.903 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.15 22.13 3.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 1.76 109.031 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.09 -25.0 20.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 1.1799999999999999 109.883 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 16.7 mm-40 -109.7 -58.92 1.99 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.048 -1.032 . . . . 2.1299999999999999 109.663 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 m -142.84 143.46 32.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.868 . . . . 2.2599999999999998 109.503 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.93 ' N ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -46.69 -34.23 4.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 2.6000000000000001 109.137 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 79.99 -164.01 47.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.586 -1.406 . . . . 1.6200000000000001 109.586 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 22' ' ' TRP . 34.8 Cg_exo -53.83 -21.52 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.841 2.36 . . . . 1.7 112.326 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CD1' ' CD1' ' A' ' 55' ' ' TYR . 4.3 m95 -53.05 -167.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.4199999999999999 109.356 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 161.9 39.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 1.6399999999999999 109.391 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.643 HD22 ' HG2' ' A' ' 30' ' ' PRO . 2.2 pp -160.08 137.88 9.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 2.0499999999999998 109.688 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 1.72 109.331 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 110.14 -28.58 10.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.84 -1.304 . . . . 1.7 109.84 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.784 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.9 -142.7 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.296 . . . . 0.96999999999999997 109.454 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.784 ' N ' ' OG1' ' A' ' 27' ' ' THR . 3.6 p -91.62 -165.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 1.8 109.313 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.17 111.86 49.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 2.3999999999999999 109.003 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.643 ' HG2' HD22 ' A' ' 24' ' ' LEU . 78.5 Cg_exo -44.21 154.76 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.216 1.944 . . . . 1.1299999999999999 111.981 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' MET . 23.7 t -139.43 100.35 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.971 . . . . 1.05 110.21 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.71 82.58 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.65 0.738 . . . . 1.8200000000000001 109.179 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.78 -114.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.76 . . . . 1.1699999999999999 110.023 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 2.1 m-20 -58.35 66.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 2.21 109.759 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 59.27 6.19 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 1.1899999999999999 109.562 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.663 HH11 ' CG ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.45 141.84 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.216 . . . . 2.9100000000000001 109.424 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -113.8 123.55 50.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 109.031 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.547 ' SG ' ' C ' ' A' ' 141' ' ' PHE . 4.5 t -128.15 153.2 47.13 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.272 -0.971 . . . . 1.0600000000000001 110.559 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.15 120.02 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.548 -0.908 . . . . 1.3700000000000001 108.548 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.568 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -77.39 117.44 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 4.79 109.469 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.671 HD21 ' OG1' ' A' ' 27' ' ' THR . 4.5 mm? -114.6 94.45 36.76 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.257 -0.902 . . . . 3.54 109.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.36 -43.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.223 2.615 . . . . 3.7400000000000002 111.984 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.77 141.47 3.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.397 -1.481 . . . . 2.0299999999999998 109.397 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.19 -0.43 1.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.999 -1.24 . . . . 2.4100000000000001 109.999 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.752 ' OE1' ' HB2' ' A' ' 51' ' ' ALA . 5.6 mm-40 -99.17 -160.92 0.83 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.127 -1.22 . . . . 2.96 109.428 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.43 -57.74 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 2.0800000000000001 109.842 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.68 ' OD1' ' CD1' ' A' ' 49' ' ' TRP . 3.5 p30 -99.76 150.94 37.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.224 -1.162 . . . . 3.6099999999999999 109.58 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' ASP . 84.8 Cg_exo -40.18 -55.41 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.875 2.383 . . . . 2.3599999999999999 112.343 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.68 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 2.1 p90 -70.63 47.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 3.8700000000000001 109.463 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 47' ' ' ASN . 67.8 m-20 -116.11 -8.51 11.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 2.3799999999999999 109.709 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' ' OE1' ' A' ' 45' ' ' GLN . . . -172.8 116.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.952 . . . . 1.1100000000000001 109.564 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.501 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 174.3 166.99 33.18 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.68 -1.248 . . . . 0.93999999999999995 110.186 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.97 -169.48 1.62 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -1.093 . . . . 0.95999999999999996 109.421 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -159.64 162.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.92000000000000004 109.805 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.791 ' CD1' ' CD1' ' A' ' 22' ' ' TRP . 20.1 t80 -176.82 140.4 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.821 . . . . 1.71 109.403 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -113.31 -164.19 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.38 -0.825 . . . . 2.7799999999999998 109.472 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 9' ' ' LEU . . . 86.06 47.07 5.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.504 -1.438 . . . . 2.48 109.504 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.538 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 22.2 t -151.12 75.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 3.79 109.521 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' VAL . 75.7 Cg_exo -44.04 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.906 2.404 . . . . 2.3999999999999999 112.191 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 119' ' ' PHE . 2.7 t -142.37 120.86 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 3.0800000000000001 109.595 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -137.93 107.67 0.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.323 -1.511 . . . . 3.0499999999999998 109.323 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.7 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.3 tm-20 -42.46 172.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 6.0499999999999998 109.182 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.671 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 80.67 -45.15 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.479 . . . . 2.54 109.404 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -99.56 135.56 40.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 4.0300000000000002 109.084 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.4 m -99.84 148.78 24.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.168 -0.957 . . . . 2.9100000000000001 109.763 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -107.92 177.98 4.65 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 2.3799999999999999 109.583 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -151.39 160.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.489 -0.757 . . . . 2.6099999999999999 109.468 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 109' ' ' ARG . 10.1 tp -143.69 114.3 7.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 3.6099999999999999 109.666 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 4.8 p -109.23 83.66 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.966 . . . . 2.27 108.828 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.613 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 24.9 p90 -93.89 132.99 37.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 2.0099999999999998 111.302 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.673 HG23 ' CG2' ' A' ' 108' ' ' THR . 0.8 OUTLIER -83.71 98.68 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 1.8 108.445 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -144.97 152.03 39.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.05 . . . . 0.95999999999999996 110.093 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.7 p -132.95 121.99 23.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.486 -0.759 . . . . 0.93000000000000005 109.055 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -83.48 132.96 34.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.67000000000000004 109.511 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.468 ' OG1' ' CB ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.62 117.08 16.31 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.323 -0.86 . . . . 0.96999999999999997 109.242 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.24 -142.46 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 124.256 -1.143 . . . . 1.02 112.227 -0.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -96.58 148.42 22.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 1.75 109.336 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.417 ' CE ' ' HB3' ' A' ' 139' ' ' TYR . 0.1 OUTLIER 168.27 153.03 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.685 . . . . 2.1600000000000001 109.29 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.88 117.92 5.1 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.705 2.27 . . . . 1.3799999999999999 112.001 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.483 ' CG1' HD23 ' A' ' 133' ' ' LEU . 27.2 m -79.93 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 2.0099999999999998 109.442 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 132' ' ' HIS . 18.0 ttm180 -114.68 90.29 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 6.0099999999999998 109.528 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.49 154.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.225 -0.922 . . . . 3.7599999999999998 108.993 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.44 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -154.25 162.97 40.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.01 . . . . 2.29 110.082 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.577 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -153.62 160.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 1.8899999999999999 109.358 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.44 -145.07 10.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.667 -1.373 . . . . 1.49 109.667 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.722 ' HB2' ' HB1' ' A' ' 125' ' ' ALA . 2.9 pt-20 -90.19 163.1 14.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 2.54 109.446 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 1.3799999999999999 109.49 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.303 0.573 . . . . 5.7400000000000002 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -125.94 176.91 6.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 2.27 110.03 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.12 -20.98 5.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.841 -0.8 . . . . 3.2799999999999998 108.841 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.804 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.84 34.04 0.92 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 3.6499999999999999 109.149 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.5 92.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 4.5999999999999996 109.888 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 111' ' ' TYR . 4.5 mt-30 -99.77 137.78 37.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 3.46 109.514 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.48 -13.54 2.3 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.652 -1.379 . . . . 3.6699999999999999 109.652 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.38 80.61 1.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.166 -1.197 . . . . 3.79 109.587 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.17 84.52 14.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 1.96 109.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.95 127.31 18.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.989 2.46 . . . . 2.9700000000000002 112.614 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.545 HD21 ' CG ' ' A' ' 109' ' ' ARG . 11.4 mt -144.94 127.03 15.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.866 . . . . 3.0600000000000001 109.325 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 1.7 t -91.98 -169.99 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 2.3399999999999999 109.511 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.17 13.31 67.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 2.1699999999999999 109.534 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.494 ' H ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -103.06 152.77 38.6 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 3.02 109.424 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.31 118.3 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.848 2.365 . . . . 1.4199999999999999 112.2 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.87 146.44 11.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 1.3700000000000001 109.477 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.673 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.15 132.86 35.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 1.72 109.712 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.545 ' CG ' HD21 ' A' ' 102' ' ' LEU . 3.6 mmp_? -101.96 134.11 45.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.91 -1.144 . . . . 4.7000000000000002 107.91 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -109.69 106.05 15.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.033 -0.667 . . . . 3.2799999999999998 110.389 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CB ' HE22 ' A' ' 97' ' ' GLN . 42.1 m-85 -109.74 124.88 52.01 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.312 -0.996 . . . . 2.96 108.312 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.07 163.79 23.0 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 3.4100000000000001 109.922 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.804 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 4.2 p90 -166.76 -168.2 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 2.77 109.471 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.98 154.01 25.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 2.23 109.458 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -90.24 59.12 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 4.1100000000000003 109.799 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.516 ' C ' ' O ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -33.62 -40.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 6.8600000000000003 109.908 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' OG ' ' A' ' 115' ' ' SER . 2.8 mt -109.93 -169.55 1.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 5.1200000000000001 109.767 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.684 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.7 OUTLIER -129.76 158.85 38.26 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.257 -0.902 . . . . 4.0599999999999996 109.585 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 49.4 m-85 -166.42 96.53 0.73 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 5.4400000000000004 109.28 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.81 165.56 24.4 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.591 2.194 . . . . 4.04 112.334 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.51 -13.09 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.951 2.434 . . . . 3.8999999999999999 112.095 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -109.46 8.49 25.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 4.1399999999999997 109.535 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . -96.87 174.02 29.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.495 -1.442 . . . . 3.5699999999999998 109.495 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 27.3 t0 -71.15 34.61 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 3.5899999999999999 109.482 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 86' ' ' GLU . . . 179.87 87.8 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 109.424 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.38 -160.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.784 2.323 . . . . 1.3899999999999999 112.328 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.565 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -64.62 154.6 48.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.556 -1.418 . . . . 1.1899999999999999 109.556 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.449 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -149.7 140.74 22.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -1.153 . . . . 2.0099999999999998 109.633 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.7 t -144.78 144.15 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 1.28 108.454 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.489 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -157.61 114.33 2.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.98 -1.075 . . . . 0.97999999999999998 110.015 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.5 m-30 -94.66 88.2 5.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.425 -0.797 . . . . 1.73 109.263 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 27.9 m170 -99.42 137.64 37.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.955 . . . . 2.3199999999999998 109.747 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.36 52.54 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.1099999999999999 109.536 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . . . -40.01 123.73 2.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.902 -1.279 . . . . 1.77 109.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' A' ' 138' ' ' ALA . 2.2 mptp? -167.5 44.81 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.711 -0.876 . . . . 5.0599999999999996 108.831 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . 40.97 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.412 -1.329 . . . . 2.6400000000000001 107.412 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . 69.87 28.38 71.99 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.779 -1.728 . . . . 2.5099999999999998 108.779 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.695 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -91.7 56.55 3.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -1.203 . . . . 2.3199999999999998 110.377 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 135' ' ' LYS . 10.6 p90 -177.11 -153.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.838 -1.164 . . . . 1.6100000000000001 110.459 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.468 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 1.0 OUTLIER -159.3 157.35 30.34 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.696 -0.853 . . . . 1.6499999999999999 108.696 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.547 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 13.0 t80 -135.28 103.17 5.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.041 -1.037 . . . . 1.6799999999999999 110.07 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.7 m -106.44 110.6 22.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 110.169 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.488 HG12 ' N ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -138.97 146.22 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 1.22 109.505 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.488 ' N ' HG12 ' A' ' 143' ' ' ILE . 3.6 p -136.31 -4.55 2.11 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.355 -0.538 . . . . 1.3300000000000001 109.688 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.505 ' CD ' HG21 ' A' ' 71' ' ' THR . 2.3 mt-30 -140.83 151.27 44.22 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.272 -0.971 . . . . 3.2999999999999998 110.073 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.578 HG21 ' CH2' ' A' ' 22' ' ' TRP . 13.0 p -163.08 122.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -0.845 . . . . 2.2599999999999998 109.507 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.96 139.69 23.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 2.7599999999999998 109.637 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.825 HD11 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -113.17 149.47 33.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 4.5700000000000003 109.403 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.805 ' N ' HD12 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -167.7 -163.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 3.0699999999999998 109.531 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.654 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 2.0 109.346 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.459 ' O ' ' OG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.492 -0.559 . . . . 2.8300000000000001 109.492 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.535 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -96.81 126.29 41.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 4.75 109.486 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.43 HD13 ' CG ' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -84.06 -13.82 52.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.153 -0.967 . . . . 4.9500000000000002 109.596 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.65 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -119.89 83.37 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 2.8599999999999999 108.692 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.28 34.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.025 2.484 . . . . 3.8300000000000001 111.87 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.65 ' H ' HD13 ' A' ' 10' ' ' LEU . 44.3 t60 -134.78 99.03 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.425 -0.797 . . . . 2.52 109.475 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.543 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -137.58 54.97 1.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.97 109.333 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.647 ' O ' ' N ' ' A' ' 16' ' ' ALA . 22.7 t -159.61 83.3 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 1.96 109.675 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -63.43 50.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 1.76 108.868 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -55.52 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 1.1799999999999999 110.13 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -109.88 39.37 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 2.1299999999999999 109.851 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.6 153.3 2.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.145 -0.972 . . . . 2.2599999999999998 109.699 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.947 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 2.6000000000000001 109.563 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' H ' HD22 ' A' ' 19' ' ' LEU . . . 76.61 174.16 38.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.781 -1.328 . . . . 1.6200000000000001 109.781 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.23 -16.37 4.72 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.694 2.263 . . . . 1.7 112.039 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.833 ' CH2' HG21 ' A' ' 146' ' ' VAL . 14.3 m95 -68.15 160.98 27.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 2.4199999999999999 109.08 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -109.68 148.24 31.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.009 . . . . 1.6399999999999999 109.642 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -135.35 129.58 33.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 2.0499999999999998 109.51 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.619 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.27 159.63 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 1.72 109.573 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.9 -32.34 7.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.042 -1.223 . . . . 1.7 110.042 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.754 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.7 -141.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.105 -1.232 . . . . 0.96999999999999997 109.662 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.754 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.1 p -91.09 132.39 36.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 1.8 109.316 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 tt0 -36.88 102.56 0.24 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 2.3999999999999999 109.072 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' SER . 50.0 Cg_exo -46.54 152.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.296 1.997 . . . . 1.1299999999999999 111.689 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' MET . 81.6 t -137.74 115.25 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 1.05 110.241 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.61 90.88 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.573 -0.704 . . . . 1.8200000000000001 109.75 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.53 -112.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 1.1699999999999999 109.664 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -59.43 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 2.21 109.626 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 60.0 5.03 3.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 1.1899999999999999 109.552 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.634 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -123.04 148.39 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -1.145 . . . . 2.9100000000000001 109.531 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.625 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.5 OUTLIER -114.39 132.39 56.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 0.93000000000000005 109.713 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.17 153.01 40.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 1.0600000000000001 109.676 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.3 m -126.07 137.88 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.905 -0.776 . . . . 1.3700000000000001 108.905 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.633 ' N ' ' OG ' ' A' ' 28' ' ' SER . 17.6 m-20 -73.0 110.14 7.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 4.79 109.475 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.618 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.2 mm? -117.81 75.02 9.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 3.54 109.556 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.01 -157.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.767 2.311 . . . . 3.7400000000000002 112.195 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.47 130.12 9.68 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 2.0299999999999998 109.548 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.99 35.81 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.532 -1.427 . . . . 2.4100000000000001 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.619 HE22 ' CB ' ' A' ' 50' ' ' ASP . 3.3 mm-40 -99.93 106.1 17.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -1.122 . . . . 2.96 109.491 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.2 14.42 1.25 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.659 -1.376 . . . . 2.0800000000000001 109.659 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.751 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -179.91 151.04 0.57 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.195 -1.179 . . . . 3.6099999999999999 109.519 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 50' ' ' ASP . 44.5 Cg_endo -71.8 -54.16 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.853 2.369 . . . . 2.3599999999999999 112.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.459 ' CE3' ' HG2' ' A' ' 48' ' ' PRO . 11.1 p90 -62.88 45.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 3.8700000000000001 109.384 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.789 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -135.48 39.75 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 2.3799999999999999 109.353 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 156.92 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 1.1100000000000001 109.528 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.83 170.08 20.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.644 -1.382 . . . . 0.93999999999999995 109.644 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 143' ' ' ILE . 1.7 pp -108.58 142.82 38.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -1.113 . . . . 0.95999999999999996 109.422 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 55' ' ' TYR . 4.5 t -120.0 174.79 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.92000000000000004 109.896 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.684 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 48.8 t80 179.11 144.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.71 109.527 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.684 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -99.72 -164.84 1.16 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 2.7799999999999998 109.463 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.91 66.95 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.602 -1.399 . . . . 2.48 109.602 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.766 ' CG1' ' H ' ' A' ' 128' ' ' GLN . 8.9 p -151.85 73.68 7.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.253 -1.145 . . . . 3.79 109.466 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.43 ' CG ' HD13 ' A' ' 9' ' ' LEU . 58.2 Cg_endo -76.14 157.91 37.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.873 2.382 . . . . 2.3999999999999999 112.364 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.723 HG13 ' CD1' ' A' ' 66' ' ' TYR . 3.4 t -148.83 102.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 3.0800000000000001 109.386 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -73.72 119.87 6.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.595 -1.402 . . . . 3.0499999999999998 109.595 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.539 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 15.7 tt0 -58.63 125.37 23.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.136 . . . . 6.0499999999999998 109.53 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 132.85 -47.56 1.0 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.679 -1.368 . . . . 2.54 109.679 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.8 mt-10 -99.8 166.89 10.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -1.15 . . . . 4.0300000000000002 109.594 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.46 134.32 49.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 2.9100000000000001 109.434 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.723 ' CD1' HG13 ' A' ' 60' ' ' VAL . 38.1 m-85 -97.22 -179.09 4.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 2.3799999999999999 109.499 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -154.71 139.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 2.6099999999999999 109.576 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HA ' HD12 ' A' ' 68' ' ' LEU . 9.3 tp -120.88 118.17 29.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 3.6099999999999999 109.416 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.04 83.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.577 -0.898 . . . . 2.27 108.577 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 28.0 p90 -93.73 143.14 26.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.855 . . . . 2.0099999999999998 111.358 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -89.33 130.59 35.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.488 -0.93 . . . . 1.8 108.488 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.798 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -170.29 135.19 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.891 -1.13 . . . . 0.95999999999999996 110.254 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.9 p -119.82 122.91 42.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.821 . . . . 0.93000000000000005 108.946 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.879 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -85.57 125.74 33.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.67000000000000004 109.565 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -138.76 113.63 8.5 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.271 -0.893 . . . . 0.96999999999999997 109.75 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.3 Cg_exo -64.54 -141.81 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.624 0 C-N-CA 124.349 -1.104 . . . . 1.02 112.276 -0.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -99.17 151.03 21.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 1.75 109.825 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.511 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.35 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.861 -0.792 . . . . 2.1600000000000001 108.861 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.12 168.94 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.829 2.353 . . . . 1.3799999999999999 112.86 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 100' ' ' ALA . 2.9 m -137.21 170.85 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 2.0099999999999998 109.128 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.715 ' HD3' ' HZ1' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -116.4 105.52 12.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 6.0099999999999998 109.771 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.87 159.43 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.261 -0.9 . . . . 3.7599999999999998 109.219 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -157.69 149.65 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 2.29 109.834 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.51 ' CG1' HG21 ' A' ' 58' ' ' VAL . 1.1 t -149.13 155.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 1.8899999999999999 109.701 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.96 -133.27 5.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.563 -1.415 . . . . 1.49 109.563 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.4 pm0 -90.08 -179.07 5.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 2.54 109.384 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 1.3799999999999999 109.546 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.557 ' O ' ' CE1' ' A' ' 119' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.299 0.571 . . . . 5.7400000000000002 110.011 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.44 161.03 13.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.287 -0.883 . . . . 2.27 110.081 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -119.91 -14.14 8.97 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.733 -0.84 . . . . 3.2799999999999998 108.733 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.755 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.56 36.03 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.381 -0.825 . . . . 3.6499999999999999 108.916 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -80.67 70.99 7.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 4.5999999999999996 109.624 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.86 111.01 23.35 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 3.46 108.851 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.13 13.27 55.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 3.6699999999999999 109.711 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.92 67.52 0.78 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.174 -1.192 . . . . 3.79 109.824 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -107.32 99.76 29.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.074 -1.016 . . . . 1.96 109.288 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.83 135.99 11.69 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.606 2.204 . . . . 2.9700000000000002 112.673 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 74' ' ' ALA . 94.2 mt -142.15 131.11 23.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 3.0600000000000001 109.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 105' ' ' GLU . 9.8 t -92.41 -165.56 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 109.491 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.19 33.9 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.499 -1.44 . . . . 2.1699999999999999 109.499 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.505 ' H ' HG23 ' A' ' 103' ' ' THR . 8.7 pt-20 -121.53 138.48 28.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.248 -1.148 . . . . 3.02 109.433 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.27 120.5 6.01 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.593 2.195 . . . . 1.4199999999999999 112.069 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.678 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -171.03 160.43 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 1.3700000000000001 109.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.593 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.93 149.07 22.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 1.72 109.687 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.798 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -114.3 136.43 52.98 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.745 -1.206 . . . . 4.7000000000000002 107.745 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -114.34 107.94 16.24 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.848 -0.741 . . . . 3.2799999999999998 110.706 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 8.0 m-85 -109.77 115.98 30.84 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.374 -0.972 . . . . 2.96 108.374 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -101.71 142.63 32.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.831 . . . . 3.4100000000000001 109.712 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.92 163.94 26.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 2.77 109.413 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.5 109.34 21.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 2.23 109.798 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.7 m -56.23 105.66 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.287 -0.883 . . . . 4.1100000000000003 109.193 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.85 ' O ' HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -108.8 -10.31 15.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 6.8600000000000003 109.616 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -136.59 126.5 25.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 5.1200000000000001 109.531 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.64 117.72 5.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 4.0599999999999996 109.372 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.557 ' CE1' ' O ' ' A' ' 92' ' ' ARG . 57.9 m-85 -120.78 66.74 13.9 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 5.4400000000000004 109.588 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.78 166.58 27.15 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.783 2.322 . . . . 4.04 112.154 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 65.6 Cg_endo -79.87 -13.2 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.853 2.369 . . . . 3.8999999999999999 112.003 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -109.57 -12.71 14.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.331 -0.855 . . . . 4.1399999999999997 109.642 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.06 -70.95 0.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 3.5699999999999998 109.423 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 1.4 m-20 -129.75 -7.21 4.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 3.5899999999999999 109.387 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -179.96 150.02 0.53 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 2.0800000000000001 109.377 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HA ' ' CA ' ' A' ' 121' ' ' PRO . 10.4 Cg_endo -57.23 -7.11 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.943 2.429 . . . . 1.3899999999999999 112.217 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.12 172.37 12.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 1.1899999999999999 109.56 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.766 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 6.5 tp-100 -153.81 140.29 18.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 2.0099999999999998 109.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 84' ' ' VAL . 3.6 t -153.68 87.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.374 -0.973 . . . . 1.28 108.374 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.533 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -97.4 123.44 41.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.97999999999999998 110.532 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.58 81.52 1.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.61 -0.885 . . . . 1.73 108.61 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 81' ' ' ARG . 32.4 m170 -99.65 136.27 39.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 2.3199999999999998 109.956 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -131.05 -5.47 3.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.343 -0.848 . . . . 2.1099999999999999 109.353 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -43.26 124.41 4.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.473 -1.451 . . . . 1.77 109.473 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.715 ' HZ1' ' HD3' ' A' ' 81' ' ' ARG . 15.6 mttp -163.93 128.21 2.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 5.0599999999999996 109.74 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.62 -14.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.294 -1.002 . . . . 2.6400000000000001 108.294 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -118.16 3.15 16.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.227 -1.549 . . . . 2.5099999999999998 109.227 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -51.42 -161.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -1.07 . . . . 2.3199999999999998 109.647 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.879 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -168.35 -113.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.051 -1.031 . . . . 1.6100000000000001 110.24 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -125.85 139.82 53.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 1.6499999999999999 109.127 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.3 t80 -121.36 107.61 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 1.6799999999999999 109.79 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.17 91.29 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.73999999999999999 109.863 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.642 HD13 HD21 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -107.87 141.88 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 1.22 109.072 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.2 p -138.48 -0.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.56 -0.712 . . . . 1.3300000000000001 109.443 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.642 ' N ' ' OG1' ' A' ' 71' ' ' THR . 2.5 mt-30 -149.57 160.94 43.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.975 . . . . 3.2999999999999998 110.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.833 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.9 p -166.64 103.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.83 . . . . 2.2599999999999998 109.44 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.3 144.18 36.16 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 2.7599999999999998 109.624 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 149' ' ' THR . 1.3 tp -134.21 113.49 12.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 4.5700000000000003 109.337 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.679 ' N ' HD12 ' A' ' 148' ' ' LEU . 9.0 t -155.76 -166.35 2.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 3.0699999999999998 109.54 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 2.0 109.417 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.589 ' N ' ' HG1' ' A' ' 149' ' ' THR . 20.2 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.399 -0.593 . . . . 2.8300000000000001 109.399 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' OE2' ' OG ' ' A' ' 147' ' ' SER . 7.7 tp10 -65.26 109.86 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 4.75 109.578 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -32.68 39.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 4.9500000000000002 109.328 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.939 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -113.02 96.06 36.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 2.8599999999999999 109.073 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.02 38.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.844 2.363 . . . . 3.8300000000000001 112.852 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.679 ' N ' ' O ' ' A' ' 10' ' ' LEU . 27.7 t60 -129.81 131.42 46.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 2.52 109.316 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 56.17 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 1.97 109.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 16' ' ' ALA . 8.3 t -158.57 68.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 1.96 109.711 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -65.48 34.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 1.76 108.949 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -81.56 -33.38 31.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.1799999999999999 109.85 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.587 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 14.9 mm-40 -109.84 -70.2 0.82 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.137 -0.977 . . . . 2.1299999999999999 109.556 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 20' ' ' GLY . 49.8 m -107.49 144.08 34.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 2.2599999999999998 109.462 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -61.9 12.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 2.6000000000000001 109.703 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.626 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 66.23 177.12 7.5 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.83 -1.308 . . . . 1.6200000000000001 109.83 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.04 10.97 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.687 2.258 . . . . 1.7 112.204 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.795 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.2 m0 -74.41 -174.15 1.94 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 2.4199999999999999 109.501 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.405 ' CB ' HG13 ' A' ' 54' ' ' VAL . 1.6 m -117.3 145.78 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 1.6399999999999999 109.287 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.633 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 6.4 tt -151.67 143.86 23.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 2.0499999999999998 110.407 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.711 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.34 175.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.587 -0.696 . . . . 1.72 109.479 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.12 -23.35 18.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.967 -1.253 . . . . 1.7 109.967 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.72 -142.98 0.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.252 . . . . 0.96999999999999997 109.339 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.3 p -91.72 -164.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 1.8 109.223 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 29' ' ' GLU . 3.4 tm-20 -90.12 111.33 46.2 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 2.3999999999999999 108.774 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.471 ' CG ' HD22 ' A' ' 24' ' ' LEU . 72.9 Cg_exo -43.32 147.48 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.24 1.96 . . . . 1.1299999999999999 112.009 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 37' ' ' MET . 3.8 t -129.98 95.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.05 109.866 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.97 88.25 4.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.8200000000000001 109.451 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -74.02 -140.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 1.1699999999999999 109.952 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' A' ' 33' ' ' ALA . 24.4 t70 -35.33 -87.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 2.21 109.523 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -131.28 36.87 2.17 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.621 -1.391 . . . . 1.1899999999999999 109.621 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.34 157.48 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -1.2 . . . . 2.9100000000000001 109.579 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.615 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -129.51 135.27 48.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.324 -0.86 . . . . 0.93000000000000005 109.333 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 143.23 50.66 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.479 -0.888 . . . . 1.0600000000000001 110.281 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -113.62 144.15 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.796 -0.816 . . . . 1.3700000000000001 108.796 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.658 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -76.84 106.26 8.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 4.79 109.624 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.4 mm? -116.41 81.53 11.07 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 3.54 109.344 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.865 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 50.7 Cg_exo -49.54 -144.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.944 2.429 . . . . 3.7400000000000002 112.275 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.04 70.33 0.29 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 2.0299999999999998 109.557 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.05 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.554 -1.419 . . . . 2.4100000000000001 109.554 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 46' ' ' GLY . 2.8 mt-30 -99.99 91.51 4.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 2.96 109.428 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -39.66 -43.64 2.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.558 -1.417 . . . . 2.0800000000000001 109.558 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.718 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -99.89 128.57 30.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.247 -1.149 . . . . 3.6099999999999999 109.382 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.28 -26.17 7.75 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.499 2.133 . . . . 2.3599999999999999 112.626 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.656 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -92.02 34.18 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.976 . . . . 3.8700000000000001 109.868 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.656 ' OD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.9 OUTLIER -100.19 1.76 42.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 2.3799999999999999 109.676 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.5 -173.52 1.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 1.1100000000000001 109.713 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.29 -171.77 14.29 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.486 -1.446 . . . . 0.93999999999999995 109.486 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.3 pp -115.89 140.71 48.97 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.244 -1.15 . . . . 0.95999999999999996 109.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -128.22 163.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.92000000000000004 109.614 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.939 ' CE2' HD12 ' A' ' 10' ' ' LEU . 20.2 t80 -159.82 155.42 25.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 1.71 109.444 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.694 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -113.09 -164.29 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.201 -0.937 . . . . 2.7799999999999998 109.471 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.691 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 73.95 69.57 1.37 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 2.48 109.365 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 HD21 ' A' ' 148' ' ' LEU . 49.0 t -162.05 96.85 1.21 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 3.79 109.447 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.15 121.92 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.652 2.235 . . . . 2.3999999999999999 112.09 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 73.0 t -103.33 155.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 3.0800000000000001 109.594 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 60' ' ' VAL . . . -162.67 129.29 2.02 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.614 -1.394 . . . . 3.0499999999999998 109.614 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.691 ' N ' ' OG ' ' A' ' 115' ' ' SER . 1.7 pp20? -61.28 -161.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -1.104 . . . . 6.0499999999999998 109.383 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 62' ' ' GLU . . . 62.22 -49.19 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 2.54 109.67 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.3 mm-40 -99.76 160.3 14.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 4.0300000000000002 109.261 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.8 m -112.94 146.4 39.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 2.9100000000000001 109.683 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.681 ' CD2' ' OG1' ' A' ' 150' ' ' THR . 81.1 m-85 -106.14 174.33 5.93 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.238 -0.914 . . . . 2.3799999999999999 109.803 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.5 t -152.19 128.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.524 -0.735 . . . . 2.6099999999999999 109.247 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 109' ' ' ARG . 6.7 tp -114.8 116.8 29.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.092 -1.005 . . . . 3.6099999999999999 109.851 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.78 81.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 2.27 108.83 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 12.5 p90 -93.67 138.63 31.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.0099999999999998 111.139 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.668 HG23 ' CG2' ' A' ' 108' ' ' THR . 0.7 OUTLIER -86.88 133.09 33.65 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.642 -0.873 . . . . 1.8 108.642 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -173.83 128.29 0.4 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.98 -1.075 . . . . 0.95999999999999996 110.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -111.24 122.41 47.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.93000000000000005 108.873 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.79 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -80.91 129.74 34.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.67000000000000004 109.652 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.526 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -142.73 111.67 5.78 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.332 -0.855 . . . . 0.96999999999999997 109.594 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.56 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.0 Cg_exo -63.81 -141.82 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.248 -1.146 . . . . 1.02 112.372 -0.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -106.62 155.74 19.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.75 109.701 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.51 167.22 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 2.1600000000000001 108.942 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -84.7 149.29 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.779 2.319 . . . . 1.3799999999999999 112.59 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.636 HG22 ' HB3' ' A' ' 100' ' ' ALA . 1.2 m -125.61 179.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.895 . . . . 2.0099999999999998 109.315 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -127.96 97.95 4.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 6.0099999999999998 109.816 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -99.6 143.17 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.37 -0.831 . . . . 3.7599999999999998 108.845 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.602 HD21 ' CE1' ' A' ' 132' ' ' HIS . 2.1 pp -145.63 156.71 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 2.29 109.988 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -155.07 146.99 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 1.8899999999999999 109.345 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 170.16 -148.74 11.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.711 -1.356 . . . . 1.49 109.711 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.706 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.12 -161.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -1.119 . . . . 2.54 109.456 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.496 -1.442 . . . . 1.3799999999999999 109.496 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.539 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.433 -0.58 . . . . 5.7400000000000002 109.433 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -116.39 164.85 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 2.27 109.969 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.497 ' HB1' ' HE2' ' A' ' 113' ' ' PHE . . . -109.93 -21.19 12.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.757 -0.831 . . . . 3.2799999999999998 108.757 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' HG23 ' A' ' 84' ' ' VAL . 2.1 t80 -90.66 38.13 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.497 -0.927 . . . . 3.6499999999999999 108.497 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.68 114.55 19.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 4.5999999999999996 109.932 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.499 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -141.06 132.98 27.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 3.46 108.725 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -121.65 9.32 9.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.776 -1.33 . . . . 3.6699999999999999 109.776 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.35 65.31 0.76 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -1.169 . . . . 3.79 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.636 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.89 94.9 21.66 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 1.96 109.152 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.9 133.93 10.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.745 2.297 . . . . 2.9700000000000002 112.793 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 109' ' ' ARG . 35.6 mt -136.92 137.17 39.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 3.0600000000000001 109.144 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 9.0 t -96.87 -155.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.935 . . . . 2.3399999999999999 109.509 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -104.46 56.86 0.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 2.1699999999999999 109.542 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -150.85 150.47 27.97 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.299 -1.118 . . . . 3.02 109.433 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 118.33 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.717 2.278 . . . . 1.4199999999999999 112.137 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.831 ' HB3' HH22 ' A' ' 109' ' ' ARG . . . -166.39 147.3 6.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 1.3700000000000001 109.543 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.668 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.41 144.45 25.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.72 109.797 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.831 HH22 ' HB3' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -105.14 134.18 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.939 -1.134 . . . . 4.7000000000000002 107.939 178.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -109.54 105.27 14.53 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.92 -0.712 . . . . 3.2799999999999998 110.163 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.499 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 39.0 m-85 -109.6 102.29 11.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.448 -0.945 . . . . 2.96 108.448 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -110.47 166.41 11.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.301 -0.874 . . . . 3.4100000000000001 109.901 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.509 ' O ' ' CB ' ' A' ' 65' ' ' SER . 2.3 p90 -177.67 -162.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 2.77 109.237 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -123.05 143.05 50.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.339 -0.85 . . . . 2.23 109.38 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.691 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -86.89 161.56 18.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 4.1100000000000003 109.678 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -127.86 -15.28 4.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 6.8600000000000003 109.602 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.574 HD23 ' CE2' ' A' ' 119' ' ' PHE . 1.6 tp -123.43 155.63 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 5.1200000000000001 109.543 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 109.33 21.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 4.0599999999999996 109.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.574 ' CE2' HD23 ' A' ' 117' ' ' LEU . 23.8 m-85 -114.77 92.46 29.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.892 . . . . 5.4400000000000004 109.58 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.23 165.9 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.774 2.316 . . . . 4.04 112.122 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.11 -22.74 7.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.796 2.331 . . . . 3.8999999999999999 111.989 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.03 115.27 29.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.842 . . . . 4.1399999999999997 109.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 147.07 -136.53 6.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 3.5699999999999998 109.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' GLY . 10.8 m-20 -43.79 -85.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -1.136 . . . . 3.5899999999999999 109.458 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -129.86 149.7 73.8 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 2.0800000000000001 109.458 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.24 -158.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.722 2.281 . . . . 1.3899999999999999 112.244 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.524 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -65.37 163.27 39.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.482 -1.447 . . . . 1.1899999999999999 109.482 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.16 153.05 38.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -1.107 . . . . 2.0099999999999998 109.682 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.443 HG23 ' C ' ' A' ' 128' ' ' GLN . 45.7 t -155.84 131.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.187 -1.042 . . . . 1.28 108.187 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -139.65 100.09 3.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.888 -1.132 . . . . 0.97999999999999998 110.531 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD2' HD11 ' A' ' 53' ' ' LEU . 2.9 m-30 -85.04 99.23 10.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.522 -0.918 . . . . 1.73 108.522 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.602 ' CE1' HD21 ' A' ' 83' ' ' LEU . 41.6 m170 -99.77 136.1 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 2.3199999999999998 109.816 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -132.73 -36.47 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 2.1099999999999999 109.397 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -40.8 116.59 0.85 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 1.77 109.426 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.945 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 6.6 mtpp -163.83 149.62 11.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 5.0599999999999996 109.631 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -42.91 -15.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 2.6400000000000001 108.475 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -114.43 -4.14 22.06 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.259 -1.536 . . . . 2.5099999999999998 109.259 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.945 ' HB2' ' H ' ' A' ' 135' ' ' LYS . . . -42.96 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -1.082 . . . . 2.3199999999999998 109.485 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.79 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -168.68 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 1.6100000000000001 109.876 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -124.17 134.07 53.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 1.6499999999999999 108.911 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.1 t80 -114.79 105.89 13.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.06 -1.025 . . . . 1.6799999999999999 109.736 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.95 87.77 3.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.73999999999999999 109.888 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 140.68 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 1.22 109.058 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.436 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 42.6 p -137.56 -1.0 2.11 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.667 -0.646 . . . . 1.3300000000000001 109.453 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.566 ' N ' ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -151.26 167.27 28.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 3.2999999999999998 109.881 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 146' ' ' VAL . 2.9 p -175.73 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 2.2599999999999998 109.416 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.524 ' OG ' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -131.53 131.3 43.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 2.7599999999999998 109.778 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.694 HD21 HG13 ' A' ' 58' ' ' VAL . 5.2 tp -110.4 118.86 37.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 4.5700000000000003 109.324 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -123.19 175.19 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 3.0699999999999998 109.502 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.681 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.0 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 150' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.359 -0.608 . . . . 2.8300000000000001 109.359 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -134.06 96.33 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 4.75 109.531 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 9' ' ' LEU . 12.4 mt -66.03 -40.78 91.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 4.9500000000000002 109.403 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.838 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -114.92 94.21 37.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.853 . . . . 2.8599999999999999 109.004 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 45.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.791 2.327 . . . . 3.8300000000000001 112.557 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 10' ' ' LEU . 34.1 t60 -137.94 130.78 29.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.023 . . . . 2.52 109.575 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 t -170.08 70.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 1.97 109.376 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.5 m -164.66 63.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.96 109.629 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.824 ' CD2' HD11 ' A' ' 143' ' ' ILE . 4.3 m-30 -67.73 27.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.76 109.118 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.706 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.09 -40.05 12.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.1799999999999999 109.867 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 13.4 mm-40 -109.71 -73.09 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 2.1299999999999999 109.671 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -88.04 145.55 25.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 2.2599999999999998 109.445 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' SD ' ' A' ' 37' ' ' MET . 7.1 mt -62.17 -59.22 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 2.6000000000000001 109.437 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.28 169.92 14.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 1.6200000000000001 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.445 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 43.2 Cg_endo -72.2 5.04 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.852 2.368 . . . . 1.7 112.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.978 ' CH2' HG21 ' A' ' 146' ' ' VAL . 10.8 m95 -76.17 -175.47 3.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.4199999999999999 109.463 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 1.6399999999999999 109.237 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.054 ' O ' HD12 ' A' ' 24' ' ' LEU . 3.3 pp -142.84 131.96 23.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 2.0499999999999998 109.433 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.12 170.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 1.72 109.782 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.88 -31.09 8.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.029 -1.229 . . . . 1.7 110.029 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.82 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.97 -142.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.271 . . . . 0.96999999999999997 109.417 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.82 ' N ' ' OG1' ' A' ' 27' ' ' THR . 90.1 p -90.81 138.53 31.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.975 . . . . 1.8 109.45 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 28' ' ' SER . 4.9 mt-10 -41.38 104.19 0.33 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 2.3999999999999999 109.179 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HG2' HD22 ' A' ' 24' ' ' LEU . 51.3 Cg_exo -46.78 156.73 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.366 2.044 . . . . 1.1299999999999999 111.854 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -143.42 122.04 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 1.05 110.09 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.715 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.62 85.26 3.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 1.8200000000000001 109.501 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 1.1699999999999999 109.761 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.24 -67.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 2.21 109.522 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.706 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.49 48.48 0.75 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.629 -1.389 . . . . 1.1899999999999999 109.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.58 ' HB2' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -170.69 148.48 2.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.126 -1.22 . . . . 2.9100000000000001 109.657 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 19' ' ' LEU . 36.4 ttp -109.77 128.63 55.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.93000000000000005 109.107 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -123.46 159.97 27.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.2 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m -128.88 134.51 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.901 -0.777 . . . . 1.3700000000000001 108.901 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.612 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -73.57 106.51 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.825 . . . . 4.79 109.705 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.2 mm? -118.15 61.04 4.01 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.276 -0.89 . . . . 3.54 109.334 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.37 -91.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.726 2.284 . . . . 3.7400000000000002 112.283 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -150.89 158.88 27.89 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.516 -1.434 . . . . 2.0299999999999998 109.516 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.92 42.59 1.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 2.4100000000000001 109.459 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.693 HE21 ' C ' ' A' ' 134' ' ' GLY . 3.8 mm100 -99.87 148.26 24.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 2.96 109.297 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.94 -69.59 0.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.959 -1.256 . . . . 2.0800000000000001 109.959 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.686 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.8 p30 -99.79 145.26 29.85 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.129 -1.218 . . . . 3.6099999999999999 109.616 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.75 -20.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.892 2.395 . . . . 2.3599999999999999 112.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.686 ' CE3' ' OD1' ' A' ' 47' ' ' ASN . 1.3 p-90 -119.49 36.94 4.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 3.8700000000000001 110.355 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 8.5 m-20 -79.81 -0.35 34.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.091 -1.005 . . . . 2.3799999999999999 109.097 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 27' ' ' THR . . . -166.43 126.61 1.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 1.1100000000000001 109.315 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.489 ' C ' HD23 ' A' ' 53' ' ' LEU . . . 169.0 -173.91 43.51 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.84 -1.304 . . . . 0.93999999999999995 109.84 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.591 ' C ' HG22 ' A' ' 54' ' ' VAL . 5.3 mt -106.9 -178.02 3.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.148 . . . . 0.95999999999999996 109.545 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -165.54 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.92000000000000004 109.707 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.977 ' O ' HG12 ' A' ' 129' ' ' VAL . 37.6 t80 -179.77 137.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 1.71 109.396 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.513 HD21 ' HG2' ' A' ' 128' ' ' GLN . 1.1 m-80 -119.05 86.11 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.248 -0.907 . . . . 2.7799999999999998 109.518 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.23 66.56 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 2.48 109.591 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 58' ' ' VAL . 2.5 p -166.01 85.51 0.96 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.248 -1.148 . . . . 3.79 109.528 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.57 175.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.781 2.32 . . . . 2.3999999999999999 112.212 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.427 HG21 ' HD2' ' A' ' 119' ' ' PHE . 58.1 t -136.91 131.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 3.0800000000000001 109.507 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -117.11 80.53 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 3.0499999999999998 109.475 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 61' ' ' GLY . 28.6 tt0 -35.23 118.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -1.087 . . . . 6.0499999999999998 109.589 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 129.15 -39.48 1.84 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.646 -1.382 . . . . 2.54 109.646 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.9 mt-10 -99.94 173.06 6.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 4.0300000000000002 109.62 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.5 m -119.34 143.63 47.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 2.9100000000000001 109.326 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.642 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 27.5 m-85 -108.81 -178.39 3.57 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 2.3799999999999999 109.659 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.8 t -151.7 158.36 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 2.6099999999999999 109.497 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.586 HD12 HD22 ' A' ' 148' ' ' LEU . 11.7 tp -143.05 112.01 6.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 3.6099999999999999 109.68 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.31 86.81 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 2.27 108.787 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.9 p90 -93.98 141.51 28.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 2.0099999999999998 111.16 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 2.7 p -84.82 88.55 7.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 1.8 108.3 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -129.68 156.96 43.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.117 . . . . 0.95999999999999996 110.756 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.8 p -147.36 120.11 8.64 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.596 -0.89 . . . . 0.93000000000000005 108.596 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.595 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -88.13 133.36 34.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.67000000000000004 109.839 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.456 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.8 116.9 16.05 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.431 -0.793 . . . . 0.96999999999999997 109.078 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.595 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -66.07 -142.53 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.676 0 C-N-CA 124.29 -1.129 . . . . 1.02 112.551 -0.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.652 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -106.86 154.79 20.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 1.75 109.724 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.8 mtm 167.08 169.67 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.778 . . . . 2.1600000000000001 109.092 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.15 131.65 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.872 2.381 . . . . 1.3799999999999999 112.55 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.956 HG12 ' OH ' ' A' ' 139' ' ' TYR . 1.2 m -107.26 174.03 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 2.0099999999999998 109.279 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -126.48 98.29 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 6.0099999999999998 109.804 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -102.68 155.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.27 -0.894 . . . . 3.7599999999999998 109.165 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.863 HD21 ' CE1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -147.69 157.98 43.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 2.29 109.798 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.4 OUTLIER -151.98 164.4 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 1.8899999999999999 109.38 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 146.73 -159.24 27.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.612 -1.395 . . . . 1.49 109.612 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.684 ' OE1' ' CE1' ' A' ' 119' ' ' PHE . 7.3 pt-20 -90.2 -155.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.129 . . . . 2.54 109.45 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.51 ' C ' ' HB1' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.567 -1.413 . . . . 1.3799999999999999 109.567 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.619 ' CZ ' ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.53 -0.545 . . . . 5.7400000000000002 109.53 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -111.34 172.16 7.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 2.27 109.988 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.76 -18.99 5.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.892 -0.781 . . . . 3.2799999999999998 108.892 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.94 34.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 3.6499999999999999 109.308 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 82.18 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 4.5999999999999996 109.428 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 98' ' ' GLY . 2.1 tt0 -103.41 156.86 17.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 3.46 109.093 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -146.24 7.86 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.696 -1.362 . . . . 3.6699999999999999 109.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -120.69 75.62 1.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.167 -1.196 . . . . 3.79 109.78 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.704 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -120.34 86.51 38.74 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 1.96 109.242 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.641 ' O ' HD22 ' A' ' 102' ' ' LEU . 13.1 Cg_exo -66.52 127.54 17.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.149 2.566 . . . . 2.9700000000000002 112.82 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 101' ' ' PRO . 3.5 mm? -118.57 147.61 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 3.0600000000000001 108.999 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.578 ' O ' ' O ' ' A' ' 74' ' ' ALA . 5.0 t -97.61 -170.58 2.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 2.3399999999999999 109.828 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 105' ' ' GLU . . . -103.72 36.34 4.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.691 -1.364 . . . . 2.1699999999999999 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' H ' HG23 ' A' ' 103' ' ' THR . 71.3 mt-10 -156.09 148.21 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 3.02 109.262 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -40.8 118.26 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.696 2.264 . . . . 1.4199999999999999 112.143 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.663 ' HB1' ' NH1' ' A' ' 109' ' ' ARG . . . -160.9 138.34 9.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 1.3700000000000001 109.648 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.531 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.54 151.51 21.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 1.72 109.907 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.663 ' NH1' ' HB1' ' A' ' 107' ' ' ALA . 3.7 mpt_? -124.36 142.14 51.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 4.7000000000000002 108.029 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.63 104.67 12.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 3.2799999999999998 110.757 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.561 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 8.8 m-30 -109.88 120.11 41.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.499 -0.926 . . . . 2.96 108.499 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.655 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -124.95 169.65 11.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 3.4100000000000001 109.67 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.5 p90 -155.23 -177.76 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 2.77 109.499 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.535 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -111.4 106.14 14.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.364 -0.835 . . . . 2.23 109.558 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.535 ' C ' ' O ' ' A' ' 114' ' ' THR . 3.8 m -36.01 129.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 4.1100000000000003 109.347 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.469 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 10.9 m120 -125.17 -7.21 7.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 6.8600000000000003 109.507 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -148.94 129.98 14.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 5.1200000000000001 109.424 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.471 ' N ' HD13 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -80.26 113.25 18.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 4.0599999999999996 109.551 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CE1' ' OE1' ' A' ' 86' ' ' GLU . 44.6 m-85 -110.02 146.94 35.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 5.4400000000000004 109.353 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.47 166.3 30.22 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.691 2.261 . . . . 4.04 112.163 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 126' ' ' PRO . 73.4 Cg_endo -81.02 -39.72 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.777 2.318 . . . . 3.8999999999999999 112.071 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -122.44 -150.93 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.874 . . . . 4.1399999999999997 109.478 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.08 -142.54 15.66 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.572 -1.411 . . . . 3.5699999999999998 109.572 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -114.33 10.94 17.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -1.094 . . . . 3.5899999999999999 109.447 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.51 ' HB1' ' C ' ' A' ' 87' ' ' GLY . . . -165.75 54.22 0.33 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 2.0800000000000001 109.545 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 55.1 Cg_endo -74.09 -158.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.846 2.364 . . . . 1.3899999999999999 112.223 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 126' ' ' PRO . . . -39.97 155.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.627 -1.389 . . . . 1.1899999999999999 109.627 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -155.2 137.85 15.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -1.159 . . . . 2.0099999999999998 109.553 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.977 HG12 ' O ' ' A' ' 55' ' ' TYR . 8.3 p -153.48 149.34 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.674 -0.861 . . . . 1.28 108.674 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -159.13 115.57 2.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.033 . . . . 0.97999999999999998 110.207 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.563 ' HA ' HG12 ' A' ' 82' ' ' VAL . 6.8 m-30 -85.63 105.29 16.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 1.73 108.435 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.863 ' CE1' HD21 ' A' ' 83' ' ' LEU . 56.9 m170 -99.43 121.24 40.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 2.3199999999999998 109.757 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.86 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -152.17 66.7 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 2.1099999999999999 109.496 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.693 ' C ' HE21 ' A' ' 45' ' ' GLN . . . -157.11 103.91 0.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 1.77 109.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -153.48 -175.34 5.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 5.0599999999999996 109.638 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -44.87 -12.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.34 -0.985 . . . . 2.6400000000000001 108.34 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -113.33 1.94 25.17 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.345 -1.502 . . . . 2.5099999999999998 109.345 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -37.44 165.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.392 -1.064 . . . . 2.3199999999999998 109.656 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.956 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -161.21 -108.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 1.6100000000000001 109.555 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -138.66 139.61 38.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 1.6499999999999999 109.111 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.659 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 30.7 t80 -124.34 120.4 32.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.062 -1.024 . . . . 1.6799999999999999 109.921 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.87 101.74 8.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.73999999999999999 109.893 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.824 HD11 ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -100.82 135.66 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.22 109.013 179.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.57 ' OG ' ' OG1' ' A' ' 71' ' ' THR . 3.5 p -109.16 -21.28 12.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.902 -0.777 . . . . 1.3300000000000001 108.902 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.68 ' N ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -170.43 -174.94 1.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.256 -0.978 . . . . 3.2999999999999998 110.533 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.978 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.8 p -161.42 108.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.872 -0.788 . . . . 2.2599999999999998 108.872 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.11 143.27 33.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 2.7599999999999998 110.197 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.586 HD22 HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -123.9 110.27 14.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.46 -0.775 . . . . 4.5700000000000003 109.039 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.551 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -131.58 167.79 18.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 3.0699999999999998 109.808 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.495 ' H ' HG12 ' A' ' 7' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 2.0 109.328 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.788 ' N ' ' HG1' ' A' ' 149' ' ' THR . 1.4 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.422 -0.584 . . . . 2.8300000000000001 109.422 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.46 109.02 11.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 4.75 109.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.455 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -77.79 -50.1 13.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 4.9500000000000002 109.318 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.732 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -96.55 108.6 43.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 2.8599999999999999 109.352 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.7 29.13 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.089 1.86 . . . . 3.8300000000000001 111.624 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.672 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 19.4 t60 -124.36 72.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 2.52 109.586 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 5.7 t -112.06 41.67 1.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 1.97 109.318 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.623 ' C ' ' H ' ' A' ' 16' ' ' ALA . 32.7 m -127.0 64.94 1.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 1.96 109.779 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.573 ' CE1' ' NE2' ' A' ' 12' ' ' HIS . 3.5 m-85 -67.2 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.76 109.029 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.623 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.12 -20.49 23.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.1799999999999999 110.113 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.464 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 34.2 mt-10 -109.9 -83.91 0.56 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.02 -1.05 . . . . 2.1299999999999999 109.948 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 m -104.94 151.77 23.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 2.2599999999999998 109.628 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -47.99 62.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 2.6000000000000001 109.423 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 102.54 -173.03 22.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.725 -1.35 . . . . 1.6200000000000001 109.725 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 36.0 Cg_endo -69.21 -18.38 39.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 1.7 112.194 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.732 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 11.2 m0 -56.79 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 2.4199999999999999 109.139 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 1.6 m -151.43 136.78 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.6399999999999999 109.599 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 25' ' ' TYR . 9.3 tt -133.28 152.74 51.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 2.0499999999999998 109.574 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.87 177.43 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 1.72 109.444 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 93.03 -30.33 7.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.831 -1.307 . . . . 1.7 109.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.829 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.96 -141.96 0.38 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -1.185 . . . . 0.96999999999999997 109.276 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.829 ' N ' ' OG1' ' A' ' 27' ' ' THR . 23.7 p -90.68 140.27 29.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.171 -0.956 . . . . 1.8 108.989 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 2.6 mp0 -36.95 128.67 0.75 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 2.3999999999999999 109.102 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HG3' HD22 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -71.73 158.75 52.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.262 1.975 . . . . 1.1299999999999999 111.681 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -145.83 116.28 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.025 -1.047 . . . . 1.05 110.589 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -71.17 72.64 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 1.8200000000000001 109.14 178.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -73.43 -135.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 1.1699999999999999 109.78 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -41.66 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.792 . . . . 2.21 109.34 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 34.52 45.47 0.5 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.7 -1.36 . . . . 1.1899999999999999 109.7 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.656 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -164.01 146.61 9.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.097 -1.237 . . . . 2.9100000000000001 109.812 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.45 ' CG ' ' HB2' ' A' ' 30' ' ' PRO . 11.8 tmm? -108.97 124.77 51.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.93000000000000005 109.121 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 2.0 t -124.79 155.02 40.04 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 1.0600000000000001 110.378 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.751 HG23 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -127.48 164.55 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.459 -0.941 . . . . 1.3700000000000001 108.459 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.541 ' CG ' ' OG ' ' A' ' 28' ' ' SER . 21.0 m-20 -99.09 112.69 24.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 4.79 109.627 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.973 ' N ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.27 84.65 9.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 3.54 109.202 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.42 -92.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.848 2.366 . . . . 3.7400000000000002 112.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' GLY . . . -162.33 -139.99 2.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.439 . . . . 2.0299999999999998 109.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 43' ' ' GLY . . . 35.79 43.09 0.57 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.549 -1.42 . . . . 2.4100000000000001 109.549 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 46' ' ' GLY . 15.6 mm-40 -99.9 129.74 46.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -1.17 . . . . 2.96 109.489 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -35.75 -44.28 0.67 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 2.0800000000000001 109.619 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.669 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -179.95 157.49 0.79 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 3.6099999999999999 109.5 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.4 -34.97 3.39 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.794 2.329 . . . . 2.3599999999999999 112.379 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.684 ' CD1' ' O ' ' A' ' 49' ' ' TRP . 35.5 p90 -101.74 60.86 0.88 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 3.8700000000000001 109.501 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 26.8 m-20 -136.58 0.92 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 2.3799999999999999 109.483 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.41 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -162.58 -170.87 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.1100000000000001 109.459 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 -155.96 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.93999999999999995 109.517 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 53' ' ' LEU . 1.5 pt? -127.04 157.62 39.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.18 -1.188 . . . . 0.95999999999999996 109.66 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 55' ' ' TYR . 1.3 p -138.26 -176.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.92000000000000004 110.102 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.67 ' H ' HG22 ' A' ' 54' ' ' VAL . 30.4 t80 177.93 147.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.34 0.591 . . . . 1.71 109.576 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.82 129.57 56.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.321 -0.862 . . . . 2.7799999999999998 109.48 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' H ' ' HA3' ' A' ' 127' ' ' GLY . . . 147.29 84.03 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.386 -1.486 . . . . 2.48 109.386 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 58' ' ' VAL . 1.3 p -169.88 70.45 0.63 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.111 . . . . 3.79 109.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.688 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.61 159.58 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.824 2.349 . . . . 2.3999999999999999 111.963 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 2.0 t -151.39 85.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.165 -0.959 . . . . 3.0800000000000001 109.723 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.56 ' C ' ' OG ' ' A' ' 115' ' ' SER . . . -88.69 112.22 3.9 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.087 -1.605 . . . . 3.0499999999999998 109.087 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' N ' ' OG ' ' A' ' 115' ' ' SER . 34.5 mt-10 -31.01 135.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.553 -0.969 . . . . 6.0499999999999998 110.037 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 95.37 -16.54 61.06 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.972 -1.251 . . . . 2.54 109.972 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 115' ' ' SER . 17.4 mt-10 -99.89 146.93 26.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 4.0300000000000002 109.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 150' ' ' THR . 4.0 m -111.87 133.63 53.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 2.9100000000000001 109.159 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.688 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 30.8 m-85 -109.7 178.07 4.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.147 -0.97 . . . . 2.3799999999999999 109.921 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.4 t -151.8 165.55 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.504 -0.747 . . . . 2.6099999999999999 109.476 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 148' ' ' LEU . 1.9 tp -147.34 111.13 5.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.868 . . . . 3.6099999999999999 109.476 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.9 p -109.83 93.15 4.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 2.27 109.163 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.92 143.77 26.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.205 -0.935 . . . . 2.0099999999999998 110.679 -179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.5 p -101.58 108.52 20.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.43 -0.952 . . . . 1.8 108.43 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.515 ' O ' HD22 ' A' ' 102' ' ' LEU . . . -154.43 143.4 21.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.789 -1.194 . . . . 0.95999999999999996 110.597 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -113.98 127.22 55.87 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.631 -0.878 . . . . 0.93000000000000005 108.631 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -97.42 129.3 44.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.67000000000000004 110.009 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.459 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.6 115.89 14.82 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.394 -0.816 . . . . 0.96999999999999997 109.156 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -65.85 -142.54 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.435 -1.069 . . . . 1.02 112.489 -0.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -106.2 150.32 25.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 1.75 109.532 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.5 155.11 0.15 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 2.1600000000000001 109.476 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 45.5 Cg_endo -72.94 122.84 8.46 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.825 2.35 . . . . 1.3799999999999999 112.143 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 102' ' ' LEU . 1.5 m -93.85 175.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 2.0099999999999998 109.378 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.74 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.05 145.77 36.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 6.0099999999999998 109.688 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.787 HG13 ' HG2' ' A' ' 97' ' ' GLN . 1.4 p -147.29 152.4 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 3.7599999999999998 109.326 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.473 HD21 ' CE1' ' A' ' 132' ' ' HIS . 2.6 pp -155.43 149.27 25.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 2.29 109.81 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 128' ' ' GLN . 1.1 t -144.7 152.58 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 1.8899999999999999 109.453 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 168.24 -150.24 15.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.758 -1.337 . . . . 1.49 109.758 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.539 ' C ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -90.15 -165.1 1.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -1.064 . . . . 2.54 109.598 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 1.3799999999999999 109.526 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.431 -0.581 . . . . 5.7400000000000002 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -100.25 164.8 11.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 2.27 109.862 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.18 -17.77 10.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.396 -0.815 . . . . 3.2799999999999998 108.829 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.414 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.64 35.38 0.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.362 -0.836 . . . . 3.6499999999999999 109.193 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -77.85 88.43 4.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 4.5999999999999996 109.605 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.787 ' HG2' HG13 ' A' ' 82' ' ' VAL . 4.0 pt20 -121.98 148.81 44.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 3.46 109.353 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.716 ' CA ' ' HE ' ' A' ' 81' ' ' ARG . . . -136.76 30.11 2.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.83 -1.308 . . . . 3.6699999999999999 109.83 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.544 ' O ' ' OH ' ' A' ' 111' ' ' TYR . 1.7 m -115.12 66.72 0.69 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -1.19 . . . . 3.79 109.636 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.89 93.45 17.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 1.96 109.563 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.6 118.42 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.713 2.276 . . . . 2.9700000000000002 112.218 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.714 HD12 HG11 ' A' ' 80' ' ' VAL . 25.3 mt -120.56 155.92 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 3.0600000000000001 109.494 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 1.3 t -110.39 -167.29 1.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 2.3399999999999999 109.616 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -78.98 -25.75 59.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.761 -1.335 . . . . 2.1699999999999999 109.761 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.83 164.01 17.32 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 3.02 109.408 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -43.28 118.73 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.688 2.259 . . . . 1.4199999999999999 112.088 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.514 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . . . -135.26 117.97 16.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 1.3700000000000001 109.746 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.667 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.69 148.98 21.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 1.72 110.21 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.667 ' NH1' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -127.84 139.69 52.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.21 -1.033 . . . . 4.7000000000000002 108.21 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.99 104.87 9.82 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.957 -0.697 . . . . 3.2799999999999998 109.991 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.544 ' OH ' ' O ' ' A' ' 99' ' ' SER . 41.2 m-85 -109.69 129.61 55.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.221 -0.924 . . . . 2.96 108.867 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -129.42 157.01 43.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.833 . . . . 3.4100000000000001 109.775 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.539 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 3.4 p90 -146.28 -178.51 6.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 2.77 109.552 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.57 137.03 47.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.463 -0.773 . . . . 2.23 109.642 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.56 ' OG ' ' C ' ' A' ' 61' ' ' GLY . 22.8 t -64.11 118.39 8.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 4.1100000000000003 109.602 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -18.82 13.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 6.8600000000000003 109.233 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -132.5 -162.6 1.25 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.292 -0.88 . . . . 5.1200000000000001 109.568 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.708 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -118.92 133.82 55.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.266 -0.896 . . . . 4.0599999999999996 109.506 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -153.66 70.57 6.62 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 5.4400000000000004 109.534 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.443 ' HB2' ' H ' ' A' ' 123' ' ' GLY . 39.4 Cg_exo -56.75 169.46 1.8 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.815 2.343 . . . . 4.04 112.009 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.16 -31.41 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.754 2.302 . . . . 3.8999999999999999 112.06 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 123' ' ' GLY . 24.1 t0 -119.25 -11.94 9.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 4.1399999999999997 109.572 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -56.94 -150.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 3.5699999999999998 109.564 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 123' ' ' GLY . 0.5 OUTLIER -36.33 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -1.152 . . . . 3.5899999999999999 109.415 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -115.61 150.11 44.18 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 2.0800000000000001 109.445 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.9 -158.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.761 2.307 . . . . 1.3899999999999999 112.252 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . -82.34 166.62 46.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.552 -1.419 . . . . 1.1899999999999999 109.552 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.68 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -147.25 142.62 27.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 2.0099999999999998 109.867 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 129' ' ' VAL . 5.2 p -163.24 110.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.278 -1.008 . . . . 1.28 108.278 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -118.83 132.27 56.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.97999999999999998 110.871 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.464 ' HB2' ' CD2' ' A' ' 53' ' ' LEU . 4.0 m-30 -101.02 111.83 24.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 1.73 108.199 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.526 ' CE1' ' CB ' ' A' ' 49' ' ' TRP . 58.5 m170 -99.37 131.12 45.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 2.3199999999999998 109.565 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 141' ' ' PHE . 3.0 mt -133.23 -43.45 0.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 109.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -38.79 127.43 1.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.841 -1.304 . . . . 1.77 109.841 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.716 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 31.4 mtmt -164.69 134.79 3.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 5.0599999999999996 109.584 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -40.29 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.389 -0.967 . . . . 2.6400000000000001 108.389 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.13 14.8 7.85 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.047 -1.621 . . . . 2.5099999999999998 109.047 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.716 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -49.5 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -1.038 . . . . 2.3199999999999998 110.062 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.673 ' OH ' HG12 ' A' ' 80' ' ' VAL . 8.3 p90 -160.03 -130.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.004 -1.06 . . . . 1.6100000000000001 109.429 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 22.5 mt-10 -116.93 135.81 53.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 1.6499999999999999 109.33 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 14.8 t80 -118.51 108.45 15.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 1.6799999999999999 110.038 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.504 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 78.7 m -111.94 100.83 9.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.297 -0.877 . . . . 0.73999999999999999 110.003 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.99 143.75 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 1.22 109.086 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' PHE . 6.0 p -131.8 -5.84 3.6 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.64 . . . . 1.3300000000000001 109.275 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.571 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.3 mt-30 -153.85 160.02 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.299 -0.961 . . . . 3.2999999999999998 110.233 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.613 ' N ' ' OG1' ' A' ' 13' ' ' THR . 10.8 p -178.15 124.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.007 -0.738 . . . . 2.2599999999999998 109.007 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.95 135.41 29.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 2.7599999999999998 109.911 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.584 HD11 HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -108.38 144.51 35.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 4.5700000000000003 109.362 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.788 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 2.8 t -164.97 -173.26 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 3.0699999999999998 109.559 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.569 HG23 HG21 ' A' ' 7' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 2.0 109.437 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLU . 58.0 t . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.307 0.575 . . . . 2.8300000000000001 109.523 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -36.07 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 4.75 109.423 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . 12.1 mt -103.82 11.43 35.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.284 -0.885 . . . . 4.9500000000000002 109.679 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.705 ' O ' ' N ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -114.38 113.7 45.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 2.8599999999999999 108.444 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.51 19.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.647 2.232 . . . . 3.8300000000000001 113.66 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.705 ' N ' ' O ' ' A' ' 10' ' ' LEU . 83.5 t60 -170.69 136.89 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.674 -1.266 . . . . 2.52 110.404 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.591 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.3 OUTLIER -170.83 68.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 1.97 109.341 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 13' ' ' THR . 50.5 m -170.31 87.66 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 1.96 110.083 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -90.24 41.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 1.76 109.056 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.22 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 1.1799999999999999 109.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -109.75 39.47 2.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.195 -0.941 . . . . 2.1299999999999999 109.696 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.21 148.89 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 2.2599999999999998 109.53 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 19' ' ' LEU . 1.6 pp -74.06 -10.85 60.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 2.6000000000000001 109.427 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 75.03 -146.81 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.357 -1.497 . . . . 1.6200000000000001 109.357 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 22' ' ' TRP . 64.6 Cg_endo -81.53 -23.1 5.16 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.893 2.396 . . . . 1.7 112.076 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.679 ' CH2' HG11 ' A' ' 146' ' ' VAL . 11.3 m0 -45.94 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 2.4199999999999999 108.896 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -113.53 164.81 13.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 1.6399999999999999 108.985 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' A' ' 30' ' ' PRO . 3.0 mt -156.54 132.63 9.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 2.0499999999999998 109.78 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.733 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 171.63 -167.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 1.72 109.394 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.0 -30.39 0.93 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.754 -1.339 . . . . 1.7 109.754 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.746 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -109.87 -141.12 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -1.186 . . . . 0.96999999999999997 109.445 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.746 ' N ' ' OG1' ' A' ' 27' ' ' THR . 11.4 p -90.92 -162.75 0.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.084 -0.709 . . . . 1.8 109.084 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.4 111.63 48.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 2.3999999999999999 109.134 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.818 ' HG2' HD13 ' A' ' 24' ' ' LEU . 53.0 Cg_exo -50.04 140.87 31.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.167 1.911 . . . . 1.1299999999999999 111.786 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.19 112.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.033 . . . . 1.05 109.898 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.422 ' HA ' ' CB ' ' A' ' 37' ' ' MET . 0.9 OUTLIER -90.03 127.24 36.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 1.8200000000000001 109.349 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -120.8 -110.07 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.955 . . . . 1.1699999999999999 109.62 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 3.4 p-10 -60.28 63.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.96 . . . . 2.21 109.595 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 69.33 -17.51 0.6 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.676 -1.369 . . . . 1.1899999999999999 109.676 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -106.04 170.74 7.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -1.194 . . . . 2.9100000000000001 109.736 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.492 ' CE ' HD11 ' A' ' 24' ' ' LEU . 9.6 ptt? -148.28 166.23 28.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.93000000000000005 109.09 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -146.65 150.79 36.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 1.0600000000000001 110.535 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.907 HG23 HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.97 148.6 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.245 -1.02 . . . . 1.3700000000000001 108.245 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 1.1 m-20 -83.85 105.85 15.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 4.79 109.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.907 HD21 HG23 ' A' ' 39' ' ' VAL . 1.8 mm? -112.97 78.25 2.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 3.54 108.898 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 62.0 Cg_endo -77.26 -159.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.771 2.314 . . . . 3.7400000000000002 112.388 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.87 63.01 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 2.0299999999999998 109.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.26 36.01 0.96 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.451 -1.46 . . . . 2.4100000000000001 109.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 6.1 mm-40 -99.97 112.7 24.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -1.126 . . . . 2.96 109.544 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.673 ' C ' HD22 ' A' ' 47' ' ' ASN . . . -54.75 -10.94 2.51 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.571 -1.412 . . . . 2.0800000000000001 109.571 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.673 HD22 ' C ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -165.85 156.61 11.76 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -1.178 . . . . 3.6099999999999999 109.444 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HG3' ' NH1' ' A' ' 81' ' ' ARG . 44.5 Cg_endo -72.6 -27.27 15.58 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.711 2.274 . . . . 2.3599999999999999 112.216 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 1.6 p90 -83.72 35.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 3.8700000000000001 109.444 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.663 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 19.8 m-20 -136.82 46.33 2.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 2.3799999999999999 109.465 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 172.5 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 1.1100000000000001 109.451 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.86 -163.33 25.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.534 -1.426 . . . . 0.93999999999999995 109.534 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.75 -172.7 2.39 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.223 -1.163 . . . . 0.95999999999999996 109.388 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 55' ' ' TYR . 93.2 t -162.08 167.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.92000000000000004 108.943 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.642 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.0 t80 -176.19 172.94 2.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 1.71 109.516 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.26 -164.61 1.03 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.218 -0.926 . . . . 2.7799999999999998 109.626 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.594 ' O ' HD12 ' A' ' 10' ' ' LEU . . . 79.96 64.84 1.82 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.517 -1.433 . . . . 2.48 109.517 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -152.23 79.78 6.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.176 -1.191 . . . . 3.79 109.405 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.77 120.33 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.737 2.292 . . . . 2.3999999999999999 112.08 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.547 HG12 ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -105.41 119.15 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 3.0800000000000001 109.619 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.677 ' N ' ' OH ' ' A' ' 66' ' ' TYR . . . -128.58 95.93 0.4 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.332 -1.507 . . . . 3.0499999999999998 109.332 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.674 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -35.2 144.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 6.0499999999999998 109.372 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.34 -36.39 4.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 2.54 109.522 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 114' ' ' THR . 28.2 mt-10 -99.74 178.58 4.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -1.167 . . . . 4.0300000000000002 109.224 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -132.51 119.91 21.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.126 -0.984 . . . . 2.9100000000000001 109.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.677 ' OH ' ' N ' ' A' ' 61' ' ' GLY . 56.1 m-85 -94.06 162.93 13.68 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.302 -0.874 . . . . 2.3799999999999999 109.431 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.7 t -146.9 108.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.693 . . . . 2.6099999999999999 109.557 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 69' ' ' SER . 7.8 tt -96.29 144.83 26.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.071 -1.018 . . . . 3.6099999999999999 109.22 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.877 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.85 104.85 5.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.888 . . . . 2.27 108.98 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 109' ' ' ARG . 2.9 p90 -94.17 143.48 26.34 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.082 -1.047 . . . . 2.0099999999999998 110.899 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.62 96.74 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.557 -0.905 . . . . 1.8 108.557 179.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -164.21 178.6 7.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.874 -1.141 . . . . 0.95999999999999996 110.838 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 153.68 36.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.064 -0.717 . . . . 0.93000000000000005 109.064 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -95.85 138.83 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.67000000000000004 109.558 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.508 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -137.47 114.28 9.58 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 121.156 -0.965 . . . . 0.96999999999999997 109.712 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 31.5 Cg_endo -64.64 -144.38 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.075 -1.219 . . . . 1.02 111.875 -0.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.85 150.78 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.59 -1.319 . . . . 1.75 109.589 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.557 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER 159.65 156.98 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 2.1600000000000001 109.334 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.574 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 62.5 Cg_endo -76.99 147.96 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.918 2.412 . . . . 1.3799999999999999 112.422 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.733 HG11 HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -111.19 -172.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 2.0099999999999998 109.343 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.661 ' N ' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -122.43 142.75 50.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 6.0099999999999998 109.556 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.3 p -146.92 149.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.243 -0.91 . . . . 3.7599999999999998 109.396 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -151.27 151.55 31.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 2.29 109.735 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.524 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -150.76 169.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 1.8899999999999999 109.345 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.81 -155.96 26.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.631 -1.388 . . . . 1.49 109.631 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.72 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -90.39 -174.13 4.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.127 . . . . 2.54 109.495 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.496 -1.442 . . . . 1.3799999999999999 109.496 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.65 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.285 0.564 . . . . 5.7400000000000002 109.588 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -122.51 174.43 7.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 2.27 109.99 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -126.69 -18.04 4.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.73 . . . . 3.2799999999999998 109.115 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.644 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.74 41.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 3.6499999999999999 109.356 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.96 81.22 8.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 4.5999999999999996 109.602 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.1 tt0 -127.07 114.93 18.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.206 -0.934 . . . . 3.46 109.046 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.34 21.97 29.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.805 -1.318 . . . . 3.6699999999999999 109.805 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 97' ' ' GLN . 1.7 m -110.11 90.86 3.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -1.17 . . . . 3.79 109.531 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.678 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -128.07 86.86 57.01 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 1.96 109.57 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.81 118.94 5.91 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.964 2.443 . . . . 2.9700000000000002 112.395 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.733 HD12 HG11 ' A' ' 80' ' ' VAL . 12.2 mt -120.89 168.02 11.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 3.0600000000000001 109.346 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -122.82 -177.68 3.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 2.3399999999999999 109.563 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -91.6 59.21 2.95 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.513 -1.435 . . . . 2.1699999999999999 109.513 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -171.78 131.72 0.75 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 3.02 109.191 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -41.04 122.65 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.488 2.125 . . . . 1.4199999999999999 112.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.84 146.06 9.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 1.3700000000000001 109.565 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.434 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.75 150.31 21.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 1.72 110.26 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -126.47 152.33 46.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.379 -1.341 . . . . 4.7000000000000002 107.379 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' O ' ' CD1' ' A' ' 111' ' ' TYR . 13.8 mp0 -125.02 158.29 34.08 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.375 -0.93 . . . . 3.2799999999999998 110.701 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.653 ' CD1' ' O ' ' A' ' 110' ' ' GLU . 42.9 m-85 -160.57 103.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.474 -0.936 . . . . 2.96 108.474 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.682 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -114.02 169.6 8.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 3.4100000000000001 109.836 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.644 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 3.7 p90 -177.5 -173.5 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 2.77 109.857 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -119.69 150.91 39.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.52 -0.737 . . . . 2.23 109.418 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.547 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -90.2 169.77 10.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 4.1100000000000003 109.842 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -125.07 -20.28 4.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 6.8600000000000003 109.285 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 118' ' ' THR . 9.3 tt -128.46 170.86 12.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 5.1200000000000001 109.305 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.884 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -89.76 107.75 19.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 4.0599999999999996 109.542 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.715 ' CE1' HD22 ' A' ' 117' ' ' LEU . 42.5 m-85 -117.14 75.95 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 5.4400000000000004 109.499 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.56 163.27 32.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.682 2.255 . . . . 4.04 112.269 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.03 -12.97 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.846 2.364 . . . . 3.8999999999999999 111.965 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.46 129.44 55.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 4.1399999999999997 109.487 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.64 -65.18 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.425 -1.47 . . . . 3.5699999999999998 109.425 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -172.91 47.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -1.135 . . . . 3.5899999999999999 109.463 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 127' ' ' GLY . . . 179.92 58.83 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 2.0800000000000001 109.585 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.22 -2.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.11 2.54 . . . . 1.3899999999999999 112.078 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 122.29 150.21 8.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.286 -1.526 . . . . 1.1899999999999999 109.286 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -146.99 129.73 16.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.236 . . . . 2.0099999999999998 109.846 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 1.4 p -153.15 94.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.289 -1.004 . . . . 1.28 108.289 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.571 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -102.9 136.42 42.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.282 -0.886 . . . . 0.97999999999999998 110.563 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.515 ' HB2' HD12 ' A' ' 53' ' ' LEU . 2.9 m-30 -105.92 96.04 6.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.825 -0.805 . . . . 1.73 108.825 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 54.8 m170 -99.95 129.08 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 2.3199999999999998 109.785 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.616 HD22 ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -132.05 -28.4 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 2.1099999999999999 109.45 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -46.28 144.95 3.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 1.77 109.693 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.881 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 14.6 mtpp -164.08 141.04 6.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.139 . . . . 5.0599999999999996 109.668 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.33 -20.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 2.6400000000000001 108.602 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -131.36 18.1 4.99 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 2.5099999999999998 108.943 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.881 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -49.45 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 2.3199999999999998 110.218 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.6 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -153.78 -110.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 1.6100000000000001 109.394 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.63 152.74 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.896 -1.128 . . . . 1.6499999999999999 109.023 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.616 ' CG ' HD22 ' A' ' 133' ' ' LEU . 50.3 t80 -134.29 123.8 24.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.006 -1.059 . . . . 1.6799999999999999 110.181 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 1.8 m -112.67 118.78 35.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.73999999999999999 109.43 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.03 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.006 0.908 . . . . 1.22 109.859 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.674 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 93.0 p -135.37 -19.75 1.66 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.27 -0.641 . . . . 1.3300000000000001 109.27 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -148.9 163.18 38.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.917 . . . . 3.2999999999999998 109.484 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.679 HG11 ' CH2' ' A' ' 22' ' ' TRP . 10.5 p -177.2 123.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2599999999999998 109.556 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.52 151.61 9.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 2.7599999999999998 109.524 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 148' ' ' LEU . 1.0 OUTLIER -115.96 173.19 6.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 4.5700000000000003 109.584 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER -157.01 -166.89 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 3.0699999999999998 109.467 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.653 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.2 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 2.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.369 -0.604 . . . . 2.8300000000000001 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -86.04 84.53 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 4.75 109.503 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 59' ' ' PRO . 1.5 mt -67.01 -22.0 65.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 4.9500000000000002 109.297 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 10' ' ' LEU . 3.1 tm? -126.26 78.16 71.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 2.8599999999999999 108.679 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.32 40.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.03 2.487 . . . . 3.8300000000000001 112.77 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.811 ' H ' HD13 ' A' ' 10' ' ' LEU . 9.3 t60 -136.2 94.29 3.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 2.52 109.516 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -140.19 52.66 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 1.97 109.328 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -146.48 71.92 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 1.96 109.676 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 19' ' ' LEU . 4.7 m-30 -63.0 41.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 1.76 109.048 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.654 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -90.1 -39.13 13.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 1.1799999999999999 109.959 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 8.4 mt-10 -109.74 -83.71 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 2.1299999999999999 109.856 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -103.34 144.11 31.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 2.2599999999999998 109.589 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 15' ' ' PHE . 4.5 mt -58.15 -55.85 29.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 2.6000000000000001 109.469 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 102.53 -163.66 16.52 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.4 . . . . 1.6200000000000001 109.601 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.04 -36.91 67.06 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.74 2.294 . . . . 1.7 112.117 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.837 ' CH2' HG11 ' A' ' 146' ' ' VAL . 21.2 m95 -55.09 159.91 2.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 2.4199999999999999 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.06 177.29 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 1.6399999999999999 109.342 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 24' ' ' LEU . 1.3 pt? -176.06 151.53 1.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 2.0499999999999998 109.631 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.685 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 170.32 178.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 1.72 109.713 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.585 ' C ' ' HB2' ' A' ' 51' ' ' ALA . . . 86.22 -4.55 85.89 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.297 . . . . 1.7 109.859 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.903 ' OG1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.74 -143.17 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.27 . . . . 0.96999999999999997 109.504 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.792 ' N ' ' OG1' ' A' ' 27' ' ' THR . 86.1 p -91.5 -151.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.314 -0.866 . . . . 1.8 109.003 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -90.68 110.41 41.22 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 2.3999999999999999 109.102 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 56.4 Cg_endo -76.43 143.12 24.38 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.144 1.896 . . . . 1.1299999999999999 111.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -144.65 122.03 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 1.05 110.631 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.27 84.6 5.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.682 . . . . 1.8200000000000001 109.182 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.75 -140.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.1699999999999999 109.976 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.54 -68.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 2.21 109.401 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.638 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.46 43.85 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.438 -1.465 . . . . 1.1899999999999999 109.438 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.53 145.49 11.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 2.9100000000000001 109.63 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 37' ' ' MET . 18.4 tmm? -111.23 132.75 54.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.93000000000000005 109.042 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.3 m -123.48 152.11 42.05 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0600000000000001 110.24 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG13 ' SD ' ' A' ' 37' ' ' MET . 3.4 m -135.25 115.62 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.392 -0.966 . . . . 1.3700000000000001 108.392 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.794 ' O ' HD22 ' A' ' 41' ' ' LEU . 3.4 m-20 -72.41 123.64 23.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 4.79 109.929 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.903 HD21 ' OG1' ' A' ' 27' ' ' THR . 3.7 mm? -132.52 61.07 54.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.912 . . . . 3.54 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 43' ' ' GLY . 53.8 Cg_endo -96.05 -43.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.456 2.771 . . . . 3.7400000000000002 112.164 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 42' ' ' PRO . . . -16.76 -108.13 0.0 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 111.771 -0.532 . . . . 2.0299999999999998 111.771 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.07 61.63 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.197 -1.561 . . . . 2.4100000000000001 109.197 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 136' ' ' ALA . 2.7 mm100 -99.37 97.15 8.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -1.208 . . . . 2.96 109.7 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.51 58.92 3.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.658 -1.377 . . . . 2.0800000000000001 109.658 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.586 ' C ' ' H ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -152.51 90.19 3.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.6099999999999999 109.464 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.62 2.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.907 2.405 . . . . 2.3599999999999999 112.503 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.685 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -127.67 34.54 4.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 3.8700000000000001 109.599 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.685 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 1.4 m-20 -109.98 -2.25 17.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 2.3799999999999999 109.57 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB2' ' C ' ' A' ' 26' ' ' GLY . . . -176.9 172.14 2.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -0.964 . . . . 1.1100000000000001 109.689 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.638 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 144.3 178.0 19.63 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.718 -1.353 . . . . 0.93999999999999995 109.718 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.567 ' C ' HG22 ' A' ' 54' ' ' VAL . 8.2 mt -88.14 -176.57 5.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -1.092 . . . . 0.95999999999999996 109.234 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.567 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.23 162.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.92000000000000004 110.015 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.589 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 26.3 t80 175.83 146.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.586 -0.696 . . . . 1.71 109.297 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.589 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -112.93 -164.69 0.93 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 109.494 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.24 56.65 7.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.647 -1.381 . . . . 2.48 109.647 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.847 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.5 p -126.06 92.02 46.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 3.79 109.377 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.548 ' HG2' HD13 ' A' ' 9' ' ' LEU . 61.1 Cg_endo -80.39 131.4 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.718 2.279 . . . . 2.3999999999999999 112.277 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 21.1 t -141.98 113.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 3.0800000000000001 109.462 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -93.37 111.38 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.534 -1.426 . . . . 3.0499999999999998 109.534 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.506 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 1.8 tm-20 -42.47 145.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 6.0499999999999998 109.486 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.677 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 106.14 -35.02 5.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 2.54 109.633 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.622 ' O ' ' N ' ' A' ' 115' ' ' SER . 13.3 mt-10 -99.97 173.14 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 4.0300000000000002 109.558 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.578 ' O ' ' OG1' ' A' ' 150' ' ' THR . 51.7 m -121.02 143.79 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 2.9100000000000001 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.591 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 22.0 m-85 -109.31 -178.5 3.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 2.3799999999999999 109.703 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.9 t -152.21 159.18 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.487 -0.758 . . . . 2.6099999999999999 109.554 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 131' ' ' PHE . 1.8 tp -143.29 114.06 7.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 3.6099999999999999 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.8 p -109.24 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 2.27 108.878 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.3 p90 -94.08 150.19 20.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 2.0099999999999998 111.013 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.47 135.19 37.42 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.537 -0.912 . . . . 1.8 108.537 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.575 ' O ' HD22 ' A' ' 102' ' ' LEU . . . -171.68 135.16 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.011 -1.055 . . . . 0.95999999999999996 110.089 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -130.58 120.97 24.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.93000000000000005 108.979 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -96.18 138.88 33.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.67000000000000004 109.611 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.457 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.6 116.15 16.07 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.903 . . . . 0.96999999999999997 109.465 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.01 -144.44 0.17 OUTLIER 'Cis proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.217 -1.16 . . . . 1.02 112.225 0.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' OG1' ' A' ' 103' ' ' THR . 4.0 m-20 -109.21 163.17 13.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.75 110.154 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.465 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.0 mtm 165.17 168.08 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.701 -0.851 . . . . 2.1600000000000001 108.701 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.36 137.91 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.741 2.294 . . . . 1.3799999999999999 112.466 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.77 HG12 ' OH ' ' A' ' 139' ' ' TYR . 0.8 OUTLIER -112.56 -178.4 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.0099999999999998 109.198 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.666 ' N ' HG23 ' A' ' 80' ' ' VAL . 7.7 ttt180 -121.75 155.72 34.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 6.0099999999999998 109.772 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.47 ' HB ' HE21 ' A' ' 97' ' ' GLN . 35.1 t -154.58 150.85 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 3.7599999999999998 109.11 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -146.78 147.03 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.091 -1.006 . . . . 2.29 109.769 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -153.66 156.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.576 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.07 -161.52 24.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 1.49 109.593 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.662 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -89.73 -177.06 5.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 2.54 109.536 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.56 -1.416 . . . . 1.3799999999999999 109.56 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.56 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.501 -0.555 . . . . 5.7400000000000002 109.501 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -102.47 169.81 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 2.27 110.119 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.29 -16.84 6.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.886 -0.783 . . . . 3.2799999999999998 108.886 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.64 36.45 0.9 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 3.6499999999999999 109.281 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.428 ' CG ' HG23 ' A' ' 93' ' ' THR . 29.4 mt-10 -83.15 71.45 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.95 . . . . 4.5999999999999996 109.548 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.47 HE21 ' HB ' ' A' ' 82' ' ' VAL . 12.6 pt20 -100.07 167.27 10.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 3.46 109.467 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -146.47 8.38 1.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.695 -1.362 . . . . 3.6699999999999999 109.695 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -116.23 94.22 4.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -1.159 . . . . 3.79 109.628 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.756 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -134.1 85.36 39.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 1.96 109.485 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.99 133.28 57.2 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.957 2.438 . . . . 2.9700000000000002 112.47 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 72' ' ' ALA . 11.4 mt -148.74 123.94 10.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 3.0600000000000001 109.257 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -116.07 175.67 5.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 2.3399999999999999 109.607 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.422 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -67.52 32.93 0.21 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.395 -1.482 . . . . 2.1699999999999999 109.395 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 103' ' ' THR . 15.1 tt0 -110.41 95.44 22.46 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.357 -1.084 . . . . 3.02 109.362 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -47.29 118.34 2.81 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.572 2.182 . . . . 1.4199999999999999 112.254 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.594 ' CB ' HH12 ' A' ' 109' ' ' ARG . . . -175.73 166.79 3.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 1.3700000000000001 109.31 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -90.44 145.44 24.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 1.72 110.311 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.594 HH12 ' CB ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -108.62 138.76 44.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.711 -1.218 . . . . 4.7000000000000002 107.711 178.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.01 102.28 11.29 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.434 -0.791 . . . . 3.2799999999999998 110.526 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 12.3 m-30 -109.53 115.0 29.11 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.484 -0.932 . . . . 2.96 108.484 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.659 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -125.66 165.41 18.63 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.3 -0.875 . . . . 3.4100000000000001 109.573 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.5 p90 -154.19 -178.06 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.875 . . . . 2.77 109.511 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.539 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -105.99 101.09 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 2.23 109.513 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 34.9 p -36.22 104.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 4.1100000000000003 109.353 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.792 ' C ' HD22 ' A' ' 117' ' ' LEU . 2.4 m120 -93.44 -32.89 14.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 6.8600000000000003 109.405 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.792 HD22 ' C ' ' A' ' 116' ' ' ASN . 4.6 mm? -122.39 -175.22 3.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 5.1200000000000001 109.28 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.53 114.95 27.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 4.0599999999999996 109.629 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 117' ' ' LEU . 5.5 m-85 -112.85 79.24 3.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.955 . . . . 5.4400000000000004 109.35 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.82 152.24 28.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.705 2.27 . . . . 4.04 112.245 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 125' ' ' ALA . 71.8 Cg_endo -80.33 -32.68 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.597 2.198 . . . . 3.8999999999999999 111.814 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 123' ' ' GLY . 24.3 m-20 -109.84 -30.34 7.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 4.1399999999999997 109.55 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -36.46 -34.04 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 3.5699999999999998 109.531 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.6 OUTLIER -173.72 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 3.5899999999999999 109.508 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -137.18 153.24 74.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 2.0800000000000001 109.566 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -68.8 -10.97 30.64 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.947 2.432 . . . . 1.3899999999999999 112.337 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.9 178.21 17.29 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 1.1899999999999999 109.348 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -154.35 120.99 5.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -1.227 . . . . 2.0099999999999998 109.775 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 84' ' ' VAL . 16.4 t -144.42 120.7 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.711 -0.848 . . . . 1.28 108.711 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -141.38 131.55 24.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.013 . . . . 0.97999999999999998 110.444 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.472 ' HZ ' HD21 ' A' ' 68' ' ' LEU . 4.7 m-30 -94.46 115.62 27.82 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.666 -0.864 . . . . 1.73 108.666 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.581 ' O ' ' O ' ' A' ' 81' ' ' ARG . 23.8 m170 -100.02 122.81 43.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 2.3199999999999998 110.064 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -147.13 10.22 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.862 . . . . 2.1099999999999999 109.27 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.557 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -75.52 126.71 8.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.304 -1.518 . . . . 1.77 109.304 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 138' ' ' ALA . 6.7 mtpm? -165.81 131.27 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 5.0599999999999996 109.618 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.685 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -49.34 -29.89 6.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.409 -1.33 . . . . 2.6400000000000001 107.409 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -96.19 7.42 66.77 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.14 -1.984 . . . . 2.5099999999999998 108.14 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.52 -130.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.862 0.839 . . . . 2.3199999999999998 110.743 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.77 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.3 OUTLIER 162.38 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 1.6100000000000001 109.515 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.63 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -84.42 125.55 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 1.6499999999999999 109.09 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 13.6 t80 -106.39 112.78 25.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.803 . . . . 1.6799999999999999 109.285 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.7 m -113.78 96.27 5.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.1 -1.0 . . . . 0.73999999999999999 110.086 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.452 HD11 ' CG2' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -107.96 142.91 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.22 109.221 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 p -134.33 -3.82 2.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.647 -0.658 . . . . 1.3300000000000001 109.278 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 9.4 mt-30 -147.54 162.08 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 3.2999999999999998 110.124 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.837 HG11 ' CH2' ' A' ' 22' ' ' TRP . 93.2 t -160.11 79.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.955 -0.757 . . . . 2.2599999999999998 108.955 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.423 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -80.3 147.82 30.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 2.7599999999999998 110.051 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 149' ' ' THR . 1.2 tp -151.6 112.24 4.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.426 -0.796 . . . . 4.5700000000000003 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.653 ' N ' HD12 ' A' ' 148' ' ' LEU . 7.8 t -166.66 -155.86 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 3.0699999999999998 109.532 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 65' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 2.0 109.348 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.769 ' N ' ' HG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.496 -0.557 . . . . 2.8300000000000001 109.496 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 4.75 109.44 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 -30.99 52.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 4.9500000000000002 109.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.027 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -114.95 96.11 43.81 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 2.8599999999999999 109.325 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.79 45.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.748 2.299 . . . . 3.8300000000000001 112.673 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.622 ' N ' ' O ' ' A' ' 10' ' ' LEU . 54.8 t60 -133.25 107.46 8.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.98 . . . . 2.52 109.438 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.28 59.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 1.97 109.465 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 16' ' ' ALA . 47.3 t -160.9 69.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 1.96 109.658 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.3 m-30 -62.57 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 1.76 109.209 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -83.44 -34.69 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.737 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.687 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 21.8 mm-40 -109.72 -84.71 0.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 2.1299999999999999 109.344 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 20' ' ' GLY . 3.8 p -103.04 142.87 33.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 2.2599999999999998 109.233 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.82 6.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.098 -1.001 . . . . 2.6000000000000001 109.496 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 73.64 -148.65 40.51 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.201 -1.16 . . . . 1.6200000000000001 110.201 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 22' ' ' TRP . 98.6 Cg_endo -88.94 -10.64 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.268 2.646 . . . . 1.7 111.996 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.781 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.4 m95 -54.94 -170.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 2.4199999999999999 109.757 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -128.26 166.18 19.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 1.6399999999999999 109.255 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.832 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -170.74 156.34 5.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 2.0499999999999998 109.755 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER 158.13 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 1.72 109.803 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 89.6 -28.83 6.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.965 -1.112 . . . . 1.7 110.411 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.758 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.71 -141.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.349 . . . . 0.96999999999999997 109.627 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' ' OG1' ' A' ' 27' ' ' THR . 16.3 p -91.02 133.14 35.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.459 -0.776 . . . . 1.8 109.43 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -36.99 101.34 0.22 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 2.3999999999999999 109.214 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 51.5 Cg_exo -46.63 150.5 2.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.35 2.033 . . . . 1.1299999999999999 111.709 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.7 t -136.57 117.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.998 . . . . 1.05 110.207 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -81.45 89.16 6.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.725 . . . . 1.8200000000000001 109.763 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -63.6 -140.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 1.1699999999999999 109.492 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -40.09 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 2.21 109.541 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.558 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -138.97 35.64 1.96 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.568 -1.413 . . . . 1.1899999999999999 109.568 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.17 152.1 31.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -1.128 . . . . 2.9100000000000001 109.508 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.28 134.52 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.93000000000000005 109.303 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.71 154.23 46.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.335 -0.946 . . . . 1.0600000000000001 110.471 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.5 m -123.65 134.12 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.629 -0.878 . . . . 1.3700000000000001 108.629 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.671 ' N ' ' OG ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -74.99 105.85 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 4.79 109.795 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.6 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.5 mm? -117.94 74.82 10.17 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 3.54 109.314 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.47 -56.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.784 2.323 . . . . 3.7400000000000002 112.195 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 136' ' ' ALA . . . 161.44 -150.66 20.49 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.543 -1.423 . . . . 2.0299999999999998 109.543 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.03 -0.36 6.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 2.4100000000000001 109.501 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.671 ' O ' ' N ' ' A' ' 47' ' ' ASN . 2.8 mt-30 -99.38 73.63 1.88 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.256 -1.143 . . . . 2.96 109.539 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.85 49.88 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.392 -1.483 . . . . 2.0800000000000001 109.392 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.674 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -160.84 87.33 1.74 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -1.114 . . . . 3.6099999999999999 109.429 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.59 -9.88 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.912 2.408 . . . . 2.3599999999999999 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -112.34 31.42 6.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 3.8700000000000001 109.548 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 30.6 m-20 -123.02 36.78 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 2.3799999999999999 109.364 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 27' ' ' THR . . . 175.46 119.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.1100000000000001 109.389 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 159.37 -152.71 23.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.884 -1.286 . . . . 0.93999999999999995 109.884 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -144.24 170.46 15.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.95999999999999996 109.355 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.695 HG13 ' HB2' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -152.97 172.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.05 -1.031 . . . . 0.92000000000000004 110.084 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 1.027 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 58.3 t80 -178.43 148.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 1.71 109.556 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.454 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -110.93 -164.92 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 2.7799999999999998 109.575 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.08 67.39 1.63 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.399 . . . . 2.48 109.604 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG13 HD21 ' A' ' 148' ' ' LEU . 3.9 t -147.96 91.93 4.77 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -1.185 . . . . 3.79 109.505 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.683 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 60.9 Cg_endo -80.44 154.19 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.763 2.309 . . . . 2.3999999999999999 112.128 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.592 HG13 ' CE1' ' A' ' 66' ' ' TYR . 2.0 t -151.7 148.39 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 3.0800000000000001 109.736 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -142.94 116.07 0.98 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.228 -1.549 . . . . 3.0499999999999998 109.228 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.684 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -34.35 146.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -1.151 . . . . 6.0499999999999998 109.762 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.679 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 91.75 -16.6 58.91 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.88 -1.288 . . . . 2.54 109.88 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.671 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.6 mt-10 -112.47 160.92 17.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -1.219 . . . . 4.0300000000000002 109.836 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -128.29 140.91 51.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 2.9100000000000001 109.116 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 20.9 m-85 -107.07 177.13 4.95 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.077 -1.014 . . . . 2.3799999999999999 109.885 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -147.58 165.25 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.468 -0.77 . . . . 2.6099999999999999 109.593 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 148' ' ' LEU . 8.3 tp -149.9 118.82 6.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 3.6099999999999999 109.515 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.96 80.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 2.27 109.151 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 50.2 p90 -94.44 146.14 24.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.718 . . . . 2.0099999999999998 110.831 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.17 138.48 32.81 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.642 -0.873 . . . . 1.8 108.642 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.839 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -176.24 122.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.012 -1.055 . . . . 0.95999999999999996 110.142 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -112.44 122.5 47.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.749 -0.834 . . . . 0.93000000000000005 108.749 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -91.24 132.65 35.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.258 -0.901 . . . . 0.67000000000000004 109.85 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.478 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -135.63 113.97 11.11 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.384 -0.823 . . . . 0.96999999999999997 109.28 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.578 ' O ' ' C ' ' A' ' 74' ' ' ALA . 18.7 Cg_exo -65.21 -142.25 0.15 OUTLIER 'Cis proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.321 -1.116 . . . . 1.02 112.636 -0.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.662 ' O ' ' SD ' ' A' ' 78' ' ' MET . 1.1 m-20 -108.59 154.97 21.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 1.75 109.726 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 170.34 154.44 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 2.1600000000000001 109.433 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.19 129.08 12.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.778 2.319 . . . . 1.3799999999999999 112.306 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -106.12 -178.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 2.0099999999999998 109.244 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.65 ' N ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -129.16 147.08 50.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 6.0099999999999998 109.715 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -150.0 155.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 3.7599999999999998 109.216 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.505 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -141.65 151.28 42.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.132 -0.98 . . . . 2.29 109.856 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG13 HG23 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -150.33 162.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 1.8899999999999999 109.472 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 139.56 -147.75 19.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.708 -1.357 . . . . 1.49 109.708 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.715 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.41 162.45 15.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -1.114 . . . . 2.54 109.469 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.563 ' C ' ' HB1' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.493 -1.443 . . . . 1.3799999999999999 109.493 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.732 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 5.7400000000000002 109.637 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -101.9 174.18 6.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 2.27 109.877 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HD21 ' A' ' 116' ' ' ASN . . . -127.43 -17.16 4.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.49 -0.756 . . . . 3.2799999999999998 109.168 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.408 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.72 36.42 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 3.6499999999999999 109.43 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -83.96 70.99 10.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 4.5999999999999996 109.479 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.846 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -102.03 178.86 4.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 3.46 109.563 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.633 ' CA ' ' OE1' ' A' ' 97' ' ' GLN . . . -157.75 17.09 0.33 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.617 -1.393 . . . . 3.6699999999999999 109.617 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.846 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.7 m -111.05 63.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 3.79 109.686 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.12 97.18 29.02 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 1.96 109.253 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.699 ' C ' HD22 ' A' ' 102' ' ' LEU . 60.5 Cg_endo -79.58 118.2 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.67 2.247 . . . . 2.9700000000000002 112.667 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 72' ' ' ALA . 4.1 mm? -115.87 143.05 45.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 3.0600000000000001 109.169 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.613 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -127.36 166.56 17.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 2.3399999999999999 109.522 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.93 24.49 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 2.1699999999999999 109.505 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.613 ' H ' ' C ' ' A' ' 103' ' ' THR . 13.3 tt0 -109.9 96.59 25.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 3.02 109.363 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.14 118.43 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.551 2.167 . . . . 1.4199999999999999 112.195 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.801 ' HB3' ' NH2' ' A' ' 109' ' ' ARG . . . -169.99 164.2 9.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.846 . . . . 1.3700000000000001 109.439 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.579 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.29 140.24 29.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 1.72 109.859 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.801 ' NH2' ' HB3' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -105.45 134.8 47.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.842 -1.17 . . . . 4.7000000000000002 107.842 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -109.11 99.79 9.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 3.2799999999999998 110.893 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.3 m-30 -109.93 130.3 55.55 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.319 -0.993 . . . . 2.96 108.319 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.67 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -134.4 163.21 30.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 3.4100000000000001 109.849 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.621 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -142.97 173.47 11.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 2.77 109.516 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 121.33 42.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 2.23 109.776 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 93.5 p -48.97 143.81 5.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 4.1100000000000003 109.431 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 6.7 p-10 -134.31 -46.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 6.8600000000000003 109.516 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.774 HD22 ' CE1' ' A' ' 119' ' ' PHE . 5.0 tt -109.97 175.25 5.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 5.1200000000000001 109.461 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.727 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -92.95 124.32 36.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 4.0599999999999996 109.864 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.774 ' CE1' HD22 ' A' ' 117' ' ' LEU . 45.0 m-85 -134.75 93.63 17.75 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 5.4400000000000004 109.258 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.6 165.53 22.66 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.678 2.252 . . . . 4.04 112.267 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.83 -14.5 12.47 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.858 2.372 . . . . 3.8999999999999999 112.079 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 2.5 p-10 -109.65 115.52 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 4.1399999999999997 109.527 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . 167.64 173.17 35.5 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 3.5699999999999998 109.475 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -75.97 26.64 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 3.5899999999999999 109.499 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.563 ' HB1' ' C ' ' A' ' 87' ' ' GLY . . . 179.94 74.11 0.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 2.0800000000000001 109.543 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' A' ' 127' ' ' GLY . 56.0 Cg_endo -75.31 -158.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.77 2.314 . . . . 1.3899999999999999 112.249 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -39.16 163.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.587 -1.405 . . . . 1.1899999999999999 109.587 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -162.28 122.22 2.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -1.181 . . . . 2.0099999999999998 109.721 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 55' ' ' TYR . 8.4 p -146.53 130.52 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.424 -0.954 . . . . 1.28 108.424 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.695 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -148.26 123.26 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.961 -1.087 . . . . 0.97999999999999998 110.731 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.9 m-30 -86.92 118.93 26.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.807 -1.183 . . . . 1.73 107.807 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.505 ' ND1' HD21 ' A' ' 83' ' ' LEU . 6.1 m170 -99.94 131.87 45.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 2.3199999999999998 110.151 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 134' ' ' GLY . 3.8 mp -134.4 -105.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 2.1099999999999999 109.124 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 32.49 98.16 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.048 -1.221 . . . . 1.77 110.048 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.7 mtpt -146.68 123.67 11.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 5.0599999999999996 109.857 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.16 -20.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.147 -0.97 . . . . 2.6400000000000001 108.46 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -120.66 13.35 10.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.025 -1.63 . . . . 2.5099999999999998 109.025 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.616 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -52.17 -152.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.967 . . . . 2.3199999999999998 110.26 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.555 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 11.9 p90 -164.63 -131.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -0.99 . . . . 1.6100000000000001 109.374 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.417 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 26.5 mt-10 -120.3 128.29 53.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 1.6499999999999999 109.38 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.595 ' CD2' HG22 ' A' ' 143' ' ' ILE . 5.5 t80 -107.91 111.36 23.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 1.6799999999999999 109.661 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -107.5 88.43 2.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.73999999999999999 110.141 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.595 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -99.32 135.87 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 1.22 108.844 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 15' ' ' PHE . 60.0 p -128.05 -0.9 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 1.3300000000000001 109.313 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 23.7 mt-30 -152.2 174.61 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 3.2999999999999998 109.977 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 146' ' ' VAL . 8.0 p -177.24 92.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 2.2599999999999998 109.102 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.39 144.68 31.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 2.7599999999999998 110.056 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.641 HD21 HG13 ' A' ' 58' ' ' VAL . 8.9 tp -130.08 120.09 24.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 4.5700000000000003 109.019 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.769 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 2.6 t -158.06 -170.18 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 3.0699999999999998 109.661 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.551 HG23 HG21 ' A' ' 7' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 2.0 109.45 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.872 ' N ' ' HG1' ' A' ' 149' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.368 -0.604 . . . . 2.8300000000000001 109.368 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.484 ' H ' HG12 ' A' ' 7' ' ' VAL . 3.1 tt0 -175.33 86.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 4.75 109.636 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -83.97 -18.57 36.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 4.9500000000000002 109.425 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 10' ' ' LEU . 3.0 tm? -130.06 86.31 54.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 2.8599999999999999 108.782 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.37 41.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.35 2.7 . . . . 3.8300000000000001 113.509 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.709 ' H ' HD13 ' A' ' 10' ' ' LEU . 16.8 t60 -152.26 111.69 3.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.878 -1.139 . . . . 2.52 109.463 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.541 ' OG1' ' C ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -159.89 65.65 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 1.97 109.506 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 16' ' ' ALA . 23.4 m -153.03 66.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 1.96 109.592 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.544 ' CD2' HD11 ' A' ' 143' ' ' ILE . 4.6 m-30 -63.22 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 1.76 109.11 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -89.95 -78.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 1.1799999999999999 109.915 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.16 38.61 2.25 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.247 -0.908 . . . . 2.1299999999999999 109.867 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.97 150.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 2.2599999999999998 109.59 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -87.04 -69.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 2.6000000000000001 109.577 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 113.53 -172.03 14.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.408 -1.477 . . . . 1.6200000000000001 109.408 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.5 Cg_endo -70.31 -10.0 27.15 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.703 2.269 . . . . 1.7 112.189 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.916 ' CH2' HG21 ' A' ' 146' ' ' VAL . 7.8 m95 -61.91 -169.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 2.4199999999999999 109.246 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.8 m -150.37 162.27 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 1.6399999999999999 109.496 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 19' ' ' LEU . 2.7 pp -160.82 149.96 16.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 2.0499999999999998 109.489 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -177.52 133.92 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.72 109.437 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 148.51 -40.08 0.94 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.827 -1.309 . . . . 1.7 109.827 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.817 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -110.01 -141.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.96999999999999997 109.39 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.817 ' N ' ' OG1' ' A' ' 27' ' ' THR . 47.8 p -90.86 155.86 18.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 1.8 109.434 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -49.91 110.89 1.79 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.3999999999999999 109.03 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' CG ' HD13 ' A' ' 24' ' ' LEU . 49.9 Cg_exo -47.29 171.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.192 1.928 . . . . 1.1299999999999999 111.775 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.51 109.68 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.026 -1.046 . . . . 1.05 110.054 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.725 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.2 85.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 1.8200000000000001 109.289 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.19 -140.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 1.1699999999999999 109.74 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.609 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 7.3 p-10 -53.23 -57.0 12.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 2.21 109.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.38 44.47 0.69 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.405 -1.478 . . . . 1.1899999999999999 109.405 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.46 143.96 7.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -1.118 . . . . 2.9100000000000001 109.728 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.53 ' SD ' ' C ' ' A' ' 37' ' ' MET . 4.9 tmm? -110.87 124.86 52.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.93000000000000005 109.058 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.6 m -122.12 157.98 30.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -0.902 . . . . 1.0600000000000001 110.226 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -137.0 146.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 1.3700000000000001 108.687 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.606 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -75.67 121.39 22.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 4.79 109.207 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.652 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.3 mm? -117.76 36.7 0.23 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.084 -1.01 . . . . 3.54 110.998 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 84.8 Cg_endo -80.59 -95.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.491 2.127 . . . . 3.7400000000000002 111.427 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . 46.33 -107.8 0.21 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.699 -0.961 . . . . 2.0299999999999998 110.699 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.4 57.31 0.01 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.44 -1.864 . . . . 2.4100000000000001 108.44 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 136' ' ' ALA . 32.8 mt-30 -99.58 104.75 16.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -1.056 . . . . 2.96 110.027 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' N ' ' HB2' ' A' ' 136' ' ' ALA . . . -77.55 40.42 1.79 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.408 -1.477 . . . . 2.0800000000000001 109.408 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.648 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.3 OUTLIER -159.43 93.04 1.8 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 3.6099999999999999 109.528 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.66 ' O ' ' N ' ' A' ' 50' ' ' ASP . 52.0 Cg_exo -49.6 -38.8 45.93 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.804 2.336 . . . . 2.3599999999999999 112.407 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.475 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 11.8 p90 -62.68 50.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 3.8700000000000001 109.527 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.3 m-20 -149.48 13.29 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 2.3799999999999999 109.698 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 175.18 152.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 1.1100000000000001 109.515 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.1 176.05 24.38 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.923 -1.271 . . . . 0.93999999999999995 109.923 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 53' ' ' LEU . 5.4 mt -85.18 -177.15 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -1.134 . . . . 0.95999999999999996 109.205 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -162.16 159.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.151 -0.968 . . . . 0.92000000000000004 110.989 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.634 ' OH ' ' CD2' ' A' ' 10' ' ' LEU . 41.2 t80 178.63 124.19 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.41 -0.589 . . . . 1.71 109.41 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -101.35 -171.23 1.95 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.24 -0.913 . . . . 2.7799999999999998 109.498 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.694 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 80.88 72.24 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.65 -1.38 . . . . 2.48 109.65 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 57' ' ' GLY . 11.0 m -161.92 68.12 2.18 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 3.79 109.413 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.36 148.59 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.854 2.369 . . . . 2.3999999999999999 112.227 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.61 101.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 3.0800000000000001 109.53 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -92.45 116.02 4.97 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.481 -1.448 . . . . 3.0499999999999998 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' C ' ' OG ' ' A' ' 115' ' ' SER . 1.6 tm-20 -47.74 149.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.143 -1.21 . . . . 6.0499999999999998 109.544 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 93.39 -24.37 25.71 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.748 -1.341 . . . . 2.54 109.748 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.661 ' N ' ' OG ' ' A' ' 115' ' ' SER . 1.4 mm-40 -101.52 164.62 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -1.172 . . . . 4.0300000000000002 109.659 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.482 ' OG ' HG22 ' A' ' 114' ' ' THR . 47.7 m -131.34 135.27 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 2.9100000000000001 109.433 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 63.0 m-85 -105.36 178.19 4.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.229 -0.92 . . . . 2.3799999999999999 109.852 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 3.0 t -152.03 151.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 2.6099999999999999 109.31 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 148' ' ' LEU . 6.5 tp -137.58 118.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 3.6099999999999999 109.785 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -109.64 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.518 -0.919 . . . . 2.27 108.518 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.0 p90 -94.12 145.99 24.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 2.0099999999999998 111.453 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -91.78 134.29 34.87 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.321 -0.992 . . . . 1.8 108.321 178.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.769 ' N ' ' NH2' ' A' ' 109' ' ' ARG . . . -164.0 113.31 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.816 -1.178 . . . . 0.95999999999999996 110.395 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HG ' ' HB2' ' A' ' 142' ' ' CYS . 23.9 p -103.48 122.6 45.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.641 -0.874 . . . . 0.93000000000000005 108.641 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.836 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -93.31 135.39 34.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.67000000000000004 109.752 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.516 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.21 112.07 6.63 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.225 -0.922 . . . . 0.96999999999999997 109.717 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.7 Cg_exo -64.09 -141.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.748 0 C-N-CA 124.253 -1.145 . . . . 1.02 112.393 -0.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.48 150.71 24.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 1.75 109.757 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.644 ' CE ' ' HZ1' ' A' ' 135' ' ' LYS . 0.5 OUTLIER 173.01 154.54 0.25 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.1600000000000001 109.34 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.25 140.68 22.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.767 2.311 . . . . 1.3799999999999999 112.149 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 100' ' ' ALA . 7.3 m -111.84 -179.55 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 2.0099999999999998 109.461 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.733 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.24 151.21 44.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 6.0099999999999998 109.565 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 97' ' ' GLN . 2.1 p -154.37 154.51 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 3.7599999999999998 109.536 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.74 ' CD1' HE22 ' A' ' 128' ' ' GLN . 0.8 OUTLIER -151.19 141.93 22.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.957 . . . . 2.29 109.751 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 129' ' ' VAL . 0.9 OUTLIER -153.34 146.36 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 1.8899999999999999 109.663 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.12 -132.09 4.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.588 -1.405 . . . . 1.49 109.588 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' CD ' ' CE1' ' A' ' 119' ' ' PHE . 15.2 pt-20 -90.33 134.31 34.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 2.54 109.417 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.614 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.646 -1.382 . . . . 1.3799999999999999 109.646 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.521 -0.548 . . . . 5.7400000000000002 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -176.83 -164.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 2.27 109.692 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.7 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.7 -25.63 10.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.614 -0.884 . . . . 3.2799999999999998 108.614 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -91.17 35.99 0.92 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 3.6499999999999999 108.992 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.18 43.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.079 -1.013 . . . . 4.5999999999999996 109.492 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.504 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -104.42 114.47 28.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.264 -0.897 . . . . 3.46 109.149 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -103.57 13.94 53.98 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 3.6699999999999999 109.543 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -92.6 64.02 4.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -1.124 . . . . 3.79 109.526 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . . . -104.72 101.8 30.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 1.96 109.166 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.54 121.79 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.519 2.146 . . . . 2.9700000000000002 112.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.541 HD22 ' CZ ' ' A' ' 109' ' ' ARG . 63.0 mt -127.33 130.33 49.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 3.0600000000000001 109.327 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -119.73 -179.78 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 2.3399999999999999 109.601 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -66.76 24.05 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.445 -1.462 . . . . 2.1699999999999999 109.445 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.627 ' OE2' ' HB2' ' A' ' 107' ' ' ALA . 6.7 tm-20 -112.17 92.98 20.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.304 -1.115 . . . . 3.02 109.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.83 118.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.66 2.24 . . . . 1.4199999999999999 112.255 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.648 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . . . -166.06 162.41 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 1.3700000000000001 109.406 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.59 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -91.19 146.71 23.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 1.72 109.914 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.769 ' NH2' ' N ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -109.75 134.81 51.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.66 -1.237 . . . . 4.7000000000000002 107.66 177.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.54 ' OE1' ' C ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -114.35 102.26 9.94 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.93 -0.708 . . . . 3.2799999999999998 110.599 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 14.8 m-85 -109.83 122.0 46.52 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.498 -0.927 . . . . 2.96 108.498 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.68 133.75 55.64 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.251 -0.906 . . . . 3.4100000000000001 109.721 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.727 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -118.3 164.11 15.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 2.77 109.285 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.522 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -104.79 104.9 14.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 2.23 109.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 53.7 p -35.93 107.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 4.1100000000000003 109.25 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 15.7 t30 -86.04 -55.06 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 6.8600000000000003 109.706 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.705 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -111.31 -158.64 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 5.1200000000000001 109.804 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.705 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -117.24 150.56 38.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.363 -0.836 . . . . 4.0599999999999996 109.393 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 72.8 m-85 -162.45 73.91 2.17 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.86 . . . . 5.4400000000000004 109.548 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.35 167.87 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.858 2.372 . . . . 4.04 112.011 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.53 -15.66 10.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.813 2.342 . . . . 3.8999999999999999 112.091 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.637 ' OD2' ' N ' ' A' ' 123' ' ' GLY . 5.5 p-10 -111.29 -113.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.888 . . . . 4.1399999999999997 109.443 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.637 ' N ' ' OD2' ' A' ' 122' ' ' ASP . . . 36.12 -112.5 0.13 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.654 -1.379 . . . . 3.5699999999999998 109.654 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.8 -102.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -1.16 . . . . 3.5899999999999999 109.527 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.614 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -101.84 152.73 38.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 2.0800000000000001 109.493 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 -158.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.838 2.359 . . . . 1.3899999999999999 112.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -77.17 164.2 52.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.586 -1.406 . . . . 1.1899999999999999 109.586 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.74 HE22 ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -142.36 126.24 17.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 2.0099999999999998 109.439 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.649 HG22 ' CG1' ' A' ' 84' ' ' VAL . 19.3 t -139.09 90.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.57 -0.9 . . . . 1.28 108.57 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -112.62 122.14 46.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.97999999999999998 110.45 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -84.21 117.13 23.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.422 -0.955 . . . . 1.73 108.422 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.567 ' O ' ' O ' ' A' ' 81' ' ' ARG . 13.4 m170 -99.5 119.38 37.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 2.3199999999999998 110.044 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.802 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -136.59 -0.9 2.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 2.1099999999999999 109.421 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.78 135.0 32.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.256 -1.538 . . . . 1.77 109.256 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.644 ' HZ1' ' CE ' ' A' ' 78' ' ' MET . 9.3 mtmt -166.81 129.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 5.0599999999999996 109.552 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.02 -26.67 1.88 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.467 -1.308 . . . . 2.6400000000000001 107.467 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -104.28 11.98 51.53 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.293 -1.923 . . . . 2.5099999999999998 108.293 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.51 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.645 0.736 . . . . 2.3199999999999998 110.641 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.836 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 179.93 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.609 -1.307 . . . . 1.6100000000000001 110.715 -179.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.428 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 49.7 mt-10 -123.67 143.57 50.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 1.6499999999999999 109.25 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.556 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 15.2 t80 -126.22 120.63 30.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 1.6799999999999999 109.727 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.487 ' HB2' ' HG ' ' A' ' 73' ' ' SER . 1.7 m -119.06 97.29 5.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 109.853 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.544 HD11 ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -106.45 141.61 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 1.22 109.261 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.4 p -139.02 -2.62 1.66 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.617 -0.677 . . . . 1.3300000000000001 109.556 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 71' ' ' THR . 14.0 mt-30 -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 3.2999999999999998 110.242 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.916 HG21 ' CH2' ' A' ' 22' ' ' TRP . 2.8 p -160.94 73.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.004 -0.739 . . . . 2.2599999999999998 109.004 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.443 ' N ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -76.48 147.1 38.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 2.7599999999999998 110.18 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 58' ' ' VAL . 8.6 tp -138.56 101.59 4.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.492 -0.755 . . . . 4.5700000000000003 109.106 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.872 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -149.07 -176.61 5.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 3.0699999999999998 109.726 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.518 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.9 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 2.0 109.281 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.698 ' N ' ' HG1' ' A' ' 149' ' ' THR . 22.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.425 -0.583 . . . . 2.8300000000000001 109.425 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.39 104.38 16.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 4.75 109.531 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.34 -15.83 55.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 4.9500000000000002 109.523 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -121.75 94.97 48.17 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 2.8599999999999999 108.819 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.99 26.83 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.388 2.059 . . . . 3.8300000000000001 111.548 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.562 ' H ' HD13 ' A' ' 10' ' ' LEU . 30.6 t60 -123.39 84.71 2.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 2.52 109.594 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -129.1 50.26 2.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 1.97 109.331 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 16' ' ' ALA . 25.0 p -128.26 64.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 1.96 109.786 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CE2' HD21 ' A' ' 24' ' ' LEU . 4.5 m-30 -64.73 35.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.957 . . . . 1.76 108.967 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.625 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.35 -48.73 6.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 1.1799999999999999 110.282 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.3 mm-40 -109.9 -83.51 0.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 2.1299999999999999 109.87 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 m -76.95 144.5 38.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 2.2599999999999998 109.662 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.704 ' CD2' HD13 ' A' ' 24' ' ' LEU . 1.6 tp -60.13 -57.86 11.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.322 -0.861 . . . . 2.6000000000000001 109.487 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.3 -177.83 17.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.559 -1.416 . . . . 1.6200000000000001 109.559 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.78 -5.94 16.41 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.857 2.371 . . . . 1.7 112.16 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.947 ' CH2' HG21 ' A' ' 146' ' ' VAL . 8.8 m95 -65.35 -164.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 2.4199999999999999 109.222 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.6 m -144.58 131.88 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 1.6399999999999999 109.845 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.899 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.7 148.94 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 2.0499999999999998 109.452 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 163.9 -168.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 1.72 109.749 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.84 -22.89 1.77 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.103 -1.199 . . . . 1.7 110.103 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.77 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.77 -142.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.249 . . . . 0.96999999999999997 109.224 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.77 ' N ' ' OG1' ' A' ' 27' ' ' THR . 91.1 p -90.95 129.9 36.92 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.171 -0.955 . . . . 1.8 109.17 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.562 ' C ' ' O ' ' A' ' 28' ' ' SER . 18.5 mt-10 -33.93 98.53 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 2.3999999999999999 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 28' ' ' SER . 54.9 Cg_exo -46.92 146.14 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.372 2.048 . . . . 1.1299999999999999 111.821 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.94 116.58 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.053 . . . . 1.05 110.014 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.73 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.81 89.69 3.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.46 -0.775 . . . . 1.8200000000000001 109.472 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.16 -140.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.5 -0.75 . . . . 1.1699999999999999 110.295 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -69.56 15.55 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 2.21 110.358 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.612 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 148.71 -6.75 0.89 Allowed Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.396 -1.383 . . . . 1.1899999999999999 110.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.631 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.73 146.08 47.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.359 . . . . 2.9100000000000001 109.803 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.572 ' SD ' ' C ' ' A' ' 37' ' ' MET . 1.6 tmm? -109.84 129.76 55.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 0.93000000000000005 108.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.03 145.8 51.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 1.0600000000000001 110.57 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -115.58 174.95 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.983 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -134.39 135.22 42.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.028 -1.045 . . . . 4.79 109.696 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.983 HD22 ' C ' ' A' ' 40' ' ' ASP . 3.7 mm? -135.62 60.91 39.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.985 . . . . 3.54 110.489 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 41' ' ' LEU . 61.2 Cg_endo -98.38 -15.16 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.091 2.528 . . . . 3.7400000000000002 112.203 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.38 -142.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.932 -0.867 . . . . 2.0299999999999998 110.932 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 136' ' ' ALA . . . -133.98 78.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.678 -1.369 . . . . 2.4100000000000001 109.678 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -99.7 127.02 45.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -1.217 . . . . 2.96 109.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.77 64.81 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.579 -1.408 . . . . 2.0800000000000001 109.579 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.659 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -173.56 135.19 0.66 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.152 . . . . 3.6099999999999999 109.411 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.676 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 60.1 Cg_endo -75.94 -13.31 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.549 2.166 . . . . 2.3599999999999999 112.375 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.691 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -111.77 38.65 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 3.8700000000000001 110.002 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.743 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -119.35 38.08 3.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 2.3799999999999999 109.542 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.743 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 160.39 133.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.1100000000000001 109.639 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.36 -162.22 28.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.866 -1.294 . . . . 0.93999999999999995 109.866 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -136.06 168.84 18.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -1.174 . . . . 0.95999999999999996 109.293 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 23' ' ' SER . 1.5 p -155.48 164.8 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.083 -1.011 . . . . 0.92000000000000004 110.137 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 63.7 t80 -178.63 141.67 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.576 -0.703 . . . . 1.71 109.656 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.691 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 8.2 m120 -88.1 -152.86 0.22 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.331 -0.856 . . . . 2.7799999999999998 109.366 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.82 79.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 2.48 109.546 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.802 HG22 ' CD2' ' A' ' 148' ' ' LEU . 5.6 t -117.76 68.57 6.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.15 . . . . 3.79 109.562 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.405 ' C ' HG23 ' A' ' 60' ' ' VAL . 38.0 Cg_endo -70.05 160.7 48.69 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.716 2.277 . . . . 2.3999999999999999 112.132 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.85 HG12 ' OG ' ' A' ' 115' ' ' SER . 20.3 t -151.94 132.31 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 3.0800000000000001 109.612 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.35 104.22 1.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.495 -1.442 . . . . 3.0499999999999998 109.495 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.8 tm-20 -35.4 121.0 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -1.119 . . . . 6.0499999999999998 109.562 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 130.66 -45.09 1.16 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.889 -1.285 . . . . 2.54 109.889 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.5 mm-40 -100.03 171.76 7.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -1.156 . . . . 4.0300000000000002 109.804 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.2 m -116.21 144.71 43.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 2.9100000000000001 109.297 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.728 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 20.2 m-85 -108.28 179.43 4.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.198 -0.939 . . . . 2.3799999999999999 109.773 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.4 t -150.34 141.74 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -0.766 . . . . 2.6099999999999999 109.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 70' ' ' PHE . 3.8 tp -124.59 119.9 30.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 3.6099999999999999 108.883 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -115.65 90.13 3.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.031 . . . . 2.27 109.897 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.72 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.64 147.58 22.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 2.0099999999999998 110.878 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -97.1 113.64 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 1.8 109.176 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -178.58 176.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.914 -1.116 . . . . 0.95999999999999996 110.667 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -156.07 154.04 30.35 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.087 -0.708 . . . . 0.93000000000000005 109.087 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -94.04 134.18 36.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.67000000000000004 109.612 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.451 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.71 116.04 14.73 Favored Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.279 -0.888 . . . . 0.96999999999999997 109.559 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.5 Cg_exo -65.89 -141.9 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.427 -1.072 . . . . 1.02 112.562 -0.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -91.26 151.96 20.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 1.75 109.786 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.1 mtp 161.09 157.3 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 2.1600000000000001 109.347 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 64.2 Cg_endo -77.56 147.32 25.06 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.779 2.32 . . . . 1.3799999999999999 112.235 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 100' ' ' ALA . 4.4 m -113.91 170.68 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 2.0099999999999998 109.425 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.419 ' C ' HG23 ' A' ' 82' ' ' VAL . 2.3 mtp180 -109.93 151.21 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 6.0099999999999998 109.352 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 97' ' ' GLN . 19.5 t -152.59 149.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 3.7599999999999998 109.581 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.732 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.3 pp -150.92 145.84 25.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 2.29 109.463 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.4 t -146.49 152.06 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 1.8899999999999999 109.729 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 163.64 -148.45 14.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 1.49 109.455 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.667 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 12.1 pm0 -90.14 179.1 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -1.102 . . . . 2.54 109.339 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.409 . . . . 1.3799999999999999 109.576 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.724 ' CG ' HH11 ' A' ' 92' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.471 -0.566 . . . . 5.7400000000000002 109.471 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -104.37 161.41 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 2.27 109.958 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -112.26 -18.68 12.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.704 -0.85 . . . . 3.2799999999999998 108.704 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.677 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.79 35.78 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 3.6499999999999999 109.286 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.89 57.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 4.5999999999999996 109.394 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.689 HE22 ' CA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -100.0 129.5 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 3.46 108.87 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 97' ' ' GLN . . . -119.21 -9.9 8.43 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.763 -1.208 . . . . 3.6699999999999999 110.142 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.689 ' CA ' HE22 ' A' ' 97' ' ' GLN . 1.8 m -80.42 77.1 7.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.253 . . . . 3.79 109.551 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -117.88 85.33 22.56 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.96 109.593 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.73 127.28 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.976 2.451 . . . . 2.9700000000000002 112.509 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.567 HD21 ' NE ' ' A' ' 109' ' ' ARG . 6.3 mt -142.28 127.56 18.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 3.0600000000000001 109.379 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 105' ' ' GLU . 9.3 t -111.67 -165.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 2.3399999999999999 109.733 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.18 31.99 3.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.438 . . . . 2.1699999999999999 109.504 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' H ' HG23 ' A' ' 103' ' ' THR . 2.8 mt-10 -109.68 96.44 23.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 3.02 109.345 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -46.88 118.2 2.58 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.53 2.153 . . . . 1.4199999999999999 112.248 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -169.13 169.8 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 1.3700000000000001 109.491 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.25 143.85 26.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 1.72 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.719 ' CD ' ' N ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.17 131.64 51.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.79 -1.189 . . . . 4.7000000000000002 107.79 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' CG ' HG12 ' A' ' 67' ' ' VAL . 14.6 tt0 -117.4 96.18 5.29 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.632 -0.827 . . . . 3.2799999999999998 110.548 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 6.7 m-30 -109.46 117.24 33.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.178 -1.045 . . . . 2.96 108.178 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.728 ' HB1' ' O ' ' A' ' 66' ' ' TYR . . . -115.98 174.18 6.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -0.893 . . . . 3.4100000000000001 109.822 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 2.0 p90 -154.71 179.28 9.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.333 -0.854 . . . . 2.77 109.618 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.52 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -107.64 106.9 17.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.438 -0.789 . . . . 2.23 109.614 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.85 ' OG ' HG12 ' A' ' 60' ' ' VAL . 8.2 t -36.06 116.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 4.1100000000000003 109.322 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.525 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.5 OUTLIER -96.95 -50.46 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 6.8600000000000003 109.527 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 117' ' ' LEU . 2.5 mt -112.92 -166.0 1.04 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 5.1200000000000001 109.662 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.01 124.75 50.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 4.0599999999999996 109.419 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.644 ' CE1' ' CD ' ' A' ' 86' ' ' GLU . 34.1 m-85 -137.02 66.04 53.37 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 5.4400000000000004 109.472 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.64 166.9 25.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.858 2.372 . . . . 4.04 112.097 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.99 -19.66 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.763 2.309 . . . . 3.8999999999999999 112.002 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -110.28 111.76 23.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 4.1399999999999997 109.455 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.02 -138.06 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.575 -1.41 . . . . 3.5699999999999998 109.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.12 . . . . 3.5899999999999999 109.484 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.86 149.75 66.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 2.0800000000000001 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.12 -158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.789 2.326 . . . . 1.3899999999999999 112.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.56 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -64.93 172.29 20.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.648 -1.381 . . . . 1.1899999999999999 109.648 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.6 114.36 5.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -1.129 . . . . 2.0099999999999998 109.739 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -133.34 134.11 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.952 -1.129 . . . . 1.28 107.952 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.12 119.91 5.7 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.836 -1.146 . . . . 0.97999999999999998 110.718 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.7 m-30 -83.9 120.57 26.24 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.048 -1.093 . . . . 1.73 108.048 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.732 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 1.6 m170 -99.67 116.09 30.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 2.3199999999999998 109.896 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -138.45 37.44 2.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 2.1099999999999999 109.162 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -92.72 110.39 3.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.437 -1.465 . . . . 1.77 109.437 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 137' ' ' GLY . 56.8 mttt -159.78 134.87 8.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -1.14 . . . . 5.0599999999999996 109.856 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -37.25 -23.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.701 -0.852 . . . . 2.6400000000000001 108.701 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.725 ' C ' ' H ' ' A' ' 139' ' ' TYR . . . -135.11 24.38 3.42 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.51 -1.436 . . . . 2.5099999999999998 109.51 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.785 ' HB3' ' CB ' ' A' ' 41' ' ' LEU . . . -52.93 7.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.299 . . . . 2.3199999999999998 110.486 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.725 ' H ' ' C ' ' A' ' 137' ' ' GLY . 6.3 p90 48.32 -165.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.379 0.609 . . . . 1.6100000000000001 110.751 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 4.8 mt-10 -96.99 159.59 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.6499999999999999 110.459 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -129.81 102.64 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.907 -0.775 . . . . 1.6799999999999999 108.907 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 7.5 m -87.06 119.25 27.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.73999999999999999 110.267 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.447 HG23 ' SD ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -133.23 144.73 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.822 0.82 . . . . 1.22 109.35 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.463 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 92.9 p -136.85 -11.64 1.75 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.284 -0.567 . . . . 1.3300000000000001 109.556 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -155.88 168.47 27.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.98 . . . . 3.2999999999999998 109.997 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.947 HG21 ' CH2' ' A' ' 22' ' ' TRP . 7.8 p -150.37 131.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.432 -0.792 . . . . 2.2599999999999998 109.26 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -115.57 150.3 36.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.089 -1.007 . . . . 2.7599999999999998 109.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.802 ' CD2' HG22 ' A' ' 58' ' ' VAL . 1.7 tp -157.86 114.01 2.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 4.5700000000000003 109.365 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.698 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 9.7 t -164.36 -155.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 3.0699999999999998 109.478 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.428 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.93 . . . . 2.0 109.361 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.473 -0.566 . . . . 2.8300000000000001 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.555 ' OE2' ' N ' ' A' ' 148' ' ' LEU . 25.1 tp10 -87.52 97.02 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 4.75 109.504 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.553 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.88 -35.42 72.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 4.9500000000000002 109.444 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.564 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -110.47 93.96 17.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 2.8599999999999999 108.65 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.81 26.46 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.299 1.999 . . . . 3.8300000000000001 111.525 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.564 ' H ' HD13 ' A' ' 10' ' ' LEU . 46.4 t60 -119.88 95.56 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 2.52 109.602 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 2.6 t -130.4 51.07 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 1.97 109.304 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.7 m -114.4 52.91 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 1.96 109.769 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.02 20.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 1.76 108.984 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.608 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.11 -65.62 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 1.1799999999999999 110.009 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 18' ' ' SER . 1.4 mt-10 -109.96 38.88 2.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 2.1299999999999999 109.911 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 2.5 p 170.16 144.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.161 -0.962 . . . . 2.2599999999999998 109.708 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.603 HD11 ' CD2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.02 -69.19 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 2.6000000000000001 109.433 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.18 177.58 19.53 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.546 -1.422 . . . . 1.6200000000000001 109.546 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -53.5 -21.47 18.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.762 2.308 . . . . 1.7 112.048 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.676 ' CH2' HG21 ' A' ' 146' ' ' VAL . 18.0 m95 -58.33 167.81 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 2.4199999999999999 109.502 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.9 m -132.45 176.58 8.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 1.6399999999999999 109.046 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.603 ' CD2' HD11 ' A' ' 19' ' ' LEU . 1.4 pp -175.63 153.15 1.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 2.0499999999999998 110.059 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.688 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -178.44 136.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.538 -0.726 . . . . 1.72 109.111 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 135.27 -27.68 3.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.944 -1.263 . . . . 1.7 109.944 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.769 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.66 -141.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.027 -1.278 . . . . 0.96999999999999997 109.554 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.769 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.8 p -91.52 -167.17 1.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.959 -0.756 . . . . 1.8 108.959 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.57 110.61 42.43 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 2.3999999999999999 108.916 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -45.37 138.24 10.31 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.228 1.952 . . . . 1.1299999999999999 111.829 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.777 ' O ' HG13 ' A' ' 31' ' ' VAL . 12.5 p -118.69 93.52 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 1.05 109.932 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.07 81.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.506 -0.746 . . . . 1.8200000000000001 109.446 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -98.74 -109.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 1.1699999999999999 109.617 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 35' ' ' GLY . 3.0 t0 -51.62 79.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 2.21 109.577 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 35.62 47.14 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.586 -1.405 . . . . 1.1899999999999999 109.586 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -176.51 151.56 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 2.9100000000000001 109.498 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 37' ' ' MET . 4.8 ptt? -109.46 130.94 55.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.93000000000000005 109.803 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.5 m -109.97 128.74 55.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.793 . . . . 1.0600000000000001 109.563 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.1 133.04 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 1.3700000000000001 109.22 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.3 m-20 -80.53 128.76 33.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 4.79 109.248 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.824 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 3.5 mm? -110.28 95.54 22.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 3.54 109.587 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.675 ' O ' ' NZ ' ' A' ' 135' ' ' LYS . 52.5 Cg_endo -78.95 144.08 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.604 2.203 . . . . 3.7400000000000002 112.147 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' HB2' ' A' ' 138' ' ' ALA . . . -81.09 161.49 43.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.826 -1.31 . . . . 2.0299999999999998 109.826 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.16 -7.25 1.16 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.059 -1.216 . . . . 2.4100000000000001 110.059 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.457 ' OE1' ' CB ' ' A' ' 50' ' ' ASP . 41.5 mt-30 -120.69 174.3 6.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.023 -1.281 . . . . 2.96 109.785 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.97 -8.25 3.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.488 -1.445 . . . . 2.0800000000000001 109.488 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -99.96 133.29 21.74 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -1.175 . . . . 3.6099999999999999 109.353 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.17 1.03 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.478 2.119 . . . . 2.3599999999999999 112.652 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.67 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.1 p-90 -118.53 38.39 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 3.8700000000000001 110.09 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 0.8 OUTLIER -112.41 12.72 20.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.998 . . . . 2.3799999999999999 109.691 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . 179.72 134.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 1.1100000000000001 109.383 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 169.63 171.13 34.92 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.609 -1.281 . . . . 0.93999999999999995 110.222 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 54' ' ' VAL . 7.3 mt -75.65 -178.19 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -1.153 . . . . 0.95999999999999996 109.31 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.637 HG12 ' N ' ' A' ' 55' ' ' TYR . 99.2 t -161.08 167.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.92000000000000004 109.65 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.637 ' N ' HG12 ' A' ' 54' ' ' VAL . 32.0 t80 176.22 145.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.512 -0.743 . . . . 1.71 109.414 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.577 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -107.66 171.7 7.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.936 . . . . 2.7799999999999998 109.589 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 93.62 70.87 1.13 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 2.48 109.53 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 57' ' ' GLY . 43.0 t -162.41 86.79 1.45 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 3.79 109.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.553 ' HD2' HD13 ' A' ' 9' ' ' LEU . 59.1 Cg_endo -79.07 162.88 25.86 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.676 2.251 . . . . 2.3999999999999999 112.153 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.26 114.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 3.0800000000000001 109.654 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -108.6 135.31 12.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.295 -1.522 . . . . 3.0499999999999998 109.295 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CD ' HG23 ' A' ' 118' ' ' THR . 6.5 pt-20 -72.7 139.32 47.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -1.156 . . . . 6.0499999999999998 109.656 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 125.24 -50.0 0.89 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.631 -1.387 . . . . 2.54 109.631 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.97 157.76 16.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.126 -1.22 . . . . 4.0300000000000002 109.654 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -100.01 134.36 43.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 2.9100000000000001 109.294 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.696 ' O ' HG23 ' A' ' 67' ' ' VAL . 74.8 m-85 -92.95 174.48 7.21 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 2.3799999999999999 109.689 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 66' ' ' TYR . 54.4 t -162.6 118.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 2.6099999999999999 109.482 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 69' ' ' SER . 9.7 tt -109.6 158.71 17.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 3.6099999999999999 109.158 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.697 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -154.41 106.46 2.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 2.27 109.427 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 2.1 p90 -94.39 147.51 23.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.106 -0.996 . . . . 2.0099999999999998 110.378 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -100.19 94.54 6.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.851 -0.796 . . . . 1.8 108.851 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HB2' ' HB ' ' A' ' 143' ' ' ILE . . . -163.79 -177.08 4.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.039 -1.038 . . . . 0.95999999999999996 109.709 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.417 ' HA ' HD22 ' A' ' 102' ' ' LEU . 13.2 p -164.46 136.92 4.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -0.827 . . . . 0.93000000000000005 109.333 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -87.81 145.11 26.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.67000000000000004 109.119 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 104' ' ' GLY . 0.7 OUTLIER -131.8 116.76 16.01 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.96999999999999997 109.343 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.3 Cg_exo -66.07 -142.59 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.384 -1.09 . . . . 1.02 112.495 -0.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -95.35 151.53 19.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 1.75 109.576 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.574 ' SD ' ' CG ' ' A' ' 139' ' ' TYR . 7.4 ptm 178.21 151.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 2.1600000000000001 109.511 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.674 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 56.8 Cg_endo -74.41 122.01 7.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.764 2.309 . . . . 1.3799999999999999 112.233 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.94 HG11 HD12 ' A' ' 102' ' ' LEU . 2.9 m -102.39 172.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 2.0099999999999998 109.476 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 79' ' ' PRO . 8.8 mpt_? -114.14 166.27 11.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 6.0099999999999998 109.461 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 81' ' ' ARG . 88.5 t -160.32 156.45 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 3.7599999999999998 109.311 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.715 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -159.56 148.08 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 2.29 109.441 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -150.76 148.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -0.972 . . . . 1.8899999999999999 109.929 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.83 2.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.218 -1.553 . . . . 1.49 109.218 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.5 pt-20 -90.35 178.7 6.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -1.172 . . . . 2.54 109.384 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.54 -1.424 . . . . 1.3799999999999999 109.54 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.738 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.489 -0.56 . . . . 5.7400000000000002 109.489 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.508 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -127.95 161.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 2.27 109.824 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.95 -19.88 12.94 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.871 -0.789 . . . . 3.2799999999999998 108.871 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.0 39.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 3.6499999999999999 109.212 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -86.73 94.26 9.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 4.5999999999999996 109.83 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.682 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 6.5 pt20 -116.62 -156.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.168 -0.958 . . . . 3.46 109.164 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . 177.14 -26.05 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.981 -1.247 . . . . 3.6699999999999999 109.981 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -91.87 94.81 9.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -1.226 . . . . 3.79 109.811 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.575 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -133.16 79.23 62.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 1.96 109.361 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.76 132.28 41.02 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.051 2.501 . . . . 2.9700000000000002 112.657 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.94 HD12 HG11 ' A' ' 80' ' ' VAL . 12.3 mt -124.35 151.06 44.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 3.0600000000000001 109.208 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 74' ' ' ALA . 13.6 t -95.26 -162.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 2.3399999999999999 109.831 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 75' ' ' THR . . . -96.02 -32.92 6.54 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 2.1699999999999999 109.777 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 103' ' ' THR . 1.6 mp0 -99.96 164.09 17.13 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.138 -1.213 . . . . 3.02 109.485 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.14 128.66 7.71 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.841 2.361 . . . . 1.4199999999999999 112.019 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 72' ' ' ALA . . . -160.73 140.91 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 1.3700000000000001 109.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -90.99 144.29 25.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.802 . . . . 1.72 110.204 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.73 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -128.43 149.99 50.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.023 -1.473 . . . . 4.7000000000000002 107.023 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -139.56 159.71 41.54 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.655 -1.218 . . . . 3.2799999999999998 111.186 -178.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.682 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 7.1 m-85 -134.86 121.11 20.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.3 -1.0 . . . . 2.96 108.3 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' A' ' 67' ' ' VAL . . . -114.49 139.56 49.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 3.4100000000000001 109.655 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -147.77 164.03 34.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 2.77 109.629 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.39 112.38 24.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.422 -0.799 . . . . 2.23 109.497 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.672 ' O ' ' N ' ' A' ' 63' ' ' GLY . 6.6 t -60.83 109.18 0.99 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.957 . . . . 4.1100000000000003 109.452 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -123.52 22.99 9.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 6.8600000000000003 109.435 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' A' ' 119' ' ' PHE . 0.4 OUTLIER -148.91 104.96 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 5.1200000000000001 109.366 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.542 HG23 ' CD ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -51.51 107.51 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 4.0599999999999996 109.45 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CE2' HD12 ' A' ' 117' ' ' LEU . 7.3 m-85 -124.9 92.08 48.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 5.4400000000000004 109.635 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.546 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 31.9 Cg_exo -56.46 -170.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.519 2.146 . . . . 4.04 111.367 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.546 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 23.3 Cg_exo -60.74 -76.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.282 1.988 . . . . 3.8999999999999999 111.283 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 30.6 t0 -173.06 -163.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.123 -0.986 . . . . 4.1399999999999997 109.887 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.495 ' H ' ' CG ' ' A' ' 122' ' ' ASP . . . -109.48 -35.63 2.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.195 -1.962 . . . . 3.5699999999999998 108.195 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -128.93 -41.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 3.5899999999999999 108.286 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -113.35 92.93 24.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.362 -0.977 . . . . 2.0800000000000001 108.362 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 125' ' ' ALA . 45.3 Cg_exo -48.63 -139.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.727 2.284 . . . . 1.3899999999999999 113.15 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -33.07 155.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.856 -1.298 . . . . 1.1899999999999999 109.856 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -158.92 151.56 21.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.333 -1.098 . . . . 2.0099999999999998 109.46 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 84' ' ' VAL . 17.1 t -153.53 155.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.448 -0.945 . . . . 1.28 108.448 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -163.35 111.32 1.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.908 -1.12 . . . . 0.97999999999999998 110.468 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.404 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 5.0 m-30 -83.37 101.41 11.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.089 -1.078 . . . . 1.73 108.089 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.715 ' ND1' HD21 ' A' ' 83' ' ' LEU . 5.0 m170 -98.83 128.57 45.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 2.3199999999999998 110.476 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -112.73 -45.62 3.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.907 -0.775 . . . . 2.1099999999999999 108.907 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.81 153.85 29.78 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.103 -1.199 . . . . 1.77 110.103 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.675 ' NZ ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -99.66 -143.66 0.33 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.044 . . . . 5.0599999999999996 109.304 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 135' ' ' LYS . . . 67.44 -61.07 0.37 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.017 -1.105 . . . . 2.6400000000000001 108.017 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -88.97 35.22 3.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.016 -2.034 . . . . 2.5099999999999998 108.016 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.824 ' HB1' ' O ' ' A' ' 41' ' ' LEU . . . -28.75 151.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.868 -0.784 . . . . 2.3199999999999998 110.631 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.586 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 5.1 p90 -173.99 -132.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.767 -0.827 . . . . 1.6100000000000001 108.767 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 14.5 mt-10 -146.73 127.33 14.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 1.6499999999999999 109.741 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -117.46 106.66 13.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 1.6799999999999999 109.131 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.494 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 72.4 m -109.81 120.58 42.93 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.084 -1.01 . . . . 0.73999999999999999 110.546 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -120.36 146.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.76 . . . . 1.22 109.052 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.482 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 93.3 p -126.75 -10.04 6.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.962 -0.755 . . . . 1.3300000000000001 108.962 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.57 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -161.9 167.24 25.03 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.607 -0.837 . . . . 3.2999999999999998 109.813 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.676 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.3 p -149.38 123.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 2.2599999999999998 109.382 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.57 165.69 10.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.177 -0.952 . . . . 2.7599999999999998 109.592 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 58' ' ' VAL . 10.0 tp -173.87 120.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 4.5700000000000003 109.428 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.669 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.5 OUTLIER 179.0 -156.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 3.0699999999999998 109.475 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.669 ' N ' ' OG1' ' A' ' 149' ' ' THR . 8.8 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 2.0 109.531 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.85 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.687 0.756 . . . . 2.8300000000000001 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.643 ' N ' ' OG1' ' A' ' 149' ' ' THR . 3.6 mt-10 159.25 84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.31 -0.626 . . . . 4.75 109.31 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.436 HD23 ' HD2' ' A' ' 59' ' ' PRO . 2.2 mp -91.52 17.03 9.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.223 -0.923 . . . . 4.9500000000000002 109.16 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 12' ' ' HIS . 3.1 tm? -175.27 96.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 2.8599999999999999 109.155 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.66 43.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.05 2.5 . . . . 3.8300000000000001 113.396 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.698 ' N ' HD13 ' A' ' 10' ' ' LEU . 9.8 t60 -162.84 103.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 2.52 109.492 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.549 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -150.42 45.17 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 1.97 109.367 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 16' ' ' ALA . 2.0 t -140.24 93.71 2.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.96 109.562 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 144' ' ' SER . 8.6 m-85 -75.91 39.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 1.76 109.196 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.618 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.03 -33.08 16.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.1799999999999999 109.756 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.685 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 22.2 mt-10 -109.85 -76.66 0.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 2.1299999999999999 109.63 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -111.87 143.93 42.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 2.2599999999999998 109.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -49.36 -33.76 14.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 2.6000000000000001 109.591 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 91.08 -159.71 26.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 1.6200000000000001 109.5 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.09 -9.18 17.87 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.72 2.28 . . . . 1.7 112.233 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 13.8 m95 -68.44 150.25 48.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 2.4199999999999999 109.006 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -109.89 170.29 8.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 1.6399999999999999 110.058 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.649 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.4 pp -176.57 165.05 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 2.0499999999999998 109.6 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.758 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.35 -165.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 1.72 109.503 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.43 -21.14 2.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.197 -1.161 . . . . 1.7 110.197 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.765 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.71 -143.64 0.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.28 . . . . 0.96999999999999997 109.459 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.765 ' N ' ' OG1' ' A' ' 27' ' ' THR . 49.4 p -92.13 -159.07 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.293 -0.879 . . . . 1.8 108.85 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -90.36 127.34 53.36 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 2.3999999999999999 108.593 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HG3' HD11 ' A' ' 24' ' ' LEU . 33.0 Cg_endo -69.01 135.79 33.23 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.02 1.813 . . . . 1.1299999999999999 111.495 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.73 110.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 1.05 110.362 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.82 73.76 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 1.8200000000000001 109.238 178.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.14 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 1.1699999999999999 109.901 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.454 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 12.4 t70 -45.72 83.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 2.21 109.521 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 42.37 35.16 1.81 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.535 -1.426 . . . . 1.1899999999999999 109.535 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 33' ' ' ALA . 9.6 ptp180 -148.46 142.58 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 2.9100000000000001 109.666 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.618 ' C ' ' SD ' ' A' ' 37' ' ' MET . 14.7 tmm? -112.68 127.73 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.93000000000000005 109.578 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.661 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -122.57 138.52 54.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.838 . . . . 1.0600000000000001 109.858 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.18 150.85 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.415 -0.957 . . . . 1.3700000000000001 108.415 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.756 ' C ' HD22 ' A' ' 41' ' ' LEU . 21.9 m-20 -81.06 119.69 23.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.1 -1.0 . . . . 4.79 109.348 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.786 ' N ' HD22 ' A' ' 41' ' ' LEU . 3.0 mm? -116.37 32.79 0.16 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.092 -1.005 . . . . 3.54 110.736 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 86.1 Cg_endo -81.07 -97.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.194 1.929 . . . . 3.7400000000000002 111.697 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.21 -96.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.424 -1.07 . . . . 2.0299999999999998 110.424 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.71 48.84 0.04 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.425 -1.87 . . . . 2.4100000000000001 108.425 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.674 ' O ' ' N ' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -99.73 116.26 31.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.463 -1.022 . . . . 2.96 109.857 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -76.18 52.75 3.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.524 -1.43 . . . . 2.0800000000000001 109.524 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.67 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -161.19 134.73 4.84 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.227 -1.16 . . . . 3.6099999999999999 109.462 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 63.1 Cg_endo -76.83 0.35 9.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.605 2.203 . . . . 2.3599999999999999 112.724 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.485 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 5.2 p90 -110.15 67.88 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 3.8700000000000001 109.649 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 1.2 m-20 -140.18 -31.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 2.3799999999999999 109.763 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.658 ' HB1' HG22 ' A' ' 27' ' ' THR . . . -152.87 163.88 38.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 109.605 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 144.9 171.49 14.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.875 -1.29 . . . . 0.93999999999999995 109.875 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.459 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.8 pp -107.41 145.82 32.47 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -1.14 . . . . 0.95999999999999996 109.162 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 55' ' ' TYR . 17.7 t -131.19 169.83 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.951 . . . . 0.92000000000000004 110.068 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 40.5 t80 -171.09 143.3 1.93 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.495 -0.753 . . . . 1.71 109.42 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -113.16 -167.28 1.17 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.302 -0.874 . . . . 2.7799999999999998 109.397 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.7 55.62 2.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.64 -1.384 . . . . 2.48 109.64 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.578 ' CG2' HD21 ' A' ' 148' ' ' LEU . 1.1 p -149.08 100.5 3.41 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 3.79 109.421 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HD2' HD23 ' A' ' 9' ' ' LEU . 58.3 Cg_endo -78.93 126.96 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.49 2.126 . . . . 2.3999999999999999 112.018 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -103.19 74.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.92 . . . . 3.0800000000000001 109.813 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -84.71 90.64 1.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.953 -1.659 . . . . 3.0499999999999998 108.953 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -34.56 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -1.127 . . . . 6.0499999999999998 109.884 -179.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.73 -67.18 0.56 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.638 -1.385 . . . . 2.54 109.638 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -100.0 170.68 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -1.152 . . . . 4.0300000000000002 109.632 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 m -99.98 139.41 35.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 2.9100000000000001 109.323 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.05 177.64 4.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -0.98 . . . . 2.3799999999999999 109.846 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.658 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.6 t -150.63 137.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 2.6099999999999999 109.634 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tp -119.94 115.1 23.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 3.6099999999999999 109.106 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -112.98 100.29 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 2.27 109.33 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -94.1 135.04 35.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 2.0099999999999998 110.599 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.679 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 10.9 p -93.49 94.22 8.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.441 -0.948 . . . . 1.8 108.441 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 143' ' ' ILE . . . -165.36 164.2 19.77 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.617 -1.233 . . . . 0.95999999999999996 110.624 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -139.81 146.61 39.63 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.843 -0.799 . . . . 0.93000000000000005 108.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -84.6 133.8 34.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.67000000000000004 109.358 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.506 ' O ' ' CD ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.71 115.74 15.83 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.37 -0.831 . . . . 0.96999999999999997 109.062 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -67.1 -142.2 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.605 0 C-N-CA 124.311 -1.12 . . . . 1.02 112.298 0.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.64 149.36 22.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 1.75 109.613 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.5 mtt 159.73 163.47 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.372 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.33 150.78 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.877 2.384 . . . . 1.3799999999999999 112.224 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -116.23 169.0 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 2.0099999999999998 109.393 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 132' ' ' HIS . 13.5 ttt180 -114.2 137.68 51.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 6.0099999999999998 109.52 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.81 149.45 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.341 -0.85 . . . . 3.7599999999999998 109.38 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -147.5 147.09 29.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 2.29 109.752 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.2 t -151.8 149.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 1.8899999999999999 109.614 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 160.62 -147.03 13.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.584 -1.407 . . . . 1.49 109.584 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.667 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.1 pm0 -90.04 176.85 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -1.162 . . . . 2.54 109.547 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.603 -1.399 . . . . 1.3799999999999999 109.603 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.403 ' HE ' ' C ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.46 -0.57 . . . . 5.7400000000000002 109.46 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -105.42 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 2.27 109.951 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.659 ' HB2' HD22 ' A' ' 117' ' ' LEU . . . -109.88 -24.8 10.64 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.771 -0.826 . . . . 3.2799999999999998 108.771 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -91.03 33.84 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 3.6499999999999999 109.186 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.84 59.25 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 4.5999999999999996 109.582 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.6 tt0 -103.07 156.4 17.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 3.46 109.134 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -145.87 8.54 1.53 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.696 -1.362 . . . . 3.6699999999999999 109.696 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.33 59.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -1.165 . . . . 3.79 109.589 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.545 ' HB3' HG23 ' A' ' 80' ' ' VAL . . . -101.54 107.37 50.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 1.96 109.204 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -78.04 134.36 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.528 2.152 . . . . 2.9700000000000002 112.544 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 102' ' ' LEU . 12.3 mt -131.2 156.63 45.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 3.0600000000000001 109.411 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -103.44 -155.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 2.3399999999999999 109.512 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.634 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -113.45 30.76 7.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 2.1699999999999999 109.523 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -154.41 149.89 21.12 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -1.179 . . . . 3.02 109.379 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.26 126.2 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.872 2.381 . . . . 1.4199999999999999 112.106 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.888 ' HB1' ' NH1' ' A' ' 109' ' ' ARG . . . -163.34 132.84 4.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 1.3700000000000001 109.655 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.35 141.39 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 1.72 110.395 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.888 ' NH1' ' HB1' ' A' ' 107' ' ' ALA . 3.9 mpt_? -120.16 143.61 48.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.317 -1.364 . . . . 4.7000000000000002 107.317 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -128.88 112.74 14.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.977 . . . . 3.2799999999999998 110.838 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 4.5 m-30 -113.44 115.28 27.8 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.201 -1.037 . . . . 2.96 108.201 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.658 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -117.96 171.87 7.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.277 -0.889 . . . . 3.4100000000000001 110.024 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -173.14 175.45 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 2.77 109.673 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -87.7 113.19 23.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 2.23 109.751 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.8 t -52.82 110.03 0.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 4.1100000000000003 109.39 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 114' ' ' THR . 30.4 m120 -129.14 28.61 5.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.838 . . . . 6.8600000000000003 109.505 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' A' ' 94' ' ' ALA . 4.6 tp -133.4 118.47 18.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 5.1200000000000001 109.398 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -77.59 127.38 32.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.881 . . . . 4.0599999999999996 109.558 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 8.4 m-85 -163.52 94.63 1.08 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 5.4400000000000004 109.363 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.67 165.78 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.604 2.203 . . . . 4.04 112.259 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.0 -14.93 12.03 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.815 2.343 . . . . 3.8999999999999999 112.044 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.84 121.67 45.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 4.1399999999999997 109.478 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.67 -175.42 19.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 3.5699999999999998 109.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.93 53.5 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 3.5899999999999999 109.454 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 119' ' ' PHE . . . -178.03 65.69 0.19 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.0800000000000001 109.464 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.12 -158.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.874 2.383 . . . . 1.3899999999999999 112.301 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.444 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -80.95 157.29 39.15 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.538 -1.425 . . . . 1.1899999999999999 109.538 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.667 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -146.94 126.58 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 2.0099999999999998 109.878 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.42 85.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.66 -0.867 . . . . 1.28 108.66 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.659 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -103.31 127.1 50.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.97999999999999998 110.56 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.435 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . 2.9 m-30 -105.12 96.75 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.295 -1.002 . . . . 1.73 108.295 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 9.3 m170 -99.39 138.37 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 2.3199999999999998 110.238 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.853 ' N ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -141.83 6.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 2.1099999999999999 109.21 179.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -62.11 147.51 48.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.572 -1.411 . . . . 1.77 109.572 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.624 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 0.4 OUTLIER 179.48 132.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -1.09 . . . . 5.0599999999999996 109.339 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -47.14 -24.3 0.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.765 -1.198 . . . . 2.6400000000000001 107.765 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.611 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -106.29 8.55 41.41 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.577 -1.809 . . . . 2.5099999999999998 108.577 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.12 -163.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.919 . . . . 2.3199999999999998 110.023 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD2' ' C ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -173.73 -112.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 1.6100000000000001 109.94 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.506 ' CD ' ' O ' ' A' ' 75' ' ' THR . 2.2 mp0 -129.61 153.79 47.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.754 -1.216 . . . . 1.6499999999999999 109.678 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.661 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 26.7 t80 -136.29 126.49 26.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.226 -0.921 . . . . 1.6799999999999999 109.721 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.85 98.61 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.73999999999999999 110.185 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.587 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -109.81 143.82 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.405 -0.809 . . . . 1.22 108.883 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 15' ' ' PHE . 95.4 p -128.89 -18.1 3.85 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.075 -0.65 . . . . 1.3300000000000001 109.409 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.679 ' N ' ' OG1' ' A' ' 71' ' ' THR . 4.2 mt-30 -152.74 166.79 31.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.173 -1.011 . . . . 3.2999999999999998 110.61 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 146' ' ' VAL . 7.3 p -169.92 91.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.917 -0.772 . . . . 2.2599999999999998 108.917 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.73 140.67 29.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 2.7599999999999998 110.482 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.578 HD21 ' CG2' ' A' ' 58' ' ' VAL . 6.9 tp -124.23 94.82 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.608 -0.886 . . . . 4.5700000000000003 108.608 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.74 ' OG1' ' N ' ' A' ' 7' ' ' VAL . 8.2 t 177.87 -144.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 3.0699999999999998 109.156 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.471 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 9.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.109 -0.994 . . . . 2.0 109.658 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.397 -0.594 . . . . 2.8300000000000001 109.397 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.12 100.4 13.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 4.75 109.551 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.56 -8.63 56.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 4.9500000000000002 109.496 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.683 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.3 tm? -140.96 85.93 11.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 2.8599999999999999 108.797 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.58 40.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.996 2.464 . . . . 3.8300000000000001 112.22 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.683 ' H ' HD13 ' A' ' 10' ' ' LEU . 19.6 t60 -143.11 123.1 13.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 2.52 109.641 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.567 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -170.1 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -0.858 . . . . 1.97 109.199 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.627 ' C ' ' H ' ' A' ' 16' ' ' ALA . 46.2 m -109.94 63.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 1.96 109.719 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -66.5 21.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 1.76 109.188 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.07 -63.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 1.1799999999999999 109.939 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' SER . 3.4 mm-40 -111.73 39.87 2.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 2.1299999999999999 109.912 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 1.9 m 160.39 147.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 2.2599999999999998 109.79 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 -72.04 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 2.6000000000000001 109.608 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 118.98 -167.48 13.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.515 -1.434 . . . . 1.6200000000000001 109.515 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 17.1 Cg_exo -62.02 -20.14 68.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.567 2.178 . . . . 1.7 111.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 13.8 m95 -65.46 -166.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 2.4199999999999999 109.414 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -150.29 174.65 12.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 1.6399999999999999 109.619 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.662 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 54.7 tp -170.85 148.1 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 2.0499999999999998 109.451 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.745 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 165.04 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 1.72 109.691 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 79.31 -22.09 3.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.849 -1.3 . . . . 1.7 109.849 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.94 -142.01 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -1.213 . . . . 0.96999999999999997 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.1 p -90.67 136.91 32.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 1.8 109.163 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 28' ' ' SER . 51.9 mm-40 -32.5 97.03 0.1 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 2.3999999999999999 109.732 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 28' ' ' SER . 32.1 Cg_exo -53.13 163.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 1.1299999999999999 111.342 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 30' ' ' PRO . 97.0 t -154.17 134.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.155 . . . . 1.05 110.742 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -90.07 85.91 6.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.583 0.706 . . . . 1.8200000000000001 109.407 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.52 -139.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.1699999999999999 109.996 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.55 76.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.406 -0.809 . . . . 2.21 110.059 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 55.49 23.38 34.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.942 -1.263 . . . . 1.1899999999999999 109.942 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 33' ' ' ALA . 2.2 ptp180 -136.25 143.15 44.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -1.211 . . . . 2.9100000000000001 109.435 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.77 ' SD ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -114.61 148.4 38.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.93000000000000005 109.411 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.77 ' N ' ' SD ' ' A' ' 37' ' ' MET . 3.8 t -157.03 163.37 39.13 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.574 -0.85 . . . . 1.0600000000000001 110.17 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG23 HD13 ' A' ' 41' ' ' LEU . 21.5 m -136.14 150.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.265 -1.013 . . . . 1.3700000000000001 108.265 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.733 ' C ' HD12 ' A' ' 41' ' ' LEU . 18.9 m-20 -97.9 99.25 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 4.79 110.183 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.733 HD12 ' C ' ' A' ' 40' ' ' ASP . 8.5 mp -113.15 91.09 17.77 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 3.54 109.12 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.45 -87.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.906 2.404 . . . . 3.7400000000000002 112.318 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.2 96.19 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.441 . . . . 2.0299999999999998 109.499 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.47 31.96 0.05 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.515 -1.434 . . . . 2.4100000000000001 109.515 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.479 ' NE2' ' HA3' ' A' ' 134' ' ' GLY . 2.9 mt-30 -99.99 174.19 6.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -1.173 . . . . 2.96 109.41 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.66 -41.88 8.06 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 2.0800000000000001 109.502 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' OD2' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -167.01 157.54 10.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 3.6099999999999999 109.426 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.51 -39.87 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.842 2.361 . . . . 2.3599999999999999 112.211 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.608 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 4.9 p90 -91.9 55.33 2.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.917 . . . . 3.8700000000000001 109.47 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.649 ' OD2' ' N ' ' A' ' 47' ' ' ASN . 70.4 m-20 -128.33 1.94 5.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 2.3799999999999999 109.458 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.416 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -175.31 172.95 2.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 1.1100000000000001 109.509 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 24' ' ' LEU . . . 131.42 -164.38 23.47 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.586 -1.405 . . . . 0.93999999999999995 109.586 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD21 ' CD2' ' A' ' 131' ' ' PHE . 1.1 pp -109.73 161.77 15.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -1.093 . . . . 0.95999999999999996 109.2 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 129' ' ' VAL . 2.1 t -152.21 161.12 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.92000000000000004 109.769 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 33.1 t80 -175.31 147.79 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 1.71 109.476 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.681 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.3 m-80 -107.16 160.94 15.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.263 -0.898 . . . . 2.7799999999999998 109.396 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 112.75 74.15 0.67 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 2.48 109.577 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.498 HG22 ' HA3' ' A' ' 127' ' ' GLY . 19.7 m -155.45 66.2 4.64 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.247 -1.149 . . . . 3.79 109.439 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.63 137.01 41.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.759 2.306 . . . . 2.3999999999999999 112.155 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 66' ' ' TYR . 10.6 t -135.66 139.99 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 3.0800000000000001 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -107.73 117.17 5.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.51 -1.436 . . . . 3.0499999999999998 109.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -45.69 128.03 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 6.0499999999999998 109.526 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.461 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 113.25 -25.77 11.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.686 -1.366 . . . . 2.54 109.686 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' O ' ' OG ' ' A' ' 115' ' ' SER . 4.9 mt-10 -100.05 173.58 6.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -1.163 . . . . 4.0300000000000002 109.646 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 2.9100000000000001 109.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.711 ' CD1' HG22 ' A' ' 60' ' ' VAL . 41.7 m-85 -104.36 -179.63 4.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.268 -0.895 . . . . 2.3799999999999999 109.592 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 112' ' ' ALA . 1.4 p -160.93 143.84 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 2.6099999999999999 109.668 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -126.52 118.46 24.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 3.6099999999999999 109.512 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.51 94.59 5.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 2.27 109.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 4.4 p90 -93.64 147.01 23.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.096 -1.002 . . . . 2.0099999999999998 110.954 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.3 p -95.02 112.56 24.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.188 -1.041 . . . . 1.8 108.188 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 143' ' ' ILE . . . -165.51 153.71 11.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.696 -1.253 . . . . 0.95999999999999996 110.797 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.52 148.67 49.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.713 -0.847 . . . . 0.93000000000000005 108.713 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' N ' ' O ' ' A' ' 103' ' ' THR . . . -113.13 124.79 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.984 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.584 ' CA ' ' H ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -130.72 132.79 24.17 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.309 -0.869 . . . . 0.96999999999999997 108.704 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.611 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.5 Cg_exo -73.15 27.7 0.43 Allowed 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 124.665 -0.973 . . . . 1.02 112.779 -0.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.716 ' O ' ' SD ' ' A' ' 78' ' ' MET . 2.4 m-20 89.29 152.52 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.514 -0.551 . . . . 1.75 109.514 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.716 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 161.54 174.57 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.965 -1.124 . . . . 2.1600000000000001 107.965 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.507 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 10.5 Cg_endo -81.98 145.74 14.18 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.454 2.102 . . . . 1.3799999999999999 112.218 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.886 HG12 ' OH ' ' A' ' 139' ' ' TYR . 7.5 m -113.58 159.15 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 2.0099999999999998 109.719 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.12 123.5 49.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 6.0099999999999998 109.236 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.415 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER -136.18 149.09 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 3.7599999999999998 109.521 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 1.3 pp -145.67 144.41 30.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.29 109.664 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -151.82 151.48 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 1.8899999999999999 109.781 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.52 -137.6 5.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.451 -1.46 . . . . 1.49 109.451 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -88.52 -165.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 2.54 109.446 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.56 -1.416 . . . . 1.3799999999999999 109.56 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.639 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.481 -0.563 . . . . 5.7400000000000002 109.481 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -128.28 167.95 16.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 2.27 109.892 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.92 -23.15 11.51 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.651 -0.87 . . . . 3.2799999999999998 108.651 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.99 36.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.358 -0.839 . . . . 3.6499999999999999 108.945 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -84.5 44.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 4.5999999999999996 109.595 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.581 ' O ' ' CG ' ' A' ' 97' ' ' GLN . 10.1 pt20 -102.4 121.18 41.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 3.46 109.341 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -111.24 6.3 28.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.587 -1.405 . . . . 3.6699999999999999 109.587 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.37 77.26 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -1.139 . . . . 3.79 109.514 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.759 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -116.98 81.8 12.75 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.117 -0.99 . . . . 1.96 109.448 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 45.2 Cg_exo -52.09 143.05 42.76 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.845 2.363 . . . . 2.9700000000000002 112.29 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.466 HD12 HG11 ' A' ' 80' ' ' VAL . 14.0 mt -143.58 154.19 43.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 3.0600000000000001 109.505 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.44 -162.4 0.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.3399999999999999 109.608 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.676 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -102.1 -9.68 41.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.64 -1.384 . . . . 2.1699999999999999 109.64 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.549 ' OE2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -99.89 134.46 20.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.181 -1.188 . . . . 3.02 108.957 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.549 ' O ' ' OE2' ' A' ' 105' ' ' GLU . 85.7 Cg_exo -37.27 117.55 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 1.4199999999999999 112.139 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.43 137.08 16.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 1.3700000000000001 109.674 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.07 152.5 20.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 1.72 109.831 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.729 ' CG ' HH11 ' A' ' 109' ' ' ARG . 0.0 OUTLIER -129.36 138.92 51.81 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.051 -1.092 . . . . 4.7000000000000002 108.051 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -120.57 118.45 30.24 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.759 -0.776 . . . . 3.2799999999999998 110.671 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.759 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 7.3 m-85 -115.16 118.83 34.44 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.549 -0.908 . . . . 2.96 108.549 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.422 ' HB2' HG23 ' A' ' 67' ' ' VAL . . . -107.85 146.64 32.0 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 3.4100000000000001 109.948 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.739 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -129.71 163.35 26.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 2.77 109.32 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.53 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -97.96 104.44 16.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 2.23 109.63 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.4 m -37.16 104.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 4.1100000000000003 109.305 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.15 14.72 27.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 6.8600000000000003 109.556 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 118' ' ' THR . 8.3 tt -169.21 171.86 7.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 5.1200000000000001 109.444 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.842 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -95.26 114.84 26.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.175 -0.953 . . . . 4.0599999999999996 109.697 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 117' ' ' LEU . 55.5 m-85 -110.58 94.53 19.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 5.4400000000000004 109.402 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.26 158.18 23.05 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.611 2.207 . . . . 4.04 112.196 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.34 -27.53 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.723 2.282 . . . . 3.8999999999999999 111.948 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 19.3 p-10 -109.96 -163.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 4.1399999999999997 109.478 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 66.23 169.3 3.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.573 -1.411 . . . . 3.5699999999999998 109.573 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.22 45.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 3.5899999999999999 109.423 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -163.18 55.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 2.0800000000000001 109.54 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 47.5 Cg_endo -72.91 -158.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.827 2.352 . . . . 1.3899999999999999 112.189 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.498 ' HA3' HG22 ' A' ' 58' ' ' VAL . . . -86.91 157.06 29.26 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.542 -1.423 . . . . 1.1899999999999999 109.542 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -141.91 114.48 8.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -1.178 . . . . 2.0099999999999998 109.582 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.5 t -131.66 128.5 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 1.28 108.853 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -157.0 114.56 3.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.97999999999999998 110.101 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.477 ' CD2' HD21 ' A' ' 53' ' ' LEU . 4.9 m-30 -92.21 119.38 31.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.645 -0.872 . . . . 1.73 108.645 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 42.0 m170 -105.4 127.1 52.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 2.3199999999999998 109.623 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -128.87 -34.67 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 2.1099999999999999 109.468 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.54 127.16 0.57 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.651 -1.38 . . . . 1.77 109.651 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.684 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 16.4 mttt -166.99 130.71 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 5.0599999999999996 109.73 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.36 -19.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.095 -1.076 . . . . 2.6400000000000001 108.095 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.1 17.11 7.14 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.815 -1.714 . . . . 2.5099999999999998 108.815 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.684 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -51.43 -151.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.943 . . . . 2.3199999999999998 110.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.886 ' OH ' HG12 ' A' ' 80' ' ' VAL . 2.7 p90 -171.91 -161.82 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 1.6100000000000001 109.511 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.57 142.85 26.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 1.6499999999999999 109.718 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.559 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 31.1 t80 -128.07 107.61 9.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.481 -0.762 . . . . 1.6799999999999999 109.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 69.8 m -110.36 102.84 11.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.11 -0.994 . . . . 0.73999999999999999 110.989 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -120.88 144.43 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.486 -0.931 . . . . 1.22 108.486 178.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 143' ' ' ILE . 29.6 p -121.91 -8.7 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.95 -0.7 . . . . 1.3300000000000001 109.815 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.582 ' O ' ' OG1' ' A' ' 71' ' ' THR . 11.9 pt20 -168.9 176.77 5.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.649 -1.22 . . . . 3.2999999999999998 111.023 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.562 ' O ' ' OG1' ' A' ' 13' ' ' THR . 7.3 p -170.42 159.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.073 -0.714 . . . . 2.2599999999999998 109.073 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.467 ' N ' HG22 ' A' ' 146' ' ' VAL . 0.3 OUTLIER -148.74 158.54 44.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 2.7599999999999998 109.78 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 149' ' ' THR . 1.1 pp -143.72 155.22 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 4.5700000000000003 109.428 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.78 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 3.0699999999999998 109.546 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.664 ' N ' ' OG1' ' A' ' 149' ' ' THR . 4.7 t . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 2.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.393 -0.595 . . . . 2.8300000000000001 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -125.67 86.13 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 4.75 109.479 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.46 -33.84 74.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 4.9500000000000002 109.395 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER -108.17 95.43 15.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.632 -0.877 . . . . 2.8599999999999999 108.632 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.39 49.1 1.35 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.081 1.854 . . . . 3.8300000000000001 111.983 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.619 ' H ' HD13 ' A' ' 10' ' ' LEU . 82.0 t60 -152.77 129.46 10.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.391 -0.818 . . . . 2.52 109.639 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.637 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -167.45 57.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 1.97 109.492 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.8 t -151.22 67.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 1.96 109.552 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -62.64 39.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 1.76 109.091 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -86.79 -36.84 18.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 1.1799999999999999 109.858 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.691 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 15.3 mm-40 -111.7 -57.73 2.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 2.1299999999999999 109.581 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 p -128.2 143.54 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 2.2599999999999998 109.468 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.857 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -55.36 -15.98 3.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 2.6000000000000001 109.465 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 83.43 -154.37 31.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.571 -1.411 . . . . 1.6200000000000001 109.571 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.47 -11.51 15.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 1.7 112.089 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 10.9 m95 -65.14 -163.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 2.4199999999999999 109.307 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.671 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.7 m -156.58 164.0 38.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 1.6399999999999999 109.313 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -168.38 160.07 11.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 2.0499999999999998 109.803 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.73 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 167.04 177.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 1.72 109.558 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 92.26 -23.44 27.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.941 -1.264 . . . . 1.7 109.941 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.785 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.86 -142.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.24 . . . . 0.96999999999999997 109.271 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.785 ' N ' ' OG1' ' A' ' 27' ' ' THR . 33.4 p -91.09 130.19 37.01 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.185 -0.947 . . . . 1.8 109.096 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.554 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -35.81 100.44 0.2 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 2.3999999999999999 109.176 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HG2' HD13 ' A' ' 24' ' ' LEU . 64.2 Cg_exo -46.11 154.07 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.381 2.054 . . . . 1.1299999999999999 111.643 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' MET . 4.2 t -138.53 115.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.996 -1.065 . . . . 1.05 110.395 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.45 84.28 3.18 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.534 0.683 . . . . 1.8200000000000001 109.218 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -78.39 -119.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.425 -0.797 . . . . 1.1699999999999999 110.229 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.804 ' H ' HH12 ' A' ' 36' ' ' ARG . 22.5 t0 -58.36 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.21 110.15 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 64.04 8.28 28.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.748 -1.341 . . . . 1.1899999999999999 109.748 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.804 HH12 ' H ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -126.91 144.45 50.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -1.233 . . . . 2.9100000000000001 109.604 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.778 ' HE2' HG13 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -109.87 130.44 55.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.93000000000000005 109.015 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -127.77 153.51 46.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.44 -0.904 . . . . 1.0600000000000001 110.593 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.778 HG13 ' HE2' ' A' ' 37' ' ' MET . 1.5 m -122.69 163.43 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.351 -0.981 . . . . 1.3700000000000001 108.351 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.864 ' C ' HD22 ' A' ' 41' ' ' LEU . 34.3 m-20 -107.78 102.54 11.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 4.79 110.189 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.864 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.2 mm? -126.33 48.23 2.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 3.54 109.265 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 76.9 Cg_exo -39.02 -71.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.904 2.402 . . . . 3.7400000000000002 112.34 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.7 77.85 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 2.0299999999999998 109.545 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.87 28.69 0.23 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.477 -1.449 . . . . 2.4100000000000001 109.477 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.425 ' NE2' ' HB3' ' A' ' 50' ' ' ASP . 8.7 mm-40 -99.95 144.04 29.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 2.96 109.501 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.29 -66.18 1.89 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.55 -1.42 . . . . 2.0800000000000001 109.55 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.772 ' ND2' ' NE1' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -99.89 156.72 35.01 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.172 -1.193 . . . . 3.6099999999999999 109.518 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 50' ' ' ASP . 46.3 Cg_endo -72.63 -33.52 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.827 2.351 . . . . 2.3599999999999999 112.314 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.772 ' NE1' ' ND2' ' A' ' 47' ' ' ASN . 28.7 p90 -73.65 21.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 3.8700000000000001 109.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 23.2 m-20 -102.49 26.57 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 2.3799999999999999 109.51 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 168.99 129.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 1.1100000000000001 109.488 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 159.29 163.96 13.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.8 -1.32 . . . . 0.93999999999999995 109.8 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -92.03 -169.31 2.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -1.098 . . . . 0.95999999999999996 109.341 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 23' ' ' SER . 1.5 p -174.32 165.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.288 -0.883 . . . . 0.92000000000000004 110.182 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.692 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 16.5 t80 173.16 140.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.511 -0.743 . . . . 1.71 109.405 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.692 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -102.5 -177.24 3.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.185 -0.947 . . . . 2.7799999999999998 109.618 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.37 61.81 1.37 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.626 -1.389 . . . . 2.48 109.626 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 58' ' ' VAL . 4.8 m -152.56 60.34 3.35 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 3.79 109.415 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 54.4 Cg_exo -47.22 146.9 6.14 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.875 2.383 . . . . 2.3999999999999999 112.192 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.03 92.36 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 3.0800000000000001 109.502 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -84.66 111.35 3.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 3.0499999999999998 109.513 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.56 123.53 13.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -1.104 . . . . 6.0499999999999998 109.466 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.79 -44.41 1.18 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 2.54 109.669 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' O ' ' OG ' ' A' ' 115' ' ' SER . 7.2 mt-10 -100.01 -179.98 4.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -1.152 . . . . 4.0300000000000002 109.634 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' OG1' ' A' ' 150' ' ' THR . 69.7 m -128.19 138.32 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.386 -0.821 . . . . 2.9100000000000001 109.362 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 44.5 m-85 -101.95 179.48 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 2.3799999999999999 109.624 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -152.15 141.72 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 2.6099999999999999 109.234 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.718 ' CD1' HD22 ' A' ' 148' ' ' LEU . 6.3 tp -127.91 113.11 15.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 3.6099999999999999 109.954 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.54 92.59 4.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.421 -0.955 . . . . 2.27 108.421 179.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 30.9 p90 -93.87 147.92 22.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 2.0099999999999998 111.074 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -98.59 105.24 17.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.265 -1.013 . . . . 1.8 108.265 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.482 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -152.02 159.18 43.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.725 -1.235 . . . . 0.95999999999999996 110.823 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.26 124.65 20.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.807 -0.812 . . . . 0.93000000000000005 108.807 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -86.16 129.46 34.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.67000000000000004 109.787 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.464 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.53 116.09 14.96 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.96999999999999997 109.302 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.73 -142.52 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 124.374 -1.094 . . . . 1.02 112.463 -0.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -95.5 151.49 19.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.917 . . . . 1.75 109.66 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 160.37 162.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 2.1600000000000001 109.401 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.568 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 57.8 Cg_endo -76.2 138.74 20.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.922 2.415 . . . . 1.3799999999999999 112.526 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -104.91 169.76 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 2.0099999999999998 109.287 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.741 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -109.91 149.03 30.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.399 -0.813 . . . . 6.0099999999999998 109.444 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 81' ' ' ARG . 19.3 t -152.64 148.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 3.7599999999999998 109.343 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.623 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.4 pp -152.55 146.07 24.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 2.29 109.739 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 129' ' ' VAL . 0.9 OUTLIER -153.69 149.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 1.8899999999999999 109.63 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.94 -141.29 7.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.48 -1.448 . . . . 1.49 109.48 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.734 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -89.94 -158.62 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -1.127 . . . . 2.54 109.459 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.478 -1.449 . . . . 1.3799999999999999 109.478 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.253 0.549 . . . . 5.7400000000000002 109.536 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.35 163.86 16.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 2.27 109.89 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.04 -20.33 12.75 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.801 -0.815 . . . . 3.2799999999999998 108.801 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.81 36.16 0.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.844 . . . . 3.6499999999999999 109.16 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.83 56.34 3.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 4.5999999999999996 109.558 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -107.42 124.63 50.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 3.46 109.192 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -117.52 3.5 17.86 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.545 -1.422 . . . . 3.6699999999999999 109.545 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -89.28 72.61 8.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -1.157 . . . . 3.79 109.466 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.812 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -116.16 93.76 39.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 1.96 109.446 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 12.5 Cg_exo -65.98 116.9 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.855 2.37 . . . . 2.9700000000000002 112.512 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 101' ' ' PRO . 3.3 mm? -117.42 152.88 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 3.0600000000000001 109.339 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 8.5 t -105.21 -161.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.92 . . . . 2.3399999999999999 109.651 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -93.59 -22.31 26.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.75 -1.34 . . . . 2.1699999999999999 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -99.96 149.88 36.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.213 . . . . 3.02 109.437 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.46 118.87 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.771 2.314 . . . . 1.4199999999999999 112.062 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -144.17 126.01 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 1.3700000000000001 109.718 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.1 151.54 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 1.72 110.075 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.714 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -135.38 138.2 43.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.471 -0.937 . . . . 4.7000000000000002 108.471 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -117.67 111.65 19.44 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.979 -0.688 . . . . 3.2799999999999998 110.516 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -109.86 117.74 34.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.562 -0.903 . . . . 2.96 108.562 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.28 140.65 39.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.219 -0.926 . . . . 3.4100000000000001 109.665 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.721 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -126.3 162.87 24.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 2.77 109.45 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -98.94 103.48 15.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.23 109.531 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 61' ' ' GLY . 3.4 m -37.15 110.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 4.1100000000000003 109.356 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.819 ' O ' HD22 ' A' ' 117' ' ' LEU . 9.8 p-10 -115.98 -10.38 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 6.8600000000000003 109.467 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.819 HD22 ' O ' ' A' ' 116' ' ' ASN . 2.1 mm? -130.1 128.47 41.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 5.1200000000000001 109.459 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.13 113.81 12.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 4.0599999999999996 109.465 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 117' ' ' LEU . 18.3 m-85 -125.31 75.55 68.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 5.4400000000000004 109.483 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -52.91 167.2 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.746 2.297 . . . . 4.04 112.069 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.67 -24.44 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.771 2.314 . . . . 3.8999999999999999 112.076 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -110.39 160.77 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 4.1399999999999997 109.5 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.9 -137.16 13.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.541 -1.424 . . . . 3.5699999999999998 109.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 123' ' ' GLY . 20.5 m-20 -36.7 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 3.5899999999999999 109.497 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.5 150.55 34.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 2.0800000000000001 109.419 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.68 -158.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.801 2.334 . . . . 1.3899999999999999 112.2 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.517 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -61.86 168.03 14.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.531 -1.427 . . . . 1.1899999999999999 109.531 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.97 133.22 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -1.108 . . . . 2.0099999999999998 109.595 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.517 HG22 HG13 ' A' ' 84' ' ' VAL . 59.8 t -139.56 151.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.644 -0.872 . . . . 1.28 108.644 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -167.02 112.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 0.97999999999999998 110.207 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -85.56 112.9 21.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.319 -0.863 . . . . 1.73 108.703 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.623 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 2.4 m170 -99.77 120.51 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.3199999999999998 109.978 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -140.06 5.09 2.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 2.1099999999999999 109.271 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -80.26 122.18 5.67 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.526 -1.43 . . . . 1.77 109.526 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.69 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.4 mtpp -163.96 135.78 4.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 5.0599999999999996 109.668 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.91 -13.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.404 -0.961 . . . . 2.6400000000000001 108.404 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -121.57 5.35 10.8 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.099 -1.601 . . . . 2.5099999999999998 109.099 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -52.34 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -1.035 . . . . 2.3199999999999998 109.937 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.568 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -170.78 -161.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.934 -1.103 . . . . 1.6100000000000001 109.411 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -80.18 143.34 33.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 1.6499999999999999 109.486 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.482 ' CE1' ' HB1' ' A' ' 72' ' ' ALA . 28.6 t80 -126.56 110.27 13.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 1.6799999999999999 109.239 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.0 104.83 14.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 110.558 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.51 HG23 ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -120.27 142.77 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 1.22 108.74 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 24.8 p -137.73 -3.42 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.636 -0.665 . . . . 1.3300000000000001 109.567 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.539 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -154.92 160.24 41.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.143 -0.973 . . . . 3.2999999999999998 110.061 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.637 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.2 t -143.38 152.61 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.434 -0.791 . . . . 2.2599999999999998 109.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 69' ' ' SER . 26.5 t -125.62 128.23 47.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 2.7599999999999998 109.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.718 HD22 ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -129.82 111.6 12.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 4.5700000000000003 109.208 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.584 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -160.98 -171.66 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 3.0699999999999998 109.626 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 65' ' ' SER . 7.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 2.0 109.433 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.82 ' N ' ' HG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.412 -0.588 . . . . 2.8300000000000001 109.412 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -85.53 82.16 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 4.75 109.477 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.615 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -44.39 -19.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 4.9500000000000002 109.444 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER -121.66 84.17 42.76 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.8599999999999999 108.628 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.1 20.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.973 2.448 . . . . 3.8300000000000001 112.131 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.58 ' H ' ' C ' ' A' ' 10' ' ' LEU . 69.9 t60 -118.64 99.29 6.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 2.52 109.672 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.892 ' O ' HG23 ' A' ' 13' ' ' THR . 5.5 t -139.12 56.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 1.97 109.339 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.619 ' C ' ' H ' ' A' ' 16' ' ' ALA . 44.4 m -142.49 61.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 1.96 109.785 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.7 m-30 -66.05 33.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 1.76 109.0 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.626 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.06 -35.26 15.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.1799999999999999 110.014 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -109.97 -84.53 0.55 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.121 -0.987 . . . . 2.1299999999999999 109.599 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 p -94.35 144.02 25.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.2599999999999998 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -55.77 -53.57 55.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 2.6000000000000001 109.459 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.472 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 111.98 -164.14 12.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 1.6200000000000001 109.682 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 56.7 Cg_endo -76.31 -4.51 15.15 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.833 2.355 . . . . 1.7 112.367 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.863 ' CH2' HG11 ' A' ' 146' ' ' VAL . 8.3 m95 -66.67 -177.63 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 2.4199999999999999 109.418 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -133.6 167.32 20.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 1.6399999999999999 109.277 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.008 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.5 pp 179.43 142.76 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.133 -0.979 . . . . 2.0499999999999998 109.809 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.82 173.78 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.464 -0.773 . . . . 1.72 109.453 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 102.29 -31.87 8.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.199 -1.16 . . . . 1.7 110.199 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.79 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.86 -141.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.957 -1.319 . . . . 0.96999999999999997 109.645 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.79 ' N ' ' OG1' ' A' ' 27' ' ' THR . 13.7 p -91.35 132.71 36.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.538 -0.726 . . . . 1.8 109.329 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 pt-20 -37.44 106.96 0.37 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.139 -0.976 . . . . 2.3999999999999999 109.055 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HG2' HD22 ' A' ' 24' ' ' LEU . 53.6 Cg_exo -45.54 150.01 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.226 1.951 . . . . 1.1299999999999999 111.691 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 t -136.83 123.07 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 1.05 110.103 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.84 115.4 17.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 1.8200000000000001 109.362 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 35' ' ' GLY . . . -81.76 -140.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 1.1699999999999999 109.733 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.53 13.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 2.21 110.057 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.626 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 144.11 -4.77 1.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.945 -1.262 . . . . 1.1899999999999999 109.945 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -121.57 152.22 39.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.005 -1.291 . . . . 2.9100000000000001 109.571 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.656 ' SD ' HD23 ' A' ' 19' ' ' LEU . 59.2 ttp -116.65 134.37 54.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.93000000000000005 109.338 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -129.93 154.11 47.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 110.161 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.9 m -123.74 140.85 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.682 -0.858 . . . . 1.3700000000000001 108.682 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.72 ' C ' HD12 ' A' ' 41' ' ' LEU . 53.1 m-20 -79.8 108.87 13.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 4.79 109.704 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 133' ' ' LEU . 8.2 mp -116.29 76.29 6.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 3.54 109.508 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 61.2 Cg_endo -77.54 -74.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.796 2.331 . . . . 3.7400000000000002 112.201 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . -173.52 -157.37 15.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.588 -1.405 . . . . 2.0299999999999998 109.588 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 77.19 -4.0 56.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.658 -1.377 . . . . 2.4100000000000001 109.658 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.671 ' O ' ' N ' ' A' ' 47' ' ' ASN . 7.8 mm-40 -100.01 66.79 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -1.119 . . . . 2.96 109.435 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.77 49.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.59 -1.404 . . . . 2.0800000000000001 109.59 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.671 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -169.68 89.28 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.107 . . . . 3.6099999999999999 109.422 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.7 -0.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.876 2.384 . . . . 2.3599999999999999 112.356 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.674 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -122.88 34.08 5.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 3.8700000000000001 109.572 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.0 m-20 -108.7 -19.62 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 2.3799999999999999 109.654 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -139.77 177.42 7.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 1.1100000000000001 109.71 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 128.65 171.82 13.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.615 -1.394 . . . . 0.93999999999999995 109.615 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.571 ' C ' HG22 ' A' ' 54' ' ' VAL . 3.2 mt -89.74 -177.29 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 0.95999999999999996 109.323 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.31 174.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.92000000000000004 109.92 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 22' ' ' TRP . 18.1 t80 176.98 129.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.43 -0.794 . . . . 1.71 109.46 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.38 115.14 28.78 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.252 -0.905 . . . . 2.7799999999999998 109.525 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 70.96 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.48 -1.448 . . . . 2.48 109.48 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -170.06 95.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.343 -1.092 . . . . 3.79 109.416 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.453 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 58.7 Cg_endo -79.35 127.06 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.594 2.196 . . . . 2.3999999999999999 112.186 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.1 t -100.03 135.19 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 3.0800000000000001 109.578 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -115.23 101.79 1.07 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 3.0499999999999998 109.338 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 61' ' ' GLY . 14.9 tt0 -35.53 144.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.166 . . . . 6.0499999999999998 109.612 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.675 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 96.35 -25.94 23.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.692 -1.363 . . . . 2.54 109.692 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 115' ' ' SER . 18.0 mt-10 -104.84 164.84 11.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -1.175 . . . . 4.0300000000000002 109.767 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 58.2 m -120.7 141.41 50.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 2.9100000000000001 109.228 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.61 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 28.0 m-85 -108.55 -179.21 3.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 2.3799999999999999 109.73 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.675 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.0 t -152.76 144.83 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.489 -0.757 . . . . 2.6099999999999999 109.341 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.44 116.46 16.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 3.6099999999999999 109.797 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.74 95.88 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 2.27 108.874 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -93.08 139.41 30.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 2.0099999999999998 110.85 -179.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -94.51 104.75 16.71 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.857 -0.794 . . . . 1.8 108.857 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -175.97 169.18 2.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.792 -1.192 . . . . 0.95999999999999996 110.635 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.16 172.18 13.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.763 -0.829 . . . . 0.93000000000000005 108.763 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -120.59 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.67000000000000004 109.949 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.47 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.59 115.6 14.73 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.311 -0.868 . . . . 0.96999999999999997 109.468 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.0 Cg_exo -65.79 -142.18 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 124.392 -1.087 . . . . 1.02 112.341 -0.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -102.23 149.36 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 1.75 109.602 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.15 153.58 0.13 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 2.1600000000000001 109.438 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.72 163.78 28.68 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.829 2.353 . . . . 1.3799999999999999 112.491 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 35.8 m -136.5 -178.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.346 -0.846 . . . . 2.0099999999999998 109.305 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.717 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -126.56 117.78 23.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 6.0099999999999998 109.658 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.602 HG13 ' CD ' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -119.7 151.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 3.7599999999999998 109.259 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 130' ' ' ALA . 2.9 pp -143.03 156.39 44.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 2.29 109.909 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.456 ' CG2' ' C ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -154.03 159.8 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 1.8899999999999999 109.428 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 144.99 -142.92 11.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.578 -1.409 . . . . 1.49 109.578 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -90.17 -165.88 1.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 2.54 109.44 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.644 ' H ' ' HB3' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.556 -1.418 . . . . 1.3799999999999999 109.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.414 -0.588 . . . . 5.7400000000000002 109.414 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.463 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -139.77 173.53 11.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 2.27 109.966 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HB1' ' OD1' ' A' ' 116' ' ' ASN . . . -123.65 -19.62 5.74 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.823 -0.806 . . . . 3.2799999999999998 108.823 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.583 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.68 34.72 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 3.6499999999999999 109.203 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 4.5999999999999996 109.538 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' CD ' HG13 ' A' ' 82' ' ' VAL . 4.9 pt20 -107.79 -156.25 0.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 3.46 109.425 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -173.16 -35.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.688 -1.365 . . . . 3.6699999999999999 109.688 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -80.07 90.21 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -1.146 . . . . 3.79 109.518 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' HG23 ' A' ' 80' ' ' VAL . . . -123.13 78.71 51.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 1.96 109.461 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.83 127.14 24.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.018 2.479 . . . . 2.9700000000000002 112.547 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 102' ' ' LEU . 55.9 mt -140.41 145.74 37.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.0600000000000001 109.297 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -127.45 175.11 8.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 2.3399999999999999 109.701 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -77.79 17.68 5.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 2.1699999999999999 109.527 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -102.48 103.8 33.94 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.279 -1.13 . . . . 3.02 109.165 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -44.75 117.5 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.3 2.0 . . . . 1.4199999999999999 112.188 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.762 ' HB1' HH12 ' A' ' 109' ' ' ARG . . . -165.16 156.82 14.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.925 . . . . 1.3700000000000001 109.603 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.639 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.24 136.02 33.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.368 -0.833 . . . . 1.72 110.221 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.762 HH12 ' HB1' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -110.23 142.02 42.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.665 -1.235 . . . . 4.7000000000000002 107.665 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.75 105.69 13.59 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.763 -0.775 . . . . 3.2799999999999998 110.457 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -109.09 109.18 20.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.172 -1.048 . . . . 2.96 108.172 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -116.85 169.14 9.62 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 3.4100000000000001 109.807 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.3 p90 -154.73 -178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.835 . . . . 2.77 109.514 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -109.92 106.15 15.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.36 -0.837 . . . . 2.23 109.689 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.675 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 59.8 p -35.97 119.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 4.1100000000000003 109.316 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.527 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 3.7 m120 -96.26 -49.24 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 6.8600000000000003 109.576 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.72 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.81 -156.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 5.1200000000000001 109.646 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.72 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -119.52 144.83 46.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.349 -0.844 . . . . 4.0599999999999996 109.491 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.56 ' CD1' ' O ' ' A' ' 118' ' ' THR . 74.6 m-85 -157.86 62.29 2.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 5.4400000000000004 109.497 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.503 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 45.7 Cg_exo -52.28 -173.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.852 2.368 . . . . 4.04 112.071 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 5.0 Cg_exo -71.23 -31.45 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.047 2.498 . . . . 3.8999999999999999 111.857 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -111.0 -161.56 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 4.1399999999999997 109.478 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 88.21 -149.02 21.08 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.514 -1.435 . . . . 3.5699999999999998 109.514 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.654 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -44.73 -50.03 10.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 3.5899999999999999 109.434 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.644 ' HB3' ' H ' ' A' ' 87' ' ' GLY . . . -165.68 155.09 10.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.0800000000000001 109.457 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.91 -158.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 1.3899999999999999 112.205 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.99 168.61 9.88 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.546 -1.422 . . . . 1.1899999999999999 109.546 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.566 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -148.86 118.77 7.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -1.175 . . . . 2.0099999999999998 109.656 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 54' ' ' VAL . 38.9 t -136.02 137.74 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 1.28 108.636 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -160.27 112.15 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.999 -1.063 . . . . 0.97999999999999998 110.506 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.4 m-30 -89.0 110.43 21.12 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.519 -0.919 . . . . 1.73 108.519 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.475 ' CD2' ' HA ' ' A' ' 49' ' ' TRP . 31.2 m80 -99.69 138.37 36.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 2.3199999999999998 110.031 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -155.93 17.11 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 2.1099999999999999 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -77.18 139.09 22.85 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.616 -1.393 . . . . 1.77 109.616 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 137' ' ' GLY . 18.7 mtpt -166.25 127.49 1.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.134 . . . . 5.0599999999999996 109.81 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.17 -15.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.0 -1.111 . . . . 2.6400000000000001 108.0 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.52 17.13 6.96 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.747 -1.741 . . . . 2.5099999999999998 108.747 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.86 -158.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.918 . . . . 2.3199999999999998 110.714 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.647 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 2.2 p90 -152.73 -119.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 1.6100000000000001 109.391 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.464 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 2.3 mt-10 -135.9 143.88 45.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 1.6499999999999999 109.228 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 38.1 t80 -124.5 127.39 47.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 1.6799999999999999 109.454 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.94 115.56 25.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.73999999999999999 110.506 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.41 143.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.759 0.79 . . . . 1.22 109.017 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' PHE . 52.3 p -120.66 -19.86 7.28 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.466 -0.939 . . . . 1.3300000000000001 108.466 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.563 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.9 pt20 -171.36 172.27 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.843 -0.743 . . . . 3.2999999999999998 109.646 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.863 HG11 ' CH2' ' A' ' 22' ' ' TRP . 8.8 p -147.16 141.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 2.2599999999999998 109.51 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.441 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -114.91 158.94 21.29 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.912 . . . . 2.7599999999999998 109.527 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 149' ' ' THR . 1.6 tp -168.22 114.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 4.5700000000000003 109.381 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.82 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 7.0 t -156.68 -164.03 1.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 3.0699999999999998 109.484 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.419 ' N ' ' OG1' ' A' ' 149' ' ' THR . 7.7 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 2.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.126 ' N ' ' HG1' ' A' ' 149' ' ' THR . 48.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.311 -0.626 . . . . 2.8300000000000001 109.311 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.598 ' C ' ' H ' ' A' ' 10' ' ' LEU . 6.3 pm0 -51.02 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 4.75 109.669 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 7' ' ' VAL . 8.6 mp -54.22 -1.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 4.9500000000000002 109.276 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.05 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -140.5 95.85 7.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 2.8599999999999999 108.943 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.07 38.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 3.8300000000000001 112.703 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.678 ' N ' ' O ' ' A' ' 10' ' ' LEU . 33.7 t60 -133.44 115.65 15.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 2.52 109.337 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.579 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -154.41 63.38 0.68 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.347 -0.846 . . . . 1.97 109.283 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 16' ' ' ALA . 16.2 m -159.47 66.8 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 1.96 109.512 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.8 m-30 -67.11 27.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 1.76 109.195 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.613 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.17 -29.53 18.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.847 . . . . 1.1799999999999999 109.956 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.458 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 4.3 mt-10 -109.73 -83.64 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 2.1299999999999999 109.78 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.4 m -96.46 143.77 27.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 2.2599999999999998 109.593 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' A' ' 37' ' ' MET . 3.9 mt -54.11 -51.38 64.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 2.6000000000000001 109.418 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.37 -171.59 16.76 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.591 -1.404 . . . . 1.6200000000000001 109.591 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 22' ' ' TRP . 47.5 Cg_endo -72.99 -18.54 24.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.759 2.306 . . . . 1.7 112.147 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.766 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.5 m95 -53.06 -174.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 2.4199999999999999 109.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -135.81 173.79 11.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 1.6399999999999999 109.525 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.573 HD13 ' CG ' ' A' ' 30' ' ' PRO . 2.7 pp -177.81 142.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 2.0499999999999998 109.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.91 170.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 1.72 109.793 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.06 -29.73 10.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.97 -1.252 . . . . 1.7 109.97 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.773 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.73 -141.94 0.38 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.083 -1.245 . . . . 0.96999999999999997 109.3 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.773 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.7 p -91.15 -170.58 2.7 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 1.8 109.172 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.22 111.34 46.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 109.041 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.573 ' CG ' HD13 ' A' ' 24' ' ' LEU . 76.7 Cg_exo -44.66 134.9 9.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.201 1.934 . . . . 1.1299999999999999 111.921 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 37' ' ' MET . 9.2 t -116.95 105.07 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 1.05 109.918 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -69.24 77.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.568 -0.708 . . . . 1.8200000000000001 109.416 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -60.67 -140.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.1699999999999999 109.766 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -35.48 -76.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 2.21 109.503 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.21 49.71 0.71 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.586 -1.406 . . . . 1.1899999999999999 109.586 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -173.15 150.38 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 2.9100000000000001 109.398 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' HD21 ' A' ' 19' ' ' LEU . 4.5 ptt? -108.87 134.03 52.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 109.562 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.68 135.51 54.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.627 -0.829 . . . . 1.0600000000000001 110.427 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.1 m -106.07 140.66 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.672 -0.862 . . . . 1.3700000000000001 108.672 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.645 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.2 m-20 -77.35 106.53 9.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 4.79 109.922 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 133' ' ' LEU . 6.6 mp -114.26 80.67 5.92 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 3.54 109.157 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.23 -95.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 3.7400000000000002 112.263 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.17 137.29 4.85 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.651 -1.379 . . . . 2.0299999999999998 109.651 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 155.71 -17.85 0.49 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 2.4100000000000001 109.51 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.601 HE22 ' H ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -99.51 61.99 1.2 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.235 -1.156 . . . . 2.96 109.632 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -36.48 -33.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.249 -1.54 . . . . 2.0800000000000001 109.249 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -107.69 101.83 41.97 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.364 -1.08 . . . . 3.6099999999999999 109.037 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.449 ' O ' ' CG ' ' A' ' 132' ' ' HIS . 36.2 Cg_exo -56.36 44.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.457 2.105 . . . . 2.3599999999999999 112.315 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.693 ' CH2' ' OD2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -117.12 49.75 1.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.99 . . . . 3.8700000000000001 111.28 -179.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.693 ' OD2' ' CH2' ' A' ' 49' ' ' TRP . 23.9 m-20 -165.07 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 2.3799999999999999 109.465 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.601 ' H ' HE22 ' A' ' 45' ' ' GLN . . . -81.06 120.04 24.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 1.1100000000000001 109.546 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.604 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 162.59 179.2 37.03 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.683 -1.246 . . . . 0.93999999999999995 110.041 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.979 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.5 mm? -100.07 168.01 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -1.04 . . . . 0.95999999999999996 109.009 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -155.89 166.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.92000000000000004 109.825 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 1.05 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 13.1 t80 173.92 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 1.71 109.571 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.568 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-80 -98.93 150.03 22.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 109.548 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.434 ' H ' ' HA3' ' A' ' 127' ' ' GLY . . . 127.69 52.54 0.14 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 2.48 109.589 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.721 HG13 HD22 ' A' ' 148' ' ' LEU . 14.7 t -142.79 70.59 19.64 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 3.79 109.457 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -47.66 143.57 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.834 2.356 . . . . 2.3999999999999999 112.208 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.53 122.04 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 3.0800000000000001 109.461 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.17 91.72 0.69 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 3.0499999999999998 109.492 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 3.5 tm-20 -41.81 120.42 1.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 6.0499999999999998 109.46 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.31 -48.82 0.93 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.807 -1.317 . . . . 2.54 109.807 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.507 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.6 mp0 -100.03 179.71 4.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 4.0300000000000002 109.623 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.57 ' OG ' HG22 ' A' ' 114' ' ' THR . 58.5 m -120.28 140.99 50.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 2.9100000000000001 109.396 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 38.6 m-85 -109.53 -178.13 3.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.202 -0.936 . . . . 2.3799999999999999 109.474 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 66' ' ' TYR . 22.9 t -152.79 130.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 2.6099999999999999 109.511 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 69' ' ' SER . 8.0 tt -110.7 147.51 34.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 3.6099999999999999 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.968 ' N ' HD23 ' A' ' 68' ' ' LEU . 1.6 p -130.2 91.05 3.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 2.27 109.455 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 109' ' ' ARG . 29.5 p90 -94.63 139.56 31.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 2.0099999999999998 110.966 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.801 HG23 HG23 ' A' ' 108' ' ' THR . 1.1 p -97.0 134.68 40.05 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.641 -0.874 . . . . 1.8 108.641 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.803 ' N ' HH22 ' A' ' 109' ' ' ARG . . . 169.37 -170.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.951 -1.093 . . . . 0.95999999999999996 110.481 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -169.11 147.68 3.88 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.816 -0.809 . . . . 0.93000000000000005 108.816 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -104.72 134.04 48.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.116 -0.99 . . . . 0.67000000000000004 109.85 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.45 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.04 116.4 15.63 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.4 -0.812 . . . . 0.96999999999999997 109.292 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.21 -142.29 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.665 0 C-N-CA 124.297 -1.126 . . . . 1.02 112.344 -0.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -104.96 148.8 26.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.75 109.253 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.724 ' SD ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 ptp 174.43 154.45 0.3 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 2.1600000000000001 109.535 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.14 117.93 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.57 2.18 . . . . 1.3799999999999999 111.871 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -97.45 179.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.878 . . . . 2.0099999999999998 109.536 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -120.14 150.92 39.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 6.0099999999999998 109.65 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -142.47 147.89 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 3.7599999999999998 109.118 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -143.81 148.26 35.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 2.29 110.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -154.41 164.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.775 . . . . 1.8899999999999999 109.413 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.68 -138.9 6.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.687 -1.365 . . . . 1.49 109.687 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.1 pm0 -90.17 177.31 6.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -1.145 . . . . 2.54 109.489 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.523 -1.431 . . . . 1.3799999999999999 109.523 -179.968 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.554 ' C ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.427 -0.583 . . . . 5.7400000000000002 109.427 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER 179.96 -179.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 2.27 109.954 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.575 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.04 -22.1 4.91 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.873 -0.788 . . . . 3.2799999999999998 108.873 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.67 43.06 1.13 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.286 -0.884 . . . . 3.6499999999999999 109.227 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -86.59 61.0 6.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.111 -0.993 . . . . 4.5999999999999996 109.464 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.5 tt0 -99.93 161.57 13.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 3.46 109.04 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -135.43 -30.22 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.781 -1.327 . . . . 3.6699999999999999 109.781 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.01 95.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.259 -1.142 . . . . 3.79 109.819 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.769 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -137.41 77.48 40.82 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 1.96 109.32 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.03 120.06 6.2 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.027 2.485 . . . . 2.9700000000000002 112.701 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.427 HD12 ' CG2' ' A' ' 80' ' ' VAL . 11.9 mt -137.9 132.88 33.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 3.0600000000000001 109.357 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 5.1 t -128.84 -151.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 2.3399999999999999 109.521 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.31 58.34 2.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.632 -1.387 . . . . 2.1699999999999999 109.632 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.23 84.25 59.8 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -1.104 . . . . 3.02 109.481 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.726 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 51.0 Cg_exo -48.65 124.91 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.814 2.343 . . . . 1.4199999999999999 112.188 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 161.03 174.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 1.3700000000000001 109.444 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.801 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.08 131.9 35.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 1.72 109.929 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.803 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -100.74 140.97 34.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.092 -1.448 . . . . 4.7000000000000002 107.092 177.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 7.8 mt-10 -108.73 123.39 48.93 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.515 -0.874 . . . . 3.2799999999999998 110.94 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.769 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 7.5 m-85 -109.96 119.56 39.7 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.302 -0.999 . . . . 2.96 108.302 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.96 124.68 45.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.941 . . . . 3.4100000000000001 109.941 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.704 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -133.5 165.42 24.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 2.77 109.436 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.57 HG22 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -108.16 125.68 51.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 2.23 109.748 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 4.2 m -52.7 124.38 13.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.28 -0.887 . . . . 4.1100000000000003 109.213 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.68 ' O ' HD22 ' A' ' 117' ' ' LEU . 3.4 m120 -111.04 -46.67 3.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.151 -0.968 . . . . 6.8600000000000003 109.698 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 116' ' ' ASN . 3.3 mm? -120.96 139.72 52.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 5.1200000000000001 109.638 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.682 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -70.19 159.56 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 4.0599999999999996 109.291 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.682 ' CG ' ' O ' ' A' ' 118' ' ' THR . 32.1 m-85 -168.05 93.44 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 5.4400000000000004 109.492 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.09 165.8 21.31 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.722 2.281 . . . . 4.04 112.177 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.81 -15.05 12.22 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.716 2.278 . . . . 3.8999999999999999 112.042 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.83 132.65 53.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 4.1399999999999997 109.442 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.41 -137.47 9.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.546 -1.422 . . . . 3.5699999999999998 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -121.48 39.14 3.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 3.5899999999999999 109.454 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 86' ' ' GLU . . . -179.92 71.23 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 109.495 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.72 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.752 2.301 . . . . 1.3899999999999999 112.306 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -65.59 154.28 50.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.599 -1.401 . . . . 1.1899999999999999 109.599 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 9.2 tp-100 -151.52 130.46 12.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.104 -1.233 . . . . 2.0099999999999998 109.578 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.625 ' CG2' HG21 ' A' ' 58' ' ' VAL . 21.2 t -138.47 139.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 1.28 108.623 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.08 1.94 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.855 -1.153 . . . . 0.97999999999999998 110.929 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.3 m-30 -90.72 112.09 23.71 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.207 -1.035 . . . . 1.73 108.207 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.449 ' CG ' ' O ' ' A' ' 48' ' ' PRO . 34.8 m170 -99.88 131.3 45.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 2.3199999999999998 110.259 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.58 -23.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 2.1099999999999999 109.896 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.06 133.65 0.37 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.763 -1.335 . . . . 1.77 109.763 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 137' ' ' GLY . 29.7 mtmt -169.03 127.03 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -1.135 . . . . 5.0599999999999996 109.763 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.91 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.911 -1.144 . . . . 2.6400000000000001 107.911 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.04 18.61 7.44 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.037 -1.625 . . . . 2.5099999999999998 109.037 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.44 -154.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.625 -0.926 . . . . 2.3199999999999998 110.756 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.724 ' CD1' ' SD ' ' A' ' 78' ' ' MET . 7.4 p90 -158.91 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.995 -1.066 . . . . 1.6100000000000001 109.277 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.455 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 74.6 mm-40 -126.65 130.55 50.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 1.6499999999999999 108.867 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -107.71 114.64 28.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 1.6799999999999999 109.974 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.501 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 36.6 m -110.93 114.35 27.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.275 -0.891 . . . . 0.73999999999999999 109.65 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -123.26 145.03 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 1.22 109.517 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' PHE . 0.7 OUTLIER -131.0 -12.74 3.64 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.299 -0.63 . . . . 1.3300000000000001 109.299 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.578 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -158.93 158.95 34.34 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.372 -0.931 . . . . 3.2999999999999998 110.181 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.527 HG22 ' C ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -162.39 129.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 2.2599999999999998 108.91 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.96 144.06 8.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.062 . . . . 2.7599999999999998 109.675 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.721 HD22 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -122.11 164.99 16.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 4.5700000000000003 109.523 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 1.126 ' HG1' ' N ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -177.68 -174.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 3.0699999999999998 109.655 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.597 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.6 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 2.0 109.438 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.469 -0.567 . . . . 2.8300000000000001 109.469 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 7' ' ' VAL . 8.4 tt0 -37.21 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 4.75 109.626 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 mt -61.92 -34.59 76.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 4.9500000000000002 109.275 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.011 HD13 ' H ' ' A' ' 12' ' ' HIS . 2.8 tm? -107.53 100.4 34.04 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 2.8599999999999999 108.576 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.39 30.42 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.7 2.267 . . . . 3.8300000000000001 112.997 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 1.011 ' H ' HD13 ' A' ' 10' ' ' LEU . 28.2 t60 -115.42 82.05 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.848 -1.158 . . . . 2.52 109.369 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.492 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -121.27 45.85 2.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 1.97 109.338 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.1 t -125.45 72.19 1.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 1.96 109.461 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -83.21 23.95 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.198 -0.939 . . . . 1.76 109.362 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.784 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.02 -35.12 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 1.1799999999999999 109.696 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 26.4 mm-40 -109.86 -83.16 0.56 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.138 -0.976 . . . . 2.1299999999999999 109.729 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 m -88.22 144.44 26.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 2.2599999999999998 109.535 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.56 -58.45 8.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 2.6000000000000001 109.515 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.1 -169.98 13.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 1.6200000000000001 109.573 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 22' ' ' TRP . 55.9 Cg_endo -75.4 -19.21 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.793 2.329 . . . . 1.7 112.205 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.57 ' O ' ' O ' ' A' ' 21' ' ' PRO . 11.3 m95 -50.95 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 2.4199999999999999 109.345 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -143.25 169.85 16.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 1.6399999999999999 109.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.76 138.64 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 2.0499999999999998 109.574 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.96 159.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 1.72 109.439 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 107.45 -26.91 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.865 -1.294 . . . . 1.7 109.865 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.78 -142.35 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.96999999999999997 109.201 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 12.4 p -91.61 -162.14 0.89 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.459 -0.775 . . . . 1.8 108.999 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.01 131.4 39.27 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 2.3999999999999999 108.811 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.66 132.29 23.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.246 1.964 . . . . 1.1299999999999999 111.839 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 37' ' ' MET . 40.8 t -118.83 111.19 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.05 109.888 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.707 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.49 85.54 5.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.657 -0.652 . . . . 1.8200000000000001 109.49 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.25 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 1.1699999999999999 109.689 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.26 -68.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 2.21 109.369 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.784 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -141.55 35.19 1.82 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.465 . . . . 1.1899999999999999 109.436 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.77 147.89 28.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -1.12 . . . . 2.9100000000000001 109.64 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.5 ptt? -121.18 132.78 55.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 0.93000000000000005 109.231 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 m -128.89 145.02 51.33 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.452 -0.899 . . . . 1.0600000000000001 110.376 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.16 145.43 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.705 -0.85 . . . . 1.3700000000000001 108.705 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.695 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -75.12 123.39 25.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 4.79 109.802 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.695 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.4 mm? -122.69 75.02 45.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 3.54 109.258 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.663 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 51.6 Cg_exo -48.14 -167.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.871 2.381 . . . . 3.7400000000000002 112.359 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 136' ' ' ALA . . . -124.45 62.01 0.58 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.507 -1.437 . . . . 2.0299999999999998 109.507 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . -154.48 15.28 0.55 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 2.4100000000000001 109.627 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -99.93 91.35 4.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -1.164 . . . . 2.96 109.477 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.29 -7.95 61.26 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.496 -1.442 . . . . 2.0800000000000001 109.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.634 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.2 OUTLIER -99.9 121.68 53.38 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.274 -1.133 . . . . 3.6099999999999999 109.371 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.17 5.86 4.28 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.433 2.089 . . . . 2.3599999999999999 112.308 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.493 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -122.98 33.15 5.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 3.8700000000000001 109.604 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.762 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 34.5 m-20 -126.02 43.17 3.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 2.3799999999999999 109.433 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 159.59 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 1.1100000000000001 109.553 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 164.88 157.97 10.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.009 -1.236 . . . . 0.93999999999999995 110.009 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.64 ' CD1' HD13 ' A' ' 143' ' ' ILE . 7.5 mt -77.17 -176.3 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -1.135 . . . . 0.95999999999999996 109.157 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.88 159.18 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.92000000000000004 109.593 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' HD23 ' A' ' 10' ' ' LEU . 46.2 t80 178.92 143.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.384 -0.823 . . . . 1.71 109.648 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.4 m-80 -111.17 -164.75 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 2.7799999999999998 109.524 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 82.82 74.33 1.2 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 2.48 109.572 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 57' ' ' GLY . 52.2 t -161.12 77.57 2.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.107 . . . . 3.79 109.52 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.45 155.99 1.95 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.815 2.343 . . . . 2.3999999999999999 112.135 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -135.99 114.66 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 3.0800000000000001 109.614 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -138.99 101.89 0.33 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.256 -1.537 . . . . 3.0499999999999998 109.256 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 63' ' ' GLY . 7.0 tp10 -38.19 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -1.087 . . . . 6.0499999999999998 109.452 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 103.35 -56.41 0.6 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.576 -1.409 . . . . 2.54 109.576 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.66 141.89 31.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.116 . . . . 4.0300000000000002 109.334 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -99.89 120.54 39.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 2.9100000000000001 109.553 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' C ' ' CG2' ' A' ' 67' ' ' VAL . 81.7 m-85 -85.55 174.71 9.26 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 2.3799999999999999 109.505 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.831 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -155.43 132.82 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 2.6099999999999999 109.323 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tt -114.07 130.56 56.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.966 . . . . 3.6099999999999999 109.498 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.2 p -118.16 94.86 4.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 2.27 108.736 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 11.2 p90 -93.28 135.48 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.05 -1.031 . . . . 2.0099999999999998 111.091 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.588 HG22 ' CG2' ' A' ' 108' ' ' THR . 19.1 p -90.31 109.25 20.35 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.547 -0.908 . . . . 1.8 108.547 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -158.89 165.92 33.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.624 -1.23 . . . . 0.95999999999999996 110.817 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.8 p -129.42 163.1 26.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.914 -0.773 . . . . 0.93000000000000005 108.914 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' HB1' ' HE2' ' A' ' 139' ' ' TYR . . . -124.39 119.3 28.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.593 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.46 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.79 116.74 16.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.057 -1.027 . . . . 0.96999999999999997 110.113 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.582 ' O ' ' O ' ' A' ' 74' ' ' ALA . 20.1 Cg_exo -65.87 -142.15 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.687 0 C-N-CA 124.232 -1.153 . . . . 1.02 112.05 -0.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' C ' ' CG ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -97.86 149.39 22.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 1.75 109.208 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.697 ' SD ' ' CE2' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 165.21 159.82 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 2.1600000000000001 109.795 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.34 119.24 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.711 2.274 . . . . 1.3799999999999999 112.032 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.19 169.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 2.0099999999999998 109.44 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.739 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -109.83 139.42 44.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.917 . . . . 6.0099999999999998 109.313 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -141.05 148.26 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 3.7599999999999998 109.533 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -147.21 144.0 28.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 2.29 109.487 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 129' ' ' VAL . 1.0 OUTLIER -152.84 145.03 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 1.8899999999999999 110.342 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 128' ' ' GLN . . . 142.21 -109.62 0.58 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.881 -1.288 . . . . 1.49 109.881 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' CD ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -89.98 164.87 14.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -1.181 . . . . 2.54 109.663 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.593 -1.403 . . . . 1.3799999999999999 109.593 179.862 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.166 0.507 . . . . 5.7400000000000002 109.766 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.688 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 1.8 t -128.85 -150.93 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 2.27 110.275 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.688 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -119.01 -22.32 7.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.239 -0.652 . . . . 3.2799999999999998 109.239 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.509 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.11 41.66 1.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.787 -1.196 . . . . 3.6499999999999999 109.235 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -90.01 44.28 1.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.983 -1.073 . . . . 4.5999999999999996 109.537 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 111' ' ' TYR . 7.3 pt20 -106.67 137.18 45.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 3.46 109.431 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 82' ' ' VAL . . . -128.49 20.28 5.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.664 -1.374 . . . . 3.6699999999999999 109.664 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -104.84 76.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 3.79 109.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.76 102.03 53.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 1.96 109.333 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.79 118.81 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.702 2.268 . . . . 2.9700000000000002 112.608 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.6 159.82 33.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 3.0600000000000001 109.522 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 2.4 t -103.5 -148.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 2.3399999999999999 109.86 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.597 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -110.2 29.65 9.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 2.1699999999999999 109.805 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.492 ' H ' HG23 ' A' ' 103' ' ' THR . 5.2 pt-20 -139.59 147.96 54.15 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.201 -1.176 . . . . 3.02 109.205 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -40.48 117.35 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.592 2.194 . . . . 1.4199999999999999 111.882 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.38 127.69 11.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.151 -0.968 . . . . 1.3700000000000001 109.811 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.588 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.62 141.14 29.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.44 -0.787 . . . . 1.72 109.853 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 111' ' ' TYR . 9.1 mmm-85 -113.26 136.44 52.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.377 -0.972 . . . . 4.7000000000000002 108.377 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -117.18 107.36 14.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.175 -0.61 . . . . 3.2799999999999998 109.883 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 109' ' ' ARG . 42.3 m-85 -109.95 114.76 28.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 2.96 109.083 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -103.38 170.48 7.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -0.873 . . . . 3.4100000000000001 109.611 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.436 ' CD2' ' C ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 179.05 161.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 2.77 109.767 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.37 155.01 20.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 2.23 109.307 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -90.13 44.15 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 4.1100000000000003 109.954 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 115' ' ' SER . 6.9 m120 -39.92 -17.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 6.8600000000000003 109.576 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.799 HD12 ' CZ ' ' A' ' 119' ' ' PHE . 1.2 mm? -109.87 143.82 39.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 5.1200000000000001 109.436 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.85 107.75 18.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 4.0599999999999996 109.681 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.799 ' CZ ' HD12 ' A' ' 117' ' ' LEU . 43.0 m-85 -133.69 98.26 15.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 5.4400000000000004 109.181 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.28 165.58 23.34 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.52 2.147 . . . . 4.04 112.239 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.03 -14.59 12.16 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.836 2.357 . . . . 3.8999999999999999 112.069 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -109.66 123.24 49.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 4.1399999999999997 109.602 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.554 ' O ' ' OD1' ' A' ' 124' ' ' ASP . . . 150.02 -84.34 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.478 -1.449 . . . . 3.5699999999999998 109.478 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 123' ' ' GLY . 4.5 m-20 -162.21 -37.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 3.5899999999999999 109.452 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -112.59 93.45 23.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 2.0800000000000001 109.417 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.98 -159.17 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.744 2.296 . . . . 1.3899999999999999 112.273 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.57 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -72.84 -178.99 35.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 1.1899999999999999 109.603 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.467 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -170.25 141.18 2.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -1.094 . . . . 2.0099999999999998 109.707 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.797 HG22 HG13 ' A' ' 84' ' ' VAL . 67.3 t -138.71 151.48 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.973 -1.121 . . . . 1.28 107.973 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -165.66 111.72 0.9 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.815 -1.154 . . . . 0.97999999999999998 110.48 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.514 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.8 m-30 -94.12 84.38 4.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.456 -0.942 . . . . 1.73 108.456 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.493 ' NE2' ' HB1' ' A' ' 130' ' ' ALA . 19.6 m170 -98.73 132.53 44.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 2.3199999999999998 110.173 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.828 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.65 2.32 2.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 2.1099999999999999 109.268 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -48.95 136.4 19.8 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.517 -1.433 . . . . 1.77 109.517 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.668 ' O ' ' N ' ' A' ' 137' ' ' GLY . 19.5 mtpt -165.72 130.14 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -1.157 . . . . 5.0599999999999996 109.869 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 43' ' ' GLY . . . -42.58 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.87 -1.159 . . . . 2.6400000000000001 107.87 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.47 17.1 7.44 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.734 -1.747 . . . . 2.5099999999999998 108.734 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 42' ' ' PRO . . . -51.13 -149.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.903 . . . . 2.3199999999999998 110.432 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.697 ' CE2' ' SD ' ' A' ' 78' ' ' MET . 0.0 OUTLIER -171.7 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.008 . . . . 1.6100000000000001 110.597 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.674 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 13.9 mt-10 -137.26 140.79 41.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 1.6499999999999999 109.351 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.627 ' HB2' HD22 ' A' ' 133' ' ' LEU . 42.0 t80 -117.53 128.3 54.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.865 . . . . 1.6799999999999999 109.374 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.41 110.66 17.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.126 -0.984 . . . . 0.73999999999999999 109.977 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.64 HD13 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -119.66 144.68 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 1.22 109.279 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 88.6 p -130.06 -15.23 3.81 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.205 -0.665 . . . . 1.3300000000000001 109.205 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.466 ' CG ' ' C ' ' A' ' 144' ' ' SER . 3.0 mt-30 -155.51 177.52 11.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 3.2999999999999998 110.015 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 146' ' ' VAL . 3.9 p -177.04 124.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.815 . . . . 2.2599999999999998 109.461 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 176.74 11.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 2.7599999999999998 109.775 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.744 ' C ' HG22 ' A' ' 149' ' ' THR . 1.3 pp -155.37 -161.35 1.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 4.5700000000000003 109.394 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.66 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 3.0699999999999998 109.5 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.475 ' H ' HG12 ' A' ' 7' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 2.0 109.371 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.271 0.558 . . . . 2.8300000000000001 109.511 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -85.74 83.08 7.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 4.75 109.468 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.547 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -61.93 -33.03 73.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 4.9500000000000002 109.426 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.612 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -109.07 96.02 19.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 2.8599999999999999 108.653 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.5 27.07 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.32 2.014 . . . . 3.8300000000000001 111.693 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.612 ' H ' HD13 ' A' ' 10' ' ' LEU . 48.2 t60 -128.31 74.21 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 2.52 109.478 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 10.1 t -112.96 41.58 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 1.97 109.43 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 16' ' ' ALA . 6.5 t -115.85 59.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 1.96 109.668 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -65.49 16.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 1.76 109.263 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.05 -22.39 21.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 1.1799999999999999 109.848 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -109.81 -84.29 0.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.1299999999999999 109.633 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m -109.0 153.78 23.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 2.2599999999999998 109.443 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 37' ' ' MET . 2.2 mt -56.76 -54.26 48.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 2.6000000000000001 109.547 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 103.22 -149.24 17.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.6200000000000001 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.72 -27.49 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.748 2.299 . . . . 1.7 112.252 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.903 ' CH2' HG11 ' A' ' 146' ' ' VAL . 15.4 m95 -52.01 167.59 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 2.4199999999999999 109.256 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -131.87 179.25 6.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -0.959 . . . . 1.6399999999999999 109.676 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.443 HD13 ' CG ' ' A' ' 30' ' ' PRO . 2.9 pp 179.35 152.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 2.0499999999999998 109.504 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -179.06 152.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 1.72 109.529 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.71 -24.63 13.01 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.909 -1.139 . . . . 1.7 110.435 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.78 -144.27 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.381 . . . . 0.96999999999999997 109.583 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 7.9 p -92.8 135.22 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 1.8 109.291 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -41.27 104.25 0.34 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.976 -1.078 . . . . 2.3999999999999999 108.588 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' CG ' HD13 ' A' ' 24' ' ' LEU . 51.7 Cg_exo -46.95 166.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.183 1.922 . . . . 1.1299999999999999 111.83 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 t -151.08 121.16 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.07 -1.019 . . . . 1.05 110.182 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -76.2 92.96 3.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.85 . . . . 1.8200000000000001 109.341 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.68 -140.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 1.1699999999999999 109.531 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' OD1' ' C ' ' A' ' 34' ' ' ASP . 39.6 t0 -58.6 -43.41 89.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.965 . . . . 2.21 109.368 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.566 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -160.74 48.35 0.38 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.271 -1.531 . . . . 1.1899999999999999 109.271 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -171.29 146.29 2.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -1.11 . . . . 2.9100000000000001 109.496 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.492 ' SD ' HD21 ' A' ' 19' ' ' LEU . 40.4 ttp -109.58 133.76 52.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.246 -0.908 . . . . 0.93000000000000005 109.068 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.696 ' SG ' ' OE2' ' A' ' 140' ' ' GLU . 0.5 OUTLIER -127.76 173.61 9.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.229 -0.919 . . . . 1.0600000000000001 110.434 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 3.1 m -149.26 144.97 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.875 -0.787 . . . . 1.3700000000000001 108.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.608 ' C ' HD22 ' A' ' 41' ' ' LEU . 35.4 m-20 -82.48 106.48 14.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.88 . . . . 4.79 109.289 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.608 HD22 ' C ' ' A' ' 40' ' ' ASP . 3.8 mm? -113.5 80.1 4.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 3.54 109.654 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.37 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.756 2.304 . . . . 3.7400000000000002 112.238 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -120.24 115.58 3.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.539 -1.425 . . . . 2.0299999999999998 109.539 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.675 ' H ' ' H ' ' A' ' 136' ' ' ALA . . . -174.88 -40.83 0.05 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.843 -1.303 . . . . 2.4100000000000001 109.843 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.847 ' HB2' ' HZ2' ' A' ' 135' ' ' LYS . 12.0 mt-30 -100.0 125.35 46.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -1.153 . . . . 2.96 109.586 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.89 65.88 0.27 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 2.0800000000000001 109.344 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.659 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -146.03 96.6 4.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.36 -1.082 . . . . 3.6099999999999999 109.396 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 53.1 Cg_exo -48.44 4.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.852 2.368 . . . . 2.3599999999999999 113.079 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.598 ' N ' ' O ' ' A' ' 47' ' ' ASN . 1.4 p-90 -127.59 34.32 4.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.885 -1.134 . . . . 3.8700000000000001 109.667 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 30.7 m-20 -132.97 39.05 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 2.3799999999999999 109.215 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 158.78 94.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 1.1100000000000001 109.259 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . -171.9 174.13 45.21 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.864 -1.295 . . . . 0.93999999999999995 109.864 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.537 ' C ' HG22 ' A' ' 54' ' ' VAL . 6.6 mt -95.05 -178.1 4.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 0.95999999999999996 109.526 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.537 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -162.94 162.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.92000000000000004 109.293 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 15.2 t80 172.26 140.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 1.71 109.72 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.689 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.4 m120 -94.38 -168.1 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 2.7799999999999998 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.678 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 82.3 74.62 1.17 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 2.48 109.463 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 58' ' ' VAL . 48.6 t -161.31 69.74 2.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.275 -1.132 . . . . 3.79 109.547 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HD2' HD13 ' A' ' 9' ' ' LEU . 42.0 Cg_endo -71.85 120.51 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.789 2.326 . . . . 2.3999999999999999 112.136 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.727 HG12 ' OG ' ' A' ' 115' ' ' SER . 4.7 t -112.5 141.25 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 3.0800000000000001 109.532 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -116.5 98.9 0.83 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.464 -1.454 . . . . 3.0499999999999998 109.464 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 61.8 tt0 -35.64 130.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 6.0499999999999998 109.546 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 111.08 -32.36 6.57 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 2.54 109.626 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.3 mt-10 -100.01 177.9 4.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -1.157 . . . . 4.0300000000000002 109.525 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -128.53 143.79 51.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 2.9100000000000001 109.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 27.2 m-85 -112.75 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.156 -0.965 . . . . 2.3799999999999999 109.677 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.406 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.4 t -152.8 137.24 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.551 -0.718 . . . . 2.6099999999999999 109.281 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 148' ' ' LEU . 0.7 OUTLIER -120.83 121.51 38.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 3.6099999999999999 109.782 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.1 p -109.52 85.47 2.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 2.27 108.745 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.7 p90 -93.63 143.56 26.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 2.0099999999999998 111.167 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -93.39 122.91 36.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.609 -0.885 . . . . 1.8 108.609 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.801 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -163.44 147.11 10.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 0.95999999999999996 110.385 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.37 135.9 52.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.877 -0.786 . . . . 0.93000000000000005 108.877 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.859 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -107.6 116.73 32.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.67000000000000004 109.819 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' ' CG ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -131.24 119.09 17.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.96999999999999997 109.831 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.9 Cg_exo -66.17 -142.19 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.305 -1.123 . . . . 1.02 112.372 -0.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 159.24 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 1.75 109.809 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.513 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.9 mtt 162.83 154.98 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 2.1600000000000001 109.215 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.71 148.65 32.9 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.812 2.341 . . . . 1.3799999999999999 112.628 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -122.91 172.1 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 2.0099999999999998 109.056 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 132' ' ' HIS . 14.9 ttt180 -134.81 95.54 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 6.0099999999999998 109.921 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' HA ' ' H ' ' A' ' 132' ' ' HIS . 1.4 m -99.88 148.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 3.7599999999999998 108.939 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.6 pp -139.73 152.98 47.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 2.29 109.99 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.588 HG13 ' HA ' ' A' ' 129' ' ' VAL . 1.3 t -149.15 157.7 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 1.8899999999999999 109.389 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.88 -143.78 8.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.622 -1.391 . . . . 1.49 109.622 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.662 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 0.3 OUTLIER -90.24 -176.33 4.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 2.54 109.409 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.613 -1.395 . . . . 1.3799999999999999 109.613 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.721 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.437 -0.579 . . . . 5.7400000000000002 109.437 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.18 169.43 10.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 2.27 109.954 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 116' ' ' ASN . . . -124.02 -15.9 6.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 3.2799999999999998 108.881 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.482 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.51 36.88 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 3.6499999999999999 109.155 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -76.38 98.1 4.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.98 . . . . 4.5999999999999996 109.504 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.724 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -106.15 137.12 44.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 3.46 109.128 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.562 ' N ' ' NE2' ' A' ' 97' ' ' GLN . . . -136.73 -0.25 2.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.766 -1.334 . . . . 3.6699999999999999 109.766 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.724 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.6 m -122.8 63.37 0.98 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.131 -1.217 . . . . 3.79 109.773 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.812 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -112.89 96.39 37.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 1.96 109.494 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.41 125.76 5.84 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.791 2.327 . . . . 2.9700000000000002 112.573 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 70.7 mt -133.4 149.24 51.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 3.0600000000000001 109.271 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 105' ' ' GLU . 1.8 t -136.69 -174.92 3.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 2.3399999999999999 109.58 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -63.13 38.62 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.566 -1.414 . . . . 2.1699999999999999 109.566 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 103' ' ' THR . 17.3 tp10 -117.33 78.85 11.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 3.02 109.387 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.53 118.94 2.83 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.801 2.334 . . . . 1.4199999999999999 112.17 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.671 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -174.32 169.72 3.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 1.3700000000000001 109.58 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.543 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.82 141.15 29.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 1.72 109.881 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.801 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.55 137.06 49.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.705 -1.22 . . . . 4.7000000000000002 107.705 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 110' ' ' GLU . 6.2 mp0 -111.22 107.43 16.74 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.847 -0.741 . . . . 3.2799999999999998 110.977 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.6 m-30 -109.89 110.69 21.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.186 -1.042 . . . . 2.96 108.186 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.13 153.25 22.36 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.232 -0.917 . . . . 3.4100000000000001 109.777 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.667 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -141.08 173.82 11.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 2.77 109.289 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -101.35 111.44 23.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 2.23 109.655 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.727 ' OG ' HG12 ' A' ' 60' ' ' VAL . 6.9 t -41.03 125.99 2.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 4.1100000000000003 109.353 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.737 ' O ' HD22 ' A' ' 117' ' ' LEU . 6.4 p-10 -121.21 -30.64 4.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 6.8600000000000003 109.522 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 116' ' ' ASN . 3.4 mm? -123.97 123.82 41.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 5.1200000000000001 109.472 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -65.56 116.28 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 4.0599999999999996 109.393 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 23.8 m-85 -122.45 79.61 46.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 5.4400000000000004 109.48 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.83 168.98 2.05 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.808 2.338 . . . . 4.04 111.96 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.66 -16.89 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.696 2.264 . . . . 3.8999999999999999 112.117 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.59 176.59 4.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 4.1399999999999997 109.409 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.78 -156.17 18.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 3.5699999999999998 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 5.0 p-10 -35.87 -72.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -1.134 . . . . 3.5899999999999999 109.565 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -137.63 150.34 67.84 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 2.0800000000000001 109.463 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.86 -158.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.824 2.35 . . . . 1.3899999999999999 112.246 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -58.36 157.31 19.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.428 . . . . 1.1899999999999999 109.529 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.3 149.42 34.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -1.165 . . . . 2.0099999999999998 109.484 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.588 ' HA ' HG13 ' A' ' 84' ' ' VAL . 58.0 t -150.58 150.83 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.627 -0.879 . . . . 1.28 108.627 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.35 99.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.004 -1.06 . . . . 0.97999999999999998 110.369 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 4.8 m-30 -70.18 114.34 8.23 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 1.73 108.144 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 48' ' ' PRO . 1.2 m170 -99.28 133.2 43.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 2.3199999999999998 110.388 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 134' ' ' GLY . 4.6 mp -127.81 -40.79 1.7 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.78 . . . . 2.1099999999999999 109.064 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 55.71 147.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 1.77 109.693 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.847 ' HZ2' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -99.8 -150.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.169 . . . . 5.0599999999999996 109.547 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 135' ' ' LYS . . . 78.46 6.11 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 2.6400000000000001 109.055 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.29 10.03 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.136 -1.586 . . . . 2.5099999999999998 109.136 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.02 -149.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -1.084 . . . . 2.3199999999999998 109.573 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.859 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -166.74 -114.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.392 -0.818 . . . . 1.6100000000000001 109.828 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.696 ' OE2' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.02 141.58 51.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 1.6499999999999999 108.773 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.666 ' CE1' ' HB1' ' A' ' 72' ' ' ALA . 18.2 t80 -125.84 114.86 19.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -0.841 . . . . 1.6799999999999999 110.045 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 140' ' ' GLU . 1.5 m -117.71 103.16 9.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.73999999999999999 110.014 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 143.42 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 1.22 109.013 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.445 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 49.6 p -137.84 -1.17 2.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.601 -0.687 . . . . 1.3300000000000001 109.358 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.571 ' O ' ' OG1' ' A' ' 71' ' ' THR . 7.3 mt-30 -153.06 153.84 33.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 3.2999999999999998 109.98 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.903 HG11 ' CH2' ' A' ' 22' ' ' TRP . 88.1 t -160.18 121.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 2.2599999999999998 109.369 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 p -152.01 171.73 17.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.011 . . . . 2.7599999999999998 109.702 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.817 HD23 ' N ' ' A' ' 148' ' ' LEU . 1.9 pt? -157.94 -162.44 1.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 4.5700000000000003 109.508 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.34 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 3.0699999999999998 109.443 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.668 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.5 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 2.0 109.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' N ' ' HG1' ' A' ' 149' ' ' THR . 1.4 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.474 -0.565 . . . . 2.8300000000000001 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.651 ' OE1' ' N ' ' A' ' 9' ' ' LEU . 3.8 tp10 -49.93 106.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 4.75 109.485 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.651 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 3.9 mt -85.7 28.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.91 . . . . 4.9500000000000002 109.445 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.749 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.0 tm? -157.19 89.09 2.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 2.8599999999999999 108.889 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -53.72 43.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.186 2.591 . . . . 3.8300000000000001 113.321 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.675 ' N ' ' O ' ' A' ' 10' ' ' LEU . 11.7 t60 -158.39 102.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.892 -1.13 . . . . 2.52 109.53 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.443 ' CB ' ' O ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -147.04 43.91 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 1.97 109.469 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 16' ' ' ALA . 68.8 m -155.77 81.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.96 109.947 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.41 36.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 1.76 108.988 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -78.46 -30.43 47.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.599 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 1.9 mt-10 -110.38 -73.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 2.1299999999999999 109.501 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.8 m -109.24 145.25 36.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 2.2599999999999998 109.504 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 37' ' ' MET . 4.4 mt -51.39 -48.22 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 2.6000000000000001 109.522 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 97.74 -172.87 27.65 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.502 -1.439 . . . . 1.6200000000000001 109.502 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.0 Cg_endo -69.86 -20.68 34.07 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.739 2.293 . . . . 1.7 112.189 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.575 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 8.6 m95 -53.55 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.993 . . . . 2.4199999999999999 109.286 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -141.51 167.53 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 1.6399999999999999 109.782 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.908 HD22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -174.58 167.59 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 2.0499999999999998 109.4 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.737 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.74 -176.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 1.72 109.649 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 94.34 -28.85 9.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 1.7 109.842 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.814 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.85 -142.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 0.96999999999999997 109.306 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.814 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.6 p -91.02 -163.8 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 1.8 109.254 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.25 111.58 47.83 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 2.3999999999999999 109.022 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HB3' ' CG ' ' A' ' 37' ' ' MET . 56.3 Cg_exo -45.71 159.76 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.268 1.979 . . . . 1.1299999999999999 112.022 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -143.52 109.24 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 1.05 109.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -69.82 72.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 1.8200000000000001 109.456 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -65.31 -138.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.1699999999999999 109.644 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.67 81.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.82 . . . . 2.21 109.526 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 47.5 30.68 6.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.639 -1.384 . . . . 1.1899999999999999 109.639 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.45 142.81 30.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -1.144 . . . . 2.9100000000000001 109.564 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 19' ' ' LEU . 5.3 ttp -109.87 125.24 52.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.93000000000000005 109.163 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 56.8 m -124.6 154.79 40.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.917 . . . . 1.0600000000000001 110.084 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.96 139.4 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.525 -0.734 . . . . 1.3700000000000001 109.025 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.719 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -91.12 122.21 33.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 4.79 109.649 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.761 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 9.0 mp -113.29 92.98 24.29 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 3.54 109.344 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 51.1 Cg_exo -50.03 -57.02 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.031 2.487 . . . . 3.7400000000000002 112.625 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 138' ' ' ALA . . . 117.99 146.53 8.17 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.783 -1.327 . . . . 2.0299999999999998 109.783 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 33.34 0.73 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.863 -1.295 . . . . 2.4100000000000001 109.863 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.525 ' NE2' ' CB ' ' A' ' 50' ' ' ASP . 9.1 mt-30 -118.26 150.48 39.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.113 -1.228 . . . . 2.96 109.648 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.13 56.83 0.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.383 -1.487 . . . . 2.0800000000000001 109.383 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.623 ' ND2' ' N ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -174.48 98.49 0.29 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.199 -1.177 . . . . 3.6099999999999999 109.393 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD2' ' CZ3' ' A' ' 49' ' ' TRP . 77.6 Cg_exo -46.27 -21.62 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.613 2.209 . . . . 2.3599999999999999 112.431 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 39.2 p90 -106.9 65.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 3.8700000000000001 109.494 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' NE2' ' A' ' 45' ' ' GLN . 1.2 m-20 -134.99 6.57 3.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 2.3799999999999999 109.695 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -177.06 154.75 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 1.1100000000000001 109.721 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.43 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 144.11 -169.33 26.29 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.879 -1.288 . . . . 0.93999999999999995 109.879 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.975 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -97.34 152.18 19.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -1.074 . . . . 0.95999999999999996 109.134 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.901 HG13 ' HB2' ' A' ' 130' ' ' ALA . 2.0 t -144.53 162.87 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.92000000000000004 110.083 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.69 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 18.7 t80 175.58 149.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 1.71 109.4 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.69 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 1.4 m-80 -101.37 176.8 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 2.7799999999999998 109.527 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 95.6 76.99 1.34 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 2.48 109.563 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 57' ' ' GLY . 0.7 OUTLIER -156.8 70.3 4.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 3.79 109.498 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.674 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.48 131.67 28.28 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.801 2.334 . . . . 2.3999999999999999 112.191 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.07 114.24 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 3.0800000000000001 109.521 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.18 103.55 1.11 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.521 -1.432 . . . . 3.0499999999999998 109.521 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HB2' ' N ' ' A' ' 117' ' ' LEU . 3.4 tm-20 -47.34 139.05 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.138 . . . . 6.0499999999999998 109.529 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.11 -37.18 3.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.688 -1.365 . . . . 2.54 109.688 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' SER . 2.7 mt-10 -99.99 168.88 9.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -1.18 . . . . 4.0300000000000002 109.574 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.6 m -115.0 139.93 49.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 2.9100000000000001 109.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.674 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 22.9 m-85 -104.61 -178.32 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.115 -0.99 . . . . 2.3799999999999999 109.549 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -153.76 121.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 2.6099999999999999 109.639 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 148' ' ' LEU . 1.4 tp -111.52 115.96 30.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 3.6099999999999999 109.23 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -109.88 86.46 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.067 -1.02 . . . . 2.27 109.198 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 6.9 p90 -94.9 139.29 31.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.442 -0.786 . . . . 2.0099999999999998 111.295 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 108' ' ' THR . 0.7 OUTLIER -98.35 119.6 37.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.499 -0.926 . . . . 1.8 108.499 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 141' ' ' PHE . . . -171.57 134.68 0.85 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.077 -1.015 . . . . 0.95999999999999996 110.024 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB2' ' N ' ' A' ' 105' ' ' GLU . 53.2 p -124.26 122.38 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 109.21 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.596 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -91.67 135.95 33.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.67000000000000004 109.386 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.449 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.16 117.06 16.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.351 -0.843 . . . . 0.96999999999999997 109.49 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -66.52 -142.42 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.66 0 C-N-CA 124.305 -1.123 . . . . 1.02 112.199 -0.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.453 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.7 OUTLIER -104.85 152.18 22.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 1.75 109.38 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.453 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 1.4 mtm -176.42 156.93 1.52 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 2.1600000000000001 109.157 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.82 118.9 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.752 2.301 . . . . 1.3799999999999999 112.402 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 98' ' ' GLY . 4.7 m -99.19 176.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 2.0099999999999998 109.275 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 132' ' ' HIS . 18.7 ttm180 -122.67 146.47 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 6.0099999999999998 109.728 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.29 155.27 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.301 -0.874 . . . . 3.7599999999999998 109.45 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.11 156.95 43.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 2.29 109.608 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.556 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.0 OUTLIER -146.79 138.3 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 1.8899999999999999 109.681 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.56 -155.71 22.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.472 -1.451 . . . . 1.49 109.472 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.691 ' OE2' ' CG ' ' A' ' 119' ' ' PHE . 21.6 pm0 -88.82 -155.02 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 2.54 109.482 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.445 ' CA ' HE22 ' A' ' 128' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.3799999999999999 109.669 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.58 ' O ' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.51 -0.552 . . . . 5.7400000000000002 109.51 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.94 176.37 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 2.27 109.786 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.505 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -113.93 -22.77 9.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.897 -0.779 . . . . 3.2799999999999998 108.897 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.84 34.26 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 3.6499999999999999 109.35 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 1.3 tm-20 -79.03 82.21 5.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 4.5999999999999996 109.486 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.52 ' CG ' ' N ' ' A' ' 98' ' ' GLY . 3.9 pt20 -108.99 -160.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 3.46 109.522 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 97' ' ' GLN . . . -173.49 -41.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.534 -1.426 . . . . 3.6699999999999999 109.534 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.48 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 3.79 109.585 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 98' ' ' GLY . . . -122.02 96.3 46.8 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 1.96 109.417 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.42 130.7 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.815 2.344 . . . . 2.9700000000000002 112.754 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -132.65 140.32 48.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 3.0600000000000001 109.297 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.66 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -93.93 -160.98 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 2.3399999999999999 109.514 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.66 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -107.66 33.08 6.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 2.1699999999999999 109.637 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.474 ' N ' ' HB2' ' A' ' 73' ' ' SER . 0.4 OUTLIER -119.12 142.07 31.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -1.166 . . . . 3.02 109.351 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.682 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 55.3 Cg_endo -73.52 136.55 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.584 2.189 . . . . 1.4199999999999999 112.217 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 165.48 160.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 1.3700000000000001 109.662 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -83.56 131.03 35.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 1.72 110.062 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 69' ' ' SER . 3.2 mmt180 -93.51 146.42 23.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.648 -1.612 . . . . 4.7000000000000002 106.648 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.02 105.83 16.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.936 -1.103 . . . . 3.2799999999999998 110.192 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.48 76.2 0.99 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.683 -0.858 . . . . 2.96 108.683 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.851 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -99.97 164.89 11.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 3.4100000000000001 109.712 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 4.2 p90 -164.96 -174.21 3.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 2.77 109.607 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.41 HG22 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -109.28 112.22 24.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -0.811 . . . . 2.23 109.57 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 64' ' ' GLU . 6.8 t -47.27 125.11 7.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 4.1100000000000003 109.395 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.792 ' O ' HD22 ' A' ' 117' ' ' LEU . 7.8 t-20 -124.2 1.03 8.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 6.8600000000000003 109.422 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -145.98 120.41 9.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 5.1200000000000001 109.444 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.648 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -67.93 140.16 56.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 4.0599999999999996 109.58 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.691 ' CG ' ' OE2' ' A' ' 86' ' ' GLU . 18.4 m-85 -170.01 76.67 0.64 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 5.4400000000000004 109.524 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.12 169.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.86 2.373 . . . . 4.04 111.944 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 125' ' ' ALA . 66.2 Cg_endo -80.46 -16.14 10.81 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.801 2.334 . . . . 3.8999999999999999 112.082 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 123' ' ' GLY . 17.4 p-10 -109.95 -46.43 3.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 4.1399999999999997 109.516 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -39.42 -45.02 2.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.489 -1.444 . . . . 3.5699999999999998 109.489 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.19 -73.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 3.5899999999999999 109.473 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -139.82 162.19 52.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 2.0800000000000001 109.4 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 125' ' ' ALA . 6.6 Cg_endo -52.68 -5.37 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.028 2.485 . . . . 1.3899999999999999 112.202 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 120.82 161.19 11.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.51 -1.436 . . . . 1.1899999999999999 109.51 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 2.3 tt0 -149.15 105.82 3.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -1.148 . . . . 2.0099999999999998 109.718 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 84' ' ' VAL . 1.7 p -139.09 118.39 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.648 -0.871 . . . . 1.28 108.648 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.901 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -142.23 139.34 31.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 0.97999999999999998 110.583 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -94.73 109.31 21.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.711 -0.848 . . . . 1.73 108.711 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.644 ' O ' ' N ' ' A' ' 81' ' ' ARG . 6.3 m170 -99.74 119.8 38.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 2.3199999999999998 109.733 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.883 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -112.3 -3.56 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 2.1099999999999999 109.126 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 46.13 -179.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.377 -1.489 . . . . 1.77 109.377 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.418 ' NZ ' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mtmt -125.41 24.28 7.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.282 . . . . 5.0599999999999996 109.592 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.2 -21.69 63.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.714 -1.217 . . . . 2.6400000000000001 107.714 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.698 ' O ' ' CD2' ' A' ' 139' ' ' TYR . . . -130.1 54.91 0.78 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.655 -2.178 . . . . 2.5099999999999998 107.655 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.761 ' HB1' ' O ' ' A' ' 41' ' ' LEU . . . -29.62 154.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.807 0.813 . . . . 2.3199999999999998 110.825 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 174.5 -163.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 1.6100000000000001 109.132 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.43 120.28 39.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 1.6499999999999999 109.728 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 72' ' ' ALA . 6.4 t80 -102.15 106.87 17.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.867 . . . . 1.6799999999999999 108.796 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.37 101.18 10.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.73999999999999999 110.566 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 140.71 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 1.22 108.878 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.677 ' OG ' ' NE2' ' A' ' 145' ' ' GLN . 53.0 p -133.43 -7.51 2.91 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 109.516 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.677 ' NE2' ' OG ' ' A' ' 144' ' ' SER . 1.8 mm-40 -146.62 161.46 40.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 3.2999999999999998 109.663 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 146' ' ' VAL . 8.4 p -176.23 109.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.2599999999999998 109.758 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 p -153.54 162.77 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 2.7599999999999998 109.47 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.701 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.5 pp -143.43 171.97 13.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 4.5700000000000003 109.42 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -165.85 -168.19 1.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 3.0699999999999998 109.482 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.581 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.3 t . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.203 -0.935 . . . . 2.0 109.486 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.272 -0.64 . . . . 2.8300000000000001 109.272 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.576 ' C ' ' O ' ' A' ' 7' ' ' VAL . 5.6 tt0 24.23 65.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.025 0.44 . . . . 4.75 110.659 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' ' 148' ' ' LEU . 12.3 mt -56.02 -49.12 74.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 4.9500000000000002 108.859 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 55' ' ' TYR . 1.2 tp -101.34 116.05 64.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.003 . . . . 2.8599999999999999 108.293 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.58 27.84 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.215 1.943 . . . . 3.8300000000000001 111.946 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.551 ' O ' HD23 ' A' ' 10' ' ' LEU . 35.9 t60 -137.02 139.15 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 2.52 109.502 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.576 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.07 54.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 1.97 109.338 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -164.41 73.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.96 109.572 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -62.97 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.76 108.897 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -74.05 -46.96 40.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 1.1799999999999999 109.925 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.674 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.9 mt-10 -109.78 -84.02 0.56 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 2.1299999999999999 109.542 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.8 m -94.41 142.98 26.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 2.2599999999999998 109.465 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.692 ' HB2' HD21 ' A' ' 24' ' ' LEU . 2.1 pp -57.62 -12.56 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 2.6000000000000001 109.558 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.571 ' O ' HD12 ' A' ' 19' ' ' LEU . . . 82.1 -147.05 25.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.36 -1.496 . . . . 1.6200000000000001 109.36 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.31 -11.78 13.1 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.671 2.247 . . . . 1.7 112.143 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.591 ' CH2' HG11 ' A' ' 146' ' ' VAL . 10.6 m95 -66.51 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 2.4199999999999999 109.284 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.726 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 m -156.44 126.84 6.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 1.6399999999999999 109.559 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.841 ' N ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -121.08 133.17 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.958 . . . . 2.0499999999999998 109.554 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.681 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.97 153.35 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 1.72 109.597 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 109.69 -22.92 23.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.951 -1.259 . . . . 1.7 109.951 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.823 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.91 -142.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.998 -1.295 . . . . 0.96999999999999997 109.373 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.823 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.3 p -90.96 141.54 28.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 1.8 109.41 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -37.38 101.59 0.22 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.966 . . . . 2.3999999999999999 109.236 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HG2' HD12 ' A' ' 24' ' ' LEU . 59.9 Cg_exo -46.27 160.94 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.404 2.069 . . . . 1.1299999999999999 111.879 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.828 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.7 p -138.35 97.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 1.05 110.318 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.32 84.41 3.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.454 -0.779 . . . . 1.8200000000000001 109.096 178.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.15 -140.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 1.1699999999999999 109.925 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 2.21 109.563 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . -141.73 47.25 0.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.727 -1.349 . . . . 1.1899999999999999 109.727 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.716 ' NH2' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -168.43 148.88 4.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 2.9100000000000001 109.752 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.736 ' CE ' HD13 ' A' ' 24' ' ' LEU . 58.2 ttp -123.43 129.24 50.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.419 -0.8 . . . . 0.93000000000000005 109.224 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.716 ' SG ' ' NH2' ' A' ' 36' ' ' ARG . 59.3 m -122.65 146.55 47.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.607 -0.837 . . . . 1.0600000000000001 110.072 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HD13 ' A' ' 41' ' ' LEU . 3.0 m -122.69 160.25 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.62 -0.881 . . . . 1.3700000000000001 108.62 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.772 ' C ' HD12 ' A' ' 41' ' ' LEU . 2.9 m-20 -105.9 99.69 9.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 4.79 110.119 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.772 HD12 ' C ' ' A' ' 40' ' ' ASP . 7.2 mp -113.73 79.76 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 3.54 109.137 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.18 -158.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.872 2.381 . . . . 3.7400000000000002 112.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 136' ' ' ALA . . . -96.09 123.85 7.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.444 -1.462 . . . . 2.0299999999999998 109.444 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.0 -14.83 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 2.4100000000000001 109.535 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 27.4 mt-30 -99.79 70.11 1.62 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -1.184 . . . . 2.96 109.435 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.83 49.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.548 -1.421 . . . . 2.0800000000000001 109.548 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -164.65 87.14 1.08 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.223 -1.163 . . . . 3.6099999999999999 109.494 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 51.3 Cg_exo -48.73 -6.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.826 2.351 . . . . 2.3599999999999999 112.173 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.479 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.3 p90 -100.25 37.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 3.8700000000000001 109.485 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 46.3 m-20 -146.1 32.79 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 2.3799999999999999 109.434 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 172.97 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 1.1100000000000001 109.403 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.6 173.7 41.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.783 -1.327 . . . . 0.93999999999999995 109.783 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 5.2 mp -99.67 175.94 5.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 0.95999999999999996 109.245 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 0.6 OUTLIER -152.95 167.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.92000000000000004 110.51 -179.61 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.687 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 5.4 t80 -177.65 132.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 1.71 109.162 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.687 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -107.59 159.79 16.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.946 . . . . 2.7799999999999998 109.66 -179.709 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.01 77.52 1.03 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.447 . . . . 2.48 109.484 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 58' ' ' VAL . 55.2 t -149.85 60.91 4.71 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.142 . . . . 3.79 109.556 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 50.5 Cg_exo -48.57 142.59 17.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.775 2.316 . . . . 2.3999999999999999 112.102 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 3.0 t -134.45 153.97 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 3.0800000000000001 109.629 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -136.04 112.34 0.96 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.461 -1.455 . . . . 3.0499999999999998 109.461 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.2 tm-20 -39.06 135.11 0.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.144 . . . . 6.0499999999999998 109.668 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 97.22 -14.36 63.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.885 -1.286 . . . . 2.54 109.885 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' HB2' ' A' ' 115' ' ' SER . 2.2 mm-40 -100.79 157.45 16.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 4.0300000000000002 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -118.96 121.37 39.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 2.9100000000000001 109.176 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 51.7 m-85 -98.19 178.54 5.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.203 -0.935 . . . . 2.3799999999999999 109.743 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -163.61 133.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 2.6099999999999999 109.41 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -118.18 122.03 42.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 3.6099999999999999 109.736 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.4 p -112.2 100.25 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.88 -0.785 . . . . 2.27 108.88 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 2.2 p90 -93.96 146.31 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 2.0099999999999998 110.95 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -99.63 107.01 19.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.124 -1.065 . . . . 1.8 108.124 178.534 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -157.52 156.26 31.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.697 -1.252 . . . . 0.95999999999999996 110.862 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' GLU . 97.0 p -132.27 121.48 23.66 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.856 -0.794 . . . . 0.93000000000000005 108.856 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -81.53 129.91 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.817 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.463 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -130.81 116.92 17.17 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.382 -0.824 . . . . 0.96999999999999997 109.287 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.591 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.35 -144.77 0.18 OUTLIER 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.104 -1.207 . . . . 1.02 111.998 0.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' ' CG ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.03 154.62 19.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.698 -1.251 . . . . 1.75 109.39 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.657 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 157.17 154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.385 -0.822 . . . . 2.1600000000000001 109.264 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.552 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 68.0 Cg_endo -77.55 141.96 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.821 2.347 . . . . 1.3799999999999999 112.356 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 98' ' ' GLY . 35.1 m -108.4 170.3 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 2.0099999999999998 109.362 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 132' ' ' HIS . 0.1 OUTLIER -109.85 156.18 20.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 6.0099999999999998 109.437 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 83' ' ' LEU . 2.7 p -156.94 159.31 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 3.7599999999999998 109.51 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.693 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -154.66 143.67 21.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 2.29 109.702 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.692 ' CG1' HG22 ' A' ' 129' ' ' VAL . 0.4 OUTLIER -153.79 161.18 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 1.8899999999999999 109.467 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 133.77 -164.56 24.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 1.49 109.548 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.687 ' OE2' ' CZ ' ' A' ' 119' ' ' PHE . 12.7 pm0 -84.08 35.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 2.54 109.428 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' O ' ' OE1' ' A' ' 128' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.636 -1.386 . . . . 1.3799999999999999 109.636 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.68 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.294 0.568 . . . . 5.7400000000000002 109.789 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.622 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -144.05 -172.34 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 2.27 109.984 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -125.28 -23.39 4.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.89 -0.781 . . . . 3.2799999999999998 108.89 179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.47 42.52 1.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 3.6499999999999999 109.254 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.528 ' CD ' ' O ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.87 49.4 1.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.988 -1.07 . . . . 4.5999999999999996 109.482 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -112.52 153.87 26.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 3.46 109.234 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -140.21 4.33 2.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 3.6699999999999999 109.576 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -77.28 62.31 2.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.79 109.451 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.47 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -104.7 106.71 55.9 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 1.96 109.324 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.726 ' O ' HD22 ' A' ' 102' ' ' LEU . 60.6 Cg_endo -78.63 123.44 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.576 2.184 . . . . 2.9700000000000002 112.676 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 101' ' ' PRO . 4.3 mm? -124.32 173.24 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 3.0600000000000001 109.358 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -138.11 -174.11 3.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 2.3399999999999999 109.788 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -86.78 42.39 3.15 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.626 -1.389 . . . . 2.1699999999999999 109.626 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.9 mt-10 -162.24 160.95 21.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 3.02 109.114 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.5 115.58 2.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.641 2.227 . . . . 1.4199999999999999 111.715 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.39 124.65 9.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 1.3700000000000001 109.754 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.49 150.28 21.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.809 . . . . 1.72 109.994 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -131.4 143.08 50.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.706 -1.22 . . . . 4.7000000000000002 107.706 178.246 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.671 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 5.3 mt-10 -127.32 128.26 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.374 -0.93 . . . . 3.2799999999999998 110.814 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' CB ' ' A' ' 100' ' ' ALA . 6.9 m-85 -124.56 119.08 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.655 -0.869 . . . . 2.96 108.655 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.625 ' HB2' HG23 ' A' ' 67' ' ' VAL . . . -106.34 146.85 29.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 3.4100000000000001 110.007 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.728 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -130.92 164.68 24.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 2.77 109.267 179.681 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.4 122.4 43.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 2.23 109.819 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.495 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 6.1 m -59.77 129.83 43.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 4.1100000000000003 109.393 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -114.99 -19.81 10.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 6.8600000000000003 109.551 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.892 ' H ' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -142.44 -153.1 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 5.1200000000000001 109.276 179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.56 148.4 47.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.246 -0.909 . . . . 4.0599999999999996 109.687 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.818 ' CE2' HD13 ' A' ' 117' ' ' LEU . 44.4 m-85 -147.47 91.46 5.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 5.4400000000000004 109.302 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.84 165.74 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.815 2.343 . . . . 4.04 112.227 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 -15.5 12.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.697 2.265 . . . . 3.8999999999999999 112.02 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.83 132.42 54.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -0.873 . . . . 4.1399999999999997 109.549 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.28 -148.05 19.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 3.5699999999999998 109.525 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.5 30.0 7.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 3.5899999999999999 109.441 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -177.85 70.0 0.21 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 2.0800000000000001 109.437 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.55 -158.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.842 2.361 . . . . 1.3899999999999999 112.185 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.38 149.91 50.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.528 -1.429 . . . . 1.1899999999999999 109.528 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.566 ' OE1' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -148.09 128.02 13.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 2.0099999999999998 109.536 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.692 HG22 ' CG1' ' A' ' 84' ' ' VAL . 32.8 t -138.75 137.45 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.465 -0.939 . . . . 1.28 108.465 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -155.24 109.74 2.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.186 -1.006 . . . . 0.97999999999999998 110.262 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -80.6 103.53 10.52 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.847 -0.797 . . . . 1.73 108.847 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.693 ' ND1' HD21 ' A' ' 83' ' ' LEU . 7.0 m170 -99.58 128.77 45.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.935 . . . . 2.3199999999999998 109.713 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.69 -32.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 2.1099999999999999 109.449 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.554 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -39.6 131.96 2.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.566 -1.414 . . . . 1.77 109.566 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.858 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 47.2 mttt -165.6 140.4 4.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 5.0599999999999996 109.594 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.82 -20.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 2.6400000000000001 108.565 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.51 12.93 7.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.112 -1.595 . . . . 2.5099999999999998 109.112 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.858 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -50.42 -164.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -1.039 . . . . 2.3199999999999998 109.898 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.556 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 1.1 p90 -166.61 -161.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 1.6100000000000001 109.385 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -81.67 151.31 27.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 1.6499999999999999 109.733 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 12.8 t80 -137.19 113.36 9.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.893 . . . . 1.6799999999999999 109.319 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.7 m -106.14 96.53 6.54 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.128 -0.983 . . . . 0.73999999999999999 110.154 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.509 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.05 139.05 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 1.22 108.954 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.673 ' OG ' ' NE2' ' A' ' 145' ' ' GLN . 78.3 p -132.81 -14.03 2.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.563 -0.711 . . . . 1.3300000000000001 109.715 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.673 ' NE2' ' OG ' ' A' ' 144' ' ' SER . 0.8 OUTLIER -147.9 164.59 33.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 3.2999999999999998 110.146 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.591 HG11 ' CH2' ' A' ' 22' ' ' TRP . 8.7 p -178.51 126.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.935 -0.765 . . . . 2.2599999999999998 108.935 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.48 147.73 40.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.068 -1.02 . . . . 2.7599999999999998 110.076 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 9' ' ' LEU . 32.2 tp -116.72 135.6 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 4.5700000000000003 109.231 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -150.68 -177.25 5.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.025 . . . . 3.0699999999999998 109.725 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.564 ' N ' ' OG1' ' A' ' 149' ' ' THR . 2.7 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 2.0 109.576 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.816 ' N ' ' HG1' ' A' ' 149' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.364 0.602 . . . . 1.73 109.39 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.7 79.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.858 . . . . 2.7400000000000002 109.715 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.81 -14.27 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.898 . . . . 1.72 109.19 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -126.38 85.88 59.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 1.96 108.874 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.91 37.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.154 2.57 . . . . 1.8700000000000001 112.391 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.712 ' H ' HD13 ' A' ' 10' ' ' LEU . 57.2 t60 -145.53 101.1 3.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 1.26 109.315 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 13' ' ' THR . 7.7 t -142.37 52.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.267 -0.895 . . . . 1.0900000000000001 109.453 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -139.38 68.11 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 1.8799999999999999 109.609 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -67.1 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 1.3200000000000001 109.127 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.25 -36.07 14.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 1.0800000000000001 110.196 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 3.0 mm-40 -109.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 2.9700000000000002 110.137 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -99.38 151.29 21.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.6499999999999999 109.87 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.817 ' CD2' HD21 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -59.37 -60.02 4.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.845 . . . . 1.95 109.304 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.503 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.37 -164.32 12.32 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.67000000000000004 109.523 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.55 -2.71 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.834 2.356 . . . . 0.70999999999999996 112.276 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.557 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 11.8 m95 -75.13 -177.09 3.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.89 . . . . 0.56999999999999995 109.321 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -140.07 175.84 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.83999999999999997 109.295 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.817 HD21 ' CD2' ' A' ' 19' ' ' LEU . 1.8 pp -179.29 164.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 1.9099999999999999 109.938 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.675 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 162.71 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 2.6499999999999999 109.718 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.61 -21.97 9.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.038 -1.225 . . . . 0.57999999999999996 110.038 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.879 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.69 -142.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.287 . . . . 0.56999999999999995 109.49 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.2 p -91.78 -175.87 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.92000000000000004 108.984 179.389 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -81.02 111.65 25.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 2.5899999999999999 108.815 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 28' ' ' SER . 54.1 Cg_exo -49.26 155.02 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.317 2.011 . . . . 0.88 111.855 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' MET . 44.9 t -142.41 106.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 1.1599999999999999 109.986 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.68 82.92 3.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 1.3700000000000001 109.128 179.127 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.569 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.72999999999999998 109.938 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' ALA . 2.6 m-20 -41.47 -65.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 2.4900000000000002 109.448 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -147.88 26.34 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.299 -1.52 . . . . 0.81999999999999995 109.299 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -141.03 145.02 35.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -1.122 . . . . 3.4700000000000002 109.641 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 30' ' ' PRO . 45.4 ttp -112.85 127.35 56.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 1.4399999999999999 109.128 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.606 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -121.3 156.82 31.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 1.22 110.346 -179.358 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 HD23 ' A' ' 41' ' ' LEU . 2.2 m -125.61 142.23 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.685 -0.857 . . . . 0.53000000000000003 108.685 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.784 ' C ' HD22 ' A' ' 41' ' ' LEU . 5.7 m-20 -77.26 111.98 13.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 1.52 109.817 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.6 mm? -122.87 68.56 34.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 1.4299999999999999 109.408 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.99 -92.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.835 2.357 . . . . 1.9299999999999999 112.308 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.07 36.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.53 -1.428 . . . . 2.02 109.53 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.86 -9.02 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 1.7 109.482 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.684 HE22 ' HB2' ' A' ' 51' ' ' ALA . 16.3 mt-30 -99.87 119.03 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 2.0800000000000001 109.522 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.52 46.94 1.18 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.513 -1.435 . . . . 2.0299999999999998 109.513 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -171.25 102.95 0.39 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.174 -1.192 . . . . 2.29 109.67 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -47.32 -26.11 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.322 . . . . 1.5800000000000001 112.363 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.646 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 27.0 p90 -93.98 44.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 3.3399999999999999 109.665 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.48 ' CG ' ' CG ' ' A' ' 47' ' ' ASN . 1.9 m-20 -131.35 11.88 4.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 1.97 109.343 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.684 ' HB2' HE22 ' A' ' 45' ' ' GLN . . . -174.3 140.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 0.91000000000000003 109.269 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 146.57 -174.36 26.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.678 -1.369 . . . . 0.59999999999999998 109.678 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' C ' HG22 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -104.21 -173.57 2.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -1.197 . . . . 1.6499999999999999 109.921 -179.953 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.54 172.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.704 . . . . 1.48 109.376 -179.767 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 17.8 t80 170.48 142.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 1.4399999999999999 109.664 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.635 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -103.27 -164.72 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.252 -0.905 . . . . 0.94999999999999996 109.469 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 58' ' ' VAL . . . 79.72 68.89 1.44 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.411 -1.476 . . . . 0.83999999999999997 109.411 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 57' ' ' GLY . 43.4 t -153.93 73.82 6.38 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.33 -1.1 . . . . 1.6299999999999999 109.544 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.25 120.85 7.66 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.553 2.169 . . . . 0.83999999999999997 112.043 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.39 130.19 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.226 -0.921 . . . . 1.1599999999999999 109.663 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -113.08 102.52 1.29 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.81999999999999995 109.362 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.567 ' O ' ' OE1' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -42.8 124.76 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 2.73 109.598 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.02 -39.18 2.14 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.77 -1.332 . . . . 0.98999999999999999 109.77 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.534 ' O ' ' OG ' ' A' ' 115' ' ' SER . 10.3 mt-10 -100.22 170.12 8.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -1.147 . . . . 2.5899999999999999 109.697 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -116.85 145.14 43.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.81999999999999995 109.269 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 33.3 m-85 -110.84 179.49 4.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.123 -0.986 . . . . 1.47 109.671 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.3 t -152.78 149.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.98999999999999999 109.316 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' ARG . 3.4 tp -134.06 116.96 16.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.85999999999999999 109.858 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 83.2 p -109.4 85.85 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.464 -0.939 . . . . 1.1499999999999999 108.464 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 49.9 p90 -92.61 137.08 32.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 1.05 111.275 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.3 p -84.24 114.41 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.193 -1.04 . . . . 0.72999999999999998 108.193 178.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 148.04 15.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.781 -1.199 . . . . 0.69999999999999996 110.671 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 131.12 39.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.689 -0.856 . . . . 0.78000000000000003 108.689 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.774 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -93.36 127.57 39.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 109.728 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.497 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -134.19 114.39 12.64 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.307 -0.871 . . . . 0.60999999999999999 109.261 179.882 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.635 ' O ' ' C ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.74 -141.98 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.895 -1.294 . . . . 0.80000000000000004 112.407 -0.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.663 ' O ' ' CG ' ' A' ' 78' ' ' MET . 1.4 m-20 -98.94 160.15 14.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 1.3999999999999999 109.634 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.663 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 156.91 155.83 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.85 . . . . 1.9299999999999999 109.268 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.62 145.3 41.5 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.884 2.389 . . . . 0.79000000000000004 112.376 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.112 HG11 HD12 ' A' ' 102' ' ' LEU . 0.7 OUTLIER -117.45 172.7 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.76000000000000001 109.222 179.939 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.483 ' N ' HG23 ' A' ' 80' ' ' VAL . 20.0 ttt180 -119.69 134.36 55.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.93 . . . . 3.0499999999999998 109.6 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.527 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -137.99 150.13 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 1.55 109.248 179.795 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -145.99 152.33 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.85999999999999999 109.832 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.756 HG13 HG22 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -154.95 154.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.923 . . . . 0.56999999999999995 109.632 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 148.33 -149.04 21.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.653 -1.379 . . . . 0.57999999999999996 109.653 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.76 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.9 pm0 -90.08 178.38 6.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 2.7400000000000002 109.715 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.544 -1.422 . . . . 1.6299999999999999 109.544 179.994 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.871 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.317 0.58 . . . . 3.4199999999999999 109.452 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -125.78 -171.37 2.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.96999999999999997 109.814 -179.815 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.665 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -118.45 -24.06 6.96 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.904 -0.776 . . . . 0.94999999999999996 108.904 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -90.49 41.36 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -0.958 . . . . 1.6299999999999999 108.719 179.915 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.46 64.75 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.971 . . . . 2.7799999999999998 109.886 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' VAL . 4.0 pt20 -109.08 153.9 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 2.2799999999999998 109.177 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.6 11.61 4.3 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.8 -1.32 . . . . 0.94999999999999996 109.8 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -105.36 77.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -1.181 . . . . 0.88 109.388 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.797 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -119.81 79.53 24.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.943 . . . . 0.58999999999999997 109.677 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -52.75 126.45 21.18 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.882 2.388 . . . . 0.73999999999999999 112.384 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.112 HD12 HG11 ' A' ' 80' ' ' VAL . 20.6 mt -133.02 137.78 46.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 1.1699999999999999 109.326 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.1 OUTLIER -109.06 -179.33 3.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 1.0800000000000001 109.477 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.473 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -84.63 40.56 2.97 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.525 -1.43 . . . . 1.3500000000000001 109.525 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.38 120.59 12.66 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -1.111 . . . . 3.4900000000000002 109.402 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.35 118.42 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.391 2.06 . . . . 0.97999999999999998 111.806 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -160.85 141.96 11.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.48 109.904 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.0 138.57 31.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.774 . . . . 0.96999999999999997 109.706 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 69' ' ' SER . 18.4 mmt180 -109.03 136.62 48.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 4.1799999999999997 108.685 178.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 10.4 mt-10 -113.95 103.36 11.08 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.181 -0.607 . . . . 2.3799999999999999 109.698 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 16.1 m-85 -109.13 120.09 41.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 1.51 108.424 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.45 156.53 25.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.306 -0.872 . . . . 0.87 109.923 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.0 p90 -144.78 178.98 7.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.456 -0.778 . . . . 1.8300000000000001 109.161 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -105.4 115.8 30.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.448 -0.782 . . . . 1.0900000000000001 109.633 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 10.7 m -48.82 123.2 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.907 . . . . 1.6200000000000001 109.418 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 114' ' ' THR . 16.0 m120 -113.97 -38.25 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 2.3900000000000001 109.571 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -112.93 143.21 44.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 2.54 109.618 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.67 103.99 11.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 1.0800000000000001 109.54 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.668 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 43.5 m-85 -112.26 95.97 33.07 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 1.9299999999999999 109.247 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.56 166.15 24.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.682 2.254 . . . . 1.21 112.274 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.54 -19.61 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.9 2.4 . . . . 1.5800000000000001 111.934 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.1 136.64 54.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 3.5 109.457 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.84 -111.87 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 2.0899999999999999 109.548 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.37 -17.56 14.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -1.128 . . . . 3.6699999999999999 109.418 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -167.38 122.31 0.84 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 2.1000000000000001 109.384 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.63 -159.74 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.542 2.162 . . . . 1.72 112.195 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -57.87 168.59 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.78000000000000003 109.493 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.21 135.08 12.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 2.1899999999999999 109.433 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.756 HG22 HG13 ' A' ' 84' ' ' VAL . 41.3 t -141.12 148.79 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.4299999999999999 108.769 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.27 105.77 0.66 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.101 -0.999 . . . . 0.46999999999999997 110.029 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 7.7 m-30 -83.56 109.99 17.86 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.33 -0.989 . . . . 1.3799999999999999 108.33 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.418 ' CE1' HD21 ' A' ' 83' ' ' LEU . 44.4 m170 -99.38 120.23 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.945 . . . . 1.1399999999999999 110.084 -179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.839 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -129.97 -7.56 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 1.1499999999999999 109.141 179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -57.69 126.03 41.02 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.401 -1.48 . . . . 1.27 109.401 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.708 ' O ' ' N ' ' A' ' 138' ' ' ALA . 11.0 mtpt -161.55 128.23 3.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -1.187 . . . . 4.7400000000000002 109.987 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.08 -18.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.94 -1.133 . . . . 1.5900000000000001 107.94 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.703 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -118.27 10.14 13.29 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.837 -1.705 . . . . 1.6100000000000001 108.837 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.708 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.76 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.61 -0.936 . . . . 1.6899999999999999 109.858 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.828 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -168.74 -114.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.012 . . . . 2.0 110.038 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.4 mt-10 -130.8 138.48 49.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 2.2999999999999998 109.235 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 12.2 t80 -117.35 116.62 27.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 1.47 109.595 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.01 98.38 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.44 110.043 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -114.06 141.67 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.81999999999999995 109.256 179.548 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 86.5 p -130.74 -10.68 3.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.682 -0.636 . . . . 0.64000000000000001 109.346 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.644 ' N ' ' OG1' ' A' ' 71' ' ' THR . 3.8 mt-30 -148.37 177.41 9.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 1.9399999999999999 110.359 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.606 ' O ' ' CG1' ' A' ' 146' ' ' VAL . 1.1 p -179.17 117.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 1.1499999999999999 108.821 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.57 ' OG ' ' OG ' ' A' ' 69' ' ' SER . 60.1 p -124.6 151.17 45.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.013 -1.054 . . . . 1.6100000000000001 110.123 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.957 HD12 ' N ' ' A' ' 149' ' ' THR . 0.2 OUTLIER -135.67 122.39 21.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.458 -0.776 . . . . 1.3 108.968 179.728 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.957 ' N ' HD12 ' A' ' 148' ' ' LEU . 1.2 t -148.21 -159.97 1.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.053 -1.03 . . . . 1.21 109.666 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.624 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.2 t . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 1.77 109.33 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.477 -0.564 . . . . 5.4699999999999998 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.63 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.897 . . . . 4.5300000000000002 109.514 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.508 ' O ' ' C ' ' A' ' 4' ' ' ASP . 3.5 mm? -75.55 174.1 10.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 5.1399999999999997 109.501 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.522 ' O ' ' OG ' ' A' ' 5' ' ' SER . 49.2 t0 -35.99 115.64 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 5.3799999999999999 109.45 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 6' ' ' GLU . 24.8 p 59.09 101.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 4.8300000000000001 109.504 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -40.71 168.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 3.4300000000000002 109.432 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 7' ' ' VAL . 42.2 t -106.87 54.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 2.8300000000000001 109.458 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 7' ' ' VAL . 19.5 tp10 -35.85 119.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 4.75 109.344 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' A' ' 148' ' ' LEU . 12.3 mt -88.19 -31.96 18.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 4.9500000000000002 109.801 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 57' ' ' GLY . 1.0 OUTLIER -113.47 129.92 24.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 2.8599999999999999 108.968 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -67.33 59.36 0.69 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.424 2.083 . . . . 3.8300000000000001 113.343 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.496 ' C ' HG22 ' A' ' 13' ' ' THR . 36.2 t60 -165.38 126.65 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.007 . . . . 2.52 109.752 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.53 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -170.37 70.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 1.97 109.318 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.47 ' HA ' ' NE2' ' A' ' 145' ' ' GLN . 30.5 t -161.33 82.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.117 -0.989 . . . . 1.96 109.8 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.2 m-30 -90.12 24.84 2.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 1.76 109.243 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.23 17.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 1.1799999999999999 109.815 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.677 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 19.6 mm-40 -109.67 -49.5 3.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.184 -0.947 . . . . 2.1299999999999999 109.588 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.8 p -136.39 152.03 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 2.2599999999999998 109.377 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.983 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -85.07 26.97 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 2.6000000000000001 109.191 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 44.41 -151.64 0.64 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.572 -1.411 . . . . 1.6200000000000001 109.572 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 67.4 Cg_endo -81.0 9.45 3.81 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.748 2.299 . . . . 1.7 112.555 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.789 ' NE1' ' CD2' ' A' ' 55' ' ' TYR . 10.6 m95 -70.94 172.15 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.006 . . . . 2.4199999999999999 109.275 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.92 177.64 4.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 1.6399999999999999 109.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.968 ' O ' HD12 ' A' ' 24' ' ' LEU . 4.2 pp -178.46 123.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 2.0499999999999998 109.349 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.2 169.12 2.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 1.72 110.305 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 -26.54 22.2 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.098 -1.201 . . . . 1.7 110.098 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.799 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.9 -142.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.03 -1.276 . . . . 0.96999999999999997 109.394 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.799 ' N ' ' OG1' ' A' ' 27' ' ' THR . 67.0 p -91.14 132.56 35.99 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.251 -0.906 . . . . 1.8 109.236 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -36.83 101.75 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 2.3999999999999999 109.234 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.708 ' HG2' HD13 ' A' ' 24' ' ' LEU . 50.3 Cg_exo -48.16 159.06 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.303 2.002 . . . . 1.1299999999999999 111.551 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' MET . 3.5 t -148.11 114.35 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.937 -1.102 . . . . 1.05 110.659 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.677 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -74.05 79.49 1.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.049 -0.722 . . . . 1.8200000000000001 109.049 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.26 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.519 -0.738 . . . . 1.1699999999999999 109.872 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 33' ' ' ALA . 69.0 m-20 -35.65 -70.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 2.21 109.441 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.88 33.12 1.28 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.626 -1.39 . . . . 1.1899999999999999 109.626 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -153.35 150.6 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -1.206 . . . . 2.9100000000000001 109.664 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.527 ' SD ' ' CB ' ' A' ' 30' ' ' PRO . 33.7 ttp -109.05 132.23 54.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.93000000000000005 109.769 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 58.4 m -124.02 156.25 36.82 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.675 -0.81 . . . . 1.0600000000000001 110.211 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.9 m -131.47 129.58 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.684 -0.858 . . . . 1.3700000000000001 108.684 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' H ' ' HG ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -73.65 109.39 7.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 4.79 109.622 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.2 mm? -118.19 35.01 0.21 Allowed Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.155 -0.965 . . . . 3.54 110.897 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 98.6 Cg_endo -81.87 -24.02 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.521 2.148 . . . . 3.7400000000000002 111.738 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.542 ' C ' ' O ' ' A' ' 42' ' ' PRO . . . -26.61 -97.87 0.01 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.076 -0.81 . . . . 2.0299999999999998 111.076 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.36 54.61 0.01 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.42 -1.872 . . . . 2.4100000000000001 108.42 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 136' ' ' ALA . 20.7 mt-30 -99.7 111.92 24.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 2.96 109.97 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.531 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -81.74 55.26 4.88 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.46 -1.456 . . . . 2.0800000000000001 109.46 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -166.87 96.34 0.69 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 3.6099999999999999 109.427 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 50' ' ' ASP . 56.1 Cg_exo -47.77 -40.46 31.6 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.735 2.29 . . . . 2.3599999999999999 112.494 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 19.3 p90 -62.95 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 3.8700000000000001 109.413 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -133.16 -57.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.24 -0.912 . . . . 2.3799999999999999 109.659 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.702 ' HB1' HG22 ' A' ' 27' ' ' THR . . . -122.1 146.36 47.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.956 . . . . 1.1100000000000001 109.728 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.612 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 163.35 175.72 34.61 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.615 -1.278 . . . . 0.93999999999999995 110.359 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 53' ' ' LEU . 2.1 mm? -100.36 167.91 10.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.617 -0.931 . . . . 0.95999999999999996 108.736 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG2' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -154.47 155.4 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.92000000000000004 109.875 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.789 ' CD2' ' NE1' ' A' ' 22' ' ' TRP . 30.1 t80 -177.75 148.91 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 1.71 109.436 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.64 168.14 9.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 2.7799999999999998 109.568 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.732 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 101.47 81.72 1.6 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 2.48 109.604 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.755 ' CG2' ' H ' ' A' ' 128' ' ' GLN . 5.9 m -163.21 59.76 0.87 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 3.79 109.39 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 56.9 Cg_exo -47.0 149.85 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.881 2.388 . . . . 2.3999999999999999 112.274 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 1.6 t -144.62 121.74 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 3.0800000000000001 109.522 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -96.81 94.89 1.67 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.493 -1.443 . . . . 3.0499999999999998 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.534 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 13.6 tt0 -38.46 117.4 0.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 6.0499999999999998 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 128.2 -35.82 2.63 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.664 -1.374 . . . . 2.54 109.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.91 172.33 7.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.234 -1.156 . . . . 4.0300000000000002 109.5 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -113.78 137.5 51.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 2.9100000000000001 109.482 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.486 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 37.1 m-85 -105.72 -178.78 3.75 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.21 -0.932 . . . . 2.3799999999999999 109.463 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.407 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -150.91 140.38 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 2.6099999999999999 109.917 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.587 HD12 ' HB3' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -116.73 120.41 38.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 3.6099999999999999 109.01 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.68 89.89 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.055 -1.028 . . . . 2.27 109.44 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.682 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.4 137.01 33.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 2.0099999999999998 110.675 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.555 ' OG1' ' CB ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.06 105.63 17.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.391 -0.818 . . . . 1.8 109.058 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.553 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -175.28 169.82 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.828 -1.17 . . . . 0.95999999999999996 110.677 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.43 159.82 41.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.042 -0.725 . . . . 0.93000000000000005 109.042 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.834 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -102.91 137.56 40.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.67000000000000004 109.682 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.52 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.44 112.54 6.57 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.258 -0.901 . . . . 0.96999999999999997 109.639 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.3 Cg_exo -63.87 -141.72 0.14 OUTLIER 'Cis proline' 0 N--CA 1.496 1.633 0 C-N-CA 124.218 -1.159 . . . . 1.02 112.439 -0.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -104.94 151.03 24.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 1.75 110.023 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' O ' ' A' ' 137' ' ' GLY . 1.7 mtm 166.25 163.5 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.817 -0.809 . . . . 2.1600000000000001 108.817 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -83.95 153.9 13.03 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.744 2.296 . . . . 1.3799999999999999 112.591 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.633 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 17.5 m -128.5 -166.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 2.0099999999999998 109.253 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.57 ' O ' ' O ' ' A' ' 132' ' ' HIS . 57.0 ttt180 -136.65 141.61 43.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.067 -1.02 . . . . 6.0099999999999998 109.836 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' OE1' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.97 149.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 3.7599999999999998 109.259 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.594 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -142.79 149.22 38.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 2.29 109.876 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.656 HG13 HG23 ' A' ' 129' ' ' VAL . 1.3 t -151.4 146.09 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 1.8899999999999999 109.696 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.86 -142.0 7.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.476 -1.45 . . . . 1.49 109.476 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 22.8 pt-20 -90.07 -158.78 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -1.193 . . . . 2.54 109.471 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.62 50.47 0.51 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.518 -1.433 . . . . 1.3799999999999999 109.518 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.7 140.45 3.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.499 -1.44 . . . . 2.54 109.499 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . 94.59 -132.37 11.12 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 4.1399999999999997 109.587 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -40.13 -32.44 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -1.14 . . . . 5.1299999999999999 109.443 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.639 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 8.1 m-85 60.7 -37.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.769 . . . . 5.79 109.808 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -55.19 130.17 41.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 5.7400000000000002 109.48 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -115.86 169.92 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 2.27 109.921 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.9 -23.34 11.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.647 -0.871 . . . . 3.2799999999999998 108.647 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.799 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.97 34.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 3.6499999999999999 109.123 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB2' HG23 ' A' ' 93' ' ' THR . 0.6 OUTLIER -89.59 104.74 17.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 4.5999999999999996 109.64 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.498 ' OE1' HG13 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -141.26 176.48 8.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 3.46 109.515 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.47 14.11 0.61 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.643 -1.383 . . . . 3.6699999999999999 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -112.33 60.84 0.63 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -1.182 . . . . 3.79 109.546 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.52 101.93 30.82 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 1.96 109.083 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.32 131.97 11.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.539 2.159 . . . . 2.9700000000000002 112.593 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.08 134.48 23.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 3.0600000000000001 109.264 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.664 ' O ' ' N ' ' A' ' 105' ' ' GLU . 9.0 t -138.32 -161.63 1.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 2.3399999999999999 109.523 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.514 ' H ' ' HG1' ' A' ' 103' ' ' THR . . . -62.6 37.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.445 -1.462 . . . . 2.1699999999999999 109.445 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 103' ' ' THR . 13.8 tp10 -112.25 93.1 20.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.279 -1.13 . . . . 3.02 109.359 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 58.4 Cg_endo -79.53 118.18 3.84 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.715 2.277 . . . . 1.4199999999999999 112.177 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 173.96 -175.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 1.3700000000000001 109.48 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.4 118.82 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 1.72 110.283 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -93.26 137.13 32.87 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.356 -1.35 . . . . 4.7000000000000002 107.356 177.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.44 118.58 37.14 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.441 -0.787 . . . . 3.2799999999999998 109.666 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -107.94 109.92 21.53 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.036 -1.098 . . . . 2.96 108.036 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.27 45.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.025 -1.047 . . . . 3.4100000000000001 110.066 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.799 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -133.57 166.88 21.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 2.77 109.176 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.13 126.47 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.228 -0.92 . . . . 2.23 109.866 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 63' ' ' GLY . 3.9 m -69.25 122.78 19.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.261 -0.899 . . . . 4.1100000000000003 109.326 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.534 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -117.67 -9.98 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 6.8600000000000003 109.54 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.641 HD23 ' CZ ' ' A' ' 119' ' ' PHE . 13.1 tp -141.49 124.2 16.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 5.1200000000000001 109.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.459 ' N ' HD12 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -63.92 144.74 56.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 4.0599999999999996 109.498 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.641 ' CZ ' HD23 ' A' ' 117' ' ' LEU . 32.9 m-85 -142.88 92.22 7.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 5.4400000000000004 109.515 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.35 165.81 20.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.76 2.307 . . . . 4.04 112.215 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.99 -17.93 10.45 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.766 2.31 . . . . 3.8999999999999999 112.007 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.99 132.29 54.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 4.1399999999999997 109.509 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 133.44 50.77 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.523 -1.431 . . . . 3.5699999999999998 109.523 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 123' ' ' GLY . 1.3 t70 37.92 22.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -1.132 . . . . 3.5899999999999999 109.48 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -151.77 72.07 8.05 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 2.0800000000000001 109.397 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.22 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.791 2.327 . . . . 1.3899999999999999 112.233 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.513 ' HA3' ' H ' ' A' ' 57' ' ' GLY . . . -72.92 157.07 52.24 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.631 -1.388 . . . . 1.1899999999999999 109.631 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.755 ' H ' ' CG2' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -150.77 140.44 21.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -1.131 . . . . 2.0099999999999998 109.587 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 129' ' ' VAL . 4.5 p -161.53 112.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -0.9 . . . . 1.28 108.828 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.414 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -122.74 112.22 17.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.167 -0.958 . . . . 0.97999999999999998 110.12 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -71.8 113.79 9.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.646 -0.872 . . . . 1.73 108.646 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 81' ' ' ARG . 1.6 m170 -99.66 100.69 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.199 -0.938 . . . . 2.3199999999999998 109.828 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.682 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -109.72 -21.34 12.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 2.1099999999999999 109.075 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.626 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -47.19 139.81 8.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.166 -1.573 . . . . 1.77 109.166 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.626 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER 179.54 129.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.108 . . . . 5.0599999999999996 109.234 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.01 -22.76 0.65 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.618 -1.253 . . . . 2.6400000000000001 107.618 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.642 ' O ' ' SD ' ' A' ' 78' ' ' MET . . . -105.24 7.11 43.3 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.466 -1.854 . . . . 2.5099999999999998 108.466 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.618 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -51.82 -145.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.803 -0.822 . . . . 2.3199999999999998 110.285 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.834 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 171.89 -112.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 1.6100000000000001 110.024 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.14 136.04 45.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 1.6499999999999999 109.061 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.553 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 52.9 t80 -122.7 116.71 24.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.083 -1.011 . . . . 1.6799999999999999 109.816 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.51 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 12.4 m -106.75 114.29 28.29 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.249 -0.907 . . . . 0.73999999999999999 109.561 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.748 HD12 ' N ' ' A' ' 144' ' ' SER . 0.1 OUTLIER -119.97 141.2 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 1.22 109.471 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.748 ' N ' HD12 ' A' ' 143' ' ' ILE . 2.0 p -127.72 -17.21 4.57 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.163 -0.68 . . . . 1.3300000000000001 109.163 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.677 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -152.28 159.28 43.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.379 -0.825 . . . . 3.2999999999999998 109.378 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 146' ' ' VAL . 11.9 p -165.94 126.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 2.2599999999999998 109.429 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.509 ' OG ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -167.21 146.39 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 2.7599999999999998 109.428 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.587 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.8 pp -111.26 146.39 37.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 4.5700000000000003 109.511 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 150' ' ' THR . 2.1 t -133.57 -157.92 0.85 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -0.876 . . . . 3.0699999999999998 109.483 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.55 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -139.64 -41.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 2.0 109.358 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.519 ' N ' ' CG2' ' A' ' 150' ' ' THR . 1.0 OUTLIER 71.38 104.69 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.422 -0.799 . . . . 2.1499999999999999 109.427 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -135.68 149.24 49.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 2.8199999999999998 109.437 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.95 -1.024 . . . . 3.54 109.48 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.531 -0.544 . . . . 5.4699999999999998 109.531 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -91.72 -112.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 4.5300000000000002 109.452 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.667 ' CD2' ' H ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER -168.1 -156.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 5.1399999999999997 109.471 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.667 ' H ' ' CD2' ' A' ' 3' ' ' LEU . 26.5 t70 -118.07 25.47 10.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 5.3799999999999999 109.492 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.568 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -103.89 35.8 2.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 4.8300000000000001 109.477 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 5' ' ' SER . 30.2 mt-10 35.89 94.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 3.4300000000000002 109.41 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 7' ' ' VAL . 2.1 t -45.73 162.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.89 . . . . 2.8300000000000001 109.467 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -141.15 64.39 1.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 4.75 109.507 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.825 ' HB2' HD11 ' A' ' 148' ' ' LEU . 0.6 OUTLIER -79.95 16.46 1.18 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.925 . . . . 4.9500000000000002 109.403 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.697 ' O ' ' N ' ' A' ' 12' ' ' HIS . 1.2 tt -118.08 82.33 17.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.143 -1.058 . . . . 2.8599999999999999 108.143 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' C ' ' OH ' ' A' ' 55' ' ' TYR . 36.7 Cg_exo -53.02 36.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.099 2.533 . . . . 3.8300000000000001 113.285 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.697 ' N ' ' O ' ' A' ' 10' ' ' LEU . 38.8 t60 -170.34 138.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.995 -1.066 . . . . 2.52 109.579 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.517 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.35 70.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 1.97 109.592 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.7 p -169.84 77.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.141 -0.974 . . . . 1.96 109.903 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.15 22.13 3.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.938 . . . . 1.76 109.031 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.09 -25.0 20.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 1.1799999999999999 109.883 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 16.7 mm-40 -109.7 -58.92 1.99 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.048 -1.032 . . . . 2.1299999999999999 109.663 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 m -142.84 143.46 32.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.868 . . . . 2.2599999999999998 109.503 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -46.69 -34.23 4.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.945 . . . . 2.6000000000000001 109.137 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 79.99 -164.01 47.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.586 -1.406 . . . . 1.6200000000000001 109.586 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 22' ' ' TRP . 34.8 Cg_exo -53.83 -21.52 20.68 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.841 2.36 . . . . 1.7 112.326 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CD1' ' CD1' ' A' ' 55' ' ' TYR . 4.3 m95 -53.05 -167.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.4199999999999999 109.356 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 161.9 39.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 1.6399999999999999 109.391 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.643 HD22 ' HG2' ' A' ' 30' ' ' PRO . 2.2 pp -160.08 137.88 9.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 2.0499999999999998 109.688 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.6 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 1.72 109.331 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 110.14 -28.58 10.21 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.84 -1.304 . . . . 1.7 109.84 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.784 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.9 -142.7 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.296 . . . . 0.96999999999999997 109.454 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.784 ' N ' ' OG1' ' A' ' 27' ' ' THR . 3.6 p -91.62 -165.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 1.8 109.313 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -90.17 111.86 49.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 2.3999999999999999 109.003 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.643 ' HG2' HD22 ' A' ' 24' ' ' LEU . 78.5 Cg_exo -44.21 154.76 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.216 1.944 . . . . 1.1299999999999999 111.981 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' MET . 23.7 t -139.43 100.35 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.971 . . . . 1.05 110.21 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.71 82.58 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.65 0.738 . . . . 1.8200000000000001 109.179 178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.78 -114.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.76 . . . . 1.1699999999999999 110.023 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 2.1 m-20 -58.35 66.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 2.21 109.759 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 59.27 6.19 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.562 -1.415 . . . . 1.1899999999999999 109.562 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.45 141.84 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -1.216 . . . . 2.9100000000000001 109.424 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -113.8 123.55 50.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 109.031 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.547 ' SG ' ' C ' ' A' ' 141' ' ' PHE . 4.5 t -128.15 153.2 47.13 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.272 -0.971 . . . . 1.0600000000000001 110.559 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.15 120.02 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.548 -0.908 . . . . 1.3700000000000001 108.548 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.568 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -77.39 117.44 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 4.79 109.469 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.671 HD21 ' OG1' ' A' ' 27' ' ' THR . 4.5 mm? -114.6 94.45 36.76 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.257 -0.902 . . . . 3.54 109.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.36 -43.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.223 2.615 . . . . 3.7400000000000002 111.984 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.77 141.47 3.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.397 -1.481 . . . . 2.0299999999999998 109.397 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.19 -0.43 1.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.999 -1.24 . . . . 2.4100000000000001 109.999 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.752 ' OE1' ' HB2' ' A' ' 51' ' ' ALA . 5.6 mm-40 -99.17 -160.92 0.83 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.127 -1.22 . . . . 2.96 109.428 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.43 -57.74 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.842 -1.303 . . . . 2.0800000000000001 109.842 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.68 ' OD1' ' CD1' ' A' ' 49' ' ' TRP . 3.5 p30 -99.76 150.94 37.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.224 -1.162 . . . . 3.6099999999999999 109.58 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' ASP . 84.8 Cg_exo -40.18 -55.41 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.875 2.383 . . . . 2.3599999999999999 112.343 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.68 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 2.1 p90 -70.63 47.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 3.8700000000000001 109.463 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD2' ' N ' ' A' ' 47' ' ' ASN . 67.8 m-20 -116.11 -8.51 11.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 2.3799999999999999 109.709 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.752 ' HB2' ' OE1' ' A' ' 45' ' ' GLN . . . -172.8 116.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.952 . . . . 1.1100000000000001 109.564 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.501 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 174.3 166.99 33.18 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.68 -1.248 . . . . 0.93999999999999995 110.186 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.97 -169.48 1.62 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -1.093 . . . . 0.95999999999999996 109.421 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -159.64 162.56 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.92000000000000004 109.805 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.791 ' CD1' ' CD1' ' A' ' 22' ' ' TRP . 20.1 t80 -176.82 140.4 0.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.821 . . . . 1.71 109.403 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -113.31 -164.19 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.38 -0.825 . . . . 2.7799999999999998 109.472 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 9' ' ' LEU . . . 86.06 47.07 5.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.504 -1.438 . . . . 2.48 109.504 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.538 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 22.2 t -151.12 75.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.131 . . . . 3.79 109.521 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 58' ' ' VAL . 75.7 Cg_exo -44.04 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.906 2.404 . . . . 2.3999999999999999 112.191 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 119' ' ' PHE . 2.7 t -142.37 120.86 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 3.0800000000000001 109.595 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -137.93 107.67 0.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.323 -1.511 . . . . 3.0499999999999998 109.323 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.7 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.3 tm-20 -42.46 172.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 6.0499999999999998 109.182 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.671 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 80.67 -45.15 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.479 . . . . 2.54 109.404 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -99.56 135.56 40.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 4.0300000000000002 109.084 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.4 m -99.84 148.78 24.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.168 -0.957 . . . . 2.9100000000000001 109.763 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -107.92 177.98 4.65 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 2.3799999999999999 109.583 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -151.39 160.81 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.489 -0.757 . . . . 2.6099999999999999 109.468 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 109' ' ' ARG . 10.1 tp -143.69 114.3 7.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 3.6099999999999999 109.666 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 4.8 p -109.23 83.66 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.966 . . . . 2.27 108.828 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.613 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 24.9 p90 -93.89 132.99 37.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 2.0099999999999998 111.302 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.673 HG23 ' CG2' ' A' ' 108' ' ' THR . 0.8 OUTLIER -83.71 98.68 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.445 -0.946 . . . . 1.8 108.445 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -144.97 152.03 39.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.05 . . . . 0.95999999999999996 110.093 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.7 p -132.95 121.99 23.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.486 -0.759 . . . . 0.93000000000000005 109.055 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -83.48 132.96 34.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.67000000000000004 109.511 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.468 ' OG1' ' CB ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.62 117.08 16.31 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.323 -0.86 . . . . 0.96999999999999997 109.242 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.24 -142.46 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 124.256 -1.143 . . . . 1.02 112.227 -0.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -96.58 148.42 22.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 1.75 109.336 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.417 ' CE ' ' HB3' ' A' ' 139' ' ' TYR . 0.1 OUTLIER 168.27 153.03 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.685 . . . . 2.1600000000000001 109.29 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.88 117.92 5.1 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.705 2.27 . . . . 1.3799999999999999 112.001 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.483 ' CG1' HD23 ' A' ' 133' ' ' LEU . 27.2 m -79.93 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 2.0099999999999998 109.442 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 132' ' ' HIS . 18.0 ttm180 -114.68 90.29 3.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 6.0099999999999998 109.528 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.49 154.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.225 -0.922 . . . . 3.7599999999999998 108.993 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.44 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -154.25 162.97 40.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.01 . . . . 2.29 110.082 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.577 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.1 t -153.62 160.06 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 1.8899999999999999 109.358 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.44 -145.07 10.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.667 -1.373 . . . . 1.49 109.667 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.722 ' HB2' ' HB1' ' A' ' 125' ' ' ALA . 2.9 pt-20 -90.19 163.1 14.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -1.124 . . . . 2.54 109.446 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.82 22.98 12.17 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 1.3799999999999999 109.49 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -155.57 -156.74 7.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.54 -1.424 . . . . 2.54 109.54 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.28 -55.78 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 4.1399999999999997 109.551 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.687 ' O ' ' CG ' ' A' ' 91' ' ' TYR . . . -176.52 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -1.125 . . . . 5.1299999999999999 109.451 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.687 ' CG ' ' O ' ' A' ' 90' ' ' ALA . 7.5 m-85 -178.36 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 5.79 109.576 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 91' ' ' TYR . 8.3 mmt180 -34.72 117.0 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 5.7400000000000002 109.564 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -125.94 176.91 6.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 2.27 110.03 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.12 -20.98 5.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.841 -0.8 . . . . 3.2799999999999998 108.841 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.804 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.84 34.04 0.92 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 3.6499999999999999 109.149 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.5 92.26 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 4.5999999999999996 109.888 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 111' ' ' TYR . 4.5 mt-30 -99.77 137.78 37.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 3.46 109.514 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.48 -13.54 2.3 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.652 -1.379 . . . . 3.6699999999999999 109.652 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.38 80.61 1.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.166 -1.197 . . . . 3.79 109.587 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.17 84.52 14.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 1.96 109.404 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.95 127.31 18.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.989 2.46 . . . . 2.9700000000000002 112.614 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.545 HD21 ' CG ' ' A' ' 109' ' ' ARG . 11.4 mt -144.94 127.03 15.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.866 . . . . 3.0600000000000001 109.325 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 1.7 t -91.98 -169.99 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 2.3399999999999999 109.511 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.17 13.31 67.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.534 -1.426 . . . . 2.1699999999999999 109.534 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.494 ' H ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -103.06 152.77 38.6 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 3.02 109.424 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.31 118.3 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.848 2.365 . . . . 1.4199999999999999 112.2 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.87 146.44 11.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 1.3700000000000001 109.477 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.673 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.15 132.86 35.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 1.72 109.712 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.545 ' CG ' HD21 ' A' ' 102' ' ' LEU . 3.6 mmp_? -101.96 134.11 45.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.91 -1.144 . . . . 4.7000000000000002 107.91 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -109.69 106.05 15.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.033 -0.667 . . . . 3.2799999999999998 110.389 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CB ' HE22 ' A' ' 97' ' ' GLN . 42.1 m-85 -109.74 124.88 52.01 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.312 -0.996 . . . . 2.96 108.312 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.07 163.79 23.0 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 3.4100000000000001 109.922 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.804 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 4.2 p90 -166.76 -168.2 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 2.77 109.471 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.98 154.01 25.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.495 -0.753 . . . . 2.23 109.458 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -90.24 59.12 4.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 4.1100000000000003 109.799 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.516 ' C ' ' O ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -33.62 -40.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 6.8600000000000003 109.908 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' OG ' ' A' ' 115' ' ' SER . 2.8 mt -109.93 -169.55 1.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 5.1200000000000001 109.767 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.684 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.7 OUTLIER -129.76 158.85 38.26 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.257 -0.902 . . . . 4.0599999999999996 109.585 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 49.4 m-85 -166.42 96.53 0.73 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 5.4400000000000004 109.28 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.81 165.56 24.4 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.591 2.194 . . . . 4.04 112.334 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.51 -13.09 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.951 2.434 . . . . 3.8999999999999999 112.095 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -109.46 8.49 25.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 4.1399999999999997 109.535 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . -96.87 174.02 29.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.495 -1.442 . . . . 3.5699999999999998 109.495 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 27.3 t0 -71.15 34.61 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -1.132 . . . . 3.5899999999999999 109.482 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.722 ' HB1' ' HB2' ' A' ' 86' ' ' GLU . . . 179.87 87.8 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 109.424 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -80.38 -160.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.784 2.323 . . . . 1.3899999999999999 112.328 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.565 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -64.62 154.6 48.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.556 -1.418 . . . . 1.1899999999999999 109.556 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.449 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -149.7 140.74 22.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -1.153 . . . . 2.0099999999999998 109.633 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.7 t -144.78 144.15 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.454 -0.943 . . . . 1.28 108.454 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.489 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -157.61 114.33 2.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.98 -1.075 . . . . 0.97999999999999998 110.015 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.501 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.5 m-30 -94.66 88.2 5.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.425 -0.797 . . . . 1.73 109.263 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 27.9 m170 -99.42 137.64 37.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.955 . . . . 2.3199999999999998 109.747 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -129.36 52.54 1.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.1099999999999999 109.536 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . . . -40.01 123.73 2.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.902 -1.279 . . . . 1.77 109.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' A' ' 138' ' ' ALA . 2.2 mptp? -167.5 44.81 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.711 -0.876 . . . . 5.0599999999999996 108.831 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . 40.97 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.412 -1.329 . . . . 2.6400000000000001 107.412 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . 69.87 28.38 71.99 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.779 -1.728 . . . . 2.5099999999999998 108.779 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.695 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -91.7 56.55 3.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -1.203 . . . . 2.3199999999999998 110.377 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 135' ' ' LYS . 10.6 p90 -177.11 -153.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.838 -1.164 . . . . 1.6100000000000001 110.459 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.468 ' CB ' ' OG1' ' A' ' 75' ' ' THR . 1.0 OUTLIER -159.3 157.35 30.34 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.696 -0.853 . . . . 1.6499999999999999 108.696 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.547 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 13.0 t80 -135.28 103.17 5.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.041 -1.037 . . . . 1.6799999999999999 110.07 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.7 m -106.44 110.6 22.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 110.169 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.488 HG12 ' N ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -138.97 146.22 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 1.22 109.505 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.488 ' N ' HG12 ' A' ' 143' ' ' ILE . 3.6 p -136.31 -4.55 2.11 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.355 -0.538 . . . . 1.3300000000000001 109.688 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.505 ' CD ' HG21 ' A' ' 71' ' ' THR . 2.3 mt-30 -140.83 151.27 44.22 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.272 -0.971 . . . . 3.2999999999999998 110.073 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.578 HG21 ' CH2' ' A' ' 22' ' ' TRP . 13.0 p -163.08 122.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -0.845 . . . . 2.2599999999999998 109.507 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.96 139.69 23.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 2.7599999999999998 109.637 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.825 HD11 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -113.17 149.47 33.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 4.5700000000000003 109.403 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.805 ' N ' HD12 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -167.7 -163.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 3.0699999999999998 109.531 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.654 ' N ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -172.92 -41.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 2.0 109.346 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 150' ' ' THR . 40.0 p 45.02 -166.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.471 -0.768 . . . . 2.1499999999999999 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.69 20.1 10.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 2.8199999999999998 109.447 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.43 ' OXT' HG22 ' A' ' 153' ' ' THR . 4.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.028 -0.987 . . . . 3.54 109.438 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.504 -0.554 . . . . 5.4699999999999998 109.504 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.925 ' O ' HD12 ' A' ' 3' ' ' LEU . 56.7 p 53.46 79.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 4.5300000000000002 109.437 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.925 HD12 ' O ' ' A' ' 2' ' ' SER . 2.3 mp -141.03 175.18 9.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 5.1399999999999997 109.491 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -56.76 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 5.3799999999999999 109.497 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER 48.77 100.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 4.8300000000000001 109.482 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.32 124.0 25.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 3.4300000000000002 109.45 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.459 ' O ' ' OG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER -84.4 92.98 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 2.8300000000000001 109.492 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.535 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -96.81 126.29 41.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 4.75 109.486 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.43 HD13 ' CG ' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -84.06 -13.82 52.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.153 -0.967 . . . . 4.9500000000000002 109.596 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.65 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -119.89 83.37 29.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 2.8599999999999999 108.692 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.28 34.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.025 2.484 . . . . 3.8300000000000001 111.87 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.65 ' H ' HD13 ' A' ' 10' ' ' LEU . 44.3 t60 -134.78 99.03 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.425 -0.797 . . . . 2.52 109.475 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.543 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -137.58 54.97 1.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 1.97 109.333 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.647 ' O ' ' N ' ' A' ' 16' ' ' ALA . 22.7 t -159.61 83.3 0.75 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 1.96 109.675 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -63.43 50.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 1.76 108.868 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -55.52 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 1.1799999999999999 110.13 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -109.88 39.37 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 2.1299999999999999 109.851 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.6 153.3 2.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.145 -0.972 . . . . 2.2599999999999998 109.699 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.947 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.93 -13.85 59.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 2.6000000000000001 109.563 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' H ' HD22 ' A' ' 19' ' ' LEU . . . 76.61 174.16 38.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.781 -1.328 . . . . 1.6200000000000001 109.781 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.23 -16.37 4.72 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.694 2.263 . . . . 1.7 112.039 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.833 ' CH2' HG21 ' A' ' 146' ' ' VAL . 14.3 m95 -68.15 160.98 27.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 2.4199999999999999 109.08 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -109.68 148.24 31.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.086 -1.009 . . . . 1.6399999999999999 109.642 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -135.35 129.58 33.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 2.0499999999999998 109.51 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.619 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.27 159.63 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 1.72 109.573 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.9 -32.34 7.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.042 -1.223 . . . . 1.7 110.042 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.754 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.7 -141.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.105 -1.232 . . . . 0.96999999999999997 109.662 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.754 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.1 p -91.09 132.39 36.07 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 1.8 109.316 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 tt0 -36.88 102.56 0.24 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 2.3999999999999999 109.072 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' SER . 50.0 Cg_exo -46.54 152.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.296 1.997 . . . . 1.1299999999999999 111.689 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' MET . 81.6 t -137.74 115.25 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 1.05 110.241 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.61 90.88 4.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.573 -0.704 . . . . 1.8200000000000001 109.75 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -84.53 -112.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 1.1699999999999999 109.664 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 0.2 OUTLIER -59.43 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 2.21 109.626 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 60.0 5.03 3.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 1.1899999999999999 109.552 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.634 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -123.04 148.39 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -1.145 . . . . 2.9100000000000001 109.531 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.625 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.5 OUTLIER -114.39 132.39 56.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 0.93000000000000005 109.713 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.17 153.01 40.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 1.0600000000000001 109.676 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 1.3 m -126.07 137.88 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.905 -0.776 . . . . 1.3700000000000001 108.905 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.633 ' N ' ' OG ' ' A' ' 28' ' ' SER . 17.6 m-20 -73.0 110.14 7.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 4.79 109.475 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.618 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.2 mm? -117.81 75.02 9.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 3.54 109.556 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.01 -157.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.767 2.311 . . . . 3.7400000000000002 112.195 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.47 130.12 9.68 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 2.0299999999999998 109.548 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.99 35.81 0.12 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.532 -1.427 . . . . 2.4100000000000001 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.619 HE22 ' CB ' ' A' ' 50' ' ' ASP . 3.3 mm-40 -99.93 106.1 17.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -1.122 . . . . 2.96 109.491 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.2 14.42 1.25 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.659 -1.376 . . . . 2.0800000000000001 109.659 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.751 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -179.91 151.04 0.57 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.195 -1.179 . . . . 3.6099999999999999 109.519 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 50' ' ' ASP . 44.5 Cg_endo -71.8 -54.16 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.853 2.369 . . . . 2.3599999999999999 112.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.459 ' CE3' ' HG2' ' A' ' 48' ' ' PRO . 11.1 p90 -62.88 45.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 3.8700000000000001 109.384 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.789 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -135.48 39.75 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.907 . . . . 2.3799999999999999 109.353 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 156.92 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 1.1100000000000001 109.528 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.83 170.08 20.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.644 -1.382 . . . . 0.93999999999999995 109.644 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 143' ' ' ILE . 1.7 pp -108.58 142.82 38.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -1.113 . . . . 0.95999999999999996 109.422 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 55' ' ' TYR . 4.5 t -120.0 174.79 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.92000000000000004 109.896 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.684 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 48.8 t80 179.11 144.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 1.71 109.527 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.684 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -99.72 -164.84 1.16 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 2.7799999999999998 109.463 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.91 66.95 1.87 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.602 -1.399 . . . . 2.48 109.602 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.766 ' CG1' ' H ' ' A' ' 128' ' ' GLN . 8.9 p -151.85 73.68 7.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.253 -1.145 . . . . 3.79 109.466 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.43 ' CG ' HD13 ' A' ' 9' ' ' LEU . 58.2 Cg_endo -76.14 157.91 37.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.873 2.382 . . . . 2.3999999999999999 112.364 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.723 HG13 ' CD1' ' A' ' 66' ' ' TYR . 3.4 t -148.83 102.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 3.0800000000000001 109.386 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -73.72 119.87 6.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.595 -1.402 . . . . 3.0499999999999998 109.595 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.539 ' CD ' ' O ' ' A' ' 116' ' ' ASN . 15.7 tt0 -58.63 125.37 23.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.136 . . . . 6.0499999999999998 109.53 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 132.85 -47.56 1.0 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.679 -1.368 . . . . 2.54 109.679 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.8 mt-10 -99.8 166.89 10.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -1.15 . . . . 4.0300000000000002 109.594 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.46 134.32 49.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 2.9100000000000001 109.434 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.723 ' CD1' HG13 ' A' ' 60' ' ' VAL . 38.1 m-85 -97.22 -179.09 4.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 2.3799999999999999 109.499 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -154.71 139.42 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 2.6099999999999999 109.576 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HA ' HD12 ' A' ' 68' ' ' LEU . 9.3 tp -120.88 118.17 29.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 3.6099999999999999 109.416 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.04 83.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.577 -0.898 . . . . 2.27 108.577 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 28.0 p90 -93.73 143.14 26.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.855 . . . . 2.0099999999999998 111.358 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -89.33 130.59 35.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.488 -0.93 . . . . 1.8 108.488 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.798 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -170.29 135.19 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.891 -1.13 . . . . 0.95999999999999996 110.254 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.9 p -119.82 122.91 42.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.821 . . . . 0.93000000000000005 108.946 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.879 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -85.57 125.74 33.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 0.67000000000000004 109.565 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.504 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -138.76 113.63 8.5 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.271 -0.893 . . . . 0.96999999999999997 109.75 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.3 Cg_exo -64.54 -141.81 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.624 0 C-N-CA 124.349 -1.104 . . . . 1.02 112.276 -0.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -99.17 151.03 21.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.196 -0.94 . . . . 1.75 109.825 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.511 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.35 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.861 -0.792 . . . . 2.1600000000000001 108.861 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -86.12 168.94 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.829 2.353 . . . . 1.3799999999999999 112.86 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 100' ' ' ALA . 2.9 m -137.21 170.85 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 2.0099999999999998 109.128 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.715 ' HD3' ' HZ1' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -116.4 105.52 12.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 6.0099999999999998 109.771 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.87 159.43 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.261 -0.9 . . . . 3.7599999999999998 109.219 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -157.69 149.65 22.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 2.29 109.834 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.51 ' CG1' HG21 ' A' ' 58' ' ' VAL . 1.1 t -149.13 155.45 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 1.8899999999999999 109.701 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.96 -133.27 5.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.563 -1.415 . . . . 1.49 109.563 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.4 pm0 -90.08 -179.07 5.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 2.54 109.384 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.415 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -169.07 32.82 0.18 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 1.3799999999999999 109.546 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -143.77 -100.35 0.33 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.604 -1.398 . . . . 2.54 109.604 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 88' ' ' GLY . . . -44.17 -100.84 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.554 -1.418 . . . . 4.1399999999999997 109.554 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.96 25.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 5.1299999999999999 109.446 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.637 ' CE1' ' CG ' ' A' ' 124' ' ' ASP . 3.6 m-85 -66.15 80.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 5.79 109.583 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 91' ' ' TYR . 0.4 OUTLIER -29.85 151.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.596 -0.69 . . . . 5.7400000000000002 110.011 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.44 161.03 13.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.287 -0.883 . . . . 2.27 110.081 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -119.91 -14.14 8.97 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.733 -0.84 . . . . 3.2799999999999998 108.733 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.755 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.56 36.03 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.381 -0.825 . . . . 3.6499999999999999 108.916 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -80.67 70.99 7.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 4.5999999999999996 109.624 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -99.86 111.01 23.35 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.244 -0.91 . . . . 3.46 108.851 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.13 13.27 55.63 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 3.6699999999999999 109.711 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.92 67.52 0.78 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.174 -1.192 . . . . 3.79 109.824 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -107.32 99.76 29.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.074 -1.016 . . . . 1.96 109.288 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -79.83 135.99 11.69 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.606 2.204 . . . . 2.9700000000000002 112.673 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 74' ' ' ALA . 94.2 mt -142.15 131.11 23.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 3.0600000000000001 109.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 105' ' ' GLU . 9.8 t -92.41 -165.56 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 109.491 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.19 33.9 4.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.499 -1.44 . . . . 2.1699999999999999 109.499 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.505 ' H ' HG23 ' A' ' 103' ' ' THR . 8.7 pt-20 -121.53 138.48 28.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.248 -1.148 . . . . 3.02 109.433 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.27 120.5 6.01 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.593 2.195 . . . . 1.4199999999999999 112.069 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.678 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -171.03 160.43 6.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 1.3700000000000001 109.491 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.593 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.93 149.07 22.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 1.72 109.687 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.798 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -114.3 136.43 52.98 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.745 -1.206 . . . . 4.7000000000000002 107.745 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -114.34 107.94 16.24 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.848 -0.741 . . . . 3.2799999999999998 110.706 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 8.0 m-85 -109.77 115.98 30.84 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.374 -0.972 . . . . 2.96 108.374 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -101.71 142.63 32.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.831 . . . . 3.4100000000000001 109.712 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.92 163.94 26.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 2.77 109.413 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.5 109.34 21.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 2.23 109.798 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.7 m -56.23 105.66 0.21 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.287 -0.883 . . . . 4.1100000000000003 109.193 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.85 ' O ' HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -108.8 -10.31 15.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 6.8600000000000003 109.616 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -136.59 126.5 25.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 5.1200000000000001 109.531 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.64 117.72 5.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.22 -0.925 . . . . 4.0599999999999996 109.372 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.557 ' CE1' ' O ' ' A' ' 92' ' ' ARG . 57.9 m-85 -120.78 66.74 13.9 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 5.4400000000000004 109.588 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.78 166.58 27.15 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.783 2.322 . . . . 4.04 112.154 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 65.6 Cg_endo -79.87 -13.2 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.853 2.369 . . . . 3.8999999999999999 112.003 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -109.57 -12.71 14.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.331 -0.855 . . . . 4.1399999999999997 109.642 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.06 -70.95 0.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.423 -1.471 . . . . 3.5699999999999998 109.423 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.637 ' CG ' ' CE1' ' A' ' 91' ' ' TYR . 1.4 m-20 -129.75 -7.21 4.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -1.134 . . . . 3.5899999999999999 109.387 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -179.96 150.02 0.53 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 2.0800000000000001 109.377 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HA ' ' CA ' ' A' ' 121' ' ' PRO . 10.4 Cg_endo -57.23 -7.11 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.943 2.429 . . . . 1.3899999999999999 112.217 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.12 172.37 12.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 1.1899999999999999 109.56 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.766 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 6.5 tp-100 -153.81 140.29 18.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 2.0099999999999998 109.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 84' ' ' VAL . 3.6 t -153.68 87.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.374 -0.973 . . . . 1.28 108.374 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.533 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -97.4 123.44 41.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.97999999999999998 110.532 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -106.58 81.52 1.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.61 -0.885 . . . . 1.73 108.61 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 81' ' ' ARG . 32.4 m170 -99.65 136.27 39.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 2.3199999999999998 109.956 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -131.05 -5.47 3.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.343 -0.848 . . . . 2.1099999999999999 109.353 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -43.26 124.41 4.49 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.473 -1.451 . . . . 1.77 109.473 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.715 ' HZ1' ' HD3' ' A' ' 81' ' ' ARG . 15.6 mttp -163.93 128.21 2.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 5.0599999999999996 109.74 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.62 -14.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.294 -1.002 . . . . 2.6400000000000001 108.294 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -118.16 3.15 16.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.227 -1.549 . . . . 2.5099999999999998 109.227 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -51.42 -161.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -1.07 . . . . 2.3199999999999998 109.647 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.879 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -168.35 -113.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.051 -1.031 . . . . 1.6100000000000001 110.24 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -125.85 139.82 53.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 1.6499999999999999 109.127 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.506 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.3 t80 -121.36 107.61 12.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 1.6799999999999999 109.79 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.17 91.29 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.73999999999999999 109.863 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.642 HD13 HD21 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -107.87 141.88 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 1.22 109.072 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.2 p -138.48 -0.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.56 -0.712 . . . . 1.3300000000000001 109.443 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.642 ' N ' ' OG1' ' A' ' 71' ' ' THR . 2.5 mt-30 -149.57 160.94 43.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.975 . . . . 3.2999999999999998 110.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.833 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.9 p -166.64 103.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.83 . . . . 2.2599999999999998 109.44 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.3 144.18 36.16 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.233 -0.917 . . . . 2.7599999999999998 109.624 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 149' ' ' THR . 1.3 tp -134.21 113.49 12.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 4.5700000000000003 109.337 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.679 ' N ' HD12 ' A' ' 148' ' ' LEU . 9.0 t -155.76 -166.35 2.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 3.0699999999999998 109.54 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -133.68 -41.05 0.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 2.0 109.417 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.52 ' N ' ' CG2' ' A' ' 150' ' ' THR . 47.9 m -60.99 148.64 39.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.474 -0.766 . . . . 2.1499999999999999 109.455 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.18 -165.28 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 2.8199999999999998 109.483 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.96 -1.019 . . . . 3.54 109.392 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.433 -0.58 . . . . 5.4699999999999998 109.433 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 t -100.46 -117.85 0.16 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 4.5300000000000002 109.497 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -147.2 -162.59 1.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 5.1399999999999997 109.419 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.561 ' O ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -53.61 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 5.3799999999999999 109.402 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 6' ' ' GLU . 29.6 t -72.87 174.66 7.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 4.8300000000000001 109.502 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 5' ' ' SER . 0.6 OUTLIER 35.04 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 3.4300000000000002 109.57 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 151' ' ' SER . 20.2 t -98.68 84.58 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 2.8300000000000001 109.399 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' OE2' ' OG ' ' A' ' 147' ' ' SER . 7.7 tp10 -65.26 109.86 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 4.75 109.578 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -32.68 39.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.366 -0.834 . . . . 4.9500000000000002 109.328 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.939 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -113.02 96.06 36.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 2.8599999999999999 109.073 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.02 38.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.844 2.363 . . . . 3.8300000000000001 112.852 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.679 ' N ' ' O ' ' A' ' 10' ' ' LEU . 27.7 t60 -129.81 131.42 46.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 2.52 109.316 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.16 56.17 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 1.97 109.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 16' ' ' ALA . 8.3 t -158.57 68.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 1.96 109.711 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -65.48 34.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 1.76 108.949 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -81.56 -33.38 31.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 1.1799999999999999 109.85 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.587 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 14.9 mm-40 -109.84 -70.2 0.82 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.137 -0.977 . . . . 2.1299999999999999 109.556 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 20' ' ' GLY . 49.8 m -107.49 144.08 34.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 2.2599999999999998 109.462 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -61.9 12.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 2.6000000000000001 109.703 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.626 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 66.23 177.12 7.5 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.83 -1.308 . . . . 1.6200000000000001 109.83 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.04 10.97 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.687 2.258 . . . . 1.7 112.204 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.795 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 10.2 m0 -74.41 -174.15 1.94 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 2.4199999999999999 109.501 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.405 ' CB ' HG13 ' A' ' 54' ' ' VAL . 1.6 m -117.3 145.78 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 1.6399999999999999 109.287 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.633 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 6.4 tt -151.67 143.86 23.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 2.0499999999999998 110.407 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.711 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.34 175.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.587 -0.696 . . . . 1.72 109.479 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.12 -23.35 18.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.967 -1.253 . . . . 1.7 109.967 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.72 -142.98 0.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.252 . . . . 0.96999999999999997 109.339 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.3 p -91.72 -164.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 1.8 109.223 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 29' ' ' GLU . 3.4 tm-20 -90.12 111.33 46.2 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 2.3999999999999999 108.774 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.471 ' CG ' HD22 ' A' ' 24' ' ' LEU . 72.9 Cg_exo -43.32 147.48 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.24 1.96 . . . . 1.1299999999999999 112.009 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 37' ' ' MET . 3.8 t -129.98 95.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 1.05 109.866 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.97 88.25 4.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.539 -0.726 . . . . 1.8200000000000001 109.451 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -74.02 -140.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 1.1699999999999999 109.952 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' A' ' 33' ' ' ALA . 24.4 t70 -35.33 -87.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 2.21 109.523 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -131.28 36.87 2.17 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.621 -1.391 . . . . 1.1899999999999999 109.621 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -152.34 157.48 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -1.2 . . . . 2.9100000000000001 109.579 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.615 ' SD ' ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -129.51 135.27 48.41 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.324 -0.86 . . . . 0.93000000000000005 109.333 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.25 143.23 50.66 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.479 -0.888 . . . . 1.0600000000000001 110.281 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -113.62 144.15 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.796 -0.816 . . . . 1.3700000000000001 108.796 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.658 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -76.84 106.26 8.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 4.79 109.624 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.4 mm? -116.41 81.53 11.07 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 3.54 109.344 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.865 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 50.7 Cg_exo -49.54 -144.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.944 2.429 . . . . 3.7400000000000002 112.275 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.04 70.33 0.29 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 2.0299999999999998 109.557 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.05 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.554 -1.419 . . . . 2.4100000000000001 109.554 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 46' ' ' GLY . 2.8 mt-30 -99.99 91.51 4.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 2.96 109.428 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -39.66 -43.64 2.32 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.558 -1.417 . . . . 2.0800000000000001 109.558 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.718 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -99.89 128.57 30.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.247 -1.149 . . . . 3.6099999999999999 109.382 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.28 -26.17 7.75 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.499 2.133 . . . . 2.3599999999999999 112.626 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.656 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -92.02 34.18 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.976 . . . . 3.8700000000000001 109.868 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.656 ' OD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.9 OUTLIER -100.19 1.76 42.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 2.3799999999999999 109.676 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.5 -173.52 1.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 1.1100000000000001 109.713 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.29 -171.77 14.29 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.486 -1.446 . . . . 0.93999999999999995 109.486 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.3 pp -115.89 140.71 48.97 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.244 -1.15 . . . . 0.95999999999999996 109.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -128.22 163.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.92000000000000004 109.614 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.939 ' CE2' HD12 ' A' ' 10' ' ' LEU . 20.2 t80 -159.82 155.42 25.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 1.71 109.444 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.694 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -113.09 -164.29 0.91 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.201 -0.937 . . . . 2.7799999999999998 109.471 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.691 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 73.95 69.57 1.37 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 2.48 109.365 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 HD21 ' A' ' 148' ' ' LEU . 49.0 t -162.05 96.85 1.21 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 3.79 109.447 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.15 121.92 5.05 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.652 2.235 . . . . 2.3999999999999999 112.09 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 73.0 t -103.33 155.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 3.0800000000000001 109.594 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 60' ' ' VAL . . . -162.67 129.29 2.02 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.614 -1.394 . . . . 3.0499999999999998 109.614 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.691 ' N ' ' OG ' ' A' ' 115' ' ' SER . 1.7 pp20? -61.28 -161.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -1.104 . . . . 6.0499999999999998 109.383 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 62' ' ' GLU . . . 62.22 -49.19 0.05 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 2.54 109.67 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 62' ' ' GLU . 16.3 mm-40 -99.76 160.3 14.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 4.0300000000000002 109.261 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 3.8 m -112.94 146.4 39.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.157 -0.965 . . . . 2.9100000000000001 109.683 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.681 ' CD2' ' OG1' ' A' ' 150' ' ' THR . 81.1 m-85 -106.14 174.33 5.93 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.238 -0.914 . . . . 2.3799999999999999 109.803 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.5 t -152.19 128.43 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.524 -0.735 . . . . 2.6099999999999999 109.247 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 109' ' ' ARG . 6.7 tp -114.8 116.8 29.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.092 -1.005 . . . . 3.6099999999999999 109.851 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.2 p -109.78 81.78 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 2.27 108.83 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 12.5 p90 -93.67 138.63 31.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.0099999999999998 111.139 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.668 HG23 ' CG2' ' A' ' 108' ' ' THR . 0.7 OUTLIER -86.88 133.09 33.65 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.642 -0.873 . . . . 1.8 108.642 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -173.83 128.29 0.4 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.98 -1.075 . . . . 0.95999999999999996 110.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -111.24 122.41 47.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.93000000000000005 108.873 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.79 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -80.91 129.74 34.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.67000000000000004 109.652 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.526 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -142.73 111.67 5.78 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.332 -0.855 . . . . 0.96999999999999997 109.594 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' O ' ' C ' ' A' ' 74' ' ' ALA . 23.0 Cg_exo -63.81 -141.82 0.14 OUTLIER 'Cis proline' 0 N--CA 1.497 1.699 0 C-N-CA 124.248 -1.146 . . . . 1.02 112.372 -0.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.52 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -106.62 155.74 19.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.75 109.701 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.52 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 2.3 mtm 163.51 167.22 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 2.1600000000000001 108.942 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -84.7 149.29 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.779 2.319 . . . . 1.3799999999999999 112.59 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.636 HG22 ' HB3' ' A' ' 100' ' ' ALA . 1.2 m -125.61 179.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.267 -0.895 . . . . 2.0099999999999998 109.315 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -127.96 97.95 4.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 6.0099999999999998 109.816 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -99.6 143.17 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.37 -0.831 . . . . 3.7599999999999998 108.845 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.602 HD21 ' CE1' ' A' ' 132' ' ' HIS . 2.1 pp -145.63 156.71 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 2.29 109.988 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.7 OUTLIER -155.07 146.99 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 1.8899999999999999 109.345 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 170.16 -148.74 11.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.711 -1.356 . . . . 1.49 109.711 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.706 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.12 -161.35 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -1.119 . . . . 2.54 109.456 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.446 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -150.66 92.87 0.14 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.496 -1.442 . . . . 1.3799999999999999 109.496 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.497 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -155.5 -133.74 1.75 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.664 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . -78.32 146.91 30.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.535 -1.426 . . . . 4.1399999999999997 109.535 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' O ' ' CD2' ' A' ' 91' ' ' TYR . . . 62.4 -38.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -1.161 . . . . 5.1299999999999999 109.496 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 89' ' ' GLY . 1.7 m-85 75.2 16.16 2.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 5.79 109.49 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -37.15 112.19 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 5.7400000000000002 109.433 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -116.39 164.85 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 2.27 109.969 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.497 ' HB1' ' HE2' ' A' ' 113' ' ' PHE . . . -109.93 -21.19 12.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.757 -0.831 . . . . 3.2799999999999998 108.757 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' HG23 ' A' ' 84' ' ' VAL . 2.1 t80 -90.66 38.13 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.497 -0.927 . . . . 3.6499999999999999 108.497 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.68 114.55 19.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 4.5999999999999996 109.932 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.499 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -141.06 132.98 27.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 3.46 108.725 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -121.65 9.32 9.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.776 -1.33 . . . . 3.6699999999999999 109.776 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -118.35 65.31 0.76 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -1.169 . . . . 3.79 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.636 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.89 94.9 21.66 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 1.96 109.152 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.9 133.93 10.42 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.745 2.297 . . . . 2.9700000000000002 112.793 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.592 HD21 ' HG3' ' A' ' 109' ' ' ARG . 35.6 mt -136.92 137.17 39.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -0.805 . . . . 3.0600000000000001 109.144 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 9.0 t -96.87 -155.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.935 . . . . 2.3399999999999999 109.509 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -104.46 56.86 0.54 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 2.1699999999999999 109.542 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -150.85 150.47 27.97 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.299 -1.118 . . . . 3.02 109.433 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.42 118.33 5.61 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.717 2.278 . . . . 1.4199999999999999 112.137 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.831 ' HB3' HH22 ' A' ' 109' ' ' ARG . . . -166.39 147.3 6.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 1.3700000000000001 109.543 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.668 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -90.41 144.45 25.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.72 109.797 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.831 HH22 ' HB3' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -105.14 134.18 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.939 -1.134 . . . . 4.7000000000000002 107.939 178.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -109.54 105.27 14.53 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.92 -0.712 . . . . 3.2799999999999998 110.163 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.499 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 39.0 m-85 -109.6 102.29 11.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.448 -0.945 . . . . 2.96 108.448 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -110.47 166.41 11.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.301 -0.874 . . . . 3.4100000000000001 109.901 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.509 ' O ' ' CB ' ' A' ' 65' ' ' SER . 2.3 p90 -177.67 -162.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 2.77 109.237 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -123.05 143.05 50.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.339 -0.85 . . . . 2.23 109.38 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.691 ' OG ' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -86.89 161.56 18.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 4.1100000000000003 109.678 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -127.86 -15.28 4.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 6.8600000000000003 109.602 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.574 HD23 ' CE2' ' A' ' 119' ' ' PHE . 1.6 tp -123.43 155.63 37.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 5.1200000000000001 109.543 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 109.33 21.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 4.0599999999999996 109.403 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.574 ' CE2' HD23 ' A' ' 117' ' ' LEU . 23.8 m-85 -114.77 92.46 29.79 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.892 . . . . 5.4400000000000004 109.58 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.23 165.9 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.774 2.316 . . . . 4.04 112.122 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.11 -22.74 7.01 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.796 2.331 . . . . 3.8999999999999999 111.989 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -110.03 115.27 29.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.842 . . . . 4.1399999999999997 109.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 147.07 -136.53 6.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 3.5699999999999998 109.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 123' ' ' GLY . 10.8 m-20 -43.79 -85.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -1.136 . . . . 3.5899999999999999 109.458 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -129.86 149.7 73.8 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.91 . . . . 2.0800000000000001 109.458 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.24 -158.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.722 2.281 . . . . 1.3899999999999999 112.244 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.524 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -65.37 163.27 39.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.482 -1.447 . . . . 1.1899999999999999 109.482 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.16 153.05 38.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -1.107 . . . . 2.0099999999999998 109.682 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.443 HG23 ' C ' ' A' ' 128' ' ' GLN . 45.7 t -155.84 131.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.187 -1.042 . . . . 1.28 108.187 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -139.65 100.09 3.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.888 -1.132 . . . . 0.97999999999999998 110.531 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD2' HD11 ' A' ' 53' ' ' LEU . 2.9 m-30 -85.04 99.23 10.89 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.522 -0.918 . . . . 1.73 108.522 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' CE1' HD21 ' A' ' 83' ' ' LEU . 41.6 m170 -99.77 136.1 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 2.3199999999999998 109.816 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -132.73 -36.47 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 2.1099999999999999 109.397 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -40.8 116.59 0.85 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 1.77 109.426 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.945 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 6.6 mtpp -163.83 149.62 11.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 5.0599999999999996 109.631 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -42.91 -15.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 2.6400000000000001 108.475 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -114.43 -4.14 22.06 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.259 -1.536 . . . . 2.5099999999999998 109.259 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.945 ' HB2' ' H ' ' A' ' 135' ' ' LYS . . . -42.96 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -1.082 . . . . 2.3199999999999998 109.485 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.79 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -168.68 -111.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 1.6100000000000001 109.876 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -124.17 134.07 53.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 1.6499999999999999 108.911 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 3.1 t80 -114.79 105.89 13.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.06 -1.025 . . . . 1.6799999999999999 109.736 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.95 87.77 3.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.73999999999999999 109.888 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.53 140.68 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 1.22 109.058 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.436 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 42.6 p -137.56 -1.0 2.11 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.667 -0.646 . . . . 1.3300000000000001 109.453 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.566 ' N ' ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -151.26 167.27 28.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 3.2999999999999998 109.881 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 146' ' ' VAL . 2.9 p -175.73 116.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 2.2599999999999998 109.416 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.524 ' OG ' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -131.53 131.3 43.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 2.7599999999999998 109.778 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.694 HD21 HG13 ' A' ' 58' ' ' VAL . 5.2 tp -110.4 118.86 37.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 4.5700000000000003 109.324 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -123.19 175.19 6.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 3.0699999999999998 109.502 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.681 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -165.66 -41.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.0 109.343 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 150' ' ' THR . 0.3 OUTLIER 50.25 170.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 2.1499999999999999 109.447 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.51 -177.69 4.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 2.8199999999999998 109.546 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 153' ' ' THR . 5.7 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.004 -0.998 . . . . 3.54 109.428 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.6 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.321 0.581 . . . . 5.4699999999999998 109.545 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.9 m 156.12 78.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 4.5300000000000002 109.479 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.9 OUTLIER -167.4 -156.12 0.2 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 5.1399999999999997 109.44 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 3' ' ' LEU . 11.0 p30 -56.27 -147.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 5.3799999999999999 109.411 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.539 ' C ' ' O ' ' A' ' 4' ' ' ASP . 2.9 p 36.12 -155.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 4.8300000000000001 109.532 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.0 109.09 10.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 3.4300000000000002 109.445 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 150' ' ' THR . 1.0 OUTLIER -51.53 165.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 2.8300000000000001 109.359 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -134.06 96.33 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 4.75 109.531 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 9' ' ' LEU . 12.4 mt -66.03 -40.78 91.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 4.9500000000000002 109.403 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.838 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -114.92 94.21 37.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.853 . . . . 2.8599999999999999 109.004 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 45.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.791 2.327 . . . . 3.8300000000000001 112.557 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 10' ' ' LEU . 34.1 t60 -137.94 130.78 29.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.064 -1.023 . . . . 2.52 109.575 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 t -170.08 70.32 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 1.97 109.376 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.5 m -164.66 63.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.96 109.629 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.824 ' CD2' HD11 ' A' ' 143' ' ' ILE . 4.3 m-30 -67.73 27.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 1.76 109.118 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.706 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.09 -40.05 12.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.1799999999999999 109.867 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 13.4 mm-40 -109.71 -73.09 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 2.1299999999999999 109.671 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -88.04 145.55 25.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 2.2599999999999998 109.445 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' SD ' ' A' ' 37' ' ' MET . 7.1 mt -62.17 -59.22 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 2.6000000000000001 109.437 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.28 169.92 14.13 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 1.6200000000000001 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.445 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 43.2 Cg_endo -72.2 5.04 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.852 2.368 . . . . 1.7 112.15 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.978 ' CH2' HG21 ' A' ' 146' ' ' VAL . 10.8 m95 -76.17 -175.47 3.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.4199999999999999 109.463 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 1.6399999999999999 109.237 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.054 ' O ' HD12 ' A' ' 24' ' ' LEU . 3.3 pp -142.84 131.96 23.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 2.0499999999999998 109.433 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.12 170.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 1.72 109.782 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.88 -31.09 8.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.029 -1.229 . . . . 1.7 110.029 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.82 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.97 -142.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.271 . . . . 0.96999999999999997 109.417 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.82 ' N ' ' OG1' ' A' ' 27' ' ' THR . 90.1 p -90.81 138.53 31.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.975 . . . . 1.8 109.45 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 28' ' ' SER . 4.9 mt-10 -41.38 104.19 0.33 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 2.3999999999999999 109.179 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HG2' HD22 ' A' ' 24' ' ' LEU . 51.3 Cg_exo -46.78 156.73 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.366 2.044 . . . . 1.1299999999999999 111.854 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -143.42 122.04 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.05 -1.031 . . . . 1.05 110.09 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.715 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.62 85.26 3.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 1.8200000000000001 109.501 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -0.821 . . . . 1.1699999999999999 109.761 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.24 -67.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 2.21 109.522 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.706 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.49 48.48 0.75 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.629 -1.389 . . . . 1.1899999999999999 109.629 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.58 ' HB2' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -170.69 148.48 2.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.126 -1.22 . . . . 2.9100000000000001 109.657 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.614 ' SD ' HD21 ' A' ' 19' ' ' LEU . 36.4 ttp -109.77 128.63 55.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.93000000000000005 109.107 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -123.46 159.97 27.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.2 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 141' ' ' PHE . 2.2 m -128.88 134.51 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.901 -0.777 . . . . 1.3700000000000001 108.901 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.612 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.7 OUTLIER -73.57 106.51 5.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.825 . . . . 4.79 109.705 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.2 mm? -118.15 61.04 4.01 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.276 -0.89 . . . . 3.54 109.334 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.37 -91.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.726 2.284 . . . . 3.7400000000000002 112.283 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -150.89 158.88 27.89 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.516 -1.434 . . . . 2.0299999999999998 109.516 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.92 42.59 1.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.459 -1.456 . . . . 2.4100000000000001 109.459 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.693 HE21 ' C ' ' A' ' 134' ' ' GLY . 3.8 mm100 -99.87 148.26 24.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -1.165 . . . . 2.96 109.297 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.94 -69.59 0.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.959 -1.256 . . . . 2.0800000000000001 109.959 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.686 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.8 p30 -99.79 145.26 29.85 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.129 -1.218 . . . . 3.6099999999999999 109.616 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.75 -20.0 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.892 2.395 . . . . 2.3599999999999999 112.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.686 ' CE3' ' OD1' ' A' ' 47' ' ' ASN . 1.3 p-90 -119.49 36.94 4.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.936 -1.103 . . . . 3.8700000000000001 110.355 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 8.5 m-20 -79.81 -0.35 34.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.091 -1.005 . . . . 2.3799999999999999 109.097 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 27' ' ' THR . . . -166.43 126.61 1.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 1.1100000000000001 109.315 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' C ' HD23 ' A' ' 53' ' ' LEU . . . 169.0 -173.91 43.51 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.84 -1.304 . . . . 0.93999999999999995 109.84 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' C ' HG22 ' A' ' 54' ' ' VAL . 5.3 mt -106.9 -178.02 3.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -1.148 . . . . 0.95999999999999996 109.545 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -165.54 166.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.92000000000000004 109.707 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.977 ' O ' HG12 ' A' ' 129' ' ' VAL . 37.6 t80 -179.77 137.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 1.71 109.396 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.513 HD21 ' HG2' ' A' ' 128' ' ' GLN . 1.1 m-80 -119.05 86.11 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.248 -0.907 . . . . 2.7799999999999998 109.518 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.23 66.56 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 2.48 109.591 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 58' ' ' VAL . 2.5 p -166.01 85.51 0.96 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.248 -1.148 . . . . 3.79 109.528 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.57 175.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.781 2.32 . . . . 2.3999999999999999 112.212 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.427 HG21 ' HD2' ' A' ' 119' ' ' PHE . 58.1 t -136.91 131.98 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 3.0800000000000001 109.507 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -117.11 80.53 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 3.0499999999999998 109.475 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 61' ' ' GLY . 28.6 tt0 -35.23 118.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -1.087 . . . . 6.0499999999999998 109.589 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 129.15 -39.48 1.84 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.646 -1.382 . . . . 2.54 109.646 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.9 mt-10 -99.94 173.06 6.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 4.0300000000000002 109.62 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.5 m -119.34 143.63 47.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.88 . . . . 2.9100000000000001 109.326 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.642 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 27.5 m-85 -108.81 -178.39 3.57 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 2.3799999999999999 109.659 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.8 t -151.7 158.36 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 2.6099999999999999 109.497 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.586 HD12 HD22 ' A' ' 148' ' ' LEU . 11.7 tp -143.05 112.01 6.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 3.6099999999999999 109.68 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.31 86.81 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 2.27 108.787 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.9 p90 -93.98 141.51 28.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.387 -0.821 . . . . 2.0099999999999998 111.16 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 2.7 p -84.82 88.55 7.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 1.8 108.3 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -129.68 156.96 43.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.117 . . . . 0.95999999999999996 110.756 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.8 p -147.36 120.11 8.64 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.596 -0.89 . . . . 0.93000000000000005 108.596 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.595 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -88.13 133.36 34.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.67000000000000004 109.839 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.456 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.8 116.9 16.05 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.431 -0.793 . . . . 0.96999999999999997 109.078 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.595 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -66.07 -142.53 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.676 0 C-N-CA 124.29 -1.129 . . . . 1.02 112.551 -0.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.652 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -106.86 154.79 20.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 1.75 109.724 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.8 mtm 167.08 169.67 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.778 . . . . 2.1600000000000001 109.092 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.15 131.65 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.872 2.381 . . . . 1.3799999999999999 112.55 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.956 HG12 ' OH ' ' A' ' 139' ' ' TYR . 1.2 m -107.26 174.03 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 2.0099999999999998 109.279 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -126.48 98.29 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.955 . . . . 6.0099999999999998 109.804 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 131' ' ' PHE . 0.1 OUTLIER -102.68 155.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.27 -0.894 . . . . 3.7599999999999998 109.165 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.863 HD21 ' CE1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -147.69 157.98 43.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.144 -0.973 . . . . 2.29 109.798 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.4 OUTLIER -151.98 164.4 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -0.864 . . . . 1.8899999999999999 109.38 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 146.73 -159.24 27.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.612 -1.395 . . . . 1.49 109.612 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.684 ' OE1' ' CE1' ' A' ' 119' ' ' PHE . 7.3 pt-20 -90.2 -155.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.129 . . . . 2.54 109.45 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.51 ' C ' ' HB1' ' A' ' 125' ' ' ALA . . . -175.67 72.9 0.08 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.567 -1.413 . . . . 1.3799999999999999 109.567 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -143.12 -88.48 0.1 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 2.54 109.655 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . -57.09 -136.16 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.591 -1.404 . . . . 4.1399999999999997 109.591 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.508 ' O ' ' C ' ' A' ' 91' ' ' TYR . . . -63.66 36.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -1.13 . . . . 5.1299999999999999 109.489 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER 36.03 52.33 0.84 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.227 -0.921 . . . . 5.79 109.4 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.619 ' CZ ' ' CB ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -82.01 113.63 20.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 5.7400000000000002 109.53 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -111.34 172.16 7.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 2.27 109.988 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.76 -18.99 5.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.892 -0.781 . . . . 3.2799999999999998 108.892 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.94 34.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 3.6499999999999999 109.308 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.68 82.18 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 4.5999999999999996 109.428 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 98' ' ' GLY . 2.1 tt0 -103.41 156.86 17.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 3.46 109.093 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -146.24 7.86 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.696 -1.362 . . . . 3.6699999999999999 109.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -120.69 75.62 1.14 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.167 -1.196 . . . . 3.79 109.78 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.704 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -120.34 86.51 38.74 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 1.96 109.242 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.641 ' O ' HD22 ' A' ' 102' ' ' LEU . 13.1 Cg_exo -66.52 127.54 17.46 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.149 2.566 . . . . 2.9700000000000002 112.82 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 101' ' ' PRO . 3.5 mm? -118.57 147.61 43.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 3.0600000000000001 108.999 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.578 ' O ' ' O ' ' A' ' 74' ' ' ALA . 5.0 t -97.61 -170.58 2.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.193 -0.942 . . . . 2.3399999999999999 109.828 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 105' ' ' GLU . . . -103.72 36.34 4.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.691 -1.364 . . . . 2.1699999999999999 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' H ' HG23 ' A' ' 103' ' ' THR . 71.3 mt-10 -156.09 148.21 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 3.02 109.262 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -40.8 118.26 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.696 2.264 . . . . 1.4199999999999999 112.143 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.663 ' HB1' ' NH1' ' A' ' 109' ' ' ARG . . . -160.9 138.34 9.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 1.3700000000000001 109.648 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.531 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.54 151.51 21.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 1.72 109.907 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.663 ' NH1' ' HB1' ' A' ' 107' ' ' ALA . 3.7 mpt_? -124.36 142.14 51.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.029 -1.1 . . . . 4.7000000000000002 108.029 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -114.63 104.67 12.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.556 -0.715 . . . . 3.2799999999999998 110.757 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.561 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 8.8 m-30 -109.88 120.11 41.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.499 -0.926 . . . . 2.96 108.499 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.655 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -124.95 169.65 11.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.283 -0.886 . . . . 3.4100000000000001 109.67 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.5 p90 -155.23 -177.76 6.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 2.77 109.499 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.535 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -111.4 106.14 14.97 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.364 -0.835 . . . . 2.23 109.558 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.535 ' C ' ' O ' ' A' ' 114' ' ' THR . 3.8 m -36.01 129.82 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 4.1100000000000003 109.347 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.469 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 10.9 m120 -125.17 -7.21 7.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.88 . . . . 6.8600000000000003 109.507 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -148.94 129.98 14.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 5.1200000000000001 109.424 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.471 ' N ' HD13 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -80.26 113.25 18.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 4.0599999999999996 109.551 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CE1' ' OE1' ' A' ' 86' ' ' GLU . 44.6 m-85 -110.02 146.94 35.2 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 5.4400000000000004 109.353 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.47 166.3 30.22 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.691 2.261 . . . . 4.04 112.163 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 126' ' ' PRO . 73.4 Cg_endo -81.02 -39.72 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.777 2.318 . . . . 3.8999999999999999 112.071 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -122.44 -150.93 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.874 . . . . 4.1399999999999997 109.478 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.08 -142.54 15.66 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.572 -1.411 . . . . 3.5699999999999998 109.572 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -114.33 10.94 17.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -1.094 . . . . 3.5899999999999999 109.447 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.51 ' HB1' ' C ' ' A' ' 87' ' ' GLY . . . -165.75 54.22 0.33 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 2.0800000000000001 109.545 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 55.1 Cg_endo -74.09 -158.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.846 2.364 . . . . 1.3899999999999999 112.223 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 126' ' ' PRO . . . -39.97 155.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.627 -1.389 . . . . 1.1899999999999999 109.627 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -155.2 137.85 15.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -1.159 . . . . 2.0099999999999998 109.553 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.977 HG12 ' O ' ' A' ' 55' ' ' TYR . 8.3 p -153.48 149.34 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.674 -0.861 . . . . 1.28 108.674 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -159.13 115.57 2.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.033 . . . . 0.97999999999999998 110.207 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.563 ' HA ' HG12 ' A' ' 82' ' ' VAL . 6.8 m-30 -85.63 105.29 16.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.435 -0.95 . . . . 1.73 108.435 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.863 ' CE1' HD21 ' A' ' 83' ' ' LEU . 56.9 m170 -99.43 121.24 40.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 2.3199999999999998 109.757 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.86 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -152.17 66.7 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.853 . . . . 2.1099999999999999 109.496 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.693 ' C ' HE21 ' A' ' 45' ' ' GLN . . . -157.11 103.91 0.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 1.77 109.562 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -153.48 -175.34 5.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 5.0599999999999996 109.638 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -44.87 -12.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.34 -0.985 . . . . 2.6400000000000001 108.34 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -113.33 1.94 25.17 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.345 -1.502 . . . . 2.5099999999999998 109.345 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -37.44 165.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.392 -1.064 . . . . 2.3199999999999998 109.656 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.956 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -161.21 -108.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 1.6100000000000001 109.555 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -138.66 139.61 38.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 1.6499999999999999 109.111 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.659 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 30.7 t80 -124.34 120.4 32.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.062 -1.024 . . . . 1.6799999999999999 109.921 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.87 101.74 8.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.73999999999999999 109.893 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.824 HD11 ' CD2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -100.82 135.66 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.22 109.013 179.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.57 ' OG ' ' OG1' ' A' ' 71' ' ' THR . 3.5 p -109.16 -21.28 12.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.902 -0.777 . . . . 1.3300000000000001 108.902 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.68 ' N ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -170.43 -174.94 1.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.256 -0.978 . . . . 3.2999999999999998 110.533 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.978 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.8 p -161.42 108.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.872 -0.788 . . . . 2.2599999999999998 108.872 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.11 143.27 33.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 2.7599999999999998 110.197 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.586 HD22 HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -123.9 110.27 14.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.46 -0.775 . . . . 4.5700000000000003 109.039 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.551 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -131.58 167.79 18.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -0.999 . . . . 3.0699999999999998 109.808 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.7 OUTLIER -145.14 -41.08 0.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 2.0 109.328 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.515 ' N ' ' CG2' ' A' ' 150' ' ' THR . 6.9 t 64.22 103.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.435 -0.791 . . . . 2.1499999999999999 109.431 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.509 ' HB3' ' OG ' ' A' ' 2' ' ' SER . . . -118.55 99.48 6.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 2.8199999999999998 109.454 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.01 -0.995 . . . . 3.54 109.427 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.479 -0.563 . . . . 5.4699999999999998 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t 54.86 40.9 32.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 4.5300000000000002 109.442 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 4' ' ' ASP . 2.5 mt -86.62 -173.53 4.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.202 -0.936 . . . . 5.1399999999999997 109.509 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.57 ' O ' ' O ' ' A' ' 5' ' ' SER . 2.1 t70 -57.69 -140.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 5.3799999999999999 109.474 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 4' ' ' ASP . 18.1 t -51.44 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 4.8300000000000001 109.456 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -52.87 135.25 36.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 3.4300000000000002 109.446 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 150' ' ' THR . 1.4 t -75.45 76.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 2.8300000000000001 109.422 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.46 109.02 11.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 4.75 109.5 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.455 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -77.79 -50.1 13.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 4.9500000000000002 109.318 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.732 ' CD1' ' HE1' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -96.55 108.6 43.42 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 2.8599999999999999 109.352 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.7 29.13 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.089 1.86 . . . . 3.8300000000000001 111.624 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.672 ' O ' ' CG ' ' A' ' 12' ' ' HIS . 19.4 t60 -124.36 72.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 2.52 109.586 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 5.7 t -112.06 41.67 1.92 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 1.97 109.318 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.623 ' C ' ' H ' ' A' ' 16' ' ' ALA . 32.7 m -127.0 64.94 1.3 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 1.96 109.779 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.573 ' CE1' ' NE2' ' A' ' 12' ' ' HIS . 3.5 m-85 -67.2 20.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.939 . . . . 1.76 109.029 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.623 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.12 -20.49 23.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.1799999999999999 110.113 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.464 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 34.2 mt-10 -109.9 -83.91 0.56 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.02 -1.05 . . . . 2.1299999999999999 109.948 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.9 m -104.94 151.77 23.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 2.2599999999999998 109.628 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -47.99 62.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 2.6000000000000001 109.423 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 102.54 -173.03 22.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.725 -1.35 . . . . 1.6200000000000001 109.725 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 36.0 Cg_endo -69.21 -18.38 39.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 1.7 112.194 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.732 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 11.2 m0 -56.79 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 2.4199999999999999 109.139 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 1.6 m -151.43 136.78 17.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 1.6399999999999999 109.599 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 25' ' ' TYR . 9.3 tt -133.28 152.74 51.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 2.0499999999999998 109.574 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.87 177.43 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 1.72 109.444 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.41 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 93.03 -30.33 7.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.831 -1.307 . . . . 1.7 109.831 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.829 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.96 -141.96 0.38 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.186 -1.185 . . . . 0.96999999999999997 109.276 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.829 ' N ' ' OG1' ' A' ' 27' ' ' THR . 23.7 p -90.68 140.27 29.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.171 -0.956 . . . . 1.8 108.989 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 2.6 mp0 -36.95 128.67 0.75 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 2.3999999999999999 109.102 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HG3' HD22 ' A' ' 24' ' ' LEU . 43.3 Cg_endo -71.73 158.75 52.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.262 1.975 . . . . 1.1299999999999999 111.681 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.9 t -145.83 116.28 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.025 -1.047 . . . . 1.05 110.589 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -71.17 72.64 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.556 -0.715 . . . . 1.8200000000000001 109.14 178.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -73.43 -135.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 1.1699999999999999 109.78 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -41.66 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.792 . . . . 2.21 109.34 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 34.52 45.47 0.5 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.7 -1.36 . . . . 1.1899999999999999 109.7 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -164.01 146.61 9.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.097 -1.237 . . . . 2.9100000000000001 109.812 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.45 ' CG ' ' HB2' ' A' ' 30' ' ' PRO . 11.8 tmm? -108.97 124.77 51.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.93000000000000005 109.121 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 2.0 t -124.79 155.02 40.04 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 1.0600000000000001 110.378 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.751 HG23 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -127.48 164.55 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.459 -0.941 . . . . 1.3700000000000001 108.459 179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.541 ' CG ' ' OG ' ' A' ' 28' ' ' SER . 21.0 m-20 -99.09 112.69 24.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 4.79 109.627 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.973 ' N ' HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.27 84.65 9.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 3.54 109.202 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.42 -92.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.848 2.366 . . . . 3.7400000000000002 112.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' GLY . . . -162.33 -139.99 2.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.439 . . . . 2.0299999999999998 109.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 43' ' ' GLY . . . 35.79 43.09 0.57 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.549 -1.42 . . . . 2.4100000000000001 109.549 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.523 ' O ' ' C ' ' A' ' 46' ' ' GLY . 15.6 mm-40 -99.9 129.74 46.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.211 -1.17 . . . . 2.96 109.489 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -35.75 -44.28 0.67 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 2.0800000000000001 109.619 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.669 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -179.95 157.49 0.79 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 3.6099999999999999 109.5 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -42.4 -34.97 3.39 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.794 2.329 . . . . 2.3599999999999999 112.379 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.684 ' CD1' ' O ' ' A' ' 49' ' ' TRP . 35.5 p90 -101.74 60.86 0.88 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 3.8700000000000001 109.501 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.669 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 26.8 m-20 -136.58 0.92 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 2.3799999999999999 109.483 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.41 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -162.58 -170.87 2.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 1.1100000000000001 109.459 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 -155.96 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.517 -1.433 . . . . 0.93999999999999995 109.517 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 53' ' ' LEU . 1.5 pt? -127.04 157.62 39.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.18 -1.188 . . . . 0.95999999999999996 109.66 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 55' ' ' TYR . 1.3 p -138.26 -176.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.92000000000000004 110.102 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.67 ' H ' HG22 ' A' ' 54' ' ' VAL . 30.4 t80 177.93 147.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.34 0.591 . . . . 1.71 109.576 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.82 129.57 56.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.321 -0.862 . . . . 2.7799999999999998 109.48 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' H ' ' HA3' ' A' ' 127' ' ' GLY . . . 147.29 84.03 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.386 -1.486 . . . . 2.48 109.386 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 58' ' ' VAL . 1.3 p -169.88 70.45 0.63 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.111 . . . . 3.79 109.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.688 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.61 159.58 1.38 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 122.824 2.349 . . . . 2.3999999999999999 111.963 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 2.0 t -151.39 85.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.165 -0.959 . . . . 3.0800000000000001 109.723 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.56 ' C ' ' OG ' ' A' ' 115' ' ' SER . . . -88.69 112.22 3.9 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.087 -1.605 . . . . 3.0499999999999998 109.087 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' N ' ' OG ' ' A' ' 115' ' ' SER . 34.5 mt-10 -31.01 135.07 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.553 -0.969 . . . . 6.0499999999999998 110.037 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 95.37 -16.54 61.06 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.972 -1.251 . . . . 2.54 109.972 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 115' ' ' SER . 17.4 mt-10 -99.89 146.93 26.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 4.0300000000000002 109.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 150' ' ' THR . 4.0 m -111.87 133.63 53.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 2.9100000000000001 109.159 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.688 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 30.8 m-85 -109.7 178.07 4.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.147 -0.97 . . . . 2.3799999999999999 109.921 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.4 t -151.8 165.55 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.504 -0.747 . . . . 2.6099999999999999 109.476 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 148' ' ' LEU . 1.9 tp -147.34 111.13 5.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.868 . . . . 3.6099999999999999 109.476 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.9 p -109.83 93.15 4.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 2.27 109.163 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.92 143.77 26.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.205 -0.935 . . . . 2.0099999999999998 110.679 -179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.5 p -101.58 108.52 20.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.43 -0.952 . . . . 1.8 108.43 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.515 ' O ' HD22 ' A' ' 102' ' ' LEU . . . -154.43 143.4 21.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.789 -1.194 . . . . 0.95999999999999996 110.597 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -113.98 127.22 55.87 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.631 -0.878 . . . . 0.93000000000000005 108.631 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -97.42 129.3 44.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.67000000000000004 110.009 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.459 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.6 115.89 14.82 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.394 -0.816 . . . . 0.96999999999999997 109.156 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -65.85 -142.54 0.16 OUTLIER 'Cis proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.435 -1.069 . . . . 1.02 112.489 -0.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -106.2 150.32 25.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 1.75 109.532 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.5 155.11 0.15 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 2.1600000000000001 109.476 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 45.5 Cg_endo -72.94 122.84 8.46 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.825 2.35 . . . . 1.3799999999999999 112.143 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.714 HG11 HD12 ' A' ' 102' ' ' LEU . 1.5 m -93.85 175.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 2.0099999999999998 109.378 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.74 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.05 145.77 36.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 6.0099999999999998 109.688 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.787 HG13 ' HG2' ' A' ' 97' ' ' GLN . 1.4 p -147.29 152.4 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 3.7599999999999998 109.326 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.473 HD21 ' CE1' ' A' ' 132' ' ' HIS . 2.6 pp -155.43 149.27 25.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 2.29 109.81 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 128' ' ' GLN . 1.1 t -144.7 152.58 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.308 -0.87 . . . . 1.8899999999999999 109.453 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 168.24 -150.24 15.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.758 -1.337 . . . . 1.49 109.758 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.539 ' C ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -90.15 -165.1 1.27 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -1.064 . . . . 2.54 109.598 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -127.54 -0.59 6.71 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 1.3799999999999999 109.526 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . 177.13 -171.98 44.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.533 -1.427 . . . . 2.54 109.533 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.788 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 48.22 17.17 0.61 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 4.1399999999999997 109.595 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.788 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 155.81 55.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -1.146 . . . . 5.1299999999999999 109.374 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -45.65 -43.18 12.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 5.79 109.526 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 91' ' ' TYR . 11.4 ptm180 -36.01 111.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 5.7400000000000002 109.431 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -100.25 164.8 11.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 2.27 109.862 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.18 -17.77 10.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.396 -0.815 . . . . 3.2799999999999998 108.829 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.414 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.64 35.38 0.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.362 -0.836 . . . . 3.6499999999999999 109.193 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -77.85 88.43 4.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 4.5999999999999996 109.605 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.787 ' HG2' HG13 ' A' ' 82' ' ' VAL . 4.0 pt20 -121.98 148.81 44.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 3.46 109.353 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.716 ' CA ' ' HE ' ' A' ' 81' ' ' ARG . . . -136.76 30.11 2.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.83 -1.308 . . . . 3.6699999999999999 109.83 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.544 ' O ' ' OH ' ' A' ' 111' ' ' TYR . 1.7 m -115.12 66.72 0.69 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.176 -1.19 . . . . 3.79 109.636 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.89 93.45 17.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 1.96 109.563 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.6 118.42 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.713 2.276 . . . . 2.9700000000000002 112.218 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.714 HD12 HG11 ' A' ' 80' ' ' VAL . 25.3 mt -120.56 155.92 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 3.0600000000000001 109.494 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 1.3 t -110.39 -167.29 1.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 2.3399999999999999 109.616 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.562 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -78.98 -25.75 59.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.761 -1.335 . . . . 2.1699999999999999 109.761 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.83 164.01 17.32 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 3.02 109.408 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -43.28 118.73 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.688 2.259 . . . . 1.4199999999999999 112.088 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.514 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . . . -135.26 117.97 16.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.892 . . . . 1.3700000000000001 109.746 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.667 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.69 148.98 21.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 1.72 110.21 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.667 ' NH1' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -127.84 139.69 52.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.21 -1.033 . . . . 4.7000000000000002 108.21 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.99 104.87 9.82 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.957 -0.697 . . . . 3.2799999999999998 109.991 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.544 ' OH ' ' O ' ' A' ' 99' ' ' SER . 41.2 m-85 -109.69 129.61 55.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.221 -0.924 . . . . 2.96 108.867 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -129.42 157.01 43.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.833 . . . . 3.4100000000000001 109.775 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.539 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 3.4 p90 -146.28 -178.51 6.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 2.77 109.552 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.57 137.03 47.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.463 -0.773 . . . . 2.23 109.642 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.56 ' OG ' ' C ' ' A' ' 61' ' ' GLY . 22.8 t -64.11 118.39 8.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 4.1100000000000003 109.602 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -18.82 13.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 6.8600000000000003 109.233 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -132.5 -162.6 1.25 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.292 -0.88 . . . . 5.1200000000000001 109.568 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.708 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -118.92 133.82 55.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.266 -0.896 . . . . 4.0599999999999996 109.506 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -153.66 70.57 6.62 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 5.4400000000000004 109.534 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.443 ' HB2' ' H ' ' A' ' 123' ' ' GLY . 39.4 Cg_exo -56.75 169.46 1.8 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.815 2.343 . . . . 4.04 112.009 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.16 -31.41 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.754 2.302 . . . . 3.8999999999999999 112.06 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 123' ' ' GLY . 24.1 t0 -119.25 -11.94 9.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 4.1399999999999997 109.572 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -56.94 -150.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 3.5699999999999998 109.564 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 123' ' ' GLY . 0.5 OUTLIER -36.33 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -1.152 . . . . 3.5899999999999999 109.415 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -115.61 150.11 44.18 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 2.0800000000000001 109.445 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.9 -158.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.761 2.307 . . . . 1.3899999999999999 112.252 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . -82.34 166.62 46.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.552 -1.419 . . . . 1.1899999999999999 109.552 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.68 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -147.25 142.62 27.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 2.0099999999999998 109.867 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 129' ' ' VAL . 5.2 p -163.24 110.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.278 -1.008 . . . . 1.28 108.278 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -118.83 132.27 56.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.97999999999999998 110.871 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.464 ' HB2' ' CD2' ' A' ' 53' ' ' LEU . 4.0 m-30 -101.02 111.83 24.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.199 -1.037 . . . . 1.73 108.199 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.526 ' CE1' ' CB ' ' A' ' 49' ' ' TRP . 58.5 m170 -99.37 131.12 45.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 2.3199999999999998 109.565 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 141' ' ' PHE . 3.0 mt -133.23 -43.45 0.86 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 109.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -38.79 127.43 1.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.841 -1.304 . . . . 1.77 109.841 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.716 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 31.4 mtmt -164.69 134.79 3.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 5.0599999999999996 109.584 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -40.29 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.389 -0.967 . . . . 2.6400000000000001 108.389 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.13 14.8 7.85 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.047 -1.621 . . . . 2.5099999999999998 109.047 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.716 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -49.5 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -1.038 . . . . 2.3199999999999998 110.062 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.673 ' OH ' HG12 ' A' ' 80' ' ' VAL . 8.3 p90 -160.03 -130.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.004 -1.06 . . . . 1.6100000000000001 109.429 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 22.5 mt-10 -116.93 135.81 53.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 1.6499999999999999 109.33 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 14.8 t80 -118.51 108.45 15.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.948 -1.095 . . . . 1.6799999999999999 110.038 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.504 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 78.7 m -111.94 100.83 9.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.297 -0.877 . . . . 0.73999999999999999 110.003 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.99 143.75 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 1.22 109.086 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' PHE . 6.0 p -131.8 -5.84 3.6 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.64 . . . . 1.3300000000000001 109.275 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.571 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.3 mt-30 -153.85 160.02 42.04 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.299 -0.961 . . . . 3.2999999999999998 110.233 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.613 ' N ' ' OG1' ' A' ' 13' ' ' THR . 10.8 p -178.15 124.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.007 -0.738 . . . . 2.2599999999999998 109.007 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.95 135.41 29.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 2.7599999999999998 109.911 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.584 HD11 HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -108.38 144.51 35.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 4.5700000000000003 109.362 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.515 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 2.8 t -164.97 -173.26 2.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 3.0699999999999998 109.559 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.713 HG23 ' H ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -139.13 -103.53 0.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 2.0 109.437 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.713 ' H ' HG23 ' A' ' 150' ' ' THR . 0.5 OUTLIER 84.88 92.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.86 . . . . 2.1499999999999999 109.449 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.87 -155.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 2.8199999999999998 109.44 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.568 ' OXT' HG22 ' A' ' 153' ' ' THR . 16.6 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.0 -1.0 . . . . 3.54 109.452 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.425 -0.583 . . . . 5.4699999999999998 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 1.1 p -95.79 -57.89 2.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 4.5300000000000002 109.432 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.515 ' H ' ' HB2' ' A' ' 151' ' ' SER . 1.0 OUTLIER 52.79 20.6 1.65 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 5.1399999999999997 109.325 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 1.8 m-20 -63.64 83.72 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.712 -0.617 . . . . 5.3799999999999999 109.498 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ASP . 33.9 t 58.38 150.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 4.8300000000000001 109.48 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -53.83 178.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 3.4300000000000002 109.502 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.543 ' O ' ' C ' ' A' ' 8' ' ' GLU . 58.0 t -150.88 75.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 2.8300000000000001 109.523 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -36.07 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 4.75 109.423 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . 12.1 mt -103.82 11.43 35.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.284 -0.885 . . . . 4.9500000000000002 109.679 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.705 ' O ' ' N ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -114.38 113.7 45.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 2.8599999999999999 108.444 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.51 19.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.647 2.232 . . . . 3.8300000000000001 113.66 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.705 ' N ' ' O ' ' A' ' 10' ' ' LEU . 83.5 t60 -170.69 136.89 1.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.674 -1.266 . . . . 2.52 110.404 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.591 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.3 OUTLIER -170.83 68.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 1.97 109.341 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 13' ' ' THR . 50.5 m -170.31 87.66 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 1.96 110.083 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -90.24 41.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 1.76 109.056 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.22 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 1.1799999999999999 109.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -109.75 39.47 2.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.195 -0.941 . . . . 2.1299999999999999 109.696 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.21 148.89 0.39 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 2.2599999999999998 109.53 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 19' ' ' LEU . 1.6 pp -74.06 -10.85 60.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 2.6000000000000001 109.427 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 12' ' ' HIS . . . 75.03 -146.81 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.357 -1.497 . . . . 1.6200000000000001 109.357 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.574 ' O ' ' O ' ' A' ' 22' ' ' TRP . 64.6 Cg_endo -81.53 -23.1 5.16 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.893 2.396 . . . . 1.7 112.076 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.679 ' CH2' HG11 ' A' ' 146' ' ' VAL . 11.3 m0 -45.94 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 2.4199999999999999 108.896 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -113.53 164.81 13.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.098 -1.001 . . . . 1.6399999999999999 108.985 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' A' ' 30' ' ' PRO . 3.0 mt -156.54 132.63 9.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 2.0499999999999998 109.78 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.733 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 171.63 -167.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 1.72 109.394 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.0 -30.39 0.93 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.754 -1.339 . . . . 1.7 109.754 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.746 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -109.87 -141.12 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -1.186 . . . . 0.96999999999999997 109.445 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.746 ' N ' ' OG1' ' A' ' 27' ' ' THR . 11.4 p -90.92 -162.75 0.94 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.084 -0.709 . . . . 1.8 109.084 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.4 111.63 48.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 2.3999999999999999 109.134 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.818 ' HG2' HD13 ' A' ' 24' ' ' LEU . 53.0 Cg_exo -50.04 140.87 31.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.167 1.911 . . . . 1.1299999999999999 111.786 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.19 112.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.046 -1.033 . . . . 1.05 109.898 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.422 ' HA ' ' CB ' ' A' ' 37' ' ' MET . 0.9 OUTLIER -90.03 127.24 36.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 1.8200000000000001 109.349 179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -120.8 -110.07 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.955 . . . . 1.1699999999999999 109.62 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 3.4 p-10 -60.28 63.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.96 . . . . 2.21 109.595 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 69.33 -17.51 0.6 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.676 -1.369 . . . . 1.1899999999999999 109.676 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -106.04 170.74 7.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.171 -1.194 . . . . 2.9100000000000001 109.736 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.492 ' CE ' HD11 ' A' ' 24' ' ' LEU . 9.6 ptt? -148.28 166.23 28.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.464 -0.772 . . . . 0.93000000000000005 109.09 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -146.65 150.79 36.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.117 -0.99 . . . . 1.0600000000000001 110.535 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.907 HG23 HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.97 148.6 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.245 -1.02 . . . . 1.3700000000000001 108.245 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 1.1 m-20 -83.85 105.85 15.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 4.79 109.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.907 HD21 HG23 ' A' ' 39' ' ' VAL . 1.8 mm? -112.97 78.25 2.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 3.54 108.898 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 62.0 Cg_endo -77.26 -159.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.771 2.314 . . . . 3.7400000000000002 112.388 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.87 63.01 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 2.0299999999999998 109.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.26 36.01 0.96 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.451 -1.46 . . . . 2.4100000000000001 109.451 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.663 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 6.1 mm-40 -99.97 112.7 24.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -1.126 . . . . 2.96 109.544 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.673 ' C ' HD22 ' A' ' 47' ' ' ASN . . . -54.75 -10.94 2.51 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.571 -1.412 . . . . 2.0800000000000001 109.571 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.673 HD22 ' C ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -165.85 156.61 11.76 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -1.178 . . . . 3.6099999999999999 109.444 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HG3' ' NH1' ' A' ' 81' ' ' ARG . 44.5 Cg_endo -72.6 -27.27 15.58 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.711 2.274 . . . . 2.3599999999999999 112.216 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 1.6 p90 -83.72 35.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 3.8700000000000001 109.444 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.663 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 19.8 m-20 -136.82 46.33 2.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 2.3799999999999999 109.465 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 172.5 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 1.1100000000000001 109.451 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.86 -163.33 25.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.534 -1.426 . . . . 0.93999999999999995 109.534 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.616 ' H ' HD12 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -119.75 -172.7 2.39 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.223 -1.163 . . . . 0.95999999999999996 109.388 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 55' ' ' TYR . 93.2 t -162.08 167.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.92000000000000004 108.943 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.642 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.0 t80 -176.19 172.94 2.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 1.71 109.516 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -118.26 -164.61 1.03 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.218 -0.926 . . . . 2.7799999999999998 109.626 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.594 ' O ' HD12 ' A' ' 10' ' ' LEU . . . 79.96 64.84 1.82 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.517 -1.433 . . . . 2.48 109.517 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -152.23 79.78 6.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.176 -1.191 . . . . 3.79 109.405 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.77 120.33 5.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.737 2.292 . . . . 2.3999999999999999 112.08 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.547 HG12 ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -105.41 119.15 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 3.0800000000000001 109.619 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.677 ' N ' ' OH ' ' A' ' 66' ' ' TYR . . . -128.58 95.93 0.4 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.332 -1.507 . . . . 3.0499999999999998 109.332 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.674 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -35.2 144.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 6.0499999999999998 109.372 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.34 -36.39 4.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 2.54 109.522 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 114' ' ' THR . 28.2 mt-10 -99.74 178.58 4.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -1.167 . . . . 4.0300000000000002 109.224 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -132.51 119.91 21.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.126 -0.984 . . . . 2.9100000000000001 109.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' OH ' ' N ' ' A' ' 61' ' ' GLY . 56.1 m-85 -94.06 162.93 13.68 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.302 -0.874 . . . . 2.3799999999999999 109.431 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.7 t -146.9 108.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.693 . . . . 2.6099999999999999 109.557 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 69' ' ' SER . 7.8 tt -96.29 144.83 26.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.071 -1.018 . . . . 3.6099999999999999 109.22 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.877 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.85 104.85 5.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.888 . . . . 2.27 108.98 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 109' ' ' ARG . 2.9 p90 -94.17 143.48 26.34 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.082 -1.047 . . . . 2.0099999999999998 110.899 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -97.62 96.74 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.557 -0.905 . . . . 1.8 108.557 179.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -164.21 178.6 7.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.874 -1.141 . . . . 0.95999999999999996 110.838 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 153.68 36.33 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.064 -0.717 . . . . 0.93000000000000005 109.064 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -95.85 138.83 32.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.67000000000000004 109.558 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.508 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -137.47 114.28 9.58 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 121.156 -0.965 . . . . 0.96999999999999997 109.712 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' O ' ' C ' ' A' ' 74' ' ' ALA . 31.5 Cg_endo -64.64 -144.38 0.16 OUTLIER 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.075 -1.219 . . . . 1.02 111.875 -0.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.85 150.78 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.59 -1.319 . . . . 1.75 109.589 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.557 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER 159.65 156.98 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.48 -0.762 . . . . 2.1600000000000001 109.334 179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.574 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 62.5 Cg_endo -76.99 147.96 27.32 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.918 2.412 . . . . 1.3799999999999999 112.422 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.733 HG11 HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -111.19 -172.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 2.0099999999999998 109.343 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.661 ' N ' HG23 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -122.43 142.75 50.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 6.0099999999999998 109.556 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.3 p -146.92 149.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.243 -0.91 . . . . 3.7599999999999998 109.396 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -151.27 151.55 31.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 2.29 109.735 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.524 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -150.76 169.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 1.8899999999999999 109.345 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.81 -155.96 26.42 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.631 -1.388 . . . . 1.49 109.631 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.72 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -90.39 -174.13 4.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -1.127 . . . . 2.54 109.495 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.81 36.08 1.07 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.496 -1.442 . . . . 1.3799999999999999 109.496 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.468 ' N ' ' HB2' ' A' ' 91' ' ' TYR . . . -92.41 47.22 2.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.563 -1.415 . . . . 2.54 109.563 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 64.94 -121.11 20.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.417 -1.473 . . . . 4.1399999999999997 109.417 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -44.73 -10.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -1.164 . . . . 5.1299999999999999 109.193 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 89' ' ' GLY . 5.0 m-85 -60.04 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.378 -0.826 . . . . 5.79 109.528 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.689 ' H ' ' CD ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -51.42 173.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 5.7400000000000002 109.588 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -122.51 174.43 7.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 2.27 109.99 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -126.69 -18.04 4.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.73 . . . . 3.2799999999999998 109.115 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.644 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.74 41.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 3.6499999999999999 109.356 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.96 81.22 8.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.076 -1.015 . . . . 4.5999999999999996 109.602 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.1 tt0 -127.07 114.93 18.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.206 -0.934 . . . . 3.46 109.046 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.34 21.97 29.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.805 -1.318 . . . . 3.6699999999999999 109.805 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 97' ' ' GLN . 1.7 m -110.11 90.86 3.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -1.17 . . . . 3.79 109.531 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.678 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -128.07 86.86 57.01 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 1.96 109.57 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.81 118.94 5.91 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.964 2.443 . . . . 2.9700000000000002 112.395 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.733 HD12 HG11 ' A' ' 80' ' ' VAL . 12.2 mt -120.89 168.02 11.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 3.0600000000000001 109.346 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -122.82 -177.68 3.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 2.3399999999999999 109.563 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.503 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -91.6 59.21 2.95 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.513 -1.435 . . . . 2.1699999999999999 109.513 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -171.78 131.72 0.75 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 3.02 109.191 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -41.04 122.65 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.488 2.125 . . . . 1.4199999999999999 112.123 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.84 146.06 9.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 1.3700000000000001 109.565 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.434 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.75 150.31 21.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 1.72 110.26 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -126.47 152.33 46.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.379 -1.341 . . . . 4.7000000000000002 107.379 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' O ' ' CD1' ' A' ' 111' ' ' TYR . 13.8 mp0 -125.02 158.29 34.08 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.375 -0.93 . . . . 3.2799999999999998 110.701 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.653 ' CD1' ' O ' ' A' ' 110' ' ' GLU . 42.9 m-85 -160.57 103.34 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.474 -0.936 . . . . 2.96 108.474 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.682 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -114.02 169.6 8.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 3.4100000000000001 109.836 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.644 ' CE1' ' CD2' ' A' ' 95' ' ' PHE . 3.7 p90 -177.5 -173.5 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -0.88 . . . . 2.77 109.857 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -119.69 150.91 39.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.52 -0.737 . . . . 2.23 109.418 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.547 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -90.2 169.77 10.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 4.1100000000000003 109.842 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -125.07 -20.28 4.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 6.8600000000000003 109.285 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 118' ' ' THR . 9.3 tt -128.46 170.86 12.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.367 -0.833 . . . . 5.1200000000000001 109.305 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.884 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -89.76 107.75 19.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.167 -0.958 . . . . 4.0599999999999996 109.542 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.715 ' CE1' HD22 ' A' ' 117' ' ' LEU . 42.5 m-85 -117.14 75.95 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 5.4400000000000004 109.499 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.56 163.27 32.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.682 2.255 . . . . 4.04 112.269 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.03 -12.97 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.846 2.364 . . . . 3.8999999999999999 111.965 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.46 129.44 55.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 4.1399999999999997 109.487 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.64 -65.18 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.425 -1.47 . . . . 3.5699999999999998 109.425 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.6 OUTLIER -172.91 47.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -1.135 . . . . 3.5899999999999999 109.463 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.558 ' C ' ' H ' ' A' ' 127' ' ' GLY . . . 179.92 58.83 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 2.0800000000000001 109.585 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -48.22 -2.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.11 2.54 . . . . 1.3899999999999999 112.078 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 122.29 150.21 8.13 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.286 -1.526 . . . . 1.1899999999999999 109.286 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -146.99 129.73 16.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.1 -1.236 . . . . 2.0099999999999998 109.846 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 55' ' ' TYR . 1.4 p -153.15 94.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.289 -1.004 . . . . 1.28 108.289 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.571 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -102.9 136.42 42.75 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.282 -0.886 . . . . 0.97999999999999998 110.563 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.515 ' HB2' HD12 ' A' ' 53' ' ' LEU . 2.9 m-30 -105.92 96.04 6.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.825 -0.805 . . . . 1.73 108.825 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.574 ' O ' ' O ' ' A' ' 81' ' ' ARG . 54.8 m170 -99.95 129.08 45.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 2.3199999999999998 109.785 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.616 HD22 ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -132.05 -28.4 1.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 2.1099999999999999 109.45 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -46.28 144.95 3.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 1.77 109.693 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.881 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 14.6 mtpp -164.08 141.04 6.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.139 . . . . 5.0599999999999996 109.668 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.33 -20.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 2.6400000000000001 108.602 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -131.36 18.1 4.99 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 2.5099999999999998 108.943 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.881 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -49.45 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -1.036 . . . . 2.3199999999999998 110.218 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.6 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -153.78 -110.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 1.6100000000000001 109.394 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.63 152.74 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.896 -1.128 . . . . 1.6499999999999999 109.023 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.616 ' CG ' HD22 ' A' ' 133' ' ' LEU . 50.3 t80 -134.29 123.8 24.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.006 -1.059 . . . . 1.6799999999999999 110.181 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 1.8 m -112.67 118.78 35.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.913 . . . . 0.73999999999999999 109.43 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.61 145.03 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.006 0.908 . . . . 1.22 109.859 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.674 ' O ' ' NE2' ' A' ' 145' ' ' GLN . 93.0 p -135.37 -19.75 1.66 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.27 -0.641 . . . . 1.3300000000000001 109.27 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -148.9 163.18 38.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.917 . . . . 3.2999999999999998 109.484 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.679 HG11 ' CH2' ' A' ' 22' ' ' TRP . 10.5 p -177.2 123.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2599999999999998 109.556 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.52 151.61 9.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 2.7599999999999998 109.524 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 148' ' ' LEU . 1.0 OUTLIER -115.96 173.19 6.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 4.5700000000000003 109.584 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER -157.01 -166.89 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 3.0699999999999998 109.467 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.653 ' N ' ' OG1' ' A' ' 149' ' ' THR . 9.2 t -165.02 -153.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 2.0 109.484 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.515 ' HB2' ' H ' ' A' ' 3' ' ' LEU . 2.6 p -151.26 99.48 2.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 2.1499999999999999 109.472 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.88 -172.71 4.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -0.861 . . . . 2.8199999999999998 109.47 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.981 -1.009 . . . . 3.54 109.463 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.478 -0.564 . . . . 5.4699999999999998 109.478 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 t 56.5 -73.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 4.5300000000000002 109.425 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER 53.59 -156.83 0.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 5.1399999999999997 109.467 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' O ' ' C ' ' A' ' 5' ' ' SER . 7.8 t0 55.8 -170.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 5.3799999999999999 109.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.528 ' C ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -36.21 147.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 4.8300000000000001 109.454 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 8' ' ' GLU . 9.3 mt-10 -71.25 132.6 45.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 3.4300000000000002 109.533 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.959 HG23 ' OG ' ' A' ' 151' ' ' SER . 2.3 t -63.73 82.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 2.8300000000000001 109.369 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' GLU . 1.8 tp10 -86.04 84.53 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.922 . . . . 4.75 109.503 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 59' ' ' PRO . 1.5 mt -67.01 -22.0 65.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 4.9500000000000002 109.297 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 10' ' ' LEU . 3.1 tm? -126.26 78.16 71.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 2.8599999999999999 108.679 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.32 40.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 123.03 2.487 . . . . 3.8300000000000001 112.77 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.811 ' H ' HD13 ' A' ' 10' ' ' LEU . 9.3 t60 -136.2 94.29 3.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 2.52 109.516 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.653 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -140.19 52.66 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 1.97 109.328 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -146.48 71.92 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 1.96 109.676 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 19' ' ' LEU . 4.7 m-30 -63.0 41.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 1.76 109.048 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.654 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -90.1 -39.13 13.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 1.1799999999999999 109.959 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 8.4 mt-10 -109.74 -83.71 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 2.1299999999999999 109.856 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -103.34 144.11 31.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 2.2599999999999998 109.589 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 15' ' ' PHE . 4.5 mt -58.15 -55.85 29.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 2.6000000000000001 109.469 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 102.53 -163.66 16.52 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.4 . . . . 1.6200000000000001 109.601 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.04 -36.91 67.06 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.74 2.294 . . . . 1.7 112.117 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.837 ' CH2' HG11 ' A' ' 146' ' ' VAL . 21.2 m95 -55.09 159.91 2.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 2.4199999999999999 109.455 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.06 177.29 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 1.6399999999999999 109.342 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 24' ' ' LEU . 1.3 pt? -176.06 151.53 1.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 2.0499999999999998 109.631 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.685 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 170.32 178.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 1.72 109.713 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.585 ' C ' ' HB2' ' A' ' 51' ' ' ALA . . . 86.22 -4.55 85.89 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.859 -1.297 . . . . 1.7 109.859 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.903 ' OG1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -109.74 -143.17 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.27 . . . . 0.96999999999999997 109.504 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.792 ' N ' ' OG1' ' A' ' 27' ' ' THR . 86.1 p -91.5 -151.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.314 -0.866 . . . . 1.8 109.003 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -90.68 110.41 41.22 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 2.3999999999999999 109.102 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 56.4 Cg_endo -76.43 143.12 24.38 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.144 1.896 . . . . 1.1299999999999999 111.557 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -144.65 122.03 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 1.05 110.631 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.27 84.6 5.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.682 . . . . 1.8200000000000001 109.182 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.75 -140.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.461 -0.774 . . . . 1.1699999999999999 109.976 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -47.54 -68.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 2.21 109.401 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.638 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.46 43.85 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.438 -1.465 . . . . 1.1899999999999999 109.438 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.53 145.49 11.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 2.9100000000000001 109.63 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 37' ' ' MET . 18.4 tmm? -111.23 132.75 54.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.93000000000000005 109.042 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 82.3 m -123.48 152.11 42.05 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.259 -0.901 . . . . 1.0600000000000001 110.24 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG13 ' SD ' ' A' ' 37' ' ' MET . 3.4 m -135.25 115.62 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.392 -0.966 . . . . 1.3700000000000001 108.392 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.794 ' O ' HD22 ' A' ' 41' ' ' LEU . 3.4 m-20 -72.41 123.64 23.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 4.79 109.929 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.903 HD21 ' OG1' ' A' ' 27' ' ' THR . 3.7 mm? -132.52 61.07 54.85 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.912 . . . . 3.54 110.225 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.584 ' O ' ' O ' ' A' ' 43' ' ' GLY . 53.8 Cg_endo -96.05 -43.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.456 2.771 . . . . 3.7400000000000002 112.164 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 42' ' ' PRO . . . -16.76 -108.13 0.0 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 111.771 -0.532 . . . . 2.0299999999999998 111.771 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.07 61.63 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.197 -1.561 . . . . 2.4100000000000001 109.197 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 136' ' ' ALA . 2.7 mm100 -99.37 97.15 8.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -1.208 . . . . 2.96 109.7 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.51 58.92 3.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.658 -1.377 . . . . 2.0800000000000001 109.658 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.586 ' C ' ' H ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -152.51 90.19 3.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.6099999999999999 109.464 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.62 2.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.907 2.405 . . . . 2.3599999999999999 112.503 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.685 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -127.67 34.54 4.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 3.8700000000000001 109.599 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.685 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 1.4 m-20 -109.98 -2.25 17.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 2.3799999999999999 109.57 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB2' ' C ' ' A' ' 26' ' ' GLY . . . -176.9 172.14 2.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -0.964 . . . . 1.1100000000000001 109.689 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.638 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 144.3 178.0 19.63 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.718 -1.353 . . . . 0.93999999999999995 109.718 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.567 ' C ' HG22 ' A' ' 54' ' ' VAL . 8.2 mt -88.14 -176.57 5.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -1.092 . . . . 0.95999999999999996 109.234 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -164.23 162.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.92000000000000004 110.015 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.589 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 26.3 t80 175.83 146.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.586 -0.696 . . . . 1.71 109.297 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.589 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -112.93 -164.69 0.93 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 109.494 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.24 56.65 7.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.647 -1.381 . . . . 2.48 109.647 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.847 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.5 p -126.06 92.02 46.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 3.79 109.377 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.548 ' HG2' HD13 ' A' ' 9' ' ' LEU . 61.1 Cg_endo -80.39 131.4 8.53 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.718 2.279 . . . . 2.3999999999999999 112.277 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' HA ' ' CE1' ' A' ' 66' ' ' TYR . 21.1 t -141.98 113.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 3.0800000000000001 109.462 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -93.37 111.38 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.534 -1.426 . . . . 3.0499999999999998 109.534 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.506 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 1.8 tm-20 -42.47 145.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 6.0499999999999998 109.486 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.677 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 106.14 -35.02 5.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 2.54 109.633 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.622 ' O ' ' N ' ' A' ' 115' ' ' SER . 13.3 mt-10 -99.97 173.14 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 4.0300000000000002 109.558 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.578 ' O ' ' OG1' ' A' ' 150' ' ' THR . 51.7 m -121.02 143.79 48.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 2.9100000000000001 109.418 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.591 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 22.0 m-85 -109.31 -178.5 3.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 2.3799999999999999 109.703 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.9 t -152.21 159.18 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.487 -0.758 . . . . 2.6099999999999999 109.554 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.472 HD21 ' HZ ' ' A' ' 131' ' ' PHE . 1.8 tp -143.29 114.06 7.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 3.6099999999999999 109.392 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.8 p -109.24 75.85 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.924 . . . . 2.27 108.878 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.3 p90 -94.08 150.19 20.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 2.0099999999999998 111.013 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.47 135.19 37.42 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.537 -0.912 . . . . 1.8 108.537 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.575 ' O ' HD22 ' A' ' 102' ' ' LEU . . . -171.68 135.16 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.011 -1.055 . . . . 0.95999999999999996 110.089 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -130.58 120.97 24.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.93000000000000005 108.979 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -96.18 138.88 33.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.67000000000000004 109.611 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.457 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.6 116.15 16.07 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.903 . . . . 0.96999999999999997 109.465 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.01 -144.44 0.17 OUTLIER 'Cis proline' 0 N--CA 1.499 1.828 0 C-N-CA 124.217 -1.16 . . . . 1.02 112.225 0.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' OD2' ' OG1' ' A' ' 103' ' ' THR . 4.0 m-20 -109.21 163.17 13.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.75 110.154 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.465 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.0 mtm 165.17 168.08 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.701 -0.851 . . . . 2.1600000000000001 108.701 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.36 137.91 12.11 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.741 2.294 . . . . 1.3799999999999999 112.466 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.77 HG12 ' OH ' ' A' ' 139' ' ' TYR . 0.8 OUTLIER -112.56 -178.4 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.0099999999999998 109.198 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.666 ' N ' HG23 ' A' ' 80' ' ' VAL . 7.7 ttt180 -121.75 155.72 34.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 6.0099999999999998 109.772 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.47 ' HB ' HE21 ' A' ' 97' ' ' GLN . 35.1 t -154.58 150.85 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 3.7599999999999998 109.11 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.5 OUTLIER -146.78 147.03 30.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.091 -1.006 . . . . 2.29 109.769 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 129' ' ' VAL . 0.8 OUTLIER -153.66 156.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.576 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.584 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.07 -161.52 24.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.593 -1.403 . . . . 1.49 109.593 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.662 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -89.73 -177.06 5.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 2.54 109.536 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.22 0.19 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.56 -1.416 . . . . 1.3799999999999999 109.56 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.42 -115.9 1.15 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.579 -1.409 . . . . 2.54 109.579 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . -125.47 139.04 11.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 4.1399999999999997 109.516 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 89' ' ' GLY . . . 62.62 -41.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -1.164 . . . . 5.1299999999999999 109.359 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.678 ' N ' ' O ' ' A' ' 89' ' ' GLY . 1.5 m-85 -73.75 80.23 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 5.79 109.431 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.56 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.45 -178.61 4.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 5.7400000000000002 109.501 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -102.47 169.81 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 2.27 110.119 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.29 -16.84 6.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.886 -0.783 . . . . 3.2799999999999998 108.886 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.64 36.45 0.9 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 3.6499999999999999 109.281 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.428 ' CG ' HG23 ' A' ' 93' ' ' THR . 29.4 mt-10 -83.15 71.45 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.95 . . . . 4.5999999999999996 109.548 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.47 HE21 ' HB ' ' A' ' 82' ' ' VAL . 12.6 pt20 -100.07 167.27 10.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 3.46 109.467 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -146.47 8.38 1.38 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.695 -1.362 . . . . 3.6699999999999999 109.695 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -116.23 94.22 4.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.229 -1.159 . . . . 3.79 109.628 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.756 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -134.1 85.36 39.89 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 1.96 109.485 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.99 133.28 57.2 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.957 2.438 . . . . 2.9700000000000002 112.47 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 72' ' ' ALA . 11.4 mt -148.74 123.94 10.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 3.0600000000000001 109.257 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.58 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -116.07 175.67 5.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 2.3399999999999999 109.607 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.422 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -67.52 32.93 0.21 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.395 -1.482 . . . . 2.1699999999999999 109.395 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 103' ' ' THR . 15.1 tt0 -110.41 95.44 22.46 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.357 -1.084 . . . . 3.02 109.362 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -47.29 118.34 2.81 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.572 2.182 . . . . 1.4199999999999999 112.254 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.594 ' CB ' HH12 ' A' ' 109' ' ' ARG . . . -175.73 166.79 3.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 1.3700000000000001 109.31 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.567 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -90.44 145.44 24.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 1.72 110.311 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.594 HH12 ' CB ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -108.62 138.76 44.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.711 -1.218 . . . . 4.7000000000000002 107.711 178.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -109.01 102.28 11.29 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.434 -0.791 . . . . 3.2799999999999998 110.526 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 12.3 m-30 -109.53 115.0 29.11 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.484 -0.932 . . . . 2.96 108.484 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.659 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -125.66 165.41 18.63 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.3 -0.875 . . . . 3.4100000000000001 109.573 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.5 p90 -154.19 -178.06 6.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.875 . . . . 2.77 109.511 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.539 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -105.99 101.09 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.816 . . . . 2.23 109.513 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 34.9 p -36.22 104.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 4.1100000000000003 109.353 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.792 ' C ' HD22 ' A' ' 117' ' ' LEU . 2.4 m120 -93.44 -32.89 14.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 6.8600000000000003 109.405 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.792 HD22 ' C ' ' A' ' 116' ' ' ASN . 4.6 mm? -122.39 -175.22 3.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 5.1200000000000001 109.28 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.53 114.95 27.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 4.0599999999999996 109.629 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 117' ' ' LEU . 5.5 m-85 -112.85 79.24 3.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.173 -0.955 . . . . 5.4400000000000004 109.35 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.82 152.24 28.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.705 2.27 . . . . 4.04 112.245 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 125' ' ' ALA . 71.8 Cg_endo -80.33 -32.68 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.597 2.198 . . . . 3.8999999999999999 111.814 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 123' ' ' GLY . 24.3 m-20 -109.84 -30.34 7.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 4.1399999999999997 109.55 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -36.46 -34.04 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 3.5699999999999998 109.531 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.6 OUTLIER -173.72 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 3.5899999999999999 109.508 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -137.18 153.24 74.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 2.0800000000000001 109.566 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -68.8 -10.97 30.64 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.947 2.432 . . . . 1.3899999999999999 112.337 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.9 178.21 17.29 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 1.1899999999999999 109.348 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -154.35 120.99 5.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.114 -1.227 . . . . 2.0099999999999998 109.775 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 84' ' ' VAL . 16.4 t -144.42 120.7 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.711 -0.848 . . . . 1.28 108.711 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -141.38 131.55 24.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.013 . . . . 0.97999999999999998 110.444 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.472 ' HZ ' HD21 ' A' ' 68' ' ' LEU . 4.7 m-30 -94.46 115.62 27.82 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.666 -0.864 . . . . 1.73 108.666 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.581 ' O ' ' O ' ' A' ' 81' ' ' ARG . 23.8 m170 -100.02 122.81 43.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 2.3199999999999998 110.064 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -147.13 10.22 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.862 . . . . 2.1099999999999999 109.27 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.557 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -75.52 126.71 8.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.304 -1.518 . . . . 1.77 109.304 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 138' ' ' ALA . 6.7 mtpm? -165.81 131.27 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 5.0599999999999996 109.618 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.685 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -49.34 -29.89 6.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.409 -1.33 . . . . 2.6400000000000001 107.409 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -96.19 7.42 66.77 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.14 -1.984 . . . . 2.5099999999999998 108.14 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.52 -130.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.862 0.839 . . . . 2.3199999999999998 110.743 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.77 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.3 OUTLIER 162.38 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 1.6100000000000001 109.515 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.63 ' OE1' ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -84.42 125.55 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 1.6499999999999999 109.09 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 13.6 t80 -106.39 112.78 25.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.803 . . . . 1.6799999999999999 109.285 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 30.7 m -113.78 96.27 5.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.1 -1.0 . . . . 0.73999999999999999 110.086 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.452 HD11 ' CG2' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -107.96 142.91 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 1.22 109.221 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 p -134.33 -3.82 2.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.647 -0.658 . . . . 1.3300000000000001 109.278 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 9.4 mt-30 -147.54 162.08 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 3.2999999999999998 110.124 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.837 HG11 ' CH2' ' A' ' 22' ' ' TRP . 93.2 t -160.11 79.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.955 -0.757 . . . . 2.2599999999999998 108.955 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.423 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -80.3 147.82 30.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 2.7599999999999998 110.051 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 149' ' ' THR . 1.2 tp -151.6 112.24 4.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.426 -0.796 . . . . 4.5700000000000003 109.183 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.653 ' N ' HD12 ' A' ' 148' ' ' LEU . 7.8 t -166.66 -155.86 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 3.0699999999999998 109.532 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 65' ' ' SER . 0.8 OUTLIER -144.71 -41.19 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 2.0 109.348 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.959 ' OG ' HG23 ' A' ' 7' ' ' VAL . 1.5 p -52.24 164.92 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 2.1499999999999999 109.462 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.99 96.62 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 2.8199999999999998 109.545 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 4' ' ' ASP . 31.8 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.042 -0.98 . . . . 3.54 109.428 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.528 -0.545 . . . . 5.4699999999999998 109.528 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 4' ' ' ASP . 25.2 t -58.19 -123.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 4.5300000000000002 109.405 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.492 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.8 mm? -71.52 20.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 5.1399999999999997 109.415 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.562 ' H ' ' C ' ' A' ' 2' ' ' SER . 0.3 OUTLIER 63.46 173.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.415 -0.587 . . . . 5.3799999999999999 109.415 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 4' ' ' ASP . 13.6 p 36.07 -155.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 4.8300000000000001 109.512 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.83 134.21 45.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 3.4300000000000002 109.433 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 150' ' ' THR . 0.2 OUTLIER -80.33 66.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 2.8300000000000001 109.496 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 4.75 109.44 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 -30.99 52.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 4.9500000000000002 109.466 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.027 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -114.95 96.11 43.81 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 2.8599999999999999 109.325 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.79 45.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.748 2.299 . . . . 3.8300000000000001 112.673 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.622 ' N ' ' O ' ' A' ' 10' ' ' LEU . 54.8 t60 -133.25 107.46 8.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.98 . . . . 2.52 109.438 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.28 59.34 1.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.284 -0.885 . . . . 1.97 109.465 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 16' ' ' ALA . 47.3 t -160.9 69.04 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 1.96 109.658 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 144' ' ' SER . 3.3 m-30 -62.57 38.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 1.76 109.209 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -83.44 -34.69 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.737 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.687 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 21.8 mm-40 -109.72 -84.71 0.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 2.1299999999999999 109.344 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 20' ' ' GLY . 3.8 p -103.04 142.87 33.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 2.2599999999999998 109.233 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.82 6.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.098 -1.001 . . . . 2.6000000000000001 109.496 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 73.64 -148.65 40.51 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.201 -1.16 . . . . 1.6200000000000001 110.201 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 22' ' ' TRP . 98.6 Cg_endo -88.94 -10.64 4.08 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.268 2.646 . . . . 1.7 111.996 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.781 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.4 m95 -54.94 -170.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 2.4199999999999999 109.757 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -128.26 166.18 19.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 1.6399999999999999 109.255 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.832 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -170.74 156.34 5.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 2.0499999999999998 109.755 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER 158.13 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 1.72 109.803 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 89.6 -28.83 6.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.965 -1.112 . . . . 1.7 110.411 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.758 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.71 -141.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.349 . . . . 0.96999999999999997 109.627 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.758 ' N ' ' OG1' ' A' ' 27' ' ' THR . 16.3 p -91.02 133.14 35.54 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.459 -0.776 . . . . 1.8 109.43 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -36.99 101.34 0.22 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 2.3999999999999999 109.214 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 28' ' ' SER . 51.5 Cg_exo -46.63 150.5 2.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.35 2.033 . . . . 1.1299999999999999 111.709 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.7 t -136.57 117.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.102 -0.998 . . . . 1.05 110.207 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -81.45 89.16 6.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.725 . . . . 1.8200000000000001 109.763 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -63.6 -140.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 1.1699999999999999 109.492 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -40.09 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 2.21 109.541 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.558 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -138.97 35.64 1.96 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.568 -1.413 . . . . 1.1899999999999999 109.568 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.17 152.1 31.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -1.128 . . . . 2.9100000000000001 109.508 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -119.28 134.52 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.872 . . . . 0.93000000000000005 109.303 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.71 154.23 46.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.335 -0.946 . . . . 1.0600000000000001 110.471 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.5 m -123.65 134.12 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.629 -0.878 . . . . 1.3700000000000001 108.629 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.671 ' N ' ' OG ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -74.99 105.85 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 4.79 109.795 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.6 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.5 mm? -117.94 74.82 10.17 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.897 . . . . 3.54 109.314 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.47 -56.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.784 2.323 . . . . 3.7400000000000002 112.195 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 136' ' ' ALA . . . 161.44 -150.66 20.49 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.543 -1.423 . . . . 2.0299999999999998 109.543 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.03 -0.36 6.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 2.4100000000000001 109.501 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.671 ' O ' ' N ' ' A' ' 47' ' ' ASN . 2.8 mt-30 -99.38 73.63 1.88 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.256 -1.143 . . . . 2.96 109.539 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.85 49.88 0.06 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.392 -1.483 . . . . 2.0800000000000001 109.392 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.674 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -160.84 87.33 1.74 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -1.114 . . . . 3.6099999999999999 109.429 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.59 -9.88 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.912 2.408 . . . . 2.3599999999999999 112.347 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -112.34 31.42 6.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 3.8700000000000001 109.548 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD2' ' ND2' ' A' ' 47' ' ' ASN . 30.6 m-20 -123.02 36.78 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 2.3799999999999999 109.364 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 27' ' ' THR . . . 175.46 119.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.1100000000000001 109.389 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 159.37 -152.71 23.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.884 -1.286 . . . . 0.93999999999999995 109.884 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -144.24 170.46 15.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 0.95999999999999996 109.355 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.695 HG13 ' HB2' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -152.97 172.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.05 -1.031 . . . . 0.92000000000000004 110.084 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 1.027 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 58.3 t80 -178.43 148.8 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 1.71 109.556 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.454 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -110.93 -164.92 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.23 -0.919 . . . . 2.7799999999999998 109.575 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.08 67.39 1.63 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.399 . . . . 2.48 109.604 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG13 HD21 ' A' ' 148' ' ' LEU . 3.9 t -147.96 91.93 4.77 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -1.185 . . . . 3.79 109.505 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.683 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 60.9 Cg_endo -80.44 154.19 21.15 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.763 2.309 . . . . 2.3999999999999999 112.128 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.592 HG13 ' CE1' ' A' ' 66' ' ' TYR . 2.0 t -151.7 148.39 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.927 . . . . 3.0800000000000001 109.736 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -142.94 116.07 0.98 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.228 -1.549 . . . . 3.0499999999999998 109.228 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.684 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -34.35 146.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -1.151 . . . . 6.0499999999999998 109.762 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.679 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 91.75 -16.6 58.91 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.88 -1.288 . . . . 2.54 109.88 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.671 ' N ' ' OG ' ' A' ' 115' ' ' SER . 9.6 mt-10 -112.47 160.92 17.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -1.219 . . . . 4.0300000000000002 109.836 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -128.29 140.91 51.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 2.9100000000000001 109.116 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 20.9 m-85 -107.07 177.13 4.95 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.077 -1.014 . . . . 2.3799999999999999 109.885 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -147.58 165.25 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.468 -0.77 . . . . 2.6099999999999999 109.593 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 148' ' ' LEU . 8.3 tp -149.9 118.82 6.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 3.6099999999999999 109.515 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -109.96 80.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 2.27 109.151 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 50.2 p90 -94.44 146.14 24.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.718 . . . . 2.0099999999999998 110.831 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.674 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.1 p -95.17 138.48 32.81 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.642 -0.873 . . . . 1.8 108.642 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.839 ' O ' HD12 ' A' ' 102' ' ' LEU . . . -176.24 122.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.012 -1.055 . . . . 0.95999999999999996 110.142 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -112.44 122.5 47.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.749 -0.834 . . . . 0.93000000000000005 108.749 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . -91.24 132.65 35.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.258 -0.901 . . . . 0.67000000000000004 109.85 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.478 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -135.63 113.97 11.11 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.384 -0.823 . . . . 0.96999999999999997 109.28 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.578 ' O ' ' C ' ' A' ' 74' ' ' ALA . 18.7 Cg_exo -65.21 -142.25 0.15 OUTLIER 'Cis proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.321 -1.116 . . . . 1.02 112.636 -0.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.662 ' O ' ' SD ' ' A' ' 78' ' ' MET . 1.1 m-20 -108.59 154.97 21.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 1.75 109.726 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 170.34 154.44 0.19 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 2.1600000000000001 109.433 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.19 129.08 12.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.778 2.319 . . . . 1.3799999999999999 112.306 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.685 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -106.12 -178.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 2.0099999999999998 109.244 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.65 ' N ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -129.16 147.08 50.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 6.0099999999999998 109.715 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -150.0 155.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 3.7599999999999998 109.216 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.505 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -141.65 151.28 42.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.132 -0.98 . . . . 2.29 109.856 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG13 HG23 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -150.33 162.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 1.8899999999999999 109.472 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 139.56 -147.75 19.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.708 -1.357 . . . . 1.49 109.708 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.715 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -90.41 162.45 15.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -1.114 . . . . 2.54 109.469 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.563 ' C ' ' HB1' ' A' ' 125' ' ' ALA . . . -112.02 62.42 0.3 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.493 -1.443 . . . . 1.3799999999999999 109.493 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.44 -157.72 7.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.58 -1.408 . . . . 2.54 109.58 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . -101.16 -97.59 2.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.528 -1.429 . . . . 4.1399999999999997 109.528 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -36.09 -50.13 0.69 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -1.189 . . . . 5.1299999999999999 109.415 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 0.7 OUTLIER -59.45 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.221 -0.924 . . . . 5.79 109.463 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.732 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -55.92 170.9 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 5.7400000000000002 109.637 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -101.9 174.18 6.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 2.27 109.877 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HD21 ' A' ' 116' ' ' ASN . . . -127.43 -17.16 4.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.49 -0.756 . . . . 3.2799999999999998 109.168 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.408 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.72 36.42 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.089 -1.007 . . . . 3.6499999999999999 109.43 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -83.96 70.99 10.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 4.5999999999999996 109.479 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.846 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -102.03 178.86 4.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 3.46 109.563 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.633 ' CA ' ' OE1' ' A' ' 97' ' ' GLN . . . -157.75 17.09 0.33 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.617 -1.393 . . . . 3.6699999999999999 109.617 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.846 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.7 m -111.05 63.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 3.79 109.686 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -110.12 97.18 29.02 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 1.96 109.253 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.699 ' C ' HD22 ' A' ' 102' ' ' LEU . 60.5 Cg_endo -79.58 118.2 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.67 2.247 . . . . 2.9700000000000002 112.667 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 72' ' ' ALA . 4.1 mm? -115.87 143.05 45.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 3.0600000000000001 109.169 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.613 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -127.36 166.56 17.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 2.3399999999999999 109.522 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.93 24.49 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 2.1699999999999999 109.505 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.613 ' H ' ' C ' ' A' ' 103' ' ' THR . 13.3 tt0 -109.9 96.59 25.33 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 3.02 109.363 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -47.14 118.43 2.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.551 2.167 . . . . 1.4199999999999999 112.195 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.801 ' HB3' ' NH2' ' A' ' 109' ' ' ARG . . . -169.99 164.2 9.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.846 . . . . 1.3700000000000001 109.439 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.579 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.29 140.24 29.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 1.72 109.859 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.801 ' NH2' ' HB3' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -105.45 134.8 47.96 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.842 -1.17 . . . . 4.7000000000000002 107.842 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -109.11 99.79 9.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 3.2799999999999998 110.893 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.3 m-30 -109.93 130.3 55.55 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.319 -0.993 . . . . 2.96 108.319 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.67 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -134.4 163.21 30.19 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 3.4100000000000001 109.849 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.621 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -142.97 173.47 11.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 2.77 109.516 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.06 121.33 42.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 2.23 109.776 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 93.5 p -48.97 143.81 5.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 4.1100000000000003 109.431 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 6.7 p-10 -134.31 -46.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 6.8600000000000003 109.516 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.774 HD22 ' CE1' ' A' ' 119' ' ' PHE . 5.0 tt -109.97 175.25 5.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 5.1200000000000001 109.461 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.727 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -92.95 124.32 36.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 4.0599999999999996 109.864 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.774 ' CE1' HD22 ' A' ' 117' ' ' LEU . 45.0 m-85 -134.75 93.63 17.75 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 5.4400000000000004 109.258 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.6 165.53 22.66 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.678 2.252 . . . . 4.04 112.267 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.83 -14.5 12.47 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.858 2.372 . . . . 3.8999999999999999 112.079 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 2.5 p-10 -109.65 115.52 30.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 4.1399999999999997 109.527 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 125' ' ' ALA . . . 167.64 173.17 35.5 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.475 -1.45 . . . . 3.5699999999999998 109.475 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -75.97 26.64 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 3.5899999999999999 109.499 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.563 ' HB1' ' C ' ' A' ' 87' ' ' GLY . . . 179.94 74.11 0.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 2.0800000000000001 109.543 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' A' ' 127' ' ' GLY . 56.0 Cg_endo -75.31 -158.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.77 2.314 . . . . 1.3899999999999999 112.249 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -39.16 163.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.587 -1.405 . . . . 1.1899999999999999 109.587 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -162.28 122.22 2.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -1.181 . . . . 2.0099999999999998 109.721 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 55' ' ' TYR . 8.4 p -146.53 130.52 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.424 -0.954 . . . . 1.28 108.424 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.695 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -148.26 123.26 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.961 -1.087 . . . . 0.97999999999999998 110.731 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.9 m-30 -86.92 118.93 26.63 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.807 -1.183 . . . . 1.73 107.807 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.505 ' ND1' HD21 ' A' ' 83' ' ' LEU . 6.1 m170 -99.94 131.87 45.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 2.3199999999999998 110.151 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 134' ' ' GLY . 3.8 mp -134.4 -105.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 2.1099999999999999 109.124 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.586 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 32.49 98.16 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.048 -1.221 . . . . 1.77 110.048 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.7 mtpt -146.68 123.67 11.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 5.0599999999999996 109.857 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.16 -20.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.147 -0.97 . . . . 2.6400000000000001 108.46 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -120.66 13.35 10.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.025 -1.63 . . . . 2.5099999999999998 109.025 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.616 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -52.17 -152.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.967 . . . . 2.3199999999999998 110.26 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.555 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 11.9 p90 -164.63 -131.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -0.99 . . . . 1.6100000000000001 109.374 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.417 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 26.5 mt-10 -120.3 128.29 53.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.895 -1.128 . . . . 1.6499999999999999 109.38 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.595 ' CD2' HG22 ' A' ' 143' ' ' ILE . 5.5 t80 -107.91 111.36 23.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 1.6799999999999999 109.661 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -107.5 88.43 2.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.73999999999999999 110.141 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.595 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -99.32 135.87 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 1.22 108.844 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 15' ' ' PHE . 60.0 p -128.05 -0.9 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 1.3300000000000001 109.313 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.674 ' N ' ' OG1' ' A' ' 71' ' ' THR . 23.7 mt-30 -152.2 174.61 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 3.2999999999999998 109.977 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 146' ' ' VAL . 8.0 p -177.24 92.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 2.2599999999999998 109.102 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.39 144.68 31.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 2.7599999999999998 110.056 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.641 HD21 HG13 ' A' ' 58' ' ' VAL . 8.9 tp -130.08 120.09 24.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 4.5700000000000003 109.019 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.486 ' OG1' ' N ' ' A' ' 150' ' ' THR . 2.6 t -158.06 -170.18 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 3.0699999999999998 109.661 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.708 HG23 ' H ' ' A' ' 151' ' ' SER . 0.7 OUTLIER -139.97 -103.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 2.0 109.45 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.708 ' H ' HG23 ' A' ' 150' ' ' THR . 4.0 p 85.23 62.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 2.1499999999999999 109.445 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.517 ' HB3' ' OG ' ' A' ' 2' ' ' SER . . . 48.02 -148.63 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 2.8199999999999998 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.969 -1.015 . . . . 3.54 109.434 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.498 -0.556 . . . . 5.4699999999999998 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.656 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -87.16 -79.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 4.5300000000000002 109.456 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.656 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.9 mt -143.5 157.16 44.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 5.1399999999999997 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' O ' ' C ' ' A' ' 5' ' ' SER . 25.5 m-20 -93.06 -164.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 5.3799999999999999 109.444 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.5 OUTLIER 36.14 35.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -0.857 . . . . 4.8300000000000001 109.462 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.573 ' O ' ' O ' ' A' ' 5' ' ' SER . 2.6 mp0 50.62 168.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.39 -0.819 . . . . 3.4300000000000002 109.476 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -102.63 -156.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 2.8300000000000001 109.368 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.484 ' H ' HG12 ' A' ' 7' ' ' VAL . 3.1 tt0 -175.33 86.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 4.75 109.636 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -83.97 -18.57 36.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 4.9500000000000002 109.425 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 10' ' ' LEU . 3.0 tm? -130.06 86.31 54.82 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 2.8599999999999999 108.782 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.37 41.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.35 2.7 . . . . 3.8300000000000001 113.509 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.709 ' H ' HD13 ' A' ' 10' ' ' LEU . 16.8 t60 -152.26 111.69 3.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.878 -1.139 . . . . 2.52 109.463 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.541 ' OG1' ' C ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -159.89 65.65 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 1.97 109.506 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 16' ' ' ALA . 23.4 m -153.03 66.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 1.96 109.592 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.544 ' CD2' HD11 ' A' ' 143' ' ' ILE . 4.6 m-30 -63.22 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 1.76 109.11 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -89.95 -78.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 1.1799999999999999 109.915 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -109.16 38.61 2.25 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.247 -0.908 . . . . 2.1299999999999999 109.867 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.97 150.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 2.2599999999999998 109.59 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -87.04 -69.82 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 2.6000000000000001 109.577 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 113.53 -172.03 14.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.408 -1.477 . . . . 1.6200000000000001 109.408 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.5 Cg_endo -70.31 -10.0 27.15 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.703 2.269 . . . . 1.7 112.189 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.916 ' CH2' HG21 ' A' ' 146' ' ' VAL . 7.8 m95 -61.91 -169.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 2.4199999999999999 109.246 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.8 m -150.37 162.27 40.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 1.6399999999999999 109.496 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 19' ' ' LEU . 2.7 pp -160.82 149.96 16.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.883 . . . . 2.0499999999999998 109.489 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -177.52 133.92 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 1.72 109.437 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 148.51 -40.08 0.94 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.827 -1.309 . . . . 1.7 109.827 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.817 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -110.01 -141.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.96999999999999997 109.39 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.817 ' N ' ' OG1' ' A' ' 27' ' ' THR . 47.8 p -90.86 155.86 18.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 1.8 109.434 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -49.91 110.89 1.79 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 2.3999999999999999 109.03 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' CG ' HD13 ' A' ' 24' ' ' LEU . 49.9 Cg_exo -47.29 171.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.192 1.928 . . . . 1.1299999999999999 111.775 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.51 109.68 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.026 -1.046 . . . . 1.05 110.054 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.725 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -74.2 85.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 1.8200000000000001 109.289 179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.19 -140.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.399 -0.813 . . . . 1.1699999999999999 109.74 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.609 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 7.3 p-10 -53.23 -57.0 12.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 2.21 109.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.38 44.47 0.69 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.405 -1.478 . . . . 1.1899999999999999 109.405 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.46 143.96 7.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -1.118 . . . . 2.9100000000000001 109.728 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.53 ' SD ' ' C ' ' A' ' 37' ' ' MET . 4.9 tmm? -110.87 124.86 52.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.357 -0.839 . . . . 0.93000000000000005 109.058 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 60.6 m -122.12 157.98 30.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -0.902 . . . . 1.0600000000000001 110.226 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -137.0 146.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.687 -0.857 . . . . 1.3700000000000001 108.687 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.606 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -75.67 121.39 22.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 4.79 109.207 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.652 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 4.3 mm? -117.76 36.7 0.23 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.084 -1.01 . . . . 3.54 110.998 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 84.8 Cg_endo -80.59 -95.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.491 2.127 . . . . 3.7400000000000002 111.427 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . 46.33 -107.8 0.21 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.699 -0.961 . . . . 2.0299999999999998 110.699 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.4 57.31 0.01 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.44 -1.864 . . . . 2.4100000000000001 108.44 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.684 ' O ' ' N ' ' A' ' 136' ' ' ALA . 32.8 mt-30 -99.58 104.75 16.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -1.056 . . . . 2.96 110.027 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' N ' ' HB2' ' A' ' 136' ' ' ALA . . . -77.55 40.42 1.79 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.408 -1.477 . . . . 2.0800000000000001 109.408 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.648 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 0.3 OUTLIER -159.43 93.04 1.8 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -1.148 . . . . 3.6099999999999999 109.528 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.66 ' O ' ' N ' ' A' ' 50' ' ' ASP . 52.0 Cg_exo -49.6 -38.8 45.93 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.804 2.336 . . . . 2.3599999999999999 112.407 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.475 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 11.8 p90 -62.68 50.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 3.8700000000000001 109.527 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.66 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.3 m-20 -149.48 13.29 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 2.3799999999999999 109.698 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 175.18 152.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.155 -0.965 . . . . 1.1100000000000001 109.515 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.1 176.05 24.38 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.923 -1.271 . . . . 0.93999999999999995 109.923 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 53' ' ' LEU . 5.4 mt -85.18 -177.15 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -1.134 . . . . 0.95999999999999996 109.205 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -162.16 159.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.151 -0.968 . . . . 0.92000000000000004 110.989 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.634 ' OH ' ' CD2' ' A' ' 10' ' ' LEU . 41.2 t80 178.63 124.19 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.41 -0.589 . . . . 1.71 109.41 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -101.35 -171.23 1.95 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.24 -0.913 . . . . 2.7799999999999998 109.498 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.694 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 80.88 72.24 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.65 -1.38 . . . . 2.48 109.65 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 57' ' ' GLY . 11.0 m -161.92 68.12 2.18 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 3.79 109.413 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.36 148.59 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.854 2.369 . . . . 2.3999999999999999 112.227 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t -128.61 101.02 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 3.0800000000000001 109.53 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -92.45 116.02 4.97 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.481 -1.448 . . . . 3.0499999999999998 109.481 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' C ' ' OG ' ' A' ' 115' ' ' SER . 1.6 tm-20 -47.74 149.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.143 -1.21 . . . . 6.0499999999999998 109.544 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 93.39 -24.37 25.71 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.748 -1.341 . . . . 2.54 109.748 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.661 ' N ' ' OG ' ' A' ' 115' ' ' SER . 1.4 mm-40 -101.52 164.62 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -1.172 . . . . 4.0300000000000002 109.659 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.482 ' OG ' HG22 ' A' ' 114' ' ' THR . 47.7 m -131.34 135.27 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 2.9100000000000001 109.433 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 63.0 m-85 -105.36 178.19 4.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.229 -0.92 . . . . 2.3799999999999999 109.852 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 3.0 t -152.03 151.77 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 2.6099999999999999 109.31 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 148' ' ' LEU . 6.5 tp -137.58 118.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 3.6099999999999999 109.785 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -109.64 78.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.518 -0.919 . . . . 2.27 108.518 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 34.0 p90 -94.12 145.99 24.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 2.0099999999999998 111.453 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -91.78 134.29 34.87 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.321 -0.992 . . . . 1.8 108.321 178.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.769 ' N ' ' NH2' ' A' ' 109' ' ' ARG . . . -164.0 113.31 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.816 -1.178 . . . . 0.95999999999999996 110.395 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HG ' ' HB2' ' A' ' 142' ' ' CYS . 23.9 p -103.48 122.6 45.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.641 -0.874 . . . . 0.93000000000000005 108.641 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.836 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -93.31 135.39 34.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.67000000000000004 109.752 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.516 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -141.21 112.07 6.63 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.225 -0.922 . . . . 0.96999999999999997 109.717 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 74' ' ' ALA . 22.7 Cg_exo -64.09 -141.92 0.14 OUTLIER 'Cis proline' 0 N--CA 1.498 1.748 0 C-N-CA 124.253 -1.145 . . . . 1.02 112.393 -0.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.48 150.71 24.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 1.75 109.757 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.644 ' CE ' ' HZ1' ' A' ' 135' ' ' LYS . 0.5 OUTLIER 173.01 154.54 0.25 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 2.1600000000000001 109.34 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.25 140.68 22.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.767 2.311 . . . . 1.3799999999999999 112.149 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 100' ' ' ALA . 7.3 m -111.84 -179.55 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 2.0099999999999998 109.461 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.733 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.24 151.21 44.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 6.0099999999999998 109.565 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 97' ' ' GLN . 2.1 p -154.37 154.51 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.281 -0.887 . . . . 3.7599999999999998 109.536 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.74 ' CD1' HE22 ' A' ' 128' ' ' GLN . 0.8 OUTLIER -151.19 141.93 22.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.957 . . . . 2.29 109.751 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.649 ' CG1' HG22 ' A' ' 129' ' ' VAL . 0.9 OUTLIER -153.34 146.36 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 1.8899999999999999 109.663 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.12 -132.09 4.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.588 -1.405 . . . . 1.49 109.588 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' CD ' ' CE1' ' A' ' 119' ' ' PHE . 15.2 pt-20 -90.33 134.31 34.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 2.54 109.417 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.614 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -114.35 93.98 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.646 -1.382 . . . . 1.3799999999999999 109.646 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . 166.63 119.43 0.48 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 90' ' ' ALA . . . 42.03 99.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.615 -1.394 . . . . 4.1399999999999997 109.615 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 89' ' ' GLY . . . 82.51 80.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -1.148 . . . . 5.1299999999999999 109.461 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.528 ' O ' ' C ' ' A' ' 92' ' ' ARG . 32.9 m-85 -59.81 -2.15 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 5.79 109.489 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.624 ' HG2' ' HB1' ' A' ' 90' ' ' ALA . 2.8 ptp180 -35.75 150.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 5.7400000000000002 109.521 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -176.83 -164.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 2.27 109.692 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.7 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -109.7 -25.63 10.29 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.614 -0.884 . . . . 3.2799999999999998 108.614 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.636 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -91.17 35.99 0.92 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 3.6499999999999999 108.992 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.18 43.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.079 -1.013 . . . . 4.5999999999999996 109.492 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.504 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -104.42 114.47 28.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.264 -0.897 . . . . 3.46 109.149 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -103.57 13.94 53.98 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 3.6699999999999999 109.543 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -92.6 64.02 4.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -1.124 . . . . 3.79 109.526 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' ' CG2' ' A' ' 80' ' ' VAL . . . -104.72 101.8 30.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.861 . . . . 1.96 109.166 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.54 121.79 5.28 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.519 2.146 . . . . 2.9700000000000002 112.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.541 HD22 ' CZ ' ' A' ' 109' ' ' ARG . 63.0 mt -127.33 130.33 49.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 3.0600000000000001 109.327 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -119.73 -179.78 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 2.3399999999999999 109.601 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -66.76 24.05 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.445 -1.462 . . . . 2.1699999999999999 109.445 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.627 ' OE2' ' HB2' ' A' ' 107' ' ' ALA . 6.7 tm-20 -112.17 92.98 20.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.304 -1.115 . . . . 3.02 109.38 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.83 118.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.66 2.24 . . . . 1.4199999999999999 112.255 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.648 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . . . -166.06 162.41 17.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 1.3700000000000001 109.406 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.59 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -91.19 146.71 23.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 1.72 109.914 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.769 ' NH2' ' N ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -109.75 134.81 51.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.66 -1.237 . . . . 4.7000000000000002 107.66 177.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.54 ' OE1' ' C ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -114.35 102.26 9.94 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.93 -0.708 . . . . 3.2799999999999998 110.599 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 14.8 m-85 -109.83 122.0 46.52 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.498 -0.927 . . . . 2.96 108.498 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.68 133.75 55.64 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.251 -0.906 . . . . 3.4100000000000001 109.721 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.727 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -118.3 164.11 15.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 2.77 109.285 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.522 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -104.79 104.9 14.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 2.23 109.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.68 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 53.7 p -35.93 107.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 4.1100000000000003 109.25 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 15.7 t30 -86.04 -55.06 4.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 6.8600000000000003 109.706 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.705 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -111.31 -158.64 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 5.1200000000000001 109.804 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.705 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -117.24 150.56 38.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.363 -0.836 . . . . 4.0599999999999996 109.393 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.684 ' CG ' ' O ' ' A' ' 118' ' ' THR . 72.8 m-85 -162.45 73.91 2.17 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.86 . . . . 5.4400000000000004 109.548 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.35 167.87 1.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.858 2.372 . . . . 4.04 112.011 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.53 -15.66 10.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.813 2.342 . . . . 3.8999999999999999 112.091 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.637 ' OD2' ' N ' ' A' ' 123' ' ' GLY . 5.5 p-10 -111.29 -113.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.888 . . . . 4.1399999999999997 109.443 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.637 ' N ' ' OD2' ' A' ' 122' ' ' ASP . . . 36.12 -112.5 0.13 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.654 -1.379 . . . . 3.5699999999999998 109.654 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -77.8 -102.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -1.16 . . . . 3.5899999999999999 109.527 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.614 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -101.84 152.73 38.19 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 2.0800000000000001 109.493 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.42 -158.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.838 2.359 . . . . 1.3899999999999999 112.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -77.17 164.2 52.56 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.586 -1.406 . . . . 1.1899999999999999 109.586 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.74 HE22 ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -142.36 126.24 17.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -1.162 . . . . 2.0099999999999998 109.439 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.649 HG22 ' CG1' ' A' ' 84' ' ' VAL . 19.3 t -139.09 90.13 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.57 -0.9 . . . . 1.28 108.57 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -112.62 122.14 46.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.441 -0.787 . . . . 0.97999999999999998 110.45 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -84.21 117.13 23.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.422 -0.955 . . . . 1.73 108.422 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.567 ' O ' ' O ' ' A' ' 81' ' ' ARG . 13.4 m170 -99.5 119.38 37.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 2.3199999999999998 110.044 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.802 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -136.59 -0.9 2.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 2.1099999999999999 109.421 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.78 135.0 32.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.256 -1.538 . . . . 1.77 109.256 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.644 ' HZ1' ' CE ' ' A' ' 78' ' ' MET . 9.3 mtmt -166.81 129.01 1.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 5.0599999999999996 109.552 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -48.02 -26.67 1.88 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.467 -1.308 . . . . 2.6400000000000001 107.467 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -104.28 11.98 51.53 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.293 -1.923 . . . . 2.5099999999999998 108.293 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.51 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.645 0.736 . . . . 2.3199999999999998 110.641 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.836 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 179.93 -114.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.609 -1.307 . . . . 1.6100000000000001 110.715 -179.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.428 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 49.7 mt-10 -123.67 143.57 50.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 1.6499999999999999 109.25 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.556 ' CD2' ' CD2' ' A' ' 133' ' ' LEU . 15.2 t80 -126.22 120.63 30.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 1.6799999999999999 109.727 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.487 ' HB2' ' HG ' ' A' ' 73' ' ' SER . 1.7 m -119.06 97.29 5.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 109.853 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.544 HD11 ' CD2' ' A' ' 15' ' ' PHE . 0.1 OUTLIER -106.45 141.61 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 1.22 109.261 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.4 p -139.02 -2.62 1.66 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.617 -0.677 . . . . 1.3300000000000001 109.556 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 71' ' ' THR . 14.0 mt-30 -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 3.2999999999999998 110.242 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.916 HG21 ' CH2' ' A' ' 22' ' ' TRP . 2.8 p -160.94 73.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.004 -0.739 . . . . 2.2599999999999998 109.004 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.443 ' N ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -76.48 147.1 38.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 2.7599999999999998 110.18 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 58' ' ' VAL . 8.6 tp -138.56 101.59 4.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.492 -0.755 . . . . 4.5700000000000003 109.106 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.2 OUTLIER -149.07 -176.61 5.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 3.0699999999999998 109.726 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 151' ' ' SER . 1.9 t -139.06 -111.5 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 2.0 109.281 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.681 ' H ' HG23 ' A' ' 150' ' ' THR . 0.1 OUTLIER 64.33 -168.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 2.1499999999999999 109.541 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.667 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -169.94 89.63 0.17 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.915 . . . . 2.8199999999999998 109.483 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 153' ' ' THR . 72.1 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.031 -0.985 . . . . 3.54 109.479 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.453 -0.573 . . . . 5.4699999999999998 109.453 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 41.73 -88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 4.5300000000000002 109.475 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.773 HD13 ' H ' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -85.0 155.56 21.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 5.1399999999999997 109.488 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.773 ' H ' HD13 ' A' ' 3' ' ' LEU . 26.2 m-20 -36.17 112.95 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 5.3799999999999999 109.478 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER 57.31 -156.46 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 4.8300000000000001 109.452 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' HB2' HG21 ' A' ' 149' ' ' THR . 0.3 OUTLIER -131.53 129.74 41.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.882 . . . . 3.4300000000000002 109.468 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 t -57.91 95.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 2.8300000000000001 109.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.39 104.38 16.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.319 -0.863 . . . . 4.75 109.531 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.34 -15.83 55.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 4.9500000000000002 109.523 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -121.75 94.97 48.17 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 2.8599999999999999 108.819 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.99 26.83 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.388 2.059 . . . . 3.8300000000000001 111.548 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.562 ' H ' HD13 ' A' ' 10' ' ' LEU . 30.6 t60 -123.39 84.71 2.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.422 -0.799 . . . . 2.52 109.594 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -129.1 50.26 2.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 1.97 109.331 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 16' ' ' ALA . 25.0 p -128.26 64.39 1.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 1.96 109.786 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CE2' HD21 ' A' ' 24' ' ' LEU . 4.5 m-30 -64.73 35.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.957 . . . . 1.76 108.967 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.625 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.35 -48.73 6.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 1.1799999999999999 110.282 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.3 mm-40 -109.9 -83.51 0.56 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 2.1299999999999999 109.87 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 m -76.95 144.5 38.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 2.2599999999999998 109.662 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.704 ' CD2' HD13 ' A' ' 24' ' ' LEU . 1.6 tp -60.13 -57.86 11.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.322 -0.861 . . . . 2.6000000000000001 109.487 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.3 -177.83 17.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.559 -1.416 . . . . 1.6200000000000001 109.559 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.78 -5.94 16.41 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.857 2.371 . . . . 1.7 112.16 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.947 ' CH2' HG21 ' A' ' 146' ' ' VAL . 8.8 m95 -65.35 -164.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 2.4199999999999999 109.222 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.6 m -144.58 131.88 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 1.6399999999999999 109.845 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.899 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.7 148.94 41.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 2.0499999999999998 109.452 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 163.9 -168.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 1.72 109.749 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.84 -22.89 1.77 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.103 -1.199 . . . . 1.7 110.103 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.77 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.77 -142.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.076 -1.249 . . . . 0.96999999999999997 109.224 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.77 ' N ' ' OG1' ' A' ' 27' ' ' THR . 91.1 p -90.95 129.9 36.92 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.171 -0.955 . . . . 1.8 109.17 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.562 ' C ' ' O ' ' A' ' 28' ' ' SER . 18.5 mt-10 -33.93 98.53 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 2.3999999999999999 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 28' ' ' SER . 54.9 Cg_exo -46.92 146.14 6.22 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.372 2.048 . . . . 1.1299999999999999 111.821 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.94 116.58 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.016 -1.053 . . . . 1.05 110.014 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.73 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.81 89.69 3.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.46 -0.775 . . . . 1.8200000000000001 109.472 179.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -55.16 -140.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.5 -0.75 . . . . 1.1699999999999999 110.295 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.637 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -69.56 15.55 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 2.21 110.358 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.612 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 148.71 -6.75 0.89 Allowed Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.396 -1.383 . . . . 1.1899999999999999 110.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.631 ' CG ' HH11 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -122.73 146.08 47.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.359 . . . . 2.9100000000000001 109.803 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.572 ' SD ' ' C ' ' A' ' 37' ' ' MET . 1.6 tmm? -109.84 129.76 55.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.827 . . . . 0.93000000000000005 108.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.03 145.8 51.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 1.0600000000000001 110.57 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -115.58 174.95 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.983 ' C ' HD22 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -134.39 135.22 42.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.028 -1.045 . . . . 4.79 109.696 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.983 HD22 ' C ' ' A' ' 40' ' ' ASP . 3.7 mm? -135.62 60.91 39.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.985 . . . . 3.54 110.489 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 41' ' ' LEU . 61.2 Cg_endo -98.38 -15.16 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.091 2.528 . . . . 3.7400000000000002 112.203 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.38 -142.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.932 -0.867 . . . . 2.0299999999999998 110.932 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 136' ' ' ALA . . . -133.98 78.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.678 -1.369 . . . . 2.4100000000000001 109.678 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -99.7 127.02 45.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -1.217 . . . . 2.96 109.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.77 64.81 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.579 -1.408 . . . . 2.0800000000000001 109.579 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.659 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -173.56 135.19 0.66 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.241 -1.152 . . . . 3.6099999999999999 109.411 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.676 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 60.1 Cg_endo -75.94 -13.31 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.549 2.166 . . . . 2.3599999999999999 112.375 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.691 ' CZ3' ' OD1' ' A' ' 50' ' ' ASP . 1.0 OUTLIER -111.77 38.65 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 3.8700000000000001 110.002 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.743 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -119.35 38.08 3.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 2.3799999999999999 109.542 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.743 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 160.39 133.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.1100000000000001 109.639 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.36 -162.22 28.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.866 -1.294 . . . . 0.93999999999999995 109.866 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' CD2' ' CG ' ' A' ' 131' ' ' PHE . 0.3 OUTLIER -136.06 168.84 18.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -1.174 . . . . 0.95999999999999996 109.293 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 23' ' ' SER . 1.5 p -155.48 164.8 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.083 -1.011 . . . . 0.92000000000000004 110.137 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 63.7 t80 -178.63 141.67 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.576 -0.703 . . . . 1.71 109.656 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.691 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 8.2 m120 -88.1 -152.86 0.22 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.331 -0.856 . . . . 2.7799999999999998 109.366 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.82 79.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 2.48 109.546 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.802 HG22 ' CD2' ' A' ' 148' ' ' LEU . 5.6 t -117.76 68.57 6.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.15 . . . . 3.79 109.562 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.405 ' C ' HG23 ' A' ' 60' ' ' VAL . 38.0 Cg_endo -70.05 160.7 48.69 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.716 2.277 . . . . 2.3999999999999999 112.132 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.85 HG12 ' OG ' ' A' ' 115' ' ' SER . 20.3 t -151.94 132.31 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 3.0800000000000001 109.612 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.35 104.22 1.98 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.495 -1.442 . . . . 3.0499999999999998 109.495 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.8 tm-20 -35.4 121.0 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -1.119 . . . . 6.0499999999999998 109.562 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 130.66 -45.09 1.16 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.889 -1.285 . . . . 2.54 109.889 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.509 ' OE1' ' OG1' ' A' ' 153' ' ' THR . 1.5 mm-40 -100.03 171.76 7.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -1.156 . . . . 4.0300000000000002 109.804 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.2 m -116.21 144.71 43.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 2.9100000000000001 109.297 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.728 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 20.2 m-85 -108.28 179.43 4.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.198 -0.939 . . . . 2.3799999999999999 109.773 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 112' ' ' ALA . 1.4 t -150.34 141.74 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -0.766 . . . . 2.6099999999999999 109.594 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 70' ' ' PHE . 3.8 tp -124.59 119.9 30.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 3.6099999999999999 108.883 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -115.65 90.13 3.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.051 -1.031 . . . . 2.27 109.897 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.72 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -93.64 147.58 22.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 2.0099999999999998 110.878 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -97.1 113.64 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.596 -0.69 . . . . 1.8 109.176 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 142' ' ' CYS . . . -178.58 176.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.914 -1.116 . . . . 0.95999999999999996 110.667 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 p -156.07 154.04 30.35 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.087 -0.708 . . . . 0.93000000000000005 109.087 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.568 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -94.04 134.18 36.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.67000000000000004 109.612 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.451 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.71 116.04 14.73 Favored Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.279 -0.888 . . . . 0.96999999999999997 109.559 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.5 Cg_exo -65.89 -141.9 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.679 0 C-N-CA 124.427 -1.072 . . . . 1.02 112.562 -0.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -91.26 151.96 20.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.862 . . . . 1.75 109.786 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 1.1 mtp 161.09 157.3 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 2.1600000000000001 109.347 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 64.2 Cg_endo -77.56 147.32 25.06 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.779 2.32 . . . . 1.3799999999999999 112.235 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 100' ' ' ALA . 4.4 m -113.91 170.68 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 2.0099999999999998 109.425 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' C ' HG23 ' A' ' 82' ' ' VAL . 2.3 mtp180 -109.93 151.21 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 6.0099999999999998 109.352 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' O ' ' O ' ' A' ' 97' ' ' GLN . 19.5 t -152.59 149.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 3.7599999999999998 109.581 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.732 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.3 pp -150.92 145.84 25.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 2.29 109.463 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.4 t -146.49 152.06 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 1.8899999999999999 109.729 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 163.64 -148.45 14.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 1.49 109.455 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.667 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 12.1 pm0 -90.14 179.1 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -1.102 . . . . 2.54 109.339 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.66 49.0 0.67 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.409 . . . . 1.3799999999999999 109.576 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 125' ' ' ALA . . . 153.35 35.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.428 . . . . 2.54 109.531 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.71 -69.49 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.512 -1.435 . . . . 4.1399999999999997 109.512 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -132.55 -4.15 3.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -1.164 . . . . 5.1299999999999999 109.501 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CG ' ' C ' ' A' ' 90' ' ' ALA . 5.8 m-85 68.43 -7.49 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 5.79 109.443 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.724 ' CG ' HH11 ' A' ' 92' ' ' ARG . 1.0 OUTLIER -86.29 113.07 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 5.7400000000000002 109.471 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -104.37 161.41 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 2.27 109.958 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -112.26 -18.68 12.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.704 -0.85 . . . . 3.2799999999999998 108.704 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.677 ' CE2' ' CD1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.79 35.78 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 3.6499999999999999 109.286 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.89 57.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 4.5999999999999996 109.394 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.689 HE22 ' CA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -100.0 129.5 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 3.46 108.87 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 97' ' ' GLN . . . -119.21 -9.9 8.43 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.763 -1.208 . . . . 3.6699999999999999 110.142 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.689 ' CA ' HE22 ' A' ' 97' ' ' GLN . 1.8 m -80.42 77.1 7.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.253 . . . . 3.79 109.551 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -117.88 85.33 22.56 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 1.96 109.593 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -55.73 127.28 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.976 2.451 . . . . 2.9700000000000002 112.509 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.567 HD21 ' NE ' ' A' ' 109' ' ' ARG . 6.3 mt -142.28 127.56 18.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 3.0600000000000001 109.379 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 105' ' ' GLU . 9.3 t -111.67 -165.75 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 2.3399999999999999 109.733 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.18 31.99 3.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.438 . . . . 2.1699999999999999 109.504 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' H ' HG23 ' A' ' 103' ' ' THR . 2.8 mt-10 -109.68 96.44 23.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 3.02 109.345 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -46.88 118.2 2.58 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.53 2.153 . . . . 1.4199999999999999 112.248 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -169.13 169.8 9.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 1.3700000000000001 109.491 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.25 143.85 26.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 1.72 110.232 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.719 ' CD ' ' N ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -104.17 131.64 51.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.79 -1.189 . . . . 4.7000000000000002 107.79 178.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' CG ' HG12 ' A' ' 67' ' ' VAL . 14.6 tt0 -117.4 96.18 5.29 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.632 -0.827 . . . . 3.2799999999999998 110.548 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 6.7 m-30 -109.46 117.24 33.5 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.178 -1.045 . . . . 2.96 108.178 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.728 ' HB1' ' O ' ' A' ' 66' ' ' TYR . . . -115.98 174.18 6.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -0.893 . . . . 3.4100000000000001 109.822 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CD1' ' CE2' ' A' ' 95' ' ' PHE . 2.0 p90 -154.71 179.28 9.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.333 -0.854 . . . . 2.77 109.618 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.52 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -107.64 106.9 17.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.438 -0.789 . . . . 2.23 109.614 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.85 ' OG ' HG12 ' A' ' 60' ' ' VAL . 8.2 t -36.06 116.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 4.1100000000000003 109.322 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.525 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.5 OUTLIER -96.95 -50.46 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 6.8600000000000003 109.527 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 117' ' ' LEU . 2.5 mt -112.92 -166.0 1.04 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 5.1200000000000001 109.662 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.01 124.75 50.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 4.0599999999999996 109.419 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.644 ' CE1' ' CD ' ' A' ' 86' ' ' GLU . 34.1 m-85 -137.02 66.04 53.37 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 5.4400000000000004 109.472 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.64 166.9 25.89 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.858 2.372 . . . . 4.04 112.097 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.99 -19.66 9.38 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.763 2.309 . . . . 3.8999999999999999 112.002 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.61 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -110.28 111.76 23.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 4.1399999999999997 109.455 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.02 -138.06 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.575 -1.41 . . . . 3.5699999999999998 109.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.79 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.12 . . . . 3.5899999999999999 109.484 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' A' ' 88' ' ' GLY . . . -125.86 149.75 66.79 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 2.0800000000000001 109.429 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.12 -158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.789 2.326 . . . . 1.3899999999999999 112.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.56 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -64.93 172.29 20.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.648 -1.381 . . . . 1.1899999999999999 109.648 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -148.6 114.36 5.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -1.129 . . . . 2.0099999999999998 109.739 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -133.34 134.11 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.952 -1.129 . . . . 1.28 107.952 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.12 119.91 5.7 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.836 -1.146 . . . . 0.97999999999999998 110.718 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.535 ' CG ' ' CD2' ' A' ' 53' ' ' LEU . 6.7 m-30 -83.9 120.57 26.24 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.048 -1.093 . . . . 1.73 108.048 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.732 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 1.6 m170 -99.67 116.09 30.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 2.3199999999999998 109.896 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -138.45 37.44 2.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 2.1099999999999999 109.162 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -92.72 110.39 3.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.437 -1.465 . . . . 1.77 109.437 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 137' ' ' GLY . 56.8 mttt -159.78 134.87 8.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -1.14 . . . . 5.0599999999999996 109.856 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -37.25 -23.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.701 -0.852 . . . . 2.6400000000000001 108.701 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.725 ' C ' ' H ' ' A' ' 139' ' ' TYR . . . -135.11 24.38 3.42 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.51 -1.436 . . . . 2.5099999999999998 109.51 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.785 ' HB3' ' CB ' ' A' ' 41' ' ' LEU . . . -52.93 7.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.299 . . . . 2.3199999999999998 110.486 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.725 ' H ' ' C ' ' A' ' 137' ' ' GLY . 6.3 p90 48.32 -165.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.379 0.609 . . . . 1.6100000000000001 110.751 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 39' ' ' VAL . 4.8 mt-10 -96.99 159.59 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.6499999999999999 110.459 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -129.81 102.64 6.41 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.907 -0.775 . . . . 1.6799999999999999 108.907 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 7.5 m -87.06 119.25 27.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.73999999999999999 110.267 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.447 HG23 ' SD ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -133.23 144.73 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.822 0.82 . . . . 1.22 109.35 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.463 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 92.9 p -136.85 -11.64 1.75 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.284 -0.567 . . . . 1.3300000000000001 109.556 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.463 ' CG ' ' C ' ' A' ' 144' ' ' SER . 0.0 OUTLIER -155.88 168.47 27.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.98 . . . . 3.2999999999999998 109.997 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.947 HG21 ' CH2' ' A' ' 22' ' ' TRP . 7.8 p -150.37 131.13 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.432 -0.792 . . . . 2.2599999999999998 109.26 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -115.57 150.3 36.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.089 -1.007 . . . . 2.7599999999999998 109.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.802 ' CD2' HG22 ' A' ' 58' ' ' VAL . 1.7 tp -157.86 114.01 2.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 4.5700000000000003 109.365 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.672 ' N ' HD12 ' A' ' 148' ' ' LEU . 9.7 t -164.36 -155.83 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 3.0699999999999998 109.478 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.517 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -135.49 -41.05 0.71 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -0.93 . . . . 2.0 109.361 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.561 ' O ' ' O ' ' A' ' 152' ' ' ALA . 0.9 OUTLIER 58.21 55.65 4.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.75 . . . . 2.1499999999999999 109.478 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 151' ' ' SER . . . 38.87 -164.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 2.8199999999999998 109.485 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.509 ' OG1' ' OE1' ' A' ' 64' ' ' GLU . 62.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.002 -0.999 . . . . 3.54 109.48 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.312 0.577 . . . . 5.4699999999999998 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.668 ' OG ' ' N ' ' A' ' 3' ' ' LEU . 11.1 t -105.08 -139.99 0.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 4.5300000000000002 109.488 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.668 ' N ' ' OG ' ' A' ' 2' ' ' SER . 1.9 mp -99.11 173.29 6.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 5.1399999999999997 109.492 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 3' ' ' LEU . 10.5 t70 -35.91 130.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 5.3799999999999999 109.496 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER 44.74 -169.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 4.8300000000000001 109.412 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -155.87 143.01 19.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 3.4300000000000002 109.537 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.65 87.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.857 . . . . 2.8300000000000001 109.473 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.555 ' OE2' ' N ' ' A' ' 148' ' ' LEU . 25.1 tp10 -87.52 97.02 10.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 4.75 109.504 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.553 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.88 -35.42 72.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 4.9500000000000002 109.444 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.564 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -110.47 93.96 17.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 2.8599999999999999 108.65 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.81 26.46 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.299 1.999 . . . . 3.8300000000000001 111.525 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.564 ' H ' HD13 ' A' ' 10' ' ' LEU . 46.4 t60 -119.88 95.56 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 2.52 109.602 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 2.6 t -130.4 51.07 2.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 1.97 109.304 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 16' ' ' ALA . 3.7 m -114.4 52.91 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 1.96 109.769 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.02 20.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 1.76 108.984 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.608 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.11 -65.62 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 1.1799999999999999 110.009 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 18' ' ' SER . 1.4 mt-10 -109.96 38.88 2.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.122 -0.986 . . . . 2.1299999999999999 109.911 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 2.5 p 170.16 144.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.161 -0.962 . . . . 2.2599999999999998 109.708 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.603 HD11 ' CD2' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.02 -69.19 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 2.6000000000000001 109.433 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.18 177.58 19.53 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.546 -1.422 . . . . 1.6200000000000001 109.546 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -53.5 -21.47 18.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.762 2.308 . . . . 1.7 112.048 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.676 ' CH2' HG21 ' A' ' 146' ' ' VAL . 18.0 m95 -58.33 167.81 1.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 2.4199999999999999 109.502 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 54' ' ' VAL . 1.9 m -132.45 176.58 8.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 1.6399999999999999 109.046 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.603 ' CD2' HD11 ' A' ' 19' ' ' LEU . 1.4 pp -175.63 153.15 1.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 2.0499999999999998 110.059 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.688 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -178.44 136.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.538 -0.726 . . . . 1.72 109.111 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 135.27 -27.68 3.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.944 -1.263 . . . . 1.7 109.944 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.769 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.66 -141.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.027 -1.278 . . . . 0.96999999999999997 109.554 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.769 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.8 p -91.52 -167.17 1.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.959 -0.756 . . . . 1.8 108.959 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.57 110.61 42.43 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.248 -0.908 . . . . 2.3999999999999999 108.916 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -45.37 138.24 10.31 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.228 1.952 . . . . 1.1299999999999999 111.829 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.777 ' O ' HG13 ' A' ' 31' ' ' VAL . 12.5 p -118.69 93.52 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 1.05 109.932 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -67.07 81.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.506 -0.746 . . . . 1.8200000000000001 109.446 179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -98.74 -109.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 1.1699999999999999 109.617 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 35' ' ' GLY . 3.0 t0 -51.62 79.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 2.21 109.577 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 35.62 47.14 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.586 -1.405 . . . . 1.1899999999999999 109.586 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -176.51 151.56 0.97 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -1.12 . . . . 2.9100000000000001 109.498 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 37' ' ' MET . 4.8 ptt? -109.46 130.94 55.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.93000000000000005 109.803 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.5 m -109.97 128.74 55.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.793 . . . . 1.0600000000000001 109.563 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.1 133.04 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.389 -0.819 . . . . 1.3700000000000001 109.22 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 27' ' ' THR . 1.3 m-20 -80.53 128.76 33.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 4.79 109.248 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.824 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 3.5 mm? -110.28 95.54 22.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 3.54 109.587 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.675 ' O ' ' NZ ' ' A' ' 135' ' ' LYS . 52.5 Cg_endo -78.95 144.08 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.604 2.203 . . . . 3.7400000000000002 112.147 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.518 ' N ' ' HB2' ' A' ' 138' ' ' ALA . . . -81.09 161.49 43.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.826 -1.31 . . . . 2.0299999999999998 109.826 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.16 -7.25 1.16 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.059 -1.216 . . . . 2.4100000000000001 110.059 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.457 ' OE1' ' CB ' ' A' ' 50' ' ' ASP . 41.5 mt-30 -120.69 174.3 6.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.023 -1.281 . . . . 2.96 109.785 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.97 -8.25 3.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.488 -1.445 . . . . 2.0800000000000001 109.488 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -99.96 133.29 21.74 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -1.175 . . . . 3.6099999999999999 109.353 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.17 1.03 9.13 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.478 2.119 . . . . 2.3599999999999999 112.652 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.67 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.1 p-90 -118.53 38.39 3.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 3.8700000000000001 110.09 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 0.8 OUTLIER -112.41 12.72 20.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.998 . . . . 2.3799999999999999 109.691 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . 179.72 134.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 1.1100000000000001 109.383 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 169.63 171.13 34.92 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.609 -1.281 . . . . 0.93999999999999995 110.222 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 54' ' ' VAL . 7.3 mt -75.65 -178.19 4.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.241 -1.153 . . . . 0.95999999999999996 109.31 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.637 HG12 ' N ' ' A' ' 55' ' ' TYR . 99.2 t -161.08 167.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.92000000000000004 109.65 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.637 ' N ' HG12 ' A' ' 54' ' ' VAL . 32.0 t80 176.22 145.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.512 -0.743 . . . . 1.71 109.414 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.577 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -107.66 171.7 7.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.203 -0.936 . . . . 2.7799999999999998 109.589 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 93.62 70.87 1.13 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 2.48 109.53 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 57' ' ' GLY . 43.0 t -162.41 86.79 1.45 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.33 -1.1 . . . . 3.79 109.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.553 ' HD2' HD13 ' A' ' 9' ' ' LEU . 59.1 Cg_endo -79.07 162.88 25.86 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.676 2.251 . . . . 2.3999999999999999 112.153 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.26 114.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 3.0800000000000001 109.654 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.573 ' O ' ' OG ' ' A' ' 115' ' ' SER . . . -108.6 135.31 12.77 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.295 -1.522 . . . . 3.0499999999999998 109.295 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CD ' HG23 ' A' ' 118' ' ' THR . 6.5 pt-20 -72.7 139.32 47.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -1.156 . . . . 6.0499999999999998 109.656 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 115' ' ' SER . . . 125.24 -50.0 0.89 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.631 -1.387 . . . . 2.54 109.631 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.97 157.76 16.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.126 -1.22 . . . . 4.0300000000000002 109.654 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -100.01 134.36 43.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 2.9100000000000001 109.294 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.696 ' O ' HG23 ' A' ' 67' ' ' VAL . 74.8 m-85 -92.95 174.48 7.21 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.169 -0.957 . . . . 2.3799999999999999 109.689 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 66' ' ' TYR . 54.4 t -162.6 118.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.487 -0.758 . . . . 2.6099999999999999 109.482 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 69' ' ' SER . 9.7 tt -109.6 158.71 17.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 3.6099999999999999 109.158 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.697 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -154.41 106.46 2.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 2.27 109.427 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 2.1 p90 -94.39 147.51 23.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.106 -0.996 . . . . 2.0099999999999998 110.378 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -100.19 94.54 6.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.851 -0.796 . . . . 1.8 108.851 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HB2' ' HB ' ' A' ' 143' ' ' ILE . . . -163.79 -177.08 4.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.039 -1.038 . . . . 0.95999999999999996 109.709 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.417 ' HA ' HD22 ' A' ' 102' ' ' LEU . 13.2 p -164.46 136.92 4.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -0.827 . . . . 0.93000000000000005 109.333 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -87.81 145.11 26.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.67000000000000004 109.119 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 104' ' ' GLY . 0.7 OUTLIER -131.8 116.76 16.01 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.314 -0.866 . . . . 0.96999999999999997 109.343 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.59 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.3 Cg_exo -66.07 -142.59 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.384 -1.09 . . . . 1.02 112.495 -0.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -95.35 151.53 19.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 1.75 109.576 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.574 ' SD ' ' CG ' ' A' ' 139' ' ' TYR . 7.4 ptm 178.21 151.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 2.1600000000000001 109.511 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.674 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 56.8 Cg_endo -74.41 122.01 7.19 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.764 2.309 . . . . 1.3799999999999999 112.233 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.94 HG11 HD12 ' A' ' 102' ' ' LEU . 2.9 m -102.39 172.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 2.0099999999999998 109.476 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 79' ' ' PRO . 8.8 mpt_? -114.14 166.27 11.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 6.0099999999999998 109.461 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 81' ' ' ARG . 88.5 t -160.32 156.45 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 3.7599999999999998 109.311 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.715 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -159.56 148.08 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 2.29 109.441 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -150.76 148.32 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -0.972 . . . . 1.8899999999999999 109.929 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.83 2.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.218 -1.553 . . . . 1.49 109.218 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.668 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.5 pt-20 -90.35 178.7 6.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -1.172 . . . . 2.54 109.384 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 125' ' ' ALA . . . -133.52 38.68 1.82 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.54 -1.424 . . . . 1.3799999999999999 109.54 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 122' ' ' ASP . . . 162.41 126.17 0.81 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.533 -1.427 . . . . 2.54 109.533 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . 122.61 -149.64 16.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.503 -1.439 . . . . 4.1399999999999997 109.503 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.596 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -54.25 -3.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 5.1299999999999999 109.494 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.686 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 3.8 m-85 53.47 1.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.898 . . . . 5.79 109.566 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.738 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.2 OUTLIER -57.57 118.92 5.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 5.7400000000000002 109.489 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.508 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -127.95 161.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 2.27 109.824 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.95 -19.88 12.94 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.871 -0.789 . . . . 3.2799999999999998 108.871 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.0 39.16 0.98 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 3.6499999999999999 109.212 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -86.73 94.26 9.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 4.5999999999999996 109.83 -179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.682 ' OE1' ' CD2' ' A' ' 111' ' ' TYR . 6.5 pt20 -116.62 -156.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.168 -0.958 . . . . 3.46 109.164 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . 177.14 -26.05 0.06 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.981 -1.247 . . . . 3.6699999999999999 109.981 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -91.87 94.81 9.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -1.226 . . . . 3.79 109.811 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.575 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -133.16 79.23 62.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 1.96 109.361 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.76 132.28 41.02 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.051 2.501 . . . . 2.9700000000000002 112.657 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.94 HD12 HG11 ' A' ' 80' ' ' VAL . 12.3 mt -124.35 151.06 44.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 3.0600000000000001 109.208 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 74' ' ' ALA . 13.6 t -95.26 -162.07 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 2.3399999999999999 109.831 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 75' ' ' THR . . . -96.02 -32.92 6.54 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 2.1699999999999999 109.777 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 103' ' ' THR . 1.6 mp0 -99.96 164.09 17.13 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.138 -1.213 . . . . 3.02 109.485 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -44.14 128.66 7.71 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.841 2.361 . . . . 1.4199999999999999 112.019 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 72' ' ' ALA . . . -160.73 140.91 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 1.3700000000000001 109.674 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 70' ' ' PHE . 0.7 OUTLIER -90.99 144.29 25.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.802 . . . . 1.72 110.204 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.73 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -128.43 149.99 50.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.023 -1.473 . . . . 4.7000000000000002 107.023 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.503 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -139.56 159.71 41.54 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.655 -1.218 . . . . 3.2799999999999998 111.186 -178.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.682 ' CD2' ' OE1' ' A' ' 97' ' ' GLN . 7.1 m-85 -134.86 121.11 20.14 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.3 -1.0 . . . . 2.96 108.3 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.507 ' HB2' HG22 ' A' ' 67' ' ' VAL . . . -114.49 139.56 49.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 3.4100000000000001 109.655 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -147.77 164.03 34.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 2.77 109.629 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.39 112.38 24.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.422 -0.799 . . . . 2.23 109.497 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.672 ' O ' ' N ' ' A' ' 63' ' ' GLY . 6.6 t -60.83 109.18 0.99 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.168 -0.957 . . . . 4.1100000000000003 109.452 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -123.52 22.99 9.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 6.8600000000000003 109.435 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' A' ' 119' ' ' PHE . 0.4 OUTLIER -148.91 104.96 3.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 5.1200000000000001 109.366 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.542 HG23 ' CD ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -51.51 107.51 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.947 . . . . 4.0599999999999996 109.45 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CE2' HD12 ' A' ' 117' ' ' LEU . 7.3 m-85 -124.9 92.08 48.28 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 5.4400000000000004 109.635 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.546 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 31.9 Cg_exo -56.46 -170.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.519 2.146 . . . . 4.04 111.367 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.546 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 23.3 Cg_exo -60.74 -76.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.282 1.988 . . . . 3.8999999999999999 111.283 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 88' ' ' GLY . 30.6 t0 -173.06 -163.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.123 -0.986 . . . . 4.1399999999999997 109.887 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.495 ' H ' ' CG ' ' A' ' 122' ' ' ASP . . . -109.48 -35.63 2.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.195 -1.962 . . . . 3.5699999999999998 108.195 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -128.93 -41.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 3.5899999999999999 108.286 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -113.35 92.93 24.46 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.362 -0.977 . . . . 2.0800000000000001 108.362 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 125' ' ' ALA . 45.3 Cg_exo -48.63 -139.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.727 2.284 . . . . 1.3899999999999999 113.15 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' O ' ' A' ' 126' ' ' PRO . . . -33.07 155.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.856 -1.298 . . . . 1.1899999999999999 109.856 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -158.92 151.56 21.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.333 -1.098 . . . . 2.0099999999999998 109.46 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.452 HG13 HG13 ' A' ' 84' ' ' VAL . 17.1 t -153.53 155.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.448 -0.945 . . . . 1.28 108.448 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -163.35 111.32 1.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.908 -1.12 . . . . 0.97999999999999998 110.468 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.404 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 5.0 m-30 -83.37 101.41 11.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.089 -1.078 . . . . 1.73 108.089 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.715 ' ND1' HD21 ' A' ' 83' ' ' LEU . 5.0 m170 -98.83 128.57 45.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.002 . . . . 2.3199999999999998 110.476 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -112.73 -45.62 3.2 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.907 -0.775 . . . . 2.1099999999999999 108.907 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.81 153.85 29.78 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.103 -1.199 . . . . 1.77 110.103 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' NZ ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -99.66 -143.66 0.33 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.044 . . . . 5.0599999999999996 109.304 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 135' ' ' LYS . . . 67.44 -61.07 0.37 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.017 -1.105 . . . . 2.6400000000000001 108.017 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -88.97 35.22 3.71 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.016 -2.034 . . . . 2.5099999999999998 108.016 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.824 ' HB1' ' O ' ' A' ' 41' ' ' LEU . . . -28.75 151.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.868 -0.784 . . . . 2.3199999999999998 110.631 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.586 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 5.1 p90 -173.99 -132.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.767 -0.827 . . . . 1.6100000000000001 108.767 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 14.5 mt-10 -146.73 127.33 14.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 1.6499999999999999 109.741 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -117.46 106.66 13.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 1.6799999999999999 109.131 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.494 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 72.4 m -109.81 120.58 42.93 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.084 -1.01 . . . . 0.73999999999999999 110.546 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -120.36 146.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.76 . . . . 1.22 109.052 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.482 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 93.3 p -126.75 -10.04 6.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.962 -0.755 . . . . 1.3300000000000001 108.962 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.57 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -161.9 167.24 25.03 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.607 -0.837 . . . . 3.2999999999999998 109.813 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.676 HG21 ' CH2' ' A' ' 22' ' ' TRP . 9.3 p -149.38 123.91 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 2.2599999999999998 109.382 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.57 165.69 10.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.177 -0.952 . . . . 2.7599999999999998 109.592 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 58' ' ' VAL . 10.0 tp -173.87 120.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 4.5700000000000003 109.428 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.669 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.5 OUTLIER 179.0 -156.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 3.0699999999999998 109.475 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.728 HG23 ' N ' ' A' ' 151' ' ' SER . 8.8 t -131.32 -123.7 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 2.0 109.531 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.728 ' N ' HG23 ' A' ' 150' ' ' THR . 5.0 p -166.1 66.97 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 2.1499999999999999 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.34 -160.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 2.8199999999999998 109.445 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.979 -1.01 . . . . 3.54 109.475 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.307 0.575 . . . . 5.4699999999999998 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.594 ' OG ' ' N ' ' A' ' 151' ' ' SER . 0.3 OUTLIER -111.39 -140.04 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 4.5300000000000002 109.452 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 2' ' ' SER . 2.8 mp 37.16 -161.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 5.1399999999999997 109.441 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 60.3 47.11 9.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 5.3799999999999999 109.433 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.706 ' OG ' HG22 ' A' ' 150' ' ' THR . 2.5 p -178.82 -151.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 4.8300000000000001 109.452 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.777 ' O ' ' N ' ' A' ' 8' ' ' GLU . 3.8 mt-10 -115.4 17.77 16.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 3.4300000000000002 109.985 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.85 HG22 ' O ' ' A' ' 7' ' ' VAL . 2.1 p 28.82 29.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.687 0.756 . . . . 2.8300000000000001 109.497 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.777 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.6 mt-10 159.25 84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.31 -0.626 . . . . 4.75 109.31 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.436 HD23 ' HD2' ' A' ' 59' ' ' PRO . 2.2 mp -91.52 17.03 9.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.223 -0.923 . . . . 4.9500000000000002 109.16 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 12' ' ' HIS . 3.1 tm? -175.27 96.42 0.27 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 2.8599999999999999 109.155 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.66 43.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.05 2.5 . . . . 3.8300000000000001 113.396 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.698 ' N ' HD13 ' A' ' 10' ' ' LEU . 9.8 t60 -162.84 103.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 2.52 109.492 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.549 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -150.42 45.17 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 1.97 109.367 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 16' ' ' ALA . 2.0 t -140.24 93.71 2.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.96 109.562 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 144' ' ' SER . 8.6 m-85 -75.91 39.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 1.76 109.196 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.618 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.03 -33.08 16.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.1799999999999999 109.756 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.685 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 22.2 mt-10 -109.85 -76.66 0.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.224 -0.922 . . . . 2.1299999999999999 109.63 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 p -111.87 143.93 42.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 2.2599999999999998 109.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.828 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -49.36 -33.76 14.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 2.6000000000000001 109.591 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 91.08 -159.71 26.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 1.6200000000000001 109.5 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.09 -9.18 17.87 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.72 2.28 . . . . 1.7 112.233 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 13.8 m95 -68.44 150.25 48.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 2.4199999999999999 109.006 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -109.89 170.29 8.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 1.6399999999999999 110.058 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.649 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 1.4 pp -176.57 165.05 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 2.0499999999999998 109.6 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.758 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.35 -165.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 1.72 109.503 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.43 -21.14 2.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.197 -1.161 . . . . 1.7 110.197 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.765 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.71 -143.64 0.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.28 . . . . 0.96999999999999997 109.459 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.765 ' N ' ' OG1' ' A' ' 27' ' ' THR . 49.4 p -92.13 -159.07 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.293 -0.879 . . . . 1.8 108.85 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -90.36 127.34 53.36 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 2.3999999999999999 108.593 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HG3' HD11 ' A' ' 24' ' ' LEU . 33.0 Cg_endo -69.01 135.79 33.23 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.02 1.813 . . . . 1.1299999999999999 111.495 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.73 110.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 1.05 110.362 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.82 73.76 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 1.8200000000000001 109.238 178.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.14 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 1.1699999999999999 109.901 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.454 ' HB3' ' NE ' ' A' ' 36' ' ' ARG . 12.4 t70 -45.72 83.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 2.21 109.521 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 42.37 35.16 1.81 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.535 -1.426 . . . . 1.1899999999999999 109.535 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 33' ' ' ALA . 9.6 ptp180 -148.46 142.58 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 2.9100000000000001 109.666 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.618 ' SD ' ' C ' ' A' ' 37' ' ' MET . 14.7 tmm? -112.68 127.73 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.93000000000000005 109.578 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.661 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -122.57 138.52 54.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.838 . . . . 1.0600000000000001 109.858 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -116.18 150.85 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.415 -0.957 . . . . 1.3700000000000001 108.415 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.756 ' C ' HD22 ' A' ' 41' ' ' LEU . 21.9 m-20 -81.06 119.69 23.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.1 -1.0 . . . . 4.79 109.348 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.786 ' N ' HD22 ' A' ' 41' ' ' LEU . 3.0 mm? -116.37 32.79 0.16 Allowed Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.092 -1.005 . . . . 3.54 110.736 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 86.1 Cg_endo -81.07 -97.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.194 1.929 . . . . 3.7400000000000002 111.697 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.21 -96.21 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.424 -1.07 . . . . 2.0299999999999998 110.424 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.71 48.84 0.04 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.425 -1.87 . . . . 2.4100000000000001 108.425 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.674 ' O ' ' N ' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -99.73 116.26 31.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.463 -1.022 . . . . 2.96 109.857 -179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -76.18 52.75 3.0 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.524 -1.43 . . . . 2.0800000000000001 109.524 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.67 ' ND2' ' OD1' ' A' ' 50' ' ' ASP . 0.5 OUTLIER -161.19 134.73 4.84 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.227 -1.16 . . . . 3.6099999999999999 109.462 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 63.1 Cg_endo -76.83 0.35 9.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.605 2.203 . . . . 2.3599999999999999 112.724 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.485 ' CE2' ' HB2' ' A' ' 47' ' ' ASN . 5.2 p90 -110.15 67.88 0.66 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 3.8700000000000001 109.649 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.67 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 1.2 m-20 -140.18 -31.85 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 2.3799999999999999 109.763 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.658 ' HB1' HG22 ' A' ' 27' ' ' THR . . . -152.87 163.88 38.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 109.605 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 144.9 171.49 14.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.875 -1.29 . . . . 0.93999999999999995 109.875 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.459 ' H ' ' HG ' ' A' ' 53' ' ' LEU . 1.8 pp -107.41 145.82 32.47 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -1.14 . . . . 0.95999999999999996 109.162 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 55' ' ' TYR . 17.7 t -131.19 169.83 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.951 . . . . 0.92000000000000004 110.068 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 40.5 t80 -171.09 143.3 1.93 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.495 -0.753 . . . . 1.71 109.42 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -113.16 -167.28 1.17 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.302 -0.874 . . . . 2.7799999999999998 109.397 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.7 55.62 2.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.64 -1.384 . . . . 2.48 109.64 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.578 ' CG2' HD21 ' A' ' 148' ' ' LEU . 1.1 p -149.08 100.5 3.41 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 3.79 109.421 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HD2' HD23 ' A' ' 9' ' ' LEU . 58.3 Cg_endo -78.93 126.96 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.49 2.126 . . . . 2.3999999999999999 112.018 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -103.19 74.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.92 . . . . 3.0800000000000001 109.813 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -84.71 90.64 1.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.953 -1.659 . . . . 3.0499999999999998 108.953 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -34.56 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -1.127 . . . . 6.0499999999999998 109.884 -179.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.73 -67.18 0.56 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.638 -1.385 . . . . 2.54 109.638 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -100.0 170.68 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -1.152 . . . . 4.0300000000000002 109.632 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 m -99.98 139.41 35.68 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 2.9100000000000001 109.323 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.05 177.64 4.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -0.98 . . . . 2.3799999999999999 109.846 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.658 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.6 t -150.63 137.78 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 2.6099999999999999 109.634 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tp -119.94 115.1 23.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 3.6099999999999999 109.106 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -112.98 100.29 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.318 -0.864 . . . . 2.27 109.33 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.2 OUTLIER -94.1 135.04 35.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 2.0099999999999998 110.599 -179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.679 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 10.9 p -93.49 94.22 8.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.441 -0.948 . . . . 1.8 108.441 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 143' ' ' ILE . . . -165.36 164.2 19.77 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.617 -1.233 . . . . 0.95999999999999996 110.624 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -139.81 146.61 39.63 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.843 -0.799 . . . . 0.93000000000000005 108.843 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -84.6 133.8 34.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.67000000000000004 109.358 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.506 ' O ' ' CD ' ' A' ' 140' ' ' GLU . 0.7 OUTLIER -131.71 115.74 15.83 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.37 -0.831 . . . . 0.96999999999999997 109.062 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -67.1 -142.2 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.605 0 C-N-CA 124.311 -1.12 . . . . 1.02 112.298 0.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -89.64 149.36 22.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.989 . . . . 1.75 109.613 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.5 mtt 159.73 163.47 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.372 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.33 150.78 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.877 2.384 . . . . 1.3799999999999999 112.224 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -116.23 169.0 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 2.0099999999999998 109.393 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 132' ' ' HIS . 13.5 ttt180 -114.2 137.68 51.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.935 . . . . 6.0099999999999998 109.52 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -139.81 149.45 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.341 -0.85 . . . . 3.7599999999999998 109.38 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -147.5 147.09 29.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 2.29 109.752 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.2 t -151.8 149.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.901 . . . . 1.8899999999999999 109.614 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.535 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 160.62 -147.03 13.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.584 -1.407 . . . . 1.49 109.584 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.667 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 1.1 pm0 -90.04 176.85 6.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -1.162 . . . . 2.54 109.547 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.72 22.87 4.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.603 -1.399 . . . . 1.3799999999999999 109.603 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -166.32 148.13 13.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 2.54 109.558 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 88' ' ' GLY . . . 56.35 145.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.547 -1.421 . . . . 4.1399999999999997 109.547 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . 36.26 76.26 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -1.122 . . . . 5.1299999999999999 109.445 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -64.82 15.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 5.79 109.521 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -86.03 116.99 24.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 5.7400000000000002 109.46 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -105.42 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 2.27 109.951 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.659 ' HB2' HD22 ' A' ' 117' ' ' LEU . . . -109.88 -24.8 10.64 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.771 -0.826 . . . . 3.2799999999999998 108.771 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -91.03 33.84 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 3.6499999999999999 109.186 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -80.84 59.25 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.178 -0.951 . . . . 4.5999999999999996 109.582 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 1.6 tt0 -103.07 156.4 17.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 3.46 109.134 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 97' ' ' GLN . . . -145.87 8.54 1.53 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.696 -1.362 . . . . 3.6699999999999999 109.696 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.33 59.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -1.165 . . . . 3.79 109.589 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.545 ' HB3' HG23 ' A' ' 80' ' ' VAL . . . -101.54 107.37 50.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 1.96 109.204 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -78.04 134.36 13.04 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.528 2.152 . . . . 2.9700000000000002 112.544 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 102' ' ' LEU . 12.3 mt -131.2 156.63 45.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 3.0600000000000001 109.411 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -103.44 -155.16 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 2.3399999999999999 109.512 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.634 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -113.45 30.76 7.06 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.523 -1.431 . . . . 2.1699999999999999 109.523 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -154.41 149.89 21.12 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.196 -1.179 . . . . 3.02 109.379 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -39.26 126.2 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.872 2.381 . . . . 1.4199999999999999 112.106 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.888 ' HB1' ' NH1' ' A' ' 109' ' ' ARG . . . -163.34 132.84 4.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.94 . . . . 1.3700000000000001 109.655 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.35 141.39 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 1.72 110.395 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.888 ' NH1' ' HB1' ' A' ' 107' ' ' ALA . 3.9 mpt_? -120.16 143.61 48.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.317 -1.364 . . . . 4.7000000000000002 107.317 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -128.88 112.74 14.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.977 . . . . 3.2799999999999998 110.838 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 111' ' ' TYR . 4.5 m-30 -113.44 115.28 27.8 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.201 -1.037 . . . . 2.96 108.201 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.658 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -117.96 171.87 7.78 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.277 -0.889 . . . . 3.4100000000000001 110.024 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.679 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -173.14 175.45 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.494 -0.754 . . . . 2.77 109.673 179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.473 ' O ' ' OD1' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -87.7 113.19 23.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 2.23 109.751 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.8 t -52.82 110.03 0.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 4.1100000000000003 109.39 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 114' ' ' THR . 30.4 m120 -129.14 28.61 5.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.838 . . . . 6.8600000000000003 109.505 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' A' ' 94' ' ' ALA . 4.6 tp -133.4 118.47 18.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 5.1200000000000001 109.398 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -77.59 127.38 32.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.881 . . . . 4.0599999999999996 109.558 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 8.4 m-85 -163.52 94.63 1.08 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 5.4400000000000004 109.363 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -79.67 165.78 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.604 2.203 . . . . 4.04 112.259 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.0 -14.93 12.03 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.815 2.343 . . . . 3.8999999999999999 112.044 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.84 121.67 45.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 4.1399999999999997 109.478 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.67 -175.42 19.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 3.5699999999999998 109.513 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.533 ' O ' ' C ' ' A' ' 88' ' ' GLY . 6.7 m-20 -79.93 53.5 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 3.5899999999999999 109.454 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 119' ' ' PHE . . . -178.03 65.69 0.19 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.0800000000000001 109.464 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.12 -158.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.874 2.383 . . . . 1.3899999999999999 112.301 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.444 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -80.95 157.29 39.15 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.538 -1.425 . . . . 1.1899999999999999 109.538 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.667 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -146.94 126.58 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 2.0099999999999998 109.878 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.42 85.43 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.66 -0.867 . . . . 1.28 108.66 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.659 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -103.31 127.1 50.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.97999999999999998 110.56 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.435 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . 2.9 m-30 -105.12 96.75 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.295 -1.002 . . . . 1.73 108.295 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 9.3 m170 -99.39 138.37 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 2.3199999999999998 110.238 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.853 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -141.83 6.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 2.1099999999999999 109.21 179.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.624 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -62.11 147.51 48.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.572 -1.411 . . . . 1.77 109.572 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.624 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 0.4 OUTLIER 179.48 132.44 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -1.09 . . . . 5.0599999999999996 109.339 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.674 ' N ' ' O ' ' A' ' 45' ' ' GLN . . . -47.14 -24.3 0.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.765 -1.198 . . . . 2.6400000000000001 107.765 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.611 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -106.29 8.55 41.41 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.577 -1.809 . . . . 2.5099999999999998 108.577 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.12 -163.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.919 . . . . 2.3199999999999998 110.023 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD2' ' C ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -173.73 -112.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 1.6100000000000001 109.94 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.506 ' CD ' ' O ' ' A' ' 75' ' ' THR . 2.2 mp0 -129.61 153.79 47.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.754 -1.216 . . . . 1.6499999999999999 109.678 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.661 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 26.7 t80 -136.29 126.49 26.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.226 -0.921 . . . . 1.6799999999999999 109.721 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.85 98.61 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.73999999999999999 110.185 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.587 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -109.81 143.82 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.405 -0.809 . . . . 1.22 108.883 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 15' ' ' PHE . 95.4 p -128.89 -18.1 3.85 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.075 -0.65 . . . . 1.3300000000000001 109.409 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.679 ' N ' ' OG1' ' A' ' 71' ' ' THR . 4.2 mt-30 -152.74 166.79 31.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.173 -1.011 . . . . 3.2999999999999998 110.61 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 146' ' ' VAL . 7.3 p -169.92 91.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.917 -0.772 . . . . 2.2599999999999998 108.917 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.73 140.67 29.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 2.7599999999999998 110.482 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.578 HD21 ' CG2' ' A' ' 58' ' ' VAL . 6.9 tp -124.23 94.82 4.33 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.608 -0.886 . . . . 4.5700000000000003 108.608 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.74 ' OG1' ' N ' ' A' ' 7' ' ' VAL . 8.2 t 177.87 -144.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 3.0699999999999998 109.156 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.706 HG22 ' OG ' ' A' ' 5' ' ' SER . 9.1 t -125.97 -160.8 1.0 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.109 -0.994 . . . . 2.0 109.658 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.63 ' CB ' ' O ' ' A' ' 150' ' ' THR . 0.4 OUTLIER 84.37 110.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.366 -0.833 . . . . 2.1499999999999999 109.388 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -156.21 94.18 1.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 2.8199999999999998 109.541 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.977 -1.011 . . . . 3.54 109.472 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.425 -0.583 . . . . 5.4699999999999998 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 3' ' ' LEU . 44.8 p -80.76 -139.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 4.5300000000000002 109.505 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' SER . 0.6 OUTLIER -44.72 165.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 5.1399999999999997 109.439 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 3' ' ' LEU . 7.3 m-20 -36.42 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 5.3799999999999999 109.527 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 3' ' ' LEU . 0.9 OUTLIER 58.36 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 4.8300000000000001 109.491 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' C ' ' O ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -36.48 125.17 0.82 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 3.4300000000000002 109.496 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -67.17 88.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 2.8300000000000001 109.397 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.12 100.4 13.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 4.75 109.551 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 mt -72.56 -8.63 56.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 4.9500000000000002 109.496 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.683 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.3 tm? -140.96 85.93 11.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 2.8599999999999999 108.797 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.58 40.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.996 2.464 . . . . 3.8300000000000001 112.22 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.683 ' H ' HD13 ' A' ' 10' ' ' LEU . 19.6 t60 -143.11 123.1 13.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.201 -0.937 . . . . 2.52 109.641 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.567 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -170.1 43.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.328 -0.858 . . . . 1.97 109.199 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.627 ' C ' ' H ' ' A' ' 16' ' ' ALA . 46.2 m -109.94 63.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 1.96 109.719 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -66.5 21.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 1.76 109.188 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.07 -63.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 1.1799999999999999 109.939 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' SER . 3.4 mm-40 -111.73 39.87 2.26 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 2.1299999999999999 109.912 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 17' ' ' GLU . 1.9 m 160.39 147.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 2.2599999999999998 109.79 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.76 -72.04 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 2.6000000000000001 109.608 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 118.98 -167.48 13.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.515 -1.434 . . . . 1.6200000000000001 109.515 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 17.1 Cg_exo -62.02 -20.14 68.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.567 2.178 . . . . 1.7 111.818 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 13.8 m95 -65.46 -166.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 2.4199999999999999 109.414 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -150.29 174.65 12.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 1.6399999999999999 109.619 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.662 ' C ' ' CG ' ' A' ' 25' ' ' TYR . 54.7 tp -170.85 148.1 2.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 2.0499999999999998 109.451 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.745 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 165.04 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 1.72 109.691 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 51' ' ' ALA . . . 79.31 -22.09 3.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.849 -1.3 . . . . 1.7 109.849 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.94 -142.01 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -1.213 . . . . 0.96999999999999997 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.1 p -90.67 136.91 32.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 1.8 109.163 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 28' ' ' SER . 51.9 mm-40 -32.5 97.03 0.1 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 2.3999999999999999 109.732 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.524 ' N ' ' O ' ' A' ' 28' ' ' SER . 32.1 Cg_exo -53.13 163.46 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.528 2.152 . . . . 1.1299999999999999 111.342 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 30' ' ' PRO . 97.0 t -154.17 134.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.155 . . . . 1.05 110.742 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -90.07 85.91 6.43 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.583 0.706 . . . . 1.8200000000000001 109.407 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -68.52 -139.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.1699999999999999 109.996 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.55 76.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.406 -0.809 . . . . 2.21 110.059 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 55.49 23.38 34.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.942 -1.263 . . . . 1.1899999999999999 109.942 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 33' ' ' ALA . 2.2 ptp180 -136.25 143.15 44.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -1.211 . . . . 2.9100000000000001 109.435 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.77 ' SD ' ' N ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -114.61 148.4 38.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.93000000000000005 109.411 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.77 ' N ' ' SD ' ' A' ' 37' ' ' MET . 3.8 t -157.03 163.37 39.13 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.574 -0.85 . . . . 1.0600000000000001 110.17 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG23 HD13 ' A' ' 41' ' ' LEU . 21.5 m -136.14 150.17 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.265 -1.013 . . . . 1.3700000000000001 108.265 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.733 ' C ' HD12 ' A' ' 41' ' ' LEU . 18.9 m-20 -97.9 99.25 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 4.79 110.183 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.733 HD12 ' C ' ' A' ' 40' ' ' ASP . 8.5 mp -113.15 91.09 17.77 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 3.54 109.12 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.45 -87.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.906 2.404 . . . . 3.7400000000000002 112.318 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.2 96.19 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.441 . . . . 2.0299999999999998 109.499 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.47 31.96 0.05 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.515 -1.434 . . . . 2.4100000000000001 109.515 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.479 ' NE2' ' HA3' ' A' ' 134' ' ' GLY . 2.9 mt-30 -99.99 174.19 6.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -1.173 . . . . 2.96 109.41 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.66 -41.88 8.06 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.502 -1.439 . . . . 2.0800000000000001 109.502 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' OD2' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -167.01 157.54 10.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 3.6099999999999999 109.426 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.51 -39.87 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.842 2.361 . . . . 2.3599999999999999 112.211 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.608 ' CD1' ' OD1' ' A' ' 47' ' ' ASN . 4.9 p90 -91.9 55.33 2.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.917 . . . . 3.8700000000000001 109.47 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.649 ' OD2' ' N ' ' A' ' 47' ' ' ASN . 70.4 m-20 -128.33 1.94 5.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 2.3799999999999999 109.458 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.416 ' CB ' ' HA3' ' A' ' 26' ' ' GLY . . . -175.31 172.95 2.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.956 . . . . 1.1100000000000001 109.509 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 24' ' ' LEU . . . 131.42 -164.38 23.47 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.586 -1.405 . . . . 0.93999999999999995 109.586 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD21 ' CD2' ' A' ' 131' ' ' PHE . 1.1 pp -109.73 161.77 15.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -1.093 . . . . 0.95999999999999996 109.2 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 129' ' ' VAL . 2.1 t -152.21 161.12 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.979 . . . . 0.92000000000000004 109.769 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 33.1 t80 -175.31 147.79 0.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 1.71 109.476 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.681 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.3 m-80 -107.16 160.94 15.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.263 -0.898 . . . . 2.7799999999999998 109.396 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 112.75 74.15 0.67 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 2.48 109.577 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.498 HG22 ' HA3' ' A' ' 127' ' ' GLY . 19.7 m -155.45 66.2 4.64 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.247 -1.149 . . . . 3.79 109.439 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.63 137.01 41.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.759 2.306 . . . . 2.3999999999999999 112.155 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 66' ' ' TYR . 10.6 t -135.66 139.99 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 3.0800000000000001 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -107.73 117.17 5.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.51 -1.436 . . . . 3.0499999999999998 109.51 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -45.69 128.03 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 6.0499999999999998 109.526 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.461 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 113.25 -25.77 11.01 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.686 -1.366 . . . . 2.54 109.686 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' O ' ' OG ' ' A' ' 115' ' ' SER . 4.9 mt-10 -100.05 173.58 6.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.222 -1.163 . . . . 4.0300000000000002 109.646 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 2.9100000000000001 109.38 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.711 ' CD1' HG22 ' A' ' 60' ' ' VAL . 41.7 m-85 -104.36 -179.63 4.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.268 -0.895 . . . . 2.3799999999999999 109.592 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 112' ' ' ALA . 1.4 p -160.93 143.84 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 2.6099999999999999 109.668 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -126.52 118.46 24.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.332 -0.855 . . . . 3.6099999999999999 109.512 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.51 94.59 5.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 2.27 109.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 4.4 p90 -93.64 147.01 23.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.096 -1.002 . . . . 2.0099999999999998 110.954 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.3 p -95.02 112.56 24.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.188 -1.041 . . . . 1.8 108.188 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 143' ' ' ILE . . . -165.51 153.71 11.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.696 -1.253 . . . . 0.95999999999999996 110.797 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.52 148.67 49.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.713 -0.847 . . . . 0.93000000000000005 108.713 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' N ' ' O ' ' A' ' 103' ' ' THR . . . -113.13 124.79 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.984 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.584 ' CA ' ' H ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -130.72 132.79 24.17 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.309 -0.869 . . . . 0.96999999999999997 108.704 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.611 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 7.5 Cg_exo -73.15 27.7 0.43 Allowed 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 124.665 -0.973 . . . . 1.02 112.779 -0.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.716 ' O ' ' SD ' ' A' ' 78' ' ' MET . 2.4 m-20 89.29 152.52 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.514 -0.551 . . . . 1.75 109.514 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.716 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 161.54 174.57 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 107.965 -1.124 . . . . 2.1600000000000001 107.965 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.507 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 10.5 Cg_endo -81.98 145.74 14.18 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.454 2.102 . . . . 1.3799999999999999 112.218 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.886 HG12 ' OH ' ' A' ' 139' ' ' TYR . 7.5 m -113.58 159.15 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 2.0099999999999998 109.719 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.12 123.5 49.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 6.0099999999999998 109.236 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.415 ' H ' ' HA2' ' A' ' 98' ' ' GLY . 0.5 OUTLIER -136.18 149.09 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.235 -0.916 . . . . 3.7599999999999998 109.521 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 1.3 pp -145.67 144.41 30.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 2.29 109.664 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -151.82 151.48 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 1.8899999999999999 109.781 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.52 -137.6 5.08 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.451 -1.46 . . . . 1.49 109.451 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 89' ' ' GLY . 3.3 pt-20 -88.52 -165.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 2.54 109.446 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.9 50.34 0.49 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.56 -1.416 . . . . 1.3799999999999999 109.56 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . -162.03 -150.86 6.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 2.54 109.587 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 90' ' ' ALA . . . -44.88 166.63 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 4.1399999999999997 109.51 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.603 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . 43.31 74.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -1.157 . . . . 5.1299999999999999 109.468 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -65.5 15.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 5.79 109.461 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.639 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -60.93 122.73 15.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.243 -0.91 . . . . 5.7400000000000002 109.481 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -128.28 167.95 16.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 2.27 109.892 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.92 -23.15 11.51 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.651 -0.87 . . . . 3.2799999999999998 108.651 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CD2' ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.99 36.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.358 -0.839 . . . . 3.6499999999999999 108.945 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -84.5 44.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 4.5999999999999996 109.595 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.581 ' O ' ' CG ' ' A' ' 97' ' ' GLN . 10.1 pt20 -102.4 121.18 41.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 3.46 109.341 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -111.24 6.3 28.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.587 -1.405 . . . . 3.6699999999999999 109.587 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -99.37 77.26 2.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -1.139 . . . . 3.79 109.514 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.759 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -116.98 81.8 12.75 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.117 -0.99 . . . . 1.96 109.448 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 45.2 Cg_exo -52.09 143.05 42.76 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.845 2.363 . . . . 2.9700000000000002 112.29 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.466 HD12 HG11 ' A' ' 80' ' ' VAL . 14.0 mt -143.58 154.19 43.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 3.0600000000000001 109.505 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.44 -162.4 0.89 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.3399999999999999 109.608 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.676 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -102.1 -9.68 41.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.64 -1.384 . . . . 2.1699999999999999 109.64 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.549 ' OE2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -99.89 134.46 20.95 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.181 -1.188 . . . . 3.02 108.957 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.549 ' O ' ' OE2' ' A' ' 105' ' ' GLU . 85.7 Cg_exo -37.27 117.55 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.529 2.153 . . . . 1.4199999999999999 112.139 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -152.43 137.08 16.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 1.3700000000000001 109.674 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.07 152.5 20.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 1.72 109.831 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.729 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -129.36 138.92 51.81 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.051 -1.092 . . . . 4.7000000000000002 108.051 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.628 ' CD ' ' N ' ' A' ' 110' ' ' GLU . 0.9 OUTLIER -120.57 118.45 30.24 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.759 -0.776 . . . . 3.2799999999999998 110.671 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.759 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 7.3 m-85 -115.16 118.83 34.44 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.549 -0.908 . . . . 2.96 108.549 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.422 ' HB2' HG23 ' A' ' 67' ' ' VAL . . . -107.85 146.64 32.0 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 3.4100000000000001 109.948 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.739 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -129.71 163.35 26.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.819 . . . . 2.77 109.32 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.53 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -97.96 104.44 16.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 2.23 109.63 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 3.4 m -37.16 104.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 4.1100000000000003 109.305 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.15 14.72 27.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 6.8600000000000003 109.556 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.842 HD23 ' N ' ' A' ' 118' ' ' THR . 8.3 tt -169.21 171.86 7.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 5.1200000000000001 109.444 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.842 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -95.26 114.84 26.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.175 -0.953 . . . . 4.0599999999999996 109.697 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 117' ' ' LEU . 55.5 m-85 -110.58 94.53 19.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 5.4400000000000004 109.402 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.26 158.18 23.05 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.611 2.207 . . . . 4.04 112.196 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.34 -27.53 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.723 2.282 . . . . 3.8999999999999999 111.948 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 19.3 p-10 -109.96 -163.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 4.1399999999999997 109.478 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 125' ' ' ALA . . . 66.23 169.3 3.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.573 -1.411 . . . . 3.5699999999999998 109.573 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.22 45.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -1.155 . . . . 3.5899999999999999 109.423 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 123' ' ' GLY . . . -163.18 55.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 2.0800000000000001 109.54 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 125' ' ' ALA . 47.5 Cg_endo -72.91 -158.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.827 2.352 . . . . 1.3899999999999999 112.189 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.498 ' HA3' HG22 ' A' ' 58' ' ' VAL . . . -86.91 157.06 29.26 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.542 -1.423 . . . . 1.1899999999999999 109.542 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -141.91 114.48 8.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -1.178 . . . . 2.0099999999999998 109.582 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.5 t -131.66 128.5 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 1.28 108.853 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -157.0 114.56 3.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.97999999999999998 110.101 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.477 ' CD2' HD21 ' A' ' 53' ' ' LEU . 4.9 m-30 -92.21 119.38 31.78 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.645 -0.872 . . . . 1.73 108.645 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 49' ' ' TRP . 42.0 m170 -105.4 127.1 52.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 2.3199999999999998 109.623 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -128.87 -34.67 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 2.1099999999999999 109.468 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.54 127.16 0.57 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.651 -1.38 . . . . 1.77 109.651 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.684 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 16.4 mttt -166.99 130.71 1.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -1.097 . . . . 5.0599999999999996 109.73 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.36 -19.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.095 -1.076 . . . . 2.6400000000000001 108.095 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.1 17.11 7.14 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.815 -1.714 . . . . 2.5099999999999998 108.815 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.684 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -51.43 -151.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.943 . . . . 2.3199999999999998 110.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.886 ' OH ' HG12 ' A' ' 80' ' ' VAL . 2.7 p90 -171.91 -161.82 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 1.6100000000000001 109.511 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.57 142.85 26.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 1.6499999999999999 109.718 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.559 ' C ' ' SG ' ' A' ' 38' ' ' CYS . 31.1 t80 -128.07 107.61 9.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.481 -0.762 . . . . 1.6799999999999999 109.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 69.8 m -110.36 102.84 11.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.11 -0.994 . . . . 0.73999999999999999 110.989 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -120.88 144.43 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.486 -0.931 . . . . 1.22 108.486 178.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 143' ' ' ILE . 29.6 p -121.91 -8.7 8.85 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.95 -0.7 . . . . 1.3300000000000001 109.815 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.582 ' O ' ' OG1' ' A' ' 71' ' ' THR . 11.9 pt20 -168.9 176.77 5.28 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.649 -1.22 . . . . 3.2999999999999998 111.023 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.562 ' O ' ' OG1' ' A' ' 13' ' ' THR . 7.3 p -170.42 159.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.073 -0.714 . . . . 2.2599999999999998 109.073 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.467 ' N ' HG22 ' A' ' 146' ' ' VAL . 0.3 OUTLIER -148.74 158.54 44.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 2.7599999999999998 109.78 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 149' ' ' THR . 1.1 pp -143.72 155.22 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 4.5700000000000003 109.428 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.0 OUTLIER 169.78 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.144 -0.973 . . . . 3.0699999999999998 109.546 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.664 ' N ' ' OG1' ' A' ' 149' ' ' THR . 4.7 t -126.73 -121.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 2.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 150' ' ' THR . 0.2 OUTLIER 177.34 161.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 2.1499999999999999 109.434 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.14 95.3 9.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 2.8199999999999998 109.421 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.022 -0.99 . . . . 3.54 109.516 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.558 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.452 -0.573 . . . . 5.4699999999999998 109.452 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -57.68 -139.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 4.5300000000000002 109.461 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 5' ' ' SER . 1.0 OUTLIER 38.47 -160.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 5.1399999999999997 109.426 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' LEU . 8.1 m-20 42.63 19.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 5.3799999999999999 109.455 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -177.23 -155.96 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 4.8300000000000001 109.47 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 7' ' ' VAL . 5.9 pm0 -171.69 89.53 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.838 . . . . 3.4300000000000002 109.447 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 7' ' ' VAL . 2.3 t -43.2 142.25 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 2.8300000000000001 109.393 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -125.67 86.13 2.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 4.75 109.479 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.46 -33.84 74.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 4.9500000000000002 109.395 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER -108.17 95.43 15.42 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.632 -0.877 . . . . 2.8599999999999999 108.632 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.39 49.1 1.35 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.081 1.854 . . . . 3.8300000000000001 111.983 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.619 ' H ' HD13 ' A' ' 10' ' ' LEU . 82.0 t60 -152.77 129.46 10.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.391 -0.818 . . . . 2.52 109.639 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.637 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -167.45 57.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 1.97 109.492 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.8 t -151.22 67.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 1.96 109.552 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -62.64 39.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 1.76 109.091 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.675 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -86.79 -36.84 18.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 1.1799999999999999 109.858 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.691 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 15.3 mm-40 -111.7 -57.73 2.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.118 -0.989 . . . . 2.1299999999999999 109.581 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 p -128.2 143.54 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 2.2599999999999998 109.468 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.857 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -55.36 -15.98 3.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.332 -0.855 . . . . 2.6000000000000001 109.465 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 83.43 -154.37 31.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.571 -1.411 . . . . 1.6200000000000001 109.571 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.47 -11.51 15.73 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.711 2.274 . . . . 1.7 112.089 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 10.9 m95 -65.14 -163.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 2.4199999999999999 109.307 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.671 ' HB2' HG13 ' A' ' 54' ' ' VAL . 1.7 m -156.58 164.0 38.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 1.6399999999999999 109.313 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -168.38 160.07 11.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 2.0499999999999998 109.803 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.73 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 167.04 177.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 1.72 109.558 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 92.26 -23.44 27.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.941 -1.264 . . . . 1.7 109.941 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.785 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.86 -142.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.24 . . . . 0.96999999999999997 109.271 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.785 ' N ' ' OG1' ' A' ' 27' ' ' THR . 33.4 p -91.09 130.19 37.01 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.185 -0.947 . . . . 1.8 109.096 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.554 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -35.81 100.44 0.2 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 2.3999999999999999 109.176 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HG2' HD13 ' A' ' 24' ' ' LEU . 64.2 Cg_exo -46.11 154.07 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.381 2.054 . . . . 1.1299999999999999 111.643 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' MET . 4.2 t -138.53 115.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.996 -1.065 . . . . 1.05 110.395 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.694 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.45 84.28 3.18 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.534 0.683 . . . . 1.8200000000000001 109.218 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -78.39 -119.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.425 -0.797 . . . . 1.1699999999999999 110.229 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.804 ' H ' HH12 ' A' ' 36' ' ' ARG . 22.5 t0 -58.36 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.21 110.15 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 64.04 8.28 28.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.748 -1.341 . . . . 1.1899999999999999 109.748 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.804 HH12 ' H ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -126.91 144.45 50.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -1.233 . . . . 2.9100000000000001 109.604 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.778 ' HE2' HG13 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -109.87 130.44 55.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.93000000000000005 109.015 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -127.77 153.51 46.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.44 -0.904 . . . . 1.0600000000000001 110.593 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.778 HG13 ' HE2' ' A' ' 37' ' ' MET . 1.5 m -122.69 163.43 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.351 -0.981 . . . . 1.3700000000000001 108.351 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.864 ' C ' HD22 ' A' ' 41' ' ' LEU . 34.3 m-20 -107.78 102.54 11.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 4.79 110.189 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.864 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.2 mm? -126.33 48.23 2.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 3.54 109.265 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 41' ' ' LEU . 76.9 Cg_exo -39.02 -71.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.904 2.402 . . . . 3.7400000000000002 112.34 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.7 77.85 0.04 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 2.0299999999999998 109.545 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.87 28.69 0.23 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.477 -1.449 . . . . 2.4100000000000001 109.477 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.425 ' NE2' ' HB3' ' A' ' 50' ' ' ASP . 8.7 mm-40 -99.95 144.04 29.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 2.96 109.501 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.29 -66.18 1.89 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.55 -1.42 . . . . 2.0800000000000001 109.55 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.772 ' ND2' ' NE1' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -99.89 156.72 35.01 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.172 -1.193 . . . . 3.6099999999999999 109.518 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 50' ' ' ASP . 46.3 Cg_endo -72.63 -33.52 8.27 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.827 2.351 . . . . 2.3599999999999999 112.314 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.772 ' NE1' ' ND2' ' A' ' 47' ' ' ASN . 28.7 p90 -73.65 21.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 3.8700000000000001 109.48 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 23.2 m-20 -102.49 26.57 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 2.3799999999999999 109.51 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 168.99 129.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 1.1100000000000001 109.488 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 159.29 163.96 13.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.8 -1.32 . . . . 0.93999999999999995 109.8 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -92.03 -169.31 2.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.333 -1.098 . . . . 0.95999999999999996 109.341 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 23' ' ' SER . 1.5 p -174.32 165.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.288 -0.883 . . . . 0.92000000000000004 110.182 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.692 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 16.5 t80 173.16 140.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.511 -0.743 . . . . 1.71 109.405 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.692 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -102.5 -177.24 3.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.185 -0.947 . . . . 2.7799999999999998 109.618 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.37 61.81 1.37 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.626 -1.389 . . . . 2.48 109.626 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 58' ' ' VAL . 4.8 m -152.56 60.34 3.35 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 3.79 109.415 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 54.4 Cg_exo -47.22 146.9 6.14 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.875 2.383 . . . . 2.3999999999999999 112.192 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.03 92.36 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 3.0800000000000001 109.502 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 115' ' ' SER . . . -84.66 111.35 3.48 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.513 -1.435 . . . . 3.0499999999999998 109.513 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -54.56 123.53 13.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -1.104 . . . . 6.0499999999999998 109.466 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.79 -44.41 1.18 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 2.54 109.669 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' O ' ' OG ' ' A' ' 115' ' ' SER . 7.2 mt-10 -100.01 -179.98 4.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -1.152 . . . . 4.0300000000000002 109.634 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' OG1' ' A' ' 150' ' ' THR . 69.7 m -128.19 138.32 52.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.386 -0.821 . . . . 2.9100000000000001 109.362 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 44.5 m-85 -101.95 179.48 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 2.3799999999999999 109.624 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -152.15 141.72 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 2.6099999999999999 109.234 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.718 ' CD1' HD22 ' A' ' 148' ' ' LEU . 6.3 tp -127.91 113.11 15.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 3.6099999999999999 109.954 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.54 92.59 4.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.421 -0.955 . . . . 2.27 108.421 179.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 30.9 p90 -93.87 147.92 22.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 2.0099999999999998 111.074 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -98.59 105.24 17.36 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.265 -1.013 . . . . 1.8 108.265 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.482 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -152.02 159.18 43.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.725 -1.235 . . . . 0.95999999999999996 110.823 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.26 124.65 20.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.807 -0.812 . . . . 0.93000000000000005 108.807 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -86.16 129.46 34.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.67000000000000004 109.787 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.464 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.53 116.09 14.96 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.96999999999999997 109.302 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.586 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.73 -142.52 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.651 0 C-N-CA 124.374 -1.094 . . . . 1.02 112.463 -0.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -95.5 151.49 19.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.917 . . . . 1.75 109.66 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER 160.37 162.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 2.1600000000000001 109.401 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.568 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 57.8 Cg_endo -76.2 138.74 20.56 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.922 2.415 . . . . 1.3799999999999999 112.526 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -104.91 169.76 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 2.0099999999999998 109.287 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.741 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -109.91 149.03 30.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.399 -0.813 . . . . 6.0099999999999998 109.444 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 81' ' ' ARG . 19.3 t -152.64 148.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.257 -0.902 . . . . 3.7599999999999998 109.343 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.623 ' CD2' ' ND1' ' A' ' 132' ' ' HIS . 1.4 pp -152.55 146.07 24.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 2.29 109.739 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 129' ' ' VAL . 0.9 OUTLIER -153.69 149.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 1.8899999999999999 109.63 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.94 -141.29 7.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.48 -1.448 . . . . 1.49 109.48 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.734 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -89.94 -158.62 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -1.127 . . . . 2.54 109.459 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 86' ' ' GLU . . . -166.24 68.98 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.478 -1.449 . . . . 1.3799999999999999 109.478 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' A' ' 89' ' ' GLY . . . 171.58 109.15 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.507 -1.437 . . . . 2.54 109.507 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 54.05 164.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.539 -1.424 . . . . 4.1399999999999997 109.539 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.665 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 63.14 -45.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -1.155 . . . . 5.1299999999999999 109.52 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.668 ' N ' ' O ' ' A' ' 89' ' ' GLY . 56.5 m-85 44.55 10.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.903 . . . . 5.79 109.475 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -76.79 114.09 15.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 5.7400000000000002 109.536 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.35 163.86 16.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 2.27 109.89 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.04 -20.33 12.75 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.801 -0.815 . . . . 3.2799999999999998 108.801 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.81 36.16 0.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.844 . . . . 3.6499999999999999 109.16 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.83 56.34 3.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 4.5999999999999996 109.558 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -107.42 124.63 50.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 3.46 109.192 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -117.52 3.5 17.86 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.545 -1.422 . . . . 3.6699999999999999 109.545 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -89.28 72.61 8.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -1.157 . . . . 3.79 109.466 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.812 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -116.16 93.76 39.97 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 1.96 109.446 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.678 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 12.5 Cg_exo -65.98 116.9 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.855 2.37 . . . . 2.9700000000000002 112.512 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 101' ' ' PRO . 3.3 mm? -117.42 152.88 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 3.0600000000000001 109.339 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 74' ' ' ALA . 8.5 t -105.21 -161.14 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.92 . . . . 2.3399999999999999 109.651 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -93.59 -22.31 26.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.75 -1.34 . . . . 2.1699999999999999 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -99.96 149.88 36.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.213 . . . . 3.02 109.437 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -40.46 118.87 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.771 2.314 . . . . 1.4199999999999999 112.062 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -144.17 126.01 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 1.3700000000000001 109.718 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.1 151.54 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 1.72 110.075 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.714 HH11 ' CG ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -135.38 138.2 43.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.471 -0.937 . . . . 4.7000000000000002 108.471 178.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -117.67 111.65 19.44 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.979 -0.688 . . . . 3.2799999999999998 110.516 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -109.86 117.74 34.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.562 -0.903 . . . . 2.96 108.562 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.28 140.65 39.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.219 -0.926 . . . . 3.4100000000000001 109.665 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.721 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -126.3 162.87 24.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 2.77 109.45 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -98.94 103.48 15.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 2.23 109.531 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 61' ' ' GLY . 3.4 m -37.15 110.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 4.1100000000000003 109.356 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.819 ' O ' HD22 ' A' ' 117' ' ' LEU . 9.8 p-10 -115.98 -10.38 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 6.8600000000000003 109.467 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.819 HD22 ' O ' ' A' ' 116' ' ' ASN . 2.1 mm? -130.1 128.47 41.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 5.1200000000000001 109.459 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.13 113.81 12.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 4.0599999999999996 109.465 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 117' ' ' LEU . 18.3 m-85 -125.31 75.55 68.51 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 5.4400000000000004 109.483 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -52.91 167.2 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.746 2.297 . . . . 4.04 112.069 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.67 -24.44 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.771 2.314 . . . . 3.8999999999999999 112.076 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -110.39 160.77 16.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.35 -0.844 . . . . 4.1399999999999997 109.5 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.525 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.9 -137.16 13.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.541 -1.424 . . . . 3.5699999999999998 109.541 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 123' ' ' GLY . 20.5 m-20 -36.7 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 3.5899999999999999 109.497 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.5 150.55 34.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 2.0800000000000001 109.419 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.68 -158.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.801 2.334 . . . . 1.3899999999999999 112.2 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.517 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -61.86 168.03 14.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.531 -1.427 . . . . 1.1899999999999999 109.531 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.97 133.22 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -1.108 . . . . 2.0099999999999998 109.595 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.517 HG22 HG13 ' A' ' 84' ' ' VAL . 59.8 t -139.56 151.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.644 -0.872 . . . . 1.28 108.644 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -167.02 112.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 0.97999999999999998 110.207 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -85.56 112.9 21.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.319 -0.863 . . . . 1.73 108.703 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.623 ' ND1' ' CD2' ' A' ' 83' ' ' LEU . 2.4 m170 -99.77 120.51 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.3199999999999998 109.978 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -140.06 5.09 2.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.412 -0.805 . . . . 2.1099999999999999 109.271 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -80.26 122.18 5.67 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.526 -1.43 . . . . 1.77 109.526 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.69 ' O ' ' N ' ' A' ' 137' ' ' GLY . 6.4 mtpp -163.96 135.78 4.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 5.0599999999999996 109.668 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.91 -13.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.404 -0.961 . . . . 2.6400000000000001 108.404 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -121.57 5.35 10.8 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.099 -1.601 . . . . 2.5099999999999998 109.099 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -52.34 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -1.035 . . . . 2.3199999999999998 109.937 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.568 ' OH ' ' O ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -170.78 -161.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.934 -1.103 . . . . 1.6100000000000001 109.411 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -80.18 143.34 33.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.081 -1.012 . . . . 1.6499999999999999 109.486 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.482 ' CE1' ' HB1' ' A' ' 72' ' ' ALA . 28.6 t80 -126.56 110.27 13.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 1.6799999999999999 109.239 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.0 104.83 14.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.73999999999999999 110.558 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.51 HG23 ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -120.27 142.77 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.891 . . . . 1.22 108.74 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.446 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 24.8 p -137.73 -3.42 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.636 -0.665 . . . . 1.3300000000000001 109.567 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.539 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -154.92 160.24 41.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.143 -0.973 . . . . 3.2999999999999998 110.061 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.637 ' N ' ' OG1' ' A' ' 13' ' ' THR . 2.2 t -143.38 152.61 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.434 -0.791 . . . . 2.2599999999999998 109.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 69' ' ' SER . 26.5 t -125.62 128.23 47.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 2.7599999999999998 109.899 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.718 HD22 ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -129.82 111.6 12.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 4.5700000000000003 109.208 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.584 ' N ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -160.98 -171.66 3.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 3.0699999999999998 109.626 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.727 HG23 ' N ' ' A' ' 151' ' ' SER . 7.7 t -156.85 -122.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 2.0 109.433 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.727 ' N ' HG23 ' A' ' 150' ' ' THR . 2.7 m -160.48 58.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 2.1499999999999999 109.437 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.467 ' N ' ' HB3' ' A' ' 2' ' ' SER . . . -150.61 -166.98 2.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 2.8199999999999998 109.516 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.976 -1.011 . . . . 3.54 109.495 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.327 0.584 . . . . 5.4699999999999998 109.53 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.698 ' O ' HD22 ' A' ' 3' ' ' LEU . 11.4 t -141.27 71.3 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 4.5300000000000002 109.498 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 2' ' ' SER . 1.1 mm? -128.54 -173.34 2.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 5.1399999999999997 109.422 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 5' ' ' SER . 3.9 p30 -89.33 -140.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 5.3799999999999999 109.492 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 0.1 OUTLIER 52.63 -171.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 4.8300000000000001 109.427 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -147.89 103.61 3.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 3.4300000000000002 109.506 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.573 ' O ' ' OG1' ' A' ' 149' ' ' THR . 0.2 OUTLIER -76.99 97.2 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 2.8300000000000001 109.412 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -85.53 82.16 8.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 4.75 109.477 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.615 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -44.39 -19.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 4.9500000000000002 109.444 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.58 ' C ' ' H ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER -121.66 84.17 42.76 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.8599999999999999 108.628 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.1 20.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.973 2.448 . . . . 3.8300000000000001 112.131 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.58 ' H ' ' C ' ' A' ' 10' ' ' LEU . 69.9 t60 -118.64 99.29 6.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 2.52 109.672 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.892 ' O ' HG23 ' A' ' 13' ' ' THR . 5.5 t -139.12 56.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 1.97 109.339 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.619 ' C ' ' H ' ' A' ' 16' ' ' ALA . 44.4 m -142.49 61.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 1.96 109.785 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.7 m-30 -66.05 33.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.108 -0.995 . . . . 1.76 109.0 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.626 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.06 -35.26 15.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 1.1799999999999999 110.014 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -109.97 -84.53 0.55 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.121 -0.987 . . . . 2.1299999999999999 109.599 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 p -94.35 144.02 25.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 2.2599999999999998 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -55.77 -53.57 55.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 2.6000000000000001 109.459 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.472 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 111.98 -164.14 12.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 1.6200000000000001 109.682 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 56.7 Cg_endo -76.31 -4.51 15.15 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.833 2.355 . . . . 1.7 112.367 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.863 ' CH2' HG11 ' A' ' 146' ' ' VAL . 8.3 m95 -66.67 -177.63 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 2.4199999999999999 109.418 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -133.6 167.32 20.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.339 -0.851 . . . . 1.6399999999999999 109.277 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.008 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.5 pp 179.43 142.76 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.133 -0.979 . . . . 2.0499999999999998 109.809 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -178.82 173.78 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.464 -0.773 . . . . 1.72 109.453 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 102.29 -31.87 8.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.199 -1.16 . . . . 1.7 110.199 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.79 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.86 -141.94 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.957 -1.319 . . . . 0.96999999999999997 109.645 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.79 ' N ' ' OG1' ' A' ' 27' ' ' THR . 13.7 p -91.35 132.71 36.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.538 -0.726 . . . . 1.8 109.329 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 28' ' ' SER . 1.8 pt-20 -37.44 106.96 0.37 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.139 -0.976 . . . . 2.3999999999999999 109.055 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.684 ' HG2' HD22 ' A' ' 24' ' ' LEU . 53.6 Cg_exo -45.54 150.01 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.226 1.951 . . . . 1.1299999999999999 111.691 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 t -136.83 123.07 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 1.05 110.103 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -77.84 115.4 17.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 1.8200000000000001 109.362 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 35' ' ' GLY . . . -81.76 -140.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 1.1699999999999999 109.733 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.53 13.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 2.21 110.057 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.626 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 144.11 -4.77 1.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.945 -1.262 . . . . 1.1899999999999999 109.945 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -121.57 152.22 39.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.005 -1.291 . . . . 2.9100000000000001 109.571 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.656 ' SD ' HD23 ' A' ' 19' ' ' LEU . 59.2 ttp -116.65 134.37 54.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.93000000000000005 109.338 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -129.93 154.11 47.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 110.161 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.9 m -123.74 140.85 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.682 -0.858 . . . . 1.3700000000000001 108.682 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.72 ' C ' HD12 ' A' ' 41' ' ' LEU . 53.1 m-20 -79.8 108.87 13.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 4.79 109.704 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 133' ' ' LEU . 8.2 mp -116.29 76.29 6.76 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 3.54 109.508 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 43' ' ' GLY . 61.2 Cg_endo -77.54 -74.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.796 2.331 . . . . 3.7400000000000002 112.201 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 42' ' ' PRO . . . -173.52 -157.37 15.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.588 -1.405 . . . . 2.0299999999999998 109.588 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 77.19 -4.0 56.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.658 -1.377 . . . . 2.4100000000000001 109.658 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.671 ' O ' ' N ' ' A' ' 47' ' ' ASN . 7.8 mm-40 -100.01 66.79 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -1.119 . . . . 2.96 109.435 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.77 49.6 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.59 -1.404 . . . . 2.0800000000000001 109.59 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.671 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.1 OUTLIER -169.68 89.28 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -1.107 . . . . 3.6099999999999999 109.422 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.7 -0.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.876 2.384 . . . . 2.3599999999999999 112.356 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.674 ' CE3' ' OD1' ' A' ' 50' ' ' ASP . 1.3 p-90 -122.88 34.08 5.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 3.8700000000000001 109.572 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.674 ' OD1' ' CE3' ' A' ' 49' ' ' TRP . 2.0 m-20 -108.7 -19.62 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 2.3799999999999999 109.654 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -139.77 177.42 7.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 1.1100000000000001 109.71 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 128.65 171.82 13.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.615 -1.394 . . . . 0.93999999999999995 109.615 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.571 ' C ' HG22 ' A' ' 54' ' ' VAL . 3.2 mt -89.74 -177.29 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.187 . . . . 0.95999999999999996 109.323 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.31 174.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.92000000000000004 109.92 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 22' ' ' TRP . 18.1 t80 176.98 129.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.43 -0.794 . . . . 1.71 109.46 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.38 115.14 28.78 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.252 -0.905 . . . . 2.7799999999999998 109.525 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.41 70.96 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.48 -1.448 . . . . 2.48 109.48 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -170.06 95.24 0.48 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.343 -1.092 . . . . 3.79 109.416 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 58.7 Cg_endo -79.35 127.06 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.594 2.196 . . . . 2.3999999999999999 112.186 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.1 t -100.03 135.19 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 3.0800000000000001 109.578 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -115.23 101.79 1.07 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 3.0499999999999998 109.338 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' C ' ' O ' ' A' ' 61' ' ' GLY . 14.9 tt0 -35.53 144.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.166 . . . . 6.0499999999999998 109.612 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.675 ' N ' ' OG ' ' A' ' 115' ' ' SER . . . 96.35 -25.94 23.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.692 -1.363 . . . . 2.54 109.692 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 115' ' ' SER . 18.0 mt-10 -104.84 164.84 11.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -1.175 . . . . 4.0300000000000002 109.767 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 58.2 m -120.7 141.41 50.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 2.9100000000000001 109.228 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.61 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 28.0 m-85 -108.55 -179.21 3.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 2.3799999999999999 109.73 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.675 HG13 ' HB2' ' A' ' 112' ' ' ALA . 2.0 t -152.76 144.83 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.489 -0.757 . . . . 2.6099999999999999 109.341 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.44 116.46 16.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 3.6099999999999999 109.797 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.0 p -109.74 95.88 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 2.27 108.874 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -93.08 139.41 30.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.977 . . . . 2.0099999999999998 110.85 -179.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -94.51 104.75 16.71 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.857 -0.794 . . . . 1.8 108.857 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -175.97 169.18 2.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.792 -1.192 . . . . 0.95999999999999996 110.635 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.16 172.18 13.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.763 -0.829 . . . . 0.93000000000000005 108.763 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -120.59 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.126 -0.984 . . . . 0.67000000000000004 109.949 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.47 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.59 115.6 14.73 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.311 -0.868 . . . . 0.96999999999999997 109.468 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.0 Cg_exo -65.79 -142.18 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 C-N-CA 124.392 -1.087 . . . . 1.02 112.341 -0.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.667 ' O ' ' SD ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -102.23 149.36 24.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 1.75 109.602 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.667 ' SD ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 168.15 153.58 0.13 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 2.1600000000000001 109.438 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.72 163.78 28.68 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.829 2.353 . . . . 1.3799999999999999 112.491 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' ' OH ' ' A' ' 139' ' ' TYR . 35.8 m -136.5 -178.84 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.346 -0.846 . . . . 2.0099999999999998 109.305 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.717 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -126.56 117.78 23.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 6.0099999999999998 109.658 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.602 HG13 ' CD ' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -119.7 151.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 3.7599999999999998 109.259 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 130' ' ' ALA . 2.9 pp -143.03 156.39 44.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.135 -0.978 . . . . 2.29 109.909 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.456 ' CG2' ' C ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -154.03 159.8 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 1.8899999999999999 109.428 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 144.99 -142.92 11.27 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.578 -1.409 . . . . 1.49 109.578 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.67 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 0.8 OUTLIER -90.17 -165.88 1.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 2.54 109.44 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.644 ' H ' ' HB3' ' A' ' 125' ' ' ALA . . . -149.46 84.29 0.17 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.556 -1.418 . . . . 1.3799999999999999 109.556 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.67 ' N ' ' OE2' ' A' ' 86' ' ' GLU . . . -130.67 -154.47 7.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.481 -1.448 . . . . 2.54 109.481 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.685 ' O ' ' CD2' ' A' ' 91' ' ' TYR . . . -70.83 -66.68 2.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 4.1399999999999997 109.496 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' TYR . . . -66.3 2.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -1.17 . . . . 5.1299999999999999 109.477 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.685 ' CD2' ' O ' ' A' ' 89' ' ' GLY . 39.6 m-85 38.58 47.86 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 5.79 109.456 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -63.8 117.23 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 5.7400000000000002 109.414 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -139.77 173.53 11.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 2.27 109.966 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HB1' ' OD1' ' A' ' 116' ' ' ASN . . . -123.65 -19.62 5.74 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.823 -0.806 . . . . 3.2799999999999998 108.823 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.583 ' CD2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.68 34.72 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 3.6499999999999999 109.203 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.84 87.3 7.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 4.5999999999999996 109.538 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' CD ' HG13 ' A' ' 82' ' ' VAL . 4.9 pt20 -107.79 -156.25 0.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 3.46 109.425 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -173.16 -35.84 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.688 -1.365 . . . . 3.6699999999999999 109.688 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -80.07 90.21 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -1.146 . . . . 3.79 109.518 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HB3' HG23 ' A' ' 80' ' ' VAL . . . -123.13 78.71 51.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 1.96 109.461 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.83 127.14 24.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.018 2.479 . . . . 2.9700000000000002 112.547 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 102' ' ' LEU . 55.9 mt -140.41 145.74 37.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.0600000000000001 109.297 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.597 ' O ' ' N ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -127.45 175.11 8.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 2.3399999999999999 109.701 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -77.79 17.68 5.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 2.1699999999999999 109.527 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -102.48 103.8 33.94 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.279 -1.13 . . . . 3.02 109.165 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -44.75 117.5 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.3 2.0 . . . . 1.4199999999999999 112.188 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.762 ' HB1' HH12 ' A' ' 109' ' ' ARG . . . -165.16 156.82 14.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.925 . . . . 1.3700000000000001 109.603 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.639 ' O ' ' CZ ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -91.24 136.02 33.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.368 -0.833 . . . . 1.72 110.221 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.762 HH12 ' HB1' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -110.23 142.02 42.39 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.665 -1.235 . . . . 4.7000000000000002 107.665 178.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.75 105.69 13.59 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.763 -0.775 . . . . 3.2799999999999998 110.457 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -109.09 109.18 20.12 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.172 -1.048 . . . . 2.96 108.172 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -116.85 169.14 9.62 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 3.4100000000000001 109.807 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.3 p90 -154.73 -178.92 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.835 . . . . 2.77 109.514 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.509 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -109.92 106.15 15.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.36 -0.837 . . . . 2.23 109.689 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.675 ' OG ' ' N ' ' A' ' 63' ' ' GLY . 59.8 p -35.97 119.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 4.1100000000000003 109.316 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.527 ' O ' ' CD ' ' A' ' 62' ' ' GLU . 3.7 m120 -96.26 -49.24 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 6.8600000000000003 109.576 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.72 ' CD2' ' H ' ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.81 -156.89 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 5.1200000000000001 109.646 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.72 ' H ' ' CD2' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -119.52 144.83 46.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.349 -0.844 . . . . 4.0599999999999996 109.491 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.56 ' CD1' ' O ' ' A' ' 118' ' ' THR . 74.6 m-85 -157.86 62.29 2.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 5.4400000000000004 109.497 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.503 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 45.7 Cg_exo -52.28 -173.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.852 2.368 . . . . 4.04 112.071 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 120' ' ' PRO . 5.0 Cg_exo -71.23 -31.45 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.047 2.498 . . . . 3.8999999999999999 111.857 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -111.0 -161.56 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 4.1399999999999997 109.478 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 88.21 -149.02 21.08 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.514 -1.435 . . . . 3.5699999999999998 109.514 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.654 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -44.73 -50.03 10.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 3.5899999999999999 109.434 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.644 ' HB3' ' H ' ' A' ' 87' ' ' GLY . . . -165.68 155.09 10.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 2.0800000000000001 109.457 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.91 -158.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.828 2.352 . . . . 1.3899999999999999 112.205 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.99 168.61 9.88 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.546 -1.422 . . . . 1.1899999999999999 109.546 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.566 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -148.86 118.77 7.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -1.175 . . . . 2.0099999999999998 109.656 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 54' ' ' VAL . 38.9 t -136.02 137.74 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.636 -0.876 . . . . 1.28 108.636 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -160.27 112.15 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.999 -1.063 . . . . 0.97999999999999998 110.506 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.4 m-30 -89.0 110.43 21.12 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.519 -0.919 . . . . 1.73 108.519 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.475 ' CD2' ' HA ' ' A' ' 49' ' ' TRP . 31.2 m80 -99.69 138.37 36.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 2.3199999999999998 110.031 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -155.93 17.11 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 2.1099999999999999 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -77.18 139.09 22.85 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.616 -1.393 . . . . 1.77 109.616 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' A' ' 137' ' ' GLY . 18.7 mtpt -166.25 127.49 1.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -1.134 . . . . 5.0599999999999996 109.81 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.17 -15.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.0 -1.111 . . . . 2.6400000000000001 108.0 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -125.52 17.13 6.96 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.747 -1.741 . . . . 2.5099999999999998 108.747 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -48.86 -158.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.64 -0.918 . . . . 2.3199999999999998 110.714 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.647 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 2.2 p90 -152.73 -119.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 1.6100000000000001 109.391 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.464 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 2.3 mt-10 -135.9 143.88 45.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 1.6499999999999999 109.228 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.66 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 38.1 t80 -124.5 127.39 47.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 1.6799999999999999 109.454 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.94 115.56 25.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.73999999999999999 110.506 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.41 143.38 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.759 0.79 . . . . 1.22 109.017 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' PHE . 52.3 p -120.66 -19.86 7.28 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.466 -0.939 . . . . 1.3300000000000001 108.466 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.563 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.9 pt20 -171.36 172.27 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.843 -0.743 . . . . 3.2999999999999998 109.646 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.863 HG11 ' CH2' ' A' ' 22' ' ' TRP . 8.8 p -147.16 141.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 2.2599999999999998 109.51 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.441 ' CB ' ' OG ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -114.91 158.94 21.29 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -0.912 . . . . 2.7599999999999998 109.527 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 149' ' ' THR . 1.6 tp -168.22 114.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 4.5700000000000003 109.381 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.678 ' N ' HD12 ' A' ' 148' ' ' LEU . 7.0 t -156.68 -164.03 1.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 3.0699999999999998 109.484 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.774 HG23 ' N ' ' A' ' 151' ' ' SER . 7.7 t -150.88 -143.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 2.0 109.464 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.774 ' N ' HG23 ' A' ' 150' ' ' THR . 1.1 m 38.49 39.72 0.33 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 2.1499999999999999 109.488 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.32 126.06 22.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 2.8199999999999998 109.499 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.07 -0.967 . . . . 3.54 109.499 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.485 -0.561 . . . . 5.4699999999999998 109.485 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -106.72 80.01 1.41 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 4.5300000000000002 109.436 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.622 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER -147.81 -175.51 4.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 5.1399999999999997 109.642 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 1.7 t70 84.58 168.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 5.3799999999999999 109.587 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.841 ' OG ' ' HB1' ' A' ' 152' ' ' ALA . 0.8 OUTLIER 48.08 175.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 4.8300000000000001 109.484 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.91 121.13 16.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 3.4300000000000002 109.564 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.78 ' O ' HD12 ' A' ' 9' ' ' LEU . 48.6 t -108.79 64.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 2.8300000000000001 109.311 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.598 ' C ' ' H ' ' A' ' 10' ' ' LEU . 6.3 pm0 -51.02 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 4.75 109.669 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.78 HD12 ' O ' ' A' ' 7' ' ' VAL . 8.6 mp -54.22 -1.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.257 -0.902 . . . . 4.9500000000000002 109.276 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.05 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -140.5 95.85 7.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 2.8599999999999999 108.943 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.07 38.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 3.8300000000000001 112.703 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.678 ' N ' ' O ' ' A' ' 10' ' ' LEU . 33.7 t60 -133.44 115.65 15.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 2.52 109.337 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.579 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.2 OUTLIER -154.41 63.38 0.68 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.347 -0.846 . . . . 1.97 109.283 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 16' ' ' ALA . 16.2 m -159.47 66.8 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.241 -0.912 . . . . 1.96 109.512 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 144' ' ' SER . 4.8 m-30 -67.11 27.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 1.76 109.195 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.17 -29.53 18.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.847 . . . . 1.1799999999999999 109.956 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.458 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 4.3 mt-10 -109.73 -83.64 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 2.1299999999999999 109.78 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.4 m -96.46 143.77 27.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 2.2599999999999998 109.593 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' A' ' 37' ' ' MET . 3.9 mt -54.11 -51.38 64.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 2.6000000000000001 109.418 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.37 -171.59 16.76 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.591 -1.404 . . . . 1.6200000000000001 109.591 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 22' ' ' TRP . 47.5 Cg_endo -72.99 -18.54 24.09 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.759 2.306 . . . . 1.7 112.147 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.766 ' HE1' ' CD1' ' A' ' 10' ' ' LEU . 9.5 m95 -53.06 -174.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 2.4199999999999999 109.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -135.81 173.79 11.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 1.6399999999999999 109.525 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.573 HD13 ' CG ' ' A' ' 30' ' ' PRO . 2.7 pp -177.81 142.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 2.0499999999999998 109.446 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.594 ' CD1' ' C ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.91 170.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 1.72 109.793 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.06 -29.73 10.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.97 -1.252 . . . . 1.7 109.97 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.773 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.73 -141.94 0.38 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.083 -1.245 . . . . 0.96999999999999997 109.3 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.773 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.7 p -91.15 -170.58 2.7 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.369 -0.832 . . . . 1.8 109.172 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.22 111.34 46.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 109.041 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.573 ' CG ' HD13 ' A' ' 24' ' ' LEU . 76.7 Cg_exo -44.66 134.9 9.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.201 1.934 . . . . 1.1299999999999999 111.921 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 37' ' ' MET . 9.2 t -116.95 105.07 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 1.05 109.918 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -69.24 77.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.568 -0.708 . . . . 1.8200000000000001 109.416 179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 34' ' ' ASP . . . -60.67 -140.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 1.1699999999999999 109.766 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -35.48 -76.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 2.21 109.503 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -143.21 49.71 0.71 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.586 -1.406 . . . . 1.1899999999999999 109.586 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -173.15 150.38 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 2.9100000000000001 109.398 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' HD21 ' A' ' 19' ' ' LEU . 4.5 ptt? -108.87 134.03 52.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 109.562 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.68 135.51 54.96 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.627 -0.829 . . . . 1.0600000000000001 110.427 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 2.1 m -106.07 140.66 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.672 -0.862 . . . . 1.3700000000000001 108.672 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.2 m-20 -77.35 106.53 9.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 4.79 109.922 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 133' ' ' LEU . 6.6 mp -114.26 80.67 5.92 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 3.54 109.157 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.23 -95.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 3.7400000000000002 112.263 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.17 137.29 4.85 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.651 -1.379 . . . . 2.0299999999999998 109.651 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . 155.71 -17.85 0.49 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 2.4100000000000001 109.51 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.601 HE22 ' H ' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -99.51 61.99 1.2 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.235 -1.156 . . . . 2.96 109.632 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 45' ' ' GLN . . . -36.48 -33.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.249 -1.54 . . . . 2.0800000000000001 109.249 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -107.69 101.83 41.97 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.364 -1.08 . . . . 3.6099999999999999 109.037 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' O ' ' CG ' ' A' ' 132' ' ' HIS . 36.2 Cg_exo -56.36 44.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.457 2.105 . . . . 2.3599999999999999 112.315 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.693 ' CH2' ' OD2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -117.12 49.75 1.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.99 . . . . 3.8700000000000001 111.28 -179.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.693 ' OD2' ' CH2' ' A' ' 49' ' ' TRP . 23.9 m-20 -165.07 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 2.3799999999999999 109.465 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.601 ' H ' HE22 ' A' ' 45' ' ' GLN . . . -81.06 120.04 24.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 1.1100000000000001 109.546 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.604 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 162.59 179.2 37.03 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.683 -1.246 . . . . 0.93999999999999995 110.041 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.979 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.5 mm? -100.07 168.01 10.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -1.04 . . . . 0.95999999999999996 109.009 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -155.89 166.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.92000000000000004 109.825 -179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 1.05 ' CZ ' HD12 ' A' ' 10' ' ' LEU . 13.1 t80 173.92 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 1.71 109.571 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.568 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-80 -98.93 150.03 22.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.281 -0.887 . . . . 2.7799999999999998 109.548 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' H ' ' HA3' ' A' ' 127' ' ' GLY . . . 127.69 52.54 0.14 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 2.48 109.589 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.721 HG13 HD22 ' A' ' 148' ' ' LEU . 14.7 t -142.79 70.59 19.64 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 3.79 109.457 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -47.66 143.57 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.834 2.356 . . . . 2.3999999999999999 112.208 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.53 122.04 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 3.0800000000000001 109.461 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -108.17 91.72 0.69 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 3.0499999999999998 109.492 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 62' ' ' GLU . 3.5 tm-20 -41.81 120.42 1.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 6.0499999999999998 109.46 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 134.31 -48.82 0.93 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.807 -1.317 . . . . 2.54 109.807 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' O ' ' OG ' ' A' ' 115' ' ' SER . 3.6 mp0 -100.03 179.71 4.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 4.0300000000000002 109.623 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.57 ' OG ' HG22 ' A' ' 114' ' ' THR . 58.5 m -120.28 140.99 50.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 2.9100000000000001 109.396 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 38.6 m-85 -109.53 -178.13 3.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.202 -0.936 . . . . 2.3799999999999999 109.474 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 66' ' ' TYR . 22.9 t -152.79 130.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 2.6099999999999999 109.511 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 69' ' ' SER . 8.0 tt -110.7 147.51 34.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 3.6099999999999999 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.968 ' N ' HD23 ' A' ' 68' ' ' LEU . 1.6 p -130.2 91.05 3.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 2.27 109.455 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CE1' ' HB2' ' A' ' 109' ' ' ARG . 29.5 p90 -94.63 139.56 31.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 2.0099999999999998 110.966 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.801 HG23 HG23 ' A' ' 108' ' ' THR . 1.1 p -97.0 134.68 40.05 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.641 -0.874 . . . . 1.8 108.641 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.803 ' N ' HH22 ' A' ' 109' ' ' ARG . . . 169.37 -170.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.951 -1.093 . . . . 0.95999999999999996 110.481 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -169.11 147.68 3.88 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.816 -0.809 . . . . 0.93000000000000005 108.816 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -104.72 134.04 48.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.116 -0.99 . . . . 0.67000000000000004 109.85 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.45 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -132.04 116.4 15.63 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.4 -0.812 . . . . 0.96999999999999997 109.292 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.0 Cg_exo -66.21 -142.29 0.15 OUTLIER 'Cis proline' 0 N--CA 1.496 1.665 0 C-N-CA 124.297 -1.126 . . . . 1.02 112.344 -0.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -104.96 148.8 26.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.75 109.253 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.724 ' SD ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 ptp 174.43 154.45 0.3 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 2.1600000000000001 109.535 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.14 117.93 5.38 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.57 2.18 . . . . 1.3799999999999999 111.871 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' O ' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -97.45 179.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.878 . . . . 2.0099999999999998 109.536 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.738 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -120.14 150.92 39.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 6.0099999999999998 109.65 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -142.47 147.89 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 3.7599999999999998 109.118 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.3 pp -143.81 148.26 35.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 2.29 110.121 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' O ' ' OG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -154.41 164.42 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.775 . . . . 1.8899999999999999 109.413 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.68 -138.9 6.77 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.687 -1.365 . . . . 1.49 109.687 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 1.1 pm0 -90.17 177.31 6.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -1.145 . . . . 2.54 109.489 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -128.89 57.44 0.72 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.523 -1.431 . . . . 1.3799999999999999 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.33 -176.9 39.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.538 -1.425 . . . . 2.54 109.538 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.605 ' C ' ' H ' ' A' ' 91' ' ' TYR . . . 68.84 -149.7 49.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.576 -1.41 . . . . 4.1399999999999997 109.576 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.587 ' C ' ' H ' ' A' ' 92' ' ' ARG . . . -59.93 6.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -1.141 . . . . 5.1299999999999999 109.508 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.605 ' H ' ' C ' ' A' ' 89' ' ' GLY . 80.6 m-85 57.66 -2.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 5.79 109.483 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.587 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -52.77 -174.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 5.7400000000000002 109.427 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER 179.96 -179.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 2.27 109.954 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.575 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -124.04 -22.1 4.91 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.873 -0.788 . . . . 3.2799999999999998 108.873 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.67 43.06 1.13 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.286 -0.884 . . . . 3.6499999999999999 109.227 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -86.59 61.0 6.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.111 -0.993 . . . . 4.5999999999999996 109.464 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.5 tt0 -99.93 161.57 13.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 3.46 109.04 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -135.43 -30.22 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.781 -1.327 . . . . 3.6699999999999999 109.781 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.01 95.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.259 -1.142 . . . . 3.79 109.819 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.769 ' HB1' ' OH ' ' A' ' 111' ' ' TYR . . . -137.41 77.48 40.82 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 1.96 109.32 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.03 120.06 6.2 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.027 2.485 . . . . 2.9700000000000002 112.701 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.427 HD12 ' CG2' ' A' ' 80' ' ' VAL . 11.9 mt -137.9 132.88 33.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 3.0600000000000001 109.357 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 5.1 t -128.84 -151.19 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 2.3399999999999999 109.521 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -92.31 58.34 2.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.632 -1.387 . . . . 2.1699999999999999 109.632 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.23 84.25 59.8 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -1.104 . . . . 3.02 109.481 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.726 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 51.0 Cg_exo -48.65 124.91 11.7 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.814 2.343 . . . . 1.4199999999999999 112.188 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 161.03 174.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 1.3700000000000001 109.444 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.801 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.08 131.9 35.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 1.72 109.929 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.803 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -100.74 140.97 34.26 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.092 -1.448 . . . . 4.7000000000000002 107.092 177.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 7.8 mt-10 -108.73 123.39 48.93 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.515 -0.874 . . . . 3.2799999999999998 110.94 -178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.769 ' OH ' ' HB1' ' A' ' 100' ' ' ALA . 7.5 m-85 -109.96 119.56 39.7 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.302 -0.999 . . . . 2.96 108.302 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.96 124.68 45.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.194 -0.941 . . . . 3.4100000000000001 109.941 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.704 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -133.5 165.42 24.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 2.77 109.436 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.57 HG22 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -108.16 125.68 51.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.395 -0.816 . . . . 2.23 109.748 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 4.2 m -52.7 124.38 13.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.28 -0.887 . . . . 4.1100000000000003 109.213 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.68 ' O ' HD22 ' A' ' 117' ' ' LEU . 3.4 m120 -111.04 -46.67 3.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.151 -0.968 . . . . 6.8600000000000003 109.698 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 116' ' ' ASN . 3.3 mm? -120.96 139.72 52.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.144 -0.972 . . . . 5.1200000000000001 109.638 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.682 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -70.19 159.56 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 4.0599999999999996 109.291 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.682 ' CG ' ' O ' ' A' ' 118' ' ' THR . 32.1 m-85 -168.05 93.44 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 5.4400000000000004 109.492 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.09 165.8 21.31 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.722 2.281 . . . . 4.04 112.177 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.81 -15.05 12.22 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.716 2.278 . . . . 3.8999999999999999 112.042 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.83 132.65 53.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 4.1399999999999997 109.442 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 134.41 -137.47 9.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.546 -1.422 . . . . 3.5699999999999998 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -121.48 39.14 3.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -1.146 . . . . 3.5899999999999999 109.454 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 86' ' ' GLU . . . -179.92 71.23 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 109.495 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.72 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.752 2.301 . . . . 1.3899999999999999 112.306 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.568 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -65.59 154.28 50.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.599 -1.401 . . . . 1.1899999999999999 109.599 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLU . 9.2 tp-100 -151.52 130.46 12.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.104 -1.233 . . . . 2.0099999999999998 109.578 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.625 ' CG2' HG21 ' A' ' 58' ' ' VAL . 21.2 t -138.47 139.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 1.28 108.623 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.08 1.94 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.855 -1.153 . . . . 0.97999999999999998 110.929 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.3 m-30 -90.72 112.09 23.71 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.207 -1.035 . . . . 1.73 108.207 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.449 ' CG ' ' O ' ' A' ' 48' ' ' PRO . 34.8 m170 -99.88 131.3 45.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 2.3199999999999998 110.259 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.58 -23.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.334 -0.854 . . . . 2.1099999999999999 109.896 179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -34.06 133.65 0.37 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.763 -1.335 . . . . 1.77 109.763 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 137' ' ' GLY . 29.7 mtmt -169.03 127.03 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -1.135 . . . . 5.0599999999999996 109.763 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.49 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -41.91 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.911 -1.144 . . . . 2.6400000000000001 107.911 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.04 18.61 7.44 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.037 -1.625 . . . . 2.5099999999999998 109.037 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.653 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -49.44 -154.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.625 -0.926 . . . . 2.3199999999999998 110.756 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.724 ' CD1' ' SD ' ' A' ' 78' ' ' MET . 7.4 p90 -158.91 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.995 -1.066 . . . . 1.6100000000000001 109.277 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.455 ' N ' ' CD2' ' A' ' 139' ' ' TYR . 74.6 mm-40 -126.65 130.55 50.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.163 -0.96 . . . . 1.6499999999999999 108.867 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -107.71 114.64 28.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 1.6799999999999999 109.974 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.501 ' HB3' ' NH1' ' A' ' 36' ' ' ARG . 36.6 m -110.93 114.35 27.61 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.275 -0.891 . . . . 0.73999999999999999 109.65 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -123.26 145.03 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 1.22 109.517 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' PHE . 0.7 OUTLIER -131.0 -12.74 3.64 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.299 -0.63 . . . . 1.3300000000000001 109.299 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.578 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -158.93 158.95 34.34 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.372 -0.931 . . . . 3.2999999999999998 110.181 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.527 HG22 ' C ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -162.39 129.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 2.2599999999999998 108.91 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.96 144.06 8.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.062 . . . . 2.7599999999999998 109.675 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.721 HD22 HG13 ' A' ' 58' ' ' VAL . 1.5 pp -122.11 164.99 16.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 4.5700000000000003 109.523 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.76 ' CB ' ' H ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -177.68 -174.71 0.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 3.0699999999999998 109.655 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.777 HG23 ' N ' ' A' ' 151' ' ' SER . 1.6 t -178.54 -159.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.414 -0.804 . . . . 2.0 109.438 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.777 ' N ' HG23 ' A' ' 150' ' ' THR . 25.8 t 33.4 -155.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 2.1499999999999999 109.863 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.841 ' HB1' ' OG ' ' A' ' 5' ' ' SER . . . 174.52 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 2.8199999999999998 109.467 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.036 -0.983 . . . . 3.54 109.463 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.294 0.569 . . . . 5.4699999999999998 109.504 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 3' ' ' LEU . 91.4 p 36.74 -140.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 4.5300000000000002 109.508 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.576 ' O ' ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER 54.18 156.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 5.1399999999999997 109.572 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 3' ' ' LEU . 3.3 m-20 38.79 -164.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 5.3799999999999999 109.535 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.534 ' C ' ' O ' ' A' ' 4' ' ' ASP . 18.5 m 35.83 84.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 4.8300000000000001 109.551 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 8' ' ' GLU . 48.5 mp0 -52.79 117.09 2.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 3.4300000000000002 109.421 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.6 p -68.59 35.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 2.8300000000000001 109.469 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 6' ' ' GLU . 8.4 tt0 -37.21 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 4.75 109.626 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 mt -61.92 -34.59 76.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 4.9500000000000002 109.275 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.011 HD13 ' H ' ' A' ' 12' ' ' HIS . 2.8 tm? -107.53 100.4 34.04 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.576 -0.898 . . . . 2.8599999999999999 108.576 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.39 30.42 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.7 2.267 . . . . 3.8300000000000001 112.997 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 1.011 ' H ' HD13 ' A' ' 10' ' ' LEU . 28.2 t60 -115.42 82.05 1.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.848 -1.158 . . . . 2.52 109.369 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.492 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -121.27 45.85 2.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 1.97 109.338 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.1 t -125.45 72.19 1.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 1.96 109.461 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -83.21 23.95 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.198 -0.939 . . . . 1.76 109.362 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.784 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -90.02 -35.12 15.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 1.1799999999999999 109.696 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 26.4 mm-40 -109.86 -83.16 0.56 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.138 -0.976 . . . . 2.1299999999999999 109.729 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.3 m -88.22 144.44 26.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 2.2599999999999998 109.535 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mt -60.56 -58.45 8.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 2.6000000000000001 109.515 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.1 -169.98 13.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 1.6200000000000001 109.573 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 22' ' ' TRP . 55.9 Cg_endo -75.4 -19.21 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.793 2.329 . . . . 1.7 112.205 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.57 ' O ' ' O ' ' A' ' 21' ' ' PRO . 11.3 m95 -50.95 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 2.4199999999999999 109.345 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.8 m -143.25 169.85 16.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 1.6399999999999999 109.509 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.76 138.64 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 2.0499999999999998 109.574 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.96 159.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 1.72 109.439 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 107.45 -26.91 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.865 -1.294 . . . . 1.7 109.865 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.783 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.78 -142.35 0.38 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.118 -1.225 . . . . 0.96999999999999997 109.201 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.783 ' N ' ' OG1' ' A' ' 27' ' ' THR . 12.4 p -91.61 -162.14 0.89 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.459 -0.775 . . . . 1.8 108.999 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.01 131.4 39.27 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 2.3999999999999999 108.811 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.66 132.29 23.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.246 1.964 . . . . 1.1299999999999999 111.839 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 37' ' ' MET . 40.8 t -118.83 111.19 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.05 109.888 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.707 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -80.49 85.54 5.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.657 -0.652 . . . . 1.8200000000000001 109.49 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.25 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 1.1699999999999999 109.689 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.26 -68.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -0.945 . . . . 2.21 109.369 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.784 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -141.55 35.19 1.82 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.436 -1.465 . . . . 1.1899999999999999 109.436 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.77 147.89 28.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -1.12 . . . . 2.9100000000000001 109.64 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 2.5 ptt? -121.18 132.78 55.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 0.93000000000000005 109.231 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 m -128.89 145.02 51.33 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.452 -0.899 . . . . 1.0600000000000001 110.376 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.16 145.43 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.705 -0.85 . . . . 1.3700000000000001 108.705 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.695 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -75.12 123.39 25.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 4.79 109.802 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.695 HD22 ' O ' ' A' ' 40' ' ' ASP . 4.4 mm? -122.69 75.02 45.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 3.54 109.258 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.663 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 51.6 Cg_exo -48.14 -167.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.871 2.381 . . . . 3.7400000000000002 112.359 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 136' ' ' ALA . . . -124.45 62.01 0.58 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.507 -1.437 . . . . 2.0299999999999998 109.507 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . -154.48 15.28 0.55 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.627 -1.389 . . . . 2.4100000000000001 109.627 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -99.93 91.35 4.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -1.164 . . . . 2.96 109.477 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.29 -7.95 61.26 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.496 -1.442 . . . . 2.0800000000000001 109.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.634 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.2 OUTLIER -99.9 121.68 53.38 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.274 -1.133 . . . . 3.6099999999999999 109.371 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.17 5.86 4.28 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.433 2.089 . . . . 2.3599999999999999 112.308 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.493 ' CH2' ' HB3' ' A' ' 47' ' ' ASN . 1.3 p-90 -122.98 33.15 5.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 3.8700000000000001 109.604 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.762 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 34.5 m-20 -126.02 43.17 3.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 2.3799999999999999 109.433 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 159.59 111.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 1.1100000000000001 109.553 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 131' ' ' PHE . . . 164.88 157.97 10.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.009 -1.236 . . . . 0.93999999999999995 110.009 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.64 ' CD1' HD13 ' A' ' 143' ' ' ILE . 7.5 mt -77.17 -176.3 4.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.27 -1.135 . . . . 0.95999999999999996 109.157 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.88 159.18 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.92000000000000004 109.593 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' HD23 ' A' ' 10' ' ' LEU . 46.2 t80 178.92 143.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.384 -0.823 . . . . 1.71 109.648 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.57 ' OD1' ' O ' ' A' ' 127' ' ' GLY . 1.4 m-80 -111.17 -164.75 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 2.7799999999999998 109.524 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 82.82 74.33 1.2 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 2.48 109.572 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 57' ' ' GLY . 52.2 t -161.12 77.57 2.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.107 . . . . 3.79 109.52 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.45 155.99 1.95 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.815 2.343 . . . . 2.3999999999999999 112.135 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -135.99 114.66 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 3.0800000000000001 109.614 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . -138.99 101.89 0.33 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.256 -1.537 . . . . 3.0499999999999998 109.256 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 63' ' ' GLY . 7.0 tp10 -38.19 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -1.087 . . . . 6.0499999999999998 109.452 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.683 ' N ' ' OE1' ' A' ' 62' ' ' GLU . . . 103.35 -56.41 0.6 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.576 -1.409 . . . . 2.54 109.576 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 152' ' ' ALA . 3.9 mm-40 -99.66 141.89 31.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.116 . . . . 4.0300000000000002 109.334 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -99.89 120.54 39.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 2.9100000000000001 109.553 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' C ' ' CG2' ' A' ' 67' ' ' VAL . 81.7 m-85 -85.55 174.71 9.26 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 2.3799999999999999 109.505 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.831 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -155.43 132.82 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 2.6099999999999999 109.323 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.2 tt -114.07 130.56 56.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.966 . . . . 3.6099999999999999 109.498 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.2 p -118.16 94.86 4.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 2.27 108.736 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.598 ' O ' ' CD1' ' A' ' 70' ' ' PHE . 11.2 p90 -93.28 135.48 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.05 -1.031 . . . . 2.0099999999999998 111.091 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.588 HG22 ' CG2' ' A' ' 108' ' ' THR . 19.1 p -90.31 109.25 20.35 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.547 -0.908 . . . . 1.8 108.547 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -158.89 165.92 33.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.624 -1.23 . . . . 0.95999999999999996 110.817 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.8 p -129.42 163.1 26.55 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.914 -0.773 . . . . 0.93000000000000005 108.914 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' HB1' ' HE2' ' A' ' 139' ' ' TYR . . . -124.39 119.3 28.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.593 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.46 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.79 116.74 16.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.057 -1.027 . . . . 0.96999999999999997 110.113 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.582 ' O ' ' O ' ' A' ' 74' ' ' ALA . 20.1 Cg_exo -65.87 -142.15 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.687 0 C-N-CA 124.232 -1.153 . . . . 1.02 112.05 -0.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' C ' ' CG ' ' A' ' 78' ' ' MET . 0.2 OUTLIER -97.86 149.39 22.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 1.75 109.208 179.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.697 ' SD ' ' CE2' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 165.21 159.82 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 2.1600000000000001 109.795 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.34 119.24 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.711 2.274 . . . . 1.3799999999999999 112.032 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.19 169.43 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 2.0099999999999998 109.44 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.739 HH11 ' CG ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -109.83 139.42 44.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.917 . . . . 6.0099999999999998 109.313 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -141.05 148.26 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 3.7599999999999998 109.533 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -147.21 144.0 28.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 2.29 109.487 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 129' ' ' VAL . 1.0 OUTLIER -152.84 145.03 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 1.8899999999999999 110.342 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 128' ' ' GLN . . . 142.21 -109.62 0.58 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.881 -1.288 . . . . 1.49 109.881 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' CD ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -89.98 164.87 14.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -1.181 . . . . 2.54 109.663 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.81 -34.03 0.36 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.593 -1.403 . . . . 1.3799999999999999 109.593 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 89' ' ' GLY . . . -80.93 165.58 47.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.542 -1.423 . . . . 2.54 109.542 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 35.7 -130.34 0.78 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.573 -1.411 . . . . 4.1399999999999997 109.573 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -142.13 39.82 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -1.16 . . . . 5.1299999999999999 109.439 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.564 ' O ' ' C ' ' A' ' 92' ' ' ARG . 2.8 m-30 -57.67 80.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 5.79 109.555 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 90' ' ' ALA . 6.5 ptp180 -29.76 149.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.549 -0.719 . . . . 5.7400000000000002 109.766 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.688 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 1.8 t -128.85 -150.93 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 2.27 110.275 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.688 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -119.01 -22.32 7.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.239 -0.652 . . . . 3.2799999999999998 109.239 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.509 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -91.11 41.66 1.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.787 -1.196 . . . . 3.6499999999999999 109.235 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -90.01 44.28 1.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.983 -1.073 . . . . 4.5999999999999996 109.537 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 111' ' ' TYR . 7.3 pt20 -106.67 137.18 45.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 3.46 109.431 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 82' ' ' VAL . . . -128.49 20.28 5.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.664 -1.374 . . . . 3.6699999999999999 109.664 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 m -104.84 76.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -1.099 . . . . 3.79 109.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.76 102.03 53.3 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.141 -0.975 . . . . 1.96 109.333 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.79 118.81 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.702 2.268 . . . . 2.9700000000000002 112.608 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.6 159.82 33.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 3.0600000000000001 109.522 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 2.4 t -103.5 -148.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 2.3399999999999999 109.86 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.597 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -110.2 29.65 9.01 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 2.1699999999999999 109.805 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.492 ' H ' HG23 ' A' ' 103' ' ' THR . 5.2 pt-20 -139.59 147.96 54.15 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.201 -1.176 . . . . 3.02 109.205 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -40.48 117.35 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.592 2.194 . . . . 1.4199999999999999 111.882 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.38 127.69 11.37 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.151 -0.968 . . . . 1.3700000000000001 109.811 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.588 ' CG2' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.62 141.14 29.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.44 -0.787 . . . . 1.72 109.853 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 111' ' ' TYR . 9.1 mmm-85 -113.26 136.44 52.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.377 -0.972 . . . . 4.7000000000000002 108.377 178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -117.18 107.36 14.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.175 -0.61 . . . . 3.2799999999999998 109.883 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 109' ' ' ARG . 42.3 m-85 -109.95 114.76 28.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.319 -0.863 . . . . 2.96 109.083 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.831 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -103.38 170.48 7.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -0.873 . . . . 3.4100000000000001 109.611 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.436 ' CD2' ' C ' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 179.05 161.68 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.915 . . . . 2.77 109.767 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.37 155.01 20.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 2.23 109.307 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -90.13 44.15 1.19 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.108 -0.995 . . . . 4.1100000000000003 109.954 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 115' ' ' SER . 6.9 m120 -39.92 -17.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 6.8600000000000003 109.576 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.799 HD12 ' CZ ' ' A' ' 119' ' ' PHE . 1.2 mm? -109.87 143.82 39.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 5.1200000000000001 109.436 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.85 107.75 18.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 4.0599999999999996 109.681 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.799 ' CZ ' HD12 ' A' ' 117' ' ' LEU . 43.0 m-85 -133.69 98.26 15.0 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 5.4400000000000004 109.181 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.28 165.58 23.34 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.52 2.147 . . . . 4.04 112.239 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.03 -14.59 12.16 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.836 2.357 . . . . 3.8999999999999999 112.069 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -109.66 123.24 49.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 4.1399999999999997 109.602 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.554 ' O ' ' OD1' ' A' ' 124' ' ' ASP . . . 150.02 -84.34 0.17 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.478 -1.449 . . . . 3.5699999999999998 109.478 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 123' ' ' GLY . 4.5 m-20 -162.21 -37.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 3.5899999999999999 109.452 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -112.59 93.45 23.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 2.0800000000000001 109.417 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.98 -159.17 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.744 2.296 . . . . 1.3899999999999999 112.273 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.57 ' O ' ' OD1' ' A' ' 56' ' ' ASN . . . -72.84 -178.99 35.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 1.1899999999999999 109.603 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.467 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -170.25 141.18 2.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -1.094 . . . . 2.0099999999999998 109.707 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.797 HG22 HG13 ' A' ' 84' ' ' VAL . 67.3 t -138.71 151.48 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.973 -1.121 . . . . 1.28 107.973 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -165.66 111.72 0.9 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.815 -1.154 . . . . 0.97999999999999998 110.48 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.514 ' O ' ' CA ' ' A' ' 52' ' ' GLY . 4.8 m-30 -94.12 84.38 4.45 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.456 -0.942 . . . . 1.73 108.456 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.493 ' NE2' ' HB1' ' A' ' 130' ' ' ALA . 19.6 m170 -98.73 132.53 44.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 2.3199999999999998 110.173 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.828 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.65 2.32 2.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 2.1099999999999999 109.268 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -48.95 136.4 19.8 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.517 -1.433 . . . . 1.77 109.517 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.668 ' O ' ' N ' ' A' ' 137' ' ' GLY . 19.5 mtpt -165.72 130.14 2.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -1.157 . . . . 5.0599999999999996 109.869 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.564 ' O ' ' O ' ' A' ' 43' ' ' GLY . . . -42.58 -17.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.87 -1.159 . . . . 2.6400000000000001 107.87 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.47 17.1 7.44 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.734 -1.747 . . . . 2.5099999999999998 108.734 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 42' ' ' PRO . . . -51.13 -149.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.903 . . . . 2.3199999999999998 110.432 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.697 ' CE2' ' SD ' ' A' ' 78' ' ' MET . 0.0 OUTLIER -171.7 -114.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.008 . . . . 1.6100000000000001 110.597 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.674 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 13.9 mt-10 -137.26 140.79 41.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 1.6499999999999999 109.351 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.627 ' HB2' HD22 ' A' ' 133' ' ' LEU . 42.0 t80 -117.53 128.3 54.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.317 -0.865 . . . . 1.6799999999999999 109.374 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.41 110.66 17.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.126 -0.984 . . . . 0.73999999999999999 109.977 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.64 HD13 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -119.66 144.68 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 1.22 109.279 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 88.6 p -130.06 -15.23 3.81 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.205 -0.665 . . . . 1.3300000000000001 109.205 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.466 ' CG ' ' C ' ' A' ' 144' ' ' SER . 3.0 mt-30 -155.51 177.52 11.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 3.2999999999999998 110.015 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 146' ' ' VAL . 3.9 p -177.04 124.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.815 . . . . 2.2599999999999998 109.461 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 176.74 11.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 2.7599999999999998 109.775 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.744 ' C ' HG22 ' A' ' 149' ' ' THR . 1.3 pp -155.37 -161.35 1.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 4.5700000000000003 109.394 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.66 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 3.0699999999999998 109.5 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -123.53 -41.26 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 2.0 109.371 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.504 ' N ' ' CG2' ' A' ' 150' ' ' THR . 3.0 m 45.19 65.65 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.389 -0.819 . . . . 2.1499999999999999 109.499 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.556 ' O ' ' OE1' ' A' ' 64' ' ' GLU . . . 61.3 -157.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.84 . . . . 2.8199999999999998 109.486 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.069 -0.967 . . . . 3.54 109.456 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.482 -0.562 . . . . 5.4699999999999998 109.482 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.722 ' H ' ' CB ' ' A' ' 152' ' ' ALA . 1.3 m 43.0 80.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 4.5300000000000002 109.431 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.544 HD23 ' OG ' ' A' ' 5' ' ' SER . 1.5 tp -113.91 137.92 51.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 5.1399999999999997 109.422 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.45 22.67 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 5.3799999999999999 109.405 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.544 ' OG ' HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -99.97 -159.51 0.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 4.8300000000000001 109.521 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 8' ' ' GLU . 53.2 mt-10 -118.18 74.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 3.4300000000000002 109.503 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLU . 4.2 t -36.81 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 2.8300000000000001 109.511 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' GLU . 4.9 tt0 -85.74 83.08 7.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 4.75 109.468 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.547 HD13 ' HD2' ' A' ' 59' ' ' PRO . 0.7 OUTLIER -61.93 -33.03 73.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 4.9500000000000002 109.426 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.612 HD13 ' H ' ' A' ' 12' ' ' HIS . 0.7 OUTLIER -109.07 96.02 19.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 2.8599999999999999 108.653 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.5 27.07 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.32 2.014 . . . . 3.8300000000000001 111.693 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.612 ' H ' HD13 ' A' ' 10' ' ' LEU . 48.2 t60 -128.31 74.21 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 2.52 109.478 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 146' ' ' VAL . 10.1 t -112.96 41.58 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 1.97 109.43 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 16' ' ' ALA . 6.5 t -115.85 59.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 1.96 109.668 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -65.49 16.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 1.76 109.263 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.05 -22.39 21.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 1.1799999999999999 109.848 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -109.81 -84.29 0.55 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 2.1299999999999999 109.633 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m -109.0 153.78 23.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 2.2599999999999998 109.443 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 37' ' ' MET . 2.2 mt -56.76 -54.26 48.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 2.6000000000000001 109.547 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA3' ' NE2' ' A' ' 12' ' ' HIS . . . 103.22 -149.24 17.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.6200000000000001 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.72 -27.49 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.748 2.299 . . . . 1.7 112.252 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.903 ' CH2' HG11 ' A' ' 146' ' ' VAL . 15.4 m95 -52.01 167.59 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 2.4199999999999999 109.256 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -131.87 179.25 6.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.166 -0.959 . . . . 1.6399999999999999 109.676 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.443 HD13 ' CG ' ' A' ' 30' ' ' PRO . 2.9 pp 179.35 152.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 2.0499999999999998 109.504 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -179.06 152.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 1.72 109.529 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.71 -24.63 13.01 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.909 -1.139 . . . . 1.7 110.435 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.813 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.78 -144.27 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.381 . . . . 0.96999999999999997 109.583 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.813 ' N ' ' OG1' ' A' ' 27' ' ' THR . 7.9 p -92.8 135.22 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 1.8 109.291 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -41.27 104.25 0.34 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.976 -1.078 . . . . 2.3999999999999999 108.588 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' CG ' HD13 ' A' ' 24' ' ' LEU . 51.7 Cg_exo -46.95 166.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.183 1.922 . . . . 1.1299999999999999 111.83 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.8 t -151.08 121.16 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.07 -1.019 . . . . 1.05 110.182 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -76.2 92.96 3.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.85 . . . . 1.8200000000000001 109.341 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.68 -140.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 1.1699999999999999 109.531 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' OD1' ' C ' ' A' ' 34' ' ' ASP . 39.6 t0 -58.6 -43.41 89.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.965 . . . . 2.21 109.368 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.566 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -160.74 48.35 0.38 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.271 -1.531 . . . . 1.1899999999999999 109.271 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -171.29 146.29 2.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -1.11 . . . . 2.9100000000000001 109.496 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.492 ' SD ' HD21 ' A' ' 19' ' ' LEU . 40.4 ttp -109.58 133.76 52.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.246 -0.908 . . . . 0.93000000000000005 109.068 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.696 ' SG ' ' OE2' ' A' ' 140' ' ' GLU . 0.5 OUTLIER -127.76 173.61 9.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.229 -0.919 . . . . 1.0600000000000001 110.434 -179.267 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG1' ' HG3' ' A' ' 30' ' ' PRO . 3.1 m -149.26 144.97 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.875 -0.787 . . . . 1.3700000000000001 108.875 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.608 ' C ' HD22 ' A' ' 41' ' ' LEU . 35.4 m-20 -82.48 106.48 14.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.88 . . . . 4.79 109.289 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.608 HD22 ' C ' ' A' ' 40' ' ' ASP . 3.8 mm? -113.5 80.1 4.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 3.54 109.654 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.37 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.756 2.304 . . . . 3.7400000000000002 112.238 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' HA2' ' H ' ' A' ' 136' ' ' ALA . . . -120.24 115.58 3.0 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.539 -1.425 . . . . 2.0299999999999998 109.539 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.675 ' H ' ' H ' ' A' ' 136' ' ' ALA . . . -174.88 -40.83 0.05 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.843 -1.303 . . . . 2.4100000000000001 109.843 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.847 ' HB2' ' HZ2' ' A' ' 135' ' ' LYS . 12.0 mt-30 -100.0 125.35 46.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -1.153 . . . . 2.96 109.586 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -105.89 65.88 0.27 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 2.0800000000000001 109.344 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.659 ' ND2' ' OD2' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -146.03 96.6 4.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.36 -1.082 . . . . 3.6099999999999999 109.396 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 53.1 Cg_exo -48.44 4.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.852 2.368 . . . . 2.3599999999999999 113.079 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.598 ' N ' ' O ' ' A' ' 47' ' ' ASN . 1.4 p-90 -127.59 34.32 4.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.885 -1.134 . . . . 3.8700000000000001 109.667 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 30.7 m-20 -132.97 39.05 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 2.3799999999999999 109.215 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 158.78 94.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 1.1100000000000001 109.259 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . -171.9 174.13 45.21 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.864 -1.295 . . . . 0.93999999999999995 109.864 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.537 ' C ' HG22 ' A' ' 54' ' ' VAL . 6.6 mt -95.05 -178.1 4.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 0.95999999999999996 109.526 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.537 HG22 ' C ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -162.94 162.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.422 -0.798 . . . . 0.92000000000000004 109.293 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 15.2 t80 172.26 140.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 1.71 109.72 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.689 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 1.4 m120 -94.38 -168.1 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 2.7799999999999998 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.678 ' O ' HG23 ' A' ' 58' ' ' VAL . . . 82.3 74.62 1.17 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.463 -1.455 . . . . 2.48 109.463 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 58' ' ' VAL . 48.6 t -161.31 69.74 2.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.275 -1.132 . . . . 3.79 109.547 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.547 ' HD2' HD13 ' A' ' 9' ' ' LEU . 42.0 Cg_endo -71.85 120.51 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.789 2.326 . . . . 2.3999999999999999 112.136 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.727 HG12 ' OG ' ' A' ' 115' ' ' SER . 4.7 t -112.5 141.25 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 3.0800000000000001 109.532 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -116.5 98.9 0.83 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.464 -1.454 . . . . 3.0499999999999998 109.464 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 61' ' ' GLY . 61.8 tt0 -35.64 130.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 6.0499999999999998 109.546 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' N ' ' HB3' ' A' ' 115' ' ' SER . . . 111.08 -32.36 6.57 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.626 -1.39 . . . . 2.54 109.626 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 115' ' ' SER . 1.3 mt-10 -100.01 177.9 4.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -1.157 . . . . 4.0300000000000002 109.525 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -128.53 143.79 51.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 2.9100000000000001 109.457 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 27.2 m-85 -112.75 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.156 -0.965 . . . . 2.3799999999999999 109.677 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.406 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.4 t -152.8 137.24 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.551 -0.718 . . . . 2.6099999999999999 109.281 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 148' ' ' LEU . 0.7 OUTLIER -120.83 121.51 38.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.108 -0.995 . . . . 3.6099999999999999 109.782 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 3.1 p -109.52 85.47 2.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 2.27 108.745 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 27.7 p90 -93.63 143.56 26.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 2.0099999999999998 111.167 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -93.39 122.91 36.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.609 -0.885 . . . . 1.8 108.609 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.801 ' N ' HH22 ' A' ' 109' ' ' ARG . . . -163.44 147.11 10.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 0.95999999999999996 110.385 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.37 135.9 52.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.877 -0.786 . . . . 0.93000000000000005 108.877 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.859 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -107.6 116.73 32.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.67000000000000004 109.819 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.521 ' OG1' ' CG ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -131.24 119.09 17.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.96999999999999997 109.831 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 74' ' ' ALA . 18.9 Cg_exo -66.17 -142.19 0.15 OUTLIER 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.305 -1.123 . . . . 1.02 112.372 -0.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 159.24 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 1.75 109.809 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.513 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 2.9 mtt 162.83 154.98 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.428 -0.795 . . . . 2.1600000000000001 109.215 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.71 148.65 32.9 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.812 2.341 . . . . 1.3799999999999999 112.628 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -122.91 172.1 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 2.0099999999999998 109.056 179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 132' ' ' HIS . 14.9 ttt180 -134.81 95.54 3.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 6.0099999999999998 109.921 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' HA ' ' H ' ' A' ' 132' ' ' HIS . 1.4 m -99.88 148.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.262 -0.899 . . . . 3.7599999999999998 108.939 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 83' ' ' LEU . 1.6 pp -139.73 152.98 47.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 2.29 109.99 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.588 HG13 ' HA ' ' A' ' 129' ' ' VAL . 1.3 t -149.15 157.7 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 1.8899999999999999 109.389 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.88 -143.78 8.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.622 -1.391 . . . . 1.49 109.622 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.662 ' O ' ' NE2' ' A' ' 128' ' ' GLN . 0.3 OUTLIER -90.24 -176.33 4.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.117 . . . . 2.54 109.409 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 125' ' ' ALA . . . -126.33 66.99 0.54 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.613 -1.395 . . . . 1.3799999999999999 109.613 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.53 ' O ' ' CD ' ' A' ' 86' ' ' GLU . . . 110.34 167.65 19.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.568 -1.413 . . . . 2.54 109.568 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -32.53 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.502 -1.439 . . . . 4.1399999999999997 109.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . -172.19 73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -1.17 . . . . 5.1299999999999999 109.47 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 90' ' ' ALA . 1.8 m-85 -36.94 -24.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 5.79 109.438 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.721 ' CG ' HH11 ' A' ' 92' ' ' ARG . 0.1 OUTLIER -42.98 119.55 1.54 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 5.7400000000000002 109.437 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -121.18 169.43 10.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 2.27 109.954 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 116' ' ' ASN . . . -124.02 -15.9 6.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 3.2799999999999998 108.881 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.482 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -90.51 36.88 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 3.6499999999999999 109.155 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -76.38 98.1 4.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.98 . . . . 4.5999999999999996 109.504 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.724 ' NE2' ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -106.15 137.12 44.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 3.46 109.128 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.562 ' N ' ' NE2' ' A' ' 97' ' ' GLN . . . -136.73 -0.25 2.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.766 -1.334 . . . . 3.6699999999999999 109.766 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.724 ' H ' ' NE2' ' A' ' 97' ' ' GLN . 1.6 m -122.8 63.37 0.98 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.131 -1.217 . . . . 3.79 109.773 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.812 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -112.89 96.39 37.78 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 1.96 109.494 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.41 125.76 5.84 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.791 2.327 . . . . 2.9700000000000002 112.573 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 70.7 mt -133.4 149.24 51.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 3.0600000000000001 109.271 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.652 ' O ' ' N ' ' A' ' 105' ' ' GLU . 1.8 t -136.69 -174.92 3.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 2.3399999999999999 109.58 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -63.13 38.62 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.566 -1.414 . . . . 2.1699999999999999 109.566 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' A' ' 103' ' ' THR . 17.3 tp10 -117.33 78.85 11.04 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 3.02 109.387 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -46.53 118.94 2.83 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.801 2.334 . . . . 1.4199999999999999 112.17 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.671 ' O ' ' NH1' ' A' ' 109' ' ' ARG . . . -174.32 169.72 3.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 1.3700000000000001 109.58 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.543 ' CG2' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.82 141.15 29.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 1.72 109.881 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.801 HH22 ' N ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.55 137.06 49.88 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.705 -1.22 . . . . 4.7000000000000002 107.705 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 110' ' ' GLU . 6.2 mp0 -111.22 107.43 16.74 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.847 -0.741 . . . . 3.2799999999999998 110.977 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 9.6 m-30 -109.89 110.69 21.73 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.186 -1.042 . . . . 2.96 108.186 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.13 153.25 22.36 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.232 -0.917 . . . . 3.4100000000000001 109.777 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.667 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.5 OUTLIER -141.08 173.82 11.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.86 . . . . 2.77 109.289 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -101.35 111.44 23.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 2.23 109.655 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.727 ' OG ' HG12 ' A' ' 60' ' ' VAL . 6.9 t -41.03 125.99 2.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 4.1100000000000003 109.353 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.737 ' O ' HD22 ' A' ' 117' ' ' LEU . 6.4 p-10 -121.21 -30.64 4.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 6.8600000000000003 109.522 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 116' ' ' ASN . 3.4 mm? -123.97 123.82 41.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 5.1200000000000001 109.472 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -65.56 116.28 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 4.0599999999999996 109.393 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 86' ' ' GLU . 23.8 m-85 -122.45 79.61 46.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 5.4400000000000004 109.48 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.83 168.98 2.05 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.808 2.338 . . . . 4.04 111.96 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.66 -16.89 10.16 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.696 2.264 . . . . 3.8999999999999999 112.117 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.59 176.59 4.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 4.1399999999999997 109.409 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . 102.78 -156.17 18.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.562 -1.415 . . . . 3.5699999999999998 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 5.0 p-10 -35.87 -72.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -1.134 . . . . 3.5899999999999999 109.565 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 87' ' ' GLY . . . -137.63 150.34 67.84 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 2.0800000000000001 109.463 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.86 -158.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.824 2.35 . . . . 1.3899999999999999 112.246 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' CG ' ' A' ' 56' ' ' ASN . . . -58.36 157.31 19.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.428 . . . . 1.1899999999999999 109.529 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.662 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -145.3 149.42 34.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -1.165 . . . . 2.0099999999999998 109.484 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.588 ' HA ' HG13 ' A' ' 84' ' ' VAL . 58.0 t -150.58 150.83 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.627 -0.879 . . . . 1.28 108.627 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.35 99.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.004 -1.06 . . . . 0.97999999999999998 110.369 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.414 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 4.8 m-30 -70.18 114.34 8.23 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 1.73 108.144 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 48' ' ' PRO . 1.2 m170 -99.28 133.2 43.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 2.3199999999999998 110.388 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.561 ' O ' ' O ' ' A' ' 134' ' ' GLY . 4.6 mp -127.81 -40.79 1.7 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.78 . . . . 2.1099999999999999 109.064 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 55.71 147.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 1.77 109.693 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.847 ' HZ2' ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -99.8 -150.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.169 . . . . 5.0599999999999996 109.547 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 135' ' ' LYS . . . 78.46 6.11 2.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 2.6400000000000001 109.055 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 166.29 10.03 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.136 -1.586 . . . . 2.5099999999999998 109.136 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.02 -149.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -1.084 . . . . 2.3199999999999998 109.573 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.859 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -166.74 -114.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.392 -0.818 . . . . 1.6100000000000001 109.828 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.696 ' OE2' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -123.02 141.58 51.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 1.6499999999999999 108.773 179.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.666 ' CE1' ' HB1' ' A' ' 72' ' ' ALA . 18.2 t80 -125.84 114.86 19.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.354 -0.841 . . . . 1.6799999999999999 110.045 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 140' ' ' GLU . 1.5 m -117.71 103.16 9.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.73999999999999999 110.014 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 143.42 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 1.22 109.013 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.445 ' C ' ' CG ' ' A' ' 145' ' ' GLN . 49.6 p -137.84 -1.17 2.04 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.601 -0.687 . . . . 1.3300000000000001 109.358 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.571 ' O ' ' OG1' ' A' ' 71' ' ' THR . 7.3 mt-30 -153.06 153.84 33.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 3.2999999999999998 109.98 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.903 HG11 ' CH2' ' A' ' 22' ' ' TRP . 88.1 t -160.18 121.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 2.2599999999999998 109.369 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 p -152.01 171.73 17.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.083 -1.011 . . . . 2.7599999999999998 109.702 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.817 HD23 ' N ' ' A' ' 148' ' ' LEU . 1.9 pt? -157.94 -162.44 1.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 4.5700000000000003 109.508 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.756 HG22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER 165.34 -165.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 3.0699999999999998 109.443 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.668 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.5 t -163.93 -115.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 2.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 153' ' ' THR . 0.5 OUTLIER 158.9 35.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 2.1499999999999999 109.393 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.722 ' CB ' ' H ' ' A' ' 2' ' ' SER . . . 37.06 23.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 2.8199999999999998 109.444 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 151' ' ' SER . 10.4 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.043 -0.979 . . . . 3.54 109.461 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.499 -0.556 . . . . 5.4699999999999998 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.646 ' OG ' ' N ' ' A' ' 152' ' ' ALA . 95.0 p -72.72 -107.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 4.5300000000000002 109.445 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 4' ' ' ASP . 4.4 tp 53.1 -155.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 5.1399999999999997 109.415 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.616 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -44.43 176.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 5.3799999999999999 109.538 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER 84.13 164.17 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 4.8300000000000001 109.478 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -106.87 133.14 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 3.4300000000000002 109.502 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.21 51.73 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.867 . . . . 2.8300000000000001 109.474 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.651 ' OE1' ' N ' ' A' ' 9' ' ' LEU . 3.8 tp10 -49.93 106.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.902 . . . . 4.75 109.485 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.651 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 3.9 mt -85.7 28.09 0.8 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.91 . . . . 4.9500000000000002 109.445 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.749 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.0 tm? -157.19 89.09 2.55 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 2.8599999999999999 108.889 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -53.72 43.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.186 2.591 . . . . 3.8300000000000001 113.321 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.675 ' N ' ' O ' ' A' ' 10' ' ' LEU . 11.7 t60 -158.39 102.8 1.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.892 -1.13 . . . . 2.52 109.53 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.443 ' CB ' ' O ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -147.04 43.91 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 1.97 109.469 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.542 ' C ' ' H ' ' A' ' 16' ' ' ALA . 68.8 m -155.77 81.73 1.02 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.145 -0.972 . . . . 1.96 109.947 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -69.41 36.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 1.76 108.988 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HA2' ' A' ' 35' ' ' GLY . . . -78.46 -30.43 47.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.599 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.592 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 1.9 mt-10 -110.38 -73.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 2.1299999999999999 109.501 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.8 m -109.24 145.25 36.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 2.2599999999999998 109.504 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 37' ' ' MET . 4.4 mt -51.39 -48.22 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 2.6000000000000001 109.522 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 97.74 -172.87 27.65 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.502 -1.439 . . . . 1.6200000000000001 109.502 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 37.0 Cg_endo -69.86 -20.68 34.07 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.739 2.293 . . . . 1.7 112.189 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.575 ' CE2' ' CD2' ' A' ' 55' ' ' TYR . 8.6 m95 -53.55 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.993 . . . . 2.4199999999999999 109.286 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -141.51 167.53 21.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 1.6399999999999999 109.782 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.908 HD22 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -174.58 167.59 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.303 -0.873 . . . . 2.0499999999999998 109.4 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.737 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 166.74 -176.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 1.72 109.649 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 94.34 -28.85 9.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 1.7 109.842 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.814 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.85 -142.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 0.96999999999999997 109.306 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.814 ' N ' ' OG1' ' A' ' 27' ' ' THR . 4.6 p -91.02 -163.8 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 1.8 109.254 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.25 111.58 47.83 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 2.3999999999999999 109.022 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HB3' ' CG ' ' A' ' 37' ' ' MET . 56.3 Cg_exo -45.71 159.76 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.268 1.979 . . . . 1.1299999999999999 112.022 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.4 t -143.52 109.24 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 1.05 109.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -69.82 72.55 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 1.8200000000000001 109.456 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 35' ' ' GLY . . . -65.31 -138.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 1.1699999999999999 109.644 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.67 81.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.82 . . . . 2.21 109.526 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 47.5 30.68 6.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.639 -1.384 . . . . 1.1899999999999999 109.639 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -144.45 142.81 30.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -1.144 . . . . 2.9100000000000001 109.564 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 19' ' ' LEU . 5.3 ttp -109.87 125.24 52.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.93000000000000005 109.163 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HD3' ' A' ' 36' ' ' ARG . 56.8 m -124.6 154.79 40.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.917 . . . . 1.0600000000000001 110.084 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.96 139.4 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.525 -0.734 . . . . 1.3700000000000001 109.025 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.719 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -91.12 122.21 33.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 4.79 109.649 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.761 ' O ' ' HB1' ' A' ' 138' ' ' ALA . 9.0 mp -113.29 92.98 24.29 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 3.54 109.344 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 51.1 Cg_exo -50.03 -57.02 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.031 2.487 . . . . 3.7400000000000002 112.625 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 138' ' ' ALA . . . 117.99 146.53 8.17 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.783 -1.327 . . . . 2.0299999999999998 109.783 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 33.34 0.73 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.863 -1.295 . . . . 2.4100000000000001 109.863 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.525 ' NE2' ' CB ' ' A' ' 50' ' ' ASP . 9.1 mt-30 -118.26 150.48 39.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.113 -1.228 . . . . 2.96 109.648 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.13 56.83 0.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.383 -1.487 . . . . 2.0800000000000001 109.383 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.623 ' ND2' ' N ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -174.48 98.49 0.29 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.199 -1.177 . . . . 3.6099999999999999 109.393 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD2' ' CZ3' ' A' ' 49' ' ' TRP . 77.6 Cg_exo -46.27 -21.62 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.613 2.209 . . . . 2.3599999999999999 112.431 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 39.2 p90 -106.9 65.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 3.8700000000000001 109.494 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' NE2' ' A' ' 45' ' ' GLN . 1.2 m-20 -134.99 6.57 3.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 2.3799999999999999 109.695 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -177.06 154.75 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 1.1100000000000001 109.721 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.43 ' C ' HD22 ' A' ' 53' ' ' LEU . . . 144.11 -169.33 26.29 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.879 -1.288 . . . . 0.93999999999999995 109.879 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.975 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -97.34 152.18 19.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.374 -1.074 . . . . 0.95999999999999996 109.134 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.901 HG13 ' HB2' ' A' ' 130' ' ' ALA . 2.0 t -144.53 162.87 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.92000000000000004 110.083 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.69 ' CE2' ' O ' ' A' ' 56' ' ' ASN . 18.7 t80 175.58 149.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 1.71 109.4 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.69 ' O ' ' CE2' ' A' ' 55' ' ' TYR . 1.4 m-80 -101.37 176.8 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 2.7799999999999998 109.527 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 58' ' ' VAL . . . 95.6 76.99 1.34 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 2.48 109.563 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 57' ' ' GLY . 0.7 OUTLIER -156.8 70.3 4.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 3.79 109.498 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.674 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 51.1 Cg_exo -49.48 131.67 28.28 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.801 2.334 . . . . 2.3999999999999999 112.191 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.07 114.24 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 3.0800000000000001 109.521 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -117.18 103.55 1.11 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.521 -1.432 . . . . 3.0499999999999998 109.521 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HB2' ' N ' ' A' ' 117' ' ' LEU . 3.4 tm-20 -47.34 139.05 6.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -1.138 . . . . 6.0499999999999998 109.529 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.11 -37.18 3.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.688 -1.365 . . . . 2.54 109.688 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' SER . 2.7 mt-10 -99.99 168.88 9.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -1.18 . . . . 4.0300000000000002 109.574 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 37.6 m -115.0 139.93 49.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 2.9100000000000001 109.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.674 ' CZ ' ' O ' ' A' ' 59' ' ' PRO . 22.9 m-85 -104.61 -178.32 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.115 -0.99 . . . . 2.3799999999999999 109.549 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.851 HG13 ' HB2' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -153.76 121.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 2.6099999999999999 109.639 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 148' ' ' LEU . 1.4 tp -111.52 115.96 30.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 3.6099999999999999 109.23 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -109.88 86.46 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.067 -1.02 . . . . 2.27 109.198 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 6.9 p90 -94.9 139.29 31.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.442 -0.786 . . . . 2.0099999999999998 111.295 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 108' ' ' THR . 0.7 OUTLIER -98.35 119.6 37.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.499 -0.926 . . . . 1.8 108.499 178.414 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 141' ' ' PHE . . . -171.57 134.68 0.85 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.077 -1.015 . . . . 0.95999999999999996 110.024 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB2' ' N ' ' A' ' 105' ' ' GLU . 53.2 p -124.26 122.38 37.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 109.21 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.596 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -91.67 135.95 33.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.67000000000000004 109.386 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.449 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -131.16 117.06 16.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 O-C-N 121.351 -0.843 . . . . 0.96999999999999997 109.49 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.1 Cg_exo -66.52 -142.42 0.16 OUTLIER 'Cis proline' 0 N--CA 1.496 1.66 0 C-N-CA 124.305 -1.123 . . . . 1.02 112.199 -0.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.453 ' O ' ' CE ' ' A' ' 78' ' ' MET . 0.7 OUTLIER -104.85 152.18 22.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 1.75 109.38 179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.453 ' CE ' ' O ' ' A' ' 77' ' ' ASP . 1.4 mtm -176.42 156.93 1.52 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 2.1600000000000001 109.157 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.82 118.9 4.94 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.752 2.301 . . . . 1.3799999999999999 112.402 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 98' ' ' GLY . 4.7 m -99.19 176.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 2.0099999999999998 109.275 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 132' ' ' HIS . 18.7 ttm180 -122.67 146.47 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 6.0099999999999998 109.728 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.29 155.27 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.301 -0.874 . . . . 3.7599999999999998 109.45 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.11 156.95 43.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 2.29 109.608 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.556 ' O ' ' OG1' ' A' ' 93' ' ' THR . 1.0 OUTLIER -146.79 138.3 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 1.8899999999999999 109.681 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 136.56 -155.71 22.72 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.472 -1.451 . . . . 1.49 109.472 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.691 ' OE2' ' CG ' ' A' ' 119' ' ' PHE . 21.6 pm0 -88.82 -155.02 0.32 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 2.54 109.482 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.445 ' CA ' HE22 ' A' ' 128' ' ' GLN . . . 167.56 14.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.3799999999999999 109.669 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.35 -110.36 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 2.54 109.49 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 91' ' ' TYR . . . -81.9 -135.3 1.99 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.46 -1.456 . . . . 4.1399999999999997 109.46 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.48 0.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 5.1299999999999999 109.393 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER -69.77 80.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 5.79 109.46 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.58 ' O ' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -71.52 167.62 19.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.943 . . . . 5.7400000000000002 109.51 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -99.94 176.37 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 2.27 109.786 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.505 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -113.93 -22.77 9.94 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.897 -0.779 . . . . 3.2799999999999998 108.897 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -90.84 34.26 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 3.6499999999999999 109.35 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' C ' ' OE1' ' A' ' 96' ' ' GLU . 1.3 tm-20 -79.03 82.21 5.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 4.5999999999999996 109.486 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.52 ' CG ' ' N ' ' A' ' 98' ' ' GLY . 3.9 pt20 -108.99 -160.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 3.46 109.522 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 97' ' ' GLN . . . -173.49 -41.18 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.534 -1.426 . . . . 3.6699999999999999 109.534 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.48 79.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 3.79 109.585 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 98' ' ' GLY . . . -122.02 96.3 46.8 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 1.96 109.417 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.42 130.7 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.815 2.344 . . . . 2.9700000000000002 112.754 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -132.65 140.32 48.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 3.0600000000000001 109.297 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.66 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -93.93 -160.98 0.81 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 2.3399999999999999 109.514 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.66 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -107.66 33.08 6.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 2.1699999999999999 109.637 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.474 ' N ' ' HB2' ' A' ' 73' ' ' SER . 0.4 OUTLIER -119.12 142.07 31.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.218 -1.166 . . . . 3.02 109.351 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.682 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 55.3 Cg_endo -73.52 136.55 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.584 2.189 . . . . 1.4199999999999999 112.217 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PRO . . . 165.48 160.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 1.3700000000000001 109.662 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -83.56 131.03 35.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 1.72 110.062 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 69' ' ' SER . 3.2 mmt180 -93.51 146.42 23.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.648 -1.612 . . . . 4.7000000000000002 106.648 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.02 105.83 16.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.936 -1.103 . . . . 3.2799999999999998 110.192 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -109.48 76.2 0.99 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.683 -0.858 . . . . 2.96 108.683 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.851 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -99.97 164.89 11.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 3.4100000000000001 109.712 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' CE1' ' CE2' ' A' ' 95' ' ' PHE . 4.2 p90 -164.96 -174.21 3.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 2.77 109.607 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.41 HG22 ' OG ' ' A' ' 65' ' ' SER . 0.7 OUTLIER -109.28 112.22 24.24 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -0.811 . . . . 2.23 109.57 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 64' ' ' GLU . 6.8 t -47.27 125.11 7.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 4.1100000000000003 109.395 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.792 ' O ' HD22 ' A' ' 117' ' ' LEU . 7.8 t-20 -124.2 1.03 8.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 6.8600000000000003 109.422 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -145.98 120.41 9.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 5.1200000000000001 109.444 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.648 ' O ' ' CG ' ' A' ' 119' ' ' PHE . 0.8 OUTLIER -67.93 140.16 56.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 4.0599999999999996 109.58 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.691 ' CG ' ' OE2' ' A' ' 86' ' ' GLU . 18.4 m-85 -170.01 76.67 0.64 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 5.4400000000000004 109.524 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.12 169.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.86 2.373 . . . . 4.04 111.944 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.575 ' O ' ' O ' ' A' ' 125' ' ' ALA . 66.2 Cg_endo -80.46 -16.14 10.81 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.801 2.334 . . . . 3.8999999999999999 112.082 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' ' C ' ' A' ' 123' ' ' GLY . 17.4 p-10 -109.95 -46.43 3.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 4.1399999999999997 109.516 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.487 ' C ' ' O ' ' A' ' 122' ' ' ASP . . . -39.42 -45.02 2.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.489 -1.444 . . . . 3.5699999999999998 109.489 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.19 -73.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 3.5899999999999999 109.473 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 121' ' ' PRO . . . -139.82 162.19 52.08 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 2.0800000000000001 109.4 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 125' ' ' ALA . 6.6 Cg_endo -52.68 -5.37 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 123.028 2.485 . . . . 1.3899999999999999 112.202 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 125' ' ' ALA . . . 120.82 161.19 11.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.51 -1.436 . . . . 1.1899999999999999 109.51 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 2.3 tt0 -149.15 105.82 3.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -1.148 . . . . 2.0099999999999998 109.718 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 84' ' ' VAL . 1.7 p -139.09 118.39 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.648 -0.871 . . . . 1.28 108.648 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.901 ' HB2' HG13 ' A' ' 54' ' ' VAL . . . -142.23 139.34 31.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -0.976 . . . . 0.97999999999999998 110.583 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -94.73 109.31 21.27 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.711 -0.848 . . . . 1.73 108.711 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.644 ' O ' ' N ' ' A' ' 81' ' ' ARG . 6.3 m170 -99.74 119.8 38.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 2.3199999999999998 109.733 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.883 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -112.3 -3.56 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 2.1099999999999999 109.126 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . 46.13 -179.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.377 -1.489 . . . . 1.77 109.377 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.418 ' NZ ' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mtmt -125.41 24.28 7.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.021 -1.282 . . . . 5.0599999999999996 109.592 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.2 -21.69 63.94 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.714 -1.217 . . . . 2.6400000000000001 107.714 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.698 ' O ' ' CD2' ' A' ' 139' ' ' TYR . . . -130.1 54.91 0.78 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.655 -2.178 . . . . 2.5099999999999998 107.655 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.761 ' HB1' ' O ' ' A' ' 41' ' ' LEU . . . -29.62 154.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.807 0.813 . . . . 2.3199999999999998 110.825 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 0.0 OUTLIER 174.5 -163.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 1.6100000000000001 109.132 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -114.43 120.28 39.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.993 . . . . 1.6499999999999999 109.728 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 72' ' ' ALA . 6.4 t80 -102.15 106.87 17.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.867 . . . . 1.6799999999999999 108.796 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.0 m -106.37 101.18 10.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.73999999999999999 110.566 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 140.71 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -0.814 . . . . 1.22 108.878 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.677 ' OG ' ' NE2' ' A' ' 145' ' ' GLN . 53.0 p -133.43 -7.51 2.91 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 109.516 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.677 ' NE2' ' OG ' ' A' ' 144' ' ' SER . 1.8 mm-40 -146.62 161.46 40.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 3.2999999999999998 109.663 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 146' ' ' VAL . 8.4 p -176.23 109.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.2599999999999998 109.758 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.5 p -153.54 162.77 40.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 2.7599999999999998 109.47 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.701 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.5 pp -143.43 171.97 13.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 4.5700000000000003 109.42 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -165.85 -168.19 1.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 3.0699999999999998 109.482 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.667 HG23 ' N ' ' A' ' 151' ' ' SER . 9.3 t -146.36 -135.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.203 -0.935 . . . . 2.0 109.486 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.667 ' N ' HG23 ' A' ' 150' ' ' THR . 0.0 OUTLIER 170.95 125.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 2.1499999999999999 109.426 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.646 ' N ' ' OG ' ' A' ' 2' ' ' SER . . . 60.74 166.35 0.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -0.922 . . . . 2.8199999999999998 109.417 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.979 -1.01 . . . . 3.54 109.491 -179.992 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.477 -0.564 . . . . 5.4699999999999998 109.477 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.546 ' O ' ' C ' ' A' ' 3' ' ' LEU . 0.7 OUTLIER -113.71 -33.75 5.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 4.5300000000000002 109.432 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -35.09 111.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 5.1399999999999997 109.618 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.558 ' OD1' ' OG ' ' A' ' 5' ' ' SER . 7.1 p30 -148.46 19.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 5.3799999999999999 109.277 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.558 ' OG ' ' OD1' ' A' ' 4' ' ' ASP . 2.1 p 167.92 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 4.8300000000000001 109.276 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.654 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -34.71 120.87 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 3.4300000000000002 109.698 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -71.25 23.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 2.8300000000000001 109.272 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 6' ' ' GLU . 5.6 tt0 24.23 65.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.025 0.44 . . . . 4.75 110.659 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' ' 148' ' ' LEU . 12.3 mt -56.02 -49.12 74.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.063 -1.023 . . . . 4.9500000000000002 108.859 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.649 HD13 ' CZ ' ' A' ' 55' ' ' TYR . 1.2 tp -101.34 116.05 64.26 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.293 -1.003 . . . . 2.8599999999999999 108.293 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.58 27.84 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.215 1.943 . . . . 3.8300000000000001 111.946 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.551 ' O ' HD23 ' A' ' 10' ' ' LEU . 35.9 t60 -137.02 139.15 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 2.52 109.502 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.576 ' O ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -170.07 54.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 1.97 109.338 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -164.41 73.43 0.25 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -0.921 . . . . 1.96 109.572 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -62.97 40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 1.76 108.897 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 14' ' ' SER . . . -74.05 -46.96 40.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 1.1799999999999999 109.925 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.674 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 6.9 mt-10 -109.78 -84.02 0.56 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 2.1299999999999999 109.542 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.8 m -94.41 142.98 26.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 2.2599999999999998 109.465 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.692 ' HB2' HD21 ' A' ' 24' ' ' LEU . 2.1 pp -57.62 -12.56 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.875 . . . . 2.6000000000000001 109.558 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.571 ' O ' HD12 ' A' ' 19' ' ' LEU . . . 82.1 -147.05 25.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.36 -1.496 . . . . 1.6200000000000001 109.36 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.31 -11.78 13.1 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.671 2.247 . . . . 1.7 112.143 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' CH2' HG11 ' A' ' 146' ' ' VAL . 10.6 m95 -66.51 -164.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 2.4199999999999999 109.284 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.726 ' C ' HD23 ' A' ' 24' ' ' LEU . 1.8 m -156.44 126.84 6.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 1.6399999999999999 109.559 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.841 ' N ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -121.08 133.17 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.958 . . . . 2.0499999999999998 109.554 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.681 ' CD1' ' O ' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -177.97 153.35 0.81 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 1.72 109.597 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 109.69 -22.92 23.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.951 -1.259 . . . . 1.7 109.951 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.823 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -109.91 -142.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.998 -1.295 . . . . 0.96999999999999997 109.373 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.823 ' N ' ' OG1' ' A' ' 27' ' ' THR . 6.3 p -90.96 141.54 28.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 1.8 109.41 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.8 OUTLIER -37.38 101.59 0.22 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.966 . . . . 2.3999999999999999 109.236 179.705 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.665 ' HG2' HD12 ' A' ' 24' ' ' LEU . 59.9 Cg_exo -46.27 160.94 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.404 2.069 . . . . 1.1299999999999999 111.879 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.828 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.7 p -138.35 97.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 1.05 110.318 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -77.32 84.41 3.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.454 -0.779 . . . . 1.8200000000000001 109.096 178.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.15 -140.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -0.786 . . . . 1.1699999999999999 109.925 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -58.72 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 2.21 109.563 -179.806 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' ' CB ' ' A' ' 16' ' ' ALA . . . -141.73 47.25 0.85 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.727 -1.349 . . . . 1.1899999999999999 109.727 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.716 ' NH2' ' SG ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -168.43 148.88 4.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 2.9100000000000001 109.752 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.736 ' CE ' HD13 ' A' ' 24' ' ' LEU . 58.2 ttp -123.43 129.24 50.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.419 -0.8 . . . . 0.93000000000000005 109.224 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.716 ' SG ' ' NH2' ' A' ' 36' ' ' ARG . 59.3 m -122.65 146.55 47.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.607 -0.837 . . . . 1.0600000000000001 110.072 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HD13 ' A' ' 41' ' ' LEU . 3.0 m -122.69 160.25 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.62 -0.881 . . . . 1.3700000000000001 108.62 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.772 ' C ' HD12 ' A' ' 41' ' ' LEU . 2.9 m-20 -105.9 99.69 9.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 4.79 110.119 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.772 HD12 ' C ' ' A' ' 40' ' ' ASP . 7.2 mp -113.73 79.76 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 3.54 109.137 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.18 -158.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.872 2.381 . . . . 3.7400000000000002 112.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 136' ' ' ALA . . . -96.09 123.85 7.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.444 -1.462 . . . . 2.0299999999999998 109.444 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.0 -14.83 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 2.4100000000000001 109.535 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 50' ' ' ASP . 27.4 mt-30 -99.79 70.11 1.62 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -1.184 . . . . 2.96 109.435 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.83 49.63 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.548 -1.421 . . . . 2.0800000000000001 109.548 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -164.65 87.14 1.08 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.223 -1.163 . . . . 3.6099999999999999 109.494 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 51.3 Cg_exo -48.73 -6.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.826 2.351 . . . . 2.3599999999999999 112.173 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.479 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.3 p90 -100.25 37.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 3.8700000000000001 109.485 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.668 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 46.3 m-20 -146.1 32.79 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 2.3799999999999999 109.434 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . 172.97 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 1.1100000000000001 109.403 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.6 173.7 41.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.783 -1.327 . . . . 0.93999999999999995 109.783 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' C ' ' CG2' ' A' ' 54' ' ' VAL . 5.2 mp -99.67 175.94 5.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 0.95999999999999996 109.245 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 129' ' ' VAL . 0.6 OUTLIER -152.95 167.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.92000000000000004 110.51 -179.61 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.687 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 5.4 t80 -177.65 132.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 1.71 109.162 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.687 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -107.59 159.79 16.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.946 . . . . 2.7799999999999998 109.66 -179.709 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.01 77.52 1.03 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.447 . . . . 2.48 109.484 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 58' ' ' VAL . 55.2 t -149.85 60.91 4.71 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.142 . . . . 3.79 109.556 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 58' ' ' VAL . 50.5 Cg_exo -48.57 142.59 17.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.775 2.316 . . . . 2.3999999999999999 112.102 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 3.0 t -134.45 153.97 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 3.0800000000000001 109.629 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -136.04 112.34 0.96 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.461 -1.455 . . . . 3.0499999999999998 109.461 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.2 tm-20 -39.06 135.11 0.97 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.144 . . . . 6.0499999999999998 109.668 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 115' ' ' SER . . . 97.22 -14.36 63.7 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.885 -1.286 . . . . 2.54 109.885 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' HB2' ' A' ' 115' ' ' SER . 2.2 mm-40 -100.79 157.45 16.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 4.0300000000000002 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.8 m -118.96 121.37 39.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 2.9100000000000001 109.176 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 51.7 m-85 -98.19 178.54 5.04 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.203 -0.935 . . . . 2.3799999999999999 109.743 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -163.61 133.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 2.6099999999999999 109.41 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -118.18 122.03 42.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 3.6099999999999999 109.736 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 2.4 p -112.2 100.25 8.68 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.88 -0.785 . . . . 2.27 108.88 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 2.2 p90 -93.96 146.31 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 2.0099999999999998 110.95 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -99.63 107.01 19.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.124 -1.065 . . . . 1.8 108.124 178.534 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 141' ' ' PHE . . . -157.52 156.26 31.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.697 -1.252 . . . . 0.95999999999999996 110.862 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' GLU . 97.0 p -132.27 121.48 23.66 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.856 -0.794 . . . . 0.93000000000000005 108.856 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' O ' ' O ' ' A' ' 76' ' ' PRO . . . -81.53 129.91 34.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.817 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.463 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -130.81 116.92 17.17 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.382 -0.824 . . . . 0.96999999999999997 109.287 179.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.591 ' O ' ' O ' ' A' ' 74' ' ' ALA . 36.5 Cg_endo -66.35 -144.77 0.18 OUTLIER 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.104 -1.207 . . . . 1.02 111.998 0.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' ' CG ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.03 154.62 19.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.698 -1.251 . . . . 1.75 109.39 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.657 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 157.17 154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.385 -0.822 . . . . 2.1600000000000001 109.264 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.552 ' O ' ' OH ' ' A' ' 139' ' ' TYR . 68.0 Cg_endo -77.55 141.96 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.821 2.347 . . . . 1.3799999999999999 112.356 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' A' ' 98' ' ' GLY . 35.1 m -108.4 170.3 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 2.0099999999999998 109.362 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 132' ' ' HIS . 0.1 OUTLIER -109.85 156.18 20.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 6.0099999999999998 109.437 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 83' ' ' LEU . 2.7 p -156.94 159.31 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.295 -0.878 . . . . 3.7599999999999998 109.51 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.693 HD21 ' ND1' ' A' ' 132' ' ' HIS . 0.5 OUTLIER -154.66 143.67 21.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 2.29 109.702 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.692 ' CG1' HG22 ' A' ' 129' ' ' VAL . 0.4 OUTLIER -153.79 161.18 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 1.8899999999999999 109.467 179.954 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 133.77 -164.56 24.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 1.49 109.548 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.687 ' OE2' ' CZ ' ' A' ' 119' ' ' PHE . 12.7 pm0 -84.08 35.54 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -1.122 . . . . 2.54 109.428 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' O ' ' OE1' ' A' ' 128' ' ' GLN . . . -41.41 86.63 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.636 -1.386 . . . . 1.3799999999999999 109.636 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 86' ' ' GLU . . . -139.76 59.53 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.627 -1.389 . . . . 2.54 109.627 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.664 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 56.0 123.48 0.01 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.482 -1.447 . . . . 4.1399999999999997 109.482 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 62.89 -49.7 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 5.1299999999999999 109.392 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 89' ' ' GLY . 40.3 m-85 -53.86 79.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 5.79 109.39 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.68 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -48.09 -175.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 5.7400000000000002 109.789 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.622 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -144.05 -172.34 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.887 . . . . 2.27 109.984 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -125.28 -23.39 4.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.89 -0.781 . . . . 3.2799999999999998 108.89 179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -90.47 42.52 1.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 3.6499999999999999 109.254 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' CD ' ' O ' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.87 49.4 1.78 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.988 -1.07 . . . . 4.5999999999999996 109.482 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -112.52 153.87 26.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 3.46 109.234 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . -140.21 4.33 2.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 3.6699999999999999 109.576 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -77.28 62.31 2.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 3.79 109.451 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.47 ' CB ' ' OH ' ' A' ' 111' ' ' TYR . . . -104.7 106.71 55.9 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 1.96 109.324 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.726 ' O ' HD22 ' A' ' 102' ' ' LEU . 60.6 Cg_endo -78.63 123.44 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.576 2.184 . . . . 2.9700000000000002 112.676 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 101' ' ' PRO . 4.3 mm? -124.32 173.24 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 3.0600000000000001 109.358 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -138.11 -174.11 3.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 2.3399999999999999 109.788 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -86.78 42.39 3.15 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.626 -1.389 . . . . 2.1699999999999999 109.626 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.9 mt-10 -162.24 160.95 21.15 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -1.117 . . . . 3.02 109.114 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -53.5 115.58 2.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.641 2.227 . . . . 1.4199999999999999 111.715 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -150.39 124.65 9.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 1.3700000000000001 109.754 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.49 150.28 21.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.809 . . . . 1.72 109.994 179.763 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.671 ' NH2' ' O ' ' A' ' 110' ' ' GLU . 0.4 OUTLIER -131.4 143.08 50.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.706 -1.22 . . . . 4.7000000000000002 107.706 178.246 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.671 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 5.3 mt-10 -127.32 128.26 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.374 -0.93 . . . . 3.2799999999999998 110.814 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' CB ' ' A' ' 100' ' ' ALA . 6.9 m-85 -124.56 119.08 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.655 -0.869 . . . . 2.96 108.655 178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.625 ' HB2' HG23 ' A' ' 67' ' ' VAL . . . -106.34 146.85 29.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 3.4100000000000001 110.007 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.728 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -130.92 164.68 24.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 2.77 109.267 179.681 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.4 122.4 43.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 2.23 109.819 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.495 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 6.1 m -59.77 129.83 43.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 4.1100000000000003 109.393 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -114.99 -19.81 10.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 6.8600000000000003 109.551 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.892 ' H ' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -142.44 -153.1 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 5.1200000000000001 109.276 179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.56 148.4 47.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.246 -0.909 . . . . 4.0599999999999996 109.687 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.818 ' CE2' HD13 ' A' ' 117' ' ' LEU . 44.4 m-85 -147.47 91.46 5.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 5.4400000000000004 109.302 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.84 165.74 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.815 2.343 . . . . 4.04 112.227 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 -15.5 12.0 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.697 2.265 . . . . 3.8999999999999999 112.02 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.83 132.42 54.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -0.873 . . . . 4.1399999999999997 109.549 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.28 -148.05 19.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 3.5699999999999998 109.525 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.5 30.0 7.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 3.5899999999999999 109.441 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 91' ' ' TYR . . . -177.85 70.0 0.21 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 2.0800000000000001 109.437 179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.55 -158.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.842 2.361 . . . . 1.3899999999999999 112.185 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.38 149.91 50.96 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.528 -1.429 . . . . 1.1899999999999999 109.528 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.566 ' OE1' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -148.09 128.02 13.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 2.0099999999999998 109.536 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.692 HG22 ' CG1' ' A' ' 84' ' ' VAL . 32.8 t -138.75 137.45 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.465 -0.939 . . . . 1.28 108.465 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 83' ' ' LEU . . . -155.24 109.74 2.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.186 -1.006 . . . . 0.97999999999999998 110.262 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -80.6 103.53 10.52 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.847 -0.797 . . . . 1.73 108.847 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.693 ' ND1' HD21 ' A' ' 83' ' ' LEU . 7.0 m170 -99.58 128.77 45.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.935 . . . . 2.3199999999999998 109.713 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -137.69 -32.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 2.1099999999999999 109.449 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.554 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -39.6 131.96 2.24 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.566 -1.414 . . . . 1.77 109.566 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.858 ' N ' ' HB2' ' A' ' 138' ' ' ALA . 47.2 mttt -165.6 140.4 4.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 5.0599999999999996 109.594 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -39.82 -20.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 2.6400000000000001 108.565 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -124.51 12.93 7.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.112 -1.595 . . . . 2.5099999999999998 109.112 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.858 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -50.42 -164.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.434 -1.039 . . . . 2.3199999999999998 109.898 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.556 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 1.1 p90 -166.61 -161.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 1.6100000000000001 109.385 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -81.67 151.31 27.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 1.6499999999999999 109.733 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 72' ' ' ALA . 12.8 t80 -137.19 113.36 9.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.893 . . . . 1.6799999999999999 109.319 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 13.7 m -106.14 96.53 6.54 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.128 -0.983 . . . . 0.73999999999999999 110.154 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.509 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.05 139.05 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 1.22 108.954 179.349 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.673 ' OG ' ' NE2' ' A' ' 145' ' ' GLN . 78.3 p -132.81 -14.03 2.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.563 -0.711 . . . . 1.3300000000000001 109.715 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.673 ' NE2' ' OG ' ' A' ' 144' ' ' SER . 0.8 OUTLIER -147.9 164.59 33.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.069 -1.019 . . . . 3.2999999999999998 110.146 -179.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.591 HG11 ' CH2' ' A' ' 22' ' ' TRP . 8.7 p -178.51 126.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.935 -0.765 . . . . 2.2599999999999998 108.935 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.48 147.73 40.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.068 -1.02 . . . . 2.7599999999999998 110.076 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 9' ' ' LEU . 32.2 tp -116.72 135.6 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 4.5700000000000003 109.231 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 150' ' ' THR . 0.1 OUTLIER -150.68 -177.25 5.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.025 . . . . 3.0699999999999998 109.725 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.817 HG23 ' N ' ' A' ' 151' ' ' SER . 2.7 t -133.6 -152.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 2.0 109.576 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.817 ' N ' HG23 ' A' ' 150' ' ' THR . 0.9 OUTLIER -118.01 127.72 54.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.835 . . . . 2.1499999999999999 109.49 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.557 ' O ' ' O ' ' A' ' 151' ' ' SER . . . -38.21 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 2.8199999999999998 109.526 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.002 -0.999 . . . . 3.54 109.467 -179.95 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.458 -0.571 . . . . 7.8399999999999999 109.458 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.564 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 1.7 p 52.24 -74.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 5.3899999999999997 108.956 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.761 ' N ' ' O ' ' A' ' 1' ' ' ALA . 3.9 tp 69.5 -153.43 0.14 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.288 -0.882 . . . . 5.5300000000000002 110.048 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 5' ' ' SER . 8.5 m-20 -43.19 156.71 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.387 -0.821 . . . . 4.4299999999999997 109.06 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER 71.12 111.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 3.0699999999999998 109.53 -179.847 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB3' HG21 ' A' ' 149' ' ' THR . 6.8 mp0 -71.21 135.88 47.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.152 -0.967 . . . . 3.6800000000000002 109.184 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 150' ' ' THR . 1.8 t -66.48 77.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.024 . . . . 1.73 109.39 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 6' ' ' GLU . 1.4 tp10 -67.7 79.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.858 . . . . 2.7400000000000002 109.715 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.81 -14.27 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.898 . . . . 1.72 109.19 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 12' ' ' HIS . 1.1 tm? -126.38 85.88 59.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 1.96 108.874 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.91 37.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.154 2.57 . . . . 1.8700000000000001 112.391 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.712 ' H ' HD13 ' A' ' 10' ' ' LEU . 57.2 t60 -145.53 101.1 3.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 1.26 109.315 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 13' ' ' THR . 7.7 t -142.37 52.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.267 -0.895 . . . . 1.0900000000000001 109.453 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -139.38 68.11 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 1.8799999999999999 109.609 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -67.1 30.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 1.3200000000000001 109.127 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 14' ' ' SER . . . -90.25 -36.07 14.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 1.0800000000000001 110.196 -179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.564 ' O ' ' CD2' ' A' ' 32' ' ' PHE . 3.0 mm-40 -109.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 2.9700000000000002 110.137 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -99.38 151.29 21.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 1.6499999999999999 109.87 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.817 ' CD2' HD21 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -59.37 -60.02 4.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.845 . . . . 1.95 109.304 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.503 ' HA3' ' CD2' ' A' ' 12' ' ' HIS . . . 116.37 -164.32 12.32 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.523 -1.431 . . . . 0.67000000000000004 109.523 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' CD2' ' A' ' 12' ' ' HIS . 57.7 Cg_endo -76.55 -2.71 12.95 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.834 2.356 . . . . 0.70999999999999996 112.276 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.557 ' CD2' ' HB2' ' A' ' 55' ' ' TYR . 11.8 m95 -75.13 -177.09 3.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.89 . . . . 0.56999999999999995 109.321 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -140.07 175.84 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.83999999999999997 109.295 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.817 HD21 ' CD2' ' A' ' 19' ' ' LEU . 1.8 pp -179.29 164.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 1.9099999999999999 109.938 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.675 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER 162.71 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 2.6499999999999999 109.718 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.61 -21.97 9.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.038 -1.225 . . . . 0.57999999999999996 110.038 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.879 ' OG1' ' N ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -109.69 -142.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.287 . . . . 0.56999999999999995 109.49 179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.879 ' N ' ' OG1' ' A' ' 27' ' ' THR . 5.2 p -91.78 -175.87 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.92000000000000004 108.984 179.389 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -81.02 111.65 25.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 2.5899999999999999 108.815 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 28' ' ' SER . 54.1 Cg_exo -49.26 155.02 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.317 2.011 . . . . 0.88 111.855 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' MET . 44.9 t -142.41 106.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 1.1599999999999999 109.986 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.698 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -76.68 82.92 3.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 1.3700000000000001 109.128 179.127 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.569 ' O ' ' O ' ' A' ' 32' ' ' PHE . . . -56.32 -140.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.72999999999999998 109.938 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 33' ' ' ALA . 2.6 m-20 -41.47 -65.8 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 2.4900000000000002 109.448 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . -147.88 26.34 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.299 -1.52 . . . . 0.81999999999999995 109.299 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -141.03 145.02 35.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -1.122 . . . . 3.4700000000000002 109.641 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 30' ' ' PRO . 45.4 ttp -112.85 127.35 56.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 1.4399999999999999 109.128 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.606 ' SG ' ' O ' ' A' ' 141' ' ' PHE . 0.3 OUTLIER -121.3 156.82 31.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 1.22 110.346 -179.358 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 HD23 ' A' ' 41' ' ' LEU . 2.2 m -125.61 142.23 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.685 -0.857 . . . . 0.53000000000000003 108.685 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.784 ' C ' HD22 ' A' ' 41' ' ' LEU . 5.7 m-20 -77.26 111.98 13.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 1.52 109.817 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD22 ' C ' ' A' ' 40' ' ' ASP . 4.6 mm? -122.87 68.56 34.27 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 1.4299999999999999 109.408 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.99 -92.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.835 2.357 . . . . 1.9299999999999999 112.308 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.79 165.07 36.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.53 -1.428 . . . . 2.02 109.53 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.86 -9.02 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 1.7 109.482 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.684 HE22 ' HB2' ' A' ' 51' ' ' ALA . 16.3 mt-30 -99.87 119.03 37.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 2.0800000000000001 109.522 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.52 46.94 1.18 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.513 -1.435 . . . . 2.0299999999999998 109.513 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -171.25 102.95 0.39 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.174 -1.192 . . . . 2.29 109.67 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -47.32 -26.11 5.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.322 . . . . 1.5800000000000001 112.363 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.646 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 27.0 p90 -93.98 44.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 3.3399999999999999 109.665 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.48 ' CG ' ' CG ' ' A' ' 47' ' ' ASN . 1.9 m-20 -131.35 11.88 4.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 1.97 109.343 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.684 ' HB2' HE22 ' A' ' 45' ' ' GLN . . . -174.3 140.63 0.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.345 -0.847 . . . . 0.91000000000000003 109.269 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 131' ' ' PHE . . . 146.57 -174.36 26.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.678 -1.369 . . . . 0.59999999999999998 109.678 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' C ' HG22 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -104.21 -173.57 2.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -1.197 . . . . 1.6499999999999999 109.921 -179.953 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -164.54 172.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.573 -0.704 . . . . 1.48 109.376 -179.767 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CZ ' ' O ' ' A' ' 56' ' ' ASN . 17.8 t80 170.48 142.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 1.4399999999999999 109.664 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.635 ' O ' ' CZ ' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -103.27 -164.72 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.252 -0.905 . . . . 0.94999999999999996 109.469 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 58' ' ' VAL . . . 79.72 68.89 1.44 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.411 -1.476 . . . . 0.83999999999999997 109.411 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 57' ' ' GLY . 43.4 t -153.93 73.82 6.38 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.33 -1.1 . . . . 1.6299999999999999 109.544 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.25 120.85 7.66 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.553 2.169 . . . . 0.83999999999999997 112.043 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.39 130.19 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.226 -0.921 . . . . 1.1599999999999999 109.663 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 62' ' ' GLU . . . -113.08 102.52 1.29 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.81999999999999995 109.362 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.567 ' O ' ' OE1' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -42.8 124.76 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 2.73 109.598 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.02 -39.18 2.14 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.77 -1.332 . . . . 0.98999999999999999 109.77 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.534 ' O ' ' OG ' ' A' ' 115' ' ' SER . 10.3 mt-10 -100.22 170.12 8.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -1.147 . . . . 2.5899999999999999 109.697 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 m -116.85 145.14 43.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.81999999999999995 109.269 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 33.3 m-85 -110.84 179.49 4.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.123 -0.986 . . . . 1.47 109.671 -179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.424 ' CG2' ' C ' ' A' ' 66' ' ' TYR . 2.3 t -152.78 149.71 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.98999999999999999 109.316 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 109' ' ' ARG . 3.4 tp -134.06 116.96 16.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.85999999999999999 109.858 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 83.2 p -109.4 85.85 2.18 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.464 -0.939 . . . . 1.1499999999999999 108.464 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 49.9 p90 -92.61 137.08 32.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 1.05 111.275 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.644 ' OG1' ' N ' ' A' ' 145' ' ' GLN . 1.3 p -84.24 114.41 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.193 -1.04 . . . . 0.72999999999999998 108.193 178.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.57 148.04 15.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.781 -1.199 . . . . 0.69999999999999996 110.671 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 131.12 39.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.689 -0.856 . . . . 0.78000000000000003 108.689 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.774 ' HB1' ' CE2' ' A' ' 139' ' ' TYR . . . -93.36 127.57 39.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 109.728 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.497 ' CA ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -134.19 114.39 12.64 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.307 -0.871 . . . . 0.60999999999999999 109.261 179.882 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.635 ' O ' ' C ' ' A' ' 74' ' ' ALA . 17.4 Cg_exo -65.74 -141.98 0.15 OUTLIER 'Cis proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.895 -1.294 . . . . 0.80000000000000004 112.407 -0.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.663 ' O ' ' CG ' ' A' ' 78' ' ' MET . 1.4 m-20 -98.94 160.15 14.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.87 . . . . 1.3999999999999999 109.634 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.663 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER 156.91 155.83 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.85 . . . . 1.9299999999999999 109.268 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.62 145.3 41.5 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.884 2.389 . . . . 0.79000000000000004 112.376 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.112 HG11 HD12 ' A' ' 102' ' ' LEU . 0.7 OUTLIER -117.45 172.7 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.76000000000000001 109.222 179.939 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.483 ' N ' HG23 ' A' ' 80' ' ' VAL . 20.0 ttt180 -119.69 134.36 55.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.93 . . . . 3.0499999999999998 109.6 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.527 ' O ' ' O ' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -137.99 150.13 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 1.55 109.248 179.795 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -145.99 152.33 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.85999999999999999 109.832 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.756 HG13 HG22 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -154.95 154.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.923 . . . . 0.56999999999999995 109.632 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 128' ' ' GLN . . . 148.33 -149.04 21.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.653 -1.379 . . . . 0.57999999999999996 109.653 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.76 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.9 pm0 -90.08 178.38 6.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 2.7400000000000002 109.715 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.08 62.63 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.544 -1.422 . . . . 1.6299999999999999 109.544 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.543 ' HA3' ' HB2' ' A' ' 125' ' ' ALA . . . 164.36 115.02 0.31 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.467 -1.453 . . . . 2.2000000000000002 109.467 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 91' ' ' TYR . . . 87.65 117.83 1.27 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 2.4700000000000002 109.397 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 92' ' ' ARG . . . 62.16 -39.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -1.179 . . . . 2.73 109.102 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.699 ' N ' ' O ' ' A' ' 89' ' ' GLY . 78.5 m-85 60.6 -42.64 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.436 -0.79 . . . . 5.7400000000000002 109.825 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.871 ' CB ' HH11 ' A' ' 92' ' ' ARG . 0.0 OUTLIER -33.6 132.19 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.974 . . . . 3.4199999999999999 109.452 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -125.78 -171.37 2.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.96999999999999997 109.814 -179.815 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.665 ' N ' ' OG1' ' A' ' 93' ' ' THR . . . -118.45 -24.06 6.96 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.904 -0.776 . . . . 0.94999999999999996 108.904 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -90.49 41.36 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -0.958 . . . . 1.6299999999999999 108.719 179.915 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.46 64.75 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.971 . . . . 2.7799999999999998 109.886 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' VAL . 4.0 pt20 -109.08 153.9 23.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 2.2799999999999998 109.177 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.6 11.61 4.3 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.8 -1.32 . . . . 0.94999999999999996 109.8 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 m -105.36 77.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -1.181 . . . . 0.88 109.388 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.797 ' HB3' HG22 ' A' ' 80' ' ' VAL . . . -119.81 79.53 24.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.943 . . . . 0.58999999999999997 109.677 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -52.75 126.45 21.18 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.882 2.388 . . . . 0.73999999999999999 112.384 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.112 HD12 HG11 ' A' ' 80' ' ' VAL . 20.6 mt -133.02 137.78 46.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 1.1699999999999999 109.326 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 104' ' ' GLY . 0.1 OUTLIER -109.06 -179.33 3.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 1.0800000000000001 109.477 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.473 ' N ' ' OG1' ' A' ' 103' ' ' THR . . . -84.63 40.56 2.97 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.525 -1.43 . . . . 1.3500000000000001 109.525 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.38 120.59 12.66 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -1.111 . . . . 3.4900000000000002 109.402 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.35 118.42 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.391 2.06 . . . . 0.97999999999999998 111.806 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -160.85 141.96 11.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.48 109.904 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.491 HG23 HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -91.0 138.57 31.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.774 . . . . 0.96999999999999997 109.706 179.763 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 69' ' ' SER . 18.4 mmt180 -109.03 136.62 48.25 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.052 -1.03 . . . . 4.1799999999999997 108.685 178.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 10.4 mt-10 -113.95 103.36 11.08 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.181 -0.607 . . . . 2.3799999999999999 109.698 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 16.1 m-85 -109.13 120.09 41.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 1.51 108.424 179.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.45 156.53 25.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.306 -0.872 . . . . 0.87 109.923 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.0 p90 -144.78 178.98 7.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.456 -0.778 . . . . 1.8300000000000001 109.161 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.45 ' O ' ' OD1' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -105.4 115.8 30.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.448 -0.782 . . . . 1.0900000000000001 109.633 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 64' ' ' GLU . 10.7 m -48.82 123.2 6.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.907 . . . . 1.6200000000000001 109.418 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 114' ' ' THR . 16.0 m120 -113.97 -38.25 4.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 2.3900000000000001 109.571 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -112.93 143.21 44.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 2.54 109.618 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.67 103.99 11.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 1.0800000000000001 109.54 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.668 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 43.5 m-85 -112.26 95.97 33.07 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 1.9299999999999999 109.247 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.56 166.15 24.25 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.682 2.254 . . . . 1.21 112.274 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.54 -19.61 8.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.9 2.4 . . . . 1.5800000000000001 111.934 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.1 136.64 54.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 3.5 109.457 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.84 -111.87 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 2.0899999999999999 109.548 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.37 -17.56 14.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -1.128 . . . . 3.6699999999999999 109.418 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' HB2' ' HA3' ' A' ' 88' ' ' GLY . . . -167.38 122.31 0.84 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 2.1000000000000001 109.384 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.63 -159.74 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.542 2.162 . . . . 1.72 112.195 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 58' ' ' VAL . . . -57.87 168.59 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.78000000000000003 109.493 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -155.21 135.08 12.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 2.1899999999999999 109.433 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.756 HG22 HG13 ' A' ' 84' ' ' VAL . 41.3 t -141.12 148.79 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.4299999999999999 108.769 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.27 105.77 0.66 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.101 -0.999 . . . . 0.46999999999999997 110.029 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 7.7 m-30 -83.56 109.99 17.86 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.33 -0.989 . . . . 1.3799999999999999 108.33 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.418 ' CE1' HD21 ' A' ' 83' ' ' LEU . 44.4 m170 -99.38 120.23 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.945 . . . . 1.1399999999999999 110.084 -179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.839 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -129.97 -7.56 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 1.1499999999999999 109.141 179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 135' ' ' LYS . . . -57.69 126.03 41.02 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.401 -1.48 . . . . 1.27 109.401 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.708 ' O ' ' N ' ' A' ' 138' ' ' ALA . 11.0 mtpt -161.55 128.23 3.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -1.187 . . . . 4.7400000000000002 109.987 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 135' ' ' LYS . . . -43.08 -18.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.94 -1.133 . . . . 1.5900000000000001 107.94 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.703 ' O ' ' O ' ' A' ' 138' ' ' ALA . . . -118.27 10.14 13.29 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.837 -1.705 . . . . 1.6100000000000001 108.837 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.708 ' N ' ' O ' ' A' ' 135' ' ' LYS . . . -48.76 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.61 -0.936 . . . . 1.6899999999999999 109.858 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.828 ' OH ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -168.74 -114.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.082 -1.012 . . . . 2.0 110.038 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.4 mt-10 -130.8 138.48 49.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 2.2999999999999998 109.235 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CG ' ' CD2' ' A' ' 133' ' ' LEU . 12.2 t80 -117.35 116.62 27.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 1.47 109.595 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.01 98.38 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.44 110.043 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -114.06 141.67 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.81999999999999995 109.256 179.548 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 86.5 p -130.74 -10.68 3.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.682 -0.636 . . . . 0.64000000000000001 109.346 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.644 ' N ' ' OG1' ' A' ' 71' ' ' THR . 3.8 mt-30 -148.37 177.41 9.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 1.9399999999999999 110.359 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.606 ' O ' ' CG1' ' A' ' 146' ' ' VAL . 1.1 p -179.17 117.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 1.1499999999999999 108.821 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.57 ' OG ' ' OG ' ' A' ' 69' ' ' SER . 60.1 p -124.6 151.17 45.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.013 -1.054 . . . . 1.6100000000000001 110.123 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.957 HD12 ' N ' ' A' ' 149' ' ' THR . 0.2 OUTLIER -135.67 122.39 21.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.458 -0.776 . . . . 1.3 108.968 179.728 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.957 ' N ' HD12 ' A' ' 148' ' ' LEU . 1.2 t -148.21 -159.97 1.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.053 -1.03 . . . . 1.21 109.666 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.624 ' N ' ' OG1' ' A' ' 149' ' ' THR . 1.2 t -141.59 -41.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.332 -0.855 . . . . 1.77 109.33 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.543 ' N ' ' CG2' ' A' ' 150' ' ' THR . 1.1 t 41.58 64.31 1.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.443 -0.785 . . . . 3.2599999999999998 109.311 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.552 ' N ' ' OG ' ' A' ' 2' ' ' SER . . . -71.1 140.22 50.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 4.71 109.504 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.081 -0.961 . . . . 7.5700000000000003 109.382 179.93 . . . . . . . . 0 0 . 1 stop_ save_